data_2k6w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k6w _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 113.402 0.889 . . . . 5.0899999999999999 113.402 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -162.38 -179.2 36.83 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 126.021 1.772 . . . . 1.3899999999999999 115.407 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -127.91 140.49 51.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.406 0.682 . . . . 2.3199999999999998 112.835 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.9 t -83.06 138.5 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.877 -1.157 . . . . 1.9299999999999999 107.877 160.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -83.87 119.75 25.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.162 -0.961 . . . . 4.3200000000000003 112.448 -164.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.03 129.13 20.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.116 1.366 . . . . 4.4900000000000002 110.619 163.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m 179.24 111.31 0.18 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.075 1.75 . . . . 2.4399999999999999 110.316 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -84.41 48.72 2.53 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.006 3.138 . . . . 2.27 110.181 167.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.65 -174.67 27.01 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.405 1.002 . . . . 1.6299999999999999 113.037 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.06 -17.01 28.63 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.685 2.256 . . . . 1.99 111.529 163.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -150.28 169.06 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.403 1.881 . . . . 2.2999999999999998 113.019 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.9 -159.59 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.469 2.307 . . . . 2.1699999999999999 109.422 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.06 166.07 27.2 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.732 1.213 . . . . 1.8799999999999999 111.247 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.72 133.58 40.11 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 1.8 111.753 162.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -120.96 148.15 44.49 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.89 2.076 . . . . 3.7200000000000002 109.707 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -169.84 154.67 5.39 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.482 1.29 . . . . 2.3300000000000001 114.482 174.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 m -74.39 143.61 44.72 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.429 1.092 . . . . 2.4300000000000002 108.655 157.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.53 130.59 21.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.706 -1.22 . . . . 2.9100000000000001 107.706 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.16 142.86 32.76 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.882 0.873 . . . . 4.2300000000000004 111.203 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -102.46 110.75 63.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.458 1.503 . . . . 0.90000000000000002 110.526 -168.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.04 -10.51 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.229 1.952 . . . . 1.04 113.524 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.51 169.71 54.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.262 0.937 . . . . 0.83999999999999997 113.673 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.471 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.3 m-20 -98.01 -4.99 35.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.93 1.692 . . . . 2.5299999999999998 112.89 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.79 159.61 38.3 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 126.053 1.741 . . . . 2.2999999999999998 109.856 167.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.75 159.02 28.13 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.889 2.392 . . . . 1.01 112.038 -169.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.43 154.16 19.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.213 1.005 . . . . 3.25 110.262 168.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 68' ' ' GLU . 36.8 ttm180 -137.95 109.35 6.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.789 1.236 . . . . 3.8799999999999999 108.814 168.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -88.76 106.92 18.68 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.639 2.376 . . . . 1.6799999999999999 108.952 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.36 -11.56 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.378 1.071 . . . . 1.6000000000000001 112.705 -172.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.86 -168.86 40.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.364 0.983 . . . . 0.56999999999999995 111.904 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.25 -179.73 7.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.571 1.148 . . . . 1.72 109.17 163.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -159.52 137.92 10.55 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 119.038 0.836 . . . . 5.5599999999999996 109.286 -167.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 161.15 48.9 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.741 1.155 . . . . 1.6599999999999999 109.92 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.91 -29.56 15.05 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.891 1.727 . . . . 0.93000000000000005 113.583 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.0 m -81.01 0.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.12 1.526 . . . . 1.8600000000000001 115.12 -166.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 160.54 39.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.656 1.182 . . . . 1.96 112.24 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -96.96 -82.07 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.777 1.231 . . . . 2.77 111.298 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -80.59 101.02 8.92 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 120.301 -1.499 . . . . 4.2599999999999998 108.954 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 p -84.78 137.21 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 125.977 1.711 . . . . 1.99 111.365 165.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -141.63 132.5 25.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.782 1.633 . . . . 2.0800000000000001 110.753 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -82.98 123.25 29.26 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 121.088 1.767 . . . . 1.6299999999999999 111.713 168.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -110.43 152.23 26.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.181 1.792 . . . . 0.66000000000000003 112.701 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -85.06 166.13 16.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.005 1.722 . . . . 2.1699999999999999 110.193 158.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.1 m -147.51 126.25 12.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 2.6499999999999999 107.481 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -140.12 164.24 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.925 0.713 . . . . 3.4199999999999999 112.925 -151.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -110.2 138.51 46.48 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.418 0.687 . . . . 4.0300000000000002 110.18 153.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -145.27 155.29 43.14 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.879 1.672 . . . . 8.2899999999999991 109.213 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.32 150.96 20.54 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.677 0.791 . . . . 3.73 110.197 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.5 t -130.89 -97.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.428 1.091 . . . . 3.0600000000000001 109.619 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.54 45.12 0.38 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.92 2.088 . . . . 3.2799999999999998 111.584 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.36 -5.55 5.21 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.776 -1.202 . . . . 1.76 113.623 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -106.08 147.77 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.182 2.193 . . . . 3.5099999999999998 109.946 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -76.28 138.42 40.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.557 0.743 . . . . 4.7000000000000002 111.229 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -137.31 151.63 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.286 1.834 . . . . 2.5 109.288 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mtm -127.4 145.35 50.85 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.288 1.035 . . . . 4.0999999999999996 111.775 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.85 37.07 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.509 1.052 . . . . 1.53 113.483 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -123.27 168.07 12.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.381 1.872 . . . . 2.7599999999999998 111.068 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.16 131.93 0.45 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 116.361 -1.78 . . . . 5.25 111.882 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.72 142.47 58.21 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 122.533 1.94 . . . . 0.69999999999999996 112.553 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.43 160.26 44.56 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.22 1.808 . . . . 1.54 110.376 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.6 -20.15 20.72 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.354 2.036 . . . . 0.76000000000000001 113.17 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -176.27 168.1 2.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.959 1.254 . . . . 2.9700000000000002 112.018 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -116.58 173.81 6.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.445 2.298 . . . . 1.8999999999999999 109.128 153.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.414 ' CD ' HH21 ' A' ' 31' ' ' ARG . 8.3 pt-20 -156.61 166.62 32.87 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.058 -1.026 . . . . 1.96 112.731 176.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 132.15 8.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.104 0.962 . . . . 1.78 109.154 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.4 165.9 30.16 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.577 1.518 . . . . 0.89000000000000001 110.762 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.43 138.71 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.194 2.596 . . . . 0.89000000000000001 111.144 171.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.471 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 59.2 mmtt 68.45 -2.69 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.011 1.724 . . . . 2.0800000000000001 113.883 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.91 -172.67 45.12 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 126.187 1.851 . . . . 0.98999999999999999 113.423 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -152.15 149.11 28.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.056 1.742 . . . . 5.5999999999999996 111.621 -171.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.04 142.08 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.616 1.567 . . . . 3.4399999999999999 108.551 161.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -106.1 123.17 47.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.966 0.803 . . . . 3.8199999999999998 109.735 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.31 69.7 0.56 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.347 1.459 . . . . 1.78 108.194 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -81.4 145.62 55.82 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.461 2.305 . . . . 3.7000000000000002 109.694 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.7 -42.7 65.99 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.148 2.566 . . . . 0.91000000000000003 112.501 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.75 59.99 4.24 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.814 0.734 . . . . 1.0800000000000001 112.171 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.63 -70.3 0.05 OUTLIER Glycine 0 N--CA 1.468 0.786 0 C-N-CA 124.053 0.835 . . . . 1.04 114.371 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -155.16 147.18 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.835 1.654 . . . . 3.0699999999999998 109.367 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -165.25 174.87 9.75 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.022 -1.049 . . . . 1.1599999999999999 110.921 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.59 132.31 50.98 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.724 -0.473 . . . . 3.1200000000000001 109.724 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -80.89 135.81 35.97 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.134 0.574 . . . . 1.6399999999999999 110.143 159.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.42 98.36 6.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.143 1.377 . . . . 2.5499999999999998 109.411 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -102.38 142.94 32.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.828 0.851 . . . . 3.3500000000000001 111.162 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.66 75.0 0.73 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.398 -1.081 . . . . 1.3100000000000001 110.398 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.2 124.11 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 117.271 0.536 . . . . 1.8700000000000001 112.142 -170.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -82.33 -6.31 59.17 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.001 0.741 . . . . 2.21 113.001 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -154.32 150.04 21.51 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.48 2.312 . . . . 4.8200000000000003 108.366 158.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.28 134.57 45.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.934 1.756 . . . . 1.8200000000000001 108.249 168.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.75 119.73 20.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.922 -0.399 . . . . 3.25 109.922 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -105.5 124.0 48.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.296 1.839 . . . . 4.3899999999999997 109.987 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.98 48.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.666 0.666 . . . . 3.0299999999999998 109.731 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 34.77 31.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 120.025 -0.319 . . . . 2.25 113.25 -167.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.99 174.27 6.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.929 -1.137 . . . . 2.8500000000000001 107.929 148.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.8 151.11 37.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.628 1.171 . . . . 3.54 108.309 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.6 t -127.53 126.99 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.901 1.281 . . . . 2.0600000000000001 109.698 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.457 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 15.0 mt-10 -75.08 142.31 43.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.255 1.026 . . . . 2.7799999999999998 111.349 161.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.37 114.12 5.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.931 -1.031 . . . . 2.6899999999999999 111.361 -172.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.02 93.84 8.17 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.028 2.531 . . . . 2.1200000000000001 109.968 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.2 mt -71.53 121.88 19.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.151 0.98 . . . . 2.02 110.678 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -95.76 128.22 42.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 1.54 111.674 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.54 137.44 52.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.419 0.687 . . . . 3.0099999999999998 112.101 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.02 130.28 21.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.342 1.457 . . . . 2.3599999999999999 114.311 -165.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.3 -144.94 22.8 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.986 -1.246 . . . . 3.0499999999999998 109.986 -164.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.27 54.44 1.54 Allowed Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.734 -1.037 . . . . 2.3799999999999999 114.135 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -120.24 140.28 51.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.863 1.831 . . . . 5.1200000000000001 111.161 168.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.45 137.45 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 125.741 1.616 . . . . 1.8700000000000001 107.581 164.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.8 mt -128.32 111.5 13.43 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.482 1.113 . . . . 2.2999999999999998 108.601 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.457 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 25.5 ttpt -81.17 122.57 27.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.352 -0.217 . . . . 3.1299999999999999 111.584 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.97 164.39 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.808 1.643 . . . . 1.99 110.237 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.55 146.08 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.969 0.908 . . . . 2.98 109.034 166.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -136.3 145.54 52.35 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.08 1.352 . . . . 2.3500000000000001 109.234 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -68.2 154.75 71.59 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.562 2.175 . . . . 0.98999999999999999 110.388 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.657 -0.868 . . . . 1.98 108.657 165.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.03 157.76 43.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.537 1.135 . . . . 3.02 110.606 -171.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.11 72.13 1.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.969 1.707 . . . . 2.3100000000000001 112.511 -168.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.0 0 C-N-CA 124.735 1.214 . . . . 5.71 110.344 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 CA--C 1.544 0.748 0 CA-C-O 119.234 -0.412 . . . . 6.1299999999999999 111.017 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.71 167.66 21.45 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 125.127 1.346 . . . . 1.6599999999999999 114.55 172.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.3 p90 -163.08 158.23 21.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.353 2.261 . . . . 1.9199999999999999 110.648 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.35 139.58 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.81 -0.556 . . . . 2.0499999999999998 110.218 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -77.73 128.93 34.84 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.307 -0.406 . . . . 6.6200000000000001 111.507 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.7 143.69 3.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.655 1.182 . . . . 3.6699999999999999 111.769 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -163.44 135.97 4.07 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.554 0.576 . . . . 3.8599999999999999 112.554 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.18 0.45 4.15 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.546 3.497 . . . . 2.73 112.447 163.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.3 171.54 25.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.922 1.249 . . . . 1.49 114.626 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.1 -13.98 18.98 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.478 3.452 . . . . 1.8300000000000001 113.861 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -122.16 163.29 19.79 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.068 0.947 . . . . 3.4700000000000002 111.863 166.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.52 178.55 10.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.292 1.437 . . . . 2.1099999999999999 111.328 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.49 139.05 46.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.591 1.557 . . . . 2.6299999999999999 111.957 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.02 150.11 48.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.161 1.385 . . . . 2.0600000000000001 112.118 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -136.09 148.51 48.32 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.551 1.541 . . . . 3.4500000000000002 109.308 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.63 152.52 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 2.6899999999999999 114.816 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 m -79.62 120.44 23.96 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 126.094 1.757 . . . . 2.5699999999999998 109.652 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.67 113.03 26.35 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.383 -0.969 . . . . 3.48 108.383 166.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -122.88 127.85 49.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.025 1.33 . . . . 3.3199999999999998 108.7 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -98.43 104.39 23.47 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.368 1.067 . . . . 1.05 109.614 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.87 -10.41 12.84 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 1.1699999999999999 113.311 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 164.49 52.04 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.276 0.941 . . . . 0.96999999999999997 113.094 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.69 -9.97 59.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.766 1.226 . . . . 3.9199999999999999 113.492 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.73 160.82 47.23 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.028 1.731 . . . . 2.6200000000000001 111.215 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.12 151.77 23.85 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.956 2.438 . . . . 1.0700000000000001 111.84 -171.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -115.55 125.59 53.18 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.264 1.426 . . . . 3.5 110.468 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -107.98 114.77 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.761 1.225 . . . . 3.6299999999999999 110.72 171.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.2 tp -97.07 114.72 26.4 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.441 2.696 . . . . 1.8 108.771 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.54 -11.04 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.068 0.947 . . . . 1.71 113.206 -165.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.77 -158.01 27.74 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 124.113 0.863 . . . . 0.55000000000000004 111.509 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.11 178.97 9.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.77 0.828 . . . . 1.76 112.181 172.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -146.6 121.35 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.535 1.134 . . . . 7.5999999999999996 109.733 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -145.46 160.68 44.25 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.665 1.986 . . . . 2.1099999999999999 108.988 -168.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -31.01 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.122 1.881 . . . . 1.9299999999999999 112.748 157.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 m -83.49 31.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.554 1.07 . . . . 2.7000000000000002 113.84 -169.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.15 161.25 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 128.029 2.532 . . . . 2.3599999999999999 109.227 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.94 -80.2 0.55 Allowed 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.8 -1.926 . . . . 3.48 105.8 160.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.43 84.94 2.54 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.14 -0.975 . . . . 4.4400000000000004 109.903 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.76 137.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.428 -0.806 . . . . 2.1099999999999999 109.619 159.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.98 122.84 27.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.792 1.237 . . . . 2.2999999999999998 110.649 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -79.71 119.14 22.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.922 1.237 . . . . 1.9199999999999999 110.597 168.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -106.99 156.16 19.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.266 1.827 . . . . 0.89000000000000001 112.23 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' C ' ' HG1' ' A' ' 48' ' ' THR . 8.0 pt-20 -112.63 -176.64 2.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 2.04 111.794 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.407 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 62.6 m -150.09 79.4 1.36 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.992 1.317 . . . . 2.4199999999999999 108.466 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -83.58 148.57 27.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.942 -1.026 . . . . 3.7999999999999998 110.214 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -90.89 155.37 18.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 4.4500000000000002 111.035 164.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -151.69 149.2 28.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.736 1.615 . . . . 7.3099999999999996 109.952 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -89.57 168.81 11.86 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.0 0.905 . . . . 3.54 111.782 164.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.61 -128.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.821 2.448 . . . . 4.2599999999999998 107.331 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.0 mp0 -76.68 60.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 121.559 1.981 . . . . 4.9500000000000002 111.14 173.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.15 2.9 55.08 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.643 1.116 . . . . 2.3500000000000001 114.008 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 63.5 mttt -87.65 126.27 34.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.354 1.462 . . . . 5.04 109.973 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 131.9 37.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.633 0.373 . . . . 5.9100000000000001 111.39 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -139.77 143.14 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.921 1.688 . . . . 2.8399999999999999 109.967 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.35 120.16 41.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.298 1.039 . . . . 3.5899999999999999 110.181 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.01 44.72 1.44 Allowed Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.092 1.197 . . . . 3.6600000000000001 116.092 -160.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -28.73 120.03 0.12 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.063 2.545 . . . . 3.3300000000000001 113.624 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -144.96 154.62 55.11 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 117.654 -1.165 . . . . 5.9800000000000004 110.395 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.17 146.88 82.85 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.03 1.82 . . . . 0.80000000000000004 110.806 164.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.11 154.83 49.99 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.115 1.366 . . . . 1.5900000000000001 110.514 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 -15.41 38.08 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.917 2.411 . . . . 1.1599999999999999 112.917 176.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -175.35 163.92 3.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 3.2999999999999998 111.119 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -113.61 173.6 6.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.613 1.965 . . . . 2.04 109.532 155.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.95 163.95 39.09 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.487 -0.758 . . . . 2.3599999999999999 112.106 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.92 132.53 10.4 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.467 1.107 . . . . 2.4199999999999999 110.019 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.13 163.14 38.91 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.437 2.758 . . . . 1.1799999999999999 111.617 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.61 140.68 76.3 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.974 2.449 . . . . 0.93999999999999995 111.266 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp 69.59 -1.43 2.27 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.649 1.979 . . . . 4.1299999999999999 113.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.44 135.21 12.91 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 127.081 2.277 . . . . 1.1299999999999999 110.987 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -103.71 138.38 40.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.466 1.507 . . . . 5.1399999999999997 110.789 161.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.23 113.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.408 1.883 . . . . 3.29 107.855 165.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -81.74 142.02 33.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.174 0.99 . . . . 3.4300000000000002 110.344 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -71.08 78.83 0.67 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.317 1.056 . . . . 1.8600000000000001 108.924 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -87.92 138.8 30.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 4.7000000000000002 109.986 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.3 -40.38 59.29 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.691 2.927 . . . . 1.0600000000000001 114.159 -165.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.83 78.44 1.95 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.005 -1.638 . . . . 1.1699999999999999 109.005 162.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.27 -88.68 0.1 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.51 1.053 . . . . 0.92000000000000004 112.622 -167.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -151.23 144.34 24.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.741 2.017 . . . . 3.0299999999999998 109.496 -171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -164.65 171.85 13.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.564 0.746 . . . . 0.83999999999999997 110.689 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.42 131.23 55.23 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.92 0.488 . . . . 3.5600000000000001 110.614 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.61 136.99 32.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.269 1.428 . . . . 1.98 110.44 163.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.49 111.2 21.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.12 1.768 . . . . 3.3900000000000001 108.822 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.67 133.44 55.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.8 0.84 . . . . 3.5800000000000001 109.642 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.65 42.53 17.22 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 111.618 -0.593 . . . . 1.79 111.618 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.41 120.49 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.687 1.595 . . . . 3.1299999999999999 113.009 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -86.59 -3.86 59.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.18 -0.918 . . . . 2.5499999999999998 112.884 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -130.57 135.64 27.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 116.704 -1.617 . . . . 5.1399999999999997 108.228 149.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -61.6 139.38 81.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.928 1.752 . . . . 2.3100000000000001 107.841 156.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.71 110.84 18.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.645 1.178 . . . . 3.2000000000000002 110.246 -162.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -90.01 131.07 36.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.686 0.755 . . . . 6.4500000000000002 110.599 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 119.86 6.87 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.123 -0.944 . . . . 2.0699999999999998 109.191 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.04 4.8 57.56 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 117.86 -1.522 . . . . 1.98 115.645 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -85.25 163.92 18.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.31 2.055 . . . . 2.9300000000000002 110.433 160.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -96.86 156.9 16.15 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.853 1.261 . . . . 3.8599999999999999 109.776 163.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.06 124.61 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 124.517 1.127 . . . . 1.8500000000000001 109.152 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -73.87 134.07 43.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.201 1.8 . . . . 3.0499999999999998 108.338 166.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mt -158.86 120.95 3.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.567 1.147 . . . . 2.4199999999999999 113.578 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.06 112.26 25.33 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.092 2.157 . . . . 2.9700000000000002 110.739 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.6 132.86 46.87 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 2.4300000000000002 111.183 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -96.42 133.69 40.52 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.813 0.845 . . . . 1.99 111.219 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -126.64 152.78 46.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.643 1.211 . . . . 3.6299999999999999 112.306 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.93 134.59 57.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.217 -0.901 . . . . 2.1800000000000002 113.142 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.92 46.26 37.97 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 119.12 -0.822 . . . . 3.9100000000000001 114.164 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.55 18.87 61.16 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.993 1.157 . . . . 1.6799999999999999 115.993 166.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.9 143.22 30.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.474 1.637 . . . . 5.0599999999999996 110.463 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -152.23 138.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.948 1.699 . . . . 2.02 108.47 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -144.74 127.72 16.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.768 0.827 . . . . 2.5899999999999999 112.523 -168.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 13.9 tppt? -71.01 135.96 48.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 3.5699999999999998 111.944 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.66 151.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.523 1.129 . . . . 2.4900000000000002 111.305 171.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.07 134.83 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.044 . . . . 4.75 112.565 -171.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.86 125.8 9.99 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.896 1.278 . . . . 4.96 109.561 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -86.76 159.41 9.05 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.608 2.872 . . . . 1.3899999999999999 110.558 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.42 137.15 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.165 0.986 . . . . 2.1699999999999999 109.971 172.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -140.71 150.4 43.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.131 0.972 . . . . 3.3100000000000001 110.452 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.79 58.83 1.15 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.772 0.829 . . . . 3.5299999999999998 109.998 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.701 1.2 . . . . 6.5 112.666 -170.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 108.832 -0.803 . . . . 6.1500000000000004 108.832 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.35 -178.67 15.41 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-N 121.226 1.83 . . . . 1.1899999999999999 116.343 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -160.3 138.06 9.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.218 -0.991 . . . . 1.9399999999999999 111.739 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.99 122.79 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.997 0.904 . . . . 2.4100000000000001 109.029 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -62.08 112.04 2.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.619 1.568 . . . . 4.7300000000000004 112.148 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -70.15 133.48 47.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.461 0.648 . . . . 3.6499999999999999 109.51 150.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.9 m -159.18 146.52 13.06 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.634 1.574 . . . . 2.9399999999999999 109.994 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -86.78 67.68 4.43 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.118 3.212 . . . . 2.6800000000000002 110.836 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -151.87 177.42 29.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.787 0.708 . . . . 1.3400000000000001 114.04 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.33 -10.11 19.04 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.831 3.02 . . . . 1.73 113.205 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -146.27 165.78 28.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.925 1.69 . . . . 2.5299999999999998 112.669 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 153.41 29.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.622 1.169 . . . . 2.2799999999999998 112.165 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.29 118.53 33.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.566 1.146 . . . . 2.6099999999999999 109.694 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.79 156.74 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.87 1.268 . . . . 2.4500000000000002 112.044 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.68 154.57 47.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.028 1.331 . . . . 3.1200000000000001 112.783 -169.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -160.93 157.97 27.35 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.926 1.29 . . . . 2.5 112.649 165.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.9 m -73.27 108.98 6.46 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.326 -0.99 . . . . 2.2400000000000002 108.326 156.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.38 129.2 34.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.07 -1.456 . . . . 4.0099999999999998 107.07 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -126.37 148.23 49.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.183 0.808 . . . . 3.0899999999999999 113.183 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -112.13 110.67 53.66 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.624 1.17 . . . . 1.1499999999999999 109.974 166.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.45 -8.37 8.53 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.045 2.497 . . . . 1.3300000000000001 113.225 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.75 155.95 37.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.434 1.016 . . . . 1.24 112.66 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 4.6 m-20 -88.88 4.67 47.08 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.313 1.845 . . . . 3.0299999999999998 113.296 -175.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.95 160.76 41.52 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.45 1.9 . . . . 2.3300000000000001 110.293 167.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.24 153.75 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.034 2.49 . . . . 1.1499999999999999 111.285 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.9 mt -107.38 153.57 22.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.426 1.09 . . . . 2.79 111.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 68' ' ' GLU . 25.9 ttm180 -130.21 113.08 14.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 3.77 110.218 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.6 105.05 17.08 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 127.701 2.4 . . . . 1.72 108.316 -174.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -94.19 -11.53 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.965 0.906 . . . . 1.8799999999999999 113.032 -172.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.86 -163.85 33.0 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.594 1.092 . . . . 0.48999999999999999 111.608 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.16 -175.11 5.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.26 1.024 . . . . 1.71 110.515 166.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 1.1 mmt85 -160.38 -172.75 3.69 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.893 1.224 . . . . 7.9900000000000002 111.214 -172.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -177.86 156.35 1.1 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 126.443 1.897 . . . . 1.8799999999999999 108.726 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.65 -22.29 73.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.767 2.311 . . . . 1.45 114.371 160.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.06 2.41 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.629 1.714 . . . . 2.6000000000000001 115.629 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.96 167.84 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.566 1.075 . . . . 2.0099999999999998 111.501 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.22 -88.51 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.546 0.738 . . . . 3.25 112.946 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -83.0 141.17 32.29 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.28 -1.008 . . . . 4.9900000000000002 108.28 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -151.82 131.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.196 0.999 . . . . 2.23 109.82 -169.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -145.0 124.45 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.367 1.467 . . . . 2.4900000000000002 110.151 -166.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.422 HD12 ' CE1' ' A' ' 84' ' ' PHE . 7.3 tt -79.38 121.29 24.96 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.066 -1.021 . . . . 1.73 110.816 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -109.19 153.12 24.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.188 1.395 . . . . 1.21 113.01 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 62' ' ' ARG . 11.9 pt-20 -110.3 -175.51 2.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.765 2.026 . . . . 2.7799999999999998 112.145 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.4 m -147.97 127.68 13.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.12 1.768 . . . . 2.71 108.503 172.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -124.78 153.51 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.326 1.45 . . . . 3.9100000000000001 110.697 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.8 149.26 25.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.198 0.999 . . . . 5.4900000000000002 111.234 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.14 144.17 15.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.933 0.893 . . . . 7.0 111.85 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.421 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -98.38 143.75 28.51 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.467 0.48 . . . . 3.8300000000000001 109.938 162.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.92 131.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.483 1.513 . . . . 4.0199999999999996 108.946 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 59.22 22.54 10.8 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.048 0.939 . . . . 3.4300000000000002 111.801 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.59 56.91 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.4 -1.437 . . . . 2.3900000000000001 114.126 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -93.99 144.2 25.68 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.943 1.697 . . . . 3.8799999999999999 110.561 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 22.3 mtpp -83.63 134.49 34.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.787 0.835 . . . . 4.4699999999999998 110.521 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.57 151.2 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.24 1.816 . . . . 2.6499999999999999 109.864 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.3 mmt -106.17 135.24 48.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.454 1.102 . . . . 5.0700000000000003 110.401 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.15 151.3 17.42 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.763 1.173 . . . . 1.8100000000000001 112.648 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.4 162.46 17.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.351 1.461 . . . . 2.9700000000000002 111.358 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 47' ' ' GLU . 14.8 ptt180 -171.59 159.66 4.87 Favored Pre-proline 0 N--CA 1.477 0.925 0 C-N-CA 126.542 1.937 . . . . 6.6200000000000001 109.761 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -69.52 159.62 52.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.417 1.412 . . . . 1.1200000000000001 111.413 164.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.84 157.1 77.8 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.427 1.491 . . . . 2.04 110.485 168.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.87 -10.84 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.936 2.424 . . . . 1.23 113.139 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.49 160.22 1.24 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.421 1.889 . . . . 3.1600000000000001 111.669 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.61 175.27 5.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.521 1.928 . . . . 1.8600000000000001 109.473 151.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.7 pt-20 -153.18 162.44 41.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.236 -0.915 . . . . 1.8799999999999999 111.102 172.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.79 135.29 10.95 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.645 0.778 . . . . 1.9099999999999999 109.843 -166.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.97 167.02 28.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.774 2.316 . . . . 1.1599999999999999 112.174 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.52 140.48 87.39 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.681 2.921 . . . . 1.0800000000000001 112.655 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 19.8 mmmt 68.12 0.77 2.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.947 2.099 . . . . 3.27 114.309 175.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.3 142.87 15.62 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 127.255 2.359 . . . . 1.22 111.571 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -107.03 157.62 17.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.523 1.529 . . . . 5.8300000000000001 112.889 166.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.37 125.46 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.342 1.857 . . . . 2.3100000000000001 109.656 173.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -83.27 127.93 34.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 4.1799999999999997 111.388 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.86 140.29 43.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.991 1.376 . . . . 2.1800000000000002 109.702 166.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -166.72 146.04 4.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 4.0999999999999996 110.491 -153.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.11 -39.45 18.5 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.133 2.555 . . . . 1.77 112.876 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.96 72.75 2.55 Favored Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.434 -1.466 . . . . 1.2 109.434 164.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.6 -94.8 0.11 Allowed Glycine 0 N--CA 1.469 0.856 0 N-CA-C 114.841 0.697 . . . . 0.98999999999999999 114.841 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -151.37 143.5 23.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.33 1.452 . . . . 2.9900000000000002 110.565 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -166.58 144.85 5.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.083 0.553 . . . . 1.4199999999999999 112.092 -166.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' CE1' HD12 ' A' ' 45' ' ' LEU . 55.6 m-85 -92.65 118.48 31.08 Favored 'General case' 0 CA--C 1.52 -0.178 0 O-C-N 121.651 -0.655 . . . . 3.1400000000000001 109.729 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 mmt -79.68 115.65 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.21 -0.663 . . . . 2.29 109.21 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.0 mt -99.76 125.45 45.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.628 1.571 . . . . 2.4100000000000001 107.946 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.57 120.42 35.76 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.412 1.485 . . . . 3.7000000000000002 107.42 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.57 89.59 0.9 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.349 -1.1 . . . . 1.49 110.349 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.4 mt -89.82 123.04 33.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.153 0.981 . . . . 1.78 109.283 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.68 -11.26 59.97 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.629 -1.295 . . . . 2.75 113.873 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -143.41 161.95 44.73 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.507 2.723 . . . . 7.9500000000000002 108.164 160.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.53 128.6 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 N-CA-C 107.07 -1.935 . . . . 1.75 107.07 147.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.99 155.46 30.75 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.11 -0.7 . . . . 4.0999999999999996 109.11 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.71 125.21 22.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.958 0.885 . . . . 5.0599999999999996 111.883 176.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.17 133.39 15.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.116 0.967 . . . . 2.8799999999999999 112.225 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.64 40.94 4.57 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.037 -0.868 . . . . 2.6099999999999999 113.382 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.6 165.79 29.32 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 126.851 2.06 . . . . 3.0099999999999998 108.271 157.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.73 158.01 16.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.087 1.755 . . . . 3.9900000000000002 111.294 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.5 t -115.66 119.94 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.858 1.263 . . . . 2.02 108.232 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 122.42 16.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.851 -1.166 . . . . 3.1899999999999999 107.851 155.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.08 131.76 54.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.507 1.523 . . . . 3.8700000000000001 107.312 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 51.2 m-20 -111.71 81.58 1.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.154 1.382 . . . . 3.5 110.417 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -66.78 118.72 10.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.336 1.854 . . . . 2.4700000000000002 110.976 -170.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.82 122.39 34.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.258 1.023 . . . . 2.1699999999999999 110.827 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.08 139.49 54.02 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.038 0.923 . . . . 3.21 111.772 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.96 128.77 22.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.1 1.36 . . . . 2.2200000000000002 113.747 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.09 60.87 3.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.236 0.922 . . . . 3.3500000000000001 113.068 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 6.77 88.83 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 116.956 1.543 . . . . 2.6699999999999999 116.956 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.72 137.64 32.75 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.248 2.024 . . . . 5.1399999999999997 110.708 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.32 133.22 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.559 1.144 . . . . 2.9900000000000002 109.214 161.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.2 mt -114.33 109.31 18.16 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.323 1.049 . . . . 2.8199999999999998 109.904 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.73 94.14 1.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 4.7599999999999998 109.278 168.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.68 156.94 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.849 0.86 . . . . 2.8199999999999998 110.065 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -103.46 139.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.482 1.113 . . . . 2.79 109.364 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 mt -142.02 153.35 63.71 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.786 2.035 . . . . 2.52 108.611 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.65 153.16 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.867 2.378 . . . . 1.1599999999999999 112.102 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.5 t -77.95 132.5 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.131 0.972 . . . . 2.4199999999999999 108.486 159.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.44 ' CD ' HH12 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -157.87 151.2 23.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.884 . . . . 3.5 110.837 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.76 115.39 30.05 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.042 1.337 . . . . 3.1600000000000001 111.805 -161.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.44 HH12 ' CD ' ' A' ' 118' ' ' GLU . 7.5 mpt_? . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 129.17 2.988 . . . . 6.6600000000000001 108.037 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 122.168 0.985 . . . . 6.0899999999999999 111.795 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.64 169.73 41.39 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.976 2.227 . . . . 2.0 110.493 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -141.99 154.34 44.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.426 0.898 . . . . 2.5 113.426 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.07 126.27 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.366 -0.834 . . . . 2.0499999999999998 109.147 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.06 108.67 12.72 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.23 1.412 . . . . 4.4100000000000001 112.414 -162.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -66.14 122.61 17.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.184 1.394 . . . . 4.1399999999999997 111.321 172.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -165.2 140.01 4.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.702 1.201 . . . . 2.9100000000000001 110.151 167.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.87 71.35 6.4 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.287 3.325 . . . . 2.1299999999999999 109.503 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.26 172.92 19.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.321 0.962 . . . . 1.49 114.443 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.05 -16.1 36.21 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.235 2.623 . . . . 2.0299999999999998 111.68 166.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -144.86 164.78 30.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.571 1.149 . . . . 3.1400000000000001 113.435 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.42 -166.35 1.64 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.375 2.27 . . . . 2.0600000000000001 109.527 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.29 164.07 38.17 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.412 0.893 . . . . 1.76 113.412 -168.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.69 139.64 40.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.677 1.191 . . . . 2.3700000000000001 111.428 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.45 140.57 41.33 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.73 2.012 . . . . 3.8999999999999999 109.236 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.49 153.73 11.38 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.18 1.178 . . . . 3.1899999999999999 114.18 -166.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -78.91 98.08 6.26 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.663 -1.236 . . . . 3.2599999999999998 107.663 157.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.09 133.67 46.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.435 1.894 . . . . 4.3600000000000003 108.589 173.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -105.44 145.28 31.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.194 0.813 . . . . 4.8700000000000001 113.194 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -122.72 110.6 31.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.65 0.78 . . . . 1.4199999999999999 109.507 150.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -91.94 -10.09 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.575 2.85 . . . . 1.54 113.513 170.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.27 33.64 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.795 1.188 . . . . 1.26 112.929 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.477 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 4.5 m-20 -87.26 4.06 44.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.071 1.748 . . . . 3.0699999999999998 113.507 -174.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.32 159.93 41.56 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.067 1.747 . . . . 2.71 110.64 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.38 149.83 21.91 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.812 2.341 . . . . 1.1599999999999999 111.208 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.59 125.83 52.96 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.962 1.305 . . . . 3.4300000000000002 109.163 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -111.25 99.66 8.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.236 1.014 . . . . 3.9199999999999999 109.205 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 tp -80.63 114.3 19.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.999 2.12 . . . . 1.9099999999999999 109.482 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.22 -11.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.507 1.123 . . . . 1.8 113.369 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.5 -166.02 37.72 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.4 1.0 . . . . 0.73999999999999999 111.791 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.15 -179.16 6.95 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.408 1.083 . . . . 1.8899999999999999 109.11 163.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -154.63 147.41 24.37 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.224 1.009 . . . . 6.9100000000000001 108.332 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -146.4 156.4 49.62 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.207 1.003 . . . . 1.76 109.792 -167.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.69 -1.11 10.78 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.166 2.578 . . . . 1.5800000000000001 113.445 166.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.64 -5.9 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 115.485 1.661 . . . . 2.1299999999999999 115.485 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.54 158.77 41.75 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.818 1.19 . . . . 1.8100000000000001 113.403 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.94 -76.62 0.52 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 3.1000000000000001 110.736 -170.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.99 114.32 19.79 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.08 -1.013 . . . . 4.9900000000000002 108.728 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.52 133.26 65.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 2.2799999999999998 109.255 176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.69 134.97 24.26 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.351 1.06 . . . . 2.2999999999999998 110.884 -170.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.74 120.4 26.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.316 1.055 . . . . 1.8600000000000001 111.04 169.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -107.15 154.58 20.96 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.303 1.841 . . . . 0.80000000000000004 112.152 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.34 -176.77 3.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.123 1.769 . . . . 2.1299999999999999 110.39 167.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -148.07 86.86 1.58 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.915 1.286 . . . . 2.3700000000000001 108.836 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -73.09 166.88 22.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.049 1.34 . . . . 3.3999999999999999 111.967 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -111.07 159.12 18.08 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.301 0.64 . . . . 4.4699999999999998 111.231 161.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -154.98 133.84 12.18 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.828 1.251 . . . . 6.8899999999999997 109.707 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 147.52 47.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.535 0.734 . . . . 3.3999999999999999 109.579 165.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.42 -40.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 115.322 1.601 . . . . 4.2000000000000002 115.322 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.4 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 4.6 tm-20 -115.89 30.98 7.0 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.507 1.923 . . . . 4.4500000000000002 109.699 175.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 -14.25 4.05 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.227 -1.546 . . . . 1.8799999999999999 113.35 -165.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 1.3 mmtp -104.15 160.29 14.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 127.725 2.41 . . . . 5.4699999999999998 110.3 170.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -92.28 146.8 23.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.467 1.655 . . . . 4.21 115.467 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.37 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.731 2.013 . . . . 2.6299999999999999 107.618 165.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -91.82 135.98 33.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.059 1.344 . . . . 4.7400000000000002 110.217 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.47 148.75 20.37 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 124.237 0.922 . . . . 1.6000000000000001 112.812 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -99.3 163.04 12.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.966 1.306 . . . . 2.6299999999999999 112.035 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -170.64 152.08 3.72 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.847 1.659 . . . . 5.7000000000000002 110.813 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.54 150.07 69.1 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.675 1.583 . . . . 0.94999999999999996 111.592 166.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.41 157.58 70.0 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.946 2.099 . . . . 1.9399999999999999 110.188 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.47 -19.47 24.96 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.638 2.225 . . . . 0.98999999999999999 112.996 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.46 166.22 3.93 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.183 1.393 . . . . 3.0499999999999998 111.687 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -118.24 176.14 5.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.767 2.427 . . . . 2.1000000000000001 108.815 156.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.32 165.09 36.84 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.095 -1.003 . . . . 2.02 111.668 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.43 134.15 10.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.68 1.592 . . . . 2.1499999999999999 108.805 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.66 165.97 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.815 2.343 . . . . 0.85999999999999999 111.739 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.56 144.47 97.75 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.557 2.838 . . . . 0.93999999999999995 112.459 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.477 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 20.4 mmmt 68.65 -5.84 0.92 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.19 2.196 . . . . 3.1499999999999999 114.823 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.51 122.22 7.29 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 126.574 2.035 . . . . 1.1899999999999999 111.028 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -88.64 136.6 32.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.015 0.526 . . . . 5.2199999999999998 110.21 157.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.9 173.36 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.904 2.082 . . . . 3.2000000000000002 110.278 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -116.63 111.65 20.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.418 1.008 . . . . 4.2699999999999996 113.639 -161.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.08 76.67 1.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.222 1.009 . . . . 2.52 108.436 156.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.51 155.19 76.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.044 0.938 . . . . 3.5299999999999998 112.427 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.51 -58.37 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.11 2.54 . . . . 1.1100000000000001 112.524 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.63 74.8 2.39 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.598 -1.001 . . . . 1.49 110.598 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.84 -75.84 0.08 OUTLIER Glycine 0 N--CA 1.469 0.835 0 C-N-CA 124.998 1.285 . . . . 1.1100000000000001 114.069 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -156.18 138.13 14.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.772 1.629 . . . . 3.79 109.926 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -168.61 164.0 12.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.654 1.57 . . . . 0.93000000000000005 111.282 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.41 129.55 41.11 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 110.429 -0.211 . . . . 3.5600000000000001 110.429 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.5 mmt -87.58 135.9 33.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.262 1.025 . . . . 1.8500000000000001 110.351 165.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.58 114.79 26.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.445 1.498 . . . . 2.8700000000000001 108.262 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.8 123.7 48.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.657 1.983 . . . . 3.8700000000000001 108.417 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.55 100.74 0.15 Allowed Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.55 -1.02 . . . . 1.49 110.55 -174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.65 120.03 36.23 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.93 0.865 . . . . 1.76 111.07 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.38 -11.68 61.02 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.204 1.402 . . . . 3.1600000000000001 113.924 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -167.09 155.52 9.08 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 126.744 2.018 . . . . 6.1399999999999997 110.235 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.4 140.52 82.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.801 1.667 . . . . 2.5299999999999998 109.318 163.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 mt -84.3 89.96 7.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.535 1.134 . . . . 3.6299999999999999 109.585 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 108.04 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.535 1.134 . . . . 5.8200000000000003 110.302 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.0 113.1 0.91 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.021 0.528 . . . . 2.1400000000000001 110.842 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.78 3.11 30.4 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 116.76 -2.133 . . . . 2.5699999999999998 116.655 -173.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.92 171.76 14.51 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.341 2.571 . . . . 4.7599999999999998 110.102 152.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -103.3 135.02 45.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.713 -1.217 . . . . 6.4900000000000002 107.713 145.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.24 125.92 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 124.221 1.009 . . . . 2.1299999999999999 108.724 168.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 136.33 56.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.688 0.756 . . . . 3.3999999999999999 110.233 162.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -147.58 124.81 11.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 123.29 1.519 . . . . 2.75 111.77 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.47 83.85 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 127.554 2.341 . . . . 2.5800000000000001 109.491 -167.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.27 120.05 12.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.585 1.154 . . . . 2.1200000000000001 110.279 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.5 mt -97.57 130.34 44.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.646 1.579 . . . . 2.0899999999999999 110.709 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -134.15 129.3 35.65 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.414 -0.804 . . . . 3.1499999999999999 111.133 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 43.36 34.25 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.844 1.657 . . . . 2.8900000000000001 113.478 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.23 -76.59 1.93 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.175 1.369 . . . . 4.4800000000000004 111.39 -167.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.773 1.069 . . . . 2.6600000000000001 115.773 -160.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.17 93.39 5.2 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.016 1.908 . . . . 8.1999999999999993 110.267 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.84 128.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 125.568 1.547 . . . . 2.3100000000000001 108.405 167.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.63 179.78 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.033 1.333 . . . . 4.54 110.456 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -134.41 119.73 18.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.251 1.02 . . . . 3.3500000000000001 108.4 154.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.42 168.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.907 -1.516 . . . . 3.98 106.907 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.0 m -125.65 144.3 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.35 1.86 . . . . 3.6200000000000001 108.922 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.4 mt -143.39 141.47 19.25 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.558 1.143 . . . . 3.27 111.482 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.1 144.86 99.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.937 3.092 . . . . 1.6100000000000001 113.793 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.08 125.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.334 -0.988 . . . . 2.3900000000000001 108.334 168.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.77 161.79 42.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.989 0.916 . . . . 3.21 110.463 -168.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.52 5.85 34.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.559 1.318 . . . . 2.5099999999999998 114.559 -156.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.188 1.795 . . . . 6.1399999999999997 111.373 -178.105 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 111.961 0.356 . . . . 5.2300000000000004 111.961 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -124.11 153.99 17.63 Favored Glycine 0 N--CA 1.469 0.847 0 C-N-CA 128.566 2.984 . . . . 1.21 111.414 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -134.64 130.91 37.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.726 1.263 . . . . 1.51 113.778 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.1 t -87.61 125.62 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.274 -0.891 . . . . 2.3100000000000001 109.604 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.71 114.62 8.98 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.766 0.827 . . . . 4.5700000000000003 112.984 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.5 143.67 30.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.657 0.741 . . . . 3.9300000000000002 110.256 149.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.2 169.87 2.14 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 129.589 3.156 . . . . 4.1799999999999997 106.787 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.97 33.81 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.428 2.752 . . . . 3.54 113.826 -170.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.45 150.55 17.28 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.621 1.105 . . . . 2.1699999999999999 114.513 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.43 -14.84 20.1 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.918 3.079 . . . . 2.0699999999999998 112.105 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -134.45 157.76 45.63 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.72 2.008 . . . . 2.4199999999999999 111.374 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.49 168.95 22.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.536 1.135 . . . . 2.6200000000000001 112.763 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.22 122.35 42.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.977 1.311 . . . . 2.4199999999999999 109.487 166.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.6 119.26 28.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.361 -0.607 . . . . 2.1499999999999999 109.361 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -95.33 141.07 29.34 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.59 1.156 . . . . 3.6299999999999999 108.876 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.432 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 4.1 pp -158.14 156.1 30.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.106 1.15 . . . . 3.2200000000000002 114.106 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.6 m -112.31 105.86 14.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.722 1.209 . . . . 2.6299999999999999 108.688 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tt -101.89 144.16 30.87 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.032 1.333 . . . . 3.7200000000000002 109.303 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -145.88 141.51 27.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.332 0.587 . . . . 3.46 112.119 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -104.53 106.38 54.13 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.928 -1.033 . . . . 1.3500000000000001 110.242 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 -12.18 13.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.506 2.137 . . . . 1.6499999999999999 113.432 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.62 172.56 54.51 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 119.166 0.894 . . . . 1.3400000000000001 113.065 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.0 m-20 -96.0 -4.26 43.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.046 1.738 . . . . 2.9900000000000002 112.492 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 155.54 44.99 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.634 1.974 . . . . 6.0 108.568 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.61 158.92 25.29 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.094 2.529 . . . . 1.4399999999999999 111.447 -171.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.45 154.05 20.86 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.315 1.046 . . . . 3.0 109.974 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -134.27 110.35 9.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.181 1.392 . . . . 4.0700000000000003 109.086 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.4 tp -88.92 124.35 34.15 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.715 2.006 . . . . 1.8200000000000001 109.246 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.53 -6.11 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.08 1.141 . . . . 1.8200000000000001 114.08 -170.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.21 -165.67 37.91 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 118.88 0.764 . . . . 0.83999999999999997 112.463 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.06 177.16 11.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.202 -0.904 . . . . 2.4199999999999999 112.433 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.29 134.43 0.89 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.065 0.848 . . . . 6.5599999999999996 112.732 162.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -129.92 157.29 77.31 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 126.53 1.932 . . . . 1.97 110.124 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.15 -23.38 66.78 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.863 2.376 . . . . 1.3500000000000001 114.84 165.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -87.95 -0.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 114.729 1.381 . . . . 2.1099999999999999 114.729 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.31 163.97 31.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.67 1.188 . . . . 1.71 111.92 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -96.11 -94.36 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.109 1.364 . . . . 3.23 109.224 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 128.87 38.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.456 -0.778 . . . . 5.6399999999999997 110.025 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -131.09 133.02 63.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.002 1.321 . . . . 2.02 110.166 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.22 136.13 33.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.228 1.411 . . . . 2.96 110.64 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.04 121.39 26.48 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.093 -1.004 . . . . 1.72 111.082 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -108.5 156.0 19.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.503 1.521 . . . . 0.87 112.414 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -101.54 179.74 4.26 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.245 -0.889 . . . . 3.0099999999999998 110.761 160.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -147.52 104.59 3.64 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.038 -1.097 . . . . 2.2999999999999998 108.038 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -122.94 155.58 36.45 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.747 1.619 . . . . 3.6099999999999999 112.899 -156.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.3 mtm -82.91 143.95 30.38 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.368 0.667 . . . . 3.52 111.127 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -167.16 129.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.063 1.345 . . . . 10.67 111.3 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.1 175.54 7.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.522 1.129 . . . . 4.2999999999999998 111.436 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 133.53 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.837 1.655 . . . . 4.8700000000000001 108.751 162.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 65.71 10.7 6.98 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.174 0.99 . . . . 4.2000000000000002 112.403 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.24 87.66 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 120.898 -1.126 . . . . 2.0099999999999998 114.089 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -96.88 142.13 29.23 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.074 1.75 . . . . 3.6099999999999999 109.699 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -75.13 131.62 40.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.282 1.433 . . . . 5.1699999999999999 113.139 -165.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 59' ' ' MET . 0.1 OUTLIER -150.71 -173.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.307 1.043 . . . . 2.8799999999999999 111.293 176.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.412 ' H ' HG12 ' A' ' 58' ' ' VAL . 2.4 ptp -146.68 -177.17 5.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.594 1.958 . . . . 4.7199999999999998 112.695 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.75 172.88 43.87 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.333 1.444 . . . . 1.0700000000000001 112.935 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -114.3 156.98 23.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.561 1.544 . . . . 2.71 109.416 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -166.32 144.39 4.55 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.052 1.341 . . . . 7.3600000000000003 110.068 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -66.31 147.66 83.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.012 1.808 . . . . 0.93999999999999995 110.414 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.08 156.83 52.0 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.544 1.538 . . . . 1.98 109.554 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.52 -22.05 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.041 1.827 . . . . 0.89000000000000001 112.334 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -173.93 165.13 4.29 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 124.482 1.113 . . . . 3.8900000000000001 111.814 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.48 175.34 5.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.422 2.289 . . . . 2.4900000000000002 109.108 158.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.73 168.66 26.74 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.666 -1.271 . . . . 2.1699999999999999 111.737 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -149.26 132.74 8.45 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.722 0.809 . . . . 2.1899999999999999 110.161 -168.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.0 164.36 34.63 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.372 2.048 . . . . 1.49 111.799 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.97 140.22 78.01 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.861 3.041 . . . . 1.52 112.188 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 63.9 mmtt 70.14 0.56 3.18 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.972 2.109 . . . . 2.8500000000000001 113.871 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.06 125.1 7.94 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 126.783 2.135 . . . . 1.6100000000000001 111.165 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 148.0 23.88 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.914 -0.643 . . . . 5.5899999999999999 112.357 154.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.73 162.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.456 1.902 . . . . 2.5 109.35 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.13 139.91 51.0 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.821 0.82 . . . . 3.02 112.47 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.36 71.7 1.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.592 1.157 . . . . 2.04 108.238 155.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -80.1 142.55 55.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.104 1.761 . . . . 4.9100000000000001 110.549 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.13 -58.82 1.52 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.969 3.779 . . . . 1.04 114.323 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.27 52.85 4.37 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 119.009 0.822 . . . . 1.21 112.067 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.28 -82.89 0.05 OUTLIER Glycine 0 N--CA 1.466 0.645 0 C-N-CA 127.627 2.537 . . . . 1.0600000000000001 111.699 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -151.27 149.78 29.79 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.005 2.122 . . . . 3.8100000000000001 108.967 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -169.25 165.22 10.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.163 0.892 . . . . 0.93000000000000005 111.292 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -103.13 118.76 37.52 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.89 0.476 . . . . 3.46 110.226 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.6 mmt -77.69 104.66 8.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 2.04 110.11 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.44 127.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.048 1.339 . . . . 2.5099999999999998 108.709 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.98 117.35 19.08 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.485 1.114 . . . . 4.0499999999999998 109.23 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.91 75.04 1.21 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.312 -1.115 . . . . 1.3200000000000001 110.312 -168.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.85 129.8 40.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.434 -0.58 . . . . 2.2799999999999998 109.434 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -80.98 7.71 10.11 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.954 1.094 . . . . 2.5899999999999999 113.954 -170.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 176.26 153.32 0.36 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.988 2.515 . . . . 5.5999999999999996 109.65 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.79 144.13 76.35 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 108.14 -1.523 . . . . 1.8700000000000001 108.14 159.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.26 152.7 18.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.946 0.898 . . . . 3.5499999999999998 109.093 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -117.01 135.05 54.0 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.863 0.865 . . . . 7.0 109.74 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 119.02 6.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.745 -1.222 . . . . 2.77 110.966 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.64 39.51 34.41 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.639 -0.663 . . . . 2.0299999999999998 113.095 -168.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -91.03 -169.88 2.49 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.083 -1.08 . . . . 2.6499999999999999 108.083 140.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.82 142.05 29.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.157 1.383 . . . . 4.0599999999999996 109.844 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.61 102.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.276 1.43 . . . . 1.98 109.461 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.442 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 3.6 mm-40 -55.52 130.6 43.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.516 -1.22 . . . . 3.1499999999999999 109.743 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.2 tt -156.34 131.67 9.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.369 1.08 . . . . 3.0899999999999999 111.171 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.77 93.9 8.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.582 2.353 . . . . 2.2799999999999998 110.454 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.83 123.07 19.97 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.402 -0.962 . . . . 2.4300000000000002 108.402 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.75 128.81 45.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.78 1.232 . . . . 1.8500000000000001 110.006 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -129.09 119.2 23.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.279 0.844 . . . . 3.3199999999999998 113.279 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 23.12 44.98 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.2 3.0 . . . . 2.0499999999999998 115.911 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.39 -56.07 1.57 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.616 1.579 . . . . 3.1299999999999999 113.382 -171.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.89 0.14 58.53 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.685 -1.619 . . . . 2.0600000000000001 116.909 -164.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 150.21 45.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.15 1.975 . . . . 4.6100000000000003 111.421 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.03 139.54 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.046 1.738 . . . . 2.2799999999999998 109.091 165.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.95 104.51 7.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.433 1.093 . . . . 2.6800000000000002 110.015 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.442 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 8.9 ttpp -72.6 88.81 1.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.07 1.348 . . . . 3.9300000000000002 110.213 172.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.3 m -114.23 140.25 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.142 1.377 . . . . 3.6200000000000001 111.166 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -100.73 133.18 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.968 1.707 . . . . 3.2000000000000002 110.92 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.64 149.91 73.37 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.861 1.265 . . . . 3.6800000000000002 111.28 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.12 151.79 83.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.941 2.427 . . . . 1.4299999999999999 113.389 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.9 t -83.43 134.8 26.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.135 1.374 . . . . 2.3300000000000001 109.087 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -137.36 157.73 45.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.102 0.961 . . . . 3.4199999999999999 109.936 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.16 112.87 25.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.91 0.884 . . . . 3.3799999999999999 111.049 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.074 1.35 . . . . 6.3899999999999997 111.317 174.41 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 108.903 -0.777 . . . . 5.5599999999999996 108.903 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.69 44.25 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 115.601 1.0 . . . . 1.48 115.601 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -153.15 150.47 29.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.651 1.98 . . . . 1.55 111.44 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -114.41 134.89 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.799 -0.815 . . . . 2.2999999999999998 108.799 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -73.75 126.7 30.94 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.086 0.773 . . . . 4.8899999999999997 113.086 -167.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -74.66 128.75 36.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.133 0.968 . . . . 4.3700000000000001 111.004 157.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -159.35 138.14 7.93 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.281 1.432 . . . . 2.9700000000000002 110.199 164.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -83.42 73.27 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 124.159 3.24 . . . . 2.6400000000000001 109.658 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.58 176.91 24.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.147 0.88 . . . . 1.4299999999999999 114.068 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.32 -4.64 15.31 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.26 3.307 . . . . 2.4399999999999999 112.934 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -140.67 164.27 30.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.518 1.127 . . . . 3.6099999999999999 112.657 170.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.36 165.26 33.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.23 1.812 . . . . 2.02 110.227 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.73 154.79 20.99 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.66 0.784 . . . . 2.1699999999999999 111.735 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.15 136.94 54.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.693 0.797 . . . . 2.0800000000000001 111.89 164.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -133.15 128.72 36.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.522 1.529 . . . . 3.27 110.922 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -166.08 159.19 15.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.709 1.374 . . . . 3.1000000000000001 114.709 -167.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -80.33 140.68 36.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.088 0.955 . . . . 2.3599999999999999 109.793 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.24 126.1 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.173 1.389 . . . . 3.3199999999999998 107.759 170.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -151.9 148.42 27.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.216 0.607 . . . . 4.1799999999999997 112.235 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -109.87 109.65 59.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.45 1.1 . . . . 1.1000000000000001 111.842 -164.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.39 -11.12 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.35 2.033 . . . . 1.22 113.466 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.11 53.74 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.227 1.394 . . . . 1.1399999999999999 114.251 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.4 -36.03 63.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.144 2.178 . . . . 6.1299999999999999 112.626 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -102.39 163.42 17.7 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.479 1.911 . . . . 2.9500000000000002 111.531 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.07 159.02 23.81 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.001 2.467 . . . . 1.1200000000000001 112.371 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.2 mt -103.3 145.54 29.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.695 1.198 . . . . 3.1499999999999999 110.423 171.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 68' ' ' GLU . 21.4 ttm180 -129.78 105.31 7.94 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.832 1.253 . . . . 4.71 108.24 167.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.3 tp -79.87 104.77 10.67 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.961 2.104 . . . . 1.71 108.352 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -95.45 -14.92 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.916 0.886 . . . . 1.8100000000000001 112.412 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.41 -163.8 33.89 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 123.775 0.702 . . . . 0.52000000000000002 112.735 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.4 177.5 9.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.147 0.979 . . . . 2.1600000000000001 110.924 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -146.44 124.19 11.89 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.034 -1.469 . . . . 7.6299999999999999 107.034 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -142.34 149.83 52.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 117.688 -1.149 . . . . 1.99 110.087 -170.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.32 -3.34 12.98 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.517 2.145 . . . . 1.0600000000000001 113.463 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.46 -4.91 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 115.641 1.719 . . . . 2.1299999999999999 115.641 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.16 144.52 50.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.681 1.192 . . . . 2.0899999999999999 110.943 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -84.08 -75.99 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.679 -0.86 . . . . 3.6600000000000001 108.679 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -91.29 126.72 36.46 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.386 -0.821 . . . . 4.8600000000000003 108.789 165.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.26 138.38 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.442 1.497 . . . . 2.1000000000000001 109.916 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -136.65 136.78 39.41 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.424 1.889 . . . . 2.3100000000000001 109.358 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.63 124.66 33.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 121.154 1.797 . . . . 1.8200000000000001 111.073 165.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -108.03 153.36 23.22 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.709 1.604 . . . . 0.89000000000000001 113.617 174.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.25 -179.42 3.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.572 2.749 . . . . 2.29 110.758 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.4 m -128.98 107.99 10.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.117 -1.438 . . . . 2.0600000000000001 107.117 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -91.23 161.76 14.92 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 122.013 0.911 . . . . 3.3199999999999998 111.686 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.5 mtm -118.67 168.01 11.12 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.09 -0.959 . . . . 4.25 110.902 156.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -176.53 163.63 2.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.335 2.654 . . . . 7.2400000000000002 109.7 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.09 147.51 22.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.586 -0.894 . . . . 3.73 108.586 165.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 p -114.24 -15.52 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 113.858 1.059 . . . . 3.8700000000000001 113.858 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.89 25.84 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.424 2.29 . . . . 4.1299999999999999 109.046 -162.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.69 -20.98 1.64 Allowed Glycine 0 N--CA 1.477 1.375 0 O-C-N 119.392 -2.067 . . . . 2.1699999999999999 113.183 -159.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.8 135.24 35.47 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.655 1.582 . . . . 5.0099999999999998 109.882 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -76.19 138.62 40.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.298 1.039 . . . . 5.29 111.855 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -134.27 150.49 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.415 2.286 . . . . 3.0 108.97 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.9 ttp -123.46 144.25 49.63 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.557 1.943 . . . . 6.1100000000000003 109.505 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.96 163.8 31.53 Favored Glycine 0 N--CA 1.469 0.838 0 CA-C-N 118.724 0.693 . . . . 1.04 113.236 173.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.68 159.88 14.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.33 1.052 . . . . 2.4500000000000002 111.281 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 -173.21 140.33 0.89 Allowed Pre-proline 0 N--CA 1.475 0.776 0 CA-C-O 116.954 -1.498 . . . . 5.29 111.402 -168.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -71.09 147.49 54.48 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.927 1.751 . . . . 0.94999999999999996 112.559 170.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.61 151.4 67.41 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.415 1.486 . . . . 1.8200000000000001 110.48 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.34 -8.82 24.18 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.055 2.503 . . . . 1.05 113.447 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -174.6 159.21 2.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.765 1.626 . . . . 3.96 111.097 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mt -108.85 172.8 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.31 1.444 . . . . 1.8899999999999999 108.98 149.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 31' ' ' ARG . 13.1 pt-20 -158.34 163.36 37.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.231 -0.918 . . . . 2.79 112.604 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -151.15 131.34 7.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.134 0.974 . . . . 2.1400000000000001 109.806 -168.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 164.49 35.53 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.296 1.998 . . . . 1.1599999999999999 111.291 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.87 133.04 42.54 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.306 2.671 . . . . 1.05 110.61 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 72.06 0.34 3.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 127.489 2.316 . . . . 2.7000000000000002 113.788 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.67 157.5 34.37 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 126.545 2.021 . . . . 1.3200000000000001 111.031 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -132.54 144.36 50.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 127.346 2.258 . . . . 5.3099999999999996 110.418 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.84 163.94 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.676 1.991 . . . . 2.8500000000000001 108.762 167.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -139.1 115.02 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.921 -0.77 . . . . 3.1899999999999999 108.921 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.37 91.17 1.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.576 . . . . 2.1099999999999999 108.781 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -110.1 151.23 42.39 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.525 2.33 . . . . 3.8999999999999999 111.784 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.04 -53.89 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.274 3.316 . . . . 1.1299999999999999 113.949 -168.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.93 93.71 1.77 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 108.413 -1.875 . . . . 1.29 108.413 164.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -85.0 0.14 Allowed Glycine 0 C--O 1.222 -0.614 0 C-N-CA 124.794 1.188 . . . . 1.0 112.698 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -155.95 145.87 21.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.579 1.952 . . . . 3.9100000000000001 110.09 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -174.09 157.49 2.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.088 0.955 . . . . 1.74 108.823 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -85.68 139.17 31.6 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 119.813 -0.755 . . . . 3.2799999999999998 109.893 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 mmt -92.42 118.94 31.46 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.419 1.087 . . . . 1.78 109.021 161.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.7 mt -100.05 114.86 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.943 1.697 . . . . 2.73 106.793 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.5 150.78 26.96 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.365 1.066 . . . . 3.96 110.741 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.19 -55.49 4.59 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 125.235 1.398 . . . . 3.6899999999999999 111.761 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt 69.9 125.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.775 3.23 . . . . 2.25 111.581 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -80.9 22.99 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.263 -1.523 . . . . 2.6499999999999999 113.074 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 160.6 153.41 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 129.816 3.246 . . . . 4.7599999999999998 109.219 -163.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.52 131.87 31.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.234 -1.871 . . . . 1.6000000000000001 107.234 151.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.1 101.52 0.41 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.928 0.891 . . . . 3.0600000000000001 110.18 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.84 97.3 1.38 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.729 -1.232 . . . . 4.7699999999999996 109.843 -172.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -44.64 124.63 4.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.123 0.969 . . . . 2.6299999999999999 111.3 172.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.5 30.46 66.65 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.013 -0.882 . . . . 1.97 114.165 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -101.45 -172.08 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.599 1.699 . . . . 3.5800000000000001 107.519 136.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -132.21 151.36 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.832 0.853 . . . . 3.5899999999999999 110.525 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.0 t -98.89 113.86 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 124.85 1.26 . . . . 2.0699999999999998 108.916 -172.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.65 138.39 46.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 124.249 0.968 . . . . 3.7599999999999998 109.441 164.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mt -155.3 116.17 3.91 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.088 0.955 . . . . 2.7599999999999998 111.091 -168.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.31 104.63 16.59 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.016 2.126 . . . . 2.8199999999999998 109.468 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 48.0 mt -75.89 126.34 30.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 2.1200000000000001 110.194 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.0 mt -97.51 121.41 39.38 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.354 1.062 . . . . 1.8799999999999999 110.638 -175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.99 119.32 31.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.856 0.836 . . . . 3.48 112.732 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.1 28.23 0.9 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.01 2.124 . . . . 2.5899999999999999 114.208 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.99 -60.07 2.2 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.707 1.622 . . . . 3.54 112.692 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.87 -7.5 86.35 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.26 1.264 . . . . 1.6799999999999999 116.26 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.39 145.38 43.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.214 2.007 . . . . 5.1500000000000004 110.194 166.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -147.68 135.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.021 1.328 . . . . 1.8999999999999999 108.829 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -144.17 127.8 17.11 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.324 1.45 . . . . 3.0 108.756 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -91.01 147.18 23.26 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.421 1.637 . . . . 3.8599999999999999 115.421 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.29 164.66 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.965 2.506 . . . . 1.99 109.466 171.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.5 132.83 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.104 0.962 . . . . 3.0600000000000001 109.181 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -145.14 145.28 26.35 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.967 1.707 . . . . 3.4199999999999999 109.537 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 153.35 67.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.372 3.381 . . . . 1.1499999999999999 114.431 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.62 127.17 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.056 0.942 . . . . 1.8600000000000001 109.007 167.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -147.25 153.85 40.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.315 1.446 . . . . 3.4700000000000002 111.351 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.21 47.56 0.96 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.347 1.459 . . . . 2.48 114.155 -161.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.934 -1.508 . . . . 7.0 112.46 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 114.915 1.45 . . . . 6.9199999999999999 114.915 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.34 46.8 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.694 2.093 . . . . 1.6599999999999999 111.683 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.21 152.7 11.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.237 1.199 . . . . 1.6299999999999999 114.237 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.45 128.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.163 1.385 . . . . 2.73 109.12 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.2 117.74 29.88 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.748 0.647 . . . . 5.7599999999999998 112.748 -166.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.5 142.13 58.53 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.244 2.218 . . . . 6.0 113.865 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -159.13 167.61 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 120.109 -1.62 . . . . 2.6699999999999999 111.448 158.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.29 -15.68 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.121 3.214 . . . . 3.1499999999999999 112.453 166.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 155.14 40.42 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 119.29 -0.728 . . . . 1.5600000000000001 112.042 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.37 -8.7 23.89 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.075 3.183 . . . . 2.29 114.373 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.87 146.97 35.55 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.005 1.322 . . . . 3.2799999999999998 111.676 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.91 -176.03 5.74 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.072 1.749 . . . . 2.5299999999999998 112.952 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.0 154.85 50.29 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.449 1.1 . . . . 2.2999999999999998 111.831 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.18 147.88 44.28 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.265 1.031 . . . . 1.9399999999999999 111.637 166.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.1 146.52 39.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.128 1.771 . . . . 3.1400000000000001 108.753 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.1 153.79 14.33 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.926 0.713 . . . . 3.0099999999999998 112.926 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.1 m -72.57 110.61 7.07 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.629 1.572 . . . . 2.1299999999999999 108.259 159.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.07 127.81 34.14 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.159 -1.423 . . . . 3.6800000000000002 107.159 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.68 114.49 20.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 4.4100000000000001 110.522 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -102.66 103.68 33.92 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.141 -0.974 . . . . 0.94999999999999996 110.686 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.13 -7.92 11.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.91 2.407 . . . . 1.1799999999999999 113.236 172.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.14 171.18 55.19 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 119.109 0.868 . . . . 0.98999999999999999 113.7 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 17.5 m-20 -101.57 0.16 35.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.367 1.867 . . . . 2.7000000000000002 113.032 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.96 159.06 39.06 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.723 1.609 . . . . 2.7599999999999998 110.451 167.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.23 154.37 18.95 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.043 2.495 . . . . 1.1399999999999999 111.142 -173.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -101.65 150.63 22.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.258 1.023 . . . . 3.5899999999999999 110.482 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 68' ' ' GLU . 31.8 ttm180 -133.7 103.06 5.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.526 1.131 . . . . 4.0899999999999999 109.409 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 tp -84.14 104.83 14.52 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.366 2.267 . . . . 1.9199999999999999 108.97 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.64 -12.93 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.154 0.982 . . . . 1.8999999999999999 113.001 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.26 -169.35 41.89 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 124.448 1.023 . . . . 0.63 111.76 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.17 -178.39 7.26 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.113 0.965 . . . . 2.0800000000000001 111.508 173.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -158.32 149.92 21.27 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 121.509 1.959 . . . . 8.0299999999999994 109.126 -175.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -154.28 152.13 25.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.019 1.327 . . . . 2.29 108.243 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.87 -25.14 60.35 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.661 2.241 . . . . 0.90000000000000002 113.418 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -79.59 -4.18 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.889 1.44 . . . . 1.9299999999999999 114.889 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.38 174.56 12.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.948 1.299 . . . . 2.1800000000000002 112.476 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -116.56 -87.97 0.6 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.84 0.856 . . . . 4.3200000000000003 110.17 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -69.35 107.05 3.14 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.511 -0.743 . . . . 5.75 109.71 -171.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -84.16 141.29 14.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.227 2.211 . . . . 3.04 110.571 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -146.72 124.2 11.7 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 2.71 109.999 166.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -81.84 115.36 21.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.184 0.993 . . . . 2.0800000000000001 110.326 169.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -100.23 151.69 21.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.737 1.615 . . . . 0.89000000000000001 111.881 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.8 177.82 5.65 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.038 -1.437 . . . . 1.99 110.689 165.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.541 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 87.5 m -147.94 102.76 3.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.24 1.416 . . . . 1.8500000000000001 107.195 171.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -112.76 153.07 28.35 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.817 1.247 . . . . 3.8900000000000001 112.523 -166.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -105.5 121.72 44.52 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.487 0.66 . . . . 4.2599999999999998 109.598 156.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -144.91 170.01 16.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.311 1.844 . . . . 8.7400000000000002 109.107 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.25 143.95 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.351 0.66 . . . . 4.2699999999999996 109.927 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.12 -87.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 4.3700000000000001 108.408 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -77.4 50.99 0.83 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.436 1.895 . . . . 2.9700000000000002 110.404 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.1 -31.93 0.42 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 126.601 2.048 . . . . 3.48 115.077 -175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.82 146.63 24.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.584 1.953 . . . . 3.48 111.37 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -68.44 118.76 11.92 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 118.845 -0.598 . . . . 5.7800000000000002 109.47 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.83 147.78 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 4.6900000000000004 111.305 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.4 mmt -77.79 141.03 39.47 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.982 1.313 . . . . 4.25 113.671 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.56 27.81 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.058 0.837 . . . . 1.25 114.13 170.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -114.63 137.42 51.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.604 1.562 . . . . 2.23 110.346 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -148.21 155.71 43.14 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.913 1.285 . . . . 7.9699999999999998 109.955 165.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.52 145.63 82.87 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.073 2.515 . . . . 0.78000000000000003 110.953 167.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.83 159.06 33.13 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 125.338 1.455 . . . . 1.8100000000000001 109.855 166.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.0 -15.14 32.48 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.625 2.217 . . . . 0.78000000000000003 113.243 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -175.74 160.77 2.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.042 1.737 . . . . 3.5800000000000001 111.02 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mt -109.87 175.94 5.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.827 1.651 . . . . 2.1699999999999999 109.517 154.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.9 pt-20 -153.52 168.26 26.75 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.363 -0.835 . . . . 2.4199999999999999 112.116 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -149.82 136.46 10.83 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.442 1.097 . . . . 2.1099999999999999 109.527 -170.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -72.25 168.0 25.33 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.405 2.07 . . . . 0.92000000000000004 112.048 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.54 145.28 99.06 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.789 2.993 . . . . 0.95999999999999996 111.915 168.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.524 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 61.24 0.9 0.46 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.865 2.172 . . . . 3.0099999999999998 116.865 -172.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 114.03 3.79 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 127.147 2.308 . . . . 0.87 111.95 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -81.9 139.26 34.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.997 -1.101 . . . . 6.1600000000000001 109.243 151.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 m -151.36 130.51 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.657 1.583 . . . . 2.9500000000000002 110.084 169.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -90.41 130.39 36.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.629 -0.669 . . . . 3.3100000000000001 111.407 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -69.81 129.17 38.84 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.364 -0.976 . . . . 2.0899999999999999 108.364 161.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -143.28 140.73 18.05 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.576 1.55 . . . . 3.75 110.865 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.7 -16.75 47.08 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.702 2.935 . . . . 1.8100000000000001 114.278 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.98 100.0 1.79 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.24 -1.944 . . . . 1.3799999999999999 108.24 152.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.541 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 142.66 -85.33 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.847 1.689 . . . . 1.77 113.089 -172.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.71 144.2 20.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.067 1.747 . . . . 3.0499999999999998 111.22 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.92 158.02 27.47 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.256 -0.903 . . . . 1.1899999999999999 110.74 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -94.28 133.05 38.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.074 0.397 . . . . 3.1699999999999999 110.814 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.2 mmt -90.62 137.18 32.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.394 1.478 . . . . 1.6100000000000001 109.906 162.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.82 126.58 45.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.503 1.521 . . . . 4.1299999999999999 108.653 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.42 147.49 52.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.233 1.413 . . . . 4.0899999999999999 110.526 -175.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 57.95 4.6 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.236 -0.746 . . . . 1.3799999999999999 111.236 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.09 120.51 12.81 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.48 0.64 . . . . 2.02 110.938 -174.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -76.23 -9.78 58.9 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.873 1.064 . . . . 3.2200000000000002 113.873 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.98 145.08 0.74 Allowed Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 127.065 2.146 . . . . 5.6500000000000004 110.152 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.37 154.15 65.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.906 2.404 . . . . 2.1299999999999999 109.885 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.71 162.03 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.044 1.338 . . . . 4.1699999999999999 111.329 -170.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -114.71 127.05 55.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.265 1.026 . . . . 6.1200000000000001 111.222 172.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.34 117.48 4.87 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.906 -0.588 . . . . 2.3900000000000001 109.747 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.13 -8.46 31.18 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.21 -1.328 . . . . 2.6000000000000001 114.683 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.34 161.2 26.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 119.637 1.718 . . . . 3.3700000000000001 109.955 162.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -111.01 156.93 20.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.636 -0.711 . . . . 5.3300000000000001 109.484 154.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.55 125.14 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.854 1.662 . . . . 2.6000000000000001 108.473 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -74.58 145.85 43.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.481 0.658 . . . . 3.9100000000000001 110.379 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 tt -154.96 126.7 7.51 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.141 0.977 . . . . 3.2999999999999998 110.643 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.43 109.92 21.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.121 2.568 . . . . 2.48 112.068 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 119.03 23.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.216 1.406 . . . . 2.0800000000000001 110.321 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.0 mt -89.95 111.15 22.13 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.802 0.841 . . . . 1.8700000000000001 109.56 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -111.98 124.08 51.64 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.707 -0.621 . . . . 3.6899999999999999 109.836 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.87 37.49 1.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.123 1.769 . . . . 2.48 113.263 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -73.23 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.722 1.153 . . . . 4.6200000000000001 112.091 -171.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.63 -30.2 60.33 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 115.739 1.055 . . . . 2.46 115.739 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -83.91 86.45 7.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 119.946 1.873 . . . . 7.6100000000000003 108.51 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -100.86 106.93 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.042 1.337 . . . . 2.5499999999999998 109.549 173.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.16 125.81 44.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.771 1.629 . . . . 4.4699999999999998 110.654 -173.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -83.14 139.04 33.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.479 1.659 . . . . 3.6299999999999999 115.479 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.81 169.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.399 1.88 . . . . 2.46 109.32 159.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.6 139.23 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.386 1.474 . . . . 2.8799999999999999 108.346 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -146.03 145.86 26.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.303 1.441 . . . . 2.6499999999999999 110.798 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.18 158.37 55.01 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 124.274 3.316 . . . . 1.1200000000000001 113.948 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.44 134.55 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.313 1.445 . . . . 2.3999999999999999 111.577 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -152.41 -172.18 4.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.878 2.071 . . . . 4.0800000000000001 109.429 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.47 124.98 35.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.964 -1.085 . . . . 3.8100000000000001 110.886 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 125.357 1.463 . . . . 9.7899999999999991 112.798 -163.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 109.655 -0.498 . . . . 4.8700000000000001 109.655 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.08 175.81 19.37 Favored Glycine 0 N--CA 1.466 0.655 0 O-C-N 121.48 -0.762 . . . . 1.4099999999999999 114.631 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -159.86 146.01 15.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.943 1.697 . . . . 1.47 110.572 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.92 138.93 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.436 -0.95 . . . . 2.2999999999999998 108.436 170.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -86.73 131.76 34.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.544 0.688 . . . . 5.7000000000000002 112.176 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -53.26 119.52 4.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.741 1.616 . . . . 5.0499999999999998 112.587 164.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -165.29 99.03 0.8 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.699 2.0 . . . . 4.3499999999999996 107.522 163.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.66 44.21 1.45 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.459 2.773 . . . . 2.9399999999999999 111.964 -168.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.94 -147.78 6.47 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.304 0.954 . . . . 1.9399999999999999 114.138 -167.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.32 -7.04 17.73 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.299 2.666 . . . . 2.04 112.798 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -154.25 156.89 37.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 2.8199999999999998 112.829 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.2 -165.36 1.9 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.387 2.675 . . . . 2.29 110.448 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.04 154.39 39.24 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.261 -0.899 . . . . 1.95 111.798 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.81 125.46 46.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.919 0.888 . . . . 2.0299999999999998 110.405 165.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -103.11 147.4 27.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.985 1.714 . . . . 3.4100000000000001 108.75 168.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -163.45 141.88 7.94 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.275 1.213 . . . . 2.7000000000000002 114.275 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.1 m -66.82 107.61 2.24 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.277 -1.008 . . . . 2.5800000000000001 108.277 161.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 134.36 36.42 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 106.944 -1.502 . . . . 3.6299999999999999 106.944 165.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.28 151.56 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.35 1.071 . . . . 3.4700000000000002 112.01 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -128.29 99.37 24.51 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.52 1.528 . . . . 0.98999999999999999 109.073 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -6.27 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.49 2.127 . . . . 1.1200000000000001 112.841 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.51 174.03 54.17 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.282 0.944 . . . . 0.88 113.994 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 4.4 m-20 -102.11 -3.79 26.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.507 1.923 . . . . 2.71 113.441 -170.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.34 161.0 33.74 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.107 1.763 . . . . 2.6000000000000001 109.98 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.65 162.76 24.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.058 2.506 . . . . 1.02 111.978 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.26 144.92 40.87 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.252 1.021 . . . . 2.9399999999999999 110.593 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -122.67 114.19 20.25 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.896 1.278 . . . . 4.3499999999999996 109.27 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.54 117.23 29.79 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.04 2.136 . . . . 1.8400000000000001 109.151 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -117.69 -4.9 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.405 1.082 . . . . 1.6499999999999999 112.938 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.71 -174.6 47.01 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.698 1.142 . . . . 0.68000000000000005 111.18 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.06 178.92 8.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.242 1.417 . . . . 1.8799999999999999 109.891 171.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.483 HH11 ' HG3' ' A' ' 36' ' ' ARG . 12.8 tpt85 -161.28 147.86 14.62 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 106.664 -1.606 . . . . 7.0099999999999998 106.664 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -149.7 157.8 38.09 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 124.6 1.16 . . . . 1.79 109.172 -166.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.05 -15.79 16.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.11 1.873 . . . . 1.51 114.351 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.7 m -101.16 2.46 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 116.025 1.861 . . . . 2.0800000000000001 116.025 -170.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 164.05 38.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.416 1.007 . . . . 2.1400000000000001 113.019 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.34 -79.67 0.54 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.731 2.012 . . . . 2.8399999999999999 111.314 -170.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 111.37 9.88 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.412 -0.958 . . . . 4.5 108.412 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -84.15 139.62 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.435 -1.257 . . . . 2.8300000000000001 110.428 158.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -142.24 122.46 13.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.597 1.159 . . . . 2.0 109.042 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -79.01 118.74 21.29 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.627 1.558 . . . . 2.3399999999999999 110.713 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -113.36 157.28 22.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 0.60999999999999999 111.869 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -112.34 167.45 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.396 1.478 . . . . 2.2000000000000002 110.372 166.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -123.26 114.79 20.7 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.741 1.616 . . . . 2.46 107.453 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -120.7 152.91 37.64 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.924 0.89 . . . . 3.5 112.809 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtp -103.03 142.78 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.82 1.648 . . . . 4.7599999999999998 110.325 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -157.8 144.83 18.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.097 1.359 . . . . 7.6600000000000001 111.503 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 137.95 31.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.284 0.493 . . . . 4.1900000000000004 111.104 166.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -146.71 126.33 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.732 1.613 . . . . 3.7200000000000002 107.324 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 63.33 20.35 12.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.589 1.156 . . . . 3.2400000000000002 111.963 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.17 -9.14 41.45 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.761 1.172 . . . . 2.3999999999999999 113.829 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -89.2 143.86 26.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.978 1.711 . . . . 4.0700000000000003 109.927 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -81.7 118.86 23.17 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.61 -0.681 . . . . 4.5300000000000002 110.875 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.03 150.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.239 1.816 . . . . 2.4500000000000002 109.717 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtm -135.24 144.65 46.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.771 1.228 . . . . 3.8900000000000001 110.676 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 177.58 32.38 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 123.773 0.702 . . . . 1.45 113.037 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -115.7 151.23 35.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.958 1.303 . . . . 2.8799999999999999 110.495 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -164.43 147.65 7.59 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.29 1.036 . . . . 6.3799999999999999 112.4 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.6 Cg_endo -70.82 153.18 64.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.229 1.953 . . . . 0.81000000000000005 112.512 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.95 159.02 70.8 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 126.438 1.895 . . . . 1.8200000000000001 110.408 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.96 -16.83 36.85 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.421 2.081 . . . . 0.80000000000000004 113.342 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -179.97 172.08 1.08 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 125.424 1.49 . . . . 3.21 111.253 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.2 173.0 7.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.611 2.365 . . . . 2.1299999999999999 109.072 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.25 166.47 33.08 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.058 -1.026 . . . . 2.29 111.747 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.2 t -150.41 137.16 11.23 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.117 1.367 . . . . 1.95 109.471 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.76 171.36 15.7 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.908 2.405 . . . . 0.97999999999999998 112.315 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.35 142.04 94.54 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.1 2.533 . . . . 0.87 111.491 166.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.463 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 64.3 mmtt 65.34 2.54 1.97 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.834 1.653 . . . . 2.2999999999999998 113.387 -174.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.49 121.98 5.79 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 127.451 2.453 . . . . 1.1399999999999999 110.242 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -113.91 131.72 56.19 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.045 1.738 . . . . 6.9500000000000002 109.51 167.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 m -159.55 134.36 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.065 1.346 . . . . 2.9900000000000002 111.083 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -79.53 134.6 36.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.24 1.019 . . . . 3.7400000000000002 112.824 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.03 69.62 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.874 1.321 . . . . 2.0800000000000001 108.517 143.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -83.14 149.35 58.58 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 128.682 2.793 . . . . 3.75 110.832 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -54.46 -37.99 89.71 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.22 2.613 . . . . 1.1899999999999999 113.552 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.63 65.09 3.37 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.078 0.854 . . . . 1.8300000000000001 111.022 168.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.39 -81.46 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.081 1.324 . . . . 1.23 113.391 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -153.33 152.18 30.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.383 1.873 . . . . 3.5099999999999998 110.19 -164.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -164.87 165.14 20.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.37 1.068 . . . . 1.1200000000000001 110.002 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -95.89 123.6 39.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.42 -1.326 . . . . 3.5499999999999998 107.42 160.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.97 129.91 34.87 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.491 -1.3 . . . . 2.6200000000000001 107.491 163.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.56 123.38 49.32 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.864 -0.791 . . . . 4.3200000000000003 108.864 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.93 132.55 55.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.143 1.777 . . . . 4.0199999999999996 109.056 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.17 96.07 0.2 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.288 -1.125 . . . . 1.45 110.288 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 mt -100.7 128.59 46.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.715 0.758 . . . . 2.1600000000000001 111.57 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -79.76 -18.95 49.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.273 1.429 . . . . 2.73 112.815 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -156.77 145.13 14.46 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.633 1.573 . . . . 6.4699999999999998 110.307 167.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.87 145.3 56.08 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.944 2.43 . . . . 1.6200000000000001 110.097 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.97 82.0 6.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.465 1.126 . . . . 3.52 110.993 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 133.8 54.6 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.962 1.705 . . . . 4.2199999999999998 109.518 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.0 135.72 52.39 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.57 -1.331 . . . . 2.8100000000000001 111.93 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.99 53.78 21.11 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.72 -0.552 . . . . 2.3700000000000001 111.72 -171.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -117.98 165.73 13.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.167 1.387 . . . . 2.8500000000000001 110.761 163.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 154.29 20.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.212 1.405 . . . . 5.1699999999999999 109.518 164.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.3 t -140.89 105.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.854 1.662 . . . . 1.8 109.05 166.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -65.64 142.35 58.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.663 0.744 . . . . 4.1799999999999997 110.209 163.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -140.63 129.96 23.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.977 0.894 . . . . 2.7799999999999998 111.13 174.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -86.59 101.81 13.57 Favored 'General case' 0 CA--C 1.552 1.047 1 C-N-CA 132.536 4.334 . . . . 2.9199999999999999 111.436 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.7 mt -82.41 122.56 28.16 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.931 -1.731 . . . . 2.2000000000000002 111.055 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.17 123.07 43.18 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.737 0.815 . . . . 1.97 110.542 -171.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.5 153.05 35.93 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.694 0.759 . . . . 3.0099999999999998 111.996 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.39 134.39 56.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.862 0.465 . . . . 2.3999999999999999 110.672 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.7 10.45 52.94 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.848 1.099 . . . . 3.9300000000000002 115.848 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.25 6.77 83.91 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 119.119 1.46 . . . . 2.1200000000000001 114.184 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -76.24 131.84 39.53 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.362 -1.081 . . . . 7.0300000000000002 109.714 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.81 140.17 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.277 1.031 . . . . 2.3799999999999999 110.2 166.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.9 mt -141.05 123.38 15.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.138 1.375 . . . . 2.9500000000000002 108.931 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -92.0 145.71 24.31 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.539 0.94 . . . . 3.5499999999999998 113.539 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.14 149.28 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.78 2.032 . . . . 2.5899999999999999 111.093 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.96 135.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.45 1.5 . . . . 4.75 111.167 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -144.71 85.19 8.58 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.83 1.652 . . . . 2.9399999999999999 110.649 -166.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.66 154.56 59.33 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.249 2.633 . . . . 1.27 112.462 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.9 t -84.35 134.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.867 0.867 . . . . 2.3199999999999998 111.384 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.98 157.49 40.65 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.096 1.358 . . . . 3.8700000000000001 111.136 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 11.99 4.72 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.832 1.653 . . . . 3.3999999999999999 113.948 171.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.233 0 CA-C-O 114.545 -2.645 . . . . 6.6500000000000004 115.704 -174.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.69 0.281 . . . . 6.9199999999999999 111.673 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.14 149.84 18.04 Favored Glycine 0 N--CA 1.465 0.6 0 O-C-N 120.879 -1.138 . . . . 1.49 112.969 162.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -153.55 151.48 29.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.476 0.917 . . . . 1.98 113.476 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.7 t -110.76 144.12 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 2.1299999999999999 110.525 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -87.79 113.76 23.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.234 1.198 . . . . 4.3399999999999999 114.234 -156.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -63.48 123.03 17.73 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.585 -0.697 . . . . 4.3799999999999999 111.906 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -159.36 147.85 13.83 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 3.1200000000000001 110.348 166.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.39 63.31 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.089 3.192 . . . . 2.5 109.61 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.99 168.5 13.72 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.263 0.935 . . . . 1.6899999999999999 113.908 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.15 -15.47 14.49 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.819 3.013 . . . . 1.8200000000000001 112.001 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -144.86 158.97 43.61 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.369 1.867 . . . . 2.3999999999999999 111.605 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.55 -177.17 6.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.852 1.261 . . . . 2.2799999999999998 111.05 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.31 149.45 30.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.626 1.17 . . . . 2.0800000000000001 110.916 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.65 128.89 55.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.45 -0.574 . . . . 2.27 109.45 160.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.17 162.93 14.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.524 1.93 . . . . 3.4100000000000001 109.98 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.436 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.1 pt? -161.38 140.87 10.3 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.792 1.405 . . . . 2.5600000000000001 114.792 166.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -79.12 137.44 37.48 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.55 -1.278 . . . . 2.4300000000000002 107.55 151.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.36 135.71 13.21 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.615 1.166 . . . . 3.6499999999999999 109.995 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.2 142.75 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.307 1.043 . . . . 3.23 113.177 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -82.17 114.21 49.29 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.592 -1.185 . . . . 0.89000000000000001 109.321 152.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -83.45 -9.64 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.166 2.578 . . . . 1.29 113.386 174.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.93 170.48 47.67 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.752 1.167 . . . . 0.82999999999999996 113.645 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 4.8 m-20 -93.87 -7.14 44.03 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.287 1.835 . . . . 2.73 112.826 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.8 159.8 35.96 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.23 1.812 . . . . 2.3399999999999999 110.436 171.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.73 158.63 28.14 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.778 2.319 . . . . 0.94999999999999996 111.793 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.67 140.14 43.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.499 1.52 . . . . 3.3300000000000001 109.64 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.64 112.13 15.77 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.237 1.015 . . . . 4.5999999999999996 109.958 171.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.13 114.94 26.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.101 2.16 . . . . 1.75 109.025 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -107.06 -10.1 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.797 1.239 . . . . 1.54 113.091 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.3 -167.59 40.02 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.993 1.282 . . . . 0.46000000000000002 110.962 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.09 176.85 11.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.041 0.936 . . . . 1.96 111.127 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -146.72 121.63 9.98 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.84 0.856 . . . . 8.7899999999999991 110.631 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.27 148.55 70.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 124.922 1.289 . . . . 1.71 108.79 -173.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.14 -1.0 10.31 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.472 2.115 . . . . 0.93000000000000005 114.15 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.37 -0.43 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.882 1.808 . . . . 1.9099999999999999 115.882 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.72 168.21 21.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.236 1.834 . . . . 2.0699999999999998 114.738 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.468 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 3.9 tp10 -104.94 -93.4 0.36 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.976 1.37 . . . . 3.1200000000000001 110.365 169.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -84.63 83.86 7.87 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.632 -1.293 . . . . 5.6699999999999999 109.541 -165.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.67 131.21 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.572 2.349 . . . . 2.4300000000000002 112.127 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -140.58 132.05 26.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.942 1.697 . . . . 2.6400000000000001 110.458 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 121.73 26.84 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.199 1.363 . . . . 1.99 111.131 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -110.7 152.42 26.57 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.217 2.207 . . . . 0.77000000000000002 113.165 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.92 137.44 32.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.719 1.608 . . . . 2.3500000000000001 109.172 155.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -101.35 146.01 28.14 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.025 -1.843 . . . . 3.2000000000000002 106.025 161.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -156.79 172.22 19.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.874 1.435 . . . . 4.1900000000000004 114.874 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.1 mtm -118.99 127.48 53.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.917 1.287 . . . . 7.6399999999999997 108.269 148.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -146.75 170.18 17.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.353 1.861 . . . . 10.65 110.054 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -102.72 156.3 17.73 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.817 0.847 . . . . 4.7400000000000002 112.316 -167.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.28 -96.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 3.8399999999999999 108.377 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -76.38 42.51 0.28 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.466 2.306 . . . . 3.7200000000000002 110.53 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.17 -15.25 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 119.816 -1.802 . . . . 2.29 114.098 -169.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -81.17 131.97 35.33 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.812 -1.405 . . . . 5.0800000000000001 110.85 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HE2' ' HB2' ' A' ' 57' ' ' LYS . 1.3 ptmm? -83.05 90.6 7.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.62 1.168 . . . . 7.9900000000000002 112.172 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.07 148.23 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.467 1.507 . . . . 4.0899999999999999 111.466 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.47 156.82 17.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.381 1.252 . . . . 7.3200000000000003 114.381 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.51 -165.21 35.94 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.759 1.647 . . . . 2.4300000000000002 111.168 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -153.1 158.74 42.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 4.1799999999999997 112.115 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -153.6 141.26 13.62 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 7.25 111.281 -170.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.26 147.17 77.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.599 2.199 . . . . 1.04 112.377 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.15 157.16 61.72 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 126.706 2.002 . . . . 1.8899999999999999 110.593 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.11 -13.49 36.4 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.854 2.369 . . . . 1.02 113.489 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.5 p90 179.04 168.52 0.95 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.937 1.695 . . . . 3.0499999999999998 110.328 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -113.92 174.41 5.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.664 1.586 . . . . 2.23 109.428 152.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.05 163.26 36.82 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.456 -0.777 . . . . 2.3599999999999999 111.066 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.72 124.78 8.78 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 2.2599999999999998 107.873 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.45 161.03 46.82 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.784 1.656 . . . . 1.1299999999999999 110.679 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.86 138.39 78.79 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.423 2.749 . . . . 0.83999999999999997 110.972 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 69.1 mmtt 68.67 -0.29 2.37 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.373 1.869 . . . . 2.3999999999999999 113.863 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.42 116.52 4.35 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 126.1 1.809 . . . . 0.96999999999999997 112.026 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -77.42 131.92 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.178 -1.011 . . . . 5.4500000000000002 109.994 156.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.01 175.88 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.875 2.07 . . . . 2.6499999999999999 110.25 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -137.89 114.3 10.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.065 0.946 . . . . 4.2699999999999996 110.502 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 85.37 0.43 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.923 -1.51 . . . . 2.3500000000000001 106.923 157.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 152.8 37.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.578 . . . . 4.5199999999999996 112.901 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.91 -41.22 48.21 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.735 2.956 . . . . 1.73 113.836 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.57 40.57 2.62 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.592 -1.115 . . . . 1.54 113.987 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.27 -61.1 0.02 OUTLIER Glycine 0 N--CA 1.472 1.054 0 CA-C-N 118.826 1.313 . . . . 1.8300000000000001 115.439 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -153.38 145.96 24.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.303 1.441 . . . . 3.7000000000000002 111.06 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -165.29 173.45 11.22 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.774 -1.204 . . . . 1.03 110.402 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.83 129.35 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.837 -0.602 . . . . 3.3599999999999999 109.659 165.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.5 mmt -80.11 121.73 25.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.431 -0.581 . . . . 1.6899999999999999 109.431 163.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.4 mt -107.74 86.34 2.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.373 1.469 . . . . 2.3799999999999999 109.555 -176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.05 142.11 29.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.993 0.917 . . . . 3.7400000000000002 109.629 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.22 60.23 4.22 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.861 0.743 . . . . 1.45 112.033 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.69 124.82 22.42 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.829 0.852 . . . . 2.0299999999999998 112.805 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.468 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 28.5 mmtp -81.29 -0.03 39.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.659 1.183 . . . . 3.9199999999999999 113.588 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.14 150.31 0.61 Allowed Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 128.85 2.86 . . . . 7.2300000000000004 109.486 177.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.39 149.76 75.37 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.488 2.125 . . . . 2.3799999999999999 110.233 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.57 108.79 14.5 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.458 -1.312 . . . . 3.3100000000000001 107.458 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.48 119.37 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.785 -1.197 . . . . 4.0999999999999996 111.368 -170.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.51 113.65 1.88 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.963 -1.125 . . . . 2.2400000000000002 107.963 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.29 -18.69 4.94 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 116.802 -2.11 . . . . 2.23 115.506 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.65 162.07 35.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.584 2.192 . . . . 3.8599999999999999 113.961 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -79.74 137.06 36.91 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.269 1.827 . . . . 4.3899999999999997 111.507 163.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.14 126.99 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 124.976 1.311 . . . . 1.95 109.41 160.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.462 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 51.7 mt-10 -71.2 141.39 50.65 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.955 -0.566 . . . . 3.1600000000000001 110.45 162.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mt -156.35 121.74 4.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.977 0.911 . . . . 2.2400000000000002 112.287 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.56 101.37 11.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.567 2.347 . . . . 2.2200000000000002 110.713 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.0 mt -76.37 115.71 16.37 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.102 1.761 . . . . 2.1000000000000001 110.121 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -85.34 124.47 31.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.864 0.866 . . . . 1.8100000000000001 110.601 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -121.71 126.02 47.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.239 0.616 . . . . 3.25 111.655 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.32 18.89 0.99 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.427 1.64 . . . . 2.8999999999999999 115.427 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.44 68.83 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.315 1.436 . . . . 4.8799999999999999 116.036 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -139.53 -26.52 0.26 Allowed Glycine 0 N--CA 1.477 1.387 0 CA-C-N 119.337 1.568 . . . . 2.54 116.592 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 141.6 28.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.325 1.563 . . . . 7.2699999999999996 109.409 172.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 p -142.39 161.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.633 -0.667 . . . . 1.8700000000000001 111.573 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.09 124.38 14.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.959 1.704 . . . . 3.6600000000000001 110.276 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 31.9 ttmt -71.71 116.59 12.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.298 -0.63 . . . . 3.75 109.298 161.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.65 153.94 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 124.514 1.126 . . . . 2.0899999999999999 108.948 158.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.99 137.25 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.439 -1.319 . . . . 3.8199999999999998 107.439 161.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.5 mt -139.63 130.13 14.34 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.198 -1.382 . . . . 2.8399999999999999 109.205 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -60.75 151.18 78.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.621 2.881 . . . . 1.4199999999999999 112.286 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.8 t -78.16 136.02 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.572 -0.705 . . . . 2.4399999999999999 109.401 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.49 151.52 35.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.59 1.156 . . . . 3.5899999999999999 109.379 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.47 55.31 0.72 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.963 1.305 . . . . 3.23 112.357 -158.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 125.3 1.44 . . . . 5.9900000000000002 108.555 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 120.873 0.368 . . . . 5.2599999999999998 111.7 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.71 164.39 27.75 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.147 1.356 . . . . 1.6899999999999999 114.15 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -161.23 154.42 21.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.205 1.402 . . . . 2.02 112.956 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -103.92 130.98 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.651 1.18 . . . . 1.8899999999999999 108.951 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -77.86 116.19 18.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.338 0.255 . . . . 4.4400000000000004 110.725 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -52.7 119.43 4.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.846 0.858 . . . . 3.3900000000000001 112.072 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 m -168.67 112.67 0.55 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.805 2.042 . . . . 2.7000000000000002 107.001 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.81 50.69 2.64 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.623 2.882 . . . . 3.7599999999999998 110.398 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -177.65 31.6 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.179 0.895 . . . . 2.0699999999999998 114.638 -167.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -66.26 -16.46 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.926 2.418 . . . . 1.8799999999999999 111.746 166.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -155.22 157.4 37.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.092 1.757 . . . . 3.4700000000000002 110.678 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.01 -174.88 5.15 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 2.2200000000000002 111.049 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.8 146.5 37.7 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.356 0.873 . . . . 2.1499999999999999 113.356 -170.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.97 146.38 49.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.134 0.974 . . . . 1.76 112.562 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -128.63 150.4 50.24 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.012 2.525 . . . . 3.6000000000000001 109.237 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.01 137.05 9.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 115.606 1.706 . . . . 3.2599999999999998 115.606 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.9 m -85.55 124.78 32.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 114.749 -1.114 . . . . 2.4100000000000001 108.932 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.02 137.23 51.98 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 127.153 2.181 . . . . 3.5099999999999998 107.814 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.14 143.17 31.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.665 0.745 . . . . 3.0899999999999999 111.027 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -111.73 105.54 56.62 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.062 -0.972 . . . . 1.52 109.154 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.47 -5.28 10.1 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.839 2.359 . . . . 1.4199999999999999 113.826 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.6 -174.35 38.41 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 124.387 0.994 . . . . 1.26 113.259 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -106.87 9.08 30.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.589 1.556 . . . . 2.3999999999999999 113.426 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.47 157.97 57.5 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.774 1.63 . . . . 3.21 110.666 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.19 157.21 13.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.26 2.64 . . . . 1.8 112.592 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.7 112.44 17.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.99 1.716 . . . . 3.5099999999999998 110.042 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -109.01 101.26 10.35 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.199 1.399 . . . . 5.2599999999999998 112.747 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 tp -80.55 106.55 12.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.306 2.242 . . . . 2.02 109.636 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.11 -14.53 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.309 1.443 . . . . 1.7 113.058 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.18 -162.19 30.94 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.251 0.929 . . . . 0.69999999999999996 111.618 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.59 -170.67 3.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.693 0.797 . . . . 1.74 111.209 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -167.44 134.75 2.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.463 -0.939 . . . . 7.2199999999999998 108.463 165.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t -136.09 143.32 43.53 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-O 117.544 -1.217 . . . . 1.8300000000000001 108.83 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.16 -20.0 56.56 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.646 2.231 . . . . 1.1399999999999999 113.145 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -77.22 3.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 113.263 0.838 . . . . 1.8400000000000001 113.263 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.2 -163.79 1.87 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.19 1.552 . . . . 1.96 115.19 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.84 -88.99 0.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.703 1.601 . . . . 3.5699999999999998 109.598 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -78.95 158.99 27.9 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.696 1.599 . . . . 8.2100000000000009 111.099 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.06 73.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 124.816 2.246 . . . . 2.04 109.315 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -96.36 120.22 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 111.997 -2.365 . . . . 4.5199999999999996 110.163 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.48 121.93 25.81 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.884 0.849 . . . . 1.72 111.509 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -107.69 155.83 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.805 2.042 . . . . 1.1299999999999999 112.006 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -104.78 177.91 4.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.369 -1.287 . . . . 2.9500000000000002 110.891 157.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -150.61 115.93 5.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.282 1.833 . . . . 2.2799999999999998 107.38 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.57 178.71 6.79 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.388 1.475 . . . . 3.75 111.587 -162.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.7 ptp -119.57 151.15 39.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.649 1.18 . . . . 4.1699999999999999 111.623 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -154.44 158.95 40.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.817 1.247 . . . . 8.6699999999999999 112.243 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.5 137.61 38.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.011 0.925 . . . . 4.0300000000000002 109.81 163.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.7 t -118.22 -93.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.434 1.494 . . . . 4.1200000000000001 109.221 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -77.92 39.07 0.28 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.126 2.17 . . . . 3.6099999999999999 110.931 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.22 -6.13 16.49 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 119.815 -1.803 . . . . 1.9099999999999999 113.825 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -107.1 155.68 19.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.132 2.173 . . . . 4.4500000000000002 110.595 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.61 140.82 29.48 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.889 1.07 . . . . 4.6600000000000001 113.889 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 t -143.25 157.89 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.794 2.037 . . . . 3.3100000000000001 108.293 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.4 ptp -74.18 173.23 10.43 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.489 0.716 . . . . 4.96 112.712 170.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.13 153.99 25.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.633 1.111 . . . . 1.28 111.254 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -124.4 143.01 50.85 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.147 1.379 . . . . 2.6499999999999999 108.576 171.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.34 145.28 7.7 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 118.089 -0.958 . . . . 7.0 112.058 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.96 150.6 82.91 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.881 2.387 . . . . 1.1000000000000001 110.703 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.96 156.37 74.26 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.358 1.463 . . . . 1.6100000000000001 109.976 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.88 -22.69 42.18 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.422 2.082 . . . . 0.78000000000000003 112.417 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -175.2 165.06 3.35 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 125.433 1.493 . . . . 2.96 111.729 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.99 171.87 7.27 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.565 1.546 . . . . 1.97 109.437 153.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.74 163.6 39.74 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.271 -0.893 . . . . 3.1899999999999999 113.292 165.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.67 129.36 22.69 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 126.093 1.757 . . . . 2.3399999999999999 109.133 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.64 161.46 43.92 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.483 2.122 . . . . 1.4199999999999999 111.076 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.12 140.74 91.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.559 2.839 . . . . 1.6100000000000001 112.251 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp 68.1 -0.24 2.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.711 2.005 . . . . 3.04 113.983 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.32 156.8 28.53 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 127.075 2.274 . . . . 1.1899999999999999 112.066 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtt85 -119.88 155.62 32.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.765 2.026 . . . . 7.0300000000000002 111.51 168.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.99 159.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.911 1.684 . . . . 2.3199999999999998 110.256 164.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.27 109.69 12.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.457 1.503 . . . . 4.1799999999999997 107.74 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.09 83.36 0.51 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.245 1.418 . . . . 2.3700000000000001 109.361 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.55 156.96 36.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.645 1.578 . . . . 4.7300000000000004 112.717 -172.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -59.72 -29.84 90.65 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.116 2.544 . . . . 0.96999999999999997 114.118 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.98 49.57 3.33 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.997 -0.89 . . . . 1.27 111.814 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.88 -71.11 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 115.558 0.983 . . . . 1.1299999999999999 115.558 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -157.63 143.79 17.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.014 2.125 . . . . 3.1400000000000001 110.485 -165.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -168.81 174.26 6.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.235 0.925 . . . . 0.82999999999999996 112.285 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -104.28 136.96 42.9 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.408 0.683 . . . . 3.4300000000000002 111.64 169.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -96.25 121.3 37.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.653 1.181 . . . . 1.8500000000000001 110.029 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.12 108.61 21.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.825 0.85 . . . . 3.7999999999999998 109.809 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.72 65.81 1.03 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.481 1.112 . . . . 3.9199999999999999 110.529 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.82 113.82 1.54 Allowed Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.621 1.582 . . . . 2.0600000000000001 111.229 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -103.34 154.61 19.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.863 1.265 . . . . 2.0299999999999998 111.195 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -125.38 -26.74 3.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.411 1.485 . . . . 3.1400000000000001 112.371 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -118.14 132.01 23.93 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-O 118.205 -0.902 . . . . 5.6799999999999997 109.077 161.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.17 124.39 11.28 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.939 -1.985 . . . . 1.74 106.939 159.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.82 121.94 16.18 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.037 1.335 . . . . 2.9300000000000002 111.089 -161.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -88.29 131.49 34.77 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.743 -1.223 . . . . 5.7400000000000002 109.874 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 119.49 5.89 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.847 -1.168 . . . . 2.8300000000000001 107.847 153.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.88 -1.6 56.66 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 118.434 -1.203 . . . . 2.6299999999999999 115.158 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.05 151.53 20.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.444 1.622 . . . . 3.1600000000000001 110.532 157.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -112.52 124.97 53.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.417 2.287 . . . . 5.9800000000000004 105.441 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.41 102.88 13.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.827 1.251 . . . . 1.9399999999999999 108.548 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.532 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 55.6 mt-10 -60.64 145.08 50.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.035 -0.53 . . . . 2.8199999999999998 110.5 163.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -158.84 132.81 7.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 3.2000000000000002 110.409 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.31 112.35 24.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.809 2.043 . . . . 2.2599999999999998 110.141 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.93 118.1 18.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.151 1.38 . . . . 2.8599999999999999 109.987 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.64 117.06 24.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.324 -0.621 . . . . 2.1299999999999999 109.324 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -116.37 121.47 42.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.152 0.797 . . . . 3.8399999999999999 113.152 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.84 28.37 0.13 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.681 2.393 . . . . 2.54 115.867 170.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.47 -61.85 3.87 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.902 1.239 . . . . 3.7000000000000002 112.519 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.51 2.54 29.85 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.99 1.556 . . . . 1.9099999999999999 116.99 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -142.64 148.89 38.17 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.414 1.607 . . . . 5.8700000000000001 112.3 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.62 139.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.851 1.66 . . . . 2.6699999999999999 109.165 162.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -145.23 135.35 23.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.658 1.183 . . . . 3.4399999999999999 111.01 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.532 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 39.9 ttmt -77.22 132.64 38.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.4 0.518 . . . . 3.1499999999999999 112.4 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.8 -179.77 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.45 1.9 . . . . 2.54 109.8 159.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.86 148.08 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 127.847 2.459 . . . . 4.1699999999999999 109.461 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -141.77 135.05 14.31 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.29 1.436 . . . . 2.7200000000000002 110.699 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.68 146.64 43.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.969 2.446 . . . . 1.46 112.391 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.1 t -76.84 138.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.597 0.759 . . . . 2.3100000000000001 109.502 165.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -140.45 151.14 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.193 0.597 . . . . 3.2799999999999998 111.386 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.43 60.53 1.17 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.801 1.64 . . . . 3.1499999999999999 111.41 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG 0.318 2.0 mmp_? . . . . . 0 C--O 1.251 1.146 0 N-CA-C 117.948 2.573 . . . . 6.1600000000000001 117.948 -161.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 110.423 -0.214 . . . . 6.7599999999999998 110.423 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.78 162.31 33.87 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 120.809 -1.182 . . . . 1.4299999999999999 114.597 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -146.49 146.47 30.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.668 1.187 . . . . 1.79 112.721 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.88 141.04 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.099 0.96 . . . . 2.1699999999999999 108.853 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -77.16 -13.61 59.92 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.677 1.362 . . . . 5.3099999999999996 114.677 -161.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.8 t80 72.85 147.25 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.077 2.951 . . . . 3.8799999999999999 112.625 -170.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -168.64 140.89 2.26 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.425 1.49 . . . . 4.6200000000000001 111.108 166.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -90.28 -13.19 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.065 3.177 . . . . 3.48 112.43 165.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -101.85 170.19 20.71 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.436 1.493 . . . . 1.75 112.865 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 -16.47 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 124.022 3.148 . . . . 2.8399999999999999 115.397 -166.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -94.63 141.86 28.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.751 1.159 . . . . 3.4500000000000002 111.458 163.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.76 179.15 7.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.788 1.635 . . . . 2.3199999999999998 111.625 164.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.28 153.61 51.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.264 1.426 . . . . 2.02 110.017 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.49 142.63 50.0 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.121 . . . . 1.98 112.21 168.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.45 147.82 41.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 3.2599999999999998 110.55 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -164.36 149.79 10.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.009 0.923 . . . . 2.6899999999999999 112.582 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -81.63 117.57 22.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.895 0.878 . . . . 2.48 108.838 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -89.93 135.46 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.162 0.585 . . . . 4.5199999999999996 110.477 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -124.15 167.69 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.052 1.341 . . . . 3.0299999999999998 109.507 173.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.71 104.71 6.93 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 123.8 0.84 . . . . 1.1699999999999999 109.914 162.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.95 -10.04 10.55 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.993 2.462 . . . . 1.77 113.168 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.35 156.79 39.73 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 124.155 0.884 . . . . 1.1399999999999999 112.461 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.9 m-20 -88.06 5.94 38.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.869 1.668 . . . . 2.75 113.391 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.22 158.71 45.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.096 1.758 . . . . 2.75 110.285 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.02 159.53 30.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.164 2.576 . . . . 1.03 111.748 -170.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.02 129.22 50.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.999 1.32 . . . . 3.5299999999999998 110.099 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -120.7 112.0 18.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.391 1.476 . . . . 3.7000000000000002 110.287 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -91.84 123.06 34.94 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.407 1.883 . . . . 2.0600000000000001 108.946 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.93 -11.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.419 1.087 . . . . 1.72 113.312 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.42 -161.68 30.82 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.144 0.878 . . . . 0.59999999999999998 111.07 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.83 -178.78 7.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.836 1.254 . . . . 1.5700000000000001 110.179 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -152.75 150.74 29.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.612 1.096 . . . . 6.4800000000000004 108.749 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -141.26 146.29 42.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 117.683 -1.151 . . . . 2.1400000000000001 108.636 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.12 -19.39 66.29 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.106 1.871 . . . . 0.84999999999999998 112.47 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m -82.94 -3.76 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.221 1.193 . . . . 2.02 114.221 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.43 177.97 9.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.856 1.207 . . . . 1.79 113.688 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -118.9 -87.67 0.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.132 1.373 . . . . 3.2799999999999998 110.421 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -78.74 103.98 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.653 -1.279 . . . . 4.2599999999999998 109.05 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.91 145.41 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.588 1.155 . . . . 3.3100000000000001 110.931 161.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -143.99 123.52 13.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.773 1.229 . . . . 2.3300000000000001 109.663 164.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.407 HD13 ' CE1' ' A' ' 84' ' ' PHE . 7.0 tt -84.86 120.79 26.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.54 1.518 . . . . 1.8200000000000001 110.997 168.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -107.41 151.88 24.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.535 1.534 . . . . 0.73999999999999999 112.856 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -86.23 166.46 15.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.262 2.225 . . . . 2.4500000000000002 110.801 163.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -150.21 126.79 10.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.387 1.475 . . . . 2.2000000000000002 108.26 170.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -149.34 156.88 42.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.571 0.952 . . . . 3.54 113.571 -155.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.8 mtm -107.48 62.22 0.62 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.869 1.668 . . . . 5.2400000000000002 111.981 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -79.42 156.13 28.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.948 -1.023 . . . . 8.4299999999999997 111.121 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.02 164.8 25.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.161 -1.051 . . . . 5.9900000000000002 108.161 158.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.3 t -156.89 -39.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.848 2.059 . . . . 4.0700000000000003 110.986 -164.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 56' ' ' LYS . 24.8 tt0 -159.09 41.34 0.22 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.115 2.966 . . . . 5.0599999999999996 108.003 -173.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.47 -19.23 0.08 OUTLIER Glycine 0 N--CA 1.479 1.558 0 C-N-CA 128.487 2.946 . . . . 2.04 114.899 -164.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 54' ' ' GLU . 41.2 pttt -83.04 134.82 35.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.347 1.459 . . . . 6.2800000000000002 109.804 175.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -88.93 120.16 30.1 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.507 -0.746 . . . . 5.1100000000000003 110.879 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.88 141.74 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.37 1.468 . . . . 2.5899999999999999 110.002 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 97.14 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.42 1.088 . . . . 5.5 109.753 165.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.75 168.31 12.75 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.462 1.03 . . . . 1.25 112.797 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.56 153.6 47.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.492 1.517 . . . . 3.0800000000000001 110.885 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -161.67 152.41 14.94 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 126.558 1.943 . . . . 7.4299999999999997 110.481 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.61 143.69 69.47 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.413 2.075 . . . . 0.65000000000000002 111.653 165.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -113.06 157.64 40.18 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.105 1.762 . . . . 1.79 110.862 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.33 -14.43 31.18 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.768 2.312 . . . . 0.66000000000000003 113.646 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.92 165.45 1.56 Allowed 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.265 1.826 . . . . 3.7000000000000002 109.914 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.69 167.62 10.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.669 1.587 . . . . 2.0699999999999998 109.359 155.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.94 163.84 31.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.702 1.001 . . . . 2.0800000000000001 113.702 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 139.84 14.53 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.632 1.573 . . . . 2.5800000000000001 109.164 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.63 169.55 14.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.401 2.067 . . . . 1.1699999999999999 111.153 168.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.22 148.58 92.49 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.757 2.305 . . . . 0.93000000000000005 111.869 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.1 mmmt 68.86 -0.62 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.789 2.036 . . . . 2.7599999999999998 114.027 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.83 -168.86 44.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.706 2.098 . . . . 1.45 114.939 -171.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -168.08 144.45 3.96 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.122 2.169 . . . . 6.4199999999999999 110.606 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.4 m -152.14 136.83 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.955 2.102 . . . . 2.9300000000000002 109.241 171.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -88.92 136.5 32.98 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.272 -0.893 . . . . 3.4399999999999999 110.867 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.36 72.72 0.96 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.508 1.147 . . . . 2.0099999999999998 108.444 156.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -85.43 145.9 43.36 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.477 1.911 . . . . 3.52 111.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -58.88 -23.54 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.823 2.349 . . . . 1.4299999999999999 113.805 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.29 35.99 4.51 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.926 1.251 . . . . 1.5700000000000001 113.617 171.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.37 -65.01 0.02 OUTLIER Glycine 0 N--CA 1.47 0.956 0 CA-C-N 118.399 1.099 . . . . 1.2 115.349 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -150.98 149.13 29.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.176 1.39 . . . . 3.4199999999999999 111.251 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -157.21 160.6 38.86 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.606 -1.309 . . . . 0.93000000000000005 111.44 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CE1' HD13 ' A' ' 45' ' ' LEU . 41.0 m-85 -96.1 120.58 36.63 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.584 -0.525 . . . . 3.1899999999999999 109.584 164.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.82 136.32 33.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.113 0.965 . . . . 2.7000000000000002 108.811 167.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.2 103.88 8.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.394 1.078 . . . . 2.5800000000000001 108.893 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.36 120.0 41.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.496 1.118 . . . . 3.9900000000000002 109.888 -173.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.03 97.43 0.62 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.069 1.318 . . . . 1.53 109.972 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -94.38 122.8 37.31 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.28 1.04 . . . . 2.0499999999999998 110.74 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -71.01 -12.89 61.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.948 0.722 . . . . 2.7000000000000002 112.948 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.426 HH12 ' CD ' ' A' ' 97' ' ' GLU . 21.2 ptt85 -153.33 139.56 12.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.001 1.72 . . . . 7.1200000000000001 109.868 168.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 145.39 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.175 2.583 . . . . 2.23 109.358 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.4 mt -92.3 167.04 12.28 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.045 0.938 . . . . 3.3700000000000001 113.044 -169.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -123.0 156.8 34.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.342 1.457 . . . . 6.1600000000000001 109.143 156.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 131.45 50.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.141 -0.689 . . . . 2.9700000000000002 109.141 161.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.96 2.54 77.93 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 117.349 -1.806 . . . . 2.3599999999999999 116.48 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.426 ' CD ' HH12 ' A' ' 91' ' ' ARG . 90.4 mt-10 -76.29 167.4 21.92 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.404 2.102 . . . . 3.3399999999999999 110.364 169.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -85.6 154.08 21.96 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.023 1.329 . . . . 5.4500000000000002 112.183 165.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.0 t -130.14 116.91 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.25 1.82 . . . . 1.97 109.414 163.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.474 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 9.6 mm-40 -71.1 140.21 50.57 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.455 -1.248 . . . . 3.7799999999999998 109.804 161.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 132.21 14.44 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.907 0.706 . . . . 2.8500000000000001 112.907 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.95 132.54 33.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.396 0.678 . . . . 2.3999999999999999 109.533 159.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.16 118.19 31.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.994 1.318 . . . . 2.3900000000000001 109.569 158.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.2 mt -95.05 131.38 41.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.417 1.087 . . . . 2.1099999999999999 111.643 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -120.27 159.5 24.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.339 1.056 . . . . 3.5499999999999998 112.418 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.86 118.31 7.04 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.255 0.835 . . . . 2.4399999999999999 113.255 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.18 -147.84 29.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.048 0.832 . . . . 2.9500000000000002 111.364 -173.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.57 56.09 4.71 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-O 119.175 -0.792 . . . . 2.4199999999999999 114.365 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -131.81 137.92 48.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.335 1.568 . . . . 5.5800000000000001 110.675 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.11 145.09 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.44 1.496 . . . . 2.6600000000000001 108.915 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.0 mt -127.53 110.2 12.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.715 1.206 . . . . 3.25 109.908 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.474 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -79.63 105.86 11.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.343 0.657 . . . . 5.1699999999999999 109.851 175.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m -105.82 -175.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.358 2.263 . . . . 2.1699999999999999 111.199 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.3 143.82 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.25 1.42 . . . . 3.1099999999999999 109.072 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.7 mt -136.14 154.6 77.49 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.072 1.749 . . . . 2.6299999999999999 109.813 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.44 154.53 27.9 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.352 2.701 . . . . 1.0700000000000001 111.272 161.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.0 t -85.89 142.12 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.359 1.863 . . . . 2.0299999999999998 108.368 159.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -122.7 -145.18 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.995 2.118 . . . . 3.4399999999999999 108.101 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.5 113.14 3.6 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 121.059 1.754 . . . . 2.5099999999999998 111.592 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 C-N-CA 127.819 2.448 . . . . 5.4400000000000004 110.813 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 110.042 -0.355 . . . . 6.4500000000000002 110.042 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.14 169.49 34.92 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.634 0.635 . . . . 2.1800000000000002 114.132 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -155.91 152.36 28.18 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.677 0.791 . . . . 3.1299999999999999 110.818 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -117.46 148.59 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.071 0.948 . . . . 2.1400000000000001 110.23 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.23 111.24 22.83 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.869 -1.144 . . . . 4.5099999999999998 113.629 -152.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -66.28 104.82 1.27 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 4.5499999999999998 111.158 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -155.79 130.57 5.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 117.559 -1.21 . . . . 3.8399999999999999 109.913 158.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.27 75.12 5.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.818 3.012 . . . . 2.9500000000000002 110.303 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.55 168.11 13.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.796 1.188 . . . . 2.1000000000000001 112.982 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.87 -31.97 46.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.423 2.082 . . . . 2.6400000000000001 110.541 167.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -113.2 152.93 29.12 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.537 1.935 . . . . 3.2400000000000002 111.932 162.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.78 -158.1 0.88 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.651 2.38 . . . . 2.3100000000000001 108.116 168.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.67 160.15 40.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.321 1.419 . . . . 2.2400000000000002 113.682 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.54 149.88 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.791 1.636 . . . . 2.0499999999999998 110.54 164.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.4 175.21 9.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.543 1.537 . . . . 3.75 110.796 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -175.01 148.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.21 1.404 . . . . 2.98 112.358 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.3 m -116.6 122.41 44.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.613 -1.625 . . . . 3.1000000000000001 106.613 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.33 139.33 11.87 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.673 0.789 . . . . 5.1399999999999997 110.392 -158.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -109.2 147.86 31.87 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.833 1.653 . . . . 2.79 113.822 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -85.56 112.6 45.61 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 114.109 -1.405 . . . . 0.80000000000000004 109.646 154.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.42 -10.26 12.23 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.099 2.533 . . . . 1.3 113.534 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.86 -179.55 53.04 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.19 0.9 . . . . 0.91000000000000003 113.767 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.527 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 7.0 m-20 -109.97 -4.23 16.05 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.955 1.702 . . . . 2.5499999999999998 113.011 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.77 159.25 34.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.832 1.653 . . . . 2.8500000000000001 110.031 165.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.88 152.53 16.88 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.089 2.526 . . . . 1.6399999999999999 111.543 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.87 157.62 15.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.414 1.085 . . . . 2.8799999999999999 111.247 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -142.09 109.05 5.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.299 1.44 . . . . 5.71 110.476 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.6 tp -95.98 113.98 25.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.449 2.3 . . . . 1.8999999999999999 109.696 -168.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.06 -12.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.977 1.311 . . . . 2.54 113.166 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.26 -158.7 28.44 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 121.303 -0.873 . . . . 0.53000000000000003 113.394 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.06 -177.56 5.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.106 0.962 . . . . 2.1800000000000002 111.106 166.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -142.76 136.23 28.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.555 1.142 . . . . 9.3000000000000007 108.491 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -141.14 147.61 48.11 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.225 1.41 . . . . 1.73 108.938 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.55 -23.19 32.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.628 1.552 . . . . 1.24 112.855 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.14 5.39 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 115.378 1.621 . . . . 2.0099999999999998 115.378 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.97 44.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.193 1.36 . . . . 2.04 113.2 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.82 -50.56 72.88 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.841 1.656 . . . . 6.5599999999999996 109.528 165.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -144.45 155.19 43.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.764 1.626 . . . . 5.4299999999999997 109.122 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.85 128.92 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 125.202 1.401 . . . . 2.1400000000000001 108.482 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -130.2 124.62 32.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.954 1.702 . . . . 2.0800000000000001 108.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -80.12 119.82 23.43 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.254 1.388 . . . . 1.9099999999999999 110.998 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -108.76 157.3 18.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.985 1.714 . . . . 0.92000000000000004 111.948 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -111.1 -177.64 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.943 1.697 . . . . 2.4399999999999999 111.75 171.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.5 m -123.22 120.94 34.64 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.22 -1.03 . . . . 2.6699999999999999 108.22 156.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -100.41 165.47 11.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.782 1.233 . . . . 3.6200000000000001 111.248 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtm -129.42 134.7 47.98 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.536 1.134 . . . . 4.6600000000000001 109.234 163.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.9 146.16 24.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.724 1.21 . . . . 7.9500000000000002 110.696 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.08 136.81 41.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.91 0.386 . . . . 3.5699999999999998 110.965 175.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.07 -95.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.308 -1.367 . . . . 3.23 107.308 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' CD ' ' HZ3' ' A' ' 56' ' ' LYS . 2.0 tm-20 -79.36 74.93 5.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.498 1.119 . . . . 4.1799999999999997 108.51 166.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.03 -11.68 0.04 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 128.874 3.13 . . . . 2.0499999999999998 118.022 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.406 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 31.9 mtmm -124.25 153.5 41.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.489 1.916 . . . . 5.29 110.94 -170.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 97.7 1.33 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.12 0.568 . . . . 4.8300000000000001 112.105 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -79.83 132.61 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 125.265 1.426 . . . . 2.6499999999999999 107.864 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.5 ptp -91.8 145.27 24.71 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.896 0.878 . . . . 3.6899999999999999 111.183 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.13 166.84 35.87 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 123.908 0.766 . . . . 1.0700000000000001 112.97 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.3 150.82 38.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.59 1.156 . . . . 2.48 111.419 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 mtp85 -163.74 155.65 14.78 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.423 1.489 . . . . 8.4600000000000009 111.388 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.93 143.38 79.16 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.597 2.198 . . . . 0.95999999999999996 110.898 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.5 155.29 54.35 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.928 1.691 . . . . 2.0099999999999998 110.543 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.36 -23.85 32.15 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.674 2.249 . . . . 0.95999999999999996 112.617 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -173.71 168.81 4.33 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.239 1.416 . . . . 2.8799999999999999 111.059 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -119.76 174.47 6.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.279 2.232 . . . . 2.2599999999999998 109.334 162.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.34 168.57 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.399 -0.813 . . . . 3.2200000000000002 111.251 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 t -147.36 129.58 7.62 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 125.202 1.401 . . . . 2.1600000000000001 108.647 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.37 163.69 35.73 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.185 1.924 . . . . 1.47 111.942 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.19 139.34 71.8 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.917 3.078 . . . . 1.1499999999999999 111.945 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.527 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 58.29 17.97 5.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 116.063 1.875 . . . . 3.3100000000000001 116.063 -172.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.23 116.82 5.46 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 128.151 2.786 . . . . 1.01 111.984 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -90.4 130.96 36.42 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 6.1600000000000001 111.738 163.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.4 m -121.32 171.32 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 2.9300000000000002 111.545 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -148.28 125.5 11.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.14 1.376 . . . . 4.6799999999999997 110.685 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -82.51 153.63 25.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.526 1.155 . . . . 2.54 110.836 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -170.65 149.26 2.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.006 1.723 . . . . 4.8899999999999997 111.817 -165.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -49.44 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.118 2.545 . . . . 2.25 111.293 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 96.42 0.91 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 107.625 -2.19 . . . . 2.3500000000000001 107.625 156.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.76 -155.73 17.15 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.745 2.116 . . . . 2.8300000000000001 112.034 -163.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -92.42 140.01 30.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.822 1.249 . . . . 3.8799999999999999 112.204 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -161.19 154.14 21.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.482 0.713 . . . . 0.90000000000000002 109.484 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -94.58 120.39 34.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.629 -0.878 . . . . 3.3399999999999999 108.629 173.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -68.75 130.5 43.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.152 -0.684 . . . . 1.6200000000000001 109.152 165.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -106.03 118.99 38.03 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.017 -1.105 . . . . 2.98 108.017 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.24 152.4 24.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 4.0599999999999996 109.834 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.82 67.6 2.02 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 124.652 1.12 . . . . 1.7 112.72 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.91 111.14 2.7 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.904 1.075 . . . . 2.2999999999999998 113.904 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -80.38 -25.19 39.27 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.999 1.32 . . . . 3.1600000000000001 112.505 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -119.78 126.65 26.81 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 106.044 -1.835 . . . . 4.9000000000000004 106.044 149.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -64.35 136.89 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 N-CA-C 107.167 -1.897 . . . . 1.8400000000000001 107.167 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.71 63.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.776 0.83 . . . . 3.4399999999999999 112.467 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 121.95 7.22 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.705 1.602 . . . . 4.4199999999999999 108.793 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.95 120.74 1.87 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.637 1.108 . . . . 2.1400000000000001 112.113 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 42.02 47.38 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.491 -0.616 . . . . 2.2799999999999998 114.325 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.44 ' H ' ' HB ' ' A' ' 117' ' ' VAL . 10.7 mm-40 -76.14 171.7 14.05 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.252 1.526 . . . . 3.6000000000000001 108.002 146.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -105.63 150.61 25.28 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.067 1.347 . . . . 4.9800000000000004 107.77 160.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.92 119.22 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.162 0.985 . . . . 2.1699999999999999 110.663 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.82 137.7 40.66 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.153 1.781 . . . . 2.9399999999999999 110.316 165.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mt -155.98 133.48 10.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.043 0.925 . . . . 2.5600000000000001 111.948 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -115.28 101.67 9.16 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.337 1.455 . . . . 2.0800000000000001 110.799 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 119.86 22.92 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.253 1.421 . . . . 2.5899999999999999 111.032 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.57 123.2 36.72 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.616 1.166 . . . . 2.0600000000000001 111.498 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.15 135.62 53.75 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.045 0.926 . . . . 2.9700000000000002 112.501 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.45 63.6 3.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.722 1.609 . . . . 3.3900000000000001 112.917 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.42 33.15 0.09 OUTLIER Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.708 2.099 . . . . 4.8399999999999999 113.956 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.61 -0.13 77.66 Favored Glycine 0 N--CA 1.476 1.342 0 CA-C-N 118.284 1.042 . . . . 1.95 114.652 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -97.86 151.1 20.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 122.629 1.204 . . . . 7.5899999999999999 113.856 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.05 151.41 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.991 2.117 . . . . 1.8799999999999999 107.617 154.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.96 119.68 32.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.447 1.099 . . . . 3.1499999999999999 109.283 167.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -74.31 133.9 42.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.289 0.236 . . . . 3.8199999999999998 110.414 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.26 145.33 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.92 1.688 . . . . 2.3599999999999999 109.493 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -125.05 125.19 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.666 0.786 . . . . 3.77 110.03 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 155.92 56.03 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.396 1.479 . . . . 4.4500000000000002 111.076 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.54 164.48 32.28 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.735 2.957 . . . . 1.5800000000000001 111.626 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 97' ' ' GLU . 13.7 t -97.39 142.14 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.384 1.074 . . . . 2.2999999999999998 111.823 167.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -145.66 162.06 38.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.961 1.705 . . . . 3.9900000000000002 113.008 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.59 62.57 2.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.012 1.725 . . . . 3.0899999999999999 111.987 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.473 -1.727 . . . . 5.2400000000000002 111.315 -176.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.236 0.382 0 CA-C-O 120.892 0.377 . . . . 5.3300000000000001 110.048 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.52 157.31 42.07 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 123.377 0.513 . . . . 1.6699999999999999 112.371 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -154.75 139.19 16.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.02 0.748 . . . . 1.49 113.02 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.5 t -93.2 132.56 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.606 -0.516 . . . . 2.3100000000000001 109.606 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -78.22 114.43 17.1 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.325 1.05 . . . . 5.3499999999999996 112.022 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -79.97 146.98 31.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.086 0.946 . . . . 5.0999999999999996 110.469 159.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.44 152.63 4.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.474 1.51 . . . . 3.3300000000000001 110.957 169.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.95 75.55 3.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.076 3.184 . . . . 3.3100000000000001 109.776 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.42 -179.67 34.4 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.671 1.028 . . . . 1.72 115.671 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.66 -15.92 19.07 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.833 3.022 . . . . 2.8599999999999999 112.877 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -147.77 160.54 42.62 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 115.077 1.51 . . . . 3.02 115.077 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.83 -168.39 2.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.252 2.221 . . . . 2.3100000000000001 110.861 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 147.46 32.37 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.235 1.014 . . . . 2.5800000000000001 112.439 -174.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.19 118.45 36.82 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.987 0.358 . . . . 2.5 110.232 159.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -101.18 142.57 32.43 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.01 1.724 . . . . 3.9199999999999999 108.547 164.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -164.1 149.64 10.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.167 1.914 . . . . 2.79 116.167 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.3 m -115.08 138.43 50.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.529 1.532 . . . . 2.9399999999999999 109.771 -173.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.11 -179.85 8.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.308 1.843 . . . . 6.2400000000000002 110.444 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.76 159.87 43.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.81 0.844 . . . . 4.9000000000000004 110.106 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.81 102.63 10.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.296 -0.865 . . . . 1.3 109.506 163.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.13 -7.12 17.07 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.875 2.383 . . . . 1.6699999999999999 113.197 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.11 177.36 54.36 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 124.325 0.964 . . . . 1.4099999999999999 113.72 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 7.1 m-20 -107.96 1.6 22.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.346 1.458 . . . . 2.5600000000000001 112.664 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -115.2 162.71 22.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.431 1.893 . . . . 3.0 109.616 164.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.14 157.8 20.23 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.685 2.257 . . . . 1.27 111.489 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -105.77 153.52 21.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 3.4399999999999999 110.1 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -134.35 115.08 13.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.486 1.115 . . . . 4.8200000000000003 111.229 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.68 112.03 23.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.213 2.605 . . . . 1.99 108.601 -174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.92 -10.11 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.834 1.254 . . . . 1.8100000000000001 113.316 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.01 -173.95 46.09 Favored Glycine 0 C--N 1.342 0.883 0 O-C-N 121.543 -0.723 . . . . 0.56000000000000005 112.116 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.18 178.83 7.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.836 1.254 . . . . 1.99 110.306 170.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.35 142.41 3.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.187 -1.042 . . . . 5.6100000000000003 108.187 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -150.78 155.26 35.56 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 117.261 -1.352 . . . . 1.6899999999999999 108.274 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.61 -14.72 41.59 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.171 1.914 . . . . 1.3600000000000001 114.246 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.63 0.19 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.991 1.849 . . . . 2.3700000000000001 115.991 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.62 144.35 44.02 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 121.261 1.846 . . . . 2.1800000000000002 114.808 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -89.29 -76.37 0.41 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 110.259 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.3 ttm-85 -80.89 127.84 33.0 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.107 -0.995 . . . . 5.0 108.803 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.0 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 2.7000000000000002 110.322 167.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -144.59 133.49 22.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.823 1.649 . . . . 2.4300000000000002 110.924 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -79.31 119.25 22.09 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 120.055 1.298 . . . . 2.2000000000000002 111.027 170.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -110.58 156.02 21.52 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.756 2.022 . . . . 0.66000000000000003 111.795 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.29 -175.38 2.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.413 . . . . 2.8500000000000001 111.978 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -132.77 118.05 18.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.698 1.599 . . . . 2.48 108.441 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -115.99 179.05 4.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.436 1.094 . . . . 3.2599999999999998 111.098 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.3 ptp -143.21 128.88 19.24 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.549 0.74 . . . . 5.21 111.57 162.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -138.27 149.58 45.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.257 1.023 . . . . 7.5499999999999998 112.111 -173.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.439 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS 0.33 1.4 pm0 -64.92 146.84 54.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.026 1.731 . . . . 4.7400000000000002 113.792 172.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 54' ' ' GLU 0.29 6.7 p -135.7 -86.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.811 2.044 . . . . 3.9300000000000002 109.198 176.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.555 ' H ' HG13 ' A' ' 53' ' ' VAL . 16.2 mt-10 -77.11 41.43 0.29 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.703 2.001 . . . . 3.6899999999999999 110.736 165.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.51 -38.66 0.87 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.152 1.358 . . . . 2.29 113.767 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -61.39 133.8 56.21 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.12 1.368 . . . . 3.9700000000000002 110.972 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.439 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 25.6 mtpp -91.34 103.34 16.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.409 0.683 . . . . 6.5599999999999996 110.884 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -99.21 141.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.028 1.731 . . . . 2.71 109.911 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.43 153.59 29.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.677 1.591 . . . . 4.5199999999999996 112.336 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.72 161.16 33.98 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 121.822 -0.549 . . . . 1.3 114.396 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -113.62 137.03 52.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.449 1.5 . . . . 3.1099999999999999 111.164 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -150.57 156.64 36.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.359 1.463 . . . . 7.0 110.227 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.92 152.0 82.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.703 2.268 . . . . 0.88 111.641 171.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.78 157.36 69.1 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 126.181 1.792 . . . . 1.74 109.659 173.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.14 -18.17 40.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.784 2.322 . . . . 1.0800000000000001 113.237 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -179.15 167.21 1.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.819 2.047 . . . . 3.5800000000000001 110.755 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -113.8 166.73 11.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.975 1.71 . . . . 2.1000000000000001 109.264 155.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 163.83 39.14 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.115 -0.991 . . . . 2.4500000000000002 111.683 174.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.08 128.77 10.18 Favored Pre-proline 0 N--CA 1.466 0.354 0 C-N-CA 125.073 1.349 . . . . 2.2599999999999998 109.609 -161.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.53 163.61 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.938 . . . . 0.79000000000000004 111.554 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.38 138.49 84.63 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.516 2.811 . . . . 1.02 111.935 172.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 36.5 mmtm 68.34 7.2 5.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.977 2.111 . . . . 2.6099999999999999 113.456 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.57 113.16 3.62 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.79 1.662 . . . . 0.96999999999999997 112.252 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 136.93 37.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.513 -0.844 . . . . 6.4000000000000004 110.456 165.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.06 159.74 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.319 1.447 . . . . 3.5800000000000001 111.808 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -154.98 92.59 1.46 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.731 1.613 . . . . 3.6699999999999999 108.079 -170.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.67 139.07 57.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.397 1.079 . . . . 2.0600000000000001 108.649 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -158.9 156.52 26.87 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 127.349 2.26 . . . . 4.2599999999999998 111.237 -163.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.2 -64.17 0.1 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.918 3.079 . . . . 1.4099999999999999 112.088 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.19 91.52 1.03 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.022 -1.631 . . . . 1.97 109.022 166.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.33 -98.91 0.18 Allowed Glycine 0 C--O 1.221 -0.664 0 C-N-CA 124.707 1.146 . . . . 1.24 112.424 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -153.58 136.59 15.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.183 1.393 . . . . 3.3999999999999999 110.299 -172.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -165.62 166.71 17.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.267 1.394 . . . . 1.8999999999999999 110.806 -170.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -102.77 116.19 32.07 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 119.282 -0.39 . . . . 3.6600000000000001 110.18 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -68.31 127.69 33.87 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.663 -0.495 . . . . 1.77 109.663 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 mt -112.81 111.01 21.49 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.907 -1.516 . . . . 2.3999999999999999 106.907 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.47 116.55 25.66 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.66 -0.867 . . . . 4.5199999999999996 108.66 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.82 112.77 0.49 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.09 -1.204 . . . . 1.8799999999999999 110.09 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -110.16 113.94 27.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.162 0.985 . . . . 1.79 111.789 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.95 -11.84 60.97 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.829 1.251 . . . . 2.8700000000000001 114.209 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -153.89 145.73 16.9 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.1 1.36 . . . . 6.6600000000000001 109.998 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.69 132.42 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.202 1.935 . . . . 2.0499999999999998 109.288 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.2 169.18 12.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.819 1.648 . . . . 3.8599999999999999 112.321 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.03 145.04 43.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.213 1.005 . . . . 5.29 110.192 155.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.62 19.95 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.676 -0.861 . . . . 2.7599999999999998 108.676 160.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.39 78.11 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 117.901 -1.499 . . . . 2.71 115.83 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -74.4 175.24 7.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.233 2.016 . . . . 3.0899999999999999 109.449 158.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -91.95 155.85 17.86 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.297 1.046 . . . . 4.4699999999999998 111.387 152.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.02 127.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.93 -1.507 . . . . 2.5299999999999998 106.93 151.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.86 155.18 20.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.953 0.882 . . . . 4.1100000000000003 111.277 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.8 tt -163.25 129.97 3.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.308 -0.87 . . . . 2.8999999999999999 112.028 -152.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -78.12 105.41 9.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.325 3.05 . . . . 2.6899999999999999 111.494 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.1 mt -79.42 119.4 22.38 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.113 -0.992 . . . . 2.0499999999999998 109.343 171.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.1 mt -96.92 126.07 41.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.565 1.146 . . . . 1.8899999999999999 111.554 -168.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.22 158.27 22.53 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.438 -0.789 . . . . 3.5699999999999998 112.929 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.39 63.7 0.79 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.819 1.648 . . . . 2.8599999999999999 113.311 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 148.73 -149.65 21.7 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.39 1.472 . . . . 2.79 111.649 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.51 43.83 1.63 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.748 1.166 . . . . 2.9100000000000001 115.038 -173.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -140.6 137.75 33.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.888 1.344 . . . . 5.9199999999999999 113.987 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.75 132.35 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 127.438 2.295 . . . . 2.0099999999999998 108.66 169.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.97 102.22 8.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.229 1.412 . . . . 3.79 109.407 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 74.26 6.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.857 0.863 . . . . 3.8399999999999999 111.157 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.75 159.32 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.037 1.335 . . . . 2.7400000000000002 112.079 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 m -100.25 139.12 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 126.636 1.974 . . . . 4.4000000000000004 109.602 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.1 mt -143.24 135.46 13.28 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.549 1.14 . . . . 2.77 109.18 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.09 162.61 41.58 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.908 2.406 . . . . 1.6799999999999999 111.474 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.36 145.83 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 2.7000000000000002 111.318 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.77 156.35 44.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.042 1.737 . . . . 3.6800000000000002 109.302 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.73 41.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.45 1.5 . . . . 3.1299999999999999 113.1 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 117.516 -1.23 . . . . 6.1100000000000003 112.974 -152.639 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.546 0.809 0 CA-C-O 118.272 -0.871 . . . . 5.6500000000000004 109.372 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.72 122.08 1.09 Allowed Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.585 1.539 . . . . 1.75 114.299 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -111.56 149.21 31.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.942 0.897 . . . . 2.3100000000000001 111.145 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.57 140.29 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.712 -0.847 . . . . 2.4199999999999999 108.712 169.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 117.1 29.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 5.0899999999999999 112.953 -151.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.45 124.66 24.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.676 0.79 . . . . 3.9900000000000002 110.983 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -160.68 141.03 8.49 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.621 1.169 . . . . 2.9700000000000002 110.273 165.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -83.75 65.98 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.06 3.173 . . . . 2.6200000000000001 109.401 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.76 171.29 14.7 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.385 0.993 . . . . 1.55 113.467 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.05 -20.79 28.38 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.186 2.591 . . . . 2.48 111.305 164.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -151.36 169.6 21.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.439 1.896 . . . . 2.9100000000000001 112.315 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.14 157.55 43.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.83 1.652 . . . . 2.3599999999999999 110.073 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.55 116.24 28.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.399 1.08 . . . . 2.2799999999999998 109.524 167.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.81 162.22 13.36 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.383 1.473 . . . . 2.5299999999999998 111.428 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.44 164.14 28.85 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.265 1.426 . . . . 4.0599999999999996 111.616 -171.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -166.7 159.01 13.56 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.977 1.311 . . . . 2.5099999999999998 113.505 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -80.1 141.4 35.83 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.914 -0.773 . . . . 2.1400000000000001 108.914 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -130.7 129.98 43.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.26 2.224 . . . . 3.0299999999999998 108.351 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' CD ' ' HE ' ' A' ' 74' ' ' ARG . 3.4 pm0 -113.9 129.28 56.61 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.335 1.454 . . . . 3.3399999999999999 110.738 171.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -86.68 110.97 36.52 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 109.115 -0.698 . . . . 1.0800000000000001 109.115 155.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -86.7 -9.5 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.792 2.328 . . . . 1.3899999999999999 113.916 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.2 167.84 31.9 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.176 0.898 . . . . 1.1000000000000001 113.197 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -87.73 -1.14 57.77 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.471 1.509 . . . . 3.3900000000000001 114.322 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.8 159.34 36.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.067 1.347 . . . . 2.6200000000000001 110.454 169.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.98 151.76 18.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.836 2.357 . . . . 1.51 111.647 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 mt -100.98 155.64 17.85 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.085 0.954 . . . . 3.0600000000000001 111.19 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.431 HH21 ' CD ' ' A' ' 68' ' ' GLU . 24.3 ttm105 -132.21 110.75 10.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.041 1.337 . . . . 4.0300000000000002 109.797 169.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.5 tp -95.06 112.48 24.18 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 127.581 2.353 . . . . 1.8100000000000001 107.807 -175.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.88 -11.12 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.904 0.881 . . . . 1.6599999999999999 112.883 -166.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.36 -164.89 34.96 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.511 1.053 . . . . 0.48999999999999999 112.033 173.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.86 -179.14 6.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.225 1.01 . . . . 2.0099999999999998 110.012 164.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -155.9 141.24 17.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.83 1.252 . . . . 6.3200000000000003 108.963 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 t -151.43 156.1 34.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 119.501 1.046 . . . . 1.95 110.69 -165.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.36 -17.23 18.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.706 2.271 . . . . 0.96999999999999997 113.974 168.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -85.33 -23.78 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.954 1.465 . . . . 1.97 114.954 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.52 152.33 50.83 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.703 1.201 . . . . 1.96 112.252 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.547 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 10.1 tp10 -86.45 -88.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.003 -0.544 . . . . 2.8700000000000001 110.037 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -82.24 90.45 6.62 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.714 -0.847 . . . . 4.1799999999999997 108.714 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.99 137.38 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.576 0.75 . . . . 2.5299999999999998 111.076 166.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -137.18 140.02 41.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.296 1.839 . . . . 2.2000000000000002 109.708 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -88.16 122.11 31.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.553 -1.342 . . . . 1.8100000000000001 111.674 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -109.46 156.36 20.18 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.287 1.435 . . . . 0.75 112.541 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.8 -178.67 3.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.316 1.846 . . . . 1.9299999999999999 112.023 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.0 m -138.1 100.78 4.24 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.969 1.708 . . . . 2.5899999999999999 108.033 163.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -92.24 153.31 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.864 1.266 . . . . 3.3999999999999999 111.778 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptp -89.23 156.97 18.43 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.306 -0.871 . . . . 4.1500000000000004 111.972 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -163.31 153.11 15.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.872 1.269 . . . . 10.880000000000001 112.887 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -81.54 176.43 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.889 0.876 . . . . 3.6600000000000001 110.698 154.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.19 -121.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 126.152 1.781 . . . . 3.7999999999999998 106.571 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -73.35 62.52 0.71 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.559 2.343 . . . . 3.6200000000000001 110.131 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.05 2.06 6.19 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.307 1.432 . . . . 2.0499999999999998 115.291 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -111.02 129.86 55.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.812 2.445 . . . . 3.3599999999999999 110.21 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.412 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -100.19 144.37 29.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.76 0.824 . . . . 6.3099999999999996 112.466 -167.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -152.5 162.14 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.672 1.589 . . . . 3.3199999999999998 109.374 -166.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.5 ptp -84.38 171.37 12.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.752 0.821 . . . . 3.9100000000000001 112.012 161.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.16 148.95 19.99 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.492 1.52 . . . . 1.52 110.767 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -112.34 155.52 23.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.322 1.049 . . . . 2.52 110.24 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -168.39 158.87 8.7 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 126.471 1.909 . . . . 5.9900000000000002 108.927 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -67.89 154.52 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 120.967 1.112 . . . . 0.88 110.343 159.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.94 156.39 65.77 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 125.284 1.433 . . . . 2.04 109.819 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.28 -16.54 39.64 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.613 2.209 . . . . 0.80000000000000004 112.833 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -178.79 167.49 1.7 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.716 1.606 . . . . 3.0600000000000001 110.593 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -117.47 172.3 7.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.201 2.2 . . . . 2.1800000000000002 109.165 159.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.431 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.2 pt-20 -154.6 161.11 41.76 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.011 -1.056 . . . . 2.1600000000000001 111.15 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -146.9 129.92 8.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.442 0.697 . . . . 1.8500000000000001 110.648 -167.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.17 162.46 38.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.056 2.504 . . . . 1.3799999999999999 112.315 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.05 136.29 64.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 124.457 3.438 . . . . 1.3799999999999999 113.356 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 64.07 2.58 1.46 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 3.02 113.794 -174.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.6 116.03 4.29 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 127.284 2.373 . . . . 0.97999999999999998 110.724 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.445 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 8.2 ttt180 -102.92 130.42 49.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.092 1.357 . . . . 6.1399999999999997 110.275 164.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -147.74 152.66 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.519 1.528 . . . . 3.4500000000000002 111.338 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 130.86 48.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.873 0.869 . . . . 3.3700000000000001 112.132 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.97 78.03 0.32 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.152 1.381 . . . . 1.8700000000000001 108.067 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -81.05 146.92 60.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 3.3900000000000001 111.095 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.38 -50.85 12.64 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.52 2.813 . . . . 0.95999999999999996 113.141 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.31 67.63 3.66 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.84 -0.904 . . . . 1.0700000000000001 110.84 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.05 -78.32 0.07 OUTLIER Glycine 0 N--CA 1.466 0.694 0 C-N-CA 124.975 1.274 . . . . 0.98999999999999999 112.807 -170.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -156.51 143.04 18.46 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.141 2.176 . . . . 3.0 109.632 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -169.76 159.11 7.87 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.895 -1.128 . . . . 1.0600000000000001 110.882 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -97.56 121.38 39.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.396 0.678 . . . . 3.54 112.028 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.8 mmt -79.25 123.64 27.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.2 1.0 . . . . 1.8200000000000001 109.557 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -104.64 79.33 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.36 1.464 . . . . 2.9700000000000002 110.485 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -78.9 128.32 33.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.626 1.103 . . . . 3.6000000000000001 109.538 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.88 74.74 0.9 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.857 -0.897 . . . . 1.3100000000000001 110.857 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.1 89.94 3.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.739 1.269 . . . . 2.8900000000000001 110.774 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.547 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 3.0 ptmt -55.44 -9.14 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.487 1.515 . . . . 3.1699999999999999 114.091 171.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -136.84 135.58 20.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.877 1.671 . . . . 6.0199999999999996 108.847 167.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 141.81 40.77 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.126 1.884 . . . . 1.7 109.115 165.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.0 81.92 7.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.567 1.147 . . . . 3.1499999999999999 110.473 -172.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.465 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -70.22 108.73 4.29 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.564 -1.335 . . . . 4.3899999999999997 109.605 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -43.07 124.98 3.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.797 0.839 . . . . 2.21 111.392 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.65 -22.06 15.52 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 115.984 -2.565 . . . . 2.1699999999999999 116.492 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.465 ' CD ' ' HZ3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -86.43 177.19 7.51 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.387 2.593 . . . . 4.2800000000000002 111.98 -177.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -96.58 132.29 42.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.373 1.869 . . . . 4.8499999999999996 112.651 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.0 t -102.5 116.34 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.849 -1.157 . . . . 2.0499999999999998 108.891 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.92 143.8 35.49 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.047 0.927 . . . . 3.0800000000000001 110.557 160.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 117.56 5.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.743 0.817 . . . . 2.8399999999999999 110.952 -168.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -81.53 95.58 7.16 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.164 2.186 . . . . 2.8199999999999998 110.377 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.8 mt -72.39 119.2 16.26 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.478 -0.764 . . . . 2.29 109.936 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.3 mt -95.4 132.19 40.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.032 0.933 . . . . 1.8200000000000001 111.249 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.24 147.09 52.55 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.434 1.111 . . . . 3.1899999999999999 112.73 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.08 136.72 56.36 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.034 1.124 . . . . 2.3300000000000001 114.034 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 48.93 13.66 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.971 0.796 . . . . 3.8100000000000001 113.63 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.46 23.8 55.57 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 115.951 1.14 . . . . 1.79 115.951 168.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -108.52 146.21 33.57 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.809 1.804 . . . . 5.1399999999999997 111.973 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.93 137.59 13.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.783 2.033 . . . . 2.0099999999999998 107.761 166.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -128.77 109.99 11.78 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.686 1.194 . . . . 2.4399999999999999 108.605 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -81.78 126.91 32.4 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.663 -0.648 . . . . 3.8100000000000001 111.88 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.1 m -118.95 167.3 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.287 1.835 . . . . 2.5899999999999999 110.259 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -116.08 139.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.839 1.255 . . . . 3.0099999999999998 110.416 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.3 mt -140.11 136.83 17.38 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 127.495 2.318 . . . . 2.4700000000000002 108.005 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.86 154.94 48.67 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.803 2.335 . . . . 1.4199999999999999 112.059 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.29 123.22 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.848 1.259 . . . . 2.52 109.48 168.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' CD ' HH22 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -156.68 166.74 32.53 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.546 1.138 . . . . 3.6000000000000001 111.712 -174.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.53 84.84 2.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.74 1.216 . . . . 2.52 113.923 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.402 HH22 ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.013 -1.106 . . . . 7.2699999999999996 108.013 148.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.779 -0.452 . . . . 5.1399999999999997 109.779 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.34 -175.21 43.7 Favored Glycine 0 N--CA 1.464 0.52 0 O-C-N 121.116 -0.99 . . . . 1.6200000000000001 112.061 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -161.12 154.14 21.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.932 1.086 . . . . 1.8799999999999999 113.932 174.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.48 140.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.762 0.825 . . . . 2.0899999999999999 109.33 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -87.11 110.94 20.46 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.674 -0.641 . . . . 5.0300000000000002 111.582 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.58 127.22 30.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.526 1.155 . . . . 4.1500000000000004 109.9 155.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -153.14 164.5 20.2 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.067 2.147 . . . . 2.75 107.551 161.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -94.08 -161.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.155 3.236 . . . . 3.46 109.111 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.55 -150.92 28.86 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.386 0.993 . . . . 3.1000000000000001 113.021 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -84.72 -16.44 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.618 2.879 . . . . 3.0800000000000001 113.843 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -153.82 160.66 42.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.735 1.754 . . . . 3.1200000000000001 115.735 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.15 177.75 7.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.94 2.096 . . . . 2.0600000000000001 110.499 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.82 144.27 45.6 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.622 1.169 . . . . 1.95 111.641 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.92 147.54 44.61 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.952 0.901 . . . . 1.8999999999999999 112.188 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.83 146.88 41.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.243 1.817 . . . . 3.3999999999999999 110.289 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.51 151.6 9.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.348 -1.47 . . . . 2.5299999999999998 114.751 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -87.76 93.41 9.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.539 1.936 . . . . 3.1099999999999999 107.354 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.02 140.6 29.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.232 1.413 . . . . 3.25 109.83 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -127.47 156.66 41.77 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.632 0.975 . . . . 3.0499999999999998 113.632 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.84 99.71 53.03 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.149 1.38 . . . . 0.97999999999999998 108.964 163.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.05 -9.34 14.18 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.093 2.529 . . . . 1.54 113.058 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -173.48 49.78 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.684 1.135 . . . . 1.1599999999999999 113.389 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.3 m-20 -113.11 0.96 15.13 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.522 1.529 . . . . 2.5 112.802 -168.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.23 160.7 42.35 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.072 1.749 . . . . 2.5699999999999998 110.257 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.47 154.44 16.04 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.109 2.539 . . . . 1.0900000000000001 111.849 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.87 130.24 52.28 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.309 1.444 . . . . 3.46 110.419 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.411 HH21 ' CD ' ' A' ' 68' ' ' GLU . 31.8 ttm180 -114.18 109.42 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.912 1.285 . . . . 3.6699999999999999 109.612 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.3 tp -90.51 107.63 19.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 126.77 2.028 . . . . 2.1899999999999999 108.428 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.0 m -101.15 -12.45 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.191 0.996 . . . . 1.9199999999999999 112.927 -168.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.1 -163.81 32.21 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.251 0.929 . . . . 0.60999999999999999 112.208 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.89 -173.18 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.562 1.145 . . . . 1.6000000000000001 110.145 164.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -161.7 137.17 7.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.763 1.625 . . . . 5.8600000000000003 107.98 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -146.74 147.21 29.27 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 117.152 -1.404 . . . . 1.99 109.341 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.35 -6.96 19.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.021 1.814 . . . . 1.1499999999999999 113.816 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -93.91 -1.68 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.574 1.694 . . . . 1.8100000000000001 115.574 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.1 150.11 34.37 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.562 1.528 . . . . 1.8400000000000001 113.809 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.85 -67.1 0.81 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.611 1.565 . . . . 3.3300000000000001 111.274 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -90.02 147.08 23.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 122.572 1.177 . . . . 4.2300000000000004 110.321 168.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.02 129.27 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.456 2.302 . . . . 2.1400000000000001 106.582 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.94 120.39 13.15 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.078 1.351 . . . . 2.0299999999999998 109.016 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -78.98 121.71 25.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.064 1.302 . . . . 1.75 110.302 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.0 m170 -111.54 152.75 27.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.298 1.839 . . . . 0.68999999999999995 112.053 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.91 -176.45 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.212 -1.358 . . . . 2.0099999999999998 110.022 165.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.6 m -126.82 75.69 1.58 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.283 1.433 . . . . 1.99 107.526 170.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -65.45 150.04 49.02 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 3.8700000000000001 112.475 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -88.18 150.36 23.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.351 1.061 . . . . 7.2699999999999996 111.931 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -155.6 155.4 33.24 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.517 1.527 . . . . 9.5999999999999996 111.481 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -99.5 148.01 24.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 3.4399999999999999 110.205 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -141.4 122.22 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 106.428 -1.693 . . . . 3.5899999999999999 106.428 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 62.76 22.81 13.6 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.911 0.884 . . . . 3.8799999999999999 112.085 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.82 69.07 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.303 -1.498 . . . . 1.8200000000000001 114.36 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -96.88 141.55 29.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.567 1.947 . . . . 3.5600000000000001 109.992 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 135.2 35.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.624 1.17 . . . . 5.7400000000000002 111.294 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.51 141.8 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.236 1.814 . . . . 2.48 109.161 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -117.41 145.18 44.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.09 0.956 . . . . 4.7199999999999998 110.167 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.76 169.14 31.19 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 125.141 1.353 . . . . 1.2 112.633 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.06 151.66 20.7 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.512 1.156 . . . . 2.2400000000000002 113.133 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -164.55 146.8 7.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.435 1.494 . . . . 7.4199999999999999 110.159 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.5 Cg_endo -68.93 153.6 72.33 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.688 1.592 . . . . 0.97999999999999998 111.314 172.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.33 157.65 60.85 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.785 1.634 . . . . 1.75 110.537 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.99 -18.08 36.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.598 2.198 . . . . 0.64000000000000001 112.981 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.26 165.44 1.84 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.099 1.759 . . . . 2.98 111.575 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -111.07 173.4 6.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.366 1.866 . . . . 1.95 109.614 152.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' CD ' HH21 ' A' ' 31' ' ' ARG . 9.9 pt-20 -155.9 168.88 25.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.423 -0.798 . . . . 1.8400000000000001 112.435 170.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.62 133.23 8.63 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.811 1.244 . . . . 1.6200000000000001 109.783 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.12 164.13 36.26 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.283 1.989 . . . . 0.89000000000000001 110.925 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.53 143.42 92.95 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.008 2.472 . . . . 0.83999999999999997 111.502 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 63.0 mmtt 67.26 0.25 2.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.79 2.036 . . . . 2.4399999999999999 113.504 -173.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.13 115.66 4.15 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 126.366 1.936 . . . . 0.94999999999999996 110.528 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.91 112.2 24.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.038 1.335 . . . . 7.7400000000000002 109.539 170.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.72 -174.98 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.007 1.723 . . . . 2.1099999999999999 111.016 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 102.92 2.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.301 1.04 . . . . 4.5499999999999998 111.023 -165.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.13 77.17 0.51 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.078 1.751 . . . . 1.8200000000000001 109.112 161.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -91.77 147.79 35.8 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 127.832 2.453 . . . . 3.6099999999999999 112.189 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.51 -64.18 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.787 3.658 . . . . 1.05 113.325 -170.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.45 97.36 1.7 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 108.439 -1.864 . . . . 1.3200000000000001 108.439 165.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.81 -90.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.924 1.249 . . . . 1.0800000000000001 112.358 -169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -148.29 141.64 25.22 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.345 1.858 . . . . 3.4700000000000002 110.143 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -169.19 169.64 9.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.687 -1.258 . . . . 1.26 110.518 -172.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.65 136.13 41.0 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.646 -0.501 . . . . 3.1899999999999999 109.646 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 mmt -91.28 126.31 36.33 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.339 -0.985 . . . . 1.71 108.339 161.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.25 111.08 22.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.41 1.484 . . . . 3.8700000000000001 107.596 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 126.63 55.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.647 1.579 . . . . 3.6899999999999999 108.841 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.15 95.46 0.09 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.046 -1.222 . . . . 1.3600000000000001 110.046 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.5 mt -92.72 124.39 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.544 0.672 . . . . 1.99 111.09 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.02 -19.73 61.81 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.8 1.037 . . . . 2.3799999999999999 113.8 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -149.5 162.66 27.89 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.738 2.015 . . . . 8.0700000000000003 108.974 164.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.86 138.36 68.19 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.276 -1.471 . . . . 1.9299999999999999 108.276 149.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.01 150.63 31.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 3.4900000000000002 109.53 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.76 0.94 51.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.296 1.221 . . . . 7.0499999999999998 114.296 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 72.2 161.89 0.25 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.27 2.628 . . . . 2.7400000000000002 112.101 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.61 -12.16 0.77 Allowed Glycine 0 N--CA 1.482 1.728 0 N-CA-C 116.8 1.48 . . . . 4.0199999999999996 116.8 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.98 166.51 22.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.707 2.484 . . . . 3.7999999999999998 117.707 -153.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.61 68.55 9.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 131.659 3.984 . . . . 5.96 113.206 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.95 106.65 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 120.671 -1.268 . . . . 2.0800000000000001 111.126 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.04 129.86 44.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.667 1.587 . . . . 2.9900000000000002 110.764 160.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 mt -149.58 109.87 4.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.223 1.009 . . . . 2.8799999999999999 112.272 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.67 96.18 5.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.192 2.597 . . . . 2.02 109.47 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.9 mt -77.23 118.39 19.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.321 -0.862 . . . . 2.2200000000000002 110.608 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -91.92 127.55 37.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.151 0.98 . . . . 1.76 111.801 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -126.12 134.03 51.45 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.552 0.945 . . . . 3.8599999999999999 113.552 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 33.12 49.63 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.579 2.352 . . . . 3.0 114.142 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.93 -94.01 0.77 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.574 1.083 . . . . 3.9399999999999999 111.946 -170.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.65 23.0 7.96 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 117.381 1.712 . . . . 1.6100000000000001 117.381 -164.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -117.76 153.26 33.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.508 2.154 . . . . 5.7999999999999998 109.782 166.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.03 139.95 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.289 1.436 . . . . 2.29 109.584 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -123.31 110.97 15.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.024 1.33 . . . . 2.7999999999999998 109.48 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -85.3 108.17 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.093 -0.38 . . . . 3.5600000000000001 111.479 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -104.55 159.84 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.46 1.504 . . . . 2.04 110.937 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.97 137.99 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.347 1.059 . . . . 3.21 109.658 162.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 144.19 46.83 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.216 1.406 . . . . 2.6400000000000001 109.958 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.37 141.82 26.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.823 2.348 . . . . 1.45 110.37 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.42 153.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.82 0.848 . . . . 2.6499999999999999 112.43 167.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -146.61 158.05 43.83 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 3.8700000000000001 109.124 163.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.58 99.48 10.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.924 -1.11 . . . . 3.1000000000000001 108.109 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.222 0 CA-C-O 114.844 -2.503 . . . . 6.4100000000000001 117.275 -154.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 122.036 0.922 . . . . 6.4100000000000001 109.382 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.93 173.38 41.52 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.162 1.363 . . . . 1.27 113.818 -168.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -159.13 145.31 16.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.552 1.541 . . . . 1.71 110.571 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.3 t -91.29 143.05 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.692 1.197 . . . . 1.9399999999999999 109.303 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -69.21 116.91 10.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.626 -0.671 . . . . 4.6200000000000001 112.31 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.2 134.18 56.77 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.156 0.983 . . . . 5.1500000000000004 109.999 161.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -166.13 140.46 3.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 120.534 -1.353 . . . . 2.8399999999999999 112.456 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -92.59 68.99 0.68 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.234 3.29 . . . . 3.1099999999999999 110.348 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.01 -177.76 36.26 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.772 1.069 . . . . 1.48 115.772 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.54 -0.25 8.1 Favored 'Trans proline' 0 CA--C 1.542 0.91 1 C-N-CA 125.494 4.129 . . . . 1.71 113.371 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -134.37 152.75 51.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 3.0800000000000001 111.56 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 -170.28 3.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.211 2.204 . . . . 2.1800000000000002 109.933 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.24 152.9 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.309 1.444 . . . . 2.0299999999999998 109.412 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.2 136.69 51.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.415 1.461 . . . . 2.1099999999999999 111.902 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -120.27 135.07 55.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.015 1.726 . . . . 3.3300000000000001 110.277 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.8 152.19 11.35 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.872 -1.143 . . . . 2.8199999999999998 112.423 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 m -95.93 92.28 6.42 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.112 0.965 . . . . 2.4900000000000002 110.029 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -80.41 133.61 35.9 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.097 -0.705 . . . . 2.9500000000000002 109.097 173.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.86 145.73 50.85 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.107 1.763 . . . . 2.79 110.124 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -107.86 104.28 52.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.702 0.801 . . . . 1.1299999999999999 110.073 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.33 -12.97 11.33 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.506 2.137 . . . . 1.05 113.321 176.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.13 -174.25 49.53 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.149 0.88 . . . . 1.21 113.221 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 11.0 m-20 -112.22 6.01 18.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.594 1.557 . . . . 2.75 112.337 -173.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.5 160.92 60.01 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.86 2.064 . . . . 2.73 109.988 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.44 144.64 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.324 2.016 . . . . 1.22 112.028 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.95 121.26 41.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.363 1.465 . . . . 3.4199999999999999 108.934 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 ttm105 -110.53 97.53 6.95 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.481 1.112 . . . . 4.2300000000000004 110.753 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.67 106.74 11.92 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.292 2.237 . . . . 1.8 109.551 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.82 -13.42 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.155 1.382 . . . . 2.1099999999999999 113.524 -171.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.95 34.28 Favored Glycine 0 C--N 1.34 0.753 0 O-C-N 121.632 -0.668 . . . . 0.72999999999999998 112.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -160.77 175.41 12.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.918 0.887 . . . . 1.71 112.76 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -143.72 156.48 44.54 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.831 0.452 . . . . 8.8399999999999999 110.391 160.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 t -152.95 149.69 22.52 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.139 1.376 . . . . 2.0 108.628 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.97 -35.07 56.87 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.167 1.245 . . . . 1.48 111.24 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.97 4.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.868 1.433 . . . . 1.96 114.868 -164.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.34 170.2 14.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.186 1.794 . . . . 2.02 109.99 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -106.38 -82.84 0.53 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.413 -0.958 . . . . 2.7999999999999998 108.413 164.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.68 125.67 28.06 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.164 -0.96 . . . . 5.9900000000000002 109.072 165.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.63 138.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.196 1.799 . . . . 2.1499999999999999 109.419 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -140.07 127.69 21.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.663 1.185 . . . . 2.2799999999999998 111.927 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -78.93 122.87 26.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.767 -1.208 . . . . 1.8300000000000001 110.795 167.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -108.71 153.2 23.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.71 1.604 . . . . 0.95999999999999996 112.637 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -87.32 158.72 18.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.309 1.044 . . . . 2.23 109.803 162.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -109.31 143.91 38.17 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.161 -1.422 . . . . 2.4199999999999999 107.161 152.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -137.46 155.07 49.74 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 3.3300000000000001 111.285 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -111.02 121.81 46.31 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.101 -1.444 . . . . 4.2000000000000002 107.101 160.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -146.44 173.21 12.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.387 1.475 . . . . 8.0500000000000007 110.274 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.473 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 3.8 mp0 -73.98 155.13 38.94 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.418 0.687 . . . . 3.21 110.132 159.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.85 -98.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.948 -1.131 . . . . 4.4299999999999997 107.948 168.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -74.75 63.15 1.13 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.833 1.653 . . . . 5.46 111.723 170.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.63 -24.67 0.63 Allowed Glycine 0 N--CA 1.475 1.274 0 C-N-CA 126.462 1.982 . . . . 3.8300000000000001 115.222 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -107.56 164.03 12.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.909 2.484 . . . . 4.1600000000000001 111.628 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 8.1 tppt? -76.87 134.15 39.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.375 2.27 . . . . 4.9500000000000002 112.084 -175.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -144.08 147.35 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.345 1.858 . . . . 2.4300000000000002 109.995 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -98.0 118.54 34.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.515 1.526 . . . . 4.7000000000000002 110.303 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.16 -179.19 16.1 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.389 1.471 . . . . 1.29 113.239 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.5 mtt -142.26 158.67 43.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.413 1.485 . . . . 2.71 111.244 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.87 151.04 4.78 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.741 -1.123 . . . . 5.3899999999999997 113.437 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.31 142.05 94.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.82999999999999996 112.006 172.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.63 159.86 48.89 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 126.516 1.926 . . . . 1.5800000000000001 110.882 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.15 -21.29 18.09 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.564 2.176 . . . . 0.73999999999999999 113.455 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -171.87 163.72 6.32 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 120.27 1.396 . . . . 4.1399999999999997 112.395 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -115.03 173.51 6.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.199 2.2 . . . . 2.0299999999999998 109.24 155.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.91 164.27 38.68 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.645 -0.659 . . . . 2.5600000000000001 112.13 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.1 t -139.25 125.79 12.53 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 125.412 1.485 . . . . 2.3599999999999999 108.733 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.21 159.13 54.13 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.124 1.883 . . . . 1.25 110.512 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.77 140.5 93.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.959 2.439 . . . . 1.1299999999999999 111.654 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 64.1 mmtt 72.17 -8.52 1.14 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.27 2.228 . . . . 2.2400000000000002 113.997 -177.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.05 -172.93 49.6 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.882 1.706 . . . . 1.47 112.873 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -160.61 161.76 32.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.965 2.106 . . . . 5.4299999999999997 111.843 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.8 129.88 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.112 1.365 . . . . 2.75 110.007 170.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.455 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -88.88 122.29 32.1 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.22 0.533 . . . . 3.3599999999999999 110.307 165.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -68.89 68.14 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.368 1.867 . . . . 2.0499999999999998 109.954 169.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 7.9 ptpp? -70.85 142.27 87.94 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.472 1.509 . . . . 3.6699999999999999 110.32 174.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.41 -57.02 2.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.55 2.833 . . . . 1.3799999999999999 112.233 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.96 78.0 2.01 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.357 -1.097 . . . . 1.54 110.357 166.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.23 -79.61 0.08 OUTLIER Glycine 0 N--CA 1.466 0.637 0 C-N-CA 127.119 2.295 . . . . 1.02 111.415 -175.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -153.84 147.49 25.2 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.631 1.972 . . . . 3.8100000000000001 108.905 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -159.7 154.13 23.94 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 120.496 -1.378 . . . . 0.95999999999999996 109.276 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -92.39 104.03 16.4 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.329 -1.36 . . . . 3.0600000000000001 107.329 167.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 129.61 40.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.603 -0.888 . . . . 2.7000000000000002 108.603 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -114.81 122.14 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.647 1.579 . . . . 2.77 109.016 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.02 155.85 36.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.333 1.053 . . . . 3.9100000000000001 110.668 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.92 -64.25 4.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.129 1.347 . . . . 3.5099999999999998 112.29 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt 74.1 110.96 0.07 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.568 2.747 . . . . 2.46 115.526 164.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -89.17 -3.73 58.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.579 -1.325 . . . . 2.9500000000000002 113.595 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -137.35 138.61 25.43 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 126.193 1.797 . . . . 6.1399999999999997 108.77 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.97 130.13 17.38 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 N-CA-C 107.469 -1.781 . . . . 1.77 107.469 159.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.55 85.1 6.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.411 0.684 . . . . 3.8500000000000001 109.563 -170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HE3' ' CG ' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -102.8 142.37 34.04 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.344 1.058 . . . . 4.5800000000000001 111.463 175.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.17 142.06 48.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 114.546 1.313 . . . . 2.7400000000000002 114.546 -170.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.39 52.12 28.24 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.781 -0.645 . . . . 2.0 112.789 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' CG ' ' HE3' ' A' ' 94' ' ' LYS . 2.8 mt-10 -107.51 -175.74 2.87 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.549 -1.278 . . . . 2.4900000000000002 107.549 147.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.51 120.43 31.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.76 0.79 . . . . 4.7400000000000002 109.277 166.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.11 103.85 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.774 -0.824 . . . . 2.2200000000000002 108.774 168.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 141.62 40.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.313 1.054 . . . . 3.5 110.672 162.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.43 ' HA ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -155.25 130.58 9.65 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.171 -0.956 . . . . 4.5199999999999996 111.881 -167.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.71 121.25 38.34 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.443 1.097 . . . . 2.3199999999999998 109.413 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -95.36 119.11 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.174 1.389 . . . . 2.1600000000000001 110.012 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 mt -92.28 124.55 36.42 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.002 0.921 . . . . 1.9199999999999999 110.505 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.91 126.67 50.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.141 0.977 . . . . 3.6000000000000001 112.542 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 50.07 21.12 0.69 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.258 1.823 . . . . 2.8999999999999999 114.821 171.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.53 -61.12 2.82 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.695 1.14 . . . . 3.2400000000000002 112.361 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.79 1.37 53.95 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.188 1.635 . . . . 1.8899999999999999 117.188 -165.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -137.24 146.24 44.55 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.71 1.755 . . . . 6.75 111.351 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.01 148.46 23.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.121 1.368 . . . . 1.8899999999999999 109.822 163.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -143.37 133.03 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.396 1.878 . . . . 2.7799999999999998 109.657 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -85.65 140.74 30.31 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.624 0.602 . . . . 3.0600000000000001 112.624 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -125.52 177.23 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.606 1.962 . . . . 2.0299999999999998 109.461 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -155.21 140.69 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.404 0.547 . . . . 2.9500000000000002 111.002 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.32 152.39 19.91 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.965 1.306 . . . . 3.75 112.844 -171.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -79.27 -170.28 0.97 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.24 3.293 . . . . 1.21 112.346 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.42 84.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 126.857 2.063 . . . . 2.2400000000000002 111.389 -161.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -128.89 172.88 10.9 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 119.983 -1.698 . . . . 5.4800000000000004 114.553 -171.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.07 142.19 28.89 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.67 -1.269 . . . . 3.3700000000000001 113.532 -167.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 C-N-CA 126.702 2.001 . . . . 7.7599999999999998 111.528 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 CA--C 1.55 0.966 0 N-CA-C 109.312 -0.625 . . . . 5.21 109.312 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.11 165.68 21.77 Favored Glycine 0 N--CA 1.475 1.239 0 O-C-N 120.296 -1.503 . . . . 1.24 113.371 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.2 p90 -167.09 163.26 15.72 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.122 1.369 . . . . 1.8600000000000001 111.805 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -127.4 135.6 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.277 -0.889 . . . . 2.52 110.522 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -88.68 129.52 35.51 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.469 1.128 . . . . 5.4100000000000001 113.605 -169.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -79.55 141.33 36.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.108 2.163 . . . . 4.2599999999999998 112.562 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -162.8 152.26 13.01 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.329 1.451 . . . . 2.79 110.943 165.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.45 56.55 4.3 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.546 3.497 . . . . 2.4399999999999999 109.706 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.81 174.86 17.65 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.661 1.124 . . . . 1.3200000000000001 114.068 -172.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.13 -15.22 13.02 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.904 3.069 . . . . 1.95 112.556 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -143.89 154.3 43.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.479 1.912 . . . . 2.4700000000000002 111.834 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.29 -179.85 8.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.728 1.611 . . . . 2.0600000000000001 110.751 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.67 49.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.18 0.807 . . . . 2.2999999999999998 113.18 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.48 141.66 36.58 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.998 0.519 . . . . 2.0099999999999998 110.763 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -117.67 157.26 26.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.937 1.695 . . . . 3.4199999999999999 110.08 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -167.47 148.07 5.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.994 1.479 . . . . 2.29 114.994 166.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.4 m -75.83 140.38 42.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.528 -1.214 . . . . 2.2200000000000002 109.636 157.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.33 130.63 15.6 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.687 1.195 . . . . 3.8199999999999998 109.069 168.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -136.95 152.64 50.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.284 1.04 . . . . 4.5300000000000002 112.276 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -104.15 102.49 32.74 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.066 1.346 . . . . 1.3200000000000001 110.528 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.71 -9.19 14.63 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.315 2.01 . . . . 1.9199999999999999 113.603 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.17 -170.44 44.87 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.362 0.982 . . . . 1.5 112.998 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.2 m-20 -120.86 9.95 10.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.782 1.233 . . . . 2.6600000000000001 112.943 -168.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.76 159.4 53.55 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.047 1.739 . . . . 3.3799999999999999 110.69 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.67 153.51 15.36 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.757 2.305 . . . . 2.1699999999999999 111.805 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.19 142.24 43.64 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.732 1.613 . . . . 3.1200000000000001 109.019 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -141.41 107.49 5.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.712 0.805 . . . . 4.4100000000000001 109.805 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.37 129.14 44.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.277 2.631 . . . . 3.4399999999999999 109.218 -165.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.84 -9.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.136 1.162 . . . . 1.77 114.136 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.19 -160.75 28.77 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.069 -1.02 . . . . 0.55000000000000004 112.285 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 -174.25 4.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.942 1.697 . . . . 1.71 110.664 165.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -150.84 144.87 25.32 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.609 1.963 . . . . 8.5199999999999996 109.136 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -141.01 151.26 61.83 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 120.376 1.444 . . . . 1.6100000000000001 109.462 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.0 -22.14 48.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.359 2.039 . . . . 0.88 113.851 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.91 2.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 115.178 1.547 . . . . 2.04 115.178 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 175.6 12.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.652 1.181 . . . . 1.9099999999999999 112.306 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.468 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 8.0 tp10 -110.56 -89.36 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.575 1.15 . . . . 2.8399999999999999 109.894 178.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -77.72 100.6 6.29 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 120.667 -1.27 . . . . 5.0499999999999998 108.932 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -82.24 135.04 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.664 1.585 . . . . 2.3700000000000001 111.147 162.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.1 147.48 51.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.822 2.449 . . . . 2.1699999999999999 108.407 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 tt -92.79 124.1 36.54 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.9 1.682 . . . . 2.27 111.162 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.7 m170 -114.01 152.47 30.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.317 1.447 . . . . 0.93000000000000005 112.635 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -98.74 166.43 11.32 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 2.1600000000000001 110.319 167.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -125.14 117.69 24.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.591 1.156 . . . . 2.2799999999999998 108.166 167.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -119.64 -177.59 3.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.44 1.496 . . . . 3.4100000000000001 112.084 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -140.33 163.19 33.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.424 1.09 . . . . 3.6099999999999999 111.895 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.36 166.82 20.39 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.641 1.577 . . . . 6.9199999999999999 112.023 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 135.42 40.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.537 1.535 . . . . 4.8499999999999996 108.445 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.8 -113.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.745 1.618 . . . . 4.1500000000000004 107.025 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 0.8 OUTLIER -77.26 67.19 3.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.519 1.054 . . . . 4.3099999999999996 108.931 164.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.89 -22.01 0.46 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 127.323 2.392 . . . . 2.5 115.953 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 12.5 ptpt -74.93 133.82 41.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.5 1.92 . . . . 4.9000000000000004 110.134 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.95 127.63 36.48 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.927 0.891 . . . . 6.3399999999999999 109.67 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.12 152.58 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.657 1.583 . . . . 3.7200000000000002 109.876 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.5 ptp -83.96 162.13 20.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.505 1.522 . . . . 4.7199999999999998 113.32 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.52 172.93 33.68 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.669 1.604 . . . . 1.48 113.122 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtt -137.09 154.55 50.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.554 1.542 . . . . 3.0099999999999998 110.472 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -168.77 154.11 6.21 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.683 1.193 . . . . 6.0499999999999998 111.144 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 3.8 Cg_endo -68.6 152.38 74.67 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.46 1.44 . . . . 0.76000000000000001 112.085 171.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.97 149.36 68.28 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 125.945 1.698 . . . . 1.8300000000000001 109.842 172.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.31 -19.08 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.903 2.402 . . . . 1.0900000000000001 113.909 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -172.61 171.56 4.49 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.804 1.184 . . . . 2.9500000000000002 113.117 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.23 175.26 10.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.839 2.456 . . . . 4.1200000000000001 109.373 159.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.45 168.8 25.92 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 120.602 -1.311 . . . . 2.3900000000000001 111.132 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -149.65 137.73 11.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 124.72 1.208 . . . . 2.4500000000000002 108.737 -167.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.77 171.73 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.655 1.57 . . . . 1.76 110.146 166.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.97 146.86 91.79 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.344 2.03 . . . . 1.78 110.322 160.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 59.4 mmtt 69.61 -2.72 1.85 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.696 1.998 . . . . 2.46 114.024 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.21 148.43 20.74 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 126.985 2.231 . . . . 1.1200000000000001 111.688 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.2 ttp-105 -106.27 142.64 35.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.432 1.893 . . . . 7.0599999999999996 111.505 168.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.86 147.26 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.475 1.51 . . . . 3.9399999999999999 108.473 161.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -128.13 112.28 14.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.334 -1.358 . . . . 3.4100000000000001 107.334 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.09 63.05 0.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.57 1.948 . . . . 2.2799999999999998 108.971 171.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -79.48 150.95 74.21 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 128.8 2.84 . . . . 3.96 111.545 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.4 -35.69 92.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.52 2.814 . . . . 1.2 113.641 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.72 60.06 1.77 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.189 0.9 . . . . 1.73 111.867 168.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.89 -73.6 0.05 OUTLIER Glycine 0 N--CA 1.469 0.859 0 C-N-CA 125.225 1.393 . . . . 1.3799999999999999 113.94 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -153.01 154.72 35.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.122 1.769 . . . . 3.3999999999999999 111.01 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -163.99 169.93 17.32 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.107 0.963 . . . . 1.28 109.879 176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.21 126.61 42.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.789 -0.819 . . . . 3.3500000000000001 108.789 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -81.69 120.82 25.6 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.426 1.091 . . . . 1.77 109.219 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -111.65 113.01 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.147 1.379 . . . . 2.5 107.976 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.41 139.83 41.28 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.433 1.493 . . . . 3.7599999999999998 109.293 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.08 66.3 1.94 Allowed Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.489 -1.045 . . . . 1.29 110.489 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 mt -70.03 123.54 21.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.04 0.536 . . . . 2.1800000000000002 110.568 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.468 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 77.1 mttt -83.19 19.83 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.015 0.926 . . . . 2.5099999999999998 113.154 -172.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 173.9 155.98 0.3 Allowed Pre-proline 0 CA--C 1.544 0.718 1 C-N-CA 131.893 4.077 . . . . 5.2400000000000002 107.945 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.73 133.68 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 N-CA-C 106.626 -2.105 . . . . 2.4199999999999999 106.626 147.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.9 116.55 5.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.55 0.69 . . . . 3.5099999999999998 109.155 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -71.23 107.67 4.35 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.416 -0.802 . . . . 5.1699999999999999 109.939 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.82 1.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.909 -1.119 . . . . 2.4399999999999999 109.461 164.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.49 38.67 7.02 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 118.755 -1.025 . . . . 2.1800000000000002 113.958 -165.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -135.75 -178.92 5.35 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 119.275 1.538 . . . . 3.46 108.659 149.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.78 150.31 37.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.158 0.98 . . . . 5.0599999999999996 110.589 166.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.99 113.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.98 1.712 . . . . 2.3700000000000001 108.031 172.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.22 137.69 57.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.909 -0.587 . . . . 2.9399999999999999 109.477 160.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -149.55 133.44 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.41 1.084 . . . . 2.8100000000000001 111.993 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.55 87.76 2.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.786 2.034 . . . . 2.6299999999999999 109.146 -167.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 mt -69.28 125.17 25.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.766 2.026 . . . . 2.1000000000000001 111.077 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.3 mt -94.51 138.67 32.13 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.511 1.124 . . . . 1.9399999999999999 111.464 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -135.08 138.54 43.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.432 1.093 . . . . 3.0 111.238 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.8 126.55 12.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.595 1.558 . . . . 2.3399999999999999 113.342 -167.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.25 -145.58 19.16 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 110.757 -0.937 . . . . 3.29 110.757 -166.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.27 27.48 9.32 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 115.74 1.056 . . . . 2.5099999999999998 115.74 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.63 131.22 46.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.27 2.035 . . . . 5.5700000000000003 112.079 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.73 123.32 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.108 1.363 . . . . 2.4500000000000002 109.284 162.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.76 119.8 33.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.809 1.644 . . . . 4.2800000000000002 108.477 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.54 147.09 23.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.328 1.233 . . . . 3.29 114.328 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.96 172.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 127.86 2.464 . . . . 2.0499999999999998 109.492 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.82 140.99 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.828 1.651 . . . . 3.25 108.017 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.79 133.81 10.59 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.147 1.379 . . . . 2.2799999999999998 110.83 -166.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 147.77 67.34 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.105 2.537 . . . . 1.05 114.168 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.7 t -79.27 132.49 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.538 0.735 . . . . 2.25 110.496 168.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -133.7 156.26 48.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.125 1.77 . . . . 3.8999999999999999 112.164 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.57 84.42 7.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.093 0.957 . . . . 2.5699999999999998 109.457 164.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.907 -1.52 . . . . 6.6200000000000001 112.16 -163.419 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 108.86 -0.792 . . . . 5.2699999999999996 108.86 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.88 165.48 38.74 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.327 -0.858 . . . . 1.7 114.224 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -159.53 158.98 32.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.628 1.171 . . . . 2.54 114.001 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.08 130.03 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.573 -1.269 . . . . 2.4399999999999999 107.573 164.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -84.48 -2.6 57.51 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.841 1.793 . . . . 4.7999999999999998 115.841 -164.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.4 t80 65.88 152.21 0.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.496 2.318 . . . . 4.4199999999999999 113.671 -170.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -159.54 146.8 12.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.943 2.097 . . . . 4.6600000000000001 108.25 157.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.88 -7.84 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.324 2.683 . . . . 3.4500000000000002 112.283 169.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.57 -167.05 43.16 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.462 1.029 . . . . 1.8999999999999999 114.213 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.01 -9.33 22.08 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.503 2.802 . . . . 2.1099999999999999 113.359 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -152.33 161.89 41.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.081 1.352 . . . . 2.7599999999999998 114.397 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.57 -174.09 4.78 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.668 2.387 . . . . 2.1699999999999999 111.953 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.08 159.58 41.49 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.063 1.345 . . . . 2.1200000000000001 111.51 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.65 163.35 37.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.465 1.506 . . . . 2.46 113.273 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -145.24 152.74 40.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.363 1.865 . . . . 3.1800000000000002 110.874 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -166.13 158.44 14.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.547 1.139 . . . . 3.1099999999999999 112.068 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.5 m -90.73 138.59 31.46 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.667 -1.234 . . . . 2.3300000000000001 107.667 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.6 132.1 56.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.943 1.297 . . . . 3.3100000000000001 107.767 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.55 135.36 53.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.727 0.811 . . . . 3.3100000000000001 111.761 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -101.69 115.56 64.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.348 1.059 . . . . 0.91000000000000003 109.7 163.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -88.57 -8.9 5.09 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.241 2.627 . . . . 1.3899999999999999 114.4 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.06 162.97 32.86 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 119.434 1.016 . . . . 1.22 113.355 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.31 -0.52 50.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.347 1.459 . . . . 3.0800000000000001 114.178 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.91 158.04 36.91 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.999 1.32 . . . . 2.6200000000000001 110.53 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.38 155.23 18.89 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.214 2.61 . . . . 1.25 111.198 -173.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.25 153.86 20.48 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.347 1.059 . . . . 3.1600000000000001 111.316 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.436 HH21 ' CD ' ' A' ' 68' ' ' GLU . 27.9 ttm180 -130.65 114.42 15.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.153 1.381 . . . . 4.0099999999999998 109.185 167.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.45 114.41 26.17 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.246 2.618 . . . . 1.8700000000000001 108.893 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.05 -10.54 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 1.8500000000000001 113.571 -166.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.19 31.44 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.616 -0.678 . . . . 0.55000000000000004 112.704 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.03 179.95 7.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.597 0.759 . . . . 1.99 111.924 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -154.47 149.69 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.94 -1.133 . . . . 7.2300000000000004 107.94 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -162.49 153.79 15.06 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.45 -1.262 . . . . 1.6899999999999999 108.725 -170.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.42 -7.95 16.04 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.32 2.013 . . . . 1.1100000000000001 114.489 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 m -98.48 -3.95 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 116.142 1.905 . . . . 1.9099999999999999 116.142 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.51 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.944 1.298 . . . . 2.0099999999999998 110.666 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -93.95 -74.75 0.52 Allowed 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.575 -0.528 . . . . 4.4500000000000002 109.575 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -80.77 107.75 13.84 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.481 -0.933 . . . . 5.1799999999999997 108.481 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -113.18 125.01 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.913 0.885 . . . . 3.0 108.763 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -134.13 122.7 23.26 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.889 1.276 . . . . 2.6299999999999999 110.384 -162.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.59 122.53 26.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.227 1.013 . . . . 2.0 110.461 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 7.2 m170 -108.1 156.87 18.8 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.452 1.901 . . . . 1.02 112.832 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -105.24 -177.51 3.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.16 2.584 . . . . 2.0299999999999998 111.473 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -133.12 99.54 4.59 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.749 -1.574 . . . . 2.9399999999999999 106.749 154.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.3 151.51 41.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.462 0.305 . . . . 3.7799999999999998 110.63 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 ptp -97.97 157.92 15.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.55 0.34 . . . . 4.0700000000000003 110.797 155.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -176.1 160.96 2.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.583 2.353 . . . . 7.6600000000000001 110.274 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 0.6 OUTLIER -95.73 154.26 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.029 0.932 . . . . 3.7000000000000002 108.795 169.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 t -133.17 -96.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.281 1.033 . . . . 3.1800000000000002 108.967 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -75.84 54.94 0.85 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.267 1.827 . . . . 3.1899999999999999 110.34 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.99 -17.57 0.53 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.137 1.827 . . . . 2.1099999999999999 115.261 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.8 152.69 20.2 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.01 1.724 . . . . 3.48 111.162 -168.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.494 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 28.1 mmmt -62.64 131.74 50.02 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.846 0.858 . . . . 4.8700000000000001 111.183 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.34 151.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.037 1.735 . . . . 3.1699999999999999 109.335 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.8 mtm -128.64 141.51 51.33 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.602 1.161 . . . . 4.0899999999999999 110.302 163.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.86 163.57 30.5 Favored Glycine 0 N--CA 1.469 0.844 0 C-N-CA 123.753 0.692 . . . . 1.24 112.689 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -97.74 158.47 15.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.965 0.906 . . . . 2.4199999999999999 112.771 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.6 mtt-85 -164.83 145.8 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 126.724 2.009 . . . . 7.2400000000000002 109.053 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.8 Cg_endo -70.59 152.9 65.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 CA-C-N 121.526 1.581 . . . . 1.28 110.111 160.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.17 156.2 57.52 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.252 1.421 . . . . 2.02 110.037 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.32 -14.4 34.28 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.812 2.341 . . . . 0.89000000000000001 113.015 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -178.96 162.15 1.24 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.115 1.766 . . . . 3.73 110.861 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -108.59 174.55 5.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.925 1.69 . . . . 2.0699999999999998 109.316 153.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.436 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.2 pt-20 -154.74 165.24 37.21 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.908 -1.12 . . . . 2.3399999999999999 111.204 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -149.63 135.36 10.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 118.573 -0.727 . . . . 2.0099999999999998 110.502 -164.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.98 165.8 31.19 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.264 1.976 . . . . 0.96999999999999997 112.116 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.31 138.84 83.6 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.391 3.394 . . . . 1.2 112.62 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.1 2.83 1.54 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.344 1.857 . . . . 2.98 113.808 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.09 115.51 4.13 Favored Glycine 0 C--O 1.228 -0.23 0 C-N-CA 127.422 2.439 . . . . 0.89000000000000001 111.626 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -85.43 134.36 34.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.248 -0.976 . . . . 7.6699999999999999 109.978 155.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.34 168.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.749 2.02 . . . . 2.21 109.6 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -134.47 124.77 26.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.824 0.85 . . . . 3.6400000000000001 110.781 -164.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.06 75.63 5.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.716 -0.846 . . . . 2.0499999999999998 108.716 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 ptpm? -79.59 136.27 55.84 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.278 -0.867 . . . . 3.5299999999999998 110.525 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.47 -58.51 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.933 3.755 . . . . 1.1100000000000001 113.566 -163.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 106.78 2.61 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 107.817 -2.113 . . . . 1.23 107.817 160.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.51 -88.65 0.17 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 124.654 1.121 . . . . 1.22 111.266 -163.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -150.62 144.55 25.32 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.891 2.076 . . . . 3.0299999999999998 109.926 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -165.8 174.2 9.87 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.937 -1.102 . . . . 1.0 110.618 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -110.9 128.8 55.93 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.994 0.918 . . . . 3.6800000000000002 109.971 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 mmt -86.71 136.98 32.82 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.073 0.949 . . . . 2.1000000000000001 109.633 165.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.7 mt -116.67 117.0 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.516 1.527 . . . . 3.2999999999999998 109.105 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.82 142.35 51.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.896 1.678 . . . . 3.5499999999999998 111.069 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.99 59.57 4.24 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.041 -1.223 . . . . 1.5900000000000001 110.041 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.8 mt -66.8 129.42 39.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.156 0.979 . . . . 1.8200000000000001 111.713 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.59 -10.19 49.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.785 1.234 . . . . 2.7200000000000002 112.875 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -155.38 146.19 16.33 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.621 1.568 . . . . 6.8499999999999996 110.305 163.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.28 127.49 15.88 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 107.378 -1.816 . . . . 2.0699999999999998 107.378 158.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mp -87.49 167.73 13.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.102 0.961 . . . . 3.79 111.277 -171.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 145.98 48.15 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.032 -1.043 . . . . 5.8700000000000001 110.524 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.07 125.95 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.372 -0.603 . . . . 2.23 109.372 158.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.24 8.86 68.02 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 118.094 -1.392 . . . . 1.8999999999999999 115.712 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.45 173.73 9.44 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.943 1.872 . . . . 3.21 109.429 157.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -118.64 158.7 24.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.816 1.647 . . . . 4.4699999999999998 110.099 167.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.1 t -132.45 120.31 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.319 1.848 . . . . 1.98 110.25 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.424 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -82.57 147.0 28.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.57 1.148 . . . . 3.29 110.321 173.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -157.02 140.29 15.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.52 0.728 . . . . 2.8900000000000001 112.935 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.61 115.47 30.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.863 2.465 . . . . 2.9300000000000002 111.546 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.3 125.03 28.44 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.827 -1.17 . . . . 3.8700000000000001 109.828 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.31 126.81 39.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.789 0.436 . . . . 1.97 110.328 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -124.69 154.28 41.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.646 1.212 . . . . 3.0299999999999998 112.245 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.06 128.52 37.61 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.86 1.059 . . . . 2.4900000000000002 113.86 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.17 50.41 10.49 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.194 0.902 . . . . 3.6800000000000002 114.073 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.53 76.47 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.034 1.173 . . . . 1.8400000000000001 116.034 166.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.09 135.75 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.47 1.635 . . . . 5.7400000000000002 109.971 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.8 p -150.82 139.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 125.081 1.352 . . . . 2.0899999999999999 108.95 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.7 mt -139.05 134.78 33.45 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.244 1.018 . . . . 2.54 111.871 -172.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 2.9 tpmt? -80.17 135.95 36.39 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.198 . . . . 3.8199999999999998 113.113 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.93 173.65 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 125.158 1.383 . . . . 2.5499999999999998 111.88 156.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.16 153.75 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.121 1.768 . . . . 3.2999999999999998 108.74 165.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 mt -143.5 135.28 12.96 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.945 2.098 . . . . 2.7799999999999998 110.09 -172.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.32 159.28 49.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.257 2.638 . . . . 1.0800000000000001 111.988 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.33 131.2 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.123 0.969 . . . . 1.97 110.989 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.59 -170.05 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.782 3.233 . . . . 4.0099999999999998 110.796 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.1 70.58 1.15 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.181 -0.949 . . . . 3.6699999999999999 111.275 167.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.899 1.444 . . . . 5.4100000000000001 114.899 -145.561 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 109.535 -0.543 . . . . 6.0199999999999996 109.535 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 20' ' ' LEU . . . -99.91 128.3 9.53 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 121.259 -0.901 . . . . 2.0899999999999999 114.342 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -119.91 177.14 5.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.385 1.074 . . . . 2.1200000000000001 112.031 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.16 135.45 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.245 1.018 . . . . 2.1499999999999999 108.605 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.73 139.32 56.34 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.891 1.071 . . . . 9.6600000000000001 113.891 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -74.2 29.3 0.08 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.809 1.644 . . . . 5.1399999999999997 114.967 177.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.7 p -69.9 134.37 87.87 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 119.706 -1.871 . . . . 3.21 113.181 -159.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.2 -20.39 24.83 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.951 2.434 . . . . 2.4100000000000001 112.073 169.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.39 122.83 6.24 Favored Glycine 0 CA--C 1.534 1.253 0 N-CA-C 108.678 -1.769 . . . . 3.52 108.678 162.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.83 -39.99 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.006 1.903 . . . . 4.9500000000000002 112.34 -172.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -90.23 137.14 32.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.042 0.837 . . . . 5.6200000000000001 110.784 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 167.27 178.98 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.089 2.556 . . . . 4.2800000000000002 112.139 -172.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.69 28.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.655 1.982 . . . . 2.9100000000000001 114.001 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.04 155.65 45.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.788 1.635 . . . . 2.29 110.839 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.88 164.92 26.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.358 1.063 . . . . 3.6600000000000001 112.15 -158.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 2.6 pt? -168.38 155.03 7.41 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.659 1.355 . . . . 2.6099999999999999 114.659 164.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.9 m -76.03 136.86 39.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.874 -1.158 . . . . 2.5899999999999999 107.874 151.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -149.02 136.04 19.89 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.265 1.026 . . . . 3.1200000000000001 109.436 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.34 165.42 27.94 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.836 0.826 . . . . 3.4700000000000002 112.774 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -114.87 89.91 20.89 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 114.132 -1.395 . . . . 0.88 110.16 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.14 -5.77 17.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 1.3899999999999999 112.922 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.59 172.72 50.7 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.329 0.966 . . . . 1.0 113.333 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.8 m-20 -100.79 -1.56 34.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 2.7400000000000002 113.276 -172.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -119.09 159.04 46.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.866 1.666 . . . . 2.6699999999999999 110.548 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.87 156.88 27.31 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.966 2.444 . . . . 1.29 112.317 -168.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.9 102.71 7.92 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.607 1.563 . . . . 3.27 109.732 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttp-105 -92.38 113.44 25.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.103 1.361 . . . . 4.8300000000000001 111.031 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -103.95 109.67 21.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 128.324 2.65 . . . . 2.6600000000000001 108.592 -171.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -99.79 -17.0 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.654 1.182 . . . . 1.7 113.377 -168.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.28 -168.25 39.35 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.95 0.786 . . . . 0.48999999999999999 111.99 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.01 177.36 8.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.825 0.85 . . . . 2.1099999999999999 110.901 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -163.45 128.44 2.99 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.496 1.043 . . . . 6.46 108.487 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -136.06 153.22 76.67 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.504 -1.236 . . . . 1.7 109.089 -177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.79 -28.63 86.76 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.125 1.883 . . . . 1.29 113.379 166.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.6 -5.1 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 115.036 1.495 . . . . 2.4300000000000002 115.036 -168.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.68 170.44 15.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.321 1.448 . . . . 1.6599999999999999 113.029 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -113.6 -81.4 0.6 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.76 1.624 . . . . 2.8599999999999999 111.553 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -80.98 111.18 17.22 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 120.971 -1.081 . . . . 4.5599999999999996 109.105 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.86 131.72 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.461 1.905 . . . . 2.25 109.79 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -147.47 131.92 17.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.452 1.101 . . . . 2.0800000000000001 110.539 -167.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.37 119.82 22.94 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.156 1.344 . . . . 1.95 110.672 170.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -109.65 157.8 18.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.332 1.853 . . . . 0.81999999999999995 111.519 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.03 -176.53 3.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.837 0.855 . . . . 3.1200000000000001 111.535 164.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 m -146.65 99.66 3.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.929 1.292 . . . . 2.1099999999999999 107.609 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -106.29 -177.99 3.52 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.523 1.529 . . . . 3.23 112.636 -166.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -138.67 143.39 39.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.946 1.299 . . . . 3.8500000000000001 110.673 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -155.39 159.59 40.01 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.227 1.411 . . . . 7.9400000000000004 111.595 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -97.74 151.79 19.79 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.686 1.194 . . . . 3.73 112.253 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.15 -92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.365 1.466 . . . . 3.5699999999999998 109.577 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 56' ' ' LYS . 23.9 tt0 -74.88 36.78 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.35 2.26 . . . . 4.6900000000000004 110.873 171.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -18.2 0.63 Allowed Glycine 0 CA--C 1.538 1.499 0 O-C-N 120.421 -1.424 . . . . 2.0600000000000001 113.398 -158.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 54' ' ' GLU . 85.3 mttt -79.62 135.53 36.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.262 1.825 . . . . 4.3799999999999999 109.628 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 125.19 32.17 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.543 1.137 . . . . 6.9400000000000004 112.915 -175.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -123.34 147.82 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.603 1.961 . . . . 2.3799999999999999 109.408 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.9 ptp -94.95 155.62 16.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.533 1.133 . . . . 4.6399999999999997 113.565 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.05 169.17 33.1 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 123.899 0.761 . . . . 1.0600000000000001 113.251 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.6 mtt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.116 1.367 . . . . 2.8199999999999998 110.153 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -159.1 150.14 16.26 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 117.282 -1.342 . . . . 7.0099999999999998 110.03 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.26 146.37 75.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.843 1.696 . . . . 0.96999999999999997 110.142 164.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 m -113.56 160.27 32.34 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 126.028 1.731 . . . . 1.8 110.115 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.74 -24.36 47.47 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.212 1.941 . . . . 0.93000000000000005 112.29 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -178.05 163.6 1.75 Allowed 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.836 1.654 . . . . 3.7000000000000002 111.712 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -108.54 173.16 6.44 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.034 1.334 . . . . 1.95 109.38 150.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.39 161.61 42.17 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.366 -0.834 . . . . 2.9900000000000002 111.852 162.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.69 126.04 22.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.254 1.821 . . . . 1.8899999999999999 108.041 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.74 163.12 40.19 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.657 2.238 . . . . 1.05 110.374 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -61.7 136.66 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.645 2.23 . . . . 1.01 110.717 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.445 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 58.5 mmtt 67.15 2.62 2.85 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.821 2.049 . . . . 2.3199999999999998 113.809 -174.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.79 172.67 44.49 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.548 2.023 . . . . 0.95999999999999996 111.395 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -156.14 147.48 22.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 112.392 -1.904 . . . . 4.7300000000000004 111.923 -171.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.11 155.4 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.783 1.633 . . . . 3.2200000000000002 110.716 168.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -128.52 114.11 16.33 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.802 -1.555 . . . . 3.9700000000000002 106.802 167.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.78 91.62 3.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.086 1.354 . . . . 1.9399999999999999 112.315 -166.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.634 1.174 . . . . 3.6499999999999999 111.631 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.56 -17.87 58.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.929 2.419 . . . . 1.1899999999999999 113.197 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.6 52.98 0.85 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.706 1.146 . . . . 1.1200000000000001 111.486 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.9 -76.08 0.06 OUTLIER Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.591 1.091 . . . . 0.92000000000000004 114.767 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -153.81 137.6 16.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.602 1.961 . . . . 3.1200000000000001 110.026 -170.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -166.6 173.82 9.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.947 0.899 . . . . 0.98999999999999999 110.294 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.49 124.72 50.02 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 118.499 -0.762 . . . . 3.21 110.237 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.39 132.56 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.198 0.908 . . . . 2.3300000000000001 109.568 163.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.28 132.42 54.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.578 1.151 . . . . 2.4199999999999999 109.015 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.63 117.15 12.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.069 2.147 . . . . 3.7599999999999998 108.966 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.94 111.84 0.31 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.268 -1.133 . . . . 1.75 110.268 -170.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.4 mt -112.39 141.94 45.52 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.483 0.659 . . . . 2.5899999999999999 111.279 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -82.73 1.91 36.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.655 0.782 . . . . 2.8799999999999999 112.403 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -150.15 156.81 37.68 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 127.451 2.3 . . . . 4.9299999999999997 111.151 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.23 165.29 32.9 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.166 1.911 . . . . 1.8600000000000001 109.157 151.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -112.57 131.02 55.81 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.941 -0.763 . . . . 4.0199999999999996 108.941 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.94 122.32 18.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.399 1.079 . . . . 4.1100000000000003 108.265 -169.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.34 28.51 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.024 1.284 . . . . 2.5099999999999998 112.482 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 45.23 8.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.487 0.565 . . . . 2.48 113.669 -172.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.97 165.76 24.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.454 -1.027 . . . . 2.71 109.199 141.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -115.34 155.32 27.56 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.168 0.987 . . . . 4.7199999999999998 112.159 -168.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.72 118.41 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.488 1.915 . . . . 2.3300000000000001 109.654 -173.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.61 146.28 48.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.753 0.311 . . . . 2.8700000000000001 110.202 163.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.4 tt -155.29 126.18 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.558 0.743 . . . . 2.77 111.679 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.81 112.52 21.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.836 3.254 . . . . 2.1899999999999999 111.347 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.5 mt -81.47 124.0 29.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.523 1.129 . . . . 2.2999999999999998 108.566 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 mt -96.85 127.38 42.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.933 1.293 . . . . 1.8 109.878 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.59 162.92 14.24 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.869 -1.145 . . . . 3.5 112.581 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.53 101.54 1.01 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.786 -0.571 . . . . 2.6800000000000002 111.472 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.86 19.0 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.506 1.05 . . . . 3.0299999999999998 111.601 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.56 54.55 4.37 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.23 0.919 . . . . 2.3799999999999999 115.182 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -145.03 136.62 25.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 1.486 . . . . 5.5999999999999996 112.39 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.08 134.57 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 125.75 1.62 . . . . 2.4300000000000002 107.884 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.8 mt -143.85 124.93 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.081 1.352 . . . . 3.3799999999999999 108.491 -170.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.75 150.55 22.24 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.077 1.51 . . . . 4.6100000000000003 115.077 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -120.08 168.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.367 2.267 . . . . 2.2799999999999998 108.87 163.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.52 141.83 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.368 1.067 . . . . 3.2999999999999998 109.288 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.8 mt -131.85 131.69 22.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.319 1.848 . . . . 3.1000000000000001 108.765 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.91 155.51 43.36 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.53 2.153 . . . . 1.52 111.124 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.5 t -86.2 123.49 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.161 -1.051 . . . . 2.1099999999999999 108.161 164.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.05 160.11 28.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.01 1.324 . . . . 3.3700000000000001 110.615 -177.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -82.55 51.52 1.87 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.809 1.04 . . . . 3.79 113.809 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.165 1.786 . . . . 6.2599999999999998 112.331 -174.022 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.771 0.795 . . . . 5.8099999999999996 111.513 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -86.88 162.94 34.5 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 126.347 1.927 . . . . 1.4399999999999999 114.455 -172.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -147.92 150.11 33.48 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.749 0.819 . . . . 1.8700000000000001 112.444 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -103.79 134.32 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.234 1.414 . . . . 2.1000000000000001 108.267 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ttt-85 -86.8 100.3 12.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.182 1.178 . . . . 5.1699999999999999 114.182 -162.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.63 133.26 55.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.823 0.82 . . . . 4.0 110.773 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -162.91 157.36 17.96 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.965 1.706 . . . . 3.2999999999999998 110.014 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -86.54 67.04 4.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.721 2.948 . . . . 3.21 110.219 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.98 164.29 28.89 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.693 1.037 . . . . 1.5600000000000001 115.693 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -80.1 -9.72 14.02 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.64 3.56 . . . . 1.74 112.594 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -142.3 151.98 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.2 1.8 . . . . 2.3500000000000001 111.072 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.61 -163.86 1.52 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.548 1.539 . . . . 2.1000000000000001 111.237 -173.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.66 156.09 39.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.088 1.355 . . . . 2.2799999999999998 110.66 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.92 148.76 45.09 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.948 0.899 . . . . 1.8600000000000001 110.631 156.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -128.07 178.01 6.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.828 1.651 . . . . 3.8300000000000001 110.124 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.506 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.5 pt? -169.92 161.15 8.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.137 1.775 . . . . 2.6800000000000002 111.199 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -98.2 145.01 27.04 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.702 -1.592 . . . . 2.7000000000000002 106.702 154.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.46 127.61 7.66 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.438 1.095 . . . . 3.4300000000000002 110.377 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 151.26 29.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.467 1.507 . . . . 2.7400000000000002 111.544 173.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -98.23 109.15 50.95 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.051 -0.977 . . . . 1.25 110.105 161.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.19 -8.87 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.884 2.389 . . . . 1.8799999999999999 113.787 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.44 171.04 49.38 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.359 0.981 . . . . 1.6299999999999999 113.271 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.0 m-20 -94.98 -5.0 45.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.312 1.845 . . . . 3.04 112.66 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.58 158.06 39.74 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.83 2.052 . . . . 5.8200000000000003 108.595 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.83 151.61 24.67 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.907 2.405 . . . . 1.29 111.62 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -102.23 133.14 47.59 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.06 0.944 . . . . 3.1099999999999999 111.018 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 68' ' ' GLU . 26.5 ttm180 -117.1 107.84 14.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.902 1.281 . . . . 3.73 110.501 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -95.14 114.52 26.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.644 2.378 . . . . 1.8100000000000001 109.192 -169.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.65 -9.44 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.506 1.122 . . . . 1.95 112.968 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.13 -171.54 44.61 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.481 1.039 . . . . 0.53000000000000003 111.438 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.8 170.07 21.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.018 1.327 . . . . 1.53 110.735 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -158.39 115.59 2.87 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 120.057 1.298 . . . . 5.6600000000000001 109.376 -165.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 t -127.03 159.33 65.33 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 117.759 -1.115 . . . . 1.78 109.353 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.93 -22.75 48.09 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.533 2.155 . . . . 0.95999999999999996 113.685 164.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.253 3.9 m -87.91 8.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.383 1.623 . . . . 2.04 115.383 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.94 161.94 41.31 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.805 -1.185 . . . . 1.8899999999999999 113.677 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.7 -88.61 0.28 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.022 1.729 . . . . 2.96 110.516 174.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -81.48 121.54 26.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 4.3200000000000003 110.286 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.91 142.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 2.98 111.36 164.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -140.71 116.09 10.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.946 1.298 . . . . 2.23 110.091 166.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.8 tt -76.83 119.19 20.25 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 120.897 1.681 . . . . 1.6899999999999999 110.639 170.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -105.09 152.07 23.22 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.035 1.334 . . . . 0.65000000000000002 112.549 177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.46 179.82 5.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.606 1.962 . . . . 2.48 110.941 165.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 m -144.26 93.15 2.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.86 1.664 . . . . 2.1499999999999999 107.906 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.79 146.4 23.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.42 1.105 . . . . 3.7000000000000002 111.833 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -87.51 147.82 25.19 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.912 1.285 . . . . 4.8799999999999999 110.34 165.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.57 152.75 23.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.564 1.546 . . . . 6.9800000000000004 110.918 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.59 141.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.122 -1.066 . . . . 4.0599999999999996 108.122 156.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.88 120.6 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.535 1.534 . . . . 3.5099999999999998 106.997 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 62.07 23.8 14.09 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.946 0.899 . . . . 3.3599999999999999 111.602 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.88 -10.72 38.28 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.065 1.317 . . . . 2.1400000000000001 114.275 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -87.35 140.93 29.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.921 1.689 . . . . 3.7200000000000002 109.705 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -79.65 128.28 33.2 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.424 -0.798 . . . . 4.5 111.003 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -135.69 150.13 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.864 1.665 . . . . 2.6499999999999999 110.443 -170.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.7 tpp -119.85 138.88 53.13 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.255 1.422 . . . . 4.4800000000000004 109.223 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.08 141.28 11.08 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 118.92 0.782 . . . . 1.3100000000000001 113.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -89.3 165.31 14.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.717 0.807 . . . . 2.7599999999999998 111.176 169.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 -176.07 138.14 0.5 Allowed Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 116.455 -1.736 . . . . 5.2699999999999996 111.146 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.84 139.03 38.96 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 122.75 2.018 . . . . 0.78000000000000003 111.607 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.67 156.07 42.99 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 126.033 1.733 . . . . 1.51 111.163 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.74 -17.21 33.28 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.989 2.46 . . . . 0.69999999999999996 113.087 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -177.52 165.89 2.19 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.857 2.063 . . . . 2.9199999999999999 111.424 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.51 173.5 6.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.952 1.701 . . . . 1.78 109.384 155.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 31' ' ' ARG . 6.9 pt-20 -152.96 164.25 38.3 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.382 -0.824 . . . . 2.1499999999999999 113.075 170.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -139.53 129.23 14.08 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.046 1.738 . . . . 1.9199999999999999 109.03 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.38 161.99 42.76 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.691 2.261 . . . . 0.87 111.727 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.21 135.93 65.31 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.772 2.981 . . . . 1.2 112.333 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 63.6 mmtt 68.08 1.02 2.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.316 1.847 . . . . 3.04 113.9 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.42 -178.48 45.46 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 126.109 1.814 . . . . 1.45 111.023 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -160.11 163.74 33.57 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.065 1.346 . . . . 5.4299999999999997 112.425 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.91 154.2 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.376 1.47 . . . . 2.7000000000000002 111.115 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.516 ' CD ' ' HZ3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.5 123.49 47.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.645 1.178 . . . . 3.3599999999999999 109.448 164.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.3 146.34 43.23 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 1.9099999999999999 109.645 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.516 ' HZ3' ' CD ' ' A' ' 76' ' ' GLU . 9.2 ptpp? -153.99 151.12 23.99 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.89 0.876 . . . . 4.2300000000000004 112.285 -163.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.59 -50.93 4.69 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.757 2.972 . . . . 1.02 112.233 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.27 90.44 1.56 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 109.07 -1.612 . . . . 1.3 109.07 162.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.57 -90.22 0.11 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 123.659 0.647 . . . . 0.91000000000000003 114.075 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -153.26 140.24 19.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.287 1.435 . . . . 3.02 110.3 -170.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -162.64 156.59 20.84 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.239 0.616 . . . . 1.3700000000000001 111.307 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.485 ' CE1' HD11 ' A' ' 45' ' ' LEU . 71.5 m-85 -90.51 112.77 24.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 3.4300000000000002 109.012 166.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.2 125.59 27.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.469 -0.938 . . . . 2.25 108.469 167.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.92 117.16 34.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.786 -1.19 . . . . 2.6200000000000001 107.786 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.65 110.75 20.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.965 1.306 . . . . 4.0899999999999999 108.188 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.21 98.52 0.7 Allowed Glycine 0 N--CA 1.47 0.904 0 C-N-CA 124.346 0.974 . . . . 1.5900000000000001 111.19 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 mt -96.34 128.78 43.57 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.649 0.779 . . . . 1.95 110.916 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -18.74 53.85 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.493 0.923 . . . . 3.0600000000000001 113.493 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.9 150.85 77.71 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 125.885 1.674 . . . . 5.2800000000000002 108.268 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.98 118.59 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 107.048 -1.943 . . . . 1.51 107.048 155.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.39 108.54 1.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.177 1.391 . . . . 2.9199999999999999 111.492 -160.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -80.45 105.05 11.42 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.149 -0.969 . . . . 5.4699999999999998 110.885 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.47 111.86 0.79 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.715 -1.217 . . . . 2.4100000000000001 107.715 152.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 5.89 34.41 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 117.312 -1.827 . . . . 2.3599999999999999 116.228 -166.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.45 169.21 8.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.731 2.265 . . . . 3.4199999999999999 111.748 160.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.76 141.66 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.633 1.573 . . . . 4.6799999999999997 109.454 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.64 112.51 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.776 0.831 . . . . 2.0800000000000001 110.815 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 45.9 mt-10 -64.89 148.31 51.66 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.999 0.52 . . . . 3.0099999999999998 111.181 163.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.77 116.71 4.5 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.415 1.102 . . . . 4.4000000000000004 109.87 174.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.41 116.61 21.96 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.732 2.813 . . . . 1.99 111.029 170.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.0 mt -83.73 118.77 24.11 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.34 1.456 . . . . 3.3700000000000001 110.313 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt -93.95 122.01 36.01 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.328 0.513 . . . . 1.8700000000000001 109.785 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -120.31 152.57 37.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.296 1.046 . . . . 3.6699999999999999 112.235 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.87 113.62 1.57 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.59 1.156 . . . . 2.6200000000000001 112.993 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 76.06 0.86 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.332 1.444 . . . . 3.3399999999999999 113.268 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.26 -6.6 56.52 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 116.744 1.458 . . . . 2.6800000000000002 116.744 163.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -86.98 128.01 35.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.183 1.991 . . . . 5.9900000000000002 110.122 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.58 135.68 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.181 1.392 . . . . 2.25 108.957 168.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.43 125.06 19.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.445 1.098 . . . . 3.3300000000000001 110.26 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.451 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 31.2 ttmt -83.28 135.49 34.73 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.345 0.869 . . . . 3.5800000000000001 113.345 -177.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.46 175.57 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.565 1.546 . . . . 2.0699999999999998 109.804 157.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.07 141.51 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.787 1.635 . . . . 3.0600000000000001 107.742 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.7 mt -143.91 160.14 50.94 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.794 1.638 . . . . 3.1000000000000001 111.267 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.49 169.07 19.07 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.738 3.626 . . . . 1.1799999999999999 112.679 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.1 t -107.2 133.28 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.43 1.892 . . . . 1.9099999999999999 110.72 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 151.51 42.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.085 1.354 . . . . 4.9000000000000004 111.044 170.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.33 85.35 6.88 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.074 -1.016 . . . . 3.1400000000000001 110.62 163.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.244 -1.36 . . . . 8.75 111.54 171.7 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 121.425 0.631 . . . . 5.54 111.019 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.78 174.73 55.19 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.506 1.05 . . . . 1.9399999999999999 113.367 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -155.0 158.7 39.56 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.779 1.232 . . . . 2.5800000000000001 112.069 -175.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.5 t -113.19 146.43 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 121.017 -1.052 . . . . 2.4199999999999999 109.373 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.99 140.08 40.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.806 -0.758 . . . . 6.4000000000000004 111.71 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -47.06 127.19 10.04 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.466 1.507 . . . . 4.7699999999999996 110.953 160.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -174.5 106.0 0.28 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.909 2.084 . . . . 3.7799999999999998 109.781 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -88.04 19.18 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.918 3.079 . . . . 2.7999999999999998 111.707 170.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.1 -165.26 38.95 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.836 1.208 . . . . 1.51 113.724 -171.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.57 -19.39 21.66 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.029 2.486 . . . . 1.8 112.647 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -146.68 165.06 30.71 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.829 1.252 . . . . 2.5600000000000001 113.186 -178.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 -179.92 8.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.441 1.497 . . . . 2.54 112.426 177.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.55 135.64 51.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.716 1.606 . . . . 2.1699999999999999 110.065 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.37 123.81 41.32 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.205 0.526 . . . . 1.8400000000000001 110.165 162.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -92.04 154.9 18.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.319 1.448 . . . . 3.1699999999999999 108.238 164.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -166.63 136.78 3.18 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.27 -0.894 . . . . 2.6200000000000001 113.028 175.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.2 m -79.35 148.28 32.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.011 -1.45 . . . . 2.1800000000000002 107.613 165.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.13 141.0 18.2 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.035 1.734 . . . . 3.2799999999999998 107.507 -176.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -144.31 132.49 21.75 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.881 -1.137 . . . . 3.2799999999999998 110.579 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.63 109.6 39.7 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.341 1.456 . . . . 1.04 109.895 177.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.87 -9.88 14.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.629 2.219 . . . . 1.28 113.91 176.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.28 173.92 54.78 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.042 0.829 . . . . 1.1200000000000001 113.961 -172.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 18.3 m-20 -104.26 3.45 32.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.404 1.881 . . . . 3.0899999999999999 112.491 178.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -116.33 164.58 17.6 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.691 1.996 . . . . 2.48 109.868 163.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.14 159.29 15.38 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.062 2.508 . . . . 1.0600000000000001 112.048 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.9 mt -106.6 154.59 20.69 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.624 1.17 . . . . 2.8199999999999998 110.985 168.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.4 ttp-105 -141.93 114.92 8.69 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.248 1.419 . . . . 6.0499999999999998 112.081 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.94 118.52 33.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.262 3.025 . . . . 2.1899999999999999 110.019 -176.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.86 -20.0 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.589 1.156 . . . . 2.1400000000000001 113.768 -173.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.15 16.81 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.509 -0.744 . . . . 1.1000000000000001 111.688 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.75 176.89 11.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.851 0.86 . . . . 2.5899999999999999 111.452 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -156.74 146.28 20.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.561 -0.903 . . . . 8.0199999999999996 108.561 172.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -142.72 157.61 61.42 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.721 -1.133 . . . . 1.6699999999999999 108.717 174.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.14 -25.34 50.85 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.352 2.035 . . . . 1.25 113.795 160.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.4 2.71 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 115.631 1.715 . . . . 1.8100000000000001 115.631 -165.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.55 152.2 29.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.294 0.952 . . . . 1.6699999999999999 113.367 -177.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.32 -88.34 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.558 1.943 . . . . 2.98 110.436 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -77.88 116.77 18.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.395 1.478 . . . . 5.3600000000000003 109.34 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.34 134.93 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.68 1.592 . . . . 2.2799999999999998 109.584 174.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.55 138.26 44.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.012 1.725 . . . . 1.95 110.606 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -84.51 109.89 18.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.486 1.114 . . . . 4.2599999999999998 109.444 172.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -113.59 154.36 27.31 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.027 1.331 . . . . 1.2 113.682 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.4 164.92 11.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.912 2.085 . . . . 1.8200000000000001 111.431 171.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 27.6 m -130.15 111.67 12.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.955 1.302 . . . . 2.2400000000000002 108.551 170.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -112.67 154.79 25.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.805 1.242 . . . . 3.21 113.308 -174.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 159.12 15.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.693 1.197 . . . . 4.4900000000000002 110.894 164.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.25 146.97 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.383 1.473 . . . . 9.3399999999999999 111.399 -167.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.439 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -103.64 143.71 32.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.494 1.118 . . . . 5.0499999999999998 112.352 175.444 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.97 133.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.955 1.702 . . . . 4.71 109.246 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 67.61 6.07 4.77 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.588 1.155 . . . . 3.8399999999999999 112.641 -171.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.49 4.94 89.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.724 1.631 . . . . 2.8300000000000001 113.789 -166.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -100.76 148.72 24.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.711 2.004 . . . . 4.1299999999999999 110.99 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.439 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -85.59 149.27 25.46 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.375 -0.828 . . . . 4.9699999999999998 112.423 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.04 152.92 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.473 1.909 . . . . 4.3300000000000001 109.366 175.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.5 mtm -112.56 155.45 24.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.181 0.992 . . . . 4.7400000000000002 112.072 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.72 177.35 32.89 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.223 0.916 . . . . 1.4399999999999999 112.731 173.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -125.17 157.79 35.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.17 1.388 . . . . 3.25 110.511 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.13 157.38 63.76 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.299 -1.334 . . . . 7.54 108.506 161.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.34 141.65 82.47 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.903 1.358 . . . . 1.3400000000000001 110.264 151.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.37 153.46 41.99 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 126.522 1.929 . . . . 2.02 110.27 178.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.01 -31.44 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.533 2.155 . . . . 1.52 112.943 -174.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.3 p90 164.47 148.17 0.02 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 126.807 2.043 . . . . 4.1900000000000004 107.909 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.59 145.41 46.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.715 -1.13 . . . . 5.1799999999999997 108.257 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.277 0.0 OUTLIER -141.27 155.24 46.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.803 1.038 . . . . 3.3599999999999999 113.803 -175.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.8 t -139.25 132.18 15.57 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 113.919 -1.491 . . . . 1.8999999999999999 109.443 -156.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.23 166.96 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.07 1.847 . . . . 0.87 112.074 179.24 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -55.96 140.64 86.25 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.561 2.84 . . . . 1.0900000000000001 111.718 166.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 35.3 mmtm 67.65 -0.67 1.86 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.012 1.725 . . . . 2.4199999999999999 113.532 -174.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.79 113.92 4.39 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 126.773 2.13 . . . . 0.91000000000000003 113.363 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -80.97 133.47 35.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.316 1.446 . . . . 4.9900000000000002 109.9 162.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.9 168.88 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.738 1.615 . . . . 2.4100000000000001 110.45 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -164.1 117.22 1.41 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.708 0.403 . . . . 3.6800000000000002 111.373 -167.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.67 72.77 3.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.14 2.176 . . . . 1.8200000000000001 110.267 178.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -80.72 148.0 64.2 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 126.041 1.736 . . . . 4.2300000000000004 113.299 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -47.87 21.39 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.439 3.426 . . . . 0.91000000000000003 114.29 -168.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.66 103.4 2.74 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 107.525 -2.23 . . . . 1.24 107.525 157.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 144.6 -102.71 0.28 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.494 1.997 . . . . 1.1599999999999999 110.416 -162.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -149.1 158.76 44.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.46 1.504 . . . . 3.7999999999999998 110.619 -175.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -165.34 158.52 16.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.847 -1.158 . . . . 1.25 110.313 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -96.59 117.28 30.63 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.595 -0.691 . . . . 3.8300000000000001 109.295 171.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.27 121.54 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.064 1.346 . . . . 1.99 110.251 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.5 mt -108.02 106.29 16.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.69 1.996 . . . . 2.54 108.631 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.82 122.93 47.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.228 1.411 . . . . 3.77 109.384 -177.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.41 89.46 0.39 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.429 -1.068 . . . . 1.27 110.429 -175.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.13 122.25 27.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.641 0.721 . . . . 1.9099999999999999 111.682 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -74.44 -13.9 60.77 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.862 0.865 . . . . 2.48 112.955 172.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ptt85 -157.48 142.11 11.94 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 6.5499999999999998 110.41 165.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.76 141.8 38.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.834 3.023 . . . . 1.9099999999999999 111.186 -176.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.82 78.99 9.42 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.9 -1.148 . . . . 3.8300000000000001 107.9 177.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -69.45 162.84 26.6 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.736 0.779 . . . . 4.6900000000000004 111.555 170.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.12 132.95 53.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.204 -1.035 . . . . 3.1000000000000001 108.204 163.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.21 49.85 19.36 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.417 -0.657 . . . . 3.54 112.437 -171.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -126.22 167.55 15.28 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.538 1.135 . . . . 3.9199999999999999 109.895 163.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -134.63 151.92 51.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.781 1.232 . . . . 4.3499999999999996 111.353 172.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.59 121.17 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.713 2.005 . . . . 2.7000000000000002 108.627 -171.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.491 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 39.2 mt-10 -78.54 149.68 33.02 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.849 -0.532 . . . . 2.6099999999999999 110.034 162.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -149.41 125.55 10.71 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.63 0.372 . . . . 3.1200000000000001 111.647 166.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -91.03 108.53 19.92 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.231 3.413 . . . . 2.4399999999999999 110.067 178.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.31 131.37 37.01 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.304 1.042 . . . . 3.6299999999999999 110.294 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -101.39 122.48 43.81 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.817 0.847 . . . . 2.2000000000000002 110.733 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 137.33 52.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.585 0.958 . . . . 3.6400000000000001 113.585 -172.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.57 73.21 3.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.67 1.188 . . . . 2.6000000000000001 112.047 176.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.61 32.37 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.529 1.061 . . . . 5.3899999999999997 114.589 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.77 28.33 70.96 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 118.387 1.094 . . . . 2.6299999999999999 113.869 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.26 141.37 52.13 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.815 1.246 . . . . 5.0599999999999996 111.763 -178.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.8 136.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.131 1.772 . . . . 2.4500000000000002 107.627 159.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.8 mt -144.68 124.82 13.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.476 1.11 . . . . 2.6000000000000001 110.022 -174.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 16.0 ptpt -91.53 149.2 21.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 115.542 1.682 . . . . 3.4300000000000002 115.542 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.58 148.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.239 1.816 . . . . 3.6600000000000001 109.613 167.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.92 133.2 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.184 1.393 . . . . 4.0999999999999996 109.927 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -136.19 113.9 10.58 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.314 1.046 . . . . 3.0099999999999998 111.033 -165.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.31 158.13 37.11 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.162 2.575 . . . . 1.5 111.593 171.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.61 129.88 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.388 1.475 . . . . 3.0499999999999998 111.188 176.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.44 162.88 34.34 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.33 1.852 . . . . 3.8100000000000001 108.916 175.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.68 51.76 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.448 -1.408 . . . . 3.7599999999999998 112.683 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.391 0 CA-C-O 114.021 -2.895 . . . . 5.3899999999999997 117.173 -157.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 108.633 -0.877 . . . . 6.25 108.633 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.25 173.66 26.45 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.866 1.666 . . . . 1.6699999999999999 115.116 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -154.74 154.28 32.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.537 1.16 . . . . 2.1800000000000002 114.004 -178.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.54 144.86 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 107.04 -1.466 . . . . 2.6099999999999999 107.04 158.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -90.4 117.5 29.15 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.087 0.555 . . . . 5.21 111.263 -179.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -48.8 130.35 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.782 1.233 . . . . 4.0099999999999998 111.86 162.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 93' ' ' LEU . 33.9 m -163.4 129.73 2.33 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 128.831 2.852 . . . . 2.71 107.862 165.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -83.92 67.06 7.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.178 2.585 . . . . 2.3900000000000001 109.707 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.84 -174.43 20.45 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 115.128 0.811 . . . . 1.8 115.128 -172.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -83.48 -15.06 7.69 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 124.212 3.275 . . . . 2.0600000000000001 113.191 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -131.0 157.75 42.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.704 1.602 . . . . 4.0800000000000001 110.681 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.63 -164.35 1.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.064 1.746 . . . . 2.04 111.552 177.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.21 160.69 39.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.966 1.707 . . . . 2.0299999999999998 110.764 -178.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 158.9 43.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.095 1.358 . . . . 1.99 112.394 171.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -162.02 152.91 17.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.263 2.225 . . . . 3.9199999999999999 109.499 -173.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.23 157.74 26.16 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.893 -1.129 . . . . 2.9900000000000002 112.381 -175.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.8 m -77.96 96.8 5.13 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.571 -1.27 . . . . 2.5499999999999998 107.571 165.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 tt -88.3 148.94 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.931 1.692 . . . . 4.04 108.92 169.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -150.0 165.37 32.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.733 0.777 . . . . 4.1600000000000001 112.896 168.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -120.88 101.62 45.11 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 126.007 1.723 . . . . 0.90000000000000002 109.343 171.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.82 -5.48 15.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.95 2.433 . . . . 1.1200000000000001 113.302 174.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.02 -177.78 51.54 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.883 1.23 . . . . 0.95999999999999996 114.176 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 16.3 m-20 -112.69 1.75 15.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.275 1.43 . . . . 2.6800000000000002 113.373 -170.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.15 162.18 27.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.91 1.684 . . . . 2.5499999999999998 109.71 165.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.58 157.88 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.847 2.365 . . . . 1.1200000000000001 111.825 -172.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 mt -107.81 149.06 28.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.917 0.887 . . . . 3.1299999999999999 111.558 172.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -121.14 110.75 16.58 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.188 1.395 . . . . 7.2199999999999998 109.232 168.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.8 tp -82.93 127.25 33.35 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.838 1.255 . . . . 1.8600000000000001 108.173 175.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.6 -11.0 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.432 0.901 . . . . 1.8 113.432 -173.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.11 -162.74 33.36 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 121.564 0.536 . . . . 0.46999999999999997 112.295 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.59 178.92 8.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.465 1.506 . . . . 1.8 110.154 175.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -161.59 139.76 9.29 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.129 0.877 . . . . 7.5 109.137 167.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.6 t -145.56 146.34 29.21 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.99 1.316 . . . . 1.6100000000000001 108.811 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.91 -22.9 55.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.963 1.775 . . . . 1.3100000000000001 113.132 178.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.77 0.15 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 114.42 1.267 . . . . 2.21 114.42 -174.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.04 168.01 9.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 116.068 1.877 . . . . 2.8799999999999999 116.068 -169.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.37 -104.36 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 106.955 -1.498 . . . . 6.3300000000000001 106.955 143.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -79.49 169.37 18.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.554 1.168 . . . . 4.9800000000000004 112.464 167.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.6 132.02 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.868 1.667 . . . . 2.6899999999999999 107.865 161.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -119.94 128.44 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.89 1.276 . . . . 1.97 109.705 -175.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 84' ' ' PHE . 5.5 tt -81.54 120.09 24.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.773 1.17 . . . . 1.6699999999999999 110.628 169.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -110.33 153.05 25.44 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.592 1.557 . . . . 0.77000000000000002 112.933 176.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.22 172.13 8.16 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.443 2.297 . . . . 2.1800000000000002 110.699 165.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.1 m -133.19 92.65 3.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.115 1.366 . . . . 1.71 108.015 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -97.59 149.42 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.138 0.971 . . . . 3.3700000000000001 113.161 -163.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.3 ttp -79.05 139.4 38.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.629 1.172 . . . . 5.6600000000000001 110.086 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.58 113.93 2.61 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.54 0.736 . . . . 11.73 111.615 -175.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.01 153.69 19.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.158 0.983 . . . . 4.5800000000000001 110.613 174.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.6 t -143.51 122.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.284 -1.376 . . . . 3.48 107.284 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 69.28 8.47 6.82 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.916 1.286 . . . . 3.98 111.984 -174.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.58 85.31 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.843 1.211 . . . . 1.79 113.82 -166.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -90.94 143.14 27.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.561 1.544 . . . . 3.7799999999999998 110.225 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -75.16 132.84 41.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.713 1.605 . . . . 5.1500000000000004 113.307 -165.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.31 172.26 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.421 0.629 . . . . 2.7400000000000002 112.163 172.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.3 tpp -129.75 159.24 37.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.814 2.045 . . . . 4.29 110.133 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.45 177.75 22.06 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.009 1.766 . . . . 1.1000000000000001 112.16 173.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.3 mtt -138.9 154.49 48.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.779 1.632 . . . . 2.7799999999999998 109.66 173.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -169.82 144.0 2.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 116.401 -1.761 . . . . 5.5099999999999998 111.333 -169.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.99 150.93 87.44 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 CA-C-N 121.716 1.648 . . . . 0.89000000000000001 112.414 165.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.48 159.02 47.54 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 126.418 1.887 . . . . 2.0499999999999998 110.703 173.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -70.93 -22.16 27.06 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.683 2.255 . . . . 0.76000000000000001 112.801 173.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -175.92 171.27 2.65 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.939 1.696 . . . . 3.02 111.562 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.44 172.1 8.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.746 2.018 . . . . 1.8799999999999999 109.136 159.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.15 161.56 41.2 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.917 -1.114 . . . . 2.54 111.651 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.62 136.43 10.59 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.262 1.025 . . . . 1.99 109.679 -166.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.72 170.02 19.69 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.549 2.166 . . . . 0.84999999999999998 112.027 178.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -60.91 142.68 98.31 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.225 2.617 . . . . 0.93000000000000005 111.599 166.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 36.4 mmtm 64.55 6.57 3.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.243 1.817 . . . . 2.3900000000000001 113.506 -174.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.42 115.41 4.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 126.192 1.853 . . . . 0.96999999999999997 111.164 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.67 137.26 36.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.498 1.519 . . . . 5.6299999999999999 110.151 166.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.06 129.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.163 0.985 . . . . 2.2999999999999998 111.557 177.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.22 124.55 31.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.699 -0.852 . . . . 3.8799999999999999 108.699 165.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.1 145.49 53.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.362 -0.977 . . . . 2.02 108.362 163.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -155.92 138.85 10.67 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 117.974 -1.012 . . . . 4.4400000000000004 111.726 -166.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.79 -26.5 45.01 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.653 2.902 . . . . 1.1399999999999999 113.587 -172.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.0 87.95 1.5 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 108.084 -2.006 . . . . 1.52 108.084 155.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.85 -97.26 0.18 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.214 0.911 . . . . 1.1799999999999999 113.458 -171.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -150.91 146.45 26.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.703 2.001 . . . . 3.6699999999999999 110.469 -167.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -153.91 159.32 41.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.841 -0.537 . . . . 1.03 111.124 -175.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.41 ' CE1' HD12 ' A' ' 45' ' ' LEU . 41.7 m-85 -94.7 118.61 32.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.299 -1.001 . . . . 3.1299999999999999 108.299 164.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.09 123.15 33.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.425 -0.954 . . . . 2.6800000000000002 108.425 173.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -105.14 122.55 46.13 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.286 1.434 . . . . 3.5299999999999998 109.108 -174.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.95 151.91 39.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.37 1.068 . . . . 3.71 111.157 -170.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.85 42.65 92.2 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 123.95 0.786 . . . . 2.0099999999999998 113.219 171.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.7 mt -53.64 141.39 26.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.192 1.797 . . . . 2.3900000000000001 112.729 -171.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -70.61 -9.53 57.15 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.343 -0.848 . . . . 4.5599999999999996 112.783 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -167.23 152.06 6.86 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.824 2.05 . . . . 8.1300000000000008 111.271 173.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.29 149.22 85.23 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.847 2.365 . . . . 3.4500000000000002 110.132 162.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.445 ' HB2' ' H ' ' A' ' 11' ' ' SER . 2.4 mm? -80.23 155.51 27.31 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.596 0.712 . . . . 3.5600000000000001 111.786 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.99 -25.56 5.33 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.49 1.916 . . . . 4.5199999999999996 112.18 177.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 80.62 161.57 0.17 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.745 2.818 . . . . 2.8500000000000001 111.516 -175.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.52 57.78 16.32 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.462 -1.055 . . . . 2.6800000000000002 110.462 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -167.34 161.58 14.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.922 2.889 . . . . 3.9399999999999999 107.351 -174.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.59 161.4 16.84 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.713 1.205 . . . . 3.79 112.022 -170.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.2 t -144.6 127.78 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.718 2.007 . . . . 2.5800000000000001 109.886 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.1 140.21 41.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.931 0.492 . . . . 3.1699999999999999 110.742 165.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tt -148.08 135.57 20.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.458 1.123 . . . . 2.6600000000000001 111.299 169.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -104.52 112.29 25.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.826 2.05 . . . . 2.2799999999999998 110.68 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.14 118.38 18.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.484 . . . . 2.2799999999999998 109.805 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -93.9 121.38 35.3 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.368 0.667 . . . . 1.74 110.179 -173.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.14 124.36 47.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.477 1.132 . . . . 3.0800000000000001 113.366 -176.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 58.33 -12.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 131.027 3.731 . . . . 2.8599999999999999 117.574 170.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.03 57.2 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.528 1.537 . . . . 3.5899999999999999 113.452 -163.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.75 -0.06 1.82 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.126 1.61 . . . . 2.1499999999999999 117.126 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.4 156.81 43.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.459 1.904 . . . . 4.9500000000000002 111.294 173.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.88 128.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.82 1.248 . . . . 1.76 109.639 167.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.42 133.72 55.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.809 1.643 . . . . 3.5499999999999998 109.055 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -85.48 134.94 34.03 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.042 -1.036 . . . . 3.3300000000000001 111.474 176.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.7 164.45 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.987 1.315 . . . . 2.2400000000000002 109.841 160.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.25 142.29 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.532 -1.284 . . . . 3.3599999999999999 107.532 169.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.6 mt -136.76 138.78 27.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.918 1.287 . . . . 3.3399999999999999 109.985 -169.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.11 150.05 17.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.701 2.934 . . . . 1.3899999999999999 111.193 166.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.6 t -88.17 120.56 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.75 1.62 . . . . 2.2999999999999998 109.092 167.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 120' ' ' ARG . 46.9 mt-10 -142.49 162.06 36.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.818 1.247 . . . . 4.5999999999999996 112.194 -170.129 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.23 126.41 41.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.941 0.897 . . . . 3.71 109.105 166.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.44 HH21 ' CD ' ' A' ' 118' ' ' GLU . 92.1 mtt-85 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 129.553 3.141 . . . . 8.6300000000000008 109.325 -171.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 118.222 -0.894 . . . . 5.2999999999999998 109.057 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.89 -179.4 24.76 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.686 1.585 . . . . 1.24 114.667 175.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -170.48 156.63 5.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.708 1.603 . . . . 1.9299999999999999 111.903 170.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.03 128.9 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.822 -0.807 . . . . 1.8500000000000001 108.822 172.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.412 HH21 ' C ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -73.85 -5.13 39.11 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 117.789 2.515 . . . . 4.4699999999999998 117.789 -145.657 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 69.82 121.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.299 2.639 . . . . 5.5099999999999998 112.248 -174.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -171.36 136.92 1.03 Allowed Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 119.752 -1.843 . . . . 2.4900000000000002 112.393 178.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -93.88 -5.33 2.63 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.622 3.548 . . . . 2.8700000000000001 113.893 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.75 165.78 53.81 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 119.275 0.943 . . . . 1.48 112.53 177.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.08 -14.77 44.64 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.502 2.801 . . . . 1.95 114.54 -172.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -124.61 152.12 43.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.365 1.466 . . . . 4.2199999999999998 111.822 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.1 -168.06 2.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.551 1.94 . . . . 2.3500000000000001 111.223 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.59 156.27 44.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.523 1.129 . . . . 1.9199999999999999 112.997 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.77 140.03 53.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.294 1.437 . . . . 1.9299999999999999 111.559 169.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -119.83 150.79 39.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.575 1.55 . . . . 3.21 110.035 178.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -162.83 158.74 23.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.673 0.99 . . . . 2.8900000000000001 113.673 177.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -94.01 117.22 29.79 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.977 -1.119 . . . . 2.4900000000000002 107.977 165.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.42 135.46 34.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.596 1.958 . . . . 3.4399999999999999 108.136 175.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -145.75 146.3 31.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.971 1.1 . . . . 2.7400000000000002 113.971 170.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -110.08 109.16 59.04 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 113.971 -1.468 . . . . 0.94999999999999996 110.113 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.46 -9.88 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.669 2.246 . . . . 1.1200000000000001 113.498 175.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.24 177.86 54.13 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.316 0.96 . . . . 0.94999999999999996 114.035 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 6.8 m-20 -106.19 -1.63 23.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.911 1.685 . . . . 2.3300000000000001 112.925 -178.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.95 162.67 19.74 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 126.128 1.771 . . . . 2.4199999999999999 109.646 163.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.17 161.64 17.85 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.011 2.474 . . . . 1.21 112.018 -172.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 mt -109.0 154.5 22.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.341 1.056 . . . . 2.8500000000000001 110.488 168.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -138.01 102.62 4.74 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 5.0599999999999996 109.635 177.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -84.38 103.8 13.86 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.258 1.823 . . . . 1.76 108.702 -172.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.79 -13.87 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.682 0.793 . . . . 1.9099999999999999 112.736 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.71 -164.39 35.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 123.603 0.621 . . . . 0.68000000000000005 112.258 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.19 177.3 10.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.992 0.917 . . . . 2.1299999999999999 111.951 167.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -144.35 148.42 34.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.928 1.291 . . . . 7.9800000000000004 109.586 170.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -150.54 151.31 30.59 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 125.137 1.375 . . . . 1.8600000000000001 108.344 -168.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.4 -24.73 16.13 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.91 1.74 . . . . 0.93999999999999995 113.364 175.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 m -78.6 -19.67 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.704 1.372 . . . . 2.0800000000000001 114.704 -170.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.33 45.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.038 0.935 . . . . 1.77 111.098 -172.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.34 -71.97 0.52 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.768 0.427 . . . . 3.0499999999999998 111.427 -174.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -79.18 142.5 36.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.421 1.088 . . . . 4.6900000000000004 108.193 167.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -153.7 135.67 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 2.4300000000000002 108.512 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -145.84 139.2 26.18 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.824 1.25 . . . . 2.1299999999999999 110.144 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -81.95 119.44 23.96 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.454 1.121 . . . . 1.72 110.901 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.5 m170 -111.36 157.77 19.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.17 1.788 . . . . 1.1200000000000001 111.623 176.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -111.35 168.45 9.52 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.664 1.985 . . . . 2.4300000000000002 110.467 172.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -126.88 100.93 6.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.919 2.088 . . . . 2.2400000000000002 108.195 172.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -97.73 156.45 16.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.964 1.098 . . . . 3.7599999999999998 113.964 -167.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -85.94 148.77 25.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.808 0.843 . . . . 4.4500000000000002 111.504 166.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -160.6 163.78 32.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.34 1.456 . . . . 6.6399999999999997 111.093 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -128.5 157.87 39.95 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.39 1.876 . . . . 4.2199999999999998 108.972 175.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.7 t -153.68 124.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 125.266 1.604 . . . . 4.2599999999999998 107.756 168.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.93 15.46 6.09 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.286 1.434 . . . . 4.9100000000000001 114.323 176.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.55 28.27 39.97 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.315 1.436 . . . . 3.4199999999999999 113.785 -173.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -123.29 136.01 54.49 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.761 2.025 . . . . 4.6699999999999999 111.148 168.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.31 144.41 42.45 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.562 -0.711 . . . . 9.9700000000000006 112.686 -177.312 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.25 153.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.466 1.106 . . . . 4.29 110.582 173.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.98 131.95 52.14 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.483 1.113 . . . . 4.6600000000000001 109.857 175.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.04 -179.55 15.8 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 124.976 1.274 . . . . 1.26 112.351 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.1 mtt -132.59 158.64 41.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.756 1.222 . . . . 2.8999999999999999 111.643 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -171.63 157.61 4.5 Favored Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 125.954 1.702 . . . . 5.8600000000000003 110.878 -178.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.9 Cg_endo -71.4 153.95 60.92 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.734 1.623 . . . . 0.94999999999999996 112.11 169.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -117.85 154.77 51.3 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.731 1.612 . . . . 2.0099999999999998 109.638 164.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.26 -10.33 25.56 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.933 2.422 . . . . 1.1399999999999999 113.087 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -177.38 158.67 1.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.659 1.984 . . . . 4.0999999999999996 110.474 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.07 171.04 7.59 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.165 1.386 . . . . 2.0 109.122 148.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -156.22 161.33 40.28 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 120.956 -1.09 . . . . 2.4700000000000002 112.002 172.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 t -149.61 133.37 8.72 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 123.899 0.88 . . . . 2.2799999999999998 109.675 -160.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.39 168.84 21.22 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.122 1.881 . . . . 1.0700000000000001 111.801 177.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.43 142.11 97.63 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.645 2.897 . . . . 1.0800000000000001 111.601 166.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 35.1 mmtm 66.56 3.65 2.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.965 1.706 . . . . 2.4700000000000002 113.554 -178.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.03 115.09 4.05 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 126.123 1.821 . . . . 1.1000000000000001 112.259 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -92.4 129.11 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.213 1.405 . . . . 5.3300000000000001 109.98 160.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.0 m -144.69 156.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.346 1.858 . . . . 2.4500000000000002 110.44 -177.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.17 120.45 31.37 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.141 -0.974 . . . . 3.71 112.52 -166.337 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.18 68.8 1.98 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.843 1.657 . . . . 2.0600000000000001 109.36 168.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -77.67 149.16 77.47 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.988 1.715 . . . . 3.5499999999999998 111.615 173.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -59.24 -31.81 95.85 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.783 2.322 . . . . 1.1000000000000001 113.257 176.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.28 40.65 3.06 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.545 1.069 . . . . 1.2 113.111 169.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.26 -75.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.887 1.232 . . . . 1.3400000000000001 114.931 -175.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -153.2 147.09 25.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.044 2.137 . . . . 3.0800000000000001 109.449 -171.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -163.82 170.19 17.21 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.478 -1.389 . . . . 1.3799999999999999 111.42 -175.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -104.21 120.05 40.3 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.557 -0.534 . . . . 3.1200000000000001 109.557 170.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 mmt -76.32 129.23 36.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.945 0.898 . . . . 1.71 109.313 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.9 mt -108.06 124.91 50.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.594 1.558 . . . . 2.8599999999999999 107.364 177.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.46 118.59 11.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.66 0.784 . . . . 3.6200000000000001 109.933 -162.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.19 74.26 1.08 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 109.771 -1.331 . . . . 1.3700000000000001 109.771 -167.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mt -72.84 90.04 1.42 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.897 0.856 . . . . 2.1200000000000001 113.118 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -67.16 -11.35 57.07 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.919 1.081 . . . . 3.1800000000000002 113.919 172.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.4 mtp-105 -138.12 136.05 19.15 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.984 1.714 . . . . 5.0199999999999996 108.241 155.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.9 149.67 59.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.387 . . . . 1.8799999999999999 110.267 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.65 97.05 9.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.894 0.478 . . . . 3.1400000000000001 111.256 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -77.96 129.38 35.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.863 1.265 . . . . 4.1500000000000004 110.946 169.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.93 49.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.273 -0.892 . . . . 2.8500000000000001 109.297 171.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.73 37.47 26.4 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 118.467 0.576 . . . . 2.4500000000000002 112.92 -166.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.52 -179.28 3.87 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 106.979 -1.489 . . . . 2.9700000000000002 106.979 151.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -126.85 149.56 49.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.269 1.027 . . . . 3.7200000000000002 109.018 167.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.27 118.44 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.942 1.297 . . . . 2.02 109.702 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -81.65 146.51 30.02 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.438 1.113 . . . . 3.6600000000000001 111.41 160.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.67 123.46 8.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.84 1.256 . . . . 2.4199999999999999 110.903 -169.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.72 91.44 8.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 127.731 2.412 . . . . 2.2599999999999998 110.037 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.67 115.96 13.69 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.575 0.75 . . . . 2.6800000000000002 110.295 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.1 mt -88.2 124.77 34.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 2.0099999999999998 110.753 -173.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -125.09 124.01 40.97 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.955 0.724 . . . . 3.6099999999999999 112.955 -178.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.04 22.34 0.58 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.864 2.065 . . . . 3.2400000000000002 114.307 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.87 -56.21 1.76 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.17 1.367 . . . . 3.54 112.523 -163.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.43 8.85 52.23 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 117.499 1.76 . . . . 1.6699999999999999 117.499 -165.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 152.26 48.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.917 2.087 . . . . 4.7999999999999998 110.541 166.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.5 131.71 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.899 1.28 . . . . 1.8999999999999999 110.82 169.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.59 111.34 18.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.154 1.381 . . . . 3.9199999999999999 110.487 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 85.76 5.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.191 0.996 . . . . 3.77 110.99 178.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.73 174.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.772 1.629 . . . . 2.6299999999999999 111.255 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.4 151.51 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.057 1.343 . . . . 3.02 110.568 170.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -140.74 141.99 26.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 128.034 2.534 . . . . 2.48 109.044 176.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -70.32 149.29 63.1 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.123 1.882 . . . . 1.01 109.478 170.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.83 123.86 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.475 -1.305 . . . . 2.3100000000000001 107.475 163.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' CD ' HH22 ' A' ' 120' ' ' ARG . 0.1 OUTLIER -155.61 151.93 28.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.931 1.693 . . . . 3.02 108.068 -161.259 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.99 108.45 19.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.731 1.011 . . . . 2.7999999999999998 113.731 -157.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.418 HH22 ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.921 1.288 . . . . 6.0999999999999996 112.071 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 121.923 0.868 . . . . 6.2699999999999996 110.981 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.46 161.5 24.47 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 124.982 1.277 . . . . 1.1799999999999999 112.865 -174.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.407 ' CD1' ' HB3' ' A' ' 118' ' ' GLU . 32.1 p90 -163.14 161.4 25.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 3.2999999999999998 114.508 -175.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.61 150.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.049 0.94 . . . . 2.2400000000000002 110.092 -177.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 -88.26 114.87 25.31 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.793 0.837 . . . . 4.8300000000000001 111.477 177.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -43.81 120.57 2.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.052 2.141 . . . . 3.6200000000000001 112.888 166.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -167.76 97.83 0.61 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.727 1.611 . . . . 2.4100000000000001 110.341 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.68 70.39 7.28 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.566 2.844 . . . . 4.1600000000000001 109.253 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.03 -150.91 5.29 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.193 0.902 . . . . 2.21 114.034 -172.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.35 -21.29 11.87 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.981 2.454 . . . . 2.1600000000000001 112.716 -179.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -157.71 167.96 28.58 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.779 1.232 . . . . 2.7799999999999998 113.518 -175.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -163.04 -177.87 5.71 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.287 1.835 . . . . 2.02 112.309 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.57 52.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.695 1.598 . . . . 2.0800000000000001 111.023 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.56 138.64 54.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.936 0.789 . . . . 1.8 111.592 167.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -120.29 147.73 44.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.535 1.934 . . . . 3.7999999999999998 110.813 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pp -166.6 149.89 6.99 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.761 -1.212 . . . . 2.5899999999999999 113.874 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.29 96.51 6.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 127.748 2.419 . . . . 3.3300000000000001 108.385 168.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.65 126.69 34.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 4.0300000000000002 108.971 174.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.77 145.84 42.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.273 1.429 . . . . 3.1600000000000001 111.621 -175.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -116.08 105.68 50.64 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.93999999999999995 111.973 -173.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.48 -11.03 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.578 2.185 . . . . 1.0700000000000001 113.298 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.66 163.25 53.47 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 125.59 1.567 . . . . 0.98999999999999999 113.802 -177.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -80.08 -32.64 39.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.043 2.137 . . . . 4.9800000000000004 112.65 175.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -98.28 163.98 18.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.478 1.911 . . . . 2.6600000000000001 111.072 173.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.22 154.93 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.418 2.745 . . . . 1.46 112.012 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.06 141.27 31.21 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.622 0.769 . . . . 3.5299999999999998 110.305 171.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -125.85 109.97 13.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.509 1.124 . . . . 3.6899999999999999 110.072 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.08 122.74 32.7 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.579 1.952 . . . . 2.1499999999999999 109.776 -176.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.62 -6.77 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.29 1.036 . . . . 1.99 113.456 -172.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.0 -163.74 34.07 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.821 1.201 . . . . 0.54000000000000004 111.41 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.13 -175.73 5.58 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.469 1.508 . . . . 1.5600000000000001 110.476 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -156.26 139.72 15.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.067 1.347 . . . . 7.2599999999999998 108.932 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.26 146.38 45.56 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 117.2 -1.381 . . . . 1.7 108.464 -173.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.24 -13.12 35.44 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.548 2.165 . . . . 0.92000000000000004 114.086 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.3 -3.94 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.28 1.585 . . . . 2.0899999999999999 115.28 -176.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.65 147.39 40.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 121.094 1.77 . . . . 1.6200000000000001 112.848 -172.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -83.71 -51.44 7.25 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.733 1.613 . . . . 3.1000000000000001 110.787 178.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -111.44 141.18 45.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.536 1.134 . . . . 4.1200000000000001 110.115 170.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.29 137.08 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.071 1.348 . . . . 2.29 109.104 160.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -128.93 131.78 47.57 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.267 1.827 . . . . 2.1899999999999999 108.708 175.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.81 123.31 29.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.508 1.504 . . . . 1.8700000000000001 110.406 169.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -107.74 155.2 20.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.076 1.751 . . . . 0.78000000000000003 112.331 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -94.38 -174.15 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.651 1.981 . . . . 2.9199999999999999 111.481 167.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -145.34 80.25 1.6 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.182 1.393 . . . . 2.1699999999999999 109.18 166.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.27 143.79 52.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.952 0.882 . . . . 3.7999999999999998 111.8 -172.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtp -108.03 34.77 3.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.004 1.722 . . . . 4.0800000000000001 111.313 -172.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -70.34 156.89 38.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 8.3300000000000001 110.788 -167.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -46.7 159.54 0.09 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.781 0.833 . . . . 6.8399999999999999 110.335 146.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -163.17 -29.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.566 1.946 . . . . 4.0700000000000003 113.189 179.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 56' ' ' LYS . 37.3 mt-10 -143.95 38.89 1.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.908 2.483 . . . . 4.75 109.277 170.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -33.73 0.37 Allowed Glycine 0 N--CA 1.481 1.666 0 O-C-N 120.055 -1.653 . . . . 2.5499999999999998 113.372 -160.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 55.3 mtmt -61.08 135.22 57.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.655 1.982 . . . . 4.3200000000000003 109.851 170.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -85.79 129.69 34.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 118.212 -0.899 . . . . 5.3099999999999996 110.512 173.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.1 t -140.77 150.14 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.75 1.22 . . . . 3.0600000000000001 109.572 -169.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.9 mtm -92.9 121.8 34.63 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.228 1.011 . . . . 3.8100000000000001 112.406 172.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.73 163.59 25.52 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.146 1.355 . . . . 1.1299999999999999 111.755 171.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -107.2 152.45 24.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.24 1.016 . . . . 2.3799999999999999 112.462 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -149.64 145.5 19.19 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.317 2.247 . . . . 4.9400000000000004 108.43 171.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.12 145.76 89.74 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.42 1.543 . . . . 0.87 111.022 160.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.59 158.08 60.3 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.129 1.772 . . . . 2.1299999999999999 111.149 -179.229 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.46 -21.16 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.556 2.171 . . . . 0.70999999999999996 113.336 178.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -174.54 169.95 3.59 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.205 1.366 . . . . 3.1099999999999999 112.66 -177.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.33 174.35 9.69 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.555 2.742 . . . . 2.1000000000000001 108.871 162.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.67 168.68 26.56 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.632 -1.293 . . . . 2.2400000000000002 112.708 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 t -146.41 131.3 8.94 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 125.359 1.463 . . . . 1.95 109.519 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.0 161.05 41.96 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.607 2.205 . . . . 1.0900000000000001 111.773 176.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.89 133.7 42.95 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.959 3.106 . . . . 1.04 111.706 179.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 72.3 -2.32 2.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.226 2.21 . . . . 2.4100000000000001 113.718 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.87 -179.02 37.66 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 126.049 1.785 . . . . 1.2 111.677 178.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -160.11 158.38 30.19 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.06 1.344 . . . . 5.0199999999999996 114.571 177.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.83 172.18 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.962 2.105 . . . . 2.7400000000000002 110.731 177.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -119.33 132.99 55.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.66 1.584 . . . . 5.5599999999999996 109.048 170.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.82 81.31 6.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.832 1.301 . . . . 1.97 109.559 163.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 143.89 75.15 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.381 2.272 . . . . 5.2400000000000002 113.472 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.54 -40.19 76.37 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.771 2.314 . . . . 1.3 111.567 167.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.71 79.03 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.157 -1.177 . . . . 1.1699999999999999 110.157 164.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.98 -73.22 0.12 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 1.1000000000000001 114.696 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -158.52 139.84 13.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.593 1.957 . . . . 3.8799999999999999 109.154 -176.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -166.12 158.01 14.01 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.572 1.987 . . . . 1.3700000000000001 110.983 -175.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.08 124.02 32.78 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.951 -0.388 . . . . 3.54 109.951 170.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.79 122.21 34.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.999 1.32 . . . . 2.48 108.63 169.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.13 135.92 43.9 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.874 1.67 . . . . 2.8500000000000001 109.012 -177.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.31 125.64 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.769 1.228 . . . . 3.75 111.226 -171.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.72 104.64 0.04 OUTLIER Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.734 1.635 . . . . 1.28 110.987 -174.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.0 mt -102.11 115.68 31.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.792 1.296 . . . . 2.1899999999999999 112.832 -166.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -66.32 -25.0 66.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.118 1.367 . . . . 2.4700000000000002 112.923 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -152.78 146.54 18.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.164 2.186 . . . . 8.8100000000000005 109.826 175.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.75 131.87 9.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.239 2.626 . . . . 1.9099999999999999 111.617 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.35 127.68 33.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 2.9500000000000002 110.327 174.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.37 -166.49 1.16 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.981 0.896 . . . . 4.5099999999999998 111.325 167.094 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.08 119.72 21.18 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.162 -0.961 . . . . 2.8300000000000001 113.051 -162.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.91 -12.21 69.65 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.267 1.413 . . . . 4.2699999999999996 114.901 174.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -74.51 154.24 38.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.05 1.13 . . . . 3.5499999999999998 114.05 -157.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -80.65 90.7 5.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.539 1.936 . . . . 4.21 112.179 -166.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.59 106.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 2.2999999999999998 109.382 166.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 4.1 mt-10 -68.75 139.34 55.32 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.255 1.026 . . . . 3.0899999999999999 110.526 157.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -149.85 118.99 6.75 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.802 1.241 . . . . 2.7400000000000002 109.502 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 102.18 14.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.923 1.289 . . . . 2.5499999999999998 108.438 173.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.35 128.04 34.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.543 1.137 . . . . 4.4100000000000001 109.094 177.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -98.13 130.97 44.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.778 0.831 . . . . 1.75 110.323 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -130.11 153.55 48.38 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.724 0.773 . . . . 3.0800000000000001 112.54 -177.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.97 146.39 42.65 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.951 -0.468 . . . . 3.1400000000000001 110.774 170.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.98 27.41 23.76 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.016 0.766 . . . . 4.4400000000000004 115.016 -177.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 17.86 79.16 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-N 117.894 0.847 . . . . 1.74 113.757 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -94.51 140.47 29.8 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.574 -0.956 . . . . 5.0300000000000002 112.349 -174.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.67 128.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.067 2.147 . . . . 2.1499999999999999 107.772 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.8 mt -147.11 122.84 10.56 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.943 0.897 . . . . 2.4199999999999999 111.697 -164.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.461 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 37.5 mtmt -75.33 123.68 25.77 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.655 0.613 . . . . 3.54 112.655 177.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.5 m -93.14 159.92 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.692 0.797 . . . . 2.9300000000000002 109.477 150.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.38 118.85 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.102 0.961 . . . . 2.9399999999999999 108.543 167.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.69 141.42 36.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.105 0.962 . . . . 3.0699999999999998 111.544 -166.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.55 151.02 64.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.526 2.817 . . . . 1.05 111.753 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 74.7 t -79.21 130.72 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.004 0.922 . . . . 2.6299999999999999 110.442 160.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HB3' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -118.48 -152.39 0.5 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.043 2.537 . . . . 4.4100000000000001 106.687 160.065 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.89 8.8 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 122.783 2.538 . . . . 2.9300000000000002 117.501 -162.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.277 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 117.337 -1.315 . . . . 8.8000000000000007 113.094 179.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 109.374 -0.602 . . . . 4.75 109.374 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.44 -179.5 30.53 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 123.738 0.685 . . . . 1.5800000000000001 114.473 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -159.62 152.21 21.36 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.262 1.025 . . . . 2.1299999999999999 113.104 177.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.96 133.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.25 -1.019 . . . . 2.1600000000000001 108.25 165.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.45 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 2.9 tmt_? -98.05 100.1 11.41 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.365 2.266 . . . . 4.6699999999999999 109.017 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -57.55 148.69 23.21 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.077 0.942 . . . . 5.0499999999999998 111.445 172.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -152.03 145.2 17.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.426 1.49 . . . . 2.5800000000000001 110.01 161.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.81 71.42 7.05 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.083 3.189 . . . . 2.5600000000000001 110.371 -176.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.54 -172.81 27.19 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.055 0.836 . . . . 1.49 113.701 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.99 -3.57 13.3 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.163 3.242 . . . . 2.1299999999999999 112.815 176.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -142.8 167.0 23.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.219 1.808 . . . . 3.1000000000000001 112.521 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.64 -176.24 3.07 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.524 1.929 . . . . 2.1000000000000001 110.928 -170.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.53 157.62 39.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.133 0.879 . . . . 1.97 112.611 176.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.25 144.72 51.33 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 1.8899999999999999 110.422 165.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.85 152.33 51.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.296 1.439 . . . . 3.4300000000000002 109.277 175.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -173.17 158.66 3.7 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.042 1.127 . . . . 2.8100000000000001 114.042 175.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -82.71 130.89 35.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 126.767 2.027 . . . . 2.6600000000000001 109.532 163.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 tt -114.76 143.3 45.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.103 1.761 . . . . 4.2199999999999998 108.858 169.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.77 142.06 28.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.0 0.905 . . . . 3.1299999999999999 112.191 170.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -100.86 106.13 42.18 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.768 1.627 . . . . 0.98999999999999999 109.847 178.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.5 -9.36 17.36 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.418 2.079 . . . . 1.0900000000000001 113.361 176.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.52 -178.57 52.5 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.332 0.969 . . . . 0.97999999999999998 114.032 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.5 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 16.7 m-20 -111.77 1.28 16.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.756 1.623 . . . . 2.4500000000000002 113.162 -172.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.07 160.03 37.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.924 1.69 . . . . 2.5800000000000001 110.176 166.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.16 157.44 17.53 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.156 2.571 . . . . 1.1499999999999999 111.721 -172.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.2 mt -107.53 157.61 17.89 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.601 1.16 . . . . 3.4199999999999999 110.548 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 68' ' ' GLU . 25.8 ttm105 -134.66 116.24 14.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.731 1.212 . . . . 3.8700000000000001 109.291 169.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -97.66 117.16 31.32 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.337 2.255 . . . . 2.0299999999999998 109.508 -171.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.71 -9.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 114.038 1.125 . . . . 1.8999999999999999 114.038 -167.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.13 -163.77 32.7 Favored Glycine 0 C--N 1.34 0.791 0 O-C-N 121.418 -0.801 . . . . 0.80000000000000004 112.548 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.33 -178.32 6.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.044 0.937 . . . . 2.1099999999999999 111.183 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.73 136.16 3.61 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.88 1.218 . . . . 6.7699999999999996 108.065 176.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -138.13 152.09 71.13 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 117.403 -1.285 . . . . 1.8200000000000001 109.453 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.46 -21.0 53.98 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.35 2.033 . . . . 1.0900000000000001 113.568 169.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.3 4.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.549 1.314 . . . . 2.1000000000000001 114.549 -174.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.52 -179.01 5.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.968 1.307 . . . . 1.8899999999999999 110.787 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 7.3 tp10 -101.57 -56.86 2.2 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.211 0.604 . . . . 3.1600000000000001 110.353 173.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -120.06 161.59 20.71 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.748 0.785 . . . . 5.04 111.156 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.37 134.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.891 -1.05 . . . . 3.4199999999999999 108.988 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -118.69 134.43 55.13 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.209 1.804 . . . . 2.0099999999999998 108.798 -172.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -80.32 116.74 20.56 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.559 1.171 . . . . 2.0499999999999998 110.568 169.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -103.75 148.45 26.07 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.333 1.54 . . . . 0.71999999999999997 111.616 173.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.45 164.55 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.089 -1.414 . . . . 2.1200000000000001 109.702 159.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.441 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 91.2 m -140.77 93.39 2.6 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.56 -1.644 . . . . 2.2200000000000002 106.56 167.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -90.43 173.53 8.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.711 1.604 . . . . 3.4199999999999999 113.204 -162.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 56.1 mtm -113.32 131.34 55.99 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.37 -0.974 . . . . 4.0099999999999998 108.37 146.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -150.18 164.48 35.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.551 1.94 . . . . 8.5099999999999998 109.236 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -93.32 148.35 22.12 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.308 0.643 . . . . 3.7200000000000002 111.87 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 p -144.62 -8.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.48 1.659 . . . . 4.0700000000000003 115.48 -165.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -162.94 36.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.749 1.619 . . . . 3.4500000000000002 109.451 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.76 -11.2 1.3 Allowed Glycine 0 CA--C 1.539 1.545 0 O-C-N 120.642 -1.286 . . . . 2.3700000000000001 113.703 -160.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -113.07 150.84 31.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.224 2.21 . . . . 3.2000000000000002 111.196 -175.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 129.34 34.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.269 1.828 . . . . 7.2699999999999996 113.579 -173.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -142.37 147.57 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.369 0.986 . . . . 2.9700000000000002 111.358 -172.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.5 mtt -83.19 138.79 33.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.707 1.203 . . . . 4.5099999999999998 113.477 171.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.89 167.3 33.19 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.128 0.87 . . . . 1.0800000000000001 113.384 173.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -107.54 166.17 10.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.112 1.365 . . . . 2.6299999999999999 111.718 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.71 136.04 0.29 Allowed Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 116.21 -1.852 . . . . 5.04 110.738 -175.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.93 143.03 64.68 Favored 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 122.254 1.841 . . . . 0.63 111.344 166.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -112.51 157.83 39.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.096 1.359 . . . . 1.6599999999999999 110.0 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.25 -22.93 45.74 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.086 1.858 . . . . 0.81999999999999995 112.262 174.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -173.96 165.74 4.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.503 1.521 . . . . 3.6899999999999999 112.932 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -111.03 177.52 4.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.169 1.787 . . . . 2.21 109.306 150.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 31' ' ' ARG . 9.6 pt-20 -153.53 171.02 19.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.663 -1.273 . . . . 2.2599999999999998 111.638 175.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -151.57 134.53 8.9 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 118.36 -0.828 . . . . 2.6200000000000001 110.189 -167.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.69 169.68 21.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 121.726 1.618 . . . . 1.0900000000000001 111.434 171.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.92 142.27 74.62 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.005 3.137 . . . . 1.0800000000000001 111.849 166.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.5 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 0.4 OUTLIER 57.27 10.77 0.95 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.801 1.778 . . . . 2.6099999999999999 115.801 -168.063 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.46 116.07 4.17 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 128.244 2.831 . . . . 1.3700000000000001 110.889 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.16 137.15 35.64 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.32 1.448 . . . . 4.71 110.173 162.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.33 144.0 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.787 1.635 . . . . 2.4700000000000002 109.252 178.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -132.28 118.41 19.43 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.652 -0.499 . . . . 3.9300000000000002 109.652 -165.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.44 75.84 3.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.138 1.375 . . . . 1.9299999999999999 110.041 -173.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -72.11 131.0 85.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.55 -1.214 . . . . 5.5999999999999996 108.651 175.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.5 -40.29 85.5 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.064 2.51 . . . . 1.1299999999999999 113.018 -173.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.77 67.43 3.56 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 119.628 1.103 . . . . 1.3700000000000001 111.111 164.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 177.46 -82.17 0.07 OUTLIER Glycine 0 N--CA 1.469 0.861 0 C-N-CA 125.63 1.586 . . . . 1.01 112.637 -167.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -153.19 144.96 23.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.977 2.511 . . . . 3.0600000000000001 108.927 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.69 171.4 16.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.429 0.692 . . . . 1.03 110.568 -177.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -109.58 125.91 53.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.093 0.957 . . . . 3.3799999999999999 111.208 173.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.2 mmt -89.78 121.86 32.32 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.403 1.081 . . . . 2.0800000000000001 110.662 170.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.68 138.96 33.45 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.7 1.6 . . . . 3.1600000000000001 110.729 -178.143 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mt -144.1 140.19 29.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.175 0.806 . . . . 3.9100000000000001 113.175 -177.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 57.96 3.44 Favored Glycine 0 N--CA 1.469 0.884 0 C-N-CA 124.303 0.954 . . . . 1.6799999999999999 111.215 -176.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.8 mt -70.25 137.74 51.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.256 0.835 . . . . 1.8700000000000001 113.256 -171.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 92.0 mttt -102.88 -3.43 26.23 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.756 1.223 . . . . 2.5899999999999999 112.79 -172.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -139.01 158.56 69.46 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.106 1.362 . . . . 6.0899999999999999 108.93 152.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.03 122.43 9.74 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 N-CA-C 106.255 -2.248 . . . . 2.04 106.255 138.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.17 120.96 21.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.102 0.953 . . . . 3.3199999999999998 109.528 -166.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -67.49 109.38 3.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.511 1.125 . . . . 6.3499999999999996 108.201 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.38 113.64 0.73 Allowed 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 2.8199999999999998 113.004 172.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.47 6.58 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.812 0.72 . . . . 2.4100000000000001 113.265 -166.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.31 -169.15 1.56 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.187 1.795 . . . . 2.8300000000000001 108.662 146.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.6 162.0 33.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.735 1.214 . . . . 4.8899999999999997 110.854 177.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.9 t -132.77 133.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.009 1.724 . . . . 1.9199999999999999 109.847 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.501 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 10.6 mt-10 -80.02 148.24 31.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.138 0.494 . . . . 3.1499999999999999 111.512 164.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -151.81 120.63 6.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.091 1.356 . . . . 3.6200000000000001 109.388 175.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.86 114.14 17.54 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.429 3.092 . . . . 2.0899999999999999 109.951 170.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.14 122.51 27.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.813 1.188 . . . . 2.9199999999999999 109.449 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -97.53 127.88 43.83 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.057 0.943 . . . . 1.9399999999999999 111.243 -171.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.64 151.33 48.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.168 0.985 . . . . 3.7599999999999998 112.828 -176.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.62 158.82 35.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.717 -0.674 . . . . 2.7799999999999998 111.987 172.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.32 74.78 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.586 -0.696 . . . . 4.7699999999999996 113.899 176.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.51 63.8 2.07 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 118.219 1.01 . . . . 2.29 112.612 173.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -147.89 142.66 26.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.186 1.795 . . . . 4.5099999999999998 110.867 178.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.92 139.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.393 1.877 . . . . 2.3599999999999999 107.86 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.6 mt -143.49 108.21 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.534 1.134 . . . . 2.7000000000000002 108.811 -175.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.501 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 48.5 pttt -92.53 150.39 20.78 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.86 1.059 . . . . 2.9399999999999999 113.86 -177.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.49 159.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.795 1.238 . . . . 2.5899999999999999 110.367 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.21 148.5 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.991 1.316 . . . . 3.6099999999999999 109.849 168.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.1 mt -143.76 129.39 9.91 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.379 1.872 . . . . 2.5 109.051 -178.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.0 156.93 61.54 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.137 2.558 . . . . 1.0600000000000001 112.561 175.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -88.92 113.37 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.102 1.361 . . . . 2.3300000000000001 110.487 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -107.36 179.29 4.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.038 2.535 . . . . 4.4900000000000002 108.595 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.27 123.3 17.84 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.663 -1.273 . . . . 3.4399999999999999 109.755 171.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.45 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 4.1 tpt180 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.139 0.976 . . . . 5.4299999999999997 113.311 -161.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 CA--C 1.544 0.721 0 N-CA-C 106.867 -1.531 . . . . 5.6399999999999997 106.867 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -107.36 167.39 13.62 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 116.155 1.222 . . . . 1.1399999999999999 116.155 -163.259 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -156.14 146.29 21.44 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.616 1.567 . . . . 2.04 112.497 173.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.7 139.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.328 -1.36 . . . . 2.7799999999999998 107.328 154.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 103.22 12.64 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.931 -0.481 . . . . 4.6299999999999999 111.733 -173.128 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.93 110.0 1.22 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.591 1.186 . . . . 4.5899999999999999 110.379 163.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -158.88 144.79 12.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.986 1.714 . . . . 3.8300000000000001 108.58 161.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.76 74.23 5.3 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.061 3.174 . . . . 2.6600000000000001 111.248 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.92 148.31 19.5 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.05 1.309 . . . . 1.6499999999999999 111.756 172.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.57 -25.04 47.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.981 2.454 . . . . 1.76 111.845 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -107.73 138.85 43.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.182 1.393 . . . . 3.9900000000000002 108.982 153.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 163.78 31.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.551 1.94 . . . . 2.52 108.081 160.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.46 169.83 14.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.148 0.795 . . . . 2.0499999999999998 113.148 -177.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.2 148.62 27.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.306 1.042 . . . . 2.3700000000000001 112.482 165.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.04 159.81 41.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.017 1.727 . . . . 3.54 111.296 -172.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -163.47 146.37 10.1 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.448 1.277 . . . . 2.6400000000000001 114.448 -175.1 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -79.87 128.27 33.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.661 -1.154 . . . . 3.0699999999999998 109.679 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.17 149.07 45.52 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.709 1.603 . . . . 3.77 110.987 -175.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -157.68 153.04 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.739 0.781 . . . . 3.04 111.491 174.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -104.8 105.0 49.12 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 1.1399999999999999 109.19 177.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.09 -11.23 13.61 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.834 2.356 . . . . 1.0900000000000001 113.676 177.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.86 177.78 53.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.677 1.126 . . . . 0.98999999999999999 113.467 -174.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 7.7 m-20 -102.61 12.67 36.06 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.704 1.602 . . . . 2.3799999999999999 111.588 178.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.03 158.65 34.47 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.059 2.144 . . . . 4.2300000000000004 109.149 174.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.05 148.77 17.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.805 2.337 . . . . 1.6399999999999999 110.266 172.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -121.61 119.56 32.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.405 1.082 . . . . 4.1799999999999997 110.317 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -109.06 106.46 16.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.526 1.53 . . . . 4.4199999999999999 109.79 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -92.3 116.23 28.78 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.103 2.161 . . . . 1.8999999999999999 108.76 -173.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.78 -9.37 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.154 0.982 . . . . 1.8100000000000001 112.714 -166.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.6 -162.66 32.07 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 124.875 1.226 . . . . 0.46999999999999997 111.41 171.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.01 171.76 17.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.455 1.102 . . . . 1.9199999999999999 110.539 168.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.83 130.4 16.85 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.622 -1.621 . . . . 6.9400000000000004 106.622 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 t -127.48 157.51 72.71 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 117.385 -1.293 . . . . 1.72 108.162 177.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -63.06 -25.36 73.46 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.036 1.824 . . . . 1.1699999999999999 113.313 160.314 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -80.35 12.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.904 1.446 . . . . 2.27 114.904 -172.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.31 153.68 49.01 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.313 1.445 . . . . 2.7599999999999998 113.941 -172.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.88 -42.65 9.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.628 1.571 . . . . 4.0300000000000002 111.581 168.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.13 176.25 12.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 8.9299999999999997 110.543 151.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -155.65 144.13 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.602 1.961 . . . . 2.8300000000000001 109.569 -170.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -127.06 136.21 51.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.171 1.788 . . . . 2.2599999999999998 110.566 -176.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -88.77 123.23 32.98 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.154 1.343 . . . . 2.0099999999999998 112.067 169.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 13.3 m170 -110.88 153.54 25.31 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.762 2.025 . . . . 0.77000000000000002 113.129 175.3 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -86.23 170.28 12.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.846 1.658 . . . . 2.3300000000000001 111.278 161.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 m -146.73 126.86 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.015 1.326 . . . . 2.4900000000000002 108.182 169.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -140.85 173.46 11.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.154 1.168 . . . . 3.52 114.154 -152.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -126.89 141.98 51.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.037 1.735 . . . . 4.5 108.676 159.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -149.45 165.67 31.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.066 1.746 . . . . 9.0399999999999991 109.987 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.68 136.96 43.82 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.634 0.774 . . . . 3.8900000000000001 110.092 169.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.96 -6.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 114.228 1.196 . . . . 4.1100000000000003 114.228 173.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -168.37 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.873 2.069 . . . . 5.3700000000000001 110.682 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.42 -16.95 4.48 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.043 -1.661 . . . . 2.54 113.689 -163.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -82.58 142.13 32.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.736 1.268 . . . . 4.4500000000000002 110.374 161.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.47 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.83 127.32 35.96 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.509 1.124 . . . . 5.7599999999999998 109.358 177.766 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -135.72 145.22 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.029 1.332 . . . . 3.0299999999999998 110.157 -170.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -82.97 158.45 22.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.62 1.568 . . . . 4.2599999999999998 113.191 -176.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.59 -179.56 45.26 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.453 0.549 . . . . 1.4199999999999999 113.957 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -132.35 158.06 42.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.905 1.682 . . . . 2.3900000000000001 110.49 176.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -160.23 147.45 12.46 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.569 1.548 . . . . 6.8700000000000001 109.924 169.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.1 Cg_endo -63.72 148.14 92.24 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.655 1.57 . . . . 1.1799999999999999 110.255 163.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.26 155.13 71.83 Favored Pre-proline 0 N--CA 1.472 0.647 0 C-N-CA 125.459 1.504 . . . . 1.72 110.734 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.99 -23.88 24.69 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.666 2.244 . . . . 0.76000000000000001 112.541 178.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -171.78 165.68 6.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.388 1.075 . . . . 3.0099999999999998 112.62 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -113.94 172.79 6.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.289 1.835 . . . . 2.0899999999999999 109.188 155.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -154.61 167.86 28.71 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.543 -0.723 . . . . 2.0499999999999998 111.518 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.6 t -144.37 130.07 9.71 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.042 1.737 . . . . 2.0299999999999998 108.425 -169.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -70.43 164.7 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.319 2.013 . . . . 0.97999999999999998 110.94 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.79 139.5 91.06 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.671 2.247 . . . . 1.1499999999999999 110.547 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 37.3 mmtm 66.59 6.42 4.44 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.993 1.717 . . . . 2.6200000000000001 113.549 -175.339 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.33 120.52 5.21 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 127.701 2.572 . . . . 1.1599999999999999 112.623 -176.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -90.32 138.23 31.71 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.294 1.838 . . . . 4.7699999999999996 111.424 167.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.09 125.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.976 1.31 . . . . 2.29 112.877 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.08 121.8 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.269 1.028 . . . . 4.2300000000000004 111.586 170.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.69 147.12 46.0 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.333 1.063 . . . . 1.8999999999999999 110.07 161.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -172.25 150.71 2.4 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.964 1.306 . . . . 3.4100000000000001 111.197 -158.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.99 -47.9 9.6 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.758 2.305 . . . . 1.1399999999999999 111.515 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.19 70.95 2.86 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.807 -0.917 . . . . 1.72 110.807 166.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.44 -96.45 0.12 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.363 1.458 . . . . 1.1399999999999999 113.711 -176.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -149.37 138.32 21.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.949 1.699 . . . . 3.0699999999999998 108.695 -172.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -157.97 162.28 38.2 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.231 -0.293 . . . . 0.82999999999999996 110.794 -168.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -95.32 135.4 36.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.475 0.71 . . . . 3.4399999999999999 110.468 169.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -95.67 126.72 41.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.112 1.365 . . . . 1.6899999999999999 108.913 160.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.75 157.5 23.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.143 0.577 . . . . 3.4399999999999999 110.33 173.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 78.32 1.6 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.484 1.135 . . . . 4.1299999999999999 111.381 176.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.19 114.13 3.74 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.757 2.122 . . . . 1.6599999999999999 110.299 -170.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.16 126.31 44.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.606 1.163 . . . . 2.5299999999999998 110.444 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -92.02 -25.11 18.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.194 0.812 . . . . 3.5800000000000001 113.194 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.31 151.69 40.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.645 -0.872 . . . . 5.2199999999999998 108.645 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.95 -14.53 23.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.569 2.179 . . . . 4.0300000000000002 115.41 177.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.3 mt 66.71 102.34 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 130.996 3.719 . . . . 3.7000000000000002 110.373 -178.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -106.88 143.21 35.31 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.881 0.873 . . . . 7.1900000000000004 109.739 161.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -45.41 124.17 4.66 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.483 -0.78 . . . . 2.5499999999999998 109.643 159.325 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.57 3.08 81.47 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 117.361 -1.799 . . . . 2.1699999999999999 116.426 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.73 161.52 30.15 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 121.15 2.475 . . . . 2.6099999999999999 109.75 162.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.95 154.99 19.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.24 1.416 . . . . 3.8100000000000001 110.993 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.15 112.52 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 126.044 1.737 . . . . 2.5899999999999999 108.63 -176.117 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -74.22 142.29 45.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.231 -0.655 . . . . 3.1299999999999999 109.231 155.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt -146.57 117.32 7.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.282 1.033 . . . . 2.7799999999999998 111.326 175.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.9 92.4 8.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.678 3.191 . . . . 2.1499999999999999 109.222 170.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.68 125.25 28.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.468 1.107 . . . . 2.4399999999999999 109.68 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt -97.01 132.23 43.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.867 1.267 . . . . 1.8899999999999999 111.243 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -131.6 146.52 52.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.076 0.941 . . . . 3.6200000000000001 112.789 -174.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.34 165.13 14.67 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.749 -0.594 . . . . 2.5600000000000001 111.84 170.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.58 26.48 65.27 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.461 -0.775 . . . . 4.6799999999999997 113.272 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.87 63.04 3.48 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.823 1.201 . . . . 1.96 111.562 176.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -146.75 161.3 40.91 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 123.111 1.434 . . . . 4.8499999999999996 113.028 -171.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 p -171.9 146.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.125 2.97 . . . . 2.2999999999999998 108.137 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt -140.24 123.67 17.0 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.618 1.167 . . . . 2.79 109.192 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -81.42 126.92 32.22 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.522 0.601 . . . . 3.79 111.381 167.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.29 166.15 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.876 1.671 . . . . 4.3399999999999999 108.381 168.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.2 130.32 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.316 1.447 . . . . 2.9500000000000002 110.764 178.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mp -139.05 166.91 21.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.796 2.438 . . . . 3.5800000000000001 109.37 -176.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.67 170.78 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.14 2.56 . . . . 1.6200000000000001 113.581 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.8 t -95.77 136.79 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 127.656 2.383 . . . . 2.3500000000000001 107.721 155.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -153.53 158.68 41.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.584 0.754 . . . . 5.0499999999999998 111.548 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.21 3.35 24.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.358 1.984 . . . . 2.6400000000000001 116.358 -164.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.937 0 N-CA-C 113.492 0.923 . . . . 7.3399999999999999 113.492 -162.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.552 1.026 0 CA-C-O 120.808 0.337 . . . . 7.1699999999999999 110.733 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.26 159.27 23.29 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 115.929 1.131 . . . . 1.2 115.929 -169.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -150.41 136.99 18.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.609 1.164 . . . . 1.8 112.201 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -90.67 131.76 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.702 -0.851 . . . . 1.9299999999999999 108.702 164.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.61 47.47 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.939 0.718 . . . . 9.2400000000000002 112.939 -173.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.63 103.48 1.72 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.563 1.173 . . . . 5.1200000000000001 110.993 163.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.89 140.71 0.57 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.854 1.661 . . . . 4.0199999999999996 109.926 157.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.36 3.4 7.83 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.071 3.181 . . . . 3.7000000000000002 114.471 -173.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.01 145.88 49.74 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 119.537 1.062 . . . . 1.8100000000000001 113.028 -175.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.98 -15.07 47.38 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.113 3.209 . . . . 3.0499999999999998 113.676 -171.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -139.35 167.03 23.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.134 0.974 . . . . 3.4199999999999999 111.794 159.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 159.65 174.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.493 3.517 . . . . 4.4400000000000004 109.87 171.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.69 171.86 13.15 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.058 1.133 . . . . 3.0899999999999999 114.058 -177.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 160.12 40.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.692 2.797 . . . . 3.1600000000000001 109.151 170.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -144.0 158.28 43.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.101 0.953 . . . . 3.3900000000000001 112.644 -164.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.48 159.57 28.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.582 0.956 . . . . 2.8199999999999998 113.582 173.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 m -123.77 147.73 47.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.869 -1.514 . . . . 3.0299999999999998 107.331 164.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tp -136.83 153.43 50.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.053 1.341 . . . . 5.54 110.985 -175.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -108.95 135.61 49.85 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.53 1.932 . . . . 3.98 108.094 168.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -102.46 91.34 2.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.02 -0.514 . . . . 1.3200000000000001 109.967 160.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.45 -11.11 18.97 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.314 2.009 . . . . 2.04 113.487 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.33 52.41 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 118.907 0.776 . . . . 1.48 113.195 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.482 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.8 m-20 -88.56 3.08 51.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.741 . . . . 2.8999999999999999 113.609 -177.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.99 159.97 56.54 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.59 1.556 . . . . 3.1200000000000001 110.799 174.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.34 166.17 22.66 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.845 2.363 . . . . 1.6299999999999999 112.657 -164.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.0 154.65 21.88 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.22 1.008 . . . . 4.1600000000000001 111.008 165.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -148.88 104.99 3.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.177 1.791 . . . . 4.7999999999999998 109.654 170.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.7 tp -91.64 111.8 23.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.634 2.374 . . . . 1.9299999999999999 109.886 -168.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -97.85 -15.32 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.849 1.259 . . . . 1.8899999999999999 112.857 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.65 -164.93 36.66 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.685 -0.634 . . . . 0.56999999999999995 112.62 175.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.5 172.52 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.816 0.846 . . . . 1.8799999999999999 111.242 166.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.78 144.49 23.53 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.717 0.689 . . . . 6.1200000000000001 111.663 171.23 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 t -141.1 149.53 55.89 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 125.875 1.67 . . . . 1.77 108.93 -166.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.65 -19.23 42.1 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.124 1.883 . . . . 1.0 113.232 173.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -71.21 -4.39 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 114.331 1.234 . . . . 1.75 114.331 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.31 174.38 12.91 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.593 1.701 . . . . 2.1299999999999999 115.593 -167.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -108.58 -42.92 4.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.897 2.079 . . . . 3.3900000000000001 110.429 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -129.61 161.88 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.216 1.406 . . . . 6.3200000000000003 112.057 172.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -176.21 126.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.256 1.822 . . . . 2.79 108.798 -173.38 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -145.21 137.07 25.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.057 1.343 . . . . 4.4500000000000002 109.475 -164.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.5 123.62 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.636 0.732 . . . . 2.0099999999999998 111.461 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -107.83 153.8 22.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.719 1.608 . . . . 0.73999999999999999 113.584 173.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -91.55 170.7 9.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.875 2.07 . . . . 2.2000000000000002 110.715 158.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.9 m -149.46 114.59 5.45 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.608 1.563 . . . . 2.3300000000000001 107.837 173.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -119.8 157.21 29.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.956 1.302 . . . . 3.6899999999999999 112.841 -162.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -94.46 158.61 15.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.224 1.01 . . . . 4.29 110.555 160.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.37 150.22 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 6.7699999999999996 110.378 176.001 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.3 140.54 29.66 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.799 -0.815 . . . . 3.5299999999999998 108.799 160.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.51 114.4 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.661 1.584 . . . . 3.5600000000000001 107.365 -178.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 64.99 1.27 1.42 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.204 1.802 . . . . 4.7000000000000002 112.569 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.56 -11.76 58.05 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.644 1.593 . . . . 1.8700000000000001 113.879 -166.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -76.77 136.55 39.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.275 1.537 . . . . 5.1799999999999997 109.656 172.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -77.54 126.77 31.42 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.678 -0.639 . . . . 4.2599999999999998 110.73 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.8 t -135.25 155.74 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.58 1.952 . . . . 3.3700000000000001 109.097 -173.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.1 mtm -128.7 154.12 46.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.131 0.972 . . . . 4.1900000000000004 110.785 171.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.39 30.63 Favored Glycine 0 N--CA 1.468 0.827 0 C-N-CA 124.07 0.843 . . . . 1.25 113.333 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.56 161.42 35.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.47 1.508 . . . . 3.8500000000000001 109.954 -177.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -165.62 134.55 2.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 116.679 -1.629 . . . . 5.2800000000000002 110.311 -173.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.56 146.37 84.49 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 122.322 1.865 . . . . 0.80000000000000004 110.391 163.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.32 158.32 67.29 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 125.677 1.591 . . . . 1.8 111.237 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.53 -24.5 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.822 2.348 . . . . 0.72999999999999998 112.73 176.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -173.87 166.81 4.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.649 1.18 . . . . 2.8900000000000001 113.176 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.19 170.14 8.43 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.408 1.883 . . . . 1.98 109.799 152.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -156.65 164.56 38.03 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.354 -0.841 . . . . 1.8899999999999999 113.179 176.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -154.43 141.18 13.22 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.963 0.905 . . . . 2.2799999999999998 110.452 -160.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.38 171.54 14.96 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.343 2.028 . . . . 1.05 112.651 168.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.71 148.43 92.13 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.28 3.32 . . . . 1.2 112.267 163.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.482 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 68.2 mmtt 69.69 -2.96 1.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.71 2.004 . . . . 2.8399999999999999 114.123 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.61 115.88 4.18 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 125.824 1.678 . . . . 0.98999999999999999 111.583 -178.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.04 128.98 36.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.115 0.566 . . . . 7.9900000000000002 110.561 162.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.28 158.18 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 2.7999999999999998 112.087 -164.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -146.42 114.25 6.48 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.269 0.628 . . . . 4.0700000000000003 109.684 -141.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.24 83.39 6.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.096 0.958 . . . . 2.4300000000000002 109.13 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -72.4 142.18 84.0 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.539 -1.22 . . . . 3.73 109.769 178.027 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.51 -39.15 85.9 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.698 2.266 . . . . 1.3799999999999999 112.516 -178.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.94 61.68 4.7 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.899 0.761 . . . . 1.8 111.394 165.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -69.36 0.07 OUTLIER Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.746 1.165 . . . . 1.2 114.168 -177.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -154.12 143.67 21.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.043 1.737 . . . . 3.1699999999999999 109.052 -171.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -167.25 165.49 15.25 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.494 -0.754 . . . . 1.23 110.219 -177.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.64 135.9 37.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.962 -0.385 . . . . 3.4300000000000002 109.962 169.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -79.54 132.7 36.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.0 -0.741 . . . . 2.29 109.0 152.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.1 139.47 39.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.517 1.127 . . . . 3.02 108.687 164.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -137.38 136.42 37.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.683 1.193 . . . . 3.5800000000000001 111.38 -175.648 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 42.73 99.4 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 1.6599999999999999 111.301 178.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.312 0.2 OUTLIER -68.76 87.48 0.35 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.434 1.588 . . . . 2.73 113.91 -173.736 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -67.64 5.55 0.8 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.04 2.536 . . . . 3.02 115.553 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -127.14 105.83 22.02 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.483 1.113 . . . . 7.79 109.514 146.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.87 144.81 60.21 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.165 2.576 . . . . 2.1400000000000001 111.073 172.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.14 126.32 33.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 3.27 110.839 -177.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -98.34 -31.2 12.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.705 1.202 . . . . 5.9400000000000004 113.01 -175.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 122.06 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 1 C-N-CA 132.153 4.181 . . . . 2.5099999999999998 110.468 175.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.23 37.0 93.51 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.355 -0.692 . . . . 1.9399999999999999 113.569 178.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.92 -171.8 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 3.2200000000000002 108.629 178.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -141.99 162.06 36.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.197 0.999 . . . . 3.3500000000000001 110.673 174.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.86 119.78 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.53 1.532 . . . . 1.77 109.894 -169.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.48 135.94 52.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 3.0800000000000001 110.456 162.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -155.94 124.4 5.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.816 0.846 . . . . 2.7799999999999998 112.615 -175.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.67 105.57 17.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.739 1.616 . . . . 1.99 110.571 172.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.02 117.69 21.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.594 0.757 . . . . 2.1600000000000001 110.418 176.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.77 126.27 38.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.877 1.271 . . . . 1.6100000000000001 111.045 -169.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -122.97 139.46 54.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.179 0.807 . . . . 3.04 113.179 -175.289 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.22 104.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.273 1.029 . . . . 2.96 112.634 -177.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.26 78.57 1.05 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.012 1.292 . . . . 4.7300000000000004 113.087 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.28 -0.37 24.94 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 116.193 1.237 . . . . 1.96 116.193 169.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -110.13 132.18 54.4 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.014 1.407 . . . . 6.7699999999999996 112.761 -170.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.35 134.31 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.794 1.638 . . . . 2.02 107.384 160.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.3 mt -120.15 110.16 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.937 -1.134 . . . . 2.8799999999999999 107.937 177.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -80.04 127.6 32.48 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.16 -0.337 . . . . 3.48 110.886 176.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.5 m -125.96 161.87 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.87 1.668 . . . . 2.1899999999999999 110.499 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.66 135.94 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.302 1.041 . . . . 2.8900000000000001 108.709 165.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -127.35 147.81 63.7 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.24 1.416 . . . . 2.4199999999999999 108.943 172.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.26 161.43 44.48 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.151 2.568 . . . . 1.0800000000000001 111.942 174.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.6 133.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.302 1.441 . . . . 2.0299999999999998 108.595 165.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.64 153.82 25.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.52 1.128 . . . . 3.9500000000000002 110.023 171.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 2.69 -113.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 130.163 3.385 . . . . 4.54 117.632 175.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.455 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.775 0 CA-C-O 114.866 -2.492 . . . . 9.9499999999999993 112.348 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.236 0.363 0 CA-C-O 121.44 0.638 . . . . 5.9900000000000002 110.512 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.07 171.46 29.32 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.577 1.561 . . . . 1.26 113.694 176.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -155.36 153.8 31.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.274 1.429 . . . . 1.73 112.126 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.49 136.54 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.569 -1.271 . . . . 2.0099999999999998 107.569 172.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -86.1 -0.31 55.31 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.486 2.032 . . . . 6.1200000000000001 116.486 -153.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 60.65 168.65 0.09 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.87 1.668 . . . . 4.3700000000000001 112.511 -168.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 t -165.73 145.69 5.48 Favored Pre-proline 0 N--CA 1.47 0.559 0 O-C-N 120.457 -1.402 . . . . 4.6699999999999999 112.372 162.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.32 -6.35 11.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.455 2.77 . . . . 4.0 112.486 164.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.65 171.31 15.52 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.405 1.479 . . . . 2.2599999999999998 113.757 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.08 -3.16 13.16 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.931 3.754 . . . . 2.21 113.811 -176.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -121.83 156.51 33.1 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.215 1.806 . . . . 2.73 112.133 171.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.79 177.06 11.82 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.38 1.472 . . . . 2.1899999999999999 112.091 -171.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.57 20.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.475 1.11 . . . . 1.8799999999999999 112.753 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.31 159.3 38.7 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.072 1.138 . . . . 2.0899999999999999 114.072 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -148.24 151.28 35.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.213 2.205 . . . . 3.7599999999999998 110.634 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -168.5 151.07 5.22 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.411 0.893 . . . . 2.9300000000000002 113.411 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -95.48 131.11 41.99 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.458 1.903 . . . . 2.5800000000000001 108.92 171.115 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.32 160.68 39.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.683 1.193 . . . . 5.54 111.173 178.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.98 127.29 10.62 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.967 0.907 . . . . 3.29 110.779 -169.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -85.97 116.34 65.34 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.278 1.031 . . . . 0.93000000000000005 109.694 174.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -87.2 -14.01 4.18 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.082 2.522 . . . . 1.3100000000000001 114.374 178.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.38 174.38 32.2 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 119.212 0.915 . . . . 1.1599999999999999 113.206 -174.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.01 -2.48 58.14 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.571 1.548 . . . . 3.7400000000000002 114.587 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -97.63 158.79 32.44 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.479 1.112 . . . . 3.2400000000000002 111.138 173.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.59 157.52 12.29 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.377 2.718 . . . . 1.5900000000000001 111.229 -176.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.21 108.02 9.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.634 0.73 . . . . 3.2200000000000002 111.688 -170.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -99.96 106.23 18.0 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.696 1.198 . . . . 3.4300000000000002 111.675 -177.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.1 tp -85.4 114.86 22.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.583 1.953 . . . . 1.8400000000000001 109.431 -177.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.71 -12.19 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.829 0.851 . . . . 1.9399999999999999 112.884 -171.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.45 -168.04 40.59 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.665 1.126 . . . . 0.81000000000000005 111.098 173.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.37 140.69 20.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.638 0.775 . . . . 2.2799999999999998 110.592 167.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.431 HH21 ' CG ' ' A' ' 102' ' ' ASP . 10.4 ttp180 -108.54 139.75 42.86 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.714 1.606 . . . . 7.7999999999999998 108.538 -169.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -152.41 155.7 33.09 Favored Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 124.593 1.157 . . . . 1.8700000000000001 109.874 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -86.58 -9.9 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.729 2.286 . . . . 1.4099999999999999 113.527 165.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 m -70.27 -9.52 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.343 0.974 . . . . 3.21 113.443 176.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 160.74 30.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.171 1.351 . . . . 2.1200000000000001 112.285 -169.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.28 -68.76 0.79 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.173 1.389 . . . . 3.0099999999999998 109.14 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -82.01 111.9 18.6 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.078 -1.014 . . . . 4.3799999999999999 109.405 171.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.62 145.78 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.524 1.13 . . . . 2.46 109.444 153.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -137.25 122.87 19.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.54 1.536 . . . . 2.1400000000000001 108.542 162.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.26 119.79 22.11 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 120.934 1.697 . . . . 1.8100000000000001 110.045 167.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -109.06 157.02 19.1 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.318 1.847 . . . . 0.66000000000000003 112.247 176.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 12.1 pt-20 -104.38 168.18 9.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.852 -1.067 . . . . 2.3700000000000001 110.264 161.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.7 m -130.03 107.48 9.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.342 1.457 . . . . 2.0 107.3 170.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -113.27 154.92 26.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.859 1.264 . . . . 3.6299999999999999 112.508 -171.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -90.52 154.45 19.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.655 1.182 . . . . 4.0300000000000002 112.334 172.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.41 15.53 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.033 1.333 . . . . 6.46 113.214 177.513 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -138.74 142.13 38.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.969 1.307 . . . . 4.8200000000000003 109.473 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.59 128.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.501 1.12 . . . . 4.8399999999999999 108.981 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 56.29 28.21 13.0 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.175 0.988 . . . . 4.1699999999999999 111.011 -168.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.12 -0.42 11.74 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.506 2.003 . . . . 3.2000000000000002 114.996 -173.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.69 126.11 30.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.444 1.498 . . . . 4.6200000000000001 108.785 174.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.47 126.89 52.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.371 1.468 . . . . 7.1200000000000001 110.785 -162.228 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.8 t -145.67 153.17 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.915 1.286 . . . . 2.5299999999999998 110.586 -156.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.4 mtm -120.81 149.44 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.387 1.075 . . . . 3.48 110.413 161.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.64 158.64 27.75 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.917 0.77 . . . . 1.1399999999999999 112.733 178.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -102.73 155.48 18.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.564 1.146 . . . . 2.4100000000000001 111.897 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -163.91 146.5 7.62 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-O 117.693 -1.146 . . . . 6.3899999999999997 112.255 171.733 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.38 142.13 53.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.881 2.387 . . . . 0.80000000000000004 111.419 172.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.76 157.54 38.19 Favored Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.303 1.441 . . . . 2.1200000000000001 110.763 175.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.44 -18.66 38.4 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.434 2.089 . . . . 0.69999999999999996 112.743 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -179.42 167.04 1.47 Allowed 'General case' 0 C--N 1.347 0.459 0 C-N-CA 126.128 1.771 . . . . 2.9300000000000002 110.076 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -114.91 171.09 7.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.274 1.83 . . . . 2.0699999999999998 108.89 157.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.32 167.76 29.35 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.142 -0.974 . . . . 2.52 113.353 167.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.75 134.69 16.21 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.053 1.341 . . . . 1.8999999999999999 109.381 -172.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.42 164.58 33.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.223 1.949 . . . . 0.87 111.611 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.14 139.7 85.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.831 3.021 . . . . 0.88 111.919 174.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.54 1.67 1.4 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.345 1.858 . . . . 4.2599999999999998 115.128 -171.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 118.44 4.78 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 127.669 2.556 . . . . 0.90000000000000002 111.971 -178.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -91.79 137.03 32.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.874 1.27 . . . . 4.5599999999999996 111.021 159.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.7 m -150.31 157.45 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.785 1.634 . . . . 2.2000000000000002 110.705 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.493 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -117.12 152.62 34.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.392 1.091 . . . . 3.73 112.826 169.828 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.79 77.29 2.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.955 1.302 . . . . 2.0099999999999998 108.733 161.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -73.2 137.51 78.71 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.393 1.077 . . . . 4.0099999999999998 112.399 177.59 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.53 -34.56 85.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.905 3.07 . . . . 1.7 114.476 -169.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.7 121.54 6.29 Favored Glycine 0 N--CA 1.468 0.824 0 N-CA-C 106.889 -2.484 . . . . 1.5900000000000001 106.889 150.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.86 -94.72 0.5 Allowed Glycine 0 N--CA 1.47 0.909 0 CA-C-N 119.786 1.793 . . . . 2.27 112.967 -161.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -148.12 149.06 31.34 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.042 2.137 . . . . 3.1200000000000001 111.633 -169.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.7 163.7 14.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.307 1.043 . . . . 1.3200000000000001 109.982 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -93.39 138.19 31.96 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 122.02 -0.425 . . . . 3.8300000000000001 109.937 167.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.6 mmt -96.98 139.49 32.91 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.348 1.059 . . . . 1.55 109.421 157.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.58 142.62 51.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.484 1.513 . . . . 4.0899999999999999 109.933 -178.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -145.99 133.65 21.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 3.9399999999999999 111.505 -174.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.74 74.37 1.09 Allowed Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.274 -0.73 . . . . 1.47 111.274 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.67 119.41 25.21 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.471 0.915 . . . . 2.4300000000000002 113.471 -163.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -90.6 -8.99 48.66 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.896 1.443 . . . . 2.71 114.896 -169.684 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.22 145.08 56.16 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.204 1.401 . . . . 7.4199999999999999 108.038 160.489 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 128.76 15.19 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 107.169 -1.896 . . . . 2.4300000000000002 107.169 168.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.37 95.76 0.33 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.087 1.355 . . . . 3.52 110.506 -168.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -68.99 111.81 5.23 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 120.657 -1.277 . . . . 5.7800000000000002 108.693 177.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.94 108.93 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.123 -0.985 . . . . 2.8500000000000001 110.431 167.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.06 16.65 40.37 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 117.213 -1.882 . . . . 1.79 116.036 -170.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.08 171.59 12.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.793 2.297 . . . . 4.3899999999999997 109.045 150.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.219 1.408 . . . . 4.3300000000000001 108.621 170.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.41 119.66 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.916 0.887 . . . . 2.0899999999999999 110.062 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.71 45.12 1.04 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 128.282 2.633 . . . . 5.5999999999999996 113.185 -170.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.41 130.22 42.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.483 1.913 . . . . 2.8399999999999999 113.902 -164.18 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.431 ' CG ' HH21 ' A' ' 36' ' ' ARG . 14.2 m-20 -92.02 93.28 8.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.457 2.703 . . . . 2.3199999999999998 110.892 175.353 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.1 mt -71.48 120.61 17.31 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.396 -0.815 . . . . 2.3799999999999999 110.52 -179.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt -93.27 125.26 37.78 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.546 1.538 . . . . 2.3300000000000001 111.114 -169.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.73 125.63 44.37 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.468 0.914 . . . . 3.0800000000000001 113.468 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 53.44 11.37 0.27 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.444 2.298 . . . . 3.3799999999999999 116.685 167.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.92 4.02 46.22 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.959 -1.088 . . . . 3.3399999999999999 114.409 -168.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -129.91 -4.71 4.6 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.727 1.156 . . . . 2.3300000000000001 115.64 -171.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.69 158.37 43.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.423 2.289 . . . . 4.9800000000000004 110.831 173.123 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.8 135.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.949 1.7 . . . . 2.7799999999999998 107.582 165.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.61 115.33 12.9 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.86 1.264 . . . . 2.54 107.77 -173.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -102.84 141.64 35.31 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.456 1.28 . . . . 3.5 114.456 -171.324 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.68 167.75 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.562 1.545 . . . . 2.6600000000000001 110.09 -173.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.87 144.81 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 124.641 1.176 . . . . 3.8799999999999999 109.733 172.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.42 133.17 6.67 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.551 -0.738 . . . . 3.3999999999999999 111.162 176.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.06 150.34 82.5 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.566 2.844 . . . . 1.6599999999999999 112.623 -172.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.3 112.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.337 1.055 . . . . 2.1600000000000001 108.492 166.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.88 -169.95 2.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.099 2.96 . . . . 3.7400000000000002 108.649 178.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.53 53.0 1.8 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.202 1.556 . . . . 3.1899999999999999 115.202 -161.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 115.58 -2.152 . . . . 9.7200000000000006 115.045 178.599 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 109.53 -0.544 . . . . 4.4199999999999999 109.53 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.72 174.75 43.36 Favored Glycine 0 N--CA 1.465 0.592 0 O-C-N 121.94 -0.475 . . . . 1.45 113.96 -178.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -155.51 151.04 27.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.947 0.899 . . . . 1.54 112.167 -179.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.93 127.64 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.901 -0.499 . . . . 1.95 110.016 174.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -72.63 -11.0 60.46 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.441 1.645 . . . . 5.5099999999999998 115.441 -159.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.94 160.81 0.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.372 1.469 . . . . 4.0999999999999996 113.949 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -165.82 149.93 7.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.048 1.739 . . . . 4.9500000000000002 110.497 166.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -83.64 -9.92 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.25 2.633 . . . . 3.75 112.024 162.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.9 -168.14 13.27 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.96 1.743 . . . . 2.3799999999999999 113.962 -174.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -74.0 -27.45 12.04 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.196 2.598 . . . . 2.6200000000000001 114.955 -165.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -98.63 150.85 21.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.144 1.338 . . . . 3.1299999999999999 112.425 177.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.4 -179.9 8.53 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.032 2.133 . . . . 2.1000000000000001 111.599 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.76 167.35 21.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.15 1.78 . . . . 2.1499999999999999 111.403 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.83 155.1 36.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.351 1.061 . . . . 1.9399999999999999 112.376 172.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 142.57 24.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.362 1.865 . . . . 3.4199999999999999 109.558 -171.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -171.24 159.37 5.8 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.318 1.599 . . . . 2.8700000000000001 115.318 -174.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -71.9 138.48 48.19 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.305 1.842 . . . . 2.0899999999999999 109.365 166.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.62 146.25 49.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.118 1.767 . . . . 4.7999999999999998 111.241 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -119.72 132.97 55.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.256 1.822 . . . . 5.0499999999999998 114.002 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -98.95 109.04 52.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.678 -0.692 . . . . 1.1799999999999999 109.851 143.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -89.2 -10.62 3.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.53 2.82 . . . . 1.4399999999999999 113.565 173.254 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.58 -174.25 47.15 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.116 1.341 . . . . 0.96999999999999997 113.495 -174.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.418 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 4.8 m-20 -107.56 -4.0 18.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.963 1.705 . . . . 2.3199999999999998 113.147 -169.253 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.42 161.43 39.27 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.653 1.981 . . . . 2.7599999999999998 109.644 169.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.71 163.09 29.44 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.826 2.351 . . . . 1.4199999999999999 112.632 -167.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.26 127.56 45.8 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.884 1.274 . . . . 3.5800000000000001 111.125 -174.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 68' ' ' GLU . 22.7 ttm180 -111.16 112.98 25.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.907 1.283 . . . . 4.2300000000000004 110.648 175.175 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 tp -85.76 133.12 34.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.377 . . . . 2.1600000000000001 108.721 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.86 -13.02 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.034 0.934 . . . . 1.8999999999999999 113.516 -175.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.48 -164.98 34.47 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.002 0.811 . . . . 0.97999999999999998 111.74 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.94 -175.92 4.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.459 0.704 . . . . 1.8899999999999999 110.632 160.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.88 146.56 9.54 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.069 0.948 . . . . 6.2400000000000002 111.644 171.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -140.34 152.32 66.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.017 1.727 . . . . 1.9299999999999999 109.253 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.13 -34.05 29.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 121.585 1.602 . . . . 0.96999999999999997 112.613 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 m -70.77 -18.82 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 115.244 1.572 . . . . 1.8 115.244 -167.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.3 143.03 50.79 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.843 1.257 . . . . 1.8600000000000001 111.078 -176.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -64.48 -53.83 42.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.262 1.025 . . . . 4.4199999999999999 111.8 172.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.14 160.76 21.51 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.372 1.869 . . . . 8.3100000000000005 111.055 -170.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -159.7 135.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.824 1.65 . . . . 1.8899999999999999 110.661 -172.136 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -139.87 135.1 32.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.324 1.85 . . . . 2.4100000000000001 109.72 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -83.33 118.74 23.89 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.436 1.016 . . . . 1.79 111.012 168.144 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -106.41 155.25 19.74 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.178 1.791 . . . . 0.80000000000000004 112.044 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -157.27 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 3.75 111.019 174.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.8 m -151.32 123.98 8.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.478 2.311 . . . . 2.3900000000000001 106.598 162.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -126.86 160.51 30.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.778 1.231 . . . . 3.7599999999999998 112.431 -172.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.9 ptt? -134.24 122.18 22.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.988 1.375 . . . . 4.1299999999999999 112.587 159.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -117.52 162.41 18.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.245 1.818 . . . . 9.0700000000000003 110.927 -176.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 30.1 mp0 -77.19 144.42 38.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.893 1.677 . . . . 4.8099999999999996 111.479 171.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.49 -96.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.602 1.561 . . . . 3.2400000000000002 109.176 -176.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.02 31.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.088 1.355 . . . . 4.0300000000000002 112.44 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.58 -13.28 8.48 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.365 -1.459 . . . . 2.73 112.594 -154.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 152.72 28.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.318 1.847 . . . . 5.2699999999999996 110.763 178.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 41.6 mmtt -73.78 140.12 45.65 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.746 -0.596 . . . . 6.3099999999999996 110.668 158.539 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -132.85 145.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.159 1.784 . . . . 2.98 108.259 165.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.8 tpp -101.52 146.9 27.04 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.229 2.212 . . . . 3.8300000000000001 111.016 -175.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.11 -174.98 33.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.935 1.255 . . . . 1.4399999999999999 113.64 174.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -138.38 152.2 48.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.672 1.589 . . . . 2.7799999999999998 110.196 173.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.39 148.33 16.44 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 124.664 1.186 . . . . 5.1500000000000004 110.932 -170.035 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.41 150.32 84.39 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 121.611 1.54 . . . . 0.79000000000000004 112.49 167.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.89 159.11 73.93 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 126.559 1.944 . . . . 1.97 110.761 176.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.39 -18.35 14.02 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.039 2.493 . . . . 0.69999999999999996 114.069 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -171.74 164.55 6.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.986 1.266 . . . . 3.1299999999999999 112.552 -178.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.15 168.61 12.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.737 2.415 . . . . 2.04 108.572 161.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 31' ' ' ARG . 14.7 pt-20 -161.88 163.82 28.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.975 -1.078 . . . . 2.1800000000000002 113.274 176.23 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 t -149.2 140.69 14.44 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.3 1.04 . . . . 2.75 110.601 -169.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.35 167.34 20.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.997 2.465 . . . . 1.3400000000000001 112.016 171.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.25 146.72 97.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.604 2.87 . . . . 1.05 112.796 175.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.418 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 67.9 mmtt 66.92 -2.45 1.13 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.373 1.869 . . . . 2.04 114.571 -178.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.97 117.86 4.58 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 126.65 2.071 . . . . 0.81000000000000005 111.343 178.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -83.34 145.35 29.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.834 -0.683 . . . . 7.1900000000000004 110.229 151.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.78 179.54 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.03 1.732 . . . . 2.52 109.398 171.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -121.39 139.75 53.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.771 0.828 . . . . 3.7000000000000002 111.217 166.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.16 76.69 1.27 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.805 -1.554 . . . . 2.1099999999999999 106.805 143.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -82.87 142.19 44.8 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 117.672 -1.156 . . . . 4.6399999999999997 109.94 -177.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.66 -55.13 4.38 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.355 3.37 . . . . 1.95 114.959 -169.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.1 70.83 2.81 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.748 -0.941 . . . . 1.22 110.748 172.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.84 -76.95 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.253 1.406 . . . . 1.01 114.046 -166.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -155.63 142.1 18.63 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 3.0299999999999998 108.351 -177.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -163.1 179.12 7.72 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.254 -0.903 . . . . 1.0600000000000001 111.581 -172.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -109.29 139.92 43.61 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.108 -0.37 . . . . 3.2799999999999998 111.088 168.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 mmt -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.58 0.752 . . . . 1.9299999999999999 109.477 155.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.11 140.01 53.04 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.694 1.597 . . . . 3.8900000000000001 109.1 178.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.16 152.8 49.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.047 0.939 . . . . 4.3300000000000001 111.956 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.82 60.02 4.46 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.678 0.656 . . . . 1.5900000000000001 111.719 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -74.94 107.71 7.19 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.469 1.128 . . . . 2.21 110.866 -178.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -70.98 -6.33 37.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.565 1.546 . . . . 3.7799999999999998 115.014 -175.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -143.41 158.45 57.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.687 2.395 . . . . 8.2699999999999996 108.273 156.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.07 157.25 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.086 1.857 . . . . 2.1600000000000001 109.741 156.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.78 166.67 10.52 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.399 1.479 . . . . 3.8900000000000001 111.915 -176.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 134.08 38.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.917 1.287 . . . . 4.2999999999999998 111.427 174.085 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.7 24.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.946 -1.096 . . . . 2.4500000000000002 110.219 173.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.44 54.98 2.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.129 0.395 . . . . 2.21 112.629 -162.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -143.05 160.83 39.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.619 2.368 . . . . 3.0899999999999999 109.015 165.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -102.49 120.47 40.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.968 2.107 . . . . 4.3799999999999999 111.112 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.54 128.92 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.896 1.278 . . . . 2.0800000000000001 109.638 169.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -79.11 140.21 37.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.002 0.43 . . . . 2.52 110.976 159.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -148.26 127.13 12.67 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.892 0.877 . . . . 2.8999999999999999 112.092 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -98.34 103.73 15.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.465 1.906 . . . . 2.5099999999999998 110.732 177.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.4 mt -68.86 112.43 5.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.997 0.817 . . . . 2.8999999999999999 110.575 168.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.0 mt -87.15 129.65 34.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.734 1.213 . . . . 2.1400000000000001 111.049 -176.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.81 117.67 19.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.536 0.684 . . . . 3.5800000000000001 111.268 179.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.95 21.82 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.292 2.237 . . . . 2.7000000000000002 116.729 168.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.47 -41.86 1.42 Allowed Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.228 1.394 . . . . 3.2400000000000002 114.17 -174.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.58 -1.82 72.76 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.073 1.32 . . . . 2.3999999999999999 114.877 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -148.47 157.15 43.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.372 1.469 . . . . 5.21 113.828 179.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.97 140.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.179 2.192 . . . . 3.0299999999999998 108.224 168.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -125.55 111.97 15.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.881 1.272 . . . . 3.4900000000000002 109.29 176.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -88.78 125.72 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.771 -0.58 . . . . 3.0099999999999998 112.279 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.08 161.66 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.904 1.682 . . . . 2.5099999999999998 111.208 171.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 m -106.66 143.58 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 3.4100000000000001 109.235 163.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.38 145.87 39.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.606 1.163 . . . . 2.79 111.624 179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.15 142.8 34.72 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.231 2.621 . . . . 1.22 112.186 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -79.94 132.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.174 1.389 . . . . 1.96 109.481 165.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -147.02 139.37 24.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.766 2.427 . . . . 4.25 107.276 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.62 52.9 2.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.455 1.502 . . . . 3.3199999999999998 112.117 -170.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG 0.294 0.0 OUTLIER . . . . . 0 C--O 1.248 0.977 0 N-CA-C 117.414 2.375 . . . . 7.7599999999999998 117.414 -154.064 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.555 1.137 0 N-CA-C 108.298 -1.001 . . . . 6.4100000000000001 108.298 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.4 -171.18 19.82 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 120.065 -1.647 . . . . 1.3799999999999999 115.688 -177.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -167.48 158.46 11.49 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.109 1.763 . . . . 1.55 112.167 173.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.77 130.94 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.733 0.813 . . . . 1.78 110.028 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -78.4 120.38 23.05 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.715 1.206 . . . . 4.79 111.615 -174.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -62.46 123.66 18.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.951 1.3 . . . . 4.5700000000000003 110.459 164.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -155.83 160.93 30.44 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.866 1.666 . . . . 2.5 108.976 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.58 -159.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.303 3.335 . . . . 3.52 108.862 167.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.52 -161.5 46.58 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.88 0.752 . . . . 3.4500000000000002 112.558 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -87.22 -11.14 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.579 2.853 . . . . 2.5299999999999998 113.201 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -149.45 160.13 43.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.696 1.198 . . . . 2.3300000000000001 113.891 -168.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.5 -167.06 1.64 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.624 1.97 . . . . 2.23 110.385 -174.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.67 153.59 50.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.834 0.743 . . . . 2.3500000000000001 112.689 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.9 153.03 46.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.69 1.196 . . . . 1.75 110.281 163.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.15 156.12 46.0 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.781 1.232 . . . . 3.7599999999999998 111.2 174.485 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.13 153.4 16.06 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.679 0.992 . . . . 2.7200000000000002 113.679 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -78.54 140.09 38.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.607 -1.179 . . . . 2.3300000000000001 107.956 151.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.21 134.73 26.3 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.73 1.212 . . . . 3.0 108.262 176.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.61 157.56 43.54 Favored 'General case' 0 C--N 1.335 -0.059 0 N-CA-C 114.13 1.159 . . . . 3.4199999999999999 114.13 -170.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -115.3 105.32 52.62 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.97999999999999998 110.931 -168.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.41 -15.67 9.84 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.577 2.185 . . . . 1.1100000000000001 113.595 177.177 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 -167.91 41.35 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 119.263 0.938 . . . . 1.25 112.91 -177.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.412 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 10.2 m-20 -117.02 16.29 15.06 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.5 1.52 . . . . 2.6400000000000001 111.496 -173.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mt -120.14 162.07 35.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.167 2.187 . . . . 4.3899999999999997 109.244 -175.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.21 156.99 17.32 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.976 2.451 . . . . 1.8300000000000001 110.901 175.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.29 103.55 4.95 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.273 1.029 . . . . 3.3900000000000001 111.059 -171.608 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -96.38 106.16 18.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.972 1.309 . . . . 3.8300000000000001 111.364 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 tp -86.73 113.84 22.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.126 2.17 . . . . 2.0499999999999998 108.651 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.69 -11.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.173 0.989 . . . . 1.76 113.483 -169.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.49 -161.68 32.48 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.518 -0.739 . . . . 0.59999999999999998 112.296 178.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.72 177.34 9.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.279 1.032 . . . . 2.3900000000000001 111.374 176.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 129.79 5.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.924 -1.139 . . . . 6.0700000000000003 107.924 172.502 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -135.31 147.36 61.8 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 117.748 -1.12 . . . . 1.6599999999999999 109.232 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.68 -15.02 27.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.04 1.827 . . . . 1.6399999999999999 112.712 171.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -75.19 -0.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.035 0.834 . . . . 1.72 113.236 174.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.47 -172.28 3.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.615 1.966 . . . . 2.0099999999999998 110.311 176.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -106.63 -55.89 2.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.699 1.2 . . . . 3.0299999999999998 110.566 166.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -119.85 165.92 13.97 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 5.1299999999999999 110.907 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.3 p -155.5 135.91 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.705 0.802 . . . . 3.27 109.48 171.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -120.13 132.51 55.44 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.954 1.702 . . . . 2.1499999999999999 108.977 -173.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.85 115.34 19.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.504 1.145 . . . . 2.1499999999999999 109.855 170.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -103.16 150.87 23.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.337 -1.301 . . . . 0.71999999999999997 111.995 176.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -94.64 164.59 12.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.513 2.325 . . . . 2.3500000000000001 109.991 166.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.9 m -145.63 121.25 10.45 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.38 1.072 . . . . 2.0499999999999998 108.152 167.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.49 153.48 51.73 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.894 0.878 . . . . 3.2999999999999998 112.945 -151.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.33 47.89 0.98 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 123.084 1.421 . . . . 6.8499999999999996 111.868 -172.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -80.67 162.16 24.31 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.347 -1.751 . . . . 8.9800000000000004 110.886 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -69.5 152.07 45.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.401 2.281 . . . . 4.04 111.42 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.04 -96.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.167 1.387 . . . . 3.9500000000000002 107.645 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.65 43.22 0.14 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.28 1.832 . . . . 4.5300000000000002 111.248 169.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.94 -26.96 0.78 Allowed Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.37 -1.456 . . . . 2.5800000000000001 113.691 -167.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -74.07 145.3 44.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.67 1.588 . . . . 4.1900000000000004 110.684 175.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -75.37 133.09 41.29 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.694 0.798 . . . . 6.0199999999999996 109.996 173.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.05 149.74 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.416 1.086 . . . . 3.04 109.865 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.3 mtm -83.37 93.86 7.84 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 4.96 112.985 175.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.38 165.67 22.7 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.367 0.984 . . . . 1.27 112.328 172.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -128.64 165.93 19.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.76 1.624 . . . . 3.7599999999999998 111.098 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -178.74 144.78 0.46 Allowed Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 116.123 -1.894 . . . . 5.2400000000000002 111.224 -175.198 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.69 143.11 60.65 Favored 'Trans proline' 0 C--N 1.347 0.472 0 CA-C-N 122.095 1.784 . . . . 0.85999999999999999 111.607 160.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.56 157.28 38.76 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.202 1.401 . . . . 1.8799999999999999 110.208 169.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.68 -15.78 33.65 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.80000000000000004 113.09 175.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -175.16 160.27 2.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.715 1.606 . . . . 4.2000000000000002 111.955 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt -109.51 175.09 5.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.851 1.261 . . . . 2.2599999999999998 108.867 147.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -156.0 166.89 32.13 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.042 -1.036 . . . . 2.3300000000000001 112.837 170.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.55 132.79 16.59 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 2.29 109.899 -177.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.36 162.35 38.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.736 2.29 . . . . 1.0600000000000001 110.835 171.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.18 140.56 84.2 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.945 2.43 . . . . 1.3899999999999999 111.485 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.412 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 61.6 mmtt 71.98 -4.0 2.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.599 2.36 . . . . 2.1499999999999999 114.318 -178.698 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.29 177.35 33.55 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.784 1.659 . . . . 1.0900000000000001 112.286 177.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -144.17 151.02 38.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.863 1.665 . . . . 4.6299999999999999 112.562 175.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.96 149.77 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.786 1.635 . . . . 3.2400000000000002 108.349 164.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -135.33 109.62 8.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.685 -1.598 . . . . 4.29 106.685 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.75 77.69 6.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.86 1.314 . . . . 2.4399999999999999 111.212 -164.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -67.37 138.74 94.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 117.26 -1.352 . . . . 6.1600000000000001 110.005 174.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.19 -54.45 4.99 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.258 3.305 . . . . 1.04 113.435 -175.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.05 51.8 3.91 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.655 1.122 . . . . 1.8899999999999999 111.708 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.58 -82.9 0.04 OUTLIER Glycine 0 N--CA 1.465 0.576 0 C-N-CA 128.663 3.03 . . . . 0.96999999999999997 111.223 -171.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -150.8 143.37 24.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.427 2.291 . . . . 3.6200000000000001 108.402 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -160.57 167.16 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.351 -0.843 . . . . 1.0700000000000001 110.63 -175.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -107.16 122.59 46.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.585 0.754 . . . . 3.54 110.566 174.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 mmt -85.93 117.64 24.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.606 1.162 . . . . 1.6799999999999999 110.525 171.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.7 mt -93.46 136.15 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.931 1.292 . . . . 2.9700000000000002 110.238 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mt -140.72 132.79 27.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.561 0.619 . . . . 3.5800000000000001 112.299 -178.255 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.71 53.82 2.18 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 125.343 1.449 . . . . 1.6599999999999999 112.506 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.48 115.17 4.4 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.884 0.698 . . . . 1.8999999999999999 112.884 -168.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -86.94 -13.42 44.73 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.173 1.175 . . . . 2.8900000000000001 114.173 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -146.64 143.04 17.99 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.646 1.178 . . . . 6.6900000000000004 110.251 177.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.52 134.58 17.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.088 2.526 . . . . 1.78 109.228 171.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.41 90.07 8.14 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.786 0.835 . . . . 3.3700000000000001 111.358 -171.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -58.72 148.17 30.39 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.002 -1.061 . . . . 4.6399999999999997 113.317 169.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.79 114.73 5.89 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.517 -0.739 . . . . 2.8999999999999999 109.473 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.6 -9.7 7.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 116.63 -2.206 . . . . 1.9299999999999999 116.816 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 173.29 10.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.449 2.624 . . . . 3.8999999999999999 112.884 -177.209 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -100.16 162.12 13.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.229 1.412 . . . . 3.8599999999999999 110.085 159.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.6 t -128.42 127.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.179 1.791 . . . . 2.2799999999999998 108.155 172.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.2 136.81 35.89 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.533 1.533 . . . . 5.96 109.562 175.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 tt -154.3 130.01 10.03 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.743 1.258 . . . . 2.8500000000000001 114.342 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.82 99.78 12.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.317 3.047 . . . . 2.7599999999999998 110.989 173.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.48 117.16 17.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.941 -1.099 . . . . 2.1000000000000001 109.173 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.2 mt -91.49 126.85 36.72 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.796 0.838 . . . . 1.98 110.382 -169.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.01 126.95 45.12 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.972 1.101 . . . . 3.0 113.972 -178.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.52 23.98 1.03 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.458 1.903 . . . . 2.73 114.603 169.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.01 -55.13 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.346 1.451 . . . . 3.9300000000000002 113.004 -166.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.05 18.17 46.44 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.587 -1.674 . . . . 1.8899999999999999 116.629 -169.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -141.93 157.73 44.61 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.869 2.468 . . . . 4.9199999999999999 110.58 165.187 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.2 141.38 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 126.048 1.739 . . . . 1.95 107.851 162.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.4 106.89 12.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.668 1.187 . . . . 2.8799999999999999 107.896 173.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -79.44 128.53 33.47 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.41 -0.806 . . . . 5.9299999999999997 111.071 177.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.96 164.06 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.394 1.877 . . . . 2.4700000000000002 110.443 178.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 m -105.26 155.6 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 125.441 1.496 . . . . 4.21 109.119 164.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.7 mt -141.52 149.52 54.44 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.546 1.939 . . . . 2.4199999999999999 109.231 173.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.53 152.97 20.41 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.829 3.019 . . . . 1.01 112.348 176.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.3 t -80.38 142.04 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.276 1.03 . . . . 2.2000000000000002 111.149 168.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 166.86 32.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.807 2.043 . . . . 2.9399999999999999 111.204 -166.678 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.98 26.84 9.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.738 1.215 . . . . 2.3100000000000001 113.392 -169.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.1 mtm105 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 116.606 -1.664 . . . . 6.9199999999999999 112.382 -171.58 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 121.711 0.767 . . . . 7.2800000000000002 111.848 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.56 151.97 17.03 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.949 1.261 . . . . 1.28 114.482 -172.828 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -155.85 162.97 40.36 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.96 1.304 . . . . 1.8 110.928 -177.36 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.66 126.82 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.718 0.77 . . . . 1.8799999999999999 109.58 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.9 52.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.523 1.305 . . . . 10.869999999999999 114.523 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -97.61 139.13 33.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.856 1.262 . . . . 3.9399999999999999 108.773 162.255 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -164.28 158.12 15.61 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.798 1.239 . . . . 3.2000000000000002 110.994 166.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -83.96 57.98 5.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.494 3.462 . . . . 2.7799999999999998 110.824 177.283 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.55 160.3 27.9 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.199 -0.778 . . . . 1.5700000000000001 113.709 -177.133 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -77.53 -3.87 14.05 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.005 3.137 . . . . 2.0600000000000001 113.226 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -161.33 153.68 20.1 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.724 1.61 . . . . 2.2400000000000002 112.854 -176.158 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -176.97 160.26 1.79 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.717 1.607 . . . . 3.6800000000000002 112.045 172.703 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.94 133.77 45.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.182 1.793 . . . . 2.9900000000000002 112.372 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.76 154.77 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.172 1.389 . . . . 2.4700000000000002 111.328 172.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.07 154.39 48.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.832 0.853 . . . . 4.0700000000000003 112.481 -159.832 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -171.54 154.96 3.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.786 1.234 . . . . 2.6099999999999999 112.942 176.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 99.5 m -74.76 146.68 41.96 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.792 -0.447 . . . . 3.0299999999999998 109.792 152.739 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.98 124.75 43.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.35 2.26 . . . . 3.4100000000000001 107.979 173.53 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -102.62 134.46 45.94 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.613 1.965 . . . . 4.7699999999999996 113.315 175.612 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -99.11 106.99 41.8 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 121.573 -0.704 . . . . 1.3200000000000001 109.621 162.151 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.23 -11.15 10.99 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.584 2.19 . . . . 1.3899999999999999 112.989 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 176.17 51.21 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.644 1.116 . . . . 1.1599999999999999 113.505 -177.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 4.8 m-20 -99.59 -7.22 26.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.443 1.897 . . . . 2.6499999999999999 112.818 -175.412 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.05 160.5 38.78 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.629 1.971 . . . . 3.1899999999999999 109.894 170.012 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.74 149.98 23.82 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.061 2.508 . . . . 2.0499999999999998 112.435 -168.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 mt -96.09 154.93 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.988 0.915 . . . . 3.2000000000000002 110.784 170.71 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 68' ' ' GLU . 20.9 ttm180 -135.83 107.72 7.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.489 1.516 . . . . 4.6900000000000004 108.979 171.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.6 tp -86.03 116.3 24.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.403 2.281 . . . . 1.9099999999999999 108.818 -176.745 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.96 -13.16 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 1.72 112.772 -172.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.13 -169.19 42.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.294 1.426 . . . . 0.57999999999999996 111.636 177.58 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.43 159.57 38.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.0 1.32 . . . . 1.8899999999999999 111.138 168.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -132.16 136.9 47.42 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.68 -1.262 . . . . 7.8700000000000001 110.321 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.0 155.4 70.85 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 124.875 1.27 . . . . 1.7 108.952 -174.381 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.06 -31.49 45.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.938 1.758 . . . . 1.04 113.017 160.348 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -77.01 5.86 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.852 1.427 . . . . 2.1800000000000002 114.852 -167.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.72 29.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.851 1.66 . . . . 2.1699999999999999 111.4 -178.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.21 -81.71 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.44 0.296 . . . . 2.9100000000000001 111.055 -178.685 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -71.72 161.24 31.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.984 0.897 . . . . 4.3499999999999996 110.709 174.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.2 138.8 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.151 -1.386 . . . . 3.0899999999999999 108.268 159.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -133.14 124.17 27.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.442 -1.688 . . . . 2.2000000000000002 106.442 160.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.14 121.62 26.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.163 1.347 . . . . 1.72 109.288 166.024 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -104.85 158.1 16.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.962 1.305 . . . . 0.70999999999999996 112.346 176.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.21 -175.65 2.85 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.673 2.389 . . . . 2.21 111.627 172.333 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.1 m -134.72 104.11 5.9 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.003 1.721 . . . . 2.5899999999999999 106.407 153.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -84.45 150.4 25.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.006 0.523 . . . . 3.3700000000000001 110.805 178.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -106.95 135.86 47.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.208 1.003 . . . . 4.9699999999999998 110.859 170.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.21 -172.97 2.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.679 1.192 . . . . 7.6200000000000001 113.087 -172.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.25 149.01 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.601 2.761 . . . . 4.8600000000000003 106.666 -170.958 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.04 -42.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.454 1.502 . . . . 6.4500000000000002 112.641 177.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -81.35 10.53 5.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.021 1.728 . . . . 4.8600000000000003 112.519 168.089 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.65 -7.29 1.06 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.306 1.432 . . . . 1.8600000000000001 115.147 -167.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -72.95 133.59 44.4 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.721 -1.458 . . . . 4.3499999999999996 108.474 158.973 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 142.84 36.74 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.287 -0.634 . . . . 6.6699999999999999 109.287 166.889 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -147.89 152.37 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.819 2.047 . . . . 3.0899999999999999 109.067 -166.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.8 mtm -123.75 143.34 50.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.618 1.167 . . . . 4.1600000000000001 111.232 167.72 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.92 159.05 28.51 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.1 0.857 . . . . 1.46 113.689 -179.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.577 1.151 . . . . 2.46 112.618 -175.44 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -177.14 142.66 0.51 Allowed Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 116.663 -1.637 . . . . 5.21 110.764 -171.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -71.83 142.67 39.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 CA-C-N 122.204 1.823 . . . . 0.77000000000000002 111.827 167.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.64 157.48 47.73 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 126.052 1.741 . . . . 1.8500000000000001 110.473 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.13 -17.91 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.436 2.09 . . . . 0.66000000000000003 113.025 176.398 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -175.69 169.06 3.08 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.135 1.374 . . . . 3.1499999999999999 111.321 -177.224 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.21 175.18 5.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.645 1.978 . . . . 2.02 108.961 156.035 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.3 pt-20 -152.47 164.26 37.91 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.105 -0.997 . . . . 2.6600000000000001 111.511 176.492 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -147.58 129.06 7.28 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.17 0.988 . . . . 2.21 110.311 -172.001 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.65 157.49 35.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.996 2.464 . . . . 1.5 111.934 179.65 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.89 137.56 73.25 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.374 3.383 . . . . 1.5600000000000001 113.293 -174.908 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 68.2 mmtt 68.88 -5.46 1.01 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.261 2.224 . . . . 2.1699999999999999 114.42 -176.494 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.62 137.2 14.15 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 126.498 1.999 . . . . 1.3300000000000001 109.838 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -107.26 136.79 46.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.061 -1.07 . . . . 5.8700000000000001 110.561 158.493 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.21 149.07 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 125.378 1.471 . . . . 3.4399999999999999 110.702 -178.372 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -100.95 134.5 43.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.151 1.908 . . . . 4.0199999999999996 116.151 -167.866 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.29 78.68 1.33 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.505 1.522 . . . . 1.7 107.453 155.455 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -83.17 139.55 42.26 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.556 1.142 . . . . 3.5499999999999998 110.364 178.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.8 -53.35 7.06 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.851 3.034 . . . . 1.25 113.915 -169.147 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.04 90.45 1.68 Allowed Glycine 0 N--CA 1.469 0.894 0 N-CA-C 109.622 -1.391 . . . . 1.5600000000000001 109.622 166.017 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.15 -74.29 0.22 Allowed Glycine 0 N--CA 1.468 0.794 0 C-N-CA 124.843 1.211 . . . . 1.3700000000000001 112.767 -168.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -156.02 144.86 20.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.52 1.928 . . . . 3.1699999999999999 109.346 177.101 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -167.73 164.91 14.39 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.977 -1.077 . . . . 1.01 109.629 -176.251 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -95.92 120.33 36.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.826 0.45 . . . . 3.4100000000000001 110.183 175.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.1 mmt -76.9 100.05 5.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.643 1.211 . . . . 1.9399999999999999 109.365 163.793 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -102.02 111.11 23.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.663 -1.608 . . . . 3.1000000000000001 108.268 178.63 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.56 52.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.0 1.72 . . . . 4.3399999999999999 109.124 -173.524 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.96 63.09 2.12 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.797 -0.921 . . . . 1.5600000000000001 110.797 -174.855 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.97 117.23 13.32 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.387 0.675 . . . . 2.1499999999999999 111.427 -176.068 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -82.82 -6.93 59.66 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.689 1.366 . . . . 2.5299999999999998 114.689 -165.335 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -122.87 153.22 63.64 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.921 -1.511 . . . . 5.5700000000000003 106.921 152.451 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.34 123.71 9.79 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 107.371 -1.819 . . . . 1.71 107.371 151.34 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.35 154.36 41.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.935 1.294 . . . . 3.1899999999999999 112.069 -166.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -131.38 129.1 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.564 1.146 . . . . 7.2199999999999998 110.931 165.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.05 121.86 8.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.795 -0.816 . . . . 2.71 108.795 169.647 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.55 1.84 56.53 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-O 117.998 -1.446 . . . . 1.8899999999999999 116.127 -169.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -78.79 170.22 17.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.182 1.991 . . . . 2.7799999999999998 110.243 162.159 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -116.15 149.78 38.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.812 2.045 . . . . 5.0700000000000003 109.811 177.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.4 t -127.62 113.94 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.404 1.081 . . . . 2.2599999999999998 109.722 -178.343 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.43 ' OE2' ' HE2' ' A' ' 112' ' ' LYS . 1.2 mt-10 -68.95 134.55 49.68 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.981 0.8 . . . . 3.0899999999999999 109.646 159.459 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -147.4 116.96 7.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.565 1.146 . . . . 2.7599999999999998 112.372 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -89.68 94.58 9.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.688 2.795 . . . . 2.1800000000000002 110.543 177.651 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -74.13 123.31 24.2 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.796 1.239 . . . . 2.3500000000000001 110.815 -177.017 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 mt -96.8 129.69 44.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.831 1.252 . . . . 1.8100000000000001 111.23 -172.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.57 129.82 41.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.049 0.928 . . . . 3.0800000000000001 113.172 -173.463 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 32.37 50.41 0.18 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.671 2.388 . . . . 2.6499999999999999 113.935 175.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.26 -90.88 0.53 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.897 1.237 . . . . 3.6400000000000001 112.053 -172.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.19 15.94 19.75 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 117.399 1.719 . . . . 1.6499999999999999 117.399 -164.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -115.0 145.21 42.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.784 2.292 . . . . 6.25 109.363 166.323 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -147.8 137.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 124.906 1.282 . . . . 2.0099999999999998 108.96 167.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.5 mt -142.14 124.62 15.74 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.48 1.512 . . . . 2.7799999999999998 107.858 -175.475 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HE2' ' OE2' ' A' ' 100' ' ' GLU . 10.0 ptmt -102.96 150.12 23.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.437 1.643 . . . . 3.2799999999999998 115.437 -174.258 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.78 160.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.233 1.813 . . . . 2.1099999999999999 110.284 178.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -117.05 118.71 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.578 1.151 . . . . 2.9199999999999999 110.261 171.394 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.2 mt -108.9 150.42 40.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.331 1.852 . . . . 2.3399999999999999 109.769 178.398 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.24 155.43 19.29 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.455 2.77 . . . . 0.96999999999999997 111.698 170.068 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.42 145.36 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.924 1.29 . . . . 1.8400000000000001 109.258 163.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.64 171.14 16.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.545 1.938 . . . . 3.27 108.797 -176.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.57 3.58 7.5 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.436 2.013 . . . . 3.21 116.436 -160.476 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 130.209 3.403 . . . . 5.7199999999999998 109.272 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.991 0 CA-C-O 117.061 -1.966 . . . . 10.289999999999999 112.343 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.413 ' HA ' ' CG ' ' A' ' 3' ' ' PHE . 1.2 p 52.33 134.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 2 C-N-CA 134.999 5.319 . . . . 8.5700000000000003 117.738 -14.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.413 ' CG ' ' HA ' ' A' ' 2' ' ' SER 0.305 41.7 p90 52.84 74.19 0.31 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 131.424 3.89 . . . . 9.5999999999999996 114.077 -2.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.92 122.53 37.61 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 106.211 -1.774 . . . . 6.2599999999999998 106.211 170.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -141.81 -158.09 0.83 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.402 0.889 . . . . 5.0899999999999999 113.402 -152.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -162.38 -179.2 36.83 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 126.021 1.772 . . . . 1.3899999999999999 115.407 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -127.91 140.49 51.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.406 0.682 . . . . 2.3199999999999998 112.835 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.9 t -83.06 138.5 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.877 -1.157 . . . . 1.9299999999999999 107.877 160.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -83.87 119.75 25.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.162 -0.961 . . . . 4.3200000000000003 112.448 -164.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.03 129.13 20.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.116 1.366 . . . . 4.4900000000000002 110.619 163.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m 179.24 111.31 0.18 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.075 1.75 . . . . 2.4399999999999999 110.316 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -84.41 48.72 2.53 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.006 3.138 . . . . 2.27 110.181 167.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.65 -174.67 27.01 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.405 1.002 . . . . 1.6299999999999999 113.037 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.06 -17.01 28.63 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.685 2.256 . . . . 1.99 111.529 163.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -150.28 169.06 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.403 1.881 . . . . 2.2999999999999998 113.019 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.9 -159.59 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.469 2.307 . . . . 2.1699999999999999 109.422 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.06 166.07 27.2 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.732 1.213 . . . . 1.8799999999999999 111.247 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.72 133.58 40.11 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 1.8 111.753 162.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -120.96 148.15 44.49 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.89 2.076 . . . . 3.7200000000000002 109.707 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -169.84 154.67 5.39 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.482 1.29 . . . . 2.3300000000000001 114.482 174.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 m -74.39 143.61 44.72 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.429 1.092 . . . . 2.4300000000000002 108.655 157.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.53 130.59 21.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.706 -1.22 . . . . 2.9100000000000001 107.706 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.16 142.86 32.76 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.882 0.873 . . . . 4.2300000000000004 111.203 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -102.46 110.75 63.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.458 1.503 . . . . 0.90000000000000002 110.526 -168.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.04 -10.51 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.229 1.952 . . . . 1.04 113.524 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.51 169.71 54.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.262 0.937 . . . . 0.83999999999999997 113.673 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.471 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.3 m-20 -98.01 -4.99 35.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.93 1.692 . . . . 2.5299999999999998 112.89 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.79 159.61 38.3 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 126.053 1.741 . . . . 2.2999999999999998 109.856 167.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.75 159.02 28.13 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.889 2.392 . . . . 1.01 112.038 -169.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.43 154.16 19.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.213 1.005 . . . . 3.25 110.262 168.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 68' ' ' GLU . 36.8 ttm180 -137.95 109.35 6.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.789 1.236 . . . . 3.8799999999999999 108.814 168.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -88.76 106.92 18.68 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.639 2.376 . . . . 1.6799999999999999 108.952 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.36 -11.56 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.378 1.071 . . . . 1.6000000000000001 112.705 -172.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.86 -168.86 40.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.364 0.983 . . . . 0.56999999999999995 111.904 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.25 -179.73 7.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.571 1.148 . . . . 1.72 109.17 163.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -159.52 137.92 10.55 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 119.038 0.836 . . . . 5.5599999999999996 109.286 -167.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 161.15 48.9 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.741 1.155 . . . . 1.6599999999999999 109.92 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.91 -29.56 15.05 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.891 1.727 . . . . 0.93000000000000005 113.583 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.0 m -81.01 0.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.12 1.526 . . . . 1.8600000000000001 115.12 -166.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 160.54 39.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.656 1.182 . . . . 1.96 112.24 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -96.96 -82.07 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.777 1.231 . . . . 2.77 111.298 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -80.59 101.02 8.92 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 120.301 -1.499 . . . . 4.2599999999999998 108.954 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 p -84.78 137.21 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 125.977 1.711 . . . . 1.99 111.365 165.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -141.63 132.5 25.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.782 1.633 . . . . 2.0800000000000001 110.753 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -82.98 123.25 29.26 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 121.088 1.767 . . . . 1.6299999999999999 111.713 168.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -110.43 152.23 26.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.181 1.792 . . . . 0.66000000000000003 112.701 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -85.06 166.13 16.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.005 1.722 . . . . 2.1699999999999999 110.193 158.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.1 m -147.51 126.25 12.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 2.6499999999999999 107.481 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -140.12 164.24 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.925 0.713 . . . . 3.4199999999999999 112.925 -151.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -110.2 138.51 46.48 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.418 0.687 . . . . 4.0300000000000002 110.18 153.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -145.27 155.29 43.14 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.879 1.672 . . . . 8.2899999999999991 109.213 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.32 150.96 20.54 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.677 0.791 . . . . 3.73 110.197 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.5 t -130.89 -97.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.428 1.091 . . . . 3.0600000000000001 109.619 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.54 45.12 0.38 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.92 2.088 . . . . 3.2799999999999998 111.584 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.36 -5.55 5.21 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.776 -1.202 . . . . 1.76 113.623 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -106.08 147.77 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.182 2.193 . . . . 3.5099999999999998 109.946 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -76.28 138.42 40.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.557 0.743 . . . . 4.7000000000000002 111.229 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -137.31 151.63 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.286 1.834 . . . . 2.5 109.288 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mtm -127.4 145.35 50.85 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.288 1.035 . . . . 4.0999999999999996 111.775 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.85 37.07 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.509 1.052 . . . . 1.53 113.483 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -123.27 168.07 12.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.381 1.872 . . . . 2.7599999999999998 111.068 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.16 131.93 0.45 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 116.361 -1.78 . . . . 5.25 111.882 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -67.72 142.47 58.21 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 122.533 1.94 . . . . 0.69999999999999996 112.553 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.43 160.26 44.56 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.22 1.808 . . . . 1.54 110.376 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.6 -20.15 20.72 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.354 2.036 . . . . 0.76000000000000001 113.17 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -176.27 168.1 2.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.959 1.254 . . . . 2.9700000000000002 112.018 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -116.58 173.81 6.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.445 2.298 . . . . 1.8999999999999999 109.128 153.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.414 ' CD ' HH21 ' A' ' 31' ' ' ARG . 8.3 pt-20 -156.61 166.62 32.87 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.058 -1.026 . . . . 1.96 112.731 176.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 132.15 8.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.104 0.962 . . . . 1.78 109.154 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.4 165.9 30.16 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.577 1.518 . . . . 0.89000000000000001 110.762 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.43 138.71 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.194 2.596 . . . . 0.89000000000000001 111.144 171.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.471 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 59.2 mmtt 68.45 -2.69 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.011 1.724 . . . . 2.0800000000000001 113.883 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.91 -172.67 45.12 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 126.187 1.851 . . . . 0.98999999999999999 113.423 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -152.15 149.11 28.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.056 1.742 . . . . 5.5999999999999996 111.621 -171.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.04 142.08 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.616 1.567 . . . . 3.4399999999999999 108.551 161.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -106.1 123.17 47.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.966 0.803 . . . . 3.8199999999999998 109.735 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.31 69.7 0.56 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.347 1.459 . . . . 1.78 108.194 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -81.4 145.62 55.82 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.461 2.305 . . . . 3.7000000000000002 109.694 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.7 -42.7 65.99 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.148 2.566 . . . . 0.91000000000000003 112.501 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.75 59.99 4.24 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.814 0.734 . . . . 1.0800000000000001 112.171 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.63 -70.3 0.05 OUTLIER Glycine 0 N--CA 1.468 0.786 0 C-N-CA 124.053 0.835 . . . . 1.04 114.371 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -155.16 147.18 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.835 1.654 . . . . 3.0699999999999998 109.367 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -165.25 174.87 9.75 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.022 -1.049 . . . . 1.1599999999999999 110.921 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.59 132.31 50.98 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.724 -0.473 . . . . 3.1200000000000001 109.724 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -80.89 135.81 35.97 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.134 0.574 . . . . 1.6399999999999999 110.143 159.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.42 98.36 6.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.143 1.377 . . . . 2.5499999999999998 109.411 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -102.38 142.94 32.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.828 0.851 . . . . 3.3500000000000001 111.162 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.66 75.0 0.73 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.398 -1.081 . . . . 1.3100000000000001 110.398 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.2 124.11 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 117.271 0.536 . . . . 1.8700000000000001 112.142 -170.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -82.33 -6.31 59.17 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.001 0.741 . . . . 2.21 113.001 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -154.32 150.04 21.51 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.48 2.312 . . . . 4.8200000000000003 108.366 158.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.28 134.57 45.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.934 1.756 . . . . 1.8200000000000001 108.249 168.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.75 119.73 20.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.922 -0.399 . . . . 3.25 109.922 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -105.5 124.0 48.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.296 1.839 . . . . 4.3899999999999997 109.987 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.98 48.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.666 0.666 . . . . 3.0299999999999998 109.731 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 34.77 31.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 120.025 -0.319 . . . . 2.25 113.25 -167.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.99 174.27 6.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.929 -1.137 . . . . 2.8500000000000001 107.929 148.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.8 151.11 37.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.628 1.171 . . . . 3.54 108.309 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.6 t -127.53 126.99 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.901 1.281 . . . . 2.0600000000000001 109.698 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.457 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 15.0 mt-10 -75.08 142.31 43.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.255 1.026 . . . . 2.7799999999999998 111.349 161.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.37 114.12 5.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.931 -1.031 . . . . 2.6899999999999999 111.361 -172.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.02 93.84 8.17 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.028 2.531 . . . . 2.1200000000000001 109.968 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.2 mt -71.53 121.88 19.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.151 0.98 . . . . 2.02 110.678 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -95.76 128.22 42.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 1.54 111.674 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.54 137.44 52.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.419 0.687 . . . . 3.0099999999999998 112.101 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.02 130.28 21.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.342 1.457 . . . . 2.3599999999999999 114.311 -165.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.3 -144.94 22.8 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.986 -1.246 . . . . 3.0499999999999998 109.986 -164.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.27 54.44 1.54 Allowed Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.734 -1.037 . . . . 2.3799999999999999 114.135 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -120.24 140.28 51.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.863 1.831 . . . . 5.1200000000000001 111.161 168.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.45 137.45 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 125.741 1.616 . . . . 1.8700000000000001 107.581 164.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.8 mt -128.32 111.5 13.43 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.482 1.113 . . . . 2.2999999999999998 108.601 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.457 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 25.5 ttpt -81.17 122.57 27.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.352 -0.217 . . . . 3.1299999999999999 111.584 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.97 164.39 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.808 1.643 . . . . 1.99 110.237 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.55 146.08 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.969 0.908 . . . . 2.98 109.034 166.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -136.3 145.54 52.35 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.08 1.352 . . . . 2.3500000000000001 109.234 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -68.2 154.75 71.59 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.562 2.175 . . . . 0.98999999999999999 110.388 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.657 -0.868 . . . . 1.98 108.657 165.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.03 157.76 43.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.537 1.135 . . . . 3.02 110.606 -171.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.11 72.13 1.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.969 1.707 . . . . 2.3100000000000001 112.511 -168.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.0 0 C-N-CA 124.735 1.214 . . . . 5.71 110.344 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 109.605 -1.398 . . . . 9.5999999999999996 109.605 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 m -80.45 -135.79 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.819 1.31 . . . . 9.5099999999999998 110.155 154.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.51 47.64 0.32 Allowed 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.704 -1.247 . . . . 10.4 111.046 170.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.1 p -158.18 116.45 3.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 127.582 2.353 . . . . 6.71 107.272 -159.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -153.14 -153.51 0.48 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.778 1.231 . . . . 6.1299999999999999 111.017 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.71 167.66 21.45 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 125.127 1.346 . . . . 1.6599999999999999 114.55 172.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.3 p90 -163.08 158.23 21.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.353 2.261 . . . . 1.9199999999999999 110.648 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.35 139.58 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.81 -0.556 . . . . 2.0499999999999998 110.218 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -77.73 128.93 34.84 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.307 -0.406 . . . . 6.6200000000000001 111.507 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.7 143.69 3.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.655 1.182 . . . . 3.6699999999999999 111.769 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -163.44 135.97 4.07 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.554 0.576 . . . . 3.8599999999999999 112.554 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.18 0.45 4.15 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.546 3.497 . . . . 2.73 112.447 163.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.3 171.54 25.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.922 1.249 . . . . 1.49 114.626 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.1 -13.98 18.98 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.478 3.452 . . . . 1.8300000000000001 113.861 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -122.16 163.29 19.79 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.068 0.947 . . . . 3.4700000000000002 111.863 166.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.52 178.55 10.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.292 1.437 . . . . 2.1099999999999999 111.328 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.49 139.05 46.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.591 1.557 . . . . 2.6299999999999999 111.957 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.02 150.11 48.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.161 1.385 . . . . 2.0600000000000001 112.118 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -136.09 148.51 48.32 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.551 1.541 . . . . 3.4500000000000002 109.308 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.63 152.52 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 2.6899999999999999 114.816 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 m -79.62 120.44 23.96 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 126.094 1.757 . . . . 2.5699999999999998 109.652 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.67 113.03 26.35 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.383 -0.969 . . . . 3.48 108.383 166.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -122.88 127.85 49.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.025 1.33 . . . . 3.3199999999999998 108.7 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -98.43 104.39 23.47 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.368 1.067 . . . . 1.05 109.614 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.87 -10.41 12.84 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 1.1699999999999999 113.311 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 164.49 52.04 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.276 0.941 . . . . 0.96999999999999997 113.094 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.69 -9.97 59.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.766 1.226 . . . . 3.9199999999999999 113.492 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.73 160.82 47.23 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.028 1.731 . . . . 2.6200000000000001 111.215 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.12 151.77 23.85 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.956 2.438 . . . . 1.0700000000000001 111.84 -171.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -115.55 125.59 53.18 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.264 1.426 . . . . 3.5 110.468 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -107.98 114.77 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.761 1.225 . . . . 3.6299999999999999 110.72 171.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.2 tp -97.07 114.72 26.4 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.441 2.696 . . . . 1.8 108.771 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.54 -11.04 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.068 0.947 . . . . 1.71 113.206 -165.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.77 -158.01 27.74 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 124.113 0.863 . . . . 0.55000000000000004 111.509 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.11 178.97 9.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.77 0.828 . . . . 1.76 112.181 172.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -146.6 121.35 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.535 1.134 . . . . 7.5999999999999996 109.733 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -145.46 160.68 44.25 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.665 1.986 . . . . 2.1099999999999999 108.988 -168.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -31.01 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.122 1.881 . . . . 1.9299999999999999 112.748 157.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 m -83.49 31.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.554 1.07 . . . . 2.7000000000000002 113.84 -169.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.15 161.25 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 128.029 2.532 . . . . 2.3599999999999999 109.227 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.94 -80.2 0.55 Allowed 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.8 -1.926 . . . . 3.48 105.8 160.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.43 84.94 2.54 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.14 -0.975 . . . . 4.4400000000000004 109.903 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.76 137.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.428 -0.806 . . . . 2.1099999999999999 109.619 159.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.98 122.84 27.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.792 1.237 . . . . 2.2999999999999998 110.649 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -79.71 119.14 22.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.922 1.237 . . . . 1.9199999999999999 110.597 168.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -106.99 156.16 19.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.266 1.827 . . . . 0.89000000000000001 112.23 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' C ' ' HG1' ' A' ' 48' ' ' THR . 8.0 pt-20 -112.63 -176.64 2.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 2.04 111.794 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.407 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 62.6 m -150.09 79.4 1.36 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.992 1.317 . . . . 2.4199999999999999 108.466 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -83.58 148.57 27.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.942 -1.026 . . . . 3.7999999999999998 110.214 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -90.89 155.37 18.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 4.4500000000000002 111.035 164.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -151.69 149.2 28.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.736 1.615 . . . . 7.3099999999999996 109.952 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -89.57 168.81 11.86 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.0 0.905 . . . . 3.54 111.782 164.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.61 -128.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.821 2.448 . . . . 4.2599999999999998 107.331 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 2.0 mp0 -76.68 60.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 121.559 1.981 . . . . 4.9500000000000002 111.14 173.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.15 2.9 55.08 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.643 1.116 . . . . 2.3500000000000001 114.008 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 63.5 mttt -87.65 126.27 34.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.354 1.462 . . . . 5.04 109.973 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.1 131.9 37.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.633 0.373 . . . . 5.9100000000000001 111.39 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -139.77 143.14 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.921 1.688 . . . . 2.8399999999999999 109.967 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.35 120.16 41.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.298 1.039 . . . . 3.5899999999999999 110.181 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.01 44.72 1.44 Allowed Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.092 1.197 . . . . 3.6600000000000001 116.092 -160.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -28.73 120.03 0.12 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.063 2.545 . . . . 3.3300000000000001 113.624 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -144.96 154.62 55.11 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 117.654 -1.165 . . . . 5.9800000000000004 110.395 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.17 146.88 82.85 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.03 1.82 . . . . 0.80000000000000004 110.806 164.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.11 154.83 49.99 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.115 1.366 . . . . 1.5900000000000001 110.514 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 -15.41 38.08 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.917 2.411 . . . . 1.1599999999999999 112.917 176.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -175.35 163.92 3.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 3.2999999999999998 111.119 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -113.61 173.6 6.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.613 1.965 . . . . 2.04 109.532 155.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.95 163.95 39.09 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.487 -0.758 . . . . 2.3599999999999999 112.106 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.92 132.53 10.4 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.467 1.107 . . . . 2.4199999999999999 110.019 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.13 163.14 38.91 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.437 2.758 . . . . 1.1799999999999999 111.617 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.61 140.68 76.3 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.974 2.449 . . . . 0.93999999999999995 111.266 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp 69.59 -1.43 2.27 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.649 1.979 . . . . 4.1299999999999999 113.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.44 135.21 12.91 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 127.081 2.277 . . . . 1.1299999999999999 110.987 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -103.71 138.38 40.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.466 1.507 . . . . 5.1399999999999997 110.789 161.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.23 113.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.408 1.883 . . . . 3.29 107.855 165.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -81.74 142.02 33.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.174 0.99 . . . . 3.4300000000000002 110.344 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -71.08 78.83 0.67 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.317 1.056 . . . . 1.8600000000000001 108.924 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -87.92 138.8 30.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 4.7000000000000002 109.986 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.3 -40.38 59.29 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.691 2.927 . . . . 1.0600000000000001 114.159 -165.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.83 78.44 1.95 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.005 -1.638 . . . . 1.1699999999999999 109.005 162.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.27 -88.68 0.1 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.51 1.053 . . . . 0.92000000000000004 112.622 -167.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -151.23 144.34 24.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.741 2.017 . . . . 3.0299999999999998 109.496 -171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -164.65 171.85 13.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.564 0.746 . . . . 0.83999999999999997 110.689 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.42 131.23 55.23 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.92 0.488 . . . . 3.5600000000000001 110.614 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.61 136.99 32.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.269 1.428 . . . . 1.98 110.44 163.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.49 111.2 21.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.12 1.768 . . . . 3.3900000000000001 108.822 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.67 133.44 55.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.8 0.84 . . . . 3.5800000000000001 109.642 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.65 42.53 17.22 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 111.618 -0.593 . . . . 1.79 111.618 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.41 120.49 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.687 1.595 . . . . 3.1299999999999999 113.009 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -86.59 -3.86 59.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.18 -0.918 . . . . 2.5499999999999998 112.884 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -130.57 135.64 27.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 116.704 -1.617 . . . . 5.1399999999999997 108.228 149.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -61.6 139.38 81.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.928 1.752 . . . . 2.3100000000000001 107.841 156.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.71 110.84 18.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.645 1.178 . . . . 3.2000000000000002 110.246 -162.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -90.01 131.07 36.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.686 0.755 . . . . 6.4500000000000002 110.599 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 119.86 6.87 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.123 -0.944 . . . . 2.0699999999999998 109.191 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.04 4.8 57.56 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 117.86 -1.522 . . . . 1.98 115.645 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -85.25 163.92 18.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.31 2.055 . . . . 2.9300000000000002 110.433 160.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -96.86 156.9 16.15 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.853 1.261 . . . . 3.8599999999999999 109.776 163.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.06 124.61 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 124.517 1.127 . . . . 1.8500000000000001 109.152 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -73.87 134.07 43.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.201 1.8 . . . . 3.0499999999999998 108.338 166.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mt -158.86 120.95 3.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.567 1.147 . . . . 2.4199999999999999 113.578 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.06 112.26 25.33 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.092 2.157 . . . . 2.9700000000000002 110.739 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.6 132.86 46.87 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 2.4300000000000002 111.183 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -96.42 133.69 40.52 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.813 0.845 . . . . 1.99 111.219 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -126.64 152.78 46.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.643 1.211 . . . . 3.6299999999999999 112.306 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.93 134.59 57.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.217 -0.901 . . . . 2.1800000000000002 113.142 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.92 46.26 37.97 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 119.12 -0.822 . . . . 3.9100000000000001 114.164 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.55 18.87 61.16 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.993 1.157 . . . . 1.6799999999999999 115.993 166.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.9 143.22 30.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.474 1.637 . . . . 5.0599999999999996 110.463 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -152.23 138.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.948 1.699 . . . . 2.02 108.47 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -144.74 127.72 16.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.768 0.827 . . . . 2.5899999999999999 112.523 -168.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.449 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 13.9 tppt? -71.01 135.96 48.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 3.5699999999999998 111.944 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.66 151.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.523 1.129 . . . . 2.4900000000000002 111.305 171.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.07 134.83 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.044 . . . . 4.75 112.565 -171.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.86 125.8 9.99 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.896 1.278 . . . . 4.96 109.561 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -86.76 159.41 9.05 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.608 2.872 . . . . 1.3899999999999999 110.558 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.42 137.15 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.165 0.986 . . . . 2.1699999999999999 109.971 172.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -140.71 150.4 43.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.131 0.972 . . . . 3.3100000000000001 110.452 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.79 58.83 1.15 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.772 0.829 . . . . 3.5299999999999998 109.998 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.414 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.701 1.2 . . . . 6.5 112.666 -170.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.337 0 N-CA-C 109.636 -1.386 . . . . 14.1 109.636 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -174.58 -166.99 0.28 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.62 2.768 . . . . 10.24 106.751 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -67.72 153.79 42.94 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.483 1.038 . . . . 10.07 111.389 165.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.1 p -139.96 143.98 36.81 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.17 1.788 . . . . 7.29 110.08 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.71 -158.42 0.9 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.93 2.092 . . . . 6.1500000000000004 108.832 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.35 -178.67 15.41 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-N 121.226 1.83 . . . . 1.1899999999999999 116.343 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -160.3 138.06 9.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.218 -0.991 . . . . 1.9399999999999999 111.739 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.99 122.79 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.997 0.904 . . . . 2.4100000000000001 109.029 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -62.08 112.04 2.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.619 1.568 . . . . 4.7300000000000004 112.148 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -70.15 133.48 47.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.461 0.648 . . . . 3.6499999999999999 109.51 150.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.9 m -159.18 146.52 13.06 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.634 1.574 . . . . 2.9399999999999999 109.994 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -86.78 67.68 4.43 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.118 3.212 . . . . 2.6800000000000002 110.836 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -151.87 177.42 29.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.787 0.708 . . . . 1.3400000000000001 114.04 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.33 -10.11 19.04 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.831 3.02 . . . . 1.73 113.205 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -146.27 165.78 28.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.925 1.69 . . . . 2.5299999999999998 112.669 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 153.41 29.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.622 1.169 . . . . 2.2799999999999998 112.165 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.29 118.53 33.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.566 1.146 . . . . 2.6099999999999999 109.694 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.79 156.74 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.87 1.268 . . . . 2.4500000000000002 112.044 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.68 154.57 47.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.028 1.331 . . . . 3.1200000000000001 112.783 -169.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -160.93 157.97 27.35 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.926 1.29 . . . . 2.5 112.649 165.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.9 m -73.27 108.98 6.46 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.326 -0.99 . . . . 2.2400000000000002 108.326 156.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.38 129.2 34.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.07 -1.456 . . . . 4.0099999999999998 107.07 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -126.37 148.23 49.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.183 0.808 . . . . 3.0899999999999999 113.183 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -112.13 110.67 53.66 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.624 1.17 . . . . 1.1499999999999999 109.974 166.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.45 -8.37 8.53 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.045 2.497 . . . . 1.3300000000000001 113.225 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.75 155.95 37.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.434 1.016 . . . . 1.24 112.66 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 4.6 m-20 -88.88 4.67 47.08 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.313 1.845 . . . . 3.0299999999999998 113.296 -175.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.95 160.76 41.52 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.45 1.9 . . . . 2.3300000000000001 110.293 167.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.24 153.75 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.034 2.49 . . . . 1.1499999999999999 111.285 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.9 mt -107.38 153.57 22.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.426 1.09 . . . . 2.79 111.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 68' ' ' GLU . 25.9 ttm180 -130.21 113.08 14.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 3.77 110.218 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.6 105.05 17.08 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 127.701 2.4 . . . . 1.72 108.316 -174.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -94.19 -11.53 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.965 0.906 . . . . 1.8799999999999999 113.032 -172.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.86 -163.85 33.0 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.594 1.092 . . . . 0.48999999999999999 111.608 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.16 -175.11 5.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.26 1.024 . . . . 1.71 110.515 166.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 1.1 mmt85 -160.38 -172.75 3.69 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.893 1.224 . . . . 7.9900000000000002 111.214 -172.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -177.86 156.35 1.1 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 126.443 1.897 . . . . 1.8799999999999999 108.726 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.65 -22.29 73.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.767 2.311 . . . . 1.45 114.371 160.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.06 2.41 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.629 1.714 . . . . 2.6000000000000001 115.629 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.96 167.84 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.566 1.075 . . . . 2.0099999999999998 111.501 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.22 -88.51 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.546 0.738 . . . . 3.25 112.946 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -83.0 141.17 32.29 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.28 -1.008 . . . . 4.9900000000000002 108.28 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -151.82 131.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.196 0.999 . . . . 2.23 109.82 -169.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -145.0 124.45 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.367 1.467 . . . . 2.4900000000000002 110.151 -166.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.422 HD12 ' CE1' ' A' ' 84' ' ' PHE . 7.3 tt -79.38 121.29 24.96 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.066 -1.021 . . . . 1.73 110.816 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -109.19 153.12 24.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.188 1.395 . . . . 1.21 113.01 174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 62' ' ' ARG . 11.9 pt-20 -110.3 -175.51 2.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.765 2.026 . . . . 2.7799999999999998 112.145 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.4 m -147.97 127.68 13.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.12 1.768 . . . . 2.71 108.503 172.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -124.78 153.51 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.326 1.45 . . . . 3.9100000000000001 110.697 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.8 149.26 25.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.198 0.999 . . . . 5.4900000000000002 111.234 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.14 144.17 15.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.933 0.893 . . . . 7.0 111.85 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.421 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -98.38 143.75 28.51 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.467 0.48 . . . . 3.8300000000000001 109.938 162.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.92 131.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.483 1.513 . . . . 4.0199999999999996 108.946 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 59.22 22.54 10.8 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.048 0.939 . . . . 3.4300000000000002 111.801 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.59 56.91 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.4 -1.437 . . . . 2.3900000000000001 114.126 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -93.99 144.2 25.68 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.943 1.697 . . . . 3.8799999999999999 110.561 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 22.3 mtpp -83.63 134.49 34.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.787 0.835 . . . . 4.4699999999999998 110.521 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.57 151.2 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.24 1.816 . . . . 2.6499999999999999 109.864 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.3 mmt -106.17 135.24 48.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.454 1.102 . . . . 5.0700000000000003 110.401 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.15 151.3 17.42 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.763 1.173 . . . . 1.8100000000000001 112.648 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.4 162.46 17.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.351 1.461 . . . . 2.9700000000000002 111.358 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 47' ' ' GLU . 14.8 ptt180 -171.59 159.66 4.87 Favored Pre-proline 0 N--CA 1.477 0.925 0 C-N-CA 126.542 1.937 . . . . 6.6200000000000001 109.761 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -69.52 159.62 52.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.417 1.412 . . . . 1.1200000000000001 111.413 164.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.84 157.1 77.8 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.427 1.491 . . . . 2.04 110.485 168.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.87 -10.84 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.936 2.424 . . . . 1.23 113.139 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.49 160.22 1.24 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.421 1.889 . . . . 3.1600000000000001 111.669 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.61 175.27 5.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.521 1.928 . . . . 1.8600000000000001 109.473 151.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.7 pt-20 -153.18 162.44 41.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.236 -0.915 . . . . 1.8799999999999999 111.102 172.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.79 135.29 10.95 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.645 0.778 . . . . 1.9099999999999999 109.843 -166.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.97 167.02 28.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.774 2.316 . . . . 1.1599999999999999 112.174 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.52 140.48 87.39 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.681 2.921 . . . . 1.0800000000000001 112.655 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 19.8 mmmt 68.12 0.77 2.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.947 2.099 . . . . 3.27 114.309 175.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.3 142.87 15.62 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 127.255 2.359 . . . . 1.22 111.571 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -107.03 157.62 17.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.523 1.529 . . . . 5.8300000000000001 112.889 166.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.37 125.46 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.342 1.857 . . . . 2.3100000000000001 109.656 173.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -83.27 127.93 34.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 4.1799999999999997 111.388 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.86 140.29 43.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.991 1.376 . . . . 2.1800000000000002 109.702 166.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -166.72 146.04 4.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 4.0999999999999996 110.491 -153.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.11 -39.45 18.5 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.133 2.555 . . . . 1.77 112.876 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.96 72.75 2.55 Favored Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.434 -1.466 . . . . 1.2 109.434 164.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.6 -94.8 0.11 Allowed Glycine 0 N--CA 1.469 0.856 0 N-CA-C 114.841 0.697 . . . . 0.98999999999999999 114.841 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -151.37 143.5 23.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.33 1.452 . . . . 2.9900000000000002 110.565 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -166.58 144.85 5.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.083 0.553 . . . . 1.4199999999999999 112.092 -166.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' CE1' HD12 ' A' ' 45' ' ' LEU . 55.6 m-85 -92.65 118.48 31.08 Favored 'General case' 0 CA--C 1.52 -0.178 0 O-C-N 121.651 -0.655 . . . . 3.1400000000000001 109.729 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 mmt -79.68 115.65 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.21 -0.663 . . . . 2.29 109.21 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.0 mt -99.76 125.45 45.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.628 1.571 . . . . 2.4100000000000001 107.946 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.57 120.42 35.76 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.412 1.485 . . . . 3.7000000000000002 107.42 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.57 89.59 0.9 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.349 -1.1 . . . . 1.49 110.349 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.4 mt -89.82 123.04 33.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.153 0.981 . . . . 1.78 109.283 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.68 -11.26 59.97 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.629 -1.295 . . . . 2.75 113.873 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -143.41 161.95 44.73 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.507 2.723 . . . . 7.9500000000000002 108.164 160.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.53 128.6 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 N-CA-C 107.07 -1.935 . . . . 1.75 107.07 147.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.99 155.46 30.75 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.11 -0.7 . . . . 4.0999999999999996 109.11 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.71 125.21 22.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.958 0.885 . . . . 5.0599999999999996 111.883 176.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.17 133.39 15.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.116 0.967 . . . . 2.8799999999999999 112.225 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.64 40.94 4.57 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.037 -0.868 . . . . 2.6099999999999999 113.382 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.6 165.79 29.32 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 126.851 2.06 . . . . 3.0099999999999998 108.271 157.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.73 158.01 16.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.087 1.755 . . . . 3.9900000000000002 111.294 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.5 t -115.66 119.94 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.858 1.263 . . . . 2.02 108.232 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 122.42 16.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.851 -1.166 . . . . 3.1899999999999999 107.851 155.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.08 131.76 54.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.507 1.523 . . . . 3.8700000000000001 107.312 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 51.2 m-20 -111.71 81.58 1.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.154 1.382 . . . . 3.5 110.417 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -66.78 118.72 10.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.336 1.854 . . . . 2.4700000000000002 110.976 -170.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.82 122.39 34.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.258 1.023 . . . . 2.1699999999999999 110.827 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.08 139.49 54.02 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.038 0.923 . . . . 3.21 111.772 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.96 128.77 22.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.1 1.36 . . . . 2.2200000000000002 113.747 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.09 60.87 3.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.236 0.922 . . . . 3.3500000000000001 113.068 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 6.77 88.83 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 116.956 1.543 . . . . 2.6699999999999999 116.956 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.72 137.64 32.75 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.248 2.024 . . . . 5.1399999999999997 110.708 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.32 133.22 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.559 1.144 . . . . 2.9900000000000002 109.214 161.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.2 mt -114.33 109.31 18.16 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.323 1.049 . . . . 2.8199999999999998 109.904 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.73 94.14 1.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 4.7599999999999998 109.278 168.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.68 156.94 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.849 0.86 . . . . 2.8199999999999998 110.065 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -103.46 139.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.482 1.113 . . . . 2.79 109.364 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 mt -142.02 153.35 63.71 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.786 2.035 . . . . 2.52 108.611 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.65 153.16 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.867 2.378 . . . . 1.1599999999999999 112.102 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.5 t -77.95 132.5 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.131 0.972 . . . . 2.4199999999999999 108.486 159.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.44 ' CD ' HH12 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -157.87 151.2 23.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.884 . . . . 3.5 110.837 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.76 115.39 30.05 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.042 1.337 . . . . 3.1600000000000001 111.805 -161.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.44 HH12 ' CD ' ' A' ' 118' ' ' GLU . 7.5 mpt_? . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 129.17 2.988 . . . . 6.6600000000000001 108.037 177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 114' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.725 0 CA-C-O 119.42 -0.655 . . . . 13.43 112.24 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -73.83 32.71 0.08 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.073 1.749 . . . . 12.06 112.436 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 63.46 -10.45 0.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.252 2.221 . . . . 12.02 113.45 -152.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 2' ' ' SER . 12.9 p -60.6 146.67 44.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.157 2.183 . . . . 6.9500000000000002 111.684 166.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.01 126.75 55.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.4 1.88 . . . . 6.0899999999999999 111.795 -165.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.64 169.73 41.39 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.976 2.227 . . . . 2.0 110.493 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -141.99 154.34 44.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.426 0.898 . . . . 2.5 113.426 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.07 126.27 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.366 -0.834 . . . . 2.0499999999999998 109.147 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.06 108.67 12.72 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.23 1.412 . . . . 4.4100000000000001 112.414 -162.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -66.14 122.61 17.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.184 1.394 . . . . 4.1399999999999997 111.321 172.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -165.2 140.01 4.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.702 1.201 . . . . 2.9100000000000001 110.151 167.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.87 71.35 6.4 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.287 3.325 . . . . 2.1299999999999999 109.503 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.26 172.92 19.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.321 0.962 . . . . 1.49 114.443 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.05 -16.1 36.21 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.235 2.623 . . . . 2.0299999999999998 111.68 166.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -144.86 164.78 30.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.571 1.149 . . . . 3.1400000000000001 113.435 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.42 -166.35 1.64 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.375 2.27 . . . . 2.0600000000000001 109.527 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.29 164.07 38.17 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.412 0.893 . . . . 1.76 113.412 -168.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.69 139.64 40.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.677 1.191 . . . . 2.3700000000000001 111.428 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.45 140.57 41.33 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.73 2.012 . . . . 3.8999999999999999 109.236 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.49 153.73 11.38 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.18 1.178 . . . . 3.1899999999999999 114.18 -166.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -78.91 98.08 6.26 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.663 -1.236 . . . . 3.2599999999999998 107.663 157.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.09 133.67 46.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.435 1.894 . . . . 4.3600000000000003 108.589 173.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -105.44 145.28 31.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.194 0.813 . . . . 4.8700000000000001 113.194 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -122.72 110.6 31.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.65 0.78 . . . . 1.4199999999999999 109.507 150.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -91.94 -10.09 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.575 2.85 . . . . 1.54 113.513 170.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.27 33.64 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.795 1.188 . . . . 1.26 112.929 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.477 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 4.5 m-20 -87.26 4.06 44.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.071 1.748 . . . . 3.0699999999999998 113.507 -174.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.32 159.93 41.56 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.067 1.747 . . . . 2.71 110.64 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.38 149.83 21.91 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.812 2.341 . . . . 1.1599999999999999 111.208 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.59 125.83 52.96 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.962 1.305 . . . . 3.4300000000000002 109.163 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -111.25 99.66 8.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.236 1.014 . . . . 3.9199999999999999 109.205 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 tp -80.63 114.3 19.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.999 2.12 . . . . 1.9099999999999999 109.482 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.22 -11.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.507 1.123 . . . . 1.8 113.369 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.5 -166.02 37.72 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.4 1.0 . . . . 0.73999999999999999 111.791 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.15 -179.16 6.95 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.408 1.083 . . . . 1.8899999999999999 109.11 163.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -154.63 147.41 24.37 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.224 1.009 . . . . 6.9100000000000001 108.332 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -146.4 156.4 49.62 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.207 1.003 . . . . 1.76 109.792 -167.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.69 -1.11 10.78 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.166 2.578 . . . . 1.5800000000000001 113.445 166.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 m -101.64 -5.9 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 115.485 1.661 . . . . 2.1299999999999999 115.485 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.54 158.77 41.75 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.818 1.19 . . . . 1.8100000000000001 113.403 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.94 -76.62 0.52 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 3.1000000000000001 110.736 -170.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.99 114.32 19.79 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.08 -1.013 . . . . 4.9900000000000002 108.728 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.52 133.26 65.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 2.2799999999999998 109.255 176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.69 134.97 24.26 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.351 1.06 . . . . 2.2999999999999998 110.884 -170.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.74 120.4 26.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.316 1.055 . . . . 1.8600000000000001 111.04 169.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -107.15 154.58 20.96 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.303 1.841 . . . . 0.80000000000000004 112.152 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.34 -176.77 3.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.123 1.769 . . . . 2.1299999999999999 110.39 167.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -148.07 86.86 1.58 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.915 1.286 . . . . 2.3700000000000001 108.836 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -73.09 166.88 22.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.049 1.34 . . . . 3.3999999999999999 111.967 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -111.07 159.12 18.08 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.301 0.64 . . . . 4.4699999999999998 111.231 161.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -154.98 133.84 12.18 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.828 1.251 . . . . 6.8899999999999997 109.707 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 147.52 47.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.535 0.734 . . . . 3.3999999999999999 109.579 165.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.42 -40.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 115.322 1.601 . . . . 4.2000000000000002 115.322 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.4 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 4.6 tm-20 -115.89 30.98 7.0 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.507 1.923 . . . . 4.4500000000000002 109.699 175.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 -14.25 4.05 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.227 -1.546 . . . . 1.8799999999999999 113.35 -165.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 1.3 mmtp -104.15 160.29 14.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 127.725 2.41 . . . . 5.4699999999999998 110.3 170.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -92.28 146.8 23.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.467 1.655 . . . . 4.21 115.467 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.37 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.731 2.013 . . . . 2.6299999999999999 107.618 165.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -91.82 135.98 33.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.059 1.344 . . . . 4.7400000000000002 110.217 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.47 148.75 20.37 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 124.237 0.922 . . . . 1.6000000000000001 112.812 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -99.3 163.04 12.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.966 1.306 . . . . 2.6299999999999999 112.035 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -170.64 152.08 3.72 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.847 1.659 . . . . 5.7000000000000002 110.813 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.54 150.07 69.1 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.675 1.583 . . . . 0.94999999999999996 111.592 166.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.41 157.58 70.0 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.946 2.099 . . . . 1.9399999999999999 110.188 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.47 -19.47 24.96 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.638 2.225 . . . . 0.98999999999999999 112.996 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.46 166.22 3.93 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.183 1.393 . . . . 3.0499999999999998 111.687 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -118.24 176.14 5.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.767 2.427 . . . . 2.1000000000000001 108.815 156.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.32 165.09 36.84 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.095 -1.003 . . . . 2.02 111.668 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.43 134.15 10.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.68 1.592 . . . . 2.1499999999999999 108.805 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.66 165.97 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.815 2.343 . . . . 0.85999999999999999 111.739 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.56 144.47 97.75 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.557 2.838 . . . . 0.93999999999999995 112.459 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.477 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 20.4 mmmt 68.65 -5.84 0.92 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.19 2.196 . . . . 3.1499999999999999 114.823 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.51 122.22 7.29 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 126.574 2.035 . . . . 1.1899999999999999 111.028 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -88.64 136.6 32.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.015 0.526 . . . . 5.2199999999999998 110.21 157.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.9 173.36 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.904 2.082 . . . . 3.2000000000000002 110.278 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -116.63 111.65 20.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.418 1.008 . . . . 4.2699999999999996 113.639 -161.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.08 76.67 1.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.222 1.009 . . . . 2.52 108.436 156.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.51 155.19 76.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.044 0.938 . . . . 3.5299999999999998 112.427 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.51 -58.37 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.11 2.54 . . . . 1.1100000000000001 112.524 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.63 74.8 2.39 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.598 -1.001 . . . . 1.49 110.598 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.84 -75.84 0.08 OUTLIER Glycine 0 N--CA 1.469 0.835 0 C-N-CA 124.998 1.285 . . . . 1.1100000000000001 114.069 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -156.18 138.13 14.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.772 1.629 . . . . 3.79 109.926 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -168.61 164.0 12.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.654 1.57 . . . . 0.93000000000000005 111.282 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.41 129.55 41.11 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 110.429 -0.211 . . . . 3.5600000000000001 110.429 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.5 mmt -87.58 135.9 33.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.262 1.025 . . . . 1.8500000000000001 110.351 165.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.58 114.79 26.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.445 1.498 . . . . 2.8700000000000001 108.262 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.8 123.7 48.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.657 1.983 . . . . 3.8700000000000001 108.417 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.55 100.74 0.15 Allowed Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.55 -1.02 . . . . 1.49 110.55 -174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.65 120.03 36.23 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.93 0.865 . . . . 1.76 111.07 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.38 -11.68 61.02 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.204 1.402 . . . . 3.1600000000000001 113.924 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -167.09 155.52 9.08 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 126.744 2.018 . . . . 6.1399999999999997 110.235 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.4 140.52 82.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.801 1.667 . . . . 2.5299999999999998 109.318 163.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 mt -84.3 89.96 7.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.535 1.134 . . . . 3.6299999999999999 109.585 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 108.04 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.535 1.134 . . . . 5.8200000000000003 110.302 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.0 113.1 0.91 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.021 0.528 . . . . 2.1400000000000001 110.842 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.78 3.11 30.4 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 116.76 -2.133 . . . . 2.5699999999999998 116.655 -173.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.92 171.76 14.51 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.341 2.571 . . . . 4.7599999999999998 110.102 152.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -103.3 135.02 45.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.713 -1.217 . . . . 6.4900000000000002 107.713 145.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.24 125.92 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 124.221 1.009 . . . . 2.1299999999999999 108.724 168.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 136.33 56.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.688 0.756 . . . . 3.3999999999999999 110.233 162.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -147.58 124.81 11.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 123.29 1.519 . . . . 2.75 111.77 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.47 83.85 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 127.554 2.341 . . . . 2.5800000000000001 109.491 -167.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.27 120.05 12.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.585 1.154 . . . . 2.1200000000000001 110.279 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.5 mt -97.57 130.34 44.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.646 1.579 . . . . 2.0899999999999999 110.709 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -134.15 129.3 35.65 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.414 -0.804 . . . . 3.1499999999999999 111.133 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 43.36 34.25 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.844 1.657 . . . . 2.8900000000000001 113.478 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.23 -76.59 1.93 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.175 1.369 . . . . 4.4800000000000004 111.39 -167.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.773 1.069 . . . . 2.6600000000000001 115.773 -160.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.17 93.39 5.2 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.016 1.908 . . . . 8.1999999999999993 110.267 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.84 128.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 125.568 1.547 . . . . 2.3100000000000001 108.405 167.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.63 179.78 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.033 1.333 . . . . 4.54 110.456 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -134.41 119.73 18.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.251 1.02 . . . . 3.3500000000000001 108.4 154.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.42 168.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.907 -1.516 . . . . 3.98 106.907 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.404 ' O ' ' HA2' ' A' ' 1' ' ' GLY . 5.0 m -125.65 144.3 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.35 1.86 . . . . 3.6200000000000001 108.922 172.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.4 mt -143.39 141.47 19.25 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.558 1.143 . . . . 3.27 111.482 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.1 144.86 99.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.937 3.092 . . . . 1.6100000000000001 113.793 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.08 125.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.334 -0.988 . . . . 2.3900000000000001 108.334 168.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.77 161.79 42.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.989 0.916 . . . . 3.21 110.463 -168.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.52 5.85 34.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.559 1.318 . . . . 2.5099999999999998 114.559 -156.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.188 1.795 . . . . 6.1399999999999997 111.373 -178.105 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.484 ' H2 ' ' CD ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 107.38 -2.288 . . . . 11.630000000000001 107.38 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 m -60.49 177.02 0.31 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 119.426 -0.91 . . . . 11.34 110.743 136.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -72.73 102.56 3.38 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.119 -0.988 . . . . 12.51 109.677 167.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.7 p -143.88 170.44 15.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.137 2.175 . . . . 8.3100000000000005 109.241 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -89.59 -157.55 0.46 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.987 2.115 . . . . 5.2300000000000004 111.961 167.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -124.11 153.99 17.63 Favored Glycine 0 N--CA 1.469 0.847 0 C-N-CA 128.566 2.984 . . . . 1.21 111.414 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -134.64 130.91 37.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.726 1.263 . . . . 1.51 113.778 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.1 t -87.61 125.62 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.274 -0.891 . . . . 2.3100000000000001 109.604 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.71 114.62 8.98 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.766 0.827 . . . . 4.5700000000000003 112.984 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.5 143.67 30.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.657 0.741 . . . . 3.9300000000000002 110.256 149.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.2 169.87 2.14 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 129.589 3.156 . . . . 4.1799999999999997 106.787 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.97 33.81 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.428 2.752 . . . . 3.54 113.826 -170.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.45 150.55 17.28 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.621 1.105 . . . . 2.1699999999999999 114.513 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.43 -14.84 20.1 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.918 3.079 . . . . 2.0699999999999998 112.105 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -134.45 157.76 45.63 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.72 2.008 . . . . 2.4199999999999999 111.374 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.49 168.95 22.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.536 1.135 . . . . 2.6200000000000001 112.763 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.22 122.35 42.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.977 1.311 . . . . 2.4199999999999999 109.487 166.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.6 119.26 28.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.361 -0.607 . . . . 2.1499999999999999 109.361 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -95.33 141.07 29.34 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.59 1.156 . . . . 3.6299999999999999 108.876 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.432 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 4.1 pp -158.14 156.1 30.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.106 1.15 . . . . 3.2200000000000002 114.106 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.6 m -112.31 105.86 14.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.722 1.209 . . . . 2.6299999999999999 108.688 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tt -101.89 144.16 30.87 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.032 1.333 . . . . 3.7200000000000002 109.303 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -145.88 141.51 27.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.332 0.587 . . . . 3.46 112.119 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -104.53 106.38 54.13 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.928 -1.033 . . . . 1.3500000000000001 110.242 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 -12.18 13.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.506 2.137 . . . . 1.6499999999999999 113.432 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.62 172.56 54.51 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 119.166 0.894 . . . . 1.3400000000000001 113.065 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.0 m-20 -96.0 -4.26 43.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.046 1.738 . . . . 2.9900000000000002 112.492 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 155.54 44.99 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.634 1.974 . . . . 6.0 108.568 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.61 158.92 25.29 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.094 2.529 . . . . 1.4399999999999999 111.447 -171.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.45 154.05 20.86 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.315 1.046 . . . . 3.0 109.974 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -134.27 110.35 9.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.181 1.392 . . . . 4.0700000000000003 109.086 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.4 tp -88.92 124.35 34.15 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.715 2.006 . . . . 1.8200000000000001 109.246 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.53 -6.11 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.08 1.141 . . . . 1.8200000000000001 114.08 -170.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.21 -165.67 37.91 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 118.88 0.764 . . . . 0.83999999999999997 112.463 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.06 177.16 11.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.202 -0.904 . . . . 2.4199999999999999 112.433 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.29 134.43 0.89 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.065 0.848 . . . . 6.5599999999999996 112.732 162.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -129.92 157.29 77.31 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 126.53 1.932 . . . . 1.97 110.124 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.15 -23.38 66.78 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.863 2.376 . . . . 1.3500000000000001 114.84 165.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -87.95 -0.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 114.729 1.381 . . . . 2.1099999999999999 114.729 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.31 163.97 31.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.67 1.188 . . . . 1.71 111.92 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -96.11 -94.36 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.109 1.364 . . . . 3.23 109.224 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 128.87 38.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.456 -0.778 . . . . 5.6399999999999997 110.025 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -131.09 133.02 63.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.002 1.321 . . . . 2.02 110.166 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.22 136.13 33.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.228 1.411 . . . . 2.96 110.64 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.04 121.39 26.48 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.093 -1.004 . . . . 1.72 111.082 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -108.5 156.0 19.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.503 1.521 . . . . 0.87 112.414 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -101.54 179.74 4.26 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.245 -0.889 . . . . 3.0099999999999998 110.761 160.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -147.52 104.59 3.64 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.038 -1.097 . . . . 2.2999999999999998 108.038 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -122.94 155.58 36.45 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.747 1.619 . . . . 3.6099999999999999 112.899 -156.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.3 mtm -82.91 143.95 30.38 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.368 0.667 . . . . 3.52 111.127 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -167.16 129.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.063 1.345 . . . . 10.67 111.3 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.1 175.54 7.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.522 1.129 . . . . 4.2999999999999998 111.436 -171.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 133.53 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.837 1.655 . . . . 4.8700000000000001 108.751 162.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 65.71 10.7 6.98 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.174 0.99 . . . . 4.2000000000000002 112.403 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.24 87.66 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 120.898 -1.126 . . . . 2.0099999999999998 114.089 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -96.88 142.13 29.23 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.074 1.75 . . . . 3.6099999999999999 109.699 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -75.13 131.62 40.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.282 1.433 . . . . 5.1699999999999999 113.139 -165.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 59' ' ' MET . 0.1 OUTLIER -150.71 -173.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.307 1.043 . . . . 2.8799999999999999 111.293 176.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.412 ' H ' HG12 ' A' ' 58' ' ' VAL . 2.4 ptp -146.68 -177.17 5.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.594 1.958 . . . . 4.7199999999999998 112.695 -177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.75 172.88 43.87 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.333 1.444 . . . . 1.0700000000000001 112.935 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -114.3 156.98 23.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.561 1.544 . . . . 2.71 109.416 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -166.32 144.39 4.55 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.052 1.341 . . . . 7.3600000000000003 110.068 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -66.31 147.66 83.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.012 1.808 . . . . 0.93999999999999995 110.414 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.08 156.83 52.0 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.544 1.538 . . . . 1.98 109.554 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.52 -22.05 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.041 1.827 . . . . 0.89000000000000001 112.334 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -173.93 165.13 4.29 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 124.482 1.113 . . . . 3.8900000000000001 111.814 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.48 175.34 5.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.422 2.289 . . . . 2.4900000000000002 109.108 158.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.73 168.66 26.74 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.666 -1.271 . . . . 2.1699999999999999 111.737 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -149.26 132.74 8.45 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.722 0.809 . . . . 2.1899999999999999 110.161 -168.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.0 164.36 34.63 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.372 2.048 . . . . 1.49 111.799 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.97 140.22 78.01 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.861 3.041 . . . . 1.52 112.188 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 63.9 mmtt 70.14 0.56 3.18 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.972 2.109 . . . . 2.8500000000000001 113.871 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.06 125.1 7.94 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 126.783 2.135 . . . . 1.6100000000000001 111.165 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 148.0 23.88 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.914 -0.643 . . . . 5.5899999999999999 112.357 154.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.73 162.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.456 1.902 . . . . 2.5 109.35 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' CD ' ' H2 ' ' A' ' 1' ' ' GLY . 1.6 mp0 -119.13 139.91 51.0 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.821 0.82 . . . . 3.02 112.47 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.36 71.7 1.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.592 1.157 . . . . 2.04 108.238 155.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -80.1 142.55 55.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.104 1.761 . . . . 4.9100000000000001 110.549 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.13 -58.82 1.52 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.969 3.779 . . . . 1.04 114.323 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.27 52.85 4.37 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 119.009 0.822 . . . . 1.21 112.067 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.28 -82.89 0.05 OUTLIER Glycine 0 N--CA 1.466 0.645 0 C-N-CA 127.627 2.537 . . . . 1.0600000000000001 111.699 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -151.27 149.78 29.79 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.005 2.122 . . . . 3.8100000000000001 108.967 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -169.25 165.22 10.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.163 0.892 . . . . 0.93000000000000005 111.292 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -103.13 118.76 37.52 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.89 0.476 . . . . 3.46 110.226 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.6 mmt -77.69 104.66 8.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 2.04 110.11 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.44 127.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.048 1.339 . . . . 2.5099999999999998 108.709 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.98 117.35 19.08 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.485 1.114 . . . . 4.0499999999999998 109.23 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.91 75.04 1.21 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.312 -1.115 . . . . 1.3200000000000001 110.312 -168.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.85 129.8 40.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.434 -0.58 . . . . 2.2799999999999998 109.434 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -80.98 7.71 10.11 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.954 1.094 . . . . 2.5899999999999999 113.954 -170.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 176.26 153.32 0.36 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.988 2.515 . . . . 5.5999999999999996 109.65 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.79 144.13 76.35 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 108.14 -1.523 . . . . 1.8700000000000001 108.14 159.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.26 152.7 18.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.946 0.898 . . . . 3.5499999999999998 109.093 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -117.01 135.05 54.0 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.863 0.865 . . . . 7.0 109.74 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 119.02 6.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.745 -1.222 . . . . 2.77 110.966 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.64 39.51 34.41 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.639 -0.663 . . . . 2.0299999999999998 113.095 -168.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -91.03 -169.88 2.49 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.083 -1.08 . . . . 2.6499999999999999 108.083 140.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.82 142.05 29.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.157 1.383 . . . . 4.0599999999999996 109.844 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.61 102.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.276 1.43 . . . . 1.98 109.461 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.442 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 3.6 mm-40 -55.52 130.6 43.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.516 -1.22 . . . . 3.1499999999999999 109.743 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.2 tt -156.34 131.67 9.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.369 1.08 . . . . 3.0899999999999999 111.171 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.77 93.9 8.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.582 2.353 . . . . 2.2799999999999998 110.454 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.83 123.07 19.97 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.402 -0.962 . . . . 2.4300000000000002 108.402 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.75 128.81 45.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.78 1.232 . . . . 1.8500000000000001 110.006 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -129.09 119.2 23.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.279 0.844 . . . . 3.3199999999999998 113.279 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 23.12 44.98 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.2 3.0 . . . . 2.0499999999999998 115.911 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.39 -56.07 1.57 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.616 1.579 . . . . 3.1299999999999999 113.382 -171.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.89 0.14 58.53 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.685 -1.619 . . . . 2.0600000000000001 116.909 -164.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 150.21 45.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.15 1.975 . . . . 4.6100000000000003 111.421 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.03 139.54 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.046 1.738 . . . . 2.2799999999999998 109.091 165.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.95 104.51 7.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.433 1.093 . . . . 2.6800000000000002 110.015 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.442 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 8.9 ttpp -72.6 88.81 1.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.07 1.348 . . . . 3.9300000000000002 110.213 172.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.3 m -114.23 140.25 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.142 1.377 . . . . 3.6200000000000001 111.166 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -100.73 133.18 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.968 1.707 . . . . 3.2000000000000002 110.92 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.64 149.91 73.37 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.861 1.265 . . . . 3.6800000000000002 111.28 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.12 151.79 83.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.941 2.427 . . . . 1.4299999999999999 113.389 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.9 t -83.43 134.8 26.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.135 1.374 . . . . 2.3300000000000001 109.087 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -137.36 157.73 45.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.102 0.961 . . . . 3.4199999999999999 109.936 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.16 112.87 25.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.91 0.884 . . . . 3.3799999999999999 111.049 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.074 1.35 . . . . 6.3899999999999997 111.317 174.41 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 107.482 -2.247 . . . . 9.8000000000000007 107.482 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.92 -176.0 5.73 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.981 0.512 . . . . 9.6099999999999994 111.233 -153.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -74.9 59.35 0.9 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.565 1.146 . . . . 13.08 111.268 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.3 m 87.27 144.46 0.05 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 130.594 3.558 . . . . 7.4100000000000001 108.777 -167.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -92.45 104.2 16.55 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.903 -0.777 . . . . 5.5599999999999996 108.903 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.69 44.25 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 115.601 1.0 . . . . 1.48 115.601 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -153.15 150.47 29.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.651 1.98 . . . . 1.55 111.44 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -114.41 134.89 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.799 -0.815 . . . . 2.2999999999999998 108.799 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -73.75 126.7 30.94 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.086 0.773 . . . . 4.8899999999999997 113.086 -167.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -74.66 128.75 36.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.133 0.968 . . . . 4.3700000000000001 111.004 157.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -159.35 138.14 7.93 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.281 1.432 . . . . 2.9700000000000002 110.199 164.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -83.42 73.27 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 124.159 3.24 . . . . 2.6400000000000001 109.658 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.58 176.91 24.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.147 0.88 . . . . 1.4299999999999999 114.068 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.32 -4.64 15.31 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.26 3.307 . . . . 2.4399999999999999 112.934 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -140.67 164.27 30.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.518 1.127 . . . . 3.6099999999999999 112.657 170.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.36 165.26 33.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.23 1.812 . . . . 2.02 110.227 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.73 154.79 20.99 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.66 0.784 . . . . 2.1699999999999999 111.735 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.15 136.94 54.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.693 0.797 . . . . 2.0800000000000001 111.89 164.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -133.15 128.72 36.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.522 1.529 . . . . 3.27 110.922 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -166.08 159.19 15.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.709 1.374 . . . . 3.1000000000000001 114.709 -167.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -80.33 140.68 36.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.088 0.955 . . . . 2.3599999999999999 109.793 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.24 126.1 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.173 1.389 . . . . 3.3199999999999998 107.759 170.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -151.9 148.42 27.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.216 0.607 . . . . 4.1799999999999997 112.235 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -109.87 109.65 59.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.45 1.1 . . . . 1.1000000000000001 111.842 -164.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.39 -11.12 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.35 2.033 . . . . 1.22 113.466 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.11 53.74 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.227 1.394 . . . . 1.1399999999999999 114.251 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.4 -36.03 63.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.144 2.178 . . . . 6.1299999999999999 112.626 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -102.39 163.42 17.7 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.479 1.911 . . . . 2.9500000000000002 111.531 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.07 159.02 23.81 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.001 2.467 . . . . 1.1200000000000001 112.371 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.2 mt -103.3 145.54 29.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.695 1.198 . . . . 3.1499999999999999 110.423 171.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 68' ' ' GLU . 21.4 ttm180 -129.78 105.31 7.94 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.832 1.253 . . . . 4.71 108.24 167.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.3 tp -79.87 104.77 10.67 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.961 2.104 . . . . 1.71 108.352 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -95.45 -14.92 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.916 0.886 . . . . 1.8100000000000001 112.412 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.41 -163.8 33.89 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 123.775 0.702 . . . . 0.52000000000000002 112.735 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.4 177.5 9.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.147 0.979 . . . . 2.1600000000000001 110.924 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -146.44 124.19 11.89 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.034 -1.469 . . . . 7.6299999999999999 107.034 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -142.34 149.83 52.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 117.688 -1.149 . . . . 1.99 110.087 -170.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.32 -3.34 12.98 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.517 2.145 . . . . 1.0600000000000001 113.463 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.46 -4.91 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 115.641 1.719 . . . . 2.1299999999999999 115.641 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.16 144.52 50.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.681 1.192 . . . . 2.0899999999999999 110.943 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -84.08 -75.99 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.679 -0.86 . . . . 3.6600000000000001 108.679 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -91.29 126.72 36.46 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.386 -0.821 . . . . 4.8600000000000003 108.789 165.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.26 138.38 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.442 1.497 . . . . 2.1000000000000001 109.916 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -136.65 136.78 39.41 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.424 1.889 . . . . 2.3100000000000001 109.358 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.63 124.66 33.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 121.154 1.797 . . . . 1.8200000000000001 111.073 165.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -108.03 153.36 23.22 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.709 1.604 . . . . 0.89000000000000001 113.617 174.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.25 -179.42 3.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.572 2.749 . . . . 2.29 110.758 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.4 m -128.98 107.99 10.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.117 -1.438 . . . . 2.0600000000000001 107.117 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -91.23 161.76 14.92 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 122.013 0.911 . . . . 3.3199999999999998 111.686 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.5 mtm -118.67 168.01 11.12 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.09 -0.959 . . . . 4.25 110.902 156.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -176.53 163.63 2.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.335 2.654 . . . . 7.2400000000000002 109.7 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.09 147.51 22.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.586 -0.894 . . . . 3.73 108.586 165.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 p -114.24 -15.52 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 113.858 1.059 . . . . 3.8700000000000001 113.858 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.89 25.84 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.424 2.29 . . . . 4.1299999999999999 109.046 -162.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.69 -20.98 1.64 Allowed Glycine 0 N--CA 1.477 1.375 0 O-C-N 119.392 -2.067 . . . . 2.1699999999999999 113.183 -159.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.8 135.24 35.47 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.655 1.582 . . . . 5.0099999999999998 109.882 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -76.19 138.62 40.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.298 1.039 . . . . 5.29 111.855 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -134.27 150.49 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.415 2.286 . . . . 3.0 108.97 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.9 ttp -123.46 144.25 49.63 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.557 1.943 . . . . 6.1100000000000003 109.505 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.96 163.8 31.53 Favored Glycine 0 N--CA 1.469 0.838 0 CA-C-N 118.724 0.693 . . . . 1.04 113.236 173.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.68 159.88 14.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.33 1.052 . . . . 2.4500000000000002 111.281 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 -173.21 140.33 0.89 Allowed Pre-proline 0 N--CA 1.475 0.776 0 CA-C-O 116.954 -1.498 . . . . 5.29 111.402 -168.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -71.09 147.49 54.48 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.927 1.751 . . . . 0.94999999999999996 112.559 170.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.61 151.4 67.41 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.415 1.486 . . . . 1.8200000000000001 110.48 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.34 -8.82 24.18 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.055 2.503 . . . . 1.05 113.447 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -174.6 159.21 2.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.765 1.626 . . . . 3.96 111.097 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mt -108.85 172.8 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.31 1.444 . . . . 1.8899999999999999 108.98 149.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 31' ' ' ARG . 13.1 pt-20 -158.34 163.36 37.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.231 -0.918 . . . . 2.79 112.604 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -151.15 131.34 7.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.134 0.974 . . . . 2.1400000000000001 109.806 -168.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 164.49 35.53 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.296 1.998 . . . . 1.1599999999999999 111.291 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.87 133.04 42.54 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.306 2.671 . . . . 1.05 110.61 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 72.06 0.34 3.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 127.489 2.316 . . . . 2.7000000000000002 113.788 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.67 157.5 34.37 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 126.545 2.021 . . . . 1.3200000000000001 111.031 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -132.54 144.36 50.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 127.346 2.258 . . . . 5.3099999999999996 110.418 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.84 163.94 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.676 1.991 . . . . 2.8500000000000001 108.762 167.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -139.1 115.02 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.921 -0.77 . . . . 3.1899999999999999 108.921 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.37 91.17 1.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.576 . . . . 2.1099999999999999 108.781 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -110.1 151.23 42.39 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.525 2.33 . . . . 3.8999999999999999 111.784 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.04 -53.89 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.274 3.316 . . . . 1.1299999999999999 113.949 -168.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.93 93.71 1.77 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 108.413 -1.875 . . . . 1.29 108.413 164.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -85.0 0.14 Allowed Glycine 0 C--O 1.222 -0.614 0 C-N-CA 124.794 1.188 . . . . 1.0 112.698 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -155.95 145.87 21.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.579 1.952 . . . . 3.9100000000000001 110.09 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -174.09 157.49 2.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.088 0.955 . . . . 1.74 108.823 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -85.68 139.17 31.6 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 119.813 -0.755 . . . . 3.2799999999999998 109.893 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 mmt -92.42 118.94 31.46 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.419 1.087 . . . . 1.78 109.021 161.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.7 mt -100.05 114.86 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.943 1.697 . . . . 2.73 106.793 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.5 150.78 26.96 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.365 1.066 . . . . 3.96 110.741 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.19 -55.49 4.59 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 125.235 1.398 . . . . 3.6899999999999999 111.761 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt 69.9 125.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.775 3.23 . . . . 2.25 111.581 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -80.9 22.99 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.263 -1.523 . . . . 2.6499999999999999 113.074 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 160.6 153.41 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 129.816 3.246 . . . . 4.7599999999999998 109.219 -163.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.52 131.87 31.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.234 -1.871 . . . . 1.6000000000000001 107.234 151.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.1 101.52 0.41 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.928 0.891 . . . . 3.0600000000000001 110.18 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.84 97.3 1.38 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.729 -1.232 . . . . 4.7699999999999996 109.843 -172.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -44.64 124.63 4.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.123 0.969 . . . . 2.6299999999999999 111.3 172.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.5 30.46 66.65 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.013 -0.882 . . . . 1.97 114.165 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -101.45 -172.08 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.599 1.699 . . . . 3.5800000000000001 107.519 136.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -132.21 151.36 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.832 0.853 . . . . 3.5899999999999999 110.525 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.0 t -98.89 113.86 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 124.85 1.26 . . . . 2.0699999999999998 108.916 -172.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.65 138.39 46.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 124.249 0.968 . . . . 3.7599999999999998 109.441 164.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mt -155.3 116.17 3.91 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.088 0.955 . . . . 2.7599999999999998 111.091 -168.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.31 104.63 16.59 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.016 2.126 . . . . 2.8199999999999998 109.468 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 48.0 mt -75.89 126.34 30.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 2.1200000000000001 110.194 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.0 mt -97.51 121.41 39.38 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.354 1.062 . . . . 1.8799999999999999 110.638 -175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.99 119.32 31.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.856 0.836 . . . . 3.48 112.732 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.1 28.23 0.9 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.01 2.124 . . . . 2.5899999999999999 114.208 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.99 -60.07 2.2 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.707 1.622 . . . . 3.54 112.692 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.87 -7.5 86.35 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.26 1.264 . . . . 1.6799999999999999 116.26 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.39 145.38 43.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.214 2.007 . . . . 5.1500000000000004 110.194 166.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -147.68 135.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.021 1.328 . . . . 1.8999999999999999 108.829 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -144.17 127.8 17.11 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.324 1.45 . . . . 3.0 108.756 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -91.01 147.18 23.26 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.421 1.637 . . . . 3.8599999999999999 115.421 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.29 164.66 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.965 2.506 . . . . 1.99 109.466 171.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.5 132.83 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.104 0.962 . . . . 3.0600000000000001 109.181 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -145.14 145.28 26.35 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.967 1.707 . . . . 3.4199999999999999 109.537 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 153.35 67.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.372 3.381 . . . . 1.1499999999999999 114.431 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.62 127.17 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.056 0.942 . . . . 1.8600000000000001 109.007 167.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -147.25 153.85 40.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.315 1.446 . . . . 3.4700000000000002 111.351 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.21 47.56 0.96 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.347 1.459 . . . . 2.48 114.155 -161.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.934 -1.508 . . . . 7.0 112.46 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' H2 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.473 1.135 0 N-CA-C 108.204 -1.958 . . . . 11.800000000000001 108.204 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t 69.97 148.59 0.07 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.171 -0.677 . . . . 11.99 109.171 -137.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 63.08 13.4 6.75 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.551 1.14 . . . . 12.09 113.463 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.5 p -140.14 133.39 29.76 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 128.654 2.781 . . . . 7.2999999999999998 108.072 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -96.97 137.4 36.11 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.915 1.45 . . . . 6.9199999999999999 114.915 -153.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.34 46.8 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.694 2.093 . . . . 1.6599999999999999 111.683 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.21 152.7 11.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.237 1.199 . . . . 1.6299999999999999 114.237 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.45 128.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.163 1.385 . . . . 2.73 109.12 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.2 117.74 29.88 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.748 0.647 . . . . 5.7599999999999998 112.748 -166.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.5 142.13 58.53 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.244 2.218 . . . . 6.0 113.865 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -159.13 167.61 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 120.109 -1.62 . . . . 2.6699999999999999 111.448 158.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.29 -15.68 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.121 3.214 . . . . 3.1499999999999999 112.453 166.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 155.14 40.42 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 119.29 -0.728 . . . . 1.5600000000000001 112.042 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.37 -8.7 23.89 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.075 3.183 . . . . 2.29 114.373 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.87 146.97 35.55 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.005 1.322 . . . . 3.2799999999999998 111.676 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.91 -176.03 5.74 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.072 1.749 . . . . 2.5299999999999998 112.952 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.0 154.85 50.29 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.449 1.1 . . . . 2.2999999999999998 111.831 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.18 147.88 44.28 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.265 1.031 . . . . 1.9399999999999999 111.637 166.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.1 146.52 39.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.128 1.771 . . . . 3.1400000000000001 108.753 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.1 153.79 14.33 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.926 0.713 . . . . 3.0099999999999998 112.926 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.1 m -72.57 110.61 7.07 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.629 1.572 . . . . 2.1299999999999999 108.259 159.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.07 127.81 34.14 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.159 -1.423 . . . . 3.6800000000000002 107.159 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' CD ' ' H2 ' ' A' ' 1' ' ' GLY . 14.7 pt-20 -123.68 114.49 20.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 4.4100000000000001 110.522 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -102.66 103.68 33.92 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.141 -0.974 . . . . 0.94999999999999996 110.686 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.13 -7.92 11.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.91 2.407 . . . . 1.1799999999999999 113.236 172.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.14 171.18 55.19 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 119.109 0.868 . . . . 0.98999999999999999 113.7 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 17.5 m-20 -101.57 0.16 35.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.367 1.867 . . . . 2.7000000000000002 113.032 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.96 159.06 39.06 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.723 1.609 . . . . 2.7599999999999998 110.451 167.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.23 154.37 18.95 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.043 2.495 . . . . 1.1399999999999999 111.142 -173.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -101.65 150.63 22.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.258 1.023 . . . . 3.5899999999999999 110.482 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 68' ' ' GLU . 31.8 ttm180 -133.7 103.06 5.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.526 1.131 . . . . 4.0899999999999999 109.409 171.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 tp -84.14 104.83 14.52 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.366 2.267 . . . . 1.9199999999999999 108.97 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.64 -12.93 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.154 0.982 . . . . 1.8999999999999999 113.001 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.26 -169.35 41.89 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 124.448 1.023 . . . . 0.63 111.76 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.17 -178.39 7.26 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.113 0.965 . . . . 2.0800000000000001 111.508 173.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -158.32 149.92 21.27 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 121.509 1.959 . . . . 8.0299999999999994 109.126 -175.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -154.28 152.13 25.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.019 1.327 . . . . 2.29 108.243 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.87 -25.14 60.35 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.661 2.241 . . . . 0.90000000000000002 113.418 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -79.59 -4.18 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.889 1.44 . . . . 1.9299999999999999 114.889 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.38 174.56 12.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.948 1.299 . . . . 2.1800000000000002 112.476 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -116.56 -87.97 0.6 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.84 0.856 . . . . 4.3200000000000003 110.17 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -69.35 107.05 3.14 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.511 -0.743 . . . . 5.75 109.71 -171.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -84.16 141.29 14.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.227 2.211 . . . . 3.04 110.571 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -146.72 124.2 11.7 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 2.71 109.999 166.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -81.84 115.36 21.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.184 0.993 . . . . 2.0800000000000001 110.326 169.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -100.23 151.69 21.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.737 1.615 . . . . 0.89000000000000001 111.881 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.8 177.82 5.65 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.038 -1.437 . . . . 1.99 110.689 165.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.541 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 87.5 m -147.94 102.76 3.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.24 1.416 . . . . 1.8500000000000001 107.195 171.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -112.76 153.07 28.35 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.817 1.247 . . . . 3.8900000000000001 112.523 -166.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -105.5 121.72 44.52 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.487 0.66 . . . . 4.2599999999999998 109.598 156.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -144.91 170.01 16.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.311 1.844 . . . . 8.7400000000000002 109.107 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.25 143.95 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.351 0.66 . . . . 4.2699999999999996 109.927 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.12 -87.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 4.3700000000000001 108.408 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -77.4 50.99 0.83 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.436 1.895 . . . . 2.9700000000000002 110.404 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.1 -31.93 0.42 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 126.601 2.048 . . . . 3.48 115.077 -175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.82 146.63 24.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.584 1.953 . . . . 3.48 111.37 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -68.44 118.76 11.92 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 118.845 -0.598 . . . . 5.7800000000000002 109.47 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.83 147.78 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 4.6900000000000004 111.305 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.4 mmt -77.79 141.03 39.47 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.982 1.313 . . . . 4.25 113.671 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.56 27.81 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.058 0.837 . . . . 1.25 114.13 170.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -114.63 137.42 51.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.604 1.562 . . . . 2.23 110.346 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -148.21 155.71 43.14 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.913 1.285 . . . . 7.9699999999999998 109.955 165.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.52 145.63 82.87 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.073 2.515 . . . . 0.78000000000000003 110.953 167.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.83 159.06 33.13 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 125.338 1.455 . . . . 1.8100000000000001 109.855 166.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.0 -15.14 32.48 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.625 2.217 . . . . 0.78000000000000003 113.243 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -175.74 160.77 2.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.042 1.737 . . . . 3.5800000000000001 111.02 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mt -109.87 175.94 5.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.827 1.651 . . . . 2.1699999999999999 109.517 154.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.9 pt-20 -153.52 168.26 26.75 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.363 -0.835 . . . . 2.4199999999999999 112.116 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -149.82 136.46 10.83 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.442 1.097 . . . . 2.1099999999999999 109.527 -170.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -72.25 168.0 25.33 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.405 2.07 . . . . 0.92000000000000004 112.048 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.54 145.28 99.06 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.789 2.993 . . . . 0.95999999999999996 111.915 168.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.524 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 61.24 0.9 0.46 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.865 2.172 . . . . 3.0099999999999998 116.865 -172.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 114.03 3.79 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 127.147 2.308 . . . . 0.87 111.95 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -81.9 139.26 34.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.997 -1.101 . . . . 6.1600000000000001 109.243 151.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 m -151.36 130.51 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.657 1.583 . . . . 2.9500000000000002 110.084 169.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -90.41 130.39 36.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.629 -0.669 . . . . 3.3100000000000001 111.407 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -69.81 129.17 38.84 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.364 -0.976 . . . . 2.0899999999999999 108.364 161.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -143.28 140.73 18.05 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.576 1.55 . . . . 3.75 110.865 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.7 -16.75 47.08 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.702 2.935 . . . . 1.8100000000000001 114.278 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.98 100.0 1.79 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.24 -1.944 . . . . 1.3799999999999999 108.24 152.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 142.66 -85.33 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.847 1.689 . . . . 1.77 113.089 -172.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.71 144.2 20.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.067 1.747 . . . . 3.0499999999999998 111.22 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.92 158.02 27.47 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.256 -0.903 . . . . 1.1899999999999999 110.74 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -94.28 133.05 38.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.074 0.397 . . . . 3.1699999999999999 110.814 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.2 mmt -90.62 137.18 32.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.394 1.478 . . . . 1.6100000000000001 109.906 162.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.82 126.58 45.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.503 1.521 . . . . 4.1299999999999999 108.653 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.42 147.49 52.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.233 1.413 . . . . 4.0899999999999999 110.526 -175.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 57.95 4.6 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.236 -0.746 . . . . 1.3799999999999999 111.236 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.09 120.51 12.81 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.48 0.64 . . . . 2.02 110.938 -174.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -76.23 -9.78 58.9 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.873 1.064 . . . . 3.2200000000000002 113.873 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.98 145.08 0.74 Allowed Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 127.065 2.146 . . . . 5.6500000000000004 110.152 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.37 154.15 65.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.906 2.404 . . . . 2.1299999999999999 109.885 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.71 162.03 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.044 1.338 . . . . 4.1699999999999999 111.329 -170.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -114.71 127.05 55.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.265 1.026 . . . . 6.1200000000000001 111.222 172.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.34 117.48 4.87 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.906 -0.588 . . . . 2.3900000000000001 109.747 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.13 -8.46 31.18 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.21 -1.328 . . . . 2.6000000000000001 114.683 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.34 161.2 26.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 119.637 1.718 . . . . 3.3700000000000001 109.955 162.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -111.01 156.93 20.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.636 -0.711 . . . . 5.3300000000000001 109.484 154.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.55 125.14 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.854 1.662 . . . . 2.6000000000000001 108.473 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -74.58 145.85 43.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.481 0.658 . . . . 3.9100000000000001 110.379 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 tt -154.96 126.7 7.51 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.141 0.977 . . . . 3.2999999999999998 110.643 -174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.43 109.92 21.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.121 2.568 . . . . 2.48 112.068 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 119.03 23.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.216 1.406 . . . . 2.0800000000000001 110.321 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.0 mt -89.95 111.15 22.13 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.802 0.841 . . . . 1.8700000000000001 109.56 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -111.98 124.08 51.64 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.707 -0.621 . . . . 3.6899999999999999 109.836 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.87 37.49 1.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.123 1.769 . . . . 2.48 113.263 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -73.23 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.722 1.153 . . . . 4.6200000000000001 112.091 -171.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.63 -30.2 60.33 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 115.739 1.055 . . . . 2.46 115.739 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -83.91 86.45 7.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 119.946 1.873 . . . . 7.6100000000000003 108.51 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -100.86 106.93 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.042 1.337 . . . . 2.5499999999999998 109.549 173.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.16 125.81 44.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.771 1.629 . . . . 4.4699999999999998 110.654 -173.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -83.14 139.04 33.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.479 1.659 . . . . 3.6299999999999999 115.479 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.81 169.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.399 1.88 . . . . 2.46 109.32 159.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.6 139.23 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.386 1.474 . . . . 2.8799999999999999 108.346 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -146.03 145.86 26.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.303 1.441 . . . . 2.6499999999999999 110.798 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.18 158.37 55.01 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 124.274 3.316 . . . . 1.1200000000000001 113.948 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.44 134.55 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.313 1.445 . . . . 2.3999999999999999 111.577 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -152.41 -172.18 4.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.878 2.071 . . . . 4.0800000000000001 109.429 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.47 124.98 35.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.964 -1.085 . . . . 3.8100000000000001 110.886 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 125.357 1.463 . . . . 9.7899999999999991 112.798 -163.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.451 ' H3 ' ' CD ' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 111.369 -0.692 . . . . 9.4600000000000009 111.369 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -81.29 109.41 15.78 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.976 -0.75 . . . . 10.44 108.976 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 53.6 79.64 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.104 1.362 . . . . 11.880000000000001 111.964 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.482 HG21 ' H ' ' A' ' 5' ' ' GLU . 1.6 m 86.53 -154.08 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 128.663 2.785 . . . . 7.1200000000000001 109.376 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.482 ' H ' HG21 ' A' ' 4' ' ' THR . 2.2 tt0 176.12 177.34 0.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 130.348 3.459 . . . . 4.8700000000000001 109.655 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.08 175.81 19.37 Favored Glycine 0 N--CA 1.466 0.655 0 O-C-N 121.48 -0.762 . . . . 1.4099999999999999 114.631 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -159.86 146.01 15.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.943 1.697 . . . . 1.47 110.572 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.92 138.93 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.436 -0.95 . . . . 2.2999999999999998 108.436 170.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -86.73 131.76 34.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.544 0.688 . . . . 5.7000000000000002 112.176 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -53.26 119.52 4.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.741 1.616 . . . . 5.0499999999999998 112.587 164.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -165.29 99.03 0.8 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.699 2.0 . . . . 4.3499999999999996 107.522 163.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.66 44.21 1.45 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.459 2.773 . . . . 2.9399999999999999 111.964 -168.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.94 -147.78 6.47 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.304 0.954 . . . . 1.9399999999999999 114.138 -167.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.32 -7.04 17.73 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.299 2.666 . . . . 2.04 112.798 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -154.25 156.89 37.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 2.8199999999999998 112.829 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.2 -165.36 1.9 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.387 2.675 . . . . 2.29 110.448 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.04 154.39 39.24 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.261 -0.899 . . . . 1.95 111.798 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.81 125.46 46.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.919 0.888 . . . . 2.0299999999999998 110.405 165.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -103.11 147.4 27.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.985 1.714 . . . . 3.4100000000000001 108.75 168.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -163.45 141.88 7.94 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.275 1.213 . . . . 2.7000000000000002 114.275 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.1 m -66.82 107.61 2.24 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.277 -1.008 . . . . 2.5800000000000001 108.277 161.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 134.36 36.42 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 106.944 -1.502 . . . . 3.6299999999999999 106.944 165.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.28 151.56 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.35 1.071 . . . . 3.4700000000000002 112.01 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -128.29 99.37 24.51 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.52 1.528 . . . . 0.98999999999999999 109.073 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -6.27 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.49 2.127 . . . . 1.1200000000000001 112.841 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.51 174.03 54.17 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.282 0.944 . . . . 0.88 113.994 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 4.4 m-20 -102.11 -3.79 26.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.507 1.923 . . . . 2.71 113.441 -170.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.34 161.0 33.74 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.107 1.763 . . . . 2.6000000000000001 109.98 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.65 162.76 24.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.058 2.506 . . . . 1.02 111.978 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.26 144.92 40.87 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.252 1.021 . . . . 2.9399999999999999 110.593 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -122.67 114.19 20.25 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.896 1.278 . . . . 4.3499999999999996 109.27 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.54 117.23 29.79 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.04 2.136 . . . . 1.8400000000000001 109.151 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -117.69 -4.9 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.405 1.082 . . . . 1.6499999999999999 112.938 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.71 -174.6 47.01 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.698 1.142 . . . . 0.68000000000000005 111.18 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.06 178.92 8.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.242 1.417 . . . . 1.8799999999999999 109.891 171.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.483 HH11 ' HG3' ' A' ' 36' ' ' ARG . 12.8 tpt85 -161.28 147.86 14.62 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 106.664 -1.606 . . . . 7.0099999999999998 106.664 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -149.7 157.8 38.09 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 124.6 1.16 . . . . 1.79 109.172 -166.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.05 -15.79 16.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.11 1.873 . . . . 1.51 114.351 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.7 m -101.16 2.46 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 116.025 1.861 . . . . 2.0800000000000001 116.025 -170.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 164.05 38.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.416 1.007 . . . . 2.1400000000000001 113.019 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.34 -79.67 0.54 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.731 2.012 . . . . 2.8399999999999999 111.314 -170.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 111.37 9.88 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.412 -0.958 . . . . 4.5 108.412 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -84.15 139.62 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.435 -1.257 . . . . 2.8300000000000001 110.428 158.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -142.24 122.46 13.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.597 1.159 . . . . 2.0 109.042 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -79.01 118.74 21.29 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.627 1.558 . . . . 2.3399999999999999 110.713 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -113.36 157.28 22.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 0.60999999999999999 111.869 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -112.34 167.45 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.396 1.478 . . . . 2.2000000000000002 110.372 166.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -123.26 114.79 20.7 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.741 1.616 . . . . 2.46 107.453 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -120.7 152.91 37.64 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.924 0.89 . . . . 3.5 112.809 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtp -103.03 142.78 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.82 1.648 . . . . 4.7599999999999998 110.325 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -157.8 144.83 18.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.097 1.359 . . . . 7.6600000000000001 111.503 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 137.95 31.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.284 0.493 . . . . 4.1900000000000004 111.104 166.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -146.71 126.33 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.732 1.613 . . . . 3.7200000000000002 107.324 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 63.33 20.35 12.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.589 1.156 . . . . 3.2400000000000002 111.963 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.17 -9.14 41.45 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.761 1.172 . . . . 2.3999999999999999 113.829 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -89.2 143.86 26.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.978 1.711 . . . . 4.0700000000000003 109.927 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -81.7 118.86 23.17 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.61 -0.681 . . . . 4.5300000000000002 110.875 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.03 150.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.239 1.816 . . . . 2.4500000000000002 109.717 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtm -135.24 144.65 46.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.771 1.228 . . . . 3.8900000000000001 110.676 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 177.58 32.38 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 123.773 0.702 . . . . 1.45 113.037 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -115.7 151.23 35.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.958 1.303 . . . . 2.8799999999999999 110.495 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -164.43 147.65 7.59 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.29 1.036 . . . . 6.3799999999999999 112.4 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.6 Cg_endo -70.82 153.18 64.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.229 1.953 . . . . 0.81000000000000005 112.512 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.95 159.02 70.8 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 126.438 1.895 . . . . 1.8200000000000001 110.408 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.96 -16.83 36.85 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.421 2.081 . . . . 0.80000000000000004 113.342 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -179.97 172.08 1.08 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 125.424 1.49 . . . . 3.21 111.253 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.2 173.0 7.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.611 2.365 . . . . 2.1299999999999999 109.072 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.25 166.47 33.08 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.058 -1.026 . . . . 2.29 111.747 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.2 t -150.41 137.16 11.23 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.117 1.367 . . . . 1.95 109.471 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.76 171.36 15.7 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.908 2.405 . . . . 0.97999999999999998 112.315 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.35 142.04 94.54 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.1 2.533 . . . . 0.87 111.491 166.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.463 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 64.3 mmtt 65.34 2.54 1.97 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.834 1.653 . . . . 2.2999999999999998 113.387 -174.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.49 121.98 5.79 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 127.451 2.453 . . . . 1.1399999999999999 110.242 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -113.91 131.72 56.19 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.045 1.738 . . . . 6.9500000000000002 109.51 167.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 m -159.55 134.36 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.065 1.346 . . . . 2.9900000000000002 111.083 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -79.53 134.6 36.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.24 1.019 . . . . 3.7400000000000002 112.824 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.03 69.62 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.874 1.321 . . . . 2.0800000000000001 108.517 143.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.4 ptmm? -83.14 149.35 58.58 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 128.682 2.793 . . . . 3.75 110.832 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -54.46 -37.99 89.71 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.22 2.613 . . . . 1.1899999999999999 113.552 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.63 65.09 3.37 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.078 0.854 . . . . 1.8300000000000001 111.022 168.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.39 -81.46 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.081 1.324 . . . . 1.23 113.391 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -153.33 152.18 30.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.383 1.873 . . . . 3.5099999999999998 110.19 -164.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -164.87 165.14 20.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.37 1.068 . . . . 1.1200000000000001 110.002 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -95.89 123.6 39.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.42 -1.326 . . . . 3.5499999999999998 107.42 160.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.97 129.91 34.87 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.491 -1.3 . . . . 2.6200000000000001 107.491 163.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.56 123.38 49.32 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.864 -0.791 . . . . 4.3200000000000003 108.864 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.93 132.55 55.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.143 1.777 . . . . 4.0199999999999996 109.056 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.17 96.07 0.2 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.288 -1.125 . . . . 1.45 110.288 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 mt -100.7 128.59 46.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.715 0.758 . . . . 2.1600000000000001 111.57 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -79.76 -18.95 49.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.273 1.429 . . . . 2.73 112.815 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -156.77 145.13 14.46 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.633 1.573 . . . . 6.4699999999999998 110.307 167.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.87 145.3 56.08 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.944 2.43 . . . . 1.6200000000000001 110.097 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.97 82.0 6.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.465 1.126 . . . . 3.52 110.993 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 133.8 54.6 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.962 1.705 . . . . 4.2199999999999998 109.518 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.0 135.72 52.39 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.57 -1.331 . . . . 2.8100000000000001 111.93 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.99 53.78 21.11 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.72 -0.552 . . . . 2.3700000000000001 111.72 -171.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -117.98 165.73 13.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.167 1.387 . . . . 2.8500000000000001 110.761 163.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 154.29 20.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.212 1.405 . . . . 5.1699999999999999 109.518 164.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.3 t -140.89 105.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.854 1.662 . . . . 1.8 109.05 166.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -65.64 142.35 58.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.663 0.744 . . . . 4.1799999999999997 110.209 163.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 tt -140.63 129.96 23.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.977 0.894 . . . . 2.7799999999999998 111.13 174.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -86.59 101.81 13.57 Favored 'General case' 0 CA--C 1.552 1.047 1 C-N-CA 132.536 4.334 . . . . 2.9199999999999999 111.436 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.7 mt -82.41 122.56 28.16 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.931 -1.731 . . . . 2.2000000000000002 111.055 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.17 123.07 43.18 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.737 0.815 . . . . 1.97 110.542 -171.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.5 153.05 35.93 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.694 0.759 . . . . 3.0099999999999998 111.996 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.39 134.39 56.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.862 0.465 . . . . 2.3999999999999999 110.672 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.7 10.45 52.94 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.848 1.099 . . . . 3.9300000000000002 115.848 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.25 6.77 83.91 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 119.119 1.46 . . . . 2.1200000000000001 114.184 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -76.24 131.84 39.53 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.362 -1.081 . . . . 7.0300000000000002 109.714 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.81 140.17 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.277 1.031 . . . . 2.3799999999999999 110.2 166.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.9 mt -141.05 123.38 15.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.138 1.375 . . . . 2.9500000000000002 108.931 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -92.0 145.71 24.31 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.539 0.94 . . . . 3.5499999999999998 113.539 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.14 149.28 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.78 2.032 . . . . 2.5899999999999999 111.093 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.96 135.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.45 1.5 . . . . 4.75 111.167 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -144.71 85.19 8.58 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.83 1.652 . . . . 2.9399999999999999 110.649 -166.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.66 154.56 59.33 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.249 2.633 . . . . 1.27 112.462 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.9 t -84.35 134.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.867 0.867 . . . . 2.3199999999999998 111.384 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.98 157.49 40.65 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.096 1.358 . . . . 3.8700000000000001 111.136 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 11.99 4.72 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.832 1.653 . . . . 3.3999999999999999 113.948 171.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.233 0 CA-C-O 114.545 -2.645 . . . . 6.6500000000000004 115.704 -174.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.353 0 CA-C-O 118.99 -0.894 . . . . 14.1 112.565 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m 177.86 -179.03 0.25 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 129.536 3.134 . . . . 12.02 109.575 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -59.0 4.21 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 116.559 2.059 . . . . 13.75 116.559 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -81.68 -25.86 35.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.302 2.241 . . . . 8.5299999999999994 111.38 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -155.07 141.43 18.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.886 1.274 . . . . 6.9199999999999999 111.673 -138.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.14 149.84 18.04 Favored Glycine 0 N--CA 1.465 0.6 0 O-C-N 120.879 -1.138 . . . . 1.49 112.969 162.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -153.55 151.48 29.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.476 0.917 . . . . 1.98 113.476 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.7 t -110.76 144.12 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 2.1299999999999999 110.525 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -87.79 113.76 23.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.234 1.198 . . . . 4.3399999999999999 114.234 -156.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -63.48 123.03 17.73 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.585 -0.697 . . . . 4.3799999999999999 111.906 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -159.36 147.85 13.83 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 3.1200000000000001 110.348 166.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.39 63.31 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.089 3.192 . . . . 2.5 109.61 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.99 168.5 13.72 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.263 0.935 . . . . 1.6899999999999999 113.908 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.15 -15.47 14.49 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.819 3.013 . . . . 1.8200000000000001 112.001 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -144.86 158.97 43.61 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.369 1.867 . . . . 2.3999999999999999 111.605 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.55 -177.17 6.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.852 1.261 . . . . 2.2799999999999998 111.05 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.31 149.45 30.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.626 1.17 . . . . 2.0800000000000001 110.916 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.65 128.89 55.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.45 -0.574 . . . . 2.27 109.45 160.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.17 162.93 14.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.524 1.93 . . . . 3.4100000000000001 109.98 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.436 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.1 pt? -161.38 140.87 10.3 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.792 1.405 . . . . 2.5600000000000001 114.792 166.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -79.12 137.44 37.48 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.55 -1.278 . . . . 2.4300000000000002 107.55 151.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.36 135.71 13.21 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.615 1.166 . . . . 3.6499999999999999 109.995 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.2 142.75 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.307 1.043 . . . . 3.23 113.177 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -82.17 114.21 49.29 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.592 -1.185 . . . . 0.89000000000000001 109.321 152.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -83.45 -9.64 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.166 2.578 . . . . 1.29 113.386 174.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.93 170.48 47.67 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.752 1.167 . . . . 0.82999999999999996 113.645 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 4.8 m-20 -93.87 -7.14 44.03 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.287 1.835 . . . . 2.73 112.826 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.8 159.8 35.96 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.23 1.812 . . . . 2.3399999999999999 110.436 171.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.73 158.63 28.14 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.778 2.319 . . . . 0.94999999999999996 111.793 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.67 140.14 43.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.499 1.52 . . . . 3.3300000000000001 109.64 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.64 112.13 15.77 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.237 1.015 . . . . 4.5999999999999996 109.958 171.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.13 114.94 26.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.101 2.16 . . . . 1.75 109.025 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -107.06 -10.1 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.797 1.239 . . . . 1.54 113.091 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.3 -167.59 40.02 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.993 1.282 . . . . 0.46000000000000002 110.962 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.09 176.85 11.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.041 0.936 . . . . 1.96 111.127 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -146.72 121.63 9.98 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.84 0.856 . . . . 8.7899999999999991 110.631 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.27 148.55 70.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 124.922 1.289 . . . . 1.71 108.79 -173.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.14 -1.0 10.31 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.472 2.115 . . . . 0.93000000000000005 114.15 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.37 -0.43 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.882 1.808 . . . . 1.9099999999999999 115.882 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.72 168.21 21.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.236 1.834 . . . . 2.0699999999999998 114.738 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.468 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 3.9 tp10 -104.94 -93.4 0.36 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.976 1.37 . . . . 3.1200000000000001 110.365 169.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -84.63 83.86 7.87 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.632 -1.293 . . . . 5.6699999999999999 109.541 -165.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.67 131.21 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.572 2.349 . . . . 2.4300000000000002 112.127 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -140.58 132.05 26.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.942 1.697 . . . . 2.6400000000000001 110.458 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 121.73 26.84 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.199 1.363 . . . . 1.99 111.131 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -110.7 152.42 26.57 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.217 2.207 . . . . 0.77000000000000002 113.165 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.92 137.44 32.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.719 1.608 . . . . 2.3500000000000001 109.172 155.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -101.35 146.01 28.14 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.025 -1.843 . . . . 3.2000000000000002 106.025 161.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -156.79 172.22 19.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.874 1.435 . . . . 4.1900000000000004 114.874 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.1 mtm -118.99 127.48 53.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.917 1.287 . . . . 7.6399999999999997 108.269 148.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -146.75 170.18 17.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.353 1.861 . . . . 10.65 110.054 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -102.72 156.3 17.73 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.817 0.847 . . . . 4.7400000000000002 112.316 -167.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.28 -96.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 3.8399999999999999 108.377 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -76.38 42.51 0.28 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.466 2.306 . . . . 3.7200000000000002 110.53 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.17 -15.25 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 119.816 -1.802 . . . . 2.29 114.098 -169.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -81.17 131.97 35.33 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.812 -1.405 . . . . 5.0800000000000001 110.85 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HE2' ' HB2' ' A' ' 57' ' ' LYS . 1.3 ptmm? -83.05 90.6 7.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.62 1.168 . . . . 7.9900000000000002 112.172 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.07 148.23 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.467 1.507 . . . . 4.0899999999999999 111.466 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.47 156.82 17.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.381 1.252 . . . . 7.3200000000000003 114.381 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.51 -165.21 35.94 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.759 1.647 . . . . 2.4300000000000002 111.168 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -153.1 158.74 42.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 4.1799999999999997 112.115 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -153.6 141.26 13.62 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 7.25 111.281 -170.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.26 147.17 77.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.599 2.199 . . . . 1.04 112.377 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.15 157.16 61.72 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 126.706 2.002 . . . . 1.8899999999999999 110.593 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.11 -13.49 36.4 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.854 2.369 . . . . 1.02 113.489 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.5 p90 179.04 168.52 0.95 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.937 1.695 . . . . 3.0499999999999998 110.328 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -113.92 174.41 5.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.664 1.586 . . . . 2.23 109.428 152.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.05 163.26 36.82 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.456 -0.777 . . . . 2.3599999999999999 111.066 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.72 124.78 8.78 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 2.2599999999999998 107.873 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.45 161.03 46.82 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.784 1.656 . . . . 1.1299999999999999 110.679 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.86 138.39 78.79 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.423 2.749 . . . . 0.83999999999999997 110.972 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 69.1 mmtt 68.67 -0.29 2.37 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.373 1.869 . . . . 2.3999999999999999 113.863 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.42 116.52 4.35 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 126.1 1.809 . . . . 0.96999999999999997 112.026 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -77.42 131.92 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.178 -1.011 . . . . 5.4500000000000002 109.994 156.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.01 175.88 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.875 2.07 . . . . 2.6499999999999999 110.25 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -137.89 114.3 10.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.065 0.946 . . . . 4.2699999999999996 110.502 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 85.37 0.43 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.923 -1.51 . . . . 2.3500000000000001 106.923 157.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 152.8 37.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.578 . . . . 4.5199999999999996 112.901 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.91 -41.22 48.21 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.735 2.956 . . . . 1.73 113.836 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.57 40.57 2.62 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.592 -1.115 . . . . 1.54 113.987 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.27 -61.1 0.02 OUTLIER Glycine 0 N--CA 1.472 1.054 0 CA-C-N 118.826 1.313 . . . . 1.8300000000000001 115.439 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -153.38 145.96 24.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.303 1.441 . . . . 3.7000000000000002 111.06 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -165.29 173.45 11.22 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.774 -1.204 . . . . 1.03 110.402 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.83 129.35 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.837 -0.602 . . . . 3.3599999999999999 109.659 165.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.5 mmt -80.11 121.73 25.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.431 -0.581 . . . . 1.6899999999999999 109.431 163.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.4 mt -107.74 86.34 2.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.373 1.469 . . . . 2.3799999999999999 109.555 -176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.05 142.11 29.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.993 0.917 . . . . 3.7400000000000002 109.629 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.22 60.23 4.22 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.861 0.743 . . . . 1.45 112.033 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.69 124.82 22.42 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.829 0.852 . . . . 2.0299999999999998 112.805 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.468 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 28.5 mmtp -81.29 -0.03 39.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.659 1.183 . . . . 3.9199999999999999 113.588 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.14 150.31 0.61 Allowed Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 128.85 2.86 . . . . 7.2300000000000004 109.486 177.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.39 149.76 75.37 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.488 2.125 . . . . 2.3799999999999999 110.233 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.57 108.79 14.5 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.458 -1.312 . . . . 3.3100000000000001 107.458 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.48 119.37 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.785 -1.197 . . . . 4.0999999999999996 111.368 -170.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.51 113.65 1.88 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.963 -1.125 . . . . 2.2400000000000002 107.963 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.29 -18.69 4.94 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 116.802 -2.11 . . . . 2.23 115.506 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.65 162.07 35.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.584 2.192 . . . . 3.8599999999999999 113.961 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -79.74 137.06 36.91 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.269 1.827 . . . . 4.3899999999999997 111.507 163.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.14 126.99 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 124.976 1.311 . . . . 1.95 109.41 160.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.462 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 51.7 mt-10 -71.2 141.39 50.65 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.955 -0.566 . . . . 3.1600000000000001 110.45 162.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mt -156.35 121.74 4.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.977 0.911 . . . . 2.2400000000000002 112.287 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.56 101.37 11.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.567 2.347 . . . . 2.2200000000000002 110.713 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.0 mt -76.37 115.71 16.37 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.102 1.761 . . . . 2.1000000000000001 110.121 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -85.34 124.47 31.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.864 0.866 . . . . 1.8100000000000001 110.601 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -121.71 126.02 47.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.239 0.616 . . . . 3.25 111.655 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.32 18.89 0.99 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.427 1.64 . . . . 2.8999999999999999 115.427 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.44 68.83 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.315 1.436 . . . . 4.8799999999999999 116.036 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -139.53 -26.52 0.26 Allowed Glycine 0 N--CA 1.477 1.387 0 CA-C-N 119.337 1.568 . . . . 2.54 116.592 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 141.6 28.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.325 1.563 . . . . 7.2699999999999996 109.409 172.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 p -142.39 161.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.633 -0.667 . . . . 1.8700000000000001 111.573 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.09 124.38 14.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.959 1.704 . . . . 3.6600000000000001 110.276 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 31.9 ttmt -71.71 116.59 12.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.298 -0.63 . . . . 3.75 109.298 161.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.65 153.94 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 124.514 1.126 . . . . 2.0899999999999999 108.948 158.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.99 137.25 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.439 -1.319 . . . . 3.8199999999999998 107.439 161.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.5 mt -139.63 130.13 14.34 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.198 -1.382 . . . . 2.8399999999999999 109.205 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -60.75 151.18 78.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.621 2.881 . . . . 1.4199999999999999 112.286 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.8 t -78.16 136.02 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.572 -0.705 . . . . 2.4399999999999999 109.401 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.49 151.52 35.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.59 1.156 . . . . 3.5899999999999999 109.379 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.47 55.31 0.72 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.963 1.305 . . . . 3.23 112.357 -158.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 125.3 1.44 . . . . 5.9900000000000002 108.555 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.847 0 N-CA-C 107.367 -2.293 . . . . 10.73 107.367 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m 71.58 34.44 1.64 Allowed 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 118.243 1.022 . . . . 13.15 109.861 -156.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 78.51 179.08 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.68 2.792 . . . . 17.870000000000001 111.213 -166.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 98.82 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 130.84 3.656 . . . . 7.6200000000000001 111.351 -162.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -93.96 169.95 9.9 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.755 2.022 . . . . 5.2599999999999998 111.7 165.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.71 164.39 27.75 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.147 1.356 . . . . 1.6899999999999999 114.15 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -161.23 154.42 21.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.205 1.402 . . . . 2.02 112.956 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -103.92 130.98 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.651 1.18 . . . . 1.8899999999999999 108.951 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -77.86 116.19 18.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.338 0.255 . . . . 4.4400000000000004 110.725 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -52.7 119.43 4.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.846 0.858 . . . . 3.3900000000000001 112.072 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 m -168.67 112.67 0.55 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.805 2.042 . . . . 2.7000000000000002 107.001 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.81 50.69 2.64 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.623 2.882 . . . . 3.7599999999999998 110.398 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -177.65 31.6 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.179 0.895 . . . . 2.0699999999999998 114.638 -167.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -66.26 -16.46 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.926 2.418 . . . . 1.8799999999999999 111.746 166.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -155.22 157.4 37.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.092 1.757 . . . . 3.4700000000000002 110.678 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.01 -174.88 5.15 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 2.2200000000000002 111.049 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.8 146.5 37.7 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.356 0.873 . . . . 2.1499999999999999 113.356 -170.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.97 146.38 49.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.134 0.974 . . . . 1.76 112.562 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -128.63 150.4 50.24 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.012 2.525 . . . . 3.6000000000000001 109.237 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.01 137.05 9.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 115.606 1.706 . . . . 3.2599999999999998 115.606 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.9 m -85.55 124.78 32.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 114.749 -1.114 . . . . 2.4100000000000001 108.932 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.02 137.23 51.98 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 127.153 2.181 . . . . 3.5099999999999998 107.814 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.14 143.17 31.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.665 0.745 . . . . 3.0899999999999999 111.027 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -111.73 105.54 56.62 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.062 -0.972 . . . . 1.52 109.154 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.47 -5.28 10.1 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.839 2.359 . . . . 1.4199999999999999 113.826 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.6 -174.35 38.41 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 124.387 0.994 . . . . 1.26 113.259 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -106.87 9.08 30.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.589 1.556 . . . . 2.3999999999999999 113.426 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.47 157.97 57.5 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.774 1.63 . . . . 3.21 110.666 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.19 157.21 13.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.26 2.64 . . . . 1.8 112.592 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.7 112.44 17.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.99 1.716 . . . . 3.5099999999999998 110.042 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -109.01 101.26 10.35 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.199 1.399 . . . . 5.2599999999999998 112.747 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 tp -80.55 106.55 12.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.306 2.242 . . . . 2.02 109.636 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.11 -14.53 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.309 1.443 . . . . 1.7 113.058 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.18 -162.19 30.94 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.251 0.929 . . . . 0.69999999999999996 111.618 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.59 -170.67 3.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.693 0.797 . . . . 1.74 111.209 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -167.44 134.75 2.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.463 -0.939 . . . . 7.2199999999999998 108.463 165.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t -136.09 143.32 43.53 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-O 117.544 -1.217 . . . . 1.8300000000000001 108.83 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.16 -20.0 56.56 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.646 2.231 . . . . 1.1399999999999999 113.145 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -77.22 3.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 113.263 0.838 . . . . 1.8400000000000001 113.263 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.2 -163.79 1.87 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.19 1.552 . . . . 1.96 115.19 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.84 -88.99 0.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.703 1.601 . . . . 3.5699999999999998 109.598 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -78.95 158.99 27.9 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.696 1.599 . . . . 8.2100000000000009 111.099 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.06 73.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 124.816 2.246 . . . . 2.04 109.315 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -96.36 120.22 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 111.997 -2.365 . . . . 4.5199999999999996 110.163 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.48 121.93 25.81 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.884 0.849 . . . . 1.72 111.509 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -107.69 155.83 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.805 2.042 . . . . 1.1299999999999999 112.006 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -104.78 177.91 4.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.369 -1.287 . . . . 2.9500000000000002 110.891 157.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -150.61 115.93 5.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.282 1.833 . . . . 2.2799999999999998 107.38 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.57 178.71 6.79 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.388 1.475 . . . . 3.75 111.587 -162.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.7 ptp -119.57 151.15 39.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.649 1.18 . . . . 4.1699999999999999 111.623 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -154.44 158.95 40.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.817 1.247 . . . . 8.6699999999999999 112.243 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.5 137.61 38.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.011 0.925 . . . . 4.0300000000000002 109.81 163.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.7 t -118.22 -93.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.434 1.494 . . . . 4.1200000000000001 109.221 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -77.92 39.07 0.28 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.126 2.17 . . . . 3.6099999999999999 110.931 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.22 -6.13 16.49 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 119.815 -1.803 . . . . 1.9099999999999999 113.825 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -107.1 155.68 19.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.132 2.173 . . . . 4.4500000000000002 110.595 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.61 140.82 29.48 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.889 1.07 . . . . 4.6600000000000001 113.889 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 t -143.25 157.89 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.794 2.037 . . . . 3.3100000000000001 108.293 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.4 ptp -74.18 173.23 10.43 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.489 0.716 . . . . 4.96 112.712 170.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.13 153.99 25.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.633 1.111 . . . . 1.28 111.254 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -124.4 143.01 50.85 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.147 1.379 . . . . 2.6499999999999999 108.576 171.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -163.34 145.28 7.7 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 118.089 -0.958 . . . . 7.0 112.058 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.96 150.6 82.91 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.881 2.387 . . . . 1.1000000000000001 110.703 172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.96 156.37 74.26 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.358 1.463 . . . . 1.6100000000000001 109.976 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.88 -22.69 42.18 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.422 2.082 . . . . 0.78000000000000003 112.417 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -175.2 165.06 3.35 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 125.433 1.493 . . . . 2.96 111.729 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.99 171.87 7.27 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.565 1.546 . . . . 1.97 109.437 153.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.74 163.6 39.74 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.271 -0.893 . . . . 3.1899999999999999 113.292 165.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.67 129.36 22.69 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 126.093 1.757 . . . . 2.3399999999999999 109.133 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.64 161.46 43.92 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.483 2.122 . . . . 1.4199999999999999 111.076 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.12 140.74 91.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.559 2.839 . . . . 1.6100000000000001 112.251 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp 68.1 -0.24 2.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.711 2.005 . . . . 3.04 113.983 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.32 156.8 28.53 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 127.075 2.274 . . . . 1.1899999999999999 112.066 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtt85 -119.88 155.62 32.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.765 2.026 . . . . 7.0300000000000002 111.51 168.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.99 159.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.911 1.684 . . . . 2.3199999999999998 110.256 164.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.27 109.69 12.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.457 1.503 . . . . 4.1799999999999997 107.74 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.09 83.36 0.51 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.245 1.418 . . . . 2.3700000000000001 109.361 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.55 156.96 36.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.645 1.578 . . . . 4.7300000000000004 112.717 -172.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -59.72 -29.84 90.65 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.116 2.544 . . . . 0.96999999999999997 114.118 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.98 49.57 3.33 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.997 -0.89 . . . . 1.27 111.814 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.88 -71.11 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 115.558 0.983 . . . . 1.1299999999999999 115.558 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -157.63 143.79 17.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.014 2.125 . . . . 3.1400000000000001 110.485 -165.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -168.81 174.26 6.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.235 0.925 . . . . 0.82999999999999996 112.285 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -104.28 136.96 42.9 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.408 0.683 . . . . 3.4300000000000002 111.64 169.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -96.25 121.3 37.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.653 1.181 . . . . 1.8500000000000001 110.029 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.12 108.61 21.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.825 0.85 . . . . 3.7999999999999998 109.809 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.72 65.81 1.03 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.481 1.112 . . . . 3.9199999999999999 110.529 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.82 113.82 1.54 Allowed Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.621 1.582 . . . . 2.0600000000000001 111.229 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -103.34 154.61 19.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.863 1.265 . . . . 2.0299999999999998 111.195 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -125.38 -26.74 3.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.411 1.485 . . . . 3.1400000000000001 112.371 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -118.14 132.01 23.93 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-O 118.205 -0.902 . . . . 5.6799999999999997 109.077 161.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.17 124.39 11.28 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.939 -1.985 . . . . 1.74 106.939 159.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.82 121.94 16.18 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.037 1.335 . . . . 2.9300000000000002 111.089 -161.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -88.29 131.49 34.77 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.743 -1.223 . . . . 5.7400000000000002 109.874 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 119.49 5.89 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.847 -1.168 . . . . 2.8300000000000001 107.847 153.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.88 -1.6 56.66 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 118.434 -1.203 . . . . 2.6299999999999999 115.158 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.05 151.53 20.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.444 1.622 . . . . 3.1600000000000001 110.532 157.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -112.52 124.97 53.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.417 2.287 . . . . 5.9800000000000004 105.441 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.41 102.88 13.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.827 1.251 . . . . 1.9399999999999999 108.548 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.532 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 55.6 mt-10 -60.64 145.08 50.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.035 -0.53 . . . . 2.8199999999999998 110.5 163.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -158.84 132.81 7.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 3.2000000000000002 110.409 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.31 112.35 24.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.809 2.043 . . . . 2.2599999999999998 110.141 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.93 118.1 18.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.151 1.38 . . . . 2.8599999999999999 109.987 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.64 117.06 24.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.324 -0.621 . . . . 2.1299999999999999 109.324 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -116.37 121.47 42.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.152 0.797 . . . . 3.8399999999999999 113.152 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.84 28.37 0.13 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.681 2.393 . . . . 2.54 115.867 170.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.47 -61.85 3.87 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.902 1.239 . . . . 3.7000000000000002 112.519 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.51 2.54 29.85 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.99 1.556 . . . . 1.9099999999999999 116.99 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -142.64 148.89 38.17 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.414 1.607 . . . . 5.8700000000000001 112.3 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.62 139.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.851 1.66 . . . . 2.6699999999999999 109.165 162.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -145.23 135.35 23.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.658 1.183 . . . . 3.4399999999999999 111.01 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.532 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 39.9 ttmt -77.22 132.64 38.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.4 0.518 . . . . 3.1499999999999999 112.4 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.8 -179.77 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.45 1.9 . . . . 2.54 109.8 159.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.86 148.08 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 127.847 2.459 . . . . 4.1699999999999999 109.461 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -141.77 135.05 14.31 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.29 1.436 . . . . 2.7200000000000002 110.699 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.68 146.64 43.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.969 2.446 . . . . 1.46 112.391 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.1 t -76.84 138.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.597 0.759 . . . . 2.3100000000000001 109.502 165.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -140.45 151.14 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.193 0.597 . . . . 3.2799999999999998 111.386 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.43 60.53 1.17 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.801 1.64 . . . . 3.1499999999999999 111.41 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG 0.318 2.0 mmp_? . . . . . 0 C--O 1.251 1.146 0 N-CA-C 117.948 2.573 . . . . 6.1600000000000001 117.948 -161.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.152 0 N-CA-C 105.128 -3.189 . . . . 14.23 105.128 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p 159.46 145.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.102 -1.814 . . . . 12.300000000000001 106.102 -129.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -143.04 47.57 1.52 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.433 1.493 . . . . 10.720000000000001 111.443 -163.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.9 p -73.96 88.47 1.86 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.255 1.022 . . . . 8.3699999999999992 112.251 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.78 131.48 35.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 125.811 1.644 . . . . 6.7599999999999998 110.423 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.78 162.31 33.87 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 120.809 -1.182 . . . . 1.4299999999999999 114.597 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -146.49 146.47 30.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.668 1.187 . . . . 1.79 112.721 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.88 141.04 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.099 0.96 . . . . 2.1699999999999999 108.853 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -77.16 -13.61 59.92 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.677 1.362 . . . . 5.3099999999999996 114.677 -161.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.8 t80 72.85 147.25 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.077 2.951 . . . . 3.8799999999999999 112.625 -170.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -168.64 140.89 2.26 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.425 1.49 . . . . 4.6200000000000001 111.108 166.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -90.28 -13.19 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.065 3.177 . . . . 3.48 112.43 165.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -101.85 170.19 20.71 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.436 1.493 . . . . 1.75 112.865 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 -16.47 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 124.022 3.148 . . . . 2.8399999999999999 115.397 -166.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -94.63 141.86 28.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.751 1.159 . . . . 3.4500000000000002 111.458 163.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.76 179.15 7.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.788 1.635 . . . . 2.3199999999999998 111.625 164.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.28 153.61 51.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.264 1.426 . . . . 2.02 110.017 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.49 142.63 50.0 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.121 . . . . 1.98 112.21 168.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.45 147.82 41.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 3.2599999999999998 110.55 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -164.36 149.79 10.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.009 0.923 . . . . 2.6899999999999999 112.582 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -81.63 117.57 22.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.895 0.878 . . . . 2.48 108.838 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -89.93 135.46 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.162 0.585 . . . . 4.5199999999999996 110.477 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -124.15 167.69 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.052 1.341 . . . . 3.0299999999999998 109.507 173.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.71 104.71 6.93 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 123.8 0.84 . . . . 1.1699999999999999 109.914 162.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.95 -10.04 10.55 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.993 2.462 . . . . 1.77 113.168 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.35 156.79 39.73 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 124.155 0.884 . . . . 1.1399999999999999 112.461 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.9 m-20 -88.06 5.94 38.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.869 1.668 . . . . 2.75 113.391 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.22 158.71 45.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.096 1.758 . . . . 2.75 110.285 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.02 159.53 30.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.164 2.576 . . . . 1.03 111.748 -170.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.02 129.22 50.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.999 1.32 . . . . 3.5299999999999998 110.099 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -120.7 112.0 18.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.391 1.476 . . . . 3.7000000000000002 110.287 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -91.84 123.06 34.94 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.407 1.883 . . . . 2.0600000000000001 108.946 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.93 -11.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.419 1.087 . . . . 1.72 113.312 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.42 -161.68 30.82 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.144 0.878 . . . . 0.59999999999999998 111.07 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.83 -178.78 7.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.836 1.254 . . . . 1.5700000000000001 110.179 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -152.75 150.74 29.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.612 1.096 . . . . 6.4800000000000004 108.749 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -141.26 146.29 42.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 117.683 -1.151 . . . . 2.1400000000000001 108.636 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.12 -19.39 66.29 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.106 1.871 . . . . 0.84999999999999998 112.47 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m -82.94 -3.76 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.221 1.193 . . . . 2.02 114.221 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.43 177.97 9.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.856 1.207 . . . . 1.79 113.688 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -118.9 -87.67 0.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.132 1.373 . . . . 3.2799999999999998 110.421 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -78.74 103.98 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.653 -1.279 . . . . 4.2599999999999998 109.05 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.91 145.41 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.588 1.155 . . . . 3.3100000000000001 110.931 161.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -143.99 123.52 13.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.773 1.229 . . . . 2.3300000000000001 109.663 164.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.407 HD13 ' CE1' ' A' ' 84' ' ' PHE . 7.0 tt -84.86 120.79 26.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.54 1.518 . . . . 1.8200000000000001 110.997 168.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -107.41 151.88 24.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.535 1.534 . . . . 0.73999999999999999 112.856 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -86.23 166.46 15.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.262 2.225 . . . . 2.4500000000000002 110.801 163.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -150.21 126.79 10.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.387 1.475 . . . . 2.2000000000000002 108.26 170.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -149.34 156.88 42.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.571 0.952 . . . . 3.54 113.571 -155.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.8 mtm -107.48 62.22 0.62 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.869 1.668 . . . . 5.2400000000000002 111.981 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -79.42 156.13 28.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.948 -1.023 . . . . 8.4299999999999997 111.121 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.02 164.8 25.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.161 -1.051 . . . . 5.9900000000000002 108.161 158.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.3 t -156.89 -39.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.848 2.059 . . . . 4.0700000000000003 110.986 -164.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 56' ' ' LYS . 24.8 tt0 -159.09 41.34 0.22 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.115 2.966 . . . . 5.0599999999999996 108.003 -173.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.47 -19.23 0.08 OUTLIER Glycine 0 N--CA 1.479 1.558 0 C-N-CA 128.487 2.946 . . . . 2.04 114.899 -164.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 54' ' ' GLU . 41.2 pttt -83.04 134.82 35.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.347 1.459 . . . . 6.2800000000000002 109.804 175.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -88.93 120.16 30.1 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.507 -0.746 . . . . 5.1100000000000003 110.879 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.88 141.74 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.37 1.468 . . . . 2.5899999999999999 110.002 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 97.14 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.42 1.088 . . . . 5.5 109.753 165.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.75 168.31 12.75 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.462 1.03 . . . . 1.25 112.797 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.56 153.6 47.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.492 1.517 . . . . 3.0800000000000001 110.885 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -161.67 152.41 14.94 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 126.558 1.943 . . . . 7.4299999999999997 110.481 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.61 143.69 69.47 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.413 2.075 . . . . 0.65000000000000002 111.653 165.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -113.06 157.64 40.18 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.105 1.762 . . . . 1.79 110.862 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.33 -14.43 31.18 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.768 2.312 . . . . 0.66000000000000003 113.646 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.92 165.45 1.56 Allowed 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.265 1.826 . . . . 3.7000000000000002 109.914 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.69 167.62 10.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.669 1.587 . . . . 2.0699999999999998 109.359 155.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.94 163.84 31.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.702 1.001 . . . . 2.0800000000000001 113.702 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 139.84 14.53 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.632 1.573 . . . . 2.5800000000000001 109.164 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.63 169.55 14.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.401 2.067 . . . . 1.1699999999999999 111.153 168.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.22 148.58 92.49 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.757 2.305 . . . . 0.93000000000000005 111.869 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.1 mmmt 68.86 -0.62 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.789 2.036 . . . . 2.7599999999999998 114.027 176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.83 -168.86 44.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.706 2.098 . . . . 1.45 114.939 -171.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -168.08 144.45 3.96 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.122 2.169 . . . . 6.4199999999999999 110.606 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.4 m -152.14 136.83 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.955 2.102 . . . . 2.9300000000000002 109.241 171.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -88.92 136.5 32.98 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.272 -0.893 . . . . 3.4399999999999999 110.867 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.36 72.72 0.96 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.508 1.147 . . . . 2.0099999999999998 108.444 156.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -85.43 145.9 43.36 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.477 1.911 . . . . 3.52 111.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -58.88 -23.54 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.823 2.349 . . . . 1.4299999999999999 113.805 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.29 35.99 4.51 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.926 1.251 . . . . 1.5700000000000001 113.617 171.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.37 -65.01 0.02 OUTLIER Glycine 0 N--CA 1.47 0.956 0 CA-C-N 118.399 1.099 . . . . 1.2 115.349 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -150.98 149.13 29.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.176 1.39 . . . . 3.4199999999999999 111.251 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -157.21 160.6 38.86 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.606 -1.309 . . . . 0.93000000000000005 111.44 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.407 ' CE1' HD13 ' A' ' 45' ' ' LEU . 41.0 m-85 -96.1 120.58 36.63 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.584 -0.525 . . . . 3.1899999999999999 109.584 164.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.82 136.32 33.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.113 0.965 . . . . 2.7000000000000002 108.811 167.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.2 103.88 8.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.394 1.078 . . . . 2.5800000000000001 108.893 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.36 120.0 41.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.496 1.118 . . . . 3.9900000000000002 109.888 -173.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.03 97.43 0.62 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.069 1.318 . . . . 1.53 109.972 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -94.38 122.8 37.31 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.28 1.04 . . . . 2.0499999999999998 110.74 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -71.01 -12.89 61.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.948 0.722 . . . . 2.7000000000000002 112.948 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.426 HH12 ' CD ' ' A' ' 97' ' ' GLU . 21.2 ptt85 -153.33 139.56 12.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.001 1.72 . . . . 7.1200000000000001 109.868 168.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 145.39 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.175 2.583 . . . . 2.23 109.358 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.4 mt -92.3 167.04 12.28 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.045 0.938 . . . . 3.3700000000000001 113.044 -169.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -123.0 156.8 34.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.342 1.457 . . . . 6.1600000000000001 109.143 156.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 131.45 50.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.141 -0.689 . . . . 2.9700000000000002 109.141 161.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.96 2.54 77.93 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 117.349 -1.806 . . . . 2.3599999999999999 116.48 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.426 ' CD ' HH12 ' A' ' 91' ' ' ARG . 90.4 mt-10 -76.29 167.4 21.92 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.404 2.102 . . . . 3.3399999999999999 110.364 169.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -85.6 154.08 21.96 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.023 1.329 . . . . 5.4500000000000002 112.183 165.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.0 t -130.14 116.91 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.25 1.82 . . . . 1.97 109.414 163.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.474 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 9.6 mm-40 -71.1 140.21 50.57 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.455 -1.248 . . . . 3.7799999999999998 109.804 161.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 132.21 14.44 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.907 0.706 . . . . 2.8500000000000001 112.907 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.95 132.54 33.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.396 0.678 . . . . 2.3999999999999999 109.533 159.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.16 118.19 31.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.994 1.318 . . . . 2.3900000000000001 109.569 158.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.2 mt -95.05 131.38 41.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.417 1.087 . . . . 2.1099999999999999 111.643 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -120.27 159.5 24.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.339 1.056 . . . . 3.5499999999999998 112.418 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.86 118.31 7.04 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.255 0.835 . . . . 2.4399999999999999 113.255 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.18 -147.84 29.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.048 0.832 . . . . 2.9500000000000002 111.364 -173.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.57 56.09 4.71 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-O 119.175 -0.792 . . . . 2.4199999999999999 114.365 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -131.81 137.92 48.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.335 1.568 . . . . 5.5800000000000001 110.675 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.11 145.09 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.44 1.496 . . . . 2.6600000000000001 108.915 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.0 mt -127.53 110.2 12.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.715 1.206 . . . . 3.25 109.908 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.474 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -79.63 105.86 11.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.343 0.657 . . . . 5.1699999999999999 109.851 175.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m -105.82 -175.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.358 2.263 . . . . 2.1699999999999999 111.199 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.3 143.82 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.25 1.42 . . . . 3.1099999999999999 109.072 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.7 mt -136.14 154.6 77.49 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.072 1.749 . . . . 2.6299999999999999 109.813 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.44 154.53 27.9 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.352 2.701 . . . . 1.0700000000000001 111.272 161.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.0 t -85.89 142.12 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.359 1.863 . . . . 2.0299999999999998 108.368 159.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -122.7 -145.18 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.995 2.118 . . . . 3.4399999999999999 108.101 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.5 113.14 3.6 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 121.059 1.754 . . . . 2.5099999999999998 111.592 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 C-N-CA 127.819 2.448 . . . . 5.4400000000000004 110.813 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.336 0 N-CA-C 108.173 -1.971 . . . . 12.67 108.173 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.53 145.81 37.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.822 1.311 . . . . 10.720000000000001 111.825 165.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -122.71 30.54 6.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.633 1.173 . . . . 12.59 111.513 172.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.11 167.94 2.76 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 129.08 2.952 . . . . 7.6299999999999999 112.003 177.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.55 -179.71 5.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.055 -0.403 . . . . 6.4500000000000002 110.042 152.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.14 169.49 34.92 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.634 0.635 . . . . 2.1800000000000002 114.132 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -155.91 152.36 28.18 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.677 0.791 . . . . 3.1299999999999999 110.818 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -117.46 148.59 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.071 0.948 . . . . 2.1400000000000001 110.23 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.23 111.24 22.83 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.869 -1.144 . . . . 4.5099999999999998 113.629 -152.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -66.28 104.82 1.27 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 4.5499999999999998 111.158 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -155.79 130.57 5.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 117.559 -1.21 . . . . 3.8399999999999999 109.913 158.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.27 75.12 5.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.818 3.012 . . . . 2.9500000000000002 110.303 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.55 168.11 13.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.796 1.188 . . . . 2.1000000000000001 112.982 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.87 -31.97 46.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.423 2.082 . . . . 2.6400000000000001 110.541 167.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -113.2 152.93 29.12 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.537 1.935 . . . . 3.2400000000000002 111.932 162.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.78 -158.1 0.88 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.651 2.38 . . . . 2.3100000000000001 108.116 168.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.67 160.15 40.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.321 1.419 . . . . 2.2400000000000002 113.682 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.54 149.88 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.791 1.636 . . . . 2.0499999999999998 110.54 164.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.4 175.21 9.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.543 1.537 . . . . 3.75 110.796 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -175.01 148.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.21 1.404 . . . . 2.98 112.358 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.3 m -116.6 122.41 44.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.613 -1.625 . . . . 3.1000000000000001 106.613 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.33 139.33 11.87 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.673 0.789 . . . . 5.1399999999999997 110.392 -158.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -109.2 147.86 31.87 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.833 1.653 . . . . 2.79 113.822 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -85.56 112.6 45.61 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 114.109 -1.405 . . . . 0.80000000000000004 109.646 154.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.42 -10.26 12.23 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.099 2.533 . . . . 1.3 113.534 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.86 -179.55 53.04 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.19 0.9 . . . . 0.91000000000000003 113.767 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.527 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 7.0 m-20 -109.97 -4.23 16.05 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.955 1.702 . . . . 2.5499999999999998 113.011 -174.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.77 159.25 34.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.832 1.653 . . . . 2.8500000000000001 110.031 165.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.88 152.53 16.88 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.089 2.526 . . . . 1.6399999999999999 111.543 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.87 157.62 15.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.414 1.085 . . . . 2.8799999999999999 111.247 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -142.09 109.05 5.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.299 1.44 . . . . 5.71 110.476 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.6 tp -95.98 113.98 25.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.449 2.3 . . . . 1.8999999999999999 109.696 -168.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.06 -12.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.977 1.311 . . . . 2.54 113.166 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.26 -158.7 28.44 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 121.303 -0.873 . . . . 0.53000000000000003 113.394 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.06 -177.56 5.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.106 0.962 . . . . 2.1800000000000002 111.106 166.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -142.76 136.23 28.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.555 1.142 . . . . 9.3000000000000007 108.491 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -141.14 147.61 48.11 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.225 1.41 . . . . 1.73 108.938 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.55 -23.19 32.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.628 1.552 . . . . 1.24 112.855 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.14 5.39 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 115.378 1.621 . . . . 2.0099999999999998 115.378 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.97 44.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.193 1.36 . . . . 2.04 113.2 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.82 -50.56 72.88 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.841 1.656 . . . . 6.5599999999999996 109.528 165.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -144.45 155.19 43.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.764 1.626 . . . . 5.4299999999999997 109.122 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.85 128.92 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 125.202 1.401 . . . . 2.1400000000000001 108.482 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -130.2 124.62 32.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.954 1.702 . . . . 2.0800000000000001 108.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -80.12 119.82 23.43 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.254 1.388 . . . . 1.9099999999999999 110.998 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -108.76 157.3 18.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.985 1.714 . . . . 0.92000000000000004 111.948 176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -111.1 -177.64 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.943 1.697 . . . . 2.4399999999999999 111.75 171.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.5 m -123.22 120.94 34.64 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.22 -1.03 . . . . 2.6699999999999999 108.22 156.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -100.41 165.47 11.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.782 1.233 . . . . 3.6200000000000001 111.248 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtm -129.42 134.7 47.98 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.536 1.134 . . . . 4.6600000000000001 109.234 163.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.9 146.16 24.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.724 1.21 . . . . 7.9500000000000002 110.696 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.08 136.81 41.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.91 0.386 . . . . 3.5699999999999998 110.965 175.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.07 -95.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.308 -1.367 . . . . 3.23 107.308 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' CD ' ' HZ3' ' A' ' 56' ' ' LYS . 2.0 tm-20 -79.36 74.93 5.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.498 1.119 . . . . 4.1799999999999997 108.51 166.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.03 -11.68 0.04 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 128.874 3.13 . . . . 2.0499999999999998 118.022 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.406 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 31.9 mtmm -124.25 153.5 41.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.489 1.916 . . . . 5.29 110.94 -170.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 97.7 1.33 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.12 0.568 . . . . 4.8300000000000001 112.105 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -79.83 132.61 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 125.265 1.426 . . . . 2.6499999999999999 107.864 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.5 ptp -91.8 145.27 24.71 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.896 0.878 . . . . 3.6899999999999999 111.183 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.13 166.84 35.87 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 123.908 0.766 . . . . 1.0700000000000001 112.97 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.3 150.82 38.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.59 1.156 . . . . 2.48 111.419 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 mtp85 -163.74 155.65 14.78 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.423 1.489 . . . . 8.4600000000000009 111.388 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.93 143.38 79.16 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.597 2.198 . . . . 0.95999999999999996 110.898 169.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.5 155.29 54.35 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.928 1.691 . . . . 2.0099999999999998 110.543 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.36 -23.85 32.15 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.674 2.249 . . . . 0.95999999999999996 112.617 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -173.71 168.81 4.33 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.239 1.416 . . . . 2.8799999999999999 111.059 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -119.76 174.47 6.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.279 2.232 . . . . 2.2599999999999998 109.334 162.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.34 168.57 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.399 -0.813 . . . . 3.2200000000000002 111.251 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 t -147.36 129.58 7.62 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 125.202 1.401 . . . . 2.1600000000000001 108.647 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.37 163.69 35.73 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.185 1.924 . . . . 1.47 111.942 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.19 139.34 71.8 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.917 3.078 . . . . 1.1499999999999999 111.945 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.527 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 58.29 17.97 5.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 116.063 1.875 . . . . 3.3100000000000001 116.063 -172.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.23 116.82 5.46 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 128.151 2.786 . . . . 1.01 111.984 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -90.4 130.96 36.42 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 6.1600000000000001 111.738 163.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.4 m -121.32 171.32 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 2.9300000000000002 111.545 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -148.28 125.5 11.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.14 1.376 . . . . 4.6799999999999997 110.685 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -82.51 153.63 25.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.526 1.155 . . . . 2.54 110.836 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -170.65 149.26 2.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.006 1.723 . . . . 4.8899999999999997 111.817 -165.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -49.44 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.118 2.545 . . . . 2.25 111.293 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 96.42 0.91 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 107.625 -2.19 . . . . 2.3500000000000001 107.625 156.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.76 -155.73 17.15 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.745 2.116 . . . . 2.8300000000000001 112.034 -163.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -92.42 140.01 30.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.822 1.249 . . . . 3.8799999999999999 112.204 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -161.19 154.14 21.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.482 0.713 . . . . 0.90000000000000002 109.484 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -94.58 120.39 34.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.629 -0.878 . . . . 3.3399999999999999 108.629 173.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -68.75 130.5 43.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.152 -0.684 . . . . 1.6200000000000001 109.152 165.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -106.03 118.99 38.03 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.017 -1.105 . . . . 2.98 108.017 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.24 152.4 24.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 4.0599999999999996 109.834 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.82 67.6 2.02 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 124.652 1.12 . . . . 1.7 112.72 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.91 111.14 2.7 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.904 1.075 . . . . 2.2999999999999998 113.904 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -80.38 -25.19 39.27 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.999 1.32 . . . . 3.1600000000000001 112.505 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -119.78 126.65 26.81 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 106.044 -1.835 . . . . 4.9000000000000004 106.044 149.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -64.35 136.89 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 N-CA-C 107.167 -1.897 . . . . 1.8400000000000001 107.167 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.71 63.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.776 0.83 . . . . 3.4399999999999999 112.467 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 121.95 7.22 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.705 1.602 . . . . 4.4199999999999999 108.793 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.95 120.74 1.87 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.637 1.108 . . . . 2.1400000000000001 112.113 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 42.02 47.38 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.491 -0.616 . . . . 2.2799999999999998 114.325 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.44 ' H ' ' HB ' ' A' ' 117' ' ' VAL . 10.7 mm-40 -76.14 171.7 14.05 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.252 1.526 . . . . 3.6000000000000001 108.002 146.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -105.63 150.61 25.28 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.067 1.347 . . . . 4.9800000000000004 107.77 160.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.92 119.22 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.162 0.985 . . . . 2.1699999999999999 110.663 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.82 137.7 40.66 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.153 1.781 . . . . 2.9399999999999999 110.316 165.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mt -155.98 133.48 10.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.043 0.925 . . . . 2.5600000000000001 111.948 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -115.28 101.67 9.16 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.337 1.455 . . . . 2.0800000000000001 110.799 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 119.86 22.92 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.253 1.421 . . . . 2.5899999999999999 111.032 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.57 123.2 36.72 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.616 1.166 . . . . 2.0600000000000001 111.498 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.15 135.62 53.75 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.045 0.926 . . . . 2.9700000000000002 112.501 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.45 63.6 3.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.722 1.609 . . . . 3.3900000000000001 112.917 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.42 33.15 0.09 OUTLIER Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.708 2.099 . . . . 4.8399999999999999 113.956 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.61 -0.13 77.66 Favored Glycine 0 N--CA 1.476 1.342 0 CA-C-N 118.284 1.042 . . . . 1.95 114.652 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -97.86 151.1 20.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 122.629 1.204 . . . . 7.5899999999999999 113.856 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.05 151.41 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.991 2.117 . . . . 1.8799999999999999 107.617 154.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.96 119.68 32.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.447 1.099 . . . . 3.1499999999999999 109.283 167.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -74.31 133.9 42.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.289 0.236 . . . . 3.8199999999999998 110.414 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.26 145.33 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.92 1.688 . . . . 2.3599999999999999 109.493 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -125.05 125.19 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.666 0.786 . . . . 3.77 110.03 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 155.92 56.03 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.396 1.479 . . . . 4.4500000000000002 111.076 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.54 164.48 32.28 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.735 2.957 . . . . 1.5800000000000001 111.626 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.44 ' HB ' ' H ' ' A' ' 97' ' ' GLU . 13.7 t -97.39 142.14 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.384 1.074 . . . . 2.2999999999999998 111.823 167.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -145.66 162.06 38.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.961 1.705 . . . . 3.9900000000000002 113.008 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.59 62.57 2.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.012 1.725 . . . . 3.0899999999999999 111.987 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.473 -1.727 . . . . 5.2400000000000002 111.315 -176.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.168 0 N-CA-C 108.725 -1.75 . . . . 13.369999999999999 108.725 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 p -175.49 45.9 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.733 2.013 . . . . 14.039999999999999 108.193 -167.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 81.47 146.39 0.08 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 128.922 2.889 . . . . 15.77 110.085 -134.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -169.48 -41.6 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.42 2.288 . . . . 8.3399999999999999 109.182 -161.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.13 167.06 5.3 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.841 0.856 . . . . 5.3300000000000001 110.048 150.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.52 157.31 42.07 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 123.377 0.513 . . . . 1.6699999999999999 112.371 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -154.75 139.19 16.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.02 0.748 . . . . 1.49 113.02 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.5 t -93.2 132.56 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.606 -0.516 . . . . 2.3100000000000001 109.606 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -78.22 114.43 17.1 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.325 1.05 . . . . 5.3499999999999996 112.022 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -79.97 146.98 31.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.086 0.946 . . . . 5.0999999999999996 110.469 159.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.44 152.63 4.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.474 1.51 . . . . 3.3300000000000001 110.957 169.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.95 75.55 3.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.076 3.184 . . . . 3.3100000000000001 109.776 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.42 -179.67 34.4 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.671 1.028 . . . . 1.72 115.671 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.66 -15.92 19.07 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.833 3.022 . . . . 2.8599999999999999 112.877 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -147.77 160.54 42.62 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 115.077 1.51 . . . . 3.02 115.077 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.83 -168.39 2.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.252 2.221 . . . . 2.3100000000000001 110.861 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 147.46 32.37 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.235 1.014 . . . . 2.5800000000000001 112.439 -174.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.19 118.45 36.82 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.987 0.358 . . . . 2.5 110.232 159.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -101.18 142.57 32.43 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.01 1.724 . . . . 3.9199999999999999 108.547 164.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -164.1 149.64 10.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.167 1.914 . . . . 2.79 116.167 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.3 m -115.08 138.43 50.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.529 1.532 . . . . 2.9399999999999999 109.771 -173.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.11 -179.85 8.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.308 1.843 . . . . 6.2400000000000002 110.444 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.76 159.87 43.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.81 0.844 . . . . 4.9000000000000004 110.106 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.81 102.63 10.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.296 -0.865 . . . . 1.3 109.506 163.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.13 -7.12 17.07 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.875 2.383 . . . . 1.6699999999999999 113.197 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.11 177.36 54.36 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 124.325 0.964 . . . . 1.4099999999999999 113.72 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 7.1 m-20 -107.96 1.6 22.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.346 1.458 . . . . 2.5600000000000001 112.664 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -115.2 162.71 22.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.431 1.893 . . . . 3.0 109.616 164.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.14 157.8 20.23 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.685 2.257 . . . . 1.27 111.489 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -105.77 153.52 21.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 3.4399999999999999 110.1 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -134.35 115.08 13.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.486 1.115 . . . . 4.8200000000000003 111.229 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.68 112.03 23.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.213 2.605 . . . . 1.99 108.601 -174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.92 -10.11 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.834 1.254 . . . . 1.8100000000000001 113.316 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.01 -173.95 46.09 Favored Glycine 0 C--N 1.342 0.883 0 O-C-N 121.543 -0.723 . . . . 0.56000000000000005 112.116 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.18 178.83 7.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.836 1.254 . . . . 1.99 110.306 170.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.35 142.41 3.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.187 -1.042 . . . . 5.6100000000000003 108.187 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -150.78 155.26 35.56 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 117.261 -1.352 . . . . 1.6899999999999999 108.274 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.61 -14.72 41.59 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.171 1.914 . . . . 1.3600000000000001 114.246 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.63 0.19 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.991 1.849 . . . . 2.3700000000000001 115.991 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.62 144.35 44.02 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 121.261 1.846 . . . . 2.1800000000000002 114.808 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -89.29 -76.37 0.41 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 110.259 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.3 ttm-85 -80.89 127.84 33.0 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.107 -0.995 . . . . 5.0 108.803 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.0 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 2.7000000000000002 110.322 167.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -144.59 133.49 22.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.823 1.649 . . . . 2.4300000000000002 110.924 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -79.31 119.25 22.09 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 120.055 1.298 . . . . 2.2000000000000002 111.027 170.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -110.58 156.02 21.52 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.756 2.022 . . . . 0.66000000000000003 111.795 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.29 -175.38 2.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.413 . . . . 2.8500000000000001 111.978 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -132.77 118.05 18.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.698 1.599 . . . . 2.48 108.441 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -115.99 179.05 4.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.436 1.094 . . . . 3.2599999999999998 111.098 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.3 ptp -143.21 128.88 19.24 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.549 0.74 . . . . 5.21 111.57 162.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -138.27 149.58 45.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.257 1.023 . . . . 7.5499999999999998 112.111 -173.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.439 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS 0.33 1.4 pm0 -64.92 146.84 54.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.026 1.731 . . . . 4.7400000000000002 113.792 172.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 54' ' ' GLU 0.29 6.7 p -135.7 -86.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.811 2.044 . . . . 3.9300000000000002 109.198 176.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.555 ' H ' HG13 ' A' ' 53' ' ' VAL . 16.2 mt-10 -77.11 41.43 0.29 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.703 2.001 . . . . 3.6899999999999999 110.736 165.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.51 -38.66 0.87 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.152 1.358 . . . . 2.29 113.767 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -61.39 133.8 56.21 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.12 1.368 . . . . 3.9700000000000002 110.972 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 25.6 mtpp -91.34 103.34 16.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.409 0.683 . . . . 6.5599999999999996 110.884 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -99.21 141.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.028 1.731 . . . . 2.71 109.911 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.43 153.59 29.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.677 1.591 . . . . 4.5199999999999996 112.336 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.72 161.16 33.98 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 121.822 -0.549 . . . . 1.3 114.396 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -113.62 137.03 52.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.449 1.5 . . . . 3.1099999999999999 111.164 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -150.57 156.64 36.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.359 1.463 . . . . 7.0 110.227 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.92 152.0 82.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.703 2.268 . . . . 0.88 111.641 171.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.78 157.36 69.1 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 126.181 1.792 . . . . 1.74 109.659 173.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.14 -18.17 40.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.784 2.322 . . . . 1.0800000000000001 113.237 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -179.15 167.21 1.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.819 2.047 . . . . 3.5800000000000001 110.755 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -113.8 166.73 11.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.975 1.71 . . . . 2.1000000000000001 109.264 155.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 163.83 39.14 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.115 -0.991 . . . . 2.4500000000000002 111.683 174.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.08 128.77 10.18 Favored Pre-proline 0 N--CA 1.466 0.354 0 C-N-CA 125.073 1.349 . . . . 2.2599999999999998 109.609 -161.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.53 163.61 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.938 . . . . 0.79000000000000004 111.554 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.38 138.49 84.63 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.516 2.811 . . . . 1.02 111.935 172.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 36.5 mmtm 68.34 7.2 5.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.977 2.111 . . . . 2.6099999999999999 113.456 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.57 113.16 3.62 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.79 1.662 . . . . 0.96999999999999997 112.252 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 136.93 37.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.513 -0.844 . . . . 6.4000000000000004 110.456 165.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.06 159.74 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.319 1.447 . . . . 3.5800000000000001 111.808 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -154.98 92.59 1.46 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.731 1.613 . . . . 3.6699999999999999 108.079 -170.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.67 139.07 57.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.397 1.079 . . . . 2.0600000000000001 108.649 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -158.9 156.52 26.87 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 127.349 2.26 . . . . 4.2599999999999998 111.237 -163.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.2 -64.17 0.1 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.918 3.079 . . . . 1.4099999999999999 112.088 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.19 91.52 1.03 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.022 -1.631 . . . . 1.97 109.022 166.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.33 -98.91 0.18 Allowed Glycine 0 C--O 1.221 -0.664 0 C-N-CA 124.707 1.146 . . . . 1.24 112.424 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -153.58 136.59 15.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.183 1.393 . . . . 3.3999999999999999 110.299 -172.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -165.62 166.71 17.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.267 1.394 . . . . 1.8999999999999999 110.806 -170.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -102.77 116.19 32.07 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 119.282 -0.39 . . . . 3.6600000000000001 110.18 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -68.31 127.69 33.87 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.663 -0.495 . . . . 1.77 109.663 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 mt -112.81 111.01 21.49 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.907 -1.516 . . . . 2.3999999999999999 106.907 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.47 116.55 25.66 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.66 -0.867 . . . . 4.5199999999999996 108.66 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.82 112.77 0.49 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.09 -1.204 . . . . 1.8799999999999999 110.09 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -110.16 113.94 27.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.162 0.985 . . . . 1.79 111.789 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.95 -11.84 60.97 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.829 1.251 . . . . 2.8700000000000001 114.209 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -153.89 145.73 16.9 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.1 1.36 . . . . 6.6600000000000001 109.998 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.69 132.42 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.202 1.935 . . . . 2.0499999999999998 109.288 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.2 169.18 12.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.819 1.648 . . . . 3.8599999999999999 112.321 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.03 145.04 43.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.213 1.005 . . . . 5.29 110.192 155.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.62 19.95 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.676 -0.861 . . . . 2.7599999999999998 108.676 160.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.39 78.11 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 117.901 -1.499 . . . . 2.71 115.83 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -74.4 175.24 7.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.233 2.016 . . . . 3.0899999999999999 109.449 158.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -91.95 155.85 17.86 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.297 1.046 . . . . 4.4699999999999998 111.387 152.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.02 127.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.93 -1.507 . . . . 2.5299999999999998 106.93 151.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.86 155.18 20.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.953 0.882 . . . . 4.1100000000000003 111.277 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.8 tt -163.25 129.97 3.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.308 -0.87 . . . . 2.8999999999999999 112.028 -152.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -78.12 105.41 9.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.325 3.05 . . . . 2.6899999999999999 111.494 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.1 mt -79.42 119.4 22.38 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.113 -0.992 . . . . 2.0499999999999998 109.343 171.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.1 mt -96.92 126.07 41.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.565 1.146 . . . . 1.8899999999999999 111.554 -168.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.22 158.27 22.53 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.438 -0.789 . . . . 3.5699999999999998 112.929 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.39 63.7 0.79 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.819 1.648 . . . . 2.8599999999999999 113.311 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 148.73 -149.65 21.7 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.39 1.472 . . . . 2.79 111.649 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.51 43.83 1.63 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.748 1.166 . . . . 2.9100000000000001 115.038 -173.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -140.6 137.75 33.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.888 1.344 . . . . 5.9199999999999999 113.987 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.75 132.35 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 127.438 2.295 . . . . 2.0099999999999998 108.66 169.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.97 102.22 8.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.229 1.412 . . . . 3.79 109.407 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 74.26 6.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.857 0.863 . . . . 3.8399999999999999 111.157 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.75 159.32 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.037 1.335 . . . . 2.7400000000000002 112.079 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 m -100.25 139.12 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 126.636 1.974 . . . . 4.4000000000000004 109.602 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.1 mt -143.24 135.46 13.28 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.549 1.14 . . . . 2.77 109.18 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.09 162.61 41.58 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.908 2.406 . . . . 1.6799999999999999 111.474 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.36 145.83 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 2.7000000000000002 111.318 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.77 156.35 44.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.042 1.737 . . . . 3.6800000000000002 109.302 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.73 41.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.45 1.5 . . . . 3.1299999999999999 113.1 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 117.516 -1.23 . . . . 6.1100000000000003 112.974 -152.639 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 109.784 -1.326 . . . . 12.449999999999999 109.784 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 t -162.58 165.18 26.26 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.143 1.377 . . . . 10.279999999999999 109.438 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -85.92 62.76 7.65 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.126 1.371 . . . . 10.140000000000001 111.76 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 p -77.68 157.99 29.89 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.197 -0.668 . . . . 7.54 109.197 166.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.48 -150.89 0.32 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.142 0.977 . . . . 5.6500000000000004 109.372 -174.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.72 122.08 1.09 Allowed Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.585 1.539 . . . . 1.75 114.299 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -111.56 149.21 31.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.942 0.897 . . . . 2.3100000000000001 111.145 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.57 140.29 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.712 -0.847 . . . . 2.4199999999999999 108.712 169.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 117.1 29.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 5.0899999999999999 112.953 -151.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.45 124.66 24.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.676 0.79 . . . . 3.9900000000000002 110.983 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -160.68 141.03 8.49 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.621 1.169 . . . . 2.9700000000000002 110.273 165.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -83.75 65.98 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.06 3.173 . . . . 2.6200000000000001 109.401 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.76 171.29 14.7 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.385 0.993 . . . . 1.55 113.467 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.05 -20.79 28.38 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.186 2.591 . . . . 2.48 111.305 164.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -151.36 169.6 21.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.439 1.896 . . . . 2.9100000000000001 112.315 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.14 157.55 43.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.83 1.652 . . . . 2.3599999999999999 110.073 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.55 116.24 28.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.399 1.08 . . . . 2.2799999999999998 109.524 167.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.81 162.22 13.36 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.383 1.473 . . . . 2.5299999999999998 111.428 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.44 164.14 28.85 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.265 1.426 . . . . 4.0599999999999996 111.616 -171.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -166.7 159.01 13.56 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.977 1.311 . . . . 2.5099999999999998 113.505 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -80.1 141.4 35.83 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.914 -0.773 . . . . 2.1400000000000001 108.914 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -130.7 129.98 43.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.26 2.224 . . . . 3.0299999999999998 108.351 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' CD ' ' HE ' ' A' ' 74' ' ' ARG . 3.4 pm0 -113.9 129.28 56.61 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.335 1.454 . . . . 3.3399999999999999 110.738 171.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -86.68 110.97 36.52 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 109.115 -0.698 . . . . 1.0800000000000001 109.115 155.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -86.7 -9.5 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.792 2.328 . . . . 1.3899999999999999 113.916 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.2 167.84 31.9 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.176 0.898 . . . . 1.1000000000000001 113.197 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -87.73 -1.14 57.77 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.471 1.509 . . . . 3.3900000000000001 114.322 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.8 159.34 36.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.067 1.347 . . . . 2.6200000000000001 110.454 169.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.98 151.76 18.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.836 2.357 . . . . 1.51 111.647 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 mt -100.98 155.64 17.85 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.085 0.954 . . . . 3.0600000000000001 111.19 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.431 HH21 ' CD ' ' A' ' 68' ' ' GLU . 24.3 ttm105 -132.21 110.75 10.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.041 1.337 . . . . 4.0300000000000002 109.797 169.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.5 tp -95.06 112.48 24.18 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 127.581 2.353 . . . . 1.8100000000000001 107.807 -175.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.88 -11.12 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.904 0.881 . . . . 1.6599999999999999 112.883 -166.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.36 -164.89 34.96 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.511 1.053 . . . . 0.48999999999999999 112.033 173.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.86 -179.14 6.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.225 1.01 . . . . 2.0099999999999998 110.012 164.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -155.9 141.24 17.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.83 1.252 . . . . 6.3200000000000003 108.963 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 t -151.43 156.1 34.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 119.501 1.046 . . . . 1.95 110.69 -165.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.36 -17.23 18.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.706 2.271 . . . . 0.96999999999999997 113.974 168.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -85.33 -23.78 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.954 1.465 . . . . 1.97 114.954 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.52 152.33 50.83 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.703 1.201 . . . . 1.96 112.252 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.547 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 10.1 tp10 -86.45 -88.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.003 -0.544 . . . . 2.8700000000000001 110.037 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -82.24 90.45 6.62 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.714 -0.847 . . . . 4.1799999999999997 108.714 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.99 137.38 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.576 0.75 . . . . 2.5299999999999998 111.076 166.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -137.18 140.02 41.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.296 1.839 . . . . 2.2000000000000002 109.708 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -88.16 122.11 31.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.553 -1.342 . . . . 1.8100000000000001 111.674 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -109.46 156.36 20.18 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.287 1.435 . . . . 0.75 112.541 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.8 -178.67 3.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.316 1.846 . . . . 1.9299999999999999 112.023 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.0 m -138.1 100.78 4.24 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.969 1.708 . . . . 2.5899999999999999 108.033 163.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -92.24 153.31 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.864 1.266 . . . . 3.3999999999999999 111.778 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptp -89.23 156.97 18.43 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.306 -0.871 . . . . 4.1500000000000004 111.972 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -163.31 153.11 15.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.872 1.269 . . . . 10.880000000000001 112.887 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -81.54 176.43 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.889 0.876 . . . . 3.6600000000000001 110.698 154.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.19 -121.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 126.152 1.781 . . . . 3.7999999999999998 106.571 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -73.35 62.52 0.71 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.559 2.343 . . . . 3.6200000000000001 110.131 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.05 2.06 6.19 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.307 1.432 . . . . 2.0499999999999998 115.291 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -111.02 129.86 55.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.812 2.445 . . . . 3.3599999999999999 110.21 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.412 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -100.19 144.37 29.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.76 0.824 . . . . 6.3099999999999996 112.466 -167.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -152.5 162.14 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.672 1.589 . . . . 3.3199999999999998 109.374 -166.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.5 ptp -84.38 171.37 12.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.752 0.821 . . . . 3.9100000000000001 112.012 161.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.16 148.95 19.99 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.492 1.52 . . . . 1.52 110.767 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -112.34 155.52 23.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.322 1.049 . . . . 2.52 110.24 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -168.39 158.87 8.7 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 126.471 1.909 . . . . 5.9900000000000002 108.927 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -67.89 154.52 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 120.967 1.112 . . . . 0.88 110.343 159.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.94 156.39 65.77 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 125.284 1.433 . . . . 2.04 109.819 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.28 -16.54 39.64 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.613 2.209 . . . . 0.80000000000000004 112.833 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -178.79 167.49 1.7 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.716 1.606 . . . . 3.0600000000000001 110.593 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -117.47 172.3 7.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.201 2.2 . . . . 2.1800000000000002 109.165 159.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.431 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.2 pt-20 -154.6 161.11 41.76 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.011 -1.056 . . . . 2.1600000000000001 111.15 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -146.9 129.92 8.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.442 0.697 . . . . 1.8500000000000001 110.648 -167.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.17 162.46 38.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.056 2.504 . . . . 1.3799999999999999 112.315 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.05 136.29 64.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 124.457 3.438 . . . . 1.3799999999999999 113.356 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 64.07 2.58 1.46 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 3.02 113.794 -174.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.6 116.03 4.29 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 127.284 2.373 . . . . 0.97999999999999998 110.724 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.445 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 8.2 ttt180 -102.92 130.42 49.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.092 1.357 . . . . 6.1399999999999997 110.275 164.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -147.74 152.66 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.519 1.528 . . . . 3.4500000000000002 111.338 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 130.86 48.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.873 0.869 . . . . 3.3700000000000001 112.132 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.97 78.03 0.32 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.152 1.381 . . . . 1.8700000000000001 108.067 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -81.05 146.92 60.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 3.3900000000000001 111.095 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.38 -50.85 12.64 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.52 2.813 . . . . 0.95999999999999996 113.141 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.31 67.63 3.66 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.84 -0.904 . . . . 1.0700000000000001 110.84 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.05 -78.32 0.07 OUTLIER Glycine 0 N--CA 1.466 0.694 0 C-N-CA 124.975 1.274 . . . . 0.98999999999999999 112.807 -170.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -156.51 143.04 18.46 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.141 2.176 . . . . 3.0 109.632 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -169.76 159.11 7.87 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.895 -1.128 . . . . 1.0600000000000001 110.882 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -97.56 121.38 39.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.396 0.678 . . . . 3.54 112.028 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.8 mmt -79.25 123.64 27.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.2 1.0 . . . . 1.8200000000000001 109.557 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -104.64 79.33 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.36 1.464 . . . . 2.9700000000000002 110.485 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -78.9 128.32 33.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.626 1.103 . . . . 3.6000000000000001 109.538 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.88 74.74 0.9 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.857 -0.897 . . . . 1.3100000000000001 110.857 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.1 89.94 3.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.739 1.269 . . . . 2.8900000000000001 110.774 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.547 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 3.0 ptmt -55.44 -9.14 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.487 1.515 . . . . 3.1699999999999999 114.091 171.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -136.84 135.58 20.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.877 1.671 . . . . 6.0199999999999996 108.847 167.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 141.81 40.77 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.126 1.884 . . . . 1.7 109.115 165.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.0 81.92 7.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.567 1.147 . . . . 3.1499999999999999 110.473 -172.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.465 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -70.22 108.73 4.29 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.564 -1.335 . . . . 4.3899999999999997 109.605 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -43.07 124.98 3.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.797 0.839 . . . . 2.21 111.392 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.65 -22.06 15.52 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 115.984 -2.565 . . . . 2.1699999999999999 116.492 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.465 ' CD ' ' HZ3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -86.43 177.19 7.51 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.387 2.593 . . . . 4.2800000000000002 111.98 -177.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -96.58 132.29 42.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.373 1.869 . . . . 4.8499999999999996 112.651 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.0 t -102.5 116.34 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.849 -1.157 . . . . 2.0499999999999998 108.891 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.92 143.8 35.49 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.047 0.927 . . . . 3.0800000000000001 110.557 160.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 117.56 5.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.743 0.817 . . . . 2.8399999999999999 110.952 -168.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -81.53 95.58 7.16 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.164 2.186 . . . . 2.8199999999999998 110.377 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.8 mt -72.39 119.2 16.26 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.478 -0.764 . . . . 2.29 109.936 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.3 mt -95.4 132.19 40.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.032 0.933 . . . . 1.8200000000000001 111.249 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.24 147.09 52.55 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.434 1.111 . . . . 3.1899999999999999 112.73 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.08 136.72 56.36 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.034 1.124 . . . . 2.3300000000000001 114.034 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 48.93 13.66 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.971 0.796 . . . . 3.8100000000000001 113.63 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.46 23.8 55.57 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 115.951 1.14 . . . . 1.79 115.951 168.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -108.52 146.21 33.57 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.809 1.804 . . . . 5.1399999999999997 111.973 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.93 137.59 13.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.783 2.033 . . . . 2.0099999999999998 107.761 166.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -128.77 109.99 11.78 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.686 1.194 . . . . 2.4399999999999999 108.605 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -81.78 126.91 32.4 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.663 -0.648 . . . . 3.8100000000000001 111.88 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.1 m -118.95 167.3 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.287 1.835 . . . . 2.5899999999999999 110.259 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -116.08 139.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.839 1.255 . . . . 3.0099999999999998 110.416 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.3 mt -140.11 136.83 17.38 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 127.495 2.318 . . . . 2.4700000000000002 108.005 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.86 154.94 48.67 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.803 2.335 . . . . 1.4199999999999999 112.059 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.29 123.22 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.848 1.259 . . . . 2.52 109.48 168.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' CD ' HH22 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -156.68 166.74 32.53 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.546 1.138 . . . . 3.6000000000000001 111.712 -174.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.53 84.84 2.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.74 1.216 . . . . 2.52 113.923 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.402 HH22 ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.013 -1.106 . . . . 7.2699999999999996 108.013 148.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 110.639 -0.984 . . . . 9.4700000000000006 110.639 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -98.51 56.25 1.13 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.178 -1.045 . . . . 12.300000000000001 108.178 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 65.97 -59.17 0.32 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.553 2.341 . . . . 12.19 111.085 -157.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.2 p -49.75 141.41 10.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 128.475 2.71 . . . . 8.5999999999999996 113.117 160.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -151.46 161.42 42.72 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.658 2.383 . . . . 5.1399999999999997 109.779 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.34 -175.21 43.7 Favored Glycine 0 N--CA 1.464 0.52 0 O-C-N 121.116 -0.99 . . . . 1.6200000000000001 112.061 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -161.12 154.14 21.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.932 1.086 . . . . 1.8799999999999999 113.932 174.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.48 140.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.762 0.825 . . . . 2.0899999999999999 109.33 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -87.11 110.94 20.46 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.674 -0.641 . . . . 5.0300000000000002 111.582 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.58 127.22 30.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.526 1.155 . . . . 4.1500000000000004 109.9 155.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -153.14 164.5 20.2 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.067 2.147 . . . . 2.75 107.551 161.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -94.08 -161.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.155 3.236 . . . . 3.46 109.111 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.55 -150.92 28.86 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.386 0.993 . . . . 3.1000000000000001 113.021 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -84.72 -16.44 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.618 2.879 . . . . 3.0800000000000001 113.843 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -153.82 160.66 42.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.735 1.754 . . . . 3.1200000000000001 115.735 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.15 177.75 7.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.94 2.096 . . . . 2.0600000000000001 110.499 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.82 144.27 45.6 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.622 1.169 . . . . 1.95 111.641 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.92 147.54 44.61 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.952 0.901 . . . . 1.8999999999999999 112.188 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.83 146.88 41.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.243 1.817 . . . . 3.3999999999999999 110.289 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.51 151.6 9.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.348 -1.47 . . . . 2.5299999999999998 114.751 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -87.76 93.41 9.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.539 1.936 . . . . 3.1099999999999999 107.354 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.02 140.6 29.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.232 1.413 . . . . 3.25 109.83 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -127.47 156.66 41.77 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.632 0.975 . . . . 3.0499999999999998 113.632 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.84 99.71 53.03 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.149 1.38 . . . . 0.97999999999999998 108.964 163.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.05 -9.34 14.18 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.093 2.529 . . . . 1.54 113.058 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -173.48 49.78 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.684 1.135 . . . . 1.1599999999999999 113.389 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.3 m-20 -113.11 0.96 15.13 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.522 1.529 . . . . 2.5 112.802 -168.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.23 160.7 42.35 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.072 1.749 . . . . 2.5699999999999998 110.257 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.47 154.44 16.04 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.109 2.539 . . . . 1.0900000000000001 111.849 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.87 130.24 52.28 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.309 1.444 . . . . 3.46 110.419 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.411 HH21 ' CD ' ' A' ' 68' ' ' GLU . 31.8 ttm180 -114.18 109.42 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.912 1.285 . . . . 3.6699999999999999 109.612 176.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.3 tp -90.51 107.63 19.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 126.77 2.028 . . . . 2.1899999999999999 108.428 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.0 m -101.15 -12.45 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.191 0.996 . . . . 1.9199999999999999 112.927 -168.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.1 -163.81 32.21 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.251 0.929 . . . . 0.60999999999999999 112.208 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.89 -173.18 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.562 1.145 . . . . 1.6000000000000001 110.145 164.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -161.7 137.17 7.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.763 1.625 . . . . 5.8600000000000003 107.98 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -146.74 147.21 29.27 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 117.152 -1.404 . . . . 1.99 109.341 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.35 -6.96 19.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.021 1.814 . . . . 1.1499999999999999 113.816 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -93.91 -1.68 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.574 1.694 . . . . 1.8100000000000001 115.574 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.1 150.11 34.37 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.562 1.528 . . . . 1.8400000000000001 113.809 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.85 -67.1 0.81 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.611 1.565 . . . . 3.3300000000000001 111.274 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -90.02 147.08 23.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 122.572 1.177 . . . . 4.2300000000000004 110.321 168.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.02 129.27 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.456 2.302 . . . . 2.1400000000000001 106.582 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.94 120.39 13.15 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.078 1.351 . . . . 2.0299999999999998 109.016 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -78.98 121.71 25.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.064 1.302 . . . . 1.75 110.302 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.0 m170 -111.54 152.75 27.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.298 1.839 . . . . 0.68999999999999995 112.053 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.91 -176.45 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.212 -1.358 . . . . 2.0099999999999998 110.022 165.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.6 m -126.82 75.69 1.58 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.283 1.433 . . . . 1.99 107.526 170.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -65.45 150.04 49.02 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 3.8700000000000001 112.475 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -88.18 150.36 23.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.351 1.061 . . . . 7.2699999999999996 111.931 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -155.6 155.4 33.24 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.517 1.527 . . . . 9.5999999999999996 111.481 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -99.5 148.01 24.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 3.4399999999999999 110.205 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -141.4 122.22 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 106.428 -1.693 . . . . 3.5899999999999999 106.428 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 62.76 22.81 13.6 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.911 0.884 . . . . 3.8799999999999999 112.085 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.82 69.07 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.303 -1.498 . . . . 1.8200000000000001 114.36 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -96.88 141.55 29.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.567 1.947 . . . . 3.5600000000000001 109.992 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 135.2 35.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.624 1.17 . . . . 5.7400000000000002 111.294 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.51 141.8 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.236 1.814 . . . . 2.48 109.161 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -117.41 145.18 44.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.09 0.956 . . . . 4.7199999999999998 110.167 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.76 169.14 31.19 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 125.141 1.353 . . . . 1.2 112.633 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.06 151.66 20.7 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.512 1.156 . . . . 2.2400000000000002 113.133 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -164.55 146.8 7.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.435 1.494 . . . . 7.4199999999999999 110.159 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.5 Cg_endo -68.93 153.6 72.33 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.688 1.592 . . . . 0.97999999999999998 111.314 172.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.33 157.65 60.85 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.785 1.634 . . . . 1.75 110.537 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.99 -18.08 36.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.598 2.198 . . . . 0.64000000000000001 112.981 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.26 165.44 1.84 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.099 1.759 . . . . 2.98 111.575 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -111.07 173.4 6.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.366 1.866 . . . . 1.95 109.614 152.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' CD ' HH21 ' A' ' 31' ' ' ARG . 9.9 pt-20 -155.9 168.88 25.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.423 -0.798 . . . . 1.8400000000000001 112.435 170.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.62 133.23 8.63 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.811 1.244 . . . . 1.6200000000000001 109.783 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.12 164.13 36.26 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.283 1.989 . . . . 0.89000000000000001 110.925 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.53 143.42 92.95 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.008 2.472 . . . . 0.83999999999999997 111.502 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 63.0 mmtt 67.26 0.25 2.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.79 2.036 . . . . 2.4399999999999999 113.504 -173.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.13 115.66 4.15 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 126.366 1.936 . . . . 0.94999999999999996 110.528 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.91 112.2 24.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.038 1.335 . . . . 7.7400000000000002 109.539 170.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.72 -174.98 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.007 1.723 . . . . 2.1099999999999999 111.016 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 102.92 2.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.301 1.04 . . . . 4.5499999999999998 111.023 -165.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.13 77.17 0.51 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.078 1.751 . . . . 1.8200000000000001 109.112 161.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -91.77 147.79 35.8 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 127.832 2.453 . . . . 3.6099999999999999 112.189 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.51 -64.18 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.787 3.658 . . . . 1.05 113.325 -170.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.45 97.36 1.7 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 108.439 -1.864 . . . . 1.3200000000000001 108.439 165.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.81 -90.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.924 1.249 . . . . 1.0800000000000001 112.358 -169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -148.29 141.64 25.22 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.345 1.858 . . . . 3.4700000000000002 110.143 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -169.19 169.64 9.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.687 -1.258 . . . . 1.26 110.518 -172.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.65 136.13 41.0 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.646 -0.501 . . . . 3.1899999999999999 109.646 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 mmt -91.28 126.31 36.33 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.339 -0.985 . . . . 1.71 108.339 161.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.25 111.08 22.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.41 1.484 . . . . 3.8700000000000001 107.596 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 126.63 55.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.647 1.579 . . . . 3.6899999999999999 108.841 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.15 95.46 0.09 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.046 -1.222 . . . . 1.3600000000000001 110.046 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.5 mt -92.72 124.39 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.544 0.672 . . . . 1.99 111.09 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.02 -19.73 61.81 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.8 1.037 . . . . 2.3799999999999999 113.8 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -149.5 162.66 27.89 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.738 2.015 . . . . 8.0700000000000003 108.974 164.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.86 138.36 68.19 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.276 -1.471 . . . . 1.9299999999999999 108.276 149.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.01 150.63 31.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 3.4900000000000002 109.53 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.76 0.94 51.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.296 1.221 . . . . 7.0499999999999998 114.296 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 72.2 161.89 0.25 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.27 2.628 . . . . 2.7400000000000002 112.101 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.61 -12.16 0.77 Allowed Glycine 0 N--CA 1.482 1.728 0 N-CA-C 116.8 1.48 . . . . 4.0199999999999996 116.8 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.98 166.51 22.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.707 2.484 . . . . 3.7999999999999998 117.707 -153.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.61 68.55 9.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 131.659 3.984 . . . . 5.96 113.206 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.95 106.65 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 120.671 -1.268 . . . . 2.0800000000000001 111.126 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.04 129.86 44.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.667 1.587 . . . . 2.9900000000000002 110.764 160.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 mt -149.58 109.87 4.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.223 1.009 . . . . 2.8799999999999999 112.272 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.67 96.18 5.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.192 2.597 . . . . 2.02 109.47 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.9 mt -77.23 118.39 19.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.321 -0.862 . . . . 2.2200000000000002 110.608 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -91.92 127.55 37.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.151 0.98 . . . . 1.76 111.801 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -126.12 134.03 51.45 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.552 0.945 . . . . 3.8599999999999999 113.552 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 33.12 49.63 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.579 2.352 . . . . 3.0 114.142 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.93 -94.01 0.77 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.574 1.083 . . . . 3.9399999999999999 111.946 -170.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.65 23.0 7.96 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 117.381 1.712 . . . . 1.6100000000000001 117.381 -164.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -117.76 153.26 33.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.508 2.154 . . . . 5.7999999999999998 109.782 166.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.03 139.95 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.289 1.436 . . . . 2.29 109.584 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -123.31 110.97 15.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.024 1.33 . . . . 2.7999999999999998 109.48 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -85.3 108.17 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.093 -0.38 . . . . 3.5600000000000001 111.479 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -104.55 159.84 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.46 1.504 . . . . 2.04 110.937 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.97 137.99 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.347 1.059 . . . . 3.21 109.658 162.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 144.19 46.83 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.216 1.406 . . . . 2.6400000000000001 109.958 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.37 141.82 26.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.823 2.348 . . . . 1.45 110.37 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.42 153.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.82 0.848 . . . . 2.6499999999999999 112.43 167.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -146.61 158.05 43.83 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 3.8700000000000001 109.124 163.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.58 99.48 10.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.924 -1.11 . . . . 3.1000000000000001 108.109 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.222 0 CA-C-O 114.844 -2.503 . . . . 6.4100000000000001 117.275 -154.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.097 0 N-CA-C 110.181 -1.167 . . . . 9.5999999999999996 110.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m 51.18 46.76 25.99 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.397 1.629 . . . . 10.550000000000001 115.397 157.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 91.48 -10.97 0.25 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 129.752 3.221 . . . . 15.25 114.402 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.256 70.3 p 101.41 122.75 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.058 1 C-N-CA 133.83 4.852 . . . . 8.9000000000000004 108.806 177.503 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -72.97 103.14 3.67 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.277 1.031 . . . . 6.4100000000000001 109.382 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.93 173.38 41.52 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.162 1.363 . . . . 1.27 113.818 -168.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -159.13 145.31 16.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.552 1.541 . . . . 1.71 110.571 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.3 t -91.29 143.05 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.692 1.197 . . . . 1.9399999999999999 109.303 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -69.21 116.91 10.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.626 -0.671 . . . . 4.6200000000000001 112.31 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.2 134.18 56.77 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.156 0.983 . . . . 5.1500000000000004 109.999 161.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -166.13 140.46 3.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 120.534 -1.353 . . . . 2.8399999999999999 112.456 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -92.59 68.99 0.68 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.234 3.29 . . . . 3.1099999999999999 110.348 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.01 -177.76 36.26 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.772 1.069 . . . . 1.48 115.772 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.54 -0.25 8.1 Favored 'Trans proline' 0 CA--C 1.542 0.91 1 C-N-CA 125.494 4.129 . . . . 1.71 113.371 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -134.37 152.75 51.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 3.0800000000000001 111.56 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 -170.28 3.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.211 2.204 . . . . 2.1800000000000002 109.933 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.24 152.9 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.309 1.444 . . . . 2.0299999999999998 109.412 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.2 136.69 51.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.415 1.461 . . . . 2.1099999999999999 111.902 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -120.27 135.07 55.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.015 1.726 . . . . 3.3300000000000001 110.277 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.8 152.19 11.35 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.872 -1.143 . . . . 2.8199999999999998 112.423 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 m -95.93 92.28 6.42 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.112 0.965 . . . . 2.4900000000000002 110.029 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -80.41 133.61 35.9 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.097 -0.705 . . . . 2.9500000000000002 109.097 173.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.86 145.73 50.85 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.107 1.763 . . . . 2.79 110.124 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -107.86 104.28 52.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.702 0.801 . . . . 1.1299999999999999 110.073 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.33 -12.97 11.33 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.506 2.137 . . . . 1.05 113.321 176.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.13 -174.25 49.53 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.149 0.88 . . . . 1.21 113.221 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 11.0 m-20 -112.22 6.01 18.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.594 1.557 . . . . 2.75 112.337 -173.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.5 160.92 60.01 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.86 2.064 . . . . 2.73 109.988 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.44 144.64 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.324 2.016 . . . . 1.22 112.028 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.95 121.26 41.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.363 1.465 . . . . 3.4199999999999999 108.934 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 ttm105 -110.53 97.53 6.95 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.481 1.112 . . . . 4.2300000000000004 110.753 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.67 106.74 11.92 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.292 2.237 . . . . 1.8 109.551 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.82 -13.42 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.155 1.382 . . . . 2.1099999999999999 113.524 -171.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.95 34.28 Favored Glycine 0 C--N 1.34 0.753 0 O-C-N 121.632 -0.668 . . . . 0.72999999999999998 112.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -160.77 175.41 12.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.918 0.887 . . . . 1.71 112.76 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -143.72 156.48 44.54 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.831 0.452 . . . . 8.8399999999999999 110.391 160.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 t -152.95 149.69 22.52 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.139 1.376 . . . . 2.0 108.628 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.97 -35.07 56.87 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.167 1.245 . . . . 1.48 111.24 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.97 4.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.868 1.433 . . . . 1.96 114.868 -164.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.34 170.2 14.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.186 1.794 . . . . 2.02 109.99 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -106.38 -82.84 0.53 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.413 -0.958 . . . . 2.7999999999999998 108.413 164.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.68 125.67 28.06 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.164 -0.96 . . . . 5.9900000000000002 109.072 165.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.63 138.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.196 1.799 . . . . 2.1499999999999999 109.419 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -140.07 127.69 21.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.663 1.185 . . . . 2.2799999999999998 111.927 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -78.93 122.87 26.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.767 -1.208 . . . . 1.8300000000000001 110.795 167.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -108.71 153.2 23.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.71 1.604 . . . . 0.95999999999999996 112.637 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -87.32 158.72 18.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.309 1.044 . . . . 2.23 109.803 162.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -109.31 143.91 38.17 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.161 -1.422 . . . . 2.4199999999999999 107.161 152.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -137.46 155.07 49.74 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 3.3300000000000001 111.285 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -111.02 121.81 46.31 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.101 -1.444 . . . . 4.2000000000000002 107.101 160.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -146.44 173.21 12.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.387 1.475 . . . . 8.0500000000000007 110.274 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.473 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 3.8 mp0 -73.98 155.13 38.94 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.418 0.687 . . . . 3.21 110.132 159.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.85 -98.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.948 -1.131 . . . . 4.4299999999999997 107.948 168.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -74.75 63.15 1.13 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.833 1.653 . . . . 5.46 111.723 170.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.63 -24.67 0.63 Allowed Glycine 0 N--CA 1.475 1.274 0 C-N-CA 126.462 1.982 . . . . 3.8300000000000001 115.222 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -107.56 164.03 12.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.909 2.484 . . . . 4.1600000000000001 111.628 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 8.1 tppt? -76.87 134.15 39.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.375 2.27 . . . . 4.9500000000000002 112.084 -175.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -144.08 147.35 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.345 1.858 . . . . 2.4300000000000002 109.995 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -98.0 118.54 34.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.515 1.526 . . . . 4.7000000000000002 110.303 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.16 -179.19 16.1 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.389 1.471 . . . . 1.29 113.239 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.5 mtt -142.26 158.67 43.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.413 1.485 . . . . 2.71 111.244 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.87 151.04 4.78 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.741 -1.123 . . . . 5.3899999999999997 113.437 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.31 142.05 94.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.82999999999999996 112.006 172.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.63 159.86 48.89 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 126.516 1.926 . . . . 1.5800000000000001 110.882 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.15 -21.29 18.09 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.564 2.176 . . . . 0.73999999999999999 113.455 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -171.87 163.72 6.32 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 120.27 1.396 . . . . 4.1399999999999997 112.395 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -115.03 173.51 6.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.199 2.2 . . . . 2.0299999999999998 109.24 155.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.91 164.27 38.68 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.645 -0.659 . . . . 2.5600000000000001 112.13 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.1 t -139.25 125.79 12.53 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 125.412 1.485 . . . . 2.3599999999999999 108.733 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.21 159.13 54.13 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.124 1.883 . . . . 1.25 110.512 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.77 140.5 93.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.959 2.439 . . . . 1.1299999999999999 111.654 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 64.1 mmtt 72.17 -8.52 1.14 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.27 2.228 . . . . 2.2400000000000002 113.997 -177.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.05 -172.93 49.6 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.882 1.706 . . . . 1.47 112.873 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -160.61 161.76 32.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.965 2.106 . . . . 5.4299999999999997 111.843 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.8 129.88 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.112 1.365 . . . . 2.75 110.007 170.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.455 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -88.88 122.29 32.1 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.22 0.533 . . . . 3.3599999999999999 110.307 165.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -68.89 68.14 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.368 1.867 . . . . 2.0499999999999998 109.954 169.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 7.9 ptpp? -70.85 142.27 87.94 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.472 1.509 . . . . 3.6699999999999999 110.32 174.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.41 -57.02 2.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.55 2.833 . . . . 1.3799999999999999 112.233 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.96 78.0 2.01 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.357 -1.097 . . . . 1.54 110.357 166.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.23 -79.61 0.08 OUTLIER Glycine 0 N--CA 1.466 0.637 0 C-N-CA 127.119 2.295 . . . . 1.02 111.415 -175.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -153.84 147.49 25.2 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.631 1.972 . . . . 3.8100000000000001 108.905 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -159.7 154.13 23.94 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 120.496 -1.378 . . . . 0.95999999999999996 109.276 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -92.39 104.03 16.4 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.329 -1.36 . . . . 3.0600000000000001 107.329 167.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 129.61 40.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.603 -0.888 . . . . 2.7000000000000002 108.603 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -114.81 122.14 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.647 1.579 . . . . 2.77 109.016 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.02 155.85 36.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.333 1.053 . . . . 3.9100000000000001 110.668 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.92 -64.25 4.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.129 1.347 . . . . 3.5099999999999998 112.29 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt 74.1 110.96 0.07 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.568 2.747 . . . . 2.46 115.526 164.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -89.17 -3.73 58.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.579 -1.325 . . . . 2.9500000000000002 113.595 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -137.35 138.61 25.43 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 126.193 1.797 . . . . 6.1399999999999997 108.77 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.97 130.13 17.38 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 N-CA-C 107.469 -1.781 . . . . 1.77 107.469 159.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.55 85.1 6.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.411 0.684 . . . . 3.8500000000000001 109.563 -170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HE3' ' CG ' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -102.8 142.37 34.04 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.344 1.058 . . . . 4.5800000000000001 111.463 175.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.17 142.06 48.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 114.546 1.313 . . . . 2.7400000000000002 114.546 -170.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.39 52.12 28.24 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.781 -0.645 . . . . 2.0 112.789 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' CG ' ' HE3' ' A' ' 94' ' ' LYS . 2.8 mt-10 -107.51 -175.74 2.87 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.549 -1.278 . . . . 2.4900000000000002 107.549 147.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.51 120.43 31.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.76 0.79 . . . . 4.7400000000000002 109.277 166.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.11 103.85 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.774 -0.824 . . . . 2.2200000000000002 108.774 168.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 141.62 40.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.313 1.054 . . . . 3.5 110.672 162.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.43 ' HA ' HH21 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -155.25 130.58 9.65 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.171 -0.956 . . . . 4.5199999999999996 111.881 -167.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.71 121.25 38.34 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.443 1.097 . . . . 2.3199999999999998 109.413 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -95.36 119.11 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.174 1.389 . . . . 2.1600000000000001 110.012 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 mt -92.28 124.55 36.42 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.002 0.921 . . . . 1.9199999999999999 110.505 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.91 126.67 50.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.141 0.977 . . . . 3.6000000000000001 112.542 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 50.07 21.12 0.69 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.258 1.823 . . . . 2.8999999999999999 114.821 171.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.53 -61.12 2.82 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.695 1.14 . . . . 3.2400000000000002 112.361 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.79 1.37 53.95 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.188 1.635 . . . . 1.8899999999999999 117.188 -165.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -137.24 146.24 44.55 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.71 1.755 . . . . 6.75 111.351 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.01 148.46 23.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.121 1.368 . . . . 1.8899999999999999 109.822 163.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -143.37 133.03 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.396 1.878 . . . . 2.7799999999999998 109.657 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -85.65 140.74 30.31 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.624 0.602 . . . . 3.0600000000000001 112.624 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -125.52 177.23 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.606 1.962 . . . . 2.0299999999999998 109.461 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -155.21 140.69 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.404 0.547 . . . . 2.9500000000000002 111.002 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.32 152.39 19.91 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.965 1.306 . . . . 3.75 112.844 -171.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -79.27 -170.28 0.97 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.24 3.293 . . . . 1.21 112.346 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.42 84.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 126.857 2.063 . . . . 2.2400000000000002 111.389 -161.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -128.89 172.88 10.9 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 119.983 -1.698 . . . . 5.4800000000000004 114.553 -171.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.07 142.19 28.89 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.67 -1.269 . . . . 3.3700000000000001 113.532 -167.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 C-N-CA 126.702 2.001 . . . . 7.7599999999999998 111.528 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.921 0 N-CA-C 107.631 -2.188 . . . . 10.640000000000001 107.631 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -83.39 -21.86 32.92 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.622 0.711 . . . . 10.57 111.703 165.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -131.4 -179.02 5.11 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.98 2.112 . . . . 9.6099999999999994 110.219 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.3 p -66.66 114.78 5.85 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.809 1.244 . . . . 7.79 108.0 160.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -133.02 -179.12 5.29 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.848 2.059 . . . . 5.21 109.312 -169.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.11 165.68 21.77 Favored Glycine 0 N--CA 1.475 1.239 0 O-C-N 120.296 -1.503 . . . . 1.24 113.371 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.2 p90 -167.09 163.26 15.72 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.122 1.369 . . . . 1.8600000000000001 111.805 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -127.4 135.6 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.277 -0.889 . . . . 2.52 110.522 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -88.68 129.52 35.51 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.469 1.128 . . . . 5.4100000000000001 113.605 -169.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -79.55 141.33 36.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.108 2.163 . . . . 4.2599999999999998 112.562 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -162.8 152.26 13.01 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.329 1.451 . . . . 2.79 110.943 165.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.45 56.55 4.3 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.546 3.497 . . . . 2.4399999999999999 109.706 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.81 174.86 17.65 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.661 1.124 . . . . 1.3200000000000001 114.068 -172.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.13 -15.22 13.02 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.904 3.069 . . . . 1.95 112.556 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -143.89 154.3 43.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.479 1.912 . . . . 2.4700000000000002 111.834 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.29 -179.85 8.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.728 1.611 . . . . 2.0600000000000001 110.751 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.67 49.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.18 0.807 . . . . 2.2999999999999998 113.18 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.48 141.66 36.58 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.998 0.519 . . . . 2.0099999999999998 110.763 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -117.67 157.26 26.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.937 1.695 . . . . 3.4199999999999999 110.08 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -167.47 148.07 5.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.994 1.479 . . . . 2.29 114.994 166.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.4 m -75.83 140.38 42.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.528 -1.214 . . . . 2.2200000000000002 109.636 157.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.33 130.63 15.6 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.687 1.195 . . . . 3.8199999999999998 109.069 168.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -136.95 152.64 50.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.284 1.04 . . . . 4.5300000000000002 112.276 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -104.15 102.49 32.74 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.066 1.346 . . . . 1.3200000000000001 110.528 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.71 -9.19 14.63 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.315 2.01 . . . . 1.9199999999999999 113.603 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.17 -170.44 44.87 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.362 0.982 . . . . 1.5 112.998 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 5.2 m-20 -120.86 9.95 10.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.782 1.233 . . . . 2.6600000000000001 112.943 -168.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.76 159.4 53.55 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.047 1.739 . . . . 3.3799999999999999 110.69 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.67 153.51 15.36 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.757 2.305 . . . . 2.1699999999999999 111.805 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.19 142.24 43.64 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.732 1.613 . . . . 3.1200000000000001 109.019 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -141.41 107.49 5.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.712 0.805 . . . . 4.4100000000000001 109.805 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.37 129.14 44.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.277 2.631 . . . . 3.4399999999999999 109.218 -165.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.84 -9.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.136 1.162 . . . . 1.77 114.136 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.19 -160.75 28.77 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.069 -1.02 . . . . 0.55000000000000004 112.285 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 -174.25 4.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.942 1.697 . . . . 1.71 110.664 165.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -150.84 144.87 25.32 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.609 1.963 . . . . 8.5199999999999996 109.136 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -141.01 151.26 61.83 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 120.376 1.444 . . . . 1.6100000000000001 109.462 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.0 -22.14 48.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.359 2.039 . . . . 0.88 113.851 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.91 2.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 115.178 1.547 . . . . 2.04 115.178 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 175.6 12.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.652 1.181 . . . . 1.9099999999999999 112.306 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.468 ' CD ' ' HZ2' ' A' ' 90' ' ' LYS . 8.0 tp10 -110.56 -89.36 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.575 1.15 . . . . 2.8399999999999999 109.894 178.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -77.72 100.6 6.29 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 120.667 -1.27 . . . . 5.0499999999999998 108.932 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -82.24 135.04 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.664 1.585 . . . . 2.3700000000000001 111.147 162.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.1 147.48 51.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.822 2.449 . . . . 2.1699999999999999 108.407 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 tt -92.79 124.1 36.54 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.9 1.682 . . . . 2.27 111.162 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.7 m170 -114.01 152.47 30.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.317 1.447 . . . . 0.93000000000000005 112.635 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -98.74 166.43 11.32 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 2.1600000000000001 110.319 167.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -125.14 117.69 24.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.591 1.156 . . . . 2.2799999999999998 108.166 167.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -119.64 -177.59 3.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.44 1.496 . . . . 3.4100000000000001 112.084 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -140.33 163.19 33.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.424 1.09 . . . . 3.6099999999999999 111.895 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.36 166.82 20.39 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.641 1.577 . . . . 6.9199999999999999 112.023 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 135.42 40.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.537 1.535 . . . . 4.8499999999999996 108.445 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.8 -113.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.745 1.618 . . . . 4.1500000000000004 107.025 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 0.8 OUTLIER -77.26 67.19 3.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.519 1.054 . . . . 4.3099999999999996 108.931 164.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.89 -22.01 0.46 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 127.323 2.392 . . . . 2.5 115.953 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 12.5 ptpt -74.93 133.82 41.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.5 1.92 . . . . 4.9000000000000004 110.134 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.95 127.63 36.48 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.927 0.891 . . . . 6.3399999999999999 109.67 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.12 152.58 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.657 1.583 . . . . 3.7200000000000002 109.876 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.5 ptp -83.96 162.13 20.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.505 1.522 . . . . 4.7199999999999998 113.32 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.52 172.93 33.68 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.669 1.604 . . . . 1.48 113.122 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtt -137.09 154.55 50.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.554 1.542 . . . . 3.0099999999999998 110.472 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -168.77 154.11 6.21 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.683 1.193 . . . . 6.0499999999999998 111.144 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 3.8 Cg_endo -68.6 152.38 74.67 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.46 1.44 . . . . 0.76000000000000001 112.085 171.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.97 149.36 68.28 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 125.945 1.698 . . . . 1.8300000000000001 109.842 172.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.31 -19.08 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.903 2.402 . . . . 1.0900000000000001 113.909 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -172.61 171.56 4.49 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.804 1.184 . . . . 2.9500000000000002 113.117 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.23 175.26 10.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.839 2.456 . . . . 4.1200000000000001 109.373 159.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.45 168.8 25.92 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 120.602 -1.311 . . . . 2.3900000000000001 111.132 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -149.65 137.73 11.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 124.72 1.208 . . . . 2.4500000000000002 108.737 -167.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.77 171.73 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.655 1.57 . . . . 1.76 110.146 166.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.97 146.86 91.79 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.344 2.03 . . . . 1.78 110.322 160.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 59.4 mmtt 69.61 -2.72 1.85 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.696 1.998 . . . . 2.46 114.024 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.21 148.43 20.74 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 126.985 2.231 . . . . 1.1200000000000001 111.688 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.2 ttp-105 -106.27 142.64 35.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.432 1.893 . . . . 7.0599999999999996 111.505 168.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.86 147.26 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.475 1.51 . . . . 3.9399999999999999 108.473 161.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -128.13 112.28 14.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.334 -1.358 . . . . 3.4100000000000001 107.334 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.09 63.05 0.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.57 1.948 . . . . 2.2799999999999998 108.971 171.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -79.48 150.95 74.21 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 128.8 2.84 . . . . 3.96 111.545 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.4 -35.69 92.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.52 2.814 . . . . 1.2 113.641 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.72 60.06 1.77 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.189 0.9 . . . . 1.73 111.867 168.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.89 -73.6 0.05 OUTLIER Glycine 0 N--CA 1.469 0.859 0 C-N-CA 125.225 1.393 . . . . 1.3799999999999999 113.94 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -153.01 154.72 35.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.122 1.769 . . . . 3.3999999999999999 111.01 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -163.99 169.93 17.32 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.107 0.963 . . . . 1.28 109.879 176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.21 126.61 42.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.789 -0.819 . . . . 3.3500000000000001 108.789 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -81.69 120.82 25.6 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.426 1.091 . . . . 1.77 109.219 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -111.65 113.01 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.147 1.379 . . . . 2.5 107.976 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.41 139.83 41.28 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.433 1.493 . . . . 3.7599999999999998 109.293 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.08 66.3 1.94 Allowed Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.489 -1.045 . . . . 1.29 110.489 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 mt -70.03 123.54 21.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.04 0.536 . . . . 2.1800000000000002 110.568 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.468 ' HZ2' ' CD ' ' A' ' 41' ' ' GLU . 77.1 mttt -83.19 19.83 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.015 0.926 . . . . 2.5099999999999998 113.154 -172.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 173.9 155.98 0.3 Allowed Pre-proline 0 CA--C 1.544 0.718 1 C-N-CA 131.893 4.077 . . . . 5.2400000000000002 107.945 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.73 133.68 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 N-CA-C 106.626 -2.105 . . . . 2.4199999999999999 106.626 147.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.9 116.55 5.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.55 0.69 . . . . 3.5099999999999998 109.155 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -71.23 107.67 4.35 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.416 -0.802 . . . . 5.1699999999999999 109.939 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.82 1.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.909 -1.119 . . . . 2.4399999999999999 109.461 164.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.49 38.67 7.02 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 118.755 -1.025 . . . . 2.1800000000000002 113.958 -165.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -135.75 -178.92 5.35 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 119.275 1.538 . . . . 3.46 108.659 149.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.78 150.31 37.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.158 0.98 . . . . 5.0599999999999996 110.589 166.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.99 113.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.98 1.712 . . . . 2.3700000000000001 108.031 172.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.22 137.69 57.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.909 -0.587 . . . . 2.9399999999999999 109.477 160.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -149.55 133.44 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.41 1.084 . . . . 2.8100000000000001 111.993 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.55 87.76 2.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.786 2.034 . . . . 2.6299999999999999 109.146 -167.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 mt -69.28 125.17 25.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.766 2.026 . . . . 2.1000000000000001 111.077 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.3 mt -94.51 138.67 32.13 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.511 1.124 . . . . 1.9399999999999999 111.464 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -135.08 138.54 43.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.432 1.093 . . . . 3.0 111.238 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.8 126.55 12.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.595 1.558 . . . . 2.3399999999999999 113.342 -167.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.25 -145.58 19.16 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 110.757 -0.937 . . . . 3.29 110.757 -166.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.27 27.48 9.32 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 115.74 1.056 . . . . 2.5099999999999998 115.74 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.63 131.22 46.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.27 2.035 . . . . 5.5700000000000003 112.079 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.73 123.32 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.108 1.363 . . . . 2.4500000000000002 109.284 162.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.76 119.8 33.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.809 1.644 . . . . 4.2800000000000002 108.477 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.54 147.09 23.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.328 1.233 . . . . 3.29 114.328 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.96 172.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 127.86 2.464 . . . . 2.0499999999999998 109.492 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.82 140.99 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.828 1.651 . . . . 3.25 108.017 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.79 133.81 10.59 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.147 1.379 . . . . 2.2799999999999998 110.83 -166.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 147.77 67.34 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.105 2.537 . . . . 1.05 114.168 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.7 t -79.27 132.49 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.538 0.735 . . . . 2.25 110.496 168.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -133.7 156.26 48.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.125 1.77 . . . . 3.8999999999999999 112.164 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.57 84.42 7.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.093 0.957 . . . . 2.5699999999999998 109.457 164.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.907 -1.52 . . . . 6.6200000000000001 112.16 -163.419 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 110.543 -1.023 . . . . 11.15 110.543 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 m 160.44 -172.48 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 1 C-N-CA 132.29 4.236 . . . . 11.01 106.568 -173.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 74.53 -145.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.384 1.074 . . . . 12.460000000000001 110.815 171.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.9 134.13 42.3 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.169 0.988 . . . . 7.9400000000000004 112.93 -163.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -84.0 127.41 33.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.545 1.538 . . . . 5.2699999999999996 108.86 156.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.88 165.48 38.74 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.327 -0.858 . . . . 1.7 114.224 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -159.53 158.98 32.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.628 1.171 . . . . 2.54 114.001 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.08 130.03 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.573 -1.269 . . . . 2.4399999999999999 107.573 164.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -84.48 -2.6 57.51 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.841 1.793 . . . . 4.7999999999999998 115.841 -164.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.4 t80 65.88 152.21 0.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.496 2.318 . . . . 4.4199999999999999 113.671 -170.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -159.54 146.8 12.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.943 2.097 . . . . 4.6600000000000001 108.25 157.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.88 -7.84 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.324 2.683 . . . . 3.4500000000000002 112.283 169.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.57 -167.05 43.16 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.462 1.029 . . . . 1.8999999999999999 114.213 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.01 -9.33 22.08 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.503 2.802 . . . . 2.1099999999999999 113.359 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -152.33 161.89 41.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.081 1.352 . . . . 2.7599999999999998 114.397 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.57 -174.09 4.78 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.668 2.387 . . . . 2.1699999999999999 111.953 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.08 159.58 41.49 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.063 1.345 . . . . 2.1200000000000001 111.51 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.65 163.35 37.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.465 1.506 . . . . 2.46 113.273 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -145.24 152.74 40.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.363 1.865 . . . . 3.1800000000000002 110.874 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -166.13 158.44 14.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.547 1.139 . . . . 3.1099999999999999 112.068 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.5 m -90.73 138.59 31.46 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.667 -1.234 . . . . 2.3300000000000001 107.667 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.6 132.1 56.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.943 1.297 . . . . 3.3100000000000001 107.767 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.55 135.36 53.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.727 0.811 . . . . 3.3100000000000001 111.761 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -101.69 115.56 64.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.348 1.059 . . . . 0.91000000000000003 109.7 163.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -88.57 -8.9 5.09 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.241 2.627 . . . . 1.3899999999999999 114.4 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.06 162.97 32.86 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 119.434 1.016 . . . . 1.22 113.355 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.31 -0.52 50.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.347 1.459 . . . . 3.0800000000000001 114.178 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.91 158.04 36.91 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.999 1.32 . . . . 2.6200000000000001 110.53 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.38 155.23 18.89 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.214 2.61 . . . . 1.25 111.198 -173.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.25 153.86 20.48 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.347 1.059 . . . . 3.1600000000000001 111.316 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.436 HH21 ' CD ' ' A' ' 68' ' ' GLU . 27.9 ttm180 -130.65 114.42 15.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.153 1.381 . . . . 4.0099999999999998 109.185 167.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.45 114.41 26.17 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.246 2.618 . . . . 1.8700000000000001 108.893 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.05 -10.54 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 1.8500000000000001 113.571 -166.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.19 31.44 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.616 -0.678 . . . . 0.55000000000000004 112.704 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -151.03 179.95 7.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.597 0.759 . . . . 1.99 111.924 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -154.47 149.69 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.94 -1.133 . . . . 7.2300000000000004 107.94 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -162.49 153.79 15.06 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.45 -1.262 . . . . 1.6899999999999999 108.725 -170.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.42 -7.95 16.04 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.32 2.013 . . . . 1.1100000000000001 114.489 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 m -98.48 -3.95 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 116.142 1.905 . . . . 1.9099999999999999 116.142 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.51 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.944 1.298 . . . . 2.0099999999999998 110.666 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -93.95 -74.75 0.52 Allowed 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.575 -0.528 . . . . 4.4500000000000002 109.575 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -80.77 107.75 13.84 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.481 -0.933 . . . . 5.1799999999999997 108.481 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -113.18 125.01 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.913 0.885 . . . . 3.0 108.763 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -134.13 122.7 23.26 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.889 1.276 . . . . 2.6299999999999999 110.384 -162.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.59 122.53 26.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.227 1.013 . . . . 2.0 110.461 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 7.2 m170 -108.1 156.87 18.8 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.452 1.901 . . . . 1.02 112.832 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -105.24 -177.51 3.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.16 2.584 . . . . 2.0299999999999998 111.473 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -133.12 99.54 4.59 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.749 -1.574 . . . . 2.9399999999999999 106.749 154.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.3 151.51 41.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.462 0.305 . . . . 3.7799999999999998 110.63 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 ptp -97.97 157.92 15.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.55 0.34 . . . . 4.0700000000000003 110.797 155.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -176.1 160.96 2.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.583 2.353 . . . . 7.6600000000000001 110.274 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 0.6 OUTLIER -95.73 154.26 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.029 0.932 . . . . 3.7000000000000002 108.795 169.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 t -133.17 -96.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.281 1.033 . . . . 3.1800000000000002 108.967 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -75.84 54.94 0.85 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.267 1.827 . . . . 3.1899999999999999 110.34 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.99 -17.57 0.53 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.137 1.827 . . . . 2.1099999999999999 115.261 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.8 152.69 20.2 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.01 1.724 . . . . 3.48 111.162 -168.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.494 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 28.1 mmmt -62.64 131.74 50.02 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.846 0.858 . . . . 4.8700000000000001 111.183 175.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.34 151.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.037 1.735 . . . . 3.1699999999999999 109.335 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.8 mtm -128.64 141.51 51.33 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.602 1.161 . . . . 4.0899999999999999 110.302 163.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.86 163.57 30.5 Favored Glycine 0 N--CA 1.469 0.844 0 C-N-CA 123.753 0.692 . . . . 1.24 112.689 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -97.74 158.47 15.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.965 0.906 . . . . 2.4199999999999999 112.771 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.6 mtt-85 -164.83 145.8 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 126.724 2.009 . . . . 7.2400000000000002 109.053 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.8 Cg_endo -70.59 152.9 65.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 CA-C-N 121.526 1.581 . . . . 1.28 110.111 160.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.17 156.2 57.52 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.252 1.421 . . . . 2.02 110.037 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.32 -14.4 34.28 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.812 2.341 . . . . 0.89000000000000001 113.015 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -178.96 162.15 1.24 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.115 1.766 . . . . 3.73 110.861 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -108.59 174.55 5.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.925 1.69 . . . . 2.0699999999999998 109.316 153.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.436 ' CD ' HH21 ' A' ' 31' ' ' ARG . 10.2 pt-20 -154.74 165.24 37.21 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.908 -1.12 . . . . 2.3399999999999999 111.204 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -149.63 135.36 10.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 118.573 -0.727 . . . . 2.0099999999999998 110.502 -164.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.98 165.8 31.19 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.264 1.976 . . . . 0.96999999999999997 112.116 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.31 138.84 83.6 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.391 3.394 . . . . 1.2 112.62 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.1 2.83 1.54 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.344 1.857 . . . . 2.98 113.808 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.09 115.51 4.13 Favored Glycine 0 C--O 1.228 -0.23 0 C-N-CA 127.422 2.439 . . . . 0.89000000000000001 111.626 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -85.43 134.36 34.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.248 -0.976 . . . . 7.6699999999999999 109.978 155.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.34 168.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.749 2.02 . . . . 2.21 109.6 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -134.47 124.77 26.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.824 0.85 . . . . 3.6400000000000001 110.781 -164.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.06 75.63 5.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.716 -0.846 . . . . 2.0499999999999998 108.716 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 ptpm? -79.59 136.27 55.84 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.278 -0.867 . . . . 3.5299999999999998 110.525 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.47 -58.51 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.933 3.755 . . . . 1.1100000000000001 113.566 -163.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 106.78 2.61 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 107.817 -2.113 . . . . 1.23 107.817 160.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.51 -88.65 0.17 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 124.654 1.121 . . . . 1.22 111.266 -163.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -150.62 144.55 25.32 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.891 2.076 . . . . 3.0299999999999998 109.926 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -165.8 174.2 9.87 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.937 -1.102 . . . . 1.0 110.618 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -110.9 128.8 55.93 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.994 0.918 . . . . 3.6800000000000002 109.971 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 mmt -86.71 136.98 32.82 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.073 0.949 . . . . 2.1000000000000001 109.633 165.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.7 mt -116.67 117.0 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.516 1.527 . . . . 3.2999999999999998 109.105 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.82 142.35 51.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.896 1.678 . . . . 3.5499999999999998 111.069 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.99 59.57 4.24 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.041 -1.223 . . . . 1.5900000000000001 110.041 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.8 mt -66.8 129.42 39.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.156 0.979 . . . . 1.8200000000000001 111.713 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.59 -10.19 49.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.785 1.234 . . . . 2.7200000000000002 112.875 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -155.38 146.19 16.33 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.621 1.568 . . . . 6.8499999999999996 110.305 163.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.28 127.49 15.88 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 107.378 -1.816 . . . . 2.0699999999999998 107.378 158.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mp -87.49 167.73 13.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.102 0.961 . . . . 3.79 111.277 -171.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 145.98 48.15 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.032 -1.043 . . . . 5.8700000000000001 110.524 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.07 125.95 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.372 -0.603 . . . . 2.23 109.372 158.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.24 8.86 68.02 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 118.094 -1.392 . . . . 1.8999999999999999 115.712 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.45 173.73 9.44 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.943 1.872 . . . . 3.21 109.429 157.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -118.64 158.7 24.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.816 1.647 . . . . 4.4699999999999998 110.099 167.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.1 t -132.45 120.31 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.319 1.848 . . . . 1.98 110.25 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.424 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -82.57 147.0 28.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.57 1.148 . . . . 3.29 110.321 173.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -157.02 140.29 15.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.52 0.728 . . . . 2.8900000000000001 112.935 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -104.61 115.47 30.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.863 2.465 . . . . 2.9300000000000002 111.546 174.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.3 125.03 28.44 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.827 -1.17 . . . . 3.8700000000000001 109.828 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.31 126.81 39.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.789 0.436 . . . . 1.97 110.328 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -124.69 154.28 41.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.646 1.212 . . . . 3.0299999999999998 112.245 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.06 128.52 37.61 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.86 1.059 . . . . 2.4900000000000002 113.86 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.17 50.41 10.49 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.194 0.902 . . . . 3.6800000000000002 114.073 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.53 76.47 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.034 1.173 . . . . 1.8400000000000001 116.034 166.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.09 135.75 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.47 1.635 . . . . 5.7400000000000002 109.971 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.8 p -150.82 139.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 125.081 1.352 . . . . 2.0899999999999999 108.95 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.7 mt -139.05 134.78 33.45 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.244 1.018 . . . . 2.54 111.871 -172.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 2.9 tpmt? -80.17 135.95 36.39 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.198 . . . . 3.8199999999999998 113.113 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.93 173.65 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 125.158 1.383 . . . . 2.5499999999999998 111.88 156.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.16 153.75 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.121 1.768 . . . . 3.2999999999999998 108.74 165.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 mt -143.5 135.28 12.96 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.945 2.098 . . . . 2.7799999999999998 110.09 -172.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.32 159.28 49.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.257 2.638 . . . . 1.0800000000000001 111.988 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.33 131.2 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.123 0.969 . . . . 1.97 110.989 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.59 -170.05 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.782 3.233 . . . . 4.0099999999999998 110.796 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.1 70.58 1.15 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.181 -0.949 . . . . 3.6699999999999999 111.275 167.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.899 1.444 . . . . 5.4100000000000001 114.899 -145.561 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 108.586 -1.805 . . . . 11.789999999999999 108.586 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m 75.85 -64.8 0.34 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.645 1.578 . . . . 10.74 112.286 170.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -152.66 35.71 0.5 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.0 1.32 . . . . 11.359999999999999 113.062 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.49 146.2 41.22 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.278 -1.008 . . . . 8.0399999999999991 108.278 155.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -117.21 177.03 4.87 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.632 1.173 . . . . 6.0199999999999996 109.535 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 20' ' ' LEU . . . -99.91 128.3 9.53 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 121.259 -0.901 . . . . 2.0899999999999999 114.342 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -119.91 177.14 5.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.385 1.074 . . . . 2.1200000000000001 112.031 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.16 135.45 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.245 1.018 . . . . 2.1499999999999999 108.605 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.73 139.32 56.34 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.891 1.071 . . . . 9.6600000000000001 113.891 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -74.2 29.3 0.08 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.809 1.644 . . . . 5.1399999999999997 114.967 177.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.7 p -69.9 134.37 87.87 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 119.706 -1.871 . . . . 3.21 113.181 -159.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.2 -20.39 24.83 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.951 2.434 . . . . 2.4100000000000001 112.073 169.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.39 122.83 6.24 Favored Glycine 0 CA--C 1.534 1.253 0 N-CA-C 108.678 -1.769 . . . . 3.52 108.678 162.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.83 -39.99 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.006 1.903 . . . . 4.9500000000000002 112.34 -172.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -90.23 137.14 32.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.042 0.837 . . . . 5.6200000000000001 110.784 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 167.27 178.98 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.089 2.556 . . . . 4.2800000000000002 112.139 -172.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.69 28.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.655 1.982 . . . . 2.9100000000000001 114.001 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.04 155.65 45.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.788 1.635 . . . . 2.29 110.839 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.88 164.92 26.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.358 1.063 . . . . 3.6600000000000001 112.15 -158.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 2.6 pt? -168.38 155.03 7.41 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.659 1.355 . . . . 2.6099999999999999 114.659 164.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.9 m -76.03 136.86 39.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.874 -1.158 . . . . 2.5899999999999999 107.874 151.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -149.02 136.04 19.89 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.265 1.026 . . . . 3.1200000000000001 109.436 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.34 165.42 27.94 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.836 0.826 . . . . 3.4700000000000002 112.774 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -114.87 89.91 20.89 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 114.132 -1.395 . . . . 0.88 110.16 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.14 -5.77 17.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 1.3899999999999999 112.922 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.59 172.72 50.7 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.329 0.966 . . . . 1.0 113.333 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.8 m-20 -100.79 -1.56 34.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 2.7400000000000002 113.276 -172.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -119.09 159.04 46.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.866 1.666 . . . . 2.6699999999999999 110.548 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.87 156.88 27.31 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.966 2.444 . . . . 1.29 112.317 -168.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.9 102.71 7.92 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.607 1.563 . . . . 3.27 109.732 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttp-105 -92.38 113.44 25.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.103 1.361 . . . . 4.8300000000000001 111.031 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -103.95 109.67 21.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 128.324 2.65 . . . . 2.6600000000000001 108.592 -171.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -99.79 -17.0 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.654 1.182 . . . . 1.7 113.377 -168.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.28 -168.25 39.35 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.95 0.786 . . . . 0.48999999999999999 111.99 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.01 177.36 8.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.825 0.85 . . . . 2.1099999999999999 110.901 175.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -163.45 128.44 2.99 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.496 1.043 . . . . 6.46 108.487 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -136.06 153.22 76.67 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.504 -1.236 . . . . 1.7 109.089 -177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.79 -28.63 86.76 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.125 1.883 . . . . 1.29 113.379 166.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.6 -5.1 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 115.036 1.495 . . . . 2.4300000000000002 115.036 -168.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.68 170.44 15.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.321 1.448 . . . . 1.6599999999999999 113.029 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -113.6 -81.4 0.6 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.76 1.624 . . . . 2.8599999999999999 111.553 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -80.98 111.18 17.22 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 120.971 -1.081 . . . . 4.5599999999999996 109.105 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.86 131.72 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.461 1.905 . . . . 2.25 109.79 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -147.47 131.92 17.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.452 1.101 . . . . 2.0800000000000001 110.539 -167.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.37 119.82 22.94 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.156 1.344 . . . . 1.95 110.672 170.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -109.65 157.8 18.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.332 1.853 . . . . 0.81999999999999995 111.519 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.03 -176.53 3.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.837 0.855 . . . . 3.1200000000000001 111.535 164.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 m -146.65 99.66 3.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.929 1.292 . . . . 2.1099999999999999 107.609 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -106.29 -177.99 3.52 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.523 1.529 . . . . 3.23 112.636 -166.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -138.67 143.39 39.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.946 1.299 . . . . 3.8500000000000001 110.673 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -155.39 159.59 40.01 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.227 1.411 . . . . 7.9400000000000004 111.595 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -97.74 151.79 19.79 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.686 1.194 . . . . 3.73 112.253 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.15 -92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.365 1.466 . . . . 3.5699999999999998 109.577 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 56' ' ' LYS . 23.9 tt0 -74.88 36.78 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.35 2.26 . . . . 4.6900000000000004 110.873 171.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -18.2 0.63 Allowed Glycine 0 CA--C 1.538 1.499 0 O-C-N 120.421 -1.424 . . . . 2.0600000000000001 113.398 -158.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 54' ' ' GLU . 85.3 mttt -79.62 135.53 36.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.262 1.825 . . . . 4.3799999999999999 109.628 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 125.19 32.17 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.543 1.137 . . . . 6.9400000000000004 112.915 -175.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -123.34 147.82 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.603 1.961 . . . . 2.3799999999999999 109.408 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.9 ptp -94.95 155.62 16.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.533 1.133 . . . . 4.6399999999999997 113.565 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.05 169.17 33.1 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 123.899 0.761 . . . . 1.0600000000000001 113.251 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.6 mtt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.116 1.367 . . . . 2.8199999999999998 110.153 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -159.1 150.14 16.26 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 117.282 -1.342 . . . . 7.0099999999999998 110.03 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.26 146.37 75.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.843 1.696 . . . . 0.96999999999999997 110.142 164.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 m -113.56 160.27 32.34 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 126.028 1.731 . . . . 1.8 110.115 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.74 -24.36 47.47 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.212 1.941 . . . . 0.93000000000000005 112.29 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -178.05 163.6 1.75 Allowed 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.836 1.654 . . . . 3.7000000000000002 111.712 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -108.54 173.16 6.44 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.034 1.334 . . . . 1.95 109.38 150.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.39 161.61 42.17 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.366 -0.834 . . . . 2.9900000000000002 111.852 162.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.69 126.04 22.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.254 1.821 . . . . 1.8899999999999999 108.041 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.74 163.12 40.19 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.657 2.238 . . . . 1.05 110.374 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -61.7 136.66 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.645 2.23 . . . . 1.01 110.717 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.445 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 58.5 mmtt 67.15 2.62 2.85 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.821 2.049 . . . . 2.3199999999999998 113.809 -174.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.79 172.67 44.49 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.548 2.023 . . . . 0.95999999999999996 111.395 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -156.14 147.48 22.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 112.392 -1.904 . . . . 4.7300000000000004 111.923 -171.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.11 155.4 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.783 1.633 . . . . 3.2200000000000002 110.716 168.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -128.52 114.11 16.33 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.802 -1.555 . . . . 3.9700000000000002 106.802 167.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.78 91.62 3.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.086 1.354 . . . . 1.9399999999999999 112.315 -166.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.634 1.174 . . . . 3.6499999999999999 111.631 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.56 -17.87 58.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.929 2.419 . . . . 1.1899999999999999 113.197 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.6 52.98 0.85 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.706 1.146 . . . . 1.1200000000000001 111.486 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.9 -76.08 0.06 OUTLIER Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.591 1.091 . . . . 0.92000000000000004 114.767 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -153.81 137.6 16.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.602 1.961 . . . . 3.1200000000000001 110.026 -170.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -166.6 173.82 9.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.947 0.899 . . . . 0.98999999999999999 110.294 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.49 124.72 50.02 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 118.499 -0.762 . . . . 3.21 110.237 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.39 132.56 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.198 0.908 . . . . 2.3300000000000001 109.568 163.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.28 132.42 54.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.578 1.151 . . . . 2.4199999999999999 109.015 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.63 117.15 12.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.069 2.147 . . . . 3.7599999999999998 108.966 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.94 111.84 0.31 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.268 -1.133 . . . . 1.75 110.268 -170.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.4 mt -112.39 141.94 45.52 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.483 0.659 . . . . 2.5899999999999999 111.279 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -82.73 1.91 36.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.655 0.782 . . . . 2.8799999999999999 112.403 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -150.15 156.81 37.68 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 127.451 2.3 . . . . 4.9299999999999997 111.151 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.23 165.29 32.9 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.166 1.911 . . . . 1.8600000000000001 109.157 151.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -112.57 131.02 55.81 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.941 -0.763 . . . . 4.0199999999999996 108.941 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.94 122.32 18.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.399 1.079 . . . . 4.1100000000000003 108.265 -169.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.34 28.51 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.024 1.284 . . . . 2.5099999999999998 112.482 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 45.23 8.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.487 0.565 . . . . 2.48 113.669 -172.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.97 165.76 24.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.454 -1.027 . . . . 2.71 109.199 141.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -115.34 155.32 27.56 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.168 0.987 . . . . 4.7199999999999998 112.159 -168.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.72 118.41 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.488 1.915 . . . . 2.3300000000000001 109.654 -173.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.61 146.28 48.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.753 0.311 . . . . 2.8700000000000001 110.202 163.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.4 tt -155.29 126.18 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.558 0.743 . . . . 2.77 111.679 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.81 112.52 21.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.836 3.254 . . . . 2.1899999999999999 111.347 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.5 mt -81.47 124.0 29.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.523 1.129 . . . . 2.2999999999999998 108.566 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 mt -96.85 127.38 42.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.933 1.293 . . . . 1.8 109.878 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.59 162.92 14.24 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.869 -1.145 . . . . 3.5 112.581 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.53 101.54 1.01 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.786 -0.571 . . . . 2.6800000000000002 111.472 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.86 19.0 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.506 1.05 . . . . 3.0299999999999998 111.601 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.56 54.55 4.37 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.23 0.919 . . . . 2.3799999999999999 115.182 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -145.03 136.62 25.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 1.486 . . . . 5.5999999999999996 112.39 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.08 134.57 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 125.75 1.62 . . . . 2.4300000000000002 107.884 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.8 mt -143.85 124.93 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.081 1.352 . . . . 3.3799999999999999 108.491 -170.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.75 150.55 22.24 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.077 1.51 . . . . 4.6100000000000003 115.077 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -120.08 168.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.367 2.267 . . . . 2.2799999999999998 108.87 163.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.52 141.83 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.368 1.067 . . . . 3.2999999999999998 109.288 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.8 mt -131.85 131.69 22.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.319 1.848 . . . . 3.1000000000000001 108.765 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.91 155.51 43.36 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.53 2.153 . . . . 1.52 111.124 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.5 t -86.2 123.49 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.161 -1.051 . . . . 2.1099999999999999 108.161 164.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.05 160.11 28.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.01 1.324 . . . . 3.3700000000000001 110.615 -177.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -82.55 51.52 1.87 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.809 1.04 . . . . 3.79 113.809 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.165 1.786 . . . . 6.2599999999999998 112.331 -174.022 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.463 0 N-CA-C 109.454 -1.458 . . . . 12.640000000000001 109.454 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -70.65 -23.13 62.46 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.899 1.35 . . . . 13.91 114.409 -174.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -172.53 -176.56 1.56 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.95 2.9 . . . . 15.02 108.243 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.1 p -154.8 -43.51 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.076 2.151 . . . . 8.1099999999999994 110.877 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -106.65 177.59 4.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.757 2.023 . . . . 5.8099999999999996 111.513 -175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -86.88 162.94 34.5 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 126.347 1.927 . . . . 1.4399999999999999 114.455 -172.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -147.92 150.11 33.48 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.749 0.819 . . . . 1.8700000000000001 112.444 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -103.79 134.32 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.234 1.414 . . . . 2.1000000000000001 108.267 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ttt-85 -86.8 100.3 12.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.182 1.178 . . . . 5.1699999999999999 114.182 -162.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.63 133.26 55.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.823 0.82 . . . . 4.0 110.773 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -162.91 157.36 17.96 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.965 1.706 . . . . 3.2999999999999998 110.014 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -86.54 67.04 4.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.721 2.948 . . . . 3.21 110.219 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.98 164.29 28.89 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.693 1.037 . . . . 1.5600000000000001 115.693 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -80.1 -9.72 14.02 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.64 3.56 . . . . 1.74 112.594 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -142.3 151.98 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.2 1.8 . . . . 2.3500000000000001 111.072 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.61 -163.86 1.52 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.548 1.539 . . . . 2.1000000000000001 111.237 -173.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.66 156.09 39.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.088 1.355 . . . . 2.2799999999999998 110.66 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.92 148.76 45.09 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.948 0.899 . . . . 1.8600000000000001 110.631 156.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -128.07 178.01 6.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.828 1.651 . . . . 3.8300000000000001 110.124 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.506 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.5 pt? -169.92 161.15 8.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.137 1.775 . . . . 2.6800000000000002 111.199 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -98.2 145.01 27.04 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.702 -1.592 . . . . 2.7000000000000002 106.702 154.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.46 127.61 7.66 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.438 1.095 . . . . 3.4300000000000002 110.377 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 151.26 29.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.467 1.507 . . . . 2.7400000000000002 111.544 173.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -98.23 109.15 50.95 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.051 -0.977 . . . . 1.25 110.105 161.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.19 -8.87 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.884 2.389 . . . . 1.8799999999999999 113.787 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.44 171.04 49.38 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.359 0.981 . . . . 1.6299999999999999 113.271 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.0 m-20 -94.98 -5.0 45.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.312 1.845 . . . . 3.04 112.66 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.58 158.06 39.74 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.83 2.052 . . . . 5.8200000000000003 108.595 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.83 151.61 24.67 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.907 2.405 . . . . 1.29 111.62 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -102.23 133.14 47.59 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.06 0.944 . . . . 3.1099999999999999 111.018 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 68' ' ' GLU . 26.5 ttm180 -117.1 107.84 14.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.902 1.281 . . . . 3.73 110.501 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -95.14 114.52 26.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.644 2.378 . . . . 1.8100000000000001 109.192 -169.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.65 -9.44 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.506 1.122 . . . . 1.95 112.968 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.13 -171.54 44.61 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.481 1.039 . . . . 0.53000000000000003 111.438 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -153.8 170.07 21.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.018 1.327 . . . . 1.53 110.735 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -158.39 115.59 2.87 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 120.057 1.298 . . . . 5.6600000000000001 109.376 -165.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 t -127.03 159.33 65.33 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 117.759 -1.115 . . . . 1.78 109.353 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.93 -22.75 48.09 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.533 2.155 . . . . 0.95999999999999996 113.685 164.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.253 3.9 m -87.91 8.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.383 1.623 . . . . 2.04 115.383 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.94 161.94 41.31 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.805 -1.185 . . . . 1.8899999999999999 113.677 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.7 -88.61 0.28 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.022 1.729 . . . . 2.96 110.516 174.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -81.48 121.54 26.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 4.3200000000000003 110.286 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.91 142.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 2.98 111.36 164.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -140.71 116.09 10.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.946 1.298 . . . . 2.23 110.091 166.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' A' ' 84' ' ' PHE . 6.8 tt -76.83 119.19 20.25 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 120.897 1.681 . . . . 1.6899999999999999 110.639 170.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -105.09 152.07 23.22 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.035 1.334 . . . . 0.65000000000000002 112.549 177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.46 179.82 5.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.606 1.962 . . . . 2.48 110.941 165.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 m -144.26 93.15 2.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.86 1.664 . . . . 2.1499999999999999 107.906 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.79 146.4 23.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.42 1.105 . . . . 3.7000000000000002 111.833 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -87.51 147.82 25.19 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.912 1.285 . . . . 4.8799999999999999 110.34 165.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.57 152.75 23.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.564 1.546 . . . . 6.9800000000000004 110.918 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.59 141.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.122 -1.066 . . . . 4.0599999999999996 108.122 156.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.88 120.6 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.535 1.534 . . . . 3.5099999999999998 106.997 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 62.07 23.8 14.09 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.946 0.899 . . . . 3.3599999999999999 111.602 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.88 -10.72 38.28 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.065 1.317 . . . . 2.1400000000000001 114.275 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -87.35 140.93 29.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.921 1.689 . . . . 3.7200000000000002 109.705 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -79.65 128.28 33.2 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.424 -0.798 . . . . 4.5 111.003 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -135.69 150.13 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.864 1.665 . . . . 2.6499999999999999 110.443 -170.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.7 tpp -119.85 138.88 53.13 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.255 1.422 . . . . 4.4800000000000004 109.223 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.08 141.28 11.08 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 118.92 0.782 . . . . 1.3100000000000001 113.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -89.3 165.31 14.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.717 0.807 . . . . 2.7599999999999998 111.176 169.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 -176.07 138.14 0.5 Allowed Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 116.455 -1.736 . . . . 5.2699999999999996 111.146 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.84 139.03 38.96 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 122.75 2.018 . . . . 0.78000000000000003 111.607 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.67 156.07 42.99 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 126.033 1.733 . . . . 1.51 111.163 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.74 -17.21 33.28 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.989 2.46 . . . . 0.69999999999999996 113.087 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -177.52 165.89 2.19 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.857 2.063 . . . . 2.9199999999999999 111.424 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.51 173.5 6.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.952 1.701 . . . . 1.78 109.384 155.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 31' ' ' ARG . 6.9 pt-20 -152.96 164.25 38.3 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.382 -0.824 . . . . 2.1499999999999999 113.075 170.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -139.53 129.23 14.08 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.046 1.738 . . . . 1.9199999999999999 109.03 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.38 161.99 42.76 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.691 2.261 . . . . 0.87 111.727 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.21 135.93 65.31 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.772 2.981 . . . . 1.2 112.333 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 63.6 mmtt 68.08 1.02 2.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.316 1.847 . . . . 3.04 113.9 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.42 -178.48 45.46 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 126.109 1.814 . . . . 1.45 111.023 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -160.11 163.74 33.57 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.065 1.346 . . . . 5.4299999999999997 112.425 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.91 154.2 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.376 1.47 . . . . 2.7000000000000002 111.115 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.516 ' CD ' ' HZ3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.5 123.49 47.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.645 1.178 . . . . 3.3599999999999999 109.448 164.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.3 146.34 43.23 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 1.9099999999999999 109.645 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.516 ' HZ3' ' CD ' ' A' ' 76' ' ' GLU . 9.2 ptpp? -153.99 151.12 23.99 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.89 0.876 . . . . 4.2300000000000004 112.285 -163.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.59 -50.93 4.69 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.757 2.972 . . . . 1.02 112.233 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.27 90.44 1.56 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 109.07 -1.612 . . . . 1.3 109.07 162.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.57 -90.22 0.11 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 123.659 0.647 . . . . 0.91000000000000003 114.075 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -153.26 140.24 19.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.287 1.435 . . . . 3.02 110.3 -170.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -162.64 156.59 20.84 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.239 0.616 . . . . 1.3700000000000001 111.307 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.485 ' CE1' HD11 ' A' ' 45' ' ' LEU . 71.5 m-85 -90.51 112.77 24.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 3.4300000000000002 109.012 166.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.2 125.59 27.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.469 -0.938 . . . . 2.25 108.469 167.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.92 117.16 34.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.786 -1.19 . . . . 2.6200000000000001 107.786 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.65 110.75 20.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.965 1.306 . . . . 4.0899999999999999 108.188 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.21 98.52 0.7 Allowed Glycine 0 N--CA 1.47 0.904 0 C-N-CA 124.346 0.974 . . . . 1.5900000000000001 111.19 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 mt -96.34 128.78 43.57 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.649 0.779 . . . . 1.95 110.916 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -18.74 53.85 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.493 0.923 . . . . 3.0600000000000001 113.493 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.9 150.85 77.71 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 125.885 1.674 . . . . 5.2800000000000002 108.268 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.98 118.59 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 107.048 -1.943 . . . . 1.51 107.048 155.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.39 108.54 1.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.177 1.391 . . . . 2.9199999999999999 111.492 -160.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -80.45 105.05 11.42 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.149 -0.969 . . . . 5.4699999999999998 110.885 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.47 111.86 0.79 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.715 -1.217 . . . . 2.4100000000000001 107.715 152.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 5.89 34.41 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 117.312 -1.827 . . . . 2.3599999999999999 116.228 -166.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.45 169.21 8.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.731 2.265 . . . . 3.4199999999999999 111.748 160.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.76 141.66 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.633 1.573 . . . . 4.6799999999999997 109.454 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.64 112.51 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.776 0.831 . . . . 2.0800000000000001 110.815 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 45.9 mt-10 -64.89 148.31 51.66 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.999 0.52 . . . . 3.0099999999999998 111.181 163.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.77 116.71 4.5 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.415 1.102 . . . . 4.4000000000000004 109.87 174.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.41 116.61 21.96 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.732 2.813 . . . . 1.99 111.029 170.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.0 mt -83.73 118.77 24.11 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.34 1.456 . . . . 3.3700000000000001 110.313 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt -93.95 122.01 36.01 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.328 0.513 . . . . 1.8700000000000001 109.785 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -120.31 152.57 37.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.296 1.046 . . . . 3.6699999999999999 112.235 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.87 113.62 1.57 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.59 1.156 . . . . 2.6200000000000001 112.993 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 76.06 0.86 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.332 1.444 . . . . 3.3399999999999999 113.268 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.26 -6.6 56.52 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 116.744 1.458 . . . . 2.6800000000000002 116.744 163.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -86.98 128.01 35.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.183 1.991 . . . . 5.9900000000000002 110.122 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.58 135.68 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.181 1.392 . . . . 2.25 108.957 168.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.43 125.06 19.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.445 1.098 . . . . 3.3300000000000001 110.26 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.451 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 31.2 ttmt -83.28 135.49 34.73 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.345 0.869 . . . . 3.5800000000000001 113.345 -177.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.46 175.57 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.565 1.546 . . . . 2.0699999999999998 109.804 157.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.07 141.51 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.787 1.635 . . . . 3.0600000000000001 107.742 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.7 mt -143.91 160.14 50.94 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.794 1.638 . . . . 3.1000000000000001 111.267 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.49 169.07 19.07 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.738 3.626 . . . . 1.1799999999999999 112.679 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.1 t -107.2 133.28 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.43 1.892 . . . . 1.9099999999999999 110.72 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 151.51 42.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.085 1.354 . . . . 4.9000000000000004 111.044 170.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.33 85.35 6.88 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.074 -1.016 . . . . 3.1400000000000001 110.62 163.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.244 -1.36 . . . . 8.75 111.54 171.7 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 107.496 -2.241 . . . . 9.5099999999999998 107.496 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 4' ' ' THR . 5.7 m -157.58 161.34 38.71 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.055 0.428 . . . . 9.0600000000000005 111.405 -142.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -71.38 26.48 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.319 1.048 . . . . 13.529999999999999 111.88 164.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 2' ' ' SER . 18.2 p 52.14 -179.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.649 2.38 . . . . 8.6699999999999999 112.352 -143.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -153.03 36.38 0.48 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.074 1.75 . . . . 5.54 111.019 -176.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.78 174.73 55.19 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.506 1.05 . . . . 1.9399999999999999 113.367 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -155.0 158.7 39.56 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.779 1.232 . . . . 2.5800000000000001 112.069 -175.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.5 t -113.19 146.43 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 121.017 -1.052 . . . . 2.4199999999999999 109.373 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.99 140.08 40.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.806 -0.758 . . . . 6.4000000000000004 111.71 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -47.06 127.19 10.04 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.466 1.507 . . . . 4.7699999999999996 110.953 160.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -174.5 106.0 0.28 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.909 2.084 . . . . 3.7799999999999998 109.781 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -88.04 19.18 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.918 3.079 . . . . 2.7999999999999998 111.707 170.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.1 -165.26 38.95 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.836 1.208 . . . . 1.51 113.724 -171.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.57 -19.39 21.66 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.029 2.486 . . . . 1.8 112.647 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -146.68 165.06 30.71 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.829 1.252 . . . . 2.5600000000000001 113.186 -178.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 -179.92 8.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.441 1.497 . . . . 2.54 112.426 177.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.55 135.64 51.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.716 1.606 . . . . 2.1699999999999999 110.065 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.37 123.81 41.32 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.205 0.526 . . . . 1.8400000000000001 110.165 162.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -92.04 154.9 18.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.319 1.448 . . . . 3.1699999999999999 108.238 164.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -166.63 136.78 3.18 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.27 -0.894 . . . . 2.6200000000000001 113.028 175.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.2 m -79.35 148.28 32.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.011 -1.45 . . . . 2.1800000000000002 107.613 165.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.13 141.0 18.2 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.035 1.734 . . . . 3.2799999999999998 107.507 -176.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -144.31 132.49 21.75 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.881 -1.137 . . . . 3.2799999999999998 110.579 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.63 109.6 39.7 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.341 1.456 . . . . 1.04 109.895 177.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.87 -9.88 14.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.629 2.219 . . . . 1.28 113.91 176.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.28 173.92 54.78 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.042 0.829 . . . . 1.1200000000000001 113.961 -172.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 18.3 m-20 -104.26 3.45 32.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.404 1.881 . . . . 3.0899999999999999 112.491 178.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -116.33 164.58 17.6 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.691 1.996 . . . . 2.48 109.868 163.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.14 159.29 15.38 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.062 2.508 . . . . 1.0600000000000001 112.048 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.9 mt -106.6 154.59 20.69 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.624 1.17 . . . . 2.8199999999999998 110.985 168.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.4 ttp-105 -141.93 114.92 8.69 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.248 1.419 . . . . 6.0499999999999998 112.081 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.94 118.52 33.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.262 3.025 . . . . 2.1899999999999999 110.019 -176.128 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.86 -20.0 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.589 1.156 . . . . 2.1400000000000001 113.768 -173.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.15 16.81 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.509 -0.744 . . . . 1.1000000000000001 111.688 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.75 176.89 11.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.851 0.86 . . . . 2.5899999999999999 111.452 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -156.74 146.28 20.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.561 -0.903 . . . . 8.0199999999999996 108.561 172.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -142.72 157.61 61.42 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.721 -1.133 . . . . 1.6699999999999999 108.717 174.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.14 -25.34 50.85 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.352 2.035 . . . . 1.25 113.795 160.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.4 2.71 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 115.631 1.715 . . . . 1.8100000000000001 115.631 -165.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.55 152.2 29.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.294 0.952 . . . . 1.6699999999999999 113.367 -177.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.32 -88.34 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.558 1.943 . . . . 2.98 110.436 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -77.88 116.77 18.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.395 1.478 . . . . 5.3600000000000003 109.34 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.34 134.93 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.68 1.592 . . . . 2.2799999999999998 109.584 174.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.55 138.26 44.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.012 1.725 . . . . 1.95 110.606 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -84.51 109.89 18.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.486 1.114 . . . . 4.2599999999999998 109.444 172.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -113.59 154.36 27.31 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.027 1.331 . . . . 1.2 113.682 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.4 164.92 11.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.912 2.085 . . . . 1.8200000000000001 111.431 171.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 27.6 m -130.15 111.67 12.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.955 1.302 . . . . 2.2400000000000002 108.551 170.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -112.67 154.79 25.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.805 1.242 . . . . 3.21 113.308 -174.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 159.12 15.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.693 1.197 . . . . 4.4900000000000002 110.894 164.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.25 146.97 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.383 1.473 . . . . 9.3399999999999999 111.399 -167.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.439 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 0.7 OUTLIER -103.64 143.71 32.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.494 1.118 . . . . 5.0499999999999998 112.352 175.444 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.97 133.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.955 1.702 . . . . 4.71 109.246 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 67.61 6.07 4.77 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.588 1.155 . . . . 3.8399999999999999 112.641 -171.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.49 4.94 89.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.724 1.631 . . . . 2.8300000000000001 113.789 -166.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -100.76 148.72 24.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.711 2.004 . . . . 4.1299999999999999 110.99 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.439 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -85.59 149.27 25.46 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.375 -0.828 . . . . 4.9699999999999998 112.423 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.04 152.92 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.473 1.909 . . . . 4.3300000000000001 109.366 175.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.5 mtm -112.56 155.45 24.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.181 0.992 . . . . 4.7400000000000002 112.072 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.72 177.35 32.89 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.223 0.916 . . . . 1.4399999999999999 112.731 173.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -125.17 157.79 35.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.17 1.388 . . . . 3.25 110.511 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.13 157.38 63.76 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.299 -1.334 . . . . 7.54 108.506 161.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.34 141.65 82.47 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.903 1.358 . . . . 1.3400000000000001 110.264 151.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.37 153.46 41.99 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 126.522 1.929 . . . . 2.02 110.27 178.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.01 -31.44 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.533 2.155 . . . . 1.52 112.943 -174.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.3 p90 164.47 148.17 0.02 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 126.807 2.043 . . . . 4.1900000000000004 107.909 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.59 145.41 46.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.715 -1.13 . . . . 5.1799999999999997 108.257 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.277 0.0 OUTLIER -141.27 155.24 46.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.803 1.038 . . . . 3.3599999999999999 113.803 -175.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.8 t -139.25 132.18 15.57 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 113.919 -1.491 . . . . 1.8999999999999999 109.443 -156.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.23 166.96 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.07 1.847 . . . . 0.87 112.074 179.24 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -55.96 140.64 86.25 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.561 2.84 . . . . 1.0900000000000001 111.718 166.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 35.3 mmtm 67.65 -0.67 1.86 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.012 1.725 . . . . 2.4199999999999999 113.532 -174.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.79 113.92 4.39 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 126.773 2.13 . . . . 0.91000000000000003 113.363 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -80.97 133.47 35.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.316 1.446 . . . . 4.9900000000000002 109.9 162.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.9 168.88 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.738 1.615 . . . . 2.4100000000000001 110.45 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -164.1 117.22 1.41 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.708 0.403 . . . . 3.6800000000000002 111.373 -167.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.67 72.77 3.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.14 2.176 . . . . 1.8200000000000001 110.267 178.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -80.72 148.0 64.2 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 126.041 1.736 . . . . 4.2300000000000004 113.299 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -47.87 21.39 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.439 3.426 . . . . 0.91000000000000003 114.29 -168.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.66 103.4 2.74 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 107.525 -2.23 . . . . 1.24 107.525 157.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 144.6 -102.71 0.28 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.494 1.997 . . . . 1.1599999999999999 110.416 -162.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -149.1 158.76 44.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.46 1.504 . . . . 3.7999999999999998 110.619 -175.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -165.34 158.52 16.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.847 -1.158 . . . . 1.25 110.313 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -96.59 117.28 30.63 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.595 -0.691 . . . . 3.8300000000000001 109.295 171.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.27 121.54 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.064 1.346 . . . . 1.99 110.251 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.5 mt -108.02 106.29 16.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.69 1.996 . . . . 2.54 108.631 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.82 122.93 47.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.228 1.411 . . . . 3.77 109.384 -177.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.41 89.46 0.39 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.429 -1.068 . . . . 1.27 110.429 -175.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.13 122.25 27.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.641 0.721 . . . . 1.9099999999999999 111.682 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -74.44 -13.9 60.77 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.862 0.865 . . . . 2.48 112.955 172.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ptt85 -157.48 142.11 11.94 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 6.5499999999999998 110.41 165.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.76 141.8 38.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.834 3.023 . . . . 1.9099999999999999 111.186 -176.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.82 78.99 9.42 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.9 -1.148 . . . . 3.8300000000000001 107.9 177.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -69.45 162.84 26.6 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.736 0.779 . . . . 4.6900000000000004 111.555 170.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.12 132.95 53.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.204 -1.035 . . . . 3.1000000000000001 108.204 163.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.21 49.85 19.36 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.417 -0.657 . . . . 3.54 112.437 -171.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -126.22 167.55 15.28 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.538 1.135 . . . . 3.9199999999999999 109.895 163.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -134.63 151.92 51.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.781 1.232 . . . . 4.3499999999999996 111.353 172.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.59 121.17 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.713 2.005 . . . . 2.7000000000000002 108.627 -171.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.491 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 39.2 mt-10 -78.54 149.68 33.02 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.849 -0.532 . . . . 2.6099999999999999 110.034 162.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.9 tt -149.41 125.55 10.71 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.63 0.372 . . . . 3.1200000000000001 111.647 166.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -91.03 108.53 19.92 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.231 3.413 . . . . 2.4399999999999999 110.067 178.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.31 131.37 37.01 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.304 1.042 . . . . 3.6299999999999999 110.294 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -101.39 122.48 43.81 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.817 0.847 . . . . 2.2000000000000002 110.733 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 137.33 52.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.585 0.958 . . . . 3.6400000000000001 113.585 -172.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.57 73.21 3.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.67 1.188 . . . . 2.6000000000000001 112.047 176.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.61 32.37 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.529 1.061 . . . . 5.3899999999999997 114.589 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.77 28.33 70.96 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 118.387 1.094 . . . . 2.6299999999999999 113.869 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.26 141.37 52.13 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.815 1.246 . . . . 5.0599999999999996 111.763 -178.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.8 136.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.131 1.772 . . . . 2.4500000000000002 107.627 159.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.8 mt -144.68 124.82 13.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.476 1.11 . . . . 2.6000000000000001 110.022 -174.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 16.0 ptpt -91.53 149.2 21.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 115.542 1.682 . . . . 3.4300000000000002 115.542 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.58 148.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.239 1.816 . . . . 3.6600000000000001 109.613 167.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.92 133.2 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.184 1.393 . . . . 4.0999999999999996 109.927 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -136.19 113.9 10.58 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.314 1.046 . . . . 3.0099999999999998 111.033 -165.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.31 158.13 37.11 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.162 2.575 . . . . 1.5 111.593 171.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.61 129.88 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.388 1.475 . . . . 3.0499999999999998 111.188 176.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.44 162.88 34.34 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.33 1.852 . . . . 3.8100000000000001 108.916 175.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.68 51.76 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.448 -1.408 . . . . 3.7599999999999998 112.683 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.391 0 CA-C-O 114.021 -2.895 . . . . 5.3899999999999997 117.173 -157.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.488 0 N-CA-C 109.981 -1.247 . . . . 12.16 109.981 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.3 m -138.25 157.1 46.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.468 1.107 . . . . 9.3900000000000006 109.157 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -168.33 29.09 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.076 1.35 . . . . 12.51 111.011 -164.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 p -140.2 115.29 9.76 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.66 1.584 . . . . 7.04 109.293 -156.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -124.2 -131.53 0.26 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.684 1.193 . . . . 6.25 108.633 174.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.25 173.66 26.45 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.866 1.666 . . . . 1.6699999999999999 115.116 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -154.74 154.28 32.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.537 1.16 . . . . 2.1800000000000002 114.004 -178.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.54 144.86 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 107.04 -1.466 . . . . 2.6099999999999999 107.04 158.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -90.4 117.5 29.15 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.087 0.555 . . . . 5.21 111.263 -179.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -48.8 130.35 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.782 1.233 . . . . 4.0099999999999998 111.86 162.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 93' ' ' LEU . 33.9 m -163.4 129.73 2.33 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 128.831 2.852 . . . . 2.71 107.862 165.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -83.92 67.06 7.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.178 2.585 . . . . 2.3900000000000001 109.707 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.84 -174.43 20.45 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 115.128 0.811 . . . . 1.8 115.128 -172.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -83.48 -15.06 7.69 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 124.212 3.275 . . . . 2.0600000000000001 113.191 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -131.0 157.75 42.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.704 1.602 . . . . 4.0800000000000001 110.681 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.63 -164.35 1.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.064 1.746 . . . . 2.04 111.552 177.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.21 160.69 39.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.966 1.707 . . . . 2.0299999999999998 110.764 -178.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 158.9 43.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.095 1.358 . . . . 1.99 112.394 171.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -162.02 152.91 17.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.263 2.225 . . . . 3.9199999999999999 109.499 -173.185 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.23 157.74 26.16 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.893 -1.129 . . . . 2.9900000000000002 112.381 -175.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.8 m -77.96 96.8 5.13 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.571 -1.27 . . . . 2.5499999999999998 107.571 165.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 tt -88.3 148.94 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.931 1.692 . . . . 4.04 108.92 169.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -150.0 165.37 32.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.733 0.777 . . . . 4.1600000000000001 112.896 168.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -120.88 101.62 45.11 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 126.007 1.723 . . . . 0.90000000000000002 109.343 171.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.82 -5.48 15.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.95 2.433 . . . . 1.1200000000000001 113.302 174.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.02 -177.78 51.54 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.883 1.23 . . . . 0.95999999999999996 114.176 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 16.3 m-20 -112.69 1.75 15.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.275 1.43 . . . . 2.6800000000000002 113.373 -170.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.15 162.18 27.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.91 1.684 . . . . 2.5499999999999998 109.71 165.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.58 157.88 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.847 2.365 . . . . 1.1200000000000001 111.825 -172.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 mt -107.81 149.06 28.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.917 0.887 . . . . 3.1299999999999999 111.558 172.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -121.14 110.75 16.58 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.188 1.395 . . . . 7.2199999999999998 109.232 168.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.8 tp -82.93 127.25 33.35 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.838 1.255 . . . . 1.8600000000000001 108.173 175.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.6 -11.0 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.432 0.901 . . . . 1.8 113.432 -173.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.11 -162.74 33.36 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 121.564 0.536 . . . . 0.46999999999999997 112.295 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.59 178.92 8.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.465 1.506 . . . . 1.8 110.154 175.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -161.59 139.76 9.29 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.129 0.877 . . . . 7.5 109.137 167.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.6 t -145.56 146.34 29.21 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.99 1.316 . . . . 1.6100000000000001 108.811 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.91 -22.9 55.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.963 1.775 . . . . 1.3100000000000001 113.132 178.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.77 0.15 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 114.42 1.267 . . . . 2.21 114.42 -174.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.04 168.01 9.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 116.068 1.877 . . . . 2.8799999999999999 116.068 -169.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.37 -104.36 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 106.955 -1.498 . . . . 6.3300000000000001 106.955 143.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -79.49 169.37 18.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.554 1.168 . . . . 4.9800000000000004 112.464 167.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.6 132.02 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.868 1.667 . . . . 2.6899999999999999 107.865 161.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -119.94 128.44 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.89 1.276 . . . . 1.97 109.705 -175.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 84' ' ' PHE . 5.5 tt -81.54 120.09 24.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.773 1.17 . . . . 1.6699999999999999 110.628 169.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -110.33 153.05 25.44 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.592 1.557 . . . . 0.77000000000000002 112.933 176.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.22 172.13 8.16 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.443 2.297 . . . . 2.1800000000000002 110.699 165.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.1 m -133.19 92.65 3.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.115 1.366 . . . . 1.71 108.015 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -97.59 149.42 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.138 0.971 . . . . 3.3700000000000001 113.161 -163.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.3 ttp -79.05 139.4 38.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.629 1.172 . . . . 5.6600000000000001 110.086 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.58 113.93 2.61 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.54 0.736 . . . . 11.73 111.615 -175.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.01 153.69 19.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.158 0.983 . . . . 4.5800000000000001 110.613 174.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.6 t -143.51 122.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.284 -1.376 . . . . 3.48 107.284 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 69.28 8.47 6.82 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.916 1.286 . . . . 3.98 111.984 -174.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.58 85.31 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.843 1.211 . . . . 1.79 113.82 -166.138 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -90.94 143.14 27.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.561 1.544 . . . . 3.7799999999999998 110.225 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -75.16 132.84 41.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.713 1.605 . . . . 5.1500000000000004 113.307 -165.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.31 172.26 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.421 0.629 . . . . 2.7400000000000002 112.163 172.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.3 tpp -129.75 159.24 37.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.814 2.045 . . . . 4.29 110.133 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.45 177.75 22.06 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.009 1.766 . . . . 1.1000000000000001 112.16 173.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.3 mtt -138.9 154.49 48.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.779 1.632 . . . . 2.7799999999999998 109.66 173.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -169.82 144.0 2.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 116.401 -1.761 . . . . 5.5099999999999998 111.333 -169.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.99 150.93 87.44 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 CA-C-N 121.716 1.648 . . . . 0.89000000000000001 112.414 165.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.48 159.02 47.54 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 126.418 1.887 . . . . 2.0499999999999998 110.703 173.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -70.93 -22.16 27.06 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.683 2.255 . . . . 0.76000000000000001 112.801 173.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -175.92 171.27 2.65 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.939 1.696 . . . . 3.02 111.562 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.44 172.1 8.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.746 2.018 . . . . 1.8799999999999999 109.136 159.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.15 161.56 41.2 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.917 -1.114 . . . . 2.54 111.651 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.62 136.43 10.59 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.262 1.025 . . . . 1.99 109.679 -166.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.72 170.02 19.69 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.549 2.166 . . . . 0.84999999999999998 112.027 178.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -60.91 142.68 98.31 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.225 2.617 . . . . 0.93000000000000005 111.599 166.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 36.4 mmtm 64.55 6.57 3.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.243 1.817 . . . . 2.3900000000000001 113.506 -174.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.42 115.41 4.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 126.192 1.853 . . . . 0.96999999999999997 111.164 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.67 137.26 36.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.498 1.519 . . . . 5.6299999999999999 110.151 166.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.06 129.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.163 0.985 . . . . 2.2999999999999998 111.557 177.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.22 124.55 31.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.699 -0.852 . . . . 3.8799999999999999 108.699 165.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.1 145.49 53.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.362 -0.977 . . . . 2.02 108.362 163.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -155.92 138.85 10.67 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 117.974 -1.012 . . . . 4.4400000000000004 111.726 -166.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.79 -26.5 45.01 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.653 2.902 . . . . 1.1399999999999999 113.587 -172.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.0 87.95 1.5 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 108.084 -2.006 . . . . 1.52 108.084 155.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.85 -97.26 0.18 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.214 0.911 . . . . 1.1799999999999999 113.458 -171.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -150.91 146.45 26.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.703 2.001 . . . . 3.6699999999999999 110.469 -167.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -153.91 159.32 41.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.841 -0.537 . . . . 1.03 111.124 -175.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.41 ' CE1' HD12 ' A' ' 45' ' ' LEU . 41.7 m-85 -94.7 118.61 32.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.299 -1.001 . . . . 3.1299999999999999 108.299 164.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.09 123.15 33.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.425 -0.954 . . . . 2.6800000000000002 108.425 173.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -105.14 122.55 46.13 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.286 1.434 . . . . 3.5299999999999998 109.108 -174.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.95 151.91 39.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.37 1.068 . . . . 3.71 111.157 -170.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.85 42.65 92.2 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 123.95 0.786 . . . . 2.0099999999999998 113.219 171.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.7 mt -53.64 141.39 26.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.192 1.797 . . . . 2.3900000000000001 112.729 -171.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -70.61 -9.53 57.15 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.343 -0.848 . . . . 4.5599999999999996 112.783 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -167.23 152.06 6.86 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.824 2.05 . . . . 8.1300000000000008 111.271 173.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.29 149.22 85.23 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.847 2.365 . . . . 3.4500000000000002 110.132 162.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.445 ' HB2' ' H ' ' A' ' 11' ' ' SER . 2.4 mm? -80.23 155.51 27.31 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.596 0.712 . . . . 3.5600000000000001 111.786 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.99 -25.56 5.33 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.49 1.916 . . . . 4.5199999999999996 112.18 177.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 80.62 161.57 0.17 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.745 2.818 . . . . 2.8500000000000001 111.516 -175.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.52 57.78 16.32 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.462 -1.055 . . . . 2.6800000000000002 110.462 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -167.34 161.58 14.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.922 2.889 . . . . 3.9399999999999999 107.351 -174.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.59 161.4 16.84 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.713 1.205 . . . . 3.79 112.022 -170.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.2 t -144.6 127.78 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.718 2.007 . . . . 2.5800000000000001 109.886 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.1 140.21 41.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.931 0.492 . . . . 3.1699999999999999 110.742 165.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 tt -148.08 135.57 20.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.458 1.123 . . . . 2.6600000000000001 111.299 169.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -104.52 112.29 25.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.826 2.05 . . . . 2.2799999999999998 110.68 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.14 118.38 18.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.484 . . . . 2.2799999999999998 109.805 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -93.9 121.38 35.3 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.368 0.667 . . . . 1.74 110.179 -173.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.14 124.36 47.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.477 1.132 . . . . 3.0800000000000001 113.366 -176.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 58.33 -12.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 131.027 3.731 . . . . 2.8599999999999999 117.574 170.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.03 57.2 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.528 1.537 . . . . 3.5899999999999999 113.452 -163.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.75 -0.06 1.82 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.126 1.61 . . . . 2.1499999999999999 117.126 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.4 156.81 43.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.459 1.904 . . . . 4.9500000000000002 111.294 173.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.88 128.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.82 1.248 . . . . 1.76 109.639 167.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.42 133.72 55.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.809 1.643 . . . . 3.5499999999999998 109.055 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -85.48 134.94 34.03 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.042 -1.036 . . . . 3.3300000000000001 111.474 176.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.7 164.45 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.987 1.315 . . . . 2.2400000000000002 109.841 160.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.25 142.29 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.532 -1.284 . . . . 3.3599999999999999 107.532 169.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.6 mt -136.76 138.78 27.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.918 1.287 . . . . 3.3399999999999999 109.985 -169.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.11 150.05 17.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.701 2.934 . . . . 1.3899999999999999 111.193 166.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.6 t -88.17 120.56 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.75 1.62 . . . . 2.2999999999999998 109.092 167.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 120' ' ' ARG . 46.9 mt-10 -142.49 162.06 36.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.818 1.247 . . . . 4.5999999999999996 112.194 -170.129 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.23 126.41 41.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.941 0.897 . . . . 3.71 109.105 166.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.44 HH21 ' CD ' ' A' ' 118' ' ' GLU . 92.1 mtt-85 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 129.553 3.141 . . . . 8.6300000000000008 109.325 -171.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.323 0 N-CA-C 105.72 -2.952 . . . . 12.48 105.72 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 t 62.39 173.21 0.14 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.458 0.629 . . . . 10.75 110.524 -134.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -101.45 166.2 10.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.011 1.324 . . . . 10.31 108.473 157.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.4 p -96.43 167.24 11.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.271 0.628 . . . . 8.2699999999999996 110.956 170.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -159.26 -134.4 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.173 0.989 . . . . 5.2999999999999998 109.057 -163.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.89 -179.4 24.76 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.686 1.585 . . . . 1.24 114.667 175.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -170.48 156.63 5.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.708 1.603 . . . . 1.9299999999999999 111.903 170.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.03 128.9 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.822 -0.807 . . . . 1.8500000000000001 108.822 172.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.412 HH21 ' C ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -73.85 -5.13 39.11 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 117.789 2.515 . . . . 4.4699999999999998 117.789 -145.657 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 69.82 121.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.299 2.639 . . . . 5.5099999999999998 112.248 -174.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -171.36 136.92 1.03 Allowed Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 119.752 -1.843 . . . . 2.4900000000000002 112.393 178.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -93.88 -5.33 2.63 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.622 3.548 . . . . 2.8700000000000001 113.893 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.75 165.78 53.81 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 119.275 0.943 . . . . 1.48 112.53 177.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.08 -14.77 44.64 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.502 2.801 . . . . 1.95 114.54 -172.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -124.61 152.12 43.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.365 1.466 . . . . 4.2199999999999998 111.822 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.1 -168.06 2.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.551 1.94 . . . . 2.3500000000000001 111.223 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.59 156.27 44.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.523 1.129 . . . . 1.9199999999999999 112.997 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.77 140.03 53.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.294 1.437 . . . . 1.9299999999999999 111.559 169.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -119.83 150.79 39.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.575 1.55 . . . . 3.21 110.035 178.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -162.83 158.74 23.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.673 0.99 . . . . 2.8900000000000001 113.673 177.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -94.01 117.22 29.79 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.977 -1.119 . . . . 2.4900000000000002 107.977 165.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.42 135.46 34.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.596 1.958 . . . . 3.4399999999999999 108.136 175.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -145.75 146.3 31.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.971 1.1 . . . . 2.7400000000000002 113.971 170.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -110.08 109.16 59.04 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 113.971 -1.468 . . . . 0.94999999999999996 110.113 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.46 -9.88 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.669 2.246 . . . . 1.1200000000000001 113.498 175.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.24 177.86 54.13 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.316 0.96 . . . . 0.94999999999999996 114.035 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 6.8 m-20 -106.19 -1.63 23.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.911 1.685 . . . . 2.3300000000000001 112.925 -178.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.95 162.67 19.74 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 126.128 1.771 . . . . 2.4199999999999999 109.646 163.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.17 161.64 17.85 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.011 2.474 . . . . 1.21 112.018 -172.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 mt -109.0 154.5 22.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.341 1.056 . . . . 2.8500000000000001 110.488 168.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -138.01 102.62 4.74 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 5.0599999999999996 109.635 177.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -84.38 103.8 13.86 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.258 1.823 . . . . 1.76 108.702 -172.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.79 -13.87 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.682 0.793 . . . . 1.9099999999999999 112.736 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.71 -164.39 35.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 123.603 0.621 . . . . 0.68000000000000005 112.258 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.19 177.3 10.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.992 0.917 . . . . 2.1299999999999999 111.951 167.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -144.35 148.42 34.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.928 1.291 . . . . 7.9800000000000004 109.586 170.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -150.54 151.31 30.59 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 125.137 1.375 . . . . 1.8600000000000001 108.344 -168.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.4 -24.73 16.13 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.91 1.74 . . . . 0.93999999999999995 113.364 175.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 m -78.6 -19.67 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.704 1.372 . . . . 2.0800000000000001 114.704 -170.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.33 45.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.038 0.935 . . . . 1.77 111.098 -172.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.34 -71.97 0.52 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.768 0.427 . . . . 3.0499999999999998 111.427 -174.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -79.18 142.5 36.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.421 1.088 . . . . 4.6900000000000004 108.193 167.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -153.7 135.67 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 2.4300000000000002 108.512 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -145.84 139.2 26.18 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.824 1.25 . . . . 2.1299999999999999 110.144 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -81.95 119.44 23.96 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.454 1.121 . . . . 1.72 110.901 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.5 m170 -111.36 157.77 19.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.17 1.788 . . . . 1.1200000000000001 111.623 176.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -111.35 168.45 9.52 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.664 1.985 . . . . 2.4300000000000002 110.467 172.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -126.88 100.93 6.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.919 2.088 . . . . 2.2400000000000002 108.195 172.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -97.73 156.45 16.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.964 1.098 . . . . 3.7599999999999998 113.964 -167.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -85.94 148.77 25.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.808 0.843 . . . . 4.4500000000000002 111.504 166.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -160.6 163.78 32.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.34 1.456 . . . . 6.6399999999999997 111.093 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -128.5 157.87 39.95 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.39 1.876 . . . . 4.2199999999999998 108.972 175.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.7 t -153.68 124.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 125.266 1.604 . . . . 4.2599999999999998 107.756 168.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.93 15.46 6.09 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.286 1.434 . . . . 4.9100000000000001 114.323 176.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.55 28.27 39.97 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.315 1.436 . . . . 3.4199999999999999 113.785 -173.246 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -123.29 136.01 54.49 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.761 2.025 . . . . 4.6699999999999999 111.148 168.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.31 144.41 42.45 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.562 -0.711 . . . . 9.9700000000000006 112.686 -177.312 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.25 153.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.466 1.106 . . . . 4.29 110.582 173.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.98 131.95 52.14 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.483 1.113 . . . . 4.6600000000000001 109.857 175.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.04 -179.55 15.8 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 124.976 1.274 . . . . 1.26 112.351 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.1 mtt -132.59 158.64 41.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.756 1.222 . . . . 2.8999999999999999 111.643 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -171.63 157.61 4.5 Favored Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 125.954 1.702 . . . . 5.8600000000000003 110.878 -178.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.9 Cg_endo -71.4 153.95 60.92 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.734 1.623 . . . . 0.94999999999999996 112.11 169.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -117.85 154.77 51.3 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.731 1.612 . . . . 2.0099999999999998 109.638 164.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.26 -10.33 25.56 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.933 2.422 . . . . 1.1399999999999999 113.087 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -177.38 158.67 1.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.659 1.984 . . . . 4.0999999999999996 110.474 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.07 171.04 7.59 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.165 1.386 . . . . 2.0 109.122 148.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -156.22 161.33 40.28 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 120.956 -1.09 . . . . 2.4700000000000002 112.002 172.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 t -149.61 133.37 8.72 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 123.899 0.88 . . . . 2.2799999999999998 109.675 -160.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.39 168.84 21.22 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.122 1.881 . . . . 1.0700000000000001 111.801 177.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.43 142.11 97.63 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.645 2.897 . . . . 1.0800000000000001 111.601 166.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.454 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 35.1 mmtm 66.56 3.65 2.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.965 1.706 . . . . 2.4700000000000002 113.554 -178.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.03 115.09 4.05 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 126.123 1.821 . . . . 1.1000000000000001 112.259 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -92.4 129.11 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.213 1.405 . . . . 5.3300000000000001 109.98 160.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.0 m -144.69 156.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.346 1.858 . . . . 2.4500000000000002 110.44 -177.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.17 120.45 31.37 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.141 -0.974 . . . . 3.71 112.52 -166.337 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.18 68.8 1.98 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.843 1.657 . . . . 2.0600000000000001 109.36 168.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -77.67 149.16 77.47 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.988 1.715 . . . . 3.5499999999999998 111.615 173.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -59.24 -31.81 95.85 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.783 2.322 . . . . 1.1000000000000001 113.257 176.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.28 40.65 3.06 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.545 1.069 . . . . 1.2 113.111 169.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.26 -75.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.887 1.232 . . . . 1.3400000000000001 114.931 -175.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -153.2 147.09 25.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.044 2.137 . . . . 3.0800000000000001 109.449 -171.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -163.82 170.19 17.21 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.478 -1.389 . . . . 1.3799999999999999 111.42 -175.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -104.21 120.05 40.3 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.557 -0.534 . . . . 3.1200000000000001 109.557 170.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 mmt -76.32 129.23 36.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.945 0.898 . . . . 1.71 109.313 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.9 mt -108.06 124.91 50.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.594 1.558 . . . . 2.8599999999999999 107.364 177.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.46 118.59 11.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.66 0.784 . . . . 3.6200000000000001 109.933 -162.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.19 74.26 1.08 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 109.771 -1.331 . . . . 1.3700000000000001 109.771 -167.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mt -72.84 90.04 1.42 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.897 0.856 . . . . 2.1200000000000001 113.118 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -67.16 -11.35 57.07 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.919 1.081 . . . . 3.1800000000000002 113.919 172.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.4 mtp-105 -138.12 136.05 19.15 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.984 1.714 . . . . 5.0199999999999996 108.241 155.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.9 149.67 59.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.387 . . . . 1.8799999999999999 110.267 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.65 97.05 9.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.894 0.478 . . . . 3.1400000000000001 111.256 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -77.96 129.38 35.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.863 1.265 . . . . 4.1500000000000004 110.946 169.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.93 49.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.273 -0.892 . . . . 2.8500000000000001 109.297 171.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.73 37.47 26.4 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 118.467 0.576 . . . . 2.4500000000000002 112.92 -166.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.52 -179.28 3.87 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 106.979 -1.489 . . . . 2.9700000000000002 106.979 151.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -126.85 149.56 49.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.269 1.027 . . . . 3.7200000000000002 109.018 167.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.27 118.44 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.942 1.297 . . . . 2.02 109.702 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -81.65 146.51 30.02 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.438 1.113 . . . . 3.6600000000000001 111.41 160.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.67 123.46 8.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.84 1.256 . . . . 2.4199999999999999 110.903 -169.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.72 91.44 8.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 127.731 2.412 . . . . 2.2599999999999998 110.037 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.67 115.96 13.69 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.575 0.75 . . . . 2.6800000000000002 110.295 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.1 mt -88.2 124.77 34.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 2.0099999999999998 110.753 -173.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -125.09 124.01 40.97 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.955 0.724 . . . . 3.6099999999999999 112.955 -178.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.04 22.34 0.58 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.864 2.065 . . . . 3.2400000000000002 114.307 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.87 -56.21 1.76 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.17 1.367 . . . . 3.54 112.523 -163.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.43 8.85 52.23 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 117.499 1.76 . . . . 1.6699999999999999 117.499 -165.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 152.26 48.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.917 2.087 . . . . 4.7999999999999998 110.541 166.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.5 131.71 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.899 1.28 . . . . 1.8999999999999999 110.82 169.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.59 111.34 18.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.154 1.381 . . . . 3.9199999999999999 110.487 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 85.76 5.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.191 0.996 . . . . 3.77 110.99 178.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.73 174.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.772 1.629 . . . . 2.6299999999999999 111.255 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.4 151.51 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.057 1.343 . . . . 3.02 110.568 170.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -140.74 141.99 26.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 128.034 2.534 . . . . 2.48 109.044 176.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -70.32 149.29 63.1 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.123 1.882 . . . . 1.01 109.478 170.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.83 123.86 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.475 -1.305 . . . . 2.3100000000000001 107.475 163.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' CD ' HH22 ' A' ' 120' ' ' ARG . 0.1 OUTLIER -155.61 151.93 28.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.931 1.693 . . . . 3.02 108.068 -161.259 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.99 108.45 19.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.731 1.011 . . . . 2.7999999999999998 113.731 -157.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.418 HH22 ' CD ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.921 1.288 . . . . 6.0999999999999996 112.071 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.458 ' H2 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.472 1.077 0 N-CA-C 107.798 -2.121 . . . . 9.6699999999999999 107.798 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p 163.17 -168.44 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.42 -0.956 . . . . 9.0299999999999994 108.42 -135.134 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -61.33 -29.24 69.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.588 -0.695 . . . . 11.960000000000001 112.742 166.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m 101.98 134.82 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 1 C-N-CA 132.27 4.228 . . . . 7.6600000000000001 108.474 -176.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.97 54.19 0.7 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.754 1.222 . . . . 6.2699999999999996 110.981 -166.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.46 161.5 24.47 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 124.982 1.277 . . . . 1.1799999999999999 112.865 -174.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.407 ' CD1' ' HB3' ' A' ' 118' ' ' GLU . 32.1 p90 -163.14 161.4 25.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 3.2999999999999998 114.508 -175.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.61 150.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.049 0.94 . . . . 2.2400000000000002 110.092 -177.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 -88.26 114.87 25.31 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.793 0.837 . . . . 4.8300000000000001 111.477 177.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -43.81 120.57 2.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.052 2.141 . . . . 3.6200000000000001 112.888 166.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -167.76 97.83 0.61 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.727 1.611 . . . . 2.4100000000000001 110.341 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.68 70.39 7.28 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.566 2.844 . . . . 4.1600000000000001 109.253 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.03 -150.91 5.29 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.193 0.902 . . . . 2.21 114.034 -172.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.35 -21.29 11.87 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.981 2.454 . . . . 2.1600000000000001 112.716 -179.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -157.71 167.96 28.58 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.779 1.232 . . . . 2.7799999999999998 113.518 -175.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -163.04 -177.87 5.71 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.287 1.835 . . . . 2.02 112.309 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.57 52.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.695 1.598 . . . . 2.0800000000000001 111.023 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.56 138.64 54.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.936 0.789 . . . . 1.8 111.592 167.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -120.29 147.73 44.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.535 1.934 . . . . 3.7999999999999998 110.813 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pp -166.6 149.89 6.99 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.761 -1.212 . . . . 2.5899999999999999 113.874 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.29 96.51 6.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 127.748 2.419 . . . . 3.3300000000000001 108.385 168.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.65 126.69 34.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 4.0300000000000002 108.971 174.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.458 ' CD ' ' H2 ' ' A' ' 1' ' ' GLY . 17.7 pt-20 -137.77 145.84 42.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.273 1.429 . . . . 3.1600000000000001 111.621 -175.129 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -116.08 105.68 50.64 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.93999999999999995 111.973 -173.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.48 -11.03 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.578 2.185 . . . . 1.0700000000000001 113.298 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.66 163.25 53.47 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 125.59 1.567 . . . . 0.98999999999999999 113.802 -177.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -80.08 -32.64 39.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.043 2.137 . . . . 4.9800000000000004 112.65 175.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -98.28 163.98 18.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.478 1.911 . . . . 2.6600000000000001 111.072 173.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.22 154.93 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.418 2.745 . . . . 1.46 112.012 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.06 141.27 31.21 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.622 0.769 . . . . 3.5299999999999998 110.305 171.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -125.85 109.97 13.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.509 1.124 . . . . 3.6899999999999999 110.072 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.08 122.74 32.7 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.579 1.952 . . . . 2.1499999999999999 109.776 -176.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.62 -6.77 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.29 1.036 . . . . 1.99 113.456 -172.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.0 -163.74 34.07 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.821 1.201 . . . . 0.54000000000000004 111.41 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.13 -175.73 5.58 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.469 1.508 . . . . 1.5600000000000001 110.476 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -156.26 139.72 15.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.067 1.347 . . . . 7.2599999999999998 108.932 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.26 146.38 45.56 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 117.2 -1.381 . . . . 1.7 108.464 -173.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.24 -13.12 35.44 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.548 2.165 . . . . 0.92000000000000004 114.086 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.3 -3.94 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.28 1.585 . . . . 2.0899999999999999 115.28 -176.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.65 147.39 40.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 121.094 1.77 . . . . 1.6200000000000001 112.848 -172.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -83.71 -51.44 7.25 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.733 1.613 . . . . 3.1000000000000001 110.787 178.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -111.44 141.18 45.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.536 1.134 . . . . 4.1200000000000001 110.115 170.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.29 137.08 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.071 1.348 . . . . 2.29 109.104 160.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -128.93 131.78 47.57 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.267 1.827 . . . . 2.1899999999999999 108.708 175.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.81 123.31 29.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.508 1.504 . . . . 1.8700000000000001 110.406 169.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -107.74 155.2 20.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.076 1.751 . . . . 0.78000000000000003 112.331 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -94.38 -174.15 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.651 1.981 . . . . 2.9199999999999999 111.481 167.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -145.34 80.25 1.6 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.182 1.393 . . . . 2.1699999999999999 109.18 166.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.27 143.79 52.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.952 0.882 . . . . 3.7999999999999998 111.8 -172.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtp -108.03 34.77 3.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.004 1.722 . . . . 4.0800000000000001 111.313 -172.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -70.34 156.89 38.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 8.3300000000000001 110.788 -167.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -46.7 159.54 0.09 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.781 0.833 . . . . 6.8399999999999999 110.335 146.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -163.17 -29.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.566 1.946 . . . . 4.0700000000000003 113.189 179.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 56' ' ' LYS . 37.3 mt-10 -143.95 38.89 1.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.908 2.483 . . . . 4.75 109.277 170.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -33.73 0.37 Allowed Glycine 0 N--CA 1.481 1.666 0 O-C-N 120.055 -1.653 . . . . 2.5499999999999998 113.372 -160.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 55.3 mtmt -61.08 135.22 57.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.655 1.982 . . . . 4.3200000000000003 109.851 170.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -85.79 129.69 34.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 118.212 -0.899 . . . . 5.3099999999999996 110.512 173.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.1 t -140.77 150.14 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.75 1.22 . . . . 3.0600000000000001 109.572 -169.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.9 mtm -92.9 121.8 34.63 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.228 1.011 . . . . 3.8100000000000001 112.406 172.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.73 163.59 25.52 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.146 1.355 . . . . 1.1299999999999999 111.755 171.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -107.2 152.45 24.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.24 1.016 . . . . 2.3799999999999999 112.462 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -149.64 145.5 19.19 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.317 2.247 . . . . 4.9400000000000004 108.43 171.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.12 145.76 89.74 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.42 1.543 . . . . 0.87 111.022 160.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.59 158.08 60.3 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.129 1.772 . . . . 2.1299999999999999 111.149 -179.229 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.46 -21.16 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.556 2.171 . . . . 0.70999999999999996 113.336 178.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -174.54 169.95 3.59 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.205 1.366 . . . . 3.1099999999999999 112.66 -177.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.33 174.35 9.69 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.555 2.742 . . . . 2.1000000000000001 108.871 162.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.67 168.68 26.56 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.632 -1.293 . . . . 2.2400000000000002 112.708 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 t -146.41 131.3 8.94 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 125.359 1.463 . . . . 1.95 109.519 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.0 161.05 41.96 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.607 2.205 . . . . 1.0900000000000001 111.773 176.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.89 133.7 42.95 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.959 3.106 . . . . 1.04 111.706 179.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 72.3 -2.32 2.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.226 2.21 . . . . 2.4100000000000001 113.718 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.87 -179.02 37.66 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 126.049 1.785 . . . . 1.2 111.677 178.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -160.11 158.38 30.19 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.06 1.344 . . . . 5.0199999999999996 114.571 177.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.83 172.18 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.962 2.105 . . . . 2.7400000000000002 110.731 177.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -119.33 132.99 55.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.66 1.584 . . . . 5.5599999999999996 109.048 170.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.82 81.31 6.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.832 1.301 . . . . 1.97 109.559 163.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 143.89 75.15 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.381 2.272 . . . . 5.2400000000000002 113.472 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.54 -40.19 76.37 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.771 2.314 . . . . 1.3 111.567 167.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.71 79.03 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.157 -1.177 . . . . 1.1699999999999999 110.157 164.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.98 -73.22 0.12 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 1.1000000000000001 114.696 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -158.52 139.84 13.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.593 1.957 . . . . 3.8799999999999999 109.154 -176.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -166.12 158.01 14.01 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.572 1.987 . . . . 1.3700000000000001 110.983 -175.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.08 124.02 32.78 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.951 -0.388 . . . . 3.54 109.951 170.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.79 122.21 34.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.999 1.32 . . . . 2.48 108.63 169.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.13 135.92 43.9 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.874 1.67 . . . . 2.8500000000000001 109.012 -177.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.31 125.64 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.769 1.228 . . . . 3.75 111.226 -171.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.72 104.64 0.04 OUTLIER Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.734 1.635 . . . . 1.28 110.987 -174.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.0 mt -102.11 115.68 31.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.792 1.296 . . . . 2.1899999999999999 112.832 -166.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -66.32 -25.0 66.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.118 1.367 . . . . 2.4700000000000002 112.923 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -152.78 146.54 18.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.164 2.186 . . . . 8.8100000000000005 109.826 175.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.75 131.87 9.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.239 2.626 . . . . 1.9099999999999999 111.617 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.35 127.68 33.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 2.9500000000000002 110.327 174.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.37 -166.49 1.16 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.981 0.896 . . . . 4.5099999999999998 111.325 167.094 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.08 119.72 21.18 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.162 -0.961 . . . . 2.8300000000000001 113.051 -162.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.91 -12.21 69.65 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.267 1.413 . . . . 4.2699999999999996 114.901 174.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -74.51 154.24 38.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.05 1.13 . . . . 3.5499999999999998 114.05 -157.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -80.65 90.7 5.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.539 1.936 . . . . 4.21 112.179 -166.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.59 106.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 2.2999999999999998 109.382 166.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 4.1 mt-10 -68.75 139.34 55.32 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.255 1.026 . . . . 3.0899999999999999 110.526 157.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -149.85 118.99 6.75 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.802 1.241 . . . . 2.7400000000000002 109.502 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 102.18 14.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.923 1.289 . . . . 2.5499999999999998 108.438 173.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.35 128.04 34.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.543 1.137 . . . . 4.4100000000000001 109.094 177.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -98.13 130.97 44.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.778 0.831 . . . . 1.75 110.323 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -130.11 153.55 48.38 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.724 0.773 . . . . 3.0800000000000001 112.54 -177.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.97 146.39 42.65 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.951 -0.468 . . . . 3.1400000000000001 110.774 170.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.98 27.41 23.76 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.016 0.766 . . . . 4.4400000000000004 115.016 -177.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 17.86 79.16 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-N 117.894 0.847 . . . . 1.74 113.757 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -94.51 140.47 29.8 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.574 -0.956 . . . . 5.0300000000000002 112.349 -174.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.67 128.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.067 2.147 . . . . 2.1499999999999999 107.772 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.8 mt -147.11 122.84 10.56 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.943 0.897 . . . . 2.4199999999999999 111.697 -164.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.461 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 37.5 mtmt -75.33 123.68 25.77 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.655 0.613 . . . . 3.54 112.655 177.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.5 m -93.14 159.92 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.692 0.797 . . . . 2.9300000000000002 109.477 150.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.38 118.85 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.102 0.961 . . . . 2.9399999999999999 108.543 167.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.69 141.42 36.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.105 0.962 . . . . 3.0699999999999998 111.544 -166.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.55 151.02 64.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.526 2.817 . . . . 1.05 111.753 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 74.7 t -79.21 130.72 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.004 0.922 . . . . 2.6299999999999999 110.442 160.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HB3' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -118.48 -152.39 0.5 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.043 2.537 . . . . 4.4100000000000001 106.687 160.065 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.89 8.8 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 122.783 2.538 . . . . 2.9300000000000002 117.501 -162.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.277 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 117.337 -1.315 . . . . 8.8000000000000007 113.094 179.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.257 0 N-CA-C 105.968 -2.853 . . . . 11.09 105.968 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -59.64 166.65 2.39 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 117.348 0.574 . . . . 9.5399999999999991 110.376 130.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -147.66 112.99 5.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.092 1.757 . . . . 11.52 106.814 178.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 m 71.25 172.19 0.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.27 1.428 . . . . 8.3699999999999992 107.78 -141.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -145.42 144.97 30.94 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.326 -0.859 . . . . 4.75 109.374 166.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.44 -179.5 30.53 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 123.738 0.685 . . . . 1.5800000000000001 114.473 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -159.62 152.21 21.36 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.262 1.025 . . . . 2.1299999999999999 113.104 177.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.96 133.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.25 -1.019 . . . . 2.1600000000000001 108.25 165.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 2.9 tmt_? -98.05 100.1 11.41 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.365 2.266 . . . . 4.6699999999999999 109.017 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -57.55 148.69 23.21 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.077 0.942 . . . . 5.0499999999999998 111.445 172.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -152.03 145.2 17.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.426 1.49 . . . . 2.5800000000000001 110.01 161.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.81 71.42 7.05 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.083 3.189 . . . . 2.5600000000000001 110.371 -176.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.54 -172.81 27.19 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.055 0.836 . . . . 1.49 113.701 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.99 -3.57 13.3 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.163 3.242 . . . . 2.1299999999999999 112.815 176.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -142.8 167.0 23.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.219 1.808 . . . . 3.1000000000000001 112.521 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.64 -176.24 3.07 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.524 1.929 . . . . 2.1000000000000001 110.928 -170.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.53 157.62 39.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.133 0.879 . . . . 1.97 112.611 176.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.25 144.72 51.33 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 1.8899999999999999 110.422 165.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.85 152.33 51.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.296 1.439 . . . . 3.4300000000000002 109.277 175.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -173.17 158.66 3.7 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.042 1.127 . . . . 2.8100000000000001 114.042 175.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -82.71 130.89 35.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 126.767 2.027 . . . . 2.6600000000000001 109.532 163.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 tt -114.76 143.3 45.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.103 1.761 . . . . 4.2199999999999998 108.858 169.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.77 142.06 28.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.0 0.905 . . . . 3.1299999999999999 112.191 170.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -100.86 106.13 42.18 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.768 1.627 . . . . 0.98999999999999999 109.847 178.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.5 -9.36 17.36 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.418 2.079 . . . . 1.0900000000000001 113.361 176.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.52 -178.57 52.5 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.332 0.969 . . . . 0.97999999999999998 114.032 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.5 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 16.7 m-20 -111.77 1.28 16.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.756 1.623 . . . . 2.4500000000000002 113.162 -172.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.07 160.03 37.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.924 1.69 . . . . 2.5800000000000001 110.176 166.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.16 157.44 17.53 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.156 2.571 . . . . 1.1499999999999999 111.721 -172.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.2 mt -107.53 157.61 17.89 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.601 1.16 . . . . 3.4199999999999999 110.548 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 68' ' ' GLU . 25.8 ttm105 -134.66 116.24 14.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.731 1.212 . . . . 3.8700000000000001 109.291 169.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -97.66 117.16 31.32 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.337 2.255 . . . . 2.0299999999999998 109.508 -171.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.71 -9.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 114.038 1.125 . . . . 1.8999999999999999 114.038 -167.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.13 -163.77 32.7 Favored Glycine 0 C--N 1.34 0.791 0 O-C-N 121.418 -0.801 . . . . 0.80000000000000004 112.548 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.33 -178.32 6.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.044 0.937 . . . . 2.1099999999999999 111.183 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.73 136.16 3.61 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.88 1.218 . . . . 6.7699999999999996 108.065 176.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -138.13 152.09 71.13 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 117.403 -1.285 . . . . 1.8200000000000001 109.453 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.46 -21.0 53.98 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.35 2.033 . . . . 1.0900000000000001 113.568 169.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.3 4.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.549 1.314 . . . . 2.1000000000000001 114.549 -174.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.52 -179.01 5.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.968 1.307 . . . . 1.8899999999999999 110.787 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 7.3 tp10 -101.57 -56.86 2.2 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.211 0.604 . . . . 3.1600000000000001 110.353 173.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -120.06 161.59 20.71 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.748 0.785 . . . . 5.04 111.156 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.37 134.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.891 -1.05 . . . . 3.4199999999999999 108.988 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -118.69 134.43 55.13 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.209 1.804 . . . . 2.0099999999999998 108.798 -172.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -80.32 116.74 20.56 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.559 1.171 . . . . 2.0499999999999998 110.568 169.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -103.75 148.45 26.07 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.333 1.54 . . . . 0.71999999999999997 111.616 173.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.45 164.55 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.089 -1.414 . . . . 2.1200000000000001 109.702 159.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.441 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 91.2 m -140.77 93.39 2.6 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.56 -1.644 . . . . 2.2200000000000002 106.56 167.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -90.43 173.53 8.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.711 1.604 . . . . 3.4199999999999999 113.204 -162.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 56.1 mtm -113.32 131.34 55.99 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.37 -0.974 . . . . 4.0099999999999998 108.37 146.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -150.18 164.48 35.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.551 1.94 . . . . 8.5099999999999998 109.236 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -93.32 148.35 22.12 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.308 0.643 . . . . 3.7200000000000002 111.87 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 p -144.62 -8.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.48 1.659 . . . . 4.0700000000000003 115.48 -165.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -162.94 36.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.749 1.619 . . . . 3.4500000000000002 109.451 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.76 -11.2 1.3 Allowed Glycine 0 CA--C 1.539 1.545 0 O-C-N 120.642 -1.286 . . . . 2.3700000000000001 113.703 -160.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -113.07 150.84 31.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.224 2.21 . . . . 3.2000000000000002 111.196 -175.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 129.34 34.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.269 1.828 . . . . 7.2699999999999996 113.579 -173.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -142.37 147.57 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.369 0.986 . . . . 2.9700000000000002 111.358 -172.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.5 mtt -83.19 138.79 33.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.707 1.203 . . . . 4.5099999999999998 113.477 171.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.89 167.3 33.19 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.128 0.87 . . . . 1.0800000000000001 113.384 173.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -107.54 166.17 10.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.112 1.365 . . . . 2.6299999999999999 111.718 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.71 136.04 0.29 Allowed Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 116.21 -1.852 . . . . 5.04 110.738 -175.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.93 143.03 64.68 Favored 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 122.254 1.841 . . . . 0.63 111.344 166.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -112.51 157.83 39.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.096 1.359 . . . . 1.6599999999999999 110.0 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.25 -22.93 45.74 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.086 1.858 . . . . 0.81999999999999995 112.262 174.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -173.96 165.74 4.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.503 1.521 . . . . 3.6899999999999999 112.932 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -111.03 177.52 4.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.169 1.787 . . . . 2.21 109.306 150.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 31' ' ' ARG . 9.6 pt-20 -153.53 171.02 19.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.663 -1.273 . . . . 2.2599999999999998 111.638 175.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -151.57 134.53 8.9 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 118.36 -0.828 . . . . 2.6200000000000001 110.189 -167.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.69 169.68 21.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 121.726 1.618 . . . . 1.0900000000000001 111.434 171.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.92 142.27 74.62 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.005 3.137 . . . . 1.0800000000000001 111.849 166.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.5 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 0.4 OUTLIER 57.27 10.77 0.95 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.801 1.778 . . . . 2.6099999999999999 115.801 -168.063 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.46 116.07 4.17 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 128.244 2.831 . . . . 1.3700000000000001 110.889 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.16 137.15 35.64 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.32 1.448 . . . . 4.71 110.173 162.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.33 144.0 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.787 1.635 . . . . 2.4700000000000002 109.252 178.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -132.28 118.41 19.43 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.652 -0.499 . . . . 3.9300000000000002 109.652 -165.061 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.44 75.84 3.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.138 1.375 . . . . 1.9299999999999999 110.041 -173.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -72.11 131.0 85.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.55 -1.214 . . . . 5.5999999999999996 108.651 175.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.5 -40.29 85.5 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.064 2.51 . . . . 1.1299999999999999 113.018 -173.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.77 67.43 3.56 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 119.628 1.103 . . . . 1.3700000000000001 111.111 164.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 177.46 -82.17 0.07 OUTLIER Glycine 0 N--CA 1.469 0.861 0 C-N-CA 125.63 1.586 . . . . 1.01 112.637 -167.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -153.19 144.96 23.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.977 2.511 . . . . 3.0600000000000001 108.927 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.69 171.4 16.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.429 0.692 . . . . 1.03 110.568 -177.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -109.58 125.91 53.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.093 0.957 . . . . 3.3799999999999999 111.208 173.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.2 mmt -89.78 121.86 32.32 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.403 1.081 . . . . 2.0800000000000001 110.662 170.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.68 138.96 33.45 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.7 1.6 . . . . 3.1600000000000001 110.729 -178.143 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mt -144.1 140.19 29.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.175 0.806 . . . . 3.9100000000000001 113.175 -177.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 57.96 3.44 Favored Glycine 0 N--CA 1.469 0.884 0 C-N-CA 124.303 0.954 . . . . 1.6799999999999999 111.215 -176.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.8 mt -70.25 137.74 51.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.256 0.835 . . . . 1.8700000000000001 113.256 -171.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.502 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 92.0 mttt -102.88 -3.43 26.23 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.756 1.223 . . . . 2.5899999999999999 112.79 -172.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -139.01 158.56 69.46 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.106 1.362 . . . . 6.0899999999999999 108.93 152.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.03 122.43 9.74 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 N-CA-C 106.255 -2.248 . . . . 2.04 106.255 138.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.17 120.96 21.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.102 0.953 . . . . 3.3199999999999998 109.528 -166.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -67.49 109.38 3.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.511 1.125 . . . . 6.3499999999999996 108.201 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.38 113.64 0.73 Allowed 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 2.8199999999999998 113.004 172.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.47 6.58 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.812 0.72 . . . . 2.4100000000000001 113.265 -166.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.31 -169.15 1.56 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.187 1.795 . . . . 2.8300000000000001 108.662 146.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.6 162.0 33.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.735 1.214 . . . . 4.8899999999999997 110.854 177.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.9 t -132.77 133.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.009 1.724 . . . . 1.9199999999999999 109.847 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.501 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 10.6 mt-10 -80.02 148.24 31.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.138 0.494 . . . . 3.1499999999999999 111.512 164.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -151.81 120.63 6.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.091 1.356 . . . . 3.6200000000000001 109.388 175.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.86 114.14 17.54 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.429 3.092 . . . . 2.0899999999999999 109.951 170.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.14 122.51 27.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.813 1.188 . . . . 2.9199999999999999 109.449 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -97.53 127.88 43.83 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.057 0.943 . . . . 1.9399999999999999 111.243 -171.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.64 151.33 48.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.168 0.985 . . . . 3.7599999999999998 112.828 -176.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.62 158.82 35.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.717 -0.674 . . . . 2.7799999999999998 111.987 172.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.32 74.78 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.586 -0.696 . . . . 4.7699999999999996 113.899 176.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.51 63.8 2.07 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 118.219 1.01 . . . . 2.29 112.612 173.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -147.89 142.66 26.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.186 1.795 . . . . 4.5099999999999998 110.867 178.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.92 139.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.393 1.877 . . . . 2.3599999999999999 107.86 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.6 mt -143.49 108.21 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.534 1.134 . . . . 2.7000000000000002 108.811 -175.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.501 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 48.5 pttt -92.53 150.39 20.78 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.86 1.059 . . . . 2.9399999999999999 113.86 -177.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.49 159.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.795 1.238 . . . . 2.5899999999999999 110.367 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.21 148.5 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.991 1.316 . . . . 3.6099999999999999 109.849 168.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.1 mt -143.76 129.39 9.91 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.379 1.872 . . . . 2.5 109.051 -178.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.0 156.93 61.54 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.137 2.558 . . . . 1.0600000000000001 112.561 175.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -88.92 113.37 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.102 1.361 . . . . 2.3300000000000001 110.487 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -107.36 179.29 4.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.038 2.535 . . . . 4.4900000000000002 108.595 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.27 123.3 17.84 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.663 -1.273 . . . . 3.4399999999999999 109.755 171.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.45 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 4.1 tpt180 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.139 0.976 . . . . 5.4299999999999997 113.311 -161.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.281 0 N-CA-C 108.828 -1.709 . . . . 12.5 108.828 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 t -84.39 -151.03 0.12 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 108.241 -1.022 . . . . 12.890000000000001 108.241 148.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -68.75 68.74 0.16 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.591 1.556 . . . . 19.84 110.85 167.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.421 ' C ' ' HG1' ' A' ' 21' ' ' THR . 18.0 p -148.03 -11.66 0.37 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 128.322 2.649 . . . . 8.4900000000000002 113.675 -160.003 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -156.68 154.75 30.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 130.97 3.708 . . . . 5.6399999999999997 106.867 -172.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -107.36 167.39 13.62 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 116.155 1.222 . . . . 1.1399999999999999 116.155 -163.259 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -156.14 146.29 21.44 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.616 1.567 . . . . 2.04 112.497 173.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.7 139.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.328 -1.36 . . . . 2.7799999999999998 107.328 154.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 103.22 12.64 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.931 -0.481 . . . . 4.6299999999999999 111.733 -173.128 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.93 110.0 1.22 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.591 1.186 . . . . 4.5899999999999999 110.379 163.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -158.88 144.79 12.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.986 1.714 . . . . 3.8300000000000001 108.58 161.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.76 74.23 5.3 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.061 3.174 . . . . 2.6600000000000001 111.248 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.92 148.31 19.5 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.05 1.309 . . . . 1.6499999999999999 111.756 172.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.57 -25.04 47.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.981 2.454 . . . . 1.76 111.845 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -107.73 138.85 43.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.182 1.393 . . . . 3.9900000000000002 108.982 153.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 163.78 31.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.551 1.94 . . . . 2.52 108.081 160.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.46 169.83 14.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.148 0.795 . . . . 2.0499999999999998 113.148 -177.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.2 148.62 27.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.306 1.042 . . . . 2.3700000000000001 112.482 165.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.04 159.81 41.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.017 1.727 . . . . 3.54 111.296 -172.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -163.47 146.37 10.1 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.448 1.277 . . . . 2.6400000000000001 114.448 -175.1 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 4' ' ' THR . 5.6 m -79.87 128.27 33.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.661 -1.154 . . . . 3.0699999999999998 109.679 166.429 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.17 149.07 45.52 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.709 1.603 . . . . 3.77 110.987 -175.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -157.68 153.04 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.739 0.781 . . . . 3.04 111.491 174.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -104.8 105.0 49.12 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 1.1399999999999999 109.19 177.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.09 -11.23 13.61 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.834 2.356 . . . . 1.0900000000000001 113.676 177.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.86 177.78 53.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.677 1.126 . . . . 0.98999999999999999 113.467 -174.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 7.7 m-20 -102.61 12.67 36.06 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.704 1.602 . . . . 2.3799999999999999 111.588 178.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.03 158.65 34.47 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.059 2.144 . . . . 4.2300000000000004 109.149 174.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.05 148.77 17.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.805 2.337 . . . . 1.6399999999999999 110.266 172.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -121.61 119.56 32.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.405 1.082 . . . . 4.1799999999999997 110.317 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -109.06 106.46 16.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.526 1.53 . . . . 4.4199999999999999 109.79 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -92.3 116.23 28.78 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.103 2.161 . . . . 1.8999999999999999 108.76 -173.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.78 -9.37 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.154 0.982 . . . . 1.8100000000000001 112.714 -166.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.6 -162.66 32.07 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 124.875 1.226 . . . . 0.46999999999999997 111.41 171.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.01 171.76 17.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.455 1.102 . . . . 1.9199999999999999 110.539 168.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.83 130.4 16.85 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.622 -1.621 . . . . 6.9400000000000004 106.622 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 t -127.48 157.51 72.71 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 117.385 -1.293 . . . . 1.72 108.162 177.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -63.06 -25.36 73.46 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.036 1.824 . . . . 1.1699999999999999 113.313 160.314 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -80.35 12.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.904 1.446 . . . . 2.27 114.904 -172.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.31 153.68 49.01 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.313 1.445 . . . . 2.7599999999999998 113.941 -172.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.88 -42.65 9.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.628 1.571 . . . . 4.0300000000000002 111.581 168.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.13 176.25 12.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 8.9299999999999997 110.543 151.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -155.65 144.13 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.602 1.961 . . . . 2.8300000000000001 109.569 -170.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -127.06 136.21 51.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.171 1.788 . . . . 2.2599999999999998 110.566 -176.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -88.77 123.23 32.98 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.154 1.343 . . . . 2.0099999999999998 112.067 169.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 13.3 m170 -110.88 153.54 25.31 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.762 2.025 . . . . 0.77000000000000002 113.129 175.3 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -86.23 170.28 12.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.846 1.658 . . . . 2.3300000000000001 111.278 161.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 m -146.73 126.86 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.015 1.326 . . . . 2.4900000000000002 108.182 169.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -140.85 173.46 11.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.154 1.168 . . . . 3.52 114.154 -152.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -126.89 141.98 51.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.037 1.735 . . . . 4.5 108.676 159.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -149.45 165.67 31.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.066 1.746 . . . . 9.0399999999999991 109.987 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.68 136.96 43.82 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.634 0.774 . . . . 3.8900000000000001 110.092 169.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.96 -6.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 114.228 1.196 . . . . 4.1100000000000003 114.228 173.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -168.37 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.873 2.069 . . . . 5.3700000000000001 110.682 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.42 -16.95 4.48 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.043 -1.661 . . . . 2.54 113.689 -163.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -82.58 142.13 32.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.736 1.268 . . . . 4.4500000000000002 110.374 161.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.47 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.83 127.32 35.96 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.509 1.124 . . . . 5.7599999999999998 109.358 177.766 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -135.72 145.22 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.029 1.332 . . . . 3.0299999999999998 110.157 -170.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -82.97 158.45 22.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.62 1.568 . . . . 4.2599999999999998 113.191 -176.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.59 -179.56 45.26 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.453 0.549 . . . . 1.4199999999999999 113.957 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -132.35 158.06 42.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.905 1.682 . . . . 2.3900000000000001 110.49 176.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -160.23 147.45 12.46 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.569 1.548 . . . . 6.8700000000000001 109.924 169.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.1 Cg_endo -63.72 148.14 92.24 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.655 1.57 . . . . 1.1799999999999999 110.255 163.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.26 155.13 71.83 Favored Pre-proline 0 N--CA 1.472 0.647 0 C-N-CA 125.459 1.504 . . . . 1.72 110.734 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.99 -23.88 24.69 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.666 2.244 . . . . 0.76000000000000001 112.541 178.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -171.78 165.68 6.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.388 1.075 . . . . 3.0099999999999998 112.62 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -113.94 172.79 6.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.289 1.835 . . . . 2.0899999999999999 109.188 155.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -154.61 167.86 28.71 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.543 -0.723 . . . . 2.0499999999999998 111.518 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.6 t -144.37 130.07 9.71 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.042 1.737 . . . . 2.0299999999999998 108.425 -169.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -70.43 164.7 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.319 2.013 . . . . 0.97999999999999998 110.94 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.79 139.5 91.06 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.671 2.247 . . . . 1.1499999999999999 110.547 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.408 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 37.3 mmtm 66.59 6.42 4.44 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.993 1.717 . . . . 2.6200000000000001 113.549 -175.339 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.33 120.52 5.21 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 127.701 2.572 . . . . 1.1599999999999999 112.623 -176.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -90.32 138.23 31.71 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.294 1.838 . . . . 4.7699999999999996 111.424 167.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.09 125.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.976 1.31 . . . . 2.29 112.877 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.08 121.8 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.269 1.028 . . . . 4.2300000000000004 111.586 170.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.69 147.12 46.0 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.333 1.063 . . . . 1.8999999999999999 110.07 161.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -172.25 150.71 2.4 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.964 1.306 . . . . 3.4100000000000001 111.197 -158.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.99 -47.9 9.6 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.758 2.305 . . . . 1.1399999999999999 111.515 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.19 70.95 2.86 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.807 -0.917 . . . . 1.72 110.807 166.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.44 -96.45 0.12 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.363 1.458 . . . . 1.1399999999999999 113.711 -176.068 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -149.37 138.32 21.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.949 1.699 . . . . 3.0699999999999998 108.695 -172.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -157.97 162.28 38.2 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.231 -0.293 . . . . 0.82999999999999996 110.794 -168.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -95.32 135.4 36.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.475 0.71 . . . . 3.4399999999999999 110.468 169.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -95.67 126.72 41.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.112 1.365 . . . . 1.6899999999999999 108.913 160.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.75 157.5 23.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.143 0.577 . . . . 3.4399999999999999 110.33 173.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 78.32 1.6 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.484 1.135 . . . . 4.1299999999999999 111.381 176.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.19 114.13 3.74 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.757 2.122 . . . . 1.6599999999999999 110.299 -170.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.16 126.31 44.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.606 1.163 . . . . 2.5299999999999998 110.444 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -92.02 -25.11 18.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.194 0.812 . . . . 3.5800000000000001 113.194 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.31 151.69 40.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.645 -0.872 . . . . 5.2199999999999998 108.645 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.95 -14.53 23.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.569 2.179 . . . . 4.0300000000000002 115.41 177.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.3 mt 66.71 102.34 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 130.996 3.719 . . . . 3.7000000000000002 110.373 -178.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -106.88 143.21 35.31 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.881 0.873 . . . . 7.1900000000000004 109.739 161.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -45.41 124.17 4.66 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.483 -0.78 . . . . 2.5499999999999998 109.643 159.325 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.57 3.08 81.47 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 117.361 -1.799 . . . . 2.1699999999999999 116.426 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.73 161.52 30.15 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 121.15 2.475 . . . . 2.6099999999999999 109.75 162.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.95 154.99 19.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.24 1.416 . . . . 3.8100000000000001 110.993 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.15 112.52 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 126.044 1.737 . . . . 2.5899999999999999 108.63 -176.117 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -74.22 142.29 45.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.231 -0.655 . . . . 3.1299999999999999 109.231 155.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt -146.57 117.32 7.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.282 1.033 . . . . 2.7799999999999998 111.326 175.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.9 92.4 8.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.678 3.191 . . . . 2.1499999999999999 109.222 170.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.68 125.25 28.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.468 1.107 . . . . 2.4399999999999999 109.68 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt -97.01 132.23 43.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.867 1.267 . . . . 1.8899999999999999 111.243 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -131.6 146.52 52.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.076 0.941 . . . . 3.6200000000000001 112.789 -174.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.34 165.13 14.67 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.749 -0.594 . . . . 2.5600000000000001 111.84 170.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.58 26.48 65.27 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.461 -0.775 . . . . 4.6799999999999997 113.272 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.87 63.04 3.48 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.823 1.201 . . . . 1.96 111.562 176.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -146.75 161.3 40.91 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 123.111 1.434 . . . . 4.8499999999999996 113.028 -171.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 p -171.9 146.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.125 2.97 . . . . 2.2999999999999998 108.137 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt -140.24 123.67 17.0 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.618 1.167 . . . . 2.79 109.192 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -81.42 126.92 32.22 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.522 0.601 . . . . 3.79 111.381 167.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.29 166.15 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.876 1.671 . . . . 4.3399999999999999 108.381 168.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.2 130.32 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.316 1.447 . . . . 2.9500000000000002 110.764 178.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mp -139.05 166.91 21.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.796 2.438 . . . . 3.5800000000000001 109.37 -176.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.67 170.78 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.14 2.56 . . . . 1.6200000000000001 113.581 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.8 t -95.77 136.79 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 127.656 2.383 . . . . 2.3500000000000001 107.721 155.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -153.53 158.68 41.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.584 0.754 . . . . 5.0499999999999998 111.548 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.21 3.35 24.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.358 1.984 . . . . 2.6400000000000001 116.358 -164.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.937 0 N-CA-C 113.492 0.923 . . . . 7.3399999999999999 113.492 -162.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.884 0 N-CA-C 108.075 -2.01 . . . . 12.49 108.075 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -41.23 96.39 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.196 0.998 . . . . 11.59 112.175 163.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -129.01 162.92 26.51 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.784 1.234 . . . . 9.4900000000000002 111.151 172.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.3 p -163.2 97.96 0.92 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.969 2.508 . . . . 8.6799999999999997 107.911 163.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -81.92 66.1 7.34 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.397 1.079 . . . . 7.1699999999999999 110.733 -174.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.26 159.27 23.29 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 115.929 1.131 . . . . 1.2 115.929 -169.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -150.41 136.99 18.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.609 1.164 . . . . 1.8 112.201 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -90.67 131.76 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.702 -0.851 . . . . 1.9299999999999999 108.702 164.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.61 47.47 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.939 0.718 . . . . 9.2400000000000002 112.939 -173.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.63 103.48 1.72 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.563 1.173 . . . . 5.1200000000000001 110.993 163.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.89 140.71 0.57 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.854 1.661 . . . . 4.0199999999999996 109.926 157.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.36 3.4 7.83 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.071 3.181 . . . . 3.7000000000000002 114.471 -173.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.01 145.88 49.74 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 119.537 1.062 . . . . 1.8100000000000001 113.028 -175.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.98 -15.07 47.38 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.113 3.209 . . . . 3.0499999999999998 113.676 -171.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -139.35 167.03 23.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.134 0.974 . . . . 3.4199999999999999 111.794 159.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 159.65 174.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.493 3.517 . . . . 4.4400000000000004 109.87 171.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.69 171.86 13.15 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.058 1.133 . . . . 3.0899999999999999 114.058 -177.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 160.12 40.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.692 2.797 . . . . 3.1600000000000001 109.151 170.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -144.0 158.28 43.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.101 0.953 . . . . 3.3900000000000001 112.644 -164.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.48 159.57 28.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.582 0.956 . . . . 2.8199999999999998 113.582 173.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 m -123.77 147.73 47.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.869 -1.514 . . . . 3.0299999999999998 107.331 164.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tp -136.83 153.43 50.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.053 1.341 . . . . 5.54 110.985 -175.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -108.95 135.61 49.85 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.53 1.932 . . . . 3.98 108.094 168.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -102.46 91.34 2.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.02 -0.514 . . . . 1.3200000000000001 109.967 160.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.45 -11.11 18.97 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.314 2.009 . . . . 2.04 113.487 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.33 52.41 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 118.907 0.776 . . . . 1.48 113.195 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.482 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.8 m-20 -88.56 3.08 51.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.741 . . . . 2.8999999999999999 113.609 -177.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.99 159.97 56.54 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.59 1.556 . . . . 3.1200000000000001 110.799 174.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.34 166.17 22.66 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.845 2.363 . . . . 1.6299999999999999 112.657 -164.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.0 154.65 21.88 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.22 1.008 . . . . 4.1600000000000001 111.008 165.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -148.88 104.99 3.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.177 1.791 . . . . 4.7999999999999998 109.654 170.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.7 tp -91.64 111.8 23.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.634 2.374 . . . . 1.9299999999999999 109.886 -168.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -97.85 -15.32 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.849 1.259 . . . . 1.8899999999999999 112.857 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.65 -164.93 36.66 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.685 -0.634 . . . . 0.56999999999999995 112.62 175.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.5 172.52 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.816 0.846 . . . . 1.8799999999999999 111.242 166.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.78 144.49 23.53 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.717 0.689 . . . . 6.1200000000000001 111.663 171.23 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 t -141.1 149.53 55.89 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 125.875 1.67 . . . . 1.77 108.93 -166.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.65 -19.23 42.1 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.124 1.883 . . . . 1.0 113.232 173.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -71.21 -4.39 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 114.331 1.234 . . . . 1.75 114.331 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.31 174.38 12.91 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.593 1.701 . . . . 2.1299999999999999 115.593 -167.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -108.58 -42.92 4.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.897 2.079 . . . . 3.3900000000000001 110.429 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -129.61 161.88 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.216 1.406 . . . . 6.3200000000000003 112.057 172.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -176.21 126.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.256 1.822 . . . . 2.79 108.798 -173.38 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -145.21 137.07 25.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.057 1.343 . . . . 4.4500000000000002 109.475 -164.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.5 123.62 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.636 0.732 . . . . 2.0099999999999998 111.461 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -107.83 153.8 22.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.719 1.608 . . . . 0.73999999999999999 113.584 173.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -91.55 170.7 9.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.875 2.07 . . . . 2.2000000000000002 110.715 158.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.9 m -149.46 114.59 5.45 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.608 1.563 . . . . 2.3300000000000001 107.837 173.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -119.8 157.21 29.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.956 1.302 . . . . 3.6899999999999999 112.841 -162.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -94.46 158.61 15.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.224 1.01 . . . . 4.29 110.555 160.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.37 150.22 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 6.7699999999999996 110.378 176.001 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.3 140.54 29.66 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.799 -0.815 . . . . 3.5299999999999998 108.799 160.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.51 114.4 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.661 1.584 . . . . 3.5600000000000001 107.365 -178.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 64.99 1.27 1.42 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.204 1.802 . . . . 4.7000000000000002 112.569 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.56 -11.76 58.05 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.644 1.593 . . . . 1.8700000000000001 113.879 -166.51 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -76.77 136.55 39.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.275 1.537 . . . . 5.1799999999999997 109.656 172.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -77.54 126.77 31.42 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.678 -0.639 . . . . 4.2599999999999998 110.73 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.8 t -135.25 155.74 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.58 1.952 . . . . 3.3700000000000001 109.097 -173.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.1 mtm -128.7 154.12 46.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.131 0.972 . . . . 4.1900000000000004 110.785 171.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.39 30.63 Favored Glycine 0 N--CA 1.468 0.827 0 C-N-CA 124.07 0.843 . . . . 1.25 113.333 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.56 161.42 35.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.47 1.508 . . . . 3.8500000000000001 109.954 -177.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -165.62 134.55 2.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 116.679 -1.629 . . . . 5.2800000000000002 110.311 -173.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.56 146.37 84.49 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 122.322 1.865 . . . . 0.80000000000000004 110.391 163.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.32 158.32 67.29 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 125.677 1.591 . . . . 1.8 111.237 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.53 -24.5 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.822 2.348 . . . . 0.72999999999999998 112.73 176.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -173.87 166.81 4.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.649 1.18 . . . . 2.8900000000000001 113.176 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.19 170.14 8.43 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.408 1.883 . . . . 1.98 109.799 152.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -156.65 164.56 38.03 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.354 -0.841 . . . . 1.8899999999999999 113.179 176.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -154.43 141.18 13.22 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.963 0.905 . . . . 2.2799999999999998 110.452 -160.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.38 171.54 14.96 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.343 2.028 . . . . 1.05 112.651 168.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.71 148.43 92.13 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.28 3.32 . . . . 1.2 112.267 163.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.482 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 68.2 mmtt 69.69 -2.96 1.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.71 2.004 . . . . 2.8399999999999999 114.123 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.61 115.88 4.18 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 125.824 1.678 . . . . 0.98999999999999999 111.583 -178.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.04 128.98 36.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.115 0.566 . . . . 7.9900000000000002 110.561 162.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.28 158.18 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 2.7999999999999998 112.087 -164.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -146.42 114.25 6.48 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.269 0.628 . . . . 4.0700000000000003 109.684 -141.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.24 83.39 6.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.096 0.958 . . . . 2.4300000000000002 109.13 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -72.4 142.18 84.0 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.539 -1.22 . . . . 3.73 109.769 178.027 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.51 -39.15 85.9 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.698 2.266 . . . . 1.3799999999999999 112.516 -178.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.94 61.68 4.7 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.899 0.761 . . . . 1.8 111.394 165.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -69.36 0.07 OUTLIER Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.746 1.165 . . . . 1.2 114.168 -177.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -154.12 143.67 21.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.043 1.737 . . . . 3.1699999999999999 109.052 -171.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -167.25 165.49 15.25 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.494 -0.754 . . . . 1.23 110.219 -177.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.64 135.9 37.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.962 -0.385 . . . . 3.4300000000000002 109.962 169.336 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -79.54 132.7 36.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.0 -0.741 . . . . 2.29 109.0 152.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.1 139.47 39.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.517 1.127 . . . . 3.02 108.687 164.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -137.38 136.42 37.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.683 1.193 . . . . 3.5800000000000001 111.38 -175.648 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 42.73 99.4 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 1.6599999999999999 111.301 178.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.312 0.2 OUTLIER -68.76 87.48 0.35 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.434 1.588 . . . . 2.73 113.91 -173.736 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -67.64 5.55 0.8 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.04 2.536 . . . . 3.02 115.553 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -127.14 105.83 22.02 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.483 1.113 . . . . 7.79 109.514 146.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.87 144.81 60.21 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.165 2.576 . . . . 2.1400000000000001 111.073 172.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.14 126.32 33.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 3.27 110.839 -177.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -98.34 -31.2 12.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.705 1.202 . . . . 5.9400000000000004 113.01 -175.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 122.06 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 1 C-N-CA 132.153 4.181 . . . . 2.5099999999999998 110.468 175.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.23 37.0 93.51 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.355 -0.692 . . . . 1.9399999999999999 113.569 178.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.92 -171.8 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 3.2200000000000002 108.629 178.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -141.99 162.06 36.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.197 0.999 . . . . 3.3500000000000001 110.673 174.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.86 119.78 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.53 1.532 . . . . 1.77 109.894 -169.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.48 135.94 52.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 3.0800000000000001 110.456 162.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -155.94 124.4 5.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.816 0.846 . . . . 2.7799999999999998 112.615 -175.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.67 105.57 17.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.739 1.616 . . . . 1.99 110.571 172.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.02 117.69 21.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.594 0.757 . . . . 2.1600000000000001 110.418 176.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.77 126.27 38.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.877 1.271 . . . . 1.6100000000000001 111.045 -169.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -122.97 139.46 54.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.179 0.807 . . . . 3.04 113.179 -175.289 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.22 104.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.273 1.029 . . . . 2.96 112.634 -177.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.26 78.57 1.05 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.012 1.292 . . . . 4.7300000000000004 113.087 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.28 -0.37 24.94 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 116.193 1.237 . . . . 1.96 116.193 169.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -110.13 132.18 54.4 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.014 1.407 . . . . 6.7699999999999996 112.761 -170.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.35 134.31 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.794 1.638 . . . . 2.02 107.384 160.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.3 mt -120.15 110.16 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.937 -1.134 . . . . 2.8799999999999999 107.937 177.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -80.04 127.6 32.48 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.16 -0.337 . . . . 3.48 110.886 176.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.5 m -125.96 161.87 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.87 1.668 . . . . 2.1899999999999999 110.499 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.66 135.94 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.302 1.041 . . . . 2.8900000000000001 108.709 165.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -127.35 147.81 63.7 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.24 1.416 . . . . 2.4199999999999999 108.943 172.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.26 161.43 44.48 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.151 2.568 . . . . 1.0800000000000001 111.942 174.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.6 133.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.302 1.441 . . . . 2.0299999999999998 108.595 165.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.64 153.82 25.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.52 1.128 . . . . 3.9500000000000002 110.023 171.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 2.69 -113.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 130.163 3.385 . . . . 4.54 117.632 175.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.455 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.775 0 CA-C-O 114.866 -2.492 . . . . 9.9499999999999993 112.348 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 N-CA-C 109.205 -1.558 . . . . 12.1 109.205 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 68.75 179.43 0.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.409 1.084 . . . . 8.7699999999999996 113.312 -175.382 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -85.44 -24.52 27.42 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.677 1.191 . . . . 10.75 112.056 157.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.272 57.9 p 106.54 110.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 1 C-N-CA 133.345 4.658 . . . . 8.4100000000000001 110.806 177.291 . . . . . . . . 3 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -85.16 87.63 7.4 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.86 0.864 . . . . 5.9900000000000002 110.512 -172.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.07 171.46 29.32 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.577 1.561 . . . . 1.26 113.694 176.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -155.36 153.8 31.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.274 1.429 . . . . 1.73 112.126 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.49 136.54 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.569 -1.271 . . . . 2.0099999999999998 107.569 172.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -86.1 -0.31 55.31 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.486 2.032 . . . . 6.1200000000000001 116.486 -153.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 60.65 168.65 0.09 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.87 1.668 . . . . 4.3700000000000001 112.511 -168.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 t -165.73 145.69 5.48 Favored Pre-proline 0 N--CA 1.47 0.559 0 O-C-N 120.457 -1.402 . . . . 4.6699999999999999 112.372 162.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.32 -6.35 11.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.455 2.77 . . . . 4.0 112.486 164.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.65 171.31 15.52 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.405 1.479 . . . . 2.2599999999999998 113.757 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.08 -3.16 13.16 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.931 3.754 . . . . 2.21 113.811 -176.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -121.83 156.51 33.1 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.215 1.806 . . . . 2.73 112.133 171.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.79 177.06 11.82 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.38 1.472 . . . . 2.1899999999999999 112.091 -171.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.57 20.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.475 1.11 . . . . 1.8799999999999999 112.753 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.31 159.3 38.7 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.072 1.138 . . . . 2.0899999999999999 114.072 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -148.24 151.28 35.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.213 2.205 . . . . 3.7599999999999998 110.634 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -168.5 151.07 5.22 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.411 0.893 . . . . 2.9300000000000002 113.411 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -95.48 131.11 41.99 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.458 1.903 . . . . 2.5800000000000001 108.92 171.115 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.32 160.68 39.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.683 1.193 . . . . 5.54 111.173 178.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.98 127.29 10.62 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.967 0.907 . . . . 3.29 110.779 -169.316 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -85.97 116.34 65.34 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.278 1.031 . . . . 0.93000000000000005 109.694 174.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -87.2 -14.01 4.18 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.082 2.522 . . . . 1.3100000000000001 114.374 178.164 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.38 174.38 32.2 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 119.212 0.915 . . . . 1.1599999999999999 113.206 -174.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.01 -2.48 58.14 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.571 1.548 . . . . 3.7400000000000002 114.587 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -97.63 158.79 32.44 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.479 1.112 . . . . 3.2400000000000002 111.138 173.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.59 157.52 12.29 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.377 2.718 . . . . 1.5900000000000001 111.229 -176.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.21 108.02 9.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.634 0.73 . . . . 3.2200000000000002 111.688 -170.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -99.96 106.23 18.0 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.696 1.198 . . . . 3.4300000000000002 111.675 -177.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.1 tp -85.4 114.86 22.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.583 1.953 . . . . 1.8400000000000001 109.431 -177.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.71 -12.19 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.829 0.851 . . . . 1.9399999999999999 112.884 -171.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.45 -168.04 40.59 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.665 1.126 . . . . 0.81000000000000005 111.098 173.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.37 140.69 20.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.638 0.775 . . . . 2.2799999999999998 110.592 167.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.431 HH21 ' CG ' ' A' ' 102' ' ' ASP . 10.4 ttp180 -108.54 139.75 42.86 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.714 1.606 . . . . 7.7999999999999998 108.538 -169.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -152.41 155.7 33.09 Favored Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 124.593 1.157 . . . . 1.8700000000000001 109.874 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -86.58 -9.9 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.729 2.286 . . . . 1.4099999999999999 113.527 165.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 m -70.27 -9.52 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.343 0.974 . . . . 3.21 113.443 176.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 160.74 30.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.171 1.351 . . . . 2.1200000000000001 112.285 -169.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.28 -68.76 0.79 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.173 1.389 . . . . 3.0099999999999998 109.14 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -82.01 111.9 18.6 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.078 -1.014 . . . . 4.3799999999999999 109.405 171.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.62 145.78 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.524 1.13 . . . . 2.46 109.444 153.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -137.25 122.87 19.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.54 1.536 . . . . 2.1400000000000001 108.542 162.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.26 119.79 22.11 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 120.934 1.697 . . . . 1.8100000000000001 110.045 167.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -109.06 157.02 19.1 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.318 1.847 . . . . 0.66000000000000003 112.247 176.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 12.1 pt-20 -104.38 168.18 9.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.852 -1.067 . . . . 2.3700000000000001 110.264 161.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.7 m -130.03 107.48 9.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.342 1.457 . . . . 2.0 107.3 170.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -113.27 154.92 26.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.859 1.264 . . . . 3.6299999999999999 112.508 -171.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -90.52 154.45 19.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.655 1.182 . . . . 4.0300000000000002 112.334 172.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.41 15.53 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.033 1.333 . . . . 6.46 113.214 177.513 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -138.74 142.13 38.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.969 1.307 . . . . 4.8200000000000003 109.473 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.59 128.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.501 1.12 . . . . 4.8399999999999999 108.981 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 56.29 28.21 13.0 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.175 0.988 . . . . 4.1699999999999999 111.011 -168.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.12 -0.42 11.74 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.506 2.003 . . . . 3.2000000000000002 114.996 -173.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.69 126.11 30.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.444 1.498 . . . . 4.6200000000000001 108.785 174.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.47 126.89 52.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.371 1.468 . . . . 7.1200000000000001 110.785 -162.228 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.8 t -145.67 153.17 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.915 1.286 . . . . 2.5299999999999998 110.586 -156.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.4 mtm -120.81 149.44 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.387 1.075 . . . . 3.48 110.413 161.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.64 158.64 27.75 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.917 0.77 . . . . 1.1399999999999999 112.733 178.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -102.73 155.48 18.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.564 1.146 . . . . 2.4100000000000001 111.897 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.428 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -163.91 146.5 7.62 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-O 117.693 -1.146 . . . . 6.3899999999999997 112.255 171.733 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.38 142.13 53.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.881 2.387 . . . . 0.80000000000000004 111.419 172.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.76 157.54 38.19 Favored Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.303 1.441 . . . . 2.1200000000000001 110.763 175.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.44 -18.66 38.4 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.434 2.089 . . . . 0.69999999999999996 112.743 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -179.42 167.04 1.47 Allowed 'General case' 0 C--N 1.347 0.459 0 C-N-CA 126.128 1.771 . . . . 2.9300000000000002 110.076 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -114.91 171.09 7.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.274 1.83 . . . . 2.0699999999999998 108.89 157.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.32 167.76 29.35 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.142 -0.974 . . . . 2.52 113.353 167.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.75 134.69 16.21 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.053 1.341 . . . . 1.8999999999999999 109.381 -172.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.42 164.58 33.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.223 1.949 . . . . 0.87 111.611 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.14 139.7 85.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.831 3.021 . . . . 0.88 111.919 174.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.54 1.67 1.4 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.345 1.858 . . . . 4.2599999999999998 115.128 -171.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 118.44 4.78 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 127.669 2.556 . . . . 0.90000000000000002 111.971 -178.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -91.79 137.03 32.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.874 1.27 . . . . 4.5599999999999996 111.021 159.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.7 m -150.31 157.45 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.785 1.634 . . . . 2.2000000000000002 110.705 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.493 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -117.12 152.62 34.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.392 1.091 . . . . 3.73 112.826 169.828 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.79 77.29 2.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.955 1.302 . . . . 2.0099999999999998 108.733 161.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.493 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 0.1 OUTLIER -73.2 137.51 78.71 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.393 1.077 . . . . 4.0099999999999998 112.399 177.59 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.53 -34.56 85.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.905 3.07 . . . . 1.7 114.476 -169.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.7 121.54 6.29 Favored Glycine 0 N--CA 1.468 0.824 0 N-CA-C 106.889 -2.484 . . . . 1.5900000000000001 106.889 150.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.86 -94.72 0.5 Allowed Glycine 0 N--CA 1.47 0.909 0 CA-C-N 119.786 1.793 . . . . 2.27 112.967 -161.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -148.12 149.06 31.34 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.042 2.137 . . . . 3.1200000000000001 111.633 -169.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.7 163.7 14.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.307 1.043 . . . . 1.3200000000000001 109.982 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -93.39 138.19 31.96 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 122.02 -0.425 . . . . 3.8300000000000001 109.937 167.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.6 mmt -96.98 139.49 32.91 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.348 1.059 . . . . 1.55 109.421 157.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.58 142.62 51.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.484 1.513 . . . . 4.0899999999999999 109.933 -178.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -145.99 133.65 21.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 3.9399999999999999 111.505 -174.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.74 74.37 1.09 Allowed Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.274 -0.73 . . . . 1.47 111.274 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.67 119.41 25.21 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.471 0.915 . . . . 2.4300000000000002 113.471 -163.562 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -90.6 -8.99 48.66 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.896 1.443 . . . . 2.71 114.896 -169.684 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.22 145.08 56.16 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.204 1.401 . . . . 7.4199999999999999 108.038 160.489 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 128.76 15.19 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 107.169 -1.896 . . . . 2.4300000000000002 107.169 168.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.37 95.76 0.33 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.087 1.355 . . . . 3.52 110.506 -168.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -68.99 111.81 5.23 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 120.657 -1.277 . . . . 5.7800000000000002 108.693 177.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.94 108.93 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.123 -0.985 . . . . 2.8500000000000001 110.431 167.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.06 16.65 40.37 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 117.213 -1.882 . . . . 1.79 116.036 -170.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.08 171.59 12.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.793 2.297 . . . . 4.3899999999999997 109.045 150.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.219 1.408 . . . . 4.3300000000000001 108.621 170.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.41 119.66 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.916 0.887 . . . . 2.0899999999999999 110.062 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.71 45.12 1.04 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 128.282 2.633 . . . . 5.5999999999999996 113.185 -170.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.41 130.22 42.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.483 1.913 . . . . 2.8399999999999999 113.902 -164.18 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.431 ' CG ' HH21 ' A' ' 36' ' ' ARG . 14.2 m-20 -92.02 93.28 8.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.457 2.703 . . . . 2.3199999999999998 110.892 175.353 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.1 mt -71.48 120.61 17.31 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.396 -0.815 . . . . 2.3799999999999999 110.52 -179.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt -93.27 125.26 37.78 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.546 1.538 . . . . 2.3300000000000001 111.114 -169.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.73 125.63 44.37 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.468 0.914 . . . . 3.0800000000000001 113.468 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 53.44 11.37 0.27 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.444 2.298 . . . . 3.3799999999999999 116.685 167.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.92 4.02 46.22 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.959 -1.088 . . . . 3.3399999999999999 114.409 -168.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -129.91 -4.71 4.6 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.727 1.156 . . . . 2.3300000000000001 115.64 -171.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.69 158.37 43.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.423 2.289 . . . . 4.9800000000000004 110.831 173.123 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.8 135.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.949 1.7 . . . . 2.7799999999999998 107.582 165.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.61 115.33 12.9 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.86 1.264 . . . . 2.54 107.77 -173.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -102.84 141.64 35.31 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.456 1.28 . . . . 3.5 114.456 -171.324 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.68 167.75 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.562 1.545 . . . . 2.6600000000000001 110.09 -173.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.87 144.81 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 124.641 1.176 . . . . 3.8799999999999999 109.733 172.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.42 133.17 6.67 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.551 -0.738 . . . . 3.3999999999999999 111.162 176.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.06 150.34 82.5 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.566 2.844 . . . . 1.6599999999999999 112.623 -172.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.3 112.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.337 1.055 . . . . 2.1600000000000001 108.492 166.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.88 -169.95 2.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.099 2.96 . . . . 3.7400000000000002 108.649 178.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.53 53.0 1.8 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.202 1.556 . . . . 3.1899999999999999 115.202 -161.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 115.58 -2.152 . . . . 9.7200000000000006 115.045 178.599 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.455 0 N-CA-C 109.239 -1.544 . . . . 15.31 109.239 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -165.97 168.29 15.83 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.578 1.551 . . . . 10.68 108.5 -178.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -107.54 107.81 18.82 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.889 -1.523 . . . . 9.8300000000000001 106.889 155.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 m -149.44 112.0 4.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 105.263 -2.125 . . . . 7.8399999999999999 105.263 -177.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -116.47 125.42 51.94 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.016 -1.447 . . . . 4.4199999999999999 109.53 -155.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.72 174.75 43.36 Favored Glycine 0 N--CA 1.465 0.592 0 O-C-N 121.94 -0.475 . . . . 1.45 113.96 -178.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -155.51 151.04 27.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.947 0.899 . . . . 1.54 112.167 -179.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.93 127.64 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.901 -0.499 . . . . 1.95 110.016 174.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -72.63 -11.0 60.46 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.441 1.645 . . . . 5.5099999999999998 115.441 -159.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.94 160.81 0.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.372 1.469 . . . . 4.0999999999999996 113.949 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -165.82 149.93 7.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.048 1.739 . . . . 4.9500000000000002 110.497 166.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -83.64 -9.92 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.25 2.633 . . . . 3.75 112.024 162.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.9 -168.14 13.27 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.96 1.743 . . . . 2.3799999999999999 113.962 -174.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -74.0 -27.45 12.04 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.196 2.598 . . . . 2.6200000000000001 114.955 -165.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -98.63 150.85 21.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.144 1.338 . . . . 3.1299999999999999 112.425 177.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.4 -179.9 8.53 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.032 2.133 . . . . 2.1000000000000001 111.599 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.76 167.35 21.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.15 1.78 . . . . 2.1499999999999999 111.403 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.83 155.1 36.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.351 1.061 . . . . 1.9399999999999999 112.376 172.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 142.57 24.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.362 1.865 . . . . 3.4199999999999999 109.558 -171.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -171.24 159.37 5.8 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.318 1.599 . . . . 2.8700000000000001 115.318 -174.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -71.9 138.48 48.19 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.305 1.842 . . . . 2.0899999999999999 109.365 166.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.62 146.25 49.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.118 1.767 . . . . 4.7999999999999998 111.241 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -119.72 132.97 55.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.256 1.822 . . . . 5.0499999999999998 114.002 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -98.95 109.04 52.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.678 -0.692 . . . . 1.1799999999999999 109.851 143.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -89.2 -10.62 3.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.53 2.82 . . . . 1.4399999999999999 113.565 173.254 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.58 -174.25 47.15 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.116 1.341 . . . . 0.96999999999999997 113.495 -174.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.418 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 4.8 m-20 -107.56 -4.0 18.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.963 1.705 . . . . 2.3199999999999998 113.147 -169.253 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.42 161.43 39.27 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.653 1.981 . . . . 2.7599999999999998 109.644 169.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.71 163.09 29.44 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.826 2.351 . . . . 1.4199999999999999 112.632 -167.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.26 127.56 45.8 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.884 1.274 . . . . 3.5800000000000001 111.125 -174.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 68' ' ' GLU . 22.7 ttm180 -111.16 112.98 25.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.907 1.283 . . . . 4.2300000000000004 110.648 175.175 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 tp -85.76 133.12 34.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.377 . . . . 2.1600000000000001 108.721 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.86 -13.02 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.034 0.934 . . . . 1.8999999999999999 113.516 -175.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.48 -164.98 34.47 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.002 0.811 . . . . 0.97999999999999998 111.74 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.94 -175.92 4.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.459 0.704 . . . . 1.8899999999999999 110.632 160.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.88 146.56 9.54 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.069 0.948 . . . . 6.2400000000000002 111.644 171.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -140.34 152.32 66.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.017 1.727 . . . . 1.9299999999999999 109.253 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.13 -34.05 29.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 121.585 1.602 . . . . 0.96999999999999997 112.613 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 m -70.77 -18.82 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 115.244 1.572 . . . . 1.8 115.244 -167.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.3 143.03 50.79 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.843 1.257 . . . . 1.8600000000000001 111.078 -176.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -64.48 -53.83 42.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.262 1.025 . . . . 4.4199999999999999 111.8 172.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.14 160.76 21.51 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.372 1.869 . . . . 8.3100000000000005 111.055 -170.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -159.7 135.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.824 1.65 . . . . 1.8899999999999999 110.661 -172.136 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -139.87 135.1 32.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.324 1.85 . . . . 2.4100000000000001 109.72 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -83.33 118.74 23.89 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.436 1.016 . . . . 1.79 111.012 168.144 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -106.41 155.25 19.74 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.178 1.791 . . . . 0.80000000000000004 112.044 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -157.27 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 3.75 111.019 174.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.8 m -151.32 123.98 8.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.478 2.311 . . . . 2.3900000000000001 106.598 162.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -126.86 160.51 30.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.778 1.231 . . . . 3.7599999999999998 112.431 -172.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.9 ptt? -134.24 122.18 22.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.988 1.375 . . . . 4.1299999999999999 112.587 159.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -117.52 162.41 18.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.245 1.818 . . . . 9.0700000000000003 110.927 -176.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 30.1 mp0 -77.19 144.42 38.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.893 1.677 . . . . 4.8099999999999996 111.479 171.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.49 -96.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.602 1.561 . . . . 3.2400000000000002 109.176 -176.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.02 31.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.088 1.355 . . . . 4.0300000000000002 112.44 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.58 -13.28 8.48 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.365 -1.459 . . . . 2.73 112.594 -154.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 152.72 28.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.318 1.847 . . . . 5.2699999999999996 110.763 178.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 41.6 mmtt -73.78 140.12 45.65 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.746 -0.596 . . . . 6.3099999999999996 110.668 158.539 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -132.85 145.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.159 1.784 . . . . 2.98 108.259 165.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.8 tpp -101.52 146.9 27.04 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.229 2.212 . . . . 3.8300000000000001 111.016 -175.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.11 -174.98 33.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.935 1.255 . . . . 1.4399999999999999 113.64 174.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -138.38 152.2 48.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.672 1.589 . . . . 2.7799999999999998 110.196 173.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.39 148.33 16.44 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 124.664 1.186 . . . . 5.1500000000000004 110.932 -170.035 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.41 150.32 84.39 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 121.611 1.54 . . . . 0.79000000000000004 112.49 167.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.89 159.11 73.93 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 126.559 1.944 . . . . 1.97 110.761 176.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.39 -18.35 14.02 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.039 2.493 . . . . 0.69999999999999996 114.069 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -171.74 164.55 6.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.986 1.266 . . . . 3.1299999999999999 112.552 -178.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.15 168.61 12.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.737 2.415 . . . . 2.04 108.572 161.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 31' ' ' ARG . 14.7 pt-20 -161.88 163.82 28.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.975 -1.078 . . . . 2.1800000000000002 113.274 176.23 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 t -149.2 140.69 14.44 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.3 1.04 . . . . 2.75 110.601 -169.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.35 167.34 20.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.997 2.465 . . . . 1.3400000000000001 112.016 171.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.25 146.72 97.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.604 2.87 . . . . 1.05 112.796 175.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.418 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 67.9 mmtt 66.92 -2.45 1.13 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.373 1.869 . . . . 2.04 114.571 -178.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.97 117.86 4.58 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 126.65 2.071 . . . . 0.81000000000000005 111.343 178.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -83.34 145.35 29.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.834 -0.683 . . . . 7.1900000000000004 110.229 151.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.78 179.54 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.03 1.732 . . . . 2.52 109.398 171.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -121.39 139.75 53.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.771 0.828 . . . . 3.7000000000000002 111.217 166.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.16 76.69 1.27 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.805 -1.554 . . . . 2.1099999999999999 106.805 143.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -82.87 142.19 44.8 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 117.672 -1.156 . . . . 4.6399999999999997 109.94 -177.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.66 -55.13 4.38 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.355 3.37 . . . . 1.95 114.959 -169.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.1 70.83 2.81 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.748 -0.941 . . . . 1.22 110.748 172.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.84 -76.95 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.253 1.406 . . . . 1.01 114.046 -166.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -155.63 142.1 18.63 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 3.0299999999999998 108.351 -177.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -163.1 179.12 7.72 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.254 -0.903 . . . . 1.0600000000000001 111.581 -172.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -109.29 139.92 43.61 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.108 -0.37 . . . . 3.2799999999999998 111.088 168.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 mmt -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.58 0.752 . . . . 1.9299999999999999 109.477 155.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.11 140.01 53.04 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.694 1.597 . . . . 3.8900000000000001 109.1 178.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.16 152.8 49.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.047 0.939 . . . . 4.3300000000000001 111.956 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.82 60.02 4.46 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.678 0.656 . . . . 1.5900000000000001 111.719 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -74.94 107.71 7.19 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.469 1.128 . . . . 2.21 110.866 -178.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -70.98 -6.33 37.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.565 1.546 . . . . 3.7799999999999998 115.014 -175.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -143.41 158.45 57.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.687 2.395 . . . . 8.2699999999999996 108.273 156.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.07 157.25 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.086 1.857 . . . . 2.1600000000000001 109.741 156.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.78 166.67 10.52 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.399 1.479 . . . . 3.8900000000000001 111.915 -176.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 134.08 38.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.917 1.287 . . . . 4.2999999999999998 111.427 174.085 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.7 24.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.946 -1.096 . . . . 2.4500000000000002 110.219 173.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.44 54.98 2.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.129 0.395 . . . . 2.21 112.629 -162.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -143.05 160.83 39.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.619 2.368 . . . . 3.0899999999999999 109.015 165.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -102.49 120.47 40.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.968 2.107 . . . . 4.3799999999999999 111.112 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.54 128.92 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.896 1.278 . . . . 2.0800000000000001 109.638 169.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -79.11 140.21 37.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.002 0.43 . . . . 2.52 110.976 159.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -148.26 127.13 12.67 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.892 0.877 . . . . 2.8999999999999999 112.092 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -98.34 103.73 15.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.465 1.906 . . . . 2.5099999999999998 110.732 177.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.4 mt -68.86 112.43 5.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.997 0.817 . . . . 2.8999999999999999 110.575 168.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.0 mt -87.15 129.65 34.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.734 1.213 . . . . 2.1400000000000001 111.049 -176.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.81 117.67 19.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.536 0.684 . . . . 3.5800000000000001 111.268 179.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.95 21.82 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.292 2.237 . . . . 2.7000000000000002 116.729 168.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.47 -41.86 1.42 Allowed Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.228 1.394 . . . . 3.2400000000000002 114.17 -174.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.58 -1.82 72.76 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.073 1.32 . . . . 2.3999999999999999 114.877 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -148.47 157.15 43.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.372 1.469 . . . . 5.21 113.828 179.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.97 140.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.179 2.192 . . . . 3.0299999999999998 108.224 168.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -125.55 111.97 15.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.881 1.272 . . . . 3.4900000000000002 109.29 176.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -88.78 125.72 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.771 -0.58 . . . . 3.0099999999999998 112.279 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.08 161.66 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.904 1.682 . . . . 2.5099999999999998 111.208 171.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 m -106.66 143.58 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 3.4100000000000001 109.235 163.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.38 145.87 39.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.606 1.163 . . . . 2.79 111.624 179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.15 142.8 34.72 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.231 2.621 . . . . 1.22 112.186 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -79.94 132.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.174 1.389 . . . . 1.96 109.481 165.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -147.02 139.37 24.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.766 2.427 . . . . 4.25 107.276 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.62 52.9 2.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.455 1.502 . . . . 3.3199999999999998 112.117 -170.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG 0.294 0.0 OUTLIER . . . . . 0 C--O 1.248 0.977 0 N-CA-C 117.414 2.375 . . . . 7.7599999999999998 117.414 -154.064 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.421 0 N-CA-C 107.317 -2.313 . . . . 12.41 107.317 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 t 175.29 179.44 0.14 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.253 1.421 . . . . 9.7300000000000004 108.561 -156.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -96.23 11.99 32.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.882 1.273 . . . . 11.949999999999999 113.027 169.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.55 149.09 46.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.409 1.884 . . . . 7.6500000000000004 113.907 -178.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.35 -159.24 0.9 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 128.892 2.877 . . . . 6.4100000000000001 108.298 171.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.4 -171.18 19.82 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 120.065 -1.647 . . . . 1.3799999999999999 115.688 -177.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -167.48 158.46 11.49 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.109 1.763 . . . . 1.55 112.167 173.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.77 130.94 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.733 0.813 . . . . 1.78 110.028 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -78.4 120.38 23.05 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.715 1.206 . . . . 4.79 111.615 -174.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -62.46 123.66 18.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.951 1.3 . . . . 4.5700000000000003 110.459 164.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -155.83 160.93 30.44 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.866 1.666 . . . . 2.5 108.976 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.58 -159.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.303 3.335 . . . . 3.52 108.862 167.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.52 -161.5 46.58 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.88 0.752 . . . . 3.4500000000000002 112.558 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -87.22 -11.14 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.579 2.853 . . . . 2.5299999999999998 113.201 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -149.45 160.13 43.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.696 1.198 . . . . 2.3300000000000001 113.891 -168.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.5 -167.06 1.64 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.624 1.97 . . . . 2.23 110.385 -174.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.67 153.59 50.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.834 0.743 . . . . 2.3500000000000001 112.689 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.9 153.03 46.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.69 1.196 . . . . 1.75 110.281 163.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.15 156.12 46.0 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.781 1.232 . . . . 3.7599999999999998 111.2 174.485 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.13 153.4 16.06 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.679 0.992 . . . . 2.7200000000000002 113.679 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -78.54 140.09 38.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.607 -1.179 . . . . 2.3300000000000001 107.956 151.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.21 134.73 26.3 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.73 1.212 . . . . 3.0 108.262 176.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.61 157.56 43.54 Favored 'General case' 0 C--N 1.335 -0.059 0 N-CA-C 114.13 1.159 . . . . 3.4199999999999999 114.13 -170.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -115.3 105.32 52.62 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.97999999999999998 110.931 -168.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.41 -15.67 9.84 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.577 2.185 . . . . 1.1100000000000001 113.595 177.177 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 -167.91 41.35 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 119.263 0.938 . . . . 1.25 112.91 -177.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 10.2 m-20 -117.02 16.29 15.06 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.5 1.52 . . . . 2.6400000000000001 111.496 -173.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mt -120.14 162.07 35.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.167 2.187 . . . . 4.3899999999999997 109.244 -175.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.21 156.99 17.32 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.976 2.451 . . . . 1.8300000000000001 110.901 175.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.29 103.55 4.95 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.273 1.029 . . . . 3.3900000000000001 111.059 -171.608 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -96.38 106.16 18.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.972 1.309 . . . . 3.8300000000000001 111.364 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 tp -86.73 113.84 22.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.126 2.17 . . . . 2.0499999999999998 108.651 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.69 -11.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.173 0.989 . . . . 1.76 113.483 -169.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.49 -161.68 32.48 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.518 -0.739 . . . . 0.59999999999999998 112.296 178.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.72 177.34 9.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.279 1.032 . . . . 2.3900000000000001 111.374 176.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 129.79 5.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.924 -1.139 . . . . 6.0700000000000003 107.924 172.502 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -135.31 147.36 61.8 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 117.748 -1.12 . . . . 1.6599999999999999 109.232 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.68 -15.02 27.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.04 1.827 . . . . 1.6399999999999999 112.712 171.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -75.19 -0.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.035 0.834 . . . . 1.72 113.236 174.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.47 -172.28 3.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.615 1.966 . . . . 2.0099999999999998 110.311 176.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -106.63 -55.89 2.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.699 1.2 . . . . 3.0299999999999998 110.566 166.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -119.85 165.92 13.97 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 5.1299999999999999 110.907 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.3 p -155.5 135.91 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.705 0.802 . . . . 3.27 109.48 171.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -120.13 132.51 55.44 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.954 1.702 . . . . 2.1499999999999999 108.977 -173.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.85 115.34 19.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.504 1.145 . . . . 2.1499999999999999 109.855 170.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -103.16 150.87 23.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.337 -1.301 . . . . 0.71999999999999997 111.995 176.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -94.64 164.59 12.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.513 2.325 . . . . 2.3500000000000001 109.991 166.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.9 m -145.63 121.25 10.45 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.38 1.072 . . . . 2.0499999999999998 108.152 167.784 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.49 153.48 51.73 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.894 0.878 . . . . 3.2999999999999998 112.945 -151.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.33 47.89 0.98 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 123.084 1.421 . . . . 6.8499999999999996 111.868 -172.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -80.67 162.16 24.31 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.347 -1.751 . . . . 8.9800000000000004 110.886 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -69.5 152.07 45.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.401 2.281 . . . . 4.04 111.42 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.04 -96.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.167 1.387 . . . . 3.9500000000000002 107.645 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.65 43.22 0.14 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.28 1.832 . . . . 4.5300000000000002 111.248 169.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.94 -26.96 0.78 Allowed Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.37 -1.456 . . . . 2.5800000000000001 113.691 -167.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -74.07 145.3 44.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.67 1.588 . . . . 4.1900000000000004 110.684 175.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -75.37 133.09 41.29 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.694 0.798 . . . . 6.0199999999999996 109.996 173.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.05 149.74 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.416 1.086 . . . . 3.04 109.865 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.3 mtm -83.37 93.86 7.84 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 4.96 112.985 175.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.38 165.67 22.7 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.367 0.984 . . . . 1.27 112.328 172.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -128.64 165.93 19.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.76 1.624 . . . . 3.7599999999999998 111.098 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -178.74 144.78 0.46 Allowed Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 116.123 -1.894 . . . . 5.2400000000000002 111.224 -175.198 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.69 143.11 60.65 Favored 'Trans proline' 0 C--N 1.347 0.472 0 CA-C-N 122.095 1.784 . . . . 0.85999999999999999 111.607 160.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.56 157.28 38.76 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.202 1.401 . . . . 1.8799999999999999 110.208 169.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.68 -15.78 33.65 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.80000000000000004 113.09 175.566 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -175.16 160.27 2.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.715 1.606 . . . . 4.2000000000000002 111.955 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt -109.51 175.09 5.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.851 1.261 . . . . 2.2599999999999998 108.867 147.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -156.0 166.89 32.13 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.042 -1.036 . . . . 2.3300000000000001 112.837 170.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.55 132.79 16.59 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 2.29 109.899 -177.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.36 162.35 38.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.736 2.29 . . . . 1.0600000000000001 110.835 171.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.18 140.56 84.2 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.945 2.43 . . . . 1.3899999999999999 111.485 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.412 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 61.6 mmtt 71.98 -4.0 2.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.599 2.36 . . . . 2.1499999999999999 114.318 -178.698 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.29 177.35 33.55 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.784 1.659 . . . . 1.0900000000000001 112.286 177.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -144.17 151.02 38.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.863 1.665 . . . . 4.6299999999999999 112.562 175.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.96 149.77 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.786 1.635 . . . . 3.2400000000000002 108.349 164.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -135.33 109.62 8.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.685 -1.598 . . . . 4.29 106.685 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.75 77.69 6.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.86 1.314 . . . . 2.4399999999999999 111.212 -164.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -67.37 138.74 94.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 117.26 -1.352 . . . . 6.1600000000000001 110.005 174.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.19 -54.45 4.99 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.258 3.305 . . . . 1.04 113.435 -175.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.05 51.8 3.91 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.655 1.122 . . . . 1.8899999999999999 111.708 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.58 -82.9 0.04 OUTLIER Glycine 0 N--CA 1.465 0.576 0 C-N-CA 128.663 3.03 . . . . 0.96999999999999997 111.223 -171.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -150.8 143.37 24.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.427 2.291 . . . . 3.6200000000000001 108.402 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -160.57 167.16 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.351 -0.843 . . . . 1.0700000000000001 110.63 -175.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -107.16 122.59 46.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.585 0.754 . . . . 3.54 110.566 174.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 mmt -85.93 117.64 24.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.606 1.162 . . . . 1.6799999999999999 110.525 171.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.7 mt -93.46 136.15 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.931 1.292 . . . . 2.9700000000000002 110.238 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mt -140.72 132.79 27.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.561 0.619 . . . . 3.5800000000000001 112.299 -178.255 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.71 53.82 2.18 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 125.343 1.449 . . . . 1.6599999999999999 112.506 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.48 115.17 4.4 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.884 0.698 . . . . 1.8999999999999999 112.884 -168.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -86.94 -13.42 44.73 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.173 1.175 . . . . 2.8900000000000001 114.173 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -146.64 143.04 17.99 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.646 1.178 . . . . 6.6900000000000004 110.251 177.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.52 134.58 17.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.088 2.526 . . . . 1.78 109.228 171.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.41 90.07 8.14 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.786 0.835 . . . . 3.3700000000000001 111.358 -171.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -58.72 148.17 30.39 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.002 -1.061 . . . . 4.6399999999999997 113.317 169.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.79 114.73 5.89 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.517 -0.739 . . . . 2.8999999999999999 109.473 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.6 -9.7 7.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 116.63 -2.206 . . . . 1.9299999999999999 116.816 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 173.29 10.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.449 2.624 . . . . 3.8999999999999999 112.884 -177.209 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -100.16 162.12 13.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.229 1.412 . . . . 3.8599999999999999 110.085 159.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.6 t -128.42 127.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.179 1.791 . . . . 2.2799999999999998 108.155 172.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.2 136.81 35.89 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.533 1.533 . . . . 5.96 109.562 175.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 tt -154.3 130.01 10.03 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.743 1.258 . . . . 2.8500000000000001 114.342 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.82 99.78 12.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.317 3.047 . . . . 2.7599999999999998 110.989 173.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.48 117.16 17.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.941 -1.099 . . . . 2.1000000000000001 109.173 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.2 mt -91.49 126.85 36.72 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.796 0.838 . . . . 1.98 110.382 -169.03 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.01 126.95 45.12 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.972 1.101 . . . . 3.0 113.972 -178.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.52 23.98 1.03 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.458 1.903 . . . . 2.73 114.603 169.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.01 -55.13 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.346 1.451 . . . . 3.9300000000000002 113.004 -166.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.05 18.17 46.44 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.587 -1.674 . . . . 1.8899999999999999 116.629 -169.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -141.93 157.73 44.61 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.869 2.468 . . . . 4.9199999999999999 110.58 165.187 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.2 141.38 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 126.048 1.739 . . . . 1.95 107.851 162.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.4 106.89 12.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.668 1.187 . . . . 2.8799999999999999 107.896 173.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -79.44 128.53 33.47 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.41 -0.806 . . . . 5.9299999999999997 111.071 177.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.96 164.06 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.394 1.877 . . . . 2.4700000000000002 110.443 178.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 m -105.26 155.6 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 125.441 1.496 . . . . 4.21 109.119 164.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.7 mt -141.52 149.52 54.44 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.546 1.939 . . . . 2.4199999999999999 109.231 173.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.53 152.97 20.41 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.829 3.019 . . . . 1.01 112.348 176.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.3 t -80.38 142.04 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.276 1.03 . . . . 2.2000000000000002 111.149 168.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 166.86 32.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.807 2.043 . . . . 2.9399999999999999 111.204 -166.678 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.98 26.84 9.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.738 1.215 . . . . 2.3100000000000001 113.392 -169.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.1 mtm105 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 116.606 -1.664 . . . . 6.9199999999999999 112.382 -171.58 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 N-CA-C 106.581 -2.607 . . . . 12.75 106.581 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 p -59.03 157.07 10.67 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 118.892 -1.123 . . . . 12.85 109.754 129.373 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -132.92 8.76 4.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.618 0.97 . . . . 11.789999999999999 113.618 -176.447 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.5 p -69.15 131.05 44.35 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.135 2.174 . . . . 8.5 110.835 170.172 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.88 46.33 0.38 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.95 1.3 . . . . 7.2800000000000002 111.848 172.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.56 151.97 17.03 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.949 1.261 . . . . 1.28 114.482 -172.828 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -155.85 162.97 40.36 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.96 1.304 . . . . 1.8 110.928 -177.36 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.66 126.82 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.718 0.77 . . . . 1.8799999999999999 109.58 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.9 52.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.523 1.305 . . . . 10.869999999999999 114.523 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -97.61 139.13 33.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.856 1.262 . . . . 3.9399999999999999 108.773 162.255 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -164.28 158.12 15.61 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.798 1.239 . . . . 3.2000000000000002 110.994 166.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -83.96 57.98 5.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.494 3.462 . . . . 2.7799999999999998 110.824 177.283 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.55 160.3 27.9 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.199 -0.778 . . . . 1.5700000000000001 113.709 -177.133 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -77.53 -3.87 14.05 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.005 3.137 . . . . 2.0600000000000001 113.226 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -161.33 153.68 20.1 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.724 1.61 . . . . 2.2400000000000002 112.854 -176.158 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -176.97 160.26 1.79 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.717 1.607 . . . . 3.6800000000000002 112.045 172.703 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.94 133.77 45.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.182 1.793 . . . . 2.9900000000000002 112.372 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.76 154.77 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.172 1.389 . . . . 2.4700000000000002 111.328 172.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.07 154.39 48.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.832 0.853 . . . . 4.0700000000000003 112.481 -159.832 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -171.54 154.96 3.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.786 1.234 . . . . 2.6099999999999999 112.942 176.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 99.5 m -74.76 146.68 41.96 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.792 -0.447 . . . . 3.0299999999999998 109.792 152.739 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.98 124.75 43.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.35 2.26 . . . . 3.4100000000000001 107.979 173.53 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -102.62 134.46 45.94 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.613 1.965 . . . . 4.7699999999999996 113.315 175.612 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -99.11 106.99 41.8 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 121.573 -0.704 . . . . 1.3200000000000001 109.621 162.151 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.23 -11.15 10.99 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.584 2.19 . . . . 1.3899999999999999 112.989 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 176.17 51.21 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.644 1.116 . . . . 1.1599999999999999 113.505 -177.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 4.8 m-20 -99.59 -7.22 26.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.443 1.897 . . . . 2.6499999999999999 112.818 -175.412 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.05 160.5 38.78 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.629 1.971 . . . . 3.1899999999999999 109.894 170.012 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.74 149.98 23.82 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.061 2.508 . . . . 2.0499999999999998 112.435 -168.94 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 mt -96.09 154.93 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.988 0.915 . . . . 3.2000000000000002 110.784 170.71 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 68' ' ' GLU . 20.9 ttm180 -135.83 107.72 7.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.489 1.516 . . . . 4.6900000000000004 108.979 171.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.6 tp -86.03 116.3 24.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.403 2.281 . . . . 1.9099999999999999 108.818 -176.745 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.96 -13.16 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 1.72 112.772 -172.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.13 -169.19 42.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.294 1.426 . . . . 0.57999999999999996 111.636 177.58 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.43 159.57 38.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.0 1.32 . . . . 1.8899999999999999 111.138 168.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -132.16 136.9 47.42 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.68 -1.262 . . . . 7.8700000000000001 110.321 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.0 155.4 70.85 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 124.875 1.27 . . . . 1.7 108.952 -174.381 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.06 -31.49 45.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.938 1.758 . . . . 1.04 113.017 160.348 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -77.01 5.86 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.852 1.427 . . . . 2.1800000000000002 114.852 -167.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.72 29.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.851 1.66 . . . . 2.1699999999999999 111.4 -178.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.21 -81.71 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.44 0.296 . . . . 2.9100000000000001 111.055 -178.685 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -71.72 161.24 31.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.984 0.897 . . . . 4.3499999999999996 110.709 174.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.2 138.8 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.151 -1.386 . . . . 3.0899999999999999 108.268 159.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -133.14 124.17 27.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.442 -1.688 . . . . 2.2000000000000002 106.442 160.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.14 121.62 26.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.163 1.347 . . . . 1.72 109.288 166.024 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -104.85 158.1 16.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.962 1.305 . . . . 0.70999999999999996 112.346 176.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.21 -175.65 2.85 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.673 2.389 . . . . 2.21 111.627 172.333 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.1 m -134.72 104.11 5.9 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.003 1.721 . . . . 2.5899999999999999 106.407 153.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -84.45 150.4 25.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.006 0.523 . . . . 3.3700000000000001 110.805 178.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -106.95 135.86 47.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.208 1.003 . . . . 4.9699999999999998 110.859 170.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.21 -172.97 2.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.679 1.192 . . . . 7.6200000000000001 113.087 -172.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.25 149.01 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.601 2.761 . . . . 4.8600000000000003 106.666 -170.958 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.04 -42.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.454 1.502 . . . . 6.4500000000000002 112.641 177.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -81.35 10.53 5.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.021 1.728 . . . . 4.8600000000000003 112.519 168.089 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.65 -7.29 1.06 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.306 1.432 . . . . 1.8600000000000001 115.147 -167.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -72.95 133.59 44.4 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.721 -1.458 . . . . 4.3499999999999996 108.474 158.973 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 142.84 36.74 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.287 -0.634 . . . . 6.6699999999999999 109.287 166.889 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -147.89 152.37 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.819 2.047 . . . . 3.0899999999999999 109.067 -166.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.8 mtm -123.75 143.34 50.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.618 1.167 . . . . 4.1600000000000001 111.232 167.72 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.92 159.05 28.51 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.1 0.857 . . . . 1.46 113.689 -179.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.577 1.151 . . . . 2.46 112.618 -175.44 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -177.14 142.66 0.51 Allowed Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 116.663 -1.637 . . . . 5.21 110.764 -171.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -71.83 142.67 39.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 CA-C-N 122.204 1.823 . . . . 0.77000000000000002 111.827 167.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.64 157.48 47.73 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 126.052 1.741 . . . . 1.8500000000000001 110.473 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.13 -17.91 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.436 2.09 . . . . 0.66000000000000003 113.025 176.398 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -175.69 169.06 3.08 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.135 1.374 . . . . 3.1499999999999999 111.321 -177.224 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.21 175.18 5.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.645 1.978 . . . . 2.02 108.961 156.035 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.3 pt-20 -152.47 164.26 37.91 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.105 -0.997 . . . . 2.6600000000000001 111.511 176.492 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -147.58 129.06 7.28 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.17 0.988 . . . . 2.21 110.311 -172.001 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.65 157.49 35.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.996 2.464 . . . . 1.5 111.934 179.65 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.89 137.56 73.25 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.374 3.383 . . . . 1.5600000000000001 113.293 -174.908 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 68.2 mmtt 68.88 -5.46 1.01 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.261 2.224 . . . . 2.1699999999999999 114.42 -176.494 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.62 137.2 14.15 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 126.498 1.999 . . . . 1.3300000000000001 109.838 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -107.26 136.79 46.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.061 -1.07 . . . . 5.8700000000000001 110.561 158.493 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.21 149.07 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 125.378 1.471 . . . . 3.4399999999999999 110.702 -178.372 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -100.95 134.5 43.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.151 1.908 . . . . 4.0199999999999996 116.151 -167.866 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.29 78.68 1.33 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.505 1.522 . . . . 1.7 107.453 155.455 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -83.17 139.55 42.26 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.556 1.142 . . . . 3.5499999999999998 110.364 178.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.8 -53.35 7.06 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.851 3.034 . . . . 1.25 113.915 -169.147 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.04 90.45 1.68 Allowed Glycine 0 N--CA 1.469 0.894 0 N-CA-C 109.622 -1.391 . . . . 1.5600000000000001 109.622 166.017 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.15 -74.29 0.22 Allowed Glycine 0 N--CA 1.468 0.794 0 C-N-CA 124.843 1.211 . . . . 1.3700000000000001 112.767 -168.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -156.02 144.86 20.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.52 1.928 . . . . 3.1699999999999999 109.346 177.101 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -167.73 164.91 14.39 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.977 -1.077 . . . . 1.01 109.629 -176.251 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -95.92 120.33 36.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.826 0.45 . . . . 3.4100000000000001 110.183 175.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.1 mmt -76.9 100.05 5.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.643 1.211 . . . . 1.9399999999999999 109.365 163.793 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -102.02 111.11 23.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.663 -1.608 . . . . 3.1000000000000001 108.268 178.63 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.56 52.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.0 1.72 . . . . 4.3399999999999999 109.124 -173.524 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.96 63.09 2.12 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.797 -0.921 . . . . 1.5600000000000001 110.797 -174.855 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.97 117.23 13.32 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.387 0.675 . . . . 2.1499999999999999 111.427 -176.068 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -82.82 -6.93 59.66 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.689 1.366 . . . . 2.5299999999999998 114.689 -165.335 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -122.87 153.22 63.64 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.921 -1.511 . . . . 5.5700000000000003 106.921 152.451 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.34 123.71 9.79 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 107.371 -1.819 . . . . 1.71 107.371 151.34 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.35 154.36 41.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.935 1.294 . . . . 3.1899999999999999 112.069 -166.363 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -131.38 129.1 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.564 1.146 . . . . 7.2199999999999998 110.931 165.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.05 121.86 8.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.795 -0.816 . . . . 2.71 108.795 169.647 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.55 1.84 56.53 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-O 117.998 -1.446 . . . . 1.8899999999999999 116.127 -169.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -78.79 170.22 17.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.182 1.991 . . . . 2.7799999999999998 110.243 162.159 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -116.15 149.78 38.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.812 2.045 . . . . 5.0700000000000003 109.811 177.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.4 t -127.62 113.94 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.404 1.081 . . . . 2.2599999999999998 109.722 -178.343 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.43 ' OE2' ' HE2' ' A' ' 112' ' ' LYS . 1.2 mt-10 -68.95 134.55 49.68 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.981 0.8 . . . . 3.0899999999999999 109.646 159.459 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -147.4 116.96 7.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.565 1.146 . . . . 2.7599999999999998 112.372 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -89.68 94.58 9.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.688 2.795 . . . . 2.1800000000000002 110.543 177.651 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -74.13 123.31 24.2 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.796 1.239 . . . . 2.3500000000000001 110.815 -177.017 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 mt -96.8 129.69 44.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.831 1.252 . . . . 1.8100000000000001 111.23 -172.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.57 129.82 41.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.049 0.928 . . . . 3.0800000000000001 113.172 -173.463 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 32.37 50.41 0.18 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.671 2.388 . . . . 2.6499999999999999 113.935 175.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.26 -90.88 0.53 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.897 1.237 . . . . 3.6400000000000001 112.053 -172.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.19 15.94 19.75 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 117.399 1.719 . . . . 1.6499999999999999 117.399 -164.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 109' ' ' LYS . 0.5 OUTLIER -115.0 145.21 42.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.784 2.292 . . . . 6.25 109.363 166.323 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -147.8 137.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 124.906 1.282 . . . . 2.0099999999999998 108.96 167.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.5 mt -142.14 124.62 15.74 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.48 1.512 . . . . 2.7799999999999998 107.858 -175.475 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HE2' ' OE2' ' A' ' 100' ' ' GLU . 10.0 ptmt -102.96 150.12 23.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.437 1.643 . . . . 3.2799999999999998 115.437 -174.258 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.78 160.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.233 1.813 . . . . 2.1099999999999999 110.284 178.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -117.05 118.71 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.578 1.151 . . . . 2.9199999999999999 110.261 171.394 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.2 mt -108.9 150.42 40.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.331 1.852 . . . . 2.3399999999999999 109.769 178.398 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.24 155.43 19.29 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.455 2.77 . . . . 0.96999999999999997 111.698 170.068 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.42 145.36 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.924 1.29 . . . . 1.8400000000000001 109.258 163.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.64 171.14 16.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.545 1.938 . . . . 3.27 108.797 -176.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.57 3.58 7.5 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.436 2.013 . . . . 3.21 116.436 -160.476 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 130.209 3.403 . . . . 5.7199999999999998 109.272 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 113.402 0.889 . . . . 5.0899999999999999 113.402 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -162.38 -179.2 36.83 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 126.021 1.772 . . . . 1.26 115.407 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -127.91 140.49 51.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.406 0.682 . . . . 2.1499999999999999 112.835 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.9 t -83.06 138.5 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.877 -1.157 . . . . 0.93999999999999995 107.877 160.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -83.87 119.75 25.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.162 -0.961 . . . . 3.75 112.448 -164.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.03 129.13 20.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.116 1.366 . . . . 3.3500000000000001 110.619 163.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m 179.24 111.31 0.18 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.075 1.75 . . . . 2.04 110.316 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -84.41 48.72 2.53 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.006 3.138 . . . . 2.1899999999999999 110.181 167.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.65 -174.67 27.01 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.405 1.002 . . . . 1.6299999999999999 113.037 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.06 -17.01 28.63 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.685 2.256 . . . . 1.6100000000000001 111.529 163.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -150.28 169.06 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.403 1.881 . . . . 1.98 113.019 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.9 -159.59 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.469 2.307 . . . . 1.3100000000000001 109.422 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.06 166.07 27.2 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.732 1.213 . . . . 1.5600000000000001 111.247 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.72 133.58 40.11 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 0.98999999999999999 111.753 162.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -120.96 148.15 44.49 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.89 2.076 . . . . 2.4100000000000001 109.707 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -169.84 154.67 5.39 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.482 1.29 . . . . 1.4099999999999999 114.482 174.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 m -74.39 143.61 44.72 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.429 1.092 . . . . 1.3799999999999999 108.655 157.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.53 130.59 21.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.706 -1.22 . . . . 2.1899999999999999 107.706 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.16 142.86 32.76 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.882 0.873 . . . . 4.2300000000000004 111.203 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -102.46 110.75 63.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.458 1.503 . . . . 0.81999999999999995 110.526 -168.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.04 -10.51 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.229 1.952 . . . . 0.94999999999999996 113.524 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.51 169.71 54.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.262 0.937 . . . . 0.83999999999999997 113.673 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.01 -4.99 35.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.93 1.692 . . . . 2.5299999999999998 112.89 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.79 159.61 38.3 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 126.053 1.741 . . . . 1.6200000000000001 109.856 167.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.75 159.02 28.13 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.889 2.392 . . . . 0.93999999999999995 112.038 -169.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.43 154.16 19.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.213 1.005 . . . . 2.1099999999999999 110.262 168.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -137.95 109.35 6.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.789 1.236 . . . . 2.9199999999999999 108.814 168.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -88.76 106.92 18.68 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.639 2.376 . . . . 0.69999999999999996 108.952 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.36 -11.56 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.378 1.071 . . . . 0.53000000000000003 112.705 -172.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.86 -168.86 40.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.364 0.983 . . . . 0.56999999999999995 111.904 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.416 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -150.25 -179.73 7.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.571 1.148 . . . . 0.85999999999999999 109.17 163.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -159.52 137.92 10.55 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 119.038 0.836 . . . . 4.9400000000000004 109.286 -167.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 161.15 48.9 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.741 1.155 . . . . 0.58999999999999997 109.92 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.91 -29.56 15.05 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.891 1.727 . . . . 0.93000000000000005 113.583 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.0 m -81.01 0.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.12 1.526 . . . . 0.89000000000000001 115.12 -166.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 160.54 39.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.656 1.182 . . . . 1.02 112.24 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -96.96 -82.07 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.777 1.231 . . . . 2.77 111.298 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -80.59 101.02 8.92 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 120.301 -1.499 . . . . 3.5800000000000001 108.954 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 35' ' ' ALA . 5.6 p -84.78 137.21 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 125.977 1.711 . . . . 1.23 111.365 165.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -141.63 132.5 25.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.782 1.633 . . . . 2.0800000000000001 110.753 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -82.98 123.25 29.26 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 121.088 1.767 . . . . 0.66000000000000003 111.713 168.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.2 m170 -110.43 152.23 26.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.181 1.792 . . . . 0.56999999999999995 112.701 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -85.06 166.13 16.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.005 1.722 . . . . 2.1699999999999999 110.193 158.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.1 m -147.51 126.25 12.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 1.6200000000000001 107.481 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -140.12 164.24 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.925 0.713 . . . . 2.3700000000000001 112.925 -151.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -110.2 138.51 46.48 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.418 0.687 . . . . 3.2000000000000002 110.18 153.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -145.27 155.29 43.14 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.879 1.672 . . . . 7.29 109.213 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.32 150.96 20.54 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.677 0.791 . . . . 3.73 110.197 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.5 t -130.89 -97.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.428 1.091 . . . . 2.8599999999999999 109.619 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.54 45.12 0.38 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.92 2.088 . . . . 3.2799999999999998 111.584 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.36 -5.55 5.21 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.776 -1.202 . . . . 1.76 113.623 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -106.08 147.77 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.182 2.193 . . . . 2.8799999999999999 109.946 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -76.28 138.42 40.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.557 0.743 . . . . 4.0099999999999998 111.229 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -137.31 151.63 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.286 1.834 . . . . 1.6200000000000001 109.288 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mtm -127.4 145.35 50.85 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.288 1.035 . . . . 3.5099999999999998 111.775 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.85 37.07 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.509 1.052 . . . . 1.53 113.483 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -123.27 168.07 12.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.381 1.872 . . . . 1.8600000000000001 111.068 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.16 131.93 0.45 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 116.361 -1.78 . . . . 4.4299999999999997 111.882 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 18.2 Cg_endo -67.72 142.47 58.21 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 122.533 1.94 . . . . 0.56000000000000005 112.553 171.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.43 160.26 44.56 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.22 1.808 . . . . 0.52000000000000002 110.376 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.6 -20.15 20.72 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.354 2.036 . . . . 0.67000000000000004 113.17 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -176.27 168.1 2.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.959 1.254 . . . . 1.8300000000000001 112.018 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -116.58 173.81 6.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.445 2.298 . . . . 1.0800000000000001 109.128 153.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -156.61 166.62 32.87 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.058 -1.026 . . . . 1.96 112.731 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 132.15 8.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.104 0.962 . . . . 0.92000000000000004 109.154 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.4 165.9 30.16 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.577 1.518 . . . . 0.81999999999999995 110.762 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.43 138.71 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.194 2.596 . . . . 0.83999999999999997 111.144 171.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt 68.45 -2.69 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.011 1.724 . . . . 1.3600000000000001 113.883 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.91 -172.67 45.12 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 126.187 1.851 . . . . 0.98999999999999999 113.423 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -152.15 149.11 28.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.056 1.742 . . . . 4.8300000000000001 111.621 -171.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.04 142.08 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.616 1.567 . . . . 2.3500000000000001 108.551 161.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -106.1 123.17 47.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.966 0.803 . . . . 3.8199999999999998 109.735 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.31 69.7 0.56 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.347 1.459 . . . . 1.1799999999999999 108.194 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -81.4 145.62 55.82 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.461 2.305 . . . . 2.8900000000000001 109.694 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.7 -42.7 65.99 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.148 2.566 . . . . 0.84999999999999998 112.501 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.75 59.99 4.24 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.814 0.734 . . . . 1.0800000000000001 112.171 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.63 -70.3 0.05 OUTLIER Glycine 0 N--CA 1.468 0.786 0 C-N-CA 124.053 0.835 . . . . 0.78000000000000003 114.371 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -155.16 147.18 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.835 1.654 . . . . 1.8500000000000001 109.367 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -165.25 174.87 9.75 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.022 -1.049 . . . . 0.97999999999999998 110.921 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.59 132.31 50.98 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.724 -0.473 . . . . 1.8400000000000001 109.724 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -80.89 135.81 35.97 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.134 0.574 . . . . 1.2 110.143 159.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.42 98.36 6.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.143 1.377 . . . . 1.6200000000000001 109.411 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -102.38 142.94 32.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.828 0.851 . . . . 2.3999999999999999 111.162 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.66 75.0 0.73 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.398 -1.081 . . . . 1.3100000000000001 110.398 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.2 124.11 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 117.271 0.536 . . . . 0.98999999999999999 112.142 -170.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -82.33 -6.31 59.17 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.001 0.741 . . . . 1.4299999999999999 113.001 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -154.32 150.04 21.51 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.48 2.312 . . . . 3.9500000000000002 108.366 158.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.28 134.57 45.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.934 1.756 . . . . 1.6499999999999999 108.249 168.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.75 119.73 20.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.922 -0.399 . . . . 2.3300000000000001 109.922 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -105.5 124.0 48.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.296 1.839 . . . . 3.73 109.987 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.98 48.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.666 0.666 . . . . 2.1400000000000001 109.731 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 34.77 31.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 120.025 -0.319 . . . . 2.25 113.25 -167.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.99 174.27 6.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.929 -1.137 . . . . 2.5099999999999998 107.929 148.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.8 151.11 37.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.628 1.171 . . . . 3.54 108.309 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.6 t -127.53 126.99 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.901 1.281 . . . . 0.94999999999999996 109.698 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -75.08 142.31 43.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.255 1.026 . . . . 2.7799999999999998 111.349 161.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.37 114.12 5.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.931 -1.031 . . . . 1.6200000000000001 111.361 -172.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.02 93.84 8.17 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.028 2.531 . . . . 2.1200000000000001 109.968 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.2 mt -71.53 121.88 19.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.151 0.98 . . . . 1.1299999999999999 110.678 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -95.76 128.22 42.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 0.57999999999999996 111.674 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.54 137.44 52.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.419 0.687 . . . . 1.79 112.101 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.02 130.28 21.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.342 1.457 . . . . 2.04 114.311 -165.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.3 -144.94 22.8 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.986 -1.246 . . . . 3.0499999999999998 109.986 -164.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.27 54.44 1.54 Allowed Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.734 -1.037 . . . . 1.52 114.135 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -120.24 140.28 51.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.863 1.831 . . . . 4.5099999999999998 111.161 168.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.45 137.45 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 125.741 1.616 . . . . 0.94999999999999996 107.581 164.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.8 mt -128.32 111.5 13.43 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.482 1.113 . . . . 1.5700000000000001 108.601 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -81.17 122.57 27.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.352 -0.217 . . . . 2.2999999999999998 111.584 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.97 164.39 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.808 1.643 . . . . 1.1399999999999999 110.237 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.55 146.08 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.969 0.908 . . . . 2.0299999999999998 109.034 166.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -136.3 145.54 52.35 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.08 1.352 . . . . 1.5800000000000001 109.234 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -68.2 154.75 71.59 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.562 2.175 . . . . 0.90000000000000002 110.388 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.657 -0.868 . . . . 1.1699999999999999 108.657 165.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.03 157.76 43.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.537 1.135 . . . . 3.02 110.606 -171.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.11 72.13 1.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.969 1.707 . . . . 2.02 112.511 -168.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.0 0 C-N-CA 124.735 1.214 . . . . 4.8300000000000001 110.344 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.56 ' N ' ' HG1' ' A' ' 21' ' ' THR . 2.2 tp10 . . . . . 0 CA--C 1.544 0.748 0 CA-C-O 119.234 -0.412 . . . . 6.1299999999999999 111.017 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.71 167.66 21.45 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 125.127 1.346 . . . . 1.4399999999999999 114.55 172.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.3 p90 -163.08 158.23 21.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.353 2.261 . . . . 1.7 110.648 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.35 139.58 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.81 -0.556 . . . . 1.1299999999999999 110.218 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -77.73 128.93 34.84 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.307 -0.406 . . . . 5.7599999999999998 111.507 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.7 143.69 3.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.655 1.182 . . . . 2.7000000000000002 111.769 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -163.44 135.97 4.07 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.554 0.576 . . . . 3.23 112.554 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.18 0.45 4.15 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.546 3.497 . . . . 2.73 112.447 163.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.3 171.54 25.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.922 1.249 . . . . 1.3899999999999999 114.626 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.1 -13.98 18.98 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.478 3.452 . . . . 1.54 113.861 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -122.16 163.29 19.79 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.068 0.947 . . . . 2.7400000000000002 111.863 166.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.52 178.55 10.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.292 1.437 . . . . 1.3899999999999999 111.328 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.49 139.05 46.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.591 1.557 . . . . 1.3899999999999999 111.957 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.02 150.11 48.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.161 1.385 . . . . 0.98999999999999999 112.118 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -136.09 148.51 48.32 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.551 1.541 . . . . 2.2200000000000002 109.308 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.63 152.52 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 1.77 114.816 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.56 ' HG1' ' N ' ' A' ' 5' ' ' GLU . 8.0 m -79.62 120.44 23.96 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 126.094 1.757 . . . . 1.5700000000000001 109.652 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.67 113.03 26.35 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.383 -0.969 . . . . 2.54 108.383 166.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -122.88 127.85 49.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.025 1.33 . . . . 3.3199999999999998 108.7 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -98.43 104.39 23.47 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.368 1.067 . . . . 1.0 109.614 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.87 -10.41 12.84 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 1.1000000000000001 113.311 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 164.49 52.04 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.276 0.941 . . . . 0.96999999999999997 113.094 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.69 -9.97 59.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.766 1.226 . . . . 3.9199999999999999 113.492 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.73 160.82 47.23 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.028 1.731 . . . . 1.72 111.215 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.12 151.77 23.85 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.956 2.438 . . . . 0.97999999999999998 111.84 -171.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -115.55 125.59 53.18 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.264 1.426 . . . . 2.3500000000000001 110.468 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -107.98 114.77 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.761 1.225 . . . . 2.79 110.72 171.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.2 tp -97.07 114.72 26.4 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.441 2.696 . . . . 0.68999999999999995 108.771 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.54 -11.04 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.068 0.947 . . . . 0.53000000000000003 113.206 -165.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.77 -158.01 27.74 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 124.113 0.863 . . . . 0.55000000000000004 111.509 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.11 178.97 9.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.77 0.828 . . . . 0.90000000000000002 112.181 172.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -146.6 121.35 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.535 1.134 . . . . 6.6299999999999999 109.733 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -145.46 160.68 44.25 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.665 1.986 . . . . 0.83999999999999997 108.988 -168.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -31.01 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.122 1.881 . . . . 1.9299999999999999 112.748 157.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 m -83.49 31.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.554 1.07 . . . . 2.7000000000000002 113.84 -169.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.15 161.25 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 128.029 2.532 . . . . 1.55 109.227 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.94 -80.2 0.55 Allowed 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.8 -1.926 . . . . 3.48 105.8 160.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.43 84.94 2.54 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.14 -0.975 . . . . 3.6499999999999999 109.903 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.76 137.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.428 -0.806 . . . . 1.1899999999999999 109.619 159.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.98 122.84 27.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.792 1.237 . . . . 2.2999999999999998 110.649 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -79.71 119.14 22.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.922 1.237 . . . . 0.73999999999999999 110.597 168.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -106.99 156.16 19.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.266 1.827 . . . . 0.82999999999999996 112.23 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -112.63 -176.64 2.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 2.04 111.794 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -150.09 79.4 1.36 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.992 1.317 . . . . 1.22 108.466 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -83.58 148.57 27.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.942 -1.026 . . . . 2.6499999999999999 110.214 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -90.89 155.37 18.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 3.6699999999999999 111.035 164.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -151.69 149.2 28.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.736 1.615 . . . . 6.54 109.952 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -89.57 168.81 11.86 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.0 0.905 . . . . 3.54 111.782 164.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.61 -128.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.821 2.448 . . . . 4.0599999999999996 107.331 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.68 60.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 121.559 1.981 . . . . 4.6399999999999997 111.14 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.15 2.9 55.08 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.643 1.116 . . . . 2.2200000000000002 114.008 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -87.65 126.27 34.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.354 1.462 . . . . 4.5599999999999996 109.973 174.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.401 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -93.1 131.9 37.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.633 0.373 . . . . 5.0099999999999998 111.39 177.214 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -139.77 143.14 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.921 1.688 . . . . 2.04 109.967 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.35 120.16 41.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.298 1.039 . . . . 3.4399999999999999 110.181 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.01 44.72 1.44 Allowed Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.092 1.197 . . . . 3.6600000000000001 116.092 -160.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -28.73 120.03 0.12 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.063 2.545 . . . . 2.52 113.624 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -144.96 154.62 55.11 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 117.654 -1.165 . . . . 5.21 110.395 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.17 146.88 82.85 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.03 1.82 . . . . 0.71999999999999997 110.806 164.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.11 154.83 49.99 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.115 1.366 . . . . 0.68999999999999995 110.514 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 -15.41 38.08 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.917 2.411 . . . . 1.05 112.917 176.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -175.35 163.92 3.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 2.1400000000000001 111.119 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -113.61 173.6 6.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.613 1.965 . . . . 0.98999999999999999 109.532 155.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.95 163.95 39.09 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.487 -0.758 . . . . 2.3599999999999999 112.106 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.92 132.53 10.4 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.467 1.107 . . . . 1.0700000000000001 110.019 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.13 163.14 38.91 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.437 2.758 . . . . 1.0700000000000001 111.617 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.61 140.68 76.3 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.974 2.449 . . . . 0.93999999999999995 111.266 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp 69.59 -1.43 2.27 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.649 1.979 . . . . 2.9100000000000001 113.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.44 135.21 12.91 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 127.081 2.277 . . . . 1.1299999999999999 110.987 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -103.71 138.38 40.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.466 1.507 . . . . 4.2599999999999998 110.789 161.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.23 113.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.408 1.883 . . . . 2.2000000000000002 107.855 165.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -81.74 142.02 33.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.174 0.99 . . . . 3.4300000000000002 110.344 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -71.08 78.83 0.67 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.317 1.056 . . . . 1.02 108.924 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -87.92 138.8 30.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 3.5699999999999998 109.986 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.3 -40.38 59.29 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.691 2.927 . . . . 1.02 114.159 -165.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.83 78.44 1.95 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.005 -1.638 . . . . 1.1699999999999999 109.005 162.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.27 -88.68 0.1 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.51 1.053 . . . . 0.81000000000000005 112.622 -167.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -151.23 144.34 24.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.741 2.017 . . . . 1.8 109.496 -171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -164.65 171.85 13.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.564 0.746 . . . . 0.72999999999999998 110.689 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.42 131.23 55.23 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.92 0.488 . . . . 2.1800000000000002 110.614 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.61 136.99 32.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.269 1.428 . . . . 1.27 110.44 163.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.49 111.2 21.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.12 1.768 . . . . 2.1899999999999999 108.822 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.67 133.44 55.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.8 0.84 . . . . 2.6499999999999999 109.642 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.65 42.53 17.22 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 111.618 -0.593 . . . . 1.79 111.618 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.41 120.49 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.687 1.595 . . . . 1.75 113.009 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -86.59 -3.86 59.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.18 -0.918 . . . . 1.6599999999999999 112.884 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -130.57 135.64 27.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 116.704 -1.617 . . . . 4.2999999999999998 108.228 149.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -61.6 139.38 81.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.928 1.752 . . . . 1.99 107.841 156.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.71 110.84 18.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.645 1.178 . . . . 2.1299999999999999 110.246 -162.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -90.01 131.07 36.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.686 0.755 . . . . 5.5499999999999998 110.599 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 119.86 6.87 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.123 -0.944 . . . . 1.47 109.191 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.04 4.8 57.56 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 117.86 -1.522 . . . . 1.98 115.645 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -85.25 163.92 18.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.31 2.055 . . . . 2.9300000000000002 110.433 160.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -96.86 156.9 16.15 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.853 1.261 . . . . 3.8599999999999999 109.776 163.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.06 124.61 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 124.517 1.127 . . . . 1.01 109.152 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.87 134.07 43.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.201 1.8 . . . . 3.0499999999999998 108.338 166.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mt -158.86 120.95 3.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.567 1.147 . . . . 1.49 113.578 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.06 112.26 25.33 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.092 2.157 . . . . 2.9700000000000002 110.739 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.6 132.86 46.87 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 1.27 111.183 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -96.42 133.69 40.52 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.813 0.845 . . . . 0.71999999999999997 111.219 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -126.64 152.78 46.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.643 1.211 . . . . 2.1699999999999999 112.306 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.93 134.59 57.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.217 -0.901 . . . . 2.1000000000000001 113.142 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.92 46.26 37.97 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 119.12 -0.822 . . . . 3.9100000000000001 114.164 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.55 18.87 61.16 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.993 1.157 . . . . 1.52 115.993 166.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.9 143.22 30.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.474 1.637 . . . . 4.4900000000000002 110.463 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -152.23 138.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.948 1.699 . . . . 0.95999999999999996 108.47 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -144.74 127.72 16.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.768 0.827 . . . . 1.6299999999999999 112.523 -168.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -71.01 135.96 48.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 2.4300000000000002 111.944 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.66 151.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.523 1.129 . . . . 1.6100000000000001 111.305 171.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.07 134.83 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.044 . . . . 3.8599999999999999 112.565 -171.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.86 125.8 9.99 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.896 1.278 . . . . 3.6800000000000002 109.561 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -86.76 159.41 9.05 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.608 2.872 . . . . 1.3 110.558 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.42 137.15 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.165 0.986 . . . . 1.4199999999999999 109.971 172.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -140.71 150.4 43.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.131 0.972 . . . . 3.2999999999999998 110.452 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.79 58.83 1.15 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.772 0.829 . . . . 3.2400000000000002 109.998 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.701 1.2 . . . . 5.4900000000000002 112.666 -170.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 108.832 -0.803 . . . . 6.1500000000000004 108.832 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.35 -178.67 15.41 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-N 121.226 1.83 . . . . 1.02 116.343 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -160.3 138.06 9.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.218 -0.991 . . . . 1.6899999999999999 111.739 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.99 122.79 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.997 0.904 . . . . 1.4299999999999999 109.029 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -62.08 112.04 2.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.619 1.568 . . . . 4.0800000000000001 112.148 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -70.15 133.48 47.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.461 0.648 . . . . 2.6299999999999999 109.51 150.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.9 m -159.18 146.52 13.06 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.634 1.574 . . . . 2.3799999999999999 109.994 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -86.78 67.68 4.43 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.118 3.212 . . . . 2.6800000000000002 110.836 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -151.87 177.42 29.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.787 0.708 . . . . 1.25 114.04 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.33 -10.11 19.04 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.831 3.02 . . . . 1.4099999999999999 113.205 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -146.27 165.78 28.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.925 1.69 . . . . 2.02 112.669 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 153.41 29.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.622 1.169 . . . . 1.3 112.165 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.29 118.53 33.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.566 1.146 . . . . 1.8999999999999999 109.694 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.79 156.74 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.87 1.268 . . . . 1.2 112.044 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.68 154.57 47.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.028 1.331 . . . . 1.8899999999999999 112.783 -169.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.408 ' H ' ' HB2' ' A' ' 77' ' ' LEU . 2.0 pt? -160.93 157.97 27.35 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.926 1.29 . . . . 1.6200000000000001 112.649 165.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.9 m -73.27 108.98 6.46 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.326 -0.99 . . . . 1.23 108.326 156.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.38 129.2 34.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.07 -1.456 . . . . 2.6899999999999999 107.07 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -126.37 148.23 49.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.183 0.808 . . . . 3.0899999999999999 113.183 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -112.13 110.67 53.66 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.624 1.17 . . . . 1.1499999999999999 109.974 166.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.45 -8.37 8.53 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.045 2.497 . . . . 1.26 113.225 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.75 155.95 37.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.434 1.016 . . . . 1.24 112.66 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.439 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.6 m-20 -88.88 4.67 47.08 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.313 1.845 . . . . 3.0299999999999998 113.296 -175.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.95 160.76 41.52 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.45 1.9 . . . . 1.6499999999999999 110.293 167.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.24 153.75 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.034 2.49 . . . . 1.03 111.285 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.9 mt -107.38 153.57 22.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.426 1.09 . . . . 1.8100000000000001 111.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -130.21 113.08 14.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 2.8500000000000001 110.218 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.6 105.05 17.08 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 127.701 2.4 . . . . 0.60999999999999999 108.316 -174.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -94.19 -11.53 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.965 0.906 . . . . 0.62 113.032 -172.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.86 -163.85 33.0 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.594 1.092 . . . . 0.48999999999999999 111.608 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 101' ' ' LEU . . . -156.16 -175.11 5.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.26 1.024 . . . . 0.91000000000000003 110.515 166.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.448 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 1.1 mmt85 -160.38 -172.75 3.69 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.893 1.224 . . . . 7.2199999999999998 111.214 -172.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -177.86 156.35 1.1 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 126.443 1.897 . . . . 1.21 108.726 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.65 -22.29 73.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.767 2.311 . . . . 1.3500000000000001 114.371 160.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.06 2.41 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.629 1.714 . . . . 1.78 115.629 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.96 167.84 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.566 1.075 . . . . 0.94999999999999996 111.501 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.22 -88.51 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.546 0.738 . . . . 3.25 112.946 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -83.0 141.17 32.29 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.28 -1.008 . . . . 4.3899999999999997 108.28 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -151.82 131.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.196 0.999 . . . . 1.3300000000000001 109.82 -169.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -145.0 124.45 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.367 1.467 . . . . 2.4900000000000002 110.151 -166.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD12 ' CE1' ' A' ' 84' ' ' PHE . 7.3 tt -79.38 121.29 24.96 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.066 -1.021 . . . . 0.67000000000000004 110.816 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.8 m170 -109.19 153.12 24.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.188 1.395 . . . . 1.01 113.01 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.3 -175.51 2.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.765 2.026 . . . . 2.7799999999999998 112.145 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.4 m -147.97 127.68 13.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.12 1.768 . . . . 1.8500000000000001 108.503 172.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -124.78 153.51 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.326 1.45 . . . . 2.71 110.697 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.8 149.26 25.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.198 0.999 . . . . 4.8099999999999996 111.234 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.14 144.17 15.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.933 0.893 . . . . 6.1100000000000003 111.85 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.38 143.75 28.51 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.467 0.48 . . . . 3.8300000000000001 109.938 162.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.92 131.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.483 1.513 . . . . 3.7000000000000002 108.946 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 59.22 22.54 10.8 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.048 0.939 . . . . 3.4300000000000002 111.801 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.59 56.91 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.4 -1.437 . . . . 2.3900000000000001 114.126 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -93.99 144.2 25.68 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.943 1.697 . . . . 3.0600000000000001 110.561 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -83.63 134.49 34.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.787 0.835 . . . . 3.9100000000000001 110.521 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.57 151.2 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.24 1.816 . . . . 1.6000000000000001 109.864 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.3 mmt -106.17 135.24 48.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.454 1.102 . . . . 4.2300000000000004 110.401 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.15 151.3 17.42 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.763 1.173 . . . . 1.8100000000000001 112.648 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.4 162.46 17.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.351 1.461 . . . . 2.2599999999999998 111.358 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -171.59 159.66 4.87 Favored Pre-proline 0 N--CA 1.477 0.925 0 C-N-CA 126.542 1.937 . . . . 5.8200000000000003 109.761 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.9 Cg_endo -69.52 159.62 52.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.417 1.412 . . . . 0.91000000000000003 111.413 164.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.84 157.1 77.8 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.427 1.491 . . . . 0.90000000000000002 110.485 168.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.87 -10.84 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.936 2.424 . . . . 1.0900000000000001 113.139 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.49 160.22 1.24 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.421 1.889 . . . . 2.0099999999999998 111.669 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.61 175.27 5.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.521 1.928 . . . . 0.97999999999999998 109.473 151.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.18 162.44 41.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.236 -0.915 . . . . 1.8799999999999999 111.102 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.79 135.29 10.95 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.645 0.778 . . . . 0.93000000000000005 109.843 -166.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.97 167.02 28.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.774 2.316 . . . . 1.05 112.174 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.52 140.48 87.39 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.681 2.921 . . . . 1.0800000000000001 112.655 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.8 mmmt 68.12 0.77 2.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.947 2.099 . . . . 2.1200000000000001 114.309 175.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.3 142.87 15.62 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 127.255 2.359 . . . . 1.22 111.571 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -107.03 157.62 17.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.523 1.529 . . . . 4.9500000000000002 112.889 166.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.37 125.46 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.342 1.857 . . . . 1.4399999999999999 109.656 173.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -83.27 127.93 34.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 4.1799999999999997 111.388 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HB2' ' H ' ' A' ' 20' ' ' LEU . 10.5 mp -74.86 140.29 43.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.991 1.376 . . . . 1.54 109.702 166.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -166.72 146.04 4.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 3.2400000000000002 110.491 -153.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.11 -39.45 18.5 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.133 2.555 . . . . 1.5700000000000001 112.876 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.96 72.75 2.55 Favored Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.434 -1.466 . . . . 1.2 109.434 164.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.6 -94.8 0.11 Allowed Glycine 0 N--CA 1.469 0.856 0 N-CA-C 114.841 0.697 . . . . 0.80000000000000004 114.841 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -151.37 143.5 23.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.33 1.452 . . . . 1.78 110.565 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -166.58 144.85 5.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.083 0.553 . . . . 1.26 112.092 -166.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.451 ' CE1' HD12 ' A' ' 45' ' ' LEU . 55.6 m-85 -92.65 118.48 31.08 Favored 'General case' 0 CA--C 1.52 -0.178 0 O-C-N 121.651 -0.655 . . . . 1.8600000000000001 109.729 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 mmt -79.68 115.65 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.21 -0.663 . . . . 1.3799999999999999 109.21 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.0 mt -99.76 125.45 45.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.628 1.571 . . . . 1.48 107.946 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.57 120.42 35.76 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.412 1.485 . . . . 2.73 107.42 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.57 89.59 0.9 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.349 -1.1 . . . . 1.49 110.349 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.4 mt -89.82 123.04 33.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.153 0.981 . . . . 0.90000000000000002 109.283 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.68 -11.26 59.97 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.629 -1.295 . . . . 1.73 113.873 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -143.41 161.95 44.73 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.507 2.723 . . . . 6.4800000000000004 108.164 160.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.53 128.6 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 N-CA-C 107.07 -1.935 . . . . 1.5800000000000001 107.07 147.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.99 155.46 30.75 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.11 -0.7 . . . . 2.7599999999999998 109.11 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.71 125.21 22.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.958 0.885 . . . . 4.2699999999999996 111.883 176.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.17 133.39 15.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.116 0.967 . . . . 2.0099999999999998 112.225 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.64 40.94 4.57 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.037 -0.868 . . . . 2.6099999999999999 113.382 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.6 165.79 29.32 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 126.851 2.06 . . . . 2.5699999999999998 108.271 157.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.73 158.01 16.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.087 1.755 . . . . 3.9900000000000002 111.294 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.5 t -115.66 119.94 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.858 1.263 . . . . 0.96999999999999997 108.232 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 122.42 16.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.851 -1.166 . . . . 3.1899999999999999 107.851 155.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.419 ' CD1' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -122.08 131.76 54.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.507 1.523 . . . . 2.5699999999999998 107.312 175.333 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 51.2 m-20 -111.71 81.58 1.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.154 1.382 . . . . 3.5 110.417 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -66.78 118.72 10.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.336 1.854 . . . . 1.24 110.976 -170.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.82 122.39 34.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.258 1.023 . . . . 1.02 110.827 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.08 139.49 54.02 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.038 0.923 . . . . 2.0 111.772 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.96 128.77 22.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.1 1.36 . . . . 2.04 113.747 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.09 60.87 3.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.236 0.922 . . . . 3.3500000000000001 113.068 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 6.77 88.83 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 116.956 1.543 . . . . 2.6699999999999999 116.956 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.72 137.64 32.75 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.248 2.024 . . . . 4.3799999999999999 110.708 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.32 133.22 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.559 1.144 . . . . 1.8700000000000001 109.214 161.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.2 mt -114.33 109.31 18.16 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.323 1.049 . . . . 1.8999999999999999 109.904 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.73 94.14 1.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 3.7000000000000002 109.278 168.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.68 156.94 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.849 0.86 . . . . 1.8100000000000001 110.065 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -103.46 139.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.482 1.113 . . . . 1.9099999999999999 109.364 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 mt -142.02 153.35 63.71 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.786 2.035 . . . . 1.5800000000000001 108.611 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.65 153.16 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.867 2.378 . . . . 1.1100000000000001 112.102 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.5 t -77.95 132.5 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.131 0.972 . . . . 1.49 108.486 159.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.87 151.2 23.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.884 . . . . 3.5 110.837 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.76 115.39 30.05 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.042 1.337 . . . . 2.29 111.805 -161.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 129.17 2.988 . . . . 5.6799999999999997 108.037 177.092 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 122.168 0.985 . . . . 6.0899999999999999 111.795 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.64 169.73 41.39 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.976 2.227 . . . . 1.5900000000000001 110.493 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -141.99 154.34 44.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.426 0.898 . . . . 2.27 113.426 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.07 126.27 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.366 -0.834 . . . . 0.95999999999999996 109.147 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.06 108.67 12.72 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.23 1.412 . . . . 3.7200000000000002 112.414 -162.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -66.14 122.61 17.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.184 1.394 . . . . 2.8500000000000001 111.321 172.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -165.2 140.01 4.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.702 1.201 . . . . 2.3100000000000001 110.151 167.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.87 71.35 6.4 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.287 3.325 . . . . 2.1299999999999999 109.503 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.26 172.92 19.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.321 0.962 . . . . 1.3200000000000001 114.443 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.05 -16.1 36.21 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.235 2.623 . . . . 1.71 111.68 166.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -144.86 164.78 30.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.571 1.149 . . . . 2.4700000000000002 113.435 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.42 -166.35 1.64 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.375 2.27 . . . . 1.1499999999999999 109.527 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.29 164.07 38.17 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.412 0.893 . . . . 1.21 113.412 -168.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.69 139.64 40.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.677 1.191 . . . . 1.2 111.428 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.45 140.57 41.33 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.73 2.012 . . . . 2.6699999999999999 109.236 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.49 153.73 11.38 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.18 1.178 . . . . 2.1200000000000001 114.18 -166.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -78.91 98.08 6.26 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.663 -1.236 . . . . 2.1200000000000001 107.663 157.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.09 133.67 46.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.435 1.894 . . . . 3.23 108.589 173.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -105.44 145.28 31.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.194 0.813 . . . . 4.8700000000000001 113.194 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -122.72 110.6 31.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.65 0.78 . . . . 1.4199999999999999 109.507 150.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -91.94 -10.09 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.575 2.85 . . . . 1.4399999999999999 113.513 170.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.27 33.64 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.795 1.188 . . . . 1.26 112.929 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.5 m-20 -87.26 4.06 44.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.071 1.748 . . . . 3.0699999999999998 113.507 -174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.32 159.93 41.56 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.067 1.747 . . . . 1.8500000000000001 110.64 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.38 149.83 21.91 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.812 2.341 . . . . 1.05 111.208 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.59 125.83 52.96 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.962 1.305 . . . . 2.2599999999999998 109.163 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -111.25 99.66 8.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.236 1.014 . . . . 3.02 109.205 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 tp -80.63 114.3 19.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.999 2.12 . . . . 0.71999999999999997 109.482 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.22 -11.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.507 1.123 . . . . 0.55000000000000004 113.369 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.5 -166.02 37.72 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.4 1.0 . . . . 0.73999999999999999 111.791 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.15 -179.16 6.95 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.408 1.083 . . . . 1.0600000000000001 109.11 163.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -154.63 147.41 24.37 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.224 1.009 . . . . 6.0599999999999996 108.332 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -146.4 156.4 49.62 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.207 1.003 . . . . 0.82999999999999996 109.792 -167.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.69 -1.11 10.78 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.166 2.578 . . . . 1.5800000000000001 113.445 166.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 HG22 ' A' ' 99' ' ' VAL . 2.3 m -101.64 -5.9 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 115.485 1.661 . . . . 1.1899999999999999 115.485 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.54 158.77 41.75 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.818 1.19 . . . . 1.25 113.403 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.94 -76.62 0.52 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 3.1000000000000001 110.736 -170.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.99 114.32 19.79 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.08 -1.013 . . . . 4.0499999999999998 108.728 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.52 133.26 65.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 1.26 109.255 176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.69 134.97 24.26 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.351 1.06 . . . . 2.2999999999999998 110.884 -170.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.74 120.4 26.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.316 1.055 . . . . 0.70999999999999996 111.04 169.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 14.1 m170 -107.15 154.58 20.96 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.303 1.841 . . . . 0.71999999999999997 112.152 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.34 -176.77 3.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.123 1.769 . . . . 2.1299999999999999 110.39 167.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -148.07 86.86 1.58 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.915 1.286 . . . . 1.4399999999999999 108.836 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -73.09 166.88 22.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.049 1.34 . . . . 2.29 111.967 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -111.07 159.12 18.08 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.301 0.64 . . . . 3.5800000000000001 111.231 161.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -154.98 133.84 12.18 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.828 1.251 . . . . 6.0800000000000001 109.707 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 147.52 47.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.535 0.734 . . . . 3.3999999999999999 109.579 165.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.42 -40.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 115.322 1.601 . . . . 3.04 115.322 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -115.89 30.98 7.0 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.507 1.923 . . . . 4.4500000000000002 109.699 175.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 -14.25 4.05 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.227 -1.546 . . . . 1.8799999999999999 113.35 -165.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -104.15 160.29 14.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 127.725 2.41 . . . . 4.6500000000000004 110.3 170.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -92.28 146.8 23.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.467 1.655 . . . . 3.6800000000000002 115.467 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.37 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.731 2.013 . . . . 1.72 107.618 165.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -91.82 135.98 33.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.059 1.344 . . . . 3.75 110.217 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.47 148.75 20.37 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 124.237 0.922 . . . . 1.6000000000000001 112.812 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -99.3 163.04 12.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.966 1.306 . . . . 1.76 112.035 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -170.64 152.08 3.72 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.847 1.659 . . . . 4.9699999999999998 110.813 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.3 Cg_endo -69.54 150.07 69.1 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.675 1.583 . . . . 0.81999999999999995 111.592 166.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.41 157.58 70.0 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.946 2.099 . . . . 0.89000000000000001 110.188 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.47 -19.47 24.96 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.638 2.225 . . . . 0.85999999999999999 112.996 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.46 166.22 3.93 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.183 1.393 . . . . 1.8899999999999999 111.687 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -118.24 176.14 5.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.767 2.427 . . . . 1.05 108.815 156.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.32 165.09 36.84 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.095 -1.003 . . . . 2.02 111.668 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.43 134.15 10.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.68 1.592 . . . . 0.94999999999999996 108.805 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.66 165.97 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.815 2.343 . . . . 0.81999999999999995 111.739 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.56 144.47 97.75 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.557 2.838 . . . . 0.93000000000000005 112.459 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 20.4 mmmt 68.65 -5.84 0.92 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.19 2.196 . . . . 2.1099999999999999 114.823 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.51 122.22 7.29 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 126.574 2.035 . . . . 1.1899999999999999 111.028 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -88.64 136.6 32.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.015 0.526 . . . . 4.5 110.21 157.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.9 173.36 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.904 2.082 . . . . 2.1200000000000001 110.278 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -116.63 111.65 20.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.418 1.008 . . . . 4.2699999999999996 113.639 -161.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.08 76.67 1.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.222 1.009 . . . . 1.3899999999999999 108.436 156.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.51 155.19 76.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.044 0.938 . . . . 2.73 112.427 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.51 -58.37 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.11 2.54 . . . . 1.01 112.524 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.63 74.8 2.39 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.598 -1.001 . . . . 1.49 110.598 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.84 -75.84 0.08 OUTLIER Glycine 0 N--CA 1.469 0.835 0 C-N-CA 124.998 1.285 . . . . 1.0700000000000001 114.069 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -156.18 138.13 14.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.772 1.629 . . . . 2.3900000000000001 109.926 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -168.61 164.0 12.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.654 1.57 . . . . 0.78000000000000003 111.282 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.41 129.55 41.11 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 110.429 -0.211 . . . . 2.1899999999999999 110.429 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.5 mmt -87.58 135.9 33.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.262 1.025 . . . . 0.85999999999999999 110.351 165.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.58 114.79 26.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.445 1.498 . . . . 1.76 108.262 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.8 123.7 48.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.657 1.983 . . . . 2.8900000000000001 108.417 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.55 100.74 0.15 Allowed Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.55 -1.02 . . . . 1.49 110.55 -174.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.65 120.03 36.23 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.93 0.865 . . . . 0.93999999999999995 111.07 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.38 -11.68 61.02 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.204 1.402 . . . . 2.2599999999999998 113.924 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -167.09 155.52 9.08 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 126.744 2.018 . . . . 4.8799999999999999 110.235 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.4 140.52 82.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.801 1.667 . . . . 2.1899999999999999 109.318 163.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 39' ' ' VAL . 22.7 mt -84.3 89.96 7.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.535 1.134 . . . . 2.6299999999999999 109.585 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 108.04 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.535 1.134 . . . . 5.2199999999999998 110.302 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.0 113.1 0.91 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.021 0.528 . . . . 1.5600000000000001 110.842 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.78 3.11 30.4 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 116.76 -2.133 . . . . 2.5699999999999998 116.655 -173.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.92 171.76 14.51 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.341 2.571 . . . . 4.7599999999999998 110.102 152.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -103.3 135.02 45.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.713 -1.217 . . . . 6.4900000000000002 107.713 145.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.494 HG22 HG11 ' A' ' 39' ' ' VAL . 22.8 t -74.24 125.92 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 124.221 1.009 . . . . 1.3300000000000001 108.724 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 136.33 56.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.688 0.756 . . . . 3.3999999999999999 110.233 162.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -147.58 124.81 11.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 123.29 1.519 . . . . 1.75 111.77 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.47 83.85 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 127.554 2.341 . . . . 2.5800000000000001 109.491 -167.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.27 120.05 12.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.585 1.154 . . . . 1.26 110.279 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.5 mt -97.57 130.34 44.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.646 1.579 . . . . 0.76000000000000001 110.709 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 90.5 m-85 -134.15 129.3 35.65 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.414 -0.804 . . . . 1.95 111.133 -175.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 43.36 34.25 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.844 1.657 . . . . 2.29 113.478 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.23 -76.59 1.93 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.175 1.369 . . . . 4.4800000000000004 111.39 -167.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.773 1.069 . . . . 2.6600000000000001 115.773 -160.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -79.17 93.39 5.2 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.016 1.908 . . . . 7.2400000000000002 110.267 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.84 128.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 125.568 1.547 . . . . 1.1200000000000001 108.405 167.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.63 179.78 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.033 1.333 . . . . 3.4300000000000002 110.456 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -134.41 119.73 18.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.251 1.02 . . . . 2.54 108.4 154.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.42 168.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.907 -1.516 . . . . 2.71 106.907 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.0 m -125.65 144.3 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.35 1.86 . . . . 2.5699999999999998 108.922 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.4 mt -143.39 141.47 19.25 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.558 1.143 . . . . 2.48 111.482 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.1 144.86 99.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.937 3.092 . . . . 1.51 113.793 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.08 125.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.334 -0.988 . . . . 1.1399999999999999 108.334 168.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.77 161.79 42.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.989 0.916 . . . . 3.21 110.463 -168.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.52 5.85 34.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.559 1.318 . . . . 2.5099999999999998 114.559 -156.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.188 1.795 . . . . 5.2999999999999998 111.373 -178.105 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 111.961 0.356 . . . . 5.2300000000000004 111.961 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -124.11 153.99 17.63 Favored Glycine 0 N--CA 1.469 0.847 0 C-N-CA 128.566 2.984 . . . . 1.21 111.414 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -134.64 130.91 37.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.726 1.263 . . . . 1.3400000000000001 113.778 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.1 t -87.61 125.62 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.274 -0.891 . . . . 1.21 109.604 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.71 114.62 8.98 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.766 0.827 . . . . 3.6899999999999999 112.984 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.5 143.67 30.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.657 0.741 . . . . 2.9100000000000001 110.256 149.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.2 169.87 2.14 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 129.589 3.156 . . . . 3.52 106.787 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.97 33.81 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.428 2.752 . . . . 3.1800000000000002 113.826 -170.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.45 150.55 17.28 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.621 1.105 . . . . 2.0800000000000001 114.513 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.43 -14.84 20.1 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.918 3.079 . . . . 1.6699999999999999 112.105 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -134.45 157.76 45.63 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.72 2.008 . . . . 2.0800000000000001 111.374 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.49 168.95 22.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.536 1.135 . . . . 1.5 112.763 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.22 122.35 42.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.977 1.311 . . . . 1.71 109.487 166.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.6 119.26 28.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.361 -0.607 . . . . 1.1000000000000001 109.361 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -95.33 141.07 29.34 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.59 1.156 . . . . 2.2400000000000002 108.876 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.458 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 4.1 pp -158.14 156.1 30.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.106 1.15 . . . . 2.2400000000000002 114.106 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.6 m -112.31 105.86 14.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.722 1.209 . . . . 1.8300000000000001 108.688 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 23' ' ' GLU . 3.4 tt -101.89 144.16 30.87 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.032 1.333 . . . . 2.71 109.303 -174.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.499 ' N ' HD23 ' A' ' 22' ' ' LEU . 14.7 pt-20 -145.88 141.51 27.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.332 0.587 . . . . 3.46 112.119 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -104.53 106.38 54.13 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.928 -1.033 . . . . 1.3500000000000001 110.242 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 -12.18 13.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.506 2.137 . . . . 1.55 113.432 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.62 172.56 54.51 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 119.166 0.894 . . . . 1.3400000000000001 113.065 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -96.0 -4.26 43.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.046 1.738 . . . . 2.9900000000000002 112.492 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 155.54 44.99 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.634 1.974 . . . . 4.8499999999999996 108.568 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.61 158.92 25.29 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.094 2.529 . . . . 1.29 111.447 -171.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.45 154.05 20.86 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.315 1.046 . . . . 2.0600000000000001 109.974 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -134.27 110.35 9.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.181 1.392 . . . . 2.9500000000000002 109.086 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.4 tp -88.92 124.35 34.15 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.715 2.006 . . . . 0.71999999999999997 109.246 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.53 -6.11 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.08 1.141 . . . . 0.75 114.08 -170.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.21 -165.67 37.91 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 118.88 0.764 . . . . 0.83999999999999997 112.463 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.865 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -154.06 177.16 11.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.202 -0.904 . . . . 1.22 112.433 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.29 134.43 0.89 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.065 0.848 . . . . 5.6600000000000001 112.732 162.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -129.92 157.29 77.31 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 126.53 1.932 . . . . 1.03 110.124 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.15 -23.38 66.78 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.863 2.376 . . . . 1.1799999999999999 114.84 165.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -87.95 -0.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 114.729 1.381 . . . . 1.1699999999999999 114.729 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.31 163.97 31.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.67 1.188 . . . . 0.88 111.92 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -96.11 -94.36 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.109 1.364 . . . . 3.23 109.224 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 128.87 38.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.456 -0.778 . . . . 4.5999999999999996 110.025 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -131.09 133.02 63.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.002 1.321 . . . . 1.1499999999999999 110.166 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.22 136.13 33.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.228 1.411 . . . . 2.96 110.64 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.04 121.39 26.48 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.093 -1.004 . . . . 0.66000000000000003 111.082 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -108.5 156.0 19.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.503 1.521 . . . . 0.80000000000000004 112.414 172.222 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -101.54 179.74 4.26 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.245 -0.889 . . . . 3.0099999999999998 110.761 160.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -147.52 104.59 3.64 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.038 -1.097 . . . . 1.3 108.038 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -122.94 155.58 36.45 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.747 1.619 . . . . 2.2999999999999998 112.899 -156.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.3 mtm -82.91 143.95 30.38 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.368 0.667 . . . . 3.0 111.127 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -167.16 129.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.063 1.345 . . . . 9.1999999999999993 111.3 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -90.1 175.54 7.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.522 1.129 . . . . 4.2999999999999998 111.436 -171.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 133.53 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.837 1.655 . . . . 3.71 108.751 162.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 65.71 10.7 6.98 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.174 0.99 . . . . 4.2000000000000002 112.403 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.24 87.66 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 120.898 -1.126 . . . . 2.0099999999999998 114.089 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -96.88 142.13 29.23 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.074 1.75 . . . . 2.8100000000000001 109.699 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 11.4 tppt? -75.13 131.62 40.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.282 1.433 . . . . 4.3399999999999999 113.139 -165.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.71 -173.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.307 1.043 . . . . 1.9299999999999999 111.293 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 ptp -146.68 -177.17 5.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.594 1.958 . . . . 3.7000000000000002 112.695 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.75 172.88 43.87 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.333 1.444 . . . . 1.0700000000000001 112.935 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -114.3 156.98 23.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.561 1.544 . . . . 1.8500000000000001 109.416 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -166.32 144.39 4.55 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.052 1.341 . . . . 6.4400000000000004 110.068 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 21.2 Cg_endo -66.31 147.66 83.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.012 1.808 . . . . 0.81999999999999995 110.414 168.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.08 156.83 52.0 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.544 1.538 . . . . 0.59999999999999998 109.554 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.52 -22.05 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.041 1.827 . . . . 0.79000000000000004 112.334 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -173.93 165.13 4.29 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 124.482 1.113 . . . . 2.3999999999999999 111.814 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.48 175.34 5.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.422 2.289 . . . . 1.04 109.108 158.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.73 168.66 26.74 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.666 -1.271 . . . . 2.1699999999999999 111.737 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -149.26 132.74 8.45 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.722 0.809 . . . . 1.1699999999999999 110.161 -168.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.0 164.36 34.63 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.372 2.048 . . . . 1.4099999999999999 111.799 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.97 140.22 78.01 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.861 3.041 . . . . 1.52 112.188 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 70.14 0.56 3.18 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.972 2.109 . . . . 2.0499999999999998 113.871 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.06 125.1 7.94 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 126.783 2.135 . . . . 1.6100000000000001 111.165 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 148.0 23.88 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.914 -0.643 . . . . 4.8300000000000001 112.357 154.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.73 162.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.456 1.902 . . . . 1.6499999999999999 109.35 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.13 139.91 51.0 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.821 0.82 . . . . 3.02 112.47 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.36 71.7 1.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.592 1.157 . . . . 1.4199999999999999 108.238 155.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -80.1 142.55 55.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.104 1.761 . . . . 3.77 110.549 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.13 -58.82 1.52 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.969 3.779 . . . . 1.04 114.323 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.27 52.85 4.37 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 119.009 0.822 . . . . 1.21 112.067 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.28 -82.89 0.05 OUTLIER Glycine 0 N--CA 1.466 0.645 0 C-N-CA 127.627 2.537 . . . . 0.80000000000000004 111.699 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -151.27 149.78 29.79 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.005 2.122 . . . . 2.3599999999999999 108.967 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -169.25 165.22 10.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.163 0.892 . . . . 0.79000000000000004 111.292 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 30.7 m-85 -103.13 118.76 37.52 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.89 0.476 . . . . 2.21 110.226 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.6 mmt -77.69 104.66 8.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 1.0900000000000001 110.11 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.44 127.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.048 1.339 . . . . 1.52 108.709 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.98 117.35 19.08 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.485 1.114 . . . . 3.1699999999999999 109.23 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.91 75.04 1.21 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.312 -1.115 . . . . 1.3200000000000001 110.312 -168.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.85 129.8 40.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.434 -0.58 . . . . 1.2 109.434 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -80.98 7.71 10.11 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.954 1.094 . . . . 1.48 113.954 -170.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 176.26 153.32 0.36 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.988 2.515 . . . . 4.4299999999999997 109.65 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.79 144.13 76.35 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 108.14 -1.523 . . . . 1.6200000000000001 108.14 159.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.26 152.7 18.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.946 0.898 . . . . 2.3500000000000001 109.093 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -117.01 135.05 54.0 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.863 0.865 . . . . 6.2400000000000002 109.74 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 119.02 6.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.745 -1.222 . . . . 2.1099999999999999 110.966 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.64 39.51 34.41 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.639 -0.663 . . . . 2.0299999999999998 113.095 -168.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -91.03 -169.88 2.49 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.083 -1.08 . . . . 2.4700000000000002 108.083 140.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.82 142.05 29.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.157 1.383 . . . . 4.0599999999999996 109.844 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.61 102.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.276 1.43 . . . . 1.3300000000000001 109.461 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.497 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 3.6 mm-40 -55.52 130.6 43.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.516 -1.22 . . . . 3.1499999999999999 109.743 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.865 HD21 ' HB1' ' A' ' 35' ' ' ALA . 7.2 tt -156.34 131.67 9.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.369 1.08 . . . . 2.0899999999999999 111.171 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.77 93.9 8.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.582 2.353 . . . . 2.2799999999999998 110.454 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.83 123.07 19.97 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.402 -0.962 . . . . 1.3600000000000001 108.402 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.75 128.81 45.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.78 1.232 . . . . 0.72999999999999998 110.006 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -129.09 119.2 23.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.279 0.844 . . . . 2.0699999999999998 113.279 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 23.12 44.98 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.2 3.0 . . . . 2.02 115.911 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.39 -56.07 1.57 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.616 1.579 . . . . 3.1299999999999999 113.382 -171.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.89 0.14 58.53 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.685 -1.619 . . . . 2.0600000000000001 116.909 -164.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 150.21 45.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.15 1.975 . . . . 3.9399999999999999 111.421 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.03 139.54 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.046 1.738 . . . . 1.1100000000000001 109.091 165.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.95 104.51 7.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.433 1.093 . . . . 1.6599999999999999 110.015 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 8.9 ttpp -72.6 88.81 1.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.07 1.348 . . . . 2.79 110.213 172.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.3 m -114.23 140.25 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.142 1.377 . . . . 2.5899999999999999 111.166 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -100.73 133.18 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.968 1.707 . . . . 2.2200000000000002 110.92 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.64 149.91 73.37 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.861 1.265 . . . . 2.75 111.28 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.12 151.79 83.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.941 2.427 . . . . 1.3899999999999999 113.389 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.9 t -83.43 134.8 26.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.135 1.374 . . . . 1.48 109.087 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -137.36 157.73 45.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.102 0.961 . . . . 3.4199999999999999 109.936 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.16 112.87 25.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.91 0.884 . . . . 2.2200000000000002 111.049 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.074 1.35 . . . . 5.3300000000000001 111.317 174.41 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 108.903 -0.777 . . . . 5.5599999999999996 108.903 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.69 44.25 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 115.601 1.0 . . . . 1.0800000000000001 115.601 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -153.15 150.47 29.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.651 1.98 . . . . 1.3600000000000001 111.44 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -114.41 134.89 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.799 -0.815 . . . . 1.0600000000000001 108.799 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -73.75 126.7 30.94 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.086 0.773 . . . . 3.9399999999999999 113.086 -167.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -74.66 128.75 36.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.133 0.968 . . . . 3.04 111.004 157.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -159.35 138.14 7.93 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.281 1.432 . . . . 2.3900000000000001 110.199 164.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -83.42 73.27 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 124.159 3.24 . . . . 2.6400000000000001 109.658 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.58 176.91 24.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.147 0.88 . . . . 1.4299999999999999 114.068 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.32 -4.64 15.31 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.26 3.307 . . . . 2.0699999999999998 112.934 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -140.67 164.27 30.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.518 1.127 . . . . 3.6099999999999999 112.657 170.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.36 165.26 33.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.23 1.812 . . . . 1.3 110.227 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.73 154.79 20.99 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.66 0.784 . . . . 1.21 111.735 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.15 136.94 54.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.693 0.797 . . . . 1.0600000000000001 111.89 164.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -133.15 128.72 36.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.522 1.529 . . . . 2.0600000000000001 110.922 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -166.08 159.19 15.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.709 1.374 . . . . 1.77 114.709 -167.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -80.33 140.68 36.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.088 0.955 . . . . 1.3899999999999999 109.793 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.24 126.1 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.173 1.389 . . . . 2.2799999999999998 107.759 170.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -151.9 148.42 27.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.216 0.607 . . . . 4.1799999999999997 112.235 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -109.87 109.65 59.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.45 1.1 . . . . 1.02 111.842 -164.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.39 -11.12 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.35 2.033 . . . . 1.22 113.466 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.11 53.74 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.227 1.394 . . . . 1.1399999999999999 114.251 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.4 -36.03 63.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.144 2.178 . . . . 6.1299999999999999 112.626 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -102.39 163.42 17.7 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.479 1.911 . . . . 1.8600000000000001 111.531 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.07 159.02 23.81 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.001 2.467 . . . . 1.04 112.371 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.2 mt -103.3 145.54 29.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.695 1.198 . . . . 2.0499999999999998 110.423 171.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -129.78 105.31 7.94 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.832 1.253 . . . . 3.8300000000000001 108.24 167.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.3 tp -79.87 104.77 10.67 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.961 2.104 . . . . 0.67000000000000004 108.352 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -95.45 -14.92 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.916 0.886 . . . . 0.48999999999999999 112.412 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.41 -163.8 33.89 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 123.775 0.702 . . . . 0.52000000000000002 112.735 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.4 177.5 9.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.147 0.979 . . . . 0.84999999999999998 110.924 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -146.44 124.19 11.89 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.034 -1.469 . . . . 6.46 107.034 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -142.34 149.83 52.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 117.688 -1.149 . . . . 0.80000000000000004 110.087 -170.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.32 -3.34 12.98 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.517 2.145 . . . . 1.0600000000000001 113.463 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.46 -4.91 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 115.641 1.719 . . . . 1.0900000000000001 115.641 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.16 144.52 50.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.681 1.192 . . . . 1.1200000000000001 110.943 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -84.08 -75.99 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.679 -0.86 . . . . 3.6600000000000001 108.679 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -91.29 126.72 36.46 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.386 -0.821 . . . . 4.0300000000000002 108.789 165.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.26 138.38 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.442 1.497 . . . . 1.2 109.916 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -136.65 136.78 39.41 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.424 1.889 . . . . 2.3100000000000001 109.358 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.63 124.66 33.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 121.154 1.797 . . . . 0.72999999999999998 111.073 165.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.3 m170 -108.03 153.36 23.22 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.709 1.604 . . . . 0.82999999999999996 113.617 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.25 -179.42 3.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.572 2.749 . . . . 2.29 110.758 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.4 m -128.98 107.99 10.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.117 -1.438 . . . . 1.22 107.117 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -91.23 161.76 14.92 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 122.013 0.911 . . . . 2.21 111.686 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.5 mtm -118.67 168.01 11.12 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.09 -0.959 . . . . 3.2999999999999998 110.902 156.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -176.53 163.63 2.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.335 2.654 . . . . 6.3099999999999996 109.7 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.09 147.51 22.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.586 -0.894 . . . . 3.73 108.586 165.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 p -114.24 -15.52 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 113.858 1.059 . . . . 3.4900000000000002 113.858 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.89 25.84 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.424 2.29 . . . . 4.1299999999999999 109.046 -162.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.69 -20.98 1.64 Allowed Glycine 0 N--CA 1.477 1.375 0 O-C-N 119.392 -2.067 . . . . 2.1699999999999999 113.183 -159.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.8 135.24 35.47 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.655 1.582 . . . . 4.0800000000000001 109.882 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -76.19 138.62 40.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.298 1.039 . . . . 4.5300000000000002 111.855 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -134.27 150.49 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.415 2.286 . . . . 1.8999999999999999 108.97 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.9 ttp -123.46 144.25 49.63 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.557 1.943 . . . . 5.1100000000000003 109.505 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.96 163.8 31.53 Favored Glycine 0 N--CA 1.469 0.838 0 CA-C-N 118.724 0.693 . . . . 1.04 113.236 173.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.68 159.88 14.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.33 1.052 . . . . 1.9199999999999999 111.281 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 -173.21 140.33 0.89 Allowed Pre-proline 0 N--CA 1.475 0.776 0 CA-C-O 116.954 -1.498 . . . . 4.4400000000000004 111.402 -168.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 17.0 Cg_endo -71.09 147.49 54.48 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.927 1.751 . . . . 0.84999999999999998 112.559 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.61 151.4 67.41 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.415 1.486 . . . . 0.79000000000000004 110.48 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.34 -8.82 24.18 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.055 2.503 . . . . 0.87 113.447 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -174.6 159.21 2.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.765 1.626 . . . . 2.54 111.097 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mt -108.85 172.8 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.31 1.444 . . . . 1.1100000000000001 108.98 149.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.34 163.36 37.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.231 -0.918 . . . . 2.79 112.604 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -151.15 131.34 7.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.134 0.974 . . . . 0.91000000000000003 109.806 -168.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 164.49 35.53 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.296 1.998 . . . . 1.05 111.291 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.87 133.04 42.54 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.306 2.671 . . . . 1.05 110.61 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 72.06 0.34 3.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 127.489 2.316 . . . . 1.7 113.788 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.67 157.5 34.37 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 126.545 2.021 . . . . 1.3200000000000001 111.031 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -132.54 144.36 50.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 127.346 2.258 . . . . 4.4199999999999999 110.418 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.84 163.94 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.676 1.991 . . . . 1.8300000000000001 108.762 167.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -139.1 115.02 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.921 -0.77 . . . . 3.1899999999999999 108.921 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.37 91.17 1.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.576 . . . . 1.2 108.781 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -110.1 151.23 42.39 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.525 2.33 . . . . 3.1200000000000001 111.784 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.04 -53.89 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.274 3.316 . . . . 1.0600000000000001 113.949 -168.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.93 93.71 1.77 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 108.413 -1.875 . . . . 1.29 108.413 164.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -85.0 0.14 Allowed Glycine 0 C--O 1.222 -0.614 0 C-N-CA 124.794 1.188 . . . . 0.85999999999999999 112.698 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -155.95 145.87 21.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.579 1.952 . . . . 2.4700000000000002 110.09 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -174.09 157.49 2.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.088 0.955 . . . . 1.46 108.823 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -85.68 139.17 31.6 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 119.813 -0.755 . . . . 2.0099999999999998 109.893 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 mmt -92.42 118.94 31.46 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.419 1.087 . . . . 1.1699999999999999 109.021 161.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.7 mt -100.05 114.86 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.943 1.697 . . . . 1.78 106.793 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.5 150.78 26.96 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.365 1.066 . . . . 3.1000000000000001 110.741 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.19 -55.49 4.59 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 125.235 1.398 . . . . 3.6899999999999999 111.761 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt 69.9 125.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.775 3.23 . . . . 1.0900000000000001 111.581 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -80.9 22.99 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.263 -1.523 . . . . 1.8100000000000001 113.074 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 160.6 153.41 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 129.816 3.246 . . . . 3.8900000000000001 109.219 -163.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.52 131.87 31.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.234 -1.871 . . . . 1.4099999999999999 107.234 151.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.1 101.52 0.41 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.928 0.891 . . . . 2.1099999999999999 110.18 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.84 97.3 1.38 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.729 -1.232 . . . . 4.0099999999999998 109.843 -172.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -44.64 124.63 4.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.123 0.969 . . . . 1.8899999999999999 111.3 172.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.5 30.46 66.65 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.013 -0.882 . . . . 1.97 114.165 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -101.45 -172.08 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.599 1.699 . . . . 3.5499999999999998 107.519 136.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -132.21 151.36 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.832 0.853 . . . . 3.5899999999999999 110.525 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.0 t -98.89 113.86 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 124.85 1.26 . . . . 1.1399999999999999 108.916 -172.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.65 138.39 46.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 124.249 0.968 . . . . 3.7599999999999998 109.441 164.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mt -155.3 116.17 3.91 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.088 0.955 . . . . 1.5700000000000001 111.091 -168.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.31 104.63 16.59 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.016 2.126 . . . . 2.8199999999999998 109.468 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 48.0 mt -75.89 126.34 30.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 1.1200000000000001 110.194 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.0 mt -97.51 121.41 39.38 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.354 1.062 . . . . 0.71999999999999997 110.638 -175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.99 119.32 31.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.856 0.836 . . . . 2.04 112.732 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.1 28.23 0.9 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.01 2.124 . . . . 2.0099999999999998 114.208 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.99 -60.07 2.2 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.707 1.622 . . . . 3.54 112.692 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.87 -7.5 86.35 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.26 1.264 . . . . 1.6100000000000001 116.26 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.39 145.38 43.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.214 2.007 . . . . 4.46 110.194 166.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -147.68 135.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.021 1.328 . . . . 1.05 108.829 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -144.17 127.8 17.11 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.324 1.45 . . . . 1.8500000000000001 108.756 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -91.01 147.18 23.26 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.421 1.637 . . . . 2.8999999999999999 115.421 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.29 164.66 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.965 2.506 . . . . 1.21 109.466 171.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.5 132.83 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.104 0.962 . . . . 2.0600000000000001 109.181 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -145.14 145.28 26.35 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.967 1.707 . . . . 2.4500000000000002 109.537 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 153.35 67.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.372 3.381 . . . . 1.0 114.431 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.62 127.17 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.056 0.942 . . . . 1.1699999999999999 109.007 167.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -147.25 153.85 40.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.315 1.446 . . . . 3.4700000000000002 111.351 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.21 47.56 0.96 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.347 1.459 . . . . 2.04 114.155 -161.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.934 -1.508 . . . . 5.8099999999999996 112.46 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 114.915 1.45 . . . . 6.9199999999999999 114.915 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.34 46.8 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.694 2.093 . . . . 1.05 111.683 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.21 152.7 11.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.237 1.199 . . . . 1.4199999999999999 114.237 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.45 128.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.163 1.385 . . . . 1.45 109.12 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.2 117.74 29.88 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.748 0.647 . . . . 4.7800000000000002 112.748 -166.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.5 142.13 58.53 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.244 2.218 . . . . 4.6399999999999997 113.865 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -159.13 167.61 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 120.109 -1.62 . . . . 2.23 111.448 158.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.29 -15.68 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.121 3.214 . . . . 3.1499999999999999 112.453 166.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 155.14 40.42 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 119.29 -0.728 . . . . 1.3600000000000001 112.042 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.37 -8.7 23.89 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.075 3.183 . . . . 1.8 114.373 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.87 146.97 35.55 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.005 1.322 . . . . 3.0499999999999998 111.676 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.91 -176.03 5.74 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.072 1.749 . . . . 1.25 112.952 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.0 154.85 50.29 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.449 1.1 . . . . 1.1399999999999999 111.831 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.18 147.88 44.28 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.265 1.031 . . . . 0.94999999999999996 111.637 166.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.1 146.52 39.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.128 1.771 . . . . 1.8999999999999999 108.753 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.1 153.79 14.33 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.926 0.713 . . . . 1.73 112.926 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.1 m -72.57 110.61 7.07 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.629 1.572 . . . . 1.24 108.259 159.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.07 127.81 34.14 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.159 -1.423 . . . . 2.5499999999999998 107.159 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.68 114.49 20.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 4.4100000000000001 110.522 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -102.66 103.68 33.92 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.141 -0.974 . . . . 0.92000000000000004 110.686 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.13 -7.92 11.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.91 2.407 . . . . 1.0800000000000001 113.236 172.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.14 171.18 55.19 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 119.109 0.868 . . . . 0.98999999999999999 113.7 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -101.57 0.16 35.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.367 1.867 . . . . 2.7000000000000002 113.032 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.96 159.06 39.06 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.723 1.609 . . . . 1.8600000000000001 110.451 167.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.23 154.37 18.95 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.043 2.495 . . . . 1.0600000000000001 111.142 -173.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -101.65 150.63 22.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.258 1.023 . . . . 2.3300000000000001 110.482 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -133.7 103.06 5.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.526 1.131 . . . . 3.1099999999999999 109.409 171.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 tp -84.14 104.83 14.52 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.366 2.267 . . . . 0.82999999999999996 108.97 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.64 -12.93 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.154 0.982 . . . . 0.63 113.001 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.26 -169.35 41.89 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 124.448 1.023 . . . . 0.59999999999999998 111.76 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -158.17 -178.39 7.26 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.113 0.965 . . . . 0.88 111.508 173.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 10.4 mmt180 -158.32 149.92 21.27 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 121.509 1.959 . . . . 6.8499999999999996 109.126 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -154.28 152.13 25.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.019 1.327 . . . . 0.95999999999999996 108.243 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.87 -25.14 60.35 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.661 2.241 . . . . 0.84999999999999998 113.418 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -79.59 -4.18 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.889 1.44 . . . . 0.90000000000000002 114.889 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.38 174.56 12.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.948 1.299 . . . . 0.95999999999999996 112.476 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -116.56 -87.97 0.6 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.84 0.856 . . . . 4.3200000000000003 110.17 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -69.35 107.05 3.14 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.511 -0.743 . . . . 4.8899999999999997 109.71 -171.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -84.16 141.29 14.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.227 2.211 . . . . 2.0 110.571 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -146.72 124.2 11.7 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 2.71 109.999 166.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.429 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.2 tt -81.84 115.36 21.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.184 0.993 . . . . 0.96999999999999997 110.326 169.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.0 m170 -100.23 151.69 21.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.737 1.615 . . . . 0.87 111.881 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.8 177.82 5.65 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.038 -1.437 . . . . 1.99 110.689 165.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.573 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 87.5 m -147.94 102.76 3.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.24 1.416 . . . . 1.2 107.195 171.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -112.76 153.07 28.35 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.817 1.247 . . . . 2.5499999999999998 112.523 -166.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -105.5 121.72 44.52 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.487 0.66 . . . . 3.3700000000000001 109.598 156.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -144.91 170.01 16.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.311 1.844 . . . . 7.8799999999999999 109.107 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.25 143.95 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.351 0.66 . . . . 4.2699999999999996 109.927 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.12 -87.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 3.71 108.408 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -77.4 50.99 0.83 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.436 1.895 . . . . 2.96 110.404 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.1 -31.93 0.42 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 126.601 2.048 . . . . 3.48 115.077 -175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.82 146.63 24.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.584 1.953 . . . . 2.79 111.37 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -68.44 118.76 11.92 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 118.845 -0.598 . . . . 5.1600000000000001 109.47 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.83 147.78 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 3.3100000000000001 111.305 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.4 mmt -77.79 141.03 39.47 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.982 1.313 . . . . 3.4300000000000002 113.671 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.56 27.81 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.058 0.837 . . . . 1.25 114.13 170.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -114.63 137.42 51.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.604 1.562 . . . . 1.8200000000000001 110.346 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -148.21 155.71 43.14 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.913 1.285 . . . . 7.04 109.955 165.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 38.6 Cg_endo -65.52 145.63 82.87 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.073 2.515 . . . . 0.68999999999999995 110.953 167.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.83 159.06 33.13 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 125.338 1.455 . . . . 0.72999999999999998 109.855 166.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.0 -15.14 32.48 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.625 2.217 . . . . 0.69999999999999996 113.243 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -175.74 160.77 2.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.042 1.737 . . . . 2.1200000000000001 111.02 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mt -109.87 175.94 5.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.827 1.651 . . . . 1.2 109.517 154.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.52 168.26 26.75 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.363 -0.835 . . . . 2.4199999999999999 112.116 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -149.82 136.46 10.83 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.442 1.097 . . . . 0.85999999999999999 109.527 -170.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -72.25 168.0 25.33 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.405 2.07 . . . . 0.84999999999999998 112.048 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.54 145.28 99.06 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.789 2.993 . . . . 0.91000000000000003 111.915 168.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.24 0.9 0.46 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.865 2.172 . . . . 1.78 116.865 -172.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 114.03 3.79 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 127.147 2.308 . . . . 0.87 111.95 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -81.9 139.26 34.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.997 -1.101 . . . . 5.4500000000000002 109.243 151.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 m -151.36 130.51 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.657 1.583 . . . . 1.78 110.084 169.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -90.41 130.39 36.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.629 -0.669 . . . . 3.3100000000000001 111.407 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -69.81 129.17 38.84 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.364 -0.976 . . . . 1.76 108.364 161.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -143.28 140.73 18.05 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.576 1.55 . . . . 2.9500000000000002 110.865 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.7 -16.75 47.08 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.702 2.935 . . . . 1.8100000000000001 114.278 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.98 100.0 1.79 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.24 -1.944 . . . . 1.3700000000000001 108.24 152.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.573 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 142.66 -85.33 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.847 1.689 . . . . 1.3600000000000001 113.089 -172.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.71 144.2 20.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.067 1.747 . . . . 1.8899999999999999 111.22 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.92 158.02 27.47 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.256 -0.903 . . . . 1.0900000000000001 110.74 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 45' ' ' LEU . 49.0 m-85 -94.28 133.05 38.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.074 0.397 . . . . 1.95 110.814 170.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.2 mmt -90.62 137.18 32.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.394 1.478 . . . . 0.93000000000000005 109.906 162.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.82 126.58 45.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.503 1.521 . . . . 2.9100000000000001 108.653 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.42 147.49 52.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.233 1.413 . . . . 3.2799999999999998 110.526 -175.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 57.95 4.6 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.236 -0.746 . . . . 1.3799999999999999 111.236 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.09 120.51 12.81 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.48 0.64 . . . . 0.87 110.938 -174.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -76.23 -9.78 58.9 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.873 1.064 . . . . 2.1600000000000001 113.873 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.98 145.08 0.74 Allowed Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 127.065 2.146 . . . . 4.5199999999999996 110.152 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.37 154.15 65.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.906 2.404 . . . . 2.1299999999999999 109.885 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.71 162.03 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.044 1.338 . . . . 2.7999999999999998 111.329 -170.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -114.71 127.05 55.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.265 1.026 . . . . 5.0 111.222 172.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.34 117.48 4.87 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.906 -0.588 . . . . 1.8400000000000001 109.747 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.13 -8.46 31.18 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.21 -1.328 . . . . 2.6000000000000001 114.683 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.34 161.2 26.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 119.637 1.718 . . . . 2.79 109.955 162.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -111.01 156.93 20.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.636 -0.711 . . . . 5.3300000000000001 109.484 154.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.55 125.14 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.854 1.662 . . . . 1.55 108.473 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -74.58 145.85 43.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.481 0.658 . . . . 3.9100000000000001 110.379 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.627 HD21 ' HB1' ' A' ' 35' ' ' ALA . 3.6 tt -154.96 126.7 7.51 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.141 0.977 . . . . 1.8700000000000001 110.643 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.43 109.92 21.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.121 2.568 . . . . 2.48 112.068 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 119.03 23.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.216 1.406 . . . . 1.1399999999999999 110.321 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.0 mt -89.95 111.15 22.13 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.802 0.841 . . . . 0.69999999999999996 109.56 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 76.6 m-85 -111.98 124.08 51.64 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.707 -0.621 . . . . 2.2599999999999998 109.836 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.87 37.49 1.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.123 1.769 . . . . 2.3199999999999998 113.263 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -73.23 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.722 1.153 . . . . 4.6200000000000001 112.091 -171.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.63 -30.2 60.33 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 115.739 1.055 . . . . 2.46 115.739 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 54.1 tttp -83.91 86.45 7.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 119.946 1.873 . . . . 6.3899999999999997 108.51 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -100.86 106.93 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.042 1.337 . . . . 1.6699999999999999 109.549 173.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.16 125.81 44.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.771 1.629 . . . . 3.1200000000000001 110.654 -173.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -83.14 139.04 33.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.479 1.659 . . . . 2.7999999999999998 115.479 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.81 169.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.399 1.88 . . . . 1.3400000000000001 109.32 159.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.6 139.23 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.386 1.474 . . . . 1.98 108.346 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -146.03 145.86 26.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.303 1.441 . . . . 1.71 110.798 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.18 158.37 55.01 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 124.274 3.316 . . . . 0.97999999999999998 113.948 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.44 134.55 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.313 1.445 . . . . 1.4399999999999999 111.577 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -152.41 -172.18 4.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.878 2.071 . . . . 4.0800000000000001 109.429 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.47 124.98 35.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.964 -1.085 . . . . 2.71 110.886 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 125.357 1.463 . . . . 8.4000000000000004 112.798 -163.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 109.655 -0.498 . . . . 4.8700000000000001 109.655 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.08 175.81 19.37 Favored Glycine 0 N--CA 1.466 0.655 0 O-C-N 121.48 -0.762 . . . . 1.03 114.631 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -159.86 146.01 15.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.943 1.697 . . . . 1.3 110.572 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.92 138.93 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.436 -0.95 . . . . 1.04 108.436 170.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -86.73 131.76 34.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.544 0.688 . . . . 4.5800000000000001 112.176 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -53.26 119.52 4.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.741 1.616 . . . . 3.9399999999999999 112.587 164.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -165.29 99.03 0.8 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.699 2.0 . . . . 3.1200000000000001 107.522 163.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.66 44.21 1.45 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.459 2.773 . . . . 2.8199999999999998 111.964 -168.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.94 -147.78 6.47 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.304 0.954 . . . . 1.9399999999999999 114.138 -167.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.32 -7.04 17.73 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.299 2.666 . . . . 1.7 112.798 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -154.25 156.89 37.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 2.3100000000000001 112.829 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.2 -165.36 1.9 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.387 2.675 . . . . 1.4199999999999999 110.448 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.04 154.39 39.24 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.261 -0.899 . . . . 1.3700000000000001 111.798 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.81 125.46 46.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.919 0.888 . . . . 1.24 110.405 165.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -103.11 147.4 27.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.985 1.714 . . . . 2.0299999999999998 108.75 168.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -163.45 141.88 7.94 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.275 1.213 . . . . 1.47 114.275 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.1 m -66.82 107.61 2.24 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.277 -1.008 . . . . 1.4299999999999999 108.277 161.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 134.36 36.42 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 106.944 -1.502 . . . . 2.7000000000000002 106.944 165.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.28 151.56 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.35 1.071 . . . . 3.4700000000000002 112.01 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -128.29 99.37 24.51 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.52 1.528 . . . . 0.98999999999999999 109.073 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -6.27 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.49 2.127 . . . . 1.01 112.841 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.51 174.03 54.17 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.282 0.944 . . . . 0.88 113.994 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.11 -3.79 26.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.507 1.923 . . . . 2.71 113.441 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.34 161.0 33.74 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.107 1.763 . . . . 1.6599999999999999 109.98 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.65 162.76 24.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.058 2.506 . . . . 0.93000000000000005 111.978 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.26 144.92 40.87 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.252 1.021 . . . . 1.8100000000000001 110.593 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -122.67 114.19 20.25 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.896 1.278 . . . . 3.0899999999999999 109.27 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.54 117.23 29.79 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.04 2.136 . . . . 0.67000000000000004 109.151 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -117.69 -4.9 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.405 1.082 . . . . 0.78000000000000003 112.938 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.71 -174.6 47.01 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.698 1.142 . . . . 0.68000000000000005 111.18 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.972 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -148.06 178.92 8.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.242 1.417 . . . . 0.73999999999999999 109.891 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.497 HH11 ' HG3' ' A' ' 36' ' ' ARG . 12.8 tpt85 -161.28 147.86 14.62 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 106.664 -1.606 . . . . 6.0099999999999998 106.664 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.416 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 2.5 t -149.7 157.8 38.09 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 124.6 1.16 . . . . 0.88 109.172 -166.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.05 -15.79 16.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.11 1.873 . . . . 1.29 114.351 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.44 HG12 ' HE ' ' A' ' 91' ' ' ARG . 4.7 m -101.16 2.46 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 116.025 1.861 . . . . 0.93000000000000005 116.025 -170.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 164.05 38.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.416 1.007 . . . . 1.02 113.019 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.34 -79.67 0.54 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.731 2.012 . . . . 2.8399999999999999 111.314 -170.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 111.37 9.88 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.412 -0.958 . . . . 3.8900000000000001 108.412 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -84.15 139.62 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.435 -1.257 . . . . 1.99 110.428 158.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -142.24 122.46 13.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.597 1.159 . . . . 2.0 109.042 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -79.01 118.74 21.29 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.627 1.558 . . . . 1.03 110.713 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -113.36 157.28 22.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 0.55000000000000004 111.869 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -112.34 167.45 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.396 1.478 . . . . 2.2000000000000002 110.372 166.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -123.26 114.79 20.7 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.741 1.616 . . . . 1.26 107.453 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -120.7 152.91 37.64 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.924 0.89 . . . . 2.3300000000000001 112.809 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtp -103.03 142.78 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.82 1.648 . . . . 3.7200000000000002 110.325 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -157.8 144.83 18.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.097 1.359 . . . . 6.6500000000000004 111.503 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 137.95 31.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.284 0.493 . . . . 4.1900000000000004 111.104 166.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -146.71 126.33 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.732 1.613 . . . . 3.7200000000000002 107.324 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 63.33 20.35 12.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.589 1.156 . . . . 3.2400000000000002 111.963 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.17 -9.14 41.45 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.761 1.172 . . . . 2.3999999999999999 113.829 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -89.2 143.86 26.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.978 1.711 . . . . 3.3199999999999998 109.927 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -81.7 118.86 23.17 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.61 -0.681 . . . . 4.0199999999999996 110.875 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.03 150.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.239 1.816 . . . . 1.53 109.717 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtm -135.24 144.65 46.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.771 1.228 . . . . 3.27 110.676 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 177.58 32.38 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 123.773 0.702 . . . . 1.45 113.037 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -115.7 151.23 35.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.958 1.303 . . . . 1.8799999999999999 110.495 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -164.43 147.65 7.59 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.29 1.036 . . . . 5.6200000000000001 112.4 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.6 Cg_endo -70.82 153.18 64.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.229 1.953 . . . . 0.58999999999999997 112.512 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.95 159.02 70.8 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 126.438 1.895 . . . . 0.68000000000000005 110.408 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.96 -16.83 36.85 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.421 2.081 . . . . 0.72999999999999998 113.342 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -179.97 172.08 1.08 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 125.424 1.49 . . . . 2.0499999999999998 111.253 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.2 173.0 7.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.611 2.365 . . . . 1.0600000000000001 109.072 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.25 166.47 33.08 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.058 -1.026 . . . . 2.29 111.747 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.2 t -150.41 137.16 11.23 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.117 1.367 . . . . 0.81000000000000005 109.471 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.76 171.36 15.7 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.908 2.405 . . . . 0.97999999999999998 112.315 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.35 142.04 94.54 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.1 2.533 . . . . 0.82999999999999996 111.491 166.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt 65.34 2.54 1.97 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.834 1.653 . . . . 1.4099999999999999 113.387 -174.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.49 121.98 5.79 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 127.451 2.453 . . . . 1.1399999999999999 110.242 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -113.91 131.72 56.19 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.045 1.738 . . . . 6.0300000000000002 109.51 167.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 m -159.55 134.36 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.065 1.346 . . . . 1.77 111.083 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -79.53 134.6 36.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.24 1.019 . . . . 3.7400000000000002 112.824 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.03 69.62 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.874 1.321 . . . . 1.3799999999999999 108.517 143.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 78' ' ' LYS . 2.4 ptmm? -83.14 149.35 58.58 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 128.682 2.793 . . . . 2.8799999999999999 110.832 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -54.46 -37.99 89.71 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.22 2.613 . . . . 1.1899999999999999 113.552 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.63 65.09 3.37 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.078 0.854 . . . . 1.8300000000000001 111.022 168.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.39 -81.46 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.081 1.324 . . . . 1.23 113.391 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -153.33 152.18 30.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.383 1.873 . . . . 2.1000000000000001 110.19 -164.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -164.87 165.14 20.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.37 1.068 . . . . 0.93999999999999995 110.002 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 67.5 m-85 -95.89 123.6 39.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.42 -1.326 . . . . 2.3100000000000001 107.42 160.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.97 129.91 34.87 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.491 -1.3 . . . . 1.21 107.491 163.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.56 123.38 49.32 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.864 -0.791 . . . . 3.27 108.864 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.93 132.55 55.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.143 1.777 . . . . 3.1299999999999999 109.056 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.17 96.07 0.2 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.288 -1.125 . . . . 1.45 110.288 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 mt -100.7 128.59 46.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.715 0.758 . . . . 1.03 111.57 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -79.76 -18.95 49.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.273 1.429 . . . . 1.76 112.815 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.44 ' HE ' HG12 ' A' ' 39' ' ' VAL . 14.2 ptt180 -156.77 145.13 14.46 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.633 1.573 . . . . 5.6799999999999997 110.307 167.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.87 145.3 56.08 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.944 2.43 . . . . 1.4299999999999999 110.097 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.97 82.0 6.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.465 1.126 . . . . 2.3799999999999999 110.993 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 133.8 54.6 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.962 1.705 . . . . 3.6200000000000001 109.518 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.0 135.72 52.39 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.57 -1.331 . . . . 1.9099999999999999 111.93 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.99 53.78 21.11 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.72 -0.552 . . . . 2.3700000000000001 111.72 -171.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -117.98 165.73 13.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.167 1.387 . . . . 2.8500000000000001 110.761 163.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 154.29 20.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.212 1.405 . . . . 5.1699999999999999 109.518 164.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.3 t -140.89 105.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.854 1.662 . . . . 1.26 109.05 166.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -65.64 142.35 58.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.663 0.744 . . . . 4.1799999999999997 110.209 163.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.972 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.3 tt -140.63 129.96 23.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.977 0.894 . . . . 1.8999999999999999 111.13 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -86.59 101.81 13.57 Favored 'General case' 0 CA--C 1.552 1.047 1 C-N-CA 132.536 4.334 . . . . 2.9199999999999999 111.436 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.7 mt -82.41 122.56 28.16 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.931 -1.731 . . . . 1.1499999999999999 111.055 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.17 123.07 43.18 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.737 0.815 . . . . 0.78000000000000003 110.542 -171.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.5 153.05 35.93 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.694 0.759 . . . . 1.8 111.996 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.39 134.39 56.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.862 0.465 . . . . 2.3999999999999999 110.672 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.7 10.45 52.94 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.848 1.099 . . . . 3.9300000000000002 115.848 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.25 6.77 83.91 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 119.119 1.46 . . . . 2.1200000000000001 114.184 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -76.24 131.84 39.53 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.362 -1.081 . . . . 6.0700000000000003 109.714 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.81 140.17 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.277 1.031 . . . . 1.27 110.2 166.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.9 mt -141.05 123.38 15.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.138 1.375 . . . . 1.8500000000000001 108.931 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -92.0 145.71 24.31 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.539 0.94 . . . . 2.4700000000000002 113.539 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.14 149.28 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.78 2.032 . . . . 1.9099999999999999 111.093 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.96 135.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.45 1.5 . . . . 3.6499999999999999 111.167 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -144.71 85.19 8.58 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.83 1.652 . . . . 2.1400000000000001 110.649 -166.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.66 154.56 59.33 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.249 2.633 . . . . 1.27 112.462 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.9 t -84.35 134.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.867 0.867 . . . . 1.3899999999999999 111.384 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.98 157.49 40.65 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.096 1.358 . . . . 3.8700000000000001 111.136 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 11.99 4.72 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.832 1.653 . . . . 2.6699999999999999 113.948 171.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.233 0 CA-C-O 114.545 -2.645 . . . . 5.5099999999999998 115.704 -174.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.69 0.281 . . . . 6.9199999999999999 111.673 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.14 149.84 18.04 Favored Glycine 0 N--CA 1.465 0.6 0 O-C-N 120.879 -1.138 . . . . 1.4099999999999999 112.969 162.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.409 ' HE1' ' HB2' ' A' ' 120' ' ' ARG . 16.0 p90 -153.55 151.48 29.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.476 0.917 . . . . 1.8200000000000001 113.476 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.7 t -110.76 144.12 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 1.22 110.525 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -87.79 113.76 23.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.234 1.198 . . . . 3.7400000000000002 114.234 -156.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -63.48 123.03 17.73 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.585 -0.697 . . . . 3.25 111.906 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -159.36 147.85 13.83 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 2.48 110.348 166.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.39 63.31 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.089 3.192 . . . . 2.5 109.61 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.99 168.5 13.72 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.263 0.935 . . . . 1.6100000000000001 113.908 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.15 -15.47 14.49 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.819 3.013 . . . . 1.5 112.001 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -144.86 158.97 43.61 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.369 1.867 . . . . 1.95 111.605 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.55 -177.17 6.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.852 1.261 . . . . 1.1899999999999999 111.05 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.31 149.45 30.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.626 1.17 . . . . 1.1699999999999999 110.916 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.65 128.89 55.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.45 -0.574 . . . . 1.24 109.45 160.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.17 162.93 14.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.524 1.93 . . . . 2.0299999999999998 109.98 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.1 pt? -161.38 140.87 10.3 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.792 1.405 . . . . 1.4399999999999999 114.792 166.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -79.12 137.44 37.48 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.55 -1.278 . . . . 1.3 107.55 151.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.36 135.71 13.21 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.615 1.166 . . . . 2.9300000000000002 109.995 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.2 142.75 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.307 1.043 . . . . 3.23 113.177 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -82.17 114.21 49.29 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.592 -1.185 . . . . 0.85999999999999999 109.321 152.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -83.45 -9.64 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.166 2.578 . . . . 1.1299999999999999 113.386 174.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.93 170.48 47.67 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.752 1.167 . . . . 0.82999999999999996 113.645 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.87 -7.14 44.03 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.287 1.835 . . . . 2.73 112.826 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.8 159.8 35.96 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.23 1.812 . . . . 1.6100000000000001 110.436 171.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.73 158.63 28.14 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.778 2.319 . . . . 0.87 111.793 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.67 140.14 43.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.499 1.52 . . . . 2.0800000000000001 109.64 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.64 112.13 15.77 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.237 1.015 . . . . 3.8399999999999999 109.958 171.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.13 114.94 26.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.101 2.16 . . . . 0.59999999999999998 109.025 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -107.06 -10.1 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.797 1.239 . . . . 0.46999999999999997 113.091 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.3 -167.59 40.02 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.993 1.282 . . . . 0.46000000000000002 110.962 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.09 176.85 11.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.041 0.936 . . . . 0.77000000000000002 111.127 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -146.72 121.63 9.98 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.84 0.856 . . . . 7.8300000000000001 110.631 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.27 148.55 70.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 124.922 1.289 . . . . 0.68999999999999995 108.79 -173.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.14 -1.0 10.31 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.472 2.115 . . . . 0.81000000000000005 114.15 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.37 -0.43 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.882 1.808 . . . . 1.0600000000000001 115.882 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.72 168.21 21.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.236 1.834 . . . . 1.1299999999999999 114.738 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -104.94 -93.4 0.36 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.976 1.37 . . . . 3.1200000000000001 110.365 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -84.63 83.86 7.87 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.632 -1.293 . . . . 4.7699999999999996 109.541 -165.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.67 131.21 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.572 2.349 . . . . 1.6899999999999999 112.127 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -140.58 132.05 26.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.942 1.697 . . . . 2.6400000000000001 110.458 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 121.73 26.84 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.199 1.363 . . . . 0.68000000000000005 111.131 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -110.7 152.42 26.57 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.217 2.207 . . . . 0.66000000000000003 113.165 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.92 137.44 32.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.719 1.608 . . . . 2.3500000000000001 109.172 155.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -101.35 146.01 28.14 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.025 -1.843 . . . . 2.3599999999999999 106.025 161.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -156.79 172.22 19.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.874 1.435 . . . . 3.0499999999999998 114.874 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.1 mtm -118.99 127.48 53.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.917 1.287 . . . . 6.7800000000000002 108.269 148.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -146.75 170.18 17.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.353 1.861 . . . . 9.6199999999999992 110.054 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -102.72 156.3 17.73 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.817 0.847 . . . . 4.7400000000000002 112.316 -167.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.28 -96.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 3.4500000000000002 108.377 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -76.38 42.51 0.28 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.466 2.306 . . . . 3.7200000000000002 110.53 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.17 -15.25 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 119.816 -1.802 . . . . 2.29 114.098 -169.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -81.17 131.97 35.33 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.812 -1.405 . . . . 4.0199999999999996 110.85 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 57' ' ' LYS . 1.3 ptmm? -83.05 90.6 7.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.62 1.168 . . . . 7.0599999999999996 112.172 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.07 148.23 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.467 1.507 . . . . 3.0099999999999998 111.466 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.47 156.82 17.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.381 1.252 . . . . 6.5999999999999996 114.381 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.51 -165.21 35.94 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.759 1.647 . . . . 2.25 111.168 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -153.1 158.74 42.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 3.21 112.115 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -153.6 141.26 13.62 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 6.4000000000000004 111.281 -170.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.26 147.17 77.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.599 2.199 . . . . 0.89000000000000001 112.377 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.15 157.16 61.72 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 126.706 2.002 . . . . 0.66000000000000003 110.593 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.11 -13.49 36.4 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.854 2.369 . . . . 0.91000000000000003 113.489 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.5 p90 179.04 168.52 0.95 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.937 1.695 . . . . 1.8799999999999999 110.328 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -113.92 174.41 5.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.664 1.586 . . . . 1.0 109.428 152.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.05 163.26 36.82 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.456 -0.777 . . . . 2.3599999999999999 111.066 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.72 124.78 8.78 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 1.21 107.873 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.45 161.03 46.82 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.784 1.656 . . . . 1.04 110.679 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.86 138.39 78.79 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.423 2.749 . . . . 0.83999999999999997 110.972 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 68.67 -0.29 2.37 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.373 1.869 . . . . 1.6699999999999999 113.863 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.42 116.52 4.35 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 126.1 1.809 . . . . 0.96999999999999997 112.026 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -77.42 131.92 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.178 -1.011 . . . . 4.71 109.994 156.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.01 175.88 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.875 2.07 . . . . 1.6799999999999999 110.25 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -137.89 114.3 10.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.065 0.946 . . . . 4.2699999999999996 110.502 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 85.37 0.43 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.923 -1.51 . . . . 1.53 106.923 157.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 152.8 37.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.578 . . . . 3.7000000000000002 112.901 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.91 -41.22 48.21 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.735 2.956 . . . . 1.6200000000000001 113.836 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.57 40.57 2.62 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.592 -1.115 . . . . 1.3500000000000001 113.987 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.27 -61.1 0.02 OUTLIER Glycine 0 N--CA 1.472 1.054 0 CA-C-N 118.826 1.313 . . . . 1.22 115.439 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -153.38 145.96 24.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.303 1.441 . . . . 2.2400000000000002 111.06 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -165.29 173.45 11.22 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.774 -1.204 . . . . 0.96999999999999997 110.402 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.83 129.35 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.837 -0.602 . . . . 2.0600000000000001 109.659 165.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.5 mmt -80.11 121.73 25.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.431 -0.581 . . . . 0.91000000000000003 109.431 163.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.4 mt -107.74 86.34 2.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.373 1.469 . . . . 1.53 109.555 -176.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.05 142.11 29.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.993 0.917 . . . . 2.8700000000000001 109.629 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.22 60.23 4.22 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.861 0.743 . . . . 1.45 112.033 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.69 124.82 22.42 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.829 0.852 . . . . 1.0800000000000001 112.805 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -81.29 -0.03 39.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.659 1.183 . . . . 2.9399999999999999 113.588 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.14 150.31 0.61 Allowed Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 128.85 2.86 . . . . 6.04 109.486 177.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.39 149.76 75.37 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.488 2.125 . . . . 2.3500000000000001 110.233 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.57 108.79 14.5 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.458 -1.312 . . . . 2.52 107.458 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.48 119.37 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.785 -1.197 . . . . 3.4700000000000002 111.368 -170.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.51 113.65 1.88 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.963 -1.125 . . . . 1.71 107.963 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.29 -18.69 4.94 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 116.802 -2.11 . . . . 2.23 115.506 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.65 162.07 35.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.584 2.192 . . . . 3.8599999999999999 113.961 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -79.74 137.06 36.91 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.269 1.827 . . . . 4.3899999999999997 111.507 163.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.14 126.99 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 124.976 1.311 . . . . 0.88 109.41 160.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -71.2 141.39 50.65 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.955 -0.566 . . . . 3.1600000000000001 110.45 162.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mt -156.35 121.74 4.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.977 0.911 . . . . 1.3799999999999999 112.287 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.56 101.37 11.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.567 2.347 . . . . 2.2200000000000002 110.713 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.0 mt -76.37 115.71 16.37 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.102 1.761 . . . . 1.0700000000000001 110.121 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -85.34 124.47 31.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.864 0.866 . . . . 0.69999999999999996 110.601 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 87.6 m-85 -121.71 126.02 47.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.239 0.616 . . . . 2.02 111.655 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.32 18.89 0.99 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.427 1.64 . . . . 2.8300000000000001 115.427 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.44 68.83 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.315 1.436 . . . . 4.8799999999999999 116.036 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -139.53 -26.52 0.26 Allowed Glycine 0 N--CA 1.477 1.387 0 CA-C-N 119.337 1.568 . . . . 2.54 116.592 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -88.17 141.6 28.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.325 1.563 . . . . 6.4199999999999999 109.409 172.419 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 p -142.39 161.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.633 -0.667 . . . . 1.05 111.573 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.09 124.38 14.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.959 1.704 . . . . 2.71 110.276 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -71.71 116.59 12.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.298 -0.63 . . . . 2.79 109.298 161.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.65 153.94 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 124.514 1.126 . . . . 1.1399999999999999 108.948 158.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.99 137.25 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.439 -1.319 . . . . 2.6800000000000002 107.439 161.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.5 mt -139.63 130.13 14.34 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.198 -1.382 . . . . 1.8899999999999999 109.205 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -60.75 151.18 78.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.621 2.881 . . . . 1.3600000000000001 112.286 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.8 t -78.16 136.02 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.572 -0.705 . . . . 1.77 109.401 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.49 151.52 35.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.59 1.156 . . . . 3.5899999999999999 109.379 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.47 55.31 0.72 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.963 1.305 . . . . 2.3500000000000001 112.357 -158.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HB2' ' HE1' ' A' ' 7' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 125.3 1.44 . . . . 5.04 108.555 172.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 120.873 0.368 . . . . 5.2599999999999998 111.7 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.71 164.39 27.75 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.147 1.356 . . . . 1.27 114.15 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -161.23 154.42 21.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.205 1.402 . . . . 1.8200000000000001 112.956 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -103.92 130.98 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.651 1.18 . . . . 1.04 108.951 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -77.86 116.19 18.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.338 0.255 . . . . 3.7000000000000002 110.725 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -52.7 119.43 4.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.846 0.858 . . . . 2.3199999999999998 112.072 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 m -168.67 112.67 0.55 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.805 2.042 . . . . 2.0699999999999998 107.001 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.81 50.69 2.64 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.623 2.882 . . . . 3.4399999999999999 110.398 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -177.65 31.6 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.179 0.895 . . . . 1.8799999999999999 114.638 -167.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -66.26 -16.46 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.926 2.418 . . . . 1.6100000000000001 111.746 166.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -155.22 157.4 37.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.092 1.757 . . . . 2.7000000000000002 110.678 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.01 -174.88 5.15 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 1.1799999999999999 111.049 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.8 146.5 37.7 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.356 0.873 . . . . 1.03 113.356 -170.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.97 146.38 49.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.134 0.974 . . . . 0.85999999999999999 112.562 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -128.63 150.4 50.24 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.012 2.525 . . . . 2.2999999999999998 109.237 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.01 137.05 9.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 115.606 1.706 . . . . 2.1899999999999999 115.606 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.9 m -85.55 124.78 32.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 114.749 -1.114 . . . . 1.4099999999999999 108.932 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.02 137.23 51.98 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 127.153 2.181 . . . . 2.5099999999999998 107.814 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.14 143.17 31.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.665 0.745 . . . . 3.0899999999999999 111.027 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -111.73 105.54 56.62 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.062 -0.972 . . . . 1.28 109.154 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.47 -5.28 10.1 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.839 2.359 . . . . 1.4199999999999999 113.826 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.6 -174.35 38.41 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 124.387 0.994 . . . . 1.26 113.259 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -106.87 9.08 30.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.589 1.556 . . . . 2.3999999999999999 113.426 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.47 157.97 57.5 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.774 1.63 . . . . 2.2200000000000002 110.666 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.19 157.21 13.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.26 2.64 . . . . 1.7 112.592 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.7 112.44 17.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.99 1.716 . . . . 2.5 110.042 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -109.01 101.26 10.35 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.199 1.399 . . . . 4.1299999999999999 112.747 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 tp -80.55 106.55 12.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.306 2.242 . . . . 0.97999999999999998 109.636 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.11 -14.53 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.309 1.443 . . . . 0.68999999999999995 113.058 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.18 -162.19 30.94 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.251 0.929 . . . . 0.69999999999999996 111.618 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.817 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.59 -170.67 3.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.693 0.797 . . . . 1.1000000000000001 111.209 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -167.44 134.75 2.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.463 -0.939 . . . . 6.3600000000000003 108.463 165.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t -136.09 143.32 43.53 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-O 117.544 -1.217 . . . . 0.72999999999999998 108.83 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.16 -20.0 56.56 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.646 2.231 . . . . 1.04 113.145 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -77.22 3.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 113.263 0.838 . . . . 1.1000000000000001 113.263 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.2 -163.79 1.87 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.19 1.552 . . . . 1.3999999999999999 115.19 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.84 -88.99 0.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.703 1.601 . . . . 3.5699999999999998 109.598 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -78.95 158.99 27.9 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.696 1.599 . . . . 6.7000000000000002 111.099 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.06 73.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 124.816 2.246 . . . . 2.0 109.315 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -96.36 120.22 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 111.997 -2.365 . . . . 4.5199999999999996 110.163 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.48 121.93 25.81 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.884 0.849 . . . . 0.66000000000000003 111.509 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -107.69 155.83 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.805 2.042 . . . . 0.97999999999999998 112.006 173.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 12.0 pt-20 -104.78 177.91 4.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.369 -1.287 . . . . 2.9500000000000002 110.891 157.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -150.61 115.93 5.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.282 1.833 . . . . 1.3100000000000001 107.38 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.57 178.71 6.79 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.388 1.475 . . . . 2.6299999999999999 111.587 -162.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.7 ptp -119.57 151.15 39.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.649 1.18 . . . . 3.4300000000000002 111.623 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -154.44 158.95 40.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.817 1.247 . . . . 7.54 112.243 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.5 137.61 38.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.011 0.925 . . . . 4.0300000000000002 109.81 163.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.7 t -118.22 -93.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.434 1.494 . . . . 3.0299999999999998 109.221 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -77.92 39.07 0.28 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.126 2.17 . . . . 3.6099999999999999 110.931 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.22 -6.13 16.49 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 119.815 -1.803 . . . . 1.9099999999999999 113.825 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -107.1 155.68 19.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.132 2.173 . . . . 3.8999999999999999 110.595 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.61 140.82 29.48 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.889 1.07 . . . . 4.0300000000000002 113.889 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 t -143.25 157.89 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.794 2.037 . . . . 2.04 108.293 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.4 ptp -74.18 173.23 10.43 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.489 0.716 . . . . 4.4900000000000002 112.712 170.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.13 153.99 25.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.633 1.111 . . . . 1.28 111.254 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -124.4 143.01 50.85 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.147 1.379 . . . . 1.79 108.576 171.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.429 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -163.34 145.28 7.7 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 118.089 -0.958 . . . . 6.21 112.058 -178.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 49.8 Cg_endo -66.96 150.6 82.91 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.881 2.387 . . . . 0.92000000000000004 110.703 172.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.96 156.37 74.26 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.358 1.463 . . . . 0.57999999999999996 109.976 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.88 -22.69 42.18 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.422 2.082 . . . . 0.66000000000000003 112.417 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -175.2 165.06 3.35 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 125.433 1.493 . . . . 1.8200000000000001 111.729 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.99 171.87 7.27 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.565 1.546 . . . . 0.96999999999999997 109.437 153.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.74 163.6 39.74 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.271 -0.893 . . . . 3.1899999999999999 113.292 165.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.67 129.36 22.69 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 126.093 1.757 . . . . 1.24 109.133 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.64 161.46 43.92 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.483 2.122 . . . . 1.28 111.076 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.12 140.74 91.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.559 2.839 . . . . 1.49 112.251 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp 68.1 -0.24 2.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.711 2.005 . . . . 1.8799999999999999 113.983 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.32 156.8 28.53 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 127.075 2.274 . . . . 1.1899999999999999 112.066 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtt85 -119.88 155.62 32.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.765 2.026 . . . . 6.0499999999999998 111.51 168.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.99 159.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.911 1.684 . . . . 1.3899999999999999 110.256 164.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.27 109.69 12.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.457 1.503 . . . . 4.1799999999999997 107.74 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.09 83.36 0.51 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.245 1.418 . . . . 1.3 109.361 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.55 156.96 36.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.645 1.578 . . . . 3.8700000000000001 112.717 -172.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -59.72 -29.84 90.65 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.116 2.544 . . . . 0.96999999999999997 114.118 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.98 49.57 3.33 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.997 -0.89 . . . . 1.27 111.814 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.88 -71.11 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 115.558 0.983 . . . . 0.91000000000000003 115.558 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -157.63 143.79 17.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.014 2.125 . . . . 1.9299999999999999 110.485 -165.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -168.81 174.26 6.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.235 0.925 . . . . 0.70999999999999996 112.285 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 48.0 m-85 -104.28 136.96 42.9 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.408 0.683 . . . . 2.1899999999999999 111.64 169.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -96.25 121.3 37.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.653 1.181 . . . . 1.1899999999999999 110.029 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.12 108.61 21.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.825 0.85 . . . . 2.6200000000000001 109.809 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.72 65.81 1.03 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.481 1.112 . . . . 2.8799999999999999 110.529 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.82 113.82 1.54 Allowed Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.621 1.582 . . . . 2.0600000000000001 111.229 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -103.34 154.61 19.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.863 1.265 . . . . 1.51 111.195 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -125.38 -26.74 3.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.411 1.485 . . . . 2.3100000000000001 112.371 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -118.14 132.01 23.93 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-O 118.205 -0.902 . . . . 4.8799999999999999 109.077 161.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.17 124.39 11.28 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.939 -1.985 . . . . 1.5700000000000001 106.939 159.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.82 121.94 16.18 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.037 1.335 . . . . 1.9199999999999999 111.089 -161.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -88.29 131.49 34.77 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.743 -1.223 . . . . 4.7199999999999998 109.874 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 119.49 5.89 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.847 -1.168 . . . . 2.02 107.847 153.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.88 -1.6 56.66 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 118.434 -1.203 . . . . 2.6299999999999999 115.158 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.05 151.53 20.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.444 1.622 . . . . 3.1600000000000001 110.532 157.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -112.52 124.97 53.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.417 2.287 . . . . 5.9800000000000004 105.441 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.41 102.88 13.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.827 1.251 . . . . 1.04 108.548 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.64 145.08 50.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.035 -0.53 . . . . 2.8199999999999998 110.5 163.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.817 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.9 tt -158.84 132.81 7.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 2.04 110.409 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.31 112.35 24.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.809 2.043 . . . . 2.2599999999999998 110.141 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.93 118.1 18.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.151 1.38 . . . . 1.6599999999999999 109.987 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.64 117.06 24.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.324 -0.621 . . . . 0.98999999999999999 109.324 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -116.37 121.47 42.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.152 0.797 . . . . 2.4100000000000001 113.152 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.84 28.37 0.13 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.681 2.393 . . . . 2.54 115.867 170.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.47 -61.85 3.87 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.902 1.239 . . . . 3.7000000000000002 112.519 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.51 2.54 29.85 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.99 1.556 . . . . 1.9099999999999999 116.99 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -142.64 148.89 38.17 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.414 1.607 . . . . 5.0099999999999998 112.3 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.62 139.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.851 1.66 . . . . 1.72 109.165 162.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -145.23 135.35 23.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.658 1.183 . . . . 2.5600000000000001 111.01 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -77.22 132.64 38.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.4 0.518 . . . . 2.3700000000000001 112.4 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.8 -179.77 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.45 1.9 . . . . 1.5600000000000001 109.8 159.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.86 148.08 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 127.847 2.459 . . . . 3.1099999999999999 109.461 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -141.77 135.05 14.31 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.29 1.436 . . . . 1.96 110.699 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.68 146.64 43.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.969 2.446 . . . . 1.3400000000000001 112.391 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.1 t -76.84 138.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.597 0.759 . . . . 1.3999999999999999 109.502 165.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -140.45 151.14 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.193 0.597 . . . . 3.2799999999999998 111.386 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.43 60.53 1.17 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.801 1.64 . . . . 2.21 111.41 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG 0.318 2.0 mmp_? . . . . . 0 C--O 1.251 1.146 0 N-CA-C 117.948 2.573 . . . . 5.1500000000000004 117.948 -161.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 110.423 -0.214 . . . . 6.7599999999999998 110.423 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.78 162.31 33.87 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 120.809 -1.182 . . . . 1.01 114.597 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -146.49 146.47 30.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.668 1.187 . . . . 1.6200000000000001 112.721 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.88 141.04 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.099 0.96 . . . . 1.4299999999999999 108.853 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -77.16 -13.61 59.92 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.677 1.362 . . . . 4.5 114.677 -161.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.8 t80 72.85 147.25 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.077 2.951 . . . . 2.8700000000000001 112.625 -170.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -168.64 140.89 2.26 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.425 1.49 . . . . 3.6299999999999999 111.108 166.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -90.28 -13.19 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.065 3.177 . . . . 3.48 112.43 165.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -101.85 170.19 20.71 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.436 1.493 . . . . 1.75 112.865 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 -16.47 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 124.022 3.148 . . . . 2.2599999999999998 115.397 -166.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.63 141.86 28.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.751 1.159 . . . . 3.0299999999999998 111.458 163.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.76 179.15 7.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.788 1.635 . . . . 1.49 111.625 164.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.28 153.61 51.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.264 1.426 . . . . 1.1399999999999999 110.017 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.49 142.63 50.0 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.121 . . . . 0.95999999999999996 112.21 168.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.45 147.82 41.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 2.1099999999999999 110.55 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -164.36 149.79 10.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.009 0.923 . . . . 1.5700000000000001 112.582 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -81.63 117.57 22.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.895 0.878 . . . . 1.3799999999999999 108.838 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -89.93 135.46 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.162 0.585 . . . . 3.52 110.477 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -124.15 167.69 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.052 1.341 . . . . 3.0299999999999998 109.507 173.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.71 104.71 6.93 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 123.8 0.84 . . . . 1.1699999999999999 109.914 162.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.95 -10.04 10.55 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.993 2.462 . . . . 1.6000000000000001 113.168 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.35 156.79 39.73 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 124.155 0.884 . . . . 1.1399999999999999 112.461 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.06 5.94 38.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.869 1.668 . . . . 2.75 113.391 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.22 158.71 45.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.096 1.758 . . . . 1.78 110.285 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.02 159.53 30.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.164 2.576 . . . . 0.93000000000000005 111.748 -170.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.02 129.22 50.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.999 1.32 . . . . 2.3599999999999999 110.099 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -120.7 112.0 18.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.391 1.476 . . . . 3.02 110.287 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -91.84 123.06 34.94 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.407 1.883 . . . . 0.80000000000000004 108.946 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.93 -11.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.419 1.087 . . . . 0.66000000000000003 113.312 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.42 -161.68 30.82 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.144 0.878 . . . . 0.59999999999999998 111.07 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -154.83 -178.78 7.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.836 1.254 . . . . 0.76000000000000001 110.179 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -152.75 150.74 29.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.612 1.096 . . . . 5.5999999999999996 108.749 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -141.26 146.29 42.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 117.683 -1.151 . . . . 0.88 108.636 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.12 -19.39 66.29 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.106 1.871 . . . . 0.84999999999999998 112.47 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m -82.94 -3.76 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.221 1.193 . . . . 0.92000000000000004 114.221 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.43 177.97 9.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.856 1.207 . . . . 0.84999999999999998 113.688 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -118.9 -87.67 0.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.132 1.373 . . . . 3.2799999999999998 110.421 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -78.74 103.98 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.653 -1.279 . . . . 3.5299999999999998 109.05 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.91 145.41 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.588 1.155 . . . . 1.96 110.931 161.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -143.99 123.52 13.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.773 1.229 . . . . 2.3300000000000001 109.663 164.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.438 HD12 ' CE1' ' A' ' 84' ' ' PHE . 7.0 tt -84.86 120.79 26.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.54 1.518 . . . . 0.72999999999999998 110.997 168.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.3 m170 -107.41 151.88 24.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.535 1.534 . . . . 0.67000000000000004 112.856 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -86.23 166.46 15.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.262 2.225 . . . . 2.4500000000000002 110.801 163.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -150.21 126.79 10.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.387 1.475 . . . . 1.1000000000000001 108.26 170.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -149.34 156.88 42.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.571 0.952 . . . . 2.3799999999999999 113.571 -155.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.8 mtm -107.48 62.22 0.62 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.869 1.668 . . . . 4.4400000000000004 111.981 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -79.42 156.13 28.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.948 -1.023 . . . . 7.4800000000000004 111.121 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.02 164.8 25.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.161 -1.051 . . . . 5.9900000000000002 108.161 158.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.3 t -156.89 -39.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.848 2.059 . . . . 4.0700000000000003 110.986 -164.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -159.09 41.34 0.22 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.115 2.966 . . . . 5.0599999999999996 108.003 -173.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.47 -19.23 0.08 OUTLIER Glycine 0 N--CA 1.479 1.558 0 C-N-CA 128.487 2.946 . . . . 2.04 114.899 -164.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -83.04 134.82 35.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.347 1.459 . . . . 5.4100000000000001 109.804 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -88.93 120.16 30.1 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.507 -0.746 . . . . 4.4400000000000004 110.879 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.88 141.74 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.37 1.468 . . . . 1.76 110.002 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 97.14 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.42 1.088 . . . . 4.2800000000000002 109.753 165.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.75 168.31 12.75 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.462 1.03 . . . . 1.25 112.797 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.56 153.6 47.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.492 1.517 . . . . 2.1800000000000002 110.885 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -161.67 152.41 14.94 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 126.558 1.943 . . . . 6.0800000000000001 110.481 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 39.8 Cg_endo -66.61 143.69 69.47 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.413 2.075 . . . . 0.54000000000000004 111.653 165.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -113.06 157.64 40.18 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.105 1.762 . . . . 0.56999999999999995 110.862 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.33 -14.43 31.18 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.768 2.312 . . . . 0.58999999999999997 113.646 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.92 165.45 1.56 Allowed 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.265 1.826 . . . . 2.2400000000000002 109.914 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.69 167.62 10.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.669 1.587 . . . . 1.0600000000000001 109.359 155.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.94 163.84 31.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.702 1.001 . . . . 2.0800000000000001 113.702 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 139.84 14.53 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.632 1.573 . . . . 1.3500000000000001 109.164 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.63 169.55 14.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.401 2.067 . . . . 1.1000000000000001 111.153 168.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.22 148.58 92.49 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.757 2.305 . . . . 0.93000000000000005 111.869 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt 68.86 -0.62 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.789 2.036 . . . . 1.6399999999999999 114.027 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.83 -168.86 44.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.706 2.098 . . . . 1.45 114.939 -171.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -168.08 144.45 3.96 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.122 2.169 . . . . 5.6200000000000001 110.606 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.4 m -152.14 136.83 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.955 2.102 . . . . 2.0099999999999998 109.241 171.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -88.92 136.5 32.98 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.272 -0.893 . . . . 3.4399999999999999 110.867 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.36 72.72 0.96 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.508 1.147 . . . . 1.1799999999999999 108.444 156.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -85.43 145.9 43.36 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.477 1.911 . . . . 2.7200000000000002 111.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -58.88 -23.54 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.823 2.349 . . . . 1.4299999999999999 113.805 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.29 35.99 4.51 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.926 1.251 . . . . 1.5700000000000001 113.617 171.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.37 -65.01 0.02 OUTLIER Glycine 0 N--CA 1.47 0.956 0 CA-C-N 118.399 1.099 . . . . 0.82999999999999996 115.349 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -150.98 149.13 29.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.176 1.39 . . . . 1.99 111.251 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -157.21 160.6 38.86 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.606 -1.309 . . . . 0.81000000000000005 111.44 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 41.0 m-85 -96.1 120.58 36.63 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.584 -0.525 . . . . 1.9299999999999999 109.584 164.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.82 136.32 33.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.113 0.965 . . . . 1.1599999999999999 108.811 167.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.2 103.88 8.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.394 1.078 . . . . 1.6100000000000001 108.893 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.36 120.0 41.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.496 1.118 . . . . 3.1200000000000001 109.888 -173.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.03 97.43 0.62 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.069 1.318 . . . . 1.53 109.972 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -94.38 122.8 37.31 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.28 1.04 . . . . 1.0900000000000001 110.74 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -71.01 -12.89 61.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.948 0.722 . . . . 1.96 112.948 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 21.2 ptt85 -153.33 139.56 12.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.001 1.72 . . . . 5.9800000000000004 109.868 168.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 145.39 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.175 2.583 . . . . 1.9199999999999999 109.358 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.4 mt -92.3 167.04 12.28 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.045 0.938 . . . . 2.3599999999999999 113.044 -169.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 3.6 mmtm -123.0 156.8 34.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.342 1.457 . . . . 5.4000000000000004 109.143 156.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 131.45 50.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.141 -0.689 . . . . 2.04 109.141 161.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.96 2.54 77.93 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 117.349 -1.806 . . . . 2.3599999999999999 116.48 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 90.4 mt-10 -76.29 167.4 21.92 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.404 2.102 . . . . 3.3399999999999999 110.364 169.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -85.6 154.08 21.96 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.023 1.329 . . . . 5.4500000000000002 112.183 165.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.0 t -130.14 116.91 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.25 1.82 . . . . 1.02 109.414 163.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -71.1 140.21 50.57 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.455 -1.248 . . . . 3.7799999999999998 109.804 161.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 132.21 14.44 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.907 0.706 . . . . 1.75 112.907 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.95 132.54 33.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.396 0.678 . . . . 2.3999999999999999 109.533 159.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.16 118.19 31.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.994 1.318 . . . . 1.3100000000000001 109.569 158.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.2 mt -95.05 131.38 41.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.417 1.087 . . . . 0.81999999999999995 111.643 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -120.27 159.5 24.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.339 1.056 . . . . 2.1099999999999999 112.418 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.86 118.31 7.04 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.255 0.835 . . . . 1.96 113.255 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.18 -147.84 29.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.048 0.832 . . . . 2.9500000000000002 111.364 -173.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.57 56.09 4.71 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-O 119.175 -0.792 . . . . 1.8899999999999999 114.365 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -131.81 137.92 48.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.335 1.568 . . . . 4.9100000000000001 110.675 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.11 145.09 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.44 1.496 . . . . 1.48 108.915 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.0 mt -127.53 110.2 12.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.715 1.206 . . . . 2.3399999999999999 109.908 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.63 105.86 11.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.343 0.657 . . . . 4.2699999999999996 109.851 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m -105.82 -175.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.358 2.263 . . . . 1.1799999999999999 111.199 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.3 143.82 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.25 1.42 . . . . 2.1499999999999999 109.072 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.7 mt -136.14 154.6 77.49 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.072 1.749 . . . . 1.74 109.813 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.44 154.53 27.9 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.352 2.701 . . . . 0.98999999999999999 111.272 161.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.0 t -85.89 142.12 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.359 1.863 . . . . 1.3600000000000001 108.368 159.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -122.7 -145.18 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.995 2.118 . . . . 3.4399999999999999 108.101 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.5 113.14 3.6 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 121.059 1.754 . . . . 1.99 111.592 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 C-N-CA 127.819 2.448 . . . . 4.4900000000000002 110.813 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 110.042 -0.355 . . . . 6.4500000000000002 110.042 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.14 169.49 34.92 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.634 0.635 . . . . 1.8200000000000001 114.132 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.402 ' CD1' ' HG3' ' A' ' 120' ' ' ARG . 44.6 p90 -155.91 152.36 28.18 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.677 0.791 . . . . 2.75 110.818 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -117.46 148.59 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.071 0.948 . . . . 1.04 110.23 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.23 111.24 22.83 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.869 -1.144 . . . . 3.9199999999999999 113.629 -152.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -66.28 104.82 1.27 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 3.23 111.158 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -155.79 130.57 5.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 117.559 -1.21 . . . . 2.4700000000000002 109.913 158.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.27 75.12 5.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.818 3.012 . . . . 2.9500000000000002 110.303 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.55 168.11 13.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.796 1.188 . . . . 2.1000000000000001 112.982 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.87 -31.97 46.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.423 2.082 . . . . 2.2799999999999998 110.541 167.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -113.2 152.93 29.12 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.537 1.935 . . . . 2.6899999999999999 111.932 162.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.78 -158.1 0.88 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.651 2.38 . . . . 1.23 108.116 168.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.67 160.15 40.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.321 1.419 . . . . 1.5600000000000001 113.682 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.54 149.88 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.791 1.636 . . . . 1.3700000000000001 110.54 164.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.4 175.21 9.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.543 1.537 . . . . 2.4500000000000002 110.796 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -175.01 148.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.21 1.404 . . . . 1.99 112.358 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.3 m -116.6 122.41 44.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.613 -1.625 . . . . 2.1800000000000002 106.613 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.33 139.33 11.87 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.673 0.789 . . . . 4.2000000000000002 110.392 -158.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 1.4 pm0 -109.2 147.86 31.87 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.833 1.653 . . . . 2.79 113.822 175.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -85.56 112.6 45.61 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 114.109 -1.405 . . . . 0.80000000000000004 109.646 154.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.42 -10.26 12.23 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.099 2.533 . . . . 1.1299999999999999 113.534 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.86 -179.55 53.04 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.19 0.9 . . . . 0.91000000000000003 113.767 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -109.97 -4.23 16.05 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.955 1.702 . . . . 2.5499999999999998 113.011 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.77 159.25 34.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.832 1.653 . . . . 1.9099999999999999 110.031 165.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.88 152.53 16.88 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.089 2.526 . . . . 1.4399999999999999 111.543 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.87 157.62 15.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.414 1.085 . . . . 1.8500000000000001 111.247 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.457 ' HE ' ' HB3' ' A' ' 106' ' ' ALA . 44.0 ttp180 -142.09 109.05 5.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.299 1.44 . . . . 4.6399999999999997 110.476 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.6 tp -95.98 113.98 25.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.449 2.3 . . . . 0.71999999999999997 109.696 -168.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.06 -12.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.977 1.311 . . . . 1.3 113.166 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.26 -158.7 28.44 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 121.303 -0.873 . . . . 0.53000000000000003 113.394 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.06 -177.56 5.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.106 0.962 . . . . 0.95999999999999996 111.106 166.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -142.76 136.23 28.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.555 1.142 . . . . 8.1400000000000006 108.491 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -141.14 147.61 48.11 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.225 1.41 . . . . 0.87 108.938 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.55 -23.19 32.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.628 1.552 . . . . 1.24 112.855 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.14 5.39 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 115.378 1.621 . . . . 1.0600000000000001 115.378 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.97 44.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.193 1.36 . . . . 1.4199999999999999 113.2 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.82 -50.56 72.88 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.841 1.656 . . . . 6.5599999999999996 109.528 165.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -144.45 155.19 43.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.764 1.626 . . . . 4.4199999999999999 109.122 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.85 128.92 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 125.202 1.401 . . . . 1.22 108.482 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -130.2 124.62 32.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.954 1.702 . . . . 2.0800000000000001 108.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -80.12 119.82 23.43 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.254 1.388 . . . . 0.82999999999999996 110.998 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.5 m170 -108.76 157.3 18.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.985 1.714 . . . . 0.83999999999999997 111.948 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -111.1 -177.64 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.943 1.697 . . . . 2.4399999999999999 111.75 171.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.5 m -123.22 120.94 34.64 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.22 -1.03 . . . . 1.4199999999999999 108.22 156.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -100.41 165.47 11.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.782 1.233 . . . . 2.3100000000000001 111.248 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtm -129.42 134.7 47.98 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.536 1.134 . . . . 3.7999999999999998 109.234 163.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.9 146.16 24.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.724 1.21 . . . . 7.0800000000000001 110.696 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.08 136.81 41.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.91 0.386 . . . . 3.5699999999999998 110.965 175.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.07 -95.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.308 -1.367 . . . . 2.46 107.308 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -79.36 74.93 5.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.498 1.119 . . . . 4.1799999999999997 108.51 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.03 -11.68 0.04 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 128.874 3.13 . . . . 2.0499999999999998 118.022 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -124.25 153.5 41.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.489 1.916 . . . . 4.4199999999999999 110.94 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -70.47 97.7 1.33 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.12 0.568 . . . . 4.3099999999999996 112.105 -179.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -79.83 132.61 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 125.265 1.426 . . . . 1.48 107.864 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.5 ptp -91.8 145.27 24.71 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.896 0.878 . . . . 3.04 111.183 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.13 166.84 35.87 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 123.908 0.766 . . . . 1.0700000000000001 112.97 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.3 150.82 38.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.59 1.156 . . . . 1.8200000000000001 111.419 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 mtp85 -163.74 155.65 14.78 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.423 1.489 . . . . 7.1500000000000004 111.388 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 17.9 Cg_endo -64.93 143.38 79.16 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.597 2.198 . . . . 0.88 110.898 169.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.5 155.29 54.35 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.928 1.691 . . . . 0.69999999999999996 110.543 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.36 -23.85 32.15 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.674 2.249 . . . . 0.82999999999999996 112.617 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -173.71 168.81 4.33 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.239 1.416 . . . . 1.72 111.059 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -119.76 174.47 6.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.279 2.232 . . . . 1.0800000000000001 109.334 162.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.34 168.57 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.399 -0.813 . . . . 3.2200000000000002 111.251 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 t -147.36 129.58 7.62 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 125.202 1.401 . . . . 1.1200000000000001 108.647 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.37 163.69 35.73 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.185 1.924 . . . . 1.3200000000000001 111.942 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.19 139.34 71.8 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.917 3.078 . . . . 1.05 111.945 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.29 17.97 5.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 116.063 1.875 . . . . 2.0 116.063 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.23 116.82 5.46 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 128.151 2.786 . . . . 0.98999999999999999 111.984 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 2.0 ttm-85 -90.4 130.96 36.42 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 5.3700000000000001 111.738 163.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.4 m -121.32 171.32 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 2.0899999999999999 111.545 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -148.28 125.5 11.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.14 1.376 . . . . 4.6799999999999997 110.685 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -82.51 153.63 25.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.526 1.155 . . . . 1.8500000000000001 110.836 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 7.3 ptpt -170.65 149.26 2.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.006 1.723 . . . . 4.0 111.817 -165.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -49.44 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.118 2.545 . . . . 2.0899999999999999 111.293 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 96.42 0.91 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 107.625 -2.19 . . . . 2.3500000000000001 107.625 156.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.76 -155.73 17.15 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.745 2.116 . . . . 2.8300000000000001 112.034 -163.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -92.42 140.01 30.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.822 1.249 . . . . 2.3999999999999999 112.204 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -161.19 154.14 21.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.482 0.713 . . . . 0.78000000000000003 109.484 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -94.58 120.39 34.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.629 -0.878 . . . . 1.98 108.629 173.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -68.75 130.5 43.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.152 -0.684 . . . . 1.0900000000000001 109.152 165.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -106.03 118.99 38.03 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.017 -1.105 . . . . 1.99 108.017 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.24 152.4 24.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 3.0499999999999998 109.834 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.82 67.6 2.02 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 124.652 1.12 . . . . 1.7 112.72 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.91 111.14 2.7 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.904 1.075 . . . . 1.26 113.904 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -80.38 -25.19 39.27 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.999 1.32 . . . . 1.9299999999999999 112.505 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -119.78 126.65 26.81 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 106.044 -1.835 . . . . 4.21 106.044 149.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -64.35 136.89 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 N-CA-C 107.167 -1.897 . . . . 1.6899999999999999 107.167 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.71 63.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.776 0.83 . . . . 2.5099999999999998 112.467 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 121.95 7.22 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.705 1.602 . . . . 3.6499999999999999 108.793 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.95 120.74 1.87 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.637 1.108 . . . . 1.47 112.113 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 42.02 47.38 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.491 -0.616 . . . . 2.2799999999999998 114.325 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -76.14 171.7 14.05 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.252 1.526 . . . . 2.7400000000000002 108.002 146.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -105.63 150.61 25.28 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.067 1.347 . . . . 4.9800000000000004 107.77 160.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.92 119.22 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.162 0.985 . . . . 1.1299999999999999 110.663 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.82 137.7 40.66 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.153 1.781 . . . . 2.9399999999999999 110.316 165.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mt -155.98 133.48 10.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.043 0.925 . . . . 1.52 111.948 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -115.28 101.67 9.16 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.337 1.455 . . . . 2.0800000000000001 110.799 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 119.86 22.92 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.253 1.421 . . . . 1.4099999999999999 111.032 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.57 123.2 36.72 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.616 1.166 . . . . 0.77000000000000002 111.498 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.15 135.62 53.75 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.045 0.926 . . . . 1.77 112.501 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.457 ' HB3' ' HE ' ' A' ' 31' ' ' ARG . . . -78.45 63.6 3.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.722 1.609 . . . . 2.7599999999999998 112.917 -175.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.42 33.15 0.09 OUTLIER Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.708 2.099 . . . . 4.8399999999999999 113.956 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.61 -0.13 77.66 Favored Glycine 0 N--CA 1.476 1.342 0 CA-C-N 118.284 1.042 . . . . 1.95 114.652 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -97.86 151.1 20.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 122.629 1.204 . . . . 6.5899999999999999 113.856 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.05 151.41 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.991 2.117 . . . . 1.4099999999999999 107.617 154.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.96 119.68 32.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.447 1.099 . . . . 2.25 109.283 167.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -74.31 133.9 42.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.289 0.236 . . . . 2.7799999999999998 110.414 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.26 145.33 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.92 1.688 . . . . 1.48 109.493 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -125.05 125.19 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.666 0.786 . . . . 2.75 110.03 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 155.92 56.03 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.396 1.479 . . . . 3.3399999999999999 111.076 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.54 164.48 32.28 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.735 2.957 . . . . 1.46 111.626 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.39 142.14 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.384 1.074 . . . . 1.1899999999999999 111.823 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -145.66 162.06 38.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.961 1.705 . . . . 3.9900000000000002 113.008 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.59 62.57 2.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.012 1.725 . . . . 2.5 111.987 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 2.8 mmp_? . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.473 -1.727 . . . . 4.4100000000000001 111.315 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.236 0.382 0 CA-C-O 120.892 0.377 . . . . 5.3300000000000001 110.048 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -79.52 157.31 42.07 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 123.377 0.513 . . . . 1.21 112.371 176.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -154.75 139.19 16.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.02 0.748 . . . . 1.3500000000000001 113.02 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.5 t -93.2 132.56 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.606 -0.516 . . . . 1.3 109.606 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -78.22 114.43 17.1 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.325 1.05 . . . . 4.3200000000000003 112.022 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -79.97 146.98 31.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.086 0.946 . . . . 3.8100000000000001 110.469 159.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.44 152.63 4.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.474 1.51 . . . . 2.7200000000000002 110.957 169.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.95 75.55 3.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.076 3.184 . . . . 3.3100000000000001 109.776 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.42 -179.67 34.4 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.671 1.028 . . . . 1.72 115.671 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.66 -15.92 19.07 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.833 3.022 . . . . 2.4399999999999999 112.877 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -147.77 160.54 42.62 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 115.077 1.51 . . . . 2.5800000000000001 115.077 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.83 -168.39 2.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.252 2.221 . . . . 1.22 110.861 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 147.46 32.37 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.235 1.014 . . . . 1.5700000000000001 112.439 -174.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.19 118.45 36.82 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.987 0.358 . . . . 1.6699999999999999 110.232 159.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -101.18 142.57 32.43 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.01 1.724 . . . . 2.5099999999999998 108.547 164.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.403 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.7 pp -164.1 149.64 10.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.167 1.914 . . . . 1.96 116.167 -168.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.3 m -115.08 138.43 50.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.529 1.532 . . . . 2.0099999999999998 109.771 -173.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.11 -179.85 8.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.308 1.843 . . . . 5.2599999999999998 110.444 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.76 159.87 43.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.81 0.844 . . . . 4.9000000000000004 110.106 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.81 102.63 10.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.296 -0.865 . . . . 1.3 109.506 163.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.13 -7.12 17.07 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.875 2.383 . . . . 1.5600000000000001 113.197 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.11 177.36 54.36 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 124.325 0.964 . . . . 1.4099999999999999 113.72 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -107.96 1.6 22.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.346 1.458 . . . . 2.5600000000000001 112.664 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -115.2 162.71 22.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.431 1.893 . . . . 1.8899999999999999 109.616 164.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.14 157.8 20.23 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.685 2.257 . . . . 1.1599999999999999 111.489 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -105.77 153.52 21.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 2.2200000000000002 110.1 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -134.35 115.08 13.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.486 1.115 . . . . 3.6200000000000001 111.229 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.68 112.03 23.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.213 2.605 . . . . 0.63 108.601 -174.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.92 -10.11 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.834 1.254 . . . . 0.65000000000000002 113.316 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.01 -173.95 46.09 Favored Glycine 0 C--N 1.342 0.883 0 O-C-N 121.543 -0.723 . . . . 0.56000000000000005 112.116 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -143.18 178.83 7.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.836 1.254 . . . . 0.95999999999999996 110.306 170.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.35 142.41 3.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.187 -1.042 . . . . 4.9199999999999999 108.187 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -150.78 155.26 35.56 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 117.261 -1.352 . . . . 0.89000000000000001 108.274 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.61 -14.72 41.59 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.171 1.914 . . . . 1.2 114.246 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.63 0.19 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.991 1.849 . . . . 1.1399999999999999 115.991 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.62 144.35 44.02 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 121.261 1.846 . . . . 1.3300000000000001 114.808 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -89.29 -76.37 0.41 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 110.259 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.3 ttm-85 -80.89 127.84 33.0 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.107 -0.995 . . . . 4.2800000000000002 108.803 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.0 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 1.5600000000000001 110.322 167.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -144.59 133.49 22.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.823 1.649 . . . . 2.4300000000000002 110.924 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -79.31 119.25 22.09 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 120.055 1.298 . . . . 0.85999999999999999 111.027 170.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.1 m170 -110.58 156.02 21.52 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.756 2.022 . . . . 0.60999999999999999 111.795 175.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.29 -175.38 2.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.413 . . . . 2.8500000000000001 111.978 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -132.77 118.05 18.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.698 1.599 . . . . 1.47 108.441 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -115.99 179.05 4.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.436 1.094 . . . . 2.0899999999999999 111.098 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.3 ptp -143.21 128.88 19.24 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.549 0.74 . . . . 4.2000000000000002 111.57 162.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -138.27 149.58 45.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.257 1.023 . . . . 6.5700000000000003 112.111 -173.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 52' ' ' GLU 0.33 1.4 pm0 -64.92 146.84 54.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.026 1.731 . . . . 4.7400000000000002 113.792 172.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.69 HG13 ' H ' ' A' ' 54' ' ' GLU 0.29 6.7 p -135.7 -86.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.811 2.044 . . . . 2.8599999999999999 109.198 176.385 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.69 ' H ' HG13 ' A' ' 53' ' ' VAL . 16.2 mt-10 -77.11 41.43 0.29 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.703 2.001 . . . . 3.6899999999999999 110.736 165.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.51 -38.66 0.87 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.152 1.358 . . . . 2.29 113.767 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -61.39 133.8 56.21 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.12 1.368 . . . . 3.04 110.972 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -91.34 103.34 16.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.409 0.683 . . . . 5.7000000000000002 110.884 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -99.21 141.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.028 1.731 . . . . 1.79 109.911 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.43 153.59 29.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.677 1.591 . . . . 3.6800000000000002 112.336 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.72 161.16 33.98 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 121.822 -0.549 . . . . 1.23 114.396 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -113.62 137.03 52.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.449 1.5 . . . . 2.21 111.164 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -150.57 156.64 36.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.359 1.463 . . . . 6.1799999999999997 110.227 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 32.8 Cg_endo -65.92 152.0 82.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.703 2.268 . . . . 0.88 111.641 171.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.78 157.36 69.1 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 126.181 1.792 . . . . 0.73999999999999999 109.659 173.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.14 -18.17 40.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.784 2.322 . . . . 0.95999999999999996 113.237 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -179.15 167.21 1.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.819 2.047 . . . . 2.1099999999999999 110.755 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -113.8 166.73 11.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.975 1.71 . . . . 1.0 109.264 155.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 163.83 39.14 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.115 -0.991 . . . . 2.4500000000000002 111.683 174.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.08 128.77 10.18 Favored Pre-proline 0 N--CA 1.466 0.354 0 C-N-CA 125.073 1.349 . . . . 1.02 109.609 -161.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.53 163.61 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.938 . . . . 0.79000000000000004 111.554 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.38 138.49 84.63 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.516 2.811 . . . . 0.95999999999999996 111.935 172.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm 68.34 7.2 5.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.977 2.111 . . . . 1.6200000000000001 113.456 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.57 113.16 3.62 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.79 1.662 . . . . 0.96999999999999997 112.252 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 136.93 37.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.513 -0.844 . . . . 5.5099999999999998 110.456 165.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.06 159.74 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.319 1.447 . . . . 3.0099999999999998 111.808 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -154.98 92.59 1.46 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.731 1.613 . . . . 3.6699999999999999 108.079 -170.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.67 139.07 57.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.397 1.079 . . . . 2.0600000000000001 108.649 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -158.9 156.52 26.87 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 127.349 2.26 . . . . 3.3799999999999999 111.237 -163.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.2 -64.17 0.1 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.918 3.079 . . . . 1.3899999999999999 112.088 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.19 91.52 1.03 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.022 -1.631 . . . . 1.97 109.022 166.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.33 -98.91 0.18 Allowed Glycine 0 C--O 1.221 -0.664 0 C-N-CA 124.707 1.146 . . . . 1.24 112.424 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -153.58 136.59 15.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.183 1.393 . . . . 2.1600000000000001 110.299 -172.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -165.62 166.71 17.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.267 1.394 . . . . 1.55 110.806 -170.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 92.6 m-85 -102.77 116.19 32.07 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 119.282 -0.39 . . . . 2.2999999999999998 110.18 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -68.31 127.69 33.87 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.663 -0.495 . . . . 0.93000000000000005 109.663 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 mt -112.81 111.01 21.49 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.907 -1.516 . . . . 1.53 106.907 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.47 116.55 25.66 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.66 -0.867 . . . . 3.4700000000000002 108.66 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.82 112.77 0.49 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.09 -1.204 . . . . 1.8799999999999999 110.09 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -110.16 113.94 27.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.162 0.985 . . . . 1.01 111.789 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.95 -11.84 60.97 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.829 1.251 . . . . 1.8700000000000001 114.209 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -153.89 145.73 16.9 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.1 1.36 . . . . 5.7699999999999996 109.998 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.69 132.42 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.202 1.935 . . . . 2.0499999999999998 109.288 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.2 169.18 12.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.819 1.648 . . . . 2.6600000000000001 112.321 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.03 145.04 43.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.213 1.005 . . . . 4.5 110.192 155.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.62 19.95 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.676 -0.861 . . . . 2.0299999999999998 108.676 160.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.39 78.11 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 117.901 -1.499 . . . . 2.71 115.83 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -74.4 175.24 7.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.233 2.016 . . . . 2.3999999999999999 109.449 158.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -91.95 155.85 17.86 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.297 1.046 . . . . 4.4699999999999998 111.387 152.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.02 127.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.93 -1.507 . . . . 1.3400000000000001 106.93 151.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.86 155.18 20.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.953 0.882 . . . . 4.1100000000000003 111.277 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.788 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.8 tt -163.25 129.97 3.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.308 -0.87 . . . . 1.6899999999999999 112.028 -152.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -78.12 105.41 9.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.325 3.05 . . . . 2.6899999999999999 111.494 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.1 mt -79.42 119.4 22.38 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.113 -0.992 . . . . 1.0600000000000001 109.343 171.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.1 mt -96.92 126.07 41.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.565 1.146 . . . . 0.70999999999999996 111.554 -168.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.22 158.27 22.53 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.438 -0.789 . . . . 2.1699999999999999 112.929 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.39 63.7 0.79 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.819 1.648 . . . . 2.04 113.311 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 148.73 -149.65 21.7 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.39 1.472 . . . . 2.79 111.649 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.51 43.83 1.63 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.748 1.166 . . . . 2.0600000000000001 115.038 -173.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -140.6 137.75 33.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.888 1.344 . . . . 5.1100000000000003 113.987 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.75 132.35 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 127.438 2.295 . . . . 1.0600000000000001 108.66 169.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.97 102.22 8.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.229 1.412 . . . . 2.46 109.407 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 74.26 6.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.857 0.863 . . . . 2.7400000000000002 111.157 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.75 159.32 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.037 1.335 . . . . 1.6299999999999999 112.079 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 m -100.25 139.12 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 126.636 1.974 . . . . 3.27 109.602 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.1 mt -143.24 135.46 13.28 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.549 1.14 . . . . 1.8700000000000001 109.18 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.09 162.61 41.58 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.908 2.406 . . . . 1.5700000000000001 111.474 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.36 145.83 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 1.51 111.318 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.77 156.35 44.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.042 1.737 . . . . 3.6800000000000002 109.302 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.73 41.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.45 1.5 . . . . 2.71 113.1 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 117.516 -1.23 . . . . 5.0899999999999999 112.974 -152.639 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.546 0.809 0 CA-C-O 118.272 -0.871 . . . . 5.6500000000000004 109.372 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.72 122.08 1.09 Allowed Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.585 1.539 . . . . 1.75 114.299 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -111.56 149.21 31.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.942 0.897 . . . . 2.1200000000000001 111.145 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.57 140.29 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.712 -0.847 . . . . 1.28 108.712 169.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 117.1 29.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 3.9100000000000001 112.953 -151.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.45 124.66 24.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.676 0.79 . . . . 2.73 110.983 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -160.68 141.03 8.49 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.621 1.169 . . . . 2.3599999999999999 110.273 165.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -83.75 65.98 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.06 3.173 . . . . 2.6200000000000001 109.401 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.76 171.29 14.7 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.385 0.993 . . . . 1.55 113.467 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.05 -20.79 28.38 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.186 2.591 . . . . 2.0299999999999998 111.305 164.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -151.36 169.6 21.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.439 1.896 . . . . 2.3500000000000001 112.315 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.14 157.55 43.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.83 1.652 . . . . 1.24 110.073 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.55 116.24 28.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.399 1.08 . . . . 2.1200000000000001 109.524 167.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.81 162.22 13.36 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.383 1.473 . . . . 1.3200000000000001 111.428 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.44 164.14 28.85 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.265 1.426 . . . . 2.6400000000000001 111.616 -171.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -166.7 159.01 13.56 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.977 1.311 . . . . 1.6200000000000001 113.505 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -80.1 141.4 35.83 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.914 -0.773 . . . . 1.24 108.914 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -130.7 129.98 43.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.26 2.224 . . . . 2.1400000000000001 108.351 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 74' ' ' ARG . 3.4 pm0 -113.9 129.28 56.61 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.335 1.454 . . . . 3.3399999999999999 110.738 171.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -86.68 110.97 36.52 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 155.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -86.7 -9.5 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.792 2.328 . . . . 1.2 113.916 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.2 167.84 31.9 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.176 0.898 . . . . 1.1000000000000001 113.197 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -87.73 -1.14 57.77 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.471 1.509 . . . . 3.3900000000000001 114.322 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.8 159.34 36.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.067 1.347 . . . . 1.8400000000000001 110.454 169.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.98 151.76 18.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.836 2.357 . . . . 1.3600000000000001 111.647 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 mt -100.98 155.64 17.85 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.085 0.954 . . . . 1.8400000000000001 111.19 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -132.21 110.75 10.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.041 1.337 . . . . 3.0699999999999998 109.797 169.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.5 tp -95.06 112.48 24.18 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 127.581 2.353 . . . . 0.72999999999999998 107.807 -175.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.88 -11.12 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.904 0.881 . . . . 0.57999999999999996 112.883 -166.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.36 -164.89 34.96 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.511 1.053 . . . . 0.48999999999999999 112.033 173.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.86 -179.14 6.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.225 1.01 . . . . 0.73999999999999999 110.012 164.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -155.9 141.24 17.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.83 1.252 . . . . 5.4500000000000002 108.963 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 t -151.43 156.1 34.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 119.501 1.046 . . . . 0.75 110.69 -165.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.36 -17.23 18.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.706 2.271 . . . . 0.96999999999999997 113.974 168.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -85.33 -23.78 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.954 1.465 . . . . 1.02 114.954 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.52 152.33 50.83 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.703 1.201 . . . . 0.94999999999999996 112.252 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 10.1 tp10 -86.45 -88.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.003 -0.544 . . . . 2.8700000000000001 110.037 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -82.24 90.45 6.62 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.714 -0.847 . . . . 3.5499999999999998 108.714 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.99 137.38 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.576 0.75 . . . . 1.3899999999999999 111.076 166.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -137.18 140.02 41.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.296 1.839 . . . . 2.2000000000000002 109.708 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -88.16 122.11 31.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.553 -1.342 . . . . 0.83999999999999997 111.674 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.4 m170 -109.46 156.36 20.18 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.287 1.435 . . . . 0.65000000000000002 112.541 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.8 -178.67 3.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.316 1.846 . . . . 1.9299999999999999 112.023 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.0 m -138.1 100.78 4.24 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.969 1.708 . . . . 1.3200000000000001 108.033 163.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -92.24 153.31 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.864 1.266 . . . . 2.3300000000000001 111.778 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptp -89.23 156.97 18.43 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.306 -0.871 . . . . 4.1500000000000004 111.972 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -163.31 153.11 15.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.872 1.269 . . . . 9.7300000000000004 112.887 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -81.54 176.43 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.889 0.876 . . . . 3.6600000000000001 110.698 154.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.19 -121.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 126.152 1.781 . . . . 3.1299999999999999 106.571 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.403 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 11.9 tt0 -73.35 62.52 0.71 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.559 2.343 . . . . 3.6200000000000001 110.131 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.05 2.06 6.19 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.307 1.432 . . . . 2.0499999999999998 115.291 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 13.4 ptpt -111.02 129.86 55.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.812 2.445 . . . . 2.6400000000000001 110.21 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.438 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -100.19 144.37 29.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.76 0.824 . . . . 5.5499999999999998 112.466 -167.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -152.5 162.14 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.672 1.589 . . . . 2.1099999999999999 109.374 -166.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.5 ptp -84.38 171.37 12.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.752 0.821 . . . . 3.5 112.012 161.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.16 148.95 19.99 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.492 1.52 . . . . 1.52 110.767 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -112.34 155.52 23.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.322 1.049 . . . . 1.98 110.24 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -168.39 158.87 8.7 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 126.471 1.909 . . . . 4.8700000000000001 108.927 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.2 Cg_endo -67.89 154.52 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 120.967 1.112 . . . . 0.73999999999999999 110.343 159.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.94 156.39 65.77 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 125.284 1.433 . . . . 0.69999999999999996 109.819 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.28 -16.54 39.64 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.613 2.209 . . . . 0.76000000000000001 112.833 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -178.79 167.49 1.7 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.716 1.606 . . . . 1.9299999999999999 110.593 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -117.47 172.3 7.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.201 2.2 . . . . 1.1499999999999999 109.165 159.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.6 161.11 41.76 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.011 -1.056 . . . . 2.1600000000000001 111.15 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -146.9 129.92 8.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.442 0.697 . . . . 0.95999999999999996 110.648 -167.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.17 162.46 38.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.056 2.504 . . . . 1.25 112.315 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.05 136.29 64.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 124.457 3.438 . . . . 1.28 113.356 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 64.07 2.58 1.46 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 1.96 113.794 -174.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.6 116.03 4.29 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 127.284 2.373 . . . . 0.97999999999999998 110.724 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 8.2 ttt180 -102.92 130.42 49.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.092 1.357 . . . . 5.29 110.275 164.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -147.74 152.66 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.519 1.528 . . . . 2.1499999999999999 111.338 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 130.86 48.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.873 0.869 . . . . 3.3700000000000001 112.132 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.97 78.03 0.32 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.152 1.381 . . . . 1.1799999999999999 108.067 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -81.05 146.92 60.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 2.6899999999999999 111.095 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.38 -50.85 12.64 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.52 2.813 . . . . 0.91000000000000003 113.141 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.31 67.63 3.66 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.84 -0.904 . . . . 1.0700000000000001 110.84 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.05 -78.32 0.07 OUTLIER Glycine 0 N--CA 1.466 0.694 0 C-N-CA 124.975 1.274 . . . . 0.81999999999999995 112.807 -170.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -156.51 143.04 18.46 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.141 2.176 . . . . 1.8100000000000001 109.632 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -169.76 159.11 7.87 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.895 -1.128 . . . . 0.87 110.882 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -97.56 121.38 39.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.396 0.678 . . . . 2.1800000000000002 112.028 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.8 mmt -79.25 123.64 27.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.2 1.0 . . . . 0.97999999999999998 109.557 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -104.64 79.33 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.36 1.464 . . . . 1.8799999999999999 110.485 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -78.9 128.32 33.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.626 1.103 . . . . 2.6099999999999999 109.538 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.88 74.74 0.9 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.857 -0.897 . . . . 1.3100000000000001 110.857 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.1 89.94 3.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.739 1.269 . . . . 1.5 110.774 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 3.0 ptmt -55.44 -9.14 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.487 1.515 . . . . 1.9099999999999999 114.091 171.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -136.84 135.58 20.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.877 1.671 . . . . 5.4100000000000001 108.847 167.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 141.81 40.77 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.126 1.884 . . . . 1.53 109.115 165.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.0 81.92 7.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.567 1.147 . . . . 2.0099999999999998 110.473 -172.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.476 ' HZ2' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -70.22 108.73 4.29 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.564 -1.335 . . . . 3.7200000000000002 109.605 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -43.07 124.98 3.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.797 0.839 . . . . 1.4399999999999999 111.392 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.65 -22.06 15.52 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 115.984 -2.565 . . . . 2.1699999999999999 116.492 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.476 ' CD ' ' HZ2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -86.43 177.19 7.51 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.387 2.593 . . . . 4.2800000000000002 111.98 -177.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -96.58 132.29 42.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.373 1.869 . . . . 4.8499999999999996 112.651 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.0 t -102.5 116.34 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.849 -1.157 . . . . 1.1100000000000001 108.891 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.92 143.8 35.49 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.047 0.927 . . . . 3.0800000000000001 110.557 160.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 117.56 5.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.743 0.817 . . . . 1.72 110.952 -168.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -81.53 95.58 7.16 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.164 2.186 . . . . 2.8199999999999998 110.377 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.8 mt -72.39 119.2 16.26 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.478 -0.764 . . . . 1.3 109.936 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.3 mt -95.4 132.19 40.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.032 0.933 . . . . 0.63 111.249 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.24 147.09 52.55 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.434 1.111 . . . . 1.99 112.73 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.08 136.72 56.36 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.034 1.124 . . . . 2.1200000000000001 114.034 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 48.93 13.66 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.971 0.796 . . . . 3.8100000000000001 113.63 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.46 23.8 55.57 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 115.951 1.14 . . . . 1.76 115.951 168.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -108.52 146.21 33.57 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.809 1.804 . . . . 4.4400000000000004 111.973 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.93 137.59 13.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.783 2.033 . . . . 1.1200000000000001 107.761 166.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -128.77 109.99 11.78 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.686 1.194 . . . . 1.6200000000000001 108.605 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -81.78 126.91 32.4 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.663 -0.648 . . . . 2.7799999999999998 111.88 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.1 m -118.95 167.3 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.287 1.835 . . . . 1.6000000000000001 110.259 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -116.08 139.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.839 1.255 . . . . 2.0800000000000001 110.416 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.3 mt -140.11 136.83 17.38 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 127.495 2.318 . . . . 1.5700000000000001 108.005 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.86 154.94 48.67 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.803 2.335 . . . . 1.3700000000000001 112.059 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.29 123.22 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.848 1.259 . . . . 1.5800000000000001 109.48 168.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.68 166.74 32.53 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.546 1.138 . . . . 3.6000000000000001 111.712 -174.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.53 84.84 2.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.74 1.216 . . . . 2.52 113.923 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.013 -1.106 . . . . 6.1900000000000004 108.013 148.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.779 -0.452 . . . . 5.1399999999999997 109.779 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.34 -175.21 43.7 Favored Glycine 0 N--CA 1.464 0.52 0 O-C-N 121.116 -0.99 . . . . 1.48 112.061 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -161.12 154.14 21.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.932 1.086 . . . . 1.6699999999999999 113.932 174.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.48 140.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.762 0.825 . . . . 1.23 109.33 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -87.11 110.94 20.46 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.674 -0.641 . . . . 4.2000000000000002 111.582 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.58 127.22 30.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.526 1.155 . . . . 3.1699999999999999 109.9 155.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -153.14 164.5 20.2 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.067 2.147 . . . . 2.1299999999999999 107.551 161.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -94.08 -161.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.155 3.236 . . . . 3.46 109.111 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.55 -150.92 28.86 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.386 0.993 . . . . 2.25 113.021 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -84.72 -16.44 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.618 2.879 . . . . 2.5499999999999998 113.843 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -153.82 160.66 42.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.735 1.754 . . . . 3.1200000000000001 115.735 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.15 177.75 7.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.94 2.096 . . . . 1.3 110.499 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.82 144.27 45.6 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.622 1.169 . . . . 1.0900000000000001 111.641 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.92 147.54 44.61 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.952 0.901 . . . . 0.94999999999999996 112.188 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.83 146.88 41.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.243 1.817 . . . . 2.02 110.289 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.51 151.6 9.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.348 -1.47 . . . . 1.5 114.751 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -87.76 93.41 9.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.539 1.936 . . . . 2.0299999999999998 107.354 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.02 140.6 29.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.232 1.413 . . . . 2.1899999999999999 109.83 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -127.47 156.66 41.77 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.632 0.975 . . . . 3.0499999999999998 113.632 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.84 99.71 53.03 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.149 1.38 . . . . 0.97999999999999998 108.964 163.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.05 -9.34 14.18 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.093 2.529 . . . . 1.4099999999999999 113.058 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -173.48 49.78 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.684 1.135 . . . . 1.1599999999999999 113.389 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -113.11 0.96 15.13 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.522 1.529 . . . . 2.5 112.802 -168.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.23 160.7 42.35 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.072 1.749 . . . . 1.6899999999999999 110.257 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.47 154.44 16.04 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.109 2.539 . . . . 0.96999999999999997 111.849 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.87 130.24 52.28 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.309 1.444 . . . . 2.3399999999999999 110.419 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -114.18 109.42 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.912 1.285 . . . . 2.7400000000000002 109.612 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.3 tp -90.51 107.63 19.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 126.77 2.028 . . . . 0.84999999999999998 108.428 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.0 m -101.15 -12.45 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.191 0.996 . . . . 0.56000000000000005 112.927 -168.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.1 -163.81 32.21 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.251 0.929 . . . . 0.60999999999999999 112.208 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.89 -173.18 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.562 1.145 . . . . 0.79000000000000004 110.145 164.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -161.7 137.17 7.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.763 1.625 . . . . 4.9800000000000004 107.98 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -146.74 147.21 29.27 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 117.152 -1.404 . . . . 0.93999999999999995 109.341 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.35 -6.96 19.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.021 1.814 . . . . 0.96999999999999997 113.816 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -93.91 -1.68 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.574 1.694 . . . . 0.85999999999999999 115.574 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.1 150.11 34.37 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.562 1.528 . . . . 0.89000000000000001 113.809 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.85 -67.1 0.81 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.611 1.565 . . . . 3.3300000000000001 111.274 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -90.02 147.08 23.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 122.572 1.177 . . . . 3.6299999999999999 110.321 168.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.02 129.27 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.456 2.302 . . . . 1.1499999999999999 106.582 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.94 120.39 13.15 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.078 1.351 . . . . 2.0299999999999998 109.016 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -78.98 121.71 25.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.064 1.302 . . . . 0.66000000000000003 110.302 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.0 m170 -111.54 152.75 27.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.298 1.839 . . . . 0.59999999999999998 112.053 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.91 -176.45 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.212 -1.358 . . . . 2.0099999999999998 110.022 165.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.6 m -126.82 75.69 1.58 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.283 1.433 . . . . 1.5800000000000001 107.526 170.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -65.45 150.04 49.02 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 2.7000000000000002 112.475 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -88.18 150.36 23.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.351 1.061 . . . . 6.4900000000000002 111.931 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -155.6 155.4 33.24 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.517 1.527 . . . . 8.5 111.481 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -99.5 148.01 24.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 3.4399999999999999 110.205 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -141.4 122.22 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 106.428 -1.693 . . . . 3.5 106.428 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 62.76 22.81 13.6 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.911 0.884 . . . . 3.8799999999999999 112.085 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.82 69.07 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.303 -1.498 . . . . 1.8200000000000001 114.36 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -96.88 141.55 29.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.567 1.947 . . . . 2.7200000000000002 109.992 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 135.2 35.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.624 1.17 . . . . 5.0999999999999996 111.294 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.51 141.8 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.236 1.814 . . . . 1.3999999999999999 109.161 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -117.41 145.18 44.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.09 0.956 . . . . 4.7000000000000002 110.167 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.76 169.14 31.19 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 125.141 1.353 . . . . 1.2 112.633 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.06 151.66 20.7 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.512 1.156 . . . . 1.55 113.133 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -164.55 146.8 7.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.435 1.494 . . . . 6.54 110.159 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.5 Cg_endo -68.93 153.6 72.33 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.688 1.592 . . . . 0.68999999999999995 111.314 172.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.33 157.65 60.85 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.785 1.634 . . . . 0.46999999999999997 110.537 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.99 -18.08 36.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.598 2.198 . . . . 0.57999999999999996 112.981 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.26 165.44 1.84 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.099 1.759 . . . . 1.8100000000000001 111.575 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -111.07 173.4 6.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.366 1.866 . . . . 0.96999999999999997 109.614 152.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -155.9 168.88 25.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.423 -0.798 . . . . 1.8400000000000001 112.435 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.62 133.23 8.63 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.811 1.244 . . . . 0.80000000000000004 109.783 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.12 164.13 36.26 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.283 1.989 . . . . 0.81999999999999995 110.925 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.53 143.42 92.95 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.008 2.472 . . . . 0.77000000000000002 111.502 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt 67.26 0.25 2.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.79 2.036 . . . . 1.4399999999999999 113.504 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.13 115.66 4.15 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 126.366 1.936 . . . . 0.94999999999999996 110.528 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.91 112.2 24.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.038 1.335 . . . . 6.2699999999999996 109.539 170.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.72 -174.98 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.007 1.723 . . . . 1.54 111.016 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 102.92 2.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.301 1.04 . . . . 3.6499999999999999 111.023 -165.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.13 77.17 0.51 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.078 1.751 . . . . 1.0700000000000001 109.112 161.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -91.77 147.79 35.8 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 127.832 2.453 . . . . 2.7999999999999998 112.189 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.51 -64.18 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.787 3.658 . . . . 1.05 113.325 -170.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.45 97.36 1.7 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 108.439 -1.864 . . . . 1.3200000000000001 108.439 165.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.81 -90.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.924 1.249 . . . . 0.93000000000000005 112.358 -169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -148.29 141.64 25.22 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.345 1.858 . . . . 2.0600000000000001 110.143 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -169.19 169.64 9.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.687 -1.258 . . . . 1.01 110.518 -172.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.65 136.13 41.0 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.646 -0.501 . . . . 1.8999999999999999 109.646 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 mmt -91.28 126.31 36.33 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.339 -0.985 . . . . 1.0900000000000001 108.339 161.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.25 111.08 22.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.41 1.484 . . . . 2.71 107.596 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 126.63 55.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.647 1.579 . . . . 2.8100000000000001 108.841 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.15 95.46 0.09 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.046 -1.222 . . . . 1.3600000000000001 110.046 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.5 mt -92.72 124.39 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.544 0.672 . . . . 0.93000000000000005 111.09 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.02 -19.73 61.81 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.8 1.037 . . . . 1.4299999999999999 113.8 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -149.5 162.66 27.89 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.738 2.015 . . . . 6.96 108.974 164.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.86 138.36 68.19 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.276 -1.471 . . . . 1.77 108.276 149.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.01 150.63 31.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 2.54 109.53 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.76 0.94 51.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.296 1.221 . . . . 6.4000000000000004 114.296 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 72.2 161.89 0.25 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.27 2.628 . . . . 2.3799999999999999 112.101 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.61 -12.16 0.77 Allowed Glycine 0 N--CA 1.482 1.728 0 N-CA-C 116.8 1.48 . . . . 4.0199999999999996 116.8 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.98 166.51 22.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.707 2.484 . . . . 3.3399999999999999 117.707 -153.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.61 68.55 9.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 131.659 3.984 . . . . 5.96 113.206 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.95 106.65 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 120.671 -1.268 . . . . 1.0600000000000001 111.126 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.04 129.86 44.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.667 1.587 . . . . 2.9900000000000002 110.764 160.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 mt -149.58 109.87 4.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.223 1.009 . . . . 1.74 112.272 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.67 96.18 5.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.192 2.597 . . . . 2.02 109.47 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.9 mt -77.23 118.39 19.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.321 -0.862 . . . . 1.1799999999999999 110.608 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -91.92 127.55 37.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.151 0.98 . . . . 0.64000000000000001 111.801 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -126.12 134.03 51.45 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.552 0.945 . . . . 2.3700000000000001 113.552 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 33.12 49.63 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.579 2.352 . . . . 1.8600000000000001 114.142 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.93 -94.01 0.77 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.574 1.083 . . . . 3.9399999999999999 111.946 -170.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.65 23.0 7.96 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 117.381 1.712 . . . . 1.6100000000000001 117.381 -164.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.446 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -117.76 153.26 33.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.508 2.154 . . . . 4.9299999999999997 109.782 166.591 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.03 139.95 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.289 1.436 . . . . 1.1399999999999999 109.584 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -123.31 110.97 15.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.024 1.33 . . . . 1.8400000000000001 109.48 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -85.3 108.17 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.093 -0.38 . . . . 2.5699999999999998 111.479 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -104.55 159.84 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.46 1.504 . . . . 1.1899999999999999 110.937 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.97 137.99 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.347 1.059 . . . . 2.1499999999999999 109.658 162.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 144.19 46.83 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.216 1.406 . . . . 1.73 109.958 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.37 141.82 26.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.823 2.348 . . . . 1.3600000000000001 110.37 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.42 153.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.82 0.848 . . . . 1.6200000000000001 112.43 167.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -146.61 158.05 43.83 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 3.8700000000000001 109.124 163.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.58 99.48 10.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.924 -1.11 . . . . 2.4300000000000002 108.109 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.222 0 CA-C-O 114.844 -2.503 . . . . 5.4500000000000002 117.275 -154.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 122.036 0.922 . . . . 6.4100000000000001 109.382 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.93 173.38 41.52 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.162 1.363 . . . . 1.05 113.818 -168.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -159.13 145.31 16.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.552 1.541 . . . . 1.54 110.571 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.3 t -91.29 143.05 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.692 1.197 . . . . 1.03 109.303 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -69.21 116.91 10.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.626 -0.671 . . . . 4.0199999999999996 112.31 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.2 134.18 56.77 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.156 0.983 . . . . 4.0300000000000002 109.999 161.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -166.13 140.46 3.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 120.534 -1.353 . . . . 2.2799999999999998 112.456 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -92.59 68.99 0.68 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.234 3.29 . . . . 3.1099999999999999 110.348 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.01 -177.76 36.26 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.772 1.069 . . . . 1.48 115.772 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.54 -0.25 8.1 Favored 'Trans proline' 0 CA--C 1.542 0.91 1 C-N-CA 125.494 4.129 . . . . 1.4299999999999999 113.371 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -134.37 152.75 51.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 2.6600000000000001 111.56 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 -170.28 3.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.211 2.204 . . . . 1.1599999999999999 109.933 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.24 152.9 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.309 1.444 . . . . 1.0800000000000001 109.412 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.2 136.69 51.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.415 1.461 . . . . 1.0900000000000001 111.902 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -120.27 135.07 55.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.015 1.726 . . . . 2.0600000000000001 110.277 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.8 152.19 11.35 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.872 -1.143 . . . . 1.6200000000000001 112.423 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 m -95.93 92.28 6.42 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.112 0.965 . . . . 1.6100000000000001 110.029 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -80.41 133.61 35.9 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.097 -0.705 . . . . 2.27 109.097 173.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.86 145.73 50.85 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.107 1.763 . . . . 2.79 110.124 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -107.86 104.28 52.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.702 0.801 . . . . 1.1299999999999999 110.073 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.33 -12.97 11.33 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.506 2.137 . . . . 1.05 113.321 176.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.13 -174.25 49.53 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.149 0.88 . . . . 1.21 113.221 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -112.22 6.01 18.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.594 1.557 . . . . 2.75 112.337 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.5 160.92 60.01 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.86 2.064 . . . . 1.73 109.988 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.44 144.64 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.324 2.016 . . . . 1.1200000000000001 112.028 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.95 121.26 41.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.363 1.465 . . . . 2.3300000000000001 108.934 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 ttm105 -110.53 97.53 6.95 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.481 1.112 . . . . 3.3799999999999999 110.753 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.67 106.74 11.92 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.292 2.237 . . . . 0.75 109.551 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.82 -13.42 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.155 1.382 . . . . 0.84999999999999998 113.524 -171.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.95 34.28 Favored Glycine 0 C--N 1.34 0.753 0 O-C-N 121.632 -0.668 . . . . 0.72999999999999998 112.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB1' HD13 ' A' ' 101' ' ' LEU . . . -160.77 175.41 12.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.918 0.887 . . . . 0.92000000000000004 112.76 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.434 ' HE ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -143.72 156.48 44.54 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.831 0.452 . . . . 7.6200000000000001 110.391 160.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 t -152.95 149.69 22.52 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.139 1.376 . . . . 0.88 108.628 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.97 -35.07 56.87 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.167 1.245 . . . . 1.48 111.24 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.97 4.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.868 1.433 . . . . 1.3799999999999999 114.868 -164.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.34 170.2 14.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.186 1.794 . . . . 1.1000000000000001 109.99 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 7.1 tp10 -106.38 -82.84 0.53 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.413 -0.958 . . . . 2.7999999999999998 108.413 164.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.68 125.67 28.06 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.164 -0.96 . . . . 5.1299999999999999 109.072 165.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.63 138.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.196 1.799 . . . . 1.1899999999999999 109.419 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -140.07 127.69 21.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.663 1.185 . . . . 2.2799999999999998 111.927 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.428 HD12 ' CE1' ' A' ' 84' ' ' PHE . 4.9 tt -78.93 122.87 26.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.767 -1.208 . . . . 0.75 110.795 167.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 21.6 m170 -108.71 153.2 23.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.71 1.604 . . . . 0.81000000000000005 112.637 176.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -87.32 158.72 18.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.309 1.044 . . . . 2.23 109.803 162.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -109.31 143.91 38.17 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.161 -1.422 . . . . 1.48 107.161 152.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -137.46 155.07 49.74 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 2.1400000000000001 111.285 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -111.02 121.81 46.31 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.101 -1.444 . . . . 3.4900000000000002 107.101 160.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -146.44 173.21 12.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.387 1.475 . . . . 7.1399999999999997 110.274 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -73.98 155.13 38.94 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.418 0.687 . . . . 3.21 110.132 159.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.85 -98.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.948 -1.131 . . . . 3.7999999999999998 107.948 168.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -74.75 63.15 1.13 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.833 1.653 . . . . 5.0 111.723 170.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.63 -24.67 0.63 Allowed Glycine 0 N--CA 1.475 1.274 0 C-N-CA 126.462 1.982 . . . . 3.8300000000000001 115.222 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -107.56 164.03 12.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.909 2.484 . . . . 3.4500000000000002 111.628 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -76.87 134.15 39.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.375 2.27 . . . . 4.3300000000000001 112.084 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -144.08 147.35 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.345 1.858 . . . . 1.49 109.995 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -98.0 118.54 34.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.515 1.526 . . . . 3.79 110.303 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.16 -179.19 16.1 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.389 1.471 . . . . 1.29 113.239 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.5 mtt -142.26 158.67 43.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.413 1.485 . . . . 2.1400000000000001 111.244 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.87 151.04 4.78 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.741 -1.123 . . . . 4.7000000000000002 113.437 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 27.4 Cg_endo -61.31 142.05 94.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.65000000000000002 112.006 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.63 159.86 48.89 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 126.516 1.926 . . . . 0.47999999999999998 110.882 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.15 -21.29 18.09 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.564 2.176 . . . . 0.68000000000000005 113.455 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -171.87 163.72 6.32 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 120.27 1.396 . . . . 2.6499999999999999 112.395 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -115.03 173.51 6.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.199 2.2 . . . . 1.0900000000000001 109.24 155.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.91 164.27 38.68 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.645 -0.659 . . . . 2.5600000000000001 112.13 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.1 t -139.25 125.79 12.53 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 125.412 1.485 . . . . 1.1499999999999999 108.733 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.21 159.13 54.13 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.124 1.883 . . . . 1.25 110.512 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.77 140.5 93.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.959 2.439 . . . . 1.0800000000000001 111.654 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt 72.17 -8.52 1.14 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.27 2.228 . . . . 1.4099999999999999 113.997 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.05 -172.93 49.6 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.882 1.706 . . . . 1.47 112.873 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -160.61 161.76 32.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.965 2.106 . . . . 4.6200000000000001 111.843 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.8 129.88 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.112 1.365 . . . . 1.78 110.007 170.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.88 122.29 32.1 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.22 0.533 . . . . 3.3599999999999999 110.307 165.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -68.89 68.14 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.368 1.867 . . . . 1.4199999999999999 109.954 169.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -70.85 142.27 87.94 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.472 1.509 . . . . 2.7599999999999998 110.32 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.41 -57.02 2.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.55 2.833 . . . . 1.28 112.233 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.96 78.0 2.01 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.357 -1.097 . . . . 1.4399999999999999 110.357 166.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.23 -79.61 0.08 OUTLIER Glycine 0 N--CA 1.466 0.637 0 C-N-CA 127.119 2.295 . . . . 0.94999999999999996 111.415 -175.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -153.84 147.49 25.2 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.631 1.972 . . . . 2.3500000000000001 108.905 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -159.7 154.13 23.94 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 120.496 -1.378 . . . . 0.75 109.276 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CE1' HD12 ' A' ' 45' ' ' LEU . 56.5 m-85 -92.39 104.03 16.4 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.329 -1.36 . . . . 1.8300000000000001 107.329 167.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 129.61 40.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.603 -0.888 . . . . 1.1499999999999999 108.603 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -114.81 122.14 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.647 1.579 . . . . 1.8 109.016 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.02 155.85 36.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.333 1.053 . . . . 3.0 110.668 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.92 -64.25 4.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.129 1.347 . . . . 3.5099999999999998 112.29 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt 74.1 110.96 0.07 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.568 2.747 . . . . 1.26 115.526 164.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 41' ' ' GLU . 36.3 mttp -89.17 -3.73 58.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.579 -1.325 . . . . 1.78 113.595 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -137.35 138.61 25.43 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 126.193 1.797 . . . . 5.2300000000000004 108.77 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.97 130.13 17.38 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 N-CA-C 107.469 -1.781 . . . . 1.77 107.469 159.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.55 85.1 6.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.411 0.684 . . . . 2.71 109.563 -170.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HE3' ' HG2' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -102.8 142.37 34.04 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.344 1.058 . . . . 3.8999999999999999 111.463 175.429 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.17 142.06 48.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 114.546 1.313 . . . . 1.5800000000000001 114.546 -170.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.39 52.12 28.24 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.781 -0.645 . . . . 2.0 112.789 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HG2' ' HE3' ' A' ' 94' ' ' LYS . 2.8 mt-10 -107.51 -175.74 2.87 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.549 -1.278 . . . . 2.4900000000000002 107.549 147.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.51 120.43 31.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.76 0.79 . . . . 4.7400000000000002 109.277 166.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.11 103.85 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.774 -0.824 . . . . 0.96999999999999997 108.774 168.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 141.62 40.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.313 1.054 . . . . 3.5 110.672 162.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.417 HD13 ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -155.25 130.58 9.65 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.171 -0.956 . . . . 3.21 111.881 -167.424 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.71 121.25 38.34 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.443 1.097 . . . . 2.3199999999999998 109.413 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -95.36 119.11 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.174 1.389 . . . . 1.1499999999999999 110.012 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 mt -92.28 124.55 36.42 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.002 0.921 . . . . 0.91000000000000003 110.505 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.91 126.67 50.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.141 0.977 . . . . 2.1600000000000001 112.542 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 50.07 21.12 0.69 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.258 1.823 . . . . 2.0099999999999998 114.821 171.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.53 -61.12 2.82 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.695 1.14 . . . . 3.2400000000000002 112.361 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.79 1.37 53.95 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.188 1.635 . . . . 1.8899999999999999 117.188 -165.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -137.24 146.24 44.55 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.71 1.755 . . . . 5.8499999999999996 111.351 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.01 148.46 23.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.121 1.368 . . . . 1.25 109.822 163.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -143.37 133.03 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.396 1.878 . . . . 1.79 109.657 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -85.65 140.74 30.31 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.624 0.602 . . . . 2.1600000000000001 112.624 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -125.52 177.23 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.606 1.962 . . . . 1.22 109.461 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -155.21 140.69 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.404 0.547 . . . . 1.9299999999999999 111.002 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.32 152.39 19.91 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.965 1.306 . . . . 2.3300000000000001 112.844 -171.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -79.27 -170.28 0.97 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.24 3.293 . . . . 1.04 112.346 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.42 84.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 126.857 2.063 . . . . 2.2400000000000002 111.389 -161.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -128.89 172.88 10.9 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 119.983 -1.698 . . . . 5.4800000000000004 114.553 -171.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.07 142.19 28.89 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.67 -1.269 . . . . 3.27 113.532 -167.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 C-N-CA 126.702 2.001 . . . . 6.8499999999999996 111.528 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 CA--C 1.55 0.966 0 N-CA-C 109.312 -0.625 . . . . 5.21 109.312 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.11 165.68 21.77 Favored Glycine 0 N--CA 1.475 1.239 0 O-C-N 120.296 -1.503 . . . . 1.1100000000000001 113.371 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.2 p90 -167.09 163.26 15.72 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.122 1.369 . . . . 1.6699999999999999 111.805 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -127.4 135.6 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.277 -0.889 . . . . 1.21 110.522 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -88.68 129.52 35.51 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.469 1.128 . . . . 4.5700000000000003 113.605 -169.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -79.55 141.33 36.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.108 2.163 . . . . 2.9300000000000002 112.562 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -162.8 152.26 13.01 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.329 1.451 . . . . 2.29 110.943 165.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.45 56.55 4.3 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.546 3.497 . . . . 2.4399999999999999 109.706 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.81 174.86 17.65 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.661 1.124 . . . . 1.3 114.068 -172.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.13 -15.22 13.02 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.904 3.069 . . . . 1.5900000000000001 112.556 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -143.89 154.3 43.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.479 1.912 . . . . 2.0299999999999998 111.834 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.29 -179.85 8.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.728 1.611 . . . . 1.0900000000000001 110.751 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.67 49.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.18 0.807 . . . . 1.1299999999999999 113.18 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.48 141.66 36.58 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.998 0.519 . . . . 0.98999999999999999 110.763 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -117.67 157.26 26.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.937 1.695 . . . . 2.0499999999999998 110.08 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -167.47 148.07 5.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.994 1.479 . . . . 1.29 114.994 166.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.54 HG23 ' HD2' ' A' ' 74' ' ' ARG . 59.4 m -75.83 140.38 42.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.528 -1.214 . . . . 1.23 109.636 157.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.33 130.63 15.6 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.687 1.195 . . . . 2.98 109.069 168.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -136.95 152.64 50.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.284 1.04 . . . . 4.5300000000000002 112.276 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -104.15 102.49 32.74 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.066 1.346 . . . . 1.3200000000000001 110.528 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.71 -9.19 14.63 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.315 2.01 . . . . 1.73 113.603 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.17 -170.44 44.87 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.362 0.982 . . . . 1.5 112.998 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -120.86 9.95 10.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.782 1.233 . . . . 2.6600000000000001 112.943 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.76 159.4 53.55 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.047 1.739 . . . . 2.27 110.69 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.67 153.51 15.36 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.757 2.305 . . . . 1.9299999999999999 111.805 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.19 142.24 43.64 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.732 1.613 . . . . 2.0800000000000001 109.019 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -141.41 107.49 5.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.712 0.805 . . . . 3.4500000000000002 109.805 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.37 129.14 44.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.277 2.631 . . . . 1.98 109.218 -165.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.84 -9.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.136 1.162 . . . . 0.56999999999999995 114.136 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.19 -160.75 28.77 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.069 -1.02 . . . . 0.55000000000000004 112.285 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 -174.25 4.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.942 1.697 . . . . 0.89000000000000001 110.664 165.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -150.84 144.87 25.32 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.609 1.963 . . . . 7.6399999999999997 109.136 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -141.01 151.26 61.83 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 120.376 1.444 . . . . 0.63 109.462 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.0 -22.14 48.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.359 2.039 . . . . 0.88 113.851 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.91 2.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 115.178 1.547 . . . . 0.93000000000000005 115.178 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 175.6 12.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.652 1.181 . . . . 0.90000000000000002 112.306 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -110.56 -89.36 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.575 1.15 . . . . 2.8399999999999999 109.894 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -77.72 100.6 6.29 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 120.667 -1.27 . . . . 4.2400000000000002 108.932 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -82.24 135.04 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.664 1.585 . . . . 1.3700000000000001 111.147 162.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.1 147.48 51.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.822 2.449 . . . . 2.1699999999999999 108.407 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 tt -92.79 124.1 36.54 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.9 1.682 . . . . 1.0600000000000001 111.162 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.7 m170 -114.01 152.47 30.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.317 1.447 . . . . 0.82999999999999996 112.635 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -98.74 166.43 11.32 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 2.1600000000000001 110.319 167.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -125.14 117.69 24.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.591 1.156 . . . . 1.3200000000000001 108.166 167.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -119.64 -177.59 3.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.44 1.496 . . . . 2.2400000000000002 112.084 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -140.33 163.19 33.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.424 1.09 . . . . 2.8900000000000001 111.895 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.36 166.82 20.39 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.641 1.577 . . . . 5.8799999999999999 112.023 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 135.42 40.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.537 1.535 . . . . 4.8499999999999996 108.445 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.8 -113.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.745 1.618 . . . . 3.1899999999999999 107.025 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.26 67.19 3.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.519 1.054 . . . . 4.3099999999999996 108.931 164.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.89 -22.01 0.46 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 127.323 2.392 . . . . 2.5 115.953 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -74.93 133.82 41.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.5 1.92 . . . . 4.1699999999999999 110.134 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.95 127.63 36.48 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.927 0.891 . . . . 5.5099999999999998 109.67 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.12 152.58 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.657 1.583 . . . . 2.8500000000000001 109.876 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.5 ptp -83.96 162.13 20.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.505 1.522 . . . . 4.4900000000000002 113.32 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.52 172.93 33.68 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.669 1.604 . . . . 1.48 113.122 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtt -137.09 154.55 50.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.554 1.542 . . . . 2.8199999999999998 110.472 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -168.77 154.11 6.21 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.683 1.193 . . . . 5.3600000000000003 111.144 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 3.8 Cg_endo -68.6 152.38 74.67 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.46 1.44 . . . . 0.62 112.085 171.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.97 149.36 68.28 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 125.945 1.698 . . . . 0.70999999999999996 109.842 172.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.31 -19.08 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.903 2.402 . . . . 0.88 113.909 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -172.61 171.56 4.49 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.804 1.184 . . . . 1.8100000000000001 113.117 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.23 175.26 10.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.839 2.456 . . . . 2.8199999999999998 109.373 159.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.45 168.8 25.92 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 120.602 -1.311 . . . . 2.3900000000000001 111.132 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -149.65 137.73 11.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 124.72 1.208 . . . . 1.5 108.737 -167.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.77 171.73 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.655 1.57 . . . . 1.6299999999999999 110.146 166.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.97 146.86 91.79 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.344 2.03 . . . . 1.5800000000000001 110.322 160.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt 69.61 -2.72 1.85 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.696 1.998 . . . . 1.3799999999999999 114.024 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.21 148.43 20.74 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 126.985 2.231 . . . . 1.1200000000000001 111.688 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.54 ' HD2' HG23 ' A' ' 21' ' ' THR . 33.2 ttp-105 -106.27 142.64 35.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.432 1.893 . . . . 6.04 111.505 168.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.86 147.26 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.475 1.51 . . . . 2.75 108.473 161.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -128.13 112.28 14.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.334 -1.358 . . . . 3.4100000000000001 107.334 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.09 63.05 0.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.57 1.948 . . . . 1.49 108.971 171.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -79.48 150.95 74.21 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 128.8 2.84 . . . . 3.23 111.545 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.4 -35.69 92.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.52 2.814 . . . . 1.1699999999999999 113.641 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.72 60.06 1.77 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.189 0.9 . . . . 1.73 111.867 168.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.89 -73.6 0.05 OUTLIER Glycine 0 N--CA 1.469 0.859 0 C-N-CA 125.225 1.393 . . . . 1.3100000000000001 113.94 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -153.01 154.72 35.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.122 1.769 . . . . 2.3199999999999998 111.01 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -163.99 169.93 17.32 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.107 0.963 . . . . 1.0900000000000001 109.879 176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.21 126.61 42.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.789 -0.819 . . . . 2.1200000000000001 108.789 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -81.69 120.82 25.6 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.426 1.091 . . . . 1.1000000000000001 109.219 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -111.65 113.01 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.147 1.379 . . . . 1.47 107.976 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.41 139.83 41.28 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.433 1.493 . . . . 2.7200000000000002 109.293 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.08 66.3 1.94 Allowed Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.489 -1.045 . . . . 1.29 110.489 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 mt -70.03 123.54 21.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.04 0.536 . . . . 1.21 110.568 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -83.19 19.83 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.015 0.926 . . . . 1.45 113.154 -172.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 173.9 155.98 0.3 Allowed Pre-proline 0 CA--C 1.544 0.718 1 C-N-CA 131.893 4.077 . . . . 4.46 107.945 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.73 133.68 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 N-CA-C 106.626 -2.105 . . . . 2.1000000000000001 106.626 147.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.9 116.55 5.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.55 0.69 . . . . 2.4199999999999999 109.155 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -71.23 107.67 4.35 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.416 -0.802 . . . . 4.3799999999999999 109.939 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.82 1.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.909 -1.119 . . . . 1.52 109.461 164.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.49 38.67 7.02 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 118.755 -1.025 . . . . 2.1800000000000002 113.958 -165.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -135.75 -178.92 5.35 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 119.275 1.538 . . . . 3.46 108.659 149.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.78 150.31 37.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.158 0.98 . . . . 5.0599999999999996 110.589 166.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.99 113.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.98 1.712 . . . . 1.21 108.031 172.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.22 137.69 57.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.909 -0.587 . . . . 2.9399999999999999 109.477 160.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -149.55 133.44 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.41 1.084 . . . . 1.54 111.993 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.55 87.76 2.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.786 2.034 . . . . 2.6299999999999999 109.146 -167.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 mt -69.28 125.17 25.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.766 2.026 . . . . 1.1100000000000001 111.077 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.3 mt -94.51 138.67 32.13 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.511 1.124 . . . . 0.81999999999999995 111.464 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -135.08 138.54 43.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.432 1.093 . . . . 1.8 111.238 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.8 126.55 12.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.595 1.558 . . . . 1.79 113.342 -167.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.25 -145.58 19.16 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 110.757 -0.937 . . . . 3.29 110.757 -166.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.27 27.48 9.32 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 115.74 1.056 . . . . 2.04 115.74 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.63 131.22 46.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.27 2.035 . . . . 4.7599999999999998 112.079 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.73 123.32 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.108 1.363 . . . . 1.4099999999999999 109.284 162.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.76 119.8 33.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.809 1.644 . . . . 3.02 108.477 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.54 147.09 23.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.328 1.233 . . . . 2.4700000000000002 114.328 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.96 172.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 127.86 2.464 . . . . 1.1399999999999999 109.492 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.82 140.99 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.828 1.651 . . . . 2.1099999999999999 108.017 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.79 133.81 10.59 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.147 1.379 . . . . 1.52 110.83 -166.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 147.77 67.34 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.105 2.537 . . . . 1.03 114.168 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.7 t -79.27 132.49 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.538 0.735 . . . . 1.1399999999999999 110.496 168.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -133.7 156.26 48.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.125 1.77 . . . . 3.8999999999999999 112.164 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.57 84.42 7.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.093 0.957 . . . . 1.98 109.457 164.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.907 -1.52 . . . . 5.71 112.16 -163.419 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 108.86 -0.792 . . . . 5.2699999999999996 108.86 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.88 165.48 38.74 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.327 -0.858 . . . . 1.1299999999999999 114.224 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -159.53 158.98 32.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.628 1.171 . . . . 2.1600000000000001 114.001 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.08 130.03 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.573 -1.269 . . . . 1.25 107.573 164.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -84.48 -2.6 57.51 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.841 1.793 . . . . 3.9700000000000002 115.841 -164.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.4 t80 65.88 152.21 0.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.496 2.318 . . . . 3.3599999999999999 113.671 -170.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -159.54 146.8 12.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.943 2.097 . . . . 3.7400000000000002 108.25 157.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.88 -7.84 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.324 2.683 . . . . 3.4500000000000002 112.283 169.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.57 -167.05 43.16 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.462 1.029 . . . . 1.8999999999999999 114.213 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.01 -9.33 22.08 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.503 2.802 . . . . 1.8 113.359 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -152.33 161.89 41.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.081 1.352 . . . . 2.2200000000000002 114.397 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.57 -174.09 4.78 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.668 2.387 . . . . 1.1799999999999999 111.953 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB2' ' CE ' ' A' ' 85' ' ' MET . . . -137.08 159.58 41.49 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.063 1.345 . . . . 1.3200000000000001 111.51 174.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.65 163.35 37.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.465 1.506 . . . . 1.4099999999999999 113.273 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -145.24 152.74 40.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.363 1.865 . . . . 1.9199999999999999 110.874 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -166.13 158.44 14.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.547 1.139 . . . . 1.5900000000000001 112.068 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.5 m -90.73 138.59 31.46 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.667 -1.234 . . . . 1.25 107.667 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.6 132.1 56.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.943 1.297 . . . . 2.27 107.767 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.55 135.36 53.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.727 0.811 . . . . 3.3100000000000001 111.761 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -101.69 115.56 64.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.348 1.059 . . . . 0.91000000000000003 109.7 163.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -88.57 -8.9 5.09 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.241 2.627 . . . . 1.27 114.4 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.06 162.97 32.86 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 119.434 1.016 . . . . 1.22 113.355 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.31 -0.52 50.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.347 1.459 . . . . 3.0800000000000001 114.178 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.91 158.04 36.91 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.999 1.32 . . . . 1.8500000000000001 110.53 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.38 155.23 18.89 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.214 2.61 . . . . 1.1599999999999999 111.198 -173.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.25 153.86 20.48 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.347 1.059 . . . . 1.8899999999999999 111.316 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -130.65 114.42 15.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.153 1.381 . . . . 3.02 109.185 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.45 114.41 26.17 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.246 2.618 . . . . 0.66000000000000003 108.893 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.05 -10.54 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 0.55000000000000004 113.571 -166.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.19 31.44 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.616 -0.678 . . . . 0.55000000000000004 112.704 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.71 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.03 179.95 7.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.597 0.759 . . . . 0.80000000000000004 111.924 176.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 3.0 mmt180 -154.47 149.69 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.94 -1.133 . . . . 6.0499999999999998 107.94 172.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -162.49 153.79 15.06 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.45 -1.262 . . . . 0.72999999999999998 108.725 -170.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.42 -7.95 16.04 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.32 2.013 . . . . 1.1100000000000001 114.489 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 m -98.48 -3.95 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 116.142 1.905 . . . . 0.89000000000000001 116.142 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.51 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.944 1.298 . . . . 1.29 110.666 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -93.95 -74.75 0.52 Allowed 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.575 -0.528 . . . . 4.4500000000000002 109.575 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -80.77 107.75 13.84 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.481 -0.933 . . . . 4.5199999999999996 108.481 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -113.18 125.01 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.913 0.885 . . . . 1.8799999999999999 108.763 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -134.13 122.7 23.26 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.889 1.276 . . . . 2.6299999999999999 110.384 -162.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.59 122.53 26.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.227 1.013 . . . . 0.81999999999999995 110.461 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 7.2 m170 -108.1 156.87 18.8 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.452 1.901 . . . . 0.88 112.832 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -105.24 -177.51 3.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.16 2.584 . . . . 2.0299999999999998 111.473 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -133.12 99.54 4.59 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.749 -1.574 . . . . 1.6699999999999999 106.749 154.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.3 151.51 41.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.462 0.305 . . . . 2.4500000000000002 110.63 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 ptp -97.97 157.92 15.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.55 0.34 . . . . 3.8799999999999999 110.797 155.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -176.1 160.96 2.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.583 2.353 . . . . 6.6299999999999999 110.274 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.73 154.26 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.029 0.932 . . . . 3.7000000000000002 108.795 169.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 t -133.17 -96.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.281 1.033 . . . . 2.8700000000000001 108.967 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -75.84 54.94 0.85 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.267 1.827 . . . . 3.1899999999999999 110.34 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.99 -17.57 0.53 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.137 1.827 . . . . 2.1099999999999999 115.261 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.8 152.69 20.2 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.01 1.724 . . . . 2.6699999999999999 111.162 -168.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -62.64 131.74 50.02 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.846 0.858 . . . . 4.3700000000000001 111.183 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.34 151.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.037 1.735 . . . . 1.95 109.335 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.8 mtm -128.64 141.51 51.33 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.602 1.161 . . . . 4.0099999999999998 110.302 163.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.86 163.57 30.5 Favored Glycine 0 N--CA 1.469 0.844 0 C-N-CA 123.753 0.692 . . . . 1.24 112.689 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -97.74 158.47 15.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.965 0.906 . . . . 1.72 112.771 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.6 mtt-85 -164.83 145.8 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 126.724 2.009 . . . . 6.2699999999999996 109.053 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.8 Cg_endo -70.59 152.9 65.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 CA-C-N 121.526 1.581 . . . . 0.90000000000000002 110.111 160.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.17 156.2 57.52 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.252 1.421 . . . . 0.67000000000000004 110.037 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.32 -14.4 34.28 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.812 2.341 . . . . 0.80000000000000004 113.015 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -178.96 162.15 1.24 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.115 1.766 . . . . 2.27 110.861 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -108.59 174.55 5.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.925 1.69 . . . . 1.04 109.316 153.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.74 165.24 37.21 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.908 -1.12 . . . . 2.3399999999999999 111.204 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -149.63 135.36 10.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 118.573 -0.727 . . . . 0.88 110.502 -164.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.98 165.8 31.19 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.264 1.976 . . . . 0.89000000000000001 112.116 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.31 138.84 83.6 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.391 3.394 . . . . 1.0900000000000001 112.62 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.1 2.83 1.54 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.344 1.857 . . . . 1.99 113.808 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.09 115.51 4.13 Favored Glycine 0 C--O 1.228 -0.23 0 C-N-CA 127.422 2.439 . . . . 0.89000000000000001 111.626 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -85.43 134.36 34.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.248 -0.976 . . . . 6.6399999999999997 109.978 155.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.34 168.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.749 2.02 . . . . 1.53 109.6 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -134.47 124.77 26.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.824 0.85 . . . . 3.6400000000000001 110.781 -164.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.06 75.63 5.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.716 -0.846 . . . . 1.1799999999999999 108.716 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 ptpm? -79.59 136.27 55.84 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.278 -0.867 . . . . 2.8599999999999999 110.525 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.47 -58.51 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.933 3.755 . . . . 1.03 113.566 -163.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 106.78 2.61 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 107.817 -2.113 . . . . 1.23 107.817 160.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.51 -88.65 0.17 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 124.654 1.121 . . . . 0.93999999999999995 111.266 -163.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -150.62 144.55 25.32 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.891 2.076 . . . . 1.8100000000000001 109.926 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -165.8 174.2 9.87 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.937 -1.102 . . . . 0.84999999999999998 110.618 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -110.9 128.8 55.93 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.994 0.918 . . . . 2.2799999999999998 109.971 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.482 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 8.1 mmt -86.71 136.98 32.82 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.073 0.949 . . . . 0.89000000000000001 109.633 165.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.7 mt -116.67 117.0 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.516 1.527 . . . . 2.1099999999999999 109.105 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.82 142.35 51.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.896 1.678 . . . . 2.6299999999999999 111.069 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.99 59.57 4.24 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.041 -1.223 . . . . 1.5900000000000001 110.041 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.8 mt -66.8 129.42 39.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.156 0.979 . . . . 1.1899999999999999 111.713 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.59 -10.19 49.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.785 1.234 . . . . 1.8100000000000001 112.875 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -155.38 146.19 16.33 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.621 1.568 . . . . 5.9000000000000004 110.305 163.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.28 127.49 15.88 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 107.378 -1.816 . . . . 1.8100000000000001 107.378 158.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mp -87.49 167.73 13.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.102 0.961 . . . . 2.4100000000000001 111.277 -171.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 145.98 48.15 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.032 -1.043 . . . . 5.0300000000000002 110.524 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.07 125.95 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.372 -0.603 . . . . 1.49 109.372 158.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.24 8.86 68.02 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 118.094 -1.392 . . . . 1.8999999999999999 115.712 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.45 173.73 9.44 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.943 1.872 . . . . 2.7599999999999998 109.429 157.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -118.64 158.7 24.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.816 1.647 . . . . 4.4699999999999998 110.099 167.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.1 t -132.45 120.31 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.319 1.848 . . . . 1.01 110.25 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.57 147.0 28.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.57 1.148 . . . . 3.29 110.321 173.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.71 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.3 tt -157.02 140.29 15.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.52 0.728 . . . . 1.8500000000000001 112.935 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 1.4 m-20 -104.61 115.47 30.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.863 2.465 . . . . 2.9300000000000002 111.546 174.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.3 125.03 28.44 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.827 -1.17 . . . . 2.4100000000000001 109.828 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.31 126.81 39.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.789 0.436 . . . . 0.63 110.328 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -124.69 154.28 41.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.646 1.212 . . . . 1.8200000000000001 112.245 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.06 128.52 37.61 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.86 1.059 . . . . 1.9399999999999999 113.86 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.17 50.41 10.49 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.194 0.902 . . . . 3.6800000000000002 114.073 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.53 76.47 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.034 1.173 . . . . 1.51 116.034 166.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.09 135.75 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.47 1.635 . . . . 4.7400000000000002 109.971 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.8 p -150.82 139.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 125.081 1.352 . . . . 1.0800000000000001 108.95 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.7 mt -139.05 134.78 33.45 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.244 1.018 . . . . 1.6699999999999999 111.871 -172.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 2.9 tpmt? -80.17 135.95 36.39 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.198 . . . . 2.77 113.113 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.93 173.65 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 125.158 1.383 . . . . 1.3700000000000001 111.88 156.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.16 153.75 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.121 1.768 . . . . 2.3300000000000001 108.74 165.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 mt -143.5 135.28 12.96 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.945 2.098 . . . . 1.8200000000000001 110.09 -172.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.32 159.28 49.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.257 2.638 . . . . 1.0800000000000001 111.988 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.33 131.2 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.123 0.969 . . . . 1.3300000000000001 110.989 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.59 -170.05 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.782 3.233 . . . . 4.0099999999999998 110.796 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.1 70.58 1.15 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.181 -0.949 . . . . 3.2999999999999998 111.275 167.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.899 1.444 . . . . 4.5599999999999996 114.899 -145.561 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 109.535 -0.543 . . . . 6.0199999999999996 109.535 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.474 ' CA ' ' HA ' ' A' ' 20' ' ' LEU . . . -99.91 128.3 9.53 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 121.259 -0.901 . . . . 2.0899999999999999 114.342 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -119.91 177.14 5.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.385 1.074 . . . . 1.8999999999999999 112.031 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.16 135.45 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.245 1.018 . . . . 1.1599999999999999 108.605 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.73 139.32 56.34 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.891 1.071 . . . . 8.3599999999999994 113.891 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -74.2 29.3 0.08 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.809 1.644 . . . . 4.0 114.967 177.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.7 p -69.9 134.37 87.87 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 119.706 -1.871 . . . . 2.75 113.181 -159.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.2 -20.39 24.83 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.951 2.434 . . . . 2.2599999999999998 112.073 169.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.39 122.83 6.24 Favored Glycine 0 CA--C 1.534 1.253 0 N-CA-C 108.678 -1.769 . . . . 3.52 108.678 162.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.83 -39.99 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.006 1.903 . . . . 4.0899999999999999 112.34 -172.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -90.23 137.14 32.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.042 0.837 . . . . 4.4800000000000004 110.784 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 167.27 178.98 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.089 2.556 . . . . 3.1600000000000001 112.139 -172.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.69 28.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.655 1.982 . . . . 1.95 114.001 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.04 155.65 45.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.788 1.635 . . . . 1.1799999999999999 110.839 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.88 164.92 26.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.358 1.063 . . . . 2.4500000000000002 112.15 -158.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.474 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 2.6 pt? -168.38 155.03 7.41 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.659 1.355 . . . . 1.4199999999999999 114.659 164.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.9 m -76.03 136.86 39.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.874 -1.158 . . . . 1.5700000000000001 107.874 151.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -149.02 136.04 19.89 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.265 1.026 . . . . 2.3599999999999999 109.436 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.34 165.42 27.94 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.836 0.826 . . . . 3.4700000000000002 112.774 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -114.87 89.91 20.89 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 114.132 -1.395 . . . . 0.88 110.16 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.14 -5.77 17.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 1.21 112.922 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.59 172.72 50.7 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.329 0.966 . . . . 1.0 113.333 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.79 -1.56 34.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 2.7400000000000002 113.276 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -119.09 159.04 46.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.866 1.666 . . . . 1.8300000000000001 110.548 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.87 156.88 27.31 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.966 2.444 . . . . 1.1899999999999999 112.317 -168.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.9 102.71 7.92 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.607 1.563 . . . . 2.2799999999999998 109.732 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttp-105 -92.38 113.44 25.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.103 1.361 . . . . 3.6299999999999999 111.031 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -103.95 109.67 21.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 128.324 2.65 . . . . 1.1699999999999999 108.592 -171.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -99.79 -17.0 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.654 1.182 . . . . 0.68000000000000005 113.377 -168.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.28 -168.25 39.35 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.95 0.786 . . . . 0.48999999999999999 111.99 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -144.01 177.36 8.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.825 0.85 . . . . 0.78000000000000003 110.901 175.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -163.45 128.44 2.99 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.496 1.043 . . . . 5.4400000000000004 108.487 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -136.06 153.22 76.67 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.504 -1.236 . . . . 0.93999999999999995 109.089 -177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.79 -28.63 86.76 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.125 1.883 . . . . 1.24 113.379 166.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.6 -5.1 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 115.036 1.495 . . . . 1.3400000000000001 115.036 -168.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.68 170.44 15.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.321 1.448 . . . . 0.91000000000000003 113.029 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -113.6 -81.4 0.6 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.76 1.624 . . . . 2.8599999999999999 111.553 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -80.98 111.18 17.22 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 120.971 -1.081 . . . . 3.6899999999999999 109.105 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.86 131.72 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.461 1.905 . . . . 1.25 109.79 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -147.47 131.92 17.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.452 1.101 . . . . 2.0800000000000001 110.539 -167.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.37 119.82 22.94 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.156 1.344 . . . . 0.81999999999999995 110.672 170.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.6 m170 -109.65 157.8 18.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.332 1.853 . . . . 0.73999999999999999 111.519 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.03 -176.53 3.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.837 0.855 . . . . 3.1200000000000001 111.535 164.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 m -146.65 99.66 3.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.929 1.292 . . . . 1.0900000000000001 107.609 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -106.29 -177.99 3.52 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.523 1.529 . . . . 2.0499999999999998 112.636 -166.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -138.67 143.39 39.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.946 1.299 . . . . 3.0800000000000001 110.673 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -155.39 159.59 40.01 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.227 1.411 . . . . 6.7999999999999998 111.595 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -97.74 151.79 19.79 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.686 1.194 . . . . 3.73 112.253 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.15 -92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.365 1.466 . . . . 3.0499999999999998 109.577 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -74.88 36.78 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.35 2.26 . . . . 4.6900000000000004 110.873 171.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -18.2 0.63 Allowed Glycine 0 CA--C 1.538 1.499 0 O-C-N 120.421 -1.424 . . . . 2.0600000000000001 113.398 -158.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -79.62 135.53 36.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.262 1.825 . . . . 3.7200000000000002 109.628 -177.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 125.19 32.17 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.543 1.137 . . . . 6.04 112.915 -175.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -123.34 147.82 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.603 1.961 . . . . 1.51 109.408 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.9 ptp -94.95 155.62 16.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.533 1.133 . . . . 4.1900000000000004 113.565 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.05 169.17 33.1 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 123.899 0.761 . . . . 1.0600000000000001 113.251 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.6 mtt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.116 1.367 . . . . 2.5499999999999998 110.153 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -159.1 150.14 16.26 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 117.282 -1.342 . . . . 5.8499999999999996 110.03 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 10.0 Cg_endo -67.26 146.37 75.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.843 1.696 . . . . 0.79000000000000004 110.142 164.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 m -113.56 160.27 32.34 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 126.028 1.731 . . . . 0.65000000000000002 110.115 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.74 -24.36 47.47 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.212 1.941 . . . . 0.81999999999999995 112.29 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -178.05 163.6 1.75 Allowed 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.836 1.654 . . . . 2.2599999999999998 111.712 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -108.54 173.16 6.44 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.034 1.334 . . . . 1.03 109.38 150.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.39 161.61 42.17 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.366 -0.834 . . . . 2.9900000000000002 111.852 162.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.69 126.04 22.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.254 1.821 . . . . 1.0 108.041 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.74 163.12 40.19 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.657 2.238 . . . . 0.92000000000000004 110.374 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -61.7 136.66 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.645 2.23 . . . . 0.94999999999999996 110.717 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt 67.15 2.62 2.85 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.821 2.049 . . . . 1.47 113.809 -174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.79 172.67 44.49 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.548 2.023 . . . . 0.95999999999999996 111.395 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -156.14 147.48 22.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 112.392 -1.904 . . . . 3.9399999999999999 111.923 -171.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.11 155.4 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.783 1.633 . . . . 1.98 110.716 168.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -128.52 114.11 16.33 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.802 -1.555 . . . . 3.9700000000000002 106.802 167.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.78 91.62 3.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.086 1.354 . . . . 1.23 112.315 -166.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.634 1.174 . . . . 2.9100000000000001 111.631 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.56 -17.87 58.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.929 2.419 . . . . 1.1100000000000001 113.197 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.6 52.98 0.85 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.706 1.146 . . . . 1.1200000000000001 111.486 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.9 -76.08 0.06 OUTLIER Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.591 1.091 . . . . 0.72999999999999998 114.767 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -153.81 137.6 16.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.602 1.961 . . . . 1.8999999999999999 110.026 -170.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -166.6 173.82 9.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.947 0.899 . . . . 0.87 110.294 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.49 124.72 50.02 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 118.499 -0.762 . . . . 1.9299999999999999 110.237 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.39 132.56 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.198 0.908 . . . . 1.0 109.568 163.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.28 132.42 54.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.578 1.151 . . . . 1.5 109.015 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.63 117.15 12.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.069 2.147 . . . . 2.8199999999999998 108.966 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.94 111.84 0.31 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.268 -1.133 . . . . 1.75 110.268 -170.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.4 mt -112.39 141.94 45.52 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.483 0.659 . . . . 1.54 111.279 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -82.73 1.91 36.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.655 0.782 . . . . 1.75 112.403 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -150.15 156.81 37.68 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 127.451 2.3 . . . . 4.0700000000000003 111.151 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.23 165.29 32.9 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.166 1.911 . . . . 1.6100000000000001 109.157 151.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -112.57 131.02 55.81 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.941 -0.763 . . . . 2.73 108.941 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.94 122.32 18.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.399 1.079 . . . . 3.5299999999999998 108.265 -169.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.34 28.51 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.024 1.284 . . . . 1.3999999999999999 112.482 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 45.23 8.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.487 0.565 . . . . 2.48 113.669 -172.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.97 165.76 24.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.454 -1.027 . . . . 2.71 109.199 141.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -115.34 155.32 27.56 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.168 0.987 . . . . 4.7199999999999998 112.159 -168.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.72 118.41 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.488 1.915 . . . . 1.2 109.654 -173.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.61 146.28 48.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.753 0.311 . . . . 2.8700000000000001 110.202 163.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.4 tt -155.29 126.18 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.558 0.743 . . . . 1.8899999999999999 111.679 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.81 112.52 21.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.836 3.254 . . . . 2.1899999999999999 111.347 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.5 mt -81.47 124.0 29.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.523 1.129 . . . . 1.1299999999999999 108.566 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 mt -96.85 127.38 42.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.933 1.293 . . . . 0.68000000000000005 109.878 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 97.0 m-85 -110.59 162.92 14.24 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.869 -1.145 . . . . 2.3399999999999999 112.581 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.53 101.54 1.01 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.786 -0.571 . . . . 1.73 111.472 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.86 19.0 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.506 1.05 . . . . 3.0299999999999998 111.601 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.56 54.55 4.37 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.23 0.919 . . . . 1.6599999999999999 115.182 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 14.1 ttpt -145.03 136.62 25.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 1.486 . . . . 4.5800000000000001 112.39 172.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.08 134.57 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 125.75 1.62 . . . . 1.4099999999999999 107.884 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.8 mt -143.85 124.93 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.081 1.352 . . . . 2.1699999999999999 108.491 -170.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.75 150.55 22.24 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.077 1.51 . . . . 3.6899999999999999 115.077 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -120.08 168.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.367 2.267 . . . . 1.1499999999999999 108.87 163.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.52 141.83 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.368 1.067 . . . . 2.2200000000000002 109.288 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.8 mt -131.85 131.69 22.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.319 1.848 . . . . 2.1400000000000001 108.765 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.91 155.51 43.36 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.53 2.153 . . . . 1.4399999999999999 111.124 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.5 t -86.2 123.49 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.161 -1.051 . . . . 1.54 108.161 164.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.05 160.11 28.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.01 1.324 . . . . 3.3700000000000001 110.615 -177.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.434 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -82.55 51.52 1.87 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.809 1.04 . . . . 3.1699999999999999 113.809 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.165 1.786 . . . . 5.3899999999999997 112.331 -174.022 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.771 0.795 . . . . 5.8099999999999996 111.513 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -86.88 162.94 34.5 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 126.347 1.927 . . . . 0.98999999999999999 114.455 -172.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -147.92 150.11 33.48 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.749 0.819 . . . . 1.6599999999999999 112.444 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -103.79 134.32 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.234 1.414 . . . . 1.1100000000000001 108.267 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ttt-85 -86.8 100.3 12.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.182 1.178 . . . . 4.5700000000000003 114.182 -162.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.63 133.26 55.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.823 0.82 . . . . 2.8100000000000001 110.773 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -162.91 157.36 17.96 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.965 1.706 . . . . 2.3300000000000001 110.014 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -86.54 67.04 4.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.721 2.948 . . . . 3.21 110.219 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.98 164.29 28.89 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.693 1.037 . . . . 1.5600000000000001 115.693 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -80.1 -9.72 14.02 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.64 3.56 . . . . 1.4199999999999999 112.594 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -142.3 151.98 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.2 1.8 . . . . 2.0800000000000001 111.072 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.61 -163.86 1.52 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.548 1.539 . . . . 1.1499999999999999 111.237 -173.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.66 156.09 39.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.088 1.355 . . . . 1.21 110.66 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.92 148.76 45.09 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.948 0.899 . . . . 1.1100000000000001 110.631 156.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -128.07 178.01 6.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.828 1.651 . . . . 2.5800000000000001 110.124 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.533 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.5 pt? -169.92 161.15 8.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.137 1.775 . . . . 1.55 111.199 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -98.2 145.01 27.04 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.702 -1.592 . . . . 1.6799999999999999 106.702 154.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.46 127.61 7.66 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.438 1.095 . . . . 2.6299999999999999 110.377 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 151.26 29.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.467 1.507 . . . . 2.7400000000000002 111.544 173.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -98.23 109.15 50.95 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.051 -0.977 . . . . 1.25 110.105 161.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.19 -8.87 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.884 2.389 . . . . 1.8100000000000001 113.787 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.44 171.04 49.38 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.359 0.981 . . . . 1.6299999999999999 113.271 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.98 -5.0 45.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.312 1.845 . . . . 3.04 112.66 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.58 158.06 39.74 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.83 2.052 . . . . 4.71 108.595 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.83 151.61 24.67 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.907 2.405 . . . . 1.23 111.62 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -102.23 133.14 47.59 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.06 0.944 . . . . 2.1099999999999999 111.018 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -117.1 107.84 14.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.902 1.281 . . . . 2.8599999999999999 110.501 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -95.14 114.52 26.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.644 2.378 . . . . 0.69999999999999996 109.192 -169.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.65 -9.44 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.506 1.122 . . . . 0.69999999999999996 112.968 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.13 -171.54 44.61 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.481 1.039 . . . . 0.53000000000000003 111.438 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.713 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -153.8 170.07 21.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.018 1.327 . . . . 0.87 110.735 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -158.39 115.59 2.87 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 120.057 1.298 . . . . 4.9500000000000002 109.376 -165.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 t -127.03 159.33 65.33 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 117.759 -1.115 . . . . 0.83999999999999997 109.353 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.93 -22.75 48.09 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.533 2.155 . . . . 0.88 113.685 164.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.253 3.9 m -87.91 8.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.383 1.623 . . . . 0.97999999999999998 115.383 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.94 161.94 41.31 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.805 -1.185 . . . . 0.89000000000000001 113.677 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.7 -88.61 0.28 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.022 1.729 . . . . 2.96 110.516 174.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -81.48 121.54 26.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 3.6400000000000001 110.286 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.91 142.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 2.0299999999999998 111.36 164.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -140.71 116.09 10.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.946 1.298 . . . . 2.23 110.091 166.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.8 tt -76.83 119.19 20.25 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 120.897 1.681 . . . . 0.66000000000000003 110.639 170.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -105.09 152.07 23.22 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.035 1.334 . . . . 0.57999999999999996 112.549 177.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.46 179.82 5.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.606 1.962 . . . . 2.48 110.941 165.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 m -144.26 93.15 2.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.86 1.664 . . . . 1.0800000000000001 107.906 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.79 146.4 23.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.42 1.105 . . . . 2.3799999999999999 111.833 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -87.51 147.82 25.19 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.912 1.285 . . . . 4.3899999999999997 110.34 165.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.57 152.75 23.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.564 1.546 . . . . 6.0199999999999996 110.918 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.59 141.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.122 -1.066 . . . . 4.0599999999999996 108.122 156.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.88 120.6 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.535 1.534 . . . . 3.4700000000000002 106.997 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 62.07 23.8 14.09 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.946 0.899 . . . . 3.3599999999999999 111.602 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.88 -10.72 38.28 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.065 1.317 . . . . 2.1400000000000001 114.275 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -87.35 140.93 29.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.921 1.689 . . . . 3.2200000000000002 109.705 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -79.65 128.28 33.2 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.424 -0.798 . . . . 3.9199999999999999 111.003 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -135.69 150.13 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.864 1.665 . . . . 1.6399999999999999 110.443 -170.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.7 tpp -119.85 138.88 53.13 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.255 1.422 . . . . 3.8100000000000001 109.223 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.08 141.28 11.08 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 118.92 0.782 . . . . 1.3100000000000001 113.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -89.3 165.31 14.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.717 0.807 . . . . 1.73 111.176 169.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 -176.07 138.14 0.5 Allowed Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 116.455 -1.736 . . . . 4.4699999999999998 111.146 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.84 139.03 38.96 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 122.75 2.018 . . . . 0.60999999999999999 111.607 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.67 156.07 42.99 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 126.033 1.733 . . . . 0.5 111.163 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.74 -17.21 33.28 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.989 2.46 . . . . 0.62 113.087 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -177.52 165.89 2.19 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.857 2.063 . . . . 1.78 111.424 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.51 173.5 6.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.952 1.701 . . . . 0.96999999999999997 109.384 155.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.96 164.25 38.3 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.382 -0.824 . . . . 2.1499999999999999 113.075 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -139.53 129.23 14.08 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.046 1.738 . . . . 0.97999999999999998 109.03 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.38 161.99 42.76 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.691 2.261 . . . . 0.81000000000000005 111.727 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.21 135.93 65.31 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.772 2.981 . . . . 1.1399999999999999 112.333 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt 68.08 1.02 2.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.316 1.847 . . . . 2.2400000000000002 113.9 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.42 -178.48 45.46 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 126.109 1.814 . . . . 1.45 111.023 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -160.11 163.74 33.57 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.065 1.346 . . . . 4.6200000000000001 112.425 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.91 154.2 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.376 1.47 . . . . 1.6799999999999999 111.115 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.5 123.49 47.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.645 1.178 . . . . 3.3599999999999999 109.448 164.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.3 146.34 43.23 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 1.72 109.645 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 9.2 ptpp? -153.99 151.12 23.99 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.89 0.876 . . . . 3.1299999999999999 112.285 -163.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.59 -50.93 4.69 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.757 2.972 . . . . 0.93999999999999995 112.233 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.27 90.44 1.56 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 109.07 -1.612 . . . . 1.3 109.07 162.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.57 -90.22 0.11 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 123.659 0.647 . . . . 0.79000000000000004 114.075 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -153.26 140.24 19.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.287 1.435 . . . . 1.8200000000000001 110.3 -170.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -162.64 156.59 20.84 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.239 0.616 . . . . 1.02 111.307 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 45' ' ' LEU . 71.5 m-85 -90.51 112.77 24.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 2.0699999999999998 109.012 166.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.2 125.59 27.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.469 -0.938 . . . . 1.78 108.469 167.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.92 117.16 34.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.786 -1.19 . . . . 1.5700000000000001 107.786 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.65 110.75 20.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.965 1.306 . . . . 3.1699999999999999 108.188 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.21 98.52 0.7 Allowed Glycine 0 N--CA 1.47 0.904 0 C-N-CA 124.346 0.974 . . . . 1.5900000000000001 111.19 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 mt -96.34 128.78 43.57 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.649 0.779 . . . . 0.97999999999999998 110.916 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -18.74 53.85 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.493 0.923 . . . . 2.04 113.493 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.9 150.85 77.71 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 125.885 1.674 . . . . 4.3499999999999996 108.268 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.98 118.59 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 107.048 -1.943 . . . . 1.3999999999999999 107.048 155.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.39 108.54 1.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.177 1.391 . . . . 1.97 111.492 -160.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -80.45 105.05 11.42 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.149 -0.969 . . . . 4.6600000000000001 110.885 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.47 111.86 0.79 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.715 -1.217 . . . . 1.6000000000000001 107.715 152.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 5.89 34.41 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 117.312 -1.827 . . . . 2.3599999999999999 116.228 -166.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.45 169.21 8.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.731 2.265 . . . . 3.0299999999999998 111.748 160.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.76 141.66 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.633 1.573 . . . . 4.6799999999999997 109.454 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.64 112.51 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.776 0.831 . . . . 1.23 110.815 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.89 148.31 51.66 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.999 0.52 . . . . 3.0099999999999998 111.181 163.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.713 HD11 ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -153.77 116.71 4.5 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.415 1.102 . . . . 3.3599999999999999 109.87 174.147 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.41 116.61 21.96 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.732 2.813 . . . . 1.99 111.029 170.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.0 mt -83.73 118.77 24.11 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.34 1.456 . . . . 2.0899999999999999 110.313 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt -93.95 122.01 36.01 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.328 0.513 . . . . 0.76000000000000001 109.785 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -120.31 152.57 37.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.296 1.046 . . . . 2.27 112.235 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.87 113.62 1.57 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.59 1.156 . . . . 1.6299999999999999 112.993 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 76.06 0.86 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.332 1.444 . . . . 3.3399999999999999 113.268 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.26 -6.6 56.52 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 116.744 1.458 . . . . 2.2200000000000002 116.744 163.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -86.98 128.01 35.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.183 1.991 . . . . 5.2300000000000004 110.122 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.58 135.68 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.181 1.392 . . . . 1.3799999999999999 108.957 168.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.43 125.06 19.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.445 1.098 . . . . 2.1200000000000001 110.26 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.28 135.49 34.73 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.345 0.869 . . . . 2.6600000000000001 113.345 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.46 175.57 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.565 1.546 . . . . 1.3 109.804 157.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.07 141.51 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.787 1.635 . . . . 2.1600000000000001 107.742 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.7 mt -143.91 160.14 50.94 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.794 1.638 . . . . 2.1499999999999999 111.267 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.49 169.07 19.07 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.738 3.626 . . . . 1.1799999999999999 112.679 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.1 t -107.2 133.28 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.43 1.892 . . . . 1.04 110.72 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 151.51 42.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.085 1.354 . . . . 4.9000000000000004 111.044 170.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.33 85.35 6.88 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.074 -1.016 . . . . 2.2599999999999998 110.62 163.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.244 -1.36 . . . . 7.71 111.54 171.7 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 121.425 0.631 . . . . 5.54 111.019 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.78 174.73 55.19 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.506 1.05 . . . . 1.21 113.367 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -155.0 158.7 39.56 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.779 1.232 . . . . 2.27 112.069 -175.374 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.5 t -113.19 146.43 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 121.017 -1.052 . . . . 1.6499999999999999 109.373 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.99 140.08 40.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.806 -0.758 . . . . 5.3300000000000001 111.71 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -47.06 127.19 10.04 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.466 1.507 . . . . 3.7400000000000002 110.953 160.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -174.5 106.0 0.28 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.909 2.084 . . . . 2.7400000000000002 109.781 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -88.04 19.18 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.918 3.079 . . . . 2.7999999999999998 111.707 170.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.1 -165.26 38.95 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.836 1.208 . . . . 1.3600000000000001 113.724 -171.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.57 -19.39 21.66 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.029 2.486 . . . . 1.4399999999999999 112.647 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -146.68 165.06 30.71 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.829 1.252 . . . . 1.96 113.186 -178.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 -179.92 8.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.441 1.497 . . . . 1.27 112.426 177.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.55 135.64 51.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.716 1.606 . . . . 1.0900000000000001 110.065 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.37 123.81 41.32 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.205 0.526 . . . . 1.01 110.165 162.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -92.04 154.9 18.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.319 1.448 . . . . 1.9199999999999999 108.238 164.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -166.63 136.78 3.18 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.27 -0.894 . . . . 1.5600000000000001 113.028 175.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.2 m -79.35 148.28 32.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.011 -1.45 . . . . 1.26 107.613 165.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.13 141.0 18.2 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.035 1.734 . . . . 2.3700000000000001 107.507 -176.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -144.31 132.49 21.75 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.881 -1.137 . . . . 3.2799999999999998 110.579 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.63 109.6 39.7 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.341 1.456 . . . . 0.92000000000000004 109.895 177.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.87 -9.88 14.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.629 2.219 . . . . 1.1699999999999999 113.91 176.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.28 173.92 54.78 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.042 0.829 . . . . 1.1200000000000001 113.961 -172.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -104.26 3.45 32.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.404 1.881 . . . . 3.0899999999999999 112.491 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -116.33 164.58 17.6 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.691 1.996 . . . . 1.71 109.868 163.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.14 159.29 15.38 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.062 2.508 . . . . 1.0600000000000001 112.048 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.9 mt -106.6 154.59 20.69 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.624 1.17 . . . . 1.9299999999999999 110.985 168.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.4 ttp-105 -141.93 114.92 8.69 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.248 1.419 . . . . 4.9500000000000002 112.081 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.94 118.52 33.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.262 3.025 . . . . 0.90000000000000002 110.019 -176.128 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' HB2' ' A' ' 106' ' ' ALA . 35.0 m -115.86 -20.0 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.589 1.156 . . . . 0.77000000000000002 113.768 -173.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.15 16.81 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.509 -0.744 . . . . 1.1000000000000001 111.688 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.939 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -154.75 176.89 11.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.851 0.86 . . . . 1.1399999999999999 111.452 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 8.7 mmm180 -156.74 146.28 20.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.561 -0.903 . . . . 6.5899999999999999 108.561 172.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -142.72 157.61 61.42 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.721 -1.133 . . . . 0.67000000000000004 108.717 174.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.14 -25.34 50.85 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.352 2.035 . . . . 1.0800000000000001 113.795 160.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.4 2.71 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 115.631 1.715 . . . . 0.84999999999999998 115.631 -165.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.55 152.2 29.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.294 0.952 . . . . 0.93000000000000005 113.367 -177.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.32 -88.34 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.558 1.943 . . . . 2.98 110.436 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -77.88 116.77 18.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.395 1.478 . . . . 4.3799999999999999 109.34 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.34 134.93 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.68 1.592 . . . . 1.3300000000000001 109.584 174.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.55 138.26 44.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.012 1.725 . . . . 1.95 110.606 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.508 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 16.1 tp -84.51 109.89 18.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.486 1.114 . . . . 2.9399999999999999 109.444 172.212 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -113.59 154.36 27.31 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.027 1.331 . . . . 1.1100000000000001 113.682 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.4 164.92 11.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.912 2.085 . . . . 1.8200000000000001 111.431 171.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.6 m -130.15 111.67 12.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.955 1.302 . . . . 1.4399999999999999 108.551 170.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -112.67 154.79 25.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.805 1.242 . . . . 2.0499999999999998 113.308 -174.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 159.12 15.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.693 1.197 . . . . 3.6400000000000001 110.894 164.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.25 146.97 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.383 1.473 . . . . 8.4000000000000004 111.399 -167.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.64 143.71 32.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.494 1.118 . . . . 5.0499999999999998 112.352 175.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.97 133.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.955 1.702 . . . . 3.9199999999999999 109.246 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 67.61 6.07 4.77 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.588 1.155 . . . . 3.8399999999999999 112.641 -171.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.49 4.94 89.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.724 1.631 . . . . 2.8300000000000001 113.789 -166.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -100.76 148.72 24.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.711 2.004 . . . . 3.54 110.99 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 149.27 25.46 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.375 -0.828 . . . . 4.2999999999999998 112.423 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.04 152.92 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.473 1.909 . . . . 3.3300000000000001 109.366 175.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.5 mtm -112.56 155.45 24.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.181 0.992 . . . . 3.8199999999999998 112.072 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.72 177.35 32.89 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.223 0.916 . . . . 1.4399999999999999 112.731 173.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -125.17 157.79 35.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.17 1.388 . . . . 2.1099999999999999 110.511 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.13 157.38 63.76 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.299 -1.334 . . . . 6.3600000000000003 108.506 161.286 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.34 141.65 82.47 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.903 1.358 . . . . 1.0700000000000001 110.264 151.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.37 153.46 41.99 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 126.522 1.929 . . . . 0.78000000000000003 110.27 178.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.01 -31.44 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.533 2.155 . . . . 1.23 112.943 -174.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.3 p90 164.47 148.17 0.02 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 126.807 2.043 . . . . 2.8399999999999999 107.909 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.59 145.41 46.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.715 -1.13 . . . . 4.04 108.257 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.277 0.0 OUTLIER -141.27 155.24 46.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.803 1.038 . . . . 3.3599999999999999 113.803 -175.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.8 t -139.25 132.18 15.57 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 113.919 -1.491 . . . . 0.94999999999999996 109.443 -156.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.23 166.96 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.07 1.847 . . . . 0.80000000000000004 112.074 179.24 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -55.96 140.64 86.25 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.561 2.84 . . . . 0.94999999999999996 111.718 166.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm 67.65 -0.67 1.86 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.012 1.725 . . . . 1.73 113.532 -174.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.79 113.92 4.39 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 126.773 2.13 . . . . 0.91000000000000003 113.363 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -80.97 133.47 35.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.316 1.446 . . . . 4.1600000000000001 109.9 162.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.9 168.88 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.738 1.615 . . . . 1.5800000000000001 110.45 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -164.1 117.22 1.41 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.708 0.403 . . . . 3.6800000000000002 111.373 -167.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.67 72.77 3.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.14 2.176 . . . . 1.3500000000000001 110.267 178.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -80.72 148.0 64.2 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 126.041 1.736 . . . . 3.3100000000000001 113.299 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -47.87 21.39 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.439 3.426 . . . . 0.84999999999999998 114.29 -168.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.66 103.4 2.74 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 107.525 -2.23 . . . . 1.24 107.525 157.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.6 -102.71 0.28 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.494 1.997 . . . . 0.79000000000000004 110.416 -162.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -149.1 158.76 44.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.46 1.504 . . . . 2.3599999999999999 110.619 -175.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -165.34 158.52 16.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.847 -1.158 . . . . 1.0800000000000001 110.313 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.508 ' CZ ' HD13 ' A' ' 45' ' ' LEU . 46.8 m-85 -96.59 117.28 30.63 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.595 -0.691 . . . . 2.4500000000000002 109.295 171.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.27 121.54 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.064 1.346 . . . . 1.24 110.251 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.5 mt -108.02 106.29 16.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.69 1.996 . . . . 1.51 108.631 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.82 122.93 47.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.228 1.411 . . . . 2.7799999999999998 109.384 -177.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.41 89.46 0.39 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.429 -1.068 . . . . 1.27 110.429 -175.02 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.13 122.25 27.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.641 0.721 . . . . 0.81000000000000005 111.682 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -74.44 -13.9 60.77 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.862 0.865 . . . . 1.6899999999999999 112.955 172.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ptt85 -157.48 142.11 11.94 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 5.7699999999999996 110.41 165.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.76 141.8 38.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.834 3.023 . . . . 1.9099999999999999 111.186 -176.291 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.82 78.99 9.42 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.9 -1.148 . . . . 2.9199999999999999 107.9 177.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -69.45 162.84 26.6 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.736 0.779 . . . . 3.96 111.555 170.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.12 132.95 53.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.204 -1.035 . . . . 2.6000000000000001 108.204 163.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.21 49.85 19.36 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.417 -0.657 . . . . 3.54 112.437 -171.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -126.22 167.55 15.28 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.538 1.135 . . . . 3.0499999999999998 109.895 163.454 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -134.63 151.92 51.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.781 1.232 . . . . 4.3499999999999996 111.353 172.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.59 121.17 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.713 2.005 . . . . 1.49 108.627 -171.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.54 149.68 33.02 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.849 -0.532 . . . . 2.6099999999999999 110.034 162.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.939 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.9 tt -149.41 125.55 10.71 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.63 0.372 . . . . 2.0499999999999998 111.647 166.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -91.03 108.53 19.92 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.231 3.413 . . . . 2.4399999999999999 110.067 178.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.31 131.37 37.01 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.304 1.042 . . . . 2.5899999999999999 110.294 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -101.39 122.48 43.81 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.817 0.847 . . . . 0.91000000000000003 110.733 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 137.33 52.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.585 0.958 . . . . 2.21 113.585 -172.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.442 ' HB2' HG11 ' A' ' 33' ' ' VAL . . . -76.57 73.21 3.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.67 1.188 . . . . 2.52 112.047 176.5 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.61 32.37 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.529 1.061 . . . . 5.3899999999999997 114.589 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.77 28.33 70.96 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 118.387 1.094 . . . . 2.6299999999999999 113.869 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.26 141.37 52.13 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.815 1.246 . . . . 4.1100000000000003 111.763 -178.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.8 136.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.131 1.772 . . . . 1.28 107.627 159.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.8 mt -144.68 124.82 13.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.476 1.11 . . . . 1.75 110.022 -174.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -91.53 149.2 21.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 115.542 1.682 . . . . 2.2999999999999998 115.542 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.58 148.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.239 1.816 . . . . 2.2999999999999998 109.613 167.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.92 133.2 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.184 1.393 . . . . 2.96 109.927 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -136.19 113.9 10.58 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.314 1.046 . . . . 2.0699999999999998 111.033 -165.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.31 158.13 37.11 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.162 2.575 . . . . 1.5 111.593 171.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.61 129.88 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.388 1.475 . . . . 2.0099999999999998 111.188 176.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.44 162.88 34.34 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.33 1.852 . . . . 3.4900000000000002 108.916 175.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.68 51.76 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.448 -1.408 . . . . 2.77 112.683 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.391 0 CA-C-O 114.021 -2.895 . . . . 4.54 117.173 -157.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 108.633 -0.877 . . . . 6.25 108.633 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.25 173.66 26.45 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.866 1.666 . . . . 1.46 115.116 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -154.74 154.28 32.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.537 1.16 . . . . 1.95 114.004 -178.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.54 144.86 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 107.04 -1.466 . . . . 1.27 107.04 158.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -90.4 117.5 29.15 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.087 0.555 . . . . 4.6399999999999997 111.263 -179.066 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -48.8 130.35 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.782 1.233 . . . . 2.9199999999999999 111.86 162.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.467 ' H ' ' HB2' ' A' ' 93' ' ' LEU . 33.9 m -163.4 129.73 2.33 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 128.831 2.852 . . . . 2.1200000000000001 107.862 165.593 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -83.92 67.06 7.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.178 2.585 . . . . 2.3900000000000001 109.707 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.84 -174.43 20.45 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 115.128 0.811 . . . . 1.8 115.128 -172.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -83.48 -15.06 7.69 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 124.212 3.275 . . . . 1.8 113.191 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -131.0 157.75 42.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.704 1.602 . . . . 4.0800000000000001 110.681 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.63 -164.35 1.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.064 1.746 . . . . 1.3100000000000001 111.552 177.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.21 160.69 39.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.966 1.707 . . . . 1.24 110.764 -178.158 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 158.9 43.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.095 1.358 . . . . 0.93999999999999995 112.394 171.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -162.02 152.91 17.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.263 2.225 . . . . 2.6099999999999999 109.499 -173.185 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.23 157.74 26.16 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.893 -1.129 . . . . 1.6499999999999999 112.381 -175.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.8 m -77.96 96.8 5.13 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.571 -1.27 . . . . 1.6499999999999999 107.571 165.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 tt -88.3 148.94 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.931 1.692 . . . . 2.9700000000000002 108.92 169.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -150.0 165.37 32.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.733 0.777 . . . . 4.1600000000000001 112.896 168.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -120.88 101.62 45.11 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 126.007 1.723 . . . . 0.89000000000000001 109.343 171.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.82 -5.48 15.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.95 2.433 . . . . 1.03 113.302 174.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.02 -177.78 51.54 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.883 1.23 . . . . 0.95999999999999996 114.176 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -112.69 1.75 15.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.275 1.43 . . . . 2.6800000000000002 113.373 -170.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.15 162.18 27.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.91 1.684 . . . . 1.6799999999999999 109.71 165.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.58 157.88 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.847 2.365 . . . . 1.05 111.825 -172.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 mt -107.81 149.06 28.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.917 0.887 . . . . 2.0499999999999998 111.558 172.012 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -121.14 110.75 16.58 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.188 1.395 . . . . 6.3399999999999999 109.232 168.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.8 tp -82.93 127.25 33.35 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.838 1.255 . . . . 0.77000000000000002 108.173 175.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.6 -11.0 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.432 0.901 . . . . 0.56999999999999995 113.432 -173.28 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.11 -162.74 33.36 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 121.564 0.536 . . . . 0.46999999999999997 112.295 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.954 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -147.59 178.92 8.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.465 1.506 . . . . 0.81000000000000005 110.154 175.3 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -161.59 139.76 9.29 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.129 0.877 . . . . 6.6399999999999997 109.137 167.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.6 t -145.56 146.34 29.21 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.99 1.316 . . . . 0.69999999999999996 108.811 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.91 -22.9 55.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.963 1.775 . . . . 1.3100000000000001 113.132 178.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.77 0.15 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 114.42 1.267 . . . . 1.28 114.42 -174.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.04 168.01 9.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 116.068 1.877 . . . . 2.1000000000000001 116.068 -169.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.37 -104.36 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 106.955 -1.498 . . . . 6.3300000000000001 106.955 143.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -79.49 169.37 18.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.554 1.168 . . . . 4.1900000000000004 112.464 167.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.6 132.02 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.868 1.667 . . . . 1.46 107.865 161.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -119.94 128.44 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.89 1.276 . . . . 1.97 109.705 -175.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 84' ' ' PHE . 5.5 tt -81.54 120.09 24.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.773 1.17 . . . . 0.66000000000000003 110.628 169.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -110.33 153.05 25.44 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.592 1.557 . . . . 0.67000000000000004 112.933 176.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.22 172.13 8.16 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.443 2.297 . . . . 2.1800000000000002 110.699 165.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.1 m -133.19 92.65 3.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.115 1.366 . . . . 1.1299999999999999 108.015 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -97.59 149.42 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.138 0.971 . . . . 2.25 113.161 -163.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.3 ttp -79.05 139.4 38.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.629 1.172 . . . . 4.6399999999999997 110.086 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.58 113.93 2.61 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.54 0.736 . . . . 10.31 111.615 -175.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.01 153.69 19.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.158 0.983 . . . . 4.5800000000000001 110.613 174.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.6 t -143.51 122.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.284 -1.376 . . . . 3.4399999999999999 107.284 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 69.28 8.47 6.82 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.916 1.286 . . . . 3.98 111.984 -174.126 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.58 85.31 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.843 1.211 . . . . 1.79 113.82 -166.138 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -90.94 143.14 27.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.561 1.544 . . . . 3.0 110.225 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -75.16 132.84 41.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.713 1.605 . . . . 4.1799999999999997 113.307 -165.322 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.31 172.26 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.421 0.629 . . . . 1.8400000000000001 112.163 172.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.3 tpp -129.75 159.24 37.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.814 2.045 . . . . 3.7599999999999998 110.133 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.45 177.75 22.06 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.009 1.766 . . . . 1.1000000000000001 112.16 173.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.3 mtt -138.9 154.49 48.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.779 1.632 . . . . 2.1600000000000001 109.66 173.257 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -169.82 144.0 2.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 116.401 -1.761 . . . . 4.5599999999999996 111.333 -169.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.99 150.93 87.44 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 CA-C-N 121.716 1.648 . . . . 0.66000000000000003 112.414 165.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.48 159.02 47.54 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 126.418 1.887 . . . . 0.65000000000000002 110.703 173.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -70.93 -22.16 27.06 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.683 2.255 . . . . 0.68000000000000005 112.801 173.088 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -175.92 171.27 2.65 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.939 1.696 . . . . 1.8799999999999999 111.562 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.44 172.1 8.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.746 2.018 . . . . 0.98999999999999999 109.136 159.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.15 161.56 41.2 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.917 -1.114 . . . . 2.54 111.651 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.62 136.43 10.59 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.262 1.025 . . . . 0.87 109.679 -166.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.72 170.02 19.69 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.549 2.166 . . . . 0.80000000000000004 112.027 178.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -60.91 142.68 98.31 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.225 2.617 . . . . 0.88 111.599 166.289 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 64.55 6.57 3.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.243 1.817 . . . . 1.3600000000000001 113.506 -174.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.42 115.41 4.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 126.192 1.853 . . . . 0.96999999999999997 111.164 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.67 137.26 36.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.498 1.519 . . . . 4.8700000000000001 110.151 166.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.06 129.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.163 0.985 . . . . 1.53 111.557 177.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.22 124.55 31.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.699 -0.852 . . . . 3.8799999999999999 108.699 165.112 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.1 145.49 53.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.362 -0.977 . . . . 1.78 108.362 163.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -155.92 138.85 10.67 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 117.974 -1.012 . . . . 3.5099999999999998 111.726 -166.108 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.79 -26.5 45.01 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.653 2.902 . . . . 1.1399999999999999 113.587 -172.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.0 87.95 1.5 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 108.084 -2.006 . . . . 1.52 108.084 155.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.85 -97.26 0.18 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.214 0.911 . . . . 0.98999999999999999 113.458 -171.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -150.91 146.45 26.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.703 2.001 . . . . 2.2599999999999998 110.469 -167.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -153.91 159.32 41.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.841 -0.537 . . . . 0.91000000000000003 111.124 -175.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 41.7 m-85 -94.7 118.61 32.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.299 -1.001 . . . . 1.8799999999999999 108.299 164.338 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.09 123.15 33.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.425 -0.954 . . . . 1.0800000000000001 108.425 173.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -105.14 122.55 46.13 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.286 1.434 . . . . 2.3599999999999999 109.108 -174.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.95 151.91 39.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.37 1.068 . . . . 2.77 111.157 -170.673 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.85 42.65 92.2 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 123.95 0.786 . . . . 2.0099999999999998 113.219 171.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.7 mt -53.64 141.39 26.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.192 1.797 . . . . 1.51 112.729 -171.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -70.61 -9.53 57.15 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.343 -0.848 . . . . 3.5499999999999998 112.783 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -167.23 152.06 6.86 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.824 2.05 . . . . 7.2400000000000002 111.271 173.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.29 149.22 85.23 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.847 2.365 . . . . 3.1099999999999999 110.132 162.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.467 ' HB2' ' H ' ' A' ' 11' ' ' SER . 2.4 mm? -80.23 155.51 27.31 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.596 0.712 . . . . 2.96 111.786 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.99 -25.56 5.33 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.49 1.916 . . . . 4.5199999999999996 112.18 177.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 80.62 161.57 0.17 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.745 2.818 . . . . 1.9099999999999999 111.516 -175.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.52 57.78 16.32 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.462 -1.055 . . . . 2.6800000000000002 110.462 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -167.34 161.58 14.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.922 2.889 . . . . 3.9399999999999999 107.351 -174.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.59 161.4 16.84 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.713 1.205 . . . . 3.79 112.022 -170.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.2 t -144.6 127.78 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.718 2.007 . . . . 1.3600000000000001 109.886 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.1 140.21 41.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.931 0.492 . . . . 3.1699999999999999 110.742 165.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.954 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.2 tt -148.08 135.57 20.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.458 1.123 . . . . 1.6699999999999999 111.299 169.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.505 ' N ' HD23 ' A' ' 101' ' ' LEU . 4.5 m-20 -104.52 112.29 25.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.826 2.05 . . . . 2.2799999999999998 110.68 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.14 118.38 18.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.484 . . . . 1.26 109.805 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -93.9 121.38 35.3 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.368 0.667 . . . . 0.63 110.179 -173.106 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.14 124.36 47.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.477 1.132 . . . . 1.8700000000000001 113.366 -176.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 58.33 -12.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 131.027 3.731 . . . . 2.8599999999999999 117.574 170.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.03 57.2 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.528 1.537 . . . . 3.5899999999999999 113.452 -163.283 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.75 -0.06 1.82 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.126 1.61 . . . . 1.9099999999999999 117.126 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.4 156.81 43.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.459 1.904 . . . . 4.1699999999999999 111.294 173.076 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.88 128.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.82 1.248 . . . . 0.98999999999999999 109.639 167.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.42 133.72 55.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.809 1.643 . . . . 2.3599999999999999 109.055 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -85.48 134.94 34.03 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.042 -1.036 . . . . 2.46 111.474 176.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.7 164.45 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.987 1.315 . . . . 1.3500000000000001 109.841 160.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.25 142.29 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.532 -1.284 . . . . 2.3599999999999999 107.532 169.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.6 mt -136.76 138.78 27.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.918 1.287 . . . . 2.1000000000000001 109.985 -169.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.11 150.05 17.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.701 2.934 . . . . 1.3400000000000001 111.193 166.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.6 t -88.17 120.56 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.75 1.62 . . . . 1.5600000000000001 109.092 167.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -142.49 162.06 36.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.818 1.247 . . . . 4.5999999999999996 112.194 -170.129 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.23 126.41 41.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.941 0.897 . . . . 3.71 109.105 166.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 129.553 3.141 . . . . 7.9699999999999998 109.325 -171.371 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 118.222 -0.894 . . . . 5.2999999999999998 109.057 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.89 -179.4 24.76 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.686 1.585 . . . . 1.24 114.667 175.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -170.48 156.63 5.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.708 1.603 . . . . 1.6799999999999999 111.903 170.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.03 128.9 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.822 -0.807 . . . . 0.81999999999999995 108.822 172.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -5.13 39.11 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 117.789 2.515 . . . . 3.8100000000000001 117.789 -145.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 69.82 121.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.299 2.639 . . . . 4.0099999999999998 112.248 -174.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -171.36 136.92 1.03 Allowed Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 119.752 -1.843 . . . . 2.0 112.393 178.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -93.88 -5.33 2.63 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.622 3.548 . . . . 2.8700000000000001 113.893 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.75 165.78 53.81 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 119.275 0.943 . . . . 1.28 112.53 177.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.08 -14.77 44.64 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.502 2.801 . . . . 1.5900000000000001 114.54 -172.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -124.61 152.12 43.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.365 1.466 . . . . 4.2199999999999998 111.822 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.1 -168.06 2.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.551 1.94 . . . . 1.1899999999999999 111.223 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.59 156.27 44.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.523 1.129 . . . . 1.1200000000000001 112.997 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.77 140.03 53.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.294 1.437 . . . . 0.96999999999999997 111.559 169.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -119.83 150.79 39.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.575 1.55 . . . . 1.9299999999999999 110.035 178.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -162.83 158.74 23.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.673 0.99 . . . . 1.77 113.673 177.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -94.01 117.22 29.79 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.977 -1.119 . . . . 1.4199999999999999 107.977 165.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.42 135.46 34.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.596 1.958 . . . . 2.3799999999999999 108.136 175.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -145.75 146.3 31.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.971 1.1 . . . . 2.7400000000000002 113.971 170.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -110.08 109.16 59.04 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 113.971 -1.468 . . . . 0.93000000000000005 110.113 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.46 -9.88 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.669 2.246 . . . . 1.04 113.498 175.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.24 177.86 54.13 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.316 0.96 . . . . 0.94999999999999996 114.035 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -106.19 -1.63 23.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.911 1.685 . . . . 2.3300000000000001 112.925 -178.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.95 162.67 19.74 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 126.128 1.771 . . . . 1.6799999999999999 109.646 163.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.17 161.64 17.85 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.011 2.474 . . . . 1.0900000000000001 112.018 -172.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 mt -109.0 154.5 22.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.341 1.056 . . . . 1.9099999999999999 110.488 168.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -138.01 102.62 4.74 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 4.04 109.635 177.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -84.38 103.8 13.86 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.258 1.823 . . . . 0.65000000000000002 108.702 -172.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.79 -13.87 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.682 0.793 . . . . 0.68000000000000005 112.736 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.71 -164.39 35.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 123.603 0.621 . . . . 0.68000000000000005 112.258 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.19 177.3 10.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.992 0.917 . . . . 0.93000000000000005 111.951 167.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -144.35 148.42 34.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.928 1.291 . . . . 6.6900000000000004 109.586 170.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -150.54 151.31 30.59 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 125.137 1.375 . . . . 0.71999999999999997 108.344 -168.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.4 -24.73 16.13 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.91 1.74 . . . . 0.90000000000000002 113.364 175.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 m -78.6 -19.67 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.704 1.372 . . . . 1.22 114.704 -170.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.33 45.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.038 0.935 . . . . 0.92000000000000004 111.098 -172.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.34 -71.97 0.52 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.768 0.427 . . . . 3.0499999999999998 111.427 -174.019 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -79.18 142.5 36.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.421 1.088 . . . . 3.8399999999999999 108.193 167.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -153.7 135.67 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 1.47 108.512 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -145.84 139.2 26.18 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.824 1.25 . . . . 2.1299999999999999 110.144 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -81.95 119.44 23.96 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.454 1.121 . . . . 0.81000000000000005 110.901 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.5 m170 -111.36 157.77 19.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.17 1.788 . . . . 1.03 111.623 176.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -111.35 168.45 9.52 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.664 1.985 . . . . 2.4300000000000002 110.467 172.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -126.88 100.93 6.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.919 2.088 . . . . 1.1499999999999999 108.195 172.597 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -97.73 156.45 16.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.964 1.098 . . . . 2.4500000000000002 113.964 -167.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -85.94 148.77 25.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.808 0.843 . . . . 4.0 111.504 166.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -160.6 163.78 32.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.34 1.456 . . . . 5.54 111.093 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -128.5 157.87 39.95 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.39 1.876 . . . . 4.2199999999999998 108.972 175.318 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.7 t -153.68 124.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 125.266 1.604 . . . . 4.2599999999999998 107.756 168.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.93 15.46 6.09 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.286 1.434 . . . . 4.9100000000000001 114.323 176.114 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.55 28.27 39.97 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.315 1.436 . . . . 3.4199999999999999 113.785 -173.246 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -123.29 136.01 54.49 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.761 2.025 . . . . 3.8300000000000001 111.148 168.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.31 144.41 42.45 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.562 -0.711 . . . . 9.0600000000000005 112.686 -177.312 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.25 153.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.466 1.106 . . . . 3.1699999999999999 110.582 173.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.98 131.95 52.14 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.483 1.113 . . . . 4.0 109.857 175.799 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.04 -179.55 15.8 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 124.976 1.274 . . . . 1.26 112.351 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.1 mtt -132.59 158.64 41.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.756 1.222 . . . . 2.8300000000000001 111.643 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -171.63 157.61 4.5 Favored Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 125.954 1.702 . . . . 4.8700000000000001 110.878 -178.353 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.9 Cg_endo -71.4 153.95 60.92 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.734 1.623 . . . . 0.79000000000000004 112.11 169.257 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -117.85 154.77 51.3 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.731 1.612 . . . . 0.83999999999999997 109.638 164.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.26 -10.33 25.56 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.933 2.422 . . . . 1.01 113.087 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -177.38 158.67 1.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.659 1.984 . . . . 2.6000000000000001 110.474 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.07 171.04 7.59 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.165 1.386 . . . . 1.01 109.122 148.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -156.22 161.33 40.28 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 120.956 -1.09 . . . . 2.4700000000000002 112.002 172.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 t -149.61 133.37 8.72 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 123.899 0.88 . . . . 1.0700000000000001 109.675 -160.447 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.39 168.84 21.22 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.122 1.881 . . . . 1.0700000000000001 111.801 177.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.43 142.11 97.63 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.645 2.897 . . . . 1.04 111.601 166.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm 66.56 3.65 2.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.965 1.706 . . . . 1.45 113.554 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.03 115.09 4.05 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 126.123 1.821 . . . . 1.1000000000000001 112.259 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -92.4 129.11 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.213 1.405 . . . . 4.4500000000000002 109.98 160.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.0 m -144.69 156.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.346 1.858 . . . . 1.5700000000000001 110.44 -177.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.17 120.45 31.37 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.141 -0.974 . . . . 3.71 112.52 -166.337 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.18 68.8 1.98 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.843 1.657 . . . . 1.23 109.36 168.027 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -77.67 149.16 77.47 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.988 1.715 . . . . 2.77 111.615 173.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -59.24 -31.81 95.85 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.783 2.322 . . . . 1.01 113.257 176.3 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.28 40.65 3.06 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.545 1.069 . . . . 1.1499999999999999 113.111 169.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.26 -75.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.887 1.232 . . . . 0.94999999999999996 114.931 -175.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -153.2 147.09 25.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.044 2.137 . . . . 1.8600000000000001 109.449 -171.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -163.82 170.19 17.21 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.478 -1.389 . . . . 1.1899999999999999 111.42 -175.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -104.21 120.05 40.3 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.557 -0.534 . . . . 1.8999999999999999 109.557 170.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 mmt -76.32 129.23 36.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.945 0.898 . . . . 1.1499999999999999 109.313 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.9 mt -108.06 124.91 50.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.594 1.558 . . . . 1.8400000000000001 107.364 177.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.46 118.59 11.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.66 0.784 . . . . 2.6899999999999999 109.933 -162.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.19 74.26 1.08 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 109.771 -1.331 . . . . 1.3700000000000001 109.771 -167.469 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mt -72.84 90.04 1.42 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.897 0.856 . . . . 1.1200000000000001 113.118 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -67.16 -11.35 57.07 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.919 1.081 . . . . 2.0099999999999998 113.919 172.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.4 mtp-105 -138.12 136.05 19.15 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.984 1.714 . . . . 4.0099999999999998 108.241 155.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.9 149.67 59.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.387 . . . . 1.76 110.267 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.65 97.05 9.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.894 0.478 . . . . 2.3599999999999999 111.256 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -77.96 129.38 35.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.863 1.265 . . . . 3.5800000000000001 110.946 169.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.93 49.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.273 -0.892 . . . . 1.9199999999999999 109.297 171.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.73 37.47 26.4 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 118.467 0.576 . . . . 2.4500000000000002 112.92 -166.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.52 -179.28 3.87 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 106.979 -1.489 . . . . 2.5699999999999998 106.979 151.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -126.85 149.56 49.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.269 1.027 . . . . 3.7200000000000002 109.018 167.15 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.27 118.44 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.942 1.297 . . . . 0.97999999999999998 109.702 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -81.65 146.51 30.02 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.438 1.113 . . . . 3.6600000000000001 111.41 160.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.67 123.46 8.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.84 1.256 . . . . 1.4399999999999999 110.903 -169.047 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.72 91.44 8.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 127.731 2.412 . . . . 2.2599999999999998 110.037 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.67 115.96 13.69 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.575 0.75 . . . . 1.4099999999999999 110.295 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.1 mt -88.2 124.77 34.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 0.83999999999999997 110.753 -173.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -125.09 124.01 40.97 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.955 0.724 . . . . 2.1899999999999999 112.955 -178.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.04 22.34 0.58 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.864 2.065 . . . . 2.1499999999999999 114.307 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.87 -56.21 1.76 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.17 1.367 . . . . 3.54 112.523 -163.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.43 8.85 52.23 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 117.499 1.76 . . . . 1.6699999999999999 117.499 -165.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 152.26 48.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.917 2.087 . . . . 4.1600000000000001 110.541 166.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.5 131.71 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.899 1.28 . . . . 1.1599999999999999 110.82 169.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.59 111.34 18.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.154 1.381 . . . . 2.75 110.487 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 85.76 5.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.191 0.996 . . . . 3.0 110.99 178.123 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.73 174.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.772 1.629 . . . . 1.54 111.255 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.4 151.51 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.057 1.343 . . . . 2.0299999999999998 110.568 170.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -140.74 141.99 26.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 128.034 2.534 . . . . 1.6399999999999999 109.044 176.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -70.32 149.29 63.1 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.123 1.882 . . . . 0.91000000000000003 109.478 170.344 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.83 123.86 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.475 -1.305 . . . . 1.1799999999999999 107.475 163.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.61 151.93 28.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.931 1.693 . . . . 3.02 108.068 -161.259 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.99 108.45 19.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.731 1.011 . . . . 2.7999999999999998 113.731 -157.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.921 1.288 . . . . 5.0700000000000003 112.071 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 121.923 0.868 . . . . 6.2699999999999996 110.981 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.46 161.5 24.47 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 124.982 1.277 . . . . 0.97999999999999998 112.865 -174.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.413 ' CD1' ' HB3' ' A' ' 118' ' ' GLU . 32.1 p90 -163.14 161.4 25.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 2.75 114.508 -175.372 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.61 150.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.049 0.94 . . . . 1.45 110.092 -177.465 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 -88.26 114.87 25.31 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.793 0.837 . . . . 4.1799999999999997 111.477 177.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -43.81 120.57 2.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.052 2.141 . . . . 2.52 112.888 166.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -167.76 97.83 0.61 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.727 1.611 . . . . 1.9299999999999999 110.341 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.68 70.39 7.28 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.566 2.844 . . . . 3.5600000000000001 109.253 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.03 -150.91 5.29 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.193 0.902 . . . . 2.0099999999999998 114.034 -172.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.35 -21.29 11.87 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.981 2.454 . . . . 1.76 112.716 -179.04 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -157.71 167.96 28.58 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.779 1.232 . . . . 2.27 113.518 -175.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -163.04 -177.87 5.71 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.287 1.835 . . . . 1.1299999999999999 112.309 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.57 52.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.695 1.598 . . . . 1.0 111.023 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.56 138.64 54.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.936 0.789 . . . . 0.83999999999999997 111.592 167.06 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -120.29 147.73 44.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.535 1.934 . . . . 2.4100000000000001 110.813 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pp -166.6 149.89 6.99 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.761 -1.212 . . . . 1.6000000000000001 113.874 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.29 96.51 6.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 127.748 2.419 . . . . 2.0299999999999998 108.385 168.556 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.65 126.69 34.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 2.98 108.971 174.291 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.77 145.84 42.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.273 1.429 . . . . 3.1600000000000001 111.621 -175.129 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -116.08 105.68 50.64 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.91000000000000003 111.973 -173.162 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.48 -11.03 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.578 2.185 . . . . 0.97999999999999998 113.298 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.66 163.25 53.47 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 125.59 1.567 . . . . 0.98999999999999999 113.802 -177.59 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -80.08 -32.64 39.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.043 2.137 . . . . 4.9800000000000004 112.65 175.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -98.28 163.98 18.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.478 1.911 . . . . 1.8 111.072 173.092 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.22 154.93 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.418 2.745 . . . . 1.3200000000000001 112.012 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.06 141.27 31.21 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.622 0.769 . . . . 2.3500000000000001 110.305 171.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -125.85 109.97 13.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.509 1.124 . . . . 2.7200000000000002 110.072 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.08 122.74 32.7 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.579 1.952 . . . . 0.93000000000000005 109.776 -176.328 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.62 -6.77 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.29 1.036 . . . . 0.62 113.456 -172.167 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.0 -163.74 34.07 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.821 1.201 . . . . 0.54000000000000004 111.41 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.13 -175.73 5.58 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.469 1.508 . . . . 0.75 110.476 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -156.26 139.72 15.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.067 1.347 . . . . 6.4500000000000002 108.932 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.26 146.38 45.56 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 117.2 -1.381 . . . . 0.73999999999999999 108.464 -173.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.24 -13.12 35.44 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.548 2.165 . . . . 0.84999999999999998 114.086 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.3 -3.94 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.28 1.585 . . . . 0.96999999999999997 115.28 -176.437 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.65 147.39 40.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 121.094 1.77 . . . . 0.90000000000000002 112.848 -172.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -83.71 -51.44 7.25 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.733 1.613 . . . . 3.1000000000000001 110.787 178.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -111.44 141.18 45.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.536 1.134 . . . . 3.48 110.115 170.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.29 137.08 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.071 1.348 . . . . 1.25 109.104 160.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -128.93 131.78 47.57 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.267 1.827 . . . . 2.1899999999999999 108.708 175.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.81 123.31 29.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.508 1.504 . . . . 0.81000000000000005 110.406 169.018 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -107.74 155.2 20.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.076 1.751 . . . . 0.68999999999999995 112.331 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -94.38 -174.15 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.651 1.981 . . . . 2.9199999999999999 111.481 167.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -145.34 80.25 1.6 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.182 1.393 . . . . 1.3999999999999999 109.18 166.315 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.27 143.79 52.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.952 0.882 . . . . 2.4900000000000002 111.8 -172.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtp -108.03 34.77 3.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.004 1.722 . . . . 4.0800000000000001 111.313 -172.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -70.34 156.89 38.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 7.0199999999999996 110.788 -167.328 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -46.7 159.54 0.09 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.781 0.833 . . . . 6.8399999999999999 110.335 146.537 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -163.17 -29.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.566 1.946 . . . . 3.6200000000000001 113.189 179.427 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -143.95 38.89 1.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.908 2.483 . . . . 4.71 109.277 170.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -33.73 0.37 Allowed Glycine 0 N--CA 1.481 1.666 0 O-C-N 120.055 -1.653 . . . . 2.5499999999999998 113.372 -160.193 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -61.08 135.22 57.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.655 1.982 . . . . 3.2999999999999998 109.851 170.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -85.79 129.69 34.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 118.212 -0.899 . . . . 4.5700000000000003 110.512 173.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.1 t -140.77 150.14 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.75 1.22 . . . . 1.8300000000000001 109.572 -169.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.9 mtm -92.9 121.8 34.63 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.228 1.011 . . . . 3.4100000000000001 112.406 172.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.73 163.59 25.52 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.146 1.355 . . . . 1.1299999999999999 111.755 171.066 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -107.2 152.45 24.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.24 1.016 . . . . 1.5 112.462 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -149.64 145.5 19.19 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.317 2.247 . . . . 4.1600000000000001 108.43 171.176 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.12 145.76 89.74 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.42 1.543 . . . . 0.71999999999999997 111.022 160.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.59 158.08 60.3 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.129 1.772 . . . . 0.76000000000000001 111.149 -179.229 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.46 -21.16 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.556 2.171 . . . . 0.65000000000000002 113.336 178.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -174.54 169.95 3.59 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.205 1.366 . . . . 1.97 112.66 -177.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.33 174.35 9.69 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.555 2.742 . . . . 1.0900000000000001 108.871 162.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.67 168.68 26.56 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.632 -1.293 . . . . 2.2400000000000002 112.708 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 t -146.41 131.3 8.94 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 125.359 1.463 . . . . 1.1200000000000001 109.519 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.0 161.05 41.96 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.607 2.205 . . . . 1.0900000000000001 111.773 176.644 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.89 133.7 42.95 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.959 3.106 . . . . 0.98999999999999999 111.706 179.076 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 72.3 -2.32 2.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.226 2.21 . . . . 1.4199999999999999 113.718 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.87 -179.02 37.66 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 126.049 1.785 . . . . 1.2 111.677 178.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -160.11 158.38 30.19 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.06 1.344 . . . . 4.1500000000000004 114.571 177.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.83 172.18 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.962 2.105 . . . . 1.78 110.731 177.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -119.33 132.99 55.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.66 1.584 . . . . 5.5599999999999996 109.048 170.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.82 81.31 6.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.832 1.301 . . . . 1.46 109.559 163.147 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 143.89 75.15 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.381 2.272 . . . . 4.0899999999999999 113.472 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.54 -40.19 76.37 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.771 2.314 . . . . 1.3 111.567 167.207 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.71 79.03 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.157 -1.177 . . . . 1.1699999999999999 110.157 164.075 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.98 -73.22 0.12 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 0.95999999999999996 114.696 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -158.52 139.84 13.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.593 1.957 . . . . 2.4500000000000002 109.154 -176.301 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -166.12 158.01 14.01 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.572 1.987 . . . . 1.1100000000000001 110.983 -175.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.08 124.02 32.78 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.951 -0.388 . . . . 2.1400000000000001 109.951 170.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.79 122.21 34.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.999 1.32 . . . . 1.78 108.63 169.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.13 135.92 43.9 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.874 1.67 . . . . 1.77 109.012 -177.177 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.31 125.64 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.769 1.228 . . . . 2.9199999999999999 111.226 -171.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.72 104.64 0.04 OUTLIER Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.734 1.635 . . . . 1.28 110.987 -174.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.0 mt -102.11 115.68 31.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.792 1.296 . . . . 1.0700000000000001 112.832 -166.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -66.32 -25.0 66.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.118 1.367 . . . . 1.52 112.923 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -152.78 146.54 18.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.164 2.186 . . . . 7.4000000000000004 109.826 175.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.75 131.87 9.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.239 2.626 . . . . 1.74 111.617 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.35 127.68 33.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 2.0 110.327 174.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.37 -166.49 1.16 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.981 0.896 . . . . 3.8999999999999999 111.325 167.094 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.08 119.72 21.18 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.162 -0.961 . . . . 2.02 113.051 -162.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.91 -12.21 69.65 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.267 1.413 . . . . 4.2699999999999996 114.901 174.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -74.51 154.24 38.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.05 1.13 . . . . 3.5499999999999998 114.05 -157.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -80.65 90.7 5.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.539 1.936 . . . . 4.21 112.179 -166.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.59 106.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 1.03 109.382 166.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -68.75 139.34 55.32 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.255 1.026 . . . . 3.0899999999999999 110.526 157.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -149.85 118.99 6.75 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.802 1.241 . . . . 1.5900000000000001 109.502 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 102.18 14.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.923 1.289 . . . . 2.5499999999999998 108.438 173.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.35 128.04 34.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.543 1.137 . . . . 3.1400000000000001 109.094 177.162 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -98.13 130.97 44.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.778 0.831 . . . . 0.59999999999999998 110.323 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -130.11 153.55 48.38 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.724 0.773 . . . . 1.8799999999999999 112.54 -177.2 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.97 146.39 42.65 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.951 -0.468 . . . . 3.1400000000000001 110.774 170.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.98 27.41 23.76 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.016 0.766 . . . . 4.4400000000000004 115.016 -177.268 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 17.86 79.16 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-N 117.894 0.847 . . . . 1.74 113.757 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -94.51 140.47 29.8 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.574 -0.956 . . . . 4.3700000000000001 112.349 -174.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.67 128.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.067 2.147 . . . . 1.0700000000000001 107.772 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.8 mt -147.11 122.84 10.56 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.943 0.897 . . . . 1.5800000000000001 111.697 -164.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -75.33 123.68 25.77 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.655 0.613 . . . . 2.5600000000000001 112.655 177.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.5 m -93.14 159.92 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.692 0.797 . . . . 1.8200000000000001 109.477 150.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.38 118.85 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.102 0.961 . . . . 1.99 108.543 167.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.69 141.42 36.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.105 0.962 . . . . 2.1099999999999999 111.544 -166.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.55 151.02 64.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.526 2.817 . . . . 1.05 111.753 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 74.7 t -79.21 130.72 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.004 0.922 . . . . 1.48 110.442 160.524 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -118.48 -152.39 0.5 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.043 2.537 . . . . 4.4100000000000001 106.687 160.065 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.89 8.8 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 122.783 2.538 . . . . 2.9300000000000002 117.501 -162.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.277 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 117.337 -1.315 . . . . 7.7199999999999998 113.094 179.019 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 109.374 -0.602 . . . . 4.75 109.374 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.44 -179.5 30.53 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 123.738 0.685 . . . . 1.01 114.473 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -159.62 152.21 21.36 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.262 1.025 . . . . 1.8100000000000001 113.104 177.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.96 133.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.25 -1.019 . . . . 0.97999999999999998 108.25 165.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 2.9 tmt_? -98.05 100.1 11.41 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.365 2.266 . . . . 3.8799999999999999 109.017 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -57.55 148.69 23.21 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.077 0.942 . . . . 3.8799999999999999 111.445 172.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -152.03 145.2 17.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.426 1.49 . . . . 2.2200000000000002 110.01 161.39 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.81 71.42 7.05 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.083 3.189 . . . . 2.5600000000000001 110.371 -176.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.54 -172.81 27.19 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.055 0.836 . . . . 1.3899999999999999 113.701 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.99 -3.57 13.3 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.163 3.242 . . . . 1.79 112.815 176.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -142.8 167.0 23.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.219 1.808 . . . . 2.3999999999999999 112.521 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.64 -176.24 3.07 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.524 1.929 . . . . 1.24 110.928 -170.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.53 157.62 39.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.133 0.879 . . . . 1.1299999999999999 112.611 176.664 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.25 144.72 51.33 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 0.91000000000000003 110.422 165.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.85 152.33 51.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.296 1.439 . . . . 2.0499999999999998 109.277 175.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -173.17 158.66 3.7 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.042 1.127 . . . . 1.53 114.042 175.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -82.71 130.89 35.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 126.767 2.027 . . . . 1.53 109.532 163.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 23' ' ' GLU . 6.4 tt -114.76 143.3 45.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.103 1.761 . . . . 3.0800000000000001 108.858 169.618 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' N ' HD23 ' A' ' 22' ' ' LEU . 12.6 pt-20 -145.77 142.06 28.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.0 0.905 . . . . 3.1299999999999999 112.191 170.217 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -100.86 106.13 42.18 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.768 1.627 . . . . 0.98999999999999999 109.847 178.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.5 -9.36 17.36 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.418 2.079 . . . . 1.03 113.361 176.014 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.52 -178.57 52.5 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.332 0.969 . . . . 0.97999999999999998 114.032 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -111.77 1.28 16.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.756 1.623 . . . . 2.4500000000000002 113.162 -172.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.07 160.03 37.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.924 1.69 . . . . 1.79 110.176 166.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.16 157.44 17.53 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.156 2.571 . . . . 1.1000000000000001 111.721 -172.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.2 mt -107.53 157.61 17.89 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.601 1.16 . . . . 2.1200000000000001 110.548 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -134.66 116.24 14.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.731 1.212 . . . . 2.9300000000000002 109.291 169.448 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -97.66 117.16 31.32 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.337 2.255 . . . . 0.95999999999999996 109.508 -171.18 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.71 -9.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 114.038 1.125 . . . . 0.65000000000000002 114.038 -167.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.13 -163.77 32.7 Favored Glycine 0 C--N 1.34 0.791 0 O-C-N 121.418 -0.801 . . . . 0.80000000000000004 112.548 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.565 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -145.33 -178.32 6.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.044 0.937 . . . . 1.1599999999999999 111.183 172.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.73 136.16 3.61 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.88 1.218 . . . . 5.9299999999999997 108.065 176.553 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -138.13 152.09 71.13 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 117.403 -1.285 . . . . 0.66000000000000003 109.453 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.46 -21.0 53.98 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.35 2.033 . . . . 1.0 113.568 169.091 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.3 4.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.549 1.314 . . . . 1.01 114.549 -174.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.52 -179.01 5.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.968 1.307 . . . . 1.1599999999999999 110.787 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -101.57 -56.86 2.2 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.211 0.604 . . . . 3.1600000000000001 110.353 173.091 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -120.06 161.59 20.71 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.748 0.785 . . . . 4.1299999999999999 111.156 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.37 134.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.891 -1.05 . . . . 2.2200000000000002 108.988 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -118.69 134.43 55.13 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.209 1.804 . . . . 2.0099999999999998 108.798 -172.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -80.32 116.74 20.56 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.559 1.171 . . . . 0.89000000000000001 110.568 169.04 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -103.75 148.45 26.07 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.333 1.54 . . . . 0.58999999999999997 111.616 173.107 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.45 164.55 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.089 -1.414 . . . . 2.1200000000000001 109.702 159.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.554 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 91.2 m -140.77 93.39 2.6 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.56 -1.644 . . . . 1.3300000000000001 106.56 167.186 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -90.43 173.53 8.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.711 1.604 . . . . 2.2599999999999998 113.204 -162.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 56.1 mtm -113.32 131.34 55.99 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.37 -0.974 . . . . 3.3500000000000001 108.37 146.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -150.18 164.48 35.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.551 1.94 . . . . 7.5499999999999998 109.236 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -93.32 148.35 22.12 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.308 0.643 . . . . 3.7200000000000002 111.87 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 p -144.62 -8.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.48 1.659 . . . . 4.0499999999999998 115.48 -165.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -162.94 36.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.749 1.619 . . . . 3.2400000000000002 109.451 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.76 -11.2 1.3 Allowed Glycine 0 CA--C 1.539 1.545 0 O-C-N 120.642 -1.286 . . . . 2.3700000000000001 113.703 -160.367 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -113.07 150.84 31.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.224 2.21 . . . . 2.6200000000000001 111.196 -175.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 129.34 34.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.269 1.828 . . . . 6.1299999999999999 113.579 -173.14 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -142.37 147.57 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.369 0.986 . . . . 1.74 111.358 -172.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.5 mtt -83.19 138.79 33.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.707 1.203 . . . . 3.6200000000000001 113.477 171.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.89 167.3 33.19 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.128 0.87 . . . . 1.0800000000000001 113.384 173.554 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -107.54 166.17 10.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.112 1.365 . . . . 1.72 111.718 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.71 136.04 0.29 Allowed Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 116.21 -1.852 . . . . 4.2199999999999998 110.738 -175.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.93 143.03 64.68 Favored 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 122.254 1.841 . . . . 0.53000000000000003 111.344 166.536 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -112.51 157.83 39.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.096 1.359 . . . . 0.58999999999999997 110.0 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.25 -22.93 45.74 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.086 1.858 . . . . 0.76000000000000001 112.262 174.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -173.96 165.74 4.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.503 1.521 . . . . 2.23 112.932 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -111.03 177.52 4.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.169 1.787 . . . . 1.21 109.306 150.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.53 171.02 19.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.663 -1.273 . . . . 2.2599999999999998 111.638 175.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -151.57 134.53 8.9 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 118.36 -0.828 . . . . 1.3300000000000001 110.189 -167.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.69 169.68 21.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 121.726 1.618 . . . . 1.0900000000000001 111.434 171.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.92 142.27 74.62 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.005 3.137 . . . . 1.04 111.849 166.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 57.27 10.77 0.95 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.801 1.778 . . . . 1.3600000000000001 115.801 -168.063 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.46 116.07 4.17 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 128.244 2.831 . . . . 1.3700000000000001 110.889 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.16 137.15 35.64 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.32 1.448 . . . . 3.9300000000000002 110.173 162.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.33 144.0 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.787 1.635 . . . . 1.6299999999999999 109.252 178.198 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -132.28 118.41 19.43 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.652 -0.499 . . . . 3.9300000000000002 109.652 -165.061 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.44 75.84 3.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.138 1.375 . . . . 1.3999999999999999 110.041 -173.25 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -72.11 131.0 85.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.55 -1.214 . . . . 4.4800000000000004 108.651 175.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.5 -40.29 85.5 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.064 2.51 . . . . 1.05 113.018 -173.413 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.77 67.43 3.56 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 119.628 1.103 . . . . 1.3700000000000001 111.111 164.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 177.46 -82.17 0.07 OUTLIER Glycine 0 N--CA 1.469 0.861 0 C-N-CA 125.63 1.586 . . . . 1.01 112.637 -167.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -153.19 144.96 23.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.977 2.511 . . . . 1.8600000000000001 108.927 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.69 171.4 16.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.429 0.692 . . . . 0.82999999999999996 110.568 -177.482 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -109.58 125.91 53.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.093 0.957 . . . . 2.1699999999999999 111.208 173.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.2 mmt -89.78 121.86 32.32 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.403 1.081 . . . . 0.96999999999999997 110.662 170.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.68 138.96 33.45 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.7 1.6 . . . . 2.1200000000000001 110.729 -178.143 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mt -144.1 140.19 29.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.175 0.806 . . . . 2.8999999999999999 113.175 -177.277 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 57.96 3.44 Favored Glycine 0 N--CA 1.469 0.884 0 C-N-CA 124.303 0.954 . . . . 1.6799999999999999 111.215 -176.202 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.8 mt -70.25 137.74 51.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.256 0.835 . . . . 0.84999999999999998 113.256 -171.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -102.88 -3.43 26.23 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.756 1.223 . . . . 1.6200000000000001 112.79 -172.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -139.01 158.56 69.46 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.106 1.362 . . . . 5.21 108.93 152.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.03 122.43 9.74 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 N-CA-C 106.255 -2.248 . . . . 1.8500000000000001 106.255 138.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.17 120.96 21.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.102 0.953 . . . . 2.1400000000000001 109.528 -166.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -67.49 109.38 3.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.511 1.125 . . . . 5.5300000000000002 108.201 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.38 113.64 0.73 Allowed 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 1.9099999999999999 113.004 172.468 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.47 6.58 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.812 0.72 . . . . 2.4100000000000001 113.265 -166.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.31 -169.15 1.56 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.187 1.795 . . . . 2.7000000000000002 108.662 146.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.6 162.0 33.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.735 1.214 . . . . 4.8899999999999997 110.854 177.002 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.9 t -132.77 133.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.009 1.724 . . . . 0.97999999999999998 109.847 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.02 148.24 31.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.138 0.494 . . . . 3.1499999999999999 111.512 164.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.565 HD11 ' HB1' ' A' ' 35' ' ' ALA . 1.1 tm? -151.81 120.63 6.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.091 1.356 . . . . 2.6899999999999999 109.388 175.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.86 114.14 17.54 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.429 3.092 . . . . 2.0899999999999999 109.951 170.162 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.14 122.51 27.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.813 1.188 . . . . 1.8100000000000001 109.449 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -97.53 127.88 43.83 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.057 0.943 . . . . 0.93000000000000005 111.243 -171.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.64 151.33 48.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.168 0.985 . . . . 2.3300000000000001 112.828 -176.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.62 158.82 35.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.717 -0.674 . . . . 2.3300000000000001 111.987 172.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.32 74.78 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.586 -0.696 . . . . 4.7699999999999996 113.899 176.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.51 63.8 2.07 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 118.219 1.01 . . . . 2.29 112.612 173.277 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -147.89 142.66 26.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.186 1.795 . . . . 3.9399999999999999 110.867 178.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.92 139.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.393 1.877 . . . . 1.3899999999999999 107.86 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.6 mt -143.49 108.21 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.534 1.134 . . . . 1.96 108.811 -175.17 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -92.53 150.39 20.78 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.86 1.059 . . . . 2.1099999999999999 113.86 -177.534 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.49 159.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.795 1.238 . . . . 1.6699999999999999 110.367 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.21 148.5 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.991 1.316 . . . . 2.4500000000000002 109.849 168.332 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.1 mt -143.76 129.39 9.91 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.379 1.872 . . . . 1.6599999999999999 109.051 -178.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.0 156.93 61.54 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.137 2.558 . . . . 1.05 112.561 175.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -88.92 113.37 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.102 1.361 . . . . 1.3799999999999999 110.487 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -107.36 179.29 4.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.038 2.535 . . . . 4.4900000000000002 108.595 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.27 123.3 17.84 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.663 -1.273 . . . . 2.4900000000000002 109.755 171.449 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 4.1 tpt180 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.139 0.976 . . . . 4.6900000000000004 113.311 -161.412 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 CA--C 1.544 0.721 0 N-CA-C 106.867 -1.531 . . . . 5.6399999999999997 106.867 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -107.36 167.39 13.62 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 116.155 1.222 . . . . 1.1299999999999999 116.155 -163.259 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -156.14 146.29 21.44 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.616 1.567 . . . . 1.8700000000000001 112.497 173.654 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.7 139.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.328 -1.36 . . . . 1.6299999999999999 107.328 154.212 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 103.22 12.64 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.931 -0.481 . . . . 4.04 111.733 -173.128 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.93 110.0 1.22 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.591 1.186 . . . . 3.3199999999999998 110.379 163.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -158.88 144.79 12.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.986 1.714 . . . . 2.27 108.58 161.572 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.76 74.23 5.3 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.061 3.174 . . . . 2.6600000000000001 111.248 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.92 148.31 19.5 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.05 1.309 . . . . 1.6499999999999999 111.756 172.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.57 -25.04 47.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.981 2.454 . . . . 1.4399999999999999 111.845 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -107.73 138.85 43.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.182 1.393 . . . . 3.9900000000000002 108.982 153.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 163.78 31.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.551 1.94 . . . . 1.55 108.081 160.857 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.46 169.83 14.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.148 0.795 . . . . 1.2 113.148 -177.599 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.2 148.62 27.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.306 1.042 . . . . 1.1000000000000001 112.482 165.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.04 159.81 41.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.017 1.727 . . . . 2.1600000000000001 111.296 -172.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -163.47 146.37 10.1 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.448 1.277 . . . . 1.5900000000000001 114.448 -175.1 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -79.87 128.27 33.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.661 -1.154 . . . . 2.0299999999999998 109.679 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.17 149.07 45.52 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.709 1.603 . . . . 2.7599999999999998 110.987 -175.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -157.68 153.04 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.739 0.781 . . . . 3.04 111.491 174.339 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -104.8 105.0 49.12 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 0.98999999999999999 109.19 177.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.09 -11.23 13.61 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.834 2.356 . . . . 1.03 113.676 177.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.86 177.78 53.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.677 1.126 . . . . 0.98999999999999999 113.467 -174.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -102.61 12.67 36.06 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.704 1.602 . . . . 2.3799999999999999 111.588 178.089 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.03 158.65 34.47 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.059 2.144 . . . . 2.7799999999999998 109.149 174.265 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.05 148.77 17.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.805 2.337 . . . . 1.3999999999999999 110.266 172.364 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -121.61 119.56 32.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.405 1.082 . . . . 2.8500000000000001 110.317 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -109.06 106.46 16.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.526 1.53 . . . . 3.1600000000000001 109.79 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -92.3 116.23 28.78 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.103 2.161 . . . . 0.71999999999999997 108.76 -173.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.78 -9.37 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.154 0.982 . . . . 0.56999999999999995 112.714 -166.602 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.6 -162.66 32.07 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 124.875 1.226 . . . . 0.46999999999999997 111.41 171.651 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.01 171.76 17.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.455 1.102 . . . . 0.70999999999999996 110.539 168.187 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.83 130.4 16.85 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.622 -1.621 . . . . 6.0300000000000002 106.622 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 t -127.48 157.51 72.71 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 117.385 -1.293 . . . . 0.90000000000000002 108.162 177.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -63.06 -25.36 73.46 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.036 1.824 . . . . 1.1100000000000001 113.313 160.314 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -80.35 12.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.904 1.446 . . . . 1.25 114.904 -172.192 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.31 153.68 49.01 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.313 1.445 . . . . 1.5700000000000001 113.941 -172.222 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.88 -42.65 9.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.628 1.571 . . . . 4.0300000000000002 111.581 168.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.13 176.25 12.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 7.5599999999999996 110.543 151.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -155.65 144.13 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.602 1.961 . . . . 1.8600000000000001 109.569 -170.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -127.06 136.21 51.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.171 1.788 . . . . 2.2599999999999998 110.566 -176.808 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -88.77 123.23 32.98 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.154 1.343 . . . . 0.76000000000000001 112.067 169.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 13.3 m170 -110.88 153.54 25.31 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.762 2.025 . . . . 0.68000000000000005 113.129 175.3 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -86.23 170.28 12.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.846 1.658 . . . . 2.3300000000000001 111.278 161.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 m -146.73 126.86 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.015 1.326 . . . . 1.3200000000000001 108.182 169.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -140.85 173.46 11.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.154 1.168 . . . . 2.4199999999999999 114.154 -152.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -126.89 141.98 51.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.037 1.735 . . . . 3.98 108.676 159.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -149.45 165.67 31.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.066 1.746 . . . . 8.2200000000000006 109.987 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.68 136.96 43.82 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.634 0.774 . . . . 3.8900000000000001 110.092 169.115 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.96 -6.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 114.228 1.196 . . . . 2.9100000000000001 114.228 173.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -168.37 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.873 2.069 . . . . 4.2300000000000004 110.682 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.42 -16.95 4.48 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.043 -1.661 . . . . 2.54 113.689 -163.678 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -82.58 142.13 32.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.736 1.268 . . . . 3.6000000000000001 110.374 161.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.485 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.83 127.32 35.96 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.509 1.124 . . . . 5.0099999999999998 109.358 177.766 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -135.72 145.22 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.029 1.332 . . . . 2.1499999999999999 110.157 -170.327 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -82.97 158.45 22.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.62 1.568 . . . . 3.3500000000000001 113.191 -176.881 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.59 -179.56 45.26 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.453 0.549 . . . . 1.4199999999999999 113.957 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -132.35 158.06 42.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.905 1.682 . . . . 1.48 110.49 176.469 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -160.23 147.45 12.46 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.569 1.548 . . . . 5.6799999999999997 109.924 169.141 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.1 Cg_endo -63.72 148.14 92.24 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.655 1.57 . . . . 0.87 110.255 163.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.26 155.13 71.83 Favored Pre-proline 0 N--CA 1.472 0.647 0 C-N-CA 125.459 1.504 . . . . 0.57999999999999996 110.734 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.99 -23.88 24.69 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.666 2.244 . . . . 0.69999999999999996 112.541 178.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -171.78 165.68 6.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.388 1.075 . . . . 1.8600000000000001 112.62 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -113.94 172.79 6.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.289 1.835 . . . . 1.0 109.188 155.154 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -154.61 167.86 28.71 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.543 -0.723 . . . . 2.0499999999999998 111.518 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.6 t -144.37 130.07 9.71 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.042 1.737 . . . . 0.87 108.425 -169.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -70.43 164.7 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.319 2.013 . . . . 0.94999999999999996 110.94 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.79 139.5 91.06 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.671 2.247 . . . . 1.1000000000000001 110.547 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm 66.59 6.42 4.44 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.993 1.717 . . . . 1.5700000000000001 113.549 -175.339 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.33 120.52 5.21 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 127.701 2.572 . . . . 1.1599999999999999 112.623 -176.11 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -90.32 138.23 31.71 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.294 1.838 . . . . 4.0 111.424 167.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.09 125.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.976 1.31 . . . . 1.3700000000000001 112.877 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.08 121.8 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.269 1.028 . . . . 4.2300000000000004 111.586 170.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.69 147.12 46.0 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.333 1.063 . . . . 1.8600000000000001 110.07 161.103 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -172.25 150.71 2.4 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.964 1.306 . . . . 2.6000000000000001 111.197 -158.172 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.99 -47.9 9.6 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.758 2.305 . . . . 1.0600000000000001 111.515 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.19 70.95 2.86 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.807 -0.917 . . . . 1.72 110.807 166.509 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.44 -96.45 0.12 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.363 1.458 . . . . 1.1399999999999999 113.711 -176.068 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -149.37 138.32 21.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.949 1.699 . . . . 1.8400000000000001 108.695 -172.121 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -157.97 162.28 38.2 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.231 -0.293 . . . . 0.68999999999999995 110.794 -168.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -95.32 135.4 36.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.475 0.71 . . . . 2.1000000000000001 110.468 169.21 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -95.67 126.72 41.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.112 1.365 . . . . 1.1299999999999999 108.913 160.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.75 157.5 23.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.143 0.577 . . . . 2.3599999999999999 110.33 173.001 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 78.32 1.6 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.484 1.135 . . . . 3.0800000000000001 111.381 176.475 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.19 114.13 3.74 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.757 2.122 . . . . 1.6599999999999999 110.299 -170.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.16 126.31 44.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.606 1.163 . . . . 1.3300000000000001 110.444 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -92.02 -25.11 18.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.194 0.812 . . . . 2.46 113.194 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.31 151.69 40.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.645 -0.872 . . . . 4.4500000000000002 108.645 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.95 -14.53 23.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.569 2.179 . . . . 3.2400000000000002 115.41 177.161 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.3 mt 66.71 102.34 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 130.996 3.719 . . . . 2.5 110.373 -178.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -106.88 143.21 35.31 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.881 0.873 . . . . 6.2300000000000004 109.739 161.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -45.41 124.17 4.66 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.483 -0.78 . . . . 1.6299999999999999 109.643 159.325 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.57 3.08 81.47 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 117.361 -1.799 . . . . 2.1699999999999999 116.426 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.73 161.52 30.15 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 121.15 2.475 . . . . 2.5499999999999998 109.75 162.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.95 154.99 19.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.24 1.416 . . . . 3.8100000000000001 110.993 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.15 112.52 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 126.044 1.737 . . . . 1.6100000000000001 108.63 -176.117 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -74.22 142.29 45.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.231 -0.655 . . . . 3.1299999999999999 109.231 155.622 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt -146.57 117.32 7.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.282 1.033 . . . . 1.55 111.326 175.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.9 92.4 8.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.678 3.191 . . . . 2.1499999999999999 109.222 170.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.68 125.25 28.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.468 1.107 . . . . 1.3600000000000001 109.68 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt -97.01 132.23 43.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.867 1.267 . . . . 0.73999999999999999 111.243 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -131.6 146.52 52.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.076 0.941 . . . . 2.2000000000000002 112.789 -174.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.34 165.13 14.67 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.749 -0.594 . . . . 2.23 111.84 170.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.58 26.48 65.27 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.461 -0.775 . . . . 4.6799999999999997 113.272 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.87 63.04 3.48 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.823 1.201 . . . . 1.96 111.562 176.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -146.75 161.3 40.91 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 123.111 1.434 . . . . 4.29 113.028 -171.466 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 p -171.9 146.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.125 2.97 . . . . 1.3600000000000001 108.137 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt -140.24 123.67 17.0 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.618 1.167 . . . . 1.73 109.192 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -81.42 126.92 32.22 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.522 0.601 . . . . 2.5 111.381 167.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.29 166.15 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.876 1.671 . . . . 3.1200000000000001 108.381 168.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.2 130.32 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.316 1.447 . . . . 2.0099999999999998 110.764 178.819 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mp -139.05 166.91 21.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.796 2.438 . . . . 2.6000000000000001 109.37 -176.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.67 170.78 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.14 2.56 . . . . 1.6200000000000001 113.581 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.8 t -95.77 136.79 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 127.656 2.383 . . . . 1.5 107.721 155.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -153.53 158.68 41.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.584 0.754 . . . . 5.0499999999999998 111.548 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.21 3.35 24.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.358 1.984 . . . . 2.2400000000000002 116.358 -164.017 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.937 0 N-CA-C 113.492 0.923 . . . . 6.1600000000000001 113.492 -162.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.552 1.026 0 CA-C-O 120.808 0.337 . . . . 7.1699999999999999 110.733 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.26 159.27 23.29 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 115.929 1.131 . . . . 1.03 115.929 -169.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -150.41 136.99 18.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.609 1.164 . . . . 1.5900000000000001 112.201 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -90.67 131.76 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.702 -0.851 . . . . 0.83999999999999997 108.702 164.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.61 47.47 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.939 0.718 . . . . 7.8600000000000003 112.939 -173.102 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.63 103.48 1.72 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.563 1.173 . . . . 4.0 110.993 163.569 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.89 140.71 0.57 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.854 1.661 . . . . 3.4700000000000002 109.926 157.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.36 3.4 7.83 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.071 3.181 . . . . 3.7000000000000002 114.471 -173.11 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.01 145.88 49.74 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 119.537 1.062 . . . . 1.77 113.028 -175.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.98 -15.07 47.38 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.113 3.209 . . . . 2.4500000000000002 113.676 -171.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -139.35 167.03 23.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.134 0.974 . . . . 2.8300000000000001 111.794 159.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 159.65 174.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.493 3.517 . . . . 3.2599999999999998 109.87 171.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.69 171.86 13.15 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.058 1.133 . . . . 2.0699999999999998 114.058 -177.211 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 160.12 40.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.692 2.797 . . . . 1.8999999999999999 109.151 170.562 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -144.0 158.28 43.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.101 0.953 . . . . 2.1499999999999999 112.644 -164.034 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.48 159.57 28.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.582 0.956 . . . . 1.8500000000000001 113.582 173.524 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 m -123.77 147.73 47.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.869 -1.514 . . . . 2.23 107.331 164.067 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tp -136.83 153.43 50.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.053 1.341 . . . . 4.3399999999999999 110.985 -175.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -108.95 135.61 49.85 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.53 1.932 . . . . 3.98 108.094 168.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -102.46 91.34 2.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.02 -0.514 . . . . 1.3200000000000001 109.967 160.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.45 -11.11 18.97 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.314 2.009 . . . . 1.8500000000000001 113.487 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.33 52.41 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 118.907 0.776 . . . . 1.48 113.195 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.56 3.08 51.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.741 . . . . 2.8999999999999999 113.609 -177.381 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.99 159.97 56.54 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.59 1.556 . . . . 2.21 110.799 174.29 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.34 166.17 22.66 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.845 2.363 . . . . 1.6299999999999999 112.657 -164.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.0 154.65 21.88 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.22 1.008 . . . . 3.0299999999999998 111.008 165.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -148.88 104.99 3.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.177 1.791 . . . . 3.6699999999999999 109.654 170.734 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.7 tp -91.64 111.8 23.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.634 2.374 . . . . 0.81999999999999995 109.886 -168.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -97.85 -15.32 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.849 1.259 . . . . 0.64000000000000001 112.857 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.65 -164.93 36.66 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.685 -0.634 . . . . 0.56999999999999995 112.62 175.39 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.5 172.52 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.816 0.846 . . . . 0.82999999999999996 111.242 166.702 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.78 144.49 23.53 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.717 0.689 . . . . 5.0700000000000003 111.663 171.23 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 t -141.1 149.53 55.89 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 125.875 1.67 . . . . 0.65000000000000002 108.93 -166.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.65 -19.23 42.1 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.124 1.883 . . . . 1.0 113.232 173.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -71.21 -4.39 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 114.331 1.234 . . . . 1.3200000000000001 114.331 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.31 174.38 12.91 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.593 1.701 . . . . 1.48 115.593 -167.135 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -108.58 -42.92 4.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.897 2.079 . . . . 3.3900000000000001 110.429 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -129.61 161.88 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.216 1.406 . . . . 5.1600000000000001 112.057 172.631 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -176.21 126.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.256 1.822 . . . . 1.95 108.798 -173.38 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -145.21 137.07 25.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.057 1.343 . . . . 4.4500000000000002 109.475 -164.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.5 123.62 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.636 0.732 . . . . 0.81000000000000005 111.461 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.83 153.8 22.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.719 1.608 . . . . 0.67000000000000004 113.584 173.795 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -91.55 170.7 9.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.875 2.07 . . . . 2.2000000000000002 110.715 158.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.9 m -149.46 114.59 5.45 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.608 1.563 . . . . 1.51 107.837 173.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -119.8 157.21 29.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.956 1.302 . . . . 2.3399999999999999 112.841 -162.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -94.46 158.61 15.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.224 1.01 . . . . 3.52 110.555 160.504 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.37 150.22 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 5.96 110.378 176.001 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.3 140.54 29.66 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.799 -0.815 . . . . 3.5299999999999998 108.799 160.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.51 114.4 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.661 1.584 . . . . 2.6200000000000001 107.365 -178.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 64.99 1.27 1.42 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.204 1.802 . . . . 4.7000000000000002 112.569 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.56 -11.76 58.05 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.644 1.593 . . . . 1.8700000000000001 113.879 -166.51 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -76.77 136.55 39.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.275 1.537 . . . . 4.4800000000000004 109.656 172.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -77.54 126.77 31.42 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.678 -0.639 . . . . 3.73 110.73 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.8 t -135.25 155.74 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.58 1.952 . . . . 2.1499999999999999 109.097 -173.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.1 mtm -128.7 154.12 46.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.131 0.972 . . . . 3.5800000000000001 110.785 171.515 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.39 30.63 Favored Glycine 0 N--CA 1.468 0.827 0 C-N-CA 124.07 0.843 . . . . 1.25 113.333 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.56 161.42 35.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.47 1.508 . . . . 2.8799999999999999 109.954 -177.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -165.62 134.55 2.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 116.679 -1.629 . . . . 4.5300000000000002 110.311 -173.463 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.56 146.37 84.49 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 122.322 1.865 . . . . 0.64000000000000001 110.391 163.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.32 158.32 67.29 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 125.677 1.591 . . . . 0.66000000000000003 111.237 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.53 -24.5 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.822 2.348 . . . . 0.65000000000000002 112.73 176.315 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -173.87 166.81 4.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.649 1.18 . . . . 1.73 113.176 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.19 170.14 8.43 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.408 1.883 . . . . 1.1000000000000001 109.799 152.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -156.65 164.56 38.03 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.354 -0.841 . . . . 1.8899999999999999 113.179 176.1 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -154.43 141.18 13.22 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.963 0.905 . . . . 0.98999999999999999 110.452 -160.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.38 171.54 14.96 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.343 2.028 . . . . 0.89000000000000001 112.651 168.304 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.71 148.43 92.13 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.28 3.32 . . . . 1.0700000000000001 112.267 163.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 69.69 -2.96 1.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.71 2.004 . . . . 1.6699999999999999 114.123 179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.61 115.88 4.18 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 125.824 1.678 . . . . 0.98999999999999999 111.583 -178.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.04 128.98 36.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.115 0.566 . . . . 6.8200000000000003 110.561 162.187 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.28 158.18 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 1.76 112.087 -164.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -146.42 114.25 6.48 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.269 0.628 . . . . 4.0700000000000003 109.684 -141.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.24 83.39 6.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.096 0.958 . . . . 1.6399999999999999 109.13 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -72.4 142.18 84.0 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.539 -1.22 . . . . 2.7599999999999998 109.769 178.027 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.51 -39.15 85.9 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.698 2.266 . . . . 1.3799999999999999 112.516 -178.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.94 61.68 4.7 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.899 0.761 . . . . 1.8 111.394 165.645 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -69.36 0.07 OUTLIER Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.746 1.165 . . . . 1.2 114.168 -177.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -154.12 143.67 21.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.043 1.737 . . . . 1.96 109.052 -171.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -167.25 165.49 15.25 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.494 -0.754 . . . . 1.05 110.219 -177.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.64 135.9 37.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.962 -0.385 . . . . 2.0800000000000001 109.962 169.336 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -79.54 132.7 36.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.0 -0.741 . . . . 1.1699999999999999 109.0 152.159 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.1 139.47 39.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.517 1.127 . . . . 1.97 108.687 164.463 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -137.38 136.42 37.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.683 1.193 . . . . 2.6299999999999999 111.38 -175.648 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 42.73 99.4 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 1.6599999999999999 111.301 178.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.312 0.2 OUTLIER -68.76 87.48 0.35 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.434 1.588 . . . . 1.8500000000000001 113.91 -173.736 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -67.64 5.55 0.8 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.04 2.536 . . . . 2.1000000000000001 115.553 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -127.14 105.83 22.02 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.483 1.113 . . . . 6.3099999999999996 109.514 146.287 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.87 144.81 60.21 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.165 2.576 . . . . 1.76 111.073 172.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.14 126.32 33.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 2.0699999999999998 110.839 -177.589 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -98.34 -31.2 12.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.705 1.202 . . . . 4.9500000000000002 113.01 -175.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 122.06 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 1 C-N-CA 132.153 4.181 . . . . 1.5 110.468 175.729 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.23 37.0 93.51 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.355 -0.692 . . . . 1.9399999999999999 113.569 178.051 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.92 -171.8 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 2.9100000000000001 108.629 178.382 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -141.99 162.06 36.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.197 0.999 . . . . 3.3500000000000001 110.673 174.612 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.86 119.78 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.53 1.532 . . . . 0.83999999999999997 109.894 -169.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.48 135.94 52.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 3.0800000000000001 110.456 162.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -155.94 124.4 5.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.816 0.846 . . . . 1.5900000000000001 112.615 -175.334 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.67 105.57 17.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.739 1.616 . . . . 1.99 110.571 172.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.02 117.69 21.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.594 0.757 . . . . 1.22 110.418 176.481 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.77 126.27 38.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.877 1.271 . . . . 0.57999999999999996 111.045 -169.02 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -122.97 139.46 54.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.179 0.807 . . . . 1.8400000000000001 113.179 -175.289 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.22 104.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.273 1.029 . . . . 2.75 112.634 -177.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.26 78.57 1.05 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.012 1.292 . . . . 4.7300000000000004 113.087 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.28 -0.37 24.94 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 116.193 1.237 . . . . 1.96 116.193 169.356 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -110.13 132.18 54.4 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.014 1.407 . . . . 5.7400000000000002 112.761 -170.518 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.35 134.31 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.794 1.638 . . . . 1.1399999999999999 107.384 160.167 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.3 mt -120.15 110.16 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.937 -1.134 . . . . 1.99 107.937 177.227 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -80.04 127.6 32.48 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.16 -0.337 . . . . 2.4700000000000002 110.886 176.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.5 m -125.96 161.87 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.87 1.668 . . . . 1.1399999999999999 110.499 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.66 135.94 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.302 1.041 . . . . 1.9299999999999999 108.709 165.151 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -127.35 147.81 63.7 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.24 1.416 . . . . 1.5900000000000001 108.943 172.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.26 161.43 44.48 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.151 2.568 . . . . 1.0 111.942 174.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.6 133.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.302 1.441 . . . . 1.26 108.595 165.069 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.64 153.82 25.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.52 1.128 . . . . 3.9500000000000002 110.023 171.084 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 2.69 -113.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 130.163 3.385 . . . . 3.5299999999999998 117.632 175.497 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.775 0 CA-C-O 114.866 -2.492 . . . . 9.1199999999999992 112.348 178.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.236 0.363 0 CA-C-O 121.44 0.638 . . . . 5.9900000000000002 110.512 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.07 171.46 29.32 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.577 1.561 . . . . 1.1100000000000001 113.694 176.499 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -155.36 153.8 31.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.274 1.429 . . . . 1.5600000000000001 112.126 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 99' ' ' VAL . 90.6 t -105.49 136.54 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.569 -1.271 . . . . 1.0800000000000001 107.569 172.075 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -86.1 -0.31 55.31 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.486 2.032 . . . . 5.25 116.486 -153.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 60.65 168.65 0.09 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.87 1.668 . . . . 3.25 112.511 -168.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 t -165.73 145.69 5.48 Favored Pre-proline 0 N--CA 1.47 0.559 0 O-C-N 120.457 -1.402 . . . . 3.4399999999999999 112.372 162.556 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.32 -6.35 11.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.455 2.77 . . . . 3.3300000000000001 112.486 164.185 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.65 171.31 15.52 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.405 1.479 . . . . 1.8799999999999999 113.757 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.08 -3.16 13.16 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.931 3.754 . . . . 1.8 113.811 -176.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -121.83 156.51 33.1 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.215 1.806 . . . . 2.1400000000000001 112.133 171.539 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.79 177.06 11.82 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.38 1.472 . . . . 1.3 112.091 -171.403 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.57 20.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.475 1.11 . . . . 1.02 112.753 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.31 159.3 38.7 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.072 1.138 . . . . 1.1699999999999999 114.072 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -148.24 151.28 35.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.213 2.205 . . . . 2.4900000000000002 110.634 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -168.5 151.07 5.22 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.411 0.893 . . . . 1.6399999999999999 113.411 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -95.48 131.11 41.99 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.458 1.903 . . . . 1.6200000000000001 108.92 171.115 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.32 160.68 39.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.683 1.193 . . . . 4.4800000000000004 111.173 178.079 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.98 127.29 10.62 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.967 0.907 . . . . 3.29 110.779 -169.316 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -85.97 116.34 65.34 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.278 1.031 . . . . 0.93000000000000005 109.694 174.303 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -87.2 -14.01 4.18 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.082 2.522 . . . . 1.23 114.374 178.164 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.38 174.38 32.2 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 119.212 0.915 . . . . 1.1599999999999999 113.206 -174.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.01 -2.48 58.14 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.571 1.548 . . . . 3.7400000000000002 114.587 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -97.63 158.79 32.44 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.479 1.112 . . . . 2.02 111.138 173.656 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.59 157.52 12.29 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.377 2.718 . . . . 1.3500000000000001 111.229 -176.642 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.21 108.02 9.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.634 0.73 . . . . 2.1400000000000001 111.688 -170.885 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -99.96 106.23 18.0 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.696 1.198 . . . . 2.73 111.675 -177.019 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.1 tp -85.4 114.86 22.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.583 1.953 . . . . 0.69999999999999996 109.431 -177.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.71 -12.19 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.829 0.851 . . . . 0.88 112.884 -171.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.45 -168.04 40.59 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.665 1.126 . . . . 0.81000000000000005 111.098 173.15 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.37 140.69 20.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.638 0.775 . . . . 1.96 110.592 167.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -108.54 139.75 42.86 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.714 1.606 . . . . 6.8899999999999997 108.538 -169.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -152.41 155.7 33.09 Favored Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 124.593 1.157 . . . . 0.83999999999999997 109.874 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -86.58 -9.9 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.729 2.286 . . . . 1.4099999999999999 113.527 165.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 m -70.27 -9.52 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.343 0.974 . . . . 1.98 113.443 176.384 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 160.74 30.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.171 1.351 . . . . 0.93999999999999995 112.285 -169.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.28 -68.76 0.79 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.173 1.389 . . . . 3.0099999999999998 109.14 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -82.01 111.9 18.6 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.078 -1.014 . . . . 3.6299999999999999 109.405 171.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.62 145.78 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.524 1.13 . . . . 1.47 109.444 153.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -137.25 122.87 19.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.54 1.536 . . . . 2.1400000000000001 108.542 162.756 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.26 119.79 22.11 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 120.934 1.697 . . . . 0.68000000000000005 110.045 167.299 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -109.06 157.02 19.1 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.318 1.847 . . . . 0.58999999999999997 112.247 176.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 12.1 pt-20 -104.38 168.18 9.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.852 -1.067 . . . . 2.3700000000000001 110.264 161.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.7 m -130.03 107.48 9.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.342 1.457 . . . . 1.1299999999999999 107.3 170.49 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -113.27 154.92 26.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.859 1.264 . . . . 2.3300000000000001 112.508 -171.569 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -90.52 154.45 19.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.655 1.182 . . . . 3.3100000000000001 112.334 172.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.41 15.53 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.033 1.333 . . . . 5.5899999999999999 113.214 177.513 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -138.74 142.13 38.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.969 1.307 . . . . 4.8200000000000003 109.473 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.59 128.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.501 1.12 . . . . 3.8300000000000001 108.981 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 56.29 28.21 13.0 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.175 0.988 . . . . 4.1699999999999999 111.011 -168.313 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.12 -0.42 11.74 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.506 2.003 . . . . 3.2000000000000002 114.996 -173.285 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.69 126.11 30.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.444 1.498 . . . . 3.4199999999999999 108.785 174.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.47 126.89 52.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.371 1.468 . . . . 6.21 110.785 -162.228 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.8 t -145.67 153.17 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.915 1.286 . . . . 1.5900000000000001 110.586 -156.741 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.4 mtm -120.81 149.44 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.387 1.075 . . . . 2.8399999999999999 110.413 161.022 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.64 158.64 27.75 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.917 0.77 . . . . 1.1399999999999999 112.733 178.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -102.73 155.48 18.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.564 1.146 . . . . 1.6299999999999999 111.897 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.412 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -163.91 146.5 7.62 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-O 117.693 -1.146 . . . . 5.6699999999999999 112.255 171.733 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.38 142.13 53.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.881 2.387 . . . . 0.64000000000000001 111.419 172.005 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.76 157.54 38.19 Favored Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.303 1.441 . . . . 0.71999999999999997 110.763 175.501 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.44 -18.66 38.4 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.434 2.089 . . . . 0.62 112.743 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -179.42 167.04 1.47 Allowed 'General case' 0 C--N 1.347 0.459 0 C-N-CA 126.128 1.771 . . . . 1.8100000000000001 110.076 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -114.91 171.09 7.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.274 1.83 . . . . 0.98999999999999999 108.89 157.426 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.32 167.76 29.35 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.142 -0.974 . . . . 2.52 113.353 167.611 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.75 134.69 16.21 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.053 1.341 . . . . 0.79000000000000004 109.381 -172.237 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.42 164.58 33.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.223 1.949 . . . . 0.80000000000000004 111.611 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.14 139.7 85.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.831 3.021 . . . . 0.83999999999999997 111.919 174.501 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.54 1.67 1.4 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.345 1.858 . . . . 3.1800000000000002 115.128 -171.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 118.44 4.78 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 127.669 2.556 . . . . 0.90000000000000002 111.971 -178.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -91.79 137.03 32.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.874 1.27 . . . . 3.8300000000000001 111.021 159.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.7 m -150.31 157.45 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.785 1.634 . . . . 1.52 110.705 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.12 152.62 34.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.392 1.091 . . . . 3.73 112.826 169.828 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.79 77.29 2.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.955 1.302 . . . . 1.3999999999999999 108.733 161.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.2 137.51 78.71 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.393 1.077 . . . . 3.3700000000000001 112.399 177.59 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.53 -34.56 85.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.905 3.07 . . . . 1.6299999999999999 114.476 -169.568 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.7 121.54 6.29 Favored Glycine 0 N--CA 1.468 0.824 0 N-CA-C 106.889 -2.484 . . . . 1.47 106.889 150.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.86 -94.72 0.5 Allowed Glycine 0 N--CA 1.47 0.909 0 CA-C-N 119.786 1.793 . . . . 1.6000000000000001 112.967 -161.082 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 54.7 m-85 -148.12 149.06 31.34 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.042 2.137 . . . . 1.9199999999999999 111.633 -169.867 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.7 163.7 14.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.307 1.043 . . . . 1.01 109.982 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -93.39 138.19 31.96 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 122.02 -0.425 . . . . 2.4300000000000002 109.937 167.187 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.6 mmt -96.98 139.49 32.91 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.348 1.059 . . . . 0.83999999999999997 109.421 157.068 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.58 142.62 51.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.484 1.513 . . . . 2.8799999999999999 109.933 -178.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -145.99 133.65 21.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 3.0299999999999998 111.505 -174.838 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.74 74.37 1.09 Allowed Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.274 -0.73 . . . . 1.47 111.274 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.67 119.41 25.21 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.471 0.915 . . . . 1.1299999999999999 113.471 -163.562 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -90.6 -8.99 48.66 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.896 1.443 . . . . 1.8100000000000001 114.896 -169.684 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.22 145.08 56.16 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.204 1.401 . . . . 6.1500000000000004 108.038 160.489 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 128.76 15.19 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 107.169 -1.896 . . . . 2.0800000000000001 107.169 168.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.37 95.76 0.33 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.087 1.355 . . . . 2.3199999999999998 110.506 -168.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -68.99 111.81 5.23 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 120.657 -1.277 . . . . 4.9900000000000002 108.693 177.602 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.94 108.93 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.123 -0.985 . . . . 1.78 110.431 167.416 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.06 16.65 40.37 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 117.213 -1.882 . . . . 1.79 116.036 -170.778 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.08 171.59 12.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.793 2.297 . . . . 4.3899999999999997 109.045 150.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.219 1.408 . . . . 4.3300000000000001 108.621 170.59 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 8' ' ' VAL . 58.9 t -98.41 119.66 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.916 0.887 . . . . 1.0800000000000001 110.062 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.71 45.12 1.04 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 128.282 2.633 . . . . 5.5999999999999996 113.185 -170.756 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.41 130.22 42.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.483 1.913 . . . . 1.79 113.902 -164.18 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -92.02 93.28 8.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.457 2.703 . . . . 2.3199999999999998 110.892 175.353 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.1 mt -71.48 120.61 17.31 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.396 -0.815 . . . . 1.47 110.52 -179.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt -93.27 125.26 37.78 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.546 1.538 . . . . 1.0 111.114 -169.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.73 125.63 44.37 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.468 0.914 . . . . 1.8600000000000001 113.468 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 53.44 11.37 0.27 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.444 2.298 . . . . 2.1099999999999999 116.685 167.53 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.92 4.02 46.22 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.959 -1.088 . . . . 3.3399999999999999 114.409 -168.304 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -129.91 -4.71 4.6 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.727 1.156 . . . . 1.8 115.64 -171.147 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.69 158.37 43.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.423 2.289 . . . . 4.0999999999999996 110.831 173.123 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.8 135.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.949 1.7 . . . . 1.54 107.582 165.589 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.61 115.33 12.9 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.86 1.264 . . . . 1.72 107.77 -173.847 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -102.84 141.64 35.31 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.456 1.28 . . . . 2.7200000000000002 114.456 -171.324 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.68 167.75 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.562 1.545 . . . . 1.52 110.09 -173.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.87 144.81 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 124.641 1.176 . . . . 2.9100000000000001 109.733 172.245 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.42 133.17 6.67 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.551 -0.738 . . . . 2.3100000000000001 111.162 176.475 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.06 150.34 82.5 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.566 2.844 . . . . 1.51 112.623 -172.795 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.3 112.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.337 1.055 . . . . 1.6100000000000001 108.492 166.764 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.88 -169.95 2.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.099 2.96 . . . . 3.7400000000000002 108.649 178.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.53 53.0 1.8 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.202 1.556 . . . . 2.6200000000000001 115.202 -161.29 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 115.58 -2.152 . . . . 8.3699999999999992 115.045 178.599 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 109.53 -0.544 . . . . 4.4199999999999999 109.53 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.72 174.75 43.36 Favored Glycine 0 N--CA 1.465 0.592 0 O-C-N 121.94 -0.475 . . . . 1.1499999999999999 113.96 -178.749 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -155.51 151.04 27.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.947 0.899 . . . . 1.3799999999999999 112.167 -179.485 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.93 127.64 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.901 -0.499 . . . . 0.98999999999999999 110.016 174.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -72.63 -11.0 60.46 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.441 1.645 . . . . 4.7400000000000002 115.441 -159.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.94 160.81 0.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.372 1.469 . . . . 2.8199999999999998 113.949 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -165.82 149.93 7.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.048 1.739 . . . . 4.1900000000000004 110.497 166.816 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -83.64 -9.92 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.25 2.633 . . . . 3.75 112.024 162.298 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.9 -168.14 13.27 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.96 1.743 . . . . 2.3799999999999999 113.962 -174.283 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -74.0 -27.45 12.04 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.196 2.598 . . . . 2.1099999999999999 114.955 -165.099 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -98.63 150.85 21.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.144 1.338 . . . . 3.0 112.425 177.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.4 -179.9 8.53 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.032 2.133 . . . . 1.28 111.599 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.76 167.35 21.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.15 1.78 . . . . 1.0900000000000001 111.403 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.83 155.1 36.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.351 1.061 . . . . 1.1000000000000001 112.376 172.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 142.57 24.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.362 1.865 . . . . 2.1800000000000002 109.558 -171.895 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -171.24 159.37 5.8 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.318 1.599 . . . . 1.73 115.318 -174.293 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -71.9 138.48 48.19 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.305 1.842 . . . . 1.27 109.365 166.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.62 146.25 49.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.118 1.767 . . . . 3.6200000000000001 111.241 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -119.72 132.97 55.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.256 1.822 . . . . 5.0499999999999998 114.002 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -98.95 109.04 52.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.678 -0.692 . . . . 1.1699999999999999 109.851 143.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -89.2 -10.62 3.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.53 2.82 . . . . 1.25 113.565 173.254 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.58 -174.25 47.15 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.116 1.341 . . . . 0.92000000000000004 113.495 -174.475 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.56 -4.0 18.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.963 1.705 . . . . 2.3199999999999998 113.147 -169.253 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.42 161.43 39.27 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.653 1.981 . . . . 1.8700000000000001 109.644 169.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.71 163.09 29.44 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.826 2.351 . . . . 1.3500000000000001 112.632 -167.615 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.26 127.56 45.8 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.884 1.274 . . . . 2.3599999999999999 111.125 -174.528 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -111.16 112.98 25.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.907 1.283 . . . . 3.5099999999999998 110.648 175.175 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 tp -85.76 133.12 34.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.377 . . . . 0.96999999999999997 108.721 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.86 -13.02 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.034 0.934 . . . . 0.72999999999999998 113.516 -175.423 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.48 -164.98 34.47 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.002 0.811 . . . . 0.97999999999999998 111.74 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 102' ' ' ASP . . . -140.94 -175.92 4.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.459 0.704 . . . . 1.1399999999999999 110.632 160.651 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.88 146.56 9.54 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.069 0.948 . . . . 5.2199999999999998 111.644 171.075 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -140.34 152.32 66.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.017 1.727 . . . . 0.84999999999999998 109.253 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.13 -34.05 29.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 121.585 1.602 . . . . 0.95999999999999996 112.613 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 m -70.77 -18.82 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 115.244 1.572 . . . . 1.29 115.244 -167.028 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.3 143.03 50.79 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.843 1.257 . . . . 0.92000000000000004 111.078 -176.349 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -64.48 -53.83 42.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.262 1.025 . . . . 4.4199999999999999 111.8 172.392 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.14 160.76 21.51 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.372 1.869 . . . . 7.2400000000000002 111.055 -170.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -159.7 135.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.824 1.65 . . . . 1.1499999999999999 110.661 -172.136 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -139.87 135.1 32.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.324 1.85 . . . . 2.4100000000000001 109.72 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -83.33 118.74 23.89 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.436 1.016 . . . . 0.79000000000000004 111.012 168.144 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -106.41 155.25 19.74 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.178 1.791 . . . . 0.73999999999999999 112.044 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -157.27 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 3.75 111.019 174.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.8 m -151.32 123.98 8.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.478 2.311 . . . . 1.51 106.598 162.191 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -126.86 160.51 30.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.778 1.231 . . . . 2.48 112.431 -172.11 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.9 ptt? -134.24 122.18 22.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.988 1.375 . . . . 3.3999999999999999 112.587 159.762 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -117.52 162.41 18.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.245 1.818 . . . . 7.8499999999999996 110.927 -176.055 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.402 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 30.1 mp0 -77.19 144.42 38.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.893 1.677 . . . . 4.8099999999999996 111.479 171.989 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.49 -96.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.602 1.561 . . . . 3.2400000000000002 109.176 -176.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.02 31.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.088 1.355 . . . . 4.0300000000000002 112.44 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.58 -13.28 8.48 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.365 -1.459 . . . . 2.73 112.594 -154.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 152.72 28.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.318 1.847 . . . . 4.4100000000000001 110.763 178.745 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 41.6 mmtt -73.78 140.12 45.65 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.746 -0.596 . . . . 5.8600000000000003 110.668 158.539 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -132.85 145.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.159 1.784 . . . . 2.0699999999999998 108.259 165.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.8 tpp -101.52 146.9 27.04 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.229 2.212 . . . . 3.1499999999999999 111.016 -175.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.11 -174.98 33.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.935 1.255 . . . . 1.4399999999999999 113.64 174.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -138.38 152.2 48.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.672 1.589 . . . . 1.9099999999999999 110.196 173.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.39 148.33 16.44 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 124.664 1.186 . . . . 4.4500000000000002 110.932 -170.035 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.41 150.32 84.39 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 121.611 1.54 . . . . 0.76000000000000001 112.49 167.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.89 159.11 73.93 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 126.559 1.944 . . . . 0.82999999999999996 110.761 176.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.39 -18.35 14.02 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.039 2.493 . . . . 0.62 114.069 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -171.74 164.55 6.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.986 1.266 . . . . 2.0299999999999998 112.552 -178.665 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.15 168.61 12.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.737 2.415 . . . . 1.0600000000000001 108.572 161.165 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -161.88 163.82 28.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.975 -1.078 . . . . 2.1800000000000002 113.274 176.23 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 t -149.2 140.69 14.44 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.3 1.04 . . . . 1.53 110.601 -169.567 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.35 167.34 20.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.997 2.465 . . . . 1.23 112.016 171.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.25 146.72 97.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.604 2.87 . . . . 1.0 112.796 175.224 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt 66.92 -2.45 1.13 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.373 1.869 . . . . 1.3100000000000001 114.571 -178.991 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.97 117.86 4.58 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 126.65 2.071 . . . . 0.81000000000000005 111.343 178.673 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -83.34 145.35 29.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.834 -0.683 . . . . 6.3899999999999997 110.229 151.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.78 179.54 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.03 1.732 . . . . 1.53 109.398 171.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -121.39 139.75 53.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.771 0.828 . . . . 3.7000000000000002 111.217 166.394 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.16 76.69 1.27 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.805 -1.554 . . . . 1.1499999999999999 106.805 143.712 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -82.87 142.19 44.8 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 117.672 -1.156 . . . . 3.79 109.94 -177.596 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.66 -55.13 4.38 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.355 3.37 . . . . 1.75 114.959 -169.397 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.1 70.83 2.81 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.748 -0.941 . . . . 1.1599999999999999 110.748 172.012 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.84 -76.95 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.253 1.406 . . . . 0.90000000000000002 114.046 -166.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -155.63 142.1 18.63 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 1.8200000000000001 108.351 -177.012 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -163.1 179.12 7.72 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.254 -0.903 . . . . 0.80000000000000004 111.581 -172.934 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -109.29 139.92 43.61 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.108 -0.37 . . . . 2.0499999999999998 111.088 168.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 mmt -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.58 0.752 . . . . 1.1599999999999999 109.477 155.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.11 140.01 53.04 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.694 1.597 . . . . 2.6499999999999999 109.1 178.228 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.16 152.8 49.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.047 0.939 . . . . 3.3999999999999999 111.956 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.82 60.02 4.46 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.678 0.656 . . . . 1.5900000000000001 111.719 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -74.94 107.71 7.19 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.469 1.128 . . . . 1.3400000000000001 110.866 -178.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -70.98 -6.33 37.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.565 1.546 . . . . 2.48 115.014 -175.608 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -143.41 158.45 57.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.687 2.395 . . . . 6.9900000000000002 108.273 156.529 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.07 157.25 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.086 1.857 . . . . 2.02 109.741 156.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.78 166.67 10.52 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.399 1.479 . . . . 2.7400000000000002 111.915 -176.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 134.08 38.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.917 1.287 . . . . 3.6899999999999999 111.427 174.085 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.7 24.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.946 -1.096 . . . . 1.5900000000000001 110.219 173.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.44 54.98 2.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.129 0.395 . . . . 2.21 112.629 -162.024 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -143.05 160.83 39.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.619 2.368 . . . . 2.75 109.015 165.008 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -102.49 120.47 40.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.968 2.107 . . . . 4.3799999999999999 111.112 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.54 128.92 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.896 1.278 . . . . 0.95999999999999996 109.638 169.944 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -79.11 140.21 37.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.002 0.43 . . . . 2.52 110.976 159.454 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -148.26 127.13 12.67 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.892 0.877 . . . . 1.8799999999999999 112.092 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 18.2 m-20 -98.34 103.73 15.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.465 1.906 . . . . 2.5099999999999998 110.732 177.626 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.4 mt -68.86 112.43 5.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.997 0.817 . . . . 1.8799999999999999 110.575 168.716 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.0 mt -87.15 129.65 34.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.734 1.213 . . . . 1.0 111.049 -176.412 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.81 117.67 19.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.536 0.684 . . . . 2.3799999999999999 111.268 179.288 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.95 21.82 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.292 2.237 . . . . 1.97 116.729 168.525 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.47 -41.86 1.42 Allowed Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.228 1.394 . . . . 3.2400000000000002 114.17 -174.491 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.58 -1.82 72.76 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.073 1.32 . . . . 2.3999999999999999 114.877 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -148.47 157.15 43.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.372 1.469 . . . . 4.3799999999999999 113.828 179.082 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.97 140.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.179 2.192 . . . . 1.8700000000000001 108.224 168.402 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -125.55 111.97 15.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.881 1.272 . . . . 2.7400000000000002 109.29 176.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -88.78 125.72 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.771 -0.58 . . . . 2.1099999999999999 112.279 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.08 161.66 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.904 1.682 . . . . 1.6299999999999999 111.208 171.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 m -106.66 143.58 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 2.3799999999999999 109.235 163.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.38 145.87 39.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.606 1.163 . . . . 1.9199999999999999 111.624 179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.15 142.8 34.72 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.231 2.621 . . . . 1.1200000000000001 112.186 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -79.94 132.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.174 1.389 . . . . 1.0900000000000001 109.481 165.044 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -147.02 139.37 24.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.766 2.427 . . . . 4.25 107.276 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.62 52.9 2.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.455 1.502 . . . . 2.79 112.117 -170.473 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG 0.294 0.0 OUTLIER . . . . . 0 C--O 1.248 0.977 0 N-CA-C 117.414 2.375 . . . . 6.5700000000000003 117.414 -154.064 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.555 1.137 0 N-CA-C 108.298 -1.001 . . . . 6.4100000000000001 108.298 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.4 -171.18 19.82 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 120.065 -1.647 . . . . 0.93999999999999995 115.688 -177.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -167.48 158.46 11.49 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.109 1.763 . . . . 1.3700000000000001 112.167 173.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.77 130.94 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.733 0.813 . . . . 0.93000000000000005 110.028 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -78.4 120.38 23.05 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.715 1.206 . . . . 4.0999999999999996 111.615 -174.84 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -62.46 123.66 18.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.951 1.3 . . . . 3.2400000000000002 110.459 164.246 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -155.83 160.93 30.44 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.866 1.666 . . . . 1.95 108.976 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.58 -159.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.303 3.335 . . . . 3.52 108.862 167.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.52 -161.5 46.58 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.88 0.752 . . . . 2.3599999999999999 112.558 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -87.22 -11.14 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.579 2.853 . . . . 2.1499999999999999 113.201 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -149.45 160.13 43.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.696 1.198 . . . . 2.1800000000000002 113.891 -168.762 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.5 -167.06 1.64 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.624 1.97 . . . . 1.26 110.385 -174.723 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.67 153.59 50.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.834 0.743 . . . . 1.23 112.689 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.9 153.03 46.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.69 1.196 . . . . 0.83999999999999997 110.281 163.352 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.15 156.12 46.0 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.781 1.232 . . . . 2.3100000000000001 111.2 174.485 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.13 153.4 16.06 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.679 0.992 . . . . 1.52 113.679 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -78.54 140.09 38.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.607 -1.179 . . . . 1.24 107.956 151.337 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.21 134.73 26.3 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.73 1.212 . . . . 2.23 108.262 176.47 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.61 157.56 43.54 Favored 'General case' 0 C--N 1.335 -0.059 0 N-CA-C 114.13 1.159 . . . . 3.4199999999999999 114.13 -170.475 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -115.3 105.32 52.62 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.97999999999999998 110.931 -168.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.41 -15.67 9.84 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.577 2.185 . . . . 1.0800000000000001 113.595 177.177 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 -167.91 41.35 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 119.263 0.938 . . . . 1.25 112.91 -177.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -117.02 16.29 15.06 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.5 1.52 . . . . 2.6400000000000001 111.496 -173.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mt -120.14 162.07 35.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.167 2.187 . . . . 3.1899999999999999 109.244 -175.595 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.21 156.99 17.32 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.976 2.451 . . . . 1.5800000000000001 110.901 175.804 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.29 103.55 4.95 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.273 1.029 . . . . 2.3199999999999998 111.059 -171.608 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -96.38 106.16 18.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.972 1.309 . . . . 3.1200000000000001 111.364 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 tp -86.73 113.84 22.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.126 2.17 . . . . 0.71999999999999997 108.651 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.69 -11.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.173 0.989 . . . . 0.58999999999999997 113.483 -169.042 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.49 -161.68 32.48 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.518 -0.739 . . . . 0.59999999999999998 112.296 178.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.836 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -148.72 177.34 9.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.279 1.032 . . . . 1.03 111.374 176.143 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 129.79 5.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.924 -1.139 . . . . 5.4100000000000001 107.924 172.502 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -135.31 147.36 61.8 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 117.748 -1.12 . . . . 1.03 109.232 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.68 -15.02 27.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.04 1.827 . . . . 1.4199999999999999 112.712 171.222 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -75.19 -0.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.035 0.834 . . . . 0.84999999999999998 113.236 174.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.47 -172.28 3.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.615 1.966 . . . . 1.24 110.311 176.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -106.63 -55.89 2.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.699 1.2 . . . . 3.0299999999999998 110.566 166.056 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -119.85 165.92 13.97 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 4.1500000000000004 110.907 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.3 p -155.5 135.91 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.705 0.802 . . . . 2.0800000000000001 109.48 171.703 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -120.13 132.51 55.44 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.954 1.702 . . . . 2.1499999999999999 108.977 -173.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.85 115.34 19.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.504 1.145 . . . . 0.94999999999999996 109.855 170.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -103.16 150.87 23.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.337 -1.301 . . . . 0.64000000000000001 111.995 176.029 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -94.64 164.59 12.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.513 2.325 . . . . 2.3500000000000001 109.991 166.281 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.9 m -145.63 121.25 10.45 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.38 1.072 . . . . 1.3500000000000001 108.152 167.784 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.49 153.48 51.73 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.894 0.878 . . . . 2.1499999999999999 112.945 -151.813 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.33 47.89 0.98 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 123.084 1.421 . . . . 6.1200000000000001 111.868 -172.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -80.67 162.16 24.31 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.347 -1.751 . . . . 8.1199999999999992 110.886 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -69.5 152.07 45.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.401 2.281 . . . . 4.04 111.42 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.04 -96.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.167 1.387 . . . . 2.9700000000000002 107.645 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.65 43.22 0.14 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.28 1.832 . . . . 4.5300000000000002 111.248 169.507 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.94 -26.96 0.78 Allowed Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.37 -1.456 . . . . 2.5800000000000001 113.691 -167.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -74.07 145.3 44.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.67 1.588 . . . . 3.1899999999999999 110.684 175.491 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -75.37 133.09 41.29 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.694 0.798 . . . . 5.1500000000000004 109.996 173.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.05 149.74 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.416 1.086 . . . . 1.77 109.865 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.3 mtm -83.37 93.86 7.84 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 3.8599999999999999 112.985 175.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.38 165.67 22.7 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.367 0.984 . . . . 1.1599999999999999 112.328 172.349 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -128.64 165.93 19.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.76 1.624 . . . . 2.5899999999999999 111.098 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -178.74 144.78 0.46 Allowed Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 116.123 -1.894 . . . . 4.4500000000000002 111.224 -175.198 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.69 143.11 60.65 Favored 'Trans proline' 0 C--N 1.347 0.472 0 CA-C-N 122.095 1.784 . . . . 0.70999999999999996 111.607 160.005 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.56 157.28 38.76 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.202 1.401 . . . . 0.73999999999999999 110.208 169.267 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.68 -15.78 33.65 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.73999999999999999 113.09 175.566 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -175.16 160.27 2.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.715 1.606 . . . . 2.7200000000000002 111.955 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt -109.51 175.09 5.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.851 1.261 . . . . 1.1699999999999999 108.867 147.71 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -156.0 166.89 32.13 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.042 -1.036 . . . . 2.3300000000000001 112.837 170.491 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.55 132.79 16.59 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 1.0900000000000001 109.899 -177.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.36 162.35 38.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.736 2.29 . . . . 0.96999999999999997 110.835 171.316 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.18 140.56 84.2 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.945 2.43 . . . . 1.25 111.485 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt 71.98 -4.0 2.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.599 2.36 . . . . 1.48 114.318 -178.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.29 177.35 33.55 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.784 1.659 . . . . 1.0900000000000001 112.286 177.691 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -144.17 151.02 38.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.863 1.665 . . . . 3.8100000000000001 112.562 175.686 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.96 149.77 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.786 1.635 . . . . 2.1000000000000001 108.349 164.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -135.33 109.62 8.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.685 -1.598 . . . . 4.29 106.685 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.75 77.69 6.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.86 1.314 . . . . 1.4399999999999999 111.212 -164.338 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -67.37 138.74 94.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 117.26 -1.352 . . . . 5.0700000000000003 110.005 174.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.19 -54.45 4.99 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.258 3.305 . . . . 1.02 113.435 -175.592 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.05 51.8 3.91 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.655 1.122 . . . . 1.8899999999999999 111.708 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.58 -82.9 0.04 OUTLIER Glycine 0 N--CA 1.465 0.576 0 C-N-CA 128.663 3.03 . . . . 0.93000000000000005 111.223 -171.652 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -150.8 143.37 24.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.427 2.291 . . . . 2.2200000000000002 108.402 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -160.57 167.16 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.351 -0.843 . . . . 0.84999999999999998 110.63 -175.294 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 14.3 m-85 -107.16 122.59 46.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.585 0.754 . . . . 2.1099999999999999 110.566 174.284 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 mmt -85.93 117.64 24.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.606 1.162 . . . . 0.93999999999999995 110.525 171.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.7 mt -93.46 136.15 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.931 1.292 . . . . 1.9399999999999999 110.238 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mt -140.72 132.79 27.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.561 0.619 . . . . 2.6499999999999999 112.299 -178.255 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.71 53.82 2.18 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 125.343 1.449 . . . . 1.6599999999999999 112.506 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.48 115.17 4.4 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.884 0.698 . . . . 0.98999999999999999 112.884 -168.872 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -86.94 -13.42 44.73 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.173 1.175 . . . . 1.6499999999999999 114.173 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -146.64 143.04 17.99 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.646 1.178 . . . . 5.5499999999999998 110.251 177.184 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.52 134.58 17.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.088 2.526 . . . . 1.6000000000000001 109.228 171.44 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.41 90.07 8.14 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.786 0.835 . . . . 2.25 111.358 -171.33 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -58.72 148.17 30.39 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.002 -1.061 . . . . 3.8799999999999999 113.317 169.447 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.79 114.73 5.89 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.517 -0.739 . . . . 1.77 109.473 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.6 -9.7 7.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 116.63 -2.206 . . . . 1.9299999999999999 116.816 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 173.29 10.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.449 2.624 . . . . 3.8999999999999999 112.884 -177.209 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -100.16 162.12 13.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.229 1.412 . . . . 3.8599999999999999 110.085 159.484 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.6 t -128.42 127.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.179 1.791 . . . . 1.05 108.155 172.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.2 136.81 35.89 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.533 1.533 . . . . 5.96 109.562 175.513 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.836 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.0 tt -154.3 130.01 10.03 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.743 1.258 . . . . 1.6299999999999999 114.342 179.107 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.82 99.78 12.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.317 3.047 . . . . 2.7599999999999998 110.989 173.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.48 117.16 17.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.941 -1.099 . . . . 1.1399999999999999 109.173 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.2 mt -91.49 126.85 36.72 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.796 0.838 . . . . 0.80000000000000004 110.382 -169.03 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.01 126.95 45.12 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.972 1.101 . . . . 1.77 113.972 -178.501 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.52 23.98 1.03 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.458 1.903 . . . . 2.3199999999999998 114.603 169.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.01 -55.13 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.346 1.451 . . . . 3.9300000000000002 113.004 -166.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.05 18.17 46.44 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.587 -1.674 . . . . 1.8899999999999999 116.629 -169.069 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -141.93 157.73 44.61 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.869 2.468 . . . . 4.2300000000000004 110.58 165.187 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.2 141.38 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 126.048 1.739 . . . . 1.01 107.851 162.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.4 106.89 12.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.668 1.187 . . . . 1.8200000000000001 107.896 173.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -79.44 128.53 33.47 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.41 -0.806 . . . . 4.9699999999999998 111.071 177.771 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.96 164.06 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.394 1.877 . . . . 1.48 110.443 178.743 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 m -105.26 155.6 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 125.441 1.496 . . . . 2.96 109.119 164.615 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.7 mt -141.52 149.52 54.44 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.546 1.939 . . . . 1.6100000000000001 109.231 173.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.53 152.97 20.41 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.829 3.019 . . . . 0.93000000000000005 112.348 176.127 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.3 t -80.38 142.04 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.276 1.03 . . . . 1.25 111.149 168.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 166.86 32.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.807 2.043 . . . . 2.9399999999999999 111.204 -166.678 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.98 26.84 9.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.738 1.215 . . . . 2.0 113.392 -169.172 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.1 mtm105 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 116.606 -1.664 . . . . 5.8799999999999999 112.382 -171.58 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 121.711 0.767 . . . . 7.2800000000000002 111.848 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.56 151.97 17.03 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.949 1.261 . . . . 1.02 114.482 -172.828 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -155.85 162.97 40.36 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.96 1.304 . . . . 1.55 110.928 -177.36 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.66 126.82 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.718 0.77 . . . . 0.97999999999999998 109.58 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.9 52.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.523 1.305 . . . . 9.4700000000000006 114.523 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -97.61 139.13 33.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.856 1.262 . . . . 2.8500000000000001 108.773 162.255 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -164.28 158.12 15.61 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.798 1.239 . . . . 2.6200000000000001 110.994 166.991 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -83.96 57.98 5.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.494 3.462 . . . . 2.71 110.824 177.283 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.55 160.3 27.9 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.199 -0.778 . . . . 1.5700000000000001 113.709 -177.133 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -77.53 -3.87 14.05 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.005 3.137 . . . . 1.77 113.226 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -161.33 153.68 20.1 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.724 1.61 . . . . 2.21 112.854 -176.158 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -176.97 160.26 1.79 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.717 1.607 . . . . 2.54 112.045 172.703 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.94 133.77 45.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.182 1.793 . . . . 2.2200000000000002 112.372 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.76 154.77 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.172 1.389 . . . . 1.4299999999999999 111.328 172.413 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.07 154.39 48.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.832 0.853 . . . . 2.5899999999999999 112.481 -159.832 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -171.54 154.96 3.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.786 1.234 . . . . 1.54 112.942 176.09 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.475 HG21 ' HD3' ' A' ' 74' ' ' ARG . 99.5 m -74.76 146.68 41.96 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.792 -0.447 . . . . 1.9399999999999999 109.792 152.739 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.98 124.75 43.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.35 2.26 . . . . 2.3900000000000001 107.979 173.53 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -102.62 134.46 45.94 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.613 1.965 . . . . 4.7699999999999996 113.315 175.612 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -99.11 106.99 41.8 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 121.573 -0.704 . . . . 1.28 109.621 162.151 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.23 -11.15 10.99 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.584 2.19 . . . . 1.22 112.989 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 176.17 51.21 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.644 1.116 . . . . 1.1599999999999999 113.505 -177.047 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -99.59 -7.22 26.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.443 1.897 . . . . 2.6499999999999999 112.818 -175.412 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.05 160.5 38.78 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.629 1.971 . . . . 2.2000000000000002 109.894 170.012 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.74 149.98 23.82 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.061 2.508 . . . . 1.8500000000000001 112.435 -168.94 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 mt -96.09 154.93 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.988 0.915 . . . . 1.97 110.784 170.71 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 68' ' ' GLU . 20.9 ttm180 -135.83 107.72 7.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.489 1.516 . . . . 3.71 108.979 171.998 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.6 tp -86.03 116.3 24.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.403 2.281 . . . . 0.69999999999999996 108.818 -176.745 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.96 -13.16 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 0.54000000000000004 112.772 -172.566 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.13 -169.19 42.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.294 1.426 . . . . 0.57999999999999996 111.636 177.58 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.43 159.57 38.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.0 1.32 . . . . 1.1699999999999999 111.138 168.541 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -132.16 136.9 47.42 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.68 -1.262 . . . . 6.4299999999999997 110.321 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.0 155.4 70.85 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 124.875 1.27 . . . . 0.76000000000000001 108.952 -174.381 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.06 -31.49 45.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.938 1.758 . . . . 1.04 113.017 160.348 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -77.01 5.86 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.852 1.427 . . . . 1.3999999999999999 114.852 -167.448 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.72 29.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.851 1.66 . . . . 1.1899999999999999 111.4 -178.655 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.21 -81.71 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.44 0.296 . . . . 2.9100000000000001 111.055 -178.685 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -71.72 161.24 31.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.984 0.897 . . . . 3.8199999999999998 110.709 174.465 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.2 138.8 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.151 -1.386 . . . . 2.2000000000000002 108.268 159.078 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -133.14 124.17 27.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.442 -1.688 . . . . 2.2000000000000002 106.442 160.666 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.14 121.62 26.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.163 1.347 . . . . 0.71999999999999997 109.288 166.024 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -104.85 158.1 16.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.962 1.305 . . . . 0.65000000000000002 112.346 176.127 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.21 -175.65 2.85 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.673 2.389 . . . . 2.21 111.627 172.333 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.1 m -134.72 104.11 5.9 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.003 1.721 . . . . 1.74 106.407 153.887 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -84.45 150.4 25.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.006 0.523 . . . . 2.2999999999999998 110.805 178.858 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -106.95 135.86 47.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.208 1.003 . . . . 4.3300000000000001 110.859 170.913 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.21 -172.97 2.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.679 1.192 . . . . 6.6799999999999997 113.087 -172.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.25 149.01 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.601 2.761 . . . . 4.8600000000000003 106.666 -170.958 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.04 -42.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.454 1.502 . . . . 5.5599999999999996 112.641 177.503 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -81.35 10.53 5.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.021 1.728 . . . . 4.8600000000000003 112.519 168.089 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.65 -7.29 1.06 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.306 1.432 . . . . 1.8600000000000001 115.147 -167.523 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -72.95 133.59 44.4 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.721 -1.458 . . . . 3.5800000000000001 108.474 158.973 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 142.84 36.74 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.287 -0.634 . . . . 5.9199999999999999 109.287 166.889 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -147.89 152.37 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.819 2.047 . . . . 1.8700000000000001 109.067 -166.881 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.8 mtm -123.75 143.34 50.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.618 1.167 . . . . 3.6499999999999999 111.232 167.72 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.92 159.05 28.51 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.1 0.857 . . . . 1.46 113.689 -179.363 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.577 1.151 . . . . 1.6599999999999999 112.618 -175.44 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -177.14 142.66 0.51 Allowed Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 116.663 -1.637 . . . . 4.3499999999999996 110.764 -171.196 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -71.83 142.67 39.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 CA-C-N 122.204 1.823 . . . . 0.59999999999999998 111.827 167.956 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.64 157.48 47.73 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 126.052 1.741 . . . . 0.56000000000000005 110.473 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.13 -17.91 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.436 2.09 . . . . 0.59999999999999998 113.025 176.398 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -175.69 169.06 3.08 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.135 1.374 . . . . 2.0099999999999998 111.321 -177.224 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.21 175.18 5.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.645 1.978 . . . . 1.1499999999999999 108.961 156.035 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.3 pt-20 -152.47 164.26 37.91 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.105 -0.997 . . . . 2.6600000000000001 111.511 176.492 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -147.58 129.06 7.28 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.17 0.988 . . . . 1.1399999999999999 110.311 -172.001 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.65 157.49 35.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.996 2.464 . . . . 1.48 111.934 179.65 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.89 137.56 73.25 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.374 3.383 . . . . 1.46 113.293 -174.908 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 68.88 -5.46 1.01 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.261 2.224 . . . . 1.23 114.42 -176.494 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.62 137.2 14.15 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 126.498 1.999 . . . . 1.3300000000000001 109.838 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.475 ' HD3' HG21 ' A' ' 21' ' ' THR . 7.6 ptp180 -107.26 136.79 46.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.061 -1.07 . . . . 5.0499999999999998 110.561 158.493 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.21 149.07 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 125.378 1.471 . . . . 2.3799999999999999 110.702 -178.372 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -100.95 134.5 43.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.151 1.908 . . . . 4.0199999999999996 116.151 -167.866 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.29 78.68 1.33 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.505 1.522 . . . . 1.1399999999999999 107.453 155.455 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -83.17 139.55 42.26 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.556 1.142 . . . . 2.8599999999999999 110.364 178.127 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.8 -53.35 7.06 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.851 3.034 . . . . 1.25 113.915 -169.147 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.04 90.45 1.68 Allowed Glycine 0 N--CA 1.469 0.894 0 N-CA-C 109.622 -1.391 . . . . 1.5600000000000001 109.622 166.017 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.15 -74.29 0.22 Allowed Glycine 0 N--CA 1.468 0.794 0 C-N-CA 124.843 1.211 . . . . 1.25 112.767 -168.945 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -156.02 144.86 20.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.52 1.928 . . . . 1.96 109.346 177.101 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -167.73 164.91 14.39 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.977 -1.077 . . . . 0.78000000000000003 109.629 -176.251 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -95.92 120.33 36.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.826 0.45 . . . . 2.0299999999999998 110.183 175.341 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.1 mmt -76.9 100.05 5.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.643 1.211 . . . . 1.0900000000000001 109.365 163.793 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -102.02 111.11 23.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.663 -1.608 . . . . 1.9399999999999999 108.268 178.63 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.56 52.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.0 1.72 . . . . 3.4300000000000002 109.124 -173.524 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.96 63.09 2.12 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.797 -0.921 . . . . 1.5600000000000001 110.797 -174.855 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.97 117.23 13.32 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.387 0.675 . . . . 1.48 111.427 -176.068 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -82.82 -6.93 59.66 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.689 1.366 . . . . 1.49 114.689 -165.335 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -122.87 153.22 63.64 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.921 -1.511 . . . . 4.6200000000000001 106.921 152.451 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.34 123.71 9.79 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 107.371 -1.819 . . . . 1.71 107.371 151.34 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.35 154.36 41.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.935 1.294 . . . . 2.0800000000000001 112.069 -166.363 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -131.38 129.1 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.564 1.146 . . . . 6.0899999999999999 110.931 165.948 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.05 121.86 8.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.795 -0.816 . . . . 1.6100000000000001 108.795 169.647 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.55 1.84 56.53 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-O 117.998 -1.446 . . . . 1.8899999999999999 116.127 -169.778 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -78.79 170.22 17.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.182 1.991 . . . . 2.7200000000000002 110.243 162.159 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -116.15 149.78 38.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.812 2.045 . . . . 5.0700000000000003 109.811 177.228 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.4 t -127.62 113.94 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.404 1.081 . . . . 1.1899999999999999 109.722 -178.343 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.428 ' OE2' ' HE2' ' A' ' 112' ' ' LYS . 1.2 mt-10 -68.95 134.55 49.68 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.981 0.8 . . . . 3.0899999999999999 109.646 159.459 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -147.4 116.96 7.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.565 1.146 . . . . 1.5700000000000001 112.372 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -89.68 94.58 9.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.688 2.795 . . . . 2.1800000000000002 110.543 177.651 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -74.13 123.31 24.2 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.796 1.239 . . . . 1.1899999999999999 110.815 -177.017 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 mt -96.8 129.69 44.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.831 1.252 . . . . 0.68000000000000005 111.23 -172.655 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.57 129.82 41.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.049 0.928 . . . . 1.8899999999999999 113.172 -173.463 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 32.37 50.41 0.18 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.671 2.388 . . . . 1.6299999999999999 113.935 175.907 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.26 -90.88 0.53 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.897 1.237 . . . . 3.6400000000000001 112.053 -172.328 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.19 15.94 19.75 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 117.399 1.719 . . . . 1.5900000000000001 117.399 -164.127 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.0 145.21 42.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.784 2.292 . . . . 5.2300000000000004 109.363 166.323 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -147.8 137.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 124.906 1.282 . . . . 1.1000000000000001 108.96 167.684 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.5 mt -142.14 124.62 15.74 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.48 1.512 . . . . 1.8400000000000001 107.858 -175.475 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.428 ' HE2' ' OE2' ' A' ' 100' ' ' GLU . 10.0 ptmt -102.96 150.12 23.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.437 1.643 . . . . 2.4300000000000002 115.437 -174.258 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.78 160.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.233 1.813 . . . . 1.22 110.284 178.89 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -117.05 118.71 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.578 1.151 . . . . 1.8899999999999999 110.261 171.394 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.2 mt -108.9 150.42 40.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.331 1.852 . . . . 1.5 109.769 178.398 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.24 155.43 19.29 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.455 2.77 . . . . 0.91000000000000003 111.698 170.068 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.42 145.36 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.924 1.29 . . . . 1.26 109.258 163.989 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.64 171.14 16.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.545 1.938 . . . . 3.27 108.797 -176.793 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.57 3.58 7.5 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.436 2.013 . . . . 3.0099999999999998 116.436 -160.476 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 130.209 3.403 . . . . 4.7599999999999998 109.272 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.991 0 CA-C-O 117.061 -1.966 . . . . 9.5600000000000005 112.343 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.501 ' HA ' ' CG ' ' A' ' 3' ' ' PHE . 1.2 p 52.33 134.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 2 C-N-CA 134.999 5.319 . . . . 8.4600000000000009 117.738 -14.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.501 ' CG ' ' HA ' ' A' ' 2' ' ' SER 0.305 41.7 p90 52.84 74.19 0.31 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 131.424 3.89 . . . . 8.7899999999999991 114.077 -2.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.92 122.53 37.61 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 106.211 -1.774 . . . . 5.9100000000000001 106.211 170.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -141.81 -158.09 0.83 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.402 0.889 . . . . 5.0899999999999999 113.402 -152.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -162.38 -179.2 36.83 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 126.021 1.772 . . . . 1.26 115.407 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -127.91 140.49 51.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.406 0.682 . . . . 2.1499999999999999 112.835 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.9 t -83.06 138.5 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.877 -1.157 . . . . 0.93999999999999995 107.877 160.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -83.87 119.75 25.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.162 -0.961 . . . . 3.75 112.448 -164.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.03 129.13 20.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.116 1.366 . . . . 3.3500000000000001 110.619 163.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m 179.24 111.31 0.18 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.075 1.75 . . . . 2.04 110.316 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -84.41 48.72 2.53 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.006 3.138 . . . . 2.1899999999999999 110.181 167.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.65 -174.67 27.01 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.405 1.002 . . . . 1.6299999999999999 113.037 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.06 -17.01 28.63 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.685 2.256 . . . . 1.6100000000000001 111.529 163.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -150.28 169.06 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.403 1.881 . . . . 1.98 113.019 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.9 -159.59 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.469 2.307 . . . . 1.3100000000000001 109.422 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.06 166.07 27.2 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.732 1.213 . . . . 1.5600000000000001 111.247 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.72 133.58 40.11 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 0.98999999999999999 111.753 162.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -120.96 148.15 44.49 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.89 2.076 . . . . 2.4100000000000001 109.707 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -169.84 154.67 5.39 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.482 1.29 . . . . 1.4099999999999999 114.482 174.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 m -74.39 143.61 44.72 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.429 1.092 . . . . 1.3799999999999999 108.655 157.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.53 130.59 21.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.706 -1.22 . . . . 2.1899999999999999 107.706 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.16 142.86 32.76 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.882 0.873 . . . . 4.2300000000000004 111.203 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -102.46 110.75 63.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.458 1.503 . . . . 0.81999999999999995 110.526 -168.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.04 -10.51 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.229 1.952 . . . . 0.94999999999999996 113.524 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.51 169.71 54.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.262 0.937 . . . . 0.83999999999999997 113.673 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.01 -4.99 35.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.93 1.692 . . . . 2.5299999999999998 112.89 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.79 159.61 38.3 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 126.053 1.741 . . . . 1.6200000000000001 109.856 167.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.75 159.02 28.13 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.889 2.392 . . . . 0.93999999999999995 112.038 -169.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.43 154.16 19.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.213 1.005 . . . . 2.1099999999999999 110.262 168.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -137.95 109.35 6.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.789 1.236 . . . . 2.9199999999999999 108.814 168.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -88.76 106.92 18.68 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.639 2.376 . . . . 0.69999999999999996 108.952 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.36 -11.56 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.378 1.071 . . . . 0.53000000000000003 112.705 -172.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.86 -168.86 40.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.364 0.983 . . . . 0.56999999999999995 111.904 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -150.25 -179.73 7.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.571 1.148 . . . . 0.85999999999999999 109.17 163.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -159.52 137.92 10.55 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 119.038 0.836 . . . . 4.9400000000000004 109.286 -167.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 161.15 48.9 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.741 1.155 . . . . 0.58999999999999997 109.92 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.91 -29.56 15.05 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.891 1.727 . . . . 0.93000000000000005 113.583 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.0 m -81.01 0.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.12 1.526 . . . . 0.89000000000000001 115.12 -166.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 160.54 39.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.656 1.182 . . . . 1.02 112.24 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -96.96 -82.07 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.777 1.231 . . . . 2.77 111.298 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -80.59 101.02 8.92 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 120.301 -1.499 . . . . 3.5800000000000001 108.954 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 35' ' ' ALA . 5.6 p -84.78 137.21 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 125.977 1.711 . . . . 1.23 111.365 165.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -141.63 132.5 25.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.782 1.633 . . . . 2.0800000000000001 110.753 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -82.98 123.25 29.26 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 121.088 1.767 . . . . 0.66000000000000003 111.713 168.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.2 m170 -110.43 152.23 26.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.181 1.792 . . . . 0.56999999999999995 112.701 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -85.06 166.13 16.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.005 1.722 . . . . 2.1699999999999999 110.193 158.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.1 m -147.51 126.25 12.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 1.6200000000000001 107.481 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -140.12 164.24 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.925 0.713 . . . . 2.3700000000000001 112.925 -151.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -110.2 138.51 46.48 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.418 0.687 . . . . 3.2000000000000002 110.18 153.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -145.27 155.29 43.14 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.879 1.672 . . . . 7.29 109.213 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.32 150.96 20.54 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.677 0.791 . . . . 3.73 110.197 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.5 t -130.89 -97.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.428 1.091 . . . . 2.8599999999999999 109.619 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.54 45.12 0.38 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.92 2.088 . . . . 3.2799999999999998 111.584 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.36 -5.55 5.21 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.776 -1.202 . . . . 1.76 113.623 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -106.08 147.77 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.182 2.193 . . . . 2.8799999999999999 109.946 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -76.28 138.42 40.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.557 0.743 . . . . 4.0099999999999998 111.229 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -137.31 151.63 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.286 1.834 . . . . 1.6200000000000001 109.288 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mtm -127.4 145.35 50.85 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.288 1.035 . . . . 3.5099999999999998 111.775 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.85 37.07 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.509 1.052 . . . . 1.53 113.483 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -123.27 168.07 12.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.381 1.872 . . . . 1.8600000000000001 111.068 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.16 131.93 0.45 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 116.361 -1.78 . . . . 4.4299999999999997 111.882 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 18.2 Cg_endo -67.72 142.47 58.21 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 122.533 1.94 . . . . 0.56000000000000005 112.553 171.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.43 160.26 44.56 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.22 1.808 . . . . 0.52000000000000002 110.376 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.6 -20.15 20.72 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.354 2.036 . . . . 0.67000000000000004 113.17 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -176.27 168.1 2.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.959 1.254 . . . . 1.8300000000000001 112.018 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -116.58 173.81 6.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.445 2.298 . . . . 1.0800000000000001 109.128 153.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -156.61 166.62 32.87 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.058 -1.026 . . . . 1.96 112.731 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 132.15 8.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.104 0.962 . . . . 0.92000000000000004 109.154 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.4 165.9 30.16 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.577 1.518 . . . . 0.81999999999999995 110.762 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.43 138.71 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.194 2.596 . . . . 0.83999999999999997 111.144 171.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt 68.45 -2.69 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.011 1.724 . . . . 1.3600000000000001 113.883 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.91 -172.67 45.12 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 126.187 1.851 . . . . 0.98999999999999999 113.423 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -152.15 149.11 28.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.056 1.742 . . . . 4.8300000000000001 111.621 -171.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.04 142.08 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.616 1.567 . . . . 2.3500000000000001 108.551 161.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -106.1 123.17 47.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.966 0.803 . . . . 3.8199999999999998 109.735 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.31 69.7 0.56 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.347 1.459 . . . . 1.1799999999999999 108.194 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -81.4 145.62 55.82 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.461 2.305 . . . . 2.8900000000000001 109.694 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.7 -42.7 65.99 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.148 2.566 . . . . 0.84999999999999998 112.501 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.75 59.99 4.24 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.814 0.734 . . . . 1.0800000000000001 112.171 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.63 -70.3 0.05 OUTLIER Glycine 0 N--CA 1.468 0.786 0 C-N-CA 124.053 0.835 . . . . 0.78000000000000003 114.371 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -155.16 147.18 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.835 1.654 . . . . 1.8500000000000001 109.367 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -165.25 174.87 9.75 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.022 -1.049 . . . . 0.97999999999999998 110.921 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.59 132.31 50.98 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.724 -0.473 . . . . 1.8400000000000001 109.724 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -80.89 135.81 35.97 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.134 0.574 . . . . 1.2 110.143 159.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.42 98.36 6.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.143 1.377 . . . . 1.6200000000000001 109.411 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -102.38 142.94 32.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.828 0.851 . . . . 2.3999999999999999 111.162 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.66 75.0 0.73 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.398 -1.081 . . . . 1.3100000000000001 110.398 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.2 124.11 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 117.271 0.536 . . . . 0.98999999999999999 112.142 -170.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -82.33 -6.31 59.17 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.001 0.741 . . . . 1.4299999999999999 113.001 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -154.32 150.04 21.51 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.48 2.312 . . . . 3.9500000000000002 108.366 158.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.28 134.57 45.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.934 1.756 . . . . 1.6499999999999999 108.249 168.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.75 119.73 20.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.922 -0.399 . . . . 2.3300000000000001 109.922 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -105.5 124.0 48.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.296 1.839 . . . . 3.73 109.987 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.98 48.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.666 0.666 . . . . 2.1400000000000001 109.731 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 34.77 31.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 120.025 -0.319 . . . . 2.25 113.25 -167.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.99 174.27 6.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.929 -1.137 . . . . 2.5099999999999998 107.929 148.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.8 151.11 37.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.628 1.171 . . . . 3.54 108.309 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.6 t -127.53 126.99 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.901 1.281 . . . . 0.94999999999999996 109.698 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -75.08 142.31 43.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.255 1.026 . . . . 2.7799999999999998 111.349 161.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.37 114.12 5.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.931 -1.031 . . . . 1.6200000000000001 111.361 -172.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.02 93.84 8.17 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.028 2.531 . . . . 2.1200000000000001 109.968 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.2 mt -71.53 121.88 19.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.151 0.98 . . . . 1.1299999999999999 110.678 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -95.76 128.22 42.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 0.57999999999999996 111.674 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.54 137.44 52.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.419 0.687 . . . . 1.79 112.101 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.02 130.28 21.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.342 1.457 . . . . 2.04 114.311 -165.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.3 -144.94 22.8 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.986 -1.246 . . . . 3.0499999999999998 109.986 -164.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.27 54.44 1.54 Allowed Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.734 -1.037 . . . . 1.52 114.135 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -120.24 140.28 51.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.863 1.831 . . . . 4.5099999999999998 111.161 168.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.45 137.45 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 125.741 1.616 . . . . 0.94999999999999996 107.581 164.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.8 mt -128.32 111.5 13.43 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.482 1.113 . . . . 1.5700000000000001 108.601 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -81.17 122.57 27.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.352 -0.217 . . . . 2.2999999999999998 111.584 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.97 164.39 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.808 1.643 . . . . 1.1399999999999999 110.237 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.55 146.08 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.969 0.908 . . . . 2.0299999999999998 109.034 166.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -136.3 145.54 52.35 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.08 1.352 . . . . 1.5800000000000001 109.234 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -68.2 154.75 71.59 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.562 2.175 . . . . 0.90000000000000002 110.388 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.657 -0.868 . . . . 1.1699999999999999 108.657 165.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.03 157.76 43.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.537 1.135 . . . . 3.02 110.606 -171.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.11 72.13 1.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.969 1.707 . . . . 2.02 112.511 -168.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.0 0 C-N-CA 124.735 1.214 . . . . 4.8300000000000001 110.344 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 109.605 -1.398 . . . . 9.0399999999999991 109.605 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 m -80.45 -135.79 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.819 1.31 . . . . 9.0800000000000001 110.155 154.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.51 47.64 0.32 Allowed 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.704 -1.247 . . . . 9.6500000000000004 111.046 170.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.1 p -158.18 116.45 3.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 127.582 2.353 . . . . 6.1100000000000003 107.272 -159.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -153.14 -153.51 0.48 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.778 1.231 . . . . 6.1299999999999999 111.017 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.71 167.66 21.45 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 125.127 1.346 . . . . 1.4399999999999999 114.55 172.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.3 p90 -163.08 158.23 21.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.353 2.261 . . . . 1.7 110.648 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.35 139.58 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.81 -0.556 . . . . 1.1299999999999999 110.218 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -77.73 128.93 34.84 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.307 -0.406 . . . . 5.7599999999999998 111.507 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.7 143.69 3.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.655 1.182 . . . . 2.7000000000000002 111.769 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -163.44 135.97 4.07 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.554 0.576 . . . . 3.23 112.554 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.18 0.45 4.15 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.546 3.497 . . . . 2.73 112.447 163.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.3 171.54 25.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.922 1.249 . . . . 1.3899999999999999 114.626 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.1 -13.98 18.98 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.478 3.452 . . . . 1.54 113.861 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -122.16 163.29 19.79 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.068 0.947 . . . . 2.7400000000000002 111.863 166.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.52 178.55 10.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.292 1.437 . . . . 1.3899999999999999 111.328 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.49 139.05 46.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.591 1.557 . . . . 1.3899999999999999 111.957 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.02 150.11 48.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.161 1.385 . . . . 0.98999999999999999 112.118 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -136.09 148.51 48.32 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.551 1.541 . . . . 2.2200000000000002 109.308 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.63 152.52 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 1.77 114.816 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 m -79.62 120.44 23.96 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 126.094 1.757 . . . . 1.5700000000000001 109.652 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.67 113.03 26.35 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.383 -0.969 . . . . 2.54 108.383 166.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -122.88 127.85 49.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.025 1.33 . . . . 3.3199999999999998 108.7 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -98.43 104.39 23.47 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.368 1.067 . . . . 1.0 109.614 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.87 -10.41 12.84 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 1.1000000000000001 113.311 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 164.49 52.04 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.276 0.941 . . . . 0.96999999999999997 113.094 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.69 -9.97 59.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.766 1.226 . . . . 3.9199999999999999 113.492 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.73 160.82 47.23 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.028 1.731 . . . . 1.72 111.215 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.12 151.77 23.85 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.956 2.438 . . . . 0.97999999999999998 111.84 -171.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -115.55 125.59 53.18 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.264 1.426 . . . . 2.3500000000000001 110.468 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -107.98 114.77 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.761 1.225 . . . . 2.79 110.72 171.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.2 tp -97.07 114.72 26.4 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.441 2.696 . . . . 0.68999999999999995 108.771 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.54 -11.04 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.068 0.947 . . . . 0.53000000000000003 113.206 -165.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.77 -158.01 27.74 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 124.113 0.863 . . . . 0.55000000000000004 111.509 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.11 178.97 9.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.77 0.828 . . . . 0.90000000000000002 112.181 172.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -146.6 121.35 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.535 1.134 . . . . 6.6299999999999999 109.733 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -145.46 160.68 44.25 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.665 1.986 . . . . 0.83999999999999997 108.988 -168.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -31.01 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.122 1.881 . . . . 1.9299999999999999 112.748 157.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 m -83.49 31.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.554 1.07 . . . . 2.7000000000000002 113.84 -169.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.15 161.25 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 128.029 2.532 . . . . 1.55 109.227 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.94 -80.2 0.55 Allowed 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.8 -1.926 . . . . 3.48 105.8 160.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.43 84.94 2.54 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.14 -0.975 . . . . 3.6499999999999999 109.903 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.76 137.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.428 -0.806 . . . . 1.1899999999999999 109.619 159.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.98 122.84 27.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.792 1.237 . . . . 2.2999999999999998 110.649 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -79.71 119.14 22.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.922 1.237 . . . . 0.73999999999999999 110.597 168.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -106.99 156.16 19.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.266 1.827 . . . . 0.82999999999999996 112.23 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -112.63 -176.64 2.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 2.04 111.794 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -150.09 79.4 1.36 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.992 1.317 . . . . 1.22 108.466 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -83.58 148.57 27.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.942 -1.026 . . . . 2.6499999999999999 110.214 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -90.89 155.37 18.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 3.6699999999999999 111.035 164.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -151.69 149.2 28.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.736 1.615 . . . . 6.54 109.952 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -89.57 168.81 11.86 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.0 0.905 . . . . 3.54 111.782 164.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.61 -128.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.821 2.448 . . . . 4.0599999999999996 107.331 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.68 60.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 121.559 1.981 . . . . 4.6399999999999997 111.14 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.15 2.9 55.08 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.643 1.116 . . . . 2.2200000000000002 114.008 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -87.65 126.27 34.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.354 1.462 . . . . 4.5599999999999996 109.973 174.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.401 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -93.1 131.9 37.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.633 0.373 . . . . 5.0099999999999998 111.39 177.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -139.77 143.14 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.921 1.688 . . . . 2.04 109.967 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.35 120.16 41.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.298 1.039 . . . . 3.4399999999999999 110.181 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.01 44.72 1.44 Allowed Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.092 1.197 . . . . 3.6600000000000001 116.092 -160.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -28.73 120.03 0.12 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.063 2.545 . . . . 2.52 113.624 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -144.96 154.62 55.11 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 117.654 -1.165 . . . . 5.21 110.395 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.17 146.88 82.85 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.03 1.82 . . . . 0.71999999999999997 110.806 164.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.11 154.83 49.99 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.115 1.366 . . . . 0.68999999999999995 110.514 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 -15.41 38.08 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.917 2.411 . . . . 1.05 112.917 176.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -175.35 163.92 3.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 2.1400000000000001 111.119 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -113.61 173.6 6.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.613 1.965 . . . . 0.98999999999999999 109.532 155.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.95 163.95 39.09 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.487 -0.758 . . . . 2.3599999999999999 112.106 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.92 132.53 10.4 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.467 1.107 . . . . 1.0700000000000001 110.019 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.13 163.14 38.91 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.437 2.758 . . . . 1.0700000000000001 111.617 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.61 140.68 76.3 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.974 2.449 . . . . 0.93999999999999995 111.266 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp 69.59 -1.43 2.27 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.649 1.979 . . . . 2.9100000000000001 113.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.44 135.21 12.91 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 127.081 2.277 . . . . 1.1299999999999999 110.987 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -103.71 138.38 40.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.466 1.507 . . . . 4.2599999999999998 110.789 161.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.23 113.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.408 1.883 . . . . 2.2000000000000002 107.855 165.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -81.74 142.02 33.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.174 0.99 . . . . 3.4300000000000002 110.344 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -71.08 78.83 0.67 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.317 1.056 . . . . 1.02 108.924 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -87.92 138.8 30.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 3.5699999999999998 109.986 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.3 -40.38 59.29 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.691 2.927 . . . . 1.02 114.159 -165.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.83 78.44 1.95 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.005 -1.638 . . . . 1.1699999999999999 109.005 162.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.27 -88.68 0.1 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.51 1.053 . . . . 0.81000000000000005 112.622 -167.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -151.23 144.34 24.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.741 2.017 . . . . 1.8 109.496 -171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -164.65 171.85 13.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.564 0.746 . . . . 0.72999999999999998 110.689 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.42 131.23 55.23 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.92 0.488 . . . . 2.1800000000000002 110.614 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.61 136.99 32.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.269 1.428 . . . . 1.27 110.44 163.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.49 111.2 21.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.12 1.768 . . . . 2.1899999999999999 108.822 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.67 133.44 55.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.8 0.84 . . . . 2.6499999999999999 109.642 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.65 42.53 17.22 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 111.618 -0.593 . . . . 1.79 111.618 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.41 120.49 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.687 1.595 . . . . 1.75 113.009 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -86.59 -3.86 59.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.18 -0.918 . . . . 1.6599999999999999 112.884 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -130.57 135.64 27.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 116.704 -1.617 . . . . 4.2999999999999998 108.228 149.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -61.6 139.38 81.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.928 1.752 . . . . 1.99 107.841 156.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.71 110.84 18.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.645 1.178 . . . . 2.1299999999999999 110.246 -162.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -90.01 131.07 36.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.686 0.755 . . . . 5.5499999999999998 110.599 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 119.86 6.87 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.123 -0.944 . . . . 1.47 109.191 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.04 4.8 57.56 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 117.86 -1.522 . . . . 1.98 115.645 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -85.25 163.92 18.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.31 2.055 . . . . 2.9300000000000002 110.433 160.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -96.86 156.9 16.15 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.853 1.261 . . . . 3.8599999999999999 109.776 163.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.06 124.61 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 124.517 1.127 . . . . 1.01 109.152 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.87 134.07 43.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.201 1.8 . . . . 3.0499999999999998 108.338 166.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mt -158.86 120.95 3.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.567 1.147 . . . . 1.49 113.578 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.06 112.26 25.33 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.092 2.157 . . . . 2.9700000000000002 110.739 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.6 132.86 46.87 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 1.27 111.183 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -96.42 133.69 40.52 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.813 0.845 . . . . 0.71999999999999997 111.219 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -126.64 152.78 46.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.643 1.211 . . . . 2.1699999999999999 112.306 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.93 134.59 57.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.217 -0.901 . . . . 2.1000000000000001 113.142 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.92 46.26 37.97 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 119.12 -0.822 . . . . 3.9100000000000001 114.164 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.55 18.87 61.16 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.993 1.157 . . . . 1.52 115.993 166.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.9 143.22 30.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.474 1.637 . . . . 4.4900000000000002 110.463 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -152.23 138.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.948 1.699 . . . . 0.95999999999999996 108.47 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -144.74 127.72 16.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.768 0.827 . . . . 1.6299999999999999 112.523 -168.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -71.01 135.96 48.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 2.4300000000000002 111.944 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.66 151.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.523 1.129 . . . . 1.6100000000000001 111.305 171.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.07 134.83 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.044 . . . . 3.8599999999999999 112.565 -171.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.86 125.8 9.99 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.896 1.278 . . . . 3.6800000000000002 109.561 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -86.76 159.41 9.05 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.608 2.872 . . . . 1.3 110.558 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.42 137.15 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.165 0.986 . . . . 1.4199999999999999 109.971 172.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -140.71 150.4 43.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.131 0.972 . . . . 3.2999999999999998 110.452 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.79 58.83 1.15 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.772 0.829 . . . . 3.2400000000000002 109.998 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.701 1.2 . . . . 5.4900000000000002 112.666 -170.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.337 0 N-CA-C 109.636 -1.386 . . . . 13.33 109.636 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -174.58 -166.99 0.28 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.62 2.768 . . . . 10.24 106.751 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -67.72 153.79 42.94 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.483 1.038 . . . . 9.1799999999999997 111.389 165.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.1 p -139.96 143.98 36.81 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.17 1.788 . . . . 6.6100000000000003 110.08 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.71 -158.42 0.9 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.93 2.092 . . . . 6.1500000000000004 108.832 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.35 -178.67 15.41 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-N 121.226 1.83 . . . . 1.02 116.343 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -160.3 138.06 9.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.218 -0.991 . . . . 1.6899999999999999 111.739 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.99 122.79 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.997 0.904 . . . . 1.4299999999999999 109.029 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -62.08 112.04 2.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.619 1.568 . . . . 4.0800000000000001 112.148 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -70.15 133.48 47.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.461 0.648 . . . . 2.6299999999999999 109.51 150.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.9 m -159.18 146.52 13.06 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.634 1.574 . . . . 2.3799999999999999 109.994 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -86.78 67.68 4.43 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.118 3.212 . . . . 2.6800000000000002 110.836 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -151.87 177.42 29.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.787 0.708 . . . . 1.25 114.04 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.33 -10.11 19.04 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.831 3.02 . . . . 1.4099999999999999 113.205 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -146.27 165.78 28.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.925 1.69 . . . . 2.02 112.669 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 153.41 29.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.622 1.169 . . . . 1.3 112.165 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.29 118.53 33.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.566 1.146 . . . . 1.8999999999999999 109.694 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.79 156.74 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.87 1.268 . . . . 1.2 112.044 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.68 154.57 47.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.028 1.331 . . . . 1.8899999999999999 112.783 -169.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.408 ' H ' ' HB2' ' A' ' 77' ' ' LEU . 2.0 pt? -160.93 157.97 27.35 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.926 1.29 . . . . 1.6200000000000001 112.649 165.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.9 m -73.27 108.98 6.46 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.326 -0.99 . . . . 1.23 108.326 156.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.38 129.2 34.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.07 -1.456 . . . . 2.6899999999999999 107.07 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -126.37 148.23 49.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.183 0.808 . . . . 3.0899999999999999 113.183 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -112.13 110.67 53.66 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.624 1.17 . . . . 1.1499999999999999 109.974 166.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.45 -8.37 8.53 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.045 2.497 . . . . 1.26 113.225 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.75 155.95 37.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.434 1.016 . . . . 1.24 112.66 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.439 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.6 m-20 -88.88 4.67 47.08 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.313 1.845 . . . . 3.0299999999999998 113.296 -175.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.95 160.76 41.52 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.45 1.9 . . . . 1.6499999999999999 110.293 167.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.24 153.75 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.034 2.49 . . . . 1.03 111.285 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.9 mt -107.38 153.57 22.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.426 1.09 . . . . 1.8100000000000001 111.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -130.21 113.08 14.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 2.8500000000000001 110.218 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.6 105.05 17.08 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 127.701 2.4 . . . . 0.60999999999999999 108.316 -174.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -94.19 -11.53 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.965 0.906 . . . . 0.62 113.032 -172.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.86 -163.85 33.0 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.594 1.092 . . . . 0.48999999999999999 111.608 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 101' ' ' LEU . . . -156.16 -175.11 5.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.26 1.024 . . . . 0.91000000000000003 110.515 166.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.448 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 1.1 mmt85 -160.38 -172.75 3.69 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.893 1.224 . . . . 7.2199999999999998 111.214 -172.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -177.86 156.35 1.1 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 126.443 1.897 . . . . 1.21 108.726 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.65 -22.29 73.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.767 2.311 . . . . 1.3500000000000001 114.371 160.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.06 2.41 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.629 1.714 . . . . 1.78 115.629 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.96 167.84 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.566 1.075 . . . . 0.94999999999999996 111.501 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.22 -88.51 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.546 0.738 . . . . 3.25 112.946 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -83.0 141.17 32.29 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.28 -1.008 . . . . 4.3899999999999997 108.28 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -151.82 131.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.196 0.999 . . . . 1.3300000000000001 109.82 -169.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -145.0 124.45 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.367 1.467 . . . . 2.4900000000000002 110.151 -166.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD12 ' CE1' ' A' ' 84' ' ' PHE . 7.3 tt -79.38 121.29 24.96 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.066 -1.021 . . . . 0.67000000000000004 110.816 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.8 m170 -109.19 153.12 24.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.188 1.395 . . . . 1.01 113.01 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.3 -175.51 2.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.765 2.026 . . . . 2.7799999999999998 112.145 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.4 m -147.97 127.68 13.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.12 1.768 . . . . 1.8500000000000001 108.503 172.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -124.78 153.51 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.326 1.45 . . . . 2.71 110.697 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.8 149.26 25.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.198 0.999 . . . . 4.8099999999999996 111.234 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.14 144.17 15.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.933 0.893 . . . . 6.1100000000000003 111.85 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.38 143.75 28.51 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.467 0.48 . . . . 3.8300000000000001 109.938 162.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.92 131.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.483 1.513 . . . . 3.7000000000000002 108.946 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 59.22 22.54 10.8 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.048 0.939 . . . . 3.4300000000000002 111.801 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.59 56.91 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.4 -1.437 . . . . 2.3900000000000001 114.126 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -93.99 144.2 25.68 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.943 1.697 . . . . 3.0600000000000001 110.561 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -83.63 134.49 34.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.787 0.835 . . . . 3.9100000000000001 110.521 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.57 151.2 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.24 1.816 . . . . 1.6000000000000001 109.864 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.3 mmt -106.17 135.24 48.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.454 1.102 . . . . 4.2300000000000004 110.401 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.15 151.3 17.42 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.763 1.173 . . . . 1.8100000000000001 112.648 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.4 162.46 17.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.351 1.461 . . . . 2.2599999999999998 111.358 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -171.59 159.66 4.87 Favored Pre-proline 0 N--CA 1.477 0.925 0 C-N-CA 126.542 1.937 . . . . 5.8200000000000003 109.761 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.9 Cg_endo -69.52 159.62 52.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.417 1.412 . . . . 0.91000000000000003 111.413 164.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.84 157.1 77.8 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.427 1.491 . . . . 0.90000000000000002 110.485 168.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.87 -10.84 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.936 2.424 . . . . 1.0900000000000001 113.139 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.49 160.22 1.24 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.421 1.889 . . . . 2.0099999999999998 111.669 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.61 175.27 5.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.521 1.928 . . . . 0.97999999999999998 109.473 151.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.18 162.44 41.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.236 -0.915 . . . . 1.8799999999999999 111.102 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.79 135.29 10.95 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.645 0.778 . . . . 0.93000000000000005 109.843 -166.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.97 167.02 28.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.774 2.316 . . . . 1.05 112.174 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.52 140.48 87.39 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.681 2.921 . . . . 1.0800000000000001 112.655 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.8 mmmt 68.12 0.77 2.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.947 2.099 . . . . 2.1200000000000001 114.309 175.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.3 142.87 15.62 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 127.255 2.359 . . . . 1.22 111.571 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -107.03 157.62 17.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.523 1.529 . . . . 4.9500000000000002 112.889 166.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.37 125.46 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.342 1.857 . . . . 1.4399999999999999 109.656 173.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -83.27 127.93 34.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 4.1799999999999997 111.388 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HB2' ' H ' ' A' ' 20' ' ' LEU . 10.5 mp -74.86 140.29 43.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.991 1.376 . . . . 1.54 109.702 166.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -166.72 146.04 4.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 3.2400000000000002 110.491 -153.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.11 -39.45 18.5 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.133 2.555 . . . . 1.5700000000000001 112.876 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.96 72.75 2.55 Favored Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.434 -1.466 . . . . 1.2 109.434 164.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.6 -94.8 0.11 Allowed Glycine 0 N--CA 1.469 0.856 0 N-CA-C 114.841 0.697 . . . . 0.80000000000000004 114.841 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -151.37 143.5 23.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.33 1.452 . . . . 1.78 110.565 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -166.58 144.85 5.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.083 0.553 . . . . 1.26 112.092 -166.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.451 ' CE1' HD12 ' A' ' 45' ' ' LEU . 55.6 m-85 -92.65 118.48 31.08 Favored 'General case' 0 CA--C 1.52 -0.178 0 O-C-N 121.651 -0.655 . . . . 1.8600000000000001 109.729 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 mmt -79.68 115.65 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.21 -0.663 . . . . 1.3799999999999999 109.21 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.0 mt -99.76 125.45 45.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.628 1.571 . . . . 1.48 107.946 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.57 120.42 35.76 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.412 1.485 . . . . 2.73 107.42 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.57 89.59 0.9 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.349 -1.1 . . . . 1.49 110.349 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.4 mt -89.82 123.04 33.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.153 0.981 . . . . 0.90000000000000002 109.283 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.68 -11.26 59.97 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.629 -1.295 . . . . 1.73 113.873 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -143.41 161.95 44.73 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.507 2.723 . . . . 6.4800000000000004 108.164 160.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.53 128.6 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 N-CA-C 107.07 -1.935 . . . . 1.5800000000000001 107.07 147.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.99 155.46 30.75 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.11 -0.7 . . . . 2.7599999999999998 109.11 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.71 125.21 22.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.958 0.885 . . . . 4.2699999999999996 111.883 176.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.17 133.39 15.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.116 0.967 . . . . 2.0099999999999998 112.225 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.64 40.94 4.57 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.037 -0.868 . . . . 2.6099999999999999 113.382 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.6 165.79 29.32 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 126.851 2.06 . . . . 2.5699999999999998 108.271 157.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.73 158.01 16.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.087 1.755 . . . . 3.9900000000000002 111.294 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.5 t -115.66 119.94 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.858 1.263 . . . . 0.96999999999999997 108.232 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 122.42 16.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.851 -1.166 . . . . 3.1899999999999999 107.851 155.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.419 ' CD1' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -122.08 131.76 54.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.507 1.523 . . . . 2.5699999999999998 107.312 175.333 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 51.2 m-20 -111.71 81.58 1.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.154 1.382 . . . . 3.5 110.417 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -66.78 118.72 10.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.336 1.854 . . . . 1.24 110.976 -170.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.82 122.39 34.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.258 1.023 . . . . 1.02 110.827 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.08 139.49 54.02 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.038 0.923 . . . . 2.0 111.772 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.96 128.77 22.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.1 1.36 . . . . 2.04 113.747 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.09 60.87 3.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.236 0.922 . . . . 3.3500000000000001 113.068 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 6.77 88.83 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 116.956 1.543 . . . . 2.6699999999999999 116.956 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.72 137.64 32.75 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.248 2.024 . . . . 4.3799999999999999 110.708 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.32 133.22 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.559 1.144 . . . . 1.8700000000000001 109.214 161.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.2 mt -114.33 109.31 18.16 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.323 1.049 . . . . 1.8999999999999999 109.904 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.73 94.14 1.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 3.7000000000000002 109.278 168.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.68 156.94 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.849 0.86 . . . . 1.8100000000000001 110.065 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -103.46 139.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.482 1.113 . . . . 1.9099999999999999 109.364 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 mt -142.02 153.35 63.71 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.786 2.035 . . . . 1.5800000000000001 108.611 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.65 153.16 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.867 2.378 . . . . 1.1100000000000001 112.102 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.5 t -77.95 132.5 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.131 0.972 . . . . 1.49 108.486 159.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.87 151.2 23.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.884 . . . . 3.5 110.837 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.76 115.39 30.05 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.042 1.337 . . . . 2.29 111.805 -161.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 129.17 2.988 . . . . 5.6799999999999997 108.037 177.092 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 114' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.725 0 CA-C-O 119.42 -0.655 . . . . 12.5 112.24 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.83 32.71 0.08 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.073 1.749 . . . . 11.859999999999999 112.436 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 63.46 -10.45 0.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.252 2.221 . . . . 10.91 113.45 -152.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 p -60.6 146.67 44.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.157 2.183 . . . . 6.2000000000000002 111.684 166.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.01 126.75 55.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.4 1.88 . . . . 6.0899999999999999 111.795 -165.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.64 169.73 41.39 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.976 2.227 . . . . 1.5900000000000001 110.493 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -141.99 154.34 44.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.426 0.898 . . . . 2.27 113.426 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.07 126.27 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.366 -0.834 . . . . 0.95999999999999996 109.147 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.06 108.67 12.72 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.23 1.412 . . . . 3.7200000000000002 112.414 -162.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -66.14 122.61 17.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.184 1.394 . . . . 2.8500000000000001 111.321 172.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -165.2 140.01 4.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.702 1.201 . . . . 2.3100000000000001 110.151 167.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.87 71.35 6.4 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.287 3.325 . . . . 2.1299999999999999 109.503 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.26 172.92 19.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.321 0.962 . . . . 1.3200000000000001 114.443 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.05 -16.1 36.21 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.235 2.623 . . . . 1.71 111.68 166.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -144.86 164.78 30.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.571 1.149 . . . . 2.4700000000000002 113.435 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.42 -166.35 1.64 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.375 2.27 . . . . 1.1499999999999999 109.527 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.29 164.07 38.17 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.412 0.893 . . . . 1.21 113.412 -168.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.69 139.64 40.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.677 1.191 . . . . 1.2 111.428 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.45 140.57 41.33 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.73 2.012 . . . . 2.6699999999999999 109.236 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.49 153.73 11.38 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.18 1.178 . . . . 2.1200000000000001 114.18 -166.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -78.91 98.08 6.26 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.663 -1.236 . . . . 2.1200000000000001 107.663 157.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.09 133.67 46.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.435 1.894 . . . . 3.23 108.589 173.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -105.44 145.28 31.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.194 0.813 . . . . 4.8700000000000001 113.194 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -122.72 110.6 31.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.65 0.78 . . . . 1.4199999999999999 109.507 150.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -91.94 -10.09 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.575 2.85 . . . . 1.4399999999999999 113.513 170.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.27 33.64 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.795 1.188 . . . . 1.26 112.929 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.5 m-20 -87.26 4.06 44.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.071 1.748 . . . . 3.0699999999999998 113.507 -174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.32 159.93 41.56 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.067 1.747 . . . . 1.8500000000000001 110.64 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.38 149.83 21.91 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.812 2.341 . . . . 1.05 111.208 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.59 125.83 52.96 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.962 1.305 . . . . 2.2599999999999998 109.163 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -111.25 99.66 8.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.236 1.014 . . . . 3.02 109.205 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 tp -80.63 114.3 19.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.999 2.12 . . . . 0.71999999999999997 109.482 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.22 -11.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.507 1.123 . . . . 0.55000000000000004 113.369 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.5 -166.02 37.72 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.4 1.0 . . . . 0.73999999999999999 111.791 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.15 -179.16 6.95 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.408 1.083 . . . . 1.0600000000000001 109.11 163.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -154.63 147.41 24.37 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.224 1.009 . . . . 6.0599999999999996 108.332 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -146.4 156.4 49.62 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.207 1.003 . . . . 0.82999999999999996 109.792 -167.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.69 -1.11 10.78 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.166 2.578 . . . . 1.5800000000000001 113.445 166.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 HG22 ' A' ' 99' ' ' VAL . 2.3 m -101.64 -5.9 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 115.485 1.661 . . . . 1.1899999999999999 115.485 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.54 158.77 41.75 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.818 1.19 . . . . 1.25 113.403 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.94 -76.62 0.52 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 3.1000000000000001 110.736 -170.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.99 114.32 19.79 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.08 -1.013 . . . . 4.0499999999999998 108.728 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.52 133.26 65.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 1.26 109.255 176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.69 134.97 24.26 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.351 1.06 . . . . 2.2999999999999998 110.884 -170.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.74 120.4 26.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.316 1.055 . . . . 0.70999999999999996 111.04 169.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 14.1 m170 -107.15 154.58 20.96 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.303 1.841 . . . . 0.71999999999999997 112.152 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.34 -176.77 3.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.123 1.769 . . . . 2.1299999999999999 110.39 167.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -148.07 86.86 1.58 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.915 1.286 . . . . 1.4399999999999999 108.836 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -73.09 166.88 22.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.049 1.34 . . . . 2.29 111.967 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -111.07 159.12 18.08 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.301 0.64 . . . . 3.5800000000000001 111.231 161.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -154.98 133.84 12.18 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.828 1.251 . . . . 6.0800000000000001 109.707 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 147.52 47.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.535 0.734 . . . . 3.3999999999999999 109.579 165.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.42 -40.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 115.322 1.601 . . . . 3.04 115.322 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -115.89 30.98 7.0 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.507 1.923 . . . . 4.4500000000000002 109.699 175.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 -14.25 4.05 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.227 -1.546 . . . . 1.8799999999999999 113.35 -165.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -104.15 160.29 14.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 127.725 2.41 . . . . 4.6500000000000004 110.3 170.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -92.28 146.8 23.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.467 1.655 . . . . 3.6800000000000002 115.467 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.37 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.731 2.013 . . . . 1.72 107.618 165.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -91.82 135.98 33.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.059 1.344 . . . . 3.75 110.217 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.47 148.75 20.37 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 124.237 0.922 . . . . 1.6000000000000001 112.812 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -99.3 163.04 12.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.966 1.306 . . . . 1.76 112.035 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -170.64 152.08 3.72 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.847 1.659 . . . . 4.9699999999999998 110.813 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.3 Cg_endo -69.54 150.07 69.1 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.675 1.583 . . . . 0.81999999999999995 111.592 166.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.41 157.58 70.0 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.946 2.099 . . . . 0.89000000000000001 110.188 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.47 -19.47 24.96 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.638 2.225 . . . . 0.85999999999999999 112.996 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.46 166.22 3.93 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.183 1.393 . . . . 1.8899999999999999 111.687 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -118.24 176.14 5.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.767 2.427 . . . . 1.05 108.815 156.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.32 165.09 36.84 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.095 -1.003 . . . . 2.02 111.668 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.43 134.15 10.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.68 1.592 . . . . 0.94999999999999996 108.805 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.66 165.97 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.815 2.343 . . . . 0.81999999999999995 111.739 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.56 144.47 97.75 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.557 2.838 . . . . 0.93000000000000005 112.459 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 20.4 mmmt 68.65 -5.84 0.92 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.19 2.196 . . . . 2.1099999999999999 114.823 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.51 122.22 7.29 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 126.574 2.035 . . . . 1.1899999999999999 111.028 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -88.64 136.6 32.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.015 0.526 . . . . 4.5 110.21 157.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.9 173.36 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.904 2.082 . . . . 2.1200000000000001 110.278 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -116.63 111.65 20.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.418 1.008 . . . . 4.2699999999999996 113.639 -161.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.08 76.67 1.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.222 1.009 . . . . 1.3899999999999999 108.436 156.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.51 155.19 76.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.044 0.938 . . . . 2.73 112.427 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.51 -58.37 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.11 2.54 . . . . 1.01 112.524 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.63 74.8 2.39 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.598 -1.001 . . . . 1.49 110.598 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.84 -75.84 0.08 OUTLIER Glycine 0 N--CA 1.469 0.835 0 C-N-CA 124.998 1.285 . . . . 1.0700000000000001 114.069 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -156.18 138.13 14.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.772 1.629 . . . . 2.3900000000000001 109.926 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -168.61 164.0 12.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.654 1.57 . . . . 0.78000000000000003 111.282 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.41 129.55 41.11 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 110.429 -0.211 . . . . 2.1899999999999999 110.429 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.5 mmt -87.58 135.9 33.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.262 1.025 . . . . 0.85999999999999999 110.351 165.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.58 114.79 26.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.445 1.498 . . . . 1.76 108.262 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.8 123.7 48.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.657 1.983 . . . . 2.8900000000000001 108.417 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.55 100.74 0.15 Allowed Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.55 -1.02 . . . . 1.49 110.55 -174.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.65 120.03 36.23 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.93 0.865 . . . . 0.93999999999999995 111.07 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.38 -11.68 61.02 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.204 1.402 . . . . 2.2599999999999998 113.924 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -167.09 155.52 9.08 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 126.744 2.018 . . . . 4.8799999999999999 110.235 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.4 140.52 82.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.801 1.667 . . . . 2.1899999999999999 109.318 163.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 39' ' ' VAL . 22.7 mt -84.3 89.96 7.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.535 1.134 . . . . 2.6299999999999999 109.585 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 108.04 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.535 1.134 . . . . 5.2199999999999998 110.302 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.0 113.1 0.91 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.021 0.528 . . . . 1.5600000000000001 110.842 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.78 3.11 30.4 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 116.76 -2.133 . . . . 2.5699999999999998 116.655 -173.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.92 171.76 14.51 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.341 2.571 . . . . 4.7599999999999998 110.102 152.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -103.3 135.02 45.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.713 -1.217 . . . . 6.4900000000000002 107.713 145.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.494 HG22 HG11 ' A' ' 39' ' ' VAL . 22.8 t -74.24 125.92 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 124.221 1.009 . . . . 1.3300000000000001 108.724 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 136.33 56.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.688 0.756 . . . . 3.3999999999999999 110.233 162.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -147.58 124.81 11.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 123.29 1.519 . . . . 1.75 111.77 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.47 83.85 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 127.554 2.341 . . . . 2.5800000000000001 109.491 -167.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.27 120.05 12.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.585 1.154 . . . . 1.26 110.279 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.5 mt -97.57 130.34 44.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.646 1.579 . . . . 0.76000000000000001 110.709 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 90.5 m-85 -134.15 129.3 35.65 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.414 -0.804 . . . . 1.95 111.133 -175.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 43.36 34.25 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.844 1.657 . . . . 2.29 113.478 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.23 -76.59 1.93 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.175 1.369 . . . . 4.4800000000000004 111.39 -167.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.773 1.069 . . . . 2.6600000000000001 115.773 -160.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -79.17 93.39 5.2 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.016 1.908 . . . . 7.2400000000000002 110.267 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.84 128.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 125.568 1.547 . . . . 1.1200000000000001 108.405 167.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.63 179.78 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.033 1.333 . . . . 3.4300000000000002 110.456 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -134.41 119.73 18.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.251 1.02 . . . . 2.54 108.4 154.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.42 168.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.907 -1.516 . . . . 2.71 106.907 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.41 ' O ' ' HA2' ' A' ' 1' ' ' GLY . 5.0 m -125.65 144.3 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.35 1.86 . . . . 2.5699999999999998 108.922 172.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.4 mt -143.39 141.47 19.25 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.558 1.143 . . . . 2.48 111.482 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.1 144.86 99.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.937 3.092 . . . . 1.51 113.793 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.08 125.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.334 -0.988 . . . . 1.1399999999999999 108.334 168.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.77 161.79 42.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.989 0.916 . . . . 3.21 110.463 -168.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.52 5.85 34.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.559 1.318 . . . . 2.5099999999999998 114.559 -156.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.188 1.795 . . . . 5.2999999999999998 111.373 -178.105 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.433 ' H1 ' ' CD ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 107.38 -2.288 . . . . 11.630000000000001 107.38 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 m -60.49 177.02 0.31 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 119.426 -0.91 . . . . 11.16 110.743 136.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -72.73 102.56 3.38 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.119 -0.988 . . . . 11.31 109.677 167.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.7 p -143.88 170.44 15.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.137 2.175 . . . . 7.5800000000000001 109.241 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -89.59 -157.55 0.46 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.987 2.115 . . . . 5.2300000000000004 111.961 167.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -124.11 153.99 17.63 Favored Glycine 0 N--CA 1.469 0.847 0 C-N-CA 128.566 2.984 . . . . 1.21 111.414 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -134.64 130.91 37.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.726 1.263 . . . . 1.3400000000000001 113.778 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.1 t -87.61 125.62 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.274 -0.891 . . . . 1.21 109.604 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.71 114.62 8.98 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.766 0.827 . . . . 3.6899999999999999 112.984 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.5 143.67 30.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.657 0.741 . . . . 2.9100000000000001 110.256 149.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.2 169.87 2.14 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 129.589 3.156 . . . . 3.52 106.787 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.97 33.81 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.428 2.752 . . . . 3.1800000000000002 113.826 -170.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.45 150.55 17.28 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.621 1.105 . . . . 2.0800000000000001 114.513 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.43 -14.84 20.1 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.918 3.079 . . . . 1.6699999999999999 112.105 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -134.45 157.76 45.63 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.72 2.008 . . . . 2.0800000000000001 111.374 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.49 168.95 22.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.536 1.135 . . . . 1.5 112.763 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.22 122.35 42.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.977 1.311 . . . . 1.71 109.487 166.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.6 119.26 28.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.361 -0.607 . . . . 1.1000000000000001 109.361 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -95.33 141.07 29.34 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.59 1.156 . . . . 2.2400000000000002 108.876 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.458 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 4.1 pp -158.14 156.1 30.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.106 1.15 . . . . 2.2400000000000002 114.106 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.6 m -112.31 105.86 14.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.722 1.209 . . . . 1.8300000000000001 108.688 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 23' ' ' GLU . 3.4 tt -101.89 144.16 30.87 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.032 1.333 . . . . 2.71 109.303 -174.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.499 ' N ' HD23 ' A' ' 22' ' ' LEU . 14.7 pt-20 -145.88 141.51 27.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.332 0.587 . . . . 3.46 112.119 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -104.53 106.38 54.13 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.928 -1.033 . . . . 1.3500000000000001 110.242 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 -12.18 13.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.506 2.137 . . . . 1.55 113.432 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.62 172.56 54.51 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 119.166 0.894 . . . . 1.3400000000000001 113.065 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -96.0 -4.26 43.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.046 1.738 . . . . 2.9900000000000002 112.492 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 155.54 44.99 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.634 1.974 . . . . 4.8499999999999996 108.568 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.61 158.92 25.29 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.094 2.529 . . . . 1.29 111.447 -171.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.45 154.05 20.86 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.315 1.046 . . . . 2.0600000000000001 109.974 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -134.27 110.35 9.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.181 1.392 . . . . 2.9500000000000002 109.086 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.4 tp -88.92 124.35 34.15 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.715 2.006 . . . . 0.71999999999999997 109.246 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.53 -6.11 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.08 1.141 . . . . 0.75 114.08 -170.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.21 -165.67 37.91 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 118.88 0.764 . . . . 0.83999999999999997 112.463 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.865 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -154.06 177.16 11.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.202 -0.904 . . . . 1.22 112.433 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.29 134.43 0.89 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.065 0.848 . . . . 5.6600000000000001 112.732 162.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -129.92 157.29 77.31 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 126.53 1.932 . . . . 1.03 110.124 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.15 -23.38 66.78 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.863 2.376 . . . . 1.1799999999999999 114.84 165.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -87.95 -0.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 114.729 1.381 . . . . 1.1699999999999999 114.729 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.31 163.97 31.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.67 1.188 . . . . 0.88 111.92 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -96.11 -94.36 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.109 1.364 . . . . 3.23 109.224 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 128.87 38.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.456 -0.778 . . . . 4.5999999999999996 110.025 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -131.09 133.02 63.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.002 1.321 . . . . 1.1499999999999999 110.166 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.22 136.13 33.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.228 1.411 . . . . 2.96 110.64 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.04 121.39 26.48 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.093 -1.004 . . . . 0.66000000000000003 111.082 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -108.5 156.0 19.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.503 1.521 . . . . 0.80000000000000004 112.414 172.222 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -101.54 179.74 4.26 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.245 -0.889 . . . . 3.0099999999999998 110.761 160.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -147.52 104.59 3.64 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.038 -1.097 . . . . 1.3 108.038 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -122.94 155.58 36.45 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.747 1.619 . . . . 2.2999999999999998 112.899 -156.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.3 mtm -82.91 143.95 30.38 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.368 0.667 . . . . 3.0 111.127 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -167.16 129.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.063 1.345 . . . . 9.1999999999999993 111.3 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -90.1 175.54 7.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.522 1.129 . . . . 4.2999999999999998 111.436 -171.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 133.53 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.837 1.655 . . . . 3.71 108.751 162.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 65.71 10.7 6.98 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.174 0.99 . . . . 4.2000000000000002 112.403 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.24 87.66 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 120.898 -1.126 . . . . 2.0099999999999998 114.089 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -96.88 142.13 29.23 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.074 1.75 . . . . 2.8100000000000001 109.699 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 11.4 tppt? -75.13 131.62 40.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.282 1.433 . . . . 4.3399999999999999 113.139 -165.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.71 -173.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.307 1.043 . . . . 1.9299999999999999 111.293 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 ptp -146.68 -177.17 5.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.594 1.958 . . . . 3.7000000000000002 112.695 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.75 172.88 43.87 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.333 1.444 . . . . 1.0700000000000001 112.935 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -114.3 156.98 23.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.561 1.544 . . . . 1.8500000000000001 109.416 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -166.32 144.39 4.55 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.052 1.341 . . . . 6.4400000000000004 110.068 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 21.2 Cg_endo -66.31 147.66 83.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.012 1.808 . . . . 0.81999999999999995 110.414 168.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.08 156.83 52.0 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.544 1.538 . . . . 0.59999999999999998 109.554 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.52 -22.05 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.041 1.827 . . . . 0.79000000000000004 112.334 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -173.93 165.13 4.29 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 124.482 1.113 . . . . 2.3999999999999999 111.814 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.48 175.34 5.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.422 2.289 . . . . 1.04 109.108 158.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.73 168.66 26.74 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.666 -1.271 . . . . 2.1699999999999999 111.737 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -149.26 132.74 8.45 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.722 0.809 . . . . 1.1699999999999999 110.161 -168.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.0 164.36 34.63 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.372 2.048 . . . . 1.4099999999999999 111.799 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.97 140.22 78.01 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.861 3.041 . . . . 1.52 112.188 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 70.14 0.56 3.18 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.972 2.109 . . . . 2.0499999999999998 113.871 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.06 125.1 7.94 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 126.783 2.135 . . . . 1.6100000000000001 111.165 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 148.0 23.88 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.914 -0.643 . . . . 4.8300000000000001 112.357 154.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.73 162.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.456 1.902 . . . . 1.6499999999999999 109.35 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 1.6 mp0 -119.13 139.91 51.0 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.821 0.82 . . . . 3.02 112.47 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.36 71.7 1.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.592 1.157 . . . . 1.4199999999999999 108.238 155.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -80.1 142.55 55.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.104 1.761 . . . . 3.77 110.549 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.13 -58.82 1.52 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.969 3.779 . . . . 1.04 114.323 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.27 52.85 4.37 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 119.009 0.822 . . . . 1.21 112.067 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.28 -82.89 0.05 OUTLIER Glycine 0 N--CA 1.466 0.645 0 C-N-CA 127.627 2.537 . . . . 0.80000000000000004 111.699 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -151.27 149.78 29.79 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.005 2.122 . . . . 2.3599999999999999 108.967 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -169.25 165.22 10.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.163 0.892 . . . . 0.79000000000000004 111.292 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 30.7 m-85 -103.13 118.76 37.52 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.89 0.476 . . . . 2.21 110.226 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.6 mmt -77.69 104.66 8.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 1.0900000000000001 110.11 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.44 127.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.048 1.339 . . . . 1.52 108.709 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.98 117.35 19.08 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.485 1.114 . . . . 3.1699999999999999 109.23 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.91 75.04 1.21 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.312 -1.115 . . . . 1.3200000000000001 110.312 -168.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.85 129.8 40.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.434 -0.58 . . . . 1.2 109.434 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -80.98 7.71 10.11 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.954 1.094 . . . . 1.48 113.954 -170.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 176.26 153.32 0.36 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.988 2.515 . . . . 4.4299999999999997 109.65 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.79 144.13 76.35 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 108.14 -1.523 . . . . 1.6200000000000001 108.14 159.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.26 152.7 18.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.946 0.898 . . . . 2.3500000000000001 109.093 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -117.01 135.05 54.0 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.863 0.865 . . . . 6.2400000000000002 109.74 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 119.02 6.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.745 -1.222 . . . . 2.1099999999999999 110.966 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.64 39.51 34.41 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.639 -0.663 . . . . 2.0299999999999998 113.095 -168.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -91.03 -169.88 2.49 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.083 -1.08 . . . . 2.4700000000000002 108.083 140.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.82 142.05 29.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.157 1.383 . . . . 4.0599999999999996 109.844 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.61 102.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.276 1.43 . . . . 1.3300000000000001 109.461 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.497 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 3.6 mm-40 -55.52 130.6 43.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.516 -1.22 . . . . 3.1499999999999999 109.743 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.865 HD21 ' HB1' ' A' ' 35' ' ' ALA . 7.2 tt -156.34 131.67 9.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.369 1.08 . . . . 2.0899999999999999 111.171 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.77 93.9 8.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.582 2.353 . . . . 2.2799999999999998 110.454 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.83 123.07 19.97 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.402 -0.962 . . . . 1.3600000000000001 108.402 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.75 128.81 45.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.78 1.232 . . . . 0.72999999999999998 110.006 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -129.09 119.2 23.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.279 0.844 . . . . 2.0699999999999998 113.279 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 23.12 44.98 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.2 3.0 . . . . 2.02 115.911 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.39 -56.07 1.57 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.616 1.579 . . . . 3.1299999999999999 113.382 -171.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.89 0.14 58.53 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.685 -1.619 . . . . 2.0600000000000001 116.909 -164.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 150.21 45.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.15 1.975 . . . . 3.9399999999999999 111.421 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.03 139.54 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.046 1.738 . . . . 1.1100000000000001 109.091 165.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.95 104.51 7.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.433 1.093 . . . . 1.6599999999999999 110.015 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 8.9 ttpp -72.6 88.81 1.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.07 1.348 . . . . 2.79 110.213 172.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.3 m -114.23 140.25 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.142 1.377 . . . . 2.5899999999999999 111.166 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -100.73 133.18 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.968 1.707 . . . . 2.2200000000000002 110.92 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.64 149.91 73.37 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.861 1.265 . . . . 2.75 111.28 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.12 151.79 83.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.941 2.427 . . . . 1.3899999999999999 113.389 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.9 t -83.43 134.8 26.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.135 1.374 . . . . 1.48 109.087 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -137.36 157.73 45.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.102 0.961 . . . . 3.4199999999999999 109.936 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.16 112.87 25.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.91 0.884 . . . . 2.2200000000000002 111.049 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.074 1.35 . . . . 5.3300000000000001 111.317 174.41 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 107.482 -2.247 . . . . 9.4000000000000004 107.482 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.92 -176.0 5.73 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.981 0.512 . . . . 8.8800000000000008 111.233 -153.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -74.9 59.35 0.9 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.565 1.146 . . . . 12.24 111.268 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.3 m 87.27 144.46 0.05 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 130.594 3.558 . . . . 6.9100000000000001 108.777 -167.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -92.45 104.2 16.55 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.903 -0.777 . . . . 5.5599999999999996 108.903 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.69 44.25 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 115.601 1.0 . . . . 1.0800000000000001 115.601 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -153.15 150.47 29.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.651 1.98 . . . . 1.3600000000000001 111.44 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -114.41 134.89 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.799 -0.815 . . . . 1.0600000000000001 108.799 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -73.75 126.7 30.94 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.086 0.773 . . . . 3.9399999999999999 113.086 -167.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -74.66 128.75 36.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.133 0.968 . . . . 3.04 111.004 157.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -159.35 138.14 7.93 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.281 1.432 . . . . 2.3900000000000001 110.199 164.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -83.42 73.27 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 124.159 3.24 . . . . 2.6400000000000001 109.658 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.58 176.91 24.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.147 0.88 . . . . 1.4299999999999999 114.068 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.32 -4.64 15.31 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.26 3.307 . . . . 2.0699999999999998 112.934 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -140.67 164.27 30.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.518 1.127 . . . . 3.6099999999999999 112.657 170.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.36 165.26 33.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.23 1.812 . . . . 1.3 110.227 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.73 154.79 20.99 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.66 0.784 . . . . 1.21 111.735 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.15 136.94 54.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.693 0.797 . . . . 1.0600000000000001 111.89 164.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -133.15 128.72 36.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.522 1.529 . . . . 2.0600000000000001 110.922 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -166.08 159.19 15.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.709 1.374 . . . . 1.77 114.709 -167.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -80.33 140.68 36.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.088 0.955 . . . . 1.3899999999999999 109.793 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.24 126.1 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.173 1.389 . . . . 2.2799999999999998 107.759 170.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -151.9 148.42 27.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.216 0.607 . . . . 4.1799999999999997 112.235 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -109.87 109.65 59.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.45 1.1 . . . . 1.02 111.842 -164.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.39 -11.12 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.35 2.033 . . . . 1.22 113.466 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.11 53.74 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.227 1.394 . . . . 1.1399999999999999 114.251 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.4 -36.03 63.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.144 2.178 . . . . 6.1299999999999999 112.626 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -102.39 163.42 17.7 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.479 1.911 . . . . 1.8600000000000001 111.531 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.07 159.02 23.81 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.001 2.467 . . . . 1.04 112.371 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.2 mt -103.3 145.54 29.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.695 1.198 . . . . 2.0499999999999998 110.423 171.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -129.78 105.31 7.94 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.832 1.253 . . . . 3.8300000000000001 108.24 167.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.3 tp -79.87 104.77 10.67 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.961 2.104 . . . . 0.67000000000000004 108.352 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -95.45 -14.92 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.916 0.886 . . . . 0.48999999999999999 112.412 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.41 -163.8 33.89 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 123.775 0.702 . . . . 0.52000000000000002 112.735 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.4 177.5 9.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.147 0.979 . . . . 0.84999999999999998 110.924 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -146.44 124.19 11.89 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.034 -1.469 . . . . 6.46 107.034 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -142.34 149.83 52.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 117.688 -1.149 . . . . 0.80000000000000004 110.087 -170.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.32 -3.34 12.98 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.517 2.145 . . . . 1.0600000000000001 113.463 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.46 -4.91 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 115.641 1.719 . . . . 1.0900000000000001 115.641 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.16 144.52 50.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.681 1.192 . . . . 1.1200000000000001 110.943 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -84.08 -75.99 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.679 -0.86 . . . . 3.6600000000000001 108.679 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -91.29 126.72 36.46 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.386 -0.821 . . . . 4.0300000000000002 108.789 165.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.26 138.38 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.442 1.497 . . . . 1.2 109.916 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -136.65 136.78 39.41 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.424 1.889 . . . . 2.3100000000000001 109.358 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.63 124.66 33.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 121.154 1.797 . . . . 0.72999999999999998 111.073 165.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.3 m170 -108.03 153.36 23.22 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.709 1.604 . . . . 0.82999999999999996 113.617 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.25 -179.42 3.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.572 2.749 . . . . 2.29 110.758 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.4 m -128.98 107.99 10.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.117 -1.438 . . . . 1.22 107.117 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -91.23 161.76 14.92 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 122.013 0.911 . . . . 2.21 111.686 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.5 mtm -118.67 168.01 11.12 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.09 -0.959 . . . . 3.2999999999999998 110.902 156.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -176.53 163.63 2.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.335 2.654 . . . . 6.3099999999999996 109.7 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.09 147.51 22.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.586 -0.894 . . . . 3.73 108.586 165.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 p -114.24 -15.52 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 113.858 1.059 . . . . 3.4900000000000002 113.858 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.89 25.84 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.424 2.29 . . . . 4.1299999999999999 109.046 -162.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.69 -20.98 1.64 Allowed Glycine 0 N--CA 1.477 1.375 0 O-C-N 119.392 -2.067 . . . . 2.1699999999999999 113.183 -159.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.8 135.24 35.47 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.655 1.582 . . . . 4.0800000000000001 109.882 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -76.19 138.62 40.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.298 1.039 . . . . 4.5300000000000002 111.855 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -134.27 150.49 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.415 2.286 . . . . 1.8999999999999999 108.97 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.9 ttp -123.46 144.25 49.63 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.557 1.943 . . . . 5.1100000000000003 109.505 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.96 163.8 31.53 Favored Glycine 0 N--CA 1.469 0.838 0 CA-C-N 118.724 0.693 . . . . 1.04 113.236 173.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.68 159.88 14.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.33 1.052 . . . . 1.9199999999999999 111.281 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 -173.21 140.33 0.89 Allowed Pre-proline 0 N--CA 1.475 0.776 0 CA-C-O 116.954 -1.498 . . . . 4.4400000000000004 111.402 -168.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 17.0 Cg_endo -71.09 147.49 54.48 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.927 1.751 . . . . 0.84999999999999998 112.559 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.61 151.4 67.41 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.415 1.486 . . . . 0.79000000000000004 110.48 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.34 -8.82 24.18 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.055 2.503 . . . . 0.87 113.447 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -174.6 159.21 2.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.765 1.626 . . . . 2.54 111.097 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mt -108.85 172.8 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.31 1.444 . . . . 1.1100000000000001 108.98 149.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.34 163.36 37.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.231 -0.918 . . . . 2.79 112.604 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -151.15 131.34 7.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.134 0.974 . . . . 0.91000000000000003 109.806 -168.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 164.49 35.53 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.296 1.998 . . . . 1.05 111.291 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.87 133.04 42.54 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.306 2.671 . . . . 1.05 110.61 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 72.06 0.34 3.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 127.489 2.316 . . . . 1.7 113.788 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.67 157.5 34.37 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 126.545 2.021 . . . . 1.3200000000000001 111.031 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -132.54 144.36 50.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 127.346 2.258 . . . . 4.4199999999999999 110.418 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.84 163.94 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.676 1.991 . . . . 1.8300000000000001 108.762 167.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -139.1 115.02 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.921 -0.77 . . . . 3.1899999999999999 108.921 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.37 91.17 1.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.576 . . . . 1.2 108.781 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -110.1 151.23 42.39 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.525 2.33 . . . . 3.1200000000000001 111.784 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.04 -53.89 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.274 3.316 . . . . 1.0600000000000001 113.949 -168.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.93 93.71 1.77 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 108.413 -1.875 . . . . 1.29 108.413 164.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -85.0 0.14 Allowed Glycine 0 C--O 1.222 -0.614 0 C-N-CA 124.794 1.188 . . . . 0.85999999999999999 112.698 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -155.95 145.87 21.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.579 1.952 . . . . 2.4700000000000002 110.09 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -174.09 157.49 2.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.088 0.955 . . . . 1.46 108.823 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -85.68 139.17 31.6 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 119.813 -0.755 . . . . 2.0099999999999998 109.893 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 mmt -92.42 118.94 31.46 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.419 1.087 . . . . 1.1699999999999999 109.021 161.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.7 mt -100.05 114.86 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.943 1.697 . . . . 1.78 106.793 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.5 150.78 26.96 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.365 1.066 . . . . 3.1000000000000001 110.741 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.19 -55.49 4.59 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 125.235 1.398 . . . . 3.6899999999999999 111.761 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt 69.9 125.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.775 3.23 . . . . 1.0900000000000001 111.581 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -80.9 22.99 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.263 -1.523 . . . . 1.8100000000000001 113.074 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 160.6 153.41 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 129.816 3.246 . . . . 3.8900000000000001 109.219 -163.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.52 131.87 31.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.234 -1.871 . . . . 1.4099999999999999 107.234 151.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.1 101.52 0.41 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.928 0.891 . . . . 2.1099999999999999 110.18 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.84 97.3 1.38 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.729 -1.232 . . . . 4.0099999999999998 109.843 -172.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -44.64 124.63 4.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.123 0.969 . . . . 1.8899999999999999 111.3 172.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.5 30.46 66.65 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.013 -0.882 . . . . 1.97 114.165 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -101.45 -172.08 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.599 1.699 . . . . 3.5499999999999998 107.519 136.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -132.21 151.36 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.832 0.853 . . . . 3.5899999999999999 110.525 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.0 t -98.89 113.86 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 124.85 1.26 . . . . 1.1399999999999999 108.916 -172.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.65 138.39 46.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 124.249 0.968 . . . . 3.7599999999999998 109.441 164.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mt -155.3 116.17 3.91 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.088 0.955 . . . . 1.5700000000000001 111.091 -168.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.31 104.63 16.59 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.016 2.126 . . . . 2.8199999999999998 109.468 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 48.0 mt -75.89 126.34 30.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 1.1200000000000001 110.194 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.0 mt -97.51 121.41 39.38 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.354 1.062 . . . . 0.71999999999999997 110.638 -175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.99 119.32 31.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.856 0.836 . . . . 2.04 112.732 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.1 28.23 0.9 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.01 2.124 . . . . 2.0099999999999998 114.208 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.99 -60.07 2.2 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.707 1.622 . . . . 3.54 112.692 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.87 -7.5 86.35 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.26 1.264 . . . . 1.6100000000000001 116.26 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.39 145.38 43.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.214 2.007 . . . . 4.46 110.194 166.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -147.68 135.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.021 1.328 . . . . 1.05 108.829 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -144.17 127.8 17.11 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.324 1.45 . . . . 1.8500000000000001 108.756 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -91.01 147.18 23.26 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.421 1.637 . . . . 2.8999999999999999 115.421 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.29 164.66 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.965 2.506 . . . . 1.21 109.466 171.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.5 132.83 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.104 0.962 . . . . 2.0600000000000001 109.181 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -145.14 145.28 26.35 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.967 1.707 . . . . 2.4500000000000002 109.537 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 153.35 67.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.372 3.381 . . . . 1.0 114.431 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.62 127.17 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.056 0.942 . . . . 1.1699999999999999 109.007 167.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -147.25 153.85 40.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.315 1.446 . . . . 3.4700000000000002 111.351 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.21 47.56 0.96 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.347 1.459 . . . . 2.04 114.155 -161.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.934 -1.508 . . . . 5.8099999999999996 112.46 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.135 0 N-CA-C 108.204 -1.958 . . . . 11.800000000000001 108.204 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t 69.97 148.59 0.07 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.171 -0.677 . . . . 11.6 109.171 -137.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 63.08 13.4 6.75 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.551 1.14 . . . . 11.0 113.463 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.5 p -140.14 133.39 29.76 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 128.654 2.781 . . . . 6.46 108.072 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -96.97 137.4 36.11 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.915 1.45 . . . . 6.9199999999999999 114.915 -153.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.34 46.8 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.694 2.093 . . . . 1.05 111.683 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.21 152.7 11.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.237 1.199 . . . . 1.4199999999999999 114.237 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.45 128.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.163 1.385 . . . . 1.45 109.12 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.2 117.74 29.88 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.748 0.647 . . . . 4.7800000000000002 112.748 -166.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.5 142.13 58.53 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.244 2.218 . . . . 4.6399999999999997 113.865 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -159.13 167.61 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 120.109 -1.62 . . . . 2.23 111.448 158.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.29 -15.68 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.121 3.214 . . . . 3.1499999999999999 112.453 166.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 155.14 40.42 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 119.29 -0.728 . . . . 1.3600000000000001 112.042 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.37 -8.7 23.89 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.075 3.183 . . . . 1.8 114.373 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.87 146.97 35.55 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.005 1.322 . . . . 3.0499999999999998 111.676 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.91 -176.03 5.74 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.072 1.749 . . . . 1.25 112.952 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.0 154.85 50.29 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.449 1.1 . . . . 1.1399999999999999 111.831 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.18 147.88 44.28 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.265 1.031 . . . . 0.94999999999999996 111.637 166.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.1 146.52 39.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.128 1.771 . . . . 1.8999999999999999 108.753 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.1 153.79 14.33 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.926 0.713 . . . . 1.73 112.926 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.1 m -72.57 110.61 7.07 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.629 1.572 . . . . 1.24 108.259 159.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.07 127.81 34.14 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.159 -1.423 . . . . 2.5499999999999998 107.159 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.68 114.49 20.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 4.4100000000000001 110.522 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -102.66 103.68 33.92 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.141 -0.974 . . . . 0.92000000000000004 110.686 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.13 -7.92 11.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.91 2.407 . . . . 1.0800000000000001 113.236 172.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.14 171.18 55.19 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 119.109 0.868 . . . . 0.98999999999999999 113.7 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -101.57 0.16 35.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.367 1.867 . . . . 2.7000000000000002 113.032 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.96 159.06 39.06 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.723 1.609 . . . . 1.8600000000000001 110.451 167.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.23 154.37 18.95 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.043 2.495 . . . . 1.0600000000000001 111.142 -173.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -101.65 150.63 22.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.258 1.023 . . . . 2.3300000000000001 110.482 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -133.7 103.06 5.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.526 1.131 . . . . 3.1099999999999999 109.409 171.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 tp -84.14 104.83 14.52 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.366 2.267 . . . . 0.82999999999999996 108.97 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.64 -12.93 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.154 0.982 . . . . 0.63 113.001 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.26 -169.35 41.89 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 124.448 1.023 . . . . 0.59999999999999998 111.76 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -158.17 -178.39 7.26 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.113 0.965 . . . . 0.88 111.508 173.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 10.4 mmt180 -158.32 149.92 21.27 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 121.509 1.959 . . . . 6.8499999999999996 109.126 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -154.28 152.13 25.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.019 1.327 . . . . 0.95999999999999996 108.243 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.87 -25.14 60.35 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.661 2.241 . . . . 0.84999999999999998 113.418 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -79.59 -4.18 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.889 1.44 . . . . 0.90000000000000002 114.889 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.38 174.56 12.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.948 1.299 . . . . 0.95999999999999996 112.476 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -116.56 -87.97 0.6 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.84 0.856 . . . . 4.3200000000000003 110.17 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -69.35 107.05 3.14 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.511 -0.743 . . . . 4.8899999999999997 109.71 -171.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -84.16 141.29 14.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.227 2.211 . . . . 2.0 110.571 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -146.72 124.2 11.7 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 2.71 109.999 166.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.429 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.2 tt -81.84 115.36 21.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.184 0.993 . . . . 0.96999999999999997 110.326 169.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.0 m170 -100.23 151.69 21.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.737 1.615 . . . . 0.87 111.881 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.8 177.82 5.65 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.038 -1.437 . . . . 1.99 110.689 165.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.573 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 87.5 m -147.94 102.76 3.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.24 1.416 . . . . 1.2 107.195 171.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -112.76 153.07 28.35 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.817 1.247 . . . . 2.5499999999999998 112.523 -166.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -105.5 121.72 44.52 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.487 0.66 . . . . 3.3700000000000001 109.598 156.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -144.91 170.01 16.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.311 1.844 . . . . 7.8799999999999999 109.107 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.25 143.95 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.351 0.66 . . . . 4.2699999999999996 109.927 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.12 -87.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 3.71 108.408 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -77.4 50.99 0.83 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.436 1.895 . . . . 2.96 110.404 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.1 -31.93 0.42 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 126.601 2.048 . . . . 3.48 115.077 -175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.82 146.63 24.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.584 1.953 . . . . 2.79 111.37 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -68.44 118.76 11.92 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 118.845 -0.598 . . . . 5.1600000000000001 109.47 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.83 147.78 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 3.3100000000000001 111.305 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.4 mmt -77.79 141.03 39.47 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.982 1.313 . . . . 3.4300000000000002 113.671 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.56 27.81 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.058 0.837 . . . . 1.25 114.13 170.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -114.63 137.42 51.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.604 1.562 . . . . 1.8200000000000001 110.346 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -148.21 155.71 43.14 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.913 1.285 . . . . 7.04 109.955 165.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 38.6 Cg_endo -65.52 145.63 82.87 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.073 2.515 . . . . 0.68999999999999995 110.953 167.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.83 159.06 33.13 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 125.338 1.455 . . . . 0.72999999999999998 109.855 166.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.0 -15.14 32.48 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.625 2.217 . . . . 0.69999999999999996 113.243 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -175.74 160.77 2.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.042 1.737 . . . . 2.1200000000000001 111.02 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mt -109.87 175.94 5.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.827 1.651 . . . . 1.2 109.517 154.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.52 168.26 26.75 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.363 -0.835 . . . . 2.4199999999999999 112.116 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -149.82 136.46 10.83 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.442 1.097 . . . . 0.85999999999999999 109.527 -170.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -72.25 168.0 25.33 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.405 2.07 . . . . 0.84999999999999998 112.048 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.54 145.28 99.06 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.789 2.993 . . . . 0.91000000000000003 111.915 168.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.24 0.9 0.46 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.865 2.172 . . . . 1.78 116.865 -172.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 114.03 3.79 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 127.147 2.308 . . . . 0.87 111.95 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -81.9 139.26 34.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.997 -1.101 . . . . 5.4500000000000002 109.243 151.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 m -151.36 130.51 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.657 1.583 . . . . 1.78 110.084 169.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -90.41 130.39 36.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.629 -0.669 . . . . 3.3100000000000001 111.407 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -69.81 129.17 38.84 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.364 -0.976 . . . . 1.76 108.364 161.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -143.28 140.73 18.05 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.576 1.55 . . . . 2.9500000000000002 110.865 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.7 -16.75 47.08 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.702 2.935 . . . . 1.8100000000000001 114.278 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.98 100.0 1.79 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.24 -1.944 . . . . 1.3700000000000001 108.24 152.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.573 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 142.66 -85.33 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.847 1.689 . . . . 1.3600000000000001 113.089 -172.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.71 144.2 20.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.067 1.747 . . . . 1.8899999999999999 111.22 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.92 158.02 27.47 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.256 -0.903 . . . . 1.0900000000000001 110.74 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 45' ' ' LEU . 49.0 m-85 -94.28 133.05 38.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.074 0.397 . . . . 1.95 110.814 170.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.2 mmt -90.62 137.18 32.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.394 1.478 . . . . 0.93000000000000005 109.906 162.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.82 126.58 45.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.503 1.521 . . . . 2.9100000000000001 108.653 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.42 147.49 52.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.233 1.413 . . . . 3.2799999999999998 110.526 -175.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 57.95 4.6 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.236 -0.746 . . . . 1.3799999999999999 111.236 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.09 120.51 12.81 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.48 0.64 . . . . 0.87 110.938 -174.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -76.23 -9.78 58.9 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.873 1.064 . . . . 2.1600000000000001 113.873 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.98 145.08 0.74 Allowed Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 127.065 2.146 . . . . 4.5199999999999996 110.152 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.37 154.15 65.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.906 2.404 . . . . 2.1299999999999999 109.885 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.71 162.03 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.044 1.338 . . . . 2.7999999999999998 111.329 -170.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -114.71 127.05 55.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.265 1.026 . . . . 5.0 111.222 172.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.34 117.48 4.87 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.906 -0.588 . . . . 1.8400000000000001 109.747 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.13 -8.46 31.18 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.21 -1.328 . . . . 2.6000000000000001 114.683 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.34 161.2 26.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 119.637 1.718 . . . . 2.79 109.955 162.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -111.01 156.93 20.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.636 -0.711 . . . . 5.3300000000000001 109.484 154.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.55 125.14 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.854 1.662 . . . . 1.55 108.473 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -74.58 145.85 43.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.481 0.658 . . . . 3.9100000000000001 110.379 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.627 HD21 ' HB1' ' A' ' 35' ' ' ALA . 3.6 tt -154.96 126.7 7.51 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.141 0.977 . . . . 1.8700000000000001 110.643 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.43 109.92 21.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.121 2.568 . . . . 2.48 112.068 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 119.03 23.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.216 1.406 . . . . 1.1399999999999999 110.321 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.0 mt -89.95 111.15 22.13 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.802 0.841 . . . . 0.69999999999999996 109.56 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 76.6 m-85 -111.98 124.08 51.64 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.707 -0.621 . . . . 2.2599999999999998 109.836 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.87 37.49 1.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.123 1.769 . . . . 2.3199999999999998 113.263 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -73.23 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.722 1.153 . . . . 4.6200000000000001 112.091 -171.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.63 -30.2 60.33 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 115.739 1.055 . . . . 2.46 115.739 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 54.1 tttp -83.91 86.45 7.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 119.946 1.873 . . . . 6.3899999999999997 108.51 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -100.86 106.93 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.042 1.337 . . . . 1.6699999999999999 109.549 173.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.16 125.81 44.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.771 1.629 . . . . 3.1200000000000001 110.654 -173.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -83.14 139.04 33.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.479 1.659 . . . . 2.7999999999999998 115.479 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.81 169.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.399 1.88 . . . . 1.3400000000000001 109.32 159.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.6 139.23 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.386 1.474 . . . . 1.98 108.346 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -146.03 145.86 26.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.303 1.441 . . . . 1.71 110.798 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.18 158.37 55.01 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 124.274 3.316 . . . . 0.97999999999999998 113.948 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.44 134.55 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.313 1.445 . . . . 1.4399999999999999 111.577 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -152.41 -172.18 4.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.878 2.071 . . . . 4.0800000000000001 109.429 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.47 124.98 35.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.964 -1.085 . . . . 2.71 110.886 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 125.357 1.463 . . . . 8.4000000000000004 112.798 -163.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 111.369 -0.692 . . . . 8.8599999999999994 111.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -81.29 109.41 15.78 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.976 -0.75 . . . . 9.5800000000000001 108.976 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 53.6 79.64 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.104 1.362 . . . . 10.99 111.964 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 5' ' ' GLU . 1.6 m 86.53 -154.08 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 128.663 2.785 . . . . 6.7400000000000002 109.376 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.554 ' H ' HG22 ' A' ' 4' ' ' THR . 2.2 tt0 176.12 177.34 0.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 130.348 3.459 . . . . 4.8700000000000001 109.655 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.08 175.81 19.37 Favored Glycine 0 N--CA 1.466 0.655 0 O-C-N 121.48 -0.762 . . . . 1.03 114.631 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -159.86 146.01 15.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.943 1.697 . . . . 1.3 110.572 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.92 138.93 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.436 -0.95 . . . . 1.04 108.436 170.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -86.73 131.76 34.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.544 0.688 . . . . 4.5800000000000001 112.176 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -53.26 119.52 4.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.741 1.616 . . . . 3.9399999999999999 112.587 164.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -165.29 99.03 0.8 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.699 2.0 . . . . 3.1200000000000001 107.522 163.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.66 44.21 1.45 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.459 2.773 . . . . 2.8199999999999998 111.964 -168.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.94 -147.78 6.47 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.304 0.954 . . . . 1.9399999999999999 114.138 -167.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.32 -7.04 17.73 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.299 2.666 . . . . 1.7 112.798 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -154.25 156.89 37.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 2.3100000000000001 112.829 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.2 -165.36 1.9 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.387 2.675 . . . . 1.4199999999999999 110.448 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.04 154.39 39.24 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.261 -0.899 . . . . 1.3700000000000001 111.798 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.81 125.46 46.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.919 0.888 . . . . 1.24 110.405 165.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -103.11 147.4 27.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.985 1.714 . . . . 2.0299999999999998 108.75 168.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -163.45 141.88 7.94 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.275 1.213 . . . . 1.47 114.275 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.1 m -66.82 107.61 2.24 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.277 -1.008 . . . . 1.4299999999999999 108.277 161.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 134.36 36.42 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 106.944 -1.502 . . . . 2.7000000000000002 106.944 165.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.28 151.56 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.35 1.071 . . . . 3.4700000000000002 112.01 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -128.29 99.37 24.51 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.52 1.528 . . . . 0.98999999999999999 109.073 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -6.27 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.49 2.127 . . . . 1.01 112.841 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.51 174.03 54.17 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.282 0.944 . . . . 0.88 113.994 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.11 -3.79 26.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.507 1.923 . . . . 2.71 113.441 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.34 161.0 33.74 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.107 1.763 . . . . 1.6599999999999999 109.98 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.65 162.76 24.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.058 2.506 . . . . 0.93000000000000005 111.978 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.26 144.92 40.87 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.252 1.021 . . . . 1.8100000000000001 110.593 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -122.67 114.19 20.25 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.896 1.278 . . . . 3.0899999999999999 109.27 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.54 117.23 29.79 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.04 2.136 . . . . 0.67000000000000004 109.151 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -117.69 -4.9 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.405 1.082 . . . . 0.78000000000000003 112.938 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.71 -174.6 47.01 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.698 1.142 . . . . 0.68000000000000005 111.18 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.972 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -148.06 178.92 8.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.242 1.417 . . . . 0.73999999999999999 109.891 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.497 HH11 ' HG3' ' A' ' 36' ' ' ARG . 12.8 tpt85 -161.28 147.86 14.62 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 106.664 -1.606 . . . . 6.0099999999999998 106.664 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.416 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 2.5 t -149.7 157.8 38.09 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 124.6 1.16 . . . . 0.88 109.172 -166.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.05 -15.79 16.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.11 1.873 . . . . 1.29 114.351 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.44 HG12 ' HE ' ' A' ' 91' ' ' ARG . 4.7 m -101.16 2.46 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 116.025 1.861 . . . . 0.93000000000000005 116.025 -170.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 164.05 38.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.416 1.007 . . . . 1.02 113.019 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.34 -79.67 0.54 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.731 2.012 . . . . 2.8399999999999999 111.314 -170.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 111.37 9.88 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.412 -0.958 . . . . 3.8900000000000001 108.412 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -84.15 139.62 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.435 -1.257 . . . . 1.99 110.428 158.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -142.24 122.46 13.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.597 1.159 . . . . 2.0 109.042 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -79.01 118.74 21.29 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.627 1.558 . . . . 1.03 110.713 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -113.36 157.28 22.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 0.55000000000000004 111.869 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -112.34 167.45 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.396 1.478 . . . . 2.2000000000000002 110.372 166.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -123.26 114.79 20.7 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.741 1.616 . . . . 1.26 107.453 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -120.7 152.91 37.64 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.924 0.89 . . . . 2.3300000000000001 112.809 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtp -103.03 142.78 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.82 1.648 . . . . 3.7200000000000002 110.325 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -157.8 144.83 18.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.097 1.359 . . . . 6.6500000000000004 111.503 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 137.95 31.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.284 0.493 . . . . 4.1900000000000004 111.104 166.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -146.71 126.33 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.732 1.613 . . . . 3.7200000000000002 107.324 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 63.33 20.35 12.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.589 1.156 . . . . 3.2400000000000002 111.963 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.17 -9.14 41.45 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.761 1.172 . . . . 2.3999999999999999 113.829 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -89.2 143.86 26.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.978 1.711 . . . . 3.3199999999999998 109.927 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -81.7 118.86 23.17 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.61 -0.681 . . . . 4.0199999999999996 110.875 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.03 150.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.239 1.816 . . . . 1.53 109.717 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtm -135.24 144.65 46.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.771 1.228 . . . . 3.27 110.676 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 177.58 32.38 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 123.773 0.702 . . . . 1.45 113.037 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -115.7 151.23 35.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.958 1.303 . . . . 1.8799999999999999 110.495 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -164.43 147.65 7.59 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.29 1.036 . . . . 5.6200000000000001 112.4 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.6 Cg_endo -70.82 153.18 64.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.229 1.953 . . . . 0.58999999999999997 112.512 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.95 159.02 70.8 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 126.438 1.895 . . . . 0.68000000000000005 110.408 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.96 -16.83 36.85 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.421 2.081 . . . . 0.72999999999999998 113.342 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -179.97 172.08 1.08 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 125.424 1.49 . . . . 2.0499999999999998 111.253 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.2 173.0 7.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.611 2.365 . . . . 1.0600000000000001 109.072 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.25 166.47 33.08 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.058 -1.026 . . . . 2.29 111.747 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.2 t -150.41 137.16 11.23 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.117 1.367 . . . . 0.81000000000000005 109.471 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.76 171.36 15.7 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.908 2.405 . . . . 0.97999999999999998 112.315 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.35 142.04 94.54 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.1 2.533 . . . . 0.82999999999999996 111.491 166.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt 65.34 2.54 1.97 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.834 1.653 . . . . 1.4099999999999999 113.387 -174.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.49 121.98 5.79 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 127.451 2.453 . . . . 1.1399999999999999 110.242 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -113.91 131.72 56.19 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.045 1.738 . . . . 6.0300000000000002 109.51 167.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 m -159.55 134.36 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.065 1.346 . . . . 1.77 111.083 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -79.53 134.6 36.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.24 1.019 . . . . 3.7400000000000002 112.824 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.03 69.62 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.874 1.321 . . . . 1.3799999999999999 108.517 143.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 78' ' ' LYS . 2.4 ptmm? -83.14 149.35 58.58 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 128.682 2.793 . . . . 2.8799999999999999 110.832 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -54.46 -37.99 89.71 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.22 2.613 . . . . 1.1899999999999999 113.552 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.63 65.09 3.37 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.078 0.854 . . . . 1.8300000000000001 111.022 168.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.39 -81.46 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.081 1.324 . . . . 1.23 113.391 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -153.33 152.18 30.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.383 1.873 . . . . 2.1000000000000001 110.19 -164.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -164.87 165.14 20.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.37 1.068 . . . . 0.93999999999999995 110.002 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 67.5 m-85 -95.89 123.6 39.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.42 -1.326 . . . . 2.3100000000000001 107.42 160.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.97 129.91 34.87 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.491 -1.3 . . . . 1.21 107.491 163.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.56 123.38 49.32 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.864 -0.791 . . . . 3.27 108.864 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.93 132.55 55.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.143 1.777 . . . . 3.1299999999999999 109.056 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.17 96.07 0.2 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.288 -1.125 . . . . 1.45 110.288 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 mt -100.7 128.59 46.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.715 0.758 . . . . 1.03 111.57 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -79.76 -18.95 49.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.273 1.429 . . . . 1.76 112.815 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.44 ' HE ' HG12 ' A' ' 39' ' ' VAL . 14.2 ptt180 -156.77 145.13 14.46 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.633 1.573 . . . . 5.6799999999999997 110.307 167.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.87 145.3 56.08 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.944 2.43 . . . . 1.4299999999999999 110.097 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.97 82.0 6.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.465 1.126 . . . . 2.3799999999999999 110.993 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 133.8 54.6 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.962 1.705 . . . . 3.6200000000000001 109.518 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.0 135.72 52.39 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.57 -1.331 . . . . 1.9099999999999999 111.93 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.99 53.78 21.11 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.72 -0.552 . . . . 2.3700000000000001 111.72 -171.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -117.98 165.73 13.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.167 1.387 . . . . 2.8500000000000001 110.761 163.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 154.29 20.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.212 1.405 . . . . 5.1699999999999999 109.518 164.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.3 t -140.89 105.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.854 1.662 . . . . 1.26 109.05 166.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -65.64 142.35 58.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.663 0.744 . . . . 4.1799999999999997 110.209 163.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.972 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.3 tt -140.63 129.96 23.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.977 0.894 . . . . 1.8999999999999999 111.13 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -86.59 101.81 13.57 Favored 'General case' 0 CA--C 1.552 1.047 1 C-N-CA 132.536 4.334 . . . . 2.9199999999999999 111.436 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.7 mt -82.41 122.56 28.16 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.931 -1.731 . . . . 1.1499999999999999 111.055 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.17 123.07 43.18 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.737 0.815 . . . . 0.78000000000000003 110.542 -171.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.5 153.05 35.93 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.694 0.759 . . . . 1.8 111.996 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.39 134.39 56.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.862 0.465 . . . . 2.3999999999999999 110.672 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.7 10.45 52.94 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.848 1.099 . . . . 3.9300000000000002 115.848 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.25 6.77 83.91 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 119.119 1.46 . . . . 2.1200000000000001 114.184 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -76.24 131.84 39.53 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.362 -1.081 . . . . 6.0700000000000003 109.714 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.81 140.17 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.277 1.031 . . . . 1.27 110.2 166.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.9 mt -141.05 123.38 15.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.138 1.375 . . . . 1.8500000000000001 108.931 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -92.0 145.71 24.31 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.539 0.94 . . . . 2.4700000000000002 113.539 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.14 149.28 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.78 2.032 . . . . 1.9099999999999999 111.093 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.96 135.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.45 1.5 . . . . 3.6499999999999999 111.167 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -144.71 85.19 8.58 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.83 1.652 . . . . 2.1400000000000001 110.649 -166.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.66 154.56 59.33 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.249 2.633 . . . . 1.27 112.462 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.9 t -84.35 134.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.867 0.867 . . . . 1.3899999999999999 111.384 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.98 157.49 40.65 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.096 1.358 . . . . 3.8700000000000001 111.136 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 11.99 4.72 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.832 1.653 . . . . 2.6699999999999999 113.948 171.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.233 0 CA-C-O 114.545 -2.645 . . . . 5.5099999999999998 115.704 -174.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.353 0 CA-C-O 118.99 -0.894 . . . . 13.289999999999999 112.565 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m 177.86 -179.03 0.25 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 129.536 3.134 . . . . 11.869999999999999 109.575 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -59.0 4.21 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 116.559 2.059 . . . . 12.73 116.559 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -81.68 -25.86 35.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.302 2.241 . . . . 7.6900000000000004 111.38 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -155.07 141.43 18.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.886 1.274 . . . . 6.9199999999999999 111.673 -138.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.14 149.84 18.04 Favored Glycine 0 N--CA 1.465 0.6 0 O-C-N 120.879 -1.138 . . . . 1.4099999999999999 112.969 162.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.409 ' HE1' ' HB2' ' A' ' 120' ' ' ARG . 16.0 p90 -153.55 151.48 29.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.476 0.917 . . . . 1.8200000000000001 113.476 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.7 t -110.76 144.12 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 1.22 110.525 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -87.79 113.76 23.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.234 1.198 . . . . 3.7400000000000002 114.234 -156.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -63.48 123.03 17.73 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.585 -0.697 . . . . 3.25 111.906 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -159.36 147.85 13.83 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 2.48 110.348 166.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.39 63.31 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.089 3.192 . . . . 2.5 109.61 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.99 168.5 13.72 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.263 0.935 . . . . 1.6100000000000001 113.908 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.15 -15.47 14.49 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.819 3.013 . . . . 1.5 112.001 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -144.86 158.97 43.61 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.369 1.867 . . . . 1.95 111.605 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.55 -177.17 6.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.852 1.261 . . . . 1.1899999999999999 111.05 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.31 149.45 30.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.626 1.17 . . . . 1.1699999999999999 110.916 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.65 128.89 55.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.45 -0.574 . . . . 1.24 109.45 160.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.17 162.93 14.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.524 1.93 . . . . 2.0299999999999998 109.98 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.1 pt? -161.38 140.87 10.3 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.792 1.405 . . . . 1.4399999999999999 114.792 166.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -79.12 137.44 37.48 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.55 -1.278 . . . . 1.3 107.55 151.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.36 135.71 13.21 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.615 1.166 . . . . 2.9300000000000002 109.995 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.2 142.75 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.307 1.043 . . . . 3.23 113.177 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -82.17 114.21 49.29 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.592 -1.185 . . . . 0.85999999999999999 109.321 152.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -83.45 -9.64 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.166 2.578 . . . . 1.1299999999999999 113.386 174.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.93 170.48 47.67 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.752 1.167 . . . . 0.82999999999999996 113.645 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.87 -7.14 44.03 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.287 1.835 . . . . 2.73 112.826 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.8 159.8 35.96 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.23 1.812 . . . . 1.6100000000000001 110.436 171.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.73 158.63 28.14 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.778 2.319 . . . . 0.87 111.793 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.67 140.14 43.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.499 1.52 . . . . 2.0800000000000001 109.64 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.64 112.13 15.77 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.237 1.015 . . . . 3.8399999999999999 109.958 171.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.13 114.94 26.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.101 2.16 . . . . 0.59999999999999998 109.025 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -107.06 -10.1 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.797 1.239 . . . . 0.46999999999999997 113.091 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.3 -167.59 40.02 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.993 1.282 . . . . 0.46000000000000002 110.962 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.09 176.85 11.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.041 0.936 . . . . 0.77000000000000002 111.127 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -146.72 121.63 9.98 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.84 0.856 . . . . 7.8300000000000001 110.631 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.27 148.55 70.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 124.922 1.289 . . . . 0.68999999999999995 108.79 -173.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.14 -1.0 10.31 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.472 2.115 . . . . 0.81000000000000005 114.15 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.37 -0.43 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.882 1.808 . . . . 1.0600000000000001 115.882 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.72 168.21 21.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.236 1.834 . . . . 1.1299999999999999 114.738 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -104.94 -93.4 0.36 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.976 1.37 . . . . 3.1200000000000001 110.365 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -84.63 83.86 7.87 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.632 -1.293 . . . . 4.7699999999999996 109.541 -165.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.67 131.21 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.572 2.349 . . . . 1.6899999999999999 112.127 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -140.58 132.05 26.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.942 1.697 . . . . 2.6400000000000001 110.458 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 121.73 26.84 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.199 1.363 . . . . 0.68000000000000005 111.131 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -110.7 152.42 26.57 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.217 2.207 . . . . 0.66000000000000003 113.165 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.92 137.44 32.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.719 1.608 . . . . 2.3500000000000001 109.172 155.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -101.35 146.01 28.14 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.025 -1.843 . . . . 2.3599999999999999 106.025 161.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -156.79 172.22 19.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.874 1.435 . . . . 3.0499999999999998 114.874 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.1 mtm -118.99 127.48 53.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.917 1.287 . . . . 6.7800000000000002 108.269 148.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -146.75 170.18 17.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.353 1.861 . . . . 9.6199999999999992 110.054 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -102.72 156.3 17.73 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.817 0.847 . . . . 4.7400000000000002 112.316 -167.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.28 -96.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 3.4500000000000002 108.377 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -76.38 42.51 0.28 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.466 2.306 . . . . 3.7200000000000002 110.53 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.17 -15.25 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 119.816 -1.802 . . . . 2.29 114.098 -169.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -81.17 131.97 35.33 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.812 -1.405 . . . . 4.0199999999999996 110.85 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 57' ' ' LYS . 1.3 ptmm? -83.05 90.6 7.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.62 1.168 . . . . 7.0599999999999996 112.172 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.07 148.23 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.467 1.507 . . . . 3.0099999999999998 111.466 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.47 156.82 17.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.381 1.252 . . . . 6.5999999999999996 114.381 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.51 -165.21 35.94 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.759 1.647 . . . . 2.25 111.168 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -153.1 158.74 42.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 3.21 112.115 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -153.6 141.26 13.62 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 6.4000000000000004 111.281 -170.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.26 147.17 77.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.599 2.199 . . . . 0.89000000000000001 112.377 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.15 157.16 61.72 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 126.706 2.002 . . . . 0.66000000000000003 110.593 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.11 -13.49 36.4 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.854 2.369 . . . . 0.91000000000000003 113.489 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.5 p90 179.04 168.52 0.95 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.937 1.695 . . . . 1.8799999999999999 110.328 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -113.92 174.41 5.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.664 1.586 . . . . 1.0 109.428 152.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.05 163.26 36.82 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.456 -0.777 . . . . 2.3599999999999999 111.066 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.72 124.78 8.78 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 1.21 107.873 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.45 161.03 46.82 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.784 1.656 . . . . 1.04 110.679 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.86 138.39 78.79 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.423 2.749 . . . . 0.83999999999999997 110.972 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 68.67 -0.29 2.37 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.373 1.869 . . . . 1.6699999999999999 113.863 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.42 116.52 4.35 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 126.1 1.809 . . . . 0.96999999999999997 112.026 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -77.42 131.92 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.178 -1.011 . . . . 4.71 109.994 156.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.01 175.88 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.875 2.07 . . . . 1.6799999999999999 110.25 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -137.89 114.3 10.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.065 0.946 . . . . 4.2699999999999996 110.502 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 85.37 0.43 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.923 -1.51 . . . . 1.53 106.923 157.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 152.8 37.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.578 . . . . 3.7000000000000002 112.901 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.91 -41.22 48.21 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.735 2.956 . . . . 1.6200000000000001 113.836 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.57 40.57 2.62 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.592 -1.115 . . . . 1.3500000000000001 113.987 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.27 -61.1 0.02 OUTLIER Glycine 0 N--CA 1.472 1.054 0 CA-C-N 118.826 1.313 . . . . 1.22 115.439 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -153.38 145.96 24.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.303 1.441 . . . . 2.2400000000000002 111.06 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -165.29 173.45 11.22 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.774 -1.204 . . . . 0.96999999999999997 110.402 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.83 129.35 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.837 -0.602 . . . . 2.0600000000000001 109.659 165.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.5 mmt -80.11 121.73 25.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.431 -0.581 . . . . 0.91000000000000003 109.431 163.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.4 mt -107.74 86.34 2.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.373 1.469 . . . . 1.53 109.555 -176.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.05 142.11 29.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.993 0.917 . . . . 2.8700000000000001 109.629 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.22 60.23 4.22 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.861 0.743 . . . . 1.45 112.033 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.69 124.82 22.42 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.829 0.852 . . . . 1.0800000000000001 112.805 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -81.29 -0.03 39.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.659 1.183 . . . . 2.9399999999999999 113.588 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.14 150.31 0.61 Allowed Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 128.85 2.86 . . . . 6.04 109.486 177.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.39 149.76 75.37 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.488 2.125 . . . . 2.3500000000000001 110.233 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.57 108.79 14.5 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.458 -1.312 . . . . 2.52 107.458 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.48 119.37 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.785 -1.197 . . . . 3.4700000000000002 111.368 -170.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.51 113.65 1.88 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.963 -1.125 . . . . 1.71 107.963 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.29 -18.69 4.94 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 116.802 -2.11 . . . . 2.23 115.506 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.65 162.07 35.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.584 2.192 . . . . 3.8599999999999999 113.961 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -79.74 137.06 36.91 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.269 1.827 . . . . 4.3899999999999997 111.507 163.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.14 126.99 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 124.976 1.311 . . . . 0.88 109.41 160.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -71.2 141.39 50.65 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.955 -0.566 . . . . 3.1600000000000001 110.45 162.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mt -156.35 121.74 4.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.977 0.911 . . . . 1.3799999999999999 112.287 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.56 101.37 11.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.567 2.347 . . . . 2.2200000000000002 110.713 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.0 mt -76.37 115.71 16.37 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.102 1.761 . . . . 1.0700000000000001 110.121 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -85.34 124.47 31.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.864 0.866 . . . . 0.69999999999999996 110.601 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 87.6 m-85 -121.71 126.02 47.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.239 0.616 . . . . 2.02 111.655 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.32 18.89 0.99 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.427 1.64 . . . . 2.8300000000000001 115.427 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.44 68.83 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.315 1.436 . . . . 4.8799999999999999 116.036 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -139.53 -26.52 0.26 Allowed Glycine 0 N--CA 1.477 1.387 0 CA-C-N 119.337 1.568 . . . . 2.54 116.592 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -88.17 141.6 28.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.325 1.563 . . . . 6.4199999999999999 109.409 172.419 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 p -142.39 161.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.633 -0.667 . . . . 1.05 111.573 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.09 124.38 14.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.959 1.704 . . . . 2.71 110.276 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -71.71 116.59 12.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.298 -0.63 . . . . 2.79 109.298 161.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.65 153.94 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 124.514 1.126 . . . . 1.1399999999999999 108.948 158.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.99 137.25 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.439 -1.319 . . . . 2.6800000000000002 107.439 161.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.5 mt -139.63 130.13 14.34 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.198 -1.382 . . . . 1.8899999999999999 109.205 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -60.75 151.18 78.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.621 2.881 . . . . 1.3600000000000001 112.286 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.8 t -78.16 136.02 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.572 -0.705 . . . . 1.77 109.401 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.49 151.52 35.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.59 1.156 . . . . 3.5899999999999999 109.379 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.47 55.31 0.72 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.963 1.305 . . . . 2.3500000000000001 112.357 -158.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HB2' ' HE1' ' A' ' 7' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 125.3 1.44 . . . . 5.04 108.555 172.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.847 0 N-CA-C 107.367 -2.293 . . . . 10.73 107.367 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m 71.58 34.44 1.64 Allowed 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 118.243 1.022 . . . . 12.619999999999999 109.861 -156.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 78.51 179.08 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.68 2.792 . . . . 16.399999999999999 111.213 -166.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 98.82 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 130.84 3.656 . . . . 7.0800000000000001 111.351 -162.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -93.96 169.95 9.9 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.755 2.022 . . . . 5.2599999999999998 111.7 165.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.71 164.39 27.75 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.147 1.356 . . . . 1.27 114.15 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -161.23 154.42 21.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.205 1.402 . . . . 1.8200000000000001 112.956 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -103.92 130.98 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.651 1.18 . . . . 1.04 108.951 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -77.86 116.19 18.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.338 0.255 . . . . 3.7000000000000002 110.725 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -52.7 119.43 4.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.846 0.858 . . . . 2.3199999999999998 112.072 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 m -168.67 112.67 0.55 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.805 2.042 . . . . 2.0699999999999998 107.001 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.81 50.69 2.64 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.623 2.882 . . . . 3.4399999999999999 110.398 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -177.65 31.6 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.179 0.895 . . . . 1.8799999999999999 114.638 -167.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -66.26 -16.46 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.926 2.418 . . . . 1.6100000000000001 111.746 166.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -155.22 157.4 37.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.092 1.757 . . . . 2.7000000000000002 110.678 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.01 -174.88 5.15 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 1.1799999999999999 111.049 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.8 146.5 37.7 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.356 0.873 . . . . 1.03 113.356 -170.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.97 146.38 49.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.134 0.974 . . . . 0.85999999999999999 112.562 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -128.63 150.4 50.24 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.012 2.525 . . . . 2.2999999999999998 109.237 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.01 137.05 9.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 115.606 1.706 . . . . 2.1899999999999999 115.606 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.9 m -85.55 124.78 32.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 114.749 -1.114 . . . . 1.4099999999999999 108.932 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.02 137.23 51.98 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 127.153 2.181 . . . . 2.5099999999999998 107.814 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.14 143.17 31.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.665 0.745 . . . . 3.0899999999999999 111.027 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -111.73 105.54 56.62 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.062 -0.972 . . . . 1.28 109.154 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.47 -5.28 10.1 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.839 2.359 . . . . 1.4199999999999999 113.826 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.6 -174.35 38.41 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 124.387 0.994 . . . . 1.26 113.259 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -106.87 9.08 30.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.589 1.556 . . . . 2.3999999999999999 113.426 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.47 157.97 57.5 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.774 1.63 . . . . 2.2200000000000002 110.666 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.19 157.21 13.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.26 2.64 . . . . 1.7 112.592 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.7 112.44 17.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.99 1.716 . . . . 2.5 110.042 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -109.01 101.26 10.35 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.199 1.399 . . . . 4.1299999999999999 112.747 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 tp -80.55 106.55 12.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.306 2.242 . . . . 0.97999999999999998 109.636 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.11 -14.53 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.309 1.443 . . . . 0.68999999999999995 113.058 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.18 -162.19 30.94 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.251 0.929 . . . . 0.69999999999999996 111.618 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.817 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.59 -170.67 3.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.693 0.797 . . . . 1.1000000000000001 111.209 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -167.44 134.75 2.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.463 -0.939 . . . . 6.3600000000000003 108.463 165.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t -136.09 143.32 43.53 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-O 117.544 -1.217 . . . . 0.72999999999999998 108.83 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.16 -20.0 56.56 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.646 2.231 . . . . 1.04 113.145 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -77.22 3.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 113.263 0.838 . . . . 1.1000000000000001 113.263 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.2 -163.79 1.87 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.19 1.552 . . . . 1.3999999999999999 115.19 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.84 -88.99 0.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.703 1.601 . . . . 3.5699999999999998 109.598 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -78.95 158.99 27.9 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.696 1.599 . . . . 6.7000000000000002 111.099 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.06 73.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 124.816 2.246 . . . . 2.0 109.315 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -96.36 120.22 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 111.997 -2.365 . . . . 4.5199999999999996 110.163 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.48 121.93 25.81 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.884 0.849 . . . . 0.66000000000000003 111.509 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -107.69 155.83 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.805 2.042 . . . . 0.97999999999999998 112.006 173.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 12.0 pt-20 -104.78 177.91 4.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.369 -1.287 . . . . 2.9500000000000002 110.891 157.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -150.61 115.93 5.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.282 1.833 . . . . 1.3100000000000001 107.38 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.57 178.71 6.79 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.388 1.475 . . . . 2.6299999999999999 111.587 -162.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.7 ptp -119.57 151.15 39.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.649 1.18 . . . . 3.4300000000000002 111.623 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -154.44 158.95 40.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.817 1.247 . . . . 7.54 112.243 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.5 137.61 38.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.011 0.925 . . . . 4.0300000000000002 109.81 163.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.7 t -118.22 -93.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.434 1.494 . . . . 3.0299999999999998 109.221 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -77.92 39.07 0.28 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.126 2.17 . . . . 3.6099999999999999 110.931 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.22 -6.13 16.49 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 119.815 -1.803 . . . . 1.9099999999999999 113.825 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -107.1 155.68 19.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.132 2.173 . . . . 3.8999999999999999 110.595 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.61 140.82 29.48 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.889 1.07 . . . . 4.0300000000000002 113.889 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 t -143.25 157.89 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.794 2.037 . . . . 2.04 108.293 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.4 ptp -74.18 173.23 10.43 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.489 0.716 . . . . 4.4900000000000002 112.712 170.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.13 153.99 25.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.633 1.111 . . . . 1.28 111.254 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -124.4 143.01 50.85 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.147 1.379 . . . . 1.79 108.576 171.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.429 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -163.34 145.28 7.7 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 118.089 -0.958 . . . . 6.21 112.058 -178.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 49.8 Cg_endo -66.96 150.6 82.91 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.881 2.387 . . . . 0.92000000000000004 110.703 172.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.96 156.37 74.26 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.358 1.463 . . . . 0.57999999999999996 109.976 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.88 -22.69 42.18 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.422 2.082 . . . . 0.66000000000000003 112.417 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -175.2 165.06 3.35 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 125.433 1.493 . . . . 1.8200000000000001 111.729 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.99 171.87 7.27 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.565 1.546 . . . . 0.96999999999999997 109.437 153.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.74 163.6 39.74 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.271 -0.893 . . . . 3.1899999999999999 113.292 165.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.67 129.36 22.69 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 126.093 1.757 . . . . 1.24 109.133 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.64 161.46 43.92 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.483 2.122 . . . . 1.28 111.076 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.12 140.74 91.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.559 2.839 . . . . 1.49 112.251 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp 68.1 -0.24 2.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.711 2.005 . . . . 1.8799999999999999 113.983 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.32 156.8 28.53 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 127.075 2.274 . . . . 1.1899999999999999 112.066 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtt85 -119.88 155.62 32.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.765 2.026 . . . . 6.0499999999999998 111.51 168.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.99 159.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.911 1.684 . . . . 1.3899999999999999 110.256 164.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.27 109.69 12.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.457 1.503 . . . . 4.1799999999999997 107.74 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.09 83.36 0.51 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.245 1.418 . . . . 1.3 109.361 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.55 156.96 36.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.645 1.578 . . . . 3.8700000000000001 112.717 -172.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -59.72 -29.84 90.65 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.116 2.544 . . . . 0.96999999999999997 114.118 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.98 49.57 3.33 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.997 -0.89 . . . . 1.27 111.814 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.88 -71.11 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 115.558 0.983 . . . . 0.91000000000000003 115.558 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -157.63 143.79 17.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.014 2.125 . . . . 1.9299999999999999 110.485 -165.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -168.81 174.26 6.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.235 0.925 . . . . 0.70999999999999996 112.285 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 48.0 m-85 -104.28 136.96 42.9 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.408 0.683 . . . . 2.1899999999999999 111.64 169.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -96.25 121.3 37.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.653 1.181 . . . . 1.1899999999999999 110.029 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.12 108.61 21.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.825 0.85 . . . . 2.6200000000000001 109.809 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.72 65.81 1.03 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.481 1.112 . . . . 2.8799999999999999 110.529 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.82 113.82 1.54 Allowed Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.621 1.582 . . . . 2.0600000000000001 111.229 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -103.34 154.61 19.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.863 1.265 . . . . 1.51 111.195 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -125.38 -26.74 3.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.411 1.485 . . . . 2.3100000000000001 112.371 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -118.14 132.01 23.93 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-O 118.205 -0.902 . . . . 4.8799999999999999 109.077 161.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.17 124.39 11.28 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.939 -1.985 . . . . 1.5700000000000001 106.939 159.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.82 121.94 16.18 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.037 1.335 . . . . 1.9199999999999999 111.089 -161.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -88.29 131.49 34.77 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.743 -1.223 . . . . 4.7199999999999998 109.874 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 119.49 5.89 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.847 -1.168 . . . . 2.02 107.847 153.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.88 -1.6 56.66 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 118.434 -1.203 . . . . 2.6299999999999999 115.158 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.05 151.53 20.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.444 1.622 . . . . 3.1600000000000001 110.532 157.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -112.52 124.97 53.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.417 2.287 . . . . 5.9800000000000004 105.441 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.41 102.88 13.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.827 1.251 . . . . 1.04 108.548 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.64 145.08 50.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.035 -0.53 . . . . 2.8199999999999998 110.5 163.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.817 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.9 tt -158.84 132.81 7.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 2.04 110.409 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.31 112.35 24.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.809 2.043 . . . . 2.2599999999999998 110.141 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.93 118.1 18.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.151 1.38 . . . . 1.6599999999999999 109.987 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.64 117.06 24.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.324 -0.621 . . . . 0.98999999999999999 109.324 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -116.37 121.47 42.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.152 0.797 . . . . 2.4100000000000001 113.152 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.84 28.37 0.13 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.681 2.393 . . . . 2.54 115.867 170.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.47 -61.85 3.87 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.902 1.239 . . . . 3.7000000000000002 112.519 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.51 2.54 29.85 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.99 1.556 . . . . 1.9099999999999999 116.99 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -142.64 148.89 38.17 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.414 1.607 . . . . 5.0099999999999998 112.3 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.62 139.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.851 1.66 . . . . 1.72 109.165 162.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -145.23 135.35 23.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.658 1.183 . . . . 2.5600000000000001 111.01 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -77.22 132.64 38.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.4 0.518 . . . . 2.3700000000000001 112.4 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.8 -179.77 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.45 1.9 . . . . 1.5600000000000001 109.8 159.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.86 148.08 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 127.847 2.459 . . . . 3.1099999999999999 109.461 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -141.77 135.05 14.31 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.29 1.436 . . . . 1.96 110.699 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.68 146.64 43.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.969 2.446 . . . . 1.3400000000000001 112.391 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.1 t -76.84 138.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.597 0.759 . . . . 1.3999999999999999 109.502 165.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -140.45 151.14 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.193 0.597 . . . . 3.2799999999999998 111.386 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.43 60.53 1.17 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.801 1.64 . . . . 2.21 111.41 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG 0.318 2.0 mmp_? . . . . . 0 C--O 1.251 1.146 0 N-CA-C 117.948 2.573 . . . . 5.1500000000000004 117.948 -161.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.152 0 N-CA-C 105.128 -3.189 . . . . 13.51 105.128 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p 159.46 145.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.102 -1.814 . . . . 12.300000000000001 106.102 -129.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -143.04 47.57 1.52 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.433 1.493 . . . . 9.8100000000000005 111.443 -163.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.9 p -73.96 88.47 1.86 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.255 1.022 . . . . 7.4000000000000004 112.251 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.78 131.48 35.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 125.811 1.644 . . . . 6.7599999999999998 110.423 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.78 162.31 33.87 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 120.809 -1.182 . . . . 1.01 114.597 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -146.49 146.47 30.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.668 1.187 . . . . 1.6200000000000001 112.721 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.88 141.04 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.099 0.96 . . . . 1.4299999999999999 108.853 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -77.16 -13.61 59.92 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.677 1.362 . . . . 4.5 114.677 -161.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.8 t80 72.85 147.25 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.077 2.951 . . . . 2.8700000000000001 112.625 -170.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -168.64 140.89 2.26 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.425 1.49 . . . . 3.6299999999999999 111.108 166.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -90.28 -13.19 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.065 3.177 . . . . 3.48 112.43 165.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -101.85 170.19 20.71 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.436 1.493 . . . . 1.75 112.865 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 -16.47 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 124.022 3.148 . . . . 2.2599999999999998 115.397 -166.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.63 141.86 28.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.751 1.159 . . . . 3.0299999999999998 111.458 163.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.76 179.15 7.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.788 1.635 . . . . 1.49 111.625 164.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.28 153.61 51.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.264 1.426 . . . . 1.1399999999999999 110.017 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.49 142.63 50.0 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.121 . . . . 0.95999999999999996 112.21 168.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.45 147.82 41.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 2.1099999999999999 110.55 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -164.36 149.79 10.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.009 0.923 . . . . 1.5700000000000001 112.582 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -81.63 117.57 22.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.895 0.878 . . . . 1.3799999999999999 108.838 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -89.93 135.46 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.162 0.585 . . . . 3.52 110.477 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -124.15 167.69 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.052 1.341 . . . . 3.0299999999999998 109.507 173.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.71 104.71 6.93 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 123.8 0.84 . . . . 1.1699999999999999 109.914 162.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.95 -10.04 10.55 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.993 2.462 . . . . 1.6000000000000001 113.168 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.35 156.79 39.73 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 124.155 0.884 . . . . 1.1399999999999999 112.461 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.06 5.94 38.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.869 1.668 . . . . 2.75 113.391 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.22 158.71 45.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.096 1.758 . . . . 1.78 110.285 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.02 159.53 30.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.164 2.576 . . . . 0.93000000000000005 111.748 -170.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.02 129.22 50.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.999 1.32 . . . . 2.3599999999999999 110.099 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -120.7 112.0 18.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.391 1.476 . . . . 3.02 110.287 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -91.84 123.06 34.94 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.407 1.883 . . . . 0.80000000000000004 108.946 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.93 -11.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.419 1.087 . . . . 0.66000000000000003 113.312 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.42 -161.68 30.82 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.144 0.878 . . . . 0.59999999999999998 111.07 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -154.83 -178.78 7.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.836 1.254 . . . . 0.76000000000000001 110.179 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -152.75 150.74 29.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.612 1.096 . . . . 5.5999999999999996 108.749 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -141.26 146.29 42.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 117.683 -1.151 . . . . 0.88 108.636 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.12 -19.39 66.29 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.106 1.871 . . . . 0.84999999999999998 112.47 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m -82.94 -3.76 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.221 1.193 . . . . 0.92000000000000004 114.221 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.43 177.97 9.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.856 1.207 . . . . 0.84999999999999998 113.688 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -118.9 -87.67 0.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.132 1.373 . . . . 3.2799999999999998 110.421 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -78.74 103.98 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.653 -1.279 . . . . 3.5299999999999998 109.05 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.91 145.41 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.588 1.155 . . . . 1.96 110.931 161.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -143.99 123.52 13.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.773 1.229 . . . . 2.3300000000000001 109.663 164.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.438 HD12 ' CE1' ' A' ' 84' ' ' PHE . 7.0 tt -84.86 120.79 26.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.54 1.518 . . . . 0.72999999999999998 110.997 168.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.3 m170 -107.41 151.88 24.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.535 1.534 . . . . 0.67000000000000004 112.856 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -86.23 166.46 15.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.262 2.225 . . . . 2.4500000000000002 110.801 163.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -150.21 126.79 10.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.387 1.475 . . . . 1.1000000000000001 108.26 170.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -149.34 156.88 42.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.571 0.952 . . . . 2.3799999999999999 113.571 -155.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.8 mtm -107.48 62.22 0.62 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.869 1.668 . . . . 4.4400000000000004 111.981 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -79.42 156.13 28.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.948 -1.023 . . . . 7.4800000000000004 111.121 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.02 164.8 25.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.161 -1.051 . . . . 5.9900000000000002 108.161 158.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.3 t -156.89 -39.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.848 2.059 . . . . 4.0700000000000003 110.986 -164.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -159.09 41.34 0.22 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.115 2.966 . . . . 5.0599999999999996 108.003 -173.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.47 -19.23 0.08 OUTLIER Glycine 0 N--CA 1.479 1.558 0 C-N-CA 128.487 2.946 . . . . 2.04 114.899 -164.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -83.04 134.82 35.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.347 1.459 . . . . 5.4100000000000001 109.804 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -88.93 120.16 30.1 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.507 -0.746 . . . . 4.4400000000000004 110.879 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.88 141.74 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.37 1.468 . . . . 1.76 110.002 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 97.14 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.42 1.088 . . . . 4.2800000000000002 109.753 165.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.75 168.31 12.75 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.462 1.03 . . . . 1.25 112.797 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.56 153.6 47.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.492 1.517 . . . . 2.1800000000000002 110.885 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -161.67 152.41 14.94 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 126.558 1.943 . . . . 6.0800000000000001 110.481 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 39.8 Cg_endo -66.61 143.69 69.47 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.413 2.075 . . . . 0.54000000000000004 111.653 165.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -113.06 157.64 40.18 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.105 1.762 . . . . 0.56999999999999995 110.862 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.33 -14.43 31.18 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.768 2.312 . . . . 0.58999999999999997 113.646 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.92 165.45 1.56 Allowed 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.265 1.826 . . . . 2.2400000000000002 109.914 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.69 167.62 10.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.669 1.587 . . . . 1.0600000000000001 109.359 155.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.94 163.84 31.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.702 1.001 . . . . 2.0800000000000001 113.702 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 139.84 14.53 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.632 1.573 . . . . 1.3500000000000001 109.164 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.63 169.55 14.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.401 2.067 . . . . 1.1000000000000001 111.153 168.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.22 148.58 92.49 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.757 2.305 . . . . 0.93000000000000005 111.869 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt 68.86 -0.62 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.789 2.036 . . . . 1.6399999999999999 114.027 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.83 -168.86 44.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.706 2.098 . . . . 1.45 114.939 -171.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -168.08 144.45 3.96 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.122 2.169 . . . . 5.6200000000000001 110.606 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.4 m -152.14 136.83 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.955 2.102 . . . . 2.0099999999999998 109.241 171.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -88.92 136.5 32.98 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.272 -0.893 . . . . 3.4399999999999999 110.867 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.36 72.72 0.96 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.508 1.147 . . . . 1.1799999999999999 108.444 156.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -85.43 145.9 43.36 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.477 1.911 . . . . 2.7200000000000002 111.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -58.88 -23.54 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.823 2.349 . . . . 1.4299999999999999 113.805 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.29 35.99 4.51 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.926 1.251 . . . . 1.5700000000000001 113.617 171.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.37 -65.01 0.02 OUTLIER Glycine 0 N--CA 1.47 0.956 0 CA-C-N 118.399 1.099 . . . . 0.82999999999999996 115.349 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -150.98 149.13 29.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.176 1.39 . . . . 1.99 111.251 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -157.21 160.6 38.86 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.606 -1.309 . . . . 0.81000000000000005 111.44 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 41.0 m-85 -96.1 120.58 36.63 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.584 -0.525 . . . . 1.9299999999999999 109.584 164.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.82 136.32 33.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.113 0.965 . . . . 1.1599999999999999 108.811 167.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.2 103.88 8.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.394 1.078 . . . . 1.6100000000000001 108.893 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.36 120.0 41.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.496 1.118 . . . . 3.1200000000000001 109.888 -173.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.03 97.43 0.62 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.069 1.318 . . . . 1.53 109.972 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -94.38 122.8 37.31 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.28 1.04 . . . . 1.0900000000000001 110.74 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -71.01 -12.89 61.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.948 0.722 . . . . 1.96 112.948 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 21.2 ptt85 -153.33 139.56 12.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.001 1.72 . . . . 5.9800000000000004 109.868 168.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 145.39 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.175 2.583 . . . . 1.9199999999999999 109.358 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.4 mt -92.3 167.04 12.28 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.045 0.938 . . . . 2.3599999999999999 113.044 -169.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 3.6 mmtm -123.0 156.8 34.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.342 1.457 . . . . 5.4000000000000004 109.143 156.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 131.45 50.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.141 -0.689 . . . . 2.04 109.141 161.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.96 2.54 77.93 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 117.349 -1.806 . . . . 2.3599999999999999 116.48 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 90.4 mt-10 -76.29 167.4 21.92 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.404 2.102 . . . . 3.3399999999999999 110.364 169.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -85.6 154.08 21.96 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.023 1.329 . . . . 5.4500000000000002 112.183 165.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.0 t -130.14 116.91 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.25 1.82 . . . . 1.02 109.414 163.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -71.1 140.21 50.57 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.455 -1.248 . . . . 3.7799999999999998 109.804 161.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 132.21 14.44 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.907 0.706 . . . . 1.75 112.907 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.95 132.54 33.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.396 0.678 . . . . 2.3999999999999999 109.533 159.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.16 118.19 31.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.994 1.318 . . . . 1.3100000000000001 109.569 158.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.2 mt -95.05 131.38 41.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.417 1.087 . . . . 0.81999999999999995 111.643 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -120.27 159.5 24.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.339 1.056 . . . . 2.1099999999999999 112.418 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.86 118.31 7.04 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.255 0.835 . . . . 1.96 113.255 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.18 -147.84 29.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.048 0.832 . . . . 2.9500000000000002 111.364 -173.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.57 56.09 4.71 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-O 119.175 -0.792 . . . . 1.8899999999999999 114.365 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -131.81 137.92 48.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.335 1.568 . . . . 4.9100000000000001 110.675 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.11 145.09 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.44 1.496 . . . . 1.48 108.915 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.0 mt -127.53 110.2 12.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.715 1.206 . . . . 2.3399999999999999 109.908 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.63 105.86 11.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.343 0.657 . . . . 4.2699999999999996 109.851 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m -105.82 -175.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.358 2.263 . . . . 1.1799999999999999 111.199 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.3 143.82 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.25 1.42 . . . . 2.1499999999999999 109.072 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.7 mt -136.14 154.6 77.49 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.072 1.749 . . . . 1.74 109.813 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.44 154.53 27.9 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.352 2.701 . . . . 0.98999999999999999 111.272 161.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.0 t -85.89 142.12 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.359 1.863 . . . . 1.3600000000000001 108.368 159.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -122.7 -145.18 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.995 2.118 . . . . 3.4399999999999999 108.101 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.5 113.14 3.6 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 121.059 1.754 . . . . 1.99 111.592 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 C-N-CA 127.819 2.448 . . . . 4.4900000000000002 110.813 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.336 0 N-CA-C 108.173 -1.971 . . . . 11.800000000000001 108.173 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.53 145.81 37.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.822 1.311 . . . . 10.609999999999999 111.825 165.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -122.71 30.54 6.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.633 1.173 . . . . 11.300000000000001 111.513 172.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.11 167.94 2.76 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 129.08 2.952 . . . . 6.8700000000000001 112.003 177.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.55 -179.71 5.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.055 -0.403 . . . . 6.4500000000000002 110.042 152.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.14 169.49 34.92 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.634 0.635 . . . . 1.8200000000000001 114.132 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.402 ' CD1' ' HG3' ' A' ' 120' ' ' ARG . 44.6 p90 -155.91 152.36 28.18 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.677 0.791 . . . . 2.75 110.818 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -117.46 148.59 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.071 0.948 . . . . 1.04 110.23 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.23 111.24 22.83 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.869 -1.144 . . . . 3.9199999999999999 113.629 -152.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -66.28 104.82 1.27 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 3.23 111.158 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -155.79 130.57 5.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 117.559 -1.21 . . . . 2.4700000000000002 109.913 158.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.27 75.12 5.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.818 3.012 . . . . 2.9500000000000002 110.303 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.55 168.11 13.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.796 1.188 . . . . 2.1000000000000001 112.982 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.87 -31.97 46.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.423 2.082 . . . . 2.2799999999999998 110.541 167.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -113.2 152.93 29.12 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.537 1.935 . . . . 2.6899999999999999 111.932 162.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.78 -158.1 0.88 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.651 2.38 . . . . 1.23 108.116 168.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.67 160.15 40.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.321 1.419 . . . . 1.5600000000000001 113.682 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.54 149.88 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.791 1.636 . . . . 1.3700000000000001 110.54 164.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.4 175.21 9.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.543 1.537 . . . . 2.4500000000000002 110.796 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -175.01 148.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.21 1.404 . . . . 1.99 112.358 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.3 m -116.6 122.41 44.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.613 -1.625 . . . . 2.1800000000000002 106.613 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.33 139.33 11.87 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.673 0.789 . . . . 4.2000000000000002 110.392 -158.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 1.4 pm0 -109.2 147.86 31.87 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.833 1.653 . . . . 2.79 113.822 175.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -85.56 112.6 45.61 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 114.109 -1.405 . . . . 0.80000000000000004 109.646 154.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.42 -10.26 12.23 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.099 2.533 . . . . 1.1299999999999999 113.534 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.86 -179.55 53.04 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.19 0.9 . . . . 0.91000000000000003 113.767 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -109.97 -4.23 16.05 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.955 1.702 . . . . 2.5499999999999998 113.011 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.77 159.25 34.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.832 1.653 . . . . 1.9099999999999999 110.031 165.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.88 152.53 16.88 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.089 2.526 . . . . 1.4399999999999999 111.543 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.87 157.62 15.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.414 1.085 . . . . 1.8500000000000001 111.247 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' HE ' ' HB3' ' A' ' 106' ' ' ALA . 44.0 ttp180 -142.09 109.05 5.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.299 1.44 . . . . 4.6399999999999997 110.476 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.6 tp -95.98 113.98 25.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.449 2.3 . . . . 0.71999999999999997 109.696 -168.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.06 -12.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.977 1.311 . . . . 1.3 113.166 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.26 -158.7 28.44 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 121.303 -0.873 . . . . 0.53000000000000003 113.394 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.06 -177.56 5.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.106 0.962 . . . . 0.95999999999999996 111.106 166.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -142.76 136.23 28.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.555 1.142 . . . . 8.1400000000000006 108.491 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -141.14 147.61 48.11 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.225 1.41 . . . . 0.87 108.938 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.55 -23.19 32.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.628 1.552 . . . . 1.24 112.855 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.14 5.39 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 115.378 1.621 . . . . 1.0600000000000001 115.378 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.97 44.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.193 1.36 . . . . 1.4199999999999999 113.2 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.82 -50.56 72.88 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.841 1.656 . . . . 6.5599999999999996 109.528 165.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -144.45 155.19 43.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.764 1.626 . . . . 4.4199999999999999 109.122 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.85 128.92 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 125.202 1.401 . . . . 1.22 108.482 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -130.2 124.62 32.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.954 1.702 . . . . 2.0800000000000001 108.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -80.12 119.82 23.43 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.254 1.388 . . . . 0.82999999999999996 110.998 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.5 m170 -108.76 157.3 18.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.985 1.714 . . . . 0.83999999999999997 111.948 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -111.1 -177.64 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.943 1.697 . . . . 2.4399999999999999 111.75 171.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.5 m -123.22 120.94 34.64 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.22 -1.03 . . . . 1.4199999999999999 108.22 156.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -100.41 165.47 11.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.782 1.233 . . . . 2.3100000000000001 111.248 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtm -129.42 134.7 47.98 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.536 1.134 . . . . 3.7999999999999998 109.234 163.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.9 146.16 24.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.724 1.21 . . . . 7.0800000000000001 110.696 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.08 136.81 41.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.91 0.386 . . . . 3.5699999999999998 110.965 175.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.07 -95.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.308 -1.367 . . . . 2.46 107.308 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -79.36 74.93 5.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.498 1.119 . . . . 4.1799999999999997 108.51 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.03 -11.68 0.04 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 128.874 3.13 . . . . 2.0499999999999998 118.022 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -124.25 153.5 41.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.489 1.916 . . . . 4.4199999999999999 110.94 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -70.47 97.7 1.33 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.12 0.568 . . . . 4.3099999999999996 112.105 -179.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -79.83 132.61 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 125.265 1.426 . . . . 1.48 107.864 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.5 ptp -91.8 145.27 24.71 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.896 0.878 . . . . 3.04 111.183 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.13 166.84 35.87 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 123.908 0.766 . . . . 1.0700000000000001 112.97 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.3 150.82 38.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.59 1.156 . . . . 1.8200000000000001 111.419 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 mtp85 -163.74 155.65 14.78 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.423 1.489 . . . . 7.1500000000000004 111.388 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 17.9 Cg_endo -64.93 143.38 79.16 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.597 2.198 . . . . 0.88 110.898 169.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.5 155.29 54.35 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.928 1.691 . . . . 0.69999999999999996 110.543 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.36 -23.85 32.15 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.674 2.249 . . . . 0.82999999999999996 112.617 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -173.71 168.81 4.33 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.239 1.416 . . . . 1.72 111.059 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -119.76 174.47 6.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.279 2.232 . . . . 1.0800000000000001 109.334 162.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.34 168.57 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.399 -0.813 . . . . 3.2200000000000002 111.251 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 t -147.36 129.58 7.62 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 125.202 1.401 . . . . 1.1200000000000001 108.647 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.37 163.69 35.73 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.185 1.924 . . . . 1.3200000000000001 111.942 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.19 139.34 71.8 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.917 3.078 . . . . 1.05 111.945 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.29 17.97 5.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 116.063 1.875 . . . . 2.0 116.063 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.23 116.82 5.46 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 128.151 2.786 . . . . 0.98999999999999999 111.984 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 2.0 ttm-85 -90.4 130.96 36.42 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 5.3700000000000001 111.738 163.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.4 m -121.32 171.32 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 2.0899999999999999 111.545 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -148.28 125.5 11.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.14 1.376 . . . . 4.6799999999999997 110.685 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -82.51 153.63 25.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.526 1.155 . . . . 1.8500000000000001 110.836 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 7.3 ptpt -170.65 149.26 2.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.006 1.723 . . . . 4.0 111.817 -165.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -49.44 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.118 2.545 . . . . 2.0899999999999999 111.293 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 96.42 0.91 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 107.625 -2.19 . . . . 2.3500000000000001 107.625 156.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.76 -155.73 17.15 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.745 2.116 . . . . 2.8300000000000001 112.034 -163.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -92.42 140.01 30.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.822 1.249 . . . . 2.3999999999999999 112.204 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -161.19 154.14 21.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.482 0.713 . . . . 0.78000000000000003 109.484 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -94.58 120.39 34.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.629 -0.878 . . . . 1.98 108.629 173.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -68.75 130.5 43.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.152 -0.684 . . . . 1.0900000000000001 109.152 165.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -106.03 118.99 38.03 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.017 -1.105 . . . . 1.99 108.017 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.24 152.4 24.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 3.0499999999999998 109.834 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.82 67.6 2.02 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 124.652 1.12 . . . . 1.7 112.72 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.91 111.14 2.7 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.904 1.075 . . . . 1.26 113.904 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -80.38 -25.19 39.27 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.999 1.32 . . . . 1.9299999999999999 112.505 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -119.78 126.65 26.81 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 106.044 -1.835 . . . . 4.21 106.044 149.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -64.35 136.89 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 N-CA-C 107.167 -1.897 . . . . 1.6899999999999999 107.167 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.71 63.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.776 0.83 . . . . 2.5099999999999998 112.467 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 121.95 7.22 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.705 1.602 . . . . 3.6499999999999999 108.793 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.95 120.74 1.87 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.637 1.108 . . . . 1.47 112.113 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 42.02 47.38 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.491 -0.616 . . . . 2.2799999999999998 114.325 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -76.14 171.7 14.05 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.252 1.526 . . . . 2.7400000000000002 108.002 146.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -105.63 150.61 25.28 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.067 1.347 . . . . 4.9800000000000004 107.77 160.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.92 119.22 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.162 0.985 . . . . 1.1299999999999999 110.663 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.82 137.7 40.66 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.153 1.781 . . . . 2.9399999999999999 110.316 165.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mt -155.98 133.48 10.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.043 0.925 . . . . 1.52 111.948 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -115.28 101.67 9.16 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.337 1.455 . . . . 2.0800000000000001 110.799 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 119.86 22.92 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.253 1.421 . . . . 1.4099999999999999 111.032 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.57 123.2 36.72 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.616 1.166 . . . . 0.77000000000000002 111.498 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.15 135.62 53.75 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.045 0.926 . . . . 1.77 112.501 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.457 ' HB3' ' HE ' ' A' ' 31' ' ' ARG . . . -78.45 63.6 3.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.722 1.609 . . . . 2.7599999999999998 112.917 -175.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.42 33.15 0.09 OUTLIER Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.708 2.099 . . . . 4.8399999999999999 113.956 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.61 -0.13 77.66 Favored Glycine 0 N--CA 1.476 1.342 0 CA-C-N 118.284 1.042 . . . . 1.95 114.652 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -97.86 151.1 20.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 122.629 1.204 . . . . 6.5899999999999999 113.856 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.05 151.41 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.991 2.117 . . . . 1.4099999999999999 107.617 154.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.96 119.68 32.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.447 1.099 . . . . 2.25 109.283 167.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -74.31 133.9 42.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.289 0.236 . . . . 2.7799999999999998 110.414 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.26 145.33 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.92 1.688 . . . . 1.48 109.493 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -125.05 125.19 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.666 0.786 . . . . 2.75 110.03 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 155.92 56.03 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.396 1.479 . . . . 3.3399999999999999 111.076 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.54 164.48 32.28 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.735 2.957 . . . . 1.46 111.626 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.39 142.14 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.384 1.074 . . . . 1.1899999999999999 111.823 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -145.66 162.06 38.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.961 1.705 . . . . 3.9900000000000002 113.008 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.59 62.57 2.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.012 1.725 . . . . 2.5 111.987 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 2.8 mmp_? . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.473 -1.727 . . . . 4.4100000000000001 111.315 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.168 0 N-CA-C 108.725 -1.75 . . . . 13.039999999999999 108.725 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 p -175.49 45.9 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.733 2.013 . . . . 13.5 108.193 -167.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 81.47 146.39 0.08 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 128.922 2.889 . . . . 14.609999999999999 110.085 -134.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -169.48 -41.6 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.42 2.288 . . . . 7.8600000000000003 109.182 -161.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.13 167.06 5.3 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.841 0.856 . . . . 5.3300000000000001 110.048 150.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -79.52 157.31 42.07 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 123.377 0.513 . . . . 1.21 112.371 176.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -154.75 139.19 16.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.02 0.748 . . . . 1.3500000000000001 113.02 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.5 t -93.2 132.56 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.606 -0.516 . . . . 1.3 109.606 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -78.22 114.43 17.1 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.325 1.05 . . . . 4.3200000000000003 112.022 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -79.97 146.98 31.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.086 0.946 . . . . 3.8100000000000001 110.469 159.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.44 152.63 4.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.474 1.51 . . . . 2.7200000000000002 110.957 169.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.95 75.55 3.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.076 3.184 . . . . 3.3100000000000001 109.776 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.42 -179.67 34.4 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.671 1.028 . . . . 1.72 115.671 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.66 -15.92 19.07 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.833 3.022 . . . . 2.4399999999999999 112.877 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -147.77 160.54 42.62 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 115.077 1.51 . . . . 2.5800000000000001 115.077 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.83 -168.39 2.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.252 2.221 . . . . 1.22 110.861 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 147.46 32.37 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.235 1.014 . . . . 1.5700000000000001 112.439 -174.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.19 118.45 36.82 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.987 0.358 . . . . 1.6699999999999999 110.232 159.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -101.18 142.57 32.43 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.01 1.724 . . . . 2.5099999999999998 108.547 164.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.7 pp -164.1 149.64 10.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.167 1.914 . . . . 1.96 116.167 -168.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.3 m -115.08 138.43 50.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.529 1.532 . . . . 2.0099999999999998 109.771 -173.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.11 -179.85 8.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.308 1.843 . . . . 5.2599999999999998 110.444 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.76 159.87 43.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.81 0.844 . . . . 4.9000000000000004 110.106 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.81 102.63 10.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.296 -0.865 . . . . 1.3 109.506 163.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.13 -7.12 17.07 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.875 2.383 . . . . 1.5600000000000001 113.197 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.11 177.36 54.36 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 124.325 0.964 . . . . 1.4099999999999999 113.72 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -107.96 1.6 22.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.346 1.458 . . . . 2.5600000000000001 112.664 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -115.2 162.71 22.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.431 1.893 . . . . 1.8899999999999999 109.616 164.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.14 157.8 20.23 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.685 2.257 . . . . 1.1599999999999999 111.489 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -105.77 153.52 21.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 2.2200000000000002 110.1 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -134.35 115.08 13.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.486 1.115 . . . . 3.6200000000000001 111.229 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.68 112.03 23.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.213 2.605 . . . . 0.63 108.601 -174.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.92 -10.11 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.834 1.254 . . . . 0.65000000000000002 113.316 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.01 -173.95 46.09 Favored Glycine 0 C--N 1.342 0.883 0 O-C-N 121.543 -0.723 . . . . 0.56000000000000005 112.116 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -143.18 178.83 7.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.836 1.254 . . . . 0.95999999999999996 110.306 170.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.35 142.41 3.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.187 -1.042 . . . . 4.9199999999999999 108.187 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -150.78 155.26 35.56 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 117.261 -1.352 . . . . 0.89000000000000001 108.274 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.61 -14.72 41.59 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.171 1.914 . . . . 1.2 114.246 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.63 0.19 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.991 1.849 . . . . 1.1399999999999999 115.991 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.62 144.35 44.02 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 121.261 1.846 . . . . 1.3300000000000001 114.808 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -89.29 -76.37 0.41 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.921 1.288 . . . . 3.5800000000000001 110.259 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.3 ttm-85 -80.89 127.84 33.0 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.107 -0.995 . . . . 4.2800000000000002 108.803 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.0 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 1.5600000000000001 110.322 167.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -144.59 133.49 22.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.823 1.649 . . . . 2.4300000000000002 110.924 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -79.31 119.25 22.09 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 120.055 1.298 . . . . 0.85999999999999999 111.027 170.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.1 m170 -110.58 156.02 21.52 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.756 2.022 . . . . 0.60999999999999999 111.795 175.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.29 -175.38 2.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.413 . . . . 2.8500000000000001 111.978 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -132.77 118.05 18.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.698 1.599 . . . . 1.47 108.441 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -115.99 179.05 4.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.436 1.094 . . . . 2.0899999999999999 111.098 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.3 ptp -143.21 128.88 19.24 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.549 0.74 . . . . 4.2000000000000002 111.57 162.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -138.27 149.58 45.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.257 1.023 . . . . 6.5700000000000003 112.111 -173.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 52' ' ' GLU 0.33 1.4 pm0 -64.92 146.84 54.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.026 1.731 . . . . 4.7400000000000002 113.792 172.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.69 HG13 ' H ' ' A' ' 54' ' ' GLU 0.29 6.7 p -135.7 -86.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.811 2.044 . . . . 2.8599999999999999 109.198 176.385 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.69 ' H ' HG13 ' A' ' 53' ' ' VAL . 16.2 mt-10 -77.11 41.43 0.29 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.703 2.001 . . . . 3.6899999999999999 110.736 165.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.51 -38.66 0.87 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.152 1.358 . . . . 2.29 113.767 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -61.39 133.8 56.21 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.12 1.368 . . . . 3.04 110.972 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -91.34 103.34 16.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.409 0.683 . . . . 5.7000000000000002 110.884 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -99.21 141.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.028 1.731 . . . . 1.79 109.911 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.43 153.59 29.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.677 1.591 . . . . 3.6800000000000002 112.336 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.72 161.16 33.98 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 121.822 -0.549 . . . . 1.23 114.396 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -113.62 137.03 52.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.449 1.5 . . . . 2.21 111.164 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -150.57 156.64 36.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.359 1.463 . . . . 6.1799999999999997 110.227 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 32.8 Cg_endo -65.92 152.0 82.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.703 2.268 . . . . 0.88 111.641 171.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.78 157.36 69.1 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 126.181 1.792 . . . . 0.73999999999999999 109.659 173.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.14 -18.17 40.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.784 2.322 . . . . 0.95999999999999996 113.237 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -179.15 167.21 1.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.819 2.047 . . . . 2.1099999999999999 110.755 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -113.8 166.73 11.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.975 1.71 . . . . 1.0 109.264 155.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 163.83 39.14 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.115 -0.991 . . . . 2.4500000000000002 111.683 174.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.08 128.77 10.18 Favored Pre-proline 0 N--CA 1.466 0.354 0 C-N-CA 125.073 1.349 . . . . 1.02 109.609 -161.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.53 163.61 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.938 . . . . 0.79000000000000004 111.554 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.38 138.49 84.63 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.516 2.811 . . . . 0.95999999999999996 111.935 172.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm 68.34 7.2 5.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.977 2.111 . . . . 1.6200000000000001 113.456 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.57 113.16 3.62 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.79 1.662 . . . . 0.96999999999999997 112.252 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 136.93 37.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.513 -0.844 . . . . 5.5099999999999998 110.456 165.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.06 159.74 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.319 1.447 . . . . 3.0099999999999998 111.808 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -154.98 92.59 1.46 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.731 1.613 . . . . 3.6699999999999999 108.079 -170.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.67 139.07 57.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.397 1.079 . . . . 2.0600000000000001 108.649 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -158.9 156.52 26.87 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 127.349 2.26 . . . . 3.3799999999999999 111.237 -163.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.2 -64.17 0.1 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.918 3.079 . . . . 1.3899999999999999 112.088 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.19 91.52 1.03 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.022 -1.631 . . . . 1.97 109.022 166.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.33 -98.91 0.18 Allowed Glycine 0 C--O 1.221 -0.664 0 C-N-CA 124.707 1.146 . . . . 1.24 112.424 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -153.58 136.59 15.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.183 1.393 . . . . 2.1600000000000001 110.299 -172.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -165.62 166.71 17.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.267 1.394 . . . . 1.55 110.806 -170.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 92.6 m-85 -102.77 116.19 32.07 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 119.282 -0.39 . . . . 2.2999999999999998 110.18 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -68.31 127.69 33.87 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.663 -0.495 . . . . 0.93000000000000005 109.663 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 mt -112.81 111.01 21.49 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.907 -1.516 . . . . 1.53 106.907 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.47 116.55 25.66 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.66 -0.867 . . . . 3.4700000000000002 108.66 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.82 112.77 0.49 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.09 -1.204 . . . . 1.8799999999999999 110.09 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -110.16 113.94 27.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.162 0.985 . . . . 1.01 111.789 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.95 -11.84 60.97 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.829 1.251 . . . . 1.8700000000000001 114.209 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -153.89 145.73 16.9 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.1 1.36 . . . . 5.7699999999999996 109.998 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.69 132.42 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.202 1.935 . . . . 2.0499999999999998 109.288 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.2 169.18 12.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.819 1.648 . . . . 2.6600000000000001 112.321 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.03 145.04 43.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.213 1.005 . . . . 4.5 110.192 155.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.62 19.95 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.676 -0.861 . . . . 2.0299999999999998 108.676 160.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.39 78.11 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 117.901 -1.499 . . . . 2.71 115.83 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -74.4 175.24 7.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.233 2.016 . . . . 2.3999999999999999 109.449 158.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -91.95 155.85 17.86 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.297 1.046 . . . . 4.4699999999999998 111.387 152.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.02 127.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.93 -1.507 . . . . 1.3400000000000001 106.93 151.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.86 155.18 20.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.953 0.882 . . . . 4.1100000000000003 111.277 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.788 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.8 tt -163.25 129.97 3.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.308 -0.87 . . . . 1.6899999999999999 112.028 -152.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -78.12 105.41 9.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.325 3.05 . . . . 2.6899999999999999 111.494 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.1 mt -79.42 119.4 22.38 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.113 -0.992 . . . . 1.0600000000000001 109.343 171.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.1 mt -96.92 126.07 41.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.565 1.146 . . . . 0.70999999999999996 111.554 -168.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.22 158.27 22.53 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.438 -0.789 . . . . 2.1699999999999999 112.929 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.39 63.7 0.79 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.819 1.648 . . . . 2.04 113.311 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 148.73 -149.65 21.7 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.39 1.472 . . . . 2.79 111.649 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.51 43.83 1.63 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.748 1.166 . . . . 2.0600000000000001 115.038 -173.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -140.6 137.75 33.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.888 1.344 . . . . 5.1100000000000003 113.987 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.75 132.35 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 127.438 2.295 . . . . 1.0600000000000001 108.66 169.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.97 102.22 8.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.229 1.412 . . . . 2.46 109.407 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 74.26 6.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.857 0.863 . . . . 2.7400000000000002 111.157 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.75 159.32 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.037 1.335 . . . . 1.6299999999999999 112.079 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 m -100.25 139.12 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 126.636 1.974 . . . . 3.27 109.602 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.1 mt -143.24 135.46 13.28 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.549 1.14 . . . . 1.8700000000000001 109.18 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.09 162.61 41.58 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.908 2.406 . . . . 1.5700000000000001 111.474 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.36 145.83 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 1.51 111.318 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.77 156.35 44.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.042 1.737 . . . . 3.6800000000000002 109.302 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.73 41.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.45 1.5 . . . . 2.71 113.1 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 117.516 -1.23 . . . . 5.0899999999999999 112.974 -152.639 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 109.784 -1.326 . . . . 11.800000000000001 109.784 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 t -162.58 165.18 26.26 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.143 1.377 . . . . 9.7699999999999996 109.438 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -85.92 62.76 7.65 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.126 1.371 . . . . 9.2799999999999994 111.76 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 p -77.68 157.99 29.89 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.197 -0.668 . . . . 6.9199999999999999 109.197 166.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.48 -150.89 0.32 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.142 0.977 . . . . 5.6500000000000004 109.372 -174.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.72 122.08 1.09 Allowed Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.585 1.539 . . . . 1.75 114.299 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -111.56 149.21 31.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.942 0.897 . . . . 2.1200000000000001 111.145 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.57 140.29 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.712 -0.847 . . . . 1.28 108.712 169.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 117.1 29.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 3.9100000000000001 112.953 -151.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.45 124.66 24.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.676 0.79 . . . . 2.73 110.983 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -160.68 141.03 8.49 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.621 1.169 . . . . 2.3599999999999999 110.273 165.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -83.75 65.98 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.06 3.173 . . . . 2.6200000000000001 109.401 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.76 171.29 14.7 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.385 0.993 . . . . 1.55 113.467 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.05 -20.79 28.38 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.186 2.591 . . . . 2.0299999999999998 111.305 164.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -151.36 169.6 21.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.439 1.896 . . . . 2.3500000000000001 112.315 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.14 157.55 43.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.83 1.652 . . . . 1.24 110.073 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.55 116.24 28.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.399 1.08 . . . . 2.1200000000000001 109.524 167.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.81 162.22 13.36 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.383 1.473 . . . . 1.3200000000000001 111.428 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.44 164.14 28.85 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.265 1.426 . . . . 2.6400000000000001 111.616 -171.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -166.7 159.01 13.56 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.977 1.311 . . . . 1.6200000000000001 113.505 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -80.1 141.4 35.83 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.914 -0.773 . . . . 1.24 108.914 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -130.7 129.98 43.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.26 2.224 . . . . 2.1400000000000001 108.351 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 74' ' ' ARG . 3.4 pm0 -113.9 129.28 56.61 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.335 1.454 . . . . 3.3399999999999999 110.738 171.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -86.68 110.97 36.52 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 155.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -86.7 -9.5 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.792 2.328 . . . . 1.2 113.916 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.2 167.84 31.9 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.176 0.898 . . . . 1.1000000000000001 113.197 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -87.73 -1.14 57.77 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.471 1.509 . . . . 3.3900000000000001 114.322 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.8 159.34 36.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.067 1.347 . . . . 1.8400000000000001 110.454 169.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.98 151.76 18.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.836 2.357 . . . . 1.3600000000000001 111.647 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 mt -100.98 155.64 17.85 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.085 0.954 . . . . 1.8400000000000001 111.19 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -132.21 110.75 10.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.041 1.337 . . . . 3.0699999999999998 109.797 169.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.5 tp -95.06 112.48 24.18 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 127.581 2.353 . . . . 0.72999999999999998 107.807 -175.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.88 -11.12 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.904 0.881 . . . . 0.57999999999999996 112.883 -166.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.36 -164.89 34.96 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.511 1.053 . . . . 0.48999999999999999 112.033 173.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.86 -179.14 6.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.225 1.01 . . . . 0.73999999999999999 110.012 164.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -155.9 141.24 17.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.83 1.252 . . . . 5.4500000000000002 108.963 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 t -151.43 156.1 34.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 119.501 1.046 . . . . 0.75 110.69 -165.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.36 -17.23 18.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.706 2.271 . . . . 0.96999999999999997 113.974 168.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -85.33 -23.78 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.954 1.465 . . . . 1.02 114.954 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.52 152.33 50.83 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.703 1.201 . . . . 0.94999999999999996 112.252 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 10.1 tp10 -86.45 -88.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.003 -0.544 . . . . 2.8700000000000001 110.037 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -82.24 90.45 6.62 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.714 -0.847 . . . . 3.5499999999999998 108.714 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.99 137.38 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.576 0.75 . . . . 1.3899999999999999 111.076 166.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -137.18 140.02 41.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.296 1.839 . . . . 2.2000000000000002 109.708 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -88.16 122.11 31.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.553 -1.342 . . . . 0.83999999999999997 111.674 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.4 m170 -109.46 156.36 20.18 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.287 1.435 . . . . 0.65000000000000002 112.541 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.8 -178.67 3.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.316 1.846 . . . . 1.9299999999999999 112.023 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.0 m -138.1 100.78 4.24 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.969 1.708 . . . . 1.3200000000000001 108.033 163.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -92.24 153.31 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.864 1.266 . . . . 2.3300000000000001 111.778 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptp -89.23 156.97 18.43 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.306 -0.871 . . . . 4.1500000000000004 111.972 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -163.31 153.11 15.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.872 1.269 . . . . 9.7300000000000004 112.887 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -81.54 176.43 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.889 0.876 . . . . 3.6600000000000001 110.698 154.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.19 -121.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 126.152 1.781 . . . . 3.1299999999999999 106.571 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.403 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 11.9 tt0 -73.35 62.52 0.71 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.559 2.343 . . . . 3.6200000000000001 110.131 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.05 2.06 6.19 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.307 1.432 . . . . 2.0499999999999998 115.291 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 13.4 ptpt -111.02 129.86 55.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.812 2.445 . . . . 2.6400000000000001 110.21 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.438 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -100.19 144.37 29.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.76 0.824 . . . . 5.5499999999999998 112.466 -167.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -152.5 162.14 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.672 1.589 . . . . 2.1099999999999999 109.374 -166.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.5 ptp -84.38 171.37 12.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.752 0.821 . . . . 3.5 112.012 161.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.16 148.95 19.99 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.492 1.52 . . . . 1.52 110.767 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -112.34 155.52 23.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.322 1.049 . . . . 1.98 110.24 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -168.39 158.87 8.7 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 126.471 1.909 . . . . 4.8700000000000001 108.927 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.2 Cg_endo -67.89 154.52 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 120.967 1.112 . . . . 0.73999999999999999 110.343 159.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.94 156.39 65.77 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 125.284 1.433 . . . . 0.69999999999999996 109.819 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.28 -16.54 39.64 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.613 2.209 . . . . 0.76000000000000001 112.833 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -178.79 167.49 1.7 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.716 1.606 . . . . 1.9299999999999999 110.593 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -117.47 172.3 7.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.201 2.2 . . . . 1.1499999999999999 109.165 159.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.6 161.11 41.76 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.011 -1.056 . . . . 2.1600000000000001 111.15 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -146.9 129.92 8.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.442 0.697 . . . . 0.95999999999999996 110.648 -167.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.17 162.46 38.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.056 2.504 . . . . 1.25 112.315 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.05 136.29 64.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 124.457 3.438 . . . . 1.28 113.356 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 64.07 2.58 1.46 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 1.96 113.794 -174.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.6 116.03 4.29 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 127.284 2.373 . . . . 0.97999999999999998 110.724 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 8.2 ttt180 -102.92 130.42 49.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.092 1.357 . . . . 5.29 110.275 164.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -147.74 152.66 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.519 1.528 . . . . 2.1499999999999999 111.338 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 130.86 48.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.873 0.869 . . . . 3.3700000000000001 112.132 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.97 78.03 0.32 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.152 1.381 . . . . 1.1799999999999999 108.067 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -81.05 146.92 60.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 2.6899999999999999 111.095 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.38 -50.85 12.64 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.52 2.813 . . . . 0.91000000000000003 113.141 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.31 67.63 3.66 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.84 -0.904 . . . . 1.0700000000000001 110.84 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.05 -78.32 0.07 OUTLIER Glycine 0 N--CA 1.466 0.694 0 C-N-CA 124.975 1.274 . . . . 0.81999999999999995 112.807 -170.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -156.51 143.04 18.46 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.141 2.176 . . . . 1.8100000000000001 109.632 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -169.76 159.11 7.87 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.895 -1.128 . . . . 0.87 110.882 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -97.56 121.38 39.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.396 0.678 . . . . 2.1800000000000002 112.028 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.8 mmt -79.25 123.64 27.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.2 1.0 . . . . 0.97999999999999998 109.557 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -104.64 79.33 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.36 1.464 . . . . 1.8799999999999999 110.485 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -78.9 128.32 33.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.626 1.103 . . . . 2.6099999999999999 109.538 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.88 74.74 0.9 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.857 -0.897 . . . . 1.3100000000000001 110.857 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.1 89.94 3.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.739 1.269 . . . . 1.5 110.774 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 3.0 ptmt -55.44 -9.14 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.487 1.515 . . . . 1.9099999999999999 114.091 171.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -136.84 135.58 20.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.877 1.671 . . . . 5.4100000000000001 108.847 167.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 141.81 40.77 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.126 1.884 . . . . 1.53 109.115 165.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.0 81.92 7.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.567 1.147 . . . . 2.0099999999999998 110.473 -172.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.476 ' HZ2' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -70.22 108.73 4.29 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.564 -1.335 . . . . 3.7200000000000002 109.605 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -43.07 124.98 3.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.797 0.839 . . . . 1.4399999999999999 111.392 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.65 -22.06 15.52 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 115.984 -2.565 . . . . 2.1699999999999999 116.492 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.476 ' CD ' ' HZ2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -86.43 177.19 7.51 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.387 2.593 . . . . 4.2800000000000002 111.98 -177.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -96.58 132.29 42.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.373 1.869 . . . . 4.8499999999999996 112.651 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.0 t -102.5 116.34 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.849 -1.157 . . . . 1.1100000000000001 108.891 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.92 143.8 35.49 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.047 0.927 . . . . 3.0800000000000001 110.557 160.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 117.56 5.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.743 0.817 . . . . 1.72 110.952 -168.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -81.53 95.58 7.16 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.164 2.186 . . . . 2.8199999999999998 110.377 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.8 mt -72.39 119.2 16.26 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.478 -0.764 . . . . 1.3 109.936 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.3 mt -95.4 132.19 40.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.032 0.933 . . . . 0.63 111.249 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.24 147.09 52.55 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.434 1.111 . . . . 1.99 112.73 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.08 136.72 56.36 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.034 1.124 . . . . 2.1200000000000001 114.034 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 48.93 13.66 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.971 0.796 . . . . 3.8100000000000001 113.63 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.46 23.8 55.57 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 115.951 1.14 . . . . 1.76 115.951 168.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -108.52 146.21 33.57 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.809 1.804 . . . . 4.4400000000000004 111.973 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.93 137.59 13.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.783 2.033 . . . . 1.1200000000000001 107.761 166.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -128.77 109.99 11.78 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.686 1.194 . . . . 1.6200000000000001 108.605 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -81.78 126.91 32.4 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.663 -0.648 . . . . 2.7799999999999998 111.88 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.1 m -118.95 167.3 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.287 1.835 . . . . 1.6000000000000001 110.259 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -116.08 139.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.839 1.255 . . . . 2.0800000000000001 110.416 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.3 mt -140.11 136.83 17.38 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 127.495 2.318 . . . . 1.5700000000000001 108.005 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.86 154.94 48.67 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.803 2.335 . . . . 1.3700000000000001 112.059 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.29 123.22 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.848 1.259 . . . . 1.5800000000000001 109.48 168.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.68 166.74 32.53 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.546 1.138 . . . . 3.6000000000000001 111.712 -174.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.53 84.84 2.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.74 1.216 . . . . 2.52 113.923 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.013 -1.106 . . . . 6.1900000000000004 108.013 148.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.423 ' HA3' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 110.639 -0.984 . . . . 9.1799999999999997 110.639 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -98.51 56.25 1.13 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.178 -1.045 . . . . 11.449999999999999 108.178 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 65.97 -59.17 0.32 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.553 2.341 . . . . 11.25 111.085 -157.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.2 p -49.75 141.41 10.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 128.475 2.71 . . . . 7.6500000000000004 113.117 160.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HG2' ' HA3' ' A' ' 1' ' ' GLY . 28.1 mt-10 -151.46 161.42 42.72 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.658 2.383 . . . . 5.1399999999999997 109.779 169.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.34 -175.21 43.7 Favored Glycine 0 N--CA 1.464 0.52 0 O-C-N 121.116 -0.99 . . . . 1.48 112.061 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -161.12 154.14 21.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.932 1.086 . . . . 1.6699999999999999 113.932 174.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.48 140.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.762 0.825 . . . . 1.23 109.33 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -87.11 110.94 20.46 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.674 -0.641 . . . . 4.2000000000000002 111.582 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.58 127.22 30.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.526 1.155 . . . . 3.1699999999999999 109.9 155.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -153.14 164.5 20.2 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.067 2.147 . . . . 2.1299999999999999 107.551 161.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -94.08 -161.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.155 3.236 . . . . 3.46 109.111 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.55 -150.92 28.86 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.386 0.993 . . . . 2.25 113.021 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -84.72 -16.44 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.618 2.879 . . . . 2.5499999999999998 113.843 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -153.82 160.66 42.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.735 1.754 . . . . 3.1200000000000001 115.735 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.15 177.75 7.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.94 2.096 . . . . 1.3 110.499 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.82 144.27 45.6 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.622 1.169 . . . . 1.0900000000000001 111.641 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.92 147.54 44.61 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.952 0.901 . . . . 0.94999999999999996 112.188 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.83 146.88 41.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.243 1.817 . . . . 2.02 110.289 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.51 151.6 9.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.348 -1.47 . . . . 1.5 114.751 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -87.76 93.41 9.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.539 1.936 . . . . 2.0299999999999998 107.354 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.02 140.6 29.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.232 1.413 . . . . 2.1899999999999999 109.83 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -127.47 156.66 41.77 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.632 0.975 . . . . 3.0499999999999998 113.632 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.84 99.71 53.03 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.149 1.38 . . . . 0.97999999999999998 108.964 163.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.05 -9.34 14.18 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.093 2.529 . . . . 1.4099999999999999 113.058 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -173.48 49.78 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.684 1.135 . . . . 1.1599999999999999 113.389 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -113.11 0.96 15.13 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.522 1.529 . . . . 2.5 112.802 -168.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.23 160.7 42.35 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.072 1.749 . . . . 1.6899999999999999 110.257 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.47 154.44 16.04 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.109 2.539 . . . . 0.96999999999999997 111.849 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.87 130.24 52.28 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.309 1.444 . . . . 2.3399999999999999 110.419 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -114.18 109.42 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.912 1.285 . . . . 2.7400000000000002 109.612 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.3 tp -90.51 107.63 19.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 126.77 2.028 . . . . 0.84999999999999998 108.428 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.0 m -101.15 -12.45 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.191 0.996 . . . . 0.56000000000000005 112.927 -168.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.1 -163.81 32.21 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.251 0.929 . . . . 0.60999999999999999 112.208 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.89 -173.18 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.562 1.145 . . . . 0.79000000000000004 110.145 164.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -161.7 137.17 7.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.763 1.625 . . . . 4.9800000000000004 107.98 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -146.74 147.21 29.27 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 117.152 -1.404 . . . . 0.93999999999999995 109.341 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.35 -6.96 19.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.021 1.814 . . . . 0.96999999999999997 113.816 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -93.91 -1.68 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.574 1.694 . . . . 0.85999999999999999 115.574 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.1 150.11 34.37 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.562 1.528 . . . . 0.89000000000000001 113.809 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.85 -67.1 0.81 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.611 1.565 . . . . 3.3300000000000001 111.274 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -90.02 147.08 23.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 122.572 1.177 . . . . 3.6299999999999999 110.321 168.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.02 129.27 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.456 2.302 . . . . 1.1499999999999999 106.582 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.94 120.39 13.15 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.078 1.351 . . . . 2.0299999999999998 109.016 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -78.98 121.71 25.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.064 1.302 . . . . 0.66000000000000003 110.302 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.0 m170 -111.54 152.75 27.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.298 1.839 . . . . 0.59999999999999998 112.053 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.91 -176.45 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.212 -1.358 . . . . 2.0099999999999998 110.022 165.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.6 m -126.82 75.69 1.58 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.283 1.433 . . . . 1.5800000000000001 107.526 170.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -65.45 150.04 49.02 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 2.7000000000000002 112.475 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -88.18 150.36 23.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.351 1.061 . . . . 6.4900000000000002 111.931 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -155.6 155.4 33.24 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.517 1.527 . . . . 8.5 111.481 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -99.5 148.01 24.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 3.4399999999999999 110.205 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -141.4 122.22 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 106.428 -1.693 . . . . 3.5 106.428 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 62.76 22.81 13.6 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.911 0.884 . . . . 3.8799999999999999 112.085 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.82 69.07 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.303 -1.498 . . . . 1.8200000000000001 114.36 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -96.88 141.55 29.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.567 1.947 . . . . 2.7200000000000002 109.992 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 135.2 35.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.624 1.17 . . . . 5.0999999999999996 111.294 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.51 141.8 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.236 1.814 . . . . 1.3999999999999999 109.161 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -117.41 145.18 44.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.09 0.956 . . . . 4.7000000000000002 110.167 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.76 169.14 31.19 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 125.141 1.353 . . . . 1.2 112.633 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.06 151.66 20.7 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.512 1.156 . . . . 1.55 113.133 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -164.55 146.8 7.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.435 1.494 . . . . 6.54 110.159 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.5 Cg_endo -68.93 153.6 72.33 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.688 1.592 . . . . 0.68999999999999995 111.314 172.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.33 157.65 60.85 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.785 1.634 . . . . 0.46999999999999997 110.537 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.99 -18.08 36.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.598 2.198 . . . . 0.57999999999999996 112.981 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.26 165.44 1.84 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.099 1.759 . . . . 1.8100000000000001 111.575 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -111.07 173.4 6.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.366 1.866 . . . . 0.96999999999999997 109.614 152.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -155.9 168.88 25.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.423 -0.798 . . . . 1.8400000000000001 112.435 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.62 133.23 8.63 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.811 1.244 . . . . 0.80000000000000004 109.783 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.12 164.13 36.26 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.283 1.989 . . . . 0.81999999999999995 110.925 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.53 143.42 92.95 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.008 2.472 . . . . 0.77000000000000002 111.502 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt 67.26 0.25 2.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.79 2.036 . . . . 1.4399999999999999 113.504 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.13 115.66 4.15 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 126.366 1.936 . . . . 0.94999999999999996 110.528 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.91 112.2 24.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.038 1.335 . . . . 6.2699999999999996 109.539 170.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.72 -174.98 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.007 1.723 . . . . 1.54 111.016 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 102.92 2.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.301 1.04 . . . . 3.6499999999999999 111.023 -165.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.13 77.17 0.51 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.078 1.751 . . . . 1.0700000000000001 109.112 161.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -91.77 147.79 35.8 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 127.832 2.453 . . . . 2.7999999999999998 112.189 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.51 -64.18 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.787 3.658 . . . . 1.05 113.325 -170.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.45 97.36 1.7 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 108.439 -1.864 . . . . 1.3200000000000001 108.439 165.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.81 -90.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.924 1.249 . . . . 0.93000000000000005 112.358 -169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -148.29 141.64 25.22 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.345 1.858 . . . . 2.0600000000000001 110.143 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -169.19 169.64 9.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.687 -1.258 . . . . 1.01 110.518 -172.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.65 136.13 41.0 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.646 -0.501 . . . . 1.8999999999999999 109.646 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 mmt -91.28 126.31 36.33 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.339 -0.985 . . . . 1.0900000000000001 108.339 161.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.25 111.08 22.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.41 1.484 . . . . 2.71 107.596 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 126.63 55.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.647 1.579 . . . . 2.8100000000000001 108.841 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.15 95.46 0.09 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.046 -1.222 . . . . 1.3600000000000001 110.046 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.5 mt -92.72 124.39 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.544 0.672 . . . . 0.93000000000000005 111.09 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.02 -19.73 61.81 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.8 1.037 . . . . 1.4299999999999999 113.8 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -149.5 162.66 27.89 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.738 2.015 . . . . 6.96 108.974 164.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.86 138.36 68.19 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.276 -1.471 . . . . 1.77 108.276 149.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.01 150.63 31.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 2.54 109.53 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.76 0.94 51.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.296 1.221 . . . . 6.4000000000000004 114.296 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 72.2 161.89 0.25 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.27 2.628 . . . . 2.3799999999999999 112.101 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.61 -12.16 0.77 Allowed Glycine 0 N--CA 1.482 1.728 0 N-CA-C 116.8 1.48 . . . . 4.0199999999999996 116.8 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.98 166.51 22.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.707 2.484 . . . . 3.3399999999999999 117.707 -153.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.61 68.55 9.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 131.659 3.984 . . . . 5.96 113.206 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.95 106.65 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 120.671 -1.268 . . . . 1.0600000000000001 111.126 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.04 129.86 44.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.667 1.587 . . . . 2.9900000000000002 110.764 160.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 mt -149.58 109.87 4.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.223 1.009 . . . . 1.74 112.272 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.67 96.18 5.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.192 2.597 . . . . 2.02 109.47 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.9 mt -77.23 118.39 19.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.321 -0.862 . . . . 1.1799999999999999 110.608 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -91.92 127.55 37.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.151 0.98 . . . . 0.64000000000000001 111.801 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -126.12 134.03 51.45 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.552 0.945 . . . . 2.3700000000000001 113.552 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 33.12 49.63 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.579 2.352 . . . . 1.8600000000000001 114.142 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.93 -94.01 0.77 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.574 1.083 . . . . 3.9399999999999999 111.946 -170.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.65 23.0 7.96 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 117.381 1.712 . . . . 1.6100000000000001 117.381 -164.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -117.76 153.26 33.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.508 2.154 . . . . 4.9299999999999997 109.782 166.591 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.03 139.95 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.289 1.436 . . . . 1.1399999999999999 109.584 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -123.31 110.97 15.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.024 1.33 . . . . 1.8400000000000001 109.48 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -85.3 108.17 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.093 -0.38 . . . . 2.5699999999999998 111.479 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -104.55 159.84 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.46 1.504 . . . . 1.1899999999999999 110.937 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.97 137.99 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.347 1.059 . . . . 2.1499999999999999 109.658 162.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 144.19 46.83 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.216 1.406 . . . . 1.73 109.958 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.37 141.82 26.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.823 2.348 . . . . 1.3600000000000001 110.37 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.42 153.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.82 0.848 . . . . 1.6200000000000001 112.43 167.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -146.61 158.05 43.83 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 3.8700000000000001 109.124 163.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.58 99.48 10.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.924 -1.11 . . . . 2.4300000000000002 108.109 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.222 0 CA-C-O 114.844 -2.503 . . . . 5.4500000000000002 117.275 -154.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.097 0 N-CA-C 110.181 -1.167 . . . . 9.5999999999999996 110.181 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m 51.18 46.76 25.99 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.397 1.629 . . . . 10.08 115.397 157.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 91.48 -10.97 0.25 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 129.752 3.221 . . . . 14.19 114.402 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.256 70.3 p 101.41 122.75 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.058 1 C-N-CA 133.83 4.852 . . . . 8.0399999999999991 108.806 177.503 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -72.97 103.14 3.67 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.277 1.031 . . . . 6.4100000000000001 109.382 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.93 173.38 41.52 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.162 1.363 . . . . 1.05 113.818 -168.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -159.13 145.31 16.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.552 1.541 . . . . 1.54 110.571 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.3 t -91.29 143.05 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.692 1.197 . . . . 1.03 109.303 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -69.21 116.91 10.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.626 -0.671 . . . . 4.0199999999999996 112.31 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.2 134.18 56.77 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.156 0.983 . . . . 4.0300000000000002 109.999 161.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -166.13 140.46 3.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 120.534 -1.353 . . . . 2.2799999999999998 112.456 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -92.59 68.99 0.68 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.234 3.29 . . . . 3.1099999999999999 110.348 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.01 -177.76 36.26 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.772 1.069 . . . . 1.48 115.772 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.54 -0.25 8.1 Favored 'Trans proline' 0 CA--C 1.542 0.91 1 C-N-CA 125.494 4.129 . . . . 1.4299999999999999 113.371 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -134.37 152.75 51.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 2.6600000000000001 111.56 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 -170.28 3.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.211 2.204 . . . . 1.1599999999999999 109.933 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.24 152.9 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.309 1.444 . . . . 1.0800000000000001 109.412 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.2 136.69 51.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.415 1.461 . . . . 1.0900000000000001 111.902 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -120.27 135.07 55.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.015 1.726 . . . . 2.0600000000000001 110.277 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.8 152.19 11.35 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.872 -1.143 . . . . 1.6200000000000001 112.423 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 m -95.93 92.28 6.42 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.112 0.965 . . . . 1.6100000000000001 110.029 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -80.41 133.61 35.9 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.097 -0.705 . . . . 2.27 109.097 173.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.86 145.73 50.85 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.107 1.763 . . . . 2.79 110.124 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -107.86 104.28 52.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.702 0.801 . . . . 1.1299999999999999 110.073 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.33 -12.97 11.33 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.506 2.137 . . . . 1.05 113.321 176.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.13 -174.25 49.53 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.149 0.88 . . . . 1.21 113.221 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -112.22 6.01 18.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.594 1.557 . . . . 2.75 112.337 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.5 160.92 60.01 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.86 2.064 . . . . 1.73 109.988 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.44 144.64 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.324 2.016 . . . . 1.1200000000000001 112.028 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.95 121.26 41.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.363 1.465 . . . . 2.3300000000000001 108.934 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 ttm105 -110.53 97.53 6.95 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.481 1.112 . . . . 3.3799999999999999 110.753 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.67 106.74 11.92 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.292 2.237 . . . . 0.75 109.551 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.82 -13.42 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.155 1.382 . . . . 0.84999999999999998 113.524 -171.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.95 34.28 Favored Glycine 0 C--N 1.34 0.753 0 O-C-N 121.632 -0.668 . . . . 0.72999999999999998 112.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB1' HD13 ' A' ' 101' ' ' LEU . . . -160.77 175.41 12.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.918 0.887 . . . . 0.92000000000000004 112.76 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' HE ' ' C ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -143.72 156.48 44.54 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.831 0.452 . . . . 7.6200000000000001 110.391 160.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 t -152.95 149.69 22.52 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.139 1.376 . . . . 0.88 108.628 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.97 -35.07 56.87 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.167 1.245 . . . . 1.48 111.24 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.97 4.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.868 1.433 . . . . 1.3799999999999999 114.868 -164.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.34 170.2 14.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.186 1.794 . . . . 1.1000000000000001 109.99 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 7.1 tp10 -106.38 -82.84 0.53 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.413 -0.958 . . . . 2.7999999999999998 108.413 164.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.68 125.67 28.06 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.164 -0.96 . . . . 5.1299999999999999 109.072 165.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.63 138.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.196 1.799 . . . . 1.1899999999999999 109.419 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -140.07 127.69 21.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.663 1.185 . . . . 2.2799999999999998 111.927 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.428 HD12 ' CE1' ' A' ' 84' ' ' PHE . 4.9 tt -78.93 122.87 26.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.767 -1.208 . . . . 0.75 110.795 167.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 21.6 m170 -108.71 153.2 23.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.71 1.604 . . . . 0.81000000000000005 112.637 176.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -87.32 158.72 18.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.309 1.044 . . . . 2.23 109.803 162.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -109.31 143.91 38.17 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.161 -1.422 . . . . 1.48 107.161 152.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -137.46 155.07 49.74 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 2.1400000000000001 111.285 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -111.02 121.81 46.31 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.101 -1.444 . . . . 3.4900000000000002 107.101 160.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -146.44 173.21 12.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.387 1.475 . . . . 7.1399999999999997 110.274 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -73.98 155.13 38.94 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.418 0.687 . . . . 3.21 110.132 159.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.85 -98.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.948 -1.131 . . . . 3.7999999999999998 107.948 168.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -74.75 63.15 1.13 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.833 1.653 . . . . 5.0 111.723 170.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.63 -24.67 0.63 Allowed Glycine 0 N--CA 1.475 1.274 0 C-N-CA 126.462 1.982 . . . . 3.8300000000000001 115.222 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -107.56 164.03 12.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.909 2.484 . . . . 3.4500000000000002 111.628 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -76.87 134.15 39.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.375 2.27 . . . . 4.3300000000000001 112.084 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -144.08 147.35 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.345 1.858 . . . . 1.49 109.995 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -98.0 118.54 34.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.515 1.526 . . . . 3.79 110.303 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.16 -179.19 16.1 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.389 1.471 . . . . 1.29 113.239 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.5 mtt -142.26 158.67 43.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.413 1.485 . . . . 2.1400000000000001 111.244 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.87 151.04 4.78 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.741 -1.123 . . . . 4.7000000000000002 113.437 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 27.4 Cg_endo -61.31 142.05 94.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.65000000000000002 112.006 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.63 159.86 48.89 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 126.516 1.926 . . . . 0.47999999999999998 110.882 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.15 -21.29 18.09 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.564 2.176 . . . . 0.68000000000000005 113.455 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -171.87 163.72 6.32 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 120.27 1.396 . . . . 2.6499999999999999 112.395 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -115.03 173.51 6.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.199 2.2 . . . . 1.0900000000000001 109.24 155.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.91 164.27 38.68 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.645 -0.659 . . . . 2.5600000000000001 112.13 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.1 t -139.25 125.79 12.53 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 125.412 1.485 . . . . 1.1499999999999999 108.733 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.21 159.13 54.13 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.124 1.883 . . . . 1.25 110.512 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.77 140.5 93.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.959 2.439 . . . . 1.0800000000000001 111.654 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt 72.17 -8.52 1.14 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.27 2.228 . . . . 1.4099999999999999 113.997 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.05 -172.93 49.6 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.882 1.706 . . . . 1.47 112.873 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -160.61 161.76 32.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.965 2.106 . . . . 4.6200000000000001 111.843 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.8 129.88 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.112 1.365 . . . . 1.78 110.007 170.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.88 122.29 32.1 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.22 0.533 . . . . 3.3599999999999999 110.307 165.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -68.89 68.14 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.368 1.867 . . . . 1.4199999999999999 109.954 169.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -70.85 142.27 87.94 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.472 1.509 . . . . 2.7599999999999998 110.32 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.41 -57.02 2.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.55 2.833 . . . . 1.28 112.233 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.96 78.0 2.01 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.357 -1.097 . . . . 1.4399999999999999 110.357 166.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.23 -79.61 0.08 OUTLIER Glycine 0 N--CA 1.466 0.637 0 C-N-CA 127.119 2.295 . . . . 0.94999999999999996 111.415 -175.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -153.84 147.49 25.2 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.631 1.972 . . . . 2.3500000000000001 108.905 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -159.7 154.13 23.94 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 120.496 -1.378 . . . . 0.75 109.276 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CE1' HD12 ' A' ' 45' ' ' LEU . 56.5 m-85 -92.39 104.03 16.4 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.329 -1.36 . . . . 1.8300000000000001 107.329 167.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 129.61 40.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.603 -0.888 . . . . 1.1499999999999999 108.603 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -114.81 122.14 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.647 1.579 . . . . 1.8 109.016 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.02 155.85 36.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.333 1.053 . . . . 3.0 110.668 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.92 -64.25 4.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.129 1.347 . . . . 3.5099999999999998 112.29 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt 74.1 110.96 0.07 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.568 2.747 . . . . 1.26 115.526 164.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 41' ' ' GLU . 36.3 mttp -89.17 -3.73 58.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.579 -1.325 . . . . 1.78 113.595 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -137.35 138.61 25.43 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 126.193 1.797 . . . . 5.2300000000000004 108.77 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.97 130.13 17.38 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 N-CA-C 107.469 -1.781 . . . . 1.77 107.469 159.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.55 85.1 6.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.411 0.684 . . . . 2.71 109.563 -170.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HE3' ' HG2' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -102.8 142.37 34.04 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.344 1.058 . . . . 3.8999999999999999 111.463 175.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.17 142.06 48.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 114.546 1.313 . . . . 1.5800000000000001 114.546 -170.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.39 52.12 28.24 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.781 -0.645 . . . . 2.0 112.789 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HG2' ' HE3' ' A' ' 94' ' ' LYS . 2.8 mt-10 -107.51 -175.74 2.87 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.549 -1.278 . . . . 2.4900000000000002 107.549 147.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.51 120.43 31.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.76 0.79 . . . . 4.7400000000000002 109.277 166.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.11 103.85 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.774 -0.824 . . . . 0.96999999999999997 108.774 168.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 141.62 40.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.313 1.054 . . . . 3.5 110.672 162.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.417 HD13 ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -155.25 130.58 9.65 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.171 -0.956 . . . . 3.21 111.881 -167.424 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.71 121.25 38.34 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.443 1.097 . . . . 2.3199999999999998 109.413 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -95.36 119.11 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.174 1.389 . . . . 1.1499999999999999 110.012 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 mt -92.28 124.55 36.42 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.002 0.921 . . . . 0.91000000000000003 110.505 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.91 126.67 50.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.141 0.977 . . . . 2.1600000000000001 112.542 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 50.07 21.12 0.69 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.258 1.823 . . . . 2.0099999999999998 114.821 171.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.53 -61.12 2.82 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.695 1.14 . . . . 3.2400000000000002 112.361 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.79 1.37 53.95 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.188 1.635 . . . . 1.8899999999999999 117.188 -165.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -137.24 146.24 44.55 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.71 1.755 . . . . 5.8499999999999996 111.351 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.01 148.46 23.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.121 1.368 . . . . 1.25 109.822 163.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -143.37 133.03 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.396 1.878 . . . . 1.79 109.657 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -85.65 140.74 30.31 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.624 0.602 . . . . 2.1600000000000001 112.624 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -125.52 177.23 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.606 1.962 . . . . 1.22 109.461 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -155.21 140.69 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.404 0.547 . . . . 1.9299999999999999 111.002 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.32 152.39 19.91 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.965 1.306 . . . . 2.3300000000000001 112.844 -171.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -79.27 -170.28 0.97 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.24 3.293 . . . . 1.04 112.346 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.42 84.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 126.857 2.063 . . . . 2.2400000000000002 111.389 -161.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -128.89 172.88 10.9 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 119.983 -1.698 . . . . 5.4800000000000004 114.553 -171.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.07 142.19 28.89 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.67 -1.269 . . . . 3.27 113.532 -167.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 C-N-CA 126.702 2.001 . . . . 6.8499999999999996 111.528 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.921 0 N-CA-C 107.631 -2.188 . . . . 10.289999999999999 107.631 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -83.39 -21.86 32.92 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.622 0.711 . . . . 10.130000000000001 111.703 165.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -131.4 -179.02 5.11 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.98 2.112 . . . . 8.7899999999999991 110.219 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.3 p -66.66 114.78 5.85 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.809 1.244 . . . . 7.25 108.0 160.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -133.02 -179.12 5.29 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.848 2.059 . . . . 5.21 109.312 -169.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.11 165.68 21.77 Favored Glycine 0 N--CA 1.475 1.239 0 O-C-N 120.296 -1.503 . . . . 1.1100000000000001 113.371 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.2 p90 -167.09 163.26 15.72 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.122 1.369 . . . . 1.6699999999999999 111.805 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -127.4 135.6 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.277 -0.889 . . . . 1.21 110.522 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -88.68 129.52 35.51 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.469 1.128 . . . . 4.5700000000000003 113.605 -169.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -79.55 141.33 36.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.108 2.163 . . . . 2.9300000000000002 112.562 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -162.8 152.26 13.01 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.329 1.451 . . . . 2.29 110.943 165.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.45 56.55 4.3 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.546 3.497 . . . . 2.4399999999999999 109.706 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.81 174.86 17.65 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.661 1.124 . . . . 1.3 114.068 -172.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.13 -15.22 13.02 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.904 3.069 . . . . 1.5900000000000001 112.556 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -143.89 154.3 43.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.479 1.912 . . . . 2.0299999999999998 111.834 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.29 -179.85 8.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.728 1.611 . . . . 1.0900000000000001 110.751 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.67 49.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.18 0.807 . . . . 1.1299999999999999 113.18 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.48 141.66 36.58 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.998 0.519 . . . . 0.98999999999999999 110.763 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -117.67 157.26 26.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.937 1.695 . . . . 2.0499999999999998 110.08 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -167.47 148.07 5.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.994 1.479 . . . . 1.29 114.994 166.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.54 HG23 ' HD2' ' A' ' 74' ' ' ARG . 59.4 m -75.83 140.38 42.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.528 -1.214 . . . . 1.23 109.636 157.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.33 130.63 15.6 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.687 1.195 . . . . 2.98 109.069 168.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -136.95 152.64 50.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.284 1.04 . . . . 4.5300000000000002 112.276 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -104.15 102.49 32.74 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.066 1.346 . . . . 1.3200000000000001 110.528 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.71 -9.19 14.63 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.315 2.01 . . . . 1.73 113.603 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.17 -170.44 44.87 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.362 0.982 . . . . 1.5 112.998 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -120.86 9.95 10.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.782 1.233 . . . . 2.6600000000000001 112.943 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.76 159.4 53.55 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.047 1.739 . . . . 2.27 110.69 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.67 153.51 15.36 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.757 2.305 . . . . 1.9299999999999999 111.805 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.19 142.24 43.64 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.732 1.613 . . . . 2.0800000000000001 109.019 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -141.41 107.49 5.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.712 0.805 . . . . 3.4500000000000002 109.805 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.37 129.14 44.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.277 2.631 . . . . 1.98 109.218 -165.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.84 -9.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.136 1.162 . . . . 0.56999999999999995 114.136 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.19 -160.75 28.77 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.069 -1.02 . . . . 0.55000000000000004 112.285 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 -174.25 4.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.942 1.697 . . . . 0.89000000000000001 110.664 165.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -150.84 144.87 25.32 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.609 1.963 . . . . 7.6399999999999997 109.136 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -141.01 151.26 61.83 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 120.376 1.444 . . . . 0.63 109.462 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.0 -22.14 48.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.359 2.039 . . . . 0.88 113.851 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.91 2.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 115.178 1.547 . . . . 0.93000000000000005 115.178 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 175.6 12.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.652 1.181 . . . . 0.90000000000000002 112.306 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -110.56 -89.36 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.575 1.15 . . . . 2.8399999999999999 109.894 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -77.72 100.6 6.29 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 120.667 -1.27 . . . . 4.2400000000000002 108.932 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -82.24 135.04 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.664 1.585 . . . . 1.3700000000000001 111.147 162.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.1 147.48 51.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.822 2.449 . . . . 2.1699999999999999 108.407 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 tt -92.79 124.1 36.54 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.9 1.682 . . . . 1.0600000000000001 111.162 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.7 m170 -114.01 152.47 30.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.317 1.447 . . . . 0.82999999999999996 112.635 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -98.74 166.43 11.32 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 2.1600000000000001 110.319 167.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -125.14 117.69 24.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.591 1.156 . . . . 1.3200000000000001 108.166 167.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -119.64 -177.59 3.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.44 1.496 . . . . 2.2400000000000002 112.084 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -140.33 163.19 33.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.424 1.09 . . . . 2.8900000000000001 111.895 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.36 166.82 20.39 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.641 1.577 . . . . 5.8799999999999999 112.023 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 135.42 40.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.537 1.535 . . . . 4.8499999999999996 108.445 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.8 -113.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.745 1.618 . . . . 3.1899999999999999 107.025 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.26 67.19 3.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.519 1.054 . . . . 4.3099999999999996 108.931 164.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.89 -22.01 0.46 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 127.323 2.392 . . . . 2.5 115.953 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -74.93 133.82 41.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.5 1.92 . . . . 4.1699999999999999 110.134 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.95 127.63 36.48 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.927 0.891 . . . . 5.5099999999999998 109.67 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.12 152.58 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.657 1.583 . . . . 2.8500000000000001 109.876 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.5 ptp -83.96 162.13 20.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.505 1.522 . . . . 4.4900000000000002 113.32 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.52 172.93 33.68 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.669 1.604 . . . . 1.48 113.122 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtt -137.09 154.55 50.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.554 1.542 . . . . 2.8199999999999998 110.472 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -168.77 154.11 6.21 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.683 1.193 . . . . 5.3600000000000003 111.144 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 3.8 Cg_endo -68.6 152.38 74.67 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.46 1.44 . . . . 0.62 112.085 171.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.97 149.36 68.28 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 125.945 1.698 . . . . 0.70999999999999996 109.842 172.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.31 -19.08 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.903 2.402 . . . . 0.88 113.909 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -172.61 171.56 4.49 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.804 1.184 . . . . 1.8100000000000001 113.117 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.23 175.26 10.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.839 2.456 . . . . 2.8199999999999998 109.373 159.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.45 168.8 25.92 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 120.602 -1.311 . . . . 2.3900000000000001 111.132 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -149.65 137.73 11.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 124.72 1.208 . . . . 1.5 108.737 -167.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.77 171.73 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.655 1.57 . . . . 1.6299999999999999 110.146 166.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.97 146.86 91.79 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.344 2.03 . . . . 1.5800000000000001 110.322 160.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt 69.61 -2.72 1.85 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.696 1.998 . . . . 1.3799999999999999 114.024 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.21 148.43 20.74 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 126.985 2.231 . . . . 1.1200000000000001 111.688 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.54 ' HD2' HG23 ' A' ' 21' ' ' THR . 33.2 ttp-105 -106.27 142.64 35.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.432 1.893 . . . . 6.04 111.505 168.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.86 147.26 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.475 1.51 . . . . 2.75 108.473 161.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -128.13 112.28 14.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.334 -1.358 . . . . 3.4100000000000001 107.334 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.09 63.05 0.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.57 1.948 . . . . 1.49 108.971 171.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -79.48 150.95 74.21 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 128.8 2.84 . . . . 3.23 111.545 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.4 -35.69 92.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.52 2.814 . . . . 1.1699999999999999 113.641 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.72 60.06 1.77 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.189 0.9 . . . . 1.73 111.867 168.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.89 -73.6 0.05 OUTLIER Glycine 0 N--CA 1.469 0.859 0 C-N-CA 125.225 1.393 . . . . 1.3100000000000001 113.94 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -153.01 154.72 35.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.122 1.769 . . . . 2.3199999999999998 111.01 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -163.99 169.93 17.32 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.107 0.963 . . . . 1.0900000000000001 109.879 176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.21 126.61 42.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.789 -0.819 . . . . 2.1200000000000001 108.789 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -81.69 120.82 25.6 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.426 1.091 . . . . 1.1000000000000001 109.219 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -111.65 113.01 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.147 1.379 . . . . 1.47 107.976 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.41 139.83 41.28 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.433 1.493 . . . . 2.7200000000000002 109.293 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.08 66.3 1.94 Allowed Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.489 -1.045 . . . . 1.29 110.489 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 mt -70.03 123.54 21.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.04 0.536 . . . . 1.21 110.568 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -83.19 19.83 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.015 0.926 . . . . 1.45 113.154 -172.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 173.9 155.98 0.3 Allowed Pre-proline 0 CA--C 1.544 0.718 1 C-N-CA 131.893 4.077 . . . . 4.46 107.945 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.73 133.68 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 N-CA-C 106.626 -2.105 . . . . 2.1000000000000001 106.626 147.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.9 116.55 5.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.55 0.69 . . . . 2.4199999999999999 109.155 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -71.23 107.67 4.35 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.416 -0.802 . . . . 4.3799999999999999 109.939 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.82 1.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.909 -1.119 . . . . 1.52 109.461 164.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.49 38.67 7.02 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 118.755 -1.025 . . . . 2.1800000000000002 113.958 -165.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -135.75 -178.92 5.35 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 119.275 1.538 . . . . 3.46 108.659 149.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.78 150.31 37.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.158 0.98 . . . . 5.0599999999999996 110.589 166.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.99 113.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.98 1.712 . . . . 1.21 108.031 172.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.22 137.69 57.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.909 -0.587 . . . . 2.9399999999999999 109.477 160.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -149.55 133.44 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.41 1.084 . . . . 1.54 111.993 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.55 87.76 2.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.786 2.034 . . . . 2.6299999999999999 109.146 -167.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 mt -69.28 125.17 25.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.766 2.026 . . . . 1.1100000000000001 111.077 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.3 mt -94.51 138.67 32.13 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.511 1.124 . . . . 0.81999999999999995 111.464 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -135.08 138.54 43.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.432 1.093 . . . . 1.8 111.238 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.8 126.55 12.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.595 1.558 . . . . 1.79 113.342 -167.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.25 -145.58 19.16 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 110.757 -0.937 . . . . 3.29 110.757 -166.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.27 27.48 9.32 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 115.74 1.056 . . . . 2.04 115.74 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.63 131.22 46.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.27 2.035 . . . . 4.7599999999999998 112.079 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.73 123.32 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.108 1.363 . . . . 1.4099999999999999 109.284 162.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.76 119.8 33.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.809 1.644 . . . . 3.02 108.477 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.54 147.09 23.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.328 1.233 . . . . 2.4700000000000002 114.328 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.96 172.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 127.86 2.464 . . . . 1.1399999999999999 109.492 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.82 140.99 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.828 1.651 . . . . 2.1099999999999999 108.017 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.79 133.81 10.59 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.147 1.379 . . . . 1.52 110.83 -166.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 147.77 67.34 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.105 2.537 . . . . 1.03 114.168 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.7 t -79.27 132.49 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.538 0.735 . . . . 1.1399999999999999 110.496 168.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -133.7 156.26 48.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.125 1.77 . . . . 3.8999999999999999 112.164 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.57 84.42 7.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.093 0.957 . . . . 1.98 109.457 164.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.907 -1.52 . . . . 5.71 112.16 -163.419 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 110.543 -1.023 . . . . 10.31 110.543 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 m 160.44 -172.48 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 1 C-N-CA 132.29 4.236 . . . . 10.77 106.568 -173.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 74.53 -145.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.384 1.074 . . . . 11.41 110.815 171.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.9 134.13 42.3 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.169 0.988 . . . . 7.0499999999999998 112.93 -163.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -84.0 127.41 33.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.545 1.538 . . . . 5.2699999999999996 108.86 156.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.88 165.48 38.74 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.327 -0.858 . . . . 1.1299999999999999 114.224 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -159.53 158.98 32.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.628 1.171 . . . . 2.1600000000000001 114.001 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.08 130.03 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.573 -1.269 . . . . 1.25 107.573 164.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -84.48 -2.6 57.51 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.841 1.793 . . . . 3.9700000000000002 115.841 -164.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.4 t80 65.88 152.21 0.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.496 2.318 . . . . 3.3599999999999999 113.671 -170.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -159.54 146.8 12.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.943 2.097 . . . . 3.7400000000000002 108.25 157.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.88 -7.84 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.324 2.683 . . . . 3.4500000000000002 112.283 169.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.57 -167.05 43.16 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.462 1.029 . . . . 1.8999999999999999 114.213 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.01 -9.33 22.08 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.503 2.802 . . . . 1.8 113.359 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -152.33 161.89 41.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.081 1.352 . . . . 2.2200000000000002 114.397 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.57 -174.09 4.78 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.668 2.387 . . . . 1.1799999999999999 111.953 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB2' ' CE ' ' A' ' 85' ' ' MET . . . -137.08 159.58 41.49 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.063 1.345 . . . . 1.3200000000000001 111.51 174.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.65 163.35 37.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.465 1.506 . . . . 1.4099999999999999 113.273 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -145.24 152.74 40.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.363 1.865 . . . . 1.9199999999999999 110.874 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -166.13 158.44 14.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.547 1.139 . . . . 1.5900000000000001 112.068 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.5 m -90.73 138.59 31.46 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.667 -1.234 . . . . 1.25 107.667 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.6 132.1 56.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.943 1.297 . . . . 2.27 107.767 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.55 135.36 53.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.727 0.811 . . . . 3.3100000000000001 111.761 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -101.69 115.56 64.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.348 1.059 . . . . 0.91000000000000003 109.7 163.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -88.57 -8.9 5.09 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.241 2.627 . . . . 1.27 114.4 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.06 162.97 32.86 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 119.434 1.016 . . . . 1.22 113.355 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.31 -0.52 50.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.347 1.459 . . . . 3.0800000000000001 114.178 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.91 158.04 36.91 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.999 1.32 . . . . 1.8500000000000001 110.53 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.38 155.23 18.89 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.214 2.61 . . . . 1.1599999999999999 111.198 -173.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.25 153.86 20.48 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.347 1.059 . . . . 1.8899999999999999 111.316 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -130.65 114.42 15.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.153 1.381 . . . . 3.02 109.185 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.45 114.41 26.17 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.246 2.618 . . . . 0.66000000000000003 108.893 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.05 -10.54 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 0.55000000000000004 113.571 -166.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.19 31.44 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.616 -0.678 . . . . 0.55000000000000004 112.704 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.71 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.03 179.95 7.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.597 0.759 . . . . 0.80000000000000004 111.924 176.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 3.0 mmt180 -154.47 149.69 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.94 -1.133 . . . . 6.0499999999999998 107.94 172.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -162.49 153.79 15.06 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.45 -1.262 . . . . 0.72999999999999998 108.725 -170.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.42 -7.95 16.04 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.32 2.013 . . . . 1.1100000000000001 114.489 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 m -98.48 -3.95 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 116.142 1.905 . . . . 0.89000000000000001 116.142 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.51 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.944 1.298 . . . . 1.29 110.666 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -93.95 -74.75 0.52 Allowed 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.575 -0.528 . . . . 4.4500000000000002 109.575 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -80.77 107.75 13.84 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.481 -0.933 . . . . 4.5199999999999996 108.481 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -113.18 125.01 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.913 0.885 . . . . 1.8799999999999999 108.763 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -134.13 122.7 23.26 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.889 1.276 . . . . 2.6299999999999999 110.384 -162.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.59 122.53 26.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.227 1.013 . . . . 0.81999999999999995 110.461 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 7.2 m170 -108.1 156.87 18.8 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.452 1.901 . . . . 0.88 112.832 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -105.24 -177.51 3.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.16 2.584 . . . . 2.0299999999999998 111.473 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -133.12 99.54 4.59 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.749 -1.574 . . . . 1.6699999999999999 106.749 154.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.3 151.51 41.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.462 0.305 . . . . 2.4500000000000002 110.63 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 ptp -97.97 157.92 15.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.55 0.34 . . . . 3.8799999999999999 110.797 155.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -176.1 160.96 2.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.583 2.353 . . . . 6.6299999999999999 110.274 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.73 154.26 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.029 0.932 . . . . 3.7000000000000002 108.795 169.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 t -133.17 -96.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.281 1.033 . . . . 2.8700000000000001 108.967 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -75.84 54.94 0.85 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.267 1.827 . . . . 3.1899999999999999 110.34 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.99 -17.57 0.53 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.137 1.827 . . . . 2.1099999999999999 115.261 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.8 152.69 20.2 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.01 1.724 . . . . 2.6699999999999999 111.162 -168.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -62.64 131.74 50.02 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.846 0.858 . . . . 4.3700000000000001 111.183 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.34 151.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.037 1.735 . . . . 1.95 109.335 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.8 mtm -128.64 141.51 51.33 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.602 1.161 . . . . 4.0099999999999998 110.302 163.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.86 163.57 30.5 Favored Glycine 0 N--CA 1.469 0.844 0 C-N-CA 123.753 0.692 . . . . 1.24 112.689 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -97.74 158.47 15.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.965 0.906 . . . . 1.72 112.771 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.6 mtt-85 -164.83 145.8 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 126.724 2.009 . . . . 6.2699999999999996 109.053 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.8 Cg_endo -70.59 152.9 65.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 CA-C-N 121.526 1.581 . . . . 0.90000000000000002 110.111 160.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.17 156.2 57.52 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.252 1.421 . . . . 0.67000000000000004 110.037 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.32 -14.4 34.28 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.812 2.341 . . . . 0.80000000000000004 113.015 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -178.96 162.15 1.24 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.115 1.766 . . . . 2.27 110.861 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -108.59 174.55 5.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.925 1.69 . . . . 1.04 109.316 153.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.74 165.24 37.21 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.908 -1.12 . . . . 2.3399999999999999 111.204 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -149.63 135.36 10.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 118.573 -0.727 . . . . 0.88 110.502 -164.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.98 165.8 31.19 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.264 1.976 . . . . 0.89000000000000001 112.116 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.31 138.84 83.6 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.391 3.394 . . . . 1.0900000000000001 112.62 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.1 2.83 1.54 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.344 1.857 . . . . 1.99 113.808 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.09 115.51 4.13 Favored Glycine 0 C--O 1.228 -0.23 0 C-N-CA 127.422 2.439 . . . . 0.89000000000000001 111.626 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -85.43 134.36 34.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.248 -0.976 . . . . 6.6399999999999997 109.978 155.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.34 168.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.749 2.02 . . . . 1.53 109.6 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -134.47 124.77 26.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.824 0.85 . . . . 3.6400000000000001 110.781 -164.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.06 75.63 5.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.716 -0.846 . . . . 1.1799999999999999 108.716 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 ptpm? -79.59 136.27 55.84 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.278 -0.867 . . . . 2.8599999999999999 110.525 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.47 -58.51 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.933 3.755 . . . . 1.03 113.566 -163.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 106.78 2.61 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 107.817 -2.113 . . . . 1.23 107.817 160.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.51 -88.65 0.17 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 124.654 1.121 . . . . 0.93999999999999995 111.266 -163.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -150.62 144.55 25.32 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.891 2.076 . . . . 1.8100000000000001 109.926 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -165.8 174.2 9.87 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.937 -1.102 . . . . 0.84999999999999998 110.618 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -110.9 128.8 55.93 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.994 0.918 . . . . 2.2799999999999998 109.971 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.482 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 8.1 mmt -86.71 136.98 32.82 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.073 0.949 . . . . 0.89000000000000001 109.633 165.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.7 mt -116.67 117.0 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.516 1.527 . . . . 2.1099999999999999 109.105 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.82 142.35 51.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.896 1.678 . . . . 2.6299999999999999 111.069 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.99 59.57 4.24 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.041 -1.223 . . . . 1.5900000000000001 110.041 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.8 mt -66.8 129.42 39.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.156 0.979 . . . . 1.1899999999999999 111.713 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.59 -10.19 49.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.785 1.234 . . . . 1.8100000000000001 112.875 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -155.38 146.19 16.33 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.621 1.568 . . . . 5.9000000000000004 110.305 163.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.28 127.49 15.88 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 107.378 -1.816 . . . . 1.8100000000000001 107.378 158.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mp -87.49 167.73 13.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.102 0.961 . . . . 2.4100000000000001 111.277 -171.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 145.98 48.15 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.032 -1.043 . . . . 5.0300000000000002 110.524 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.07 125.95 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.372 -0.603 . . . . 1.49 109.372 158.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.24 8.86 68.02 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 118.094 -1.392 . . . . 1.8999999999999999 115.712 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.45 173.73 9.44 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.943 1.872 . . . . 2.7599999999999998 109.429 157.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -118.64 158.7 24.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.816 1.647 . . . . 4.4699999999999998 110.099 167.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.1 t -132.45 120.31 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.319 1.848 . . . . 1.01 110.25 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.57 147.0 28.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.57 1.148 . . . . 3.29 110.321 173.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.71 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.3 tt -157.02 140.29 15.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.52 0.728 . . . . 1.8500000000000001 112.935 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 1.4 m-20 -104.61 115.47 30.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.863 2.465 . . . . 2.9300000000000002 111.546 174.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.3 125.03 28.44 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.827 -1.17 . . . . 2.4100000000000001 109.828 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.31 126.81 39.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.789 0.436 . . . . 0.63 110.328 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -124.69 154.28 41.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.646 1.212 . . . . 1.8200000000000001 112.245 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.06 128.52 37.61 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.86 1.059 . . . . 1.9399999999999999 113.86 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.17 50.41 10.49 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.194 0.902 . . . . 3.6800000000000002 114.073 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.53 76.47 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.034 1.173 . . . . 1.51 116.034 166.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.09 135.75 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.47 1.635 . . . . 4.7400000000000002 109.971 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.8 p -150.82 139.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 125.081 1.352 . . . . 1.0800000000000001 108.95 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.7 mt -139.05 134.78 33.45 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.244 1.018 . . . . 1.6699999999999999 111.871 -172.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 2.9 tpmt? -80.17 135.95 36.39 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.198 . . . . 2.77 113.113 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.93 173.65 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 125.158 1.383 . . . . 1.3700000000000001 111.88 156.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.16 153.75 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.121 1.768 . . . . 2.3300000000000001 108.74 165.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 mt -143.5 135.28 12.96 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.945 2.098 . . . . 1.8200000000000001 110.09 -172.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.32 159.28 49.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.257 2.638 . . . . 1.0800000000000001 111.988 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.33 131.2 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.123 0.969 . . . . 1.3300000000000001 110.989 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.59 -170.05 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.782 3.233 . . . . 4.0099999999999998 110.796 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.1 70.58 1.15 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.181 -0.949 . . . . 3.2999999999999998 111.275 167.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.899 1.444 . . . . 4.5599999999999996 114.899 -145.561 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 108.586 -1.805 . . . . 10.800000000000001 108.586 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m 75.85 -64.8 0.34 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.645 1.578 . . . . 10.26 112.286 170.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -152.66 35.71 0.5 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.0 1.32 . . . . 10.26 113.062 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.49 146.2 41.22 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.278 -1.008 . . . . 7.2599999999999998 108.278 155.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -117.21 177.03 4.87 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.632 1.173 . . . . 6.0199999999999996 109.535 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.474 ' CA ' ' HA ' ' A' ' 20' ' ' LEU . . . -99.91 128.3 9.53 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 121.259 -0.901 . . . . 2.0899999999999999 114.342 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -119.91 177.14 5.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.385 1.074 . . . . 1.8999999999999999 112.031 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.16 135.45 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.245 1.018 . . . . 1.1599999999999999 108.605 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.73 139.32 56.34 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.891 1.071 . . . . 8.3599999999999994 113.891 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -74.2 29.3 0.08 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.809 1.644 . . . . 4.0 114.967 177.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.7 p -69.9 134.37 87.87 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 119.706 -1.871 . . . . 2.75 113.181 -159.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.2 -20.39 24.83 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.951 2.434 . . . . 2.2599999999999998 112.073 169.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.39 122.83 6.24 Favored Glycine 0 CA--C 1.534 1.253 0 N-CA-C 108.678 -1.769 . . . . 3.52 108.678 162.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.83 -39.99 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.006 1.903 . . . . 4.0899999999999999 112.34 -172.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -90.23 137.14 32.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.042 0.837 . . . . 4.4800000000000004 110.784 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 167.27 178.98 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.089 2.556 . . . . 3.1600000000000001 112.139 -172.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.69 28.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.655 1.982 . . . . 1.95 114.001 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.04 155.65 45.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.788 1.635 . . . . 1.1799999999999999 110.839 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.88 164.92 26.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.358 1.063 . . . . 2.4500000000000002 112.15 -158.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.474 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 2.6 pt? -168.38 155.03 7.41 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.659 1.355 . . . . 1.4199999999999999 114.659 164.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.9 m -76.03 136.86 39.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.874 -1.158 . . . . 1.5700000000000001 107.874 151.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -149.02 136.04 19.89 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.265 1.026 . . . . 2.3599999999999999 109.436 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.34 165.42 27.94 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.836 0.826 . . . . 3.4700000000000002 112.774 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -114.87 89.91 20.89 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 114.132 -1.395 . . . . 0.88 110.16 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.14 -5.77 17.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 1.21 112.922 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.59 172.72 50.7 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.329 0.966 . . . . 1.0 113.333 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.79 -1.56 34.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 2.7400000000000002 113.276 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -119.09 159.04 46.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.866 1.666 . . . . 1.8300000000000001 110.548 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.87 156.88 27.31 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.966 2.444 . . . . 1.1899999999999999 112.317 -168.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.9 102.71 7.92 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.607 1.563 . . . . 2.2799999999999998 109.732 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttp-105 -92.38 113.44 25.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.103 1.361 . . . . 3.6299999999999999 111.031 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -103.95 109.67 21.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 128.324 2.65 . . . . 1.1699999999999999 108.592 -171.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -99.79 -17.0 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.654 1.182 . . . . 0.68000000000000005 113.377 -168.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.28 -168.25 39.35 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.95 0.786 . . . . 0.48999999999999999 111.99 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -144.01 177.36 8.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.825 0.85 . . . . 0.78000000000000003 110.901 175.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -163.45 128.44 2.99 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.496 1.043 . . . . 5.4400000000000004 108.487 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -136.06 153.22 76.67 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.504 -1.236 . . . . 0.93999999999999995 109.089 -177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.79 -28.63 86.76 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.125 1.883 . . . . 1.24 113.379 166.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.6 -5.1 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 115.036 1.495 . . . . 1.3400000000000001 115.036 -168.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.68 170.44 15.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.321 1.448 . . . . 0.91000000000000003 113.029 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -113.6 -81.4 0.6 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.76 1.624 . . . . 2.8599999999999999 111.553 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -80.98 111.18 17.22 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 120.971 -1.081 . . . . 3.6899999999999999 109.105 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.86 131.72 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.461 1.905 . . . . 1.25 109.79 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -147.47 131.92 17.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.452 1.101 . . . . 2.0800000000000001 110.539 -167.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.37 119.82 22.94 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.156 1.344 . . . . 0.81999999999999995 110.672 170.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.6 m170 -109.65 157.8 18.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.332 1.853 . . . . 0.73999999999999999 111.519 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.03 -176.53 3.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.837 0.855 . . . . 3.1200000000000001 111.535 164.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 m -146.65 99.66 3.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.929 1.292 . . . . 1.0900000000000001 107.609 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -106.29 -177.99 3.52 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.523 1.529 . . . . 2.0499999999999998 112.636 -166.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -138.67 143.39 39.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.946 1.299 . . . . 3.0800000000000001 110.673 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -155.39 159.59 40.01 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.227 1.411 . . . . 6.7999999999999998 111.595 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -97.74 151.79 19.79 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.686 1.194 . . . . 3.73 112.253 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.15 -92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.365 1.466 . . . . 3.0499999999999998 109.577 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -74.88 36.78 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.35 2.26 . . . . 4.6900000000000004 110.873 171.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -18.2 0.63 Allowed Glycine 0 CA--C 1.538 1.499 0 O-C-N 120.421 -1.424 . . . . 2.0600000000000001 113.398 -158.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -79.62 135.53 36.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.262 1.825 . . . . 3.7200000000000002 109.628 -177.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 125.19 32.17 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.543 1.137 . . . . 6.04 112.915 -175.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -123.34 147.82 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.603 1.961 . . . . 1.51 109.408 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.9 ptp -94.95 155.62 16.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.533 1.133 . . . . 4.1900000000000004 113.565 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.05 169.17 33.1 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 123.899 0.761 . . . . 1.0600000000000001 113.251 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.6 mtt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.116 1.367 . . . . 2.5499999999999998 110.153 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -159.1 150.14 16.26 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 117.282 -1.342 . . . . 5.8499999999999996 110.03 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 10.0 Cg_endo -67.26 146.37 75.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.843 1.696 . . . . 0.79000000000000004 110.142 164.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 m -113.56 160.27 32.34 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 126.028 1.731 . . . . 0.65000000000000002 110.115 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.74 -24.36 47.47 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.212 1.941 . . . . 0.81999999999999995 112.29 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -178.05 163.6 1.75 Allowed 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.836 1.654 . . . . 2.2599999999999998 111.712 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -108.54 173.16 6.44 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.034 1.334 . . . . 1.03 109.38 150.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.39 161.61 42.17 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.366 -0.834 . . . . 2.9900000000000002 111.852 162.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.69 126.04 22.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.254 1.821 . . . . 1.0 108.041 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.74 163.12 40.19 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.657 2.238 . . . . 0.92000000000000004 110.374 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -61.7 136.66 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.645 2.23 . . . . 0.94999999999999996 110.717 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt 67.15 2.62 2.85 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.821 2.049 . . . . 1.47 113.809 -174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.79 172.67 44.49 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.548 2.023 . . . . 0.95999999999999996 111.395 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -156.14 147.48 22.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 112.392 -1.904 . . . . 3.9399999999999999 111.923 -171.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.11 155.4 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.783 1.633 . . . . 1.98 110.716 168.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -128.52 114.11 16.33 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.802 -1.555 . . . . 3.9700000000000002 106.802 167.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.78 91.62 3.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.086 1.354 . . . . 1.23 112.315 -166.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.634 1.174 . . . . 2.9100000000000001 111.631 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.56 -17.87 58.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.929 2.419 . . . . 1.1100000000000001 113.197 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.6 52.98 0.85 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.706 1.146 . . . . 1.1200000000000001 111.486 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.9 -76.08 0.06 OUTLIER Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.591 1.091 . . . . 0.72999999999999998 114.767 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -153.81 137.6 16.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.602 1.961 . . . . 1.8999999999999999 110.026 -170.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -166.6 173.82 9.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.947 0.899 . . . . 0.87 110.294 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.49 124.72 50.02 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 118.499 -0.762 . . . . 1.9299999999999999 110.237 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.39 132.56 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.198 0.908 . . . . 1.0 109.568 163.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.28 132.42 54.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.578 1.151 . . . . 1.5 109.015 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.63 117.15 12.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.069 2.147 . . . . 2.8199999999999998 108.966 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.94 111.84 0.31 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.268 -1.133 . . . . 1.75 110.268 -170.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.4 mt -112.39 141.94 45.52 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.483 0.659 . . . . 1.54 111.279 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -82.73 1.91 36.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.655 0.782 . . . . 1.75 112.403 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -150.15 156.81 37.68 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 127.451 2.3 . . . . 4.0700000000000003 111.151 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.23 165.29 32.9 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.166 1.911 . . . . 1.6100000000000001 109.157 151.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -112.57 131.02 55.81 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.941 -0.763 . . . . 2.73 108.941 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.94 122.32 18.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.399 1.079 . . . . 3.5299999999999998 108.265 -169.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.34 28.51 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.024 1.284 . . . . 1.3999999999999999 112.482 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 45.23 8.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.487 0.565 . . . . 2.48 113.669 -172.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.97 165.76 24.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.454 -1.027 . . . . 2.71 109.199 141.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -115.34 155.32 27.56 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.168 0.987 . . . . 4.7199999999999998 112.159 -168.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.72 118.41 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.488 1.915 . . . . 1.2 109.654 -173.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.61 146.28 48.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.753 0.311 . . . . 2.8700000000000001 110.202 163.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.4 tt -155.29 126.18 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.558 0.743 . . . . 1.8899999999999999 111.679 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.81 112.52 21.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.836 3.254 . . . . 2.1899999999999999 111.347 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.5 mt -81.47 124.0 29.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.523 1.129 . . . . 1.1299999999999999 108.566 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 mt -96.85 127.38 42.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.933 1.293 . . . . 0.68000000000000005 109.878 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 97.0 m-85 -110.59 162.92 14.24 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.869 -1.145 . . . . 2.3399999999999999 112.581 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.53 101.54 1.01 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.786 -0.571 . . . . 1.73 111.472 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.86 19.0 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.506 1.05 . . . . 3.0299999999999998 111.601 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.56 54.55 4.37 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.23 0.919 . . . . 1.6599999999999999 115.182 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 14.1 ttpt -145.03 136.62 25.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 1.486 . . . . 4.5800000000000001 112.39 172.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.08 134.57 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 125.75 1.62 . . . . 1.4099999999999999 107.884 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.8 mt -143.85 124.93 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.081 1.352 . . . . 2.1699999999999999 108.491 -170.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.75 150.55 22.24 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.077 1.51 . . . . 3.6899999999999999 115.077 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -120.08 168.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.367 2.267 . . . . 1.1499999999999999 108.87 163.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.52 141.83 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.368 1.067 . . . . 2.2200000000000002 109.288 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.8 mt -131.85 131.69 22.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.319 1.848 . . . . 2.1400000000000001 108.765 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.91 155.51 43.36 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.53 2.153 . . . . 1.4399999999999999 111.124 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.5 t -86.2 123.49 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.161 -1.051 . . . . 1.54 108.161 164.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.05 160.11 28.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.01 1.324 . . . . 3.3700000000000001 110.615 -177.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.434 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -82.55 51.52 1.87 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.809 1.04 . . . . 3.1699999999999999 113.809 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.165 1.786 . . . . 5.3899999999999997 112.331 -174.022 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.463 0 N-CA-C 109.454 -1.458 . . . . 12.130000000000001 109.454 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -70.65 -23.13 62.46 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.899 1.35 . . . . 13.43 114.409 -174.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -172.53 -176.56 1.56 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.95 2.9 . . . . 13.67 108.243 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.1 p -154.8 -43.51 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.076 2.151 . . . . 7.3600000000000003 110.877 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -106.65 177.59 4.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.757 2.023 . . . . 5.8099999999999996 111.513 -175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -86.88 162.94 34.5 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 126.347 1.927 . . . . 0.98999999999999999 114.455 -172.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -147.92 150.11 33.48 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.749 0.819 . . . . 1.6599999999999999 112.444 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -103.79 134.32 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.234 1.414 . . . . 1.1100000000000001 108.267 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ttt-85 -86.8 100.3 12.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.182 1.178 . . . . 4.5700000000000003 114.182 -162.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.63 133.26 55.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.823 0.82 . . . . 2.8100000000000001 110.773 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -162.91 157.36 17.96 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.965 1.706 . . . . 2.3300000000000001 110.014 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -86.54 67.04 4.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.721 2.948 . . . . 3.21 110.219 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.98 164.29 28.89 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.693 1.037 . . . . 1.5600000000000001 115.693 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -80.1 -9.72 14.02 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.64 3.56 . . . . 1.4199999999999999 112.594 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -142.3 151.98 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.2 1.8 . . . . 2.0800000000000001 111.072 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.61 -163.86 1.52 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.548 1.539 . . . . 1.1499999999999999 111.237 -173.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.66 156.09 39.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.088 1.355 . . . . 1.21 110.66 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.92 148.76 45.09 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.948 0.899 . . . . 1.1100000000000001 110.631 156.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -128.07 178.01 6.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.828 1.651 . . . . 2.5800000000000001 110.124 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.533 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.5 pt? -169.92 161.15 8.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.137 1.775 . . . . 1.55 111.199 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -98.2 145.01 27.04 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.702 -1.592 . . . . 1.6799999999999999 106.702 154.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.46 127.61 7.66 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.438 1.095 . . . . 2.6299999999999999 110.377 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 151.26 29.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.467 1.507 . . . . 2.7400000000000002 111.544 173.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -98.23 109.15 50.95 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.051 -0.977 . . . . 1.25 110.105 161.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.19 -8.87 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.884 2.389 . . . . 1.8100000000000001 113.787 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.44 171.04 49.38 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.359 0.981 . . . . 1.6299999999999999 113.271 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.98 -5.0 45.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.312 1.845 . . . . 3.04 112.66 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.58 158.06 39.74 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.83 2.052 . . . . 4.71 108.595 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.83 151.61 24.67 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.907 2.405 . . . . 1.23 111.62 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -102.23 133.14 47.59 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.06 0.944 . . . . 2.1099999999999999 111.018 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -117.1 107.84 14.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.902 1.281 . . . . 2.8599999999999999 110.501 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -95.14 114.52 26.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.644 2.378 . . . . 0.69999999999999996 109.192 -169.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.65 -9.44 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.506 1.122 . . . . 0.69999999999999996 112.968 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.13 -171.54 44.61 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.481 1.039 . . . . 0.53000000000000003 111.438 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.713 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -153.8 170.07 21.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.018 1.327 . . . . 0.87 110.735 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -158.39 115.59 2.87 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 120.057 1.298 . . . . 4.9500000000000002 109.376 -165.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 t -127.03 159.33 65.33 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 117.759 -1.115 . . . . 0.83999999999999997 109.353 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.93 -22.75 48.09 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.533 2.155 . . . . 0.88 113.685 164.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.253 3.9 m -87.91 8.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.383 1.623 . . . . 0.97999999999999998 115.383 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.94 161.94 41.31 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.805 -1.185 . . . . 0.89000000000000001 113.677 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.7 -88.61 0.28 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.022 1.729 . . . . 2.96 110.516 174.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -81.48 121.54 26.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 3.6400000000000001 110.286 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.91 142.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 2.0299999999999998 111.36 164.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -140.71 116.09 10.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.946 1.298 . . . . 2.23 110.091 166.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.8 tt -76.83 119.19 20.25 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 120.897 1.681 . . . . 0.66000000000000003 110.639 170.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -105.09 152.07 23.22 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.035 1.334 . . . . 0.57999999999999996 112.549 177.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.46 179.82 5.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.606 1.962 . . . . 2.48 110.941 165.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 m -144.26 93.15 2.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.86 1.664 . . . . 1.0800000000000001 107.906 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.79 146.4 23.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.42 1.105 . . . . 2.3799999999999999 111.833 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -87.51 147.82 25.19 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.912 1.285 . . . . 4.3899999999999997 110.34 165.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.57 152.75 23.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.564 1.546 . . . . 6.0199999999999996 110.918 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.59 141.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.122 -1.066 . . . . 4.0599999999999996 108.122 156.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.88 120.6 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.535 1.534 . . . . 3.4700000000000002 106.997 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 62.07 23.8 14.09 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.946 0.899 . . . . 3.3599999999999999 111.602 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.88 -10.72 38.28 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.065 1.317 . . . . 2.1400000000000001 114.275 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -87.35 140.93 29.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.921 1.689 . . . . 3.2200000000000002 109.705 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -79.65 128.28 33.2 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.424 -0.798 . . . . 3.9199999999999999 111.003 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -135.69 150.13 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.864 1.665 . . . . 1.6399999999999999 110.443 -170.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.7 tpp -119.85 138.88 53.13 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.255 1.422 . . . . 3.8100000000000001 109.223 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.08 141.28 11.08 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 118.92 0.782 . . . . 1.3100000000000001 113.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -89.3 165.31 14.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.717 0.807 . . . . 1.73 111.176 169.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 -176.07 138.14 0.5 Allowed Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 116.455 -1.736 . . . . 4.4699999999999998 111.146 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.84 139.03 38.96 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 122.75 2.018 . . . . 0.60999999999999999 111.607 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.67 156.07 42.99 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 126.033 1.733 . . . . 0.5 111.163 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.74 -17.21 33.28 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.989 2.46 . . . . 0.62 113.087 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -177.52 165.89 2.19 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.857 2.063 . . . . 1.78 111.424 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.51 173.5 6.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.952 1.701 . . . . 0.96999999999999997 109.384 155.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.96 164.25 38.3 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.382 -0.824 . . . . 2.1499999999999999 113.075 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -139.53 129.23 14.08 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.046 1.738 . . . . 0.97999999999999998 109.03 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.38 161.99 42.76 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.691 2.261 . . . . 0.81000000000000005 111.727 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.21 135.93 65.31 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.772 2.981 . . . . 1.1399999999999999 112.333 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt 68.08 1.02 2.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.316 1.847 . . . . 2.2400000000000002 113.9 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.42 -178.48 45.46 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 126.109 1.814 . . . . 1.45 111.023 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -160.11 163.74 33.57 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.065 1.346 . . . . 4.6200000000000001 112.425 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.91 154.2 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.376 1.47 . . . . 1.6799999999999999 111.115 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.5 123.49 47.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.645 1.178 . . . . 3.3599999999999999 109.448 164.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.3 146.34 43.23 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 1.72 109.645 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 9.2 ptpp? -153.99 151.12 23.99 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.89 0.876 . . . . 3.1299999999999999 112.285 -163.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.59 -50.93 4.69 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.757 2.972 . . . . 0.93999999999999995 112.233 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.27 90.44 1.56 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 109.07 -1.612 . . . . 1.3 109.07 162.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.57 -90.22 0.11 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 123.659 0.647 . . . . 0.79000000000000004 114.075 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -153.26 140.24 19.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.287 1.435 . . . . 1.8200000000000001 110.3 -170.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -162.64 156.59 20.84 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.239 0.616 . . . . 1.02 111.307 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 45' ' ' LEU . 71.5 m-85 -90.51 112.77 24.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 2.0699999999999998 109.012 166.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.2 125.59 27.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.469 -0.938 . . . . 1.78 108.469 167.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.92 117.16 34.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.786 -1.19 . . . . 1.5700000000000001 107.786 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.65 110.75 20.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.965 1.306 . . . . 3.1699999999999999 108.188 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.21 98.52 0.7 Allowed Glycine 0 N--CA 1.47 0.904 0 C-N-CA 124.346 0.974 . . . . 1.5900000000000001 111.19 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 mt -96.34 128.78 43.57 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.649 0.779 . . . . 0.97999999999999998 110.916 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -18.74 53.85 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.493 0.923 . . . . 2.04 113.493 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.9 150.85 77.71 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 125.885 1.674 . . . . 4.3499999999999996 108.268 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.98 118.59 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 107.048 -1.943 . . . . 1.3999999999999999 107.048 155.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.39 108.54 1.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.177 1.391 . . . . 1.97 111.492 -160.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -80.45 105.05 11.42 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.149 -0.969 . . . . 4.6600000000000001 110.885 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.47 111.86 0.79 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.715 -1.217 . . . . 1.6000000000000001 107.715 152.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 5.89 34.41 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 117.312 -1.827 . . . . 2.3599999999999999 116.228 -166.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.45 169.21 8.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.731 2.265 . . . . 3.0299999999999998 111.748 160.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.76 141.66 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.633 1.573 . . . . 4.6799999999999997 109.454 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.64 112.51 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.776 0.831 . . . . 1.23 110.815 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.89 148.31 51.66 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.999 0.52 . . . . 3.0099999999999998 111.181 163.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.713 HD11 ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -153.77 116.71 4.5 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.415 1.102 . . . . 3.3599999999999999 109.87 174.147 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.41 116.61 21.96 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.732 2.813 . . . . 1.99 111.029 170.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.0 mt -83.73 118.77 24.11 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.34 1.456 . . . . 2.0899999999999999 110.313 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt -93.95 122.01 36.01 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.328 0.513 . . . . 0.76000000000000001 109.785 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -120.31 152.57 37.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.296 1.046 . . . . 2.27 112.235 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.87 113.62 1.57 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.59 1.156 . . . . 1.6299999999999999 112.993 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 76.06 0.86 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.332 1.444 . . . . 3.3399999999999999 113.268 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.26 -6.6 56.52 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 116.744 1.458 . . . . 2.2200000000000002 116.744 163.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -86.98 128.01 35.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.183 1.991 . . . . 5.2300000000000004 110.122 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.58 135.68 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.181 1.392 . . . . 1.3799999999999999 108.957 168.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.43 125.06 19.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.445 1.098 . . . . 2.1200000000000001 110.26 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.28 135.49 34.73 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.345 0.869 . . . . 2.6600000000000001 113.345 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.46 175.57 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.565 1.546 . . . . 1.3 109.804 157.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.07 141.51 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.787 1.635 . . . . 2.1600000000000001 107.742 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.7 mt -143.91 160.14 50.94 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.794 1.638 . . . . 2.1499999999999999 111.267 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.49 169.07 19.07 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.738 3.626 . . . . 1.1799999999999999 112.679 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.1 t -107.2 133.28 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.43 1.892 . . . . 1.04 110.72 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 151.51 42.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.085 1.354 . . . . 4.9000000000000004 111.044 170.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.33 85.35 6.88 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.074 -1.016 . . . . 2.2599999999999998 110.62 163.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.244 -1.36 . . . . 7.71 111.54 171.7 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' H1 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 107.496 -2.241 . . . . 9.4499999999999993 107.496 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -157.58 161.34 38.71 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.055 0.428 . . . . 8.9000000000000004 111.405 -142.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -71.38 26.48 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.319 1.048 . . . . 12.44 111.88 164.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p 52.14 -179.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.649 2.38 . . . . 7.7699999999999996 112.352 -143.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -153.03 36.38 0.48 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.074 1.75 . . . . 5.54 111.019 -176.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.78 174.73 55.19 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.506 1.05 . . . . 1.21 113.367 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -155.0 158.7 39.56 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.779 1.232 . . . . 2.27 112.069 -175.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.5 t -113.19 146.43 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 121.017 -1.052 . . . . 1.6499999999999999 109.373 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.99 140.08 40.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.806 -0.758 . . . . 5.3300000000000001 111.71 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -47.06 127.19 10.04 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.466 1.507 . . . . 3.7400000000000002 110.953 160.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -174.5 106.0 0.28 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.909 2.084 . . . . 2.7400000000000002 109.781 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -88.04 19.18 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.918 3.079 . . . . 2.7999999999999998 111.707 170.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.1 -165.26 38.95 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.836 1.208 . . . . 1.3600000000000001 113.724 -171.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.57 -19.39 21.66 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.029 2.486 . . . . 1.4399999999999999 112.647 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -146.68 165.06 30.71 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.829 1.252 . . . . 1.96 113.186 -178.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 -179.92 8.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.441 1.497 . . . . 1.27 112.426 177.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.55 135.64 51.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.716 1.606 . . . . 1.0900000000000001 110.065 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.37 123.81 41.32 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.205 0.526 . . . . 1.01 110.165 162.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -92.04 154.9 18.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.319 1.448 . . . . 1.9199999999999999 108.238 164.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -166.63 136.78 3.18 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.27 -0.894 . . . . 1.5600000000000001 113.028 175.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.2 m -79.35 148.28 32.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.011 -1.45 . . . . 1.26 107.613 165.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.13 141.0 18.2 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.035 1.734 . . . . 2.3700000000000001 107.507 -176.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 20.2 pt-20 -144.31 132.49 21.75 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.881 -1.137 . . . . 3.2799999999999998 110.579 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.63 109.6 39.7 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.341 1.456 . . . . 0.92000000000000004 109.895 177.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.87 -9.88 14.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.629 2.219 . . . . 1.1699999999999999 113.91 176.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.28 173.92 54.78 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.042 0.829 . . . . 1.1200000000000001 113.961 -172.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -104.26 3.45 32.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.404 1.881 . . . . 3.0899999999999999 112.491 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -116.33 164.58 17.6 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.691 1.996 . . . . 1.71 109.868 163.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.14 159.29 15.38 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.062 2.508 . . . . 1.0600000000000001 112.048 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.9 mt -106.6 154.59 20.69 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.624 1.17 . . . . 1.9299999999999999 110.985 168.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.4 ttp-105 -141.93 114.92 8.69 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.248 1.419 . . . . 4.9500000000000002 112.081 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.94 118.52 33.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.262 3.025 . . . . 0.90000000000000002 110.019 -176.128 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' HB2' ' A' ' 106' ' ' ALA . 35.0 m -115.86 -20.0 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.589 1.156 . . . . 0.77000000000000002 113.768 -173.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.15 16.81 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.509 -0.744 . . . . 1.1000000000000001 111.688 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.939 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -154.75 176.89 11.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.851 0.86 . . . . 1.1399999999999999 111.452 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 8.7 mmm180 -156.74 146.28 20.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.561 -0.903 . . . . 6.5899999999999999 108.561 172.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -142.72 157.61 61.42 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.721 -1.133 . . . . 0.67000000000000004 108.717 174.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.14 -25.34 50.85 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.352 2.035 . . . . 1.0800000000000001 113.795 160.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.4 2.71 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 115.631 1.715 . . . . 0.84999999999999998 115.631 -165.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.55 152.2 29.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.294 0.952 . . . . 0.93000000000000005 113.367 -177.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.32 -88.34 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.558 1.943 . . . . 2.98 110.436 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -77.88 116.77 18.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.395 1.478 . . . . 4.3799999999999999 109.34 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.34 134.93 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.68 1.592 . . . . 1.3300000000000001 109.584 174.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.55 138.26 44.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.012 1.725 . . . . 1.95 110.606 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.508 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 16.1 tp -84.51 109.89 18.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.486 1.114 . . . . 2.9399999999999999 109.444 172.212 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -113.59 154.36 27.31 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.027 1.331 . . . . 1.1100000000000001 113.682 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.4 164.92 11.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.912 2.085 . . . . 1.8200000000000001 111.431 171.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.6 m -130.15 111.67 12.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.955 1.302 . . . . 1.4399999999999999 108.551 170.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -112.67 154.79 25.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.805 1.242 . . . . 2.0499999999999998 113.308 -174.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 159.12 15.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.693 1.197 . . . . 3.6400000000000001 110.894 164.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.25 146.97 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.383 1.473 . . . . 8.4000000000000004 111.399 -167.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.64 143.71 32.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.494 1.118 . . . . 5.0499999999999998 112.352 175.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.97 133.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.955 1.702 . . . . 3.9199999999999999 109.246 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 67.61 6.07 4.77 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.588 1.155 . . . . 3.8399999999999999 112.641 -171.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.49 4.94 89.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.724 1.631 . . . . 2.8300000000000001 113.789 -166.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -100.76 148.72 24.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.711 2.004 . . . . 3.54 110.99 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 149.27 25.46 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.375 -0.828 . . . . 4.2999999999999998 112.423 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.04 152.92 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.473 1.909 . . . . 3.3300000000000001 109.366 175.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.5 mtm -112.56 155.45 24.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.181 0.992 . . . . 3.8199999999999998 112.072 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.72 177.35 32.89 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.223 0.916 . . . . 1.4399999999999999 112.731 173.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -125.17 157.79 35.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.17 1.388 . . . . 2.1099999999999999 110.511 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.13 157.38 63.76 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.299 -1.334 . . . . 6.3600000000000003 108.506 161.286 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.34 141.65 82.47 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.903 1.358 . . . . 1.0700000000000001 110.264 151.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.37 153.46 41.99 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 126.522 1.929 . . . . 0.78000000000000003 110.27 178.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.01 -31.44 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.533 2.155 . . . . 1.23 112.943 -174.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.3 p90 164.47 148.17 0.02 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 126.807 2.043 . . . . 2.8399999999999999 107.909 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.59 145.41 46.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.715 -1.13 . . . . 4.04 108.257 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.277 0.0 OUTLIER -141.27 155.24 46.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.803 1.038 . . . . 3.3599999999999999 113.803 -175.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.8 t -139.25 132.18 15.57 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 113.919 -1.491 . . . . 0.94999999999999996 109.443 -156.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.23 166.96 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.07 1.847 . . . . 0.80000000000000004 112.074 179.24 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -55.96 140.64 86.25 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.561 2.84 . . . . 0.94999999999999996 111.718 166.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm 67.65 -0.67 1.86 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.012 1.725 . . . . 1.73 113.532 -174.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.79 113.92 4.39 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 126.773 2.13 . . . . 0.91000000000000003 113.363 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -80.97 133.47 35.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.316 1.446 . . . . 4.1600000000000001 109.9 162.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.9 168.88 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.738 1.615 . . . . 1.5800000000000001 110.45 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -164.1 117.22 1.41 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.708 0.403 . . . . 3.6800000000000002 111.373 -167.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.67 72.77 3.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.14 2.176 . . . . 1.3500000000000001 110.267 178.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -80.72 148.0 64.2 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 126.041 1.736 . . . . 3.3100000000000001 113.299 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -47.87 21.39 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.439 3.426 . . . . 0.84999999999999998 114.29 -168.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.66 103.4 2.74 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 107.525 -2.23 . . . . 1.24 107.525 157.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.6 -102.71 0.28 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.494 1.997 . . . . 0.79000000000000004 110.416 -162.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -149.1 158.76 44.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.46 1.504 . . . . 2.3599999999999999 110.619 -175.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -165.34 158.52 16.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.847 -1.158 . . . . 1.0800000000000001 110.313 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.508 ' CZ ' HD13 ' A' ' 45' ' ' LEU . 46.8 m-85 -96.59 117.28 30.63 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.595 -0.691 . . . . 2.4500000000000002 109.295 171.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.27 121.54 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.064 1.346 . . . . 1.24 110.251 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.5 mt -108.02 106.29 16.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.69 1.996 . . . . 1.51 108.631 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.82 122.93 47.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.228 1.411 . . . . 2.7799999999999998 109.384 -177.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.41 89.46 0.39 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.429 -1.068 . . . . 1.27 110.429 -175.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.13 122.25 27.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.641 0.721 . . . . 0.81000000000000005 111.682 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -74.44 -13.9 60.77 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.862 0.865 . . . . 1.6899999999999999 112.955 172.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ptt85 -157.48 142.11 11.94 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 5.7699999999999996 110.41 165.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.76 141.8 38.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.834 3.023 . . . . 1.9099999999999999 111.186 -176.291 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.82 78.99 9.42 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.9 -1.148 . . . . 2.9199999999999999 107.9 177.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -69.45 162.84 26.6 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.736 0.779 . . . . 3.96 111.555 170.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.12 132.95 53.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.204 -1.035 . . . . 2.6000000000000001 108.204 163.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.21 49.85 19.36 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.417 -0.657 . . . . 3.54 112.437 -171.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -126.22 167.55 15.28 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.538 1.135 . . . . 3.0499999999999998 109.895 163.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -134.63 151.92 51.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.781 1.232 . . . . 4.3499999999999996 111.353 172.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.59 121.17 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.713 2.005 . . . . 1.49 108.627 -171.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.54 149.68 33.02 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.849 -0.532 . . . . 2.6099999999999999 110.034 162.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.939 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.9 tt -149.41 125.55 10.71 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.63 0.372 . . . . 2.0499999999999998 111.647 166.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -91.03 108.53 19.92 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.231 3.413 . . . . 2.4399999999999999 110.067 178.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.31 131.37 37.01 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.304 1.042 . . . . 2.5899999999999999 110.294 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -101.39 122.48 43.81 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.817 0.847 . . . . 0.91000000000000003 110.733 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 137.33 52.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.585 0.958 . . . . 2.21 113.585 -172.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.442 ' HB2' HG11 ' A' ' 33' ' ' VAL . . . -76.57 73.21 3.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.67 1.188 . . . . 2.52 112.047 176.5 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.61 32.37 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.529 1.061 . . . . 5.3899999999999997 114.589 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.77 28.33 70.96 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 118.387 1.094 . . . . 2.6299999999999999 113.869 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.26 141.37 52.13 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.815 1.246 . . . . 4.1100000000000003 111.763 -178.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.8 136.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.131 1.772 . . . . 1.28 107.627 159.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.8 mt -144.68 124.82 13.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.476 1.11 . . . . 1.75 110.022 -174.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -91.53 149.2 21.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 115.542 1.682 . . . . 2.2999999999999998 115.542 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.58 148.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.239 1.816 . . . . 2.2999999999999998 109.613 167.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.92 133.2 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.184 1.393 . . . . 2.96 109.927 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -136.19 113.9 10.58 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.314 1.046 . . . . 2.0699999999999998 111.033 -165.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.31 158.13 37.11 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.162 2.575 . . . . 1.5 111.593 171.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.61 129.88 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.388 1.475 . . . . 2.0099999999999998 111.188 176.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.44 162.88 34.34 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.33 1.852 . . . . 3.4900000000000002 108.916 175.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.68 51.76 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.448 -1.408 . . . . 2.77 112.683 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.391 0 CA-C-O 114.021 -2.895 . . . . 4.54 117.173 -157.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.488 0 N-CA-C 109.981 -1.247 . . . . 11.57 109.981 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.3 m -138.25 157.1 46.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.468 1.107 . . . . 8.9700000000000006 109.157 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -168.33 29.09 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.076 1.35 . . . . 11.220000000000001 111.011 -164.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 p -140.2 115.29 9.76 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.66 1.584 . . . . 6.3300000000000001 109.293 -156.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -124.2 -131.53 0.26 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.684 1.193 . . . . 6.25 108.633 174.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.25 173.66 26.45 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.866 1.666 . . . . 1.46 115.116 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -154.74 154.28 32.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.537 1.16 . . . . 1.95 114.004 -178.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.54 144.86 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 107.04 -1.466 . . . . 1.27 107.04 158.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -90.4 117.5 29.15 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.087 0.555 . . . . 4.6399999999999997 111.263 -179.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -48.8 130.35 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.782 1.233 . . . . 2.9199999999999999 111.86 162.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.467 ' H ' ' HB2' ' A' ' 93' ' ' LEU . 33.9 m -163.4 129.73 2.33 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 128.831 2.852 . . . . 2.1200000000000001 107.862 165.593 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -83.92 67.06 7.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.178 2.585 . . . . 2.3900000000000001 109.707 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.84 -174.43 20.45 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 115.128 0.811 . . . . 1.8 115.128 -172.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -83.48 -15.06 7.69 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 124.212 3.275 . . . . 1.8 113.191 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -131.0 157.75 42.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.704 1.602 . . . . 4.0800000000000001 110.681 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.63 -164.35 1.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.064 1.746 . . . . 1.3100000000000001 111.552 177.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.21 160.69 39.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.966 1.707 . . . . 1.24 110.764 -178.158 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 158.9 43.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.095 1.358 . . . . 0.93999999999999995 112.394 171.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -162.02 152.91 17.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.263 2.225 . . . . 2.6099999999999999 109.499 -173.185 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.23 157.74 26.16 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.893 -1.129 . . . . 1.6499999999999999 112.381 -175.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.8 m -77.96 96.8 5.13 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.571 -1.27 . . . . 1.6499999999999999 107.571 165.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 tt -88.3 148.94 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.931 1.692 . . . . 2.9700000000000002 108.92 169.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -150.0 165.37 32.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.733 0.777 . . . . 4.1600000000000001 112.896 168.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -120.88 101.62 45.11 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 126.007 1.723 . . . . 0.89000000000000001 109.343 171.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.82 -5.48 15.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.95 2.433 . . . . 1.03 113.302 174.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.02 -177.78 51.54 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.883 1.23 . . . . 0.95999999999999996 114.176 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -112.69 1.75 15.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.275 1.43 . . . . 2.6800000000000002 113.373 -170.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.15 162.18 27.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.91 1.684 . . . . 1.6799999999999999 109.71 165.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.58 157.88 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.847 2.365 . . . . 1.05 111.825 -172.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 mt -107.81 149.06 28.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.917 0.887 . . . . 2.0499999999999998 111.558 172.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -121.14 110.75 16.58 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.188 1.395 . . . . 6.3399999999999999 109.232 168.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.8 tp -82.93 127.25 33.35 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.838 1.255 . . . . 0.77000000000000002 108.173 175.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.6 -11.0 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.432 0.901 . . . . 0.56999999999999995 113.432 -173.28 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.11 -162.74 33.36 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 121.564 0.536 . . . . 0.46999999999999997 112.295 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.954 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -147.59 178.92 8.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.465 1.506 . . . . 0.81000000000000005 110.154 175.3 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -161.59 139.76 9.29 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.129 0.877 . . . . 6.6399999999999997 109.137 167.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.6 t -145.56 146.34 29.21 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.99 1.316 . . . . 0.69999999999999996 108.811 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.91 -22.9 55.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.963 1.775 . . . . 1.3100000000000001 113.132 178.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.77 0.15 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 114.42 1.267 . . . . 1.28 114.42 -174.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.04 168.01 9.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 116.068 1.877 . . . . 2.1000000000000001 116.068 -169.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.37 -104.36 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 106.955 -1.498 . . . . 6.3300000000000001 106.955 143.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -79.49 169.37 18.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.554 1.168 . . . . 4.1900000000000004 112.464 167.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.6 132.02 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.868 1.667 . . . . 1.46 107.865 161.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -119.94 128.44 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.89 1.276 . . . . 1.97 109.705 -175.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 84' ' ' PHE . 5.5 tt -81.54 120.09 24.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.773 1.17 . . . . 0.66000000000000003 110.628 169.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -110.33 153.05 25.44 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.592 1.557 . . . . 0.67000000000000004 112.933 176.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.22 172.13 8.16 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.443 2.297 . . . . 2.1800000000000002 110.699 165.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.1 m -133.19 92.65 3.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.115 1.366 . . . . 1.1299999999999999 108.015 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -97.59 149.42 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.138 0.971 . . . . 2.25 113.161 -163.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.3 ttp -79.05 139.4 38.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.629 1.172 . . . . 4.6399999999999997 110.086 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.58 113.93 2.61 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.54 0.736 . . . . 10.31 111.615 -175.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.01 153.69 19.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.158 0.983 . . . . 4.5800000000000001 110.613 174.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.6 t -143.51 122.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.284 -1.376 . . . . 3.4399999999999999 107.284 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 69.28 8.47 6.82 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.916 1.286 . . . . 3.98 111.984 -174.126 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.58 85.31 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.843 1.211 . . . . 1.79 113.82 -166.138 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -90.94 143.14 27.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.561 1.544 . . . . 3.0 110.225 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -75.16 132.84 41.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.713 1.605 . . . . 4.1799999999999997 113.307 -165.322 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.31 172.26 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.421 0.629 . . . . 1.8400000000000001 112.163 172.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.3 tpp -129.75 159.24 37.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.814 2.045 . . . . 3.7599999999999998 110.133 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.45 177.75 22.06 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.009 1.766 . . . . 1.1000000000000001 112.16 173.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.3 mtt -138.9 154.49 48.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.779 1.632 . . . . 2.1600000000000001 109.66 173.257 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -169.82 144.0 2.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 116.401 -1.761 . . . . 4.5599999999999996 111.333 -169.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.99 150.93 87.44 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 CA-C-N 121.716 1.648 . . . . 0.66000000000000003 112.414 165.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.48 159.02 47.54 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 126.418 1.887 . . . . 0.65000000000000002 110.703 173.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -70.93 -22.16 27.06 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.683 2.255 . . . . 0.68000000000000005 112.801 173.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -175.92 171.27 2.65 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.939 1.696 . . . . 1.8799999999999999 111.562 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.44 172.1 8.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.746 2.018 . . . . 0.98999999999999999 109.136 159.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.15 161.56 41.2 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.917 -1.114 . . . . 2.54 111.651 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.62 136.43 10.59 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.262 1.025 . . . . 0.87 109.679 -166.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.72 170.02 19.69 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.549 2.166 . . . . 0.80000000000000004 112.027 178.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -60.91 142.68 98.31 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.225 2.617 . . . . 0.88 111.599 166.289 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 64.55 6.57 3.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.243 1.817 . . . . 1.3600000000000001 113.506 -174.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.42 115.41 4.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 126.192 1.853 . . . . 0.96999999999999997 111.164 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.67 137.26 36.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.498 1.519 . . . . 4.8700000000000001 110.151 166.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.06 129.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.163 0.985 . . . . 1.53 111.557 177.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.22 124.55 31.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.699 -0.852 . . . . 3.8799999999999999 108.699 165.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.1 145.49 53.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.362 -0.977 . . . . 1.78 108.362 163.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -155.92 138.85 10.67 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 117.974 -1.012 . . . . 3.5099999999999998 111.726 -166.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.79 -26.5 45.01 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.653 2.902 . . . . 1.1399999999999999 113.587 -172.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.0 87.95 1.5 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 108.084 -2.006 . . . . 1.52 108.084 155.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.85 -97.26 0.18 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.214 0.911 . . . . 0.98999999999999999 113.458 -171.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -150.91 146.45 26.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.703 2.001 . . . . 2.2599999999999998 110.469 -167.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -153.91 159.32 41.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.841 -0.537 . . . . 0.91000000000000003 111.124 -175.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 41.7 m-85 -94.7 118.61 32.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.299 -1.001 . . . . 1.8799999999999999 108.299 164.338 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.09 123.15 33.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.425 -0.954 . . . . 1.0800000000000001 108.425 173.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -105.14 122.55 46.13 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.286 1.434 . . . . 2.3599999999999999 109.108 -174.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.95 151.91 39.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.37 1.068 . . . . 2.77 111.157 -170.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.85 42.65 92.2 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 123.95 0.786 . . . . 2.0099999999999998 113.219 171.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.7 mt -53.64 141.39 26.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.192 1.797 . . . . 1.51 112.729 -171.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -70.61 -9.53 57.15 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.343 -0.848 . . . . 3.5499999999999998 112.783 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -167.23 152.06 6.86 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.824 2.05 . . . . 7.2400000000000002 111.271 173.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.29 149.22 85.23 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.847 2.365 . . . . 3.1099999999999999 110.132 162.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.467 ' HB2' ' H ' ' A' ' 11' ' ' SER . 2.4 mm? -80.23 155.51 27.31 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.596 0.712 . . . . 2.96 111.786 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.99 -25.56 5.33 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.49 1.916 . . . . 4.5199999999999996 112.18 177.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 80.62 161.57 0.17 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.745 2.818 . . . . 1.9099999999999999 111.516 -175.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.52 57.78 16.32 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.462 -1.055 . . . . 2.6800000000000002 110.462 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -167.34 161.58 14.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.922 2.889 . . . . 3.9399999999999999 107.351 -174.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.59 161.4 16.84 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.713 1.205 . . . . 3.79 112.022 -170.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.2 t -144.6 127.78 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.718 2.007 . . . . 1.3600000000000001 109.886 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.1 140.21 41.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.931 0.492 . . . . 3.1699999999999999 110.742 165.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.954 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.2 tt -148.08 135.57 20.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.458 1.123 . . . . 1.6699999999999999 111.299 169.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.505 ' N ' HD23 ' A' ' 101' ' ' LEU . 4.5 m-20 -104.52 112.29 25.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.826 2.05 . . . . 2.2799999999999998 110.68 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.14 118.38 18.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.484 . . . . 1.26 109.805 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -93.9 121.38 35.3 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.368 0.667 . . . . 0.63 110.179 -173.106 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.14 124.36 47.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.477 1.132 . . . . 1.8700000000000001 113.366 -176.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 58.33 -12.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 131.027 3.731 . . . . 2.8599999999999999 117.574 170.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.03 57.2 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.528 1.537 . . . . 3.5899999999999999 113.452 -163.283 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.75 -0.06 1.82 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.126 1.61 . . . . 1.9099999999999999 117.126 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.4 156.81 43.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.459 1.904 . . . . 4.1699999999999999 111.294 173.076 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.88 128.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.82 1.248 . . . . 0.98999999999999999 109.639 167.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.42 133.72 55.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.809 1.643 . . . . 2.3599999999999999 109.055 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -85.48 134.94 34.03 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.042 -1.036 . . . . 2.46 111.474 176.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.7 164.45 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.987 1.315 . . . . 1.3500000000000001 109.841 160.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.25 142.29 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.532 -1.284 . . . . 2.3599999999999999 107.532 169.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.6 mt -136.76 138.78 27.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.918 1.287 . . . . 2.1000000000000001 109.985 -169.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.11 150.05 17.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.701 2.934 . . . . 1.3400000000000001 111.193 166.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.6 t -88.17 120.56 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.75 1.62 . . . . 1.5600000000000001 109.092 167.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -142.49 162.06 36.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.818 1.247 . . . . 4.5999999999999996 112.194 -170.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.23 126.41 41.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.941 0.897 . . . . 3.71 109.105 166.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 129.553 3.141 . . . . 7.9699999999999998 109.325 -171.371 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.323 0 N-CA-C 105.72 -2.952 . . . . 11.98 105.72 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 t 62.39 173.21 0.14 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.458 0.629 . . . . 10.32 110.524 -134.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -101.45 166.2 10.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.011 1.324 . . . . 9.3399999999999999 108.473 157.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.4 p -96.43 167.24 11.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.271 0.628 . . . . 7.5 110.956 170.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -159.26 -134.4 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.173 0.989 . . . . 5.2999999999999998 109.057 -163.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.89 -179.4 24.76 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.686 1.585 . . . . 1.24 114.667 175.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -170.48 156.63 5.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.708 1.603 . . . . 1.6799999999999999 111.903 170.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.03 128.9 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.822 -0.807 . . . . 0.81999999999999995 108.822 172.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -5.13 39.11 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 117.789 2.515 . . . . 3.8100000000000001 117.789 -145.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 69.82 121.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.299 2.639 . . . . 4.0099999999999998 112.248 -174.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -171.36 136.92 1.03 Allowed Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 119.752 -1.843 . . . . 2.0 112.393 178.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -93.88 -5.33 2.63 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.622 3.548 . . . . 2.8700000000000001 113.893 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.75 165.78 53.81 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 119.275 0.943 . . . . 1.28 112.53 177.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.08 -14.77 44.64 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.502 2.801 . . . . 1.5900000000000001 114.54 -172.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -124.61 152.12 43.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.365 1.466 . . . . 4.2199999999999998 111.822 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.1 -168.06 2.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.551 1.94 . . . . 1.1899999999999999 111.223 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.59 156.27 44.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.523 1.129 . . . . 1.1200000000000001 112.997 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.77 140.03 53.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.294 1.437 . . . . 0.96999999999999997 111.559 169.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -119.83 150.79 39.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.575 1.55 . . . . 1.9299999999999999 110.035 178.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -162.83 158.74 23.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.673 0.99 . . . . 1.77 113.673 177.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -94.01 117.22 29.79 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.977 -1.119 . . . . 1.4199999999999999 107.977 165.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.42 135.46 34.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.596 1.958 . . . . 2.3799999999999999 108.136 175.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -145.75 146.3 31.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.971 1.1 . . . . 2.7400000000000002 113.971 170.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -110.08 109.16 59.04 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 113.971 -1.468 . . . . 0.93000000000000005 110.113 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.46 -9.88 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.669 2.246 . . . . 1.04 113.498 175.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.24 177.86 54.13 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.316 0.96 . . . . 0.94999999999999996 114.035 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -106.19 -1.63 23.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.911 1.685 . . . . 2.3300000000000001 112.925 -178.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.95 162.67 19.74 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 126.128 1.771 . . . . 1.6799999999999999 109.646 163.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.17 161.64 17.85 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.011 2.474 . . . . 1.0900000000000001 112.018 -172.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 mt -109.0 154.5 22.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.341 1.056 . . . . 1.9099999999999999 110.488 168.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -138.01 102.62 4.74 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 4.04 109.635 177.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -84.38 103.8 13.86 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.258 1.823 . . . . 0.65000000000000002 108.702 -172.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.79 -13.87 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.682 0.793 . . . . 0.68000000000000005 112.736 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.71 -164.39 35.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 123.603 0.621 . . . . 0.68000000000000005 112.258 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.19 177.3 10.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.992 0.917 . . . . 0.93000000000000005 111.951 167.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -144.35 148.42 34.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.928 1.291 . . . . 6.6900000000000004 109.586 170.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -150.54 151.31 30.59 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 125.137 1.375 . . . . 0.71999999999999997 108.344 -168.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.4 -24.73 16.13 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.91 1.74 . . . . 0.90000000000000002 113.364 175.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 m -78.6 -19.67 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.704 1.372 . . . . 1.22 114.704 -170.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.33 45.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.038 0.935 . . . . 0.92000000000000004 111.098 -172.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.34 -71.97 0.52 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.768 0.427 . . . . 3.0499999999999998 111.427 -174.019 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -79.18 142.5 36.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.421 1.088 . . . . 3.8399999999999999 108.193 167.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -153.7 135.67 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 1.47 108.512 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -145.84 139.2 26.18 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.824 1.25 . . . . 2.1299999999999999 110.144 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -81.95 119.44 23.96 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.454 1.121 . . . . 0.81000000000000005 110.901 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.5 m170 -111.36 157.77 19.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.17 1.788 . . . . 1.03 111.623 176.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -111.35 168.45 9.52 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.664 1.985 . . . . 2.4300000000000002 110.467 172.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -126.88 100.93 6.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.919 2.088 . . . . 1.1499999999999999 108.195 172.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -97.73 156.45 16.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.964 1.098 . . . . 2.4500000000000002 113.964 -167.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -85.94 148.77 25.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.808 0.843 . . . . 4.0 111.504 166.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -160.6 163.78 32.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.34 1.456 . . . . 5.54 111.093 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -128.5 157.87 39.95 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.39 1.876 . . . . 4.2199999999999998 108.972 175.318 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.7 t -153.68 124.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 125.266 1.604 . . . . 4.2599999999999998 107.756 168.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.93 15.46 6.09 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.286 1.434 . . . . 4.9100000000000001 114.323 176.114 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.55 28.27 39.97 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.315 1.436 . . . . 3.4199999999999999 113.785 -173.246 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -123.29 136.01 54.49 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.761 2.025 . . . . 3.8300000000000001 111.148 168.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.31 144.41 42.45 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.562 -0.711 . . . . 9.0600000000000005 112.686 -177.312 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.25 153.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.466 1.106 . . . . 3.1699999999999999 110.582 173.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.98 131.95 52.14 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.483 1.113 . . . . 4.0 109.857 175.799 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.04 -179.55 15.8 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 124.976 1.274 . . . . 1.26 112.351 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.1 mtt -132.59 158.64 41.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.756 1.222 . . . . 2.8300000000000001 111.643 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -171.63 157.61 4.5 Favored Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 125.954 1.702 . . . . 4.8700000000000001 110.878 -178.353 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.9 Cg_endo -71.4 153.95 60.92 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.734 1.623 . . . . 0.79000000000000004 112.11 169.257 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -117.85 154.77 51.3 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.731 1.612 . . . . 0.83999999999999997 109.638 164.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.26 -10.33 25.56 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.933 2.422 . . . . 1.01 113.087 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -177.38 158.67 1.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.659 1.984 . . . . 2.6000000000000001 110.474 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.07 171.04 7.59 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.165 1.386 . . . . 1.01 109.122 148.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -156.22 161.33 40.28 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 120.956 -1.09 . . . . 2.4700000000000002 112.002 172.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 t -149.61 133.37 8.72 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 123.899 0.88 . . . . 1.0700000000000001 109.675 -160.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.39 168.84 21.22 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.122 1.881 . . . . 1.0700000000000001 111.801 177.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.43 142.11 97.63 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.645 2.897 . . . . 1.04 111.601 166.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm 66.56 3.65 2.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.965 1.706 . . . . 1.45 113.554 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.03 115.09 4.05 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 126.123 1.821 . . . . 1.1000000000000001 112.259 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -92.4 129.11 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.213 1.405 . . . . 4.4500000000000002 109.98 160.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.0 m -144.69 156.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.346 1.858 . . . . 1.5700000000000001 110.44 -177.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.17 120.45 31.37 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.141 -0.974 . . . . 3.71 112.52 -166.337 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.18 68.8 1.98 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.843 1.657 . . . . 1.23 109.36 168.027 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -77.67 149.16 77.47 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.988 1.715 . . . . 2.77 111.615 173.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -59.24 -31.81 95.85 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.783 2.322 . . . . 1.01 113.257 176.3 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.28 40.65 3.06 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.545 1.069 . . . . 1.1499999999999999 113.111 169.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.26 -75.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.887 1.232 . . . . 0.94999999999999996 114.931 -175.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -153.2 147.09 25.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.044 2.137 . . . . 1.8600000000000001 109.449 -171.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -163.82 170.19 17.21 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.478 -1.389 . . . . 1.1899999999999999 111.42 -175.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -104.21 120.05 40.3 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.557 -0.534 . . . . 1.8999999999999999 109.557 170.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 mmt -76.32 129.23 36.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.945 0.898 . . . . 1.1499999999999999 109.313 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.9 mt -108.06 124.91 50.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.594 1.558 . . . . 1.8400000000000001 107.364 177.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.46 118.59 11.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.66 0.784 . . . . 2.6899999999999999 109.933 -162.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.19 74.26 1.08 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 109.771 -1.331 . . . . 1.3700000000000001 109.771 -167.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mt -72.84 90.04 1.42 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.897 0.856 . . . . 1.1200000000000001 113.118 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -67.16 -11.35 57.07 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.919 1.081 . . . . 2.0099999999999998 113.919 172.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.4 mtp-105 -138.12 136.05 19.15 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.984 1.714 . . . . 4.0099999999999998 108.241 155.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.9 149.67 59.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.387 . . . . 1.76 110.267 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.65 97.05 9.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.894 0.478 . . . . 2.3599999999999999 111.256 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -77.96 129.38 35.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.863 1.265 . . . . 3.5800000000000001 110.946 169.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.93 49.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.273 -0.892 . . . . 1.9199999999999999 109.297 171.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.73 37.47 26.4 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 118.467 0.576 . . . . 2.4500000000000002 112.92 -166.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.52 -179.28 3.87 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 106.979 -1.489 . . . . 2.5699999999999998 106.979 151.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -126.85 149.56 49.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.269 1.027 . . . . 3.7200000000000002 109.018 167.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.27 118.44 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.942 1.297 . . . . 0.97999999999999998 109.702 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -81.65 146.51 30.02 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.438 1.113 . . . . 3.6600000000000001 111.41 160.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.67 123.46 8.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.84 1.256 . . . . 1.4399999999999999 110.903 -169.047 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.72 91.44 8.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 127.731 2.412 . . . . 2.2599999999999998 110.037 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.67 115.96 13.69 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.575 0.75 . . . . 1.4099999999999999 110.295 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.1 mt -88.2 124.77 34.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 0.83999999999999997 110.753 -173.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -125.09 124.01 40.97 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.955 0.724 . . . . 2.1899999999999999 112.955 -178.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.04 22.34 0.58 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.864 2.065 . . . . 2.1499999999999999 114.307 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.87 -56.21 1.76 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.17 1.367 . . . . 3.54 112.523 -163.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.43 8.85 52.23 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 117.499 1.76 . . . . 1.6699999999999999 117.499 -165.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 152.26 48.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.917 2.087 . . . . 4.1600000000000001 110.541 166.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.5 131.71 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.899 1.28 . . . . 1.1599999999999999 110.82 169.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.59 111.34 18.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.154 1.381 . . . . 2.75 110.487 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 85.76 5.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.191 0.996 . . . . 3.0 110.99 178.123 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.73 174.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.772 1.629 . . . . 1.54 111.255 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.4 151.51 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.057 1.343 . . . . 2.0299999999999998 110.568 170.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -140.74 141.99 26.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 128.034 2.534 . . . . 1.6399999999999999 109.044 176.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -70.32 149.29 63.1 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.123 1.882 . . . . 0.91000000000000003 109.478 170.344 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.83 123.86 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.475 -1.305 . . . . 1.1799999999999999 107.475 163.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.61 151.93 28.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.931 1.693 . . . . 3.02 108.068 -161.259 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.99 108.45 19.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.731 1.011 . . . . 2.7999999999999998 113.731 -157.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.921 1.288 . . . . 5.0700000000000003 112.071 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.446 ' H1 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.472 1.077 0 N-CA-C 107.798 -2.121 . . . . 9.4900000000000002 107.798 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p 163.17 -168.44 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.42 -0.956 . . . . 8.8000000000000007 108.42 -135.134 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -61.33 -29.24 69.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.588 -0.695 . . . . 10.85 112.742 166.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m 101.98 134.82 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 1 C-N-CA 132.27 4.228 . . . . 7.1500000000000004 108.474 -176.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.97 54.19 0.7 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.754 1.222 . . . . 6.2699999999999996 110.981 -166.38 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.46 161.5 24.47 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 124.982 1.277 . . . . 0.97999999999999998 112.865 -174.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.413 ' CD1' ' HB3' ' A' ' 118' ' ' GLU . 32.1 p90 -163.14 161.4 25.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 2.75 114.508 -175.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.61 150.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.049 0.94 . . . . 1.45 110.092 -177.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 -88.26 114.87 25.31 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.793 0.837 . . . . 4.1799999999999997 111.477 177.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -43.81 120.57 2.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.052 2.141 . . . . 2.52 112.888 166.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -167.76 97.83 0.61 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.727 1.611 . . . . 1.9299999999999999 110.341 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.68 70.39 7.28 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.566 2.844 . . . . 3.5600000000000001 109.253 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.03 -150.91 5.29 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.193 0.902 . . . . 2.0099999999999998 114.034 -172.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.35 -21.29 11.87 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.981 2.454 . . . . 1.76 112.716 -179.04 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -157.71 167.96 28.58 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.779 1.232 . . . . 2.27 113.518 -175.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -163.04 -177.87 5.71 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.287 1.835 . . . . 1.1299999999999999 112.309 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.57 52.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.695 1.598 . . . . 1.0 111.023 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.56 138.64 54.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.936 0.789 . . . . 0.83999999999999997 111.592 167.06 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -120.29 147.73 44.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.535 1.934 . . . . 2.4100000000000001 110.813 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pp -166.6 149.89 6.99 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.761 -1.212 . . . . 1.6000000000000001 113.874 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.29 96.51 6.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 127.748 2.419 . . . . 2.0299999999999998 108.385 168.556 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.65 126.69 34.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 2.98 108.971 174.291 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.446 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 17.7 pt-20 -137.77 145.84 42.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.273 1.429 . . . . 3.1600000000000001 111.621 -175.129 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -116.08 105.68 50.64 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.91000000000000003 111.973 -173.162 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.48 -11.03 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.578 2.185 . . . . 0.97999999999999998 113.298 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.66 163.25 53.47 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 125.59 1.567 . . . . 0.98999999999999999 113.802 -177.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -80.08 -32.64 39.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.043 2.137 . . . . 4.9800000000000004 112.65 175.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -98.28 163.98 18.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.478 1.911 . . . . 1.8 111.072 173.092 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.22 154.93 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.418 2.745 . . . . 1.3200000000000001 112.012 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.06 141.27 31.21 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.622 0.769 . . . . 2.3500000000000001 110.305 171.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -125.85 109.97 13.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.509 1.124 . . . . 2.7200000000000002 110.072 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.08 122.74 32.7 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.579 1.952 . . . . 0.93000000000000005 109.776 -176.328 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.62 -6.77 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.29 1.036 . . . . 0.62 113.456 -172.167 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.0 -163.74 34.07 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.821 1.201 . . . . 0.54000000000000004 111.41 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.13 -175.73 5.58 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.469 1.508 . . . . 0.75 110.476 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -156.26 139.72 15.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.067 1.347 . . . . 6.4500000000000002 108.932 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.26 146.38 45.56 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 117.2 -1.381 . . . . 0.73999999999999999 108.464 -173.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.24 -13.12 35.44 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.548 2.165 . . . . 0.84999999999999998 114.086 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.3 -3.94 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.28 1.585 . . . . 0.96999999999999997 115.28 -176.437 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.65 147.39 40.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 121.094 1.77 . . . . 0.90000000000000002 112.848 -172.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -83.71 -51.44 7.25 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.733 1.613 . . . . 3.1000000000000001 110.787 178.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -111.44 141.18 45.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.536 1.134 . . . . 3.48 110.115 170.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.29 137.08 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.071 1.348 . . . . 1.25 109.104 160.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -128.93 131.78 47.57 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.267 1.827 . . . . 2.1899999999999999 108.708 175.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.81 123.31 29.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.508 1.504 . . . . 0.81000000000000005 110.406 169.018 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -107.74 155.2 20.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.076 1.751 . . . . 0.68999999999999995 112.331 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -94.38 -174.15 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.651 1.981 . . . . 2.9199999999999999 111.481 167.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -145.34 80.25 1.6 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.182 1.393 . . . . 1.3999999999999999 109.18 166.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.27 143.79 52.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.952 0.882 . . . . 2.4900000000000002 111.8 -172.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtp -108.03 34.77 3.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.004 1.722 . . . . 4.0800000000000001 111.313 -172.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -70.34 156.89 38.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 7.0199999999999996 110.788 -167.328 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -46.7 159.54 0.09 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.781 0.833 . . . . 6.8399999999999999 110.335 146.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -163.17 -29.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.566 1.946 . . . . 3.6200000000000001 113.189 179.427 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -143.95 38.89 1.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.908 2.483 . . . . 4.71 109.277 170.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -33.73 0.37 Allowed Glycine 0 N--CA 1.481 1.666 0 O-C-N 120.055 -1.653 . . . . 2.5499999999999998 113.372 -160.193 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -61.08 135.22 57.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.655 1.982 . . . . 3.2999999999999998 109.851 170.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -85.79 129.69 34.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 118.212 -0.899 . . . . 4.5700000000000003 110.512 173.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.1 t -140.77 150.14 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.75 1.22 . . . . 1.8300000000000001 109.572 -169.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.9 mtm -92.9 121.8 34.63 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.228 1.011 . . . . 3.4100000000000001 112.406 172.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.73 163.59 25.52 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.146 1.355 . . . . 1.1299999999999999 111.755 171.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -107.2 152.45 24.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.24 1.016 . . . . 1.5 112.462 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -149.64 145.5 19.19 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.317 2.247 . . . . 4.1600000000000001 108.43 171.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.12 145.76 89.74 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.42 1.543 . . . . 0.71999999999999997 111.022 160.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.59 158.08 60.3 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.129 1.772 . . . . 0.76000000000000001 111.149 -179.229 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.46 -21.16 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.556 2.171 . . . . 0.65000000000000002 113.336 178.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -174.54 169.95 3.59 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.205 1.366 . . . . 1.97 112.66 -177.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.33 174.35 9.69 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.555 2.742 . . . . 1.0900000000000001 108.871 162.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.67 168.68 26.56 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.632 -1.293 . . . . 2.2400000000000002 112.708 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 t -146.41 131.3 8.94 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 125.359 1.463 . . . . 1.1200000000000001 109.519 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.0 161.05 41.96 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.607 2.205 . . . . 1.0900000000000001 111.773 176.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.89 133.7 42.95 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.959 3.106 . . . . 0.98999999999999999 111.706 179.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 72.3 -2.32 2.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.226 2.21 . . . . 1.4199999999999999 113.718 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.87 -179.02 37.66 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 126.049 1.785 . . . . 1.2 111.677 178.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -160.11 158.38 30.19 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.06 1.344 . . . . 4.1500000000000004 114.571 177.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.83 172.18 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.962 2.105 . . . . 1.78 110.731 177.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -119.33 132.99 55.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.66 1.584 . . . . 5.5599999999999996 109.048 170.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.82 81.31 6.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.832 1.301 . . . . 1.46 109.559 163.147 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 143.89 75.15 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.381 2.272 . . . . 4.0899999999999999 113.472 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.54 -40.19 76.37 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.771 2.314 . . . . 1.3 111.567 167.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.71 79.03 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.157 -1.177 . . . . 1.1699999999999999 110.157 164.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.98 -73.22 0.12 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 0.95999999999999996 114.696 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -158.52 139.84 13.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.593 1.957 . . . . 2.4500000000000002 109.154 -176.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -166.12 158.01 14.01 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.572 1.987 . . . . 1.1100000000000001 110.983 -175.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.08 124.02 32.78 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.951 -0.388 . . . . 2.1400000000000001 109.951 170.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.79 122.21 34.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.999 1.32 . . . . 1.78 108.63 169.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.13 135.92 43.9 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.874 1.67 . . . . 1.77 109.012 -177.177 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.31 125.64 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.769 1.228 . . . . 2.9199999999999999 111.226 -171.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.72 104.64 0.04 OUTLIER Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.734 1.635 . . . . 1.28 110.987 -174.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.0 mt -102.11 115.68 31.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.792 1.296 . . . . 1.0700000000000001 112.832 -166.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -66.32 -25.0 66.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.118 1.367 . . . . 1.52 112.923 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -152.78 146.54 18.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.164 2.186 . . . . 7.4000000000000004 109.826 175.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.75 131.87 9.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.239 2.626 . . . . 1.74 111.617 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.35 127.68 33.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 2.0 110.327 174.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.37 -166.49 1.16 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.981 0.896 . . . . 3.8999999999999999 111.325 167.094 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.08 119.72 21.18 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.162 -0.961 . . . . 2.02 113.051 -162.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.91 -12.21 69.65 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.267 1.413 . . . . 4.2699999999999996 114.901 174.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -74.51 154.24 38.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.05 1.13 . . . . 3.5499999999999998 114.05 -157.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -80.65 90.7 5.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.539 1.936 . . . . 4.21 112.179 -166.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.59 106.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 1.03 109.382 166.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -68.75 139.34 55.32 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.255 1.026 . . . . 3.0899999999999999 110.526 157.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -149.85 118.99 6.75 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.802 1.241 . . . . 1.5900000000000001 109.502 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 102.18 14.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.923 1.289 . . . . 2.5499999999999998 108.438 173.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.35 128.04 34.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.543 1.137 . . . . 3.1400000000000001 109.094 177.162 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -98.13 130.97 44.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.778 0.831 . . . . 0.59999999999999998 110.323 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -130.11 153.55 48.38 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.724 0.773 . . . . 1.8799999999999999 112.54 -177.2 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.97 146.39 42.65 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.951 -0.468 . . . . 3.1400000000000001 110.774 170.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.98 27.41 23.76 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.016 0.766 . . . . 4.4400000000000004 115.016 -177.268 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 17.86 79.16 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-N 117.894 0.847 . . . . 1.74 113.757 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -94.51 140.47 29.8 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.574 -0.956 . . . . 4.3700000000000001 112.349 -174.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.67 128.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.067 2.147 . . . . 1.0700000000000001 107.772 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.8 mt -147.11 122.84 10.56 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.943 0.897 . . . . 1.5800000000000001 111.697 -164.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -75.33 123.68 25.77 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.655 0.613 . . . . 2.5600000000000001 112.655 177.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.5 m -93.14 159.92 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.692 0.797 . . . . 1.8200000000000001 109.477 150.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.38 118.85 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.102 0.961 . . . . 1.99 108.543 167.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.69 141.42 36.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.105 0.962 . . . . 2.1099999999999999 111.544 -166.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.55 151.02 64.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.526 2.817 . . . . 1.05 111.753 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 74.7 t -79.21 130.72 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.004 0.922 . . . . 1.48 110.442 160.524 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -118.48 -152.39 0.5 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.043 2.537 . . . . 4.4100000000000001 106.687 160.065 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.89 8.8 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 122.783 2.538 . . . . 2.9300000000000002 117.501 -162.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.277 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 117.337 -1.315 . . . . 7.7199999999999998 113.094 179.019 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.257 0 N-CA-C 105.968 -2.853 . . . . 10.91 105.968 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -59.64 166.65 2.39 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 117.348 0.574 . . . . 8.9900000000000002 110.376 130.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -147.66 112.99 5.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.092 1.757 . . . . 10.81 106.814 178.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 5' ' ' GLU . 31.9 m 71.25 172.19 0.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.27 1.428 . . . . 7.7400000000000002 107.78 -141.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 4' ' ' THR . 8.9 tp10 -145.42 144.97 30.94 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.326 -0.859 . . . . 4.75 109.374 166.168 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.44 -179.5 30.53 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 123.738 0.685 . . . . 1.01 114.473 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -159.62 152.21 21.36 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.262 1.025 . . . . 1.8100000000000001 113.104 177.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.96 133.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.25 -1.019 . . . . 0.97999999999999998 108.25 165.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 2.9 tmt_? -98.05 100.1 11.41 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.365 2.266 . . . . 3.8799999999999999 109.017 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -57.55 148.69 23.21 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.077 0.942 . . . . 3.8799999999999999 111.445 172.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -152.03 145.2 17.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.426 1.49 . . . . 2.2200000000000002 110.01 161.39 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.81 71.42 7.05 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.083 3.189 . . . . 2.5600000000000001 110.371 -176.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.54 -172.81 27.19 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.055 0.836 . . . . 1.3899999999999999 113.701 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.99 -3.57 13.3 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.163 3.242 . . . . 1.79 112.815 176.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -142.8 167.0 23.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.219 1.808 . . . . 2.3999999999999999 112.521 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.64 -176.24 3.07 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.524 1.929 . . . . 1.24 110.928 -170.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.53 157.62 39.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.133 0.879 . . . . 1.1299999999999999 112.611 176.664 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.25 144.72 51.33 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 0.91000000000000003 110.422 165.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.85 152.33 51.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.296 1.439 . . . . 2.0499999999999998 109.277 175.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -173.17 158.66 3.7 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.042 1.127 . . . . 1.53 114.042 175.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -82.71 130.89 35.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 126.767 2.027 . . . . 1.53 109.532 163.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 23' ' ' GLU . 6.4 tt -114.76 143.3 45.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.103 1.761 . . . . 3.0800000000000001 108.858 169.618 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' N ' HD23 ' A' ' 22' ' ' LEU . 12.6 pt-20 -145.77 142.06 28.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.0 0.905 . . . . 3.1299999999999999 112.191 170.217 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -100.86 106.13 42.18 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.768 1.627 . . . . 0.98999999999999999 109.847 178.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.5 -9.36 17.36 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.418 2.079 . . . . 1.03 113.361 176.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.52 -178.57 52.5 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.332 0.969 . . . . 0.97999999999999998 114.032 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -111.77 1.28 16.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.756 1.623 . . . . 2.4500000000000002 113.162 -172.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.07 160.03 37.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.924 1.69 . . . . 1.79 110.176 166.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.16 157.44 17.53 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.156 2.571 . . . . 1.1000000000000001 111.721 -172.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.2 mt -107.53 157.61 17.89 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.601 1.16 . . . . 2.1200000000000001 110.548 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -134.66 116.24 14.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.731 1.212 . . . . 2.9300000000000002 109.291 169.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -97.66 117.16 31.32 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.337 2.255 . . . . 0.95999999999999996 109.508 -171.18 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.71 -9.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 114.038 1.125 . . . . 0.65000000000000002 114.038 -167.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.13 -163.77 32.7 Favored Glycine 0 C--N 1.34 0.791 0 O-C-N 121.418 -0.801 . . . . 0.80000000000000004 112.548 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.565 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -145.33 -178.32 6.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.044 0.937 . . . . 1.1599999999999999 111.183 172.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.73 136.16 3.61 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.88 1.218 . . . . 5.9299999999999997 108.065 176.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -138.13 152.09 71.13 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 117.403 -1.285 . . . . 0.66000000000000003 109.453 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.46 -21.0 53.98 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.35 2.033 . . . . 1.0 113.568 169.091 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.3 4.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.549 1.314 . . . . 1.01 114.549 -174.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.52 -179.01 5.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.968 1.307 . . . . 1.1599999999999999 110.787 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -101.57 -56.86 2.2 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.211 0.604 . . . . 3.1600000000000001 110.353 173.091 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -120.06 161.59 20.71 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.748 0.785 . . . . 4.1299999999999999 111.156 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.37 134.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.891 -1.05 . . . . 2.2200000000000002 108.988 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -118.69 134.43 55.13 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.209 1.804 . . . . 2.0099999999999998 108.798 -172.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -80.32 116.74 20.56 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.559 1.171 . . . . 0.89000000000000001 110.568 169.04 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -103.75 148.45 26.07 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.333 1.54 . . . . 0.58999999999999997 111.616 173.107 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.45 164.55 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.089 -1.414 . . . . 2.1200000000000001 109.702 159.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.554 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 91.2 m -140.77 93.39 2.6 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.56 -1.644 . . . . 1.3300000000000001 106.56 167.186 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -90.43 173.53 8.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.711 1.604 . . . . 2.2599999999999998 113.204 -162.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 56.1 mtm -113.32 131.34 55.99 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.37 -0.974 . . . . 3.3500000000000001 108.37 146.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -150.18 164.48 35.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.551 1.94 . . . . 7.5499999999999998 109.236 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -93.32 148.35 22.12 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.308 0.643 . . . . 3.7200000000000002 111.87 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 p -144.62 -8.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.48 1.659 . . . . 4.0499999999999998 115.48 -165.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -162.94 36.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.749 1.619 . . . . 3.2400000000000002 109.451 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.76 -11.2 1.3 Allowed Glycine 0 CA--C 1.539 1.545 0 O-C-N 120.642 -1.286 . . . . 2.3700000000000001 113.703 -160.367 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -113.07 150.84 31.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.224 2.21 . . . . 2.6200000000000001 111.196 -175.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 129.34 34.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.269 1.828 . . . . 6.1299999999999999 113.579 -173.14 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -142.37 147.57 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.369 0.986 . . . . 1.74 111.358 -172.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.5 mtt -83.19 138.79 33.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.707 1.203 . . . . 3.6200000000000001 113.477 171.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.89 167.3 33.19 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.128 0.87 . . . . 1.0800000000000001 113.384 173.554 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -107.54 166.17 10.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.112 1.365 . . . . 1.72 111.718 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.71 136.04 0.29 Allowed Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 116.21 -1.852 . . . . 4.2199999999999998 110.738 -175.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.93 143.03 64.68 Favored 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 122.254 1.841 . . . . 0.53000000000000003 111.344 166.536 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -112.51 157.83 39.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.096 1.359 . . . . 0.58999999999999997 110.0 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.25 -22.93 45.74 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.086 1.858 . . . . 0.76000000000000001 112.262 174.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -173.96 165.74 4.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.503 1.521 . . . . 2.23 112.932 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -111.03 177.52 4.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.169 1.787 . . . . 1.21 109.306 150.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.53 171.02 19.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.663 -1.273 . . . . 2.2599999999999998 111.638 175.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -151.57 134.53 8.9 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 118.36 -0.828 . . . . 1.3300000000000001 110.189 -167.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.69 169.68 21.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 121.726 1.618 . . . . 1.0900000000000001 111.434 171.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.92 142.27 74.62 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.005 3.137 . . . . 1.04 111.849 166.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 57.27 10.77 0.95 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.801 1.778 . . . . 1.3600000000000001 115.801 -168.063 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.46 116.07 4.17 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 128.244 2.831 . . . . 1.3700000000000001 110.889 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.16 137.15 35.64 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.32 1.448 . . . . 3.9300000000000002 110.173 162.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.33 144.0 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.787 1.635 . . . . 1.6299999999999999 109.252 178.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -132.28 118.41 19.43 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.652 -0.499 . . . . 3.9300000000000002 109.652 -165.061 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.44 75.84 3.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.138 1.375 . . . . 1.3999999999999999 110.041 -173.25 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -72.11 131.0 85.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.55 -1.214 . . . . 4.4800000000000004 108.651 175.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.5 -40.29 85.5 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.064 2.51 . . . . 1.05 113.018 -173.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.77 67.43 3.56 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 119.628 1.103 . . . . 1.3700000000000001 111.111 164.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 177.46 -82.17 0.07 OUTLIER Glycine 0 N--CA 1.469 0.861 0 C-N-CA 125.63 1.586 . . . . 1.01 112.637 -167.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -153.19 144.96 23.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.977 2.511 . . . . 1.8600000000000001 108.927 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.69 171.4 16.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.429 0.692 . . . . 0.82999999999999996 110.568 -177.482 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -109.58 125.91 53.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.093 0.957 . . . . 2.1699999999999999 111.208 173.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.2 mmt -89.78 121.86 32.32 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.403 1.081 . . . . 0.96999999999999997 110.662 170.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.68 138.96 33.45 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.7 1.6 . . . . 2.1200000000000001 110.729 -178.143 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mt -144.1 140.19 29.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.175 0.806 . . . . 2.8999999999999999 113.175 -177.277 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 57.96 3.44 Favored Glycine 0 N--CA 1.469 0.884 0 C-N-CA 124.303 0.954 . . . . 1.6799999999999999 111.215 -176.202 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.8 mt -70.25 137.74 51.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.256 0.835 . . . . 0.84999999999999998 113.256 -171.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -102.88 -3.43 26.23 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.756 1.223 . . . . 1.6200000000000001 112.79 -172.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -139.01 158.56 69.46 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.106 1.362 . . . . 5.21 108.93 152.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.03 122.43 9.74 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 N-CA-C 106.255 -2.248 . . . . 1.8500000000000001 106.255 138.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.17 120.96 21.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.102 0.953 . . . . 2.1400000000000001 109.528 -166.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -67.49 109.38 3.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.511 1.125 . . . . 5.5300000000000002 108.201 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.38 113.64 0.73 Allowed 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 1.9099999999999999 113.004 172.468 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.47 6.58 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.812 0.72 . . . . 2.4100000000000001 113.265 -166.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.31 -169.15 1.56 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.187 1.795 . . . . 2.7000000000000002 108.662 146.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.6 162.0 33.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.735 1.214 . . . . 4.8899999999999997 110.854 177.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.9 t -132.77 133.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.009 1.724 . . . . 0.97999999999999998 109.847 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.02 148.24 31.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.138 0.494 . . . . 3.1499999999999999 111.512 164.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.565 HD11 ' HB1' ' A' ' 35' ' ' ALA . 1.1 tm? -151.81 120.63 6.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.091 1.356 . . . . 2.6899999999999999 109.388 175.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.86 114.14 17.54 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.429 3.092 . . . . 2.0899999999999999 109.951 170.162 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.14 122.51 27.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.813 1.188 . . . . 1.8100000000000001 109.449 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -97.53 127.88 43.83 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.057 0.943 . . . . 0.93000000000000005 111.243 -171.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.64 151.33 48.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.168 0.985 . . . . 2.3300000000000001 112.828 -176.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.62 158.82 35.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.717 -0.674 . . . . 2.3300000000000001 111.987 172.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.32 74.78 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.586 -0.696 . . . . 4.7699999999999996 113.899 176.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.51 63.8 2.07 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 118.219 1.01 . . . . 2.29 112.612 173.277 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -147.89 142.66 26.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.186 1.795 . . . . 3.9399999999999999 110.867 178.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.92 139.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.393 1.877 . . . . 1.3899999999999999 107.86 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.6 mt -143.49 108.21 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.534 1.134 . . . . 1.96 108.811 -175.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -92.53 150.39 20.78 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.86 1.059 . . . . 2.1099999999999999 113.86 -177.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.49 159.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.795 1.238 . . . . 1.6699999999999999 110.367 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.21 148.5 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.991 1.316 . . . . 2.4500000000000002 109.849 168.332 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.1 mt -143.76 129.39 9.91 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.379 1.872 . . . . 1.6599999999999999 109.051 -178.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.0 156.93 61.54 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.137 2.558 . . . . 1.05 112.561 175.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -88.92 113.37 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.102 1.361 . . . . 1.3799999999999999 110.487 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -107.36 179.29 4.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.038 2.535 . . . . 4.4900000000000002 108.595 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.27 123.3 17.84 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.663 -1.273 . . . . 2.4900000000000002 109.755 171.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 4.1 tpt180 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.139 0.976 . . . . 4.6900000000000004 113.311 -161.412 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.281 0 N-CA-C 108.828 -1.709 . . . . 12.41 108.828 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 t -84.39 -151.03 0.12 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 108.241 -1.022 . . . . 12.66 108.241 148.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -68.75 68.74 0.16 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.591 1.556 . . . . 18.280000000000001 110.85 167.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.0 p -148.03 -11.66 0.37 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 128.322 2.649 . . . . 7.71 113.675 -160.003 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -156.68 154.75 30.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 130.97 3.708 . . . . 5.6399999999999997 106.867 -172.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -107.36 167.39 13.62 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 116.155 1.222 . . . . 1.1299999999999999 116.155 -163.259 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -156.14 146.29 21.44 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.616 1.567 . . . . 1.8700000000000001 112.497 173.654 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.7 139.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.328 -1.36 . . . . 1.6299999999999999 107.328 154.212 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 103.22 12.64 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.931 -0.481 . . . . 4.04 111.733 -173.128 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.93 110.0 1.22 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.591 1.186 . . . . 3.3199999999999998 110.379 163.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -158.88 144.79 12.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.986 1.714 . . . . 2.27 108.58 161.572 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.76 74.23 5.3 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.061 3.174 . . . . 2.6600000000000001 111.248 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.92 148.31 19.5 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.05 1.309 . . . . 1.6499999999999999 111.756 172.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.57 -25.04 47.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.981 2.454 . . . . 1.4399999999999999 111.845 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -107.73 138.85 43.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.182 1.393 . . . . 3.9900000000000002 108.982 153.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 163.78 31.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.551 1.94 . . . . 1.55 108.081 160.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.46 169.83 14.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.148 0.795 . . . . 1.2 113.148 -177.599 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.2 148.62 27.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.306 1.042 . . . . 1.1000000000000001 112.482 165.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.04 159.81 41.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.017 1.727 . . . . 2.1600000000000001 111.296 -172.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -163.47 146.37 10.1 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.448 1.277 . . . . 1.5900000000000001 114.448 -175.1 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -79.87 128.27 33.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.661 -1.154 . . . . 2.0299999999999998 109.679 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.17 149.07 45.52 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.709 1.603 . . . . 2.7599999999999998 110.987 -175.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -157.68 153.04 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.739 0.781 . . . . 3.04 111.491 174.339 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -104.8 105.0 49.12 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 0.98999999999999999 109.19 177.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.09 -11.23 13.61 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.834 2.356 . . . . 1.03 113.676 177.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.86 177.78 53.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.677 1.126 . . . . 0.98999999999999999 113.467 -174.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -102.61 12.67 36.06 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.704 1.602 . . . . 2.3799999999999999 111.588 178.089 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.03 158.65 34.47 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.059 2.144 . . . . 2.7799999999999998 109.149 174.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.05 148.77 17.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.805 2.337 . . . . 1.3999999999999999 110.266 172.364 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -121.61 119.56 32.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.405 1.082 . . . . 2.8500000000000001 110.317 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -109.06 106.46 16.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.526 1.53 . . . . 3.1600000000000001 109.79 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -92.3 116.23 28.78 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.103 2.161 . . . . 0.71999999999999997 108.76 -173.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.78 -9.37 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.154 0.982 . . . . 0.56999999999999995 112.714 -166.602 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.6 -162.66 32.07 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 124.875 1.226 . . . . 0.46999999999999997 111.41 171.651 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.01 171.76 17.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.455 1.102 . . . . 0.70999999999999996 110.539 168.187 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.83 130.4 16.85 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.622 -1.621 . . . . 6.0300000000000002 106.622 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 t -127.48 157.51 72.71 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 117.385 -1.293 . . . . 0.90000000000000002 108.162 177.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -63.06 -25.36 73.46 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.036 1.824 . . . . 1.1100000000000001 113.313 160.314 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -80.35 12.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.904 1.446 . . . . 1.25 114.904 -172.192 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.31 153.68 49.01 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.313 1.445 . . . . 1.5700000000000001 113.941 -172.222 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.88 -42.65 9.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.628 1.571 . . . . 4.0300000000000002 111.581 168.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.13 176.25 12.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 7.5599999999999996 110.543 151.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -155.65 144.13 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.602 1.961 . . . . 1.8600000000000001 109.569 -170.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -127.06 136.21 51.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.171 1.788 . . . . 2.2599999999999998 110.566 -176.808 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -88.77 123.23 32.98 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.154 1.343 . . . . 0.76000000000000001 112.067 169.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 13.3 m170 -110.88 153.54 25.31 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.762 2.025 . . . . 0.68000000000000005 113.129 175.3 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -86.23 170.28 12.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.846 1.658 . . . . 2.3300000000000001 111.278 161.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 m -146.73 126.86 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.015 1.326 . . . . 1.3200000000000001 108.182 169.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -140.85 173.46 11.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.154 1.168 . . . . 2.4199999999999999 114.154 -152.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -126.89 141.98 51.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.037 1.735 . . . . 3.98 108.676 159.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -149.45 165.67 31.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.066 1.746 . . . . 8.2200000000000006 109.987 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.68 136.96 43.82 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.634 0.774 . . . . 3.8900000000000001 110.092 169.115 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.96 -6.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 114.228 1.196 . . . . 2.9100000000000001 114.228 173.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -168.37 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.873 2.069 . . . . 4.2300000000000004 110.682 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.42 -16.95 4.48 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.043 -1.661 . . . . 2.54 113.689 -163.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -82.58 142.13 32.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.736 1.268 . . . . 3.6000000000000001 110.374 161.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.485 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.83 127.32 35.96 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.509 1.124 . . . . 5.0099999999999998 109.358 177.766 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -135.72 145.22 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.029 1.332 . . . . 2.1499999999999999 110.157 -170.327 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -82.97 158.45 22.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.62 1.568 . . . . 3.3500000000000001 113.191 -176.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.59 -179.56 45.26 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.453 0.549 . . . . 1.4199999999999999 113.957 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -132.35 158.06 42.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.905 1.682 . . . . 1.48 110.49 176.469 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -160.23 147.45 12.46 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.569 1.548 . . . . 5.6799999999999997 109.924 169.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.1 Cg_endo -63.72 148.14 92.24 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.655 1.57 . . . . 0.87 110.255 163.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.26 155.13 71.83 Favored Pre-proline 0 N--CA 1.472 0.647 0 C-N-CA 125.459 1.504 . . . . 0.57999999999999996 110.734 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.99 -23.88 24.69 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.666 2.244 . . . . 0.69999999999999996 112.541 178.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -171.78 165.68 6.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.388 1.075 . . . . 1.8600000000000001 112.62 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -113.94 172.79 6.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.289 1.835 . . . . 1.0 109.188 155.154 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -154.61 167.86 28.71 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.543 -0.723 . . . . 2.0499999999999998 111.518 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.6 t -144.37 130.07 9.71 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.042 1.737 . . . . 0.87 108.425 -169.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -70.43 164.7 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.319 2.013 . . . . 0.94999999999999996 110.94 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.79 139.5 91.06 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.671 2.247 . . . . 1.1000000000000001 110.547 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm 66.59 6.42 4.44 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.993 1.717 . . . . 1.5700000000000001 113.549 -175.339 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.33 120.52 5.21 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 127.701 2.572 . . . . 1.1599999999999999 112.623 -176.11 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -90.32 138.23 31.71 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.294 1.838 . . . . 4.0 111.424 167.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.09 125.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.976 1.31 . . . . 1.3700000000000001 112.877 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.08 121.8 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.269 1.028 . . . . 4.2300000000000004 111.586 170.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.69 147.12 46.0 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.333 1.063 . . . . 1.8600000000000001 110.07 161.103 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -172.25 150.71 2.4 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.964 1.306 . . . . 2.6000000000000001 111.197 -158.172 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.99 -47.9 9.6 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.758 2.305 . . . . 1.0600000000000001 111.515 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.19 70.95 2.86 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.807 -0.917 . . . . 1.72 110.807 166.509 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.44 -96.45 0.12 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.363 1.458 . . . . 1.1399999999999999 113.711 -176.068 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -149.37 138.32 21.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.949 1.699 . . . . 1.8400000000000001 108.695 -172.121 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -157.97 162.28 38.2 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.231 -0.293 . . . . 0.68999999999999995 110.794 -168.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -95.32 135.4 36.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.475 0.71 . . . . 2.1000000000000001 110.468 169.21 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -95.67 126.72 41.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.112 1.365 . . . . 1.1299999999999999 108.913 160.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.75 157.5 23.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.143 0.577 . . . . 2.3599999999999999 110.33 173.001 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 78.32 1.6 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.484 1.135 . . . . 3.0800000000000001 111.381 176.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.19 114.13 3.74 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.757 2.122 . . . . 1.6599999999999999 110.299 -170.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.16 126.31 44.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.606 1.163 . . . . 1.3300000000000001 110.444 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -92.02 -25.11 18.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.194 0.812 . . . . 2.46 113.194 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.31 151.69 40.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.645 -0.872 . . . . 4.4500000000000002 108.645 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.95 -14.53 23.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.569 2.179 . . . . 3.2400000000000002 115.41 177.161 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.3 mt 66.71 102.34 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 130.996 3.719 . . . . 2.5 110.373 -178.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -106.88 143.21 35.31 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.881 0.873 . . . . 6.2300000000000004 109.739 161.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -45.41 124.17 4.66 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.483 -0.78 . . . . 1.6299999999999999 109.643 159.325 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.57 3.08 81.47 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 117.361 -1.799 . . . . 2.1699999999999999 116.426 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.73 161.52 30.15 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 121.15 2.475 . . . . 2.5499999999999998 109.75 162.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.95 154.99 19.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.24 1.416 . . . . 3.8100000000000001 110.993 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.15 112.52 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 126.044 1.737 . . . . 1.6100000000000001 108.63 -176.117 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -74.22 142.29 45.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.231 -0.655 . . . . 3.1299999999999999 109.231 155.622 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt -146.57 117.32 7.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.282 1.033 . . . . 1.55 111.326 175.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.9 92.4 8.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.678 3.191 . . . . 2.1499999999999999 109.222 170.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.68 125.25 28.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.468 1.107 . . . . 1.3600000000000001 109.68 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt -97.01 132.23 43.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.867 1.267 . . . . 0.73999999999999999 111.243 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -131.6 146.52 52.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.076 0.941 . . . . 2.2000000000000002 112.789 -174.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.34 165.13 14.67 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.749 -0.594 . . . . 2.23 111.84 170.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.58 26.48 65.27 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.461 -0.775 . . . . 4.6799999999999997 113.272 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.87 63.04 3.48 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.823 1.201 . . . . 1.96 111.562 176.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -146.75 161.3 40.91 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 123.111 1.434 . . . . 4.29 113.028 -171.466 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 p -171.9 146.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.125 2.97 . . . . 1.3600000000000001 108.137 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt -140.24 123.67 17.0 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.618 1.167 . . . . 1.73 109.192 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -81.42 126.92 32.22 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.522 0.601 . . . . 2.5 111.381 167.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.29 166.15 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.876 1.671 . . . . 3.1200000000000001 108.381 168.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.2 130.32 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.316 1.447 . . . . 2.0099999999999998 110.764 178.819 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mp -139.05 166.91 21.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.796 2.438 . . . . 2.6000000000000001 109.37 -176.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.67 170.78 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.14 2.56 . . . . 1.6200000000000001 113.581 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.8 t -95.77 136.79 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 127.656 2.383 . . . . 1.5 107.721 155.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -153.53 158.68 41.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.584 0.754 . . . . 5.0499999999999998 111.548 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.21 3.35 24.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.358 1.984 . . . . 2.2400000000000002 116.358 -164.017 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.937 0 N-CA-C 113.492 0.923 . . . . 6.1600000000000001 113.492 -162.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.884 0 N-CA-C 108.075 -2.01 . . . . 12.210000000000001 108.075 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -41.23 96.39 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.196 0.998 . . . . 11.59 112.175 163.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -129.01 162.92 26.51 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.784 1.234 . . . . 8.5700000000000003 111.151 172.026 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.3 p -163.2 97.96 0.92 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.969 2.508 . . . . 7.6600000000000001 107.911 163.054 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -81.92 66.1 7.34 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.397 1.079 . . . . 7.1699999999999999 110.733 -174.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.26 159.27 23.29 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 115.929 1.131 . . . . 1.03 115.929 -169.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -150.41 136.99 18.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.609 1.164 . . . . 1.5900000000000001 112.201 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -90.67 131.76 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.702 -0.851 . . . . 0.83999999999999997 108.702 164.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.61 47.47 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.939 0.718 . . . . 7.8600000000000003 112.939 -173.102 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.63 103.48 1.72 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.563 1.173 . . . . 4.0 110.993 163.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.89 140.71 0.57 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.854 1.661 . . . . 3.4700000000000002 109.926 157.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.36 3.4 7.83 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.071 3.181 . . . . 3.7000000000000002 114.471 -173.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.01 145.88 49.74 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 119.537 1.062 . . . . 1.77 113.028 -175.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.98 -15.07 47.38 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.113 3.209 . . . . 2.4500000000000002 113.676 -171.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -139.35 167.03 23.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.134 0.974 . . . . 2.8300000000000001 111.794 159.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 159.65 174.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.493 3.517 . . . . 3.2599999999999998 109.87 171.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.69 171.86 13.15 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.058 1.133 . . . . 2.0699999999999998 114.058 -177.211 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 160.12 40.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.692 2.797 . . . . 1.8999999999999999 109.151 170.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -144.0 158.28 43.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.101 0.953 . . . . 2.1499999999999999 112.644 -164.034 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.48 159.57 28.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.582 0.956 . . . . 1.8500000000000001 113.582 173.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 m -123.77 147.73 47.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.869 -1.514 . . . . 2.23 107.331 164.067 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tp -136.83 153.43 50.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.053 1.341 . . . . 4.3399999999999999 110.985 -175.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -108.95 135.61 49.85 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.53 1.932 . . . . 3.98 108.094 168.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -102.46 91.34 2.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.02 -0.514 . . . . 1.3200000000000001 109.967 160.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.45 -11.11 18.97 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.314 2.009 . . . . 1.8500000000000001 113.487 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.33 52.41 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 118.907 0.776 . . . . 1.48 113.195 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.56 3.08 51.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.741 . . . . 2.8999999999999999 113.609 -177.381 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.99 159.97 56.54 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.59 1.556 . . . . 2.21 110.799 174.29 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.34 166.17 22.66 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.845 2.363 . . . . 1.6299999999999999 112.657 -164.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.0 154.65 21.88 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.22 1.008 . . . . 3.0299999999999998 111.008 165.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -148.88 104.99 3.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.177 1.791 . . . . 3.6699999999999999 109.654 170.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.7 tp -91.64 111.8 23.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.634 2.374 . . . . 0.81999999999999995 109.886 -168.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -97.85 -15.32 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.849 1.259 . . . . 0.64000000000000001 112.857 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.65 -164.93 36.66 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.685 -0.634 . . . . 0.56999999999999995 112.62 175.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.5 172.52 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.816 0.846 . . . . 0.82999999999999996 111.242 166.702 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.78 144.49 23.53 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.717 0.689 . . . . 5.0700000000000003 111.663 171.23 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 t -141.1 149.53 55.89 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 125.875 1.67 . . . . 0.65000000000000002 108.93 -166.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.65 -19.23 42.1 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.124 1.883 . . . . 1.0 113.232 173.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -71.21 -4.39 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 114.331 1.234 . . . . 1.3200000000000001 114.331 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.31 174.38 12.91 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.593 1.701 . . . . 1.48 115.593 -167.135 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -108.58 -42.92 4.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.897 2.079 . . . . 3.3900000000000001 110.429 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -129.61 161.88 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.216 1.406 . . . . 5.1600000000000001 112.057 172.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -176.21 126.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.256 1.822 . . . . 1.95 108.798 -173.38 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -145.21 137.07 25.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.057 1.343 . . . . 4.4500000000000002 109.475 -164.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.5 123.62 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.636 0.732 . . . . 0.81000000000000005 111.461 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.83 153.8 22.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.719 1.608 . . . . 0.67000000000000004 113.584 173.795 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -91.55 170.7 9.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.875 2.07 . . . . 2.2000000000000002 110.715 158.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.9 m -149.46 114.59 5.45 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.608 1.563 . . . . 1.51 107.837 173.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -119.8 157.21 29.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.956 1.302 . . . . 2.3399999999999999 112.841 -162.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -94.46 158.61 15.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.224 1.01 . . . . 3.52 110.555 160.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.37 150.22 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 5.96 110.378 176.001 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.3 140.54 29.66 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.799 -0.815 . . . . 3.5299999999999998 108.799 160.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.51 114.4 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.661 1.584 . . . . 2.6200000000000001 107.365 -178.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 64.99 1.27 1.42 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.204 1.802 . . . . 4.7000000000000002 112.569 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.56 -11.76 58.05 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.644 1.593 . . . . 1.8700000000000001 113.879 -166.51 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -76.77 136.55 39.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.275 1.537 . . . . 4.4800000000000004 109.656 172.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -77.54 126.77 31.42 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.678 -0.639 . . . . 3.73 110.73 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.8 t -135.25 155.74 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.58 1.952 . . . . 2.1499999999999999 109.097 -173.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.1 mtm -128.7 154.12 46.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.131 0.972 . . . . 3.5800000000000001 110.785 171.515 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.39 30.63 Favored Glycine 0 N--CA 1.468 0.827 0 C-N-CA 124.07 0.843 . . . . 1.25 113.333 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.56 161.42 35.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.47 1.508 . . . . 2.8799999999999999 109.954 -177.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -165.62 134.55 2.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 116.679 -1.629 . . . . 4.5300000000000002 110.311 -173.463 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.56 146.37 84.49 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 122.322 1.865 . . . . 0.64000000000000001 110.391 163.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.32 158.32 67.29 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 125.677 1.591 . . . . 0.66000000000000003 111.237 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.53 -24.5 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.822 2.348 . . . . 0.65000000000000002 112.73 176.315 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -173.87 166.81 4.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.649 1.18 . . . . 1.73 113.176 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.19 170.14 8.43 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.408 1.883 . . . . 1.1000000000000001 109.799 152.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -156.65 164.56 38.03 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.354 -0.841 . . . . 1.8899999999999999 113.179 176.1 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -154.43 141.18 13.22 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.963 0.905 . . . . 0.98999999999999999 110.452 -160.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.38 171.54 14.96 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.343 2.028 . . . . 0.89000000000000001 112.651 168.304 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.71 148.43 92.13 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.28 3.32 . . . . 1.0700000000000001 112.267 163.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 69.69 -2.96 1.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.71 2.004 . . . . 1.6699999999999999 114.123 179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.61 115.88 4.18 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 125.824 1.678 . . . . 0.98999999999999999 111.583 -178.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.04 128.98 36.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.115 0.566 . . . . 6.8200000000000003 110.561 162.187 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.28 158.18 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 1.76 112.087 -164.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -146.42 114.25 6.48 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.269 0.628 . . . . 4.0700000000000003 109.684 -141.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.24 83.39 6.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.096 0.958 . . . . 1.6399999999999999 109.13 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -72.4 142.18 84.0 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.539 -1.22 . . . . 2.7599999999999998 109.769 178.027 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.51 -39.15 85.9 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.698 2.266 . . . . 1.3799999999999999 112.516 -178.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.94 61.68 4.7 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.899 0.761 . . . . 1.8 111.394 165.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -69.36 0.07 OUTLIER Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.746 1.165 . . . . 1.2 114.168 -177.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -154.12 143.67 21.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.043 1.737 . . . . 1.96 109.052 -171.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -167.25 165.49 15.25 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.494 -0.754 . . . . 1.05 110.219 -177.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.64 135.9 37.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.962 -0.385 . . . . 2.0800000000000001 109.962 169.336 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -79.54 132.7 36.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.0 -0.741 . . . . 1.1699999999999999 109.0 152.159 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.1 139.47 39.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.517 1.127 . . . . 1.97 108.687 164.463 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -137.38 136.42 37.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.683 1.193 . . . . 2.6299999999999999 111.38 -175.648 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 42.73 99.4 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 1.6599999999999999 111.301 178.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.312 0.2 OUTLIER -68.76 87.48 0.35 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.434 1.588 . . . . 1.8500000000000001 113.91 -173.736 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -67.64 5.55 0.8 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.04 2.536 . . . . 2.1000000000000001 115.553 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -127.14 105.83 22.02 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.483 1.113 . . . . 6.3099999999999996 109.514 146.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.87 144.81 60.21 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.165 2.576 . . . . 1.76 111.073 172.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.14 126.32 33.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 2.0699999999999998 110.839 -177.589 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -98.34 -31.2 12.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.705 1.202 . . . . 4.9500000000000002 113.01 -175.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 122.06 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 1 C-N-CA 132.153 4.181 . . . . 1.5 110.468 175.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.23 37.0 93.51 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.355 -0.692 . . . . 1.9399999999999999 113.569 178.051 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.92 -171.8 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 2.9100000000000001 108.629 178.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -141.99 162.06 36.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.197 0.999 . . . . 3.3500000000000001 110.673 174.612 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.86 119.78 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.53 1.532 . . . . 0.83999999999999997 109.894 -169.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.48 135.94 52.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 3.0800000000000001 110.456 162.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -155.94 124.4 5.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.816 0.846 . . . . 1.5900000000000001 112.615 -175.334 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.67 105.57 17.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.739 1.616 . . . . 1.99 110.571 172.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.02 117.69 21.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.594 0.757 . . . . 1.22 110.418 176.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.77 126.27 38.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.877 1.271 . . . . 0.57999999999999996 111.045 -169.02 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -122.97 139.46 54.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.179 0.807 . . . . 1.8400000000000001 113.179 -175.289 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.22 104.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.273 1.029 . . . . 2.75 112.634 -177.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.26 78.57 1.05 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.012 1.292 . . . . 4.7300000000000004 113.087 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.28 -0.37 24.94 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 116.193 1.237 . . . . 1.96 116.193 169.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -110.13 132.18 54.4 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.014 1.407 . . . . 5.7400000000000002 112.761 -170.518 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.35 134.31 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.794 1.638 . . . . 1.1399999999999999 107.384 160.167 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.3 mt -120.15 110.16 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.937 -1.134 . . . . 1.99 107.937 177.227 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -80.04 127.6 32.48 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.16 -0.337 . . . . 2.4700000000000002 110.886 176.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.5 m -125.96 161.87 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.87 1.668 . . . . 1.1399999999999999 110.499 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.66 135.94 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.302 1.041 . . . . 1.9299999999999999 108.709 165.151 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -127.35 147.81 63.7 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.24 1.416 . . . . 1.5900000000000001 108.943 172.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.26 161.43 44.48 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.151 2.568 . . . . 1.0 111.942 174.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.6 133.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.302 1.441 . . . . 1.26 108.595 165.069 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.64 153.82 25.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.52 1.128 . . . . 3.9500000000000002 110.023 171.084 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 2.69 -113.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 130.163 3.385 . . . . 3.5299999999999998 117.632 175.497 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.775 0 CA-C-O 114.866 -2.492 . . . . 9.1199999999999992 112.348 178.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 N-CA-C 109.205 -1.558 . . . . 11.300000000000001 109.205 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 68.75 179.43 0.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.409 1.084 . . . . 8.6300000000000008 113.312 -175.382 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -85.44 -24.52 27.42 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.677 1.191 . . . . 9.5800000000000001 112.056 157.135 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.272 57.9 p 106.54 110.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 1 C-N-CA 133.345 4.658 . . . . 7.5199999999999996 110.806 177.291 . . . . . . . . 3 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -85.16 87.63 7.4 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.86 0.864 . . . . 5.9900000000000002 110.512 -172.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.07 171.46 29.32 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.577 1.561 . . . . 1.1100000000000001 113.694 176.499 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -155.36 153.8 31.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.274 1.429 . . . . 1.5600000000000001 112.126 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 99' ' ' VAL . 90.6 t -105.49 136.54 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.569 -1.271 . . . . 1.0800000000000001 107.569 172.075 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -86.1 -0.31 55.31 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.486 2.032 . . . . 5.25 116.486 -153.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 60.65 168.65 0.09 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.87 1.668 . . . . 3.25 112.511 -168.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 t -165.73 145.69 5.48 Favored Pre-proline 0 N--CA 1.47 0.559 0 O-C-N 120.457 -1.402 . . . . 3.4399999999999999 112.372 162.556 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.32 -6.35 11.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.455 2.77 . . . . 3.3300000000000001 112.486 164.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.65 171.31 15.52 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.405 1.479 . . . . 1.8799999999999999 113.757 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.08 -3.16 13.16 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.931 3.754 . . . . 1.8 113.811 -176.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -121.83 156.51 33.1 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.215 1.806 . . . . 2.1400000000000001 112.133 171.539 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.79 177.06 11.82 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.38 1.472 . . . . 1.3 112.091 -171.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.57 20.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.475 1.11 . . . . 1.02 112.753 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.31 159.3 38.7 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.072 1.138 . . . . 1.1699999999999999 114.072 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -148.24 151.28 35.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.213 2.205 . . . . 2.4900000000000002 110.634 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -168.5 151.07 5.22 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.411 0.893 . . . . 1.6399999999999999 113.411 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -95.48 131.11 41.99 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.458 1.903 . . . . 1.6200000000000001 108.92 171.115 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.32 160.68 39.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.683 1.193 . . . . 4.4800000000000004 111.173 178.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.98 127.29 10.62 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.967 0.907 . . . . 3.29 110.779 -169.316 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -85.97 116.34 65.34 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.278 1.031 . . . . 0.93000000000000005 109.694 174.303 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -87.2 -14.01 4.18 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.082 2.522 . . . . 1.23 114.374 178.164 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.38 174.38 32.2 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 119.212 0.915 . . . . 1.1599999999999999 113.206 -174.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.01 -2.48 58.14 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.571 1.548 . . . . 3.7400000000000002 114.587 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -97.63 158.79 32.44 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.479 1.112 . . . . 2.02 111.138 173.656 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.59 157.52 12.29 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.377 2.718 . . . . 1.3500000000000001 111.229 -176.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.21 108.02 9.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.634 0.73 . . . . 2.1400000000000001 111.688 -170.885 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -99.96 106.23 18.0 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.696 1.198 . . . . 2.73 111.675 -177.019 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.1 tp -85.4 114.86 22.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.583 1.953 . . . . 0.69999999999999996 109.431 -177.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.71 -12.19 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.829 0.851 . . . . 0.88 112.884 -171.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.45 -168.04 40.59 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.665 1.126 . . . . 0.81000000000000005 111.098 173.15 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.37 140.69 20.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.638 0.775 . . . . 1.96 110.592 167.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -108.54 139.75 42.86 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.714 1.606 . . . . 6.8899999999999997 108.538 -169.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -152.41 155.7 33.09 Favored Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 124.593 1.157 . . . . 0.83999999999999997 109.874 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -86.58 -9.9 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.729 2.286 . . . . 1.4099999999999999 113.527 165.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 m -70.27 -9.52 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.343 0.974 . . . . 1.98 113.443 176.384 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 160.74 30.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.171 1.351 . . . . 0.93999999999999995 112.285 -169.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.28 -68.76 0.79 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.173 1.389 . . . . 3.0099999999999998 109.14 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -82.01 111.9 18.6 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.078 -1.014 . . . . 3.6299999999999999 109.405 171.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.62 145.78 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.524 1.13 . . . . 1.47 109.444 153.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -137.25 122.87 19.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.54 1.536 . . . . 2.1400000000000001 108.542 162.756 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.26 119.79 22.11 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 120.934 1.697 . . . . 0.68000000000000005 110.045 167.299 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -109.06 157.02 19.1 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.318 1.847 . . . . 0.58999999999999997 112.247 176.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 12.1 pt-20 -104.38 168.18 9.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.852 -1.067 . . . . 2.3700000000000001 110.264 161.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.7 m -130.03 107.48 9.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.342 1.457 . . . . 1.1299999999999999 107.3 170.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -113.27 154.92 26.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.859 1.264 . . . . 2.3300000000000001 112.508 -171.569 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -90.52 154.45 19.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.655 1.182 . . . . 3.3100000000000001 112.334 172.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.41 15.53 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.033 1.333 . . . . 5.5899999999999999 113.214 177.513 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -138.74 142.13 38.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.969 1.307 . . . . 4.8200000000000003 109.473 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.59 128.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.501 1.12 . . . . 3.8300000000000001 108.981 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 56.29 28.21 13.0 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.175 0.988 . . . . 4.1699999999999999 111.011 -168.313 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.12 -0.42 11.74 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.506 2.003 . . . . 3.2000000000000002 114.996 -173.285 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.69 126.11 30.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.444 1.498 . . . . 3.4199999999999999 108.785 174.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.47 126.89 52.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.371 1.468 . . . . 6.21 110.785 -162.228 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.8 t -145.67 153.17 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.915 1.286 . . . . 1.5900000000000001 110.586 -156.741 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.4 mtm -120.81 149.44 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.387 1.075 . . . . 2.8399999999999999 110.413 161.022 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.64 158.64 27.75 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.917 0.77 . . . . 1.1399999999999999 112.733 178.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -102.73 155.48 18.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.564 1.146 . . . . 1.6299999999999999 111.897 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.412 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -163.91 146.5 7.62 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-O 117.693 -1.146 . . . . 5.6699999999999999 112.255 171.733 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.38 142.13 53.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.881 2.387 . . . . 0.64000000000000001 111.419 172.005 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.76 157.54 38.19 Favored Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.303 1.441 . . . . 0.71999999999999997 110.763 175.501 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.44 -18.66 38.4 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.434 2.089 . . . . 0.62 112.743 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -179.42 167.04 1.47 Allowed 'General case' 0 C--N 1.347 0.459 0 C-N-CA 126.128 1.771 . . . . 1.8100000000000001 110.076 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -114.91 171.09 7.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.274 1.83 . . . . 0.98999999999999999 108.89 157.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.32 167.76 29.35 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.142 -0.974 . . . . 2.52 113.353 167.611 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.75 134.69 16.21 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.053 1.341 . . . . 0.79000000000000004 109.381 -172.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.42 164.58 33.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.223 1.949 . . . . 0.80000000000000004 111.611 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.14 139.7 85.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.831 3.021 . . . . 0.83999999999999997 111.919 174.501 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.54 1.67 1.4 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.345 1.858 . . . . 3.1800000000000002 115.128 -171.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 118.44 4.78 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 127.669 2.556 . . . . 0.90000000000000002 111.971 -178.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -91.79 137.03 32.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.874 1.27 . . . . 3.8300000000000001 111.021 159.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.7 m -150.31 157.45 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.785 1.634 . . . . 1.52 110.705 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.12 152.62 34.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.392 1.091 . . . . 3.73 112.826 169.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.79 77.29 2.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.955 1.302 . . . . 1.3999999999999999 108.733 161.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.2 137.51 78.71 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.393 1.077 . . . . 3.3700000000000001 112.399 177.59 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.53 -34.56 85.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.905 3.07 . . . . 1.6299999999999999 114.476 -169.568 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.7 121.54 6.29 Favored Glycine 0 N--CA 1.468 0.824 0 N-CA-C 106.889 -2.484 . . . . 1.47 106.889 150.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.86 -94.72 0.5 Allowed Glycine 0 N--CA 1.47 0.909 0 CA-C-N 119.786 1.793 . . . . 1.6000000000000001 112.967 -161.082 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 54.7 m-85 -148.12 149.06 31.34 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.042 2.137 . . . . 1.9199999999999999 111.633 -169.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.7 163.7 14.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.307 1.043 . . . . 1.01 109.982 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -93.39 138.19 31.96 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 122.02 -0.425 . . . . 2.4300000000000002 109.937 167.187 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.6 mmt -96.98 139.49 32.91 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.348 1.059 . . . . 0.83999999999999997 109.421 157.068 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.58 142.62 51.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.484 1.513 . . . . 2.8799999999999999 109.933 -178.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -145.99 133.65 21.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 3.0299999999999998 111.505 -174.838 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.74 74.37 1.09 Allowed Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.274 -0.73 . . . . 1.47 111.274 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.67 119.41 25.21 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.471 0.915 . . . . 1.1299999999999999 113.471 -163.562 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -90.6 -8.99 48.66 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.896 1.443 . . . . 1.8100000000000001 114.896 -169.684 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.22 145.08 56.16 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.204 1.401 . . . . 6.1500000000000004 108.038 160.489 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 128.76 15.19 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 107.169 -1.896 . . . . 2.0800000000000001 107.169 168.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.37 95.76 0.33 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.087 1.355 . . . . 2.3199999999999998 110.506 -168.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -68.99 111.81 5.23 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 120.657 -1.277 . . . . 4.9900000000000002 108.693 177.602 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.94 108.93 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.123 -0.985 . . . . 1.78 110.431 167.416 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.06 16.65 40.37 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 117.213 -1.882 . . . . 1.79 116.036 -170.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.08 171.59 12.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.793 2.297 . . . . 4.3899999999999997 109.045 150.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.219 1.408 . . . . 4.3300000000000001 108.621 170.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 8' ' ' VAL . 58.9 t -98.41 119.66 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.916 0.887 . . . . 1.0800000000000001 110.062 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.71 45.12 1.04 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 128.282 2.633 . . . . 5.5999999999999996 113.185 -170.756 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.41 130.22 42.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.483 1.913 . . . . 1.79 113.902 -164.18 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -92.02 93.28 8.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.457 2.703 . . . . 2.3199999999999998 110.892 175.353 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.1 mt -71.48 120.61 17.31 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.396 -0.815 . . . . 1.47 110.52 -179.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt -93.27 125.26 37.78 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.546 1.538 . . . . 1.0 111.114 -169.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.73 125.63 44.37 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.468 0.914 . . . . 1.8600000000000001 113.468 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 53.44 11.37 0.27 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.444 2.298 . . . . 2.1099999999999999 116.685 167.53 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.92 4.02 46.22 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.959 -1.088 . . . . 3.3399999999999999 114.409 -168.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -129.91 -4.71 4.6 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.727 1.156 . . . . 1.8 115.64 -171.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.69 158.37 43.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.423 2.289 . . . . 4.0999999999999996 110.831 173.123 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.8 135.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.949 1.7 . . . . 1.54 107.582 165.589 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.61 115.33 12.9 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.86 1.264 . . . . 1.72 107.77 -173.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -102.84 141.64 35.31 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.456 1.28 . . . . 2.7200000000000002 114.456 -171.324 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.68 167.75 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.562 1.545 . . . . 1.52 110.09 -173.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.87 144.81 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 124.641 1.176 . . . . 2.9100000000000001 109.733 172.245 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.42 133.17 6.67 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.551 -0.738 . . . . 2.3100000000000001 111.162 176.475 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.06 150.34 82.5 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.566 2.844 . . . . 1.51 112.623 -172.795 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.3 112.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.337 1.055 . . . . 1.6100000000000001 108.492 166.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.88 -169.95 2.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.099 2.96 . . . . 3.7400000000000002 108.649 178.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.53 53.0 1.8 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.202 1.556 . . . . 2.6200000000000001 115.202 -161.29 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 115.58 -2.152 . . . . 8.3699999999999992 115.045 178.599 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.455 0 N-CA-C 109.239 -1.544 . . . . 14.44 109.239 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -165.97 168.29 15.83 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.578 1.551 . . . . 10.68 108.5 -178.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -107.54 107.81 18.82 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.889 -1.523 . . . . 9.0 106.889 155.331 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 m -149.44 112.0 4.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 105.263 -2.125 . . . . 6.7800000000000002 105.263 -177.338 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -116.47 125.42 51.94 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.016 -1.447 . . . . 4.4199999999999999 109.53 -155.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.72 174.75 43.36 Favored Glycine 0 N--CA 1.465 0.592 0 O-C-N 121.94 -0.475 . . . . 1.1499999999999999 113.96 -178.749 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -155.51 151.04 27.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.947 0.899 . . . . 1.3799999999999999 112.167 -179.485 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.93 127.64 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.901 -0.499 . . . . 0.98999999999999999 110.016 174.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -72.63 -11.0 60.46 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.441 1.645 . . . . 4.7400000000000002 115.441 -159.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.94 160.81 0.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.372 1.469 . . . . 2.8199999999999998 113.949 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -165.82 149.93 7.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.048 1.739 . . . . 4.1900000000000004 110.497 166.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -83.64 -9.92 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.25 2.633 . . . . 3.75 112.024 162.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.9 -168.14 13.27 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.96 1.743 . . . . 2.3799999999999999 113.962 -174.283 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -74.0 -27.45 12.04 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.196 2.598 . . . . 2.1099999999999999 114.955 -165.099 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -98.63 150.85 21.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.144 1.338 . . . . 3.0 112.425 177.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.4 -179.9 8.53 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.032 2.133 . . . . 1.28 111.599 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.76 167.35 21.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.15 1.78 . . . . 1.0900000000000001 111.403 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.83 155.1 36.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.351 1.061 . . . . 1.1000000000000001 112.376 172.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 142.57 24.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.362 1.865 . . . . 2.1800000000000002 109.558 -171.895 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -171.24 159.37 5.8 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.318 1.599 . . . . 1.73 115.318 -174.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -71.9 138.48 48.19 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.305 1.842 . . . . 1.27 109.365 166.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.62 146.25 49.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.118 1.767 . . . . 3.6200000000000001 111.241 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -119.72 132.97 55.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.256 1.822 . . . . 5.0499999999999998 114.002 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -98.95 109.04 52.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.678 -0.692 . . . . 1.1699999999999999 109.851 143.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -89.2 -10.62 3.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.53 2.82 . . . . 1.25 113.565 173.254 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.58 -174.25 47.15 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.116 1.341 . . . . 0.92000000000000004 113.495 -174.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.56 -4.0 18.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.963 1.705 . . . . 2.3199999999999998 113.147 -169.253 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.42 161.43 39.27 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.653 1.981 . . . . 1.8700000000000001 109.644 169.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.71 163.09 29.44 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.826 2.351 . . . . 1.3500000000000001 112.632 -167.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.26 127.56 45.8 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.884 1.274 . . . . 2.3599999999999999 111.125 -174.528 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -111.16 112.98 25.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.907 1.283 . . . . 3.5099999999999998 110.648 175.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 tp -85.76 133.12 34.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.377 . . . . 0.96999999999999997 108.721 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.86 -13.02 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.034 0.934 . . . . 0.72999999999999998 113.516 -175.423 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.48 -164.98 34.47 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.002 0.811 . . . . 0.97999999999999998 111.74 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 102' ' ' ASP . . . -140.94 -175.92 4.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.459 0.704 . . . . 1.1399999999999999 110.632 160.651 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.88 146.56 9.54 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.069 0.948 . . . . 5.2199999999999998 111.644 171.075 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -140.34 152.32 66.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.017 1.727 . . . . 0.84999999999999998 109.253 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.13 -34.05 29.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 121.585 1.602 . . . . 0.95999999999999996 112.613 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 m -70.77 -18.82 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 115.244 1.572 . . . . 1.29 115.244 -167.028 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.3 143.03 50.79 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.843 1.257 . . . . 0.92000000000000004 111.078 -176.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -64.48 -53.83 42.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.262 1.025 . . . . 4.4199999999999999 111.8 172.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.14 160.76 21.51 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.372 1.869 . . . . 7.2400000000000002 111.055 -170.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -159.7 135.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.824 1.65 . . . . 1.1499999999999999 110.661 -172.136 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -139.87 135.1 32.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.324 1.85 . . . . 2.4100000000000001 109.72 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -83.33 118.74 23.89 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.436 1.016 . . . . 0.79000000000000004 111.012 168.144 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -106.41 155.25 19.74 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.178 1.791 . . . . 0.73999999999999999 112.044 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -157.27 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 3.75 111.019 174.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.8 m -151.32 123.98 8.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.478 2.311 . . . . 1.51 106.598 162.191 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -126.86 160.51 30.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.778 1.231 . . . . 2.48 112.431 -172.11 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.9 ptt? -134.24 122.18 22.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.988 1.375 . . . . 3.3999999999999999 112.587 159.762 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -117.52 162.41 18.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.245 1.818 . . . . 7.8499999999999996 110.927 -176.055 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.402 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 30.1 mp0 -77.19 144.42 38.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.893 1.677 . . . . 4.8099999999999996 111.479 171.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.49 -96.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.602 1.561 . . . . 3.2400000000000002 109.176 -176.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.02 31.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.088 1.355 . . . . 4.0300000000000002 112.44 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.58 -13.28 8.48 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.365 -1.459 . . . . 2.73 112.594 -154.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 152.72 28.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.318 1.847 . . . . 4.4100000000000001 110.763 178.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 41.6 mmtt -73.78 140.12 45.65 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.746 -0.596 . . . . 5.8600000000000003 110.668 158.539 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -132.85 145.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.159 1.784 . . . . 2.0699999999999998 108.259 165.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.8 tpp -101.52 146.9 27.04 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.229 2.212 . . . . 3.1499999999999999 111.016 -175.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.11 -174.98 33.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.935 1.255 . . . . 1.4399999999999999 113.64 174.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -138.38 152.2 48.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.672 1.589 . . . . 1.9099999999999999 110.196 173.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.39 148.33 16.44 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 124.664 1.186 . . . . 4.4500000000000002 110.932 -170.035 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.41 150.32 84.39 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 121.611 1.54 . . . . 0.76000000000000001 112.49 167.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.89 159.11 73.93 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 126.559 1.944 . . . . 0.82999999999999996 110.761 176.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.39 -18.35 14.02 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.039 2.493 . . . . 0.62 114.069 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -171.74 164.55 6.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.986 1.266 . . . . 2.0299999999999998 112.552 -178.665 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.15 168.61 12.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.737 2.415 . . . . 1.0600000000000001 108.572 161.165 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -161.88 163.82 28.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.975 -1.078 . . . . 2.1800000000000002 113.274 176.23 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 t -149.2 140.69 14.44 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.3 1.04 . . . . 1.53 110.601 -169.567 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.35 167.34 20.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.997 2.465 . . . . 1.23 112.016 171.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.25 146.72 97.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.604 2.87 . . . . 1.0 112.796 175.224 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt 66.92 -2.45 1.13 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.373 1.869 . . . . 1.3100000000000001 114.571 -178.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.97 117.86 4.58 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 126.65 2.071 . . . . 0.81000000000000005 111.343 178.673 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -83.34 145.35 29.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.834 -0.683 . . . . 6.3899999999999997 110.229 151.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.78 179.54 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.03 1.732 . . . . 1.53 109.398 171.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -121.39 139.75 53.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.771 0.828 . . . . 3.7000000000000002 111.217 166.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.16 76.69 1.27 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.805 -1.554 . . . . 1.1499999999999999 106.805 143.712 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -82.87 142.19 44.8 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 117.672 -1.156 . . . . 3.79 109.94 -177.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.66 -55.13 4.38 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.355 3.37 . . . . 1.75 114.959 -169.397 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.1 70.83 2.81 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.748 -0.941 . . . . 1.1599999999999999 110.748 172.012 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.84 -76.95 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.253 1.406 . . . . 0.90000000000000002 114.046 -166.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -155.63 142.1 18.63 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 1.8200000000000001 108.351 -177.012 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -163.1 179.12 7.72 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.254 -0.903 . . . . 0.80000000000000004 111.581 -172.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -109.29 139.92 43.61 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.108 -0.37 . . . . 2.0499999999999998 111.088 168.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 mmt -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.58 0.752 . . . . 1.1599999999999999 109.477 155.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.11 140.01 53.04 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.694 1.597 . . . . 2.6499999999999999 109.1 178.228 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.16 152.8 49.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.047 0.939 . . . . 3.3999999999999999 111.956 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.82 60.02 4.46 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.678 0.656 . . . . 1.5900000000000001 111.719 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -74.94 107.71 7.19 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.469 1.128 . . . . 1.3400000000000001 110.866 -178.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -70.98 -6.33 37.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.565 1.546 . . . . 2.48 115.014 -175.608 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -143.41 158.45 57.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.687 2.395 . . . . 6.9900000000000002 108.273 156.529 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.07 157.25 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.086 1.857 . . . . 2.02 109.741 156.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.78 166.67 10.52 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.399 1.479 . . . . 2.7400000000000002 111.915 -176.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 134.08 38.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.917 1.287 . . . . 3.6899999999999999 111.427 174.085 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.7 24.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.946 -1.096 . . . . 1.5900000000000001 110.219 173.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.44 54.98 2.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.129 0.395 . . . . 2.21 112.629 -162.024 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -143.05 160.83 39.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.619 2.368 . . . . 2.75 109.015 165.008 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -102.49 120.47 40.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.968 2.107 . . . . 4.3799999999999999 111.112 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.54 128.92 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.896 1.278 . . . . 0.95999999999999996 109.638 169.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -79.11 140.21 37.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.002 0.43 . . . . 2.52 110.976 159.454 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -148.26 127.13 12.67 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.892 0.877 . . . . 1.8799999999999999 112.092 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 18.2 m-20 -98.34 103.73 15.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.465 1.906 . . . . 2.5099999999999998 110.732 177.626 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.4 mt -68.86 112.43 5.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.997 0.817 . . . . 1.8799999999999999 110.575 168.716 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.0 mt -87.15 129.65 34.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.734 1.213 . . . . 1.0 111.049 -176.412 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.81 117.67 19.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.536 0.684 . . . . 2.3799999999999999 111.268 179.288 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.95 21.82 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.292 2.237 . . . . 1.97 116.729 168.525 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.47 -41.86 1.42 Allowed Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.228 1.394 . . . . 3.2400000000000002 114.17 -174.491 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.58 -1.82 72.76 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.073 1.32 . . . . 2.3999999999999999 114.877 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -148.47 157.15 43.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.372 1.469 . . . . 4.3799999999999999 113.828 179.082 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.97 140.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.179 2.192 . . . . 1.8700000000000001 108.224 168.402 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -125.55 111.97 15.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.881 1.272 . . . . 2.7400000000000002 109.29 176.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -88.78 125.72 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.771 -0.58 . . . . 2.1099999999999999 112.279 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.08 161.66 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.904 1.682 . . . . 1.6299999999999999 111.208 171.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 m -106.66 143.58 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 2.3799999999999999 109.235 163.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.38 145.87 39.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.606 1.163 . . . . 1.9199999999999999 111.624 179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.15 142.8 34.72 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.231 2.621 . . . . 1.1200000000000001 112.186 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -79.94 132.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.174 1.389 . . . . 1.0900000000000001 109.481 165.044 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -147.02 139.37 24.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.766 2.427 . . . . 4.25 107.276 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.62 52.9 2.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.455 1.502 . . . . 2.79 112.117 -170.473 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG 0.294 0.0 OUTLIER . . . . . 0 C--O 1.248 0.977 0 N-CA-C 117.414 2.375 . . . . 6.5700000000000003 117.414 -154.064 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.421 0 N-CA-C 107.317 -2.313 . . . . 11.75 107.317 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 t 175.29 179.44 0.14 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.253 1.421 . . . . 9.5399999999999991 108.561 -156.473 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -96.23 11.99 32.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.882 1.273 . . . . 10.720000000000001 113.027 169.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.55 149.09 46.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.409 1.884 . . . . 6.9800000000000004 113.907 -178.243 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.35 -159.24 0.9 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 128.892 2.877 . . . . 6.4100000000000001 108.298 171.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.4 -171.18 19.82 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 120.065 -1.647 . . . . 0.93999999999999995 115.688 -177.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -167.48 158.46 11.49 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.109 1.763 . . . . 1.3700000000000001 112.167 173.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.77 130.94 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.733 0.813 . . . . 0.93000000000000005 110.028 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -78.4 120.38 23.05 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.715 1.206 . . . . 4.0999999999999996 111.615 -174.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -62.46 123.66 18.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.951 1.3 . . . . 3.2400000000000002 110.459 164.246 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -155.83 160.93 30.44 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.866 1.666 . . . . 1.95 108.976 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.58 -159.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.303 3.335 . . . . 3.52 108.862 167.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.52 -161.5 46.58 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.88 0.752 . . . . 2.3599999999999999 112.558 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -87.22 -11.14 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.579 2.853 . . . . 2.1499999999999999 113.201 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -149.45 160.13 43.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.696 1.198 . . . . 2.1800000000000002 113.891 -168.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.5 -167.06 1.64 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.624 1.97 . . . . 1.26 110.385 -174.723 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.67 153.59 50.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.834 0.743 . . . . 1.23 112.689 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.9 153.03 46.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.69 1.196 . . . . 0.83999999999999997 110.281 163.352 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.15 156.12 46.0 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.781 1.232 . . . . 2.3100000000000001 111.2 174.485 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.13 153.4 16.06 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.679 0.992 . . . . 1.52 113.679 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -78.54 140.09 38.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.607 -1.179 . . . . 1.24 107.956 151.337 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.21 134.73 26.3 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.73 1.212 . . . . 2.23 108.262 176.47 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.61 157.56 43.54 Favored 'General case' 0 C--N 1.335 -0.059 0 N-CA-C 114.13 1.159 . . . . 3.4199999999999999 114.13 -170.475 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -115.3 105.32 52.62 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.97999999999999998 110.931 -168.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.41 -15.67 9.84 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.577 2.185 . . . . 1.0800000000000001 113.595 177.177 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 -167.91 41.35 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 119.263 0.938 . . . . 1.25 112.91 -177.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -117.02 16.29 15.06 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.5 1.52 . . . . 2.6400000000000001 111.496 -173.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mt -120.14 162.07 35.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.167 2.187 . . . . 3.1899999999999999 109.244 -175.595 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.21 156.99 17.32 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.976 2.451 . . . . 1.5800000000000001 110.901 175.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.29 103.55 4.95 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.273 1.029 . . . . 2.3199999999999998 111.059 -171.608 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -96.38 106.16 18.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.972 1.309 . . . . 3.1200000000000001 111.364 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 tp -86.73 113.84 22.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.126 2.17 . . . . 0.71999999999999997 108.651 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.69 -11.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.173 0.989 . . . . 0.58999999999999997 113.483 -169.042 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.49 -161.68 32.48 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.518 -0.739 . . . . 0.59999999999999998 112.296 178.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.836 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -148.72 177.34 9.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.279 1.032 . . . . 1.03 111.374 176.143 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 129.79 5.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.924 -1.139 . . . . 5.4100000000000001 107.924 172.502 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -135.31 147.36 61.8 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 117.748 -1.12 . . . . 1.03 109.232 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.68 -15.02 27.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.04 1.827 . . . . 1.4199999999999999 112.712 171.222 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -75.19 -0.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.035 0.834 . . . . 0.84999999999999998 113.236 174.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.47 -172.28 3.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.615 1.966 . . . . 1.24 110.311 176.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -106.63 -55.89 2.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.699 1.2 . . . . 3.0299999999999998 110.566 166.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -119.85 165.92 13.97 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 4.1500000000000004 110.907 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.3 p -155.5 135.91 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.705 0.802 . . . . 2.0800000000000001 109.48 171.703 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -120.13 132.51 55.44 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.954 1.702 . . . . 2.1499999999999999 108.977 -173.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.85 115.34 19.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.504 1.145 . . . . 0.94999999999999996 109.855 170.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -103.16 150.87 23.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.337 -1.301 . . . . 0.64000000000000001 111.995 176.029 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -94.64 164.59 12.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.513 2.325 . . . . 2.3500000000000001 109.991 166.281 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.9 m -145.63 121.25 10.45 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.38 1.072 . . . . 1.3500000000000001 108.152 167.784 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.49 153.48 51.73 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.894 0.878 . . . . 2.1499999999999999 112.945 -151.813 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.33 47.89 0.98 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 123.084 1.421 . . . . 6.1200000000000001 111.868 -172.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -80.67 162.16 24.31 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.347 -1.751 . . . . 8.1199999999999992 110.886 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -69.5 152.07 45.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.401 2.281 . . . . 4.04 111.42 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.04 -96.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.167 1.387 . . . . 2.9700000000000002 107.645 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.65 43.22 0.14 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.28 1.832 . . . . 4.5300000000000002 111.248 169.507 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.94 -26.96 0.78 Allowed Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.37 -1.456 . . . . 2.5800000000000001 113.691 -167.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -74.07 145.3 44.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.67 1.588 . . . . 3.1899999999999999 110.684 175.491 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -75.37 133.09 41.29 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.694 0.798 . . . . 5.1500000000000004 109.996 173.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.05 149.74 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.416 1.086 . . . . 1.77 109.865 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.3 mtm -83.37 93.86 7.84 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 3.8599999999999999 112.985 175.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.38 165.67 22.7 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.367 0.984 . . . . 1.1599999999999999 112.328 172.349 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -128.64 165.93 19.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.76 1.624 . . . . 2.5899999999999999 111.098 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -178.74 144.78 0.46 Allowed Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 116.123 -1.894 . . . . 4.4500000000000002 111.224 -175.198 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.69 143.11 60.65 Favored 'Trans proline' 0 C--N 1.347 0.472 0 CA-C-N 122.095 1.784 . . . . 0.70999999999999996 111.607 160.005 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.56 157.28 38.76 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.202 1.401 . . . . 0.73999999999999999 110.208 169.267 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.68 -15.78 33.65 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.73999999999999999 113.09 175.566 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -175.16 160.27 2.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.715 1.606 . . . . 2.7200000000000002 111.955 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt -109.51 175.09 5.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.851 1.261 . . . . 1.1699999999999999 108.867 147.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -156.0 166.89 32.13 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.042 -1.036 . . . . 2.3300000000000001 112.837 170.491 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.55 132.79 16.59 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 1.0900000000000001 109.899 -177.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.36 162.35 38.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.736 2.29 . . . . 0.96999999999999997 110.835 171.316 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.18 140.56 84.2 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.945 2.43 . . . . 1.25 111.485 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt 71.98 -4.0 2.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.599 2.36 . . . . 1.48 114.318 -178.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.29 177.35 33.55 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.784 1.659 . . . . 1.0900000000000001 112.286 177.691 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -144.17 151.02 38.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.863 1.665 . . . . 3.8100000000000001 112.562 175.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.96 149.77 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.786 1.635 . . . . 2.1000000000000001 108.349 164.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -135.33 109.62 8.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.685 -1.598 . . . . 4.29 106.685 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.75 77.69 6.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.86 1.314 . . . . 1.4399999999999999 111.212 -164.338 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -67.37 138.74 94.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 117.26 -1.352 . . . . 5.0700000000000003 110.005 174.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.19 -54.45 4.99 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.258 3.305 . . . . 1.02 113.435 -175.592 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.05 51.8 3.91 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.655 1.122 . . . . 1.8899999999999999 111.708 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.58 -82.9 0.04 OUTLIER Glycine 0 N--CA 1.465 0.576 0 C-N-CA 128.663 3.03 . . . . 0.93000000000000005 111.223 -171.652 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -150.8 143.37 24.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.427 2.291 . . . . 2.2200000000000002 108.402 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -160.57 167.16 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.351 -0.843 . . . . 0.84999999999999998 110.63 -175.294 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 14.3 m-85 -107.16 122.59 46.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.585 0.754 . . . . 2.1099999999999999 110.566 174.284 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 mmt -85.93 117.64 24.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.606 1.162 . . . . 0.93999999999999995 110.525 171.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.7 mt -93.46 136.15 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.931 1.292 . . . . 1.9399999999999999 110.238 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mt -140.72 132.79 27.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.561 0.619 . . . . 2.6499999999999999 112.299 -178.255 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.71 53.82 2.18 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 125.343 1.449 . . . . 1.6599999999999999 112.506 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.48 115.17 4.4 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.884 0.698 . . . . 0.98999999999999999 112.884 -168.872 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -86.94 -13.42 44.73 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.173 1.175 . . . . 1.6499999999999999 114.173 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -146.64 143.04 17.99 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.646 1.178 . . . . 5.5499999999999998 110.251 177.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.52 134.58 17.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.088 2.526 . . . . 1.6000000000000001 109.228 171.44 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.41 90.07 8.14 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.786 0.835 . . . . 2.25 111.358 -171.33 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -58.72 148.17 30.39 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.002 -1.061 . . . . 3.8799999999999999 113.317 169.447 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.79 114.73 5.89 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.517 -0.739 . . . . 1.77 109.473 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.6 -9.7 7.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 116.63 -2.206 . . . . 1.9299999999999999 116.816 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 173.29 10.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.449 2.624 . . . . 3.8999999999999999 112.884 -177.209 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -100.16 162.12 13.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.229 1.412 . . . . 3.8599999999999999 110.085 159.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.6 t -128.42 127.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.179 1.791 . . . . 1.05 108.155 172.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.2 136.81 35.89 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.533 1.533 . . . . 5.96 109.562 175.513 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.836 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.0 tt -154.3 130.01 10.03 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.743 1.258 . . . . 1.6299999999999999 114.342 179.107 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.82 99.78 12.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.317 3.047 . . . . 2.7599999999999998 110.989 173.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.48 117.16 17.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.941 -1.099 . . . . 1.1399999999999999 109.173 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.2 mt -91.49 126.85 36.72 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.796 0.838 . . . . 0.80000000000000004 110.382 -169.03 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.01 126.95 45.12 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.972 1.101 . . . . 1.77 113.972 -178.501 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.52 23.98 1.03 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.458 1.903 . . . . 2.3199999999999998 114.603 169.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.01 -55.13 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.346 1.451 . . . . 3.9300000000000002 113.004 -166.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.05 18.17 46.44 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.587 -1.674 . . . . 1.8899999999999999 116.629 -169.069 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -141.93 157.73 44.61 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.869 2.468 . . . . 4.2300000000000004 110.58 165.187 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.2 141.38 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 126.048 1.739 . . . . 1.01 107.851 162.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.4 106.89 12.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.668 1.187 . . . . 1.8200000000000001 107.896 173.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -79.44 128.53 33.47 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.41 -0.806 . . . . 4.9699999999999998 111.071 177.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.96 164.06 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.394 1.877 . . . . 1.48 110.443 178.743 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 m -105.26 155.6 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 125.441 1.496 . . . . 2.96 109.119 164.615 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.7 mt -141.52 149.52 54.44 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.546 1.939 . . . . 1.6100000000000001 109.231 173.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.53 152.97 20.41 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.829 3.019 . . . . 0.93000000000000005 112.348 176.127 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.3 t -80.38 142.04 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.276 1.03 . . . . 1.25 111.149 168.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 166.86 32.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.807 2.043 . . . . 2.9399999999999999 111.204 -166.678 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.98 26.84 9.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.738 1.215 . . . . 2.0 113.392 -169.172 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.1 mtm105 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 116.606 -1.664 . . . . 5.8799999999999999 112.382 -171.58 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 N-CA-C 106.581 -2.607 . . . . 12.75 106.581 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 p -59.03 157.07 10.67 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 118.892 -1.123 . . . . 12.470000000000001 109.754 129.373 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -132.92 8.76 4.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.618 0.97 . . . . 10.710000000000001 113.618 -176.447 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.5 p -69.15 131.05 44.35 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.135 2.174 . . . . 7.4699999999999998 110.835 170.172 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.88 46.33 0.38 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.95 1.3 . . . . 7.2800000000000002 111.848 172.356 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.56 151.97 17.03 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.949 1.261 . . . . 1.02 114.482 -172.828 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -155.85 162.97 40.36 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.96 1.304 . . . . 1.55 110.928 -177.36 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.66 126.82 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.718 0.77 . . . . 0.97999999999999998 109.58 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.9 52.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.523 1.305 . . . . 9.4700000000000006 114.523 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -97.61 139.13 33.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.856 1.262 . . . . 2.8500000000000001 108.773 162.255 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -164.28 158.12 15.61 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.798 1.239 . . . . 2.6200000000000001 110.994 166.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -83.96 57.98 5.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.494 3.462 . . . . 2.71 110.824 177.283 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.55 160.3 27.9 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.199 -0.778 . . . . 1.5700000000000001 113.709 -177.133 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -77.53 -3.87 14.05 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.005 3.137 . . . . 1.77 113.226 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -161.33 153.68 20.1 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.724 1.61 . . . . 2.21 112.854 -176.158 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -176.97 160.26 1.79 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.717 1.607 . . . . 2.54 112.045 172.703 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.94 133.77 45.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.182 1.793 . . . . 2.2200000000000002 112.372 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.76 154.77 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.172 1.389 . . . . 1.4299999999999999 111.328 172.413 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.07 154.39 48.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.832 0.853 . . . . 2.5899999999999999 112.481 -159.832 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -171.54 154.96 3.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.786 1.234 . . . . 1.54 112.942 176.09 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.475 HG21 ' HD3' ' A' ' 74' ' ' ARG . 99.5 m -74.76 146.68 41.96 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.792 -0.447 . . . . 1.9399999999999999 109.792 152.739 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.98 124.75 43.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.35 2.26 . . . . 2.3900000000000001 107.979 173.53 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -102.62 134.46 45.94 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.613 1.965 . . . . 4.7699999999999996 113.315 175.612 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -99.11 106.99 41.8 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 121.573 -0.704 . . . . 1.28 109.621 162.151 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.23 -11.15 10.99 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.584 2.19 . . . . 1.22 112.989 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 176.17 51.21 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.644 1.116 . . . . 1.1599999999999999 113.505 -177.047 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -99.59 -7.22 26.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.443 1.897 . . . . 2.6499999999999999 112.818 -175.412 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.05 160.5 38.78 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.629 1.971 . . . . 2.2000000000000002 109.894 170.012 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.74 149.98 23.82 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.061 2.508 . . . . 1.8500000000000001 112.435 -168.94 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 mt -96.09 154.93 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.988 0.915 . . . . 1.97 110.784 170.71 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 68' ' ' GLU . 20.9 ttm180 -135.83 107.72 7.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.489 1.516 . . . . 3.71 108.979 171.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.6 tp -86.03 116.3 24.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.403 2.281 . . . . 0.69999999999999996 108.818 -176.745 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.96 -13.16 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 0.54000000000000004 112.772 -172.566 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.13 -169.19 42.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.294 1.426 . . . . 0.57999999999999996 111.636 177.58 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.43 159.57 38.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.0 1.32 . . . . 1.1699999999999999 111.138 168.541 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -132.16 136.9 47.42 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.68 -1.262 . . . . 6.4299999999999997 110.321 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.0 155.4 70.85 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 124.875 1.27 . . . . 0.76000000000000001 108.952 -174.381 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.06 -31.49 45.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.938 1.758 . . . . 1.04 113.017 160.348 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -77.01 5.86 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.852 1.427 . . . . 1.3999999999999999 114.852 -167.448 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.72 29.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.851 1.66 . . . . 1.1899999999999999 111.4 -178.655 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.21 -81.71 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.44 0.296 . . . . 2.9100000000000001 111.055 -178.685 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -71.72 161.24 31.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.984 0.897 . . . . 3.8199999999999998 110.709 174.465 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.2 138.8 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.151 -1.386 . . . . 2.2000000000000002 108.268 159.078 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -133.14 124.17 27.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.442 -1.688 . . . . 2.2000000000000002 106.442 160.666 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.14 121.62 26.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.163 1.347 . . . . 0.71999999999999997 109.288 166.024 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -104.85 158.1 16.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.962 1.305 . . . . 0.65000000000000002 112.346 176.127 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.21 -175.65 2.85 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.673 2.389 . . . . 2.21 111.627 172.333 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.1 m -134.72 104.11 5.9 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.003 1.721 . . . . 1.74 106.407 153.887 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -84.45 150.4 25.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.006 0.523 . . . . 2.2999999999999998 110.805 178.858 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -106.95 135.86 47.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.208 1.003 . . . . 4.3300000000000001 110.859 170.913 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.21 -172.97 2.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.679 1.192 . . . . 6.6799999999999997 113.087 -172.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.25 149.01 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.601 2.761 . . . . 4.8600000000000003 106.666 -170.958 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.04 -42.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.454 1.502 . . . . 5.5599999999999996 112.641 177.503 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -81.35 10.53 5.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.021 1.728 . . . . 4.8600000000000003 112.519 168.089 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.65 -7.29 1.06 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.306 1.432 . . . . 1.8600000000000001 115.147 -167.523 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -72.95 133.59 44.4 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.721 -1.458 . . . . 3.5800000000000001 108.474 158.973 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 142.84 36.74 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.287 -0.634 . . . . 5.9199999999999999 109.287 166.889 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -147.89 152.37 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.819 2.047 . . . . 1.8700000000000001 109.067 -166.881 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.8 mtm -123.75 143.34 50.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.618 1.167 . . . . 3.6499999999999999 111.232 167.72 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.92 159.05 28.51 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.1 0.857 . . . . 1.46 113.689 -179.363 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.577 1.151 . . . . 1.6599999999999999 112.618 -175.44 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -177.14 142.66 0.51 Allowed Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 116.663 -1.637 . . . . 4.3499999999999996 110.764 -171.196 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -71.83 142.67 39.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 CA-C-N 122.204 1.823 . . . . 0.59999999999999998 111.827 167.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.64 157.48 47.73 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 126.052 1.741 . . . . 0.56000000000000005 110.473 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.13 -17.91 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.436 2.09 . . . . 0.59999999999999998 113.025 176.398 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -175.69 169.06 3.08 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.135 1.374 . . . . 2.0099999999999998 111.321 -177.224 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.21 175.18 5.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.645 1.978 . . . . 1.1499999999999999 108.961 156.035 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.3 pt-20 -152.47 164.26 37.91 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.105 -0.997 . . . . 2.6600000000000001 111.511 176.492 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -147.58 129.06 7.28 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.17 0.988 . . . . 1.1399999999999999 110.311 -172.001 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.65 157.49 35.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.996 2.464 . . . . 1.48 111.934 179.65 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.89 137.56 73.25 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.374 3.383 . . . . 1.46 113.293 -174.908 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 68.88 -5.46 1.01 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.261 2.224 . . . . 1.23 114.42 -176.494 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.62 137.2 14.15 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 126.498 1.999 . . . . 1.3300000000000001 109.838 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.475 ' HD3' HG21 ' A' ' 21' ' ' THR . 7.6 ptp180 -107.26 136.79 46.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.061 -1.07 . . . . 5.0499999999999998 110.561 158.493 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.21 149.07 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 125.378 1.471 . . . . 2.3799999999999999 110.702 -178.372 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -100.95 134.5 43.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.151 1.908 . . . . 4.0199999999999996 116.151 -167.866 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.29 78.68 1.33 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.505 1.522 . . . . 1.1399999999999999 107.453 155.455 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -83.17 139.55 42.26 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.556 1.142 . . . . 2.8599999999999999 110.364 178.127 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.8 -53.35 7.06 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.851 3.034 . . . . 1.25 113.915 -169.147 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.04 90.45 1.68 Allowed Glycine 0 N--CA 1.469 0.894 0 N-CA-C 109.622 -1.391 . . . . 1.5600000000000001 109.622 166.017 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.15 -74.29 0.22 Allowed Glycine 0 N--CA 1.468 0.794 0 C-N-CA 124.843 1.211 . . . . 1.25 112.767 -168.945 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -156.02 144.86 20.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.52 1.928 . . . . 1.96 109.346 177.101 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -167.73 164.91 14.39 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.977 -1.077 . . . . 0.78000000000000003 109.629 -176.251 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -95.92 120.33 36.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.826 0.45 . . . . 2.0299999999999998 110.183 175.341 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.1 mmt -76.9 100.05 5.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.643 1.211 . . . . 1.0900000000000001 109.365 163.793 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -102.02 111.11 23.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.663 -1.608 . . . . 1.9399999999999999 108.268 178.63 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.56 52.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.0 1.72 . . . . 3.4300000000000002 109.124 -173.524 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.96 63.09 2.12 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.797 -0.921 . . . . 1.5600000000000001 110.797 -174.855 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.97 117.23 13.32 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.387 0.675 . . . . 1.48 111.427 -176.068 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -82.82 -6.93 59.66 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.689 1.366 . . . . 1.49 114.689 -165.335 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -122.87 153.22 63.64 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.921 -1.511 . . . . 4.6200000000000001 106.921 152.451 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.34 123.71 9.79 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 107.371 -1.819 . . . . 1.71 107.371 151.34 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.35 154.36 41.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.935 1.294 . . . . 2.0800000000000001 112.069 -166.363 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -131.38 129.1 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.564 1.146 . . . . 6.0899999999999999 110.931 165.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.05 121.86 8.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.795 -0.816 . . . . 1.6100000000000001 108.795 169.647 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.55 1.84 56.53 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-O 117.998 -1.446 . . . . 1.8899999999999999 116.127 -169.778 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -78.79 170.22 17.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.182 1.991 . . . . 2.7200000000000002 110.243 162.159 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -116.15 149.78 38.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.812 2.045 . . . . 5.0700000000000003 109.811 177.228 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.4 t -127.62 113.94 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.404 1.081 . . . . 1.1899999999999999 109.722 -178.343 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.428 ' OE2' ' HE2' ' A' ' 112' ' ' LYS . 1.2 mt-10 -68.95 134.55 49.68 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.981 0.8 . . . . 3.0899999999999999 109.646 159.459 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -147.4 116.96 7.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.565 1.146 . . . . 1.5700000000000001 112.372 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -89.68 94.58 9.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.688 2.795 . . . . 2.1800000000000002 110.543 177.651 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -74.13 123.31 24.2 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.796 1.239 . . . . 1.1899999999999999 110.815 -177.017 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 mt -96.8 129.69 44.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.831 1.252 . . . . 0.68000000000000005 111.23 -172.655 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.57 129.82 41.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.049 0.928 . . . . 1.8899999999999999 113.172 -173.463 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 32.37 50.41 0.18 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.671 2.388 . . . . 1.6299999999999999 113.935 175.907 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.26 -90.88 0.53 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.897 1.237 . . . . 3.6400000000000001 112.053 -172.328 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.19 15.94 19.75 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 117.399 1.719 . . . . 1.5900000000000001 117.399 -164.127 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.0 145.21 42.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.784 2.292 . . . . 5.2300000000000004 109.363 166.323 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -147.8 137.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 124.906 1.282 . . . . 1.1000000000000001 108.96 167.684 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.5 mt -142.14 124.62 15.74 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.48 1.512 . . . . 1.8400000000000001 107.858 -175.475 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.428 ' HE2' ' OE2' ' A' ' 100' ' ' GLU . 10.0 ptmt -102.96 150.12 23.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.437 1.643 . . . . 2.4300000000000002 115.437 -174.258 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.78 160.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.233 1.813 . . . . 1.22 110.284 178.89 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -117.05 118.71 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.578 1.151 . . . . 1.8899999999999999 110.261 171.394 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.2 mt -108.9 150.42 40.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.331 1.852 . . . . 1.5 109.769 178.398 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.24 155.43 19.29 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.455 2.77 . . . . 0.91000000000000003 111.698 170.068 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.42 145.36 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.924 1.29 . . . . 1.26 109.258 163.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.64 171.14 16.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.545 1.938 . . . . 3.27 108.797 -176.793 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.57 3.58 7.5 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.436 2.013 . . . . 3.0099999999999998 116.436 -160.476 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 130.209 3.403 . . . . 4.7599999999999998 109.272 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 113.402 0.889 . . . . 5.09 113.402 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -162.38 -179.2 36.83 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 126.021 1.772 . . . . 1.26 115.407 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -127.91 140.49 51.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.406 0.682 . . . . 2.15 112.835 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.9 t -83.06 138.5 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.877 -1.157 . . . . 0.94 107.877 160.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -83.87 119.75 25.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.162 -0.961 . . . . 3.75 112.448 -164.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.03 129.13 20.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.116 1.366 . . . . 3.35 110.619 163.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m 179.24 111.31 0.18 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.075 1.75 . . . . 2.04 110.316 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -84.41 48.72 2.53 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.006 3.138 . . . . 2.19 110.181 167.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.65 -174.67 27.01 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.405 1.002 . . . . 1.63 113.037 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.06 -17.01 28.63 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.685 2.256 . . . . 1.61 111.529 163.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -150.28 169.06 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.403 1.881 . . . . 1.98 113.019 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.9 -159.59 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.469 2.307 . . . . 1.31 109.422 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.06 166.07 27.2 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.732 1.213 . . . . 1.56 111.247 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.72 133.58 40.11 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 0.99 111.753 162.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -120.96 148.15 44.49 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.89 2.076 . . . . 2.41 109.707 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -169.84 154.67 5.39 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.482 1.29 . . . . 1.41 114.482 174.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 m -74.39 143.61 44.72 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.429 1.092 . . . . 1.38 108.655 157.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.53 130.59 21.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.706 -1.22 . . . . 2.19 107.706 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.16 142.86 32.76 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.882 0.873 . . . . 4.23 111.203 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -102.46 110.75 63.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.458 1.503 . . . . 0.82 110.526 -168.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.04 -10.51 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.229 1.952 . . . . 0.95 113.524 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.51 169.71 54.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.262 0.937 . . . . 0.84 113.673 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.01 -4.99 35.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.93 1.692 . . . . 2.53 112.89 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.79 159.61 38.3 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 126.053 1.741 . . . . 1.62 109.856 167.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.75 159.02 28.13 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.889 2.392 . . . . 0.94 112.038 -169.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.43 154.16 19.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.213 1.005 . . . . 2.11 110.262 168.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -137.95 109.35 6.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.789 1.236 . . . . 2.92 108.814 168.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -88.76 106.92 18.68 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.639 2.376 . . . . 0.7 108.952 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.36 -11.56 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.378 1.071 . . . . 0.53 112.705 -172.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.86 -168.86 40.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.364 0.983 . . . . 0.57 111.904 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.416 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -150.25 -179.73 7.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.571 1.148 . . . . 0.86 109.17 163.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -159.52 137.92 10.55 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 119.038 0.836 . . . . 4.94 109.286 -167.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 161.15 48.9 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.741 1.155 . . . . 0.59 109.92 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.91 -29.56 15.05 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.891 1.727 . . . . 0.93 113.583 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.0 m -81.01 0.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.12 1.526 . . . . 0.89 115.12 -166.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 160.54 39.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.656 1.182 . . . . 1.02 112.24 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -96.96 -82.07 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.777 1.231 . . . . 2.77 111.298 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -80.59 101.02 8.92 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 120.301 -1.499 . . . . 3.58 108.954 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 35' ' ' ALA . 5.6 p -84.78 137.21 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 125.977 1.711 . . . . 1.23 111.365 165.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -141.63 132.5 25.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.782 1.633 . . . . 2.08 110.753 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -82.98 123.25 29.26 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 121.088 1.767 . . . . 0.66 111.713 168.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.2 m170 -110.43 152.23 26.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.181 1.792 . . . . 0.57 112.701 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -85.06 166.13 16.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.005 1.722 . . . . 2.17 110.193 158.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.1 m -147.51 126.25 12.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 1.62 107.481 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -140.12 164.24 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.925 0.713 . . . . 2.37 112.925 -151.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -110.2 138.51 46.48 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.418 0.687 . . . . 3.2 110.18 153.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -145.27 155.29 43.14 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.879 1.672 . . . . 7.29 109.213 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.32 150.96 20.54 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.677 0.791 . . . . 3.73 110.197 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.5 t -130.89 -97.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.428 1.091 . . . . 2.86 109.619 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.54 45.12 0.38 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.92 2.088 . . . . 3.28 111.584 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.36 -5.55 5.21 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.776 -1.202 . . . . 1.76 113.623 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -106.08 147.77 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.182 2.193 . . . . 2.88 109.946 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -76.28 138.42 40.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.557 0.743 . . . . 4.01 111.229 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -137.31 151.63 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.286 1.834 . . . . 1.62 109.288 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mtm -127.4 145.35 50.85 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.288 1.035 . . . . 3.51 111.775 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.85 37.07 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.509 1.052 . . . . 1.53 113.483 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -123.27 168.07 12.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.381 1.872 . . . . 1.86 111.068 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.16 131.93 0.45 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 116.361 -1.78 . . . . 4.43 111.882 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 18.2 Cg_endo -67.72 142.47 58.21 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 122.533 1.94 . . . . 0.56 112.553 171.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.43 160.26 44.56 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.22 1.808 . . . . 0.52 110.376 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.6 -20.15 20.72 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.354 2.036 . . . . 0.67 113.17 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -176.27 168.1 2.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.959 1.254 . . . . 1.83 112.018 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -116.58 173.81 6.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.445 2.298 . . . . 1.08 109.128 153.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -156.61 166.62 32.87 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.058 -1.026 . . . . 1.96 112.731 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 132.15 8.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.104 0.962 . . . . 0.92 109.154 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.4 165.9 30.16 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.577 1.518 . . . . 0.82 110.762 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.43 138.71 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.194 2.596 . . . . 0.84 111.144 171.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt 68.45 -2.69 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.011 1.724 . . . . 1.36 113.883 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.91 -172.67 45.12 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 126.187 1.851 . . . . 0.99 113.423 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -152.15 149.11 28.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.056 1.742 . . . . 4.83 111.621 -171.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.04 142.08 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.616 1.567 . . . . 2.35 108.551 161.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -106.1 123.17 47.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.966 0.803 . . . . 3.82 109.735 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.31 69.7 0.56 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.347 1.459 . . . . 1.18 108.194 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -81.4 145.62 55.82 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.461 2.305 . . . . 2.89 109.694 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.7 -42.7 65.99 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.148 2.566 . . . . 0.85 112.501 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.75 59.99 4.24 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.814 0.734 . . . . 1.08 112.171 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.63 -70.3 0.05 OUTLIER Glycine 0 N--CA 1.468 0.786 0 C-N-CA 124.053 0.835 . . . . 0.78 114.371 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -155.16 147.18 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.835 1.654 . . . . 1.85 109.367 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -165.25 174.87 9.75 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.022 -1.049 . . . . 0.98 110.921 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.59 132.31 50.98 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.724 -0.473 . . . . 1.84 109.724 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -80.89 135.81 35.97 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.134 0.574 . . . . 1.2 110.143 159.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.42 98.36 6.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.143 1.377 . . . . 1.62 109.411 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -102.38 142.94 32.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.828 0.851 . . . . 2.4 111.162 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.66 75.0 0.73 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.398 -1.081 . . . . 1.31 110.398 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.2 124.11 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 117.271 0.536 . . . . 0.99 112.142 -170.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -82.33 -6.31 59.17 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.001 0.741 . . . . 1.43 113.001 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -154.32 150.04 21.51 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.48 2.312 . . . . 3.95 108.366 158.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.28 134.57 45.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.934 1.756 . . . . 1.65 108.249 168.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.75 119.73 20.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.922 -0.399 . . . . 2.33 109.922 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -105.5 124.0 48.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.296 1.839 . . . . 3.73 109.987 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.98 48.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.666 0.666 . . . . 2.14 109.731 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 34.77 31.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 120.025 -0.319 . . . . 2.25 113.25 -167.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.99 174.27 6.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.929 -1.137 . . . . 2.51 107.929 148.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.8 151.11 37.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.628 1.171 . . . . 3.54 108.309 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.6 t -127.53 126.99 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.901 1.281 . . . . 0.95 109.698 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -75.08 142.31 43.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.255 1.026 . . . . 2.78 111.349 161.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.37 114.12 5.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.931 -1.031 . . . . 1.62 111.361 -172.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.02 93.84 8.17 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.028 2.531 . . . . 2.12 109.968 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.2 mt -71.53 121.88 19.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.151 0.98 . . . . 1.13 110.678 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -95.76 128.22 42.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 0.58 111.674 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.54 137.44 52.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.419 0.687 . . . . 1.79 112.101 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.02 130.28 21.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.342 1.457 . . . . 2.04 114.311 -165.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.3 -144.94 22.8 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.986 -1.246 . . . . 3.05 109.986 -164.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.27 54.44 1.54 Allowed Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.734 -1.037 . . . . 1.52 114.135 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -120.24 140.28 51.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.863 1.831 . . . . 4.51 111.161 168.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.45 137.45 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 125.741 1.616 . . . . 0.95 107.581 164.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.8 mt -128.32 111.5 13.43 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.482 1.113 . . . . 1.57 108.601 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -81.17 122.57 27.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.352 -0.217 . . . . 2.3 111.584 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.97 164.39 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.808 1.643 . . . . 1.14 110.237 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.55 146.08 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.969 0.908 . . . . 2.03 109.034 166.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -136.3 145.54 52.35 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.08 1.352 . . . . 1.58 109.234 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -68.2 154.75 71.59 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.562 2.175 . . . . 0.9 110.388 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.657 -0.868 . . . . 1.17 108.657 165.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.03 157.76 43.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.537 1.135 . . . . 3.02 110.606 -171.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.11 72.13 1.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.969 1.707 . . . . 2.02 112.511 -168.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.0 0 C-N-CA 124.735 1.214 . . . . 4.83 110.344 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.56 ' N ' ' HG1' ' A' ' 21' ' ' THR . 2.2 tp10 . . . . . 0 CA--C 1.544 0.748 0 CA-C-O 119.234 -0.412 . . . . 6.13 111.017 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.71 167.66 21.45 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 125.127 1.346 . . . . 1.44 114.55 172.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.3 p90 -163.08 158.23 21.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.353 2.261 . . . . 1.7 110.648 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.35 139.58 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.81 -0.556 . . . . 1.13 110.218 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -77.73 128.93 34.84 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.307 -0.406 . . . . 5.76 111.507 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.7 143.69 3.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.655 1.182 . . . . 2.7 111.769 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -163.44 135.97 4.07 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.554 0.576 . . . . 3.23 112.554 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.18 0.45 4.15 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.546 3.497 . . . . 2.73 112.447 163.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.3 171.54 25.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.922 1.249 . . . . 1.39 114.626 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.1 -13.98 18.98 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.478 3.452 . . . . 1.54 113.861 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -122.16 163.29 19.79 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.068 0.947 . . . . 2.74 111.863 166.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.52 178.55 10.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.292 1.437 . . . . 1.39 111.328 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.49 139.05 46.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.591 1.557 . . . . 1.39 111.957 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.02 150.11 48.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.161 1.385 . . . . 0.99 112.118 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -136.09 148.51 48.32 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.551 1.541 . . . . 2.22 109.308 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.63 152.52 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 1.77 114.816 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.56 ' HG1' ' N ' ' A' ' 5' ' ' GLU . 8.0 m -79.62 120.44 23.96 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 126.094 1.757 . . . . 1.57 109.652 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.67 113.03 26.35 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.383 -0.969 . . . . 2.54 108.383 166.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -122.88 127.85 49.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.025 1.33 . . . . 3.32 108.7 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -98.43 104.39 23.47 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.368 1.067 . . . . 1.0 109.614 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.87 -10.41 12.84 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 1.1 113.311 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 164.49 52.04 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.276 0.941 . . . . 0.97 113.094 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.69 -9.97 59.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.766 1.226 . . . . 3.92 113.492 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.73 160.82 47.23 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.028 1.731 . . . . 1.72 111.215 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.12 151.77 23.85 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.956 2.438 . . . . 0.98 111.84 -171.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -115.55 125.59 53.18 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.264 1.426 . . . . 2.35 110.468 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -107.98 114.77 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.761 1.225 . . . . 2.79 110.72 171.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.2 tp -97.07 114.72 26.4 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.441 2.696 . . . . 0.69 108.771 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.54 -11.04 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.068 0.947 . . . . 0.53 113.206 -165.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.77 -158.01 27.74 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 124.113 0.863 . . . . 0.55 111.509 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.11 178.97 9.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.77 0.828 . . . . 0.9 112.181 172.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -146.6 121.35 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.535 1.134 . . . . 6.63 109.733 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -145.46 160.68 44.25 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.665 1.986 . . . . 0.84 108.988 -168.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -31.01 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.122 1.881 . . . . 1.93 112.748 157.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 m -83.49 31.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.554 1.07 . . . . 2.7 113.84 -169.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.15 161.25 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 128.029 2.532 . . . . 1.55 109.227 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.94 -80.2 0.55 Allowed 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.8 -1.926 . . . . 3.48 105.8 160.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.43 84.94 2.54 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.14 -0.975 . . . . 3.65 109.903 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.76 137.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.428 -0.806 . . . . 1.19 109.619 159.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.98 122.84 27.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.792 1.237 . . . . 2.3 110.649 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -79.71 119.14 22.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.922 1.237 . . . . 0.74 110.597 168.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -106.99 156.16 19.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.266 1.827 . . . . 0.83 112.23 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -112.63 -176.64 2.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 2.04 111.794 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -150.09 79.4 1.36 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.992 1.317 . . . . 1.22 108.466 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -83.58 148.57 27.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.942 -1.026 . . . . 2.65 110.214 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -90.89 155.37 18.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 3.67 111.035 164.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -151.69 149.2 28.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.736 1.615 . . . . 6.54 109.952 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -89.57 168.81 11.86 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.0 0.905 . . . . 3.54 111.782 164.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.61 -128.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.821 2.448 . . . . 4.06 107.331 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.68 60.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 121.559 1.981 . . . . 4.64 111.14 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.15 2.9 55.08 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.643 1.116 . . . . 2.22 114.008 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -87.65 126.27 34.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.354 1.462 . . . . 4.56 109.973 174.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.401 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -93.1 131.9 37.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.633 0.373 . . . . 5.01 111.39 177.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -139.77 143.14 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.921 1.688 . . . . 2.04 109.967 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.35 120.16 41.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.298 1.039 . . . . 3.44 110.181 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.01 44.72 1.44 Allowed Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.092 1.197 . . . . 3.66 116.092 -160.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -28.73 120.03 0.12 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.063 2.545 . . . . 2.52 113.624 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -144.96 154.62 55.11 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 117.654 -1.165 . . . . 5.21 110.395 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.17 146.88 82.85 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.03 1.82 . . . . 0.72 110.806 164.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.11 154.83 49.99 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.115 1.366 . . . . 0.69 110.514 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 -15.41 38.08 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.917 2.411 . . . . 1.05 112.917 176.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -175.35 163.92 3.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 2.14 111.119 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -113.61 173.6 6.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.613 1.965 . . . . 0.99 109.532 155.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.95 163.95 39.09 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.487 -0.758 . . . . 2.36 112.106 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.92 132.53 10.4 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.467 1.107 . . . . 1.07 110.019 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.13 163.14 38.91 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.437 2.758 . . . . 1.07 111.617 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.61 140.68 76.3 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.974 2.449 . . . . 0.94 111.266 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp 69.59 -1.43 2.27 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.649 1.979 . . . . 2.91 113.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.44 135.21 12.91 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 127.081 2.277 . . . . 1.13 110.987 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -103.71 138.38 40.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.466 1.507 . . . . 4.26 110.789 161.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.23 113.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.408 1.883 . . . . 2.2 107.855 165.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -81.74 142.02 33.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.174 0.99 . . . . 3.43 110.344 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -71.08 78.83 0.67 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.317 1.056 . . . . 1.02 108.924 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -87.92 138.8 30.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 3.57 109.986 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.3 -40.38 59.29 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.691 2.927 . . . . 1.02 114.159 -165.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.83 78.44 1.95 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.005 -1.638 . . . . 1.17 109.005 162.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.27 -88.68 0.1 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.51 1.053 . . . . 0.81 112.622 -167.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -151.23 144.34 24.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.741 2.017 . . . . 1.8 109.496 -171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -164.65 171.85 13.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.564 0.746 . . . . 0.73 110.689 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.42 131.23 55.23 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.92 0.488 . . . . 2.18 110.614 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.61 136.99 32.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.269 1.428 . . . . 1.27 110.44 163.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.49 111.2 21.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.12 1.768 . . . . 2.19 108.822 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.67 133.44 55.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.8 0.84 . . . . 2.65 109.642 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.65 42.53 17.22 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 111.618 -0.593 . . . . 1.79 111.618 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.41 120.49 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.687 1.595 . . . . 1.75 113.009 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -86.59 -3.86 59.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.18 -0.918 . . . . 1.66 112.884 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -130.57 135.64 27.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 116.704 -1.617 . . . . 4.3 108.228 149.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -61.6 139.38 81.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.928 1.752 . . . . 1.99 107.841 156.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.71 110.84 18.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.645 1.178 . . . . 2.13 110.246 -162.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -90.01 131.07 36.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.686 0.755 . . . . 5.55 110.599 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 119.86 6.87 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.123 -0.944 . . . . 1.47 109.191 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.04 4.8 57.56 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 117.86 -1.522 . . . . 1.98 115.645 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -85.25 163.92 18.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.31 2.055 . . . . 2.93 110.433 160.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -96.86 156.9 16.15 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.853 1.261 . . . . 3.86 109.776 163.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.06 124.61 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 124.517 1.127 . . . . 1.01 109.152 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.87 134.07 43.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.201 1.8 . . . . 3.05 108.338 166.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mt -158.86 120.95 3.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.567 1.147 . . . . 1.49 113.578 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.06 112.26 25.33 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.092 2.157 . . . . 2.97 110.739 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.6 132.86 46.87 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 1.27 111.183 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -96.42 133.69 40.52 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.813 0.845 . . . . 0.72 111.219 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -126.64 152.78 46.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.643 1.211 . . . . 2.17 112.306 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.93 134.59 57.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.217 -0.901 . . . . 2.1 113.142 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.92 46.26 37.97 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 119.12 -0.822 . . . . 3.91 114.164 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.55 18.87 61.16 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.993 1.157 . . . . 1.52 115.993 166.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.9 143.22 30.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.474 1.637 . . . . 4.49 110.463 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -152.23 138.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.948 1.699 . . . . 0.96 108.47 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -144.74 127.72 16.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.768 0.827 . . . . 1.63 112.523 -168.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -71.01 135.96 48.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 2.43 111.944 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.66 151.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.523 1.129 . . . . 1.61 111.305 171.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.07 134.83 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.044 . . . . 3.86 112.565 -171.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.86 125.8 9.99 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.896 1.278 . . . . 3.68 109.561 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -86.76 159.41 9.05 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.608 2.872 . . . . 1.3 110.558 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.42 137.15 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.165 0.986 . . . . 1.42 109.971 172.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -140.71 150.4 43.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.131 0.972 . . . . 3.3 110.452 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.79 58.83 1.15 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.772 0.829 . . . . 3.24 109.998 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 120' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.701 1.2 . . . . 5.49 112.666 -170.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 108.832 -0.803 . . . . 6.15 108.832 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.35 -178.67 15.41 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-N 121.226 1.83 . . . . 1.02 116.343 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -160.3 138.06 9.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.218 -0.991 . . . . 1.69 111.739 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.99 122.79 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.997 0.904 . . . . 1.43 109.029 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -62.08 112.04 2.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.619 1.568 . . . . 4.08 112.148 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -70.15 133.48 47.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.461 0.648 . . . . 2.63 109.51 150.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.9 m -159.18 146.52 13.06 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.634 1.574 . . . . 2.38 109.994 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -86.78 67.68 4.43 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.118 3.212 . . . . 2.68 110.836 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -151.87 177.42 29.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.787 0.708 . . . . 1.25 114.04 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.33 -10.11 19.04 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.831 3.02 . . . . 1.41 113.205 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -146.27 165.78 28.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.925 1.69 . . . . 2.02 112.669 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 153.41 29.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.622 1.169 . . . . 1.3 112.165 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.29 118.53 33.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.566 1.146 . . . . 1.9 109.694 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.79 156.74 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.87 1.268 . . . . 1.2 112.044 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.68 154.57 47.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.028 1.331 . . . . 1.89 112.783 -169.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.408 ' H ' ' HB2' ' A' ' 77' ' ' LEU . 2.0 pt? -160.93 157.97 27.35 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.926 1.29 . . . . 1.62 112.649 165.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.9 m -73.27 108.98 6.46 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.326 -0.99 . . . . 1.23 108.326 156.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.38 129.2 34.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.07 -1.456 . . . . 2.69 107.07 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -126.37 148.23 49.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.183 0.808 . . . . 3.09 113.183 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -112.13 110.67 53.66 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.624 1.17 . . . . 1.15 109.974 166.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.45 -8.37 8.53 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.045 2.497 . . . . 1.26 113.225 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.75 155.95 37.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.434 1.016 . . . . 1.24 112.66 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.439 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.6 m-20 -88.88 4.67 47.08 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.313 1.845 . . . . 3.03 113.296 -175.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.95 160.76 41.52 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.45 1.9 . . . . 1.65 110.293 167.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.24 153.75 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.034 2.49 . . . . 1.03 111.285 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.9 mt -107.38 153.57 22.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.426 1.09 . . . . 1.81 111.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -130.21 113.08 14.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 2.85 110.218 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.6 105.05 17.08 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 127.701 2.4 . . . . 0.61 108.316 -174.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -94.19 -11.53 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.965 0.906 . . . . 0.62 113.032 -172.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.86 -163.85 33.0 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.594 1.092 . . . . 0.49 111.608 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 101' ' ' LEU . . . -156.16 -175.11 5.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.26 1.024 . . . . 0.91 110.515 166.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.448 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 1.1 mmt85 -160.38 -172.75 3.69 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.893 1.224 . . . . 7.22 111.214 -172.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -177.86 156.35 1.1 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 126.443 1.897 . . . . 1.21 108.726 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.65 -22.29 73.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.767 2.311 . . . . 1.35 114.371 160.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.06 2.41 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.629 1.714 . . . . 1.78 115.629 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.96 167.84 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.566 1.075 . . . . 0.95 111.501 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.22 -88.51 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.546 0.738 . . . . 3.25 112.946 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -83.0 141.17 32.29 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.28 -1.008 . . . . 4.39 108.28 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -151.82 131.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.196 0.999 . . . . 1.33 109.82 -169.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -145.0 124.45 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.367 1.467 . . . . 2.49 110.151 -166.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.451 HD12 ' CE1' ' A' ' 84' ' ' PHE . 7.3 tt -79.38 121.29 24.96 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.066 -1.021 . . . . 0.67 110.816 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.8 m170 -109.19 153.12 24.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.188 1.395 . . . . 1.01 113.01 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.3 -175.51 2.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.765 2.026 . . . . 2.78 112.145 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.4 m -147.97 127.68 13.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.12 1.768 . . . . 1.85 108.503 172.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -124.78 153.51 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.326 1.45 . . . . 2.71 110.697 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.8 149.26 25.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.198 0.999 . . . . 4.81 111.234 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.14 144.17 15.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.933 0.893 . . . . 6.11 111.85 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.38 143.75 28.51 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.467 0.48 . . . . 3.83 109.938 162.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.92 131.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.483 1.513 . . . . 3.7 108.946 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 59.22 22.54 10.8 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.048 0.939 . . . . 3.43 111.801 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.59 56.91 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.4 -1.437 . . . . 2.39 114.126 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -93.99 144.2 25.68 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.943 1.697 . . . . 3.06 110.561 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -83.63 134.49 34.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.787 0.835 . . . . 3.91 110.521 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.57 151.2 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.24 1.816 . . . . 1.6 109.864 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.3 mmt -106.17 135.24 48.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.454 1.102 . . . . 4.23 110.401 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.15 151.3 17.42 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.763 1.173 . . . . 1.81 112.648 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.4 162.46 17.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.351 1.461 . . . . 2.26 111.358 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -171.59 159.66 4.87 Favored Pre-proline 0 N--CA 1.477 0.925 0 C-N-CA 126.542 1.937 . . . . 5.82 109.761 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.9 Cg_endo -69.52 159.62 52.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.417 1.412 . . . . 0.91 111.413 164.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.84 157.1 77.8 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.427 1.491 . . . . 0.9 110.485 168.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.87 -10.84 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.936 2.424 . . . . 1.09 113.139 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.49 160.22 1.24 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.421 1.889 . . . . 2.01 111.669 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.61 175.27 5.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.521 1.928 . . . . 0.98 109.473 151.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.18 162.44 41.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.236 -0.915 . . . . 1.88 111.102 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.79 135.29 10.95 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.645 0.778 . . . . 0.93 109.843 -166.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.97 167.02 28.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.774 2.316 . . . . 1.05 112.174 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.52 140.48 87.39 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.681 2.921 . . . . 1.08 112.655 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.8 mmmt 68.12 0.77 2.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.947 2.099 . . . . 2.12 114.309 175.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.3 142.87 15.62 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 127.255 2.359 . . . . 1.22 111.571 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -107.03 157.62 17.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.523 1.529 . . . . 4.95 112.889 166.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.37 125.46 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.342 1.857 . . . . 1.44 109.656 173.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -83.27 127.93 34.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 4.18 111.388 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HB2' ' H ' ' A' ' 20' ' ' LEU . 10.5 mp -74.86 140.29 43.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.991 1.376 . . . . 1.54 109.702 166.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -166.72 146.04 4.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 3.24 110.491 -153.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.11 -39.45 18.5 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.133 2.555 . . . . 1.57 112.876 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.96 72.75 2.55 Favored Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.434 -1.466 . . . . 1.2 109.434 164.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.6 -94.8 0.11 Allowed Glycine 0 N--CA 1.469 0.856 0 N-CA-C 114.841 0.697 . . . . 0.8 114.841 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -151.37 143.5 23.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.33 1.452 . . . . 1.78 110.565 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -166.58 144.85 5.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.083 0.553 . . . . 1.26 112.092 -166.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.451 ' CE1' HD12 ' A' ' 45' ' ' LEU . 55.6 m-85 -92.65 118.48 31.08 Favored 'General case' 0 CA--C 1.52 -0.178 0 O-C-N 121.651 -0.655 . . . . 1.86 109.729 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 mmt -79.68 115.65 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.21 -0.663 . . . . 1.38 109.21 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.0 mt -99.76 125.45 45.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.628 1.571 . . . . 1.48 107.946 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.57 120.42 35.76 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.412 1.485 . . . . 2.73 107.42 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.57 89.59 0.9 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.349 -1.1 . . . . 1.49 110.349 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.4 mt -89.82 123.04 33.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.153 0.981 . . . . 0.9 109.283 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.68 -11.26 59.97 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.629 -1.295 . . . . 1.73 113.873 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -143.41 161.95 44.73 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.507 2.723 . . . . 6.48 108.164 160.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.53 128.6 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 N-CA-C 107.07 -1.935 . . . . 1.58 107.07 147.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.99 155.46 30.75 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.11 -0.7 . . . . 2.76 109.11 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.71 125.21 22.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.958 0.885 . . . . 4.27 111.883 176.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.17 133.39 15.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.116 0.967 . . . . 2.01 112.225 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.64 40.94 4.57 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.037 -0.868 . . . . 2.61 113.382 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.6 165.79 29.32 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 126.851 2.06 . . . . 2.57 108.271 157.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.73 158.01 16.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.087 1.755 . . . . 3.99 111.294 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.5 t -115.66 119.94 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.858 1.263 . . . . 0.97 108.232 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 122.42 16.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.851 -1.166 . . . . 3.19 107.851 155.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.419 ' CD1' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -122.08 131.76 54.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.507 1.523 . . . . 2.57 107.312 175.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 51.2 m-20 -111.71 81.58 1.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.154 1.382 . . . . 3.5 110.417 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -66.78 118.72 10.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.336 1.854 . . . . 1.24 110.976 -170.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.82 122.39 34.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.258 1.023 . . . . 1.02 110.827 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.08 139.49 54.02 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.038 0.923 . . . . 2.0 111.772 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.96 128.77 22.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.1 1.36 . . . . 2.04 113.747 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.09 60.87 3.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.236 0.922 . . . . 3.35 113.068 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 6.77 88.83 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 116.956 1.543 . . . . 2.67 116.956 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.72 137.64 32.75 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.248 2.024 . . . . 4.38 110.708 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.32 133.22 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.559 1.144 . . . . 1.87 109.214 161.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.2 mt -114.33 109.31 18.16 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.323 1.049 . . . . 1.9 109.904 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.73 94.14 1.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 3.7 109.278 168.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.68 156.94 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.849 0.86 . . . . 1.81 110.065 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -103.46 139.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.482 1.113 . . . . 1.91 109.364 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 mt -142.02 153.35 63.71 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.786 2.035 . . . . 1.58 108.611 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.65 153.16 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.867 2.378 . . . . 1.11 112.102 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.5 t -77.95 132.5 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.131 0.972 . . . . 1.49 108.486 159.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.87 151.2 23.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.884 . . . . 3.5 110.837 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.76 115.39 30.05 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.042 1.337 . . . . 2.29 111.805 -161.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 129.17 2.988 . . . . 5.68 108.037 177.092 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 122.168 0.985 . . . . 6.09 111.795 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.64 169.73 41.39 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.976 2.227 . . . . 1.59 110.493 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -141.99 154.34 44.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.426 0.898 . . . . 2.27 113.426 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.07 126.27 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.366 -0.834 . . . . 0.96 109.147 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.06 108.67 12.72 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.23 1.412 . . . . 3.72 112.414 -162.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -66.14 122.61 17.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.184 1.394 . . . . 2.85 111.321 172.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -165.2 140.01 4.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.702 1.201 . . . . 2.31 110.151 167.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.87 71.35 6.4 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.287 3.325 . . . . 2.13 109.503 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.26 172.92 19.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.321 0.962 . . . . 1.32 114.443 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.05 -16.1 36.21 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.235 2.623 . . . . 1.71 111.68 166.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -144.86 164.78 30.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.571 1.149 . . . . 2.47 113.435 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.42 -166.35 1.64 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.375 2.27 . . . . 1.15 109.527 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.29 164.07 38.17 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.412 0.893 . . . . 1.21 113.412 -168.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.69 139.64 40.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.677 1.191 . . . . 1.2 111.428 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.45 140.57 41.33 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.73 2.012 . . . . 2.67 109.236 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.49 153.73 11.38 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.18 1.178 . . . . 2.12 114.18 -166.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -78.91 98.08 6.26 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.663 -1.236 . . . . 2.12 107.663 157.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.09 133.67 46.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.435 1.894 . . . . 3.23 108.589 173.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -105.44 145.28 31.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.194 0.813 . . . . 4.87 113.194 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -122.72 110.6 31.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.65 0.78 . . . . 1.42 109.507 150.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -91.94 -10.09 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.575 2.85 . . . . 1.44 113.513 170.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.27 33.64 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.795 1.188 . . . . 1.26 112.929 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.5 m-20 -87.26 4.06 44.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.071 1.748 . . . . 3.07 113.507 -174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.32 159.93 41.56 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.067 1.747 . . . . 1.85 110.64 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.38 149.83 21.91 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.812 2.341 . . . . 1.05 111.208 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.59 125.83 52.96 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.962 1.305 . . . . 2.26 109.163 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -111.25 99.66 8.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.236 1.014 . . . . 3.02 109.205 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 tp -80.63 114.3 19.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.999 2.12 . . . . 0.72 109.482 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.22 -11.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.507 1.123 . . . . 0.55 113.369 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.5 -166.02 37.72 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.4 1.0 . . . . 0.74 111.791 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.15 -179.16 6.95 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.408 1.083 . . . . 1.06 109.11 163.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -154.63 147.41 24.37 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.224 1.009 . . . . 6.06 108.332 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -146.4 156.4 49.62 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.207 1.003 . . . . 0.83 109.792 -167.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.69 -1.11 10.78 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.166 2.578 . . . . 1.58 113.445 166.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 HG22 ' A' ' 99' ' ' VAL . 2.3 m -101.64 -5.9 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 115.485 1.661 . . . . 1.19 115.485 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.54 158.77 41.75 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.818 1.19 . . . . 1.25 113.403 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.94 -76.62 0.52 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 3.1 110.736 -170.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.99 114.32 19.79 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.08 -1.013 . . . . 4.05 108.728 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.52 133.26 65.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 1.26 109.255 176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.69 134.97 24.26 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.351 1.06 . . . . 2.3 110.884 -170.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.74 120.4 26.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.316 1.055 . . . . 0.71 111.04 169.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 14.1 m170 -107.15 154.58 20.96 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.303 1.841 . . . . 0.72 112.152 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.34 -176.77 3.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.123 1.769 . . . . 2.13 110.39 167.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -148.07 86.86 1.58 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.915 1.286 . . . . 1.44 108.836 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -73.09 166.88 22.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.049 1.34 . . . . 2.29 111.967 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -111.07 159.12 18.08 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.301 0.64 . . . . 3.58 111.231 161.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -154.98 133.84 12.18 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.828 1.251 . . . . 6.08 109.707 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 147.52 47.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.535 0.734 . . . . 3.4 109.579 165.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.42 -40.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 115.322 1.601 . . . . 3.04 115.322 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -115.89 30.98 7.0 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.507 1.923 . . . . 4.45 109.699 175.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 -14.25 4.05 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.227 -1.546 . . . . 1.88 113.35 -165.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -104.15 160.29 14.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 127.725 2.41 . . . . 4.65 110.3 170.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -92.28 146.8 23.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.467 1.655 . . . . 3.68 115.467 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.37 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.731 2.013 . . . . 1.72 107.618 165.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -91.82 135.98 33.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.059 1.344 . . . . 3.75 110.217 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.47 148.75 20.37 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 124.237 0.922 . . . . 1.6 112.812 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -99.3 163.04 12.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.966 1.306 . . . . 1.76 112.035 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -170.64 152.08 3.72 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.847 1.659 . . . . 4.97 110.813 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.3 Cg_endo -69.54 150.07 69.1 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.675 1.583 . . . . 0.82 111.592 166.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.41 157.58 70.0 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.946 2.099 . . . . 0.89 110.188 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.47 -19.47 24.96 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.638 2.225 . . . . 0.86 112.996 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.46 166.22 3.93 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.183 1.393 . . . . 1.89 111.687 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -118.24 176.14 5.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.767 2.427 . . . . 1.05 108.815 156.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.32 165.09 36.84 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.095 -1.003 . . . . 2.02 111.668 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.43 134.15 10.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.68 1.592 . . . . 0.95 108.805 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.66 165.97 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.815 2.343 . . . . 0.82 111.739 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.56 144.47 97.75 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.557 2.838 . . . . 0.93 112.459 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 20.4 mmmt 68.65 -5.84 0.92 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.19 2.196 . . . . 2.11 114.823 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.51 122.22 7.29 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 126.574 2.035 . . . . 1.19 111.028 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -88.64 136.6 32.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.015 0.526 . . . . 4.5 110.21 157.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.9 173.36 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.904 2.082 . . . . 2.12 110.278 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -116.63 111.65 20.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.418 1.008 . . . . 4.27 113.639 -161.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.08 76.67 1.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.222 1.009 . . . . 1.39 108.436 156.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.51 155.19 76.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.044 0.938 . . . . 2.73 112.427 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.51 -58.37 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.11 2.54 . . . . 1.01 112.524 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.63 74.8 2.39 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.598 -1.001 . . . . 1.49 110.598 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.84 -75.84 0.08 OUTLIER Glycine 0 N--CA 1.469 0.835 0 C-N-CA 124.998 1.285 . . . . 1.07 114.069 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -156.18 138.13 14.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.772 1.629 . . . . 2.39 109.926 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -168.61 164.0 12.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.654 1.57 . . . . 0.78 111.282 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.41 129.55 41.11 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 110.429 -0.211 . . . . 2.19 110.429 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.5 mmt -87.58 135.9 33.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.262 1.025 . . . . 0.86 110.351 165.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.58 114.79 26.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.445 1.498 . . . . 1.76 108.262 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.8 123.7 48.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.657 1.983 . . . . 2.89 108.417 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.55 100.74 0.15 Allowed Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.55 -1.02 . . . . 1.49 110.55 -174.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.65 120.03 36.23 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.93 0.865 . . . . 0.94 111.07 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.38 -11.68 61.02 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.204 1.402 . . . . 2.26 113.924 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -167.09 155.52 9.08 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 126.744 2.018 . . . . 4.88 110.235 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.4 140.52 82.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.801 1.667 . . . . 2.19 109.318 163.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 39' ' ' VAL . 22.7 mt -84.3 89.96 7.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.535 1.134 . . . . 2.63 109.585 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 108.04 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.535 1.134 . . . . 5.22 110.302 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.0 113.1 0.91 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.021 0.528 . . . . 1.56 110.842 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.78 3.11 30.4 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 116.76 -2.133 . . . . 2.57 116.655 -173.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.92 171.76 14.51 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.341 2.571 . . . . 4.76 110.102 152.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -103.3 135.02 45.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.713 -1.217 . . . . 6.49 107.713 145.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.494 HG22 HG11 ' A' ' 39' ' ' VAL . 22.8 t -74.24 125.92 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 124.221 1.009 . . . . 1.33 108.724 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 136.33 56.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.688 0.756 . . . . 3.4 110.233 162.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -147.58 124.81 11.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 123.29 1.519 . . . . 1.75 111.77 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.47 83.85 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 127.554 2.341 . . . . 2.58 109.491 -167.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.27 120.05 12.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.585 1.154 . . . . 1.26 110.279 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.5 mt -97.57 130.34 44.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.646 1.579 . . . . 0.76 110.709 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 90.5 m-85 -134.15 129.3 35.65 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.414 -0.804 . . . . 1.95 111.133 -175.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 43.36 34.25 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.844 1.657 . . . . 2.29 113.478 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.23 -76.59 1.93 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.175 1.369 . . . . 4.48 111.39 -167.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.773 1.069 . . . . 2.66 115.773 -160.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -79.17 93.39 5.2 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.016 1.908 . . . . 7.24 110.267 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.84 128.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 125.568 1.547 . . . . 1.12 108.405 167.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.63 179.78 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.033 1.333 . . . . 3.43 110.456 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -134.41 119.73 18.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.251 1.02 . . . . 2.54 108.4 154.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.42 168.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.907 -1.516 . . . . 2.71 106.907 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.0 m -125.65 144.3 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.35 1.86 . . . . 2.57 108.922 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.4 mt -143.39 141.47 19.25 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.558 1.143 . . . . 2.48 111.482 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.1 144.86 99.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.937 3.092 . . . . 1.51 113.793 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.08 125.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.334 -0.988 . . . . 1.14 108.334 168.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.77 161.79 42.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.989 0.916 . . . . 3.21 110.463 -168.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.52 5.85 34.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.559 1.318 . . . . 2.51 114.559 -156.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.188 1.795 . . . . 5.3 111.373 -178.105 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 111.961 0.356 . . . . 5.23 111.961 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -124.11 153.99 17.63 Favored Glycine 0 N--CA 1.469 0.847 0 C-N-CA 128.566 2.984 . . . . 1.21 111.414 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -134.64 130.91 37.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.726 1.263 . . . . 1.34 113.778 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.1 t -87.61 125.62 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.274 -0.891 . . . . 1.21 109.604 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.71 114.62 8.98 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.766 0.827 . . . . 3.69 112.984 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.5 143.67 30.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.657 0.741 . . . . 2.91 110.256 149.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.2 169.87 2.14 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 129.589 3.156 . . . . 3.52 106.787 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.97 33.81 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.428 2.752 . . . . 3.18 113.826 -170.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.45 150.55 17.28 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.621 1.105 . . . . 2.08 114.513 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.43 -14.84 20.1 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.918 3.079 . . . . 1.67 112.105 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -134.45 157.76 45.63 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.72 2.008 . . . . 2.08 111.374 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.49 168.95 22.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.536 1.135 . . . . 1.5 112.763 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.22 122.35 42.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.977 1.311 . . . . 1.71 109.487 166.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.6 119.26 28.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.361 -0.607 . . . . 1.1 109.361 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -95.33 141.07 29.34 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.59 1.156 . . . . 2.24 108.876 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.458 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 4.1 pp -158.14 156.1 30.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.106 1.15 . . . . 2.24 114.106 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.6 m -112.31 105.86 14.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.722 1.209 . . . . 1.83 108.688 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 23' ' ' GLU . 3.4 tt -101.89 144.16 30.87 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.032 1.333 . . . . 2.71 109.303 -174.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.499 ' N ' HD23 ' A' ' 22' ' ' LEU . 14.7 pt-20 -145.88 141.51 27.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.332 0.587 . . . . 3.46 112.119 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -104.53 106.38 54.13 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.928 -1.033 . . . . 1.35 110.242 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 -12.18 13.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.506 2.137 . . . . 1.55 113.432 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.62 172.56 54.51 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 119.166 0.894 . . . . 1.34 113.065 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -96.0 -4.26 43.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.046 1.738 . . . . 2.99 112.492 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 155.54 44.99 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.634 1.974 . . . . 4.85 108.568 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.61 158.92 25.29 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.094 2.529 . . . . 1.29 111.447 -171.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.45 154.05 20.86 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.315 1.046 . . . . 2.06 109.974 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -134.27 110.35 9.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.181 1.392 . . . . 2.95 109.086 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.4 tp -88.92 124.35 34.15 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.715 2.006 . . . . 0.72 109.246 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.53 -6.11 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.08 1.141 . . . . 0.75 114.08 -170.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.21 -165.67 37.91 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 118.88 0.764 . . . . 0.84 112.463 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.865 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -154.06 177.16 11.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.202 -0.904 . . . . 1.22 112.433 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.29 134.43 0.89 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.065 0.848 . . . . 5.66 112.732 162.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -129.92 157.29 77.31 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 126.53 1.932 . . . . 1.03 110.124 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.15 -23.38 66.78 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.863 2.376 . . . . 1.18 114.84 165.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -87.95 -0.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 114.729 1.381 . . . . 1.17 114.729 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.31 163.97 31.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.67 1.188 . . . . 0.88 111.92 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -96.11 -94.36 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.109 1.364 . . . . 3.23 109.224 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 128.87 38.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.456 -0.778 . . . . 4.6 110.025 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -131.09 133.02 63.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.002 1.321 . . . . 1.15 110.166 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.22 136.13 33.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.228 1.411 . . . . 2.96 110.64 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.04 121.39 26.48 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.093 -1.004 . . . . 0.66 111.082 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.6 m170 -108.5 156.0 19.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.503 1.521 . . . . 0.8 112.414 172.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -101.54 179.74 4.26 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.245 -0.889 . . . . 3.01 110.761 160.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -147.52 104.59 3.64 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.038 -1.097 . . . . 1.3 108.038 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -122.94 155.58 36.45 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.747 1.619 . . . . 2.3 112.899 -156.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.3 mtm -82.91 143.95 30.38 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.368 0.667 . . . . 3.0 111.127 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -167.16 129.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.063 1.345 . . . . 9.2 111.3 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -90.1 175.54 7.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.522 1.129 . . . . 4.3 111.436 -171.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 133.53 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.837 1.655 . . . . 3.71 108.751 162.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 65.71 10.7 6.98 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.174 0.99 . . . . 4.2 112.403 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.24 87.66 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 120.898 -1.126 . . . . 2.01 114.089 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -96.88 142.13 29.23 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.074 1.75 . . . . 2.81 109.699 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 11.4 tppt? -75.13 131.62 40.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.282 1.433 . . . . 4.34 113.139 -165.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.71 -173.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.307 1.043 . . . . 1.93 111.293 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 ptp -146.68 -177.17 5.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.594 1.958 . . . . 3.7 112.695 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.75 172.88 43.87 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.333 1.444 . . . . 1.07 112.935 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -114.3 156.98 23.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.561 1.544 . . . . 1.85 109.416 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -166.32 144.39 4.55 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.052 1.341 . . . . 6.44 110.068 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 21.2 Cg_endo -66.31 147.66 83.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.012 1.808 . . . . 0.82 110.414 168.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.08 156.83 52.0 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.544 1.538 . . . . 0.6 109.554 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.52 -22.05 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.041 1.827 . . . . 0.79 112.334 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -173.93 165.13 4.29 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 124.482 1.113 . . . . 2.4 111.814 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.48 175.34 5.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.422 2.289 . . . . 1.04 109.108 158.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.73 168.66 26.74 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.666 -1.271 . . . . 2.17 111.737 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -149.26 132.74 8.45 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.722 0.809 . . . . 1.17 110.161 -168.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.0 164.36 34.63 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.372 2.048 . . . . 1.41 111.799 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.97 140.22 78.01 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.861 3.041 . . . . 1.52 112.188 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 70.14 0.56 3.18 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.972 2.109 . . . . 2.05 113.871 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.06 125.1 7.94 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 126.783 2.135 . . . . 1.61 111.165 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 148.0 23.88 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.914 -0.643 . . . . 4.83 112.357 154.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.73 162.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.456 1.902 . . . . 1.65 109.35 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.13 139.91 51.0 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.821 0.82 . . . . 3.02 112.47 173.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.36 71.7 1.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.592 1.157 . . . . 1.42 108.238 155.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -80.1 142.55 55.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.104 1.761 . . . . 3.77 110.549 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.13 -58.82 1.52 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.969 3.779 . . . . 1.04 114.323 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.27 52.85 4.37 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 119.009 0.822 . . . . 1.21 112.067 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.28 -82.89 0.05 OUTLIER Glycine 0 N--CA 1.466 0.645 0 C-N-CA 127.627 2.537 . . . . 0.8 111.699 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -151.27 149.78 29.79 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.005 2.122 . . . . 2.36 108.967 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -169.25 165.22 10.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.163 0.892 . . . . 0.79 111.292 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 30.7 m-85 -103.13 118.76 37.52 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.89 0.476 . . . . 2.21 110.226 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.6 mmt -77.69 104.66 8.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 1.09 110.11 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.44 127.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.048 1.339 . . . . 1.52 108.709 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.98 117.35 19.08 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.485 1.114 . . . . 3.17 109.23 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.91 75.04 1.21 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.312 -1.115 . . . . 1.32 110.312 -168.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.85 129.8 40.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.434 -0.58 . . . . 1.2 109.434 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -80.98 7.71 10.11 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.954 1.094 . . . . 1.48 113.954 -170.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 176.26 153.32 0.36 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.988 2.515 . . . . 4.43 109.65 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.79 144.13 76.35 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 108.14 -1.523 . . . . 1.62 108.14 159.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.26 152.7 18.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.946 0.898 . . . . 2.35 109.093 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -117.01 135.05 54.0 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.863 0.865 . . . . 6.24 109.74 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 119.02 6.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.745 -1.222 . . . . 2.11 110.966 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.64 39.51 34.41 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.639 -0.663 . . . . 2.03 113.095 -168.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -91.03 -169.88 2.49 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.083 -1.08 . . . . 2.47 108.083 140.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.82 142.05 29.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.157 1.383 . . . . 4.06 109.844 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.61 102.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.276 1.43 . . . . 1.33 109.461 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.497 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 3.6 mm-40 -55.52 130.6 43.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.516 -1.22 . . . . 3.15 109.743 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.865 HD21 ' HB1' ' A' ' 35' ' ' ALA . 7.2 tt -156.34 131.67 9.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.369 1.08 . . . . 2.09 111.171 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.77 93.9 8.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.582 2.353 . . . . 2.28 110.454 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.83 123.07 19.97 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.402 -0.962 . . . . 1.36 108.402 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.75 128.81 45.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.78 1.232 . . . . 0.73 110.006 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -129.09 119.2 23.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.279 0.844 . . . . 2.07 113.279 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 23.12 44.98 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.2 3.0 . . . . 2.02 115.911 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.39 -56.07 1.57 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.616 1.579 . . . . 3.13 113.382 -171.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.89 0.14 58.53 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.685 -1.619 . . . . 2.06 116.909 -164.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 150.21 45.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.15 1.975 . . . . 3.94 111.421 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.03 139.54 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.046 1.738 . . . . 1.11 109.091 165.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.95 104.51 7.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.433 1.093 . . . . 1.66 110.015 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 8.9 ttpp -72.6 88.81 1.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.07 1.348 . . . . 2.79 110.213 172.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.3 m -114.23 140.25 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.142 1.377 . . . . 2.59 111.166 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -100.73 133.18 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.968 1.707 . . . . 2.22 110.92 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.64 149.91 73.37 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.861 1.265 . . . . 2.75 111.28 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.12 151.79 83.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.941 2.427 . . . . 1.39 113.389 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.9 t -83.43 134.8 26.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.135 1.374 . . . . 1.48 109.087 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -137.36 157.73 45.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.102 0.961 . . . . 3.42 109.936 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.16 112.87 25.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.91 0.884 . . . . 2.22 111.049 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.074 1.35 . . . . 5.33 111.317 174.41 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 108.903 -0.777 . . . . 5.56 108.903 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.69 44.25 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 115.601 1.0 . . . . 1.08 115.601 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -153.15 150.47 29.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.651 1.98 . . . . 1.36 111.44 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -114.41 134.89 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.799 -0.815 . . . . 1.06 108.799 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -73.75 126.7 30.94 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.086 0.773 . . . . 3.94 113.086 -167.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -74.66 128.75 36.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.133 0.968 . . . . 3.04 111.004 157.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -159.35 138.14 7.93 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.281 1.432 . . . . 2.39 110.199 164.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -83.42 73.27 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 124.159 3.24 . . . . 2.64 109.658 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.58 176.91 24.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.147 0.88 . . . . 1.43 114.068 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.32 -4.64 15.31 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.26 3.307 . . . . 2.07 112.934 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -140.67 164.27 30.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.518 1.127 . . . . 3.61 112.657 170.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.36 165.26 33.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.23 1.812 . . . . 1.3 110.227 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.73 154.79 20.99 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.66 0.784 . . . . 1.21 111.735 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.15 136.94 54.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.693 0.797 . . . . 1.06 111.89 164.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -133.15 128.72 36.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.522 1.529 . . . . 2.06 110.922 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -166.08 159.19 15.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.709 1.374 . . . . 1.77 114.709 -167.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -80.33 140.68 36.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.088 0.955 . . . . 1.39 109.793 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.24 126.1 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.173 1.389 . . . . 2.28 107.759 170.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -151.9 148.42 27.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.216 0.607 . . . . 4.18 112.235 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -109.87 109.65 59.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.45 1.1 . . . . 1.02 111.842 -164.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.39 -11.12 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.35 2.033 . . . . 1.22 113.466 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.11 53.74 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.227 1.394 . . . . 1.14 114.251 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.4 -36.03 63.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.144 2.178 . . . . 6.13 112.626 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -102.39 163.42 17.7 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.479 1.911 . . . . 1.86 111.531 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.07 159.02 23.81 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.001 2.467 . . . . 1.04 112.371 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.2 mt -103.3 145.54 29.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.695 1.198 . . . . 2.05 110.423 171.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -129.78 105.31 7.94 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.832 1.253 . . . . 3.83 108.24 167.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.3 tp -79.87 104.77 10.67 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.961 2.104 . . . . 0.67 108.352 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -95.45 -14.92 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.916 0.886 . . . . 0.49 112.412 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.41 -163.8 33.89 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 123.775 0.702 . . . . 0.52 112.735 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.4 177.5 9.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.147 0.979 . . . . 0.85 110.924 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -146.44 124.19 11.89 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.034 -1.469 . . . . 6.46 107.034 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -142.34 149.83 52.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 117.688 -1.149 . . . . 0.8 110.087 -170.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.32 -3.34 12.98 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.517 2.145 . . . . 1.06 113.463 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.46 -4.91 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 115.641 1.719 . . . . 1.09 115.641 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.16 144.52 50.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.681 1.192 . . . . 1.12 110.943 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -84.08 -75.99 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.679 -0.86 . . . . 3.66 108.679 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -91.29 126.72 36.46 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.386 -0.821 . . . . 4.03 108.789 165.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.26 138.38 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.442 1.497 . . . . 1.2 109.916 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -136.65 136.78 39.41 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.424 1.889 . . . . 2.31 109.358 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.63 124.66 33.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 121.154 1.797 . . . . 0.73 111.073 165.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.3 m170 -108.03 153.36 23.22 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.709 1.604 . . . . 0.83 113.617 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.25 -179.42 3.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.572 2.749 . . . . 2.29 110.758 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.4 m -128.98 107.99 10.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.117 -1.438 . . . . 1.22 107.117 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -91.23 161.76 14.92 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 122.013 0.911 . . . . 2.21 111.686 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.5 mtm -118.67 168.01 11.12 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.09 -0.959 . . . . 3.3 110.902 156.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -176.53 163.63 2.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.335 2.654 . . . . 6.31 109.7 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.09 147.51 22.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.586 -0.894 . . . . 3.73 108.586 165.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 p -114.24 -15.52 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 113.858 1.059 . . . . 3.49 113.858 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.89 25.84 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.424 2.29 . . . . 4.13 109.046 -162.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.69 -20.98 1.64 Allowed Glycine 0 N--CA 1.477 1.375 0 O-C-N 119.392 -2.067 . . . . 2.17 113.183 -159.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.8 135.24 35.47 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.655 1.582 . . . . 4.08 109.882 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -76.19 138.62 40.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.298 1.039 . . . . 4.53 111.855 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -134.27 150.49 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.415 2.286 . . . . 1.9 108.97 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.9 ttp -123.46 144.25 49.63 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.557 1.943 . . . . 5.11 109.505 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.96 163.8 31.53 Favored Glycine 0 N--CA 1.469 0.838 0 CA-C-N 118.724 0.693 . . . . 1.04 113.236 173.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.68 159.88 14.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.33 1.052 . . . . 1.92 111.281 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 -173.21 140.33 0.89 Allowed Pre-proline 0 N--CA 1.475 0.776 0 CA-C-O 116.954 -1.498 . . . . 4.44 111.402 -168.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 17.0 Cg_endo -71.09 147.49 54.48 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.927 1.751 . . . . 0.85 112.559 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.61 151.4 67.41 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.415 1.486 . . . . 0.79 110.48 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.34 -8.82 24.18 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.055 2.503 . . . . 0.87 113.447 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -174.6 159.21 2.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.765 1.626 . . . . 2.54 111.097 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mt -108.85 172.8 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.31 1.444 . . . . 1.11 108.98 149.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.34 163.36 37.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.231 -0.918 . . . . 2.79 112.604 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -151.15 131.34 7.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.134 0.974 . . . . 0.91 109.806 -168.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 164.49 35.53 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.296 1.998 . . . . 1.05 111.291 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.87 133.04 42.54 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.306 2.671 . . . . 1.05 110.61 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 72.06 0.34 3.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 127.489 2.316 . . . . 1.7 113.788 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.67 157.5 34.37 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 126.545 2.021 . . . . 1.32 111.031 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -132.54 144.36 50.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 127.346 2.258 . . . . 4.42 110.418 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.84 163.94 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.676 1.991 . . . . 1.83 108.762 167.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -139.1 115.02 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.921 -0.77 . . . . 3.19 108.921 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.37 91.17 1.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.576 . . . . 1.2 108.781 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -110.1 151.23 42.39 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.525 2.33 . . . . 3.12 111.784 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.04 -53.89 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.274 3.316 . . . . 1.06 113.949 -168.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.93 93.71 1.77 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 108.413 -1.875 . . . . 1.29 108.413 164.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -85.0 0.14 Allowed Glycine 0 C--O 1.222 -0.614 0 C-N-CA 124.794 1.188 . . . . 0.86 112.698 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -155.95 145.87 21.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.579 1.952 . . . . 2.47 110.09 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -174.09 157.49 2.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.088 0.955 . . . . 1.46 108.823 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -85.68 139.17 31.6 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 119.813 -0.755 . . . . 2.01 109.893 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 mmt -92.42 118.94 31.46 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.419 1.087 . . . . 1.17 109.021 161.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.7 mt -100.05 114.86 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.943 1.697 . . . . 1.78 106.793 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.5 150.78 26.96 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.365 1.066 . . . . 3.1 110.741 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.19 -55.49 4.59 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 125.235 1.398 . . . . 3.69 111.761 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt 69.9 125.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.775 3.23 . . . . 1.09 111.581 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -80.9 22.99 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.263 -1.523 . . . . 1.81 113.074 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 160.6 153.41 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 129.816 3.246 . . . . 3.89 109.219 -163.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.52 131.87 31.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.234 -1.871 . . . . 1.41 107.234 151.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.1 101.52 0.41 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.928 0.891 . . . . 2.11 110.18 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.84 97.3 1.38 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.729 -1.232 . . . . 4.01 109.843 -172.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -44.64 124.63 4.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.123 0.969 . . . . 1.89 111.3 172.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.5 30.46 66.65 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.013 -0.882 . . . . 1.97 114.165 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -101.45 -172.08 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.599 1.699 . . . . 3.55 107.519 136.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -132.21 151.36 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.832 0.853 . . . . 3.59 110.525 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.0 t -98.89 113.86 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 124.85 1.26 . . . . 1.14 108.916 -172.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.65 138.39 46.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 124.249 0.968 . . . . 3.76 109.441 164.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mt -155.3 116.17 3.91 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.088 0.955 . . . . 1.57 111.091 -168.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.31 104.63 16.59 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.016 2.126 . . . . 2.82 109.468 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 48.0 mt -75.89 126.34 30.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 1.12 110.194 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.0 mt -97.51 121.41 39.38 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.354 1.062 . . . . 0.72 110.638 -175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.99 119.32 31.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.856 0.836 . . . . 2.04 112.732 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.1 28.23 0.9 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.01 2.124 . . . . 2.01 114.208 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.99 -60.07 2.2 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.707 1.622 . . . . 3.54 112.692 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.87 -7.5 86.35 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.26 1.264 . . . . 1.61 116.26 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.39 145.38 43.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.214 2.007 . . . . 4.46 110.194 166.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -147.68 135.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.021 1.328 . . . . 1.05 108.829 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -144.17 127.8 17.11 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.324 1.45 . . . . 1.85 108.756 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -91.01 147.18 23.26 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.421 1.637 . . . . 2.9 115.421 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.29 164.66 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.965 2.506 . . . . 1.21 109.466 171.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.5 132.83 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.104 0.962 . . . . 2.06 109.181 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -145.14 145.28 26.35 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.967 1.707 . . . . 2.45 109.537 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 153.35 67.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.372 3.381 . . . . 1.0 114.431 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.62 127.17 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.056 0.942 . . . . 1.17 109.007 167.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -147.25 153.85 40.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.315 1.446 . . . . 3.47 111.351 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.21 47.56 0.96 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.347 1.459 . . . . 2.04 114.155 -161.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.934 -1.508 . . . . 5.81 112.46 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 114.915 1.45 . . . . 6.92 114.915 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.34 46.8 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.694 2.093 . . . . 1.05 111.683 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.21 152.7 11.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.237 1.199 . . . . 1.42 114.237 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.45 128.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.163 1.385 . . . . 1.45 109.12 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.2 117.74 29.88 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.748 0.647 . . . . 4.78 112.748 -166.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.5 142.13 58.53 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.244 2.218 . . . . 4.64 113.865 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -159.13 167.61 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 120.109 -1.62 . . . . 2.23 111.448 158.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.29 -15.68 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.121 3.214 . . . . 3.15 112.453 166.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 155.14 40.42 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 119.29 -0.728 . . . . 1.36 112.042 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.37 -8.7 23.89 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.075 3.183 . . . . 1.8 114.373 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.87 146.97 35.55 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.005 1.322 . . . . 3.05 111.676 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.91 -176.03 5.74 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.072 1.749 . . . . 1.25 112.952 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.0 154.85 50.29 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.449 1.1 . . . . 1.14 111.831 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.18 147.88 44.28 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.265 1.031 . . . . 0.95 111.637 166.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.1 146.52 39.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.128 1.771 . . . . 1.9 108.753 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.1 153.79 14.33 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.926 0.713 . . . . 1.73 112.926 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.1 m -72.57 110.61 7.07 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.629 1.572 . . . . 1.24 108.259 159.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.07 127.81 34.14 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.159 -1.423 . . . . 2.55 107.159 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.68 114.49 20.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 4.41 110.522 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -102.66 103.68 33.92 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.141 -0.974 . . . . 0.92 110.686 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.13 -7.92 11.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.91 2.407 . . . . 1.08 113.236 172.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.14 171.18 55.19 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 119.109 0.868 . . . . 0.99 113.7 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -101.57 0.16 35.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.367 1.867 . . . . 2.7 113.032 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.96 159.06 39.06 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.723 1.609 . . . . 1.86 110.451 167.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.23 154.37 18.95 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.043 2.495 . . . . 1.06 111.142 -173.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -101.65 150.63 22.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.258 1.023 . . . . 2.33 110.482 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -133.7 103.06 5.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.526 1.131 . . . . 3.11 109.409 171.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 tp -84.14 104.83 14.52 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.366 2.267 . . . . 0.83 108.97 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.64 -12.93 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.154 0.982 . . . . 0.63 113.001 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.26 -169.35 41.89 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 124.448 1.023 . . . . 0.6 111.76 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -158.17 -178.39 7.26 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.113 0.965 . . . . 0.88 111.508 173.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 10.4 mmt180 -158.32 149.92 21.27 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 121.509 1.959 . . . . 6.85 109.126 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -154.28 152.13 25.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.019 1.327 . . . . 0.96 108.243 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.87 -25.14 60.35 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.661 2.241 . . . . 0.85 113.418 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -79.59 -4.18 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.889 1.44 . . . . 0.9 114.889 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.38 174.56 12.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.948 1.299 . . . . 0.96 112.476 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -116.56 -87.97 0.6 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.84 0.856 . . . . 4.32 110.17 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -69.35 107.05 3.14 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.511 -0.743 . . . . 4.89 109.71 -171.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -84.16 141.29 14.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.227 2.211 . . . . 2.0 110.571 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -146.72 124.2 11.7 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 2.71 109.999 166.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.429 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.2 tt -81.84 115.36 21.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.184 0.993 . . . . 0.97 110.326 169.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.0 m170 -100.23 151.69 21.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.737 1.615 . . . . 0.87 111.881 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.8 177.82 5.65 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.038 -1.437 . . . . 1.99 110.689 165.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.573 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 87.5 m -147.94 102.76 3.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.24 1.416 . . . . 1.2 107.195 171.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -112.76 153.07 28.35 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.817 1.247 . . . . 2.55 112.523 -166.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -105.5 121.72 44.52 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.487 0.66 . . . . 3.37 109.598 156.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -144.91 170.01 16.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.311 1.844 . . . . 7.88 109.107 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.25 143.95 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.351 0.66 . . . . 4.27 109.927 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.12 -87.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 3.71 108.408 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -77.4 50.99 0.83 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.436 1.895 . . . . 2.96 110.404 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.1 -31.93 0.42 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 126.601 2.048 . . . . 3.48 115.077 -175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.82 146.63 24.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.584 1.953 . . . . 2.79 111.37 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -68.44 118.76 11.92 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 118.845 -0.598 . . . . 5.16 109.47 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.83 147.78 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 3.31 111.305 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.4 mmt -77.79 141.03 39.47 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.982 1.313 . . . . 3.43 113.671 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.56 27.81 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.058 0.837 . . . . 1.25 114.13 170.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -114.63 137.42 51.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.604 1.562 . . . . 1.82 110.346 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -148.21 155.71 43.14 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.913 1.285 . . . . 7.04 109.955 165.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 38.6 Cg_endo -65.52 145.63 82.87 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.073 2.515 . . . . 0.69 110.953 167.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.83 159.06 33.13 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 125.338 1.455 . . . . 0.73 109.855 166.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.0 -15.14 32.48 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.625 2.217 . . . . 0.7 113.243 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -175.74 160.77 2.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.042 1.737 . . . . 2.12 111.02 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mt -109.87 175.94 5.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.827 1.651 . . . . 1.2 109.517 154.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.52 168.26 26.75 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.363 -0.835 . . . . 2.42 112.116 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -149.82 136.46 10.83 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.442 1.097 . . . . 0.86 109.527 -170.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -72.25 168.0 25.33 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.405 2.07 . . . . 0.85 112.048 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.54 145.28 99.06 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.789 2.993 . . . . 0.91 111.915 168.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.24 0.9 0.46 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.865 2.172 . . . . 1.78 116.865 -172.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 114.03 3.79 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 127.147 2.308 . . . . 0.87 111.95 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -81.9 139.26 34.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.997 -1.101 . . . . 5.45 109.243 151.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 m -151.36 130.51 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.657 1.583 . . . . 1.78 110.084 169.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -90.41 130.39 36.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.629 -0.669 . . . . 3.31 111.407 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -69.81 129.17 38.84 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.364 -0.976 . . . . 1.76 108.364 161.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -143.28 140.73 18.05 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.576 1.55 . . . . 2.95 110.865 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.7 -16.75 47.08 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.702 2.935 . . . . 1.81 114.278 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.98 100.0 1.79 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.24 -1.944 . . . . 1.37 108.24 152.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.573 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 142.66 -85.33 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.847 1.689 . . . . 1.36 113.089 -172.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.71 144.2 20.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.067 1.747 . . . . 1.89 111.22 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.92 158.02 27.47 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.256 -0.903 . . . . 1.09 110.74 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 45' ' ' LEU . 49.0 m-85 -94.28 133.05 38.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.074 0.397 . . . . 1.95 110.814 170.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.2 mmt -90.62 137.18 32.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.394 1.478 . . . . 0.93 109.906 162.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.82 126.58 45.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.503 1.521 . . . . 2.91 108.653 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.42 147.49 52.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.233 1.413 . . . . 3.28 110.526 -175.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 57.95 4.6 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.236 -0.746 . . . . 1.38 111.236 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.09 120.51 12.81 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.48 0.64 . . . . 0.87 110.938 -174.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -76.23 -9.78 58.9 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.873 1.064 . . . . 2.16 113.873 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.98 145.08 0.74 Allowed Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 127.065 2.146 . . . . 4.52 110.152 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.37 154.15 65.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.906 2.404 . . . . 2.13 109.885 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.71 162.03 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.044 1.338 . . . . 2.8 111.329 -170.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -114.71 127.05 55.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.265 1.026 . . . . 5.0 111.222 172.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.34 117.48 4.87 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.906 -0.588 . . . . 1.84 109.747 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.13 -8.46 31.18 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.21 -1.328 . . . . 2.6 114.683 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.34 161.2 26.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 119.637 1.718 . . . . 2.79 109.955 162.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -111.01 156.93 20.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.636 -0.711 . . . . 5.33 109.484 154.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.55 125.14 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.854 1.662 . . . . 1.55 108.473 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -74.58 145.85 43.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.481 0.658 . . . . 3.91 110.379 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.627 HD21 ' HB1' ' A' ' 35' ' ' ALA . 3.6 tt -154.96 126.7 7.51 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.141 0.977 . . . . 1.87 110.643 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.43 109.92 21.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.121 2.568 . . . . 2.48 112.068 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 119.03 23.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.216 1.406 . . . . 1.14 110.321 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.0 mt -89.95 111.15 22.13 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.802 0.841 . . . . 0.7 109.56 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 76.6 m-85 -111.98 124.08 51.64 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.707 -0.621 . . . . 2.26 109.836 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.87 37.49 1.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.123 1.769 . . . . 2.32 113.263 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -73.23 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.722 1.153 . . . . 4.62 112.091 -171.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.63 -30.2 60.33 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 115.739 1.055 . . . . 2.46 115.739 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 54.1 tttp -83.91 86.45 7.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 119.946 1.873 . . . . 6.39 108.51 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -100.86 106.93 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.042 1.337 . . . . 1.67 109.549 173.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.16 125.81 44.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.771 1.629 . . . . 3.12 110.654 -173.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -83.14 139.04 33.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.479 1.659 . . . . 2.8 115.479 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.81 169.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.399 1.88 . . . . 1.34 109.32 159.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.6 139.23 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.386 1.474 . . . . 1.98 108.346 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -146.03 145.86 26.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.303 1.441 . . . . 1.71 110.798 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.18 158.37 55.01 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 124.274 3.316 . . . . 0.98 113.948 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.44 134.55 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.313 1.445 . . . . 1.44 111.577 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -152.41 -172.18 4.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.878 2.071 . . . . 4.08 109.429 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.47 124.98 35.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.964 -1.085 . . . . 2.71 110.886 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 125.357 1.463 . . . . 8.4 112.798 -163.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 109.655 -0.498 . . . . 4.87 109.655 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.08 175.81 19.37 Favored Glycine 0 N--CA 1.466 0.655 0 O-C-N 121.48 -0.762 . . . . 1.03 114.631 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -159.86 146.01 15.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.943 1.697 . . . . 1.3 110.572 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.92 138.93 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.436 -0.95 . . . . 1.04 108.436 170.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -86.73 131.76 34.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.544 0.688 . . . . 4.58 112.176 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -53.26 119.52 4.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.741 1.616 . . . . 3.94 112.587 164.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -165.29 99.03 0.8 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.699 2.0 . . . . 3.12 107.522 163.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.66 44.21 1.45 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.459 2.773 . . . . 2.82 111.964 -168.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.94 -147.78 6.47 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.304 0.954 . . . . 1.94 114.138 -167.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.32 -7.04 17.73 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.299 2.666 . . . . 1.7 112.798 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -154.25 156.89 37.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 2.31 112.829 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.2 -165.36 1.9 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.387 2.675 . . . . 1.42 110.448 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.04 154.39 39.24 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.261 -0.899 . . . . 1.37 111.798 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.81 125.46 46.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.919 0.888 . . . . 1.24 110.405 165.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -103.11 147.4 27.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.985 1.714 . . . . 2.03 108.75 168.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -163.45 141.88 7.94 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.275 1.213 . . . . 1.47 114.275 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.1 m -66.82 107.61 2.24 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.277 -1.008 . . . . 1.43 108.277 161.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 134.36 36.42 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 106.944 -1.502 . . . . 2.7 106.944 165.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.28 151.56 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.35 1.071 . . . . 3.47 112.01 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -128.29 99.37 24.51 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.52 1.528 . . . . 0.99 109.073 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -6.27 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.49 2.127 . . . . 1.01 112.841 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.51 174.03 54.17 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.282 0.944 . . . . 0.88 113.994 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.11 -3.79 26.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.507 1.923 . . . . 2.71 113.441 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.34 161.0 33.74 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.107 1.763 . . . . 1.66 109.98 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.65 162.76 24.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.058 2.506 . . . . 0.93 111.978 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.26 144.92 40.87 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.252 1.021 . . . . 1.81 110.593 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -122.67 114.19 20.25 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.896 1.278 . . . . 3.09 109.27 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.54 117.23 29.79 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.04 2.136 . . . . 0.67 109.151 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -117.69 -4.9 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.405 1.082 . . . . 0.78 112.938 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.71 -174.6 47.01 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.698 1.142 . . . . 0.68 111.18 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.972 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -148.06 178.92 8.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.242 1.417 . . . . 0.74 109.891 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.497 HH11 ' HG3' ' A' ' 36' ' ' ARG . 12.8 tpt85 -161.28 147.86 14.62 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 106.664 -1.606 . . . . 6.01 106.664 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.416 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 2.5 t -149.7 157.8 38.09 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 124.6 1.16 . . . . 0.88 109.172 -166.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.05 -15.79 16.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.11 1.873 . . . . 1.29 114.351 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.44 HG12 ' HE ' ' A' ' 91' ' ' ARG . 4.7 m -101.16 2.46 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 116.025 1.861 . . . . 0.93 116.025 -170.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 164.05 38.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.416 1.007 . . . . 1.02 113.019 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.34 -79.67 0.54 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.731 2.012 . . . . 2.84 111.314 -170.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 111.37 9.88 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.412 -0.958 . . . . 3.89 108.412 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -84.15 139.62 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.435 -1.257 . . . . 1.99 110.428 158.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -142.24 122.46 13.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.597 1.159 . . . . 2.0 109.042 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -79.01 118.74 21.29 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.627 1.558 . . . . 1.03 110.713 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -113.36 157.28 22.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 0.55 111.869 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -112.34 167.45 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.396 1.478 . . . . 2.2 110.372 166.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -123.26 114.79 20.7 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.741 1.616 . . . . 1.26 107.453 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -120.7 152.91 37.64 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.924 0.89 . . . . 2.33 112.809 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtp -103.03 142.78 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.82 1.648 . . . . 3.72 110.325 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -157.8 144.83 18.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.097 1.359 . . . . 6.65 111.503 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 137.95 31.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.284 0.493 . . . . 4.19 111.104 166.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -146.71 126.33 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.732 1.613 . . . . 3.72 107.324 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 63.33 20.35 12.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.589 1.156 . . . . 3.24 111.963 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.17 -9.14 41.45 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.761 1.172 . . . . 2.4 113.829 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -89.2 143.86 26.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.978 1.711 . . . . 3.32 109.927 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -81.7 118.86 23.17 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.61 -0.681 . . . . 4.02 110.875 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.03 150.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.239 1.816 . . . . 1.53 109.717 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtm -135.24 144.65 46.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.771 1.228 . . . . 3.27 110.676 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 177.58 32.38 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 123.773 0.702 . . . . 1.45 113.037 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -115.7 151.23 35.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.958 1.303 . . . . 1.88 110.495 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -164.43 147.65 7.59 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.29 1.036 . . . . 5.62 112.4 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.6 Cg_endo -70.82 153.18 64.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.229 1.953 . . . . 0.59 112.512 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.95 159.02 70.8 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 126.438 1.895 . . . . 0.68 110.408 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.96 -16.83 36.85 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.421 2.081 . . . . 0.73 113.342 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -179.97 172.08 1.08 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 125.424 1.49 . . . . 2.05 111.253 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.2 173.0 7.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.611 2.365 . . . . 1.06 109.072 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.25 166.47 33.08 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.058 -1.026 . . . . 2.29 111.747 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.2 t -150.41 137.16 11.23 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.117 1.367 . . . . 0.81 109.471 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.76 171.36 15.7 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.908 2.405 . . . . 0.98 112.315 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.35 142.04 94.54 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.1 2.533 . . . . 0.83 111.491 166.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt 65.34 2.54 1.97 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.834 1.653 . . . . 1.41 113.387 -174.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.49 121.98 5.79 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 127.451 2.453 . . . . 1.14 110.242 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -113.91 131.72 56.19 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.045 1.738 . . . . 6.03 109.51 167.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 m -159.55 134.36 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.065 1.346 . . . . 1.77 111.083 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -79.53 134.6 36.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.24 1.019 . . . . 3.74 112.824 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.03 69.62 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.874 1.321 . . . . 1.38 108.517 143.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 78' ' ' LYS . 2.4 ptmm? -83.14 149.35 58.58 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 128.682 2.793 . . . . 2.88 110.832 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -54.46 -37.99 89.71 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.22 2.613 . . . . 1.19 113.552 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.63 65.09 3.37 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.078 0.854 . . . . 1.83 111.022 168.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.39 -81.46 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.081 1.324 . . . . 1.23 113.391 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -153.33 152.18 30.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.383 1.873 . . . . 2.1 110.19 -164.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -164.87 165.14 20.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.37 1.068 . . . . 0.94 110.002 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 67.5 m-85 -95.89 123.6 39.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.42 -1.326 . . . . 2.31 107.42 160.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.97 129.91 34.87 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.491 -1.3 . . . . 1.21 107.491 163.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.56 123.38 49.32 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.864 -0.791 . . . . 3.27 108.864 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.93 132.55 55.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.143 1.777 . . . . 3.13 109.056 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.17 96.07 0.2 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.288 -1.125 . . . . 1.45 110.288 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 mt -100.7 128.59 46.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.715 0.758 . . . . 1.03 111.57 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -79.76 -18.95 49.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.273 1.429 . . . . 1.76 112.815 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.44 ' HE ' HG12 ' A' ' 39' ' ' VAL . 14.2 ptt180 -156.77 145.13 14.46 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.633 1.573 . . . . 5.68 110.307 167.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.87 145.3 56.08 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.944 2.43 . . . . 1.43 110.097 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.97 82.0 6.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.465 1.126 . . . . 2.38 110.993 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 133.8 54.6 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.962 1.705 . . . . 3.62 109.518 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.0 135.72 52.39 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.57 -1.331 . . . . 1.91 111.93 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.99 53.78 21.11 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.72 -0.552 . . . . 2.37 111.72 -171.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -117.98 165.73 13.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.167 1.387 . . . . 2.85 110.761 163.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 154.29 20.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.212 1.405 . . . . 5.17 109.518 164.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.3 t -140.89 105.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.854 1.662 . . . . 1.26 109.05 166.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -65.64 142.35 58.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.663 0.744 . . . . 4.18 110.209 163.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.972 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.3 tt -140.63 129.96 23.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.977 0.894 . . . . 1.9 111.13 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -86.59 101.81 13.57 Favored 'General case' 0 CA--C 1.552 1.047 1 C-N-CA 132.536 4.334 . . . . 2.92 111.436 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.7 mt -82.41 122.56 28.16 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.931 -1.731 . . . . 1.15 111.055 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.17 123.07 43.18 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.737 0.815 . . . . 0.78 110.542 -171.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.5 153.05 35.93 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.694 0.759 . . . . 1.8 111.996 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.39 134.39 56.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.862 0.465 . . . . 2.4 110.672 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.7 10.45 52.94 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.848 1.099 . . . . 3.93 115.848 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.25 6.77 83.91 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 119.119 1.46 . . . . 2.12 114.184 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -76.24 131.84 39.53 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.362 -1.081 . . . . 6.07 109.714 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.81 140.17 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.277 1.031 . . . . 1.27 110.2 166.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.9 mt -141.05 123.38 15.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.138 1.375 . . . . 1.85 108.931 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -92.0 145.71 24.31 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.539 0.94 . . . . 2.47 113.539 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.14 149.28 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.78 2.032 . . . . 1.91 111.093 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.96 135.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.45 1.5 . . . . 3.65 111.167 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -144.71 85.19 8.58 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.83 1.652 . . . . 2.14 110.649 -166.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.66 154.56 59.33 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.249 2.633 . . . . 1.27 112.462 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.9 t -84.35 134.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.867 0.867 . . . . 1.39 111.384 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.98 157.49 40.65 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.096 1.358 . . . . 3.87 111.136 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 11.99 4.72 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.832 1.653 . . . . 2.67 113.948 171.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.233 0 CA-C-O 114.545 -2.645 . . . . 5.51 115.704 -174.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 120.69 0.281 . . . . 6.92 111.673 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.14 149.84 18.04 Favored Glycine 0 N--CA 1.465 0.6 0 O-C-N 120.879 -1.138 . . . . 1.41 112.969 162.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.409 ' HE1' ' HB2' ' A' ' 120' ' ' ARG . 16.0 p90 -153.55 151.48 29.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.476 0.917 . . . . 1.82 113.476 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.7 t -110.76 144.12 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 1.22 110.525 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -87.79 113.76 23.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.234 1.198 . . . . 3.74 114.234 -156.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -63.48 123.03 17.73 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.585 -0.697 . . . . 3.25 111.906 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -159.36 147.85 13.83 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 2.48 110.348 166.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.39 63.31 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.089 3.192 . . . . 2.5 109.61 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.99 168.5 13.72 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.263 0.935 . . . . 1.61 113.908 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.15 -15.47 14.49 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.819 3.013 . . . . 1.5 112.001 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -144.86 158.97 43.61 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.369 1.867 . . . . 1.95 111.605 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.55 -177.17 6.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.852 1.261 . . . . 1.19 111.05 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.31 149.45 30.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.626 1.17 . . . . 1.17 110.916 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.65 128.89 55.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.45 -0.574 . . . . 1.24 109.45 160.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.17 162.93 14.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.524 1.93 . . . . 2.03 109.98 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.1 pt? -161.38 140.87 10.3 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.792 1.405 . . . . 1.44 114.792 166.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -79.12 137.44 37.48 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.55 -1.278 . . . . 1.3 107.55 151.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.36 135.71 13.21 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.615 1.166 . . . . 2.93 109.995 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.2 142.75 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.307 1.043 . . . . 3.23 113.177 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -82.17 114.21 49.29 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.592 -1.185 . . . . 0.86 109.321 152.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -83.45 -9.64 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.166 2.578 . . . . 1.13 113.386 174.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.93 170.48 47.67 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.752 1.167 . . . . 0.83 113.645 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.87 -7.14 44.03 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.287 1.835 . . . . 2.73 112.826 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.8 159.8 35.96 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.23 1.812 . . . . 1.61 110.436 171.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.73 158.63 28.14 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.778 2.319 . . . . 0.87 111.793 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.67 140.14 43.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.499 1.52 . . . . 2.08 109.64 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.64 112.13 15.77 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.237 1.015 . . . . 3.84 109.958 171.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.13 114.94 26.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.101 2.16 . . . . 0.6 109.025 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -107.06 -10.1 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.797 1.239 . . . . 0.47 113.091 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.3 -167.59 40.02 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.993 1.282 . . . . 0.46 110.962 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.09 176.85 11.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.041 0.936 . . . . 0.77 111.127 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -146.72 121.63 9.98 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.84 0.856 . . . . 7.83 110.631 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.27 148.55 70.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 124.922 1.289 . . . . 0.69 108.79 -173.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.14 -1.0 10.31 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.472 2.115 . . . . 0.81 114.15 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.37 -0.43 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.882 1.808 . . . . 1.06 115.882 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.72 168.21 21.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.236 1.834 . . . . 1.13 114.738 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -104.94 -93.4 0.36 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.976 1.37 . . . . 3.12 110.365 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -84.63 83.86 7.87 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.632 -1.293 . . . . 4.77 109.541 -165.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.67 131.21 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.572 2.349 . . . . 1.69 112.127 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -140.58 132.05 26.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.942 1.697 . . . . 2.64 110.458 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 121.73 26.84 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.199 1.363 . . . . 0.68 111.131 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -110.7 152.42 26.57 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.217 2.207 . . . . 0.66 113.165 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.92 137.44 32.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.719 1.608 . . . . 2.35 109.172 155.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -101.35 146.01 28.14 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.025 -1.843 . . . . 2.36 106.025 161.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -156.79 172.22 19.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.874 1.435 . . . . 3.05 114.874 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.1 mtm -118.99 127.48 53.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.917 1.287 . . . . 6.78 108.269 148.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -146.75 170.18 17.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.353 1.861 . . . . 9.62 110.054 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -102.72 156.3 17.73 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.817 0.847 . . . . 4.74 112.316 -167.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.28 -96.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 3.45 108.377 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -76.38 42.51 0.28 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.466 2.306 . . . . 3.72 110.53 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.17 -15.25 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 119.816 -1.802 . . . . 2.29 114.098 -169.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -81.17 131.97 35.33 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.812 -1.405 . . . . 4.02 110.85 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 57' ' ' LYS . 1.3 ptmm? -83.05 90.6 7.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.62 1.168 . . . . 7.06 112.172 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.07 148.23 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.467 1.507 . . . . 3.01 111.466 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.47 156.82 17.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.381 1.252 . . . . 6.6 114.381 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.51 -165.21 35.94 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.759 1.647 . . . . 2.25 111.168 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -153.1 158.74 42.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 3.21 112.115 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -153.6 141.26 13.62 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 6.4 111.281 -170.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.26 147.17 77.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.599 2.199 . . . . 0.89 112.377 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.15 157.16 61.72 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 126.706 2.002 . . . . 0.66 110.593 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.11 -13.49 36.4 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.854 2.369 . . . . 0.91 113.489 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.5 p90 179.04 168.52 0.95 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.937 1.695 . . . . 1.88 110.328 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -113.92 174.41 5.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.664 1.586 . . . . 1.0 109.428 152.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.05 163.26 36.82 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.456 -0.777 . . . . 2.36 111.066 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.72 124.78 8.78 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 1.21 107.873 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.45 161.03 46.82 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.784 1.656 . . . . 1.04 110.679 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.86 138.39 78.79 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.423 2.749 . . . . 0.84 110.972 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 68.67 -0.29 2.37 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.373 1.869 . . . . 1.67 113.863 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.42 116.52 4.35 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 126.1 1.809 . . . . 0.97 112.026 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -77.42 131.92 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.178 -1.011 . . . . 4.71 109.994 156.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.01 175.88 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.875 2.07 . . . . 1.68 110.25 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -137.89 114.3 10.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.065 0.946 . . . . 4.27 110.502 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 85.37 0.43 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.923 -1.51 . . . . 1.53 106.923 157.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 152.8 37.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.578 . . . . 3.7 112.901 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.91 -41.22 48.21 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.735 2.956 . . . . 1.62 113.836 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.57 40.57 2.62 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.592 -1.115 . . . . 1.35 113.987 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.27 -61.1 0.02 OUTLIER Glycine 0 N--CA 1.472 1.054 0 CA-C-N 118.826 1.313 . . . . 1.22 115.439 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -153.38 145.96 24.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.303 1.441 . . . . 2.24 111.06 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -165.29 173.45 11.22 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.774 -1.204 . . . . 0.97 110.402 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.83 129.35 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.837 -0.602 . . . . 2.06 109.659 165.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.5 mmt -80.11 121.73 25.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.431 -0.581 . . . . 0.91 109.431 163.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.4 mt -107.74 86.34 2.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.373 1.469 . . . . 1.53 109.555 -176.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.05 142.11 29.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.993 0.917 . . . . 2.87 109.629 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.22 60.23 4.22 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.861 0.743 . . . . 1.45 112.033 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.69 124.82 22.42 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.829 0.852 . . . . 1.08 112.805 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -81.29 -0.03 39.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.659 1.183 . . . . 2.94 113.588 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.14 150.31 0.61 Allowed Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 128.85 2.86 . . . . 6.04 109.486 177.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.39 149.76 75.37 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.488 2.125 . . . . 2.35 110.233 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.57 108.79 14.5 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.458 -1.312 . . . . 2.52 107.458 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.48 119.37 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.785 -1.197 . . . . 3.47 111.368 -170.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.51 113.65 1.88 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.963 -1.125 . . . . 1.71 107.963 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.29 -18.69 4.94 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 116.802 -2.11 . . . . 2.23 115.506 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.65 162.07 35.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.584 2.192 . . . . 3.86 113.961 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -79.74 137.06 36.91 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.269 1.827 . . . . 4.39 111.507 163.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.14 126.99 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 124.976 1.311 . . . . 0.88 109.41 160.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -71.2 141.39 50.65 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.955 -0.566 . . . . 3.16 110.45 162.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mt -156.35 121.74 4.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.977 0.911 . . . . 1.38 112.287 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.56 101.37 11.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.567 2.347 . . . . 2.22 110.713 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.0 mt -76.37 115.71 16.37 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.102 1.761 . . . . 1.07 110.121 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -85.34 124.47 31.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.864 0.866 . . . . 0.7 110.601 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 87.6 m-85 -121.71 126.02 47.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.239 0.616 . . . . 2.02 111.655 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.32 18.89 0.99 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.427 1.64 . . . . 2.83 115.427 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.44 68.83 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.315 1.436 . . . . 4.88 116.036 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -139.53 -26.52 0.26 Allowed Glycine 0 N--CA 1.477 1.387 0 CA-C-N 119.337 1.568 . . . . 2.54 116.592 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -88.17 141.6 28.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.325 1.563 . . . . 6.42 109.409 172.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 p -142.39 161.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.633 -0.667 . . . . 1.05 111.573 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.09 124.38 14.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.959 1.704 . . . . 2.71 110.276 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -71.71 116.59 12.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.298 -0.63 . . . . 2.79 109.298 161.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.65 153.94 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 124.514 1.126 . . . . 1.14 108.948 158.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.99 137.25 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.439 -1.319 . . . . 2.68 107.439 161.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.5 mt -139.63 130.13 14.34 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.198 -1.382 . . . . 1.89 109.205 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -60.75 151.18 78.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.621 2.881 . . . . 1.36 112.286 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.8 t -78.16 136.02 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.572 -0.705 . . . . 1.77 109.401 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.49 151.52 35.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.59 1.156 . . . . 3.59 109.379 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.47 55.31 0.72 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.963 1.305 . . . . 2.35 112.357 -158.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HB2' ' HE1' ' A' ' 7' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 125.3 1.44 . . . . 5.04 108.555 172.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 120.873 0.368 . . . . 5.26 111.7 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.71 164.39 27.75 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.147 1.356 . . . . 1.27 114.15 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -161.23 154.42 21.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.205 1.402 . . . . 1.82 112.956 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -103.92 130.98 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.651 1.18 . . . . 1.04 108.951 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -77.86 116.19 18.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.338 0.255 . . . . 3.7 110.725 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -52.7 119.43 4.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.846 0.858 . . . . 2.32 112.072 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 m -168.67 112.67 0.55 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.805 2.042 . . . . 2.07 107.001 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.81 50.69 2.64 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.623 2.882 . . . . 3.44 110.398 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -177.65 31.6 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.179 0.895 . . . . 1.88 114.638 -167.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -66.26 -16.46 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.926 2.418 . . . . 1.61 111.746 166.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -155.22 157.4 37.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.092 1.757 . . . . 2.7 110.678 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.01 -174.88 5.15 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 1.18 111.049 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.8 146.5 37.7 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.356 0.873 . . . . 1.03 113.356 -170.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.97 146.38 49.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.134 0.974 . . . . 0.86 112.562 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -128.63 150.4 50.24 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.012 2.525 . . . . 2.3 109.237 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.01 137.05 9.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 115.606 1.706 . . . . 2.19 115.606 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.9 m -85.55 124.78 32.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 114.749 -1.114 . . . . 1.41 108.932 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.02 137.23 51.98 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 127.153 2.181 . . . . 2.51 107.814 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.14 143.17 31.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.665 0.745 . . . . 3.09 111.027 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -111.73 105.54 56.62 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.062 -0.972 . . . . 1.28 109.154 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.47 -5.28 10.1 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.839 2.359 . . . . 1.42 113.826 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.6 -174.35 38.41 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 124.387 0.994 . . . . 1.26 113.259 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -106.87 9.08 30.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.589 1.556 . . . . 2.4 113.426 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.47 157.97 57.5 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.774 1.63 . . . . 2.22 110.666 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.19 157.21 13.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.26 2.64 . . . . 1.7 112.592 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.7 112.44 17.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.99 1.716 . . . . 2.5 110.042 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -109.01 101.26 10.35 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.199 1.399 . . . . 4.13 112.747 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 tp -80.55 106.55 12.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.306 2.242 . . . . 0.98 109.636 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.11 -14.53 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.309 1.443 . . . . 0.69 113.058 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.18 -162.19 30.94 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.251 0.929 . . . . 0.7 111.618 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.817 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.59 -170.67 3.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.693 0.797 . . . . 1.1 111.209 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -167.44 134.75 2.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.463 -0.939 . . . . 6.36 108.463 165.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t -136.09 143.32 43.53 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-O 117.544 -1.217 . . . . 0.73 108.83 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.16 -20.0 56.56 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.646 2.231 . . . . 1.04 113.145 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -77.22 3.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 113.263 0.838 . . . . 1.1 113.263 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.2 -163.79 1.87 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.19 1.552 . . . . 1.4 115.19 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.84 -88.99 0.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.703 1.601 . . . . 3.57 109.598 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -78.95 158.99 27.9 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.696 1.599 . . . . 6.7 111.099 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.06 73.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 124.816 2.246 . . . . 2.0 109.315 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -96.36 120.22 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 111.997 -2.365 . . . . 4.52 110.163 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.48 121.93 25.81 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.884 0.849 . . . . 0.66 111.509 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 13.8 m170 -107.69 155.83 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.805 2.042 . . . . 0.98 112.006 173.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 12.0 pt-20 -104.78 177.91 4.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.369 -1.287 . . . . 2.95 110.891 157.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -150.61 115.93 5.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.282 1.833 . . . . 1.31 107.38 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.57 178.71 6.79 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.388 1.475 . . . . 2.63 111.587 -162.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.7 ptp -119.57 151.15 39.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.649 1.18 . . . . 3.43 111.623 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -154.44 158.95 40.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.817 1.247 . . . . 7.54 112.243 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.5 137.61 38.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.011 0.925 . . . . 4.03 109.81 163.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.7 t -118.22 -93.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.434 1.494 . . . . 3.03 109.221 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -77.92 39.07 0.28 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.126 2.17 . . . . 3.61 110.931 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.22 -6.13 16.49 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 119.815 -1.803 . . . . 1.91 113.825 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -107.1 155.68 19.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.132 2.173 . . . . 3.9 110.595 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.61 140.82 29.48 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.889 1.07 . . . . 4.03 113.889 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 t -143.25 157.89 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.794 2.037 . . . . 2.04 108.293 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.4 ptp -74.18 173.23 10.43 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.489 0.716 . . . . 4.49 112.712 170.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.13 153.99 25.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.633 1.111 . . . . 1.28 111.254 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -124.4 143.01 50.85 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.147 1.379 . . . . 1.79 108.576 171.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.429 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -163.34 145.28 7.7 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 118.089 -0.958 . . . . 6.21 112.058 -178.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 49.8 Cg_endo -66.96 150.6 82.91 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.881 2.387 . . . . 0.92 110.703 172.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.96 156.37 74.26 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.358 1.463 . . . . 0.58 109.976 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.88 -22.69 42.18 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.422 2.082 . . . . 0.66 112.417 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -175.2 165.06 3.35 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 125.433 1.493 . . . . 1.82 111.729 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.99 171.87 7.27 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.565 1.546 . . . . 0.97 109.437 153.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.74 163.6 39.74 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.271 -0.893 . . . . 3.19 113.292 165.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.67 129.36 22.69 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 126.093 1.757 . . . . 1.24 109.133 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.64 161.46 43.92 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.483 2.122 . . . . 1.28 111.076 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.12 140.74 91.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.559 2.839 . . . . 1.49 112.251 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp 68.1 -0.24 2.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.711 2.005 . . . . 1.88 113.983 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.32 156.8 28.53 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 127.075 2.274 . . . . 1.19 112.066 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtt85 -119.88 155.62 32.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.765 2.026 . . . . 6.05 111.51 168.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.99 159.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.911 1.684 . . . . 1.39 110.256 164.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.27 109.69 12.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.457 1.503 . . . . 4.18 107.74 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.09 83.36 0.51 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.245 1.418 . . . . 1.3 109.361 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.55 156.96 36.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.645 1.578 . . . . 3.87 112.717 -172.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -59.72 -29.84 90.65 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.116 2.544 . . . . 0.97 114.118 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.98 49.57 3.33 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.997 -0.89 . . . . 1.27 111.814 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.88 -71.11 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 115.558 0.983 . . . . 0.91 115.558 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -157.63 143.79 17.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.014 2.125 . . . . 1.93 110.485 -165.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -168.81 174.26 6.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.235 0.925 . . . . 0.71 112.285 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 48.0 m-85 -104.28 136.96 42.9 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.408 0.683 . . . . 2.19 111.64 169.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -96.25 121.3 37.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.653 1.181 . . . . 1.19 110.029 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.12 108.61 21.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.825 0.85 . . . . 2.62 109.809 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.72 65.81 1.03 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.481 1.112 . . . . 2.88 110.529 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.82 113.82 1.54 Allowed Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.621 1.582 . . . . 2.06 111.229 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -103.34 154.61 19.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.863 1.265 . . . . 1.51 111.195 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -125.38 -26.74 3.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.411 1.485 . . . . 2.31 112.371 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -118.14 132.01 23.93 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-O 118.205 -0.902 . . . . 4.88 109.077 161.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.17 124.39 11.28 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.939 -1.985 . . . . 1.57 106.939 159.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.82 121.94 16.18 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.037 1.335 . . . . 1.92 111.089 -161.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -88.29 131.49 34.77 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.743 -1.223 . . . . 4.72 109.874 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 119.49 5.89 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.847 -1.168 . . . . 2.02 107.847 153.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.88 -1.6 56.66 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 118.434 -1.203 . . . . 2.63 115.158 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.05 151.53 20.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.444 1.622 . . . . 3.16 110.532 157.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -112.52 124.97 53.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.417 2.287 . . . . 5.98 105.441 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.41 102.88 13.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.827 1.251 . . . . 1.04 108.548 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.64 145.08 50.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.035 -0.53 . . . . 2.82 110.5 163.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.817 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.9 tt -158.84 132.81 7.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 2.04 110.409 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.31 112.35 24.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.809 2.043 . . . . 2.26 110.141 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.93 118.1 18.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.151 1.38 . . . . 1.66 109.987 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.64 117.06 24.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.324 -0.621 . . . . 0.99 109.324 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -116.37 121.47 42.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.152 0.797 . . . . 2.41 113.152 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.84 28.37 0.13 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.681 2.393 . . . . 2.54 115.867 170.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.47 -61.85 3.87 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.902 1.239 . . . . 3.7 112.519 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.51 2.54 29.85 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.99 1.556 . . . . 1.91 116.99 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -142.64 148.89 38.17 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.414 1.607 . . . . 5.01 112.3 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.62 139.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.851 1.66 . . . . 1.72 109.165 162.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -145.23 135.35 23.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.658 1.183 . . . . 2.56 111.01 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -77.22 132.64 38.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.4 0.518 . . . . 2.37 112.4 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.8 -179.77 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.45 1.9 . . . . 1.56 109.8 159.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.86 148.08 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 127.847 2.459 . . . . 3.11 109.461 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -141.77 135.05 14.31 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.29 1.436 . . . . 1.96 110.699 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.68 146.64 43.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.969 2.446 . . . . 1.34 112.391 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.1 t -76.84 138.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.597 0.759 . . . . 1.4 109.502 165.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -140.45 151.14 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.193 0.597 . . . . 3.28 111.386 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.43 60.53 1.17 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.801 1.64 . . . . 2.21 111.41 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 120' ' ' ARG 0.318 2.0 mmp_? . . . . . 0 C--O 1.251 1.146 0 N-CA-C 117.948 2.573 . . . . 5.15 117.948 -161.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 110.423 -0.214 . . . . 6.76 110.423 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.78 162.31 33.87 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 120.809 -1.182 . . . . 1.01 114.597 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -146.49 146.47 30.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.668 1.187 . . . . 1.62 112.721 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.88 141.04 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.099 0.96 . . . . 1.43 108.853 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -77.16 -13.61 59.92 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.677 1.362 . . . . 4.5 114.677 -161.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.8 t80 72.85 147.25 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.077 2.951 . . . . 2.87 112.625 -170.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -168.64 140.89 2.26 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.425 1.49 . . . . 3.63 111.108 166.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -90.28 -13.19 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.065 3.177 . . . . 3.48 112.43 165.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -101.85 170.19 20.71 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.436 1.493 . . . . 1.75 112.865 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 -16.47 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 124.022 3.148 . . . . 2.26 115.397 -166.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -94.63 141.86 28.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.751 1.159 . . . . 3.03 111.458 163.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.76 179.15 7.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.788 1.635 . . . . 1.49 111.625 164.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.28 153.61 51.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.264 1.426 . . . . 1.14 110.017 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.49 142.63 50.0 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.121 . . . . 0.96 112.21 168.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.45 147.82 41.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 2.11 110.55 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -164.36 149.79 10.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.009 0.923 . . . . 1.57 112.582 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -81.63 117.57 22.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.895 0.878 . . . . 1.38 108.838 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -89.93 135.46 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.162 0.585 . . . . 3.52 110.477 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -124.15 167.69 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.052 1.341 . . . . 3.03 109.507 173.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.71 104.71 6.93 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 123.8 0.84 . . . . 1.17 109.914 162.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.95 -10.04 10.55 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.993 2.462 . . . . 1.6 113.168 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.35 156.79 39.73 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 124.155 0.884 . . . . 1.14 112.461 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.06 5.94 38.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.869 1.668 . . . . 2.75 113.391 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.22 158.71 45.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.096 1.758 . . . . 1.78 110.285 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.02 159.53 30.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.164 2.576 . . . . 0.93 111.748 -170.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.02 129.22 50.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.999 1.32 . . . . 2.36 110.099 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -120.7 112.0 18.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.391 1.476 . . . . 3.02 110.287 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -91.84 123.06 34.94 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.407 1.883 . . . . 0.8 108.946 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.93 -11.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.419 1.087 . . . . 0.66 113.312 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.42 -161.68 30.82 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.144 0.878 . . . . 0.6 111.07 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -154.83 -178.78 7.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.836 1.254 . . . . 0.76 110.179 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -152.75 150.74 29.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.612 1.096 . . . . 5.6 108.749 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -141.26 146.29 42.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 117.683 -1.151 . . . . 0.88 108.636 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.12 -19.39 66.29 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.106 1.871 . . . . 0.85 112.47 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m -82.94 -3.76 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.221 1.193 . . . . 0.92 114.221 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.43 177.97 9.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.856 1.207 . . . . 0.85 113.688 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -118.9 -87.67 0.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.132 1.373 . . . . 3.28 110.421 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -78.74 103.98 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.653 -1.279 . . . . 3.53 109.05 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.91 145.41 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.588 1.155 . . . . 1.96 110.931 161.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -143.99 123.52 13.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.773 1.229 . . . . 2.33 109.663 164.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.438 HD12 ' CE1' ' A' ' 84' ' ' PHE . 7.0 tt -84.86 120.79 26.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.54 1.518 . . . . 0.73 110.997 168.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.3 m170 -107.41 151.88 24.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.535 1.534 . . . . 0.67 112.856 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -86.23 166.46 15.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.262 2.225 . . . . 2.45 110.801 163.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -150.21 126.79 10.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.387 1.475 . . . . 1.1 108.26 170.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -149.34 156.88 42.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.571 0.952 . . . . 2.38 113.571 -155.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.8 mtm -107.48 62.22 0.62 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.869 1.668 . . . . 4.44 111.981 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -79.42 156.13 28.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.948 -1.023 . . . . 7.48 111.121 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.02 164.8 25.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.161 -1.051 . . . . 5.99 108.161 158.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.3 t -156.89 -39.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.848 2.059 . . . . 4.07 110.986 -164.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -159.09 41.34 0.22 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.115 2.966 . . . . 5.06 108.003 -173.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.47 -19.23 0.08 OUTLIER Glycine 0 N--CA 1.479 1.558 0 C-N-CA 128.487 2.946 . . . . 2.04 114.899 -164.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -83.04 134.82 35.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.347 1.459 . . . . 5.41 109.804 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -88.93 120.16 30.1 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.507 -0.746 . . . . 4.44 110.879 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.88 141.74 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.37 1.468 . . . . 1.76 110.002 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 97.14 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.42 1.088 . . . . 4.28 109.753 165.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.75 168.31 12.75 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.462 1.03 . . . . 1.25 112.797 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.56 153.6 47.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.492 1.517 . . . . 2.18 110.885 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -161.67 152.41 14.94 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 126.558 1.943 . . . . 6.08 110.481 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 39.8 Cg_endo -66.61 143.69 69.47 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.413 2.075 . . . . 0.54 111.653 165.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -113.06 157.64 40.18 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.105 1.762 . . . . 0.57 110.862 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.33 -14.43 31.18 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.768 2.312 . . . . 0.59 113.646 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.92 165.45 1.56 Allowed 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.265 1.826 . . . . 2.24 109.914 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.69 167.62 10.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.669 1.587 . . . . 1.06 109.359 155.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.94 163.84 31.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.702 1.001 . . . . 2.08 113.702 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 139.84 14.53 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.632 1.573 . . . . 1.35 109.164 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.63 169.55 14.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.401 2.067 . . . . 1.1 111.153 168.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.22 148.58 92.49 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.757 2.305 . . . . 0.93 111.869 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt 68.86 -0.62 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.789 2.036 . . . . 1.64 114.027 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.83 -168.86 44.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.706 2.098 . . . . 1.45 114.939 -171.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -168.08 144.45 3.96 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.122 2.169 . . . . 5.62 110.606 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.4 m -152.14 136.83 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.955 2.102 . . . . 2.01 109.241 171.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -88.92 136.5 32.98 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.272 -0.893 . . . . 3.44 110.867 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.36 72.72 0.96 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.508 1.147 . . . . 1.18 108.444 156.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -85.43 145.9 43.36 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.477 1.911 . . . . 2.72 111.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -58.88 -23.54 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.823 2.349 . . . . 1.43 113.805 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.29 35.99 4.51 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.926 1.251 . . . . 1.57 113.617 171.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.37 -65.01 0.02 OUTLIER Glycine 0 N--CA 1.47 0.956 0 CA-C-N 118.399 1.099 . . . . 0.83 115.349 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -150.98 149.13 29.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.176 1.39 . . . . 1.99 111.251 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -157.21 160.6 38.86 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.606 -1.309 . . . . 0.81 111.44 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 41.0 m-85 -96.1 120.58 36.63 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.584 -0.525 . . . . 1.93 109.584 164.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.82 136.32 33.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.113 0.965 . . . . 1.16 108.811 167.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.2 103.88 8.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.394 1.078 . . . . 1.61 108.893 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.36 120.0 41.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.496 1.118 . . . . 3.12 109.888 -173.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.03 97.43 0.62 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.069 1.318 . . . . 1.53 109.972 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -94.38 122.8 37.31 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.28 1.04 . . . . 1.09 110.74 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -71.01 -12.89 61.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.948 0.722 . . . . 1.96 112.948 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 21.2 ptt85 -153.33 139.56 12.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.001 1.72 . . . . 5.98 109.868 168.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 145.39 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.175 2.583 . . . . 1.92 109.358 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.4 mt -92.3 167.04 12.28 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.045 0.938 . . . . 2.36 113.044 -169.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 3.6 mmtm -123.0 156.8 34.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.342 1.457 . . . . 5.4 109.143 156.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 131.45 50.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.141 -0.689 . . . . 2.04 109.141 161.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.96 2.54 77.93 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 117.349 -1.806 . . . . 2.36 116.48 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 90.4 mt-10 -76.29 167.4 21.92 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.404 2.102 . . . . 3.34 110.364 169.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -85.6 154.08 21.96 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.023 1.329 . . . . 5.45 112.183 165.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.0 t -130.14 116.91 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.25 1.82 . . . . 1.02 109.414 163.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -71.1 140.21 50.57 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.455 -1.248 . . . . 3.78 109.804 161.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 132.21 14.44 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.907 0.706 . . . . 1.75 112.907 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.95 132.54 33.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.396 0.678 . . . . 2.4 109.533 159.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.16 118.19 31.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.994 1.318 . . . . 1.31 109.569 158.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.2 mt -95.05 131.38 41.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.417 1.087 . . . . 0.82 111.643 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -120.27 159.5 24.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.339 1.056 . . . . 2.11 112.418 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.86 118.31 7.04 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.255 0.835 . . . . 1.96 113.255 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.18 -147.84 29.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.048 0.832 . . . . 2.95 111.364 -173.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.57 56.09 4.71 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-O 119.175 -0.792 . . . . 1.89 114.365 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -131.81 137.92 48.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.335 1.568 . . . . 4.91 110.675 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.11 145.09 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.44 1.496 . . . . 1.48 108.915 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.0 mt -127.53 110.2 12.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.715 1.206 . . . . 2.34 109.908 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.63 105.86 11.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.343 0.657 . . . . 4.27 109.851 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m -105.82 -175.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.358 2.263 . . . . 1.18 111.199 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.3 143.82 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.25 1.42 . . . . 2.15 109.072 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.7 mt -136.14 154.6 77.49 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.072 1.749 . . . . 1.74 109.813 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.44 154.53 27.9 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.352 2.701 . . . . 0.99 111.272 161.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.0 t -85.89 142.12 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.359 1.863 . . . . 1.36 108.368 159.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -122.7 -145.18 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.995 2.118 . . . . 3.44 108.101 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.5 113.14 3.6 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 121.059 1.754 . . . . 1.99 111.592 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 C-N-CA 127.819 2.448 . . . . 4.49 110.813 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 110.042 -0.355 . . . . 6.45 110.042 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.14 169.49 34.92 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.634 0.635 . . . . 1.82 114.132 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.402 ' CD1' ' HG3' ' A' ' 120' ' ' ARG . 44.6 p90 -155.91 152.36 28.18 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.677 0.791 . . . . 2.75 110.818 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -117.46 148.59 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.071 0.948 . . . . 1.04 110.23 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.23 111.24 22.83 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.869 -1.144 . . . . 3.92 113.629 -152.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -66.28 104.82 1.27 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 3.23 111.158 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -155.79 130.57 5.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 117.559 -1.21 . . . . 2.47 109.913 158.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.27 75.12 5.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.818 3.012 . . . . 2.95 110.303 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.55 168.11 13.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.796 1.188 . . . . 2.1 112.982 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.87 -31.97 46.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.423 2.082 . . . . 2.28 110.541 167.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -113.2 152.93 29.12 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.537 1.935 . . . . 2.69 111.932 162.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.78 -158.1 0.88 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.651 2.38 . . . . 1.23 108.116 168.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.67 160.15 40.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.321 1.419 . . . . 1.56 113.682 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.54 149.88 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.791 1.636 . . . . 1.37 110.54 164.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.4 175.21 9.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.543 1.537 . . . . 2.45 110.796 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -175.01 148.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.21 1.404 . . . . 1.99 112.358 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.3 m -116.6 122.41 44.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.613 -1.625 . . . . 2.18 106.613 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.33 139.33 11.87 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.673 0.789 . . . . 4.2 110.392 -158.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 1.4 pm0 -109.2 147.86 31.87 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.833 1.653 . . . . 2.79 113.822 175.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -85.56 112.6 45.61 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 114.109 -1.405 . . . . 0.8 109.646 154.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.42 -10.26 12.23 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.099 2.533 . . . . 1.13 113.534 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.86 -179.55 53.04 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.19 0.9 . . . . 0.91 113.767 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -109.97 -4.23 16.05 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.955 1.702 . . . . 2.55 113.011 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.77 159.25 34.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.832 1.653 . . . . 1.91 110.031 165.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.88 152.53 16.88 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.089 2.526 . . . . 1.44 111.543 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.87 157.62 15.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.414 1.085 . . . . 1.85 111.247 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.457 ' HE ' ' HB3' ' A' ' 106' ' ' ALA . 44.0 ttp180 -142.09 109.05 5.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.299 1.44 . . . . 4.64 110.476 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.6 tp -95.98 113.98 25.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.449 2.3 . . . . 0.72 109.696 -168.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.06 -12.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.977 1.311 . . . . 1.3 113.166 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.26 -158.7 28.44 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 121.303 -0.873 . . . . 0.53 113.394 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.06 -177.56 5.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.106 0.962 . . . . 0.96 111.106 166.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -142.76 136.23 28.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.555 1.142 . . . . 8.14 108.491 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -141.14 147.61 48.11 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.225 1.41 . . . . 0.87 108.938 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.55 -23.19 32.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.628 1.552 . . . . 1.24 112.855 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.14 5.39 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 115.378 1.621 . . . . 1.06 115.378 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.97 44.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.193 1.36 . . . . 1.42 113.2 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.82 -50.56 72.88 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.841 1.656 . . . . 6.56 109.528 165.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -144.45 155.19 43.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.764 1.626 . . . . 4.42 109.122 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.85 128.92 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 125.202 1.401 . . . . 1.22 108.482 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -130.2 124.62 32.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.954 1.702 . . . . 2.08 108.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -80.12 119.82 23.43 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.254 1.388 . . . . 0.83 110.998 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.5 m170 -108.76 157.3 18.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.985 1.714 . . . . 0.84 111.948 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -111.1 -177.64 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.943 1.697 . . . . 2.44 111.75 171.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.5 m -123.22 120.94 34.64 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.22 -1.03 . . . . 1.42 108.22 156.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -100.41 165.47 11.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.782 1.233 . . . . 2.31 111.248 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtm -129.42 134.7 47.98 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.536 1.134 . . . . 3.8 109.234 163.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.9 146.16 24.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.724 1.21 . . . . 7.08 110.696 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.08 136.81 41.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.91 0.386 . . . . 3.57 110.965 175.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.07 -95.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.308 -1.367 . . . . 2.46 107.308 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -79.36 74.93 5.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.498 1.119 . . . . 4.18 108.51 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.03 -11.68 0.04 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 128.874 3.13 . . . . 2.05 118.022 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -124.25 153.5 41.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.489 1.916 . . . . 4.42 110.94 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -70.47 97.7 1.33 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.12 0.568 . . . . 4.31 112.105 -179.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -79.83 132.61 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 125.265 1.426 . . . . 1.48 107.864 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.5 ptp -91.8 145.27 24.71 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.896 0.878 . . . . 3.04 111.183 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.13 166.84 35.87 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 123.908 0.766 . . . . 1.07 112.97 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.3 150.82 38.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.59 1.156 . . . . 1.82 111.419 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 mtp85 -163.74 155.65 14.78 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.423 1.489 . . . . 7.15 111.388 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 17.9 Cg_endo -64.93 143.38 79.16 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.597 2.198 . . . . 0.88 110.898 169.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.5 155.29 54.35 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.928 1.691 . . . . 0.7 110.543 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.36 -23.85 32.15 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.674 2.249 . . . . 0.83 112.617 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -173.71 168.81 4.33 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.239 1.416 . . . . 1.72 111.059 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -119.76 174.47 6.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.279 2.232 . . . . 1.08 109.334 162.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.34 168.57 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.399 -0.813 . . . . 3.22 111.251 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 t -147.36 129.58 7.62 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 125.202 1.401 . . . . 1.12 108.647 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.37 163.69 35.73 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.185 1.924 . . . . 1.32 111.942 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.19 139.34 71.8 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.917 3.078 . . . . 1.05 111.945 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.29 17.97 5.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 116.063 1.875 . . . . 2.0 116.063 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.23 116.82 5.46 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 128.151 2.786 . . . . 0.99 111.984 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 2.0 ttm-85 -90.4 130.96 36.42 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 5.37 111.738 163.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.4 m -121.32 171.32 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 2.09 111.545 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -148.28 125.5 11.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.14 1.376 . . . . 4.68 110.685 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -82.51 153.63 25.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.526 1.155 . . . . 1.85 110.836 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 7.3 ptpt -170.65 149.26 2.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.006 1.723 . . . . 4.0 111.817 -165.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -49.44 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.118 2.545 . . . . 2.09 111.293 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 96.42 0.91 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 107.625 -2.19 . . . . 2.35 107.625 156.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.76 -155.73 17.15 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.745 2.116 . . . . 2.83 112.034 -163.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -92.42 140.01 30.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.822 1.249 . . . . 2.4 112.204 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -161.19 154.14 21.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.482 0.713 . . . . 0.78 109.484 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -94.58 120.39 34.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.629 -0.878 . . . . 1.98 108.629 173.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -68.75 130.5 43.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.152 -0.684 . . . . 1.09 109.152 165.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -106.03 118.99 38.03 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.017 -1.105 . . . . 1.99 108.017 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.24 152.4 24.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 3.05 109.834 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.82 67.6 2.02 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 124.652 1.12 . . . . 1.7 112.72 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.91 111.14 2.7 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.904 1.075 . . . . 1.26 113.904 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -80.38 -25.19 39.27 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.999 1.32 . . . . 1.93 112.505 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -119.78 126.65 26.81 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 106.044 -1.835 . . . . 4.21 106.044 149.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -64.35 136.89 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 N-CA-C 107.167 -1.897 . . . . 1.69 107.167 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.71 63.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.776 0.83 . . . . 2.51 112.467 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 121.95 7.22 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.705 1.602 . . . . 3.65 108.793 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.95 120.74 1.87 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.637 1.108 . . . . 1.47 112.113 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 42.02 47.38 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.491 -0.616 . . . . 2.28 114.325 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -76.14 171.7 14.05 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.252 1.526 . . . . 2.74 108.002 146.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -105.63 150.61 25.28 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.067 1.347 . . . . 4.98 107.77 160.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.92 119.22 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.162 0.985 . . . . 1.13 110.663 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.82 137.7 40.66 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.153 1.781 . . . . 2.94 110.316 165.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mt -155.98 133.48 10.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.043 0.925 . . . . 1.52 111.948 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -115.28 101.67 9.16 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.337 1.455 . . . . 2.08 110.799 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 119.86 22.92 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.253 1.421 . . . . 1.41 111.032 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.57 123.2 36.72 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.616 1.166 . . . . 0.77 111.498 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.15 135.62 53.75 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.045 0.926 . . . . 1.77 112.501 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.457 ' HB3' ' HE ' ' A' ' 31' ' ' ARG . . . -78.45 63.6 3.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.722 1.609 . . . . 2.76 112.917 -175.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.42 33.15 0.09 OUTLIER Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.708 2.099 . . . . 4.84 113.956 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.61 -0.13 77.66 Favored Glycine 0 N--CA 1.476 1.342 0 CA-C-N 118.284 1.042 . . . . 1.95 114.652 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -97.86 151.1 20.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 122.629 1.204 . . . . 6.59 113.856 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.05 151.41 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.991 2.117 . . . . 1.41 107.617 154.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.96 119.68 32.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.447 1.099 . . . . 2.25 109.283 167.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -74.31 133.9 42.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.289 0.236 . . . . 2.78 110.414 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.26 145.33 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.92 1.688 . . . . 1.48 109.493 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -125.05 125.19 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.666 0.786 . . . . 2.75 110.03 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 155.92 56.03 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.396 1.479 . . . . 3.34 111.076 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.54 164.48 32.28 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.735 2.957 . . . . 1.46 111.626 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.39 142.14 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.384 1.074 . . . . 1.19 111.823 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -145.66 162.06 38.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.961 1.705 . . . . 3.99 113.008 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.59 62.57 2.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.012 1.725 . . . . 2.5 111.987 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 2.8 mmp_? . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.473 -1.727 . . . . 4.41 111.315 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.236 0.382 0 CA-C-O 120.892 0.377 . . . . 5.33 110.048 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -79.52 157.31 42.07 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 123.377 0.513 . . . . 1.21 112.371 176.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -154.75 139.19 16.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.02 0.748 . . . . 1.35 113.02 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.5 t -93.2 132.56 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.606 -0.516 . . . . 1.3 109.606 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -78.22 114.43 17.1 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.325 1.05 . . . . 4.32 112.022 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -79.97 146.98 31.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.086 0.946 . . . . 3.81 110.469 159.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.44 152.63 4.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.474 1.51 . . . . 2.72 110.957 169.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.95 75.55 3.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.076 3.184 . . . . 3.31 109.776 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.42 -179.67 34.4 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.671 1.028 . . . . 1.72 115.671 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.66 -15.92 19.07 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.833 3.022 . . . . 2.44 112.877 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -147.77 160.54 42.62 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 115.077 1.51 . . . . 2.58 115.077 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.83 -168.39 2.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.252 2.221 . . . . 1.22 110.861 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 147.46 32.37 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.235 1.014 . . . . 1.57 112.439 -174.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.19 118.45 36.82 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.987 0.358 . . . . 1.67 110.232 159.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -101.18 142.57 32.43 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.01 1.724 . . . . 2.51 108.547 164.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.403 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.7 pp -164.1 149.64 10.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.167 1.914 . . . . 1.96 116.167 -168.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.3 m -115.08 138.43 50.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.529 1.532 . . . . 2.01 109.771 -173.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.11 -179.85 8.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.308 1.843 . . . . 5.26 110.444 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.76 159.87 43.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.81 0.844 . . . . 4.9 110.106 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.81 102.63 10.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.296 -0.865 . . . . 1.3 109.506 163.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.13 -7.12 17.07 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.875 2.383 . . . . 1.56 113.197 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.11 177.36 54.36 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 124.325 0.964 . . . . 1.41 113.72 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -107.96 1.6 22.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.346 1.458 . . . . 2.56 112.664 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -115.2 162.71 22.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.431 1.893 . . . . 1.89 109.616 164.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.14 157.8 20.23 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.685 2.257 . . . . 1.16 111.489 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -105.77 153.52 21.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 2.22 110.1 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -134.35 115.08 13.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.486 1.115 . . . . 3.62 111.229 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.68 112.03 23.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.213 2.605 . . . . 0.63 108.601 -174.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.92 -10.11 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.834 1.254 . . . . 0.65 113.316 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.01 -173.95 46.09 Favored Glycine 0 C--N 1.342 0.883 0 O-C-N 121.543 -0.723 . . . . 0.56 112.116 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -143.18 178.83 7.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.836 1.254 . . . . 0.96 110.306 170.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.35 142.41 3.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.187 -1.042 . . . . 4.92 108.187 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -150.78 155.26 35.56 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 117.261 -1.352 . . . . 0.89 108.274 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.61 -14.72 41.59 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.171 1.914 . . . . 1.2 114.246 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.63 0.19 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.991 1.849 . . . . 1.14 115.991 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.62 144.35 44.02 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 121.261 1.846 . . . . 1.33 114.808 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -89.29 -76.37 0.41 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.921 1.288 . . . . 3.58 110.259 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.3 ttm-85 -80.89 127.84 33.0 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.107 -0.995 . . . . 4.28 108.803 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.0 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 1.56 110.322 167.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -144.59 133.49 22.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.823 1.649 . . . . 2.43 110.924 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -79.31 119.25 22.09 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 120.055 1.298 . . . . 0.86 111.027 170.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.1 m170 -110.58 156.02 21.52 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.756 2.022 . . . . 0.61 111.795 175.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.29 -175.38 2.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.413 . . . . 2.85 111.978 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -132.77 118.05 18.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.698 1.599 . . . . 1.47 108.441 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -115.99 179.05 4.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.436 1.094 . . . . 2.09 111.098 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.3 ptp -143.21 128.88 19.24 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.549 0.74 . . . . 4.2 111.57 162.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -138.27 149.58 45.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.257 1.023 . . . . 6.57 112.111 -173.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 52' ' ' GLU 0.33 1.4 pm0 -64.92 146.84 54.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.026 1.731 . . . . 4.74 113.792 172.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.69 HG13 ' H ' ' A' ' 54' ' ' GLU 0.29 6.7 p -135.7 -86.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.811 2.044 . . . . 2.86 109.198 176.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.69 ' H ' HG13 ' A' ' 53' ' ' VAL . 16.2 mt-10 -77.11 41.43 0.29 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.703 2.001 . . . . 3.69 110.736 165.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.51 -38.66 0.87 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.152 1.358 . . . . 2.29 113.767 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -61.39 133.8 56.21 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.12 1.368 . . . . 3.04 110.972 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -91.34 103.34 16.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.409 0.683 . . . . 5.7 110.884 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -99.21 141.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.028 1.731 . . . . 1.79 109.911 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.43 153.59 29.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.677 1.591 . . . . 3.68 112.336 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.72 161.16 33.98 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 121.822 -0.549 . . . . 1.23 114.396 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -113.62 137.03 52.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.449 1.5 . . . . 2.21 111.164 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -150.57 156.64 36.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.359 1.463 . . . . 6.18 110.227 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 32.8 Cg_endo -65.92 152.0 82.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.703 2.268 . . . . 0.88 111.641 171.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.78 157.36 69.1 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 126.181 1.792 . . . . 0.74 109.659 173.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.14 -18.17 40.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.784 2.322 . . . . 0.96 113.237 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -179.15 167.21 1.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.819 2.047 . . . . 2.11 110.755 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -113.8 166.73 11.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.975 1.71 . . . . 1.0 109.264 155.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 163.83 39.14 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.115 -0.991 . . . . 2.45 111.683 174.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.08 128.77 10.18 Favored Pre-proline 0 N--CA 1.466 0.354 0 C-N-CA 125.073 1.349 . . . . 1.02 109.609 -161.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.53 163.61 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.938 . . . . 0.79 111.554 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.38 138.49 84.63 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.516 2.811 . . . . 0.96 111.935 172.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm 68.34 7.2 5.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.977 2.111 . . . . 1.62 113.456 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.57 113.16 3.62 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.79 1.662 . . . . 0.97 112.252 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 136.93 37.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.513 -0.844 . . . . 5.51 110.456 165.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.06 159.74 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.319 1.447 . . . . 3.01 111.808 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -154.98 92.59 1.46 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.731 1.613 . . . . 3.67 108.079 -170.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.67 139.07 57.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.397 1.079 . . . . 2.06 108.649 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -158.9 156.52 26.87 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 127.349 2.26 . . . . 3.38 111.237 -163.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.2 -64.17 0.1 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.918 3.079 . . . . 1.39 112.088 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.19 91.52 1.03 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.022 -1.631 . . . . 1.97 109.022 166.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.33 -98.91 0.18 Allowed Glycine 0 C--O 1.221 -0.664 0 C-N-CA 124.707 1.146 . . . . 1.24 112.424 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -153.58 136.59 15.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.183 1.393 . . . . 2.16 110.299 -172.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -165.62 166.71 17.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.267 1.394 . . . . 1.55 110.806 -170.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 92.6 m-85 -102.77 116.19 32.07 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 119.282 -0.39 . . . . 2.3 110.18 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -68.31 127.69 33.87 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.663 -0.495 . . . . 0.93 109.663 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 mt -112.81 111.01 21.49 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.907 -1.516 . . . . 1.53 106.907 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.47 116.55 25.66 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.66 -0.867 . . . . 3.47 108.66 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.82 112.77 0.49 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.09 -1.204 . . . . 1.88 110.09 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -110.16 113.94 27.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.162 0.985 . . . . 1.01 111.789 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.95 -11.84 60.97 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.829 1.251 . . . . 1.87 114.209 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -153.89 145.73 16.9 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.1 1.36 . . . . 5.77 109.998 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.69 132.42 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.202 1.935 . . . . 2.05 109.288 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.2 169.18 12.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.819 1.648 . . . . 2.66 112.321 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.03 145.04 43.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.213 1.005 . . . . 4.5 110.192 155.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.62 19.95 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.676 -0.861 . . . . 2.03 108.676 160.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.39 78.11 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 117.901 -1.499 . . . . 2.71 115.83 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -74.4 175.24 7.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.233 2.016 . . . . 2.4 109.449 158.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -91.95 155.85 17.86 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.297 1.046 . . . . 4.47 111.387 152.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.02 127.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.93 -1.507 . . . . 1.34 106.93 151.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.86 155.18 20.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.953 0.882 . . . . 4.11 111.277 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.788 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.8 tt -163.25 129.97 3.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.308 -0.87 . . . . 1.69 112.028 -152.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -78.12 105.41 9.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.325 3.05 . . . . 2.69 111.494 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.1 mt -79.42 119.4 22.38 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.113 -0.992 . . . . 1.06 109.343 171.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.1 mt -96.92 126.07 41.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.565 1.146 . . . . 0.71 111.554 -168.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.22 158.27 22.53 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.438 -0.789 . . . . 2.17 112.929 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.39 63.7 0.79 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.819 1.648 . . . . 2.04 113.311 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 148.73 -149.65 21.7 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.39 1.472 . . . . 2.79 111.649 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.51 43.83 1.63 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.748 1.166 . . . . 2.06 115.038 -173.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -140.6 137.75 33.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.888 1.344 . . . . 5.11 113.987 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.75 132.35 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 127.438 2.295 . . . . 1.06 108.66 169.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.97 102.22 8.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.229 1.412 . . . . 2.46 109.407 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 74.26 6.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.857 0.863 . . . . 2.74 111.157 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.75 159.32 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.037 1.335 . . . . 1.63 112.079 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 m -100.25 139.12 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 126.636 1.974 . . . . 3.27 109.602 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.1 mt -143.24 135.46 13.28 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.549 1.14 . . . . 1.87 109.18 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.09 162.61 41.58 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.908 2.406 . . . . 1.57 111.474 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.36 145.83 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 1.51 111.318 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.77 156.35 44.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.042 1.737 . . . . 3.68 109.302 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.73 41.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.45 1.5 . . . . 2.71 113.1 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 117.516 -1.23 . . . . 5.09 112.974 -152.639 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.546 0.809 0 CA-C-O 118.272 -0.871 . . . . 5.65 109.372 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.72 122.08 1.09 Allowed Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.585 1.539 . . . . 1.75 114.299 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -111.56 149.21 31.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.942 0.897 . . . . 2.12 111.145 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.57 140.29 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.712 -0.847 . . . . 1.28 108.712 169.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 117.1 29.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 3.91 112.953 -151.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.45 124.66 24.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.676 0.79 . . . . 2.73 110.983 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -160.68 141.03 8.49 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.621 1.169 . . . . 2.36 110.273 165.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -83.75 65.98 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.06 3.173 . . . . 2.62 109.401 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.76 171.29 14.7 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.385 0.993 . . . . 1.55 113.467 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.05 -20.79 28.38 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.186 2.591 . . . . 2.03 111.305 164.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -151.36 169.6 21.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.439 1.896 . . . . 2.35 112.315 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.14 157.55 43.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.83 1.652 . . . . 1.24 110.073 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.55 116.24 28.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.399 1.08 . . . . 2.12 109.524 167.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.81 162.22 13.36 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.383 1.473 . . . . 1.32 111.428 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.44 164.14 28.85 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.265 1.426 . . . . 2.64 111.616 -171.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -166.7 159.01 13.56 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.977 1.311 . . . . 1.62 113.505 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -80.1 141.4 35.83 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.914 -0.773 . . . . 1.24 108.914 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -130.7 129.98 43.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.26 2.224 . . . . 2.14 108.351 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 74' ' ' ARG . 3.4 pm0 -113.9 129.28 56.61 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.335 1.454 . . . . 3.34 110.738 171.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -86.68 110.97 36.52 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 155.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -86.7 -9.5 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.792 2.328 . . . . 1.2 113.916 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.2 167.84 31.9 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.176 0.898 . . . . 1.1 113.197 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -87.73 -1.14 57.77 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.471 1.509 . . . . 3.39 114.322 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.8 159.34 36.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.067 1.347 . . . . 1.84 110.454 169.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.98 151.76 18.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.836 2.357 . . . . 1.36 111.647 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 mt -100.98 155.64 17.85 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.085 0.954 . . . . 1.84 111.19 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -132.21 110.75 10.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.041 1.337 . . . . 3.07 109.797 169.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.5 tp -95.06 112.48 24.18 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 127.581 2.353 . . . . 0.73 107.807 -175.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.88 -11.12 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.904 0.881 . . . . 0.58 112.883 -166.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.36 -164.89 34.96 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.511 1.053 . . . . 0.49 112.033 173.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.86 -179.14 6.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.225 1.01 . . . . 0.74 110.012 164.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -155.9 141.24 17.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.83 1.252 . . . . 5.45 108.963 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 t -151.43 156.1 34.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 119.501 1.046 . . . . 0.75 110.69 -165.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.36 -17.23 18.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.706 2.271 . . . . 0.97 113.974 168.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -85.33 -23.78 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.954 1.465 . . . . 1.02 114.954 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.52 152.33 50.83 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.703 1.201 . . . . 0.95 112.252 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 10.1 tp10 -86.45 -88.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.003 -0.544 . . . . 2.87 110.037 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -82.24 90.45 6.62 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.714 -0.847 . . . . 3.55 108.714 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.99 137.38 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.576 0.75 . . . . 1.39 111.076 166.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -137.18 140.02 41.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.296 1.839 . . . . 2.2 109.708 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -88.16 122.11 31.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.553 -1.342 . . . . 0.84 111.674 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.4 m170 -109.46 156.36 20.18 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.287 1.435 . . . . 0.65 112.541 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.8 -178.67 3.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.316 1.846 . . . . 1.93 112.023 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.0 m -138.1 100.78 4.24 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.969 1.708 . . . . 1.32 108.033 163.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -92.24 153.31 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.864 1.266 . . . . 2.33 111.778 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptp -89.23 156.97 18.43 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.306 -0.871 . . . . 4.15 111.972 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -163.31 153.11 15.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.872 1.269 . . . . 9.73 112.887 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -81.54 176.43 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.889 0.876 . . . . 3.66 110.698 154.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.19 -121.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 126.152 1.781 . . . . 3.13 106.571 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.403 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 11.9 tt0 -73.35 62.52 0.71 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.559 2.343 . . . . 3.62 110.131 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.05 2.06 6.19 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.307 1.432 . . . . 2.05 115.291 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 13.4 ptpt -111.02 129.86 55.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.812 2.445 . . . . 2.64 110.21 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.438 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -100.19 144.37 29.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.76 0.824 . . . . 5.55 112.466 -167.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -152.5 162.14 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.672 1.589 . . . . 2.11 109.374 -166.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.5 ptp -84.38 171.37 12.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.752 0.821 . . . . 3.5 112.012 161.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.16 148.95 19.99 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.492 1.52 . . . . 1.52 110.767 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -112.34 155.52 23.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.322 1.049 . . . . 1.98 110.24 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -168.39 158.87 8.7 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 126.471 1.909 . . . . 4.87 108.927 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.2 Cg_endo -67.89 154.52 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 120.967 1.112 . . . . 0.74 110.343 159.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.94 156.39 65.77 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 125.284 1.433 . . . . 0.7 109.819 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.28 -16.54 39.64 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.613 2.209 . . . . 0.76 112.833 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -178.79 167.49 1.7 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.716 1.606 . . . . 1.93 110.593 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -117.47 172.3 7.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.201 2.2 . . . . 1.15 109.165 159.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.6 161.11 41.76 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.011 -1.056 . . . . 2.16 111.15 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -146.9 129.92 8.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.442 0.697 . . . . 0.96 110.648 -167.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.17 162.46 38.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.056 2.504 . . . . 1.25 112.315 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.05 136.29 64.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 124.457 3.438 . . . . 1.28 113.356 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 64.07 2.58 1.46 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 1.96 113.794 -174.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.6 116.03 4.29 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 127.284 2.373 . . . . 0.98 110.724 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 8.2 ttt180 -102.92 130.42 49.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.092 1.357 . . . . 5.29 110.275 164.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -147.74 152.66 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.519 1.528 . . . . 2.15 111.338 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 130.86 48.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.873 0.869 . . . . 3.37 112.132 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.97 78.03 0.32 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.152 1.381 . . . . 1.18 108.067 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -81.05 146.92 60.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 2.69 111.095 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.38 -50.85 12.64 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.52 2.813 . . . . 0.91 113.141 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.31 67.63 3.66 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.84 -0.904 . . . . 1.07 110.84 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.05 -78.32 0.07 OUTLIER Glycine 0 N--CA 1.466 0.694 0 C-N-CA 124.975 1.274 . . . . 0.82 112.807 -170.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -156.51 143.04 18.46 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.141 2.176 . . . . 1.81 109.632 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -169.76 159.11 7.87 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.895 -1.128 . . . . 0.87 110.882 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -97.56 121.38 39.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.396 0.678 . . . . 2.18 112.028 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.8 mmt -79.25 123.64 27.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.2 1.0 . . . . 0.98 109.557 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -104.64 79.33 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.36 1.464 . . . . 1.88 110.485 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -78.9 128.32 33.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.626 1.103 . . . . 2.61 109.538 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.88 74.74 0.9 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.857 -0.897 . . . . 1.31 110.857 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.1 89.94 3.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.739 1.269 . . . . 1.5 110.774 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 3.0 ptmt -55.44 -9.14 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.487 1.515 . . . . 1.91 114.091 171.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -136.84 135.58 20.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.877 1.671 . . . . 5.41 108.847 167.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 141.81 40.77 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.126 1.884 . . . . 1.53 109.115 165.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.0 81.92 7.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.567 1.147 . . . . 2.01 110.473 -172.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.476 ' HZ2' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -70.22 108.73 4.29 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.564 -1.335 . . . . 3.72 109.605 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -43.07 124.98 3.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.797 0.839 . . . . 1.44 111.392 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.65 -22.06 15.52 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 115.984 -2.565 . . . . 2.17 116.492 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.476 ' CD ' ' HZ2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -86.43 177.19 7.51 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.387 2.593 . . . . 4.28 111.98 -177.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -96.58 132.29 42.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.373 1.869 . . . . 4.85 112.651 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.0 t -102.5 116.34 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.849 -1.157 . . . . 1.11 108.891 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.92 143.8 35.49 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.047 0.927 . . . . 3.08 110.557 160.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 117.56 5.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.743 0.817 . . . . 1.72 110.952 -168.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -81.53 95.58 7.16 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.164 2.186 . . . . 2.82 110.377 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.8 mt -72.39 119.2 16.26 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.478 -0.764 . . . . 1.3 109.936 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.3 mt -95.4 132.19 40.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.032 0.933 . . . . 0.63 111.249 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.24 147.09 52.55 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.434 1.111 . . . . 1.99 112.73 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.08 136.72 56.36 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.034 1.124 . . . . 2.12 114.034 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 48.93 13.66 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.971 0.796 . . . . 3.81 113.63 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.46 23.8 55.57 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 115.951 1.14 . . . . 1.76 115.951 168.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -108.52 146.21 33.57 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.809 1.804 . . . . 4.44 111.973 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.93 137.59 13.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.783 2.033 . . . . 1.12 107.761 166.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -128.77 109.99 11.78 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.686 1.194 . . . . 1.62 108.605 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -81.78 126.91 32.4 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.663 -0.648 . . . . 2.78 111.88 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.1 m -118.95 167.3 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.287 1.835 . . . . 1.6 110.259 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -116.08 139.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.839 1.255 . . . . 2.08 110.416 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.3 mt -140.11 136.83 17.38 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 127.495 2.318 . . . . 1.57 108.005 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.86 154.94 48.67 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.803 2.335 . . . . 1.37 112.059 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.29 123.22 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.848 1.259 . . . . 1.58 109.48 168.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.68 166.74 32.53 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.546 1.138 . . . . 3.6 111.712 -174.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.53 84.84 2.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.74 1.216 . . . . 2.52 113.923 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.013 -1.106 . . . . 6.19 108.013 148.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 109.779 -0.452 . . . . 5.14 109.779 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.34 -175.21 43.7 Favored Glycine 0 N--CA 1.464 0.52 0 O-C-N 121.116 -0.99 . . . . 1.48 112.061 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -161.12 154.14 21.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.932 1.086 . . . . 1.67 113.932 174.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.48 140.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.762 0.825 . . . . 1.23 109.33 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -87.11 110.94 20.46 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.674 -0.641 . . . . 4.2 111.582 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.58 127.22 30.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.526 1.155 . . . . 3.17 109.9 155.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -153.14 164.5 20.2 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.067 2.147 . . . . 2.13 107.551 161.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -94.08 -161.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.155 3.236 . . . . 3.46 109.111 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.55 -150.92 28.86 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.386 0.993 . . . . 2.25 113.021 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -84.72 -16.44 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.618 2.879 . . . . 2.55 113.843 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -153.82 160.66 42.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.735 1.754 . . . . 3.12 115.735 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.15 177.75 7.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.94 2.096 . . . . 1.3 110.499 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.82 144.27 45.6 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.622 1.169 . . . . 1.09 111.641 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.92 147.54 44.61 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.952 0.901 . . . . 0.95 112.188 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.83 146.88 41.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.243 1.817 . . . . 2.02 110.289 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.51 151.6 9.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.348 -1.47 . . . . 1.5 114.751 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -87.76 93.41 9.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.539 1.936 . . . . 2.03 107.354 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.02 140.6 29.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.232 1.413 . . . . 2.19 109.83 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -127.47 156.66 41.77 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.632 0.975 . . . . 3.05 113.632 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.84 99.71 53.03 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.149 1.38 . . . . 0.98 108.964 163.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.05 -9.34 14.18 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.093 2.529 . . . . 1.41 113.058 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -173.48 49.78 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.684 1.135 . . . . 1.16 113.389 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -113.11 0.96 15.13 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.522 1.529 . . . . 2.5 112.802 -168.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.23 160.7 42.35 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.072 1.749 . . . . 1.69 110.257 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.47 154.44 16.04 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.109 2.539 . . . . 0.97 111.849 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.87 130.24 52.28 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.309 1.444 . . . . 2.34 110.419 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -114.18 109.42 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.912 1.285 . . . . 2.74 109.612 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.3 tp -90.51 107.63 19.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 126.77 2.028 . . . . 0.85 108.428 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.0 m -101.15 -12.45 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.191 0.996 . . . . 0.56 112.927 -168.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.1 -163.81 32.21 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.251 0.929 . . . . 0.61 112.208 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.89 -173.18 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.562 1.145 . . . . 0.79 110.145 164.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -161.7 137.17 7.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.763 1.625 . . . . 4.98 107.98 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -146.74 147.21 29.27 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 117.152 -1.404 . . . . 0.94 109.341 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.35 -6.96 19.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.021 1.814 . . . . 0.97 113.816 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -93.91 -1.68 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.574 1.694 . . . . 0.86 115.574 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.1 150.11 34.37 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.562 1.528 . . . . 0.89 113.809 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.85 -67.1 0.81 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.611 1.565 . . . . 3.33 111.274 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -90.02 147.08 23.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 122.572 1.177 . . . . 3.63 110.321 168.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.02 129.27 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.456 2.302 . . . . 1.15 106.582 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.94 120.39 13.15 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.078 1.351 . . . . 2.03 109.016 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -78.98 121.71 25.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.064 1.302 . . . . 0.66 110.302 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.0 m170 -111.54 152.75 27.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.298 1.839 . . . . 0.6 112.053 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.91 -176.45 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.212 -1.358 . . . . 2.01 110.022 165.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.6 m -126.82 75.69 1.58 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.283 1.433 . . . . 1.58 107.526 170.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -65.45 150.04 49.02 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 2.7 112.475 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -88.18 150.36 23.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.351 1.061 . . . . 6.49 111.931 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -155.6 155.4 33.24 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.517 1.527 . . . . 8.5 111.481 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -99.5 148.01 24.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 3.44 110.205 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -141.4 122.22 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 106.428 -1.693 . . . . 3.5 106.428 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 62.76 22.81 13.6 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.911 0.884 . . . . 3.88 112.085 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.82 69.07 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.303 -1.498 . . . . 1.82 114.36 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -96.88 141.55 29.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.567 1.947 . . . . 2.72 109.992 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 135.2 35.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.624 1.17 . . . . 5.1 111.294 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.51 141.8 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.236 1.814 . . . . 1.4 109.161 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -117.41 145.18 44.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.09 0.956 . . . . 4.7 110.167 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.76 169.14 31.19 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 125.141 1.353 . . . . 1.2 112.633 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.06 151.66 20.7 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.512 1.156 . . . . 1.55 113.133 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -164.55 146.8 7.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.435 1.494 . . . . 6.54 110.159 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.5 Cg_endo -68.93 153.6 72.33 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.688 1.592 . . . . 0.69 111.314 172.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.33 157.65 60.85 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.785 1.634 . . . . 0.47 110.537 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.99 -18.08 36.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.598 2.198 . . . . 0.58 112.981 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.26 165.44 1.84 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.099 1.759 . . . . 1.81 111.575 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -111.07 173.4 6.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.366 1.866 . . . . 0.97 109.614 152.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -155.9 168.88 25.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.423 -0.798 . . . . 1.84 112.435 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.62 133.23 8.63 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.811 1.244 . . . . 0.8 109.783 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.12 164.13 36.26 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.283 1.989 . . . . 0.82 110.925 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.53 143.42 92.95 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.008 2.472 . . . . 0.77 111.502 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt 67.26 0.25 2.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.79 2.036 . . . . 1.44 113.504 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.13 115.66 4.15 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 126.366 1.936 . . . . 0.95 110.528 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.91 112.2 24.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.038 1.335 . . . . 6.27 109.539 170.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.72 -174.98 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.007 1.723 . . . . 1.54 111.016 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 102.92 2.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.301 1.04 . . . . 3.65 111.023 -165.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.13 77.17 0.51 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.078 1.751 . . . . 1.07 109.112 161.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -91.77 147.79 35.8 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 127.832 2.453 . . . . 2.8 112.189 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.51 -64.18 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.787 3.658 . . . . 1.05 113.325 -170.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.45 97.36 1.7 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 108.439 -1.864 . . . . 1.32 108.439 165.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.81 -90.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.924 1.249 . . . . 0.93 112.358 -169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -148.29 141.64 25.22 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.345 1.858 . . . . 2.06 110.143 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -169.19 169.64 9.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.687 -1.258 . . . . 1.01 110.518 -172.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.65 136.13 41.0 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.646 -0.501 . . . . 1.9 109.646 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 mmt -91.28 126.31 36.33 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.339 -0.985 . . . . 1.09 108.339 161.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.25 111.08 22.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.41 1.484 . . . . 2.71 107.596 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 126.63 55.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.647 1.579 . . . . 2.81 108.841 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.15 95.46 0.09 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.046 -1.222 . . . . 1.36 110.046 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.5 mt -92.72 124.39 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.544 0.672 . . . . 0.93 111.09 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.02 -19.73 61.81 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.8 1.037 . . . . 1.43 113.8 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -149.5 162.66 27.89 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.738 2.015 . . . . 6.96 108.974 164.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.86 138.36 68.19 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.276 -1.471 . . . . 1.77 108.276 149.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.01 150.63 31.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 2.54 109.53 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.76 0.94 51.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.296 1.221 . . . . 6.4 114.296 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 72.2 161.89 0.25 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.27 2.628 . . . . 2.38 112.101 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.61 -12.16 0.77 Allowed Glycine 0 N--CA 1.482 1.728 0 N-CA-C 116.8 1.48 . . . . 4.02 116.8 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.98 166.51 22.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.707 2.484 . . . . 3.34 117.707 -153.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.61 68.55 9.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 131.659 3.984 . . . . 5.96 113.206 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.95 106.65 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 120.671 -1.268 . . . . 1.06 111.126 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.04 129.86 44.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.667 1.587 . . . . 2.99 110.764 160.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 mt -149.58 109.87 4.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.223 1.009 . . . . 1.74 112.272 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.67 96.18 5.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.192 2.597 . . . . 2.02 109.47 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.9 mt -77.23 118.39 19.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.321 -0.862 . . . . 1.18 110.608 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -91.92 127.55 37.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.151 0.98 . . . . 0.64 111.801 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -126.12 134.03 51.45 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.552 0.945 . . . . 2.37 113.552 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 33.12 49.63 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.579 2.352 . . . . 1.86 114.142 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.93 -94.01 0.77 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.574 1.083 . . . . 3.94 111.946 -170.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.65 23.0 7.96 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 117.381 1.712 . . . . 1.61 117.381 -164.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.446 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -117.76 153.26 33.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.508 2.154 . . . . 4.93 109.782 166.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.03 139.95 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.289 1.436 . . . . 1.14 109.584 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -123.31 110.97 15.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.024 1.33 . . . . 1.84 109.48 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -85.3 108.17 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.093 -0.38 . . . . 2.57 111.479 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -104.55 159.84 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.46 1.504 . . . . 1.19 110.937 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.97 137.99 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.347 1.059 . . . . 2.15 109.658 162.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 144.19 46.83 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.216 1.406 . . . . 1.73 109.958 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.37 141.82 26.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.823 2.348 . . . . 1.36 110.37 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.42 153.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.82 0.848 . . . . 1.62 112.43 167.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -146.61 158.05 43.83 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 3.87 109.124 163.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.58 99.48 10.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.924 -1.11 . . . . 2.43 108.109 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.222 0 CA-C-O 114.844 -2.503 . . . . 5.45 117.275 -154.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 122.036 0.922 . . . . 6.41 109.382 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.93 173.38 41.52 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.162 1.363 . . . . 1.05 113.818 -168.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -159.13 145.31 16.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.552 1.541 . . . . 1.54 110.571 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.3 t -91.29 143.05 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.692 1.197 . . . . 1.03 109.303 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -69.21 116.91 10.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.626 -0.671 . . . . 4.02 112.31 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.2 134.18 56.77 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.156 0.983 . . . . 4.03 109.999 161.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -166.13 140.46 3.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 120.534 -1.353 . . . . 2.28 112.456 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -92.59 68.99 0.68 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.234 3.29 . . . . 3.11 110.348 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.01 -177.76 36.26 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.772 1.069 . . . . 1.48 115.772 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.54 -0.25 8.1 Favored 'Trans proline' 0 CA--C 1.542 0.91 1 C-N-CA 125.494 4.129 . . . . 1.43 113.371 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -134.37 152.75 51.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 2.66 111.56 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 -170.28 3.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.211 2.204 . . . . 1.16 109.933 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.24 152.9 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.309 1.444 . . . . 1.08 109.412 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.2 136.69 51.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.415 1.461 . . . . 1.09 111.902 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -120.27 135.07 55.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.015 1.726 . . . . 2.06 110.277 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.8 152.19 11.35 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.872 -1.143 . . . . 1.62 112.423 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 m -95.93 92.28 6.42 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.112 0.965 . . . . 1.61 110.029 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -80.41 133.61 35.9 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.097 -0.705 . . . . 2.27 109.097 173.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.86 145.73 50.85 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.107 1.763 . . . . 2.79 110.124 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -107.86 104.28 52.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.702 0.801 . . . . 1.13 110.073 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.33 -12.97 11.33 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.506 2.137 . . . . 1.05 113.321 176.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.13 -174.25 49.53 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.149 0.88 . . . . 1.21 113.221 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -112.22 6.01 18.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.594 1.557 . . . . 2.75 112.337 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.5 160.92 60.01 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.86 2.064 . . . . 1.73 109.988 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.44 144.64 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.324 2.016 . . . . 1.12 112.028 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.95 121.26 41.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.363 1.465 . . . . 2.33 108.934 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 ttm105 -110.53 97.53 6.95 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.481 1.112 . . . . 3.38 110.753 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.67 106.74 11.92 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.292 2.237 . . . . 0.75 109.551 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.82 -13.42 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.155 1.382 . . . . 0.85 113.524 -171.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.95 34.28 Favored Glycine 0 C--N 1.34 0.753 0 O-C-N 121.632 -0.668 . . . . 0.73 112.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB1' HD13 ' A' ' 101' ' ' LEU . . . -160.77 175.41 12.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.918 0.887 . . . . 0.92 112.76 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.434 ' C ' ' HE ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -143.72 156.48 44.54 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.831 0.452 . . . . 7.62 110.391 160.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 t -152.95 149.69 22.52 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.139 1.376 . . . . 0.88 108.628 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.97 -35.07 56.87 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.167 1.245 . . . . 1.48 111.24 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.97 4.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.868 1.433 . . . . 1.38 114.868 -164.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.34 170.2 14.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.186 1.794 . . . . 1.1 109.99 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 7.1 tp10 -106.38 -82.84 0.53 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.413 -0.958 . . . . 2.8 108.413 164.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.68 125.67 28.06 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.164 -0.96 . . . . 5.13 109.072 165.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.63 138.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.196 1.799 . . . . 1.19 109.419 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -140.07 127.69 21.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.663 1.185 . . . . 2.28 111.927 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.428 HD12 ' CE1' ' A' ' 84' ' ' PHE . 4.9 tt -78.93 122.87 26.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.767 -1.208 . . . . 0.75 110.795 167.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 21.6 m170 -108.71 153.2 23.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.71 1.604 . . . . 0.81 112.637 176.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -87.32 158.72 18.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.309 1.044 . . . . 2.23 109.803 162.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -109.31 143.91 38.17 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.161 -1.422 . . . . 1.48 107.161 152.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -137.46 155.07 49.74 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 2.14 111.285 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -111.02 121.81 46.31 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.101 -1.444 . . . . 3.49 107.101 160.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -146.44 173.21 12.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.387 1.475 . . . . 7.14 110.274 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -73.98 155.13 38.94 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.418 0.687 . . . . 3.21 110.132 159.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.85 -98.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.948 -1.131 . . . . 3.8 107.948 168.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -74.75 63.15 1.13 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.833 1.653 . . . . 5.0 111.723 170.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.63 -24.67 0.63 Allowed Glycine 0 N--CA 1.475 1.274 0 C-N-CA 126.462 1.982 . . . . 3.83 115.222 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -107.56 164.03 12.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.909 2.484 . . . . 3.45 111.628 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -76.87 134.15 39.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.375 2.27 . . . . 4.33 112.084 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -144.08 147.35 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.345 1.858 . . . . 1.49 109.995 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -98.0 118.54 34.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.515 1.526 . . . . 3.79 110.303 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.16 -179.19 16.1 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.389 1.471 . . . . 1.29 113.239 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.5 mtt -142.26 158.67 43.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.413 1.485 . . . . 2.14 111.244 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.87 151.04 4.78 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.741 -1.123 . . . . 4.7 113.437 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 27.4 Cg_endo -61.31 142.05 94.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.65 112.006 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.63 159.86 48.89 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 126.516 1.926 . . . . 0.48 110.882 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.15 -21.29 18.09 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.564 2.176 . . . . 0.68 113.455 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -171.87 163.72 6.32 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 120.27 1.396 . . . . 2.65 112.395 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -115.03 173.51 6.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.199 2.2 . . . . 1.09 109.24 155.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.91 164.27 38.68 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.645 -0.659 . . . . 2.56 112.13 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.1 t -139.25 125.79 12.53 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 125.412 1.485 . . . . 1.15 108.733 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.21 159.13 54.13 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.124 1.883 . . . . 1.25 110.512 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.77 140.5 93.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.959 2.439 . . . . 1.08 111.654 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt 72.17 -8.52 1.14 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.27 2.228 . . . . 1.41 113.997 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.05 -172.93 49.6 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.882 1.706 . . . . 1.47 112.873 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -160.61 161.76 32.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.965 2.106 . . . . 4.62 111.843 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.8 129.88 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.112 1.365 . . . . 1.78 110.007 170.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.88 122.29 32.1 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.22 0.533 . . . . 3.36 110.307 165.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -68.89 68.14 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.368 1.867 . . . . 1.42 109.954 169.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -70.85 142.27 87.94 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.472 1.509 . . . . 2.76 110.32 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.41 -57.02 2.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.55 2.833 . . . . 1.28 112.233 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.96 78.0 2.01 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.357 -1.097 . . . . 1.44 110.357 166.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.23 -79.61 0.08 OUTLIER Glycine 0 N--CA 1.466 0.637 0 C-N-CA 127.119 2.295 . . . . 0.95 111.415 -175.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -153.84 147.49 25.2 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.631 1.972 . . . . 2.35 108.905 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -159.7 154.13 23.94 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 120.496 -1.378 . . . . 0.75 109.276 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CE1' HD12 ' A' ' 45' ' ' LEU . 56.5 m-85 -92.39 104.03 16.4 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.329 -1.36 . . . . 1.83 107.329 167.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 129.61 40.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.603 -0.888 . . . . 1.15 108.603 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -114.81 122.14 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.647 1.579 . . . . 1.8 109.016 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.02 155.85 36.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.333 1.053 . . . . 3.0 110.668 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.92 -64.25 4.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.129 1.347 . . . . 3.51 112.29 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt 74.1 110.96 0.07 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.568 2.747 . . . . 1.26 115.526 164.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 41' ' ' GLU . 36.3 mttp -89.17 -3.73 58.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.579 -1.325 . . . . 1.78 113.595 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -137.35 138.61 25.43 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 126.193 1.797 . . . . 5.23 108.77 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.97 130.13 17.38 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 N-CA-C 107.469 -1.781 . . . . 1.77 107.469 159.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.55 85.1 6.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.411 0.684 . . . . 2.71 109.563 -170.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HE3' ' HG2' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -102.8 142.37 34.04 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.344 1.058 . . . . 3.9 111.463 175.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.17 142.06 48.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 114.546 1.313 . . . . 1.58 114.546 -170.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.39 52.12 28.24 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.781 -0.645 . . . . 2.0 112.789 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HG2' ' HE3' ' A' ' 94' ' ' LYS . 2.8 mt-10 -107.51 -175.74 2.87 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.549 -1.278 . . . . 2.49 107.549 147.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.51 120.43 31.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.76 0.79 . . . . 4.74 109.277 166.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.11 103.85 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.774 -0.824 . . . . 0.97 108.774 168.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 141.62 40.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.313 1.054 . . . . 3.5 110.672 162.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.417 HD13 ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -155.25 130.58 9.65 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.171 -0.956 . . . . 3.21 111.881 -167.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.71 121.25 38.34 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.443 1.097 . . . . 2.32 109.413 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -95.36 119.11 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.174 1.389 . . . . 1.15 110.012 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 mt -92.28 124.55 36.42 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.002 0.921 . . . . 0.91 110.505 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.91 126.67 50.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.141 0.977 . . . . 2.16 112.542 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 50.07 21.12 0.69 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.258 1.823 . . . . 2.01 114.821 171.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.53 -61.12 2.82 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.695 1.14 . . . . 3.24 112.361 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.79 1.37 53.95 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.188 1.635 . . . . 1.89 117.188 -165.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -137.24 146.24 44.55 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.71 1.755 . . . . 5.85 111.351 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.01 148.46 23.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.121 1.368 . . . . 1.25 109.822 163.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -143.37 133.03 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.396 1.878 . . . . 1.79 109.657 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -85.65 140.74 30.31 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.624 0.602 . . . . 2.16 112.624 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -125.52 177.23 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.606 1.962 . . . . 1.22 109.461 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -155.21 140.69 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.404 0.547 . . . . 1.93 111.002 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.32 152.39 19.91 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.965 1.306 . . . . 2.33 112.844 -171.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -79.27 -170.28 0.97 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.24 3.293 . . . . 1.04 112.346 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.42 84.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 126.857 2.063 . . . . 2.24 111.389 -161.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -128.89 172.88 10.9 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 119.983 -1.698 . . . . 5.48 114.553 -171.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.07 142.19 28.89 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.67 -1.269 . . . . 3.27 113.532 -167.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 C-N-CA 126.702 2.001 . . . . 6.85 111.528 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 CA--C 1.55 0.966 0 N-CA-C 109.312 -0.625 . . . . 5.21 109.312 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.11 165.68 21.77 Favored Glycine 0 N--CA 1.475 1.239 0 O-C-N 120.296 -1.503 . . . . 1.11 113.371 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.2 p90 -167.09 163.26 15.72 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.122 1.369 . . . . 1.67 111.805 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -127.4 135.6 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.277 -0.889 . . . . 1.21 110.522 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -88.68 129.52 35.51 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.469 1.128 . . . . 4.57 113.605 -169.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -79.55 141.33 36.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.108 2.163 . . . . 2.93 112.562 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -162.8 152.26 13.01 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.329 1.451 . . . . 2.29 110.943 165.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.45 56.55 4.3 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.546 3.497 . . . . 2.44 109.706 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.81 174.86 17.65 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.661 1.124 . . . . 1.3 114.068 -172.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.13 -15.22 13.02 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.904 3.069 . . . . 1.59 112.556 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -143.89 154.3 43.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.479 1.912 . . . . 2.03 111.834 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.29 -179.85 8.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.728 1.611 . . . . 1.09 110.751 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.67 49.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.18 0.807 . . . . 1.13 113.18 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.48 141.66 36.58 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.998 0.519 . . . . 0.99 110.763 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -117.67 157.26 26.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.937 1.695 . . . . 2.05 110.08 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -167.47 148.07 5.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.994 1.479 . . . . 1.29 114.994 166.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.54 HG23 ' HD2' ' A' ' 74' ' ' ARG . 59.4 m -75.83 140.38 42.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.528 -1.214 . . . . 1.23 109.636 157.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.33 130.63 15.6 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.687 1.195 . . . . 2.98 109.069 168.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -136.95 152.64 50.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.284 1.04 . . . . 4.53 112.276 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -104.15 102.49 32.74 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.066 1.346 . . . . 1.32 110.528 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.71 -9.19 14.63 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.315 2.01 . . . . 1.73 113.603 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.17 -170.44 44.87 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.362 0.982 . . . . 1.5 112.998 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -120.86 9.95 10.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.782 1.233 . . . . 2.66 112.943 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.76 159.4 53.55 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.047 1.739 . . . . 2.27 110.69 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.67 153.51 15.36 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.757 2.305 . . . . 1.93 111.805 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.19 142.24 43.64 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.732 1.613 . . . . 2.08 109.019 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -141.41 107.49 5.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.712 0.805 . . . . 3.45 109.805 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.37 129.14 44.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.277 2.631 . . . . 1.98 109.218 -165.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.84 -9.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.136 1.162 . . . . 0.57 114.136 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.19 -160.75 28.77 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.069 -1.02 . . . . 0.55 112.285 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 -174.25 4.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.942 1.697 . . . . 0.89 110.664 165.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -150.84 144.87 25.32 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.609 1.963 . . . . 7.64 109.136 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -141.01 151.26 61.83 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 120.376 1.444 . . . . 0.63 109.462 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.0 -22.14 48.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.359 2.039 . . . . 0.88 113.851 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.91 2.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 115.178 1.547 . . . . 0.93 115.178 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 175.6 12.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.652 1.181 . . . . 0.9 112.306 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -110.56 -89.36 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.575 1.15 . . . . 2.84 109.894 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -77.72 100.6 6.29 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 120.667 -1.27 . . . . 4.24 108.932 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -82.24 135.04 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.664 1.585 . . . . 1.37 111.147 162.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.1 147.48 51.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.822 2.449 . . . . 2.17 108.407 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 tt -92.79 124.1 36.54 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.9 1.682 . . . . 1.06 111.162 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.7 m170 -114.01 152.47 30.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.317 1.447 . . . . 0.83 112.635 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -98.74 166.43 11.32 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 2.16 110.319 167.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -125.14 117.69 24.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.591 1.156 . . . . 1.32 108.166 167.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -119.64 -177.59 3.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.44 1.496 . . . . 2.24 112.084 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -140.33 163.19 33.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.424 1.09 . . . . 2.89 111.895 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.36 166.82 20.39 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.641 1.577 . . . . 5.88 112.023 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 135.42 40.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.537 1.535 . . . . 4.85 108.445 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.8 -113.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.745 1.618 . . . . 3.19 107.025 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.26 67.19 3.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.519 1.054 . . . . 4.31 108.931 164.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.89 -22.01 0.46 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 127.323 2.392 . . . . 2.5 115.953 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -74.93 133.82 41.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.5 1.92 . . . . 4.17 110.134 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.95 127.63 36.48 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.927 0.891 . . . . 5.51 109.67 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.12 152.58 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.657 1.583 . . . . 2.85 109.876 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.5 ptp -83.96 162.13 20.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.505 1.522 . . . . 4.49 113.32 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.52 172.93 33.68 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.669 1.604 . . . . 1.48 113.122 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtt -137.09 154.55 50.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.554 1.542 . . . . 2.82 110.472 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -168.77 154.11 6.21 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.683 1.193 . . . . 5.36 111.144 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 3.8 Cg_endo -68.6 152.38 74.67 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.46 1.44 . . . . 0.62 112.085 171.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.97 149.36 68.28 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 125.945 1.698 . . . . 0.71 109.842 172.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.31 -19.08 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.903 2.402 . . . . 0.88 113.909 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -172.61 171.56 4.49 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.804 1.184 . . . . 1.81 113.117 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.23 175.26 10.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.839 2.456 . . . . 2.82 109.373 159.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.45 168.8 25.92 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 120.602 -1.311 . . . . 2.39 111.132 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -149.65 137.73 11.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 124.72 1.208 . . . . 1.5 108.737 -167.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.77 171.73 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.655 1.57 . . . . 1.63 110.146 166.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.97 146.86 91.79 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.344 2.03 . . . . 1.58 110.322 160.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt 69.61 -2.72 1.85 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.696 1.998 . . . . 1.38 114.024 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.21 148.43 20.74 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 126.985 2.231 . . . . 1.12 111.688 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.54 ' HD2' HG23 ' A' ' 21' ' ' THR . 33.2 ttp-105 -106.27 142.64 35.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.432 1.893 . . . . 6.04 111.505 168.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.86 147.26 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.475 1.51 . . . . 2.75 108.473 161.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -128.13 112.28 14.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.334 -1.358 . . . . 3.41 107.334 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.09 63.05 0.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.57 1.948 . . . . 1.49 108.971 171.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -79.48 150.95 74.21 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 128.8 2.84 . . . . 3.23 111.545 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.4 -35.69 92.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.52 2.814 . . . . 1.17 113.641 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.72 60.06 1.77 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.189 0.9 . . . . 1.73 111.867 168.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.89 -73.6 0.05 OUTLIER Glycine 0 N--CA 1.469 0.859 0 C-N-CA 125.225 1.393 . . . . 1.31 113.94 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -153.01 154.72 35.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.122 1.769 . . . . 2.32 111.01 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -163.99 169.93 17.32 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.107 0.963 . . . . 1.09 109.879 176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.21 126.61 42.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.789 -0.819 . . . . 2.12 108.789 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -81.69 120.82 25.6 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.426 1.091 . . . . 1.1 109.219 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -111.65 113.01 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.147 1.379 . . . . 1.47 107.976 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.41 139.83 41.28 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.433 1.493 . . . . 2.72 109.293 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.08 66.3 1.94 Allowed Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.489 -1.045 . . . . 1.29 110.489 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 mt -70.03 123.54 21.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.04 0.536 . . . . 1.21 110.568 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -83.19 19.83 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.015 0.926 . . . . 1.45 113.154 -172.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 173.9 155.98 0.3 Allowed Pre-proline 0 CA--C 1.544 0.718 1 C-N-CA 131.893 4.077 . . . . 4.46 107.945 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.73 133.68 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 N-CA-C 106.626 -2.105 . . . . 2.1 106.626 147.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.9 116.55 5.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.55 0.69 . . . . 2.42 109.155 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -71.23 107.67 4.35 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.416 -0.802 . . . . 4.38 109.939 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.82 1.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.909 -1.119 . . . . 1.52 109.461 164.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.49 38.67 7.02 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 118.755 -1.025 . . . . 2.18 113.958 -165.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -135.75 -178.92 5.35 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 119.275 1.538 . . . . 3.46 108.659 149.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.78 150.31 37.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.158 0.98 . . . . 5.06 110.589 166.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.99 113.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.98 1.712 . . . . 1.21 108.031 172.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.22 137.69 57.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.909 -0.587 . . . . 2.94 109.477 160.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -149.55 133.44 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.41 1.084 . . . . 1.54 111.993 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.55 87.76 2.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.786 2.034 . . . . 2.63 109.146 -167.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 mt -69.28 125.17 25.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.766 2.026 . . . . 1.11 111.077 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.3 mt -94.51 138.67 32.13 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.511 1.124 . . . . 0.82 111.464 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -135.08 138.54 43.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.432 1.093 . . . . 1.8 111.238 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.8 126.55 12.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.595 1.558 . . . . 1.79 113.342 -167.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.25 -145.58 19.16 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 110.757 -0.937 . . . . 3.29 110.757 -166.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.27 27.48 9.32 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 115.74 1.056 . . . . 2.04 115.74 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.63 131.22 46.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.27 2.035 . . . . 4.76 112.079 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.73 123.32 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.108 1.363 . . . . 1.41 109.284 162.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.76 119.8 33.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.809 1.644 . . . . 3.02 108.477 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.54 147.09 23.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.328 1.233 . . . . 2.47 114.328 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.96 172.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 127.86 2.464 . . . . 1.14 109.492 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.82 140.99 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.828 1.651 . . . . 2.11 108.017 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.79 133.81 10.59 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.147 1.379 . . . . 1.52 110.83 -166.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 147.77 67.34 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.105 2.537 . . . . 1.03 114.168 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.7 t -79.27 132.49 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.538 0.735 . . . . 1.14 110.496 168.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -133.7 156.26 48.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.125 1.77 . . . . 3.9 112.164 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.57 84.42 7.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.093 0.957 . . . . 1.98 109.457 164.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.907 -1.52 . . . . 5.71 112.16 -163.419 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 108.86 -0.792 . . . . 5.27 108.86 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.88 165.48 38.74 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.327 -0.858 . . . . 1.13 114.224 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -159.53 158.98 32.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.628 1.171 . . . . 2.16 114.001 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.08 130.03 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.573 -1.269 . . . . 1.25 107.573 164.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -84.48 -2.6 57.51 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.841 1.793 . . . . 3.97 115.841 -164.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.4 t80 65.88 152.21 0.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.496 2.318 . . . . 3.36 113.671 -170.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -159.54 146.8 12.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.943 2.097 . . . . 3.74 108.25 157.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.88 -7.84 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.324 2.683 . . . . 3.45 112.283 169.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.57 -167.05 43.16 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.462 1.029 . . . . 1.9 114.213 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.01 -9.33 22.08 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.503 2.802 . . . . 1.8 113.359 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -152.33 161.89 41.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.081 1.352 . . . . 2.22 114.397 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.57 -174.09 4.78 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.668 2.387 . . . . 1.18 111.953 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB2' ' CE ' ' A' ' 85' ' ' MET . . . -137.08 159.58 41.49 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.063 1.345 . . . . 1.32 111.51 174.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.65 163.35 37.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.465 1.506 . . . . 1.41 113.273 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -145.24 152.74 40.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.363 1.865 . . . . 1.92 110.874 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -166.13 158.44 14.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.547 1.139 . . . . 1.59 112.068 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.5 m -90.73 138.59 31.46 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.667 -1.234 . . . . 1.25 107.667 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.6 132.1 56.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.943 1.297 . . . . 2.27 107.767 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.55 135.36 53.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.727 0.811 . . . . 3.31 111.761 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -101.69 115.56 64.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.348 1.059 . . . . 0.91 109.7 163.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -88.57 -8.9 5.09 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.241 2.627 . . . . 1.27 114.4 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.06 162.97 32.86 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 119.434 1.016 . . . . 1.22 113.355 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.31 -0.52 50.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.347 1.459 . . . . 3.08 114.178 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.91 158.04 36.91 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.999 1.32 . . . . 1.85 110.53 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.38 155.23 18.89 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.214 2.61 . . . . 1.16 111.198 -173.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.25 153.86 20.48 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.347 1.059 . . . . 1.89 111.316 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -130.65 114.42 15.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.153 1.381 . . . . 3.02 109.185 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.45 114.41 26.17 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.246 2.618 . . . . 0.66 108.893 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.05 -10.54 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 0.55 113.571 -166.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.19 31.44 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.616 -0.678 . . . . 0.55 112.704 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.71 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.03 179.95 7.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.597 0.759 . . . . 0.8 111.924 176.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 3.0 mmt180 -154.47 149.69 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.94 -1.133 . . . . 6.05 107.94 172.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -162.49 153.79 15.06 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.45 -1.262 . . . . 0.73 108.725 -170.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.42 -7.95 16.04 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.32 2.013 . . . . 1.11 114.489 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 m -98.48 -3.95 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 116.142 1.905 . . . . 0.89 116.142 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.51 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.944 1.298 . . . . 1.29 110.666 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -93.95 -74.75 0.52 Allowed 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.575 -0.528 . . . . 4.45 109.575 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -80.77 107.75 13.84 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.481 -0.933 . . . . 4.52 108.481 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -113.18 125.01 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.913 0.885 . . . . 1.88 108.763 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -134.13 122.7 23.26 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.889 1.276 . . . . 2.63 110.384 -162.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.59 122.53 26.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.227 1.013 . . . . 0.82 110.461 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 7.2 m170 -108.1 156.87 18.8 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.452 1.901 . . . . 0.88 112.832 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -105.24 -177.51 3.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.16 2.584 . . . . 2.03 111.473 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -133.12 99.54 4.59 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.749 -1.574 . . . . 1.67 106.749 154.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.3 151.51 41.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.462 0.305 . . . . 2.45 110.63 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 ptp -97.97 157.92 15.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.55 0.34 . . . . 3.88 110.797 155.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -176.1 160.96 2.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.583 2.353 . . . . 6.63 110.274 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.73 154.26 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.029 0.932 . . . . 3.7 108.795 169.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 t -133.17 -96.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.281 1.033 . . . . 2.87 108.967 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -75.84 54.94 0.85 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.267 1.827 . . . . 3.19 110.34 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.99 -17.57 0.53 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.137 1.827 . . . . 2.11 115.261 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.8 152.69 20.2 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.01 1.724 . . . . 2.67 111.162 -168.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -62.64 131.74 50.02 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.846 0.858 . . . . 4.37 111.183 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.34 151.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.037 1.735 . . . . 1.95 109.335 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.8 mtm -128.64 141.51 51.33 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.602 1.161 . . . . 4.01 110.302 163.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.86 163.57 30.5 Favored Glycine 0 N--CA 1.469 0.844 0 C-N-CA 123.753 0.692 . . . . 1.24 112.689 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -97.74 158.47 15.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.965 0.906 . . . . 1.72 112.771 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.6 mtt-85 -164.83 145.8 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 126.724 2.009 . . . . 6.27 109.053 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.8 Cg_endo -70.59 152.9 65.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 CA-C-N 121.526 1.581 . . . . 0.9 110.111 160.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.17 156.2 57.52 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.252 1.421 . . . . 0.67 110.037 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.32 -14.4 34.28 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.812 2.341 . . . . 0.8 113.015 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -178.96 162.15 1.24 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.115 1.766 . . . . 2.27 110.861 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -108.59 174.55 5.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.925 1.69 . . . . 1.04 109.316 153.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.74 165.24 37.21 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.908 -1.12 . . . . 2.34 111.204 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -149.63 135.36 10.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 118.573 -0.727 . . . . 0.88 110.502 -164.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.98 165.8 31.19 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.264 1.976 . . . . 0.89 112.116 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.31 138.84 83.6 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.391 3.394 . . . . 1.09 112.62 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.1 2.83 1.54 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.344 1.857 . . . . 1.99 113.808 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.09 115.51 4.13 Favored Glycine 0 C--O 1.228 -0.23 0 C-N-CA 127.422 2.439 . . . . 0.89 111.626 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -85.43 134.36 34.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.248 -0.976 . . . . 6.64 109.978 155.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.34 168.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.749 2.02 . . . . 1.53 109.6 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -134.47 124.77 26.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.824 0.85 . . . . 3.64 110.781 -164.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.06 75.63 5.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.716 -0.846 . . . . 1.18 108.716 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 ptpm? -79.59 136.27 55.84 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.278 -0.867 . . . . 2.86 110.525 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.47 -58.51 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.933 3.755 . . . . 1.03 113.566 -163.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 106.78 2.61 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 107.817 -2.113 . . . . 1.23 107.817 160.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.51 -88.65 0.17 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 124.654 1.121 . . . . 0.94 111.266 -163.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -150.62 144.55 25.32 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.891 2.076 . . . . 1.81 109.926 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -165.8 174.2 9.87 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.937 -1.102 . . . . 0.85 110.618 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -110.9 128.8 55.93 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.994 0.918 . . . . 2.28 109.971 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.482 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 8.1 mmt -86.71 136.98 32.82 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.073 0.949 . . . . 0.89 109.633 165.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.7 mt -116.67 117.0 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.516 1.527 . . . . 2.11 109.105 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.82 142.35 51.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.896 1.678 . . . . 2.63 111.069 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.99 59.57 4.24 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.041 -1.223 . . . . 1.59 110.041 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.8 mt -66.8 129.42 39.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.156 0.979 . . . . 1.19 111.713 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.59 -10.19 49.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.785 1.234 . . . . 1.81 112.875 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -155.38 146.19 16.33 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.621 1.568 . . . . 5.9 110.305 163.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.28 127.49 15.88 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 107.378 -1.816 . . . . 1.81 107.378 158.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mp -87.49 167.73 13.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.102 0.961 . . . . 2.41 111.277 -171.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 145.98 48.15 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.032 -1.043 . . . . 5.03 110.524 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.07 125.95 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.372 -0.603 . . . . 1.49 109.372 158.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.24 8.86 68.02 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 118.094 -1.392 . . . . 1.9 115.712 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.45 173.73 9.44 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.943 1.872 . . . . 2.76 109.429 157.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -118.64 158.7 24.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.816 1.647 . . . . 4.47 110.099 167.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.1 t -132.45 120.31 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.319 1.848 . . . . 1.01 110.25 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.57 147.0 28.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.57 1.148 . . . . 3.29 110.321 173.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.71 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.3 tt -157.02 140.29 15.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.52 0.728 . . . . 1.85 112.935 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 1.4 m-20 -104.61 115.47 30.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.863 2.465 . . . . 2.93 111.546 174.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.3 125.03 28.44 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.827 -1.17 . . . . 2.41 109.828 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.31 126.81 39.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.789 0.436 . . . . 0.63 110.328 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -124.69 154.28 41.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.646 1.212 . . . . 1.82 112.245 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.06 128.52 37.61 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.86 1.059 . . . . 1.94 113.86 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.17 50.41 10.49 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.194 0.902 . . . . 3.68 114.073 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.53 76.47 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.034 1.173 . . . . 1.51 116.034 166.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.09 135.75 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.47 1.635 . . . . 4.74 109.971 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.8 p -150.82 139.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 125.081 1.352 . . . . 1.08 108.95 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.7 mt -139.05 134.78 33.45 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.244 1.018 . . . . 1.67 111.871 -172.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 2.9 tpmt? -80.17 135.95 36.39 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.198 . . . . 2.77 113.113 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.93 173.65 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 125.158 1.383 . . . . 1.37 111.88 156.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.16 153.75 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.121 1.768 . . . . 2.33 108.74 165.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 mt -143.5 135.28 12.96 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.945 2.098 . . . . 1.82 110.09 -172.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.32 159.28 49.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.257 2.638 . . . . 1.08 111.988 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.33 131.2 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.123 0.969 . . . . 1.33 110.989 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.59 -170.05 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.782 3.233 . . . . 4.01 110.796 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.1 70.58 1.15 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.181 -0.949 . . . . 3.3 111.275 167.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.899 1.444 . . . . 4.56 114.899 -145.561 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 109.535 -0.543 . . . . 6.02 109.535 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.474 ' CA ' ' HA ' ' A' ' 20' ' ' LEU . . . -99.91 128.3 9.53 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 121.259 -0.901 . . . . 2.09 114.342 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -119.91 177.14 5.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.385 1.074 . . . . 1.9 112.031 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.16 135.45 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.245 1.018 . . . . 1.16 108.605 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.73 139.32 56.34 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.891 1.071 . . . . 8.36 113.891 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -74.2 29.3 0.08 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.809 1.644 . . . . 4.0 114.967 177.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.7 p -69.9 134.37 87.87 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 119.706 -1.871 . . . . 2.75 113.181 -159.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.2 -20.39 24.83 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.951 2.434 . . . . 2.26 112.073 169.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.39 122.83 6.24 Favored Glycine 0 CA--C 1.534 1.253 0 N-CA-C 108.678 -1.769 . . . . 3.52 108.678 162.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.83 -39.99 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.006 1.903 . . . . 4.09 112.34 -172.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -90.23 137.14 32.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.042 0.837 . . . . 4.48 110.784 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 167.27 178.98 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.089 2.556 . . . . 3.16 112.139 -172.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.69 28.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.655 1.982 . . . . 1.95 114.001 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.04 155.65 45.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.788 1.635 . . . . 1.18 110.839 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.88 164.92 26.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.358 1.063 . . . . 2.45 112.15 -158.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.474 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 2.6 pt? -168.38 155.03 7.41 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.659 1.355 . . . . 1.42 114.659 164.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.9 m -76.03 136.86 39.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.874 -1.158 . . . . 1.57 107.874 151.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -149.02 136.04 19.89 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.265 1.026 . . . . 2.36 109.436 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.34 165.42 27.94 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.836 0.826 . . . . 3.47 112.774 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -114.87 89.91 20.89 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 114.132 -1.395 . . . . 0.88 110.16 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.14 -5.77 17.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 1.21 112.922 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.59 172.72 50.7 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.329 0.966 . . . . 1.0 113.333 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.79 -1.56 34.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 2.74 113.276 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -119.09 159.04 46.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.866 1.666 . . . . 1.83 110.548 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.87 156.88 27.31 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.966 2.444 . . . . 1.19 112.317 -168.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.9 102.71 7.92 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.607 1.563 . . . . 2.28 109.732 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttp-105 -92.38 113.44 25.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.103 1.361 . . . . 3.63 111.031 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -103.95 109.67 21.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 128.324 2.65 . . . . 1.17 108.592 -171.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -99.79 -17.0 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.654 1.182 . . . . 0.68 113.377 -168.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.28 -168.25 39.35 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.95 0.786 . . . . 0.49 111.99 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -144.01 177.36 8.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.825 0.85 . . . . 0.78 110.901 175.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -163.45 128.44 2.99 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.496 1.043 . . . . 5.44 108.487 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -136.06 153.22 76.67 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.504 -1.236 . . . . 0.94 109.089 -177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.79 -28.63 86.76 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.125 1.883 . . . . 1.24 113.379 166.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.6 -5.1 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 115.036 1.495 . . . . 1.34 115.036 -168.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.68 170.44 15.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.321 1.448 . . . . 0.91 113.029 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -113.6 -81.4 0.6 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.76 1.624 . . . . 2.86 111.553 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -80.98 111.18 17.22 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 120.971 -1.081 . . . . 3.69 109.105 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.86 131.72 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.461 1.905 . . . . 1.25 109.79 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -147.47 131.92 17.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.452 1.101 . . . . 2.08 110.539 -167.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.37 119.82 22.94 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.156 1.344 . . . . 0.82 110.672 170.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.6 m170 -109.65 157.8 18.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.332 1.853 . . . . 0.74 111.519 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.03 -176.53 3.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.837 0.855 . . . . 3.12 111.535 164.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 m -146.65 99.66 3.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.929 1.292 . . . . 1.09 107.609 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -106.29 -177.99 3.52 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.523 1.529 . . . . 2.05 112.636 -166.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -138.67 143.39 39.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.946 1.299 . . . . 3.08 110.673 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -155.39 159.59 40.01 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.227 1.411 . . . . 6.8 111.595 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -97.74 151.79 19.79 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.686 1.194 . . . . 3.73 112.253 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.15 -92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.365 1.466 . . . . 3.05 109.577 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -74.88 36.78 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.35 2.26 . . . . 4.69 110.873 171.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -18.2 0.63 Allowed Glycine 0 CA--C 1.538 1.499 0 O-C-N 120.421 -1.424 . . . . 2.06 113.398 -158.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -79.62 135.53 36.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.262 1.825 . . . . 3.72 109.628 -177.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 125.19 32.17 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.543 1.137 . . . . 6.04 112.915 -175.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -123.34 147.82 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.603 1.961 . . . . 1.51 109.408 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.9 ptp -94.95 155.62 16.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.533 1.133 . . . . 4.19 113.565 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.05 169.17 33.1 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 123.899 0.761 . . . . 1.06 113.251 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.6 mtt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.116 1.367 . . . . 2.55 110.153 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -159.1 150.14 16.26 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 117.282 -1.342 . . . . 5.85 110.03 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 10.0 Cg_endo -67.26 146.37 75.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.843 1.696 . . . . 0.79 110.142 164.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 m -113.56 160.27 32.34 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 126.028 1.731 . . . . 0.65 110.115 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.74 -24.36 47.47 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.212 1.941 . . . . 0.82 112.29 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -178.05 163.6 1.75 Allowed 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.836 1.654 . . . . 2.26 111.712 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -108.54 173.16 6.44 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.034 1.334 . . . . 1.03 109.38 150.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.39 161.61 42.17 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.366 -0.834 . . . . 2.99 111.852 162.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.69 126.04 22.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.254 1.821 . . . . 1.0 108.041 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.74 163.12 40.19 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.657 2.238 . . . . 0.92 110.374 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -61.7 136.66 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.645 2.23 . . . . 0.95 110.717 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt 67.15 2.62 2.85 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.821 2.049 . . . . 1.47 113.809 -174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.79 172.67 44.49 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.548 2.023 . . . . 0.96 111.395 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -156.14 147.48 22.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 112.392 -1.904 . . . . 3.94 111.923 -171.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.11 155.4 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.783 1.633 . . . . 1.98 110.716 168.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -128.52 114.11 16.33 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.802 -1.555 . . . . 3.97 106.802 167.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.78 91.62 3.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.086 1.354 . . . . 1.23 112.315 -166.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.634 1.174 . . . . 2.91 111.631 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.56 -17.87 58.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.929 2.419 . . . . 1.11 113.197 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.6 52.98 0.85 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.706 1.146 . . . . 1.12 111.486 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.9 -76.08 0.06 OUTLIER Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.591 1.091 . . . . 0.73 114.767 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -153.81 137.6 16.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.602 1.961 . . . . 1.9 110.026 -170.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -166.6 173.82 9.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.947 0.899 . . . . 0.87 110.294 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.49 124.72 50.02 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 118.499 -0.762 . . . . 1.93 110.237 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.39 132.56 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.198 0.908 . . . . 1.0 109.568 163.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.28 132.42 54.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.578 1.151 . . . . 1.5 109.015 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.63 117.15 12.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.069 2.147 . . . . 2.82 108.966 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.94 111.84 0.31 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.268 -1.133 . . . . 1.75 110.268 -170.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.4 mt -112.39 141.94 45.52 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.483 0.659 . . . . 1.54 111.279 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -82.73 1.91 36.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.655 0.782 . . . . 1.75 112.403 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -150.15 156.81 37.68 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 127.451 2.3 . . . . 4.07 111.151 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.23 165.29 32.9 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.166 1.911 . . . . 1.61 109.157 151.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -112.57 131.02 55.81 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.941 -0.763 . . . . 2.73 108.941 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.94 122.32 18.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.399 1.079 . . . . 3.53 108.265 -169.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.34 28.51 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.024 1.284 . . . . 1.4 112.482 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 45.23 8.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.487 0.565 . . . . 2.48 113.669 -172.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.97 165.76 24.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.454 -1.027 . . . . 2.71 109.199 141.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -115.34 155.32 27.56 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.168 0.987 . . . . 4.72 112.159 -168.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.72 118.41 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.488 1.915 . . . . 1.2 109.654 -173.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.61 146.28 48.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.753 0.311 . . . . 2.87 110.202 163.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.4 tt -155.29 126.18 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.558 0.743 . . . . 1.89 111.679 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.81 112.52 21.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.836 3.254 . . . . 2.19 111.347 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.5 mt -81.47 124.0 29.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.523 1.129 . . . . 1.13 108.566 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 mt -96.85 127.38 42.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.933 1.293 . . . . 0.68 109.878 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 97.0 m-85 -110.59 162.92 14.24 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.869 -1.145 . . . . 2.34 112.581 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.53 101.54 1.01 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.786 -0.571 . . . . 1.73 111.472 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.86 19.0 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.506 1.05 . . . . 3.03 111.601 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.56 54.55 4.37 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.23 0.919 . . . . 1.66 115.182 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 14.1 ttpt -145.03 136.62 25.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 1.486 . . . . 4.58 112.39 172.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.08 134.57 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 125.75 1.62 . . . . 1.41 107.884 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.8 mt -143.85 124.93 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.081 1.352 . . . . 2.17 108.491 -170.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.75 150.55 22.24 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.077 1.51 . . . . 3.69 115.077 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -120.08 168.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.367 2.267 . . . . 1.15 108.87 163.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.52 141.83 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.368 1.067 . . . . 2.22 109.288 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.8 mt -131.85 131.69 22.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.319 1.848 . . . . 2.14 108.765 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.91 155.51 43.36 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.53 2.153 . . . . 1.44 111.124 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.5 t -86.2 123.49 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.161 -1.051 . . . . 1.54 108.161 164.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.05 160.11 28.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.01 1.324 . . . . 3.37 110.615 -177.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.434 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -82.55 51.52 1.87 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.809 1.04 . . . . 3.17 113.809 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.165 1.786 . . . . 5.39 112.331 -174.022 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.771 0.795 . . . . 5.81 111.513 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -86.88 162.94 34.5 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 126.347 1.927 . . . . 0.99 114.455 -172.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -147.92 150.11 33.48 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.749 0.819 . . . . 1.66 112.444 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -103.79 134.32 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.234 1.414 . . . . 1.11 108.267 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ttt-85 -86.8 100.3 12.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.182 1.178 . . . . 4.57 114.182 -162.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.63 133.26 55.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.823 0.82 . . . . 2.81 110.773 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -162.91 157.36 17.96 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.965 1.706 . . . . 2.33 110.014 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -86.54 67.04 4.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.721 2.948 . . . . 3.21 110.219 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.98 164.29 28.89 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.693 1.037 . . . . 1.56 115.693 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -80.1 -9.72 14.02 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.64 3.56 . . . . 1.42 112.594 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -142.3 151.98 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.2 1.8 . . . . 2.08 111.072 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.61 -163.86 1.52 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.548 1.539 . . . . 1.15 111.237 -173.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.66 156.09 39.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.088 1.355 . . . . 1.21 110.66 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.92 148.76 45.09 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.948 0.899 . . . . 1.11 110.631 156.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -128.07 178.01 6.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.828 1.651 . . . . 2.58 110.124 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.533 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.5 pt? -169.92 161.15 8.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.137 1.775 . . . . 1.55 111.199 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -98.2 145.01 27.04 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.702 -1.592 . . . . 1.68 106.702 154.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.46 127.61 7.66 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.438 1.095 . . . . 2.63 110.377 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 151.26 29.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.467 1.507 . . . . 2.74 111.544 173.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -98.23 109.15 50.95 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.051 -0.977 . . . . 1.25 110.105 161.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.19 -8.87 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.884 2.389 . . . . 1.81 113.787 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.44 171.04 49.38 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.359 0.981 . . . . 1.63 113.271 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.98 -5.0 45.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.312 1.845 . . . . 3.04 112.66 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.58 158.06 39.74 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.83 2.052 . . . . 4.71 108.595 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.83 151.61 24.67 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.907 2.405 . . . . 1.23 111.62 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -102.23 133.14 47.59 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.06 0.944 . . . . 2.11 111.018 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -117.1 107.84 14.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.902 1.281 . . . . 2.86 110.501 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -95.14 114.52 26.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.644 2.378 . . . . 0.7 109.192 -169.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.65 -9.44 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.506 1.122 . . . . 0.7 112.968 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.13 -171.54 44.61 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.481 1.039 . . . . 0.53 111.438 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.713 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -153.8 170.07 21.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.018 1.327 . . . . 0.87 110.735 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -158.39 115.59 2.87 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 120.057 1.298 . . . . 4.95 109.376 -165.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 t -127.03 159.33 65.33 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 117.759 -1.115 . . . . 0.84 109.353 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.93 -22.75 48.09 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.533 2.155 . . . . 0.88 113.685 164.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.253 3.9 m -87.91 8.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.383 1.623 . . . . 0.98 115.383 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.94 161.94 41.31 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.805 -1.185 . . . . 0.89 113.677 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.7 -88.61 0.28 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.022 1.729 . . . . 2.96 110.516 174.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -81.48 121.54 26.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 3.64 110.286 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.91 142.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 2.03 111.36 164.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -140.71 116.09 10.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.946 1.298 . . . . 2.23 110.091 166.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.8 tt -76.83 119.19 20.25 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 120.897 1.681 . . . . 0.66 110.639 170.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -105.09 152.07 23.22 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.035 1.334 . . . . 0.58 112.549 177.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.46 179.82 5.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.606 1.962 . . . . 2.48 110.941 165.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 m -144.26 93.15 2.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.86 1.664 . . . . 1.08 107.906 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.79 146.4 23.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.42 1.105 . . . . 2.38 111.833 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -87.51 147.82 25.19 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.912 1.285 . . . . 4.39 110.34 165.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.57 152.75 23.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.564 1.546 . . . . 6.02 110.918 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.59 141.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.122 -1.066 . . . . 4.06 108.122 156.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.88 120.6 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.535 1.534 . . . . 3.47 106.997 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 62.07 23.8 14.09 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.946 0.899 . . . . 3.36 111.602 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.88 -10.72 38.28 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.065 1.317 . . . . 2.14 114.275 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -87.35 140.93 29.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.921 1.689 . . . . 3.22 109.705 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -79.65 128.28 33.2 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.424 -0.798 . . . . 3.92 111.003 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -135.69 150.13 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.864 1.665 . . . . 1.64 110.443 -170.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.7 tpp -119.85 138.88 53.13 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.255 1.422 . . . . 3.81 109.223 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.08 141.28 11.08 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 118.92 0.782 . . . . 1.31 113.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -89.3 165.31 14.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.717 0.807 . . . . 1.73 111.176 169.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 -176.07 138.14 0.5 Allowed Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 116.455 -1.736 . . . . 4.47 111.146 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.84 139.03 38.96 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 122.75 2.018 . . . . 0.61 111.607 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.67 156.07 42.99 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 126.033 1.733 . . . . 0.5 111.163 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.74 -17.21 33.28 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.989 2.46 . . . . 0.62 113.087 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -177.52 165.89 2.19 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.857 2.063 . . . . 1.78 111.424 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.51 173.5 6.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.952 1.701 . . . . 0.97 109.384 155.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.96 164.25 38.3 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.382 -0.824 . . . . 2.15 113.075 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -139.53 129.23 14.08 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.046 1.738 . . . . 0.98 109.03 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.38 161.99 42.76 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.691 2.261 . . . . 0.81 111.727 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.21 135.93 65.31 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.772 2.981 . . . . 1.14 112.333 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt 68.08 1.02 2.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.316 1.847 . . . . 2.24 113.9 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.42 -178.48 45.46 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 126.109 1.814 . . . . 1.45 111.023 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -160.11 163.74 33.57 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.065 1.346 . . . . 4.62 112.425 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.91 154.2 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.376 1.47 . . . . 1.68 111.115 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.5 123.49 47.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.645 1.178 . . . . 3.36 109.448 164.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.3 146.34 43.23 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 1.72 109.645 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 9.2 ptpp? -153.99 151.12 23.99 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.89 0.876 . . . . 3.13 112.285 -163.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.59 -50.93 4.69 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.757 2.972 . . . . 0.94 112.233 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.27 90.44 1.56 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 109.07 -1.612 . . . . 1.3 109.07 162.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.57 -90.22 0.11 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 123.659 0.647 . . . . 0.79 114.075 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -153.26 140.24 19.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.287 1.435 . . . . 1.82 110.3 -170.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -162.64 156.59 20.84 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.239 0.616 . . . . 1.02 111.307 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 45' ' ' LEU . 71.5 m-85 -90.51 112.77 24.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 2.07 109.012 166.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.2 125.59 27.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.469 -0.938 . . . . 1.78 108.469 167.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.92 117.16 34.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.786 -1.19 . . . . 1.57 107.786 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.65 110.75 20.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.965 1.306 . . . . 3.17 108.188 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.21 98.52 0.7 Allowed Glycine 0 N--CA 1.47 0.904 0 C-N-CA 124.346 0.974 . . . . 1.59 111.19 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 mt -96.34 128.78 43.57 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.649 0.779 . . . . 0.98 110.916 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -18.74 53.85 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.493 0.923 . . . . 2.04 113.493 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.9 150.85 77.71 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 125.885 1.674 . . . . 4.35 108.268 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.98 118.59 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 107.048 -1.943 . . . . 1.4 107.048 155.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.39 108.54 1.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.177 1.391 . . . . 1.97 111.492 -160.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -80.45 105.05 11.42 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.149 -0.969 . . . . 4.66 110.885 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.47 111.86 0.79 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.715 -1.217 . . . . 1.6 107.715 152.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 5.89 34.41 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 117.312 -1.827 . . . . 2.36 116.228 -166.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.45 169.21 8.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.731 2.265 . . . . 3.03 111.748 160.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.76 141.66 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.633 1.573 . . . . 4.68 109.454 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.64 112.51 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.776 0.831 . . . . 1.23 110.815 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.89 148.31 51.66 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.999 0.52 . . . . 3.01 111.181 163.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.713 HD11 ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -153.77 116.71 4.5 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.415 1.102 . . . . 3.36 109.87 174.147 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.41 116.61 21.96 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.732 2.813 . . . . 1.99 111.029 170.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.0 mt -83.73 118.77 24.11 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.34 1.456 . . . . 2.09 110.313 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt -93.95 122.01 36.01 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.328 0.513 . . . . 0.76 109.785 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -120.31 152.57 37.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.296 1.046 . . . . 2.27 112.235 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.87 113.62 1.57 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.59 1.156 . . . . 1.63 112.993 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 76.06 0.86 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.332 1.444 . . . . 3.34 113.268 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.26 -6.6 56.52 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 116.744 1.458 . . . . 2.22 116.744 163.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -86.98 128.01 35.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.183 1.991 . . . . 5.23 110.122 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.58 135.68 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.181 1.392 . . . . 1.38 108.957 168.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.43 125.06 19.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.445 1.098 . . . . 2.12 110.26 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.28 135.49 34.73 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.345 0.869 . . . . 2.66 113.345 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.46 175.57 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.565 1.546 . . . . 1.3 109.804 157.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.07 141.51 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.787 1.635 . . . . 2.16 107.742 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.7 mt -143.91 160.14 50.94 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.794 1.638 . . . . 2.15 111.267 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.49 169.07 19.07 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.738 3.626 . . . . 1.18 112.679 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.1 t -107.2 133.28 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.43 1.892 . . . . 1.04 110.72 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 151.51 42.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.085 1.354 . . . . 4.9 111.044 170.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.33 85.35 6.88 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.074 -1.016 . . . . 2.26 110.62 163.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.244 -1.36 . . . . 7.71 111.54 171.7 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 121.425 0.631 . . . . 5.54 111.019 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.78 174.73 55.19 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.506 1.05 . . . . 1.21 113.367 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -155.0 158.7 39.56 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.779 1.232 . . . . 2.27 112.069 -175.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.5 t -113.19 146.43 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 121.017 -1.052 . . . . 1.65 109.373 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.99 140.08 40.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.806 -0.758 . . . . 5.33 111.71 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -47.06 127.19 10.04 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.466 1.507 . . . . 3.74 110.953 160.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -174.5 106.0 0.28 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.909 2.084 . . . . 2.74 109.781 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -88.04 19.18 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.918 3.079 . . . . 2.8 111.707 170.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.1 -165.26 38.95 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.836 1.208 . . . . 1.36 113.724 -171.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.57 -19.39 21.66 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.029 2.486 . . . . 1.44 112.647 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -146.68 165.06 30.71 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.829 1.252 . . . . 1.96 113.186 -178.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 -179.92 8.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.441 1.497 . . . . 1.27 112.426 177.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.55 135.64 51.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.716 1.606 . . . . 1.09 110.065 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.37 123.81 41.32 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.205 0.526 . . . . 1.01 110.165 162.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -92.04 154.9 18.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.319 1.448 . . . . 1.92 108.238 164.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -166.63 136.78 3.18 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.27 -0.894 . . . . 1.56 113.028 175.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.2 m -79.35 148.28 32.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.011 -1.45 . . . . 1.26 107.613 165.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.13 141.0 18.2 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.035 1.734 . . . . 2.37 107.507 -176.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -144.31 132.49 21.75 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.881 -1.137 . . . . 3.28 110.579 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.63 109.6 39.7 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.341 1.456 . . . . 0.92 109.895 177.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.87 -9.88 14.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.629 2.219 . . . . 1.17 113.91 176.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.28 173.92 54.78 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.042 0.829 . . . . 1.12 113.961 -172.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -104.26 3.45 32.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.404 1.881 . . . . 3.09 112.491 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -116.33 164.58 17.6 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.691 1.996 . . . . 1.71 109.868 163.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.14 159.29 15.38 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.062 2.508 . . . . 1.06 112.048 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.9 mt -106.6 154.59 20.69 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.624 1.17 . . . . 1.93 110.985 168.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.4 ttp-105 -141.93 114.92 8.69 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.248 1.419 . . . . 4.95 112.081 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.94 118.52 33.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.262 3.025 . . . . 0.9 110.019 -176.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' HB2' ' A' ' 106' ' ' ALA . 35.0 m -115.86 -20.0 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.589 1.156 . . . . 0.77 113.768 -173.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.15 16.81 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.509 -0.744 . . . . 1.1 111.688 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.939 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -154.75 176.89 11.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.851 0.86 . . . . 1.14 111.452 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 8.7 mmm180 -156.74 146.28 20.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.561 -0.903 . . . . 6.59 108.561 172.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -142.72 157.61 61.42 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.721 -1.133 . . . . 0.67 108.717 174.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.14 -25.34 50.85 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.352 2.035 . . . . 1.08 113.795 160.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.4 2.71 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 115.631 1.715 . . . . 0.85 115.631 -165.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.55 152.2 29.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.294 0.952 . . . . 0.93 113.367 -177.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.32 -88.34 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.558 1.943 . . . . 2.98 110.436 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -77.88 116.77 18.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.395 1.478 . . . . 4.38 109.34 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.34 134.93 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.68 1.592 . . . . 1.33 109.584 174.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.55 138.26 44.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.012 1.725 . . . . 1.95 110.606 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.508 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 16.1 tp -84.51 109.89 18.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.486 1.114 . . . . 2.94 109.444 172.212 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -113.59 154.36 27.31 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.027 1.331 . . . . 1.11 113.682 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.4 164.92 11.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.912 2.085 . . . . 1.82 111.431 171.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.6 m -130.15 111.67 12.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.955 1.302 . . . . 1.44 108.551 170.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -112.67 154.79 25.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.805 1.242 . . . . 2.05 113.308 -174.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 159.12 15.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.693 1.197 . . . . 3.64 110.894 164.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.25 146.97 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.383 1.473 . . . . 8.4 111.399 -167.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.64 143.71 32.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.494 1.118 . . . . 5.05 112.352 175.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.97 133.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.955 1.702 . . . . 3.92 109.246 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 67.61 6.07 4.77 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.588 1.155 . . . . 3.84 112.641 -171.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.49 4.94 89.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.724 1.631 . . . . 2.83 113.789 -166.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -100.76 148.72 24.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.711 2.004 . . . . 3.54 110.99 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 149.27 25.46 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.375 -0.828 . . . . 4.3 112.423 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.04 152.92 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.473 1.909 . . . . 3.33 109.366 175.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.5 mtm -112.56 155.45 24.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.181 0.992 . . . . 3.82 112.072 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.72 177.35 32.89 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.223 0.916 . . . . 1.44 112.731 173.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -125.17 157.79 35.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.17 1.388 . . . . 2.11 110.511 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.13 157.38 63.76 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.299 -1.334 . . . . 6.36 108.506 161.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.34 141.65 82.47 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.903 1.358 . . . . 1.07 110.264 151.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.37 153.46 41.99 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 126.522 1.929 . . . . 0.78 110.27 178.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.01 -31.44 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.533 2.155 . . . . 1.23 112.943 -174.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.3 p90 164.47 148.17 0.02 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 126.807 2.043 . . . . 2.84 107.909 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.59 145.41 46.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.715 -1.13 . . . . 4.04 108.257 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.277 0.0 OUTLIER -141.27 155.24 46.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.803 1.038 . . . . 3.36 113.803 -175.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.8 t -139.25 132.18 15.57 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 113.919 -1.491 . . . . 0.95 109.443 -156.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.23 166.96 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.07 1.847 . . . . 0.8 112.074 179.24 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -55.96 140.64 86.25 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.561 2.84 . . . . 0.95 111.718 166.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm 67.65 -0.67 1.86 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.012 1.725 . . . . 1.73 113.532 -174.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.79 113.92 4.39 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 126.773 2.13 . . . . 0.91 113.363 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -80.97 133.47 35.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.316 1.446 . . . . 4.16 109.9 162.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.9 168.88 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.738 1.615 . . . . 1.58 110.45 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -164.1 117.22 1.41 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.708 0.403 . . . . 3.68 111.373 -167.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.67 72.77 3.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.14 2.176 . . . . 1.35 110.267 178.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -80.72 148.0 64.2 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 126.041 1.736 . . . . 3.31 113.299 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -47.87 21.39 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.439 3.426 . . . . 0.85 114.29 -168.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.66 103.4 2.74 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 107.525 -2.23 . . . . 1.24 107.525 157.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.6 -102.71 0.28 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.494 1.997 . . . . 0.79 110.416 -162.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -149.1 158.76 44.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.46 1.504 . . . . 2.36 110.619 -175.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -165.34 158.52 16.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.847 -1.158 . . . . 1.08 110.313 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.508 ' CZ ' HD13 ' A' ' 45' ' ' LEU . 46.8 m-85 -96.59 117.28 30.63 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.595 -0.691 . . . . 2.45 109.295 171.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.27 121.54 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.064 1.346 . . . . 1.24 110.251 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.5 mt -108.02 106.29 16.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.69 1.996 . . . . 1.51 108.631 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.82 122.93 47.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.228 1.411 . . . . 2.78 109.384 -177.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.41 89.46 0.39 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.429 -1.068 . . . . 1.27 110.429 -175.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.13 122.25 27.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.641 0.721 . . . . 0.81 111.682 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -74.44 -13.9 60.77 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.862 0.865 . . . . 1.69 112.955 172.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ptt85 -157.48 142.11 11.94 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 5.77 110.41 165.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.76 141.8 38.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.834 3.023 . . . . 1.91 111.186 -176.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.82 78.99 9.42 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.9 -1.148 . . . . 2.92 107.9 177.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -69.45 162.84 26.6 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.736 0.779 . . . . 3.96 111.555 170.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.12 132.95 53.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.204 -1.035 . . . . 2.6 108.204 163.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.21 49.85 19.36 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.417 -0.657 . . . . 3.54 112.437 -171.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -126.22 167.55 15.28 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.538 1.135 . . . . 3.05 109.895 163.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -134.63 151.92 51.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.781 1.232 . . . . 4.35 111.353 172.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.59 121.17 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.713 2.005 . . . . 1.49 108.627 -171.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.54 149.68 33.02 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.849 -0.532 . . . . 2.61 110.034 162.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.939 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.9 tt -149.41 125.55 10.71 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.63 0.372 . . . . 2.05 111.647 166.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -91.03 108.53 19.92 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.231 3.413 . . . . 2.44 110.067 178.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.31 131.37 37.01 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.304 1.042 . . . . 2.59 110.294 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -101.39 122.48 43.81 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.817 0.847 . . . . 0.91 110.733 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 137.33 52.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.585 0.958 . . . . 2.21 113.585 -172.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.442 ' HB2' HG11 ' A' ' 33' ' ' VAL . . . -76.57 73.21 3.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.67 1.188 . . . . 2.52 112.047 176.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.61 32.37 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.529 1.061 . . . . 5.39 114.589 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.77 28.33 70.96 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 118.387 1.094 . . . . 2.63 113.869 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.26 141.37 52.13 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.815 1.246 . . . . 4.11 111.763 -178.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.8 136.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.131 1.772 . . . . 1.28 107.627 159.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.8 mt -144.68 124.82 13.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.476 1.11 . . . . 1.75 110.022 -174.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -91.53 149.2 21.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 115.542 1.682 . . . . 2.3 115.542 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.58 148.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.239 1.816 . . . . 2.3 109.613 167.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.92 133.2 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.184 1.393 . . . . 2.96 109.927 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -136.19 113.9 10.58 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.314 1.046 . . . . 2.07 111.033 -165.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.31 158.13 37.11 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.162 2.575 . . . . 1.5 111.593 171.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.61 129.88 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.388 1.475 . . . . 2.01 111.188 176.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.44 162.88 34.34 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.33 1.852 . . . . 3.49 108.916 175.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.68 51.76 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.448 -1.408 . . . . 2.77 112.683 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.391 0 CA-C-O 114.021 -2.895 . . . . 4.54 117.173 -157.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 108.633 -0.877 . . . . 6.25 108.633 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.25 173.66 26.45 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.866 1.666 . . . . 1.46 115.116 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -154.74 154.28 32.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.537 1.16 . . . . 1.95 114.004 -178.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.54 144.86 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 107.04 -1.466 . . . . 1.27 107.04 158.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -90.4 117.5 29.15 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.087 0.555 . . . . 4.64 111.263 -179.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -48.8 130.35 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.782 1.233 . . . . 2.92 111.86 162.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.467 ' H ' ' HB2' ' A' ' 93' ' ' LEU . 33.9 m -163.4 129.73 2.33 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 128.831 2.852 . . . . 2.12 107.862 165.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -83.92 67.06 7.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.178 2.585 . . . . 2.39 109.707 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.84 -174.43 20.45 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 115.128 0.811 . . . . 1.8 115.128 -172.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -83.48 -15.06 7.69 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 124.212 3.275 . . . . 1.8 113.191 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -131.0 157.75 42.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.704 1.602 . . . . 4.08 110.681 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.63 -164.35 1.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.064 1.746 . . . . 1.31 111.552 177.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.21 160.69 39.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.966 1.707 . . . . 1.24 110.764 -178.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 158.9 43.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.095 1.358 . . . . 0.94 112.394 171.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -162.02 152.91 17.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.263 2.225 . . . . 2.61 109.499 -173.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.23 157.74 26.16 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.893 -1.129 . . . . 1.65 112.381 -175.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.8 m -77.96 96.8 5.13 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.571 -1.27 . . . . 1.65 107.571 165.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 tt -88.3 148.94 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.931 1.692 . . . . 2.97 108.92 169.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -150.0 165.37 32.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.733 0.777 . . . . 4.16 112.896 168.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -120.88 101.62 45.11 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 126.007 1.723 . . . . 0.89 109.343 171.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.82 -5.48 15.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.95 2.433 . . . . 1.03 113.302 174.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.02 -177.78 51.54 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.883 1.23 . . . . 0.96 114.176 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -112.69 1.75 15.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.275 1.43 . . . . 2.68 113.373 -170.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.15 162.18 27.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.91 1.684 . . . . 1.68 109.71 165.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.58 157.88 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.847 2.365 . . . . 1.05 111.825 -172.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 mt -107.81 149.06 28.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.917 0.887 . . . . 2.05 111.558 172.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -121.14 110.75 16.58 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.188 1.395 . . . . 6.34 109.232 168.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.8 tp -82.93 127.25 33.35 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.838 1.255 . . . . 0.77 108.173 175.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.6 -11.0 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.432 0.901 . . . . 0.57 113.432 -173.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.11 -162.74 33.36 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 121.564 0.536 . . . . 0.47 112.295 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.954 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -147.59 178.92 8.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.465 1.506 . . . . 0.81 110.154 175.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -161.59 139.76 9.29 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.129 0.877 . . . . 6.64 109.137 167.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.6 t -145.56 146.34 29.21 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.99 1.316 . . . . 0.7 108.811 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.91 -22.9 55.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.963 1.775 . . . . 1.31 113.132 178.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.77 0.15 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 114.42 1.267 . . . . 1.28 114.42 -174.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.04 168.01 9.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 116.068 1.877 . . . . 2.1 116.068 -169.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.37 -104.36 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 106.955 -1.498 . . . . 6.33 106.955 143.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -79.49 169.37 18.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.554 1.168 . . . . 4.19 112.464 167.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.6 132.02 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.868 1.667 . . . . 1.46 107.865 161.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -119.94 128.44 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.89 1.276 . . . . 1.97 109.705 -175.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 84' ' ' PHE . 5.5 tt -81.54 120.09 24.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.773 1.17 . . . . 0.66 110.628 169.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -110.33 153.05 25.44 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.592 1.557 . . . . 0.67 112.933 176.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.22 172.13 8.16 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.443 2.297 . . . . 2.18 110.699 165.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.1 m -133.19 92.65 3.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.115 1.366 . . . . 1.13 108.015 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -97.59 149.42 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.138 0.971 . . . . 2.25 113.161 -163.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.3 ttp -79.05 139.4 38.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.629 1.172 . . . . 4.64 110.086 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.58 113.93 2.61 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.54 0.736 . . . . 10.31 111.615 -175.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.01 153.69 19.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.158 0.983 . . . . 4.58 110.613 174.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.6 t -143.51 122.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.284 -1.376 . . . . 3.44 107.284 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 69.28 8.47 6.82 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.916 1.286 . . . . 3.98 111.984 -174.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.58 85.31 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.843 1.211 . . . . 1.79 113.82 -166.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -90.94 143.14 27.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.561 1.544 . . . . 3.0 110.225 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -75.16 132.84 41.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.713 1.605 . . . . 4.18 113.307 -165.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.31 172.26 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.421 0.629 . . . . 1.84 112.163 172.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.3 tpp -129.75 159.24 37.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.814 2.045 . . . . 3.76 110.133 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.45 177.75 22.06 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.009 1.766 . . . . 1.1 112.16 173.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.3 mtt -138.9 154.49 48.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.779 1.632 . . . . 2.16 109.66 173.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -169.82 144.0 2.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 116.401 -1.761 . . . . 4.56 111.333 -169.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.99 150.93 87.44 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 CA-C-N 121.716 1.648 . . . . 0.66 112.414 165.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.48 159.02 47.54 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 126.418 1.887 . . . . 0.65 110.703 173.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -70.93 -22.16 27.06 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.683 2.255 . . . . 0.68 112.801 173.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -175.92 171.27 2.65 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.939 1.696 . . . . 1.88 111.562 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.44 172.1 8.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.746 2.018 . . . . 0.99 109.136 159.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.15 161.56 41.2 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.917 -1.114 . . . . 2.54 111.651 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.62 136.43 10.59 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.262 1.025 . . . . 0.87 109.679 -166.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.72 170.02 19.69 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.549 2.166 . . . . 0.8 112.027 178.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -60.91 142.68 98.31 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.225 2.617 . . . . 0.88 111.599 166.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 64.55 6.57 3.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.243 1.817 . . . . 1.36 113.506 -174.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.42 115.41 4.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 126.192 1.853 . . . . 0.97 111.164 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.67 137.26 36.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.498 1.519 . . . . 4.87 110.151 166.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.06 129.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.163 0.985 . . . . 1.53 111.557 177.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.22 124.55 31.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.699 -0.852 . . . . 3.88 108.699 165.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.1 145.49 53.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.362 -0.977 . . . . 1.78 108.362 163.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -155.92 138.85 10.67 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 117.974 -1.012 . . . . 3.51 111.726 -166.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.79 -26.5 45.01 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.653 2.902 . . . . 1.14 113.587 -172.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.0 87.95 1.5 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 108.084 -2.006 . . . . 1.52 108.084 155.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.85 -97.26 0.18 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.214 0.911 . . . . 0.99 113.458 -171.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -150.91 146.45 26.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.703 2.001 . . . . 2.26 110.469 -167.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -153.91 159.32 41.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.841 -0.537 . . . . 0.91 111.124 -175.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 41.7 m-85 -94.7 118.61 32.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.299 -1.001 . . . . 1.88 108.299 164.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.09 123.15 33.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.425 -0.954 . . . . 1.08 108.425 173.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -105.14 122.55 46.13 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.286 1.434 . . . . 2.36 109.108 -174.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.95 151.91 39.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.37 1.068 . . . . 2.77 111.157 -170.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.85 42.65 92.2 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 123.95 0.786 . . . . 2.01 113.219 171.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.7 mt -53.64 141.39 26.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.192 1.797 . . . . 1.51 112.729 -171.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -70.61 -9.53 57.15 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.343 -0.848 . . . . 3.55 112.783 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -167.23 152.06 6.86 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.824 2.05 . . . . 7.24 111.271 173.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.29 149.22 85.23 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.847 2.365 . . . . 3.11 110.132 162.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.467 ' HB2' ' H ' ' A' ' 11' ' ' SER . 2.4 mm? -80.23 155.51 27.31 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.596 0.712 . . . . 2.96 111.786 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.99 -25.56 5.33 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.49 1.916 . . . . 4.52 112.18 177.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 80.62 161.57 0.17 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.745 2.818 . . . . 1.91 111.516 -175.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.52 57.78 16.32 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.462 -1.055 . . . . 2.68 110.462 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -167.34 161.58 14.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.922 2.889 . . . . 3.94 107.351 -174.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.59 161.4 16.84 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.713 1.205 . . . . 3.79 112.022 -170.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.2 t -144.6 127.78 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.718 2.007 . . . . 1.36 109.886 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.1 140.21 41.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.931 0.492 . . . . 3.17 110.742 165.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.954 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.2 tt -148.08 135.57 20.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.458 1.123 . . . . 1.67 111.299 169.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.505 ' N ' HD23 ' A' ' 101' ' ' LEU . 4.5 m-20 -104.52 112.29 25.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.826 2.05 . . . . 2.28 110.68 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.14 118.38 18.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.484 . . . . 1.26 109.805 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -93.9 121.38 35.3 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.368 0.667 . . . . 0.63 110.179 -173.106 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.14 124.36 47.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.477 1.132 . . . . 1.87 113.366 -176.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 58.33 -12.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 131.027 3.731 . . . . 2.86 117.574 170.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.03 57.2 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.528 1.537 . . . . 3.59 113.452 -163.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.75 -0.06 1.82 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.126 1.61 . . . . 1.91 117.126 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.4 156.81 43.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.459 1.904 . . . . 4.17 111.294 173.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.88 128.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.82 1.248 . . . . 0.99 109.639 167.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.42 133.72 55.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.809 1.643 . . . . 2.36 109.055 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -85.48 134.94 34.03 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.042 -1.036 . . . . 2.46 111.474 176.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.7 164.45 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.987 1.315 . . . . 1.35 109.841 160.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.25 142.29 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.532 -1.284 . . . . 2.36 107.532 169.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.6 mt -136.76 138.78 27.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.918 1.287 . . . . 2.1 109.985 -169.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.11 150.05 17.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.701 2.934 . . . . 1.34 111.193 166.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.6 t -88.17 120.56 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.75 1.62 . . . . 1.56 109.092 167.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -142.49 162.06 36.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.818 1.247 . . . . 4.6 112.194 -170.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.23 126.41 41.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.941 0.897 . . . . 3.71 109.105 166.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 129.553 3.141 . . . . 7.97 109.325 -171.371 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 118.222 -0.894 . . . . 5.3 109.057 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.89 -179.4 24.76 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.686 1.585 . . . . 1.24 114.667 175.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -170.48 156.63 5.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.708 1.603 . . . . 1.68 111.903 170.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.03 128.9 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.822 -0.807 . . . . 0.82 108.822 172.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -5.13 39.11 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 117.789 2.515 . . . . 3.81 117.789 -145.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 69.82 121.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.299 2.639 . . . . 4.01 112.248 -174.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -171.36 136.92 1.03 Allowed Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 119.752 -1.843 . . . . 2.0 112.393 178.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -93.88 -5.33 2.63 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.622 3.548 . . . . 2.87 113.893 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.75 165.78 53.81 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 119.275 0.943 . . . . 1.28 112.53 177.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.08 -14.77 44.64 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.502 2.801 . . . . 1.59 114.54 -172.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -124.61 152.12 43.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.365 1.466 . . . . 4.22 111.822 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.1 -168.06 2.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.551 1.94 . . . . 1.19 111.223 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.59 156.27 44.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.523 1.129 . . . . 1.12 112.997 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.77 140.03 53.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.294 1.437 . . . . 0.97 111.559 169.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -119.83 150.79 39.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.575 1.55 . . . . 1.93 110.035 178.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -162.83 158.74 23.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.673 0.99 . . . . 1.77 113.673 177.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -94.01 117.22 29.79 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.977 -1.119 . . . . 1.42 107.977 165.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.42 135.46 34.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.596 1.958 . . . . 2.38 108.136 175.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -145.75 146.3 31.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.971 1.1 . . . . 2.74 113.971 170.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -110.08 109.16 59.04 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 113.971 -1.468 . . . . 0.93 110.113 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.46 -9.88 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.669 2.246 . . . . 1.04 113.498 175.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.24 177.86 54.13 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.316 0.96 . . . . 0.95 114.035 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -106.19 -1.63 23.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.911 1.685 . . . . 2.33 112.925 -178.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.95 162.67 19.74 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 126.128 1.771 . . . . 1.68 109.646 163.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.17 161.64 17.85 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.011 2.474 . . . . 1.09 112.018 -172.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 mt -109.0 154.5 22.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.341 1.056 . . . . 1.91 110.488 168.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -138.01 102.62 4.74 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 4.04 109.635 177.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -84.38 103.8 13.86 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.258 1.823 . . . . 0.65 108.702 -172.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.79 -13.87 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.682 0.793 . . . . 0.68 112.736 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.71 -164.39 35.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 123.603 0.621 . . . . 0.68 112.258 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.19 177.3 10.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.992 0.917 . . . . 0.93 111.951 167.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -144.35 148.42 34.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.928 1.291 . . . . 6.69 109.586 170.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -150.54 151.31 30.59 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 125.137 1.375 . . . . 0.72 108.344 -168.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.4 -24.73 16.13 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.91 1.74 . . . . 0.9 113.364 175.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 m -78.6 -19.67 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.704 1.372 . . . . 1.22 114.704 -170.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.33 45.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.038 0.935 . . . . 0.92 111.098 -172.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.34 -71.97 0.52 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.768 0.427 . . . . 3.05 111.427 -174.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -79.18 142.5 36.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.421 1.088 . . . . 3.84 108.193 167.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -153.7 135.67 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 1.47 108.512 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -145.84 139.2 26.18 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.824 1.25 . . . . 2.13 110.144 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -81.95 119.44 23.96 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.454 1.121 . . . . 0.81 110.901 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.5 m170 -111.36 157.77 19.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.17 1.788 . . . . 1.03 111.623 176.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -111.35 168.45 9.52 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.664 1.985 . . . . 2.43 110.467 172.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -126.88 100.93 6.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.919 2.088 . . . . 1.15 108.195 172.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -97.73 156.45 16.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.964 1.098 . . . . 2.45 113.964 -167.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -85.94 148.77 25.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.808 0.843 . . . . 4.0 111.504 166.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -160.6 163.78 32.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.34 1.456 . . . . 5.54 111.093 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -128.5 157.87 39.95 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.39 1.876 . . . . 4.22 108.972 175.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.7 t -153.68 124.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 125.266 1.604 . . . . 4.26 107.756 168.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.93 15.46 6.09 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.286 1.434 . . . . 4.91 114.323 176.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.55 28.27 39.97 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.315 1.436 . . . . 3.42 113.785 -173.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -123.29 136.01 54.49 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.761 2.025 . . . . 3.83 111.148 168.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.31 144.41 42.45 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.562 -0.711 . . . . 9.06 112.686 -177.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.25 153.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.466 1.106 . . . . 3.17 110.582 173.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.98 131.95 52.14 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.483 1.113 . . . . 4.0 109.857 175.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.04 -179.55 15.8 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 124.976 1.274 . . . . 1.26 112.351 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.1 mtt -132.59 158.64 41.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.756 1.222 . . . . 2.83 111.643 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -171.63 157.61 4.5 Favored Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 125.954 1.702 . . . . 4.87 110.878 -178.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.9 Cg_endo -71.4 153.95 60.92 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.734 1.623 . . . . 0.79 112.11 169.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -117.85 154.77 51.3 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.731 1.612 . . . . 0.84 109.638 164.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.26 -10.33 25.56 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.933 2.422 . . . . 1.01 113.087 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -177.38 158.67 1.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.659 1.984 . . . . 2.6 110.474 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.07 171.04 7.59 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.165 1.386 . . . . 1.01 109.122 148.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -156.22 161.33 40.28 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 120.956 -1.09 . . . . 2.47 112.002 172.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 t -149.61 133.37 8.72 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 123.899 0.88 . . . . 1.07 109.675 -160.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.39 168.84 21.22 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.122 1.881 . . . . 1.07 111.801 177.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.43 142.11 97.63 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.645 2.897 . . . . 1.04 111.601 166.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm 66.56 3.65 2.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.965 1.706 . . . . 1.45 113.554 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.03 115.09 4.05 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 126.123 1.821 . . . . 1.1 112.259 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -92.4 129.11 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.213 1.405 . . . . 4.45 109.98 160.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.0 m -144.69 156.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.346 1.858 . . . . 1.57 110.44 -177.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.17 120.45 31.37 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.141 -0.974 . . . . 3.71 112.52 -166.337 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.18 68.8 1.98 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.843 1.657 . . . . 1.23 109.36 168.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -77.67 149.16 77.47 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.988 1.715 . . . . 2.77 111.615 173.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -59.24 -31.81 95.85 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.783 2.322 . . . . 1.01 113.257 176.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.28 40.65 3.06 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.545 1.069 . . . . 1.15 113.111 169.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.26 -75.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.887 1.232 . . . . 0.95 114.931 -175.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -153.2 147.09 25.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.044 2.137 . . . . 1.86 109.449 -171.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -163.82 170.19 17.21 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.478 -1.389 . . . . 1.19 111.42 -175.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -104.21 120.05 40.3 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.557 -0.534 . . . . 1.9 109.557 170.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 mmt -76.32 129.23 36.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.945 0.898 . . . . 1.15 109.313 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.9 mt -108.06 124.91 50.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.594 1.558 . . . . 1.84 107.364 177.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.46 118.59 11.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.66 0.784 . . . . 2.69 109.933 -162.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.19 74.26 1.08 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 109.771 -1.331 . . . . 1.37 109.771 -167.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mt -72.84 90.04 1.42 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.897 0.856 . . . . 1.12 113.118 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -67.16 -11.35 57.07 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.919 1.081 . . . . 2.01 113.919 172.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.4 mtp-105 -138.12 136.05 19.15 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.984 1.714 . . . . 4.01 108.241 155.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.9 149.67 59.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.387 . . . . 1.76 110.267 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.65 97.05 9.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.894 0.478 . . . . 2.36 111.256 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -77.96 129.38 35.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.863 1.265 . . . . 3.58 110.946 169.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.93 49.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.273 -0.892 . . . . 1.92 109.297 171.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.73 37.47 26.4 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 118.467 0.576 . . . . 2.45 112.92 -166.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.52 -179.28 3.87 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 106.979 -1.489 . . . . 2.57 106.979 151.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -126.85 149.56 49.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.269 1.027 . . . . 3.72 109.018 167.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.27 118.44 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.942 1.297 . . . . 0.98 109.702 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -81.65 146.51 30.02 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.438 1.113 . . . . 3.66 111.41 160.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.67 123.46 8.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.84 1.256 . . . . 1.44 110.903 -169.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.72 91.44 8.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 127.731 2.412 . . . . 2.26 110.037 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.67 115.96 13.69 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.575 0.75 . . . . 1.41 110.295 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.1 mt -88.2 124.77 34.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 0.84 110.753 -173.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -125.09 124.01 40.97 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.955 0.724 . . . . 2.19 112.955 -178.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.04 22.34 0.58 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.864 2.065 . . . . 2.15 114.307 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.87 -56.21 1.76 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.17 1.367 . . . . 3.54 112.523 -163.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.43 8.85 52.23 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 117.499 1.76 . . . . 1.67 117.499 -165.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 152.26 48.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.917 2.087 . . . . 4.16 110.541 166.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.5 131.71 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.899 1.28 . . . . 1.16 110.82 169.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.59 111.34 18.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.154 1.381 . . . . 2.75 110.487 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 85.76 5.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.191 0.996 . . . . 3.0 110.99 178.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.73 174.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.772 1.629 . . . . 1.54 111.255 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.4 151.51 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.057 1.343 . . . . 2.03 110.568 170.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -140.74 141.99 26.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 128.034 2.534 . . . . 1.64 109.044 176.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -70.32 149.29 63.1 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.123 1.882 . . . . 0.91 109.478 170.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.83 123.86 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.475 -1.305 . . . . 1.18 107.475 163.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.61 151.93 28.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.931 1.693 . . . . 3.02 108.068 -161.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.99 108.45 19.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.731 1.011 . . . . 2.8 113.731 -157.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.921 1.288 . . . . 5.07 112.071 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 121.923 0.868 . . . . 6.27 110.981 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.46 161.5 24.47 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 124.982 1.277 . . . . 0.98 112.865 -174.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.413 ' CD1' ' HB3' ' A' ' 118' ' ' GLU . 32.1 p90 -163.14 161.4 25.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 2.75 114.508 -175.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.61 150.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.049 0.94 . . . . 1.45 110.092 -177.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 -88.26 114.87 25.31 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.793 0.837 . . . . 4.18 111.477 177.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -43.81 120.57 2.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.052 2.141 . . . . 2.52 112.888 166.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -167.76 97.83 0.61 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.727 1.611 . . . . 1.93 110.341 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.68 70.39 7.28 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.566 2.844 . . . . 3.56 109.253 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.03 -150.91 5.29 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.193 0.902 . . . . 2.01 114.034 -172.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.35 -21.29 11.87 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.981 2.454 . . . . 1.76 112.716 -179.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -157.71 167.96 28.58 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.779 1.232 . . . . 2.27 113.518 -175.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -163.04 -177.87 5.71 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.287 1.835 . . . . 1.13 112.309 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.57 52.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.695 1.598 . . . . 1.0 111.023 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.56 138.64 54.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.936 0.789 . . . . 0.84 111.592 167.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -120.29 147.73 44.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.535 1.934 . . . . 2.41 110.813 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pp -166.6 149.89 6.99 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.761 -1.212 . . . . 1.6 113.874 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.29 96.51 6.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 127.748 2.419 . . . . 2.03 108.385 168.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.65 126.69 34.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 2.98 108.971 174.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.77 145.84 42.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.273 1.429 . . . . 3.16 111.621 -175.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -116.08 105.68 50.64 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.91 111.973 -173.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.48 -11.03 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.578 2.185 . . . . 0.98 113.298 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.66 163.25 53.47 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 125.59 1.567 . . . . 0.99 113.802 -177.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -80.08 -32.64 39.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.043 2.137 . . . . 4.98 112.65 175.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -98.28 163.98 18.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.478 1.911 . . . . 1.8 111.072 173.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.22 154.93 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.418 2.745 . . . . 1.32 112.012 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.06 141.27 31.21 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.622 0.769 . . . . 2.35 110.305 171.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -125.85 109.97 13.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.509 1.124 . . . . 2.72 110.072 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.08 122.74 32.7 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.579 1.952 . . . . 0.93 109.776 -176.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.62 -6.77 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.29 1.036 . . . . 0.62 113.456 -172.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.0 -163.74 34.07 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.821 1.201 . . . . 0.54 111.41 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.13 -175.73 5.58 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.469 1.508 . . . . 0.75 110.476 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -156.26 139.72 15.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.067 1.347 . . . . 6.45 108.932 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.26 146.38 45.56 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 117.2 -1.381 . . . . 0.74 108.464 -173.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.24 -13.12 35.44 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.548 2.165 . . . . 0.85 114.086 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.3 -3.94 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.28 1.585 . . . . 0.97 115.28 -176.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.65 147.39 40.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 121.094 1.77 . . . . 0.9 112.848 -172.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -83.71 -51.44 7.25 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.733 1.613 . . . . 3.1 110.787 178.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -111.44 141.18 45.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.536 1.134 . . . . 3.48 110.115 170.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.29 137.08 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.071 1.348 . . . . 1.25 109.104 160.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -128.93 131.78 47.57 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.267 1.827 . . . . 2.19 108.708 175.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.81 123.31 29.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.508 1.504 . . . . 0.81 110.406 169.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -107.74 155.2 20.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.076 1.751 . . . . 0.69 112.331 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -94.38 -174.15 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.651 1.981 . . . . 2.92 111.481 167.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -145.34 80.25 1.6 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.182 1.393 . . . . 1.4 109.18 166.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.27 143.79 52.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.952 0.882 . . . . 2.49 111.8 -172.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtp -108.03 34.77 3.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.004 1.722 . . . . 4.08 111.313 -172.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -70.34 156.89 38.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 7.02 110.788 -167.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -46.7 159.54 0.09 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.781 0.833 . . . . 6.84 110.335 146.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -163.17 -29.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.566 1.946 . . . . 3.62 113.189 179.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -143.95 38.89 1.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.908 2.483 . . . . 4.71 109.277 170.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -33.73 0.37 Allowed Glycine 0 N--CA 1.481 1.666 0 O-C-N 120.055 -1.653 . . . . 2.55 113.372 -160.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -61.08 135.22 57.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.655 1.982 . . . . 3.3 109.851 170.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -85.79 129.69 34.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 118.212 -0.899 . . . . 4.57 110.512 173.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.1 t -140.77 150.14 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.75 1.22 . . . . 1.83 109.572 -169.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.9 mtm -92.9 121.8 34.63 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.228 1.011 . . . . 3.41 112.406 172.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.73 163.59 25.52 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.146 1.355 . . . . 1.13 111.755 171.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -107.2 152.45 24.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.24 1.016 . . . . 1.5 112.462 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -149.64 145.5 19.19 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.317 2.247 . . . . 4.16 108.43 171.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.12 145.76 89.74 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.42 1.543 . . . . 0.72 111.022 160.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.59 158.08 60.3 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.129 1.772 . . . . 0.76 111.149 -179.229 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.46 -21.16 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.556 2.171 . . . . 0.65 113.336 178.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -174.54 169.95 3.59 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.205 1.366 . . . . 1.97 112.66 -177.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.33 174.35 9.69 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.555 2.742 . . . . 1.09 108.871 162.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.67 168.68 26.56 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.632 -1.293 . . . . 2.24 112.708 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 t -146.41 131.3 8.94 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 125.359 1.463 . . . . 1.12 109.519 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.0 161.05 41.96 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.607 2.205 . . . . 1.09 111.773 176.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.89 133.7 42.95 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.959 3.106 . . . . 0.99 111.706 179.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 72.3 -2.32 2.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.226 2.21 . . . . 1.42 113.718 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.87 -179.02 37.66 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 126.049 1.785 . . . . 1.2 111.677 178.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -160.11 158.38 30.19 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.06 1.344 . . . . 4.15 114.571 177.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.83 172.18 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.962 2.105 . . . . 1.78 110.731 177.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -119.33 132.99 55.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.66 1.584 . . . . 5.56 109.048 170.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.82 81.31 6.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.832 1.301 . . . . 1.46 109.559 163.147 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 143.89 75.15 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.381 2.272 . . . . 4.09 113.472 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.54 -40.19 76.37 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.771 2.314 . . . . 1.3 111.567 167.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.71 79.03 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.157 -1.177 . . . . 1.17 110.157 164.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.98 -73.22 0.12 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 0.96 114.696 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -158.52 139.84 13.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.593 1.957 . . . . 2.45 109.154 -176.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -166.12 158.01 14.01 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.572 1.987 . . . . 1.11 110.983 -175.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.08 124.02 32.78 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.951 -0.388 . . . . 2.14 109.951 170.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.79 122.21 34.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.999 1.32 . . . . 1.78 108.63 169.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.13 135.92 43.9 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.874 1.67 . . . . 1.77 109.012 -177.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.31 125.64 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.769 1.228 . . . . 2.92 111.226 -171.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.72 104.64 0.04 OUTLIER Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.734 1.635 . . . . 1.28 110.987 -174.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.0 mt -102.11 115.68 31.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.792 1.296 . . . . 1.07 112.832 -166.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -66.32 -25.0 66.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.118 1.367 . . . . 1.52 112.923 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -152.78 146.54 18.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.164 2.186 . . . . 7.4 109.826 175.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.75 131.87 9.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.239 2.626 . . . . 1.74 111.617 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.35 127.68 33.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 2.0 110.327 174.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.37 -166.49 1.16 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.981 0.896 . . . . 3.9 111.325 167.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.08 119.72 21.18 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.162 -0.961 . . . . 2.02 113.051 -162.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.91 -12.21 69.65 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.267 1.413 . . . . 4.27 114.901 174.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -74.51 154.24 38.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.05 1.13 . . . . 3.55 114.05 -157.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -80.65 90.7 5.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.539 1.936 . . . . 4.21 112.179 -166.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.59 106.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 1.03 109.382 166.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -68.75 139.34 55.32 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.255 1.026 . . . . 3.09 110.526 157.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -149.85 118.99 6.75 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.802 1.241 . . . . 1.59 109.502 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 102.18 14.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.923 1.289 . . . . 2.55 108.438 173.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.35 128.04 34.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.543 1.137 . . . . 3.14 109.094 177.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -98.13 130.97 44.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.778 0.831 . . . . 0.6 110.323 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -130.11 153.55 48.38 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.724 0.773 . . . . 1.88 112.54 -177.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.97 146.39 42.65 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.951 -0.468 . . . . 3.14 110.774 170.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.98 27.41 23.76 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.016 0.766 . . . . 4.44 115.016 -177.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 17.86 79.16 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-N 117.894 0.847 . . . . 1.74 113.757 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -94.51 140.47 29.8 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.574 -0.956 . . . . 4.37 112.349 -174.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.67 128.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.067 2.147 . . . . 1.07 107.772 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.8 mt -147.11 122.84 10.56 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.943 0.897 . . . . 1.58 111.697 -164.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -75.33 123.68 25.77 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.655 0.613 . . . . 2.56 112.655 177.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.5 m -93.14 159.92 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.692 0.797 . . . . 1.82 109.477 150.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.38 118.85 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.102 0.961 . . . . 1.99 108.543 167.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.69 141.42 36.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.105 0.962 . . . . 2.11 111.544 -166.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.55 151.02 64.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.526 2.817 . . . . 1.05 111.753 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 74.7 t -79.21 130.72 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.004 0.922 . . . . 1.48 110.442 160.524 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -118.48 -152.39 0.5 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.043 2.537 . . . . 4.41 106.687 160.065 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.89 8.8 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 122.783 2.538 . . . . 2.93 117.501 -162.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.277 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 117.337 -1.315 . . . . 7.72 113.094 179.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 109.374 -0.602 . . . . 4.75 109.374 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.44 -179.5 30.53 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 123.738 0.685 . . . . 1.01 114.473 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -159.62 152.21 21.36 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.262 1.025 . . . . 1.81 113.104 177.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.96 133.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.25 -1.019 . . . . 0.98 108.25 165.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 2.9 tmt_? -98.05 100.1 11.41 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.365 2.266 . . . . 3.88 109.017 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -57.55 148.69 23.21 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.077 0.942 . . . . 3.88 111.445 172.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -152.03 145.2 17.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.426 1.49 . . . . 2.22 110.01 161.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.81 71.42 7.05 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.083 3.189 . . . . 2.56 110.371 -176.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.54 -172.81 27.19 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.055 0.836 . . . . 1.39 113.701 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.99 -3.57 13.3 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.163 3.242 . . . . 1.79 112.815 176.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -142.8 167.0 23.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.219 1.808 . . . . 2.4 112.521 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.64 -176.24 3.07 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.524 1.929 . . . . 1.24 110.928 -170.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.53 157.62 39.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.133 0.879 . . . . 1.13 112.611 176.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.25 144.72 51.33 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 0.91 110.422 165.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.85 152.33 51.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.296 1.439 . . . . 2.05 109.277 175.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -173.17 158.66 3.7 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.042 1.127 . . . . 1.53 114.042 175.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -82.71 130.89 35.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 126.767 2.027 . . . . 1.53 109.532 163.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 23' ' ' GLU . 6.4 tt -114.76 143.3 45.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.103 1.761 . . . . 3.08 108.858 169.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' N ' HD23 ' A' ' 22' ' ' LEU . 12.6 pt-20 -145.77 142.06 28.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.0 0.905 . . . . 3.13 112.191 170.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -100.86 106.13 42.18 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.768 1.627 . . . . 0.99 109.847 178.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.5 -9.36 17.36 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.418 2.079 . . . . 1.03 113.361 176.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.52 -178.57 52.5 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.332 0.969 . . . . 0.98 114.032 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -111.77 1.28 16.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.756 1.623 . . . . 2.45 113.162 -172.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.07 160.03 37.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.924 1.69 . . . . 1.79 110.176 166.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.16 157.44 17.53 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.156 2.571 . . . . 1.1 111.721 -172.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.2 mt -107.53 157.61 17.89 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.601 1.16 . . . . 2.12 110.548 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -134.66 116.24 14.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.731 1.212 . . . . 2.93 109.291 169.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -97.66 117.16 31.32 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.337 2.255 . . . . 0.96 109.508 -171.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.71 -9.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 114.038 1.125 . . . . 0.65 114.038 -167.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.13 -163.77 32.7 Favored Glycine 0 C--N 1.34 0.791 0 O-C-N 121.418 -0.801 . . . . 0.8 112.548 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.565 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -145.33 -178.32 6.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.044 0.937 . . . . 1.16 111.183 172.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.73 136.16 3.61 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.88 1.218 . . . . 5.93 108.065 176.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -138.13 152.09 71.13 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 117.403 -1.285 . . . . 0.66 109.453 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.46 -21.0 53.98 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.35 2.033 . . . . 1.0 113.568 169.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.3 4.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.549 1.314 . . . . 1.01 114.549 -174.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.52 -179.01 5.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.968 1.307 . . . . 1.16 110.787 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -101.57 -56.86 2.2 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.211 0.604 . . . . 3.16 110.353 173.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -120.06 161.59 20.71 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.748 0.785 . . . . 4.13 111.156 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.37 134.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.891 -1.05 . . . . 2.22 108.988 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -118.69 134.43 55.13 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.209 1.804 . . . . 2.01 108.798 -172.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -80.32 116.74 20.56 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.559 1.171 . . . . 0.89 110.568 169.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -103.75 148.45 26.07 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.333 1.54 . . . . 0.59 111.616 173.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.45 164.55 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.089 -1.414 . . . . 2.12 109.702 159.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.554 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 91.2 m -140.77 93.39 2.6 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.56 -1.644 . . . . 1.33 106.56 167.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -90.43 173.53 8.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.711 1.604 . . . . 2.26 113.204 -162.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 56.1 mtm -113.32 131.34 55.99 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.37 -0.974 . . . . 3.35 108.37 146.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -150.18 164.48 35.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.551 1.94 . . . . 7.55 109.236 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -93.32 148.35 22.12 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.308 0.643 . . . . 3.72 111.87 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 p -144.62 -8.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.48 1.659 . . . . 4.05 115.48 -165.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -162.94 36.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.749 1.619 . . . . 3.24 109.451 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.76 -11.2 1.3 Allowed Glycine 0 CA--C 1.539 1.545 0 O-C-N 120.642 -1.286 . . . . 2.37 113.703 -160.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -113.07 150.84 31.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.224 2.21 . . . . 2.62 111.196 -175.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 129.34 34.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.269 1.828 . . . . 6.13 113.579 -173.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -142.37 147.57 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.369 0.986 . . . . 1.74 111.358 -172.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.5 mtt -83.19 138.79 33.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.707 1.203 . . . . 3.62 113.477 171.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.89 167.3 33.19 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.128 0.87 . . . . 1.08 113.384 173.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -107.54 166.17 10.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.112 1.365 . . . . 1.72 111.718 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.71 136.04 0.29 Allowed Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 116.21 -1.852 . . . . 4.22 110.738 -175.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.93 143.03 64.68 Favored 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 122.254 1.841 . . . . 0.53 111.344 166.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -112.51 157.83 39.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.096 1.359 . . . . 0.59 110.0 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.25 -22.93 45.74 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.086 1.858 . . . . 0.76 112.262 174.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -173.96 165.74 4.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.503 1.521 . . . . 2.23 112.932 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -111.03 177.52 4.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.169 1.787 . . . . 1.21 109.306 150.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.53 171.02 19.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.663 -1.273 . . . . 2.26 111.638 175.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -151.57 134.53 8.9 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 118.36 -0.828 . . . . 1.33 110.189 -167.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.69 169.68 21.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 121.726 1.618 . . . . 1.09 111.434 171.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.92 142.27 74.62 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.005 3.137 . . . . 1.04 111.849 166.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 57.27 10.77 0.95 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.801 1.778 . . . . 1.36 115.801 -168.063 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.46 116.07 4.17 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 128.244 2.831 . . . . 1.37 110.889 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.16 137.15 35.64 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.32 1.448 . . . . 3.93 110.173 162.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.33 144.0 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.787 1.635 . . . . 1.63 109.252 178.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -132.28 118.41 19.43 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.652 -0.499 . . . . 3.93 109.652 -165.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.44 75.84 3.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.138 1.375 . . . . 1.4 110.041 -173.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -72.11 131.0 85.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.55 -1.214 . . . . 4.48 108.651 175.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.5 -40.29 85.5 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.064 2.51 . . . . 1.05 113.018 -173.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.77 67.43 3.56 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 119.628 1.103 . . . . 1.37 111.111 164.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 177.46 -82.17 0.07 OUTLIER Glycine 0 N--CA 1.469 0.861 0 C-N-CA 125.63 1.586 . . . . 1.01 112.637 -167.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -153.19 144.96 23.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.977 2.511 . . . . 1.86 108.927 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.69 171.4 16.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.429 0.692 . . . . 0.83 110.568 -177.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -109.58 125.91 53.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.093 0.957 . . . . 2.17 111.208 173.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.2 mmt -89.78 121.86 32.32 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.403 1.081 . . . . 0.97 110.662 170.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.68 138.96 33.45 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.7 1.6 . . . . 2.12 110.729 -178.143 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mt -144.1 140.19 29.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.175 0.806 . . . . 2.9 113.175 -177.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 57.96 3.44 Favored Glycine 0 N--CA 1.469 0.884 0 C-N-CA 124.303 0.954 . . . . 1.68 111.215 -176.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.8 mt -70.25 137.74 51.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.256 0.835 . . . . 0.85 113.256 -171.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -102.88 -3.43 26.23 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.756 1.223 . . . . 1.62 112.79 -172.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -139.01 158.56 69.46 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.106 1.362 . . . . 5.21 108.93 152.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.03 122.43 9.74 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 N-CA-C 106.255 -2.248 . . . . 1.85 106.255 138.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.17 120.96 21.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.102 0.953 . . . . 2.14 109.528 -166.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -67.49 109.38 3.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.511 1.125 . . . . 5.53 108.201 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.38 113.64 0.73 Allowed 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 1.91 113.004 172.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.47 6.58 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.812 0.72 . . . . 2.41 113.265 -166.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.31 -169.15 1.56 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.187 1.795 . . . . 2.7 108.662 146.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.6 162.0 33.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.735 1.214 . . . . 4.89 110.854 177.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.9 t -132.77 133.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.009 1.724 . . . . 0.98 109.847 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.02 148.24 31.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.138 0.494 . . . . 3.15 111.512 164.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.565 HD11 ' HB1' ' A' ' 35' ' ' ALA . 1.1 tm? -151.81 120.63 6.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.091 1.356 . . . . 2.69 109.388 175.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.86 114.14 17.54 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.429 3.092 . . . . 2.09 109.951 170.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.14 122.51 27.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.813 1.188 . . . . 1.81 109.449 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -97.53 127.88 43.83 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.057 0.943 . . . . 0.93 111.243 -171.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.64 151.33 48.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.168 0.985 . . . . 2.33 112.828 -176.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.62 158.82 35.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.717 -0.674 . . . . 2.33 111.987 172.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.32 74.78 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.586 -0.696 . . . . 4.77 113.899 176.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.51 63.8 2.07 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 118.219 1.01 . . . . 2.29 112.612 173.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -147.89 142.66 26.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.186 1.795 . . . . 3.94 110.867 178.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.92 139.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.393 1.877 . . . . 1.39 107.86 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.6 mt -143.49 108.21 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.534 1.134 . . . . 1.96 108.811 -175.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -92.53 150.39 20.78 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.86 1.059 . . . . 2.11 113.86 -177.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.49 159.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.795 1.238 . . . . 1.67 110.367 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.21 148.5 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.991 1.316 . . . . 2.45 109.849 168.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.1 mt -143.76 129.39 9.91 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.379 1.872 . . . . 1.66 109.051 -178.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.0 156.93 61.54 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.137 2.558 . . . . 1.05 112.561 175.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -88.92 113.37 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.102 1.361 . . . . 1.38 110.487 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -107.36 179.29 4.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.038 2.535 . . . . 4.49 108.595 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.27 123.3 17.84 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.663 -1.273 . . . . 2.49 109.755 171.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 4.1 tpt180 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.139 0.976 . . . . 4.69 113.311 -161.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 CA--C 1.544 0.721 0 N-CA-C 106.867 -1.531 . . . . 5.64 106.867 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -107.36 167.39 13.62 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 116.155 1.222 . . . . 1.13 116.155 -163.259 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -156.14 146.29 21.44 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.616 1.567 . . . . 1.87 112.497 173.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.7 139.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.328 -1.36 . . . . 1.63 107.328 154.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 103.22 12.64 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.931 -0.481 . . . . 4.04 111.733 -173.128 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.93 110.0 1.22 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.591 1.186 . . . . 3.32 110.379 163.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -158.88 144.79 12.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.986 1.714 . . . . 2.27 108.58 161.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.76 74.23 5.3 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.061 3.174 . . . . 2.66 111.248 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.92 148.31 19.5 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.05 1.309 . . . . 1.65 111.756 172.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.57 -25.04 47.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.981 2.454 . . . . 1.44 111.845 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -107.73 138.85 43.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.182 1.393 . . . . 3.99 108.982 153.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 163.78 31.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.551 1.94 . . . . 1.55 108.081 160.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.46 169.83 14.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.148 0.795 . . . . 1.2 113.148 -177.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.2 148.62 27.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.306 1.042 . . . . 1.1 112.482 165.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.04 159.81 41.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.017 1.727 . . . . 2.16 111.296 -172.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -163.47 146.37 10.1 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.448 1.277 . . . . 1.59 114.448 -175.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -79.87 128.27 33.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.661 -1.154 . . . . 2.03 109.679 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.17 149.07 45.52 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.709 1.603 . . . . 2.76 110.987 -175.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -157.68 153.04 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.739 0.781 . . . . 3.04 111.491 174.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -104.8 105.0 49.12 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 0.99 109.19 177.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.09 -11.23 13.61 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.834 2.356 . . . . 1.03 113.676 177.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.86 177.78 53.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.677 1.126 . . . . 0.99 113.467 -174.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -102.61 12.67 36.06 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.704 1.602 . . . . 2.38 111.588 178.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.03 158.65 34.47 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.059 2.144 . . . . 2.78 109.149 174.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.05 148.77 17.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.805 2.337 . . . . 1.4 110.266 172.364 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -121.61 119.56 32.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.405 1.082 . . . . 2.85 110.317 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -109.06 106.46 16.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.526 1.53 . . . . 3.16 109.79 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -92.3 116.23 28.78 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.103 2.161 . . . . 0.72 108.76 -173.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.78 -9.37 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.154 0.982 . . . . 0.57 112.714 -166.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.6 -162.66 32.07 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 124.875 1.226 . . . . 0.47 111.41 171.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.01 171.76 17.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.455 1.102 . . . . 0.71 110.539 168.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.83 130.4 16.85 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.622 -1.621 . . . . 6.03 106.622 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 t -127.48 157.51 72.71 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 117.385 -1.293 . . . . 0.9 108.162 177.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -63.06 -25.36 73.46 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.036 1.824 . . . . 1.11 113.313 160.314 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -80.35 12.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.904 1.446 . . . . 1.25 114.904 -172.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.31 153.68 49.01 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.313 1.445 . . . . 1.57 113.941 -172.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.88 -42.65 9.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.628 1.571 . . . . 4.03 111.581 168.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.13 176.25 12.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 7.56 110.543 151.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -155.65 144.13 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.602 1.961 . . . . 1.86 109.569 -170.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -127.06 136.21 51.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.171 1.788 . . . . 2.26 110.566 -176.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -88.77 123.23 32.98 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.154 1.343 . . . . 0.76 112.067 169.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 13.3 m170 -110.88 153.54 25.31 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.762 2.025 . . . . 0.68 113.129 175.3 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -86.23 170.28 12.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.846 1.658 . . . . 2.33 111.278 161.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 m -146.73 126.86 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.015 1.326 . . . . 1.32 108.182 169.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -140.85 173.46 11.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.154 1.168 . . . . 2.42 114.154 -152.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -126.89 141.98 51.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.037 1.735 . . . . 3.98 108.676 159.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -149.45 165.67 31.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.066 1.746 . . . . 8.22 109.987 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.68 136.96 43.82 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.634 0.774 . . . . 3.89 110.092 169.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.96 -6.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 114.228 1.196 . . . . 2.91 114.228 173.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -168.37 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.873 2.069 . . . . 4.23 110.682 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.42 -16.95 4.48 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.043 -1.661 . . . . 2.54 113.689 -163.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -82.58 142.13 32.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.736 1.268 . . . . 3.6 110.374 161.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.485 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.83 127.32 35.96 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.509 1.124 . . . . 5.01 109.358 177.766 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -135.72 145.22 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.029 1.332 . . . . 2.15 110.157 -170.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -82.97 158.45 22.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.62 1.568 . . . . 3.35 113.191 -176.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.59 -179.56 45.26 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.453 0.549 . . . . 1.42 113.957 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -132.35 158.06 42.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.905 1.682 . . . . 1.48 110.49 176.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -160.23 147.45 12.46 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.569 1.548 . . . . 5.68 109.924 169.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.1 Cg_endo -63.72 148.14 92.24 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.655 1.57 . . . . 0.87 110.255 163.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.26 155.13 71.83 Favored Pre-proline 0 N--CA 1.472 0.647 0 C-N-CA 125.459 1.504 . . . . 0.58 110.734 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.99 -23.88 24.69 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.666 2.244 . . . . 0.7 112.541 178.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -171.78 165.68 6.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.388 1.075 . . . . 1.86 112.62 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -113.94 172.79 6.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.289 1.835 . . . . 1.0 109.188 155.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -154.61 167.86 28.71 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.543 -0.723 . . . . 2.05 111.518 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.6 t -144.37 130.07 9.71 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.042 1.737 . . . . 0.87 108.425 -169.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -70.43 164.7 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.319 2.013 . . . . 0.95 110.94 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.79 139.5 91.06 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.671 2.247 . . . . 1.1 110.547 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm 66.59 6.42 4.44 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.993 1.717 . . . . 1.57 113.549 -175.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.33 120.52 5.21 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 127.701 2.572 . . . . 1.16 112.623 -176.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -90.32 138.23 31.71 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.294 1.838 . . . . 4.0 111.424 167.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.09 125.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.976 1.31 . . . . 1.37 112.877 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.08 121.8 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.269 1.028 . . . . 4.23 111.586 170.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.69 147.12 46.0 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.333 1.063 . . . . 1.86 110.07 161.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -172.25 150.71 2.4 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.964 1.306 . . . . 2.6 111.197 -158.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.99 -47.9 9.6 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.758 2.305 . . . . 1.06 111.515 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.19 70.95 2.86 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.807 -0.917 . . . . 1.72 110.807 166.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.44 -96.45 0.12 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.363 1.458 . . . . 1.14 113.711 -176.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -149.37 138.32 21.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.949 1.699 . . . . 1.84 108.695 -172.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -157.97 162.28 38.2 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.231 -0.293 . . . . 0.69 110.794 -168.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -95.32 135.4 36.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.475 0.71 . . . . 2.1 110.468 169.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -95.67 126.72 41.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.112 1.365 . . . . 1.13 108.913 160.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.75 157.5 23.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.143 0.577 . . . . 2.36 110.33 173.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 78.32 1.6 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.484 1.135 . . . . 3.08 111.381 176.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.19 114.13 3.74 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.757 2.122 . . . . 1.66 110.299 -170.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.16 126.31 44.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.606 1.163 . . . . 1.33 110.444 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -92.02 -25.11 18.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.194 0.812 . . . . 2.46 113.194 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.31 151.69 40.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.645 -0.872 . . . . 4.45 108.645 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.95 -14.53 23.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.569 2.179 . . . . 3.24 115.41 177.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.3 mt 66.71 102.34 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 130.996 3.719 . . . . 2.5 110.373 -178.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -106.88 143.21 35.31 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.881 0.873 . . . . 6.23 109.739 161.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -45.41 124.17 4.66 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.483 -0.78 . . . . 1.63 109.643 159.325 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.57 3.08 81.47 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 117.361 -1.799 . . . . 2.17 116.426 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.73 161.52 30.15 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 121.15 2.475 . . . . 2.55 109.75 162.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.95 154.99 19.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.24 1.416 . . . . 3.81 110.993 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.15 112.52 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 126.044 1.737 . . . . 1.61 108.63 -176.117 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -74.22 142.29 45.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.231 -0.655 . . . . 3.13 109.231 155.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt -146.57 117.32 7.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.282 1.033 . . . . 1.55 111.326 175.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.9 92.4 8.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.678 3.191 . . . . 2.15 109.222 170.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.68 125.25 28.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.468 1.107 . . . . 1.36 109.68 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt -97.01 132.23 43.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.867 1.267 . . . . 0.74 111.243 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -131.6 146.52 52.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.076 0.941 . . . . 2.2 112.789 -174.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.34 165.13 14.67 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.749 -0.594 . . . . 2.23 111.84 170.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.58 26.48 65.27 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.461 -0.775 . . . . 4.68 113.272 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.87 63.04 3.48 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.823 1.201 . . . . 1.96 111.562 176.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -146.75 161.3 40.91 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 123.111 1.434 . . . . 4.29 113.028 -171.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 p -171.9 146.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.125 2.97 . . . . 1.36 108.137 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt -140.24 123.67 17.0 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.618 1.167 . . . . 1.73 109.192 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -81.42 126.92 32.22 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.522 0.601 . . . . 2.5 111.381 167.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.29 166.15 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.876 1.671 . . . . 3.12 108.381 168.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.2 130.32 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.316 1.447 . . . . 2.01 110.764 178.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mp -139.05 166.91 21.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.796 2.438 . . . . 2.6 109.37 -176.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.67 170.78 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.14 2.56 . . . . 1.62 113.581 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.8 t -95.77 136.79 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 127.656 2.383 . . . . 1.5 107.721 155.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -153.53 158.68 41.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.584 0.754 . . . . 5.05 111.548 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.21 3.35 24.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.358 1.984 . . . . 2.24 116.358 -164.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.937 0 N-CA-C 113.492 0.923 . . . . 6.16 113.492 -162.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.552 1.026 0 CA-C-O 120.808 0.337 . . . . 7.17 110.733 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.26 159.27 23.29 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 115.929 1.131 . . . . 1.03 115.929 -169.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -150.41 136.99 18.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.609 1.164 . . . . 1.59 112.201 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -90.67 131.76 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.702 -0.851 . . . . 0.84 108.702 164.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.61 47.47 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.939 0.718 . . . . 7.86 112.939 -173.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.63 103.48 1.72 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.563 1.173 . . . . 4.0 110.993 163.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.89 140.71 0.57 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.854 1.661 . . . . 3.47 109.926 157.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.36 3.4 7.83 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.071 3.181 . . . . 3.7 114.471 -173.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.01 145.88 49.74 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 119.537 1.062 . . . . 1.77 113.028 -175.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.98 -15.07 47.38 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.113 3.209 . . . . 2.45 113.676 -171.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -139.35 167.03 23.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.134 0.974 . . . . 2.83 111.794 159.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 159.65 174.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.493 3.517 . . . . 3.26 109.87 171.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.69 171.86 13.15 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.058 1.133 . . . . 2.07 114.058 -177.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 160.12 40.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.692 2.797 . . . . 1.9 109.151 170.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -144.0 158.28 43.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.101 0.953 . . . . 2.15 112.644 -164.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.48 159.57 28.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.582 0.956 . . . . 1.85 113.582 173.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 m -123.77 147.73 47.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.869 -1.514 . . . . 2.23 107.331 164.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tp -136.83 153.43 50.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.053 1.341 . . . . 4.34 110.985 -175.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -108.95 135.61 49.85 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.53 1.932 . . . . 3.98 108.094 168.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -102.46 91.34 2.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.02 -0.514 . . . . 1.32 109.967 160.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.45 -11.11 18.97 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.314 2.009 . . . . 1.85 113.487 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.33 52.41 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 118.907 0.776 . . . . 1.48 113.195 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.56 3.08 51.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.741 . . . . 2.9 113.609 -177.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.99 159.97 56.54 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.59 1.556 . . . . 2.21 110.799 174.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.34 166.17 22.66 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.845 2.363 . . . . 1.63 112.657 -164.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.0 154.65 21.88 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.22 1.008 . . . . 3.03 111.008 165.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -148.88 104.99 3.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.177 1.791 . . . . 3.67 109.654 170.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.7 tp -91.64 111.8 23.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.634 2.374 . . . . 0.82 109.886 -168.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -97.85 -15.32 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.849 1.259 . . . . 0.64 112.857 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.65 -164.93 36.66 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.685 -0.634 . . . . 0.57 112.62 175.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.5 172.52 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.816 0.846 . . . . 0.83 111.242 166.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.78 144.49 23.53 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.717 0.689 . . . . 5.07 111.663 171.23 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 t -141.1 149.53 55.89 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 125.875 1.67 . . . . 0.65 108.93 -166.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.65 -19.23 42.1 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.124 1.883 . . . . 1.0 113.232 173.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -71.21 -4.39 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 114.331 1.234 . . . . 1.32 114.331 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.31 174.38 12.91 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.593 1.701 . . . . 1.48 115.593 -167.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -108.58 -42.92 4.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.897 2.079 . . . . 3.39 110.429 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -129.61 161.88 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.216 1.406 . . . . 5.16 112.057 172.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -176.21 126.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.256 1.822 . . . . 1.95 108.798 -173.38 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -145.21 137.07 25.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.057 1.343 . . . . 4.45 109.475 -164.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.5 123.62 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.636 0.732 . . . . 0.81 111.461 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -107.83 153.8 22.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.719 1.608 . . . . 0.67 113.584 173.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -91.55 170.7 9.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.875 2.07 . . . . 2.2 110.715 158.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.9 m -149.46 114.59 5.45 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.608 1.563 . . . . 1.51 107.837 173.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -119.8 157.21 29.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.956 1.302 . . . . 2.34 112.841 -162.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -94.46 158.61 15.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.224 1.01 . . . . 3.52 110.555 160.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.37 150.22 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 5.96 110.378 176.001 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.3 140.54 29.66 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.799 -0.815 . . . . 3.53 108.799 160.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.51 114.4 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.661 1.584 . . . . 2.62 107.365 -178.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 64.99 1.27 1.42 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.204 1.802 . . . . 4.7 112.569 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.56 -11.76 58.05 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.644 1.593 . . . . 1.87 113.879 -166.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -76.77 136.55 39.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.275 1.537 . . . . 4.48 109.656 172.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -77.54 126.77 31.42 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.678 -0.639 . . . . 3.73 110.73 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.8 t -135.25 155.74 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.58 1.952 . . . . 2.15 109.097 -173.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.1 mtm -128.7 154.12 46.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.131 0.972 . . . . 3.58 110.785 171.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.39 30.63 Favored Glycine 0 N--CA 1.468 0.827 0 C-N-CA 124.07 0.843 . . . . 1.25 113.333 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.56 161.42 35.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.47 1.508 . . . . 2.88 109.954 -177.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -165.62 134.55 2.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 116.679 -1.629 . . . . 4.53 110.311 -173.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.56 146.37 84.49 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 122.322 1.865 . . . . 0.64 110.391 163.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.32 158.32 67.29 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 125.677 1.591 . . . . 0.66 111.237 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.53 -24.5 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.822 2.348 . . . . 0.65 112.73 176.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -173.87 166.81 4.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.649 1.18 . . . . 1.73 113.176 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.19 170.14 8.43 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.408 1.883 . . . . 1.1 109.799 152.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -156.65 164.56 38.03 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.354 -0.841 . . . . 1.89 113.179 176.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -154.43 141.18 13.22 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.963 0.905 . . . . 0.99 110.452 -160.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.38 171.54 14.96 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.343 2.028 . . . . 0.89 112.651 168.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.71 148.43 92.13 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.28 3.32 . . . . 1.07 112.267 163.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 69.69 -2.96 1.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.71 2.004 . . . . 1.67 114.123 179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.61 115.88 4.18 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 125.824 1.678 . . . . 0.99 111.583 -178.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.04 128.98 36.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.115 0.566 . . . . 6.82 110.561 162.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.28 158.18 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 1.76 112.087 -164.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -146.42 114.25 6.48 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.269 0.628 . . . . 4.07 109.684 -141.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.24 83.39 6.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.096 0.958 . . . . 1.64 109.13 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -72.4 142.18 84.0 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.539 -1.22 . . . . 2.76 109.769 178.027 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.51 -39.15 85.9 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.698 2.266 . . . . 1.38 112.516 -178.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.94 61.68 4.7 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.899 0.761 . . . . 1.8 111.394 165.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -69.36 0.07 OUTLIER Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.746 1.165 . . . . 1.2 114.168 -177.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -154.12 143.67 21.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.043 1.737 . . . . 1.96 109.052 -171.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -167.25 165.49 15.25 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.494 -0.754 . . . . 1.05 110.219 -177.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.64 135.9 37.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.962 -0.385 . . . . 2.08 109.962 169.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -79.54 132.7 36.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.0 -0.741 . . . . 1.17 109.0 152.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.1 139.47 39.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.517 1.127 . . . . 1.97 108.687 164.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -137.38 136.42 37.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.683 1.193 . . . . 2.63 111.38 -175.648 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 42.73 99.4 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 1.66 111.301 178.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.312 0.2 OUTLIER -68.76 87.48 0.35 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.434 1.588 . . . . 1.85 113.91 -173.736 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -67.64 5.55 0.8 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.04 2.536 . . . . 2.1 115.553 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -127.14 105.83 22.02 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.483 1.113 . . . . 6.31 109.514 146.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.87 144.81 60.21 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.165 2.576 . . . . 1.76 111.073 172.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.14 126.32 33.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 2.07 110.839 -177.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -98.34 -31.2 12.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.705 1.202 . . . . 4.95 113.01 -175.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 122.06 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 1 C-N-CA 132.153 4.181 . . . . 1.5 110.468 175.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.23 37.0 93.51 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.355 -0.692 . . . . 1.94 113.569 178.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.92 -171.8 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 2.91 108.629 178.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -141.99 162.06 36.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.197 0.999 . . . . 3.35 110.673 174.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.86 119.78 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.53 1.532 . . . . 0.84 109.894 -169.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.48 135.94 52.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 3.08 110.456 162.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -155.94 124.4 5.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.816 0.846 . . . . 1.59 112.615 -175.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.67 105.57 17.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.739 1.616 . . . . 1.99 110.571 172.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.02 117.69 21.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.594 0.757 . . . . 1.22 110.418 176.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.77 126.27 38.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.877 1.271 . . . . 0.58 111.045 -169.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -122.97 139.46 54.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.179 0.807 . . . . 1.84 113.179 -175.289 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.22 104.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.273 1.029 . . . . 2.75 112.634 -177.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.26 78.57 1.05 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.012 1.292 . . . . 4.73 113.087 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.28 -0.37 24.94 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 116.193 1.237 . . . . 1.96 116.193 169.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -110.13 132.18 54.4 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.014 1.407 . . . . 5.74 112.761 -170.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.35 134.31 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.794 1.638 . . . . 1.14 107.384 160.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.3 mt -120.15 110.16 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.937 -1.134 . . . . 1.99 107.937 177.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -80.04 127.6 32.48 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.16 -0.337 . . . . 2.47 110.886 176.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.5 m -125.96 161.87 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.87 1.668 . . . . 1.14 110.499 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.66 135.94 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.302 1.041 . . . . 1.93 108.709 165.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -127.35 147.81 63.7 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.24 1.416 . . . . 1.59 108.943 172.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.26 161.43 44.48 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.151 2.568 . . . . 1.0 111.942 174.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.6 133.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.302 1.441 . . . . 1.26 108.595 165.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.64 153.82 25.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.52 1.128 . . . . 3.95 110.023 171.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 2.69 -113.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 130.163 3.385 . . . . 3.53 117.632 175.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.775 0 CA-C-O 114.866 -2.492 . . . . 9.12 112.348 178.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 C--O 1.236 0.363 0 CA-C-O 121.44 0.638 . . . . 5.99 110.512 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.07 171.46 29.32 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.577 1.561 . . . . 1.11 113.694 176.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -155.36 153.8 31.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.274 1.429 . . . . 1.56 112.126 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 99' ' ' VAL . 90.6 t -105.49 136.54 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.569 -1.271 . . . . 1.08 107.569 172.075 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -86.1 -0.31 55.31 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.486 2.032 . . . . 5.25 116.486 -153.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 60.65 168.65 0.09 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.87 1.668 . . . . 3.25 112.511 -168.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 t -165.73 145.69 5.48 Favored Pre-proline 0 N--CA 1.47 0.559 0 O-C-N 120.457 -1.402 . . . . 3.44 112.372 162.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.32 -6.35 11.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.455 2.77 . . . . 3.33 112.486 164.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.65 171.31 15.52 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.405 1.479 . . . . 1.88 113.757 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.08 -3.16 13.16 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.931 3.754 . . . . 1.8 113.811 -176.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -121.83 156.51 33.1 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.215 1.806 . . . . 2.14 112.133 171.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.79 177.06 11.82 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.38 1.472 . . . . 1.3 112.091 -171.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.57 20.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.475 1.11 . . . . 1.02 112.753 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.31 159.3 38.7 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.072 1.138 . . . . 1.17 114.072 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -148.24 151.28 35.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.213 2.205 . . . . 2.49 110.634 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -168.5 151.07 5.22 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.411 0.893 . . . . 1.64 113.411 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -95.48 131.11 41.99 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.458 1.903 . . . . 1.62 108.92 171.115 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.32 160.68 39.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.683 1.193 . . . . 4.48 111.173 178.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.98 127.29 10.62 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.967 0.907 . . . . 3.29 110.779 -169.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -85.97 116.34 65.34 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.278 1.031 . . . . 0.93 109.694 174.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -87.2 -14.01 4.18 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.082 2.522 . . . . 1.23 114.374 178.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.38 174.38 32.2 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 119.212 0.915 . . . . 1.16 113.206 -174.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.01 -2.48 58.14 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.571 1.548 . . . . 3.74 114.587 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -97.63 158.79 32.44 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.479 1.112 . . . . 2.02 111.138 173.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.59 157.52 12.29 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.377 2.718 . . . . 1.35 111.229 -176.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.21 108.02 9.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.634 0.73 . . . . 2.14 111.688 -170.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -99.96 106.23 18.0 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.696 1.198 . . . . 2.73 111.675 -177.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.1 tp -85.4 114.86 22.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.583 1.953 . . . . 0.7 109.431 -177.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.71 -12.19 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.829 0.851 . . . . 0.88 112.884 -171.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.45 -168.04 40.59 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.665 1.126 . . . . 0.81 111.098 173.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.37 140.69 20.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.638 0.775 . . . . 1.96 110.592 167.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -108.54 139.75 42.86 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.714 1.606 . . . . 6.89 108.538 -169.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -152.41 155.7 33.09 Favored Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 124.593 1.157 . . . . 0.84 109.874 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -86.58 -9.9 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.729 2.286 . . . . 1.41 113.527 165.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 m -70.27 -9.52 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.343 0.974 . . . . 1.98 113.443 176.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 160.74 30.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.171 1.351 . . . . 0.94 112.285 -169.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.28 -68.76 0.79 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.173 1.389 . . . . 3.01 109.14 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -82.01 111.9 18.6 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.078 -1.014 . . . . 3.63 109.405 171.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.62 145.78 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.524 1.13 . . . . 1.47 109.444 153.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -137.25 122.87 19.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.54 1.536 . . . . 2.14 108.542 162.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.26 119.79 22.11 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 120.934 1.697 . . . . 0.68 110.045 167.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -109.06 157.02 19.1 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.318 1.847 . . . . 0.59 112.247 176.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 12.1 pt-20 -104.38 168.18 9.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.852 -1.067 . . . . 2.37 110.264 161.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.7 m -130.03 107.48 9.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.342 1.457 . . . . 1.13 107.3 170.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -113.27 154.92 26.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.859 1.264 . . . . 2.33 112.508 -171.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -90.52 154.45 19.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.655 1.182 . . . . 3.31 112.334 172.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.41 15.53 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.033 1.333 . . . . 5.59 113.214 177.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -138.74 142.13 38.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.969 1.307 . . . . 4.82 109.473 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.59 128.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.501 1.12 . . . . 3.83 108.981 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 56.29 28.21 13.0 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.175 0.988 . . . . 4.17 111.011 -168.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.12 -0.42 11.74 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.506 2.003 . . . . 3.2 114.996 -173.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.69 126.11 30.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.444 1.498 . . . . 3.42 108.785 174.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.47 126.89 52.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.371 1.468 . . . . 6.21 110.785 -162.228 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.8 t -145.67 153.17 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.915 1.286 . . . . 1.59 110.586 -156.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.4 mtm -120.81 149.44 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.387 1.075 . . . . 2.84 110.413 161.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.64 158.64 27.75 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.917 0.77 . . . . 1.14 112.733 178.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -102.73 155.48 18.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.564 1.146 . . . . 1.63 111.897 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.412 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -163.91 146.5 7.62 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-O 117.693 -1.146 . . . . 5.67 112.255 171.733 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.38 142.13 53.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.881 2.387 . . . . 0.64 111.419 172.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.76 157.54 38.19 Favored Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.303 1.441 . . . . 0.72 110.763 175.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.44 -18.66 38.4 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.434 2.089 . . . . 0.62 112.743 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -179.42 167.04 1.47 Allowed 'General case' 0 C--N 1.347 0.459 0 C-N-CA 126.128 1.771 . . . . 1.81 110.076 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -114.91 171.09 7.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.274 1.83 . . . . 0.99 108.89 157.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.32 167.76 29.35 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.142 -0.974 . . . . 2.52 113.353 167.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.75 134.69 16.21 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.053 1.341 . . . . 0.79 109.381 -172.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.42 164.58 33.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.223 1.949 . . . . 0.8 111.611 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.14 139.7 85.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.831 3.021 . . . . 0.84 111.919 174.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.54 1.67 1.4 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.345 1.858 . . . . 3.18 115.128 -171.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 118.44 4.78 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 127.669 2.556 . . . . 0.9 111.971 -178.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -91.79 137.03 32.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.874 1.27 . . . . 3.83 111.021 159.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.7 m -150.31 157.45 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.785 1.634 . . . . 1.52 110.705 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.12 152.62 34.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.392 1.091 . . . . 3.73 112.826 169.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.79 77.29 2.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.955 1.302 . . . . 1.4 108.733 161.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.2 137.51 78.71 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.393 1.077 . . . . 3.37 112.399 177.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.53 -34.56 85.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.905 3.07 . . . . 1.63 114.476 -169.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.7 121.54 6.29 Favored Glycine 0 N--CA 1.468 0.824 0 N-CA-C 106.889 -2.484 . . . . 1.47 106.889 150.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.86 -94.72 0.5 Allowed Glycine 0 N--CA 1.47 0.909 0 CA-C-N 119.786 1.793 . . . . 1.6 112.967 -161.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 54.7 m-85 -148.12 149.06 31.34 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.042 2.137 . . . . 1.92 111.633 -169.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.7 163.7 14.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.307 1.043 . . . . 1.01 109.982 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -93.39 138.19 31.96 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 122.02 -0.425 . . . . 2.43 109.937 167.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.6 mmt -96.98 139.49 32.91 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.348 1.059 . . . . 0.84 109.421 157.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.58 142.62 51.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.484 1.513 . . . . 2.88 109.933 -178.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -145.99 133.65 21.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 3.03 111.505 -174.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.74 74.37 1.09 Allowed Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.274 -0.73 . . . . 1.47 111.274 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.67 119.41 25.21 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.471 0.915 . . . . 1.13 113.471 -163.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -90.6 -8.99 48.66 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.896 1.443 . . . . 1.81 114.896 -169.684 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.22 145.08 56.16 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.204 1.401 . . . . 6.15 108.038 160.489 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 128.76 15.19 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 107.169 -1.896 . . . . 2.08 107.169 168.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.37 95.76 0.33 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.087 1.355 . . . . 2.32 110.506 -168.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -68.99 111.81 5.23 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 120.657 -1.277 . . . . 4.99 108.693 177.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.94 108.93 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.123 -0.985 . . . . 1.78 110.431 167.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.06 16.65 40.37 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 117.213 -1.882 . . . . 1.79 116.036 -170.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.08 171.59 12.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.793 2.297 . . . . 4.39 109.045 150.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.219 1.408 . . . . 4.33 108.621 170.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 8' ' ' VAL . 58.9 t -98.41 119.66 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.916 0.887 . . . . 1.08 110.062 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.71 45.12 1.04 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 128.282 2.633 . . . . 5.6 113.185 -170.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.41 130.22 42.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.483 1.913 . . . . 1.79 113.902 -164.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -92.02 93.28 8.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.457 2.703 . . . . 2.32 110.892 175.353 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.1 mt -71.48 120.61 17.31 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.396 -0.815 . . . . 1.47 110.52 -179.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt -93.27 125.26 37.78 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.546 1.538 . . . . 1.0 111.114 -169.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.73 125.63 44.37 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.468 0.914 . . . . 1.86 113.468 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 53.44 11.37 0.27 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.444 2.298 . . . . 2.11 116.685 167.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.92 4.02 46.22 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.959 -1.088 . . . . 3.34 114.409 -168.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -129.91 -4.71 4.6 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.727 1.156 . . . . 1.8 115.64 -171.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.69 158.37 43.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.423 2.289 . . . . 4.1 110.831 173.123 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.8 135.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.949 1.7 . . . . 1.54 107.582 165.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.61 115.33 12.9 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.86 1.264 . . . . 1.72 107.77 -173.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -102.84 141.64 35.31 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.456 1.28 . . . . 2.72 114.456 -171.324 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.68 167.75 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.562 1.545 . . . . 1.52 110.09 -173.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.87 144.81 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 124.641 1.176 . . . . 2.91 109.733 172.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.42 133.17 6.67 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.551 -0.738 . . . . 2.31 111.162 176.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.06 150.34 82.5 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.566 2.844 . . . . 1.51 112.623 -172.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.3 112.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.337 1.055 . . . . 1.61 108.492 166.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.88 -169.95 2.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.099 2.96 . . . . 3.74 108.649 178.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.53 53.0 1.8 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.202 1.556 . . . . 2.62 115.202 -161.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 115.58 -2.152 . . . . 8.37 115.045 178.599 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 109.53 -0.544 . . . . 4.42 109.53 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.72 174.75 43.36 Favored Glycine 0 N--CA 1.465 0.592 0 O-C-N 121.94 -0.475 . . . . 1.15 113.96 -178.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -155.51 151.04 27.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.947 0.899 . . . . 1.38 112.167 -179.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.93 127.64 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.901 -0.499 . . . . 0.99 110.016 174.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -72.63 -11.0 60.46 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.441 1.645 . . . . 4.74 115.441 -159.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.94 160.81 0.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.372 1.469 . . . . 2.82 113.949 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -165.82 149.93 7.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.048 1.739 . . . . 4.19 110.497 166.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -83.64 -9.92 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.25 2.633 . . . . 3.75 112.024 162.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.9 -168.14 13.27 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.96 1.743 . . . . 2.38 113.962 -174.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -74.0 -27.45 12.04 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.196 2.598 . . . . 2.11 114.955 -165.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -98.63 150.85 21.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.144 1.338 . . . . 3.0 112.425 177.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.4 -179.9 8.53 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.032 2.133 . . . . 1.28 111.599 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.76 167.35 21.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.15 1.78 . . . . 1.09 111.403 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.83 155.1 36.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.351 1.061 . . . . 1.1 112.376 172.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 142.57 24.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.362 1.865 . . . . 2.18 109.558 -171.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -171.24 159.37 5.8 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.318 1.599 . . . . 1.73 115.318 -174.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -71.9 138.48 48.19 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.305 1.842 . . . . 1.27 109.365 166.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.62 146.25 49.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.118 1.767 . . . . 3.62 111.241 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -119.72 132.97 55.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.256 1.822 . . . . 5.05 114.002 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -98.95 109.04 52.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.678 -0.692 . . . . 1.17 109.851 143.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -89.2 -10.62 3.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.53 2.82 . . . . 1.25 113.565 173.254 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.58 -174.25 47.15 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.116 1.341 . . . . 0.92 113.495 -174.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.56 -4.0 18.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.963 1.705 . . . . 2.32 113.147 -169.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.42 161.43 39.27 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.653 1.981 . . . . 1.87 109.644 169.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.71 163.09 29.44 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.826 2.351 . . . . 1.35 112.632 -167.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.26 127.56 45.8 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.884 1.274 . . . . 2.36 111.125 -174.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -111.16 112.98 25.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.907 1.283 . . . . 3.51 110.648 175.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 tp -85.76 133.12 34.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.377 . . . . 0.97 108.721 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.86 -13.02 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.034 0.934 . . . . 0.73 113.516 -175.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.48 -164.98 34.47 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.002 0.811 . . . . 0.98 111.74 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 102' ' ' ASP . . . -140.94 -175.92 4.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.459 0.704 . . . . 1.14 110.632 160.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.88 146.56 9.54 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.069 0.948 . . . . 5.22 111.644 171.075 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -140.34 152.32 66.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.017 1.727 . . . . 0.85 109.253 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.13 -34.05 29.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 121.585 1.602 . . . . 0.96 112.613 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 m -70.77 -18.82 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 115.244 1.572 . . . . 1.29 115.244 -167.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.3 143.03 50.79 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.843 1.257 . . . . 0.92 111.078 -176.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -64.48 -53.83 42.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.262 1.025 . . . . 4.42 111.8 172.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.14 160.76 21.51 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.372 1.869 . . . . 7.24 111.055 -170.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -159.7 135.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.824 1.65 . . . . 1.15 110.661 -172.136 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -139.87 135.1 32.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.324 1.85 . . . . 2.41 109.72 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -83.33 118.74 23.89 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.436 1.016 . . . . 0.79 111.012 168.144 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -106.41 155.25 19.74 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.178 1.791 . . . . 0.74 112.044 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -157.27 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 3.75 111.019 174.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.8 m -151.32 123.98 8.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.478 2.311 . . . . 1.51 106.598 162.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -126.86 160.51 30.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.778 1.231 . . . . 2.48 112.431 -172.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.9 ptt? -134.24 122.18 22.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.988 1.375 . . . . 3.4 112.587 159.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -117.52 162.41 18.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.245 1.818 . . . . 7.85 110.927 -176.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.402 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 30.1 mp0 -77.19 144.42 38.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.893 1.677 . . . . 4.81 111.479 171.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.49 -96.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.602 1.561 . . . . 3.24 109.176 -176.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.02 31.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.088 1.355 . . . . 4.03 112.44 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.58 -13.28 8.48 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.365 -1.459 . . . . 2.73 112.594 -154.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 152.72 28.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.318 1.847 . . . . 4.41 110.763 178.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 41.6 mmtt -73.78 140.12 45.65 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.746 -0.596 . . . . 5.86 110.668 158.539 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -132.85 145.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.159 1.784 . . . . 2.07 108.259 165.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.8 tpp -101.52 146.9 27.04 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.229 2.212 . . . . 3.15 111.016 -175.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.11 -174.98 33.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.935 1.255 . . . . 1.44 113.64 174.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -138.38 152.2 48.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.672 1.589 . . . . 1.91 110.196 173.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.39 148.33 16.44 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 124.664 1.186 . . . . 4.45 110.932 -170.035 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.41 150.32 84.39 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 121.611 1.54 . . . . 0.76 112.49 167.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.89 159.11 73.93 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 126.559 1.944 . . . . 0.83 110.761 176.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.39 -18.35 14.02 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.039 2.493 . . . . 0.62 114.069 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -171.74 164.55 6.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.986 1.266 . . . . 2.03 112.552 -178.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.15 168.61 12.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.737 2.415 . . . . 1.06 108.572 161.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -161.88 163.82 28.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.975 -1.078 . . . . 2.18 113.274 176.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 t -149.2 140.69 14.44 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.3 1.04 . . . . 1.53 110.601 -169.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.35 167.34 20.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.997 2.465 . . . . 1.23 112.016 171.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.25 146.72 97.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.604 2.87 . . . . 1.0 112.796 175.224 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt 66.92 -2.45 1.13 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.373 1.869 . . . . 1.31 114.571 -178.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.97 117.86 4.58 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 126.65 2.071 . . . . 0.81 111.343 178.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -83.34 145.35 29.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.834 -0.683 . . . . 6.39 110.229 151.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.78 179.54 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.03 1.732 . . . . 1.53 109.398 171.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -121.39 139.75 53.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.771 0.828 . . . . 3.7 111.217 166.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.16 76.69 1.27 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.805 -1.554 . . . . 1.15 106.805 143.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -82.87 142.19 44.8 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 117.672 -1.156 . . . . 3.79 109.94 -177.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.66 -55.13 4.38 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.355 3.37 . . . . 1.75 114.959 -169.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.1 70.83 2.81 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.748 -0.941 . . . . 1.16 110.748 172.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.84 -76.95 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.253 1.406 . . . . 0.9 114.046 -166.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -155.63 142.1 18.63 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 1.82 108.351 -177.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -163.1 179.12 7.72 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.254 -0.903 . . . . 0.8 111.581 -172.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -109.29 139.92 43.61 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.108 -0.37 . . . . 2.05 111.088 168.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 mmt -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.58 0.752 . . . . 1.16 109.477 155.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.11 140.01 53.04 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.694 1.597 . . . . 2.65 109.1 178.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.16 152.8 49.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.047 0.939 . . . . 3.4 111.956 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.82 60.02 4.46 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.678 0.656 . . . . 1.59 111.719 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -74.94 107.71 7.19 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.469 1.128 . . . . 1.34 110.866 -178.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -70.98 -6.33 37.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.565 1.546 . . . . 2.48 115.014 -175.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -143.41 158.45 57.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.687 2.395 . . . . 6.99 108.273 156.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.07 157.25 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.086 1.857 . . . . 2.02 109.741 156.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.78 166.67 10.52 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.399 1.479 . . . . 2.74 111.915 -176.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 134.08 38.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.917 1.287 . . . . 3.69 111.427 174.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.7 24.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.946 -1.096 . . . . 1.59 110.219 173.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.44 54.98 2.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.129 0.395 . . . . 2.21 112.629 -162.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -143.05 160.83 39.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.619 2.368 . . . . 2.75 109.015 165.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -102.49 120.47 40.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.968 2.107 . . . . 4.38 111.112 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.54 128.92 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.896 1.278 . . . . 0.96 109.638 169.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -79.11 140.21 37.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.002 0.43 . . . . 2.52 110.976 159.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -148.26 127.13 12.67 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.892 0.877 . . . . 1.88 112.092 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 18.2 m-20 -98.34 103.73 15.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.465 1.906 . . . . 2.51 110.732 177.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.4 mt -68.86 112.43 5.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.997 0.817 . . . . 1.88 110.575 168.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.0 mt -87.15 129.65 34.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.734 1.213 . . . . 1.0 111.049 -176.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.81 117.67 19.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.536 0.684 . . . . 2.38 111.268 179.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.95 21.82 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.292 2.237 . . . . 1.97 116.729 168.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.47 -41.86 1.42 Allowed Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.228 1.394 . . . . 3.24 114.17 -174.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.58 -1.82 72.76 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.073 1.32 . . . . 2.4 114.877 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -148.47 157.15 43.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.372 1.469 . . . . 4.38 113.828 179.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.97 140.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.179 2.192 . . . . 1.87 108.224 168.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -125.55 111.97 15.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.881 1.272 . . . . 2.74 109.29 176.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -88.78 125.72 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.771 -0.58 . . . . 2.11 112.279 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.08 161.66 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.904 1.682 . . . . 1.63 111.208 171.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 m -106.66 143.58 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 2.38 109.235 163.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.38 145.87 39.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.606 1.163 . . . . 1.92 111.624 179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.15 142.8 34.72 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.231 2.621 . . . . 1.12 112.186 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -79.94 132.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.174 1.389 . . . . 1.09 109.481 165.044 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -147.02 139.37 24.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.766 2.427 . . . . 4.25 107.276 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.62 52.9 2.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.455 1.502 . . . . 2.79 112.117 -170.473 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 120' ' ' ARG 0.294 0.0 OUTLIER . . . . . 0 C--O 1.248 0.977 0 N-CA-C 117.414 2.375 . . . . 6.57 117.414 -154.064 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.555 1.137 0 N-CA-C 108.298 -1.001 . . . . 6.41 108.298 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.4 -171.18 19.82 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 120.065 -1.647 . . . . 0.94 115.688 -177.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -167.48 158.46 11.49 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.109 1.763 . . . . 1.37 112.167 173.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.77 130.94 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.733 0.813 . . . . 0.93 110.028 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -78.4 120.38 23.05 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.715 1.206 . . . . 4.1 111.615 -174.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -62.46 123.66 18.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.951 1.3 . . . . 3.24 110.459 164.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -155.83 160.93 30.44 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.866 1.666 . . . . 1.95 108.976 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.58 -159.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.303 3.335 . . . . 3.52 108.862 167.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.52 -161.5 46.58 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.88 0.752 . . . . 2.36 112.558 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -87.22 -11.14 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.579 2.853 . . . . 2.15 113.201 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -149.45 160.13 43.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.696 1.198 . . . . 2.18 113.891 -168.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.5 -167.06 1.64 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.624 1.97 . . . . 1.26 110.385 -174.723 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.67 153.59 50.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.834 0.743 . . . . 1.23 112.689 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.9 153.03 46.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.69 1.196 . . . . 0.84 110.281 163.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.15 156.12 46.0 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.781 1.232 . . . . 2.31 111.2 174.485 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.13 153.4 16.06 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.679 0.992 . . . . 1.52 113.679 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -78.54 140.09 38.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.607 -1.179 . . . . 1.24 107.956 151.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.21 134.73 26.3 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.73 1.212 . . . . 2.23 108.262 176.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.61 157.56 43.54 Favored 'General case' 0 C--N 1.335 -0.059 0 N-CA-C 114.13 1.159 . . . . 3.42 114.13 -170.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -115.3 105.32 52.62 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.98 110.931 -168.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.41 -15.67 9.84 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.577 2.185 . . . . 1.08 113.595 177.177 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 -167.91 41.35 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 119.263 0.938 . . . . 1.25 112.91 -177.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -117.02 16.29 15.06 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.5 1.52 . . . . 2.64 111.496 -173.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mt -120.14 162.07 35.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.167 2.187 . . . . 3.19 109.244 -175.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.21 156.99 17.32 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.976 2.451 . . . . 1.58 110.901 175.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.29 103.55 4.95 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.273 1.029 . . . . 2.32 111.059 -171.608 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -96.38 106.16 18.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.972 1.309 . . . . 3.12 111.364 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 tp -86.73 113.84 22.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.126 2.17 . . . . 0.72 108.651 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.69 -11.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.173 0.989 . . . . 0.59 113.483 -169.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.49 -161.68 32.48 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.518 -0.739 . . . . 0.6 112.296 178.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.836 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -148.72 177.34 9.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.279 1.032 . . . . 1.03 111.374 176.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 129.79 5.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.924 -1.139 . . . . 5.41 107.924 172.502 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -135.31 147.36 61.8 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 117.748 -1.12 . . . . 1.03 109.232 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.68 -15.02 27.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.04 1.827 . . . . 1.42 112.712 171.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -75.19 -0.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.035 0.834 . . . . 0.85 113.236 174.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.47 -172.28 3.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.615 1.966 . . . . 1.24 110.311 176.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -106.63 -55.89 2.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.699 1.2 . . . . 3.03 110.566 166.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -119.85 165.92 13.97 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 4.15 110.907 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.3 p -155.5 135.91 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.705 0.802 . . . . 2.08 109.48 171.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -120.13 132.51 55.44 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.954 1.702 . . . . 2.15 108.977 -173.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.85 115.34 19.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.504 1.145 . . . . 0.95 109.855 170.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -103.16 150.87 23.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.337 -1.301 . . . . 0.64 111.995 176.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -94.64 164.59 12.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.513 2.325 . . . . 2.35 109.991 166.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.9 m -145.63 121.25 10.45 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.38 1.072 . . . . 1.35 108.152 167.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.49 153.48 51.73 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.894 0.878 . . . . 2.15 112.945 -151.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.33 47.89 0.98 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 123.084 1.421 . . . . 6.12 111.868 -172.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -80.67 162.16 24.31 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.347 -1.751 . . . . 8.12 110.886 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -69.5 152.07 45.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.401 2.281 . . . . 4.04 111.42 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.04 -96.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.167 1.387 . . . . 2.97 107.645 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.65 43.22 0.14 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.28 1.832 . . . . 4.53 111.248 169.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.94 -26.96 0.78 Allowed Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.37 -1.456 . . . . 2.58 113.691 -167.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -74.07 145.3 44.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.67 1.588 . . . . 3.19 110.684 175.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -75.37 133.09 41.29 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.694 0.798 . . . . 5.15 109.996 173.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.05 149.74 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.416 1.086 . . . . 1.77 109.865 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.3 mtm -83.37 93.86 7.84 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 3.86 112.985 175.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.38 165.67 22.7 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.367 0.984 . . . . 1.16 112.328 172.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -128.64 165.93 19.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.76 1.624 . . . . 2.59 111.098 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -178.74 144.78 0.46 Allowed Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 116.123 -1.894 . . . . 4.45 111.224 -175.198 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.69 143.11 60.65 Favored 'Trans proline' 0 C--N 1.347 0.472 0 CA-C-N 122.095 1.784 . . . . 0.71 111.607 160.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.56 157.28 38.76 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.202 1.401 . . . . 0.74 110.208 169.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.68 -15.78 33.65 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.74 113.09 175.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -175.16 160.27 2.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.715 1.606 . . . . 2.72 111.955 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt -109.51 175.09 5.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.851 1.261 . . . . 1.17 108.867 147.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -156.0 166.89 32.13 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.042 -1.036 . . . . 2.33 112.837 170.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.55 132.79 16.59 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 1.09 109.899 -177.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.36 162.35 38.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.736 2.29 . . . . 0.97 110.835 171.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.18 140.56 84.2 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.945 2.43 . . . . 1.25 111.485 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt 71.98 -4.0 2.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.599 2.36 . . . . 1.48 114.318 -178.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.29 177.35 33.55 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.784 1.659 . . . . 1.09 112.286 177.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -144.17 151.02 38.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.863 1.665 . . . . 3.81 112.562 175.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.96 149.77 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.786 1.635 . . . . 2.1 108.349 164.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -135.33 109.62 8.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.685 -1.598 . . . . 4.29 106.685 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.75 77.69 6.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.86 1.314 . . . . 1.44 111.212 -164.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -67.37 138.74 94.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 117.26 -1.352 . . . . 5.07 110.005 174.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.19 -54.45 4.99 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.258 3.305 . . . . 1.02 113.435 -175.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.05 51.8 3.91 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.655 1.122 . . . . 1.89 111.708 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.58 -82.9 0.04 OUTLIER Glycine 0 N--CA 1.465 0.576 0 C-N-CA 128.663 3.03 . . . . 0.93 111.223 -171.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -150.8 143.37 24.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.427 2.291 . . . . 2.22 108.402 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -160.57 167.16 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.351 -0.843 . . . . 0.85 110.63 -175.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 14.3 m-85 -107.16 122.59 46.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.585 0.754 . . . . 2.11 110.566 174.284 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 mmt -85.93 117.64 24.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.606 1.162 . . . . 0.94 110.525 171.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.7 mt -93.46 136.15 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.931 1.292 . . . . 1.94 110.238 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mt -140.72 132.79 27.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.561 0.619 . . . . 2.65 112.299 -178.255 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.71 53.82 2.18 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 125.343 1.449 . . . . 1.66 112.506 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.48 115.17 4.4 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.884 0.698 . . . . 0.99 112.884 -168.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -86.94 -13.42 44.73 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.173 1.175 . . . . 1.65 114.173 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -146.64 143.04 17.99 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.646 1.178 . . . . 5.55 110.251 177.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.52 134.58 17.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.088 2.526 . . . . 1.6 109.228 171.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.41 90.07 8.14 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.786 0.835 . . . . 2.25 111.358 -171.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -58.72 148.17 30.39 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.002 -1.061 . . . . 3.88 113.317 169.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.79 114.73 5.89 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.517 -0.739 . . . . 1.77 109.473 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.6 -9.7 7.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 116.63 -2.206 . . . . 1.93 116.816 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 173.29 10.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.449 2.624 . . . . 3.9 112.884 -177.209 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -100.16 162.12 13.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.229 1.412 . . . . 3.86 110.085 159.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.6 t -128.42 127.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.179 1.791 . . . . 1.05 108.155 172.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.2 136.81 35.89 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.533 1.533 . . . . 5.96 109.562 175.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.836 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.0 tt -154.3 130.01 10.03 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.743 1.258 . . . . 1.63 114.342 179.107 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.82 99.78 12.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.317 3.047 . . . . 2.76 110.989 173.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.48 117.16 17.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.941 -1.099 . . . . 1.14 109.173 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.2 mt -91.49 126.85 36.72 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.796 0.838 . . . . 0.8 110.382 -169.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.01 126.95 45.12 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.972 1.101 . . . . 1.77 113.972 -178.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.52 23.98 1.03 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.458 1.903 . . . . 2.32 114.603 169.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.01 -55.13 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.346 1.451 . . . . 3.93 113.004 -166.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.05 18.17 46.44 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.587 -1.674 . . . . 1.89 116.629 -169.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -141.93 157.73 44.61 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.869 2.468 . . . . 4.23 110.58 165.187 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.2 141.38 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 126.048 1.739 . . . . 1.01 107.851 162.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.4 106.89 12.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.668 1.187 . . . . 1.82 107.896 173.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -79.44 128.53 33.47 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.41 -0.806 . . . . 4.97 111.071 177.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.96 164.06 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.394 1.877 . . . . 1.48 110.443 178.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 m -105.26 155.6 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 125.441 1.496 . . . . 2.96 109.119 164.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.7 mt -141.52 149.52 54.44 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.546 1.939 . . . . 1.61 109.231 173.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.53 152.97 20.41 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.829 3.019 . . . . 0.93 112.348 176.127 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.3 t -80.38 142.04 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.276 1.03 . . . . 1.25 111.149 168.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 166.86 32.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.807 2.043 . . . . 2.94 111.204 -166.678 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.98 26.84 9.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.738 1.215 . . . . 2.0 113.392 -169.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.1 mtm105 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 116.606 -1.664 . . . . 5.88 112.382 -171.58 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 CA--C 1.552 1.046 0 CA-C-O 121.711 0.767 . . . . 7.28 111.848 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.56 151.97 17.03 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.949 1.261 . . . . 1.02 114.482 -172.828 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -155.85 162.97 40.36 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.96 1.304 . . . . 1.55 110.928 -177.36 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.66 126.82 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.718 0.77 . . . . 0.98 109.58 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.9 52.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.523 1.305 . . . . 9.47 114.523 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -97.61 139.13 33.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.856 1.262 . . . . 2.85 108.773 162.255 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -164.28 158.12 15.61 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.798 1.239 . . . . 2.62 110.994 166.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -83.96 57.98 5.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.494 3.462 . . . . 2.71 110.824 177.283 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.55 160.3 27.9 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.199 -0.778 . . . . 1.57 113.709 -177.133 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -77.53 -3.87 14.05 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.005 3.137 . . . . 1.77 113.226 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -161.33 153.68 20.1 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.724 1.61 . . . . 2.21 112.854 -176.158 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -176.97 160.26 1.79 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.717 1.607 . . . . 2.54 112.045 172.703 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.94 133.77 45.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.182 1.793 . . . . 2.22 112.372 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.76 154.77 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.172 1.389 . . . . 1.43 111.328 172.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.07 154.39 48.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.832 0.853 . . . . 2.59 112.481 -159.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -171.54 154.96 3.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.786 1.234 . . . . 1.54 112.942 176.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.475 HG21 ' HD3' ' A' ' 74' ' ' ARG . 99.5 m -74.76 146.68 41.96 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.792 -0.447 . . . . 1.94 109.792 152.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.98 124.75 43.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.35 2.26 . . . . 2.39 107.979 173.53 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -102.62 134.46 45.94 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.613 1.965 . . . . 4.77 113.315 175.612 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -99.11 106.99 41.8 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 121.573 -0.704 . . . . 1.28 109.621 162.151 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.23 -11.15 10.99 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.584 2.19 . . . . 1.22 112.989 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 176.17 51.21 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.644 1.116 . . . . 1.16 113.505 -177.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -99.59 -7.22 26.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.443 1.897 . . . . 2.65 112.818 -175.412 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.05 160.5 38.78 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.629 1.971 . . . . 2.2 109.894 170.012 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.74 149.98 23.82 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.061 2.508 . . . . 1.85 112.435 -168.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 mt -96.09 154.93 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.988 0.915 . . . . 1.97 110.784 170.71 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 68' ' ' GLU . 20.9 ttm180 -135.83 107.72 7.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.489 1.516 . . . . 3.71 108.979 171.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.6 tp -86.03 116.3 24.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.403 2.281 . . . . 0.7 108.818 -176.745 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.96 -13.16 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 0.54 112.772 -172.566 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.13 -169.19 42.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.294 1.426 . . . . 0.58 111.636 177.58 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.43 159.57 38.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.0 1.32 . . . . 1.17 111.138 168.541 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -132.16 136.9 47.42 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.68 -1.262 . . . . 6.43 110.321 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.0 155.4 70.85 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 124.875 1.27 . . . . 0.76 108.952 -174.381 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.06 -31.49 45.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.938 1.758 . . . . 1.04 113.017 160.348 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -77.01 5.86 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.852 1.427 . . . . 1.4 114.852 -167.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.72 29.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.851 1.66 . . . . 1.19 111.4 -178.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.21 -81.71 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.44 0.296 . . . . 2.91 111.055 -178.685 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -71.72 161.24 31.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.984 0.897 . . . . 3.82 110.709 174.465 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.2 138.8 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.151 -1.386 . . . . 2.2 108.268 159.078 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -133.14 124.17 27.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.442 -1.688 . . . . 2.2 106.442 160.666 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.14 121.62 26.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.163 1.347 . . . . 0.72 109.288 166.024 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -104.85 158.1 16.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.962 1.305 . . . . 0.65 112.346 176.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.21 -175.65 2.85 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.673 2.389 . . . . 2.21 111.627 172.333 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.1 m -134.72 104.11 5.9 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.003 1.721 . . . . 1.74 106.407 153.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -84.45 150.4 25.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.006 0.523 . . . . 2.3 110.805 178.858 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -106.95 135.86 47.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.208 1.003 . . . . 4.33 110.859 170.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.21 -172.97 2.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.679 1.192 . . . . 6.68 113.087 -172.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.25 149.01 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.601 2.761 . . . . 4.86 106.666 -170.958 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.04 -42.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.454 1.502 . . . . 5.56 112.641 177.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -81.35 10.53 5.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.021 1.728 . . . . 4.86 112.519 168.089 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.65 -7.29 1.06 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.306 1.432 . . . . 1.86 115.147 -167.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -72.95 133.59 44.4 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.721 -1.458 . . . . 3.58 108.474 158.973 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 142.84 36.74 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.287 -0.634 . . . . 5.92 109.287 166.889 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -147.89 152.37 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.819 2.047 . . . . 1.87 109.067 -166.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.8 mtm -123.75 143.34 50.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.618 1.167 . . . . 3.65 111.232 167.72 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.92 159.05 28.51 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.1 0.857 . . . . 1.46 113.689 -179.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.577 1.151 . . . . 1.66 112.618 -175.44 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -177.14 142.66 0.51 Allowed Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 116.663 -1.637 . . . . 4.35 110.764 -171.196 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -71.83 142.67 39.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 CA-C-N 122.204 1.823 . . . . 0.6 111.827 167.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.64 157.48 47.73 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 126.052 1.741 . . . . 0.56 110.473 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.13 -17.91 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.436 2.09 . . . . 0.6 113.025 176.398 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -175.69 169.06 3.08 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.135 1.374 . . . . 2.01 111.321 -177.224 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.21 175.18 5.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.645 1.978 . . . . 1.15 108.961 156.035 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.3 pt-20 -152.47 164.26 37.91 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.105 -0.997 . . . . 2.66 111.511 176.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -147.58 129.06 7.28 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.17 0.988 . . . . 1.14 110.311 -172.001 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.65 157.49 35.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.996 2.464 . . . . 1.48 111.934 179.65 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.89 137.56 73.25 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.374 3.383 . . . . 1.46 113.293 -174.908 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 68.88 -5.46 1.01 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.261 2.224 . . . . 1.23 114.42 -176.494 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.62 137.2 14.15 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 126.498 1.999 . . . . 1.33 109.838 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.475 ' HD3' HG21 ' A' ' 21' ' ' THR . 7.6 ptp180 -107.26 136.79 46.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.061 -1.07 . . . . 5.05 110.561 158.493 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.21 149.07 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 125.378 1.471 . . . . 2.38 110.702 -178.372 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -100.95 134.5 43.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.151 1.908 . . . . 4.02 116.151 -167.866 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.29 78.68 1.33 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.505 1.522 . . . . 1.14 107.453 155.455 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -83.17 139.55 42.26 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.556 1.142 . . . . 2.86 110.364 178.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.8 -53.35 7.06 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.851 3.034 . . . . 1.25 113.915 -169.147 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.04 90.45 1.68 Allowed Glycine 0 N--CA 1.469 0.894 0 N-CA-C 109.622 -1.391 . . . . 1.56 109.622 166.017 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.15 -74.29 0.22 Allowed Glycine 0 N--CA 1.468 0.794 0 C-N-CA 124.843 1.211 . . . . 1.25 112.767 -168.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -156.02 144.86 20.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.52 1.928 . . . . 1.96 109.346 177.101 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -167.73 164.91 14.39 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.977 -1.077 . . . . 0.78 109.629 -176.251 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -95.92 120.33 36.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.826 0.45 . . . . 2.03 110.183 175.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.1 mmt -76.9 100.05 5.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.643 1.211 . . . . 1.09 109.365 163.793 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -102.02 111.11 23.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.663 -1.608 . . . . 1.94 108.268 178.63 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.56 52.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.0 1.72 . . . . 3.43 109.124 -173.524 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.96 63.09 2.12 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.797 -0.921 . . . . 1.56 110.797 -174.855 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.97 117.23 13.32 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.387 0.675 . . . . 1.48 111.427 -176.068 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -82.82 -6.93 59.66 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.689 1.366 . . . . 1.49 114.689 -165.335 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -122.87 153.22 63.64 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.921 -1.511 . . . . 4.62 106.921 152.451 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.34 123.71 9.79 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 107.371 -1.819 . . . . 1.71 107.371 151.34 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.35 154.36 41.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.935 1.294 . . . . 2.08 112.069 -166.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -131.38 129.1 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.564 1.146 . . . . 6.09 110.931 165.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.05 121.86 8.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.795 -0.816 . . . . 1.61 108.795 169.647 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.55 1.84 56.53 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-O 117.998 -1.446 . . . . 1.89 116.127 -169.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -78.79 170.22 17.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.182 1.991 . . . . 2.72 110.243 162.159 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -116.15 149.78 38.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.812 2.045 . . . . 5.07 109.811 177.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.4 t -127.62 113.94 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.404 1.081 . . . . 1.19 109.722 -178.343 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.428 ' OE2' ' HE2' ' A' ' 112' ' ' LYS . 1.2 mt-10 -68.95 134.55 49.68 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.981 0.8 . . . . 3.09 109.646 159.459 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -147.4 116.96 7.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.565 1.146 . . . . 1.57 112.372 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -89.68 94.58 9.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.688 2.795 . . . . 2.18 110.543 177.651 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -74.13 123.31 24.2 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.796 1.239 . . . . 1.19 110.815 -177.017 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 mt -96.8 129.69 44.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.831 1.252 . . . . 0.68 111.23 -172.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.57 129.82 41.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.049 0.928 . . . . 1.89 113.172 -173.463 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 32.37 50.41 0.18 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.671 2.388 . . . . 1.63 113.935 175.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.26 -90.88 0.53 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.897 1.237 . . . . 3.64 112.053 -172.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.19 15.94 19.75 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 117.399 1.719 . . . . 1.59 117.399 -164.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.0 145.21 42.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.784 2.292 . . . . 5.23 109.363 166.323 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -147.8 137.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 124.906 1.282 . . . . 1.1 108.96 167.684 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.5 mt -142.14 124.62 15.74 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.48 1.512 . . . . 1.84 107.858 -175.475 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.428 ' HE2' ' OE2' ' A' ' 100' ' ' GLU . 10.0 ptmt -102.96 150.12 23.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.437 1.643 . . . . 2.43 115.437 -174.258 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.78 160.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.233 1.813 . . . . 1.22 110.284 178.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -117.05 118.71 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.578 1.151 . . . . 1.89 110.261 171.394 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.2 mt -108.9 150.42 40.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.331 1.852 . . . . 1.5 109.769 178.398 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.24 155.43 19.29 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.455 2.77 . . . . 0.91 111.698 170.068 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.42 145.36 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.924 1.29 . . . . 1.26 109.258 163.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.64 171.14 16.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.545 1.938 . . . . 3.27 108.797 -176.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.57 3.58 7.5 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.436 2.013 . . . . 3.01 116.436 -160.476 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 130.209 3.403 . . . . 4.76 109.272 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.991 0 CA-C-O 117.061 -1.966 . . . . 9.56 112.343 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.501 ' HA ' ' CG ' ' A' ' 3' ' ' PHE . 1.2 p 52.33 134.9 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 2 C-N-CA 134.999 5.319 . . . . 8.46 117.738 -14.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.501 ' CG ' ' HA ' ' A' ' 2' ' ' SER 0.305 41.7 p90 52.84 74.19 0.31 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 131.424 3.89 . . . . 8.79 114.077 -2.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.92 122.53 37.61 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 106.211 -1.774 . . . . 5.91 106.211 170.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -141.81 -158.09 0.83 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.402 0.889 . . . . 5.09 113.402 -152.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -162.38 -179.2 36.83 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 126.021 1.772 . . . . 1.26 115.407 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -127.91 140.49 51.97 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.406 0.682 . . . . 2.15 112.835 170.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.9 t -83.06 138.5 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.877 -1.157 . . . . 0.94 107.877 160.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -83.87 119.75 25.23 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.162 -0.961 . . . . 3.75 112.448 -164.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.03 129.13 20.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.116 1.366 . . . . 3.35 110.619 163.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m 179.24 111.31 0.18 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.075 1.75 . . . . 2.04 110.316 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -84.41 48.72 2.53 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.006 3.138 . . . . 2.19 110.181 167.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.65 -174.67 27.01 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.405 1.002 . . . . 1.63 113.037 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.06 -17.01 28.63 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.685 2.256 . . . . 1.61 111.529 163.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -150.28 169.06 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.403 1.881 . . . . 1.98 113.019 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.9 -159.59 0.92 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.469 2.307 . . . . 1.31 109.422 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.06 166.07 27.2 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.732 1.213 . . . . 1.56 111.247 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.72 133.58 40.11 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.369 1.068 . . . . 0.99 111.753 162.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -120.96 148.15 44.49 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.89 2.076 . . . . 2.41 109.707 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -169.84 154.67 5.39 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.482 1.29 . . . . 1.41 114.482 174.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 m -74.39 143.61 44.72 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.429 1.092 . . . . 1.38 108.655 157.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -142.53 130.59 21.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.706 -1.22 . . . . 2.19 107.706 172.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -142.16 142.86 32.76 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.882 0.873 . . . . 4.23 111.203 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -102.46 110.75 63.62 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.458 1.503 . . . . 0.82 110.526 -168.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.04 -10.51 13.89 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.229 1.952 . . . . 0.95 113.524 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.51 169.71 54.85 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.262 0.937 . . . . 0.84 113.673 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -98.01 -4.99 35.01 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.93 1.692 . . . . 2.53 112.89 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.79 159.61 38.3 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 126.053 1.741 . . . . 1.62 109.856 167.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -78.75 159.02 28.13 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.889 2.392 . . . . 0.94 112.038 -169.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.43 154.16 19.35 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.213 1.005 . . . . 2.11 110.262 168.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -137.95 109.35 6.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.789 1.236 . . . . 2.92 108.814 168.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -88.76 106.92 18.68 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.639 2.376 . . . . 0.7 108.952 -173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.36 -11.56 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.378 1.071 . . . . 0.53 112.705 -172.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.86 -168.86 40.54 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.364 0.983 . . . . 0.57 111.904 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -150.25 -179.73 7.43 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.571 1.148 . . . . 0.86 109.17 163.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -159.52 137.92 10.55 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 119.038 0.836 . . . . 4.94 109.286 -167.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -143.37 161.15 48.9 Favored Pre-proline 0 N--CA 1.477 0.892 0 CA-C-N 119.741 1.155 . . . . 0.59 109.92 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.91 -29.56 15.05 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 121.891 1.727 . . . . 0.93 113.583 164.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.0 m -81.01 0.78 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.12 1.526 . . . . 0.89 115.12 -166.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 160.54 39.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.656 1.182 . . . . 1.02 112.24 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -96.96 -82.07 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.777 1.231 . . . . 2.77 111.298 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -80.59 101.02 8.92 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 120.301 -1.499 . . . . 3.58 108.954 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 35' ' ' ALA . 5.6 p -84.78 137.21 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 125.977 1.711 . . . . 1.23 111.365 165.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -141.63 132.5 25.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.782 1.633 . . . . 2.08 110.753 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -82.98 123.25 29.26 Favored 'General case' 0 C--N 1.346 0.447 0 CA-C-N 121.088 1.767 . . . . 0.66 111.713 168.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.2 m170 -110.43 152.23 26.55 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.181 1.792 . . . . 0.57 112.701 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -85.06 166.13 16.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.005 1.722 . . . . 2.17 110.193 158.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.1 m -147.51 126.25 12.62 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.256 1.422 . . . . 1.62 107.481 168.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -140.12 164.24 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.925 0.713 . . . . 2.37 112.925 -151.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -110.2 138.51 46.48 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.418 0.687 . . . . 3.2 110.18 153.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -145.27 155.29 43.14 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.879 1.672 . . . . 7.29 109.213 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.32 150.96 20.54 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.677 0.791 . . . . 3.73 110.197 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.5 t -130.89 -97.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.428 1.091 . . . . 2.86 109.619 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -76.54 45.12 0.38 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.92 2.088 . . . . 3.28 111.584 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.36 -5.55 5.21 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.776 -1.202 . . . . 1.76 113.623 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -106.08 147.77 28.55 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.182 2.193 . . . . 2.88 109.946 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -76.28 138.42 40.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.557 0.743 . . . . 4.01 111.229 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -137.31 151.63 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.286 1.834 . . . . 1.62 109.288 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 mtm -127.4 145.35 50.85 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.288 1.035 . . . . 3.51 111.775 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.02 -173.85 37.07 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.509 1.052 . . . . 1.53 113.483 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -123.27 168.07 12.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.381 1.872 . . . . 1.86 111.068 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -175.16 131.93 0.45 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-O 116.361 -1.78 . . . . 4.43 111.882 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 18.2 Cg_endo -67.72 142.47 58.21 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 122.533 1.94 . . . . 0.56 112.553 171.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.43 160.26 44.56 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.22 1.808 . . . . 0.52 110.376 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.6 -20.15 20.72 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.354 2.036 . . . . 0.67 113.17 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -176.27 168.1 2.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.959 1.254 . . . . 1.83 112.018 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -116.58 173.81 6.41 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.445 2.298 . . . . 1.08 109.128 153.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -156.61 166.62 32.87 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.058 -1.026 . . . . 1.96 112.731 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -147.79 132.15 8.7 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 124.104 0.962 . . . . 0.92 109.154 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.4 165.9 30.16 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.577 1.518 . . . . 0.82 110.762 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.43 138.71 82.34 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.194 2.596 . . . . 0.84 111.144 171.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt 68.45 -2.69 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.011 1.724 . . . . 1.36 113.883 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.91 -172.67 45.12 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 126.187 1.851 . . . . 0.99 113.423 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -152.15 149.11 28.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.056 1.742 . . . . 4.83 111.621 -171.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.04 142.08 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.616 1.567 . . . . 2.35 108.551 161.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -106.1 123.17 47.59 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.966 0.803 . . . . 3.82 109.735 166.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.31 69.7 0.56 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.347 1.459 . . . . 1.18 108.194 162.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -81.4 145.62 55.82 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.461 2.305 . . . . 2.89 109.694 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.7 -42.7 65.99 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.148 2.566 . . . . 0.85 112.501 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.75 59.99 4.24 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.814 0.734 . . . . 1.08 112.171 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.63 -70.3 0.05 OUTLIER Glycine 0 N--CA 1.468 0.786 0 C-N-CA 124.053 0.835 . . . . 0.78 114.371 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -155.16 147.18 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.835 1.654 . . . . 1.85 109.367 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -165.25 174.87 9.75 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.022 -1.049 . . . . 0.98 110.921 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -104.59 132.31 50.98 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.724 -0.473 . . . . 1.84 109.724 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.3 mmt -80.89 135.81 35.97 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.134 0.574 . . . . 1.2 110.143 159.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.42 98.36 6.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.143 1.377 . . . . 1.62 109.411 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.9 mt -102.38 142.94 32.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.828 0.851 . . . . 2.4 111.162 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.66 75.0 0.73 Allowed Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.398 -1.081 . . . . 1.31 110.398 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.2 124.11 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 117.271 0.536 . . . . 0.99 112.142 -170.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -82.33 -6.31 59.17 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.001 0.741 . . . . 1.43 113.001 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -154.32 150.04 21.51 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 127.48 2.312 . . . . 3.95 108.366 158.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.28 134.57 45.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.934 1.756 . . . . 1.65 108.249 168.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.75 119.73 20.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.922 -0.399 . . . . 2.33 109.922 -176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -105.5 124.0 48.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.296 1.839 . . . . 3.73 109.987 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.09 130.98 48.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.666 0.666 . . . . 2.14 109.731 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.3 34.77 31.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 120.025 -0.319 . . . . 2.25 113.25 -167.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.99 174.27 6.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.929 -1.137 . . . . 2.51 107.929 148.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -116.8 151.11 37.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.628 1.171 . . . . 3.54 108.309 161.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.6 t -127.53 126.99 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.901 1.281 . . . . 0.95 109.698 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -75.08 142.31 43.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.255 1.026 . . . . 2.78 111.349 161.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.37 114.12 5.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.931 -1.031 . . . . 1.62 111.361 -172.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -84.02 93.84 8.17 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.028 2.531 . . . . 2.12 109.968 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.2 mt -71.53 121.88 19.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.151 0.98 . . . . 1.13 110.678 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.3 mt -95.76 128.22 42.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 0.58 111.674 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -127.54 137.44 52.62 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.419 0.687 . . . . 1.79 112.101 -173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.02 130.28 21.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.342 1.457 . . . . 2.04 114.311 -165.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.3 -144.94 22.8 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.986 -1.246 . . . . 3.05 109.986 -164.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.27 54.44 1.54 Allowed Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.734 -1.037 . . . . 1.52 114.135 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -120.24 140.28 51.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.863 1.831 . . . . 4.51 111.161 168.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -145.45 137.45 20.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 125.741 1.616 . . . . 0.95 107.581 164.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.8 mt -128.32 111.5 13.43 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.482 1.113 . . . . 1.57 108.601 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -81.17 122.57 27.54 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.352 -0.217 . . . . 2.3 111.584 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.97 164.39 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.808 1.643 . . . . 1.14 110.237 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.55 146.08 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.969 0.908 . . . . 2.03 109.034 166.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.6 mt -136.3 145.54 52.35 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.08 1.352 . . . . 1.58 109.234 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -68.2 154.75 71.59 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.562 2.175 . . . . 0.9 110.388 167.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.657 -0.868 . . . . 1.17 108.657 165.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.03 157.76 43.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.537 1.135 . . . . 3.02 110.606 -171.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.11 72.13 1.16 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.969 1.707 . . . . 2.02 112.511 -168.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.0 0 C-N-CA 124.735 1.214 . . . . 4.83 110.344 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 109.605 -1.398 . . . . 9.04 109.605 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 m -80.45 -135.79 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.819 1.31 . . . . 9.08 110.155 154.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -74.51 47.64 0.32 Allowed 'General case' 0 CA--C 1.546 0.82 0 O-C-N 120.704 -1.247 . . . . 9.65 111.046 170.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.1 p -158.18 116.45 3.04 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 127.582 2.353 . . . . 6.11 107.272 -159.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -153.14 -153.51 0.48 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.778 1.231 . . . . 6.13 111.017 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.71 167.66 21.45 Favored Glycine 0 C--N 1.341 0.852 0 C-N-CA 125.127 1.346 . . . . 1.44 114.55 172.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.3 p90 -163.08 158.23 21.71 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.353 2.261 . . . . 1.7 110.648 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.4 t -122.35 139.58 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.81 -0.556 . . . . 1.13 110.218 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -77.73 128.93 34.84 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.307 -0.406 . . . . 5.76 111.507 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -47.7 143.69 3.74 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.655 1.182 . . . . 2.7 111.769 169.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t -163.44 135.97 4.07 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.554 0.576 . . . . 3.23 112.554 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -92.18 0.45 4.15 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.546 3.497 . . . . 2.73 112.447 163.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.3 171.54 25.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.922 1.249 . . . . 1.39 114.626 -169.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.1 -13.98 18.98 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.478 3.452 . . . . 1.54 113.861 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -122.16 163.29 19.79 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.068 0.947 . . . . 2.74 111.863 166.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.52 178.55 10.19 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.292 1.437 . . . . 1.39 111.328 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.49 139.05 46.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.591 1.557 . . . . 1.39 111.957 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.02 150.11 48.34 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.161 1.385 . . . . 0.99 112.118 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -136.09 148.51 48.32 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.551 1.541 . . . . 2.22 109.308 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -165.63 152.52 10.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 1.77 114.816 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 m -79.62 120.44 23.96 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 126.094 1.757 . . . . 1.57 109.652 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.67 113.03 26.35 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.383 -0.969 . . . . 2.54 108.383 166.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -122.88 127.85 49.55 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.025 1.33 . . . . 3.32 108.7 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -98.43 104.39 23.47 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 124.368 1.067 . . . . 1.0 109.614 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.87 -10.41 12.84 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 1.1 113.311 175.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.67 164.49 52.04 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 124.276 0.941 . . . . 0.97 113.094 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.69 -9.97 59.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.766 1.226 . . . . 3.92 113.492 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.73 160.82 47.23 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.028 1.731 . . . . 1.72 111.215 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.12 151.77 23.85 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.956 2.438 . . . . 0.98 111.84 -171.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 mp -115.55 125.59 53.18 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.264 1.426 . . . . 2.35 110.468 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -107.98 114.77 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.761 1.225 . . . . 2.79 110.72 171.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.2 tp -97.07 114.72 26.4 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 128.441 2.696 . . . . 0.69 108.771 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.5 m -111.54 -11.04 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.068 0.947 . . . . 0.53 113.206 -165.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.77 -158.01 27.74 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 124.113 0.863 . . . . 0.55 111.509 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.11 178.97 9.6 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.77 0.828 . . . . 0.9 112.181 172.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 mmt85 -146.6 121.35 9.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.535 1.134 . . . . 6.63 109.733 -174.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -145.46 160.68 44.25 Favored Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 126.665 1.986 . . . . 0.84 108.988 -168.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 -31.01 11.76 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.122 1.881 . . . . 1.93 112.748 157.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 m -83.49 31.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.554 1.07 . . . . 2.7 113.84 -169.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -171.15 161.25 6.65 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 128.029 2.532 . . . . 1.55 109.227 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.94 -80.2 0.55 Allowed 'General case' 0 C--O 1.238 0.447 0 N-CA-C 105.8 -1.926 . . . . 3.48 105.8 160.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -75.43 84.94 2.54 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.14 -0.975 . . . . 3.65 109.903 166.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.76 137.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.428 -0.806 . . . . 1.19 109.619 159.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.98 122.84 27.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.792 1.237 . . . . 2.3 110.649 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 tt -79.71 119.14 22.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.922 1.237 . . . . 0.74 110.597 168.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -106.99 156.16 19.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.266 1.827 . . . . 0.83 112.23 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -112.63 -176.64 2.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 2.04 111.794 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -150.09 79.4 1.36 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.992 1.317 . . . . 1.22 108.466 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -83.58 148.57 27.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.942 -1.026 . . . . 2.65 110.214 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -90.89 155.37 18.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.789 -0.641 . . . . 3.67 111.035 164.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.5 ttt85 -151.69 149.2 28.83 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.736 1.615 . . . . 6.54 109.952 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -89.57 168.81 11.86 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 122.0 0.905 . . . . 3.54 111.782 164.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.61 -128.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.821 2.448 . . . . 4.06 107.331 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -76.68 60.49 1.69 Allowed 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 121.559 1.981 . . . . 4.64 111.14 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.15 2.9 55.08 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.643 1.116 . . . . 2.22 114.008 -170.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -87.65 126.27 34.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.354 1.462 . . . . 4.56 109.973 174.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.401 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -93.1 131.9 37.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.633 0.373 . . . . 5.01 111.39 177.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -139.77 143.14 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 125.921 1.688 . . . . 2.04 109.967 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -108.35 120.16 41.59 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.298 1.039 . . . . 3.44 110.181 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.01 44.72 1.44 Allowed Glycine 0 N--CA 1.475 1.276 0 N-CA-C 116.092 1.197 . . . . 3.66 116.092 -160.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -28.73 120.03 0.12 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 128.063 2.545 . . . . 2.52 113.624 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -144.96 154.62 55.11 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 117.654 -1.165 . . . . 5.21 110.395 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.17 146.88 82.85 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.03 1.82 . . . . 0.72 110.806 164.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.11 154.83 49.99 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.115 1.366 . . . . 0.69 110.514 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 -15.41 38.08 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.917 2.411 . . . . 1.05 112.917 176.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -175.35 163.92 3.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 2.14 111.119 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -113.61 173.6 6.34 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.613 1.965 . . . . 0.99 109.532 155.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -155.95 163.95 39.09 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.487 -0.758 . . . . 2.36 112.106 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.3 t -144.92 132.53 10.4 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 124.467 1.107 . . . . 1.07 110.019 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.13 163.14 38.91 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.437 2.758 . . . . 1.07 111.617 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.61 140.68 76.3 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.974 2.449 . . . . 0.94 111.266 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp 69.59 -1.43 2.27 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.649 1.979 . . . . 2.91 113.776 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.44 135.21 12.91 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 127.081 2.277 . . . . 1.13 110.987 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -103.71 138.38 40.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.466 1.507 . . . . 4.26 110.789 161.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.4 m -150.23 113.93 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 126.408 1.883 . . . . 2.2 107.855 165.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -81.74 142.02 33.03 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 124.174 0.99 . . . . 3.43 110.344 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -71.08 78.83 0.67 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.317 1.056 . . . . 1.02 108.924 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -87.92 138.8 30.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.412 1.485 . . . . 3.57 109.986 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.3 -40.38 59.29 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.691 2.927 . . . . 1.02 114.159 -165.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.83 78.44 1.95 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.005 -1.638 . . . . 1.17 109.005 162.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.27 -88.68 0.1 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.51 1.053 . . . . 0.81 112.622 -167.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -151.23 144.34 24.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.741 2.017 . . . . 1.8 109.496 -171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -164.65 171.85 13.88 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.564 0.746 . . . . 0.73 110.689 -174.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -110.42 131.23 55.23 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.92 0.488 . . . . 2.18 110.614 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.61 136.99 32.72 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.269 1.428 . . . . 1.27 110.44 163.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -112.49 111.2 21.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.12 1.768 . . . . 2.19 108.822 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.67 133.44 55.94 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.8 0.84 . . . . 2.65 109.642 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.65 42.53 17.22 Favored Glycine 0 N--CA 1.478 1.463 0 N-CA-C 111.618 -0.593 . . . . 1.79 111.618 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.41 120.49 23.22 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 125.687 1.595 . . . . 1.75 113.009 -171.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -86.59 -3.86 59.09 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.18 -0.918 . . . . 1.66 112.884 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -130.57 135.64 27.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 116.704 -1.617 . . . . 4.3 108.228 149.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -61.6 139.38 81.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.928 1.752 . . . . 1.99 107.841 156.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.71 110.84 18.11 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.645 1.178 . . . . 2.13 110.246 -162.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.449 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -90.01 131.07 36.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.686 0.755 . . . . 5.55 110.599 173.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 119.86 6.87 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.123 -0.944 . . . . 1.47 109.191 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.04 4.8 57.56 Favored Glycine 0 CA--C 1.536 1.355 0 CA-C-O 117.86 -1.522 . . . . 1.98 115.645 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -85.25 163.92 18.36 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 120.31 2.055 . . . . 2.93 110.433 160.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -96.86 156.9 16.15 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.853 1.261 . . . . 3.86 109.776 163.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.7 t -119.06 124.61 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 124.517 1.127 . . . . 1.01 109.152 170.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.87 134.07 43.23 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.201 1.8 . . . . 3.05 108.338 166.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mt -158.86 120.95 3.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.567 1.147 . . . . 1.49 113.578 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -105.06 112.26 25.33 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.092 2.157 . . . . 2.97 110.739 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.6 132.86 46.87 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.422 1.089 . . . . 1.27 111.183 172.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -96.42 133.69 40.52 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.813 0.845 . . . . 0.72 111.219 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -126.64 152.78 46.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.643 1.211 . . . . 2.17 112.306 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.93 134.59 57.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.217 -0.901 . . . . 2.1 113.142 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.92 46.26 37.97 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 119.12 -0.822 . . . . 3.91 114.164 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.55 18.87 61.16 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 115.993 1.157 . . . . 1.52 115.993 166.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.9 143.22 30.37 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.474 1.637 . . . . 4.49 110.463 169.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 p -152.23 138.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.948 1.699 . . . . 0.96 108.47 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -144.74 127.72 16.48 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.768 0.827 . . . . 1.63 112.523 -168.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -71.01 135.96 48.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.491 1.117 . . . . 2.43 111.944 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -135.66 151.06 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.523 1.129 . . . . 1.61 111.305 171.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.07 134.83 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.309 1.044 . . . . 3.86 112.565 -171.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.86 125.8 9.99 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.896 1.278 . . . . 3.68 109.561 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -86.76 159.41 9.05 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.608 2.872 . . . . 1.3 110.558 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.42 137.15 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.165 0.986 . . . . 1.42 109.971 172.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -140.71 150.4 43.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.131 0.972 . . . . 3.3 110.452 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.79 58.83 1.15 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.772 0.829 . . . . 3.24 109.998 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 120' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.163 0 C-N-CA 124.701 1.2 . . . . 5.49 112.666 -170.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.337 0 N-CA-C 109.636 -1.386 . . . . 13.33 109.636 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -174.58 -166.99 0.28 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.62 2.768 . . . . 10.24 106.751 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -67.72 153.79 42.94 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.483 1.038 . . . . 9.18 111.389 165.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.1 p -139.96 143.98 36.81 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.17 1.788 . . . . 6.61 110.08 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.71 -158.42 0.9 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.93 2.092 . . . . 6.15 108.832 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.35 -178.67 15.41 Favored Glycine 0 N--CA 1.467 0.712 0 CA-C-N 121.226 1.83 . . . . 1.02 116.343 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -160.3 138.06 9.73 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.218 -0.991 . . . . 1.69 111.739 165.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.1 t -93.99 122.79 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-O 121.997 0.904 . . . . 1.43 109.029 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -62.08 112.04 2.19 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.619 1.568 . . . . 4.08 112.148 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -70.15 133.48 47.15 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.461 0.648 . . . . 2.63 109.51 150.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.9 m -159.18 146.52 13.06 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.634 1.574 . . . . 2.38 109.994 169.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -86.78 67.68 4.43 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 124.118 3.212 . . . . 2.68 110.836 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -151.87 177.42 29.74 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.787 0.708 . . . . 1.25 114.04 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.33 -10.11 19.04 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.831 3.02 . . . . 1.41 113.205 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -146.27 165.78 28.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.925 1.69 . . . . 2.02 112.669 -173.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.82 153.41 29.74 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.622 1.169 . . . . 1.3 112.165 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.29 118.53 33.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.566 1.146 . . . . 1.9 109.694 162.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.79 156.74 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.87 1.268 . . . . 1.2 112.044 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -139.68 154.57 47.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.028 1.331 . . . . 1.89 112.783 -169.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.408 ' H ' ' HB2' ' A' ' 77' ' ' LEU . 2.0 pt? -160.93 157.97 27.35 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.926 1.29 . . . . 1.62 112.649 165.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.9 m -73.27 108.98 6.46 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.326 -0.99 . . . . 1.23 108.326 156.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.38 129.2 34.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.07 -1.456 . . . . 2.69 107.07 172.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -126.37 148.23 49.63 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.183 0.808 . . . . 3.09 113.183 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -112.13 110.67 53.66 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.624 1.17 . . . . 1.15 109.974 166.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -85.45 -8.37 8.53 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.045 2.497 . . . . 1.26 113.225 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.75 155.95 37.83 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.434 1.016 . . . . 1.24 112.66 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.439 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.6 m-20 -88.88 4.67 47.08 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.313 1.845 . . . . 3.03 113.296 -175.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.95 160.76 41.52 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 126.45 1.9 . . . . 1.65 110.293 167.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.24 153.75 21.6 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.034 2.49 . . . . 1.03 111.285 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.9 mt -107.38 153.57 22.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.426 1.09 . . . . 1.81 111.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -130.21 113.08 14.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.95 1.3 . . . . 2.85 110.218 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.1 tp -96.6 105.05 17.08 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 127.701 2.4 . . . . 0.61 108.316 -174.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -94.19 -11.53 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.965 0.906 . . . . 0.62 113.032 -172.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.86 -163.85 33.0 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 124.594 1.092 . . . . 0.49 111.608 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 101' ' ' LEU . . . -156.16 -175.11 5.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.26 1.024 . . . . 0.91 110.515 166.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.448 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 1.1 mmt85 -160.38 -172.75 3.69 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.893 1.224 . . . . 7.22 111.214 -172.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 t -177.86 156.35 1.1 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 126.443 1.897 . . . . 1.21 108.726 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.65 -22.29 73.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.767 2.311 . . . . 1.35 114.371 160.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -94.06 2.41 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 115.629 1.714 . . . . 1.78 115.629 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.96 167.84 21.12 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.566 1.075 . . . . 0.95 111.501 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -103.22 -88.51 0.4 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.546 0.738 . . . . 3.25 112.946 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -83.0 141.17 32.29 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.28 -1.008 . . . . 4.39 108.28 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -151.82 131.03 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.196 0.999 . . . . 1.33 109.82 -169.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -145.0 124.45 13.12 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.367 1.467 . . . . 2.49 110.151 -166.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.451 HD12 ' CE1' ' A' ' 84' ' ' PHE . 7.3 tt -79.38 121.29 24.96 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.066 -1.021 . . . . 0.67 110.816 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.8 m170 -109.19 153.12 24.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.188 1.395 . . . . 1.01 113.01 174.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.3 -175.51 2.75 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.765 2.026 . . . . 2.78 112.145 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.4 m -147.97 127.68 13.38 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 126.12 1.768 . . . . 1.85 108.503 172.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -124.78 153.51 42.35 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.326 1.45 . . . . 2.71 110.697 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.8 149.26 25.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.198 0.999 . . . . 4.81 111.234 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.14 144.17 15.84 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.933 0.893 . . . . 6.11 111.85 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.38 143.75 28.51 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.467 0.48 . . . . 3.83 109.938 162.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.92 131.54 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.483 1.513 . . . . 3.7 108.946 -178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 59.22 22.54 10.8 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.048 0.939 . . . . 3.43 111.801 -170.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.37 -6.59 56.91 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.4 -1.437 . . . . 2.39 114.126 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -93.99 144.2 25.68 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.943 1.697 . . . . 3.06 110.561 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -83.63 134.49 34.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.787 0.835 . . . . 3.91 110.521 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.9 t -144.57 151.2 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.24 1.816 . . . . 1.6 109.864 -171.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.3 mmt -106.17 135.24 48.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.454 1.102 . . . . 4.23 110.401 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -125.15 151.3 17.42 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 124.763 1.173 . . . . 1.81 112.648 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -115.4 162.46 17.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.351 1.461 . . . . 2.26 111.358 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -171.59 159.66 4.87 Favored Pre-proline 0 N--CA 1.477 0.925 0 C-N-CA 126.542 1.937 . . . . 5.82 109.761 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.9 Cg_endo -69.52 159.62 52.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.417 1.412 . . . . 0.91 111.413 164.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.0 m -129.84 157.1 77.8 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.427 1.491 . . . . 0.9 110.485 168.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.87 -10.84 26.91 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.936 2.424 . . . . 1.09 113.139 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.49 160.22 1.24 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.421 1.889 . . . . 2.01 111.669 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.61 175.27 5.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.521 1.928 . . . . 0.98 109.473 151.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.18 162.44 41.3 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.236 -0.915 . . . . 1.88 111.102 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.79 135.29 10.95 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.645 0.778 . . . . 0.93 109.843 -166.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.97 167.02 28.45 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.774 2.316 . . . . 1.05 112.174 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.52 140.48 87.39 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.681 2.921 . . . . 1.08 112.655 173.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 19.8 mmmt 68.12 0.77 2.54 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.947 2.099 . . . . 2.12 114.309 175.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.3 142.87 15.62 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 127.255 2.359 . . . . 1.22 111.571 -171.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -107.03 157.62 17.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.523 1.529 . . . . 4.95 112.889 166.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.37 125.46 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 126.342 1.857 . . . . 1.44 109.656 173.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 mp0 -83.27 127.93 34.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 4.18 111.388 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HB2' ' H ' ' A' ' 20' ' ' LEU . 10.5 mp -74.86 140.29 43.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 122.991 1.376 . . . . 1.54 109.702 166.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -166.72 146.04 4.73 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 125.091 1.356 . . . . 3.24 110.491 -153.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.11 -39.45 18.5 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.133 2.555 . . . . 1.57 112.876 -172.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.96 72.75 2.55 Favored Glycine 0 N--CA 1.467 0.757 0 N-CA-C 109.434 -1.466 . . . . 1.2 109.434 164.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.6 -94.8 0.11 Allowed Glycine 0 N--CA 1.469 0.856 0 N-CA-C 114.841 0.697 . . . . 0.8 114.841 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -151.37 143.5 23.99 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.33 1.452 . . . . 1.78 110.565 -168.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.3 p-80 -166.58 144.85 5.33 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.083 0.553 . . . . 1.26 112.092 -166.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.451 ' CE1' HD12 ' A' ' 45' ' ' LEU . 55.6 m-85 -92.65 118.48 31.08 Favored 'General case' 0 CA--C 1.52 -0.178 0 O-C-N 121.651 -0.655 . . . . 1.86 109.729 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 mmt -79.68 115.65 19.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.21 -0.663 . . . . 1.38 109.21 170.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.0 mt -99.76 125.45 45.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.628 1.571 . . . . 1.48 107.946 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.57 120.42 35.76 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.412 1.485 . . . . 2.73 107.42 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.57 89.59 0.9 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.349 -1.1 . . . . 1.49 110.349 -170.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.4 mt -89.82 123.04 33.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.153 0.981 . . . . 0.9 109.283 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -78.68 -11.26 59.97 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.629 -1.295 . . . . 1.73 113.873 -168.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -143.41 161.95 44.73 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 128.507 2.723 . . . . 6.48 108.164 160.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.53 128.6 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 N-CA-C 107.07 -1.935 . . . . 1.58 107.07 147.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.99 155.46 30.75 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.11 -0.7 . . . . 2.76 109.11 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.71 125.21 22.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.958 0.885 . . . . 4.27 111.883 176.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.17 133.39 15.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.116 0.967 . . . . 2.01 112.225 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.64 40.94 4.57 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.037 -0.868 . . . . 2.61 113.382 -168.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.6 165.79 29.32 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 126.851 2.06 . . . . 2.57 108.271 157.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -99.73 158.01 16.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 126.087 1.755 . . . . 3.99 111.294 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.5 t -115.66 119.94 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.858 1.263 . . . . 0.97 108.232 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 122.42 16.22 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.851 -1.166 . . . . 3.19 107.851 155.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.419 ' CD1' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -122.08 131.76 54.14 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.507 1.523 . . . . 2.57 107.312 175.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.448 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 51.2 m-20 -111.71 81.58 1.48 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.154 1.382 . . . . 3.5 110.417 -164.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -66.78 118.72 10.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.336 1.854 . . . . 1.24 110.976 -170.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.82 122.39 34.31 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.258 1.023 . . . . 1.02 110.827 -176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.08 139.49 54.02 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.038 0.923 . . . . 2.0 111.772 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.96 128.77 22.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.1 1.36 . . . . 2.04 113.747 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.09 60.87 3.19 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.236 0.922 . . . . 3.35 113.068 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.68 6.77 88.83 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 116.956 1.543 . . . . 2.67 116.956 163.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.72 137.64 32.75 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.248 2.024 . . . . 4.38 110.708 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.32 133.22 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 124.559 1.144 . . . . 1.87 109.214 161.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.2 mt -114.33 109.31 18.16 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.323 1.049 . . . . 1.9 109.904 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.73 94.14 1.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.148 0.979 . . . . 3.7 109.278 168.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.68 156.94 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.849 0.86 . . . . 1.81 110.065 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -103.46 139.17 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.482 1.113 . . . . 1.91 109.364 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.0 mt -142.02 153.35 63.71 Favored Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.786 2.035 . . . . 1.58 108.611 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.65 153.16 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.867 2.378 . . . . 1.11 112.102 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.5 t -77.95 132.5 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.131 0.972 . . . . 1.49 108.486 159.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.87 151.2 23.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.909 0.884 . . . . 3.5 110.837 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.76 115.39 30.05 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.042 1.337 . . . . 2.29 111.805 -161.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 129.17 2.988 . . . . 5.68 108.037 177.092 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 114' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.725 0 CA-C-O 119.42 -0.655 . . . . 12.5 112.24 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.83 32.71 0.08 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.073 1.749 . . . . 11.86 112.436 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 63.46 -10.45 0.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.252 2.221 . . . . 10.91 113.45 -152.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.9 p -60.6 146.67 44.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.157 2.183 . . . . 6.2 111.684 166.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.01 126.75 55.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.4 1.88 . . . . 6.09 111.795 -165.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.64 169.73 41.39 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.976 2.227 . . . . 1.59 110.493 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 10.6 p90 -141.99 154.34 44.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.426 0.898 . . . . 2.27 113.426 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.07 126.27 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.366 -0.834 . . . . 0.96 109.147 167.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.06 108.67 12.72 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 125.23 1.412 . . . . 3.72 112.414 -162.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -66.14 122.61 17.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.184 1.394 . . . . 2.85 111.321 172.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -165.2 140.01 4.18 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 124.702 1.201 . . . . 2.31 110.151 167.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -82.87 71.35 6.4 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.287 3.325 . . . . 2.13 109.503 176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.26 172.92 19.14 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.321 0.962 . . . . 1.32 114.443 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.05 -16.1 36.21 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.235 2.623 . . . . 1.71 111.68 166.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -144.86 164.78 30.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.571 1.149 . . . . 2.47 113.435 177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.42 -166.35 1.64 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.375 2.27 . . . . 1.15 109.527 -176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.29 164.07 38.17 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.412 0.893 . . . . 1.21 113.412 -168.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.69 139.64 40.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.677 1.191 . . . . 1.2 111.428 163.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.45 140.57 41.33 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.73 2.012 . . . . 2.67 109.236 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.49 153.73 11.38 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.18 1.178 . . . . 2.12 114.18 -166.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 m -78.91 98.08 6.26 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 107.663 -1.236 . . . . 2.12 107.663 157.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.09 133.67 46.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.435 1.894 . . . . 3.23 108.589 173.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -105.44 145.28 31.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.194 0.813 . . . . 4.87 113.194 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -122.72 110.6 31.68 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.65 0.78 . . . . 1.42 109.507 150.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -91.94 -10.09 2.5 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.575 2.85 . . . . 1.44 113.513 170.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.26 159.27 33.64 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.795 1.188 . . . . 1.26 112.929 -176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 4.5 m-20 -87.26 4.06 44.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.071 1.748 . . . . 3.07 113.507 -174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.32 159.93 41.56 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.067 1.747 . . . . 1.85 110.64 169.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.38 149.83 21.91 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.812 2.341 . . . . 1.05 111.208 -172.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.59 125.83 52.96 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 124.962 1.305 . . . . 2.26 109.163 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -111.25 99.66 8.44 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.236 1.014 . . . . 3.02 109.205 172.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 tp -80.63 114.3 19.42 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.999 2.12 . . . . 0.72 109.482 -174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.7 m -103.22 -11.17 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.507 1.123 . . . . 0.55 113.369 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.5 -166.02 37.72 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 124.4 1.0 . . . . 0.74 111.791 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.15 -179.16 6.95 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.408 1.083 . . . . 1.06 109.11 163.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -154.63 147.41 24.37 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.224 1.009 . . . . 6.06 108.332 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 t -146.4 156.4 49.62 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.207 1.003 . . . . 0.83 109.792 -167.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -81.69 -1.11 10.78 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.166 2.578 . . . . 1.58 113.445 166.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG11 HG22 ' A' ' 99' ' ' VAL . 2.3 m -101.64 -5.9 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 115.485 1.661 . . . . 1.19 115.485 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.54 158.77 41.75 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.818 1.19 . . . . 1.25 113.403 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.94 -76.62 0.52 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.644 1.578 . . . . 3.1 110.736 -170.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -80.99 114.32 19.79 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.08 -1.013 . . . . 4.05 108.728 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.52 133.26 65.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 1.26 109.255 176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -144.69 134.97 24.26 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.351 1.06 . . . . 2.3 110.884 -170.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.74 120.4 26.37 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 122.316 1.055 . . . . 0.71 111.04 169.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 14.1 m170 -107.15 154.58 20.96 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.303 1.841 . . . . 0.72 112.152 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -104.34 -176.77 3.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.123 1.769 . . . . 2.13 110.39 167.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -148.07 86.86 1.58 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.915 1.286 . . . . 1.44 108.836 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -73.09 166.88 22.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.049 1.34 . . . . 2.29 111.967 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.5 ptt? -111.07 159.12 18.08 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.301 0.64 . . . . 3.58 111.231 161.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -154.98 133.84 12.18 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.828 1.251 . . . . 6.08 109.707 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.52 147.52 47.65 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.535 0.734 . . . . 3.4 109.579 165.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.9 p -145.42 -40.99 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 115.322 1.601 . . . . 3.04 115.322 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -115.89 30.98 7.0 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.507 1.923 . . . . 4.45 109.699 175.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 -14.25 4.05 Favored Glycine 0 CA--C 1.535 1.338 0 O-C-N 120.227 -1.546 . . . . 1.88 113.35 -165.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -104.15 160.29 14.98 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 127.725 2.41 . . . . 4.65 110.3 170.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -92.28 146.8 23.42 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.467 1.655 . . . . 3.68 115.467 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.37 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.731 2.013 . . . . 1.72 107.618 165.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -91.82 135.98 33.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.059 1.344 . . . . 3.75 110.217 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.47 148.75 20.37 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 124.237 0.922 . . . . 1.6 112.812 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -99.3 163.04 12.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.966 1.306 . . . . 1.76 112.035 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -170.64 152.08 3.72 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 125.847 1.659 . . . . 4.97 110.813 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.3 Cg_endo -69.54 150.07 69.1 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.675 1.583 . . . . 0.82 111.592 166.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.41 157.58 70.0 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 126.946 2.099 . . . . 0.89 110.188 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.47 -19.47 24.96 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.638 2.225 . . . . 0.86 112.996 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -174.46 166.22 3.93 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.183 1.393 . . . . 1.89 111.687 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mt -118.24 176.14 5.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.767 2.427 . . . . 1.05 108.815 156.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.32 165.09 36.84 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.095 -1.003 . . . . 2.02 111.668 167.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.43 134.15 10.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.68 1.592 . . . . 0.95 108.805 -171.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.66 165.97 29.05 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.815 2.343 . . . . 0.82 111.739 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.56 144.47 97.75 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.557 2.838 . . . . 0.93 112.459 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 20.4 mmmt 68.65 -5.84 0.92 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 127.19 2.196 . . . . 2.11 114.823 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.51 122.22 7.29 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 126.574 2.035 . . . . 1.19 111.028 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -88.64 136.6 32.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.015 0.526 . . . . 4.5 110.21 157.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.9 173.36 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.904 2.082 . . . . 2.12 110.278 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -116.63 111.65 20.16 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.418 1.008 . . . . 4.27 113.639 -161.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 mp -73.08 76.67 1.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.222 1.009 . . . . 1.39 108.436 156.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.51 155.19 76.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.044 0.938 . . . . 2.73 112.427 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.51 -58.37 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.11 2.54 . . . . 1.01 112.524 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.63 74.8 2.39 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 110.598 -1.001 . . . . 1.49 110.598 171.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.84 -75.84 0.08 OUTLIER Glycine 0 N--CA 1.469 0.835 0 C-N-CA 124.998 1.285 . . . . 1.07 114.069 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -156.18 138.13 14.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.772 1.629 . . . . 2.39 109.926 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -168.61 164.0 12.29 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.654 1.57 . . . . 0.78 111.282 -172.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.41 129.55 41.11 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 110.429 -0.211 . . . . 2.19 110.429 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.5 mmt -87.58 135.9 33.17 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.262 1.025 . . . . 0.86 110.351 165.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.7 mt -113.58 114.79 26.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.445 1.498 . . . . 1.76 108.262 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.8 123.7 48.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.657 1.983 . . . . 2.89 108.417 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.55 100.74 0.15 Allowed Glycine 0 N--CA 1.471 0.99 0 N-CA-C 110.55 -1.02 . . . . 1.49 110.55 -174.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.65 120.03 36.23 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.93 0.865 . . . . 0.94 111.07 -172.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.38 -11.68 61.02 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.204 1.402 . . . . 2.26 113.924 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -167.09 155.52 9.08 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 126.744 2.018 . . . . 4.88 110.235 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -62.4 140.52 82.8 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.801 1.667 . . . . 2.19 109.318 163.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 39' ' ' VAL . 22.7 mt -84.3 89.96 7.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.535 1.134 . . . . 2.63 109.585 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 108.04 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.535 1.134 . . . . 5.22 110.302 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.0 113.1 0.91 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.021 0.528 . . . . 1.56 110.842 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.78 3.11 30.4 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 116.76 -2.133 . . . . 2.57 116.655 -173.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.92 171.76 14.51 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.341 2.571 . . . . 4.76 110.102 152.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -103.3 135.02 45.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.713 -1.217 . . . . 6.49 107.713 145.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.494 HG22 HG11 ' A' ' 39' ' ' VAL . 22.8 t -74.24 125.92 34.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 124.221 1.009 . . . . 1.33 108.724 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.45 136.33 56.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.688 0.756 . . . . 3.4 110.233 162.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -147.58 124.81 11.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 123.29 1.519 . . . . 1.75 111.77 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.47 83.85 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 127.554 2.341 . . . . 2.58 109.491 -167.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.27 120.05 12.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.585 1.154 . . . . 1.26 110.279 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.5 mt -97.57 130.34 44.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.646 1.579 . . . . 0.76 110.709 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 90.5 m-85 -134.15 129.3 35.65 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.414 -0.804 . . . . 1.95 111.133 -175.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 43.36 34.25 0.71 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.844 1.657 . . . . 2.29 113.478 -174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.23 -76.59 1.93 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.175 1.369 . . . . 4.48 111.39 -167.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.33 -34.1 74.11 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.773 1.069 . . . . 2.66 115.773 -160.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -79.17 93.39 5.2 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 120.016 1.908 . . . . 7.24 110.267 178.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.84 128.75 44.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 125.568 1.547 . . . . 1.12 108.405 167.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.63 179.78 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.033 1.333 . . . . 3.43 110.456 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -134.41 119.73 18.93 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.251 1.02 . . . . 2.54 108.4 154.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -122.42 168.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.907 -1.516 . . . . 2.71 106.907 170.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.41 ' O ' ' HA2' ' A' ' 1' ' ' GLY . 5.0 m -125.65 144.3 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.35 1.86 . . . . 2.57 108.922 172.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.4 mt -143.39 141.47 19.25 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 124.558 1.143 . . . . 2.48 111.482 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.1 144.86 99.37 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.937 3.092 . . . . 1.51 113.793 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.08 125.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 108.334 -0.988 . . . . 1.14 108.334 168.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.77 161.79 42.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.989 0.916 . . . . 3.21 110.463 -168.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.52 5.85 34.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.559 1.318 . . . . 2.51 114.559 -156.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 . . . . . 0 C--O 1.25 1.125 0 C-N-CA 126.188 1.795 . . . . 5.3 111.373 -178.105 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.433 ' H1 ' ' CD ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 107.38 -2.288 . . . . 11.63 107.38 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 m -60.49 177.02 0.31 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 119.426 -0.91 . . . . 11.16 110.743 136.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -72.73 102.56 3.38 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.119 -0.988 . . . . 11.31 109.677 167.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.7 p -143.88 170.44 15.9 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.137 2.175 . . . . 7.58 109.241 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -89.59 -157.55 0.46 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.987 2.115 . . . . 5.23 111.961 167.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -124.11 153.99 17.63 Favored Glycine 0 N--CA 1.469 0.847 0 C-N-CA 128.566 2.984 . . . . 1.21 111.414 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -134.64 130.91 37.12 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.726 1.263 . . . . 1.34 113.778 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.1 t -87.61 125.62 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.274 -0.891 . . . . 1.21 109.604 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.71 114.62 8.98 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.766 0.827 . . . . 3.69 112.984 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -82.5 143.67 30.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.657 0.741 . . . . 2.91 110.256 149.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.2 169.87 2.14 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 129.589 3.156 . . . . 3.52 106.787 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -80.97 33.81 0.54 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.428 2.752 . . . . 3.18 113.826 -170.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.45 150.55 17.28 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.621 1.105 . . . . 2.08 114.513 -169.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -75.43 -14.84 20.1 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.918 3.079 . . . . 1.67 112.105 168.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -134.45 157.76 45.63 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.72 2.008 . . . . 2.08 111.374 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.49 168.95 22.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.536 1.135 . . . . 1.5 112.763 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.22 122.35 42.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.977 1.311 . . . . 1.71 109.487 166.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.6 119.26 28.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.361 -0.607 . . . . 1.1 109.361 167.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -95.33 141.07 29.34 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.59 1.156 . . . . 2.24 108.876 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.458 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 4.1 pp -158.14 156.1 30.3 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.106 1.15 . . . . 2.24 114.106 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.6 m -112.31 105.86 14.26 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.722 1.209 . . . . 1.83 108.688 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 23' ' ' GLU . 3.4 tt -101.89 144.16 30.87 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.032 1.333 . . . . 2.71 109.303 -174.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.499 ' N ' HD23 ' A' ' 22' ' ' LEU . 14.7 pt-20 -145.88 141.51 27.9 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.332 0.587 . . . . 3.46 112.119 177.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -104.53 106.38 54.13 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 114.928 -1.033 . . . . 1.35 110.242 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -80.02 -12.18 13.33 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.506 2.137 . . . . 1.55 113.432 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.62 172.56 54.51 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 119.166 0.894 . . . . 1.34 113.065 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -96.0 -4.26 43.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.046 1.738 . . . . 2.99 112.492 -178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 155.54 44.99 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.634 1.974 . . . . 4.85 108.568 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.61 158.92 25.29 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.094 2.529 . . . . 1.29 111.447 -171.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.45 154.05 20.86 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.315 1.046 . . . . 2.06 109.974 170.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -134.27 110.35 9.44 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.181 1.392 . . . . 2.95 109.086 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.4 tp -88.92 124.35 34.15 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.715 2.006 . . . . 0.72 109.246 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.2 m -121.53 -6.11 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 114.08 1.141 . . . . 0.75 114.08 -170.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.21 -165.67 37.91 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 118.88 0.764 . . . . 0.84 112.463 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.865 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -154.06 177.16 11.38 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.202 -0.904 . . . . 1.22 112.433 177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.29 134.43 0.89 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.065 0.848 . . . . 5.66 112.732 162.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -129.92 157.29 77.31 Favored Pre-proline 0 N--CA 1.478 0.962 0 C-N-CA 126.53 1.932 . . . . 1.03 110.124 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.15 -23.38 66.78 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.863 2.376 . . . . 1.18 114.84 165.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -87.95 -0.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 114.729 1.381 . . . . 1.17 114.729 -171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.31 163.97 31.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.67 1.188 . . . . 0.88 111.92 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -96.11 -94.36 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.109 1.364 . . . . 3.23 109.224 168.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.99 128.87 38.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.456 -0.778 . . . . 4.6 110.025 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 p -131.09 133.02 63.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 125.002 1.321 . . . . 1.15 110.166 165.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -140.22 136.13 33.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.228 1.411 . . . . 2.96 110.64 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.04 121.39 26.48 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 121.093 -1.004 . . . . 0.66 111.082 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.6 m170 -108.5 156.0 19.98 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.503 1.521 . . . . 0.8 112.414 172.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -101.54 179.74 4.26 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.245 -0.889 . . . . 3.01 110.761 160.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -147.52 104.59 3.64 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.038 -1.097 . . . . 1.3 108.038 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -122.94 155.58 36.45 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.747 1.619 . . . . 2.3 112.899 -156.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 66.3 mtm -82.91 143.95 30.38 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.368 0.667 . . . . 3.0 111.127 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -167.16 129.1 1.65 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.063 1.345 . . . . 9.2 111.3 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -90.1 175.54 7.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 124.522 1.129 . . . . 4.3 111.436 -171.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 133.53 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.837 1.655 . . . . 3.71 108.751 162.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 65.71 10.7 6.98 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.174 0.99 . . . . 4.2 112.403 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.24 87.66 Favored Glycine 0 CA--C 1.535 1.327 0 O-C-N 120.898 -1.126 . . . . 2.01 114.089 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -96.88 142.13 29.23 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.074 1.75 . . . . 2.81 109.699 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HA ' ' OE1' ' A' ' 52' ' ' GLU . 11.4 tppt? -75.13 131.62 40.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.282 1.433 . . . . 4.34 113.139 -165.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.71 -173.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.307 1.043 . . . . 1.93 111.293 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.4 ptp -146.68 -177.17 5.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.594 1.958 . . . . 3.7 112.695 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.75 172.88 43.87 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.333 1.444 . . . . 1.07 112.935 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -114.3 156.98 23.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.561 1.544 . . . . 1.85 109.416 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -166.32 144.39 4.55 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.052 1.341 . . . . 6.44 110.068 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 21.2 Cg_endo -66.31 147.66 83.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.012 1.808 . . . . 0.82 110.414 168.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.08 156.83 52.0 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 125.544 1.538 . . . . 0.6 109.554 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.52 -22.05 39.13 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.041 1.827 . . . . 0.79 112.334 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -173.93 165.13 4.29 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 124.482 1.113 . . . . 2.4 111.814 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.48 175.34 5.67 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.422 2.289 . . . . 1.04 109.108 158.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.73 168.66 26.74 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 120.666 -1.271 . . . . 2.17 111.737 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 t -149.26 132.74 8.45 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 123.722 0.809 . . . . 1.17 110.161 -168.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.0 164.36 34.63 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.372 2.048 . . . . 1.41 111.799 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.97 140.22 78.01 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.861 3.041 . . . . 1.52 112.188 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt 70.14 0.56 3.18 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.972 2.109 . . . . 2.05 113.871 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.06 125.1 7.94 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 126.783 2.135 . . . . 1.61 111.165 -177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.18 148.0 23.88 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.914 -0.643 . . . . 4.83 112.357 154.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -144.73 162.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.456 1.902 . . . . 1.65 109.35 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.433 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 1.6 mp0 -119.13 139.91 51.0 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.821 0.82 . . . . 3.02 112.47 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.36 71.7 1.77 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.592 1.157 . . . . 1.42 108.238 155.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -80.1 142.55 55.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.104 1.761 . . . . 3.77 110.549 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -48.13 -58.82 1.52 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.969 3.779 . . . . 1.04 114.323 -172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.27 52.85 4.37 Favored Glycine 0 N--CA 1.474 1.232 0 CA-C-N 119.009 0.822 . . . . 1.21 112.067 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.28 -82.89 0.05 OUTLIER Glycine 0 N--CA 1.466 0.645 0 C-N-CA 127.627 2.537 . . . . 0.8 111.699 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -151.27 149.78 29.79 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.005 2.122 . . . . 2.36 108.967 -174.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -169.25 165.22 10.93 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.163 0.892 . . . . 0.79 111.292 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 30.7 m-85 -103.13 118.76 37.52 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 122.89 0.476 . . . . 2.21 110.226 176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.6 mmt -77.69 104.66 8.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 1.09 110.11 174.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 30.9 mt -87.44 127.93 35.22 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.048 1.339 . . . . 1.52 108.709 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.98 117.35 19.08 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.485 1.114 . . . . 3.17 109.23 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.91 75.04 1.21 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.312 -1.115 . . . . 1.32 110.312 -168.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.2 mt -69.85 129.8 40.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.434 -0.58 . . . . 1.2 109.434 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -80.98 7.71 10.11 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.954 1.094 . . . . 1.48 113.954 -170.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 176.26 153.32 0.36 Allowed Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 127.988 2.515 . . . . 4.43 109.65 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.79 144.13 76.35 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 N-CA-C 108.14 -1.523 . . . . 1.62 108.14 159.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.26 152.7 18.61 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.946 0.898 . . . . 2.35 109.093 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -117.01 135.05 54.0 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.863 0.865 . . . . 6.24 109.74 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 119.02 6.52 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.745 -1.222 . . . . 2.11 110.966 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.64 39.51 34.41 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.639 -0.663 . . . . 2.03 113.095 -168.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -91.03 -169.88 2.49 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.083 -1.08 . . . . 2.47 108.083 140.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.82 142.05 29.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.157 1.383 . . . . 4.06 109.844 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.61 102.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.276 1.43 . . . . 1.33 109.461 -172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.497 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 3.6 mm-40 -55.52 130.6 43.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.516 -1.22 . . . . 3.15 109.743 159.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.865 HD21 ' HB1' ' A' ' 35' ' ' ALA . 7.2 tt -156.34 131.67 9.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 122.369 1.08 . . . . 2.09 111.171 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.77 93.9 8.57 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 127.582 2.353 . . . . 2.28 110.454 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.83 123.07 19.97 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.402 -0.962 . . . . 1.36 108.402 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 mt -98.75 128.81 45.11 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.78 1.232 . . . . 0.73 110.006 -172.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -129.09 119.2 23.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.279 0.844 . . . . 2.07 113.279 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 23.12 44.98 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 129.2 3.0 . . . . 2.02 115.911 -174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.39 -56.07 1.57 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.616 1.579 . . . . 3.13 113.382 -171.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.89 0.14 58.53 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.685 -1.619 . . . . 2.06 116.909 -164.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 150.21 45.06 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 120.15 1.975 . . . . 3.94 111.421 169.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.03 139.54 22.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.046 1.738 . . . . 1.11 109.091 165.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.95 104.51 7.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.433 1.093 . . . . 1.66 110.015 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 8.9 ttpp -72.6 88.81 1.27 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.07 1.348 . . . . 2.79 110.213 172.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.3 m -114.23 140.25 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.142 1.377 . . . . 2.59 111.166 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -100.73 133.18 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.968 1.707 . . . . 2.22 110.92 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -133.64 149.91 73.37 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.861 1.265 . . . . 2.75 111.28 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.12 151.79 83.86 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.941 2.427 . . . . 1.39 113.389 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.9 t -83.43 134.8 26.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.135 1.374 . . . . 1.48 109.087 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -137.36 157.73 45.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.102 0.961 . . . . 3.42 109.936 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.16 112.87 25.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.91 0.884 . . . . 2.22 111.049 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.074 1.35 . . . . 5.33 111.317 174.41 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 107.482 -2.247 . . . . 9.4 107.482 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.92 -176.0 5.73 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.981 0.512 . . . . 8.88 111.233 -153.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -74.9 59.35 0.9 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.565 1.146 . . . . 12.24 111.268 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.3 m 87.27 144.46 0.05 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 130.594 3.558 . . . . 6.91 108.777 -167.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -92.45 104.2 16.55 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.903 -0.777 . . . . 5.56 108.903 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.82 171.69 44.25 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 115.601 1.0 . . . . 1.08 115.601 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 3.5 p90 -153.15 150.47 29.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.651 1.98 . . . . 1.36 111.44 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -114.41 134.89 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 108.799 -0.815 . . . . 1.06 108.799 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -73.75 126.7 30.94 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.086 0.773 . . . . 3.94 113.086 -167.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -74.66 128.75 36.32 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 122.133 0.968 . . . . 3.04 111.004 157.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -159.35 138.14 7.93 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.281 1.432 . . . . 2.39 110.199 164.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -83.42 73.27 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 124.159 3.24 . . . . 2.64 109.658 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.58 176.91 24.32 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.147 0.88 . . . . 1.43 114.068 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.32 -4.64 15.31 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.26 3.307 . . . . 2.07 112.934 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -140.67 164.27 30.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.518 1.127 . . . . 3.61 112.657 170.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.36 165.26 33.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.23 1.812 . . . . 1.3 110.227 166.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.73 154.79 20.99 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.66 0.784 . . . . 1.21 111.735 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.15 136.94 54.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.693 0.797 . . . . 1.06 111.89 164.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -133.15 128.72 36.67 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.522 1.529 . . . . 2.06 110.922 -173.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -166.08 159.19 15.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.709 1.374 . . . . 1.77 114.709 -167.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -80.33 140.68 36.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.088 0.955 . . . . 1.39 109.793 169.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.24 126.1 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.173 1.389 . . . . 2.28 107.759 170.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -151.9 148.42 27.77 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.216 0.607 . . . . 4.18 112.235 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -109.87 109.65 59.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.45 1.1 . . . . 1.02 111.842 -164.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.39 -11.12 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.35 2.033 . . . . 1.22 113.466 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.48 165.11 53.74 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.227 1.394 . . . . 1.14 114.251 -173.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.4 -36.03 63.47 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.144 2.178 . . . . 6.13 112.626 173.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -102.39 163.42 17.7 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 126.479 1.911 . . . . 1.86 111.531 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.07 159.02 23.81 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.001 2.467 . . . . 1.04 112.371 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.2 mt -103.3 145.54 29.8 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.695 1.198 . . . . 2.05 110.423 171.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -129.78 105.31 7.94 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.832 1.253 . . . . 3.83 108.24 167.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.3 tp -79.87 104.77 10.67 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.961 2.104 . . . . 0.67 108.352 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -95.45 -14.92 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.916 0.886 . . . . 0.49 112.412 -174.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.41 -163.8 33.89 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 123.775 0.702 . . . . 0.52 112.735 175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.4 177.5 9.93 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.147 0.979 . . . . 0.85 110.924 168.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -146.44 124.19 11.89 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 107.034 -1.469 . . . . 6.46 107.034 -173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -142.34 149.83 52.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-O 117.688 -1.149 . . . . 0.8 110.087 -170.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.32 -3.34 12.98 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.517 2.145 . . . . 1.06 113.463 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.46 -4.91 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 115.641 1.719 . . . . 1.09 115.641 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.16 144.52 50.74 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.681 1.192 . . . . 1.12 110.943 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -84.08 -75.99 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.679 -0.86 . . . . 3.66 108.679 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -91.29 126.72 36.46 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.386 -0.821 . . . . 4.03 108.789 165.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.26 138.38 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.442 1.497 . . . . 1.2 109.916 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -136.65 136.78 39.41 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.424 1.889 . . . . 2.31 109.358 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 tt -86.63 124.66 33.15 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 121.154 1.797 . . . . 0.73 111.073 165.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.3 m170 -108.03 153.36 23.22 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.709 1.604 . . . . 0.83 113.617 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -102.25 -179.42 3.98 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.572 2.749 . . . . 2.29 110.758 168.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.4 m -128.98 107.99 10.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.117 -1.438 . . . . 1.22 107.117 161.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -91.23 161.76 14.92 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 122.013 0.911 . . . . 2.21 111.686 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.5 mtm -118.67 168.01 11.12 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.09 -0.959 . . . . 3.3 110.902 156.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -176.53 163.63 2.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 128.335 2.654 . . . . 6.31 109.7 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.09 147.51 22.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.586 -0.894 . . . . 3.73 108.586 165.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.4 p -114.24 -15.52 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 113.858 1.059 . . . . 3.49 113.858 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -171.89 25.84 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.424 2.29 . . . . 4.13 109.046 -162.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.69 -20.98 1.64 Allowed Glycine 0 N--CA 1.477 1.375 0 O-C-N 119.392 -2.067 . . . . 2.17 113.183 -159.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.8 135.24 35.47 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.655 1.582 . . . . 4.08 109.882 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -76.19 138.62 40.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.298 1.039 . . . . 4.53 111.855 -178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -134.27 150.49 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 127.415 2.286 . . . . 1.9 108.97 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 3.9 ttp -123.46 144.25 49.63 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.557 1.943 . . . . 5.11 109.505 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.96 163.8 31.53 Favored Glycine 0 N--CA 1.469 0.838 0 CA-C-N 118.724 0.693 . . . . 1.04 113.236 173.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -94.68 159.88 14.87 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.33 1.052 . . . . 1.92 111.281 171.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 -173.21 140.33 0.89 Allowed Pre-proline 0 N--CA 1.475 0.776 0 CA-C-O 116.954 -1.498 . . . . 4.44 111.402 -168.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 17.0 Cg_endo -71.09 147.49 54.48 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.927 1.751 . . . . 0.85 112.559 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -124.61 151.4 67.41 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.415 1.486 . . . . 0.79 110.48 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.34 -8.82 24.18 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.055 2.503 . . . . 0.87 113.447 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -174.6 159.21 2.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.765 1.626 . . . . 2.54 111.097 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mt -108.85 172.8 6.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.31 1.444 . . . . 1.11 108.98 149.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.34 163.36 37.39 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.231 -0.918 . . . . 2.79 112.604 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -151.15 131.34 7.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.134 0.974 . . . . 0.91 109.806 -168.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.65 164.49 35.53 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.296 1.998 . . . . 1.05 111.291 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -61.87 133.04 42.54 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.306 2.671 . . . . 1.05 110.61 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 72.06 0.34 3.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 127.489 2.316 . . . . 1.7 113.788 -175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.67 157.5 34.37 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 126.545 2.021 . . . . 1.32 111.031 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -132.54 144.36 50.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 127.346 2.258 . . . . 4.42 110.418 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.84 163.94 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.676 1.991 . . . . 1.83 108.762 167.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -139.1 115.02 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.921 -0.77 . . . . 3.19 108.921 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.37 91.17 1.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.641 1.576 . . . . 1.2 108.781 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -110.1 151.23 42.39 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 127.525 2.33 . . . . 3.12 111.784 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.04 -53.89 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.274 3.316 . . . . 1.06 113.949 -168.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.93 93.71 1.77 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 108.413 -1.875 . . . . 1.29 108.413 164.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.61 -85.0 0.14 Allowed Glycine 0 C--O 1.222 -0.614 0 C-N-CA 124.794 1.188 . . . . 0.86 112.698 -173.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -155.95 145.87 21.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.579 1.952 . . . . 2.47 110.09 -174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -174.09 157.49 2.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.088 0.955 . . . . 1.46 108.823 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -85.68 139.17 31.6 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 119.813 -0.755 . . . . 2.01 109.893 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.7 mmt -92.42 118.94 31.46 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.419 1.087 . . . . 1.17 109.021 161.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.7 mt -100.05 114.86 28.49 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.943 1.697 . . . . 1.78 106.793 177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.5 150.78 26.96 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.365 1.066 . . . . 3.1 110.741 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.19 -55.49 4.59 Favored Glycine 0 N--CA 1.47 0.919 0 C-N-CA 125.235 1.398 . . . . 3.69 111.761 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.1 mt 69.9 125.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.775 3.23 . . . . 1.09 111.581 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -80.9 22.99 0.57 Allowed 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.263 -1.523 . . . . 1.81 113.074 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 160.6 153.41 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 129.816 3.246 . . . . 3.89 109.219 -163.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.52 131.87 31.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.234 -1.871 . . . . 1.41 107.234 151.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.1 101.52 0.41 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.928 0.891 . . . . 2.11 110.18 -174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.84 97.3 1.38 Allowed 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.729 -1.232 . . . . 4.01 109.843 -172.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -44.64 124.63 4.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.123 0.969 . . . . 1.89 111.3 172.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.5 30.46 66.65 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.013 -0.882 . . . . 1.97 114.165 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -101.45 -172.08 2.1 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.599 1.699 . . . . 3.55 107.519 136.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -132.21 151.36 51.85 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.832 0.853 . . . . 3.59 110.525 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.0 t -98.89 113.86 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 C-N-CA 124.85 1.26 . . . . 1.14 108.916 -172.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.65 138.39 46.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 124.249 0.968 . . . . 3.76 109.441 164.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mt -155.3 116.17 3.91 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.088 0.955 . . . . 1.57 111.091 -168.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.31 104.63 16.59 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.016 2.126 . . . . 2.82 109.468 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 48.0 mt -75.89 126.34 30.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 1.12 110.194 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.0 mt -97.51 121.41 39.38 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.354 1.062 . . . . 0.72 110.638 -175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.99 119.32 31.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.856 0.836 . . . . 2.04 112.732 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 47.1 28.23 0.9 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.01 2.124 . . . . 2.01 114.208 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.99 -60.07 2.2 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.707 1.622 . . . . 3.54 112.692 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.87 -7.5 86.35 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 116.26 1.264 . . . . 1.61 116.26 -167.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -116.39 145.38 43.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.214 2.007 . . . . 4.46 110.194 166.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -147.68 135.83 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.021 1.328 . . . . 1.05 108.829 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.0 mt -144.17 127.8 17.11 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.324 1.45 . . . . 1.85 108.756 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -91.01 147.18 23.26 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 115.421 1.637 . . . . 2.9 115.421 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.29 164.66 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 127.965 2.506 . . . . 1.21 109.466 171.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.5 132.83 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.104 0.962 . . . . 2.06 109.181 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mp -145.14 145.28 26.35 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.967 1.707 . . . . 2.45 109.537 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 153.35 67.12 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.372 3.381 . . . . 1.0 114.431 -172.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.62 127.17 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.056 0.942 . . . . 1.17 109.007 167.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -147.25 153.85 40.29 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.315 1.446 . . . . 3.47 111.351 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.21 47.56 0.96 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.347 1.459 . . . . 2.04 114.155 -161.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 116.934 -1.508 . . . . 5.81 112.46 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.135 0 N-CA-C 108.204 -1.958 . . . . 11.8 108.204 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t 69.97 148.59 0.07 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.171 -0.677 . . . . 11.6 109.171 -137.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 63.08 13.4 6.75 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.551 1.14 . . . . 11.0 113.463 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.5 p -140.14 133.39 29.76 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 128.654 2.781 . . . . 6.46 108.072 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -96.97 137.4 36.11 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.915 1.45 . . . . 6.92 114.915 -153.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.51 175.34 46.8 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.694 2.093 . . . . 1.05 111.683 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 14.2 p90 -165.21 152.7 11.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.237 1.199 . . . . 1.42 114.237 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.8 t -112.45 128.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.163 1.385 . . . . 1.45 109.12 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.2 117.74 29.88 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.748 0.647 . . . . 4.78 112.748 -166.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -64.5 142.13 58.53 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.244 2.218 . . . . 4.64 113.865 169.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -159.13 167.61 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 120.109 -1.62 . . . . 2.23 111.448 158.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.29 -15.68 3.49 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.121 3.214 . . . . 3.15 112.453 166.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.9 155.14 40.42 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 119.29 -0.728 . . . . 1.36 112.042 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.37 -8.7 23.89 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.075 3.183 . . . . 1.8 114.373 -174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -110.87 146.97 35.55 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.005 1.322 . . . . 3.05 111.676 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.91 -176.03 5.74 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.072 1.749 . . . . 1.25 112.952 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.0 154.85 50.29 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.449 1.1 . . . . 1.14 111.831 -173.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.18 147.88 44.28 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.265 1.031 . . . . 0.95 111.637 166.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.1 146.52 39.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.128 1.771 . . . . 1.9 108.753 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.1 153.79 14.33 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.926 0.713 . . . . 1.73 112.926 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.1 m -72.57 110.61 7.07 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.629 1.572 . . . . 1.24 108.259 159.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.07 127.81 34.14 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.159 -1.423 . . . . 2.55 107.159 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -123.68 114.49 20.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.908 1.683 . . . . 4.41 110.522 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -102.66 103.68 33.92 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.141 -0.974 . . . . 0.92 110.686 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -82.13 -7.92 11.99 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.91 2.407 . . . . 1.08 113.236 172.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.14 171.18 55.19 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 119.109 0.868 . . . . 0.99 113.7 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -101.57 0.16 35.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.367 1.867 . . . . 2.7 113.032 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.96 159.06 39.06 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.723 1.609 . . . . 1.86 110.451 167.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.23 154.37 18.95 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.043 2.495 . . . . 1.06 111.142 -173.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.4 mt -101.65 150.63 22.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.258 1.023 . . . . 2.33 110.482 171.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -133.7 103.06 5.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.526 1.131 . . . . 3.11 109.409 171.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 tp -84.14 104.83 14.52 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.366 2.267 . . . . 0.83 108.97 -172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.64 -12.93 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.154 0.982 . . . . 0.63 113.001 -172.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.26 -169.35 41.89 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 124.448 1.023 . . . . 0.6 111.76 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -158.17 -178.39 7.26 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.113 0.965 . . . . 0.88 111.508 173.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 10.4 mmt180 -158.32 149.92 21.27 Favored 'General case' 0 C--O 1.215 -0.73 0 CA-C-N 121.509 1.959 . . . . 6.85 109.126 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -154.28 152.13 25.69 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.019 1.327 . . . . 0.96 108.243 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.87 -25.14 60.35 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.661 2.241 . . . . 0.85 113.418 171.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -79.59 -4.18 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.889 1.44 . . . . 0.9 114.889 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.38 174.56 12.32 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.948 1.299 . . . . 0.96 112.476 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -116.56 -87.97 0.6 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.84 0.856 . . . . 4.32 110.17 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -69.35 107.05 3.14 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.511 -0.743 . . . . 4.89 109.71 -171.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -84.16 141.29 14.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 127.227 2.211 . . . . 2.0 110.571 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -146.72 124.2 11.7 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.767 1.227 . . . . 2.71 109.999 166.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.429 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.2 tt -81.84 115.36 21.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.184 0.993 . . . . 0.97 110.326 169.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 18.0 m170 -100.23 151.69 21.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.737 1.615 . . . . 0.87 111.881 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -95.8 177.82 5.65 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.038 -1.437 . . . . 1.99 110.689 165.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.573 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 87.5 m -147.94 102.76 3.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.24 1.416 . . . . 1.2 107.195 171.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -112.76 153.07 28.35 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.817 1.247 . . . . 2.55 112.523 -166.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -105.5 121.72 44.52 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.487 0.66 . . . . 3.37 109.598 156.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -144.91 170.01 16.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.311 1.844 . . . . 7.88 109.107 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.25 143.95 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.351 0.66 . . . . 4.27 109.927 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -139.12 -87.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.036 1.334 . . . . 3.71 108.408 -176.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -77.4 50.99 0.83 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.436 1.895 . . . . 2.96 110.404 170.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.1 -31.93 0.42 Allowed Glycine 0 N--CA 1.477 1.415 0 C-N-CA 126.601 2.048 . . . . 3.48 115.077 -175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.82 146.63 24.86 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.584 1.953 . . . . 2.79 111.37 -171.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -68.44 118.76 11.92 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 118.845 -0.598 . . . . 5.16 109.47 172.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.83 147.78 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 3.31 111.305 -173.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 23.4 mmt -77.79 141.03 39.47 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.982 1.313 . . . . 3.43 113.671 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.48 157.56 27.81 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.058 0.837 . . . . 1.25 114.13 170.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -114.63 137.42 51.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.604 1.562 . . . . 1.82 110.346 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -148.21 155.71 43.14 Favored Pre-proline 0 N--CA 1.472 0.663 0 C-N-CA 124.913 1.285 . . . . 7.04 109.955 165.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 38.6 Cg_endo -65.52 145.63 82.87 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.073 2.515 . . . . 0.69 110.953 167.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.83 159.06 33.13 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 125.338 1.455 . . . . 0.73 109.855 166.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.0 -15.14 32.48 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.625 2.217 . . . . 0.7 113.243 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -175.74 160.77 2.47 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 126.042 1.737 . . . . 2.12 111.02 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mt -109.87 175.94 5.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.827 1.651 . . . . 1.2 109.517 154.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.52 168.26 26.75 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.363 -0.835 . . . . 2.42 112.116 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 t -149.82 136.46 10.83 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.442 1.097 . . . . 0.86 109.527 -170.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -72.25 168.0 25.33 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.405 2.07 . . . . 0.85 112.048 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.54 145.28 99.06 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.789 2.993 . . . . 0.91 111.915 168.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.24 0.9 0.46 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 116.865 2.172 . . . . 1.78 116.865 -172.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 114.03 3.79 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 127.147 2.308 . . . . 0.87 111.95 -175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -81.9 139.26 34.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.997 -1.101 . . . . 5.45 109.243 151.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 m -151.36 130.51 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.657 1.583 . . . . 1.78 110.084 169.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -90.41 130.39 36.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.629 -0.669 . . . . 3.31 111.407 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -69.81 129.17 38.84 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.364 -0.976 . . . . 1.76 108.364 161.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -143.28 140.73 18.05 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.576 1.55 . . . . 2.95 110.865 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.7 -16.75 47.08 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.702 2.935 . . . . 1.81 114.278 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.98 100.0 1.79 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.24 -1.944 . . . . 1.37 108.24 152.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.573 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 142.66 -85.33 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.847 1.689 . . . . 1.36 113.089 -172.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.71 144.2 20.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.067 1.747 . . . . 1.89 111.22 -169.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.92 158.02 27.47 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.256 -0.903 . . . . 1.09 110.74 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' CE1' HD12 ' A' ' 45' ' ' LEU . 49.0 m-85 -94.28 133.05 38.24 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.074 0.397 . . . . 1.95 110.814 170.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 22.2 mmt -90.62 137.18 32.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.394 1.478 . . . . 0.93 109.906 162.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.82 126.58 45.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.503 1.521 . . . . 2.91 108.653 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.42 147.49 52.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.233 1.413 . . . . 3.28 110.526 -175.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 57.95 4.6 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.236 -0.746 . . . . 1.38 111.236 -176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.09 120.51 12.81 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 117.48 0.64 . . . . 0.87 110.938 -174.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -76.23 -9.78 58.9 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.873 1.064 . . . . 2.16 113.873 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.98 145.08 0.74 Allowed Pre-proline 0 N--CA 1.47 0.553 0 C-N-CA 127.065 2.146 . . . . 4.52 110.152 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.37 154.15 65.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.906 2.404 . . . . 2.13 109.885 170.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.71 162.03 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.044 1.338 . . . . 2.8 111.329 -170.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -114.71 127.05 55.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.265 1.026 . . . . 5.0 111.222 172.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.34 117.48 4.87 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.906 -0.588 . . . . 1.84 109.747 166.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.13 -8.46 31.18 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.21 -1.328 . . . . 2.6 114.683 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -79.34 161.2 26.38 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 119.637 1.718 . . . . 2.79 109.955 162.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -111.01 156.93 20.53 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.636 -0.711 . . . . 5.33 109.484 154.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.55 125.14 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 125.854 1.662 . . . . 1.55 108.473 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -74.58 145.85 43.03 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.481 0.658 . . . . 3.91 110.379 167.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.627 HD21 ' HB1' ' A' ' 35' ' ' ALA . 3.6 tt -154.96 126.7 7.51 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.141 0.977 . . . . 1.87 110.643 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.43 109.92 21.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.121 2.568 . . . . 2.48 112.068 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 119.03 23.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.216 1.406 . . . . 1.14 110.321 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.0 mt -89.95 111.15 22.13 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.802 0.841 . . . . 0.7 109.56 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 76.6 m-85 -111.98 124.08 51.64 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 121.707 -0.621 . . . . 2.26 109.836 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.87 37.49 1.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.123 1.769 . . . . 2.32 113.263 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -73.23 1.83 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.722 1.153 . . . . 4.62 112.091 -171.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.63 -30.2 60.33 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 115.739 1.055 . . . . 2.46 115.739 -161.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 54.1 tttp -83.91 86.45 7.17 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 119.946 1.873 . . . . 6.39 108.51 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.2 p -100.86 106.93 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.042 1.337 . . . . 1.67 109.549 173.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.16 125.81 44.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.771 1.629 . . . . 3.12 110.654 -173.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -83.14 139.04 33.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.479 1.659 . . . . 2.8 115.479 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.3 m -105.81 169.52 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.399 1.88 . . . . 1.34 109.32 159.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.6 139.23 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 125.386 1.474 . . . . 1.98 108.346 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -146.03 145.86 26.28 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.303 1.441 . . . . 1.71 110.798 -171.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.18 158.37 55.01 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 124.274 3.316 . . . . 0.98 113.948 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.44 134.55 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.313 1.445 . . . . 1.44 111.577 171.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -152.41 -172.18 4.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.878 2.071 . . . . 4.08 109.429 169.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -129.47 124.98 35.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.964 -1.085 . . . . 2.71 110.886 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.132 0 C-N-CA 125.357 1.463 . . . . 8.4 112.798 -163.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 111.369 -0.692 . . . . 8.86 111.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -81.29 109.41 15.78 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.976 -0.75 . . . . 9.58 108.976 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 53.6 79.64 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.104 1.362 . . . . 10.99 111.964 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 5' ' ' GLU . 1.6 m 86.53 -154.08 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 128.663 2.785 . . . . 6.74 109.376 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.554 ' H ' HG22 ' A' ' 4' ' ' THR . 2.2 tt0 176.12 177.34 0.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 130.348 3.459 . . . . 4.87 109.655 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.08 175.81 19.37 Favored Glycine 0 N--CA 1.466 0.655 0 O-C-N 121.48 -0.762 . . . . 1.03 114.631 170.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -159.86 146.01 15.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.943 1.697 . . . . 1.3 110.572 175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 t -88.92 138.93 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.436 -0.95 . . . . 1.04 108.436 170.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -86.73 131.76 34.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.544 0.688 . . . . 4.58 112.176 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -53.26 119.52 4.87 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.741 1.616 . . . . 3.94 112.587 164.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -165.29 99.03 0.8 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.699 2.0 . . . . 3.12 107.522 163.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -84.66 44.21 1.45 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.459 2.773 . . . . 2.82 111.964 -168.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.94 -147.78 6.47 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.304 0.954 . . . . 1.94 114.138 -167.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.32 -7.04 17.73 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.299 2.666 . . . . 1.7 112.798 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -154.25 156.89 37.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.303 1.441 . . . . 2.31 112.829 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.2 -165.36 1.9 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 128.387 2.675 . . . . 1.42 110.448 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.04 154.39 39.24 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.261 -0.899 . . . . 1.37 111.798 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.81 125.46 46.56 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.919 0.888 . . . . 1.24 110.405 165.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -103.11 147.4 27.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.985 1.714 . . . . 2.03 108.75 168.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -163.45 141.88 7.94 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.275 1.213 . . . . 1.47 114.275 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.1 m -66.82 107.61 2.24 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.277 -1.008 . . . . 1.43 108.277 161.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.66 134.36 36.42 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 106.944 -1.502 . . . . 2.7 106.944 165.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.28 151.56 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.35 1.071 . . . . 3.47 112.01 166.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -128.29 99.37 24.51 Favored Pre-proline 0 N--CA 1.443 -0.824 0 C-N-CA 125.52 1.528 . . . . 0.99 109.073 166.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -6.27 16.3 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.49 2.127 . . . . 1.01 112.841 173.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.51 174.03 54.17 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 124.282 0.944 . . . . 0.88 113.994 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -102.11 -3.79 26.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.507 1.923 . . . . 2.71 113.441 -170.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.34 161.0 33.74 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 126.107 1.763 . . . . 1.66 109.98 167.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.65 162.76 24.32 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.058 2.506 . . . . 0.93 111.978 -170.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.8 mt -112.26 144.92 40.87 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.252 1.021 . . . . 1.81 110.593 170.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -122.67 114.19 20.25 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.896 1.278 . . . . 3.09 109.27 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.54 117.23 29.79 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.04 2.136 . . . . 0.67 109.151 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.0 m -117.69 -4.9 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.405 1.082 . . . . 0.78 112.938 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.71 -174.6 47.01 Favored Glycine 0 C--N 1.341 0.856 0 C-N-CA 124.698 1.142 . . . . 0.68 111.18 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.972 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -148.06 178.92 8.13 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.242 1.417 . . . . 0.74 109.891 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.497 HH11 ' HG3' ' A' ' 36' ' ' ARG . 12.8 tpt85 -161.28 147.86 14.62 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 106.664 -1.606 . . . . 6.01 106.664 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.416 ' H ' ' HD2' ' A' ' 36' ' ' ARG . 2.5 t -149.7 157.8 38.09 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 124.6 1.16 . . . . 0.88 109.172 -166.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.05 -15.79 16.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.11 1.873 . . . . 1.29 114.351 171.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.44 HG12 ' HE ' ' A' ' 91' ' ' ARG . 4.7 m -101.16 2.46 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 116.025 1.861 . . . . 0.93 116.025 -170.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 164.05 38.13 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.416 1.007 . . . . 1.02 113.019 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.34 -79.67 0.54 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.731 2.012 . . . . 2.84 111.314 -170.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.75 111.37 9.88 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.412 -0.958 . . . . 3.89 108.412 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -84.15 139.62 17.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.435 -1.257 . . . . 1.99 110.428 158.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -142.24 122.46 13.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.597 1.159 . . . . 2.0 109.042 169.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 tt -79.01 118.74 21.29 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 120.627 1.558 . . . . 1.03 110.713 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m170 -113.36 157.28 22.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.343 1.857 . . . . 0.55 111.869 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -112.34 167.45 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.396 1.478 . . . . 2.2 110.372 166.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -123.26 114.79 20.7 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.741 1.616 . . . . 1.26 107.453 172.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -120.7 152.91 37.64 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.924 0.89 . . . . 2.33 112.809 -168.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtp -103.03 142.78 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.82 1.648 . . . . 3.72 110.325 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -157.8 144.83 18.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.097 1.359 . . . . 6.65 111.503 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 137.95 31.86 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.284 0.493 . . . . 4.19 111.104 166.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -146.71 126.33 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.732 1.613 . . . . 3.72 107.324 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 63.33 20.35 12.21 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.589 1.156 . . . . 3.24 111.963 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.17 -9.14 41.45 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.761 1.172 . . . . 2.4 113.829 -170.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -89.2 143.86 26.53 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.978 1.711 . . . . 3.32 109.927 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -81.7 118.86 23.17 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.61 -0.681 . . . . 4.02 110.875 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.5 t -122.03 150.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.239 1.816 . . . . 1.53 109.717 -174.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.5 mtm -135.24 144.65 46.99 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.771 1.228 . . . . 3.27 110.676 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.26 177.58 32.38 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 123.773 0.702 . . . . 1.45 113.037 175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -115.7 151.23 35.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.958 1.303 . . . . 1.88 110.495 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -164.43 147.65 7.59 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.29 1.036 . . . . 5.62 112.4 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 9.6 Cg_endo -70.82 153.18 64.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.229 1.953 . . . . 0.59 112.512 176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.95 159.02 70.8 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 126.438 1.895 . . . . 0.68 110.408 177.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.96 -16.83 36.85 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.421 2.081 . . . . 0.73 113.342 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -179.97 172.08 1.08 Allowed 'General case' 0 C--N 1.348 0.509 0 C-N-CA 125.424 1.49 . . . . 2.05 111.253 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.2 173.0 7.59 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.611 2.365 . . . . 1.06 109.072 159.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.25 166.47 33.08 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.058 -1.026 . . . . 2.29 111.747 169.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.2 t -150.41 137.16 11.23 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.117 1.367 . . . . 0.81 109.471 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.76 171.36 15.7 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.908 2.405 . . . . 0.98 112.315 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.35 142.04 94.54 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.1 2.533 . . . . 0.83 111.491 166.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt 65.34 2.54 1.97 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.834 1.653 . . . . 1.41 113.387 -174.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.49 121.98 5.79 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 127.451 2.453 . . . . 1.14 110.242 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -113.91 131.72 56.19 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 126.045 1.738 . . . . 6.03 109.51 167.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.4 m -159.55 134.36 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.065 1.346 . . . . 1.77 111.083 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -79.53 134.6 36.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 122.24 1.019 . . . . 3.74 112.824 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.03 69.62 0.05 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 122.874 1.321 . . . . 1.38 108.517 143.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 78' ' ' LYS . 2.4 ptmm? -83.14 149.35 58.58 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 128.682 2.793 . . . . 2.88 110.832 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -54.46 -37.99 89.71 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.22 2.613 . . . . 1.19 113.552 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.63 65.09 3.37 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 119.078 0.854 . . . . 1.83 111.022 168.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.39 -81.46 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.081 1.324 . . . . 1.23 113.391 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -153.33 152.18 30.81 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.383 1.873 . . . . 2.1 110.19 -164.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -164.87 165.14 20.68 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.37 1.068 . . . . 0.94 110.002 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 67.5 m-85 -95.89 123.6 39.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.42 -1.326 . . . . 2.31 107.42 160.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.97 129.91 34.87 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.491 -1.3 . . . . 1.21 107.491 163.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.56 123.38 49.32 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 108.864 -0.791 . . . . 3.27 108.864 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -120.93 132.55 55.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.143 1.777 . . . . 3.13 109.056 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.17 96.07 0.2 Allowed Glycine 0 N--CA 1.47 0.957 0 N-CA-C 110.288 -1.125 . . . . 1.45 110.288 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.3 mt -100.7 128.59 46.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 117.715 0.758 . . . . 1.03 111.57 -168.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -79.76 -18.95 49.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.273 1.429 . . . . 1.76 112.815 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.44 ' HE ' HG12 ' A' ' 39' ' ' VAL . 14.2 ptt180 -156.77 145.13 14.46 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.633 1.573 . . . . 5.68 110.307 167.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.87 145.3 56.08 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.944 2.43 . . . . 1.43 110.097 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -79.97 82.0 6.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.465 1.126 . . . . 2.38 110.993 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.42 133.8 54.6 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.962 1.705 . . . . 3.62 109.518 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.0 135.72 52.39 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.57 -1.331 . . . . 1.91 111.93 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.99 53.78 21.11 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.72 -0.552 . . . . 2.37 111.72 -171.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -117.98 165.73 13.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.167 1.387 . . . . 2.85 110.761 163.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 154.29 20.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.212 1.405 . . . . 5.17 109.518 164.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 94.3 t -140.89 105.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.854 1.662 . . . . 1.26 109.05 166.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -65.64 142.35 58.08 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.663 0.744 . . . . 4.18 110.209 163.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.972 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.3 tt -140.63 129.96 23.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.977 0.894 . . . . 1.9 111.13 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -86.59 101.81 13.57 Favored 'General case' 0 CA--C 1.552 1.047 1 C-N-CA 132.536 4.334 . . . . 2.92 111.436 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.7 mt -82.41 122.56 28.16 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 119.931 -1.731 . . . . 1.15 111.055 -174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.6 mt -99.17 123.07 43.18 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.737 0.815 . . . . 0.78 110.542 -171.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -119.5 153.05 35.93 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.694 0.759 . . . . 1.8 111.996 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.39 134.39 56.96 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.862 0.465 . . . . 2.4 110.672 172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.7 10.45 52.94 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 115.848 1.099 . . . . 3.93 115.848 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.25 6.77 83.91 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-N 119.119 1.46 . . . . 2.12 114.184 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -76.24 131.84 39.53 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.362 -1.081 . . . . 6.07 109.714 173.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.81 140.17 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.277 1.031 . . . . 1.27 110.2 166.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.9 mt -141.05 123.38 15.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.138 1.375 . . . . 1.85 108.931 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -92.0 145.71 24.31 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.539 0.94 . . . . 2.47 113.539 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.14 149.28 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.78 2.032 . . . . 1.91 111.093 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 m -91.96 135.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.45 1.5 . . . . 3.65 111.167 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.7 mt -144.71 85.19 8.58 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.83 1.652 . . . . 2.14 110.649 -166.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.66 154.56 59.33 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.249 2.633 . . . . 1.27 112.462 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 51.9 t -84.35 134.42 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 123.867 0.867 . . . . 1.39 111.384 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.98 157.49 40.65 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.096 1.358 . . . . 3.87 111.136 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.14 11.99 4.72 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.832 1.653 . . . . 2.67 113.948 171.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.233 0 CA-C-O 114.545 -2.645 . . . . 5.51 115.704 -174.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.353 0 CA-C-O 118.99 -0.894 . . . . 13.29 112.565 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 m 177.86 -179.03 0.25 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 129.536 3.134 . . . . 11.87 109.575 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -59.0 4.21 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 116.559 2.059 . . . . 12.73 116.559 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -81.68 -25.86 35.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.302 2.241 . . . . 7.69 111.38 168.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -155.07 141.43 18.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.886 1.274 . . . . 6.92 111.673 -138.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -102.14 149.84 18.04 Favored Glycine 0 N--CA 1.465 0.6 0 O-C-N 120.879 -1.138 . . . . 1.41 112.969 162.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.409 ' HE1' ' HB2' ' A' ' 120' ' ' ARG . 16.0 p90 -153.55 151.48 29.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.476 0.917 . . . . 1.82 113.476 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.7 t -110.76 144.12 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 1.22 110.525 178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -87.79 113.76 23.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.234 1.198 . . . . 3.74 114.234 -156.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -63.48 123.03 17.73 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.585 -0.697 . . . . 3.25 111.906 173.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -159.36 147.85 13.83 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.867 1.267 . . . . 2.48 110.348 166.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -85.39 63.31 5.84 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.089 3.192 . . . . 2.5 109.61 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.99 168.5 13.72 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.263 0.935 . . . . 1.61 113.908 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.15 -15.47 14.49 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.819 3.013 . . . . 1.5 112.001 165.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -144.86 158.97 43.61 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.369 1.867 . . . . 1.95 111.605 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.55 -177.17 6.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.852 1.261 . . . . 1.19 111.05 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.31 149.45 30.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.626 1.17 . . . . 1.17 110.916 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.65 128.89 55.37 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.45 -0.574 . . . . 1.24 109.45 160.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -111.17 162.93 14.43 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.524 1.93 . . . . 2.03 109.98 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 2.1 pt? -161.38 140.87 10.3 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.792 1.405 . . . . 1.44 114.792 166.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.2 m -79.12 137.44 37.48 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.55 -1.278 . . . . 1.3 107.55 151.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.36 135.71 13.21 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.615 1.166 . . . . 2.93 109.995 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -111.2 142.75 42.99 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.307 1.043 . . . . 3.23 113.177 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -82.17 114.21 49.29 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.592 -1.185 . . . . 0.86 109.321 152.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -83.45 -9.64 10.16 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.166 2.578 . . . . 1.13 113.386 174.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.93 170.48 47.67 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.752 1.167 . . . . 0.83 113.645 -173.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.87 -7.14 44.03 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.287 1.835 . . . . 2.73 112.826 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -114.8 159.8 35.96 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.23 1.812 . . . . 1.61 110.436 171.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.73 158.63 28.14 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.778 2.319 . . . . 0.87 111.793 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.67 140.14 43.87 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.499 1.52 . . . . 2.08 109.64 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.64 112.13 15.77 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.237 1.015 . . . . 3.84 109.958 171.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.1 tp -95.13 114.94 26.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.101 2.16 . . . . 0.6 109.025 -173.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -107.06 -10.1 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.797 1.239 . . . . 0.47 113.091 -171.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.3 -167.59 40.02 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 124.993 1.282 . . . . 0.46 110.962 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.09 176.85 11.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.041 0.936 . . . . 0.77 111.127 164.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -146.72 121.63 9.98 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.84 0.856 . . . . 7.83 110.631 -173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.2 t -130.27 148.55 70.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 124.922 1.289 . . . . 0.69 108.79 -173.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.14 -1.0 10.31 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.472 2.115 . . . . 0.81 114.15 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -98.37 -0.43 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 115.882 1.808 . . . . 1.06 115.882 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.72 168.21 21.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.236 1.834 . . . . 1.13 114.738 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -104.94 -93.4 0.36 Allowed 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.976 1.37 . . . . 3.12 110.365 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.6 ttt85 -84.63 83.86 7.87 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.632 -1.293 . . . . 4.77 109.541 -165.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.67 131.21 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.572 2.349 . . . . 1.69 112.127 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -140.58 132.05 26.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.942 1.697 . . . . 2.64 110.458 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.88 121.73 26.84 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.199 1.363 . . . . 0.68 111.131 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -110.7 152.42 26.57 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.217 2.207 . . . . 0.66 113.165 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.92 137.44 32.37 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.719 1.608 . . . . 2.35 109.172 155.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.8 m -101.35 146.01 28.14 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.025 -1.843 . . . . 2.36 106.025 161.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -156.79 172.22 19.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.874 1.435 . . . . 3.05 114.874 -171.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.1 mtm -118.99 127.48 53.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.917 1.287 . . . . 6.78 108.269 148.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -146.75 170.18 17.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.353 1.861 . . . . 9.62 110.054 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -102.72 156.3 17.73 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.817 0.847 . . . . 4.74 112.316 -167.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.9 t -139.28 -96.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 3.45 108.377 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -76.38 42.51 0.28 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 127.466 2.306 . . . . 3.72 110.53 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.17 -15.25 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 O-C-N 119.816 -1.802 . . . . 2.29 114.098 -169.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -81.17 131.97 35.33 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.812 -1.405 . . . . 4.02 110.85 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 57' ' ' LYS . 1.3 ptmm? -83.05 90.6 7.06 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.62 1.168 . . . . 7.06 112.172 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.07 148.23 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 125.467 1.507 . . . . 3.01 111.466 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.47 156.82 17.92 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.381 1.252 . . . . 6.6 114.381 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 175.51 -165.21 35.94 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.759 1.647 . . . . 2.25 111.168 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -153.1 158.74 42.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.788 0.835 . . . . 3.21 112.115 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.8 mtt180 -153.6 141.26 13.62 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 6.4 111.281 -170.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.26 147.17 77.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.599 2.199 . . . . 0.89 112.377 169.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.15 157.16 61.72 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 126.706 2.002 . . . . 0.66 110.593 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.11 -13.49 36.4 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.854 2.369 . . . . 0.91 113.489 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.5 p90 179.04 168.52 0.95 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.937 1.695 . . . . 1.88 110.328 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 mt -113.92 174.41 5.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.664 1.586 . . . . 1.0 109.428 152.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.05 163.26 36.82 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.456 -0.777 . . . . 2.36 111.066 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.5 t -142.72 124.78 8.78 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.755 1.222 . . . . 1.21 107.873 -172.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.45 161.03 46.82 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.784 1.656 . . . . 1.04 110.679 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.86 138.39 78.79 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.423 2.749 . . . . 0.84 110.972 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt 68.67 -0.29 2.37 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.373 1.869 . . . . 1.67 113.863 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.42 116.52 4.35 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 126.1 1.809 . . . . 0.97 112.026 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -77.42 131.92 38.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.178 -1.011 . . . . 4.71 109.994 156.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.01 175.88 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.875 2.07 . . . . 1.68 110.25 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -137.89 114.3 10.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.065 0.946 . . . . 4.27 110.502 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 85.37 0.43 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.923 -1.51 . . . . 1.53 106.923 157.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.4 152.8 37.93 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.578 . . . . 3.7 112.901 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -49.91 -41.22 48.21 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.735 2.956 . . . . 1.62 113.836 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.57 40.57 2.62 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.592 -1.115 . . . . 1.35 113.987 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.27 -61.1 0.02 OUTLIER Glycine 0 N--CA 1.472 1.054 0 CA-C-N 118.826 1.313 . . . . 1.22 115.439 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -153.38 145.96 24.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.303 1.441 . . . . 2.24 111.06 -176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -165.29 173.45 11.22 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.774 -1.204 . . . . 0.97 110.402 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -99.83 129.35 45.92 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.837 -0.602 . . . . 2.06 109.659 165.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.5 mmt -80.11 121.73 25.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.431 -0.581 . . . . 0.91 109.431 163.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.4 mt -107.74 86.34 2.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.373 1.469 . . . . 1.53 109.555 -176.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -85.05 142.11 29.8 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.993 0.917 . . . . 2.87 109.629 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.22 60.23 4.22 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 123.861 0.743 . . . . 1.45 112.033 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.0 mt -63.69 124.82 22.42 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.829 0.852 . . . . 1.08 112.805 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -81.29 -0.03 39.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.659 1.183 . . . . 2.94 113.588 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.14 150.31 0.61 Allowed Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 128.85 2.86 . . . . 6.04 109.486 177.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.39 149.76 75.37 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.488 2.125 . . . . 2.35 110.233 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.57 108.79 14.5 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.458 -1.312 . . . . 2.52 107.458 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.48 119.37 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.785 -1.197 . . . . 3.47 111.368 -170.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.51 113.65 1.88 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.963 -1.125 . . . . 1.71 107.963 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.29 -18.69 4.94 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 116.802 -2.11 . . . . 2.23 115.506 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -138.65 162.07 35.56 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.584 2.192 . . . . 3.86 113.961 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -79.74 137.06 36.91 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.269 1.827 . . . . 4.39 111.507 163.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.1 t -84.14 126.99 40.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 124.976 1.311 . . . . 0.88 109.41 160.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -71.2 141.39 50.65 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.955 -0.566 . . . . 3.16 110.45 162.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.3 mt -156.35 121.74 4.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.977 0.911 . . . . 1.38 112.287 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.56 101.37 11.53 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.567 2.347 . . . . 2.22 110.713 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 71.0 mt -76.37 115.71 16.37 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.102 1.761 . . . . 1.07 110.121 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.9 mt -85.34 124.47 31.99 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.864 0.866 . . . . 0.7 110.601 -175.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 87.6 m-85 -121.71 126.02 47.96 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.239 0.616 . . . . 2.02 111.655 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.32 18.89 0.99 Allowed 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.427 1.64 . . . . 2.83 115.427 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.21 -10.44 68.83 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.315 1.436 . . . . 4.88 116.036 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -139.53 -26.52 0.26 Allowed Glycine 0 N--CA 1.477 1.387 0 CA-C-N 119.337 1.568 . . . . 2.54 116.592 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 0.0 OUTLIER -88.17 141.6 28.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.325 1.563 . . . . 6.42 109.409 172.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.0 p -142.39 161.04 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 O-C-N 121.633 -0.667 . . . . 1.05 111.573 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.09 124.38 14.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.959 1.704 . . . . 2.71 110.276 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -71.71 116.59 12.26 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.298 -0.63 . . . . 2.79 109.298 161.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -102.65 153.94 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 124.514 1.126 . . . . 1.14 108.948 158.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.9 m -104.99 137.25 35.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 107.439 -1.319 . . . . 2.68 107.439 161.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 85.5 mt -139.63 130.13 14.34 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 117.198 -1.382 . . . . 1.89 109.205 -175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -60.75 151.18 78.53 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.621 2.881 . . . . 1.36 112.286 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.8 t -78.16 136.02 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.572 -0.705 . . . . 1.77 109.401 164.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.49 151.52 35.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.59 1.156 . . . . 3.59 109.379 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.47 55.31 0.72 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.963 1.305 . . . . 2.35 112.357 -158.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HB2' ' HE1' ' A' ' 7' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 125.3 1.44 . . . . 5.04 108.555 172.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.847 0 N-CA-C 107.367 -2.293 . . . . 10.73 107.367 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 m 71.58 34.44 1.64 Allowed 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 118.243 1.022 . . . . 12.62 109.861 -156.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 78.51 179.08 0.13 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.68 2.792 . . . . 16.4 111.213 -166.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 98.82 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 130.84 3.656 . . . . 7.08 111.351 -162.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -93.96 169.95 9.9 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.755 2.022 . . . . 5.26 111.7 165.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.71 164.39 27.75 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.147 1.356 . . . . 1.27 114.15 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.2 p90 -161.23 154.42 21.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.205 1.402 . . . . 1.82 112.956 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.3 t -103.92 130.98 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.651 1.18 . . . . 1.04 108.951 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttp85 -77.86 116.19 18.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.338 0.255 . . . . 3.7 110.725 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -52.7 119.43 4.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.846 0.858 . . . . 2.32 112.072 170.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 m -168.67 112.67 0.55 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.805 2.042 . . . . 2.07 107.001 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -85.81 50.69 2.64 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.623 2.882 . . . . 3.44 110.398 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.25 -177.65 31.6 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.179 0.895 . . . . 1.88 114.638 -167.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -66.26 -16.46 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.926 2.418 . . . . 1.61 111.746 166.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -155.22 157.4 37.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.092 1.757 . . . . 2.7 110.678 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.01 -174.88 5.15 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.865 2.066 . . . . 1.18 111.049 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.8 146.5 37.7 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.356 0.873 . . . . 1.03 113.356 -170.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.97 146.38 49.04 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.134 0.974 . . . . 0.86 112.562 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -128.63 150.4 50.24 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 128.012 2.525 . . . . 2.3 109.237 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.01 137.05 9.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 115.606 1.706 . . . . 2.19 115.606 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.9 m -85.55 124.78 32.5 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 114.749 -1.114 . . . . 1.41 108.932 171.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.02 137.23 51.98 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 127.153 2.181 . . . . 2.51 107.814 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.14 143.17 31.71 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.665 0.745 . . . . 3.09 111.027 172.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -111.73 105.54 56.62 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.062 -0.972 . . . . 1.28 109.154 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -84.47 -5.28 10.1 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.839 2.359 . . . . 1.42 113.826 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.6 -174.35 38.41 Favored Glycine 0 N--CA 1.469 0.864 0 C-N-CA 124.387 0.994 . . . . 1.26 113.259 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -106.87 9.08 30.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.589 1.556 . . . . 2.4 113.426 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -122.47 157.97 57.5 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.774 1.63 . . . . 2.22 110.666 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -84.19 157.21 13.03 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.26 2.64 . . . . 1.7 112.592 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -123.7 112.44 17.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.99 1.716 . . . . 2.5 110.042 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.6 ttp-105 -109.01 101.26 10.35 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.199 1.399 . . . . 4.13 112.747 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.2 tp -80.55 106.55 12.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.306 2.242 . . . . 0.98 109.636 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -96.11 -14.53 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.309 1.443 . . . . 0.69 113.058 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.18 -162.19 30.94 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 124.251 0.929 . . . . 0.7 111.618 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.817 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.59 -170.67 3.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.693 0.797 . . . . 1.1 111.209 176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -167.44 134.75 2.34 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.463 -0.939 . . . . 6.36 108.463 165.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 t -136.09 143.32 43.53 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-O 117.544 -1.217 . . . . 0.73 108.83 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.16 -20.0 56.56 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.646 2.231 . . . . 1.04 113.145 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -77.22 3.29 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 113.263 0.838 . . . . 1.1 113.263 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.2 -163.79 1.87 Allowed 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.19 1.552 . . . . 1.4 115.19 -171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.84 -88.99 0.45 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.703 1.601 . . . . 3.57 109.598 175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.9 mtm-85 -78.95 158.99 27.9 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.696 1.599 . . . . 6.7 111.099 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.06 73.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 124.816 2.246 . . . . 2.0 109.315 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -96.36 120.22 36.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 111.997 -2.365 . . . . 4.52 110.163 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.48 121.93 25.81 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.884 0.849 . . . . 0.66 111.509 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 13.8 m170 -107.69 155.83 19.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.805 2.042 . . . . 0.98 112.006 173.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' CD ' ' HE ' ' A' ' 62' ' ' ARG . 12.0 pt-20 -104.78 177.91 4.71 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.369 -1.287 . . . . 2.95 110.891 157.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -150.61 115.93 5.4 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.282 1.833 . . . . 1.31 107.38 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -134.57 178.71 6.79 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.388 1.475 . . . . 2.63 111.587 -162.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 15.7 ptp -119.57 151.15 39.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.649 1.18 . . . . 3.43 111.623 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -154.44 158.95 40.73 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.817 1.247 . . . . 7.54 112.243 175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.5 137.61 38.02 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.011 0.925 . . . . 4.03 109.81 163.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.7 t -118.22 -93.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.434 1.494 . . . . 3.03 109.221 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -77.92 39.07 0.28 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.126 2.17 . . . . 3.61 110.931 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.22 -6.13 16.49 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 119.815 -1.803 . . . . 1.91 113.825 -168.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -107.1 155.68 19.6 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.132 2.173 . . . . 3.9 110.595 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.61 140.82 29.48 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.889 1.07 . . . . 4.03 113.889 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 t -143.25 157.89 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 126.794 2.037 . . . . 2.04 108.293 177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 8.4 ptp -74.18 173.23 10.43 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.489 0.716 . . . . 4.49 112.712 170.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.13 153.99 25.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.633 1.111 . . . . 1.28 111.254 165.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -124.4 143.01 50.85 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.147 1.379 . . . . 1.79 108.576 171.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.429 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -163.34 145.28 7.7 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 118.089 -0.958 . . . . 6.21 112.058 -178.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 49.8 Cg_endo -66.96 150.6 82.91 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.881 2.387 . . . . 0.92 110.703 172.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.96 156.37 74.26 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.358 1.463 . . . . 0.58 109.976 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.88 -22.69 42.18 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.422 2.082 . . . . 0.66 112.417 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -175.2 165.06 3.35 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 125.433 1.493 . . . . 1.82 111.729 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.99 171.87 7.27 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.565 1.546 . . . . 0.97 109.437 153.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.74 163.6 39.74 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.271 -0.893 . . . . 3.19 113.292 165.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.67 129.36 22.69 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 126.093 1.757 . . . . 1.24 109.133 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.64 161.46 43.92 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.483 2.122 . . . . 1.28 111.076 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.12 140.74 91.05 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.559 2.839 . . . . 1.49 112.251 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp 68.1 -0.24 2.18 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.711 2.005 . . . . 1.88 113.983 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.32 156.8 28.53 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 127.075 2.274 . . . . 1.19 112.066 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mtt85 -119.88 155.62 32.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.765 2.026 . . . . 6.05 111.51 168.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.99 159.8 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.911 1.684 . . . . 1.39 110.256 164.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.27 109.69 12.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.457 1.503 . . . . 4.18 107.74 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.09 83.36 0.51 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.245 1.418 . . . . 1.3 109.361 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? -95.55 156.96 36.91 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.645 1.578 . . . . 3.87 112.717 -172.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -59.72 -29.84 90.65 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.116 2.544 . . . . 0.97 114.118 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.98 49.57 3.33 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.997 -0.89 . . . . 1.27 111.814 168.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.88 -71.11 0.05 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 115.558 0.983 . . . . 0.91 115.558 -176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -157.63 143.79 17.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.014 2.125 . . . . 1.93 110.485 -165.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -168.81 174.26 6.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.235 0.925 . . . . 0.71 112.285 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 48.0 m-85 -104.28 136.96 42.9 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.408 0.683 . . . . 2.19 111.64 169.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -96.25 121.3 37.89 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.653 1.181 . . . . 1.19 110.029 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.12 108.61 21.07 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.825 0.85 . . . . 2.62 109.809 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.72 65.81 1.03 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.481 1.112 . . . . 2.88 110.529 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.82 113.82 1.54 Allowed Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.621 1.582 . . . . 2.06 111.229 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -103.34 154.61 19.2 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.863 1.265 . . . . 1.51 111.195 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -125.38 -26.74 3.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.411 1.485 . . . . 2.31 112.371 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -118.14 132.01 23.93 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-O 118.205 -0.902 . . . . 4.88 109.077 161.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.17 124.39 11.28 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 N-CA-C 106.939 -1.985 . . . . 1.57 106.939 159.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.82 121.94 16.18 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.037 1.335 . . . . 1.92 111.089 -161.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -88.29 131.49 34.77 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.743 -1.223 . . . . 4.72 109.874 171.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 119.49 5.89 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.847 -1.168 . . . . 2.02 107.847 153.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.88 -1.6 56.66 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-O 118.434 -1.203 . . . . 2.63 115.158 -170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -91.05 151.53 20.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.444 1.622 . . . . 3.16 110.532 157.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -112.52 124.97 53.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.417 2.287 . . . . 5.98 105.441 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -90.41 102.88 13.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.827 1.251 . . . . 1.04 108.548 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.64 145.08 50.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.035 -0.53 . . . . 2.82 110.5 163.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.817 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.9 tt -158.84 132.81 7.66 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 2.04 110.409 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.31 112.35 24.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.809 2.043 . . . . 2.26 110.141 178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.2 mt -75.93 118.1 18.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.151 1.38 . . . . 1.66 109.987 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.64 117.06 24.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.324 -0.621 . . . . 0.99 109.324 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -116.37 121.47 42.02 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.152 0.797 . . . . 2.41 113.152 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 42.84 28.37 0.13 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.681 2.393 . . . . 2.54 115.867 170.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.47 -61.85 3.87 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.902 1.239 . . . . 3.7 112.519 -169.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.51 2.54 29.85 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.99 1.556 . . . . 1.91 116.99 -167.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -142.64 148.89 38.17 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.414 1.607 . . . . 5.01 112.3 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.4 p -145.62 139.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 125.851 1.66 . . . . 1.72 109.165 162.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.7 mt -145.23 135.35 23.87 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.658 1.183 . . . . 2.56 111.01 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -77.22 132.64 38.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.4 0.518 . . . . 2.37 112.4 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.8 -179.77 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.45 1.9 . . . . 1.56 109.8 159.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.86 148.08 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 127.847 2.459 . . . . 3.11 109.461 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -141.77 135.05 14.31 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.29 1.436 . . . . 1.96 110.699 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.68 146.64 43.74 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.969 2.446 . . . . 1.34 112.391 174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.1 t -76.84 138.93 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.597 0.759 . . . . 1.4 109.502 165.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -140.45 151.14 44.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.193 0.597 . . . . 3.28 111.386 171.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.43 60.53 1.17 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.801 1.64 . . . . 2.21 111.41 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 120' ' ' ARG 0.318 2.0 mmp_? . . . . . 0 C--O 1.251 1.146 0 N-CA-C 117.948 2.573 . . . . 5.15 117.948 -161.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.152 0 N-CA-C 105.128 -3.189 . . . . 13.51 105.128 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p 159.46 145.47 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.102 -1.814 . . . . 12.3 106.102 -129.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -143.04 47.57 1.52 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.433 1.493 . . . . 9.81 111.443 -163.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.9 p -73.96 88.47 1.86 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.255 1.022 . . . . 7.4 112.251 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.78 131.48 35.92 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 125.811 1.644 . . . . 6.76 110.423 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.78 162.31 33.87 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 120.809 -1.182 . . . . 1.01 114.597 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -146.49 146.47 30.55 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.668 1.187 . . . . 1.62 112.721 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.9 t -89.88 141.04 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.099 0.96 . . . . 1.43 108.853 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -77.16 -13.61 59.92 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.677 1.362 . . . . 4.5 114.677 -161.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.8 t80 72.85 147.25 0.08 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.077 2.951 . . . . 2.87 112.625 -170.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -168.64 140.89 2.26 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.425 1.49 . . . . 3.63 111.108 166.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -90.28 -13.19 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.065 3.177 . . . . 3.48 112.43 165.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -101.85 170.19 20.71 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.436 1.493 . . . . 1.75 112.865 -177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.98 -16.47 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 124.022 3.148 . . . . 2.26 115.397 -166.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -94.63 141.86 28.12 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.751 1.159 . . . . 3.03 111.458 163.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.76 179.15 7.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.788 1.635 . . . . 1.49 111.625 164.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.28 153.61 51.13 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.264 1.426 . . . . 1.14 110.017 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.49 142.63 50.0 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.501 1.121 . . . . 0.96 112.21 168.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -116.45 147.82 41.33 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 2.11 110.55 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -164.36 149.79 10.35 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.009 0.923 . . . . 1.57 112.582 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.4 m -81.63 117.57 22.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.895 0.878 . . . . 1.38 108.838 173.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -89.93 135.46 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.162 0.585 . . . . 3.52 110.477 168.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -124.15 167.69 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.052 1.341 . . . . 3.03 109.507 173.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -139.71 104.71 6.93 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 123.8 0.84 . . . . 1.17 109.914 162.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.95 -10.04 10.55 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.993 2.462 . . . . 1.6 113.168 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.35 156.79 39.73 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 124.155 0.884 . . . . 1.14 112.461 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.06 5.94 38.57 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.869 1.668 . . . . 2.75 113.391 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.22 158.71 45.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 126.096 1.758 . . . . 1.78 110.285 168.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.02 159.53 30.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.164 2.576 . . . . 0.93 111.748 -170.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.02 129.22 50.55 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.999 1.32 . . . . 2.36 110.099 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -120.7 112.0 18.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.391 1.476 . . . . 3.02 110.287 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -91.84 123.06 34.94 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.407 1.883 . . . . 0.8 108.946 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.93 -11.85 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.419 1.087 . . . . 0.66 113.312 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.42 -161.68 30.82 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 124.144 0.878 . . . . 0.6 111.07 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -154.83 -178.78 7.46 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.836 1.254 . . . . 0.76 110.179 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -152.75 150.74 29.72 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.612 1.096 . . . . 5.6 108.749 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -141.26 146.29 42.1 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 117.683 -1.151 . . . . 0.88 108.636 169.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.12 -19.39 66.29 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.106 1.871 . . . . 0.85 112.47 169.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 m -82.94 -3.76 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.221 1.193 . . . . 0.92 114.221 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.43 177.97 9.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.856 1.207 . . . . 0.85 113.688 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -118.9 -87.67 0.63 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.132 1.373 . . . . 3.28 110.421 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.1 ttm180 -78.74 103.98 9.05 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.653 -1.279 . . . . 3.53 109.05 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.91 145.41 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.588 1.155 . . . . 1.96 110.931 161.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -143.99 123.52 13.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.773 1.229 . . . . 2.33 109.663 164.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.438 HD12 ' CE1' ' A' ' 84' ' ' PHE . 7.0 tt -84.86 120.79 26.86 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 120.54 1.518 . . . . 0.73 110.997 168.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.3 m170 -107.41 151.88 24.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.535 1.534 . . . . 0.67 112.856 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -86.23 166.46 15.68 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.262 2.225 . . . . 2.45 110.801 163.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.5 m -150.21 126.79 10.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.387 1.475 . . . . 1.1 108.26 170.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -149.34 156.88 42.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.571 0.952 . . . . 2.38 113.571 -155.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 72.8 mtm -107.48 62.22 0.62 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.869 1.668 . . . . 4.44 111.981 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -79.42 156.13 28.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.948 -1.023 . . . . 7.48 111.121 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.02 164.8 25.41 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 108.161 -1.051 . . . . 5.99 108.161 158.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.3 t -156.89 -39.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.848 2.059 . . . . 4.07 110.986 -164.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -159.09 41.34 0.22 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.115 2.966 . . . . 5.06 108.003 -173.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.47 -19.23 0.08 OUTLIER Glycine 0 N--CA 1.479 1.558 0 C-N-CA 128.487 2.946 . . . . 2.04 114.899 -164.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -83.04 134.82 35.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.347 1.459 . . . . 5.41 109.804 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -88.93 120.16 30.1 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.507 -0.746 . . . . 4.44 110.879 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.88 141.74 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.37 1.468 . . . . 1.76 110.002 -171.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 97.14 7.17 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.42 1.088 . . . . 4.28 109.753 165.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.75 168.31 12.75 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 124.462 1.03 . . . . 1.25 112.797 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.56 153.6 47.46 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.492 1.517 . . . . 2.18 110.885 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -161.67 152.41 14.94 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 126.558 1.943 . . . . 6.08 110.481 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 39.8 Cg_endo -66.61 143.69 69.47 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.413 2.075 . . . . 0.54 111.653 165.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.5 m -113.06 157.64 40.18 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 126.105 1.762 . . . . 0.57 110.862 173.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -71.33 -14.43 31.18 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.768 2.312 . . . . 0.59 113.646 176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -178.92 165.45 1.56 Allowed 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.265 1.826 . . . . 2.24 109.914 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.69 167.62 10.47 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.669 1.587 . . . . 1.06 109.359 155.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -160.94 163.84 31.55 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.702 1.001 . . . . 2.08 113.702 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 139.84 14.53 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.632 1.573 . . . . 1.35 109.164 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.63 169.55 14.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.401 2.067 . . . . 1.1 111.153 168.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.22 148.58 92.49 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.757 2.305 . . . . 0.93 111.869 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt 68.86 -0.62 2.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.789 2.036 . . . . 1.64 114.027 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.83 -168.86 44.87 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.706 2.098 . . . . 1.45 114.939 -171.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -168.08 144.45 3.96 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.122 2.169 . . . . 5.62 110.606 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.4 m -152.14 136.83 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.955 2.102 . . . . 2.01 109.241 171.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -88.92 136.5 32.98 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.272 -0.893 . . . . 3.44 110.867 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.36 72.72 0.96 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.508 1.147 . . . . 1.18 108.444 156.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -85.43 145.9 43.36 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 126.477 1.911 . . . . 2.72 111.793 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -58.88 -23.54 68.04 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.823 2.349 . . . . 1.43 113.805 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.29 35.99 4.51 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.926 1.251 . . . . 1.57 113.617 171.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.37 -65.01 0.02 OUTLIER Glycine 0 N--CA 1.47 0.956 0 CA-C-N 118.399 1.099 . . . . 0.83 115.349 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -150.98 149.13 29.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.176 1.39 . . . . 1.99 111.251 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -157.21 160.6 38.86 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.606 -1.309 . . . . 0.81 111.44 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 41.0 m-85 -96.1 120.58 36.63 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.584 -0.525 . . . . 1.93 109.584 164.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.82 136.32 33.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.113 0.965 . . . . 1.16 108.811 167.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.2 103.88 8.82 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.394 1.078 . . . . 1.61 108.893 -171.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.36 120.0 41.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.496 1.118 . . . . 3.12 109.888 -173.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.03 97.43 0.62 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.069 1.318 . . . . 1.53 109.972 -173.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.8 mt -94.38 122.8 37.31 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.28 1.04 . . . . 1.09 110.74 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -71.01 -12.89 61.79 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.948 0.722 . . . . 1.96 112.948 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 21.2 ptt85 -153.33 139.56 12.38 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.001 1.72 . . . . 5.98 109.868 168.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 145.39 44.76 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.175 2.583 . . . . 1.92 109.358 169.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.4 mt -92.3 167.04 12.28 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.045 0.938 . . . . 2.36 113.044 -169.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 3.6 mmtm -123.0 156.8 34.05 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.342 1.457 . . . . 5.4 109.143 156.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 131.45 50.36 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.141 -0.689 . . . . 2.04 109.141 161.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.96 2.54 77.93 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 117.349 -1.806 . . . . 2.36 116.48 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 90.4 mt-10 -76.29 167.4 21.92 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.404 2.102 . . . . 3.34 110.364 169.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -85.6 154.08 21.96 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.023 1.329 . . . . 5.45 112.183 165.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.0 t -130.14 116.91 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.25 1.82 . . . . 1.02 109.414 163.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -71.1 140.21 50.57 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.455 -1.248 . . . . 3.78 109.804 161.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 132.21 14.44 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 112.907 0.706 . . . . 1.75 112.907 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -86.95 132.54 33.77 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.396 0.678 . . . . 2.4 109.533 159.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -94.16 118.19 31.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.994 1.318 . . . . 1.31 109.569 158.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.2 mt -95.05 131.38 41.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.417 1.087 . . . . 0.82 111.643 -176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -120.27 159.5 24.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.339 1.056 . . . . 2.11 112.418 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.86 118.31 7.04 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.255 0.835 . . . . 1.96 113.255 -172.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.18 -147.84 29.19 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.048 0.832 . . . . 2.95 111.364 -173.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.57 56.09 4.71 Favored Glycine 0 N--CA 1.472 1.036 0 CA-C-O 119.175 -0.792 . . . . 1.89 114.365 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -131.81 137.92 48.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.335 1.568 . . . . 4.91 110.675 171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.11 145.09 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.44 1.496 . . . . 1.48 108.915 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.0 mt -127.53 110.2 12.49 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.715 1.206 . . . . 2.34 109.908 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.63 105.86 11.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.343 0.657 . . . . 4.27 109.851 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m -105.82 -175.48 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.358 2.263 . . . . 1.18 111.199 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.3 143.82 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.25 1.42 . . . . 2.15 109.072 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.7 mt -136.14 154.6 77.49 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.072 1.749 . . . . 1.74 109.813 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.44 154.53 27.9 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.352 2.701 . . . . 0.99 111.272 161.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.0 t -85.89 142.12 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 126.359 1.863 . . . . 1.36 108.368 159.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -122.7 -145.18 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.995 2.118 . . . . 3.44 108.101 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -154.5 113.14 3.6 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 121.059 1.754 . . . . 1.99 111.592 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 C-N-CA 127.819 2.448 . . . . 4.49 110.813 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.336 0 N-CA-C 108.173 -1.971 . . . . 11.8 108.173 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.53 145.81 37.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.822 1.311 . . . . 10.61 111.825 165.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -122.71 30.54 6.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.633 1.173 . . . . 11.3 111.513 172.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.11 167.94 2.76 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 129.08 2.952 . . . . 6.87 112.003 177.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -91.55 -179.71 5.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.055 -0.403 . . . . 6.45 110.042 152.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.14 169.49 34.92 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.634 0.635 . . . . 1.82 114.132 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.402 ' CD1' ' HG3' ' A' ' 120' ' ' ARG . 44.6 p90 -155.91 152.36 28.18 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.677 0.791 . . . . 2.75 110.818 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.2 t -117.46 148.59 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.071 0.948 . . . . 1.04 110.23 177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -93.23 111.24 22.83 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.869 -1.144 . . . . 3.92 113.629 -152.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -66.28 104.82 1.27 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 3.23 111.158 168.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -155.79 130.57 5.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 117.559 -1.21 . . . . 2.47 109.913 158.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -81.27 75.12 5.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.818 3.012 . . . . 2.95 110.303 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -118.55 168.11 13.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.796 1.188 . . . . 2.1 112.982 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -65.87 -31.97 46.62 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.423 2.082 . . . . 2.28 110.541 167.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -113.2 152.93 29.12 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.537 1.935 . . . . 2.69 111.932 162.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.78 -158.1 0.88 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.651 2.38 . . . . 1.23 108.116 168.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.67 160.15 40.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.321 1.419 . . . . 1.56 113.682 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.54 149.88 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.791 1.636 . . . . 1.37 110.54 164.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -142.4 175.21 9.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.543 1.537 . . . . 2.45 110.796 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -175.01 148.72 1.04 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.21 1.404 . . . . 1.99 112.358 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.3 m -116.6 122.41 44.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.613 -1.625 . . . . 2.18 106.613 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -159.33 139.33 11.87 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.673 0.789 . . . . 4.2 110.392 -158.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 1.4 pm0 -109.2 147.86 31.87 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.833 1.653 . . . . 2.79 113.822 175.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -85.56 112.6 45.61 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 114.109 -1.405 . . . . 0.8 109.646 154.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -81.42 -10.26 12.23 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.099 2.533 . . . . 1.13 113.534 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.86 -179.55 53.04 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.19 0.9 . . . . 0.91 113.767 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -109.97 -4.23 16.05 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.955 1.702 . . . . 2.55 113.011 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.77 159.25 34.07 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.832 1.653 . . . . 1.91 110.031 165.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.88 152.53 16.88 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.089 2.526 . . . . 1.44 111.543 -171.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.87 157.62 15.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.414 1.085 . . . . 1.85 111.247 170.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' HE ' ' HB3' ' A' ' 106' ' ' ALA . 44.0 ttp180 -142.09 109.05 5.45 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.299 1.44 . . . . 4.64 110.476 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.6 tp -95.98 113.98 25.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.449 2.3 . . . . 0.72 109.696 -168.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 m -103.06 -12.08 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.977 1.311 . . . . 1.3 113.166 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.26 -158.7 28.44 Favored Glycine 0 C--N 1.336 0.574 0 O-C-N 121.303 -0.873 . . . . 0.53 113.394 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.06 -177.56 5.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.106 0.962 . . . . 0.96 111.106 166.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -142.76 136.23 28.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.555 1.142 . . . . 8.14 108.491 168.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -141.14 147.61 48.11 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.225 1.41 . . . . 0.87 108.938 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.55 -23.19 32.03 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.628 1.552 . . . . 1.24 112.855 174.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 m -83.14 5.39 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 115.378 1.621 . . . . 1.06 115.378 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.97 44.64 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.193 1.36 . . . . 1.42 113.2 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.82 -50.56 72.88 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.841 1.656 . . . . 6.56 109.528 165.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -144.45 155.19 43.62 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.764 1.626 . . . . 4.42 109.122 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.85 128.92 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 125.202 1.401 . . . . 1.22 108.482 176.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -130.2 124.62 32.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.954 1.702 . . . . 2.08 108.209 -176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -80.12 119.82 23.43 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 120.254 1.388 . . . . 0.83 110.998 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 16.5 m170 -108.76 157.3 18.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.985 1.714 . . . . 0.84 111.948 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -111.1 -177.64 3.26 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.943 1.697 . . . . 2.44 111.75 171.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 89.5 m -123.22 120.94 34.64 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.22 -1.03 . . . . 1.42 108.22 156.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -100.41 165.47 11.43 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.782 1.233 . . . . 2.31 111.248 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.5 mtm -129.42 134.7 47.98 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.536 1.134 . . . . 3.8 109.234 163.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.9 146.16 24.77 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.724 1.21 . . . . 7.08 110.696 -168.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.08 136.81 41.14 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.91 0.386 . . . . 3.57 110.965 175.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.0 t -127.07 -95.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.308 -1.367 . . . . 2.46 107.308 174.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -79.36 74.93 5.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.498 1.119 . . . . 4.18 108.51 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.03 -11.68 0.04 OUTLIER Glycine 0 N--CA 1.477 1.375 0 C-N-CA 128.874 3.13 . . . . 2.05 118.022 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -124.25 153.5 41.58 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.489 1.916 . . . . 4.42 110.94 -170.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -70.47 97.7 1.33 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.12 0.568 . . . . 4.31 112.105 -179.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -79.83 132.61 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 125.265 1.426 . . . . 1.48 107.864 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.5 ptp -91.8 145.27 24.71 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.896 0.878 . . . . 3.04 111.183 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.13 166.84 35.87 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 123.908 0.766 . . . . 1.07 112.97 175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.3 150.82 38.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.59 1.156 . . . . 1.82 111.419 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.3 mtp85 -163.74 155.65 14.78 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 125.423 1.489 . . . . 7.15 111.388 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 17.9 Cg_endo -64.93 143.38 79.16 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.597 2.198 . . . . 0.88 110.898 169.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.5 155.29 54.35 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.928 1.691 . . . . 0.7 110.543 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.36 -23.85 32.15 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.674 2.249 . . . . 0.83 112.617 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -173.71 168.81 4.33 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.239 1.416 . . . . 1.72 111.059 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -119.76 174.47 6.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.279 2.232 . . . . 1.08 109.334 162.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.34 168.57 19.77 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.399 -0.813 . . . . 3.22 111.251 172.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.3 t -147.36 129.58 7.62 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 125.202 1.401 . . . . 1.12 108.647 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.37 163.69 35.73 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.185 1.924 . . . . 1.32 111.942 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.19 139.34 71.8 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.917 3.078 . . . . 1.05 111.945 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.29 17.97 5.1 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 116.063 1.875 . . . . 2.0 116.063 -172.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.23 116.82 5.46 Favored Glycine 0 C--O 1.227 -0.342 0 C-N-CA 128.151 2.786 . . . . 0.99 111.984 -178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 2.0 ttm-85 -90.4 130.96 36.42 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 5.37 111.738 163.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.4 m -121.32 171.32 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 2.09 111.545 176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -148.28 125.5 11.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.14 1.376 . . . . 4.68 110.685 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -82.51 153.63 25.47 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.526 1.155 . . . . 1.85 110.836 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 78' ' ' LYS . 7.3 ptpt -170.65 149.26 2.91 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.006 1.723 . . . . 4.0 111.817 -165.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -49.44 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.118 2.545 . . . . 2.09 111.293 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.36 96.42 0.91 Allowed Glycine 0 C--N 1.342 0.888 0 N-CA-C 107.625 -2.19 . . . . 2.35 107.625 156.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.76 -155.73 17.15 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.745 2.116 . . . . 2.83 112.034 -163.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -92.42 140.01 30.01 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.822 1.249 . . . . 2.4 112.204 -173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -161.19 154.14 21.03 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.482 0.713 . . . . 0.78 109.484 -169.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -94.58 120.39 34.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.629 -0.878 . . . . 1.98 108.629 173.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.5 mmt -68.75 130.5 43.0 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.152 -0.684 . . . . 1.09 109.152 165.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.0 mt -106.03 118.99 38.03 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 108.017 -1.105 . . . . 1.99 108.017 171.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.24 152.4 24.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.076 0.95 . . . . 3.05 109.834 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 52.82 67.6 2.02 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 124.652 1.12 . . . . 1.7 112.72 172.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 62.4 mt -64.91 111.14 2.7 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.904 1.075 . . . . 1.26 113.904 -164.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -80.38 -25.19 39.27 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.999 1.32 . . . . 1.93 112.505 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -119.78 126.65 26.81 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 106.044 -1.835 . . . . 4.21 106.044 149.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -64.35 136.89 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 N-CA-C 107.167 -1.897 . . . . 1.69 107.167 162.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.71 63.05 1.56 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.776 0.83 . . . . 2.51 112.467 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 121.95 7.22 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.705 1.602 . . . . 3.65 108.793 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -42.95 120.74 1.87 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.637 1.108 . . . . 1.47 112.113 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.82 42.02 47.38 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 119.491 -0.616 . . . . 2.28 114.325 -169.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -76.14 171.7 14.05 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.252 1.526 . . . . 2.74 108.002 146.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -105.63 150.61 25.28 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.067 1.347 . . . . 4.98 107.77 160.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 43.8 t -131.92 119.22 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.162 0.985 . . . . 1.13 110.663 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.82 137.7 40.66 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.153 1.781 . . . . 2.94 110.316 165.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mt -155.98 133.48 10.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.043 0.925 . . . . 1.52 111.948 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -115.28 101.67 9.16 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.337 1.455 . . . . 2.08 110.799 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.26 119.86 22.92 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.253 1.421 . . . . 1.41 111.032 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.5 mt -93.57 123.2 36.72 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.616 1.166 . . . . 0.77 111.498 -169.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.15 135.62 53.75 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.045 0.926 . . . . 1.77 112.501 -177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.457 ' HB3' ' HE ' ' A' ' 31' ' ' ARG . . . -78.45 63.6 3.34 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.722 1.609 . . . . 2.76 112.917 -175.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.42 33.15 0.09 OUTLIER Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.708 2.099 . . . . 4.84 113.956 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.61 -0.13 77.66 Favored Glycine 0 N--CA 1.476 1.342 0 CA-C-N 118.284 1.042 . . . . 1.95 114.652 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -97.86 151.1 20.58 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 122.629 1.204 . . . . 6.59 113.856 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.05 151.41 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 126.991 2.117 . . . . 1.41 107.617 154.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.96 119.68 32.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.447 1.099 . . . . 2.25 109.283 167.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -74.31 133.9 42.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.289 0.236 . . . . 2.78 110.414 168.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.9 m -139.26 145.33 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.92 1.688 . . . . 1.48 109.493 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -125.05 125.19 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.666 0.786 . . . . 2.75 110.03 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -120.46 155.92 56.03 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.396 1.479 . . . . 3.34 111.076 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.54 164.48 32.28 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.735 2.957 . . . . 1.46 111.626 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.39 142.14 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.384 1.074 . . . . 1.19 111.823 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -145.66 162.06 38.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.961 1.705 . . . . 3.99 113.008 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.59 62.57 2.54 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.012 1.725 . . . . 2.5 111.987 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 2.8 mmp_? . . . . . 0 C--O 1.25 1.081 0 CA-C-O 116.473 -1.727 . . . . 4.41 111.315 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.168 0 N-CA-C 108.725 -1.75 . . . . 13.04 108.725 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 p -175.49 45.9 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.733 2.013 . . . . 13.5 108.193 -167.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 81.47 146.39 0.08 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 128.922 2.889 . . . . 14.61 110.085 -134.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -169.48 -41.6 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.42 2.288 . . . . 7.86 109.182 -161.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.13 167.06 5.3 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.841 0.856 . . . . 5.33 110.048 150.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -79.52 157.31 42.07 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 123.377 0.513 . . . . 1.21 112.371 176.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -154.75 139.19 16.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.02 0.748 . . . . 1.35 113.02 175.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.5 t -93.2 132.56 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 109.606 -0.516 . . . . 1.3 109.606 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -78.22 114.43 17.1 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.325 1.05 . . . . 4.32 112.022 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -79.97 146.98 31.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.086 0.946 . . . . 3.81 110.469 159.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.44 152.63 4.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.474 1.51 . . . . 2.72 110.957 169.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -84.95 75.55 3.54 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.076 3.184 . . . . 3.31 109.776 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.42 -179.67 34.4 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.671 1.028 . . . . 1.72 115.671 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.66 -15.92 19.07 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.833 3.022 . . . . 2.44 112.877 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -147.77 160.54 42.62 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 115.077 1.51 . . . . 2.58 115.077 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.83 -168.39 2.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.252 2.221 . . . . 1.22 110.861 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.3 147.46 32.37 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.235 1.014 . . . . 1.57 112.439 -174.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.19 118.45 36.82 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 117.987 0.358 . . . . 1.67 110.232 159.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -101.18 142.57 32.43 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.01 1.724 . . . . 2.51 108.547 164.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.7 pp -164.1 149.64 10.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.167 1.914 . . . . 1.96 116.167 -168.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.3 m -115.08 138.43 50.9 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.529 1.532 . . . . 2.01 109.771 -173.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.11 -179.85 8.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.308 1.843 . . . . 5.26 110.444 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.76 159.87 43.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.81 0.844 . . . . 4.9 110.106 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -95.81 102.63 10.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.296 -0.865 . . . . 1.3 109.506 163.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.13 -7.12 17.07 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.875 2.383 . . . . 1.56 113.197 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.11 177.36 54.36 Favored Glycine 0 C--N 1.342 0.915 0 C-N-CA 124.325 0.964 . . . . 1.41 113.72 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -107.96 1.6 22.69 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.346 1.458 . . . . 2.56 112.664 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -115.2 162.71 22.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.431 1.893 . . . . 1.89 109.616 164.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.14 157.8 20.23 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.685 2.257 . . . . 1.16 111.489 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.7 mt -105.77 153.52 21.77 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 2.22 110.1 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.5 ttp-105 -134.35 115.08 13.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.486 1.115 . . . . 3.62 111.229 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 tp -95.68 112.03 23.84 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.213 2.605 . . . . 0.63 108.601 -174.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.92 -10.11 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.834 1.254 . . . . 0.65 113.316 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 179.01 -173.95 46.09 Favored Glycine 0 C--N 1.342 0.883 0 O-C-N 121.543 -0.723 . . . . 0.56 112.116 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -143.18 178.83 7.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.836 1.254 . . . . 0.96 110.306 170.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.35 142.41 3.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.187 -1.042 . . . . 4.92 108.187 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 t -150.78 155.26 35.56 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 117.261 -1.352 . . . . 0.89 108.274 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -62.61 -14.72 41.59 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.171 1.914 . . . . 1.2 114.246 169.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.63 0.19 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 115.991 1.849 . . . . 1.14 115.991 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.62 144.35 44.02 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 121.261 1.846 . . . . 1.33 114.808 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -89.29 -76.37 0.41 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.921 1.288 . . . . 3.58 110.259 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.3 ttm-85 -80.89 127.84 33.0 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.107 -0.995 . . . . 4.28 108.803 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.0 129.53 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.226 1.41 . . . . 1.56 110.322 167.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -144.59 133.49 22.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.823 1.649 . . . . 2.43 110.924 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -79.31 119.25 22.09 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 120.055 1.298 . . . . 0.86 111.027 170.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 17.1 m170 -110.58 156.02 21.52 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.756 2.022 . . . . 0.61 111.795 175.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.29 -175.38 2.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.413 . . . . 2.85 111.978 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -132.77 118.05 18.56 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.698 1.599 . . . . 1.47 108.441 169.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -115.99 179.05 4.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.436 1.094 . . . . 2.09 111.098 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 25.3 ptp -143.21 128.88 19.24 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.549 0.74 . . . . 4.2 111.57 162.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -138.27 149.58 45.85 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.257 1.023 . . . . 6.57 112.111 -173.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 52' ' ' GLU 0.33 1.4 pm0 -64.92 146.84 54.4 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.026 1.731 . . . . 4.74 113.792 172.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.69 HG13 ' H ' ' A' ' 54' ' ' GLU 0.29 6.7 p -135.7 -86.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 126.811 2.044 . . . . 2.86 109.198 176.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.69 ' H ' HG13 ' A' ' 53' ' ' VAL . 16.2 mt-10 -77.11 41.43 0.29 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.703 2.001 . . . . 3.69 110.736 165.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.51 -38.66 0.87 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.152 1.358 . . . . 2.29 113.767 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -61.39 133.8 56.21 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.12 1.368 . . . . 3.04 110.972 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -91.34 103.34 16.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.409 0.683 . . . . 5.7 110.884 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.9 t -99.21 141.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.028 1.731 . . . . 1.79 109.911 -173.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.43 153.59 29.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.677 1.591 . . . . 3.68 112.336 -179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.72 161.16 33.98 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 121.822 -0.549 . . . . 1.23 114.396 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -113.62 137.03 52.17 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.449 1.5 . . . . 2.21 111.164 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.8 mtp180 -150.57 156.64 36.56 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.359 1.463 . . . . 6.18 110.227 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 32.8 Cg_endo -65.92 152.0 82.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.703 2.268 . . . . 0.88 111.641 171.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.78 157.36 69.1 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 126.181 1.792 . . . . 0.74 109.659 173.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.14 -18.17 40.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.784 2.322 . . . . 0.96 113.237 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -179.15 167.21 1.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.819 2.047 . . . . 2.11 110.755 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -113.8 166.73 11.27 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.975 1.71 . . . . 1.0 109.264 155.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.08 163.83 39.14 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.115 -0.991 . . . . 2.45 111.683 174.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.4 t -143.08 128.77 10.18 Favored Pre-proline 0 N--CA 1.466 0.354 0 C-N-CA 125.073 1.349 . . . . 1.02 109.609 -161.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.53 163.61 38.05 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.208 1.938 . . . . 0.79 111.554 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.38 138.49 84.63 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.516 2.811 . . . . 0.96 111.935 172.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm 68.34 7.2 5.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.977 2.111 . . . . 1.62 113.456 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.57 113.16 3.62 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 125.79 1.662 . . . . 0.97 112.252 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.49 136.93 37.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.513 -0.844 . . . . 5.51 110.456 165.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 m -131.06 159.74 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.319 1.447 . . . . 3.01 111.808 -174.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -154.98 92.59 1.46 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.731 1.613 . . . . 3.67 108.079 -170.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -66.67 139.07 57.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.397 1.079 . . . . 2.06 108.649 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -158.9 156.52 26.87 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 127.349 2.26 . . . . 3.38 111.237 -163.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.2 -64.17 0.1 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.918 3.079 . . . . 1.39 112.088 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.19 91.52 1.03 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.022 -1.631 . . . . 1.97 109.022 166.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.33 -98.91 0.18 Allowed Glycine 0 C--O 1.221 -0.664 0 C-N-CA 124.707 1.146 . . . . 1.24 112.424 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -153.58 136.59 15.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.183 1.393 . . . . 2.16 110.299 -172.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -165.62 166.71 17.89 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.267 1.394 . . . . 1.55 110.806 -170.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 92.6 m-85 -102.77 116.19 32.07 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 119.282 -0.39 . . . . 2.3 110.18 175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.8 mmt -68.31 127.69 33.87 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.663 -0.495 . . . . 0.93 109.663 171.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.2 mt -112.81 111.01 21.49 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.907 -1.516 . . . . 1.53 106.907 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.47 116.55 25.66 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.66 -0.867 . . . . 3.47 108.66 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.82 112.77 0.49 Allowed Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.09 -1.204 . . . . 1.88 110.09 -164.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 mt -110.16 113.94 27.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.162 0.985 . . . . 1.01 111.789 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.95 -11.84 60.97 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.829 1.251 . . . . 1.87 114.209 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -153.89 145.73 16.9 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.1 1.36 . . . . 5.77 109.998 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.69 132.42 13.22 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.202 1.935 . . . . 2.05 109.288 170.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.2 169.18 12.56 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.819 1.648 . . . . 2.66 112.321 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.03 145.04 43.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.213 1.005 . . . . 4.5 110.192 155.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.62 19.95 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.676 -0.861 . . . . 2.03 108.676 160.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.11 4.39 78.11 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 117.901 -1.499 . . . . 2.71 115.83 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -74.4 175.24 7.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.233 2.016 . . . . 2.4 109.449 158.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -91.95 155.85 17.86 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.297 1.046 . . . . 4.47 111.387 152.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.02 127.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 106.93 -1.507 . . . . 1.34 106.93 151.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.86 155.18 20.01 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.953 0.882 . . . . 4.11 111.277 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.788 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.8 tt -163.25 129.97 3.39 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.308 -0.87 . . . . 1.69 112.028 -152.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -78.12 105.41 9.32 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.325 3.05 . . . . 2.69 111.494 172.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.1 mt -79.42 119.4 22.38 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.113 -0.992 . . . . 1.06 109.343 171.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.1 mt -96.92 126.07 41.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.565 1.146 . . . . 0.71 111.554 -168.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.22 158.27 22.53 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.438 -0.789 . . . . 2.17 112.929 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -73.39 63.7 0.79 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.819 1.648 . . . . 2.04 113.311 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 148.73 -149.65 21.7 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 125.39 1.472 . . . . 2.79 111.649 -178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.51 43.83 1.63 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.748 1.166 . . . . 2.06 115.038 -173.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -140.6 137.75 33.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.888 1.344 . . . . 5.11 113.987 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 p -153.75 132.35 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 127.438 2.295 . . . . 1.06 108.66 169.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.97 102.22 8.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.229 1.412 . . . . 2.46 109.407 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 74.26 6.04 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.857 0.863 . . . . 2.74 111.157 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.75 159.32 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.037 1.335 . . . . 1.63 112.079 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.9 m -100.25 139.12 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 126.636 1.974 . . . . 3.27 109.602 167.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.1 mt -143.24 135.46 13.28 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.549 1.14 . . . . 1.87 109.18 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.09 162.61 41.58 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.908 2.406 . . . . 1.57 111.474 170.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.0 t -104.36 145.83 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.246 1.418 . . . . 1.51 111.318 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.77 156.35 44.97 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.042 1.737 . . . . 3.68 109.302 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.73 41.51 1.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.45 1.5 . . . . 2.71 113.1 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 117.516 -1.23 . . . . 5.09 112.974 -152.639 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 109.784 -1.326 . . . . 11.8 109.784 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 t -162.58 165.18 26.26 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.143 1.377 . . . . 9.77 109.438 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -85.92 62.76 7.65 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.126 1.371 . . . . 9.28 111.76 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 p -77.68 157.99 29.89 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.197 -0.668 . . . . 6.92 109.197 166.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.48 -150.89 0.32 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.142 0.977 . . . . 5.65 109.372 -174.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.72 122.08 1.09 Allowed Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.585 1.539 . . . . 1.75 114.299 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -111.56 149.21 31.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.942 0.897 . . . . 2.12 111.145 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -94.57 140.29 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.712 -0.847 . . . . 1.28 108.712 169.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 117.1 29.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 3.91 112.953 -151.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -68.45 124.66 24.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.676 0.79 . . . . 2.73 110.983 175.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -160.68 141.03 8.49 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.621 1.169 . . . . 2.36 110.273 165.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -83.75 65.98 7.31 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.06 3.173 . . . . 2.62 109.401 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.76 171.29 14.7 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.385 0.993 . . . . 1.55 113.467 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.05 -20.79 28.38 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.186 2.591 . . . . 2.03 111.305 164.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -151.36 169.6 21.58 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.439 1.896 . . . . 2.35 112.315 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.14 157.55 43.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.83 1.652 . . . . 1.24 110.073 175.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.55 116.24 28.76 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.399 1.08 . . . . 2.12 109.524 167.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.81 162.22 13.36 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.383 1.473 . . . . 1.32 111.428 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.44 164.14 28.85 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.265 1.426 . . . . 2.64 111.616 -171.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -166.7 159.01 13.56 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.977 1.311 . . . . 1.62 113.505 159.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -80.1 141.4 35.83 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.914 -0.773 . . . . 1.24 108.914 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -130.7 129.98 43.27 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.26 2.224 . . . . 2.14 108.351 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 74' ' ' ARG . 3.4 pm0 -113.9 129.28 56.61 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.335 1.454 . . . . 3.34 110.738 171.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -86.68 110.97 36.52 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 155.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -86.7 -9.5 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.792 2.328 . . . . 1.2 113.916 176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.2 167.84 31.9 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.176 0.898 . . . . 1.1 113.197 -174.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -87.73 -1.14 57.77 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.471 1.509 . . . . 3.39 114.322 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.8 159.34 36.21 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.067 1.347 . . . . 1.84 110.454 169.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.98 151.76 18.6 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.836 2.357 . . . . 1.36 111.647 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.2 mt -100.98 155.64 17.85 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.085 0.954 . . . . 1.84 111.19 173.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.3 ttm105 -132.21 110.75 10.86 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.041 1.337 . . . . 3.07 109.797 169.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.5 tp -95.06 112.48 24.18 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 127.581 2.353 . . . . 0.73 107.807 -175.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.88 -11.12 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.904 0.881 . . . . 0.58 112.883 -166.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.36 -164.89 34.96 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 124.511 1.053 . . . . 0.49 112.033 173.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -146.86 -179.14 6.59 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.225 1.01 . . . . 0.74 110.012 164.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -155.9 141.24 17.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.83 1.252 . . . . 5.45 108.963 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 t -151.43 156.1 34.69 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 119.501 1.046 . . . . 0.75 110.69 -165.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.36 -17.23 18.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.706 2.271 . . . . 0.97 113.974 168.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -85.33 -23.78 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 114.954 1.465 . . . . 1.02 114.954 -172.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.52 152.33 50.83 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.703 1.201 . . . . 0.95 112.252 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' CD ' ' HZ1' ' A' ' 90' ' ' LYS . 10.1 tp10 -86.45 -88.45 0.13 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.003 -0.544 . . . . 2.87 110.037 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -82.24 90.45 6.62 Favored 'General case' 0 CA--C 1.528 0.109 0 N-CA-C 108.714 -0.847 . . . . 3.55 108.714 177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -74.99 137.38 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 123.576 0.75 . . . . 1.39 111.076 166.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -137.18 140.02 41.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.296 1.839 . . . . 2.2 109.708 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 tt -88.16 122.11 31.33 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.553 -1.342 . . . . 0.84 111.674 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.4 m170 -109.46 156.36 20.18 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.287 1.435 . . . . 0.65 112.541 175.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.8 -178.67 3.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.316 1.846 . . . . 1.93 112.023 174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 90.0 m -138.1 100.78 4.24 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.969 1.708 . . . . 1.32 108.033 163.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -92.24 153.31 19.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.864 1.266 . . . . 2.33 111.778 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptp -89.23 156.97 18.43 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.306 -0.871 . . . . 4.15 111.972 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -163.31 153.11 15.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.872 1.269 . . . . 9.73 112.887 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -81.54 176.43 9.68 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.889 0.876 . . . . 3.66 110.698 154.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.19 -121.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 126.152 1.781 . . . . 3.13 106.571 166.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.403 ' O ' ' HE3' ' A' ' 56' ' ' LYS . 11.9 tt0 -73.35 62.52 0.71 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.559 2.343 . . . . 3.62 110.131 171.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.05 2.06 6.19 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.307 1.432 . . . . 2.05 115.291 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 13.4 ptpt -111.02 129.86 55.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.812 2.445 . . . . 2.64 110.21 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.438 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -100.19 144.37 29.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.76 0.824 . . . . 5.55 112.466 -167.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 t -152.5 162.14 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.672 1.589 . . . . 2.11 109.374 -166.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 9.5 ptp -84.38 171.37 12.7 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.752 0.821 . . . . 3.5 112.012 161.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.16 148.95 19.99 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 125.492 1.52 . . . . 1.52 110.767 168.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -112.34 155.52 23.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.322 1.049 . . . . 1.98 110.24 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -168.39 158.87 8.7 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 126.471 1.909 . . . . 4.87 108.927 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.2 Cg_endo -67.89 154.52 72.7 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 120.967 1.112 . . . . 0.74 110.343 159.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.94 156.39 65.77 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 125.284 1.433 . . . . 0.7 109.819 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.28 -16.54 39.64 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.613 2.209 . . . . 0.76 112.833 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -178.79 167.49 1.7 Allowed 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.716 1.606 . . . . 1.93 110.593 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -117.47 172.3 7.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.201 2.2 . . . . 1.15 109.165 159.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.6 161.11 41.76 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.011 -1.056 . . . . 2.16 111.15 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.2 t -146.9 129.92 8.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.442 0.697 . . . . 0.96 110.648 -167.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.17 162.46 38.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.056 2.504 . . . . 1.25 112.315 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.05 136.29 64.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 124.457 3.438 . . . . 1.28 113.356 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 64.07 2.58 1.46 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 1.96 113.794 -174.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.6 116.03 4.29 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 127.284 2.373 . . . . 0.98 110.724 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 8.2 ttt180 -102.92 130.42 49.96 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.092 1.357 . . . . 5.29 110.275 164.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.2 m -147.74 152.66 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.519 1.528 . . . . 2.15 111.338 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 130.86 48.15 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.873 0.869 . . . . 3.37 112.132 176.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.8 mp -68.97 78.03 0.32 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.152 1.381 . . . . 1.18 108.067 161.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -81.05 146.92 60.01 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 2.69 111.095 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.38 -50.85 12.64 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.52 2.813 . . . . 0.91 113.141 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -82.31 67.63 3.66 Favored Glycine 0 N--CA 1.469 0.85 0 N-CA-C 110.84 -0.904 . . . . 1.07 110.84 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.05 -78.32 0.07 OUTLIER Glycine 0 N--CA 1.466 0.694 0 C-N-CA 124.975 1.274 . . . . 0.82 112.807 -170.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -156.51 143.04 18.46 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.141 2.176 . . . . 1.81 109.632 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -169.76 159.11 7.87 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.895 -1.128 . . . . 0.87 110.882 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -97.56 121.38 39.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.396 0.678 . . . . 2.18 112.028 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.8 mmt -79.25 123.64 27.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.2 1.0 . . . . 0.98 109.557 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 39.4 mt -104.64 79.33 1.54 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.36 1.464 . . . . 1.88 110.485 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -78.9 128.32 33.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.626 1.103 . . . . 2.61 109.538 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.88 74.74 0.9 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.857 -0.897 . . . . 1.31 110.857 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.1 89.94 3.62 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.739 1.269 . . . . 1.5 110.774 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.443 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 3.0 ptmt -55.44 -9.14 0.43 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.487 1.515 . . . . 1.91 114.091 171.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -136.84 135.58 20.3 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.877 1.671 . . . . 5.41 108.847 167.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.07 141.81 40.77 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.126 1.884 . . . . 1.53 109.115 165.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.0 81.92 7.93 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.567 1.147 . . . . 2.01 110.473 -172.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.476 ' HZ2' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -70.22 108.73 4.29 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 120.564 -1.335 . . . . 3.72 109.605 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -43.07 124.98 3.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.797 0.839 . . . . 1.44 111.392 174.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 113.65 -22.06 15.52 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 115.984 -2.565 . . . . 2.17 116.492 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.476 ' CD ' ' HZ2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -86.43 177.19 7.51 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.387 2.593 . . . . 4.28 111.98 -177.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -96.58 132.29 42.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.373 1.869 . . . . 4.85 112.651 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.0 t -102.5 116.34 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.849 -1.157 . . . . 1.11 108.891 164.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.92 143.8 35.49 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.047 0.927 . . . . 3.08 110.557 160.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.28 117.56 5.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.743 0.817 . . . . 1.72 110.952 -168.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -81.53 95.58 7.16 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.164 2.186 . . . . 2.82 110.377 175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.8 mt -72.39 119.2 16.26 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.478 -0.764 . . . . 1.3 109.936 174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.3 mt -95.4 132.19 40.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.032 0.933 . . . . 0.63 111.249 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.24 147.09 52.55 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.434 1.111 . . . . 1.99 112.73 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.08 136.72 56.36 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.034 1.124 . . . . 2.12 114.034 -173.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.18 48.93 13.66 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.971 0.796 . . . . 3.81 113.63 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.46 23.8 55.57 Favored Glycine 0 N--CA 1.471 1.02 0 N-CA-C 115.951 1.14 . . . . 1.76 115.951 168.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -108.52 146.21 33.57 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.809 1.804 . . . . 4.44 111.973 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -149.93 137.59 13.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.783 2.033 . . . . 1.12 107.761 166.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -128.77 109.99 11.78 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.686 1.194 . . . . 1.62 108.605 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -81.78 126.91 32.4 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.663 -0.648 . . . . 2.78 111.88 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.1 m -118.95 167.3 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 126.287 1.835 . . . . 1.6 110.259 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -116.08 139.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.839 1.255 . . . . 2.08 110.416 172.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.3 mt -140.11 136.83 17.38 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 127.495 2.318 . . . . 1.57 108.005 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.86 154.94 48.67 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.803 2.335 . . . . 1.37 112.059 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.29 123.22 38.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.848 1.259 . . . . 1.58 109.48 168.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.68 166.74 32.53 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.546 1.138 . . . . 3.6 111.712 -174.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.53 84.84 2.2 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.74 1.216 . . . . 2.52 113.923 -165.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.013 -1.106 . . . . 6.19 108.013 148.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.423 ' HA3' ' HG2' ' A' ' 5' ' ' GLU . . . . . . . . 0 N--CA 1.473 1.129 0 N-CA-C 110.639 -0.984 . . . . 9.18 110.639 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -98.51 56.25 1.13 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.178 -1.045 . . . . 11.45 108.178 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 65.97 -59.17 0.32 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.553 2.341 . . . . 11.25 111.085 -157.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.2 p -49.75 141.41 10.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 128.475 2.71 . . . . 7.65 113.117 160.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HG2' ' HA3' ' A' ' 1' ' ' GLY . 28.1 mt-10 -151.46 161.42 42.72 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.658 2.383 . . . . 5.14 109.779 169.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 169.34 -175.21 43.7 Favored Glycine 0 N--CA 1.464 0.52 0 O-C-N 121.116 -0.99 . . . . 1.48 112.061 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.5 p90 -161.12 154.14 21.19 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.932 1.086 . . . . 1.67 113.932 174.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.9 t -116.48 140.44 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.762 0.825 . . . . 1.23 109.33 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -87.11 110.94 20.46 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.674 -0.641 . . . . 4.2 111.582 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -61.58 127.22 30.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.526 1.155 . . . . 3.17 109.9 155.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -153.14 164.5 20.2 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 127.067 2.147 . . . . 2.13 107.551 161.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -94.08 -161.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 124.155 3.236 . . . . 3.46 109.111 168.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.55 -150.92 28.86 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 124.386 0.993 . . . . 2.25 113.021 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -84.72 -16.44 5.5 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.618 2.879 . . . . 2.55 113.843 -173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -153.82 160.66 42.3 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.735 1.754 . . . . 3.12 115.735 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.15 177.75 7.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.94 2.096 . . . . 1.3 110.499 168.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.82 144.27 45.6 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.622 1.169 . . . . 1.09 111.641 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.92 147.54 44.61 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.952 0.901 . . . . 0.95 112.188 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -138.83 146.88 41.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.243 1.817 . . . . 2.02 110.289 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.51 151.6 9.64 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.348 -1.47 . . . . 1.5 114.751 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.6 m -87.76 93.41 9.44 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 126.539 1.936 . . . . 2.03 107.354 167.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.02 140.6 29.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.232 1.413 . . . . 2.19 109.83 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -127.47 156.66 41.77 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 113.632 0.975 . . . . 3.05 113.632 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.84 99.71 53.03 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.149 1.38 . . . . 0.98 108.964 163.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.05 -9.34 14.18 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.093 2.529 . . . . 1.41 113.058 175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -173.48 49.78 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.684 1.135 . . . . 1.16 113.389 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -113.11 0.96 15.13 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.522 1.529 . . . . 2.5 112.802 -168.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.23 160.7 42.35 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.072 1.749 . . . . 1.69 110.257 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -82.47 154.44 16.04 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.109 2.539 . . . . 0.97 111.849 -172.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mp -123.87 130.24 52.28 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.309 1.444 . . . . 2.34 110.419 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -114.18 109.42 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.912 1.285 . . . . 2.74 109.612 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.3 tp -90.51 107.63 19.28 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 126.77 2.028 . . . . 0.85 108.428 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.0 m -101.15 -12.45 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.191 0.996 . . . . 0.56 112.927 -168.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.1 -163.81 32.21 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.251 0.929 . . . . 0.61 112.208 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.89 -173.18 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.562 1.145 . . . . 0.79 110.145 164.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -161.7 137.17 7.57 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.763 1.625 . . . . 4.98 107.98 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -146.74 147.21 29.27 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-O 117.152 -1.404 . . . . 0.94 109.341 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.35 -6.96 19.72 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.021 1.814 . . . . 0.97 113.816 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 m -93.91 -1.68 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.574 1.694 . . . . 0.86 115.574 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.1 150.11 34.37 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.562 1.528 . . . . 0.89 113.809 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.85 -67.1 0.81 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.611 1.565 . . . . 3.33 111.274 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -90.02 147.08 23.89 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 122.572 1.177 . . . . 3.63 110.321 168.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -142.02 129.27 20.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 127.456 2.302 . . . . 1.15 106.582 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -140.94 120.39 13.15 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.078 1.351 . . . . 2.03 109.016 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -78.98 121.71 25.26 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 120.064 1.302 . . . . 0.66 110.302 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 12.0 m170 -111.54 152.75 27.17 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.298 1.839 . . . . 0.6 112.053 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -102.91 -176.45 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.212 -1.358 . . . . 2.01 110.022 165.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.6 m -126.82 75.69 1.58 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.283 1.433 . . . . 1.58 107.526 170.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -65.45 150.04 49.02 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.615 1.166 . . . . 2.7 112.475 -174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -88.18 150.36 23.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.351 1.061 . . . . 6.49 111.931 172.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -155.6 155.4 33.24 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.517 1.527 . . . . 8.5 111.481 173.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -99.5 148.01 24.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 3.44 110.205 169.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.0 t -141.4 122.22 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 106.428 -1.693 . . . . 3.5 106.428 165.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 62.76 22.81 13.6 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.911 0.884 . . . . 3.88 112.085 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.8 3.82 69.07 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.303 -1.498 . . . . 1.82 114.36 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -96.88 141.55 29.93 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.567 1.947 . . . . 2.72 109.992 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.98 135.2 35.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.624 1.17 . . . . 5.1 111.294 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.51 141.8 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.236 1.814 . . . . 1.4 109.161 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -117.41 145.18 44.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.09 0.956 . . . . 4.7 110.167 174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.76 169.14 31.19 Favored Glycine 0 N--CA 1.476 1.302 0 C-N-CA 125.141 1.353 . . . . 1.2 112.633 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -99.06 151.66 20.7 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 118.512 1.156 . . . . 1.55 113.133 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -164.55 146.8 7.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.435 1.494 . . . . 6.54 110.159 176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 5.5 Cg_endo -68.93 153.6 72.33 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 121.688 1.592 . . . . 0.69 111.314 172.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.33 157.65 60.85 Favored Pre-proline 0 N--CA 1.473 0.702 0 C-N-CA 125.785 1.634 . . . . 0.47 110.537 175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.99 -18.08 36.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.598 2.198 . . . . 0.58 112.981 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -178.26 165.44 1.84 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.099 1.759 . . . . 1.81 111.575 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -111.07 173.4 6.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.366 1.866 . . . . 0.97 109.614 152.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -155.9 168.88 25.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.423 -0.798 . . . . 1.84 112.435 170.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.62 133.23 8.63 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 124.811 1.244 . . . . 0.8 109.783 -167.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.12 164.13 36.26 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.283 1.989 . . . . 0.82 110.925 170.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.53 143.42 92.95 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.008 2.472 . . . . 0.77 111.502 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt 67.26 0.25 2.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.79 2.036 . . . . 1.44 113.504 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.13 115.66 4.15 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 126.366 1.936 . . . . 0.95 110.528 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.91 112.2 24.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.038 1.335 . . . . 6.27 109.539 170.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.72 -174.98 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 126.007 1.723 . . . . 1.54 111.016 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.27 102.92 2.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.301 1.04 . . . . 3.65 111.023 -165.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -70.13 77.17 0.51 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.078 1.751 . . . . 1.07 109.112 161.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -91.77 147.79 35.8 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 127.832 2.453 . . . . 2.8 112.189 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -50.51 -64.18 0.23 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.787 3.658 . . . . 1.05 113.325 -170.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.45 97.36 1.7 Allowed Glycine 0 C--N 1.34 0.771 0 N-CA-C 108.439 -1.864 . . . . 1.32 108.439 165.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.81 -90.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.924 1.249 . . . . 0.93 112.358 -169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -148.29 141.64 25.22 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.345 1.858 . . . . 2.06 110.143 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -169.19 169.64 9.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.687 -1.258 . . . . 1.01 110.518 -172.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.65 136.13 41.0 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.646 -0.501 . . . . 1.9 109.646 170.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 mmt -91.28 126.31 36.33 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.339 -0.985 . . . . 1.09 108.339 161.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.25 111.08 22.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.41 1.484 . . . . 2.71 107.596 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -111.56 126.63 55.2 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.647 1.579 . . . . 2.81 108.841 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.15 95.46 0.09 OUTLIER Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.046 -1.222 . . . . 1.36 110.046 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.5 mt -92.72 124.39 36.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.544 0.672 . . . . 0.93 111.09 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -72.02 -19.73 61.81 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.8 1.037 . . . . 1.43 113.8 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -149.5 162.66 27.89 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 126.738 2.015 . . . . 6.96 108.974 164.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.86 138.36 68.19 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 N-CA-C 108.276 -1.471 . . . . 1.77 108.276 149.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.8 mp -79.01 150.63 31.88 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.092 1.757 . . . . 2.54 109.53 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.76 0.94 51.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.296 1.221 . . . . 6.4 114.296 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 72.2 161.89 0.25 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.27 2.628 . . . . 2.38 112.101 -172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.61 -12.16 0.77 Allowed Glycine 0 N--CA 1.482 1.728 0 N-CA-C 116.8 1.48 . . . . 4.02 116.8 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.98 166.51 22.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 117.707 2.484 . . . . 3.34 117.707 -153.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.61 68.55 9.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 131.659 3.984 . . . . 5.96 113.206 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.95 106.65 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 120.671 -1.268 . . . . 1.06 111.126 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.04 129.86 44.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.667 1.587 . . . . 2.99 110.764 160.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 mt -149.58 109.87 4.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.223 1.009 . . . . 1.74 112.272 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.67 96.18 5.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.192 2.597 . . . . 2.02 109.47 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.9 mt -77.23 118.39 19.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.321 -0.862 . . . . 1.18 110.608 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -91.92 127.55 37.42 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.151 0.98 . . . . 0.64 111.801 -169.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -126.12 134.03 51.45 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.552 0.945 . . . . 2.37 113.552 -175.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 33.12 49.63 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.579 2.352 . . . . 1.86 114.142 171.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.93 -94.01 0.77 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.574 1.083 . . . . 3.94 111.946 -170.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.65 23.0 7.96 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 117.381 1.712 . . . . 1.61 117.381 -164.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 0.4 OUTLIER -117.76 153.26 33.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 120.508 2.154 . . . . 4.93 109.782 166.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -151.03 139.95 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.289 1.436 . . . . 1.14 109.584 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -123.31 110.97 15.86 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.024 1.33 . . . . 1.84 109.48 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -85.3 108.17 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.093 -0.38 . . . . 2.57 111.479 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 m -104.55 159.84 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.46 1.504 . . . . 1.19 110.937 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.9 p -101.97 137.99 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.347 1.059 . . . . 2.15 109.658 162.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.32 144.19 46.83 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.216 1.406 . . . . 1.73 109.958 168.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.37 141.82 26.05 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.823 2.348 . . . . 1.36 110.37 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.42 153.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.82 0.848 . . . . 1.62 112.43 167.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -146.61 158.05 43.83 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.491 1.517 . . . . 3.87 109.124 163.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.58 99.48 10.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.924 -1.11 . . . . 2.43 108.109 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.222 0 CA-C-O 114.844 -2.503 . . . . 5.45 117.275 -154.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.097 0 N-CA-C 110.181 -1.167 . . . . 9.6 110.181 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m 51.18 46.76 25.99 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.397 1.629 . . . . 10.08 115.397 157.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 91.48 -10.97 0.25 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 129.752 3.221 . . . . 14.19 114.402 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.256 70.3 p 101.41 122.75 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.058 1 C-N-CA 133.83 4.852 . . . . 8.04 108.806 177.503 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -72.97 103.14 3.67 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.277 1.031 . . . . 6.41 109.382 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.93 173.38 41.52 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 125.162 1.363 . . . . 1.05 113.818 -168.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -159.13 145.31 16.6 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.552 1.541 . . . . 1.54 110.571 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.3 t -91.29 143.05 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.692 1.197 . . . . 1.03 109.303 174.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -69.21 116.91 10.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.626 -0.671 . . . . 4.02 112.31 -174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.2 134.18 56.77 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.156 0.983 . . . . 4.03 109.999 161.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -166.13 140.46 3.65 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 120.534 -1.353 . . . . 2.28 112.456 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -92.59 68.99 0.68 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.234 3.29 . . . . 3.11 110.348 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.01 -177.76 36.26 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.772 1.069 . . . . 1.48 115.772 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -86.54 -0.25 8.1 Favored 'Trans proline' 0 CA--C 1.542 0.91 1 C-N-CA 125.494 4.129 . . . . 1.43 113.371 177.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -134.37 152.75 51.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 2.66 111.56 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.46 -170.28 3.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.211 2.204 . . . . 1.16 109.933 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.24 152.9 39.94 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.309 1.444 . . . . 1.08 109.412 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.2 136.69 51.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.415 1.461 . . . . 1.09 111.902 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -120.27 135.07 55.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.015 1.726 . . . . 2.06 110.277 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.8 152.19 11.35 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.872 -1.143 . . . . 1.62 112.423 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.2 m -95.93 92.28 6.42 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.112 0.965 . . . . 1.61 110.029 176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -80.41 133.61 35.9 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.097 -0.705 . . . . 2.27 109.097 173.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -127.86 145.73 50.85 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.107 1.763 . . . . 2.79 110.124 -174.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -107.86 104.28 52.69 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.702 0.801 . . . . 1.13 110.073 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.33 -12.97 11.33 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.506 2.137 . . . . 1.05 113.321 176.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.13 -174.25 49.53 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 124.149 0.88 . . . . 1.21 113.221 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -112.22 6.01 18.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.594 1.557 . . . . 2.75 112.337 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.5 160.92 60.01 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 126.86 2.064 . . . . 1.73 109.988 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -81.44 144.64 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.324 2.016 . . . . 1.12 112.028 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -101.95 121.26 41.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.363 1.465 . . . . 2.33 108.934 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.6 ttm105 -110.53 97.53 6.95 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.481 1.112 . . . . 3.38 110.753 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.0 tp -79.67 106.74 11.92 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.292 2.237 . . . . 0.75 109.551 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.82 -13.42 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.155 1.382 . . . . 0.85 113.524 -171.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.74 -164.95 34.28 Favored Glycine 0 C--N 1.34 0.753 0 O-C-N 121.632 -0.668 . . . . 0.73 112.841 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB1' HD13 ' A' ' 101' ' ' LEU . . . -160.77 175.41 12.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.918 0.887 . . . . 0.92 112.76 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' C ' ' HE ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -143.72 156.48 44.54 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.831 0.452 . . . . 7.62 110.391 160.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 t -152.95 149.69 22.52 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 125.139 1.376 . . . . 0.88 108.628 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.97 -35.07 56.87 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.167 1.245 . . . . 1.48 111.24 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.9 m -80.97 4.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 114.868 1.433 . . . . 1.38 114.868 -164.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.34 170.2 14.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.186 1.794 . . . . 1.1 109.99 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 7.1 tp10 -106.38 -82.84 0.53 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.413 -0.958 . . . . 2.8 108.413 164.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -72.68 125.67 28.06 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.164 -0.96 . . . . 5.13 109.072 165.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.63 138.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.196 1.799 . . . . 1.19 109.419 168.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -140.07 127.69 21.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.663 1.185 . . . . 2.28 111.927 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.428 HD12 ' CE1' ' A' ' 84' ' ' PHE . 4.9 tt -78.93 122.87 26.67 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 120.767 -1.208 . . . . 0.75 110.795 167.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 21.6 m170 -108.71 153.2 23.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.71 1.604 . . . . 0.81 112.637 176.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -87.32 158.72 18.99 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.309 1.044 . . . . 2.23 109.803 162.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -109.31 143.91 38.17 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.161 -1.422 . . . . 1.48 107.161 152.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -137.46 155.07 49.74 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 2.14 111.285 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -111.02 121.81 46.31 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.101 -1.444 . . . . 3.49 107.101 160.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -146.44 173.21 12.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.387 1.475 . . . . 7.14 110.274 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -73.98 155.13 38.94 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.418 0.687 . . . . 3.21 110.132 159.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.85 -98.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 107.948 -1.131 . . . . 3.8 107.948 168.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -74.75 63.15 1.13 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.833 1.653 . . . . 5.0 111.723 170.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.63 -24.67 0.63 Allowed Glycine 0 N--CA 1.475 1.274 0 C-N-CA 126.462 1.982 . . . . 3.83 115.222 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -107.56 164.03 12.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.909 2.484 . . . . 3.45 111.628 -178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -76.87 134.15 39.09 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.375 2.27 . . . . 4.33 112.084 -175.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -144.08 147.35 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.345 1.858 . . . . 1.49 109.995 -177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -98.0 118.54 34.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.515 1.526 . . . . 3.79 110.303 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.16 -179.19 16.1 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 125.389 1.471 . . . . 1.29 113.239 -176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.5 mtt -142.26 158.67 43.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.413 1.485 . . . . 2.14 111.244 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.87 151.04 4.78 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.741 -1.123 . . . . 4.7 113.437 169.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 27.4 Cg_endo -61.31 142.05 94.75 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.164 2.576 . . . . 0.65 112.006 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.63 159.86 48.89 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 126.516 1.926 . . . . 0.48 110.882 -178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.15 -21.29 18.09 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.564 2.176 . . . . 0.68 113.455 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -171.87 163.72 6.32 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 120.27 1.396 . . . . 2.65 112.395 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.8 mt -115.03 173.51 6.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.199 2.2 . . . . 1.09 109.24 155.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.91 164.27 38.68 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.645 -0.659 . . . . 2.56 112.13 167.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.1 t -139.25 125.79 12.53 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 125.412 1.485 . . . . 1.15 108.733 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.21 159.13 54.13 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.124 1.883 . . . . 1.25 110.512 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.77 140.5 93.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.959 2.439 . . . . 1.08 111.654 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt 72.17 -8.52 1.14 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.27 2.228 . . . . 1.41 113.997 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.05 -172.93 49.6 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 125.882 1.706 . . . . 1.47 112.873 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -160.61 161.76 32.6 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.965 2.106 . . . . 4.62 111.843 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.8 129.88 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.112 1.365 . . . . 1.78 110.007 170.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.88 122.29 32.1 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.22 0.533 . . . . 3.36 110.307 165.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -68.89 68.14 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.368 1.867 . . . . 1.42 109.954 169.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -70.85 142.27 87.94 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 125.472 1.509 . . . . 2.76 110.32 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.41 -57.02 2.45 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.55 2.833 . . . . 1.28 112.233 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.96 78.0 2.01 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.357 -1.097 . . . . 1.44 110.357 166.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.23 -79.61 0.08 OUTLIER Glycine 0 N--CA 1.466 0.637 0 C-N-CA 127.119 2.295 . . . . 0.95 111.415 -175.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -153.84 147.49 25.2 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.631 1.972 . . . . 2.35 108.905 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -159.7 154.13 23.94 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 120.496 -1.378 . . . . 0.75 109.276 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CE1' HD12 ' A' ' 45' ' ' LEU . 56.5 m-85 -92.39 104.03 16.4 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.329 -1.36 . . . . 1.83 107.329 167.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 129.61 40.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.603 -0.888 . . . . 1.15 108.603 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -114.81 122.14 45.44 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.647 1.579 . . . . 1.8 109.016 -175.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.02 155.85 36.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.333 1.053 . . . . 3.0 110.668 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.92 -64.25 4.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.129 1.347 . . . . 3.51 112.29 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt 74.1 110.96 0.07 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.568 2.747 . . . . 1.26 115.526 164.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HE3' ' OE1' ' A' ' 41' ' ' GLU . 36.3 mttp -89.17 -3.73 58.5 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 120.579 -1.325 . . . . 1.78 113.595 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -137.35 138.61 25.43 Favored Pre-proline 0 N--CA 1.467 0.413 0 C-N-CA 126.193 1.797 . . . . 5.23 108.77 171.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.97 130.13 17.38 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 N-CA-C 107.469 -1.781 . . . . 1.77 107.469 159.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.55 85.1 6.02 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.411 0.684 . . . . 2.71 109.563 -170.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HE3' ' HG2' ' A' ' 97' ' ' GLU . 0.4 OUTLIER -102.8 142.37 34.04 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.344 1.058 . . . . 3.9 111.463 175.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.17 142.06 48.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 114.546 1.313 . . . . 1.58 114.546 -170.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.39 52.12 28.24 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.781 -0.645 . . . . 2.0 112.789 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HG2' ' HE3' ' A' ' 94' ' ' LYS . 2.8 mt-10 -107.51 -175.74 2.87 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.549 -1.278 . . . . 2.49 107.549 147.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.51 120.43 31.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.76 0.79 . . . . 4.74 109.277 166.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.6 t -87.11 103.85 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.774 -0.824 . . . . 0.97 108.774 168.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.11 141.62 40.13 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 122.313 1.054 . . . . 3.5 110.672 162.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.417 HD13 ' HB1' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -155.25 130.58 9.65 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.171 -0.956 . . . . 3.21 111.881 -167.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -96.71 121.25 38.34 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.443 1.097 . . . . 2.32 109.413 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -95.36 119.11 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.174 1.389 . . . . 1.15 110.012 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 mt -92.28 124.55 36.42 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.002 0.921 . . . . 0.91 110.505 -174.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -120.91 126.67 50.6 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.141 0.977 . . . . 2.16 112.542 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 50.07 21.12 0.69 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.258 1.823 . . . . 2.01 114.821 171.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.53 -61.12 2.82 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.695 1.14 . . . . 3.24 112.361 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.79 1.37 53.95 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 117.188 1.635 . . . . 1.89 117.188 -165.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -137.24 146.24 44.55 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.71 1.755 . . . . 5.85 111.351 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.01 148.46 23.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 125.121 1.368 . . . . 1.25 109.822 163.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -143.37 133.03 23.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.396 1.878 . . . . 1.79 109.657 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -85.65 140.74 30.31 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.624 0.602 . . . . 2.16 112.624 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.1 m -125.52 177.23 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.606 1.962 . . . . 1.22 109.461 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -155.21 140.69 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 118.404 0.547 . . . . 1.93 111.002 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.32 152.39 19.91 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.965 1.306 . . . . 2.33 112.844 -171.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -79.27 -170.28 0.97 Allowed 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.24 3.293 . . . . 1.04 112.346 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 52.4 t -137.42 84.75 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 126.857 2.063 . . . . 2.24 111.389 -161.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -128.89 172.88 10.9 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 119.983 -1.698 . . . . 5.48 114.553 -171.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.07 142.19 28.89 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.67 -1.269 . . . . 3.27 113.532 -167.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 C-N-CA 126.702 2.001 . . . . 6.85 111.528 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.921 0 N-CA-C 107.631 -2.188 . . . . 10.29 107.631 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -83.39 -21.86 32.92 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 117.622 0.711 . . . . 10.13 111.703 165.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -131.4 -179.02 5.11 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.98 2.112 . . . . 8.79 110.219 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.3 p -66.66 114.78 5.85 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.809 1.244 . . . . 7.25 108.0 160.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -133.02 -179.12 5.29 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.848 2.059 . . . . 5.21 109.312 -169.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.11 165.68 21.77 Favored Glycine 0 N--CA 1.475 1.239 0 O-C-N 120.296 -1.503 . . . . 1.11 113.371 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.2 p90 -167.09 163.26 15.72 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.122 1.369 . . . . 1.67 111.805 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -127.4 135.6 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.277 -0.889 . . . . 1.21 110.522 -176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -88.68 129.52 35.51 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.469 1.128 . . . . 4.57 113.605 -169.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -79.55 141.33 36.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.108 2.163 . . . . 2.93 112.562 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -162.8 152.26 13.01 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.329 1.451 . . . . 2.29 110.943 165.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.45 56.55 4.3 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.546 3.497 . . . . 2.44 109.706 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -125.81 174.86 17.65 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.661 1.124 . . . . 1.3 114.068 -172.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.13 -15.22 13.02 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.904 3.069 . . . . 1.59 112.556 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -143.89 154.3 43.21 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.479 1.912 . . . . 2.03 111.834 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.29 -179.85 8.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.728 1.611 . . . . 1.09 110.751 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.44 140.67 49.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.18 0.807 . . . . 1.13 113.18 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -105.48 141.66 36.58 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.998 0.519 . . . . 0.99 110.763 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -117.67 157.26 26.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.937 1.695 . . . . 2.05 110.08 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -167.47 148.07 5.39 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.994 1.479 . . . . 1.29 114.994 166.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.54 HG23 ' HD2' ' A' ' 74' ' ' ARG . 59.4 m -75.83 140.38 42.24 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.528 -1.214 . . . . 1.23 109.636 157.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.33 130.63 15.6 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.687 1.195 . . . . 2.98 109.069 168.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -136.95 152.64 50.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.284 1.04 . . . . 4.53 112.276 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -104.15 102.49 32.74 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.066 1.346 . . . . 1.32 110.528 -169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.71 -9.19 14.63 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.315 2.01 . . . . 1.73 113.603 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.17 -170.44 44.87 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 124.362 0.982 . . . . 1.5 112.998 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -120.86 9.95 10.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.782 1.233 . . . . 2.66 112.943 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -122.76 159.4 53.55 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.047 1.739 . . . . 2.27 110.69 172.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.67 153.51 15.36 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.757 2.305 . . . . 1.93 111.805 -171.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.19 142.24 43.64 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.732 1.613 . . . . 2.08 109.019 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -141.41 107.49 5.2 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.712 0.805 . . . . 3.45 109.805 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.1 tt -97.37 129.14 44.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.277 2.631 . . . . 1.98 109.218 -165.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.84 -9.87 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 114.136 1.162 . . . . 0.57 114.136 -169.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 176.19 -160.75 28.77 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.069 -1.02 . . . . 0.55 112.285 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.68 -174.25 4.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.942 1.697 . . . . 0.89 110.664 165.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -150.84 144.87 25.32 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.609 1.963 . . . . 7.64 109.136 171.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.3 t -141.01 151.26 61.83 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-N 120.376 1.444 . . . . 0.63 109.462 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.0 -22.14 48.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.359 2.039 . . . . 0.88 113.851 164.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -84.91 2.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 115.178 1.547 . . . . 0.93 115.178 -172.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.34 175.6 12.07 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.652 1.181 . . . . 0.9 112.306 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -110.56 -89.36 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.575 1.15 . . . . 2.84 109.894 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -77.72 100.6 6.29 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 120.667 -1.27 . . . . 4.24 108.932 177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 p -82.24 135.04 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.664 1.585 . . . . 1.37 111.147 162.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -130.1 147.48 51.84 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.822 2.449 . . . . 2.17 108.407 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 tt -92.79 124.1 36.54 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.9 1.682 . . . . 1.06 111.162 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.7 m170 -114.01 152.47 30.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.317 1.447 . . . . 0.83 112.635 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -98.74 166.43 11.32 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.981 1.312 . . . . 2.16 110.319 167.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -125.14 117.69 24.45 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.591 1.156 . . . . 1.32 108.166 167.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -119.64 -177.59 3.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.44 1.496 . . . . 2.24 112.084 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -140.33 163.19 33.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.424 1.09 . . . . 2.89 111.895 168.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.36 166.82 20.39 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.641 1.577 . . . . 5.88 112.023 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.16 135.42 40.59 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.537 1.535 . . . . 4.85 108.445 168.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.2 t -105.8 -113.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.745 1.618 . . . . 3.19 107.025 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.26 67.19 3.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.519 1.054 . . . . 4.31 108.931 164.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.89 -22.01 0.46 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 127.323 2.392 . . . . 2.5 115.953 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -74.93 133.82 41.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.5 1.92 . . . . 4.17 110.134 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -90.95 127.63 36.48 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.927 0.891 . . . . 5.51 109.67 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.2 t -145.12 152.58 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.657 1.583 . . . . 2.85 109.876 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 7.5 ptp -83.96 162.13 20.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.505 1.522 . . . . 4.49 113.32 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.52 172.93 33.68 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.669 1.604 . . . . 1.48 113.122 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtt -137.09 154.55 50.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.554 1.542 . . . . 2.82 110.472 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -168.77 154.11 6.21 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.683 1.193 . . . . 5.36 111.144 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 3.8 Cg_endo -68.6 152.38 74.67 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.46 1.44 . . . . 0.62 112.085 171.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.97 149.36 68.28 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 125.945 1.698 . . . . 0.71 109.842 172.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.31 -19.08 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.903 2.402 . . . . 0.88 113.909 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -172.61 171.56 4.49 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.804 1.184 . . . . 1.81 113.117 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.23 175.26 10.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.839 2.456 . . . . 2.82 109.373 159.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.45 168.8 25.92 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 120.602 -1.311 . . . . 2.39 111.132 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 t -149.65 137.73 11.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 124.72 1.208 . . . . 1.5 108.737 -167.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.77 171.73 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.655 1.57 . . . . 1.63 110.146 166.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.97 146.86 91.79 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.344 2.03 . . . . 1.58 110.322 160.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt 69.61 -2.72 1.85 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.696 1.998 . . . . 1.38 114.024 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.21 148.43 20.74 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 126.985 2.231 . . . . 1.12 111.688 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.54 ' HD2' HG23 ' A' ' 21' ' ' THR . 33.2 ttp-105 -106.27 142.64 35.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.432 1.893 . . . . 6.04 111.505 168.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 m -121.86 147.26 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.475 1.51 . . . . 2.75 108.473 161.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -128.13 112.28 14.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.334 -1.358 . . . . 3.41 107.334 177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.09 63.05 0.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.57 1.948 . . . . 1.49 108.971 171.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? -79.48 150.95 74.21 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 128.8 2.84 . . . . 3.23 111.545 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -55.4 -35.69 92.39 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.52 2.814 . . . . 1.17 113.641 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.72 60.06 1.77 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.189 0.9 . . . . 1.73 111.867 168.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.89 -73.6 0.05 OUTLIER Glycine 0 N--CA 1.469 0.859 0 C-N-CA 125.225 1.393 . . . . 1.31 113.94 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -153.01 154.72 35.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.122 1.769 . . . . 2.32 111.01 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -163.99 169.93 17.32 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.107 0.963 . . . . 1.09 109.879 176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -97.21 126.61 42.51 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.789 -0.819 . . . . 2.12 108.789 166.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.9 mmt -81.69 120.82 25.6 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.426 1.091 . . . . 1.1 109.219 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.7 mt -111.65 113.01 25.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.147 1.379 . . . . 1.47 107.976 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -107.41 139.83 41.28 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.433 1.493 . . . . 2.72 109.293 176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.08 66.3 1.94 Allowed Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.489 -1.045 . . . . 1.29 110.489 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.5 mt -70.03 123.54 21.81 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.04 0.536 . . . . 1.21 110.568 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -83.19 19.83 1.39 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.015 0.926 . . . . 1.45 113.154 -172.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 173.9 155.98 0.3 Allowed Pre-proline 0 CA--C 1.544 0.718 1 C-N-CA 131.893 4.077 . . . . 4.46 107.945 -176.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -64.73 133.68 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 N-CA-C 106.626 -2.105 . . . . 2.1 106.626 147.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.9 116.55 5.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.55 0.69 . . . . 2.42 109.155 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -71.23 107.67 4.35 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.416 -0.802 . . . . 4.38 109.939 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.67 114.82 1.52 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.909 -1.119 . . . . 1.52 109.461 164.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.49 38.67 7.02 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-O 118.755 -1.025 . . . . 2.18 113.958 -165.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -135.75 -178.92 5.35 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 119.275 1.538 . . . . 3.46 108.659 149.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.78 150.31 37.12 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.158 0.98 . . . . 5.06 110.589 166.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.3 t -89.99 113.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.98 1.712 . . . . 1.21 108.031 172.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -66.22 137.69 57.16 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.909 -0.587 . . . . 2.94 109.477 160.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 mt -149.55 133.44 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.41 1.084 . . . . 1.54 111.993 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.55 87.76 2.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.786 2.034 . . . . 2.63 109.146 -167.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 mt -69.28 125.17 25.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.766 2.026 . . . . 1.11 111.077 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.3 mt -94.51 138.67 32.13 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.511 1.124 . . . . 0.82 111.464 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -135.08 138.54 43.94 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.432 1.093 . . . . 1.8 111.238 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -48.8 126.55 12.26 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.595 1.558 . . . . 1.79 113.342 -167.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.25 -145.58 19.16 Favored Glycine 0 CA--C 1.532 1.1 0 N-CA-C 110.757 -0.937 . . . . 3.29 110.757 -166.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.27 27.48 9.32 Favored Glycine 0 CA--C 1.533 1.164 0 N-CA-C 115.74 1.056 . . . . 2.04 115.74 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.63 131.22 46.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 120.27 2.035 . . . . 4.76 112.079 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.73 123.32 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.108 1.363 . . . . 1.41 109.284 162.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.76 119.8 33.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.809 1.644 . . . . 3.02 108.477 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.54 147.09 23.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.328 1.233 . . . . 2.47 114.328 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.96 172.93 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 127.86 2.464 . . . . 1.14 109.492 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.82 140.99 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.828 1.651 . . . . 2.11 108.017 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.79 133.81 10.59 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.147 1.379 . . . . 1.52 110.83 -166.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 147.77 67.34 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.105 2.537 . . . . 1.03 114.168 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 72.7 t -79.27 132.49 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.538 0.735 . . . . 1.14 110.496 168.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -133.7 156.26 48.25 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.125 1.77 . . . . 3.9 112.164 174.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.57 84.42 7.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.093 0.957 . . . . 1.98 109.457 164.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 116.907 -1.52 . . . . 5.71 112.16 -163.419 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 110.543 -1.023 . . . . 10.31 110.543 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 m 160.44 -172.48 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 1 C-N-CA 132.29 4.236 . . . . 10.77 106.568 -173.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 74.53 -145.6 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.384 1.074 . . . . 11.41 110.815 171.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.9 134.13 42.3 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.169 0.988 . . . . 7.05 112.93 -163.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -84.0 127.41 33.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.545 1.538 . . . . 5.27 108.86 156.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.88 165.48 38.74 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 121.327 -0.858 . . . . 1.13 114.224 172.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -159.53 158.98 32.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.628 1.171 . . . . 2.16 114.001 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.2 t -104.08 130.03 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.573 -1.269 . . . . 1.25 107.573 164.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.3 ptt85 -84.48 -2.6 57.51 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.841 1.793 . . . . 3.97 115.841 -164.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.4 t80 65.88 152.21 0.06 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.496 2.318 . . . . 3.36 113.671 -170.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -159.54 146.8 12.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.943 2.097 . . . . 3.74 108.25 157.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -83.88 -7.84 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.324 2.683 . . . . 3.45 112.283 169.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.57 -167.05 43.16 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 124.462 1.029 . . . . 1.9 114.213 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.01 -9.33 22.08 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.503 2.802 . . . . 1.8 113.359 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.4 p30 -152.33 161.89 41.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.081 1.352 . . . . 2.22 114.397 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.57 -174.09 4.78 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.668 2.387 . . . . 1.18 111.953 -178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB2' ' CE ' ' A' ' 85' ' ' MET . . . -137.08 159.58 41.49 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 125.063 1.345 . . . . 1.32 111.51 174.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.65 163.35 37.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.465 1.506 . . . . 1.41 113.273 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -145.24 152.74 40.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.363 1.865 . . . . 1.92 110.874 -170.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -166.13 158.44 14.38 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.547 1.139 . . . . 1.59 112.068 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.5 m -90.73 138.59 31.46 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.667 -1.234 . . . . 1.25 107.667 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.6 132.1 56.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.943 1.297 . . . . 2.27 107.767 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.55 135.36 53.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.727 0.811 . . . . 3.31 111.761 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -101.69 115.56 64.71 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.348 1.059 . . . . 0.91 109.7 163.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -88.57 -8.9 5.09 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.241 2.627 . . . . 1.27 114.4 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.06 162.97 32.86 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 119.434 1.016 . . . . 1.22 113.355 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -83.31 -0.52 50.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.347 1.459 . . . . 3.08 114.178 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.91 158.04 36.91 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.999 1.32 . . . . 1.85 110.53 169.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.38 155.23 18.89 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.214 2.61 . . . . 1.16 111.198 -173.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.4 mt -104.25 153.86 20.48 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.347 1.059 . . . . 1.89 111.316 172.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -130.65 114.42 15.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.153 1.381 . . . . 3.02 109.185 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.8 tp -95.45 114.41 26.17 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 128.246 2.618 . . . . 0.66 108.893 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.05 -10.54 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.399 1.08 . . . . 0.55 113.571 -166.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.34 -160.19 31.44 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 121.616 -0.678 . . . . 0.55 112.704 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.71 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -151.03 179.95 7.82 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.597 0.759 . . . . 0.8 111.924 176.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 3.0 mmt180 -154.47 149.69 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.94 -1.133 . . . . 6.05 107.94 172.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -162.49 153.79 15.06 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-O 117.45 -1.262 . . . . 0.73 108.725 -170.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.42 -7.95 16.04 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.32 2.013 . . . . 1.11 114.489 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 m -98.48 -3.95 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 116.142 1.905 . . . . 0.89 116.142 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.72 155.51 36.07 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.944 1.298 . . . . 1.29 110.666 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -93.95 -74.75 0.52 Allowed 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.575 -0.528 . . . . 4.45 109.575 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -80.77 107.75 13.84 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.481 -0.933 . . . . 4.52 108.481 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -113.18 125.01 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.913 0.885 . . . . 1.88 108.763 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -134.13 122.7 23.26 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.889 1.276 . . . . 2.63 110.384 -162.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 tt -79.59 122.53 26.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.227 1.013 . . . . 0.82 110.461 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 7.2 m170 -108.1 156.87 18.8 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.452 1.901 . . . . 0.88 112.832 175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -105.24 -177.51 3.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.16 2.584 . . . . 2.03 111.473 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.9 m -133.12 99.54 4.59 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 106.749 -1.574 . . . . 1.67 106.749 154.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.3 151.51 41.29 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.462 0.305 . . . . 2.45 110.63 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 18.6 ptp -97.97 157.92 15.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.55 0.34 . . . . 3.88 110.797 155.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -176.1 160.96 2.31 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.583 2.353 . . . . 6.63 110.274 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.73 154.26 17.31 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.029 0.932 . . . . 3.7 108.795 169.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 t -133.17 -96.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.281 1.033 . . . . 2.87 108.967 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -75.84 54.94 0.85 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.267 1.827 . . . . 3.19 110.34 172.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.99 -17.57 0.53 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.137 1.827 . . . . 2.11 115.261 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -100.8 152.69 20.2 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.01 1.724 . . . . 2.67 111.162 -168.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -62.64 131.74 50.02 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.846 0.858 . . . . 4.37 111.183 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -131.34 151.41 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 126.037 1.735 . . . . 1.95 109.335 172.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.8 mtm -128.64 141.51 51.33 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.602 1.161 . . . . 4.01 110.302 163.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.86 163.57 30.5 Favored Glycine 0 N--CA 1.469 0.844 0 C-N-CA 123.753 0.692 . . . . 1.24 112.689 -178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -97.74 158.47 15.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.965 0.906 . . . . 1.72 112.771 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.6 mtt-85 -164.83 145.8 6.34 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 126.724 2.009 . . . . 6.27 109.053 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 7.8 Cg_endo -70.59 152.9 65.33 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 CA-C-N 121.526 1.581 . . . . 0.9 110.111 160.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.17 156.2 57.52 Favored Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 125.252 1.421 . . . . 0.67 110.037 173.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.32 -14.4 34.28 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.812 2.341 . . . . 0.8 113.015 174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -178.96 162.15 1.24 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.115 1.766 . . . . 2.27 110.861 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -108.59 174.55 5.82 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.925 1.69 . . . . 1.04 109.316 153.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.74 165.24 37.21 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 120.908 -1.12 . . . . 2.34 111.204 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 t -149.63 135.36 10.02 Favored Pre-proline 0 N--CA 1.466 0.333 0 CA-C-O 118.573 -0.727 . . . . 0.88 110.502 -164.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.98 165.8 31.19 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.264 1.976 . . . . 0.89 112.116 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.31 138.84 83.6 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.391 3.394 . . . . 1.09 112.62 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.1 2.83 1.54 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.344 1.857 . . . . 1.99 113.808 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.09 115.51 4.13 Favored Glycine 0 C--O 1.228 -0.23 0 C-N-CA 127.422 2.439 . . . . 0.89 111.626 -174.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.6 mtt85 -85.43 134.36 34.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.248 -0.976 . . . . 6.64 109.978 155.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.34 168.74 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 126.749 2.02 . . . . 1.53 109.6 175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -134.47 124.77 26.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.824 0.85 . . . . 3.64 110.781 -164.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.6 mp -79.06 75.63 5.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.716 -0.846 . . . . 1.18 108.716 169.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 ptpm? -79.59 136.27 55.84 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 118.278 -0.867 . . . . 2.86 110.525 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.47 -58.51 1.64 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 124.933 3.755 . . . . 1.03 113.566 -163.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.1 106.78 2.61 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 107.817 -2.113 . . . . 1.23 107.817 160.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.51 -88.65 0.17 Allowed Glycine 0 N--CA 1.467 0.724 0 C-N-CA 124.654 1.121 . . . . 0.94 111.266 -163.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -150.62 144.55 25.32 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.891 2.076 . . . . 1.81 109.926 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -165.8 174.2 9.87 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.937 -1.102 . . . . 0.85 110.618 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -110.9 128.8 55.93 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.994 0.918 . . . . 2.28 109.971 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.482 ' CE ' ' HB2' ' A' ' 17' ' ' ALA . 8.1 mmt -86.71 136.98 32.82 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.073 0.949 . . . . 0.89 109.633 165.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.7 mt -116.67 117.0 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.516 1.527 . . . . 2.11 109.105 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.4 mt -124.82 142.35 51.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.896 1.678 . . . . 2.63 111.069 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.99 59.57 4.24 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 110.041 -1.223 . . . . 1.59 110.041 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.8 mt -66.8 129.42 39.83 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.156 0.979 . . . . 1.19 111.713 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.59 -10.19 49.61 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.785 1.234 . . . . 1.81 112.875 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -155.38 146.19 16.33 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.621 1.568 . . . . 5.9 110.305 163.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.28 127.49 15.88 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 107.378 -1.816 . . . . 1.81 107.378 158.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mp -87.49 167.73 13.72 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.102 0.961 . . . . 2.41 111.277 -171.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 145.98 48.15 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.032 -1.043 . . . . 5.03 110.524 165.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.07 125.95 17.1 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 109.372 -0.603 . . . . 1.49 109.372 158.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.24 8.86 68.02 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 118.094 -1.392 . . . . 1.9 115.712 -173.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -86.45 173.73 9.44 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.943 1.872 . . . . 2.76 109.429 157.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -118.64 158.7 24.98 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.816 1.647 . . . . 4.47 110.099 167.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.1 t -132.45 120.31 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.319 1.848 . . . . 1.01 110.25 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.57 147.0 28.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.57 1.148 . . . . 3.29 110.321 173.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.71 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.3 tt -157.02 140.29 15.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.52 0.728 . . . . 1.85 112.935 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 1.4 m-20 -104.61 115.47 30.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.863 2.465 . . . . 2.93 111.546 174.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.3 125.03 28.44 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.827 -1.17 . . . . 2.41 109.828 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.6 mt -94.31 126.81 39.79 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.789 0.436 . . . . 0.63 110.328 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -124.69 154.28 41.04 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.646 1.212 . . . . 1.82 112.245 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.06 128.52 37.61 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.86 1.059 . . . . 1.94 113.86 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.17 50.41 10.49 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.194 0.902 . . . . 3.68 114.073 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.53 76.47 Favored Glycine 0 N--CA 1.472 1.078 0 N-CA-C 116.034 1.173 . . . . 1.51 116.034 166.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.09 135.75 35.12 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.47 1.635 . . . . 4.74 109.971 168.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.8 p -150.82 139.02 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 125.081 1.352 . . . . 1.08 108.95 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.7 mt -139.05 134.78 33.45 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.244 1.018 . . . . 1.67 111.871 -172.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 2.9 tpmt? -80.17 135.95 36.39 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.198 . . . . 2.77 113.113 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.93 173.65 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 125.158 1.383 . . . . 1.37 111.88 156.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.16 153.75 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.121 1.768 . . . . 2.33 108.74 165.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 mt -143.5 135.28 12.96 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.945 2.098 . . . . 1.82 110.09 -172.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.32 159.28 49.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.257 2.638 . . . . 1.08 111.988 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.9 t -98.33 131.2 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.123 0.969 . . . . 1.33 110.989 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.59 -170.05 1.8 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 129.782 3.233 . . . . 4.01 110.796 176.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.1 70.58 1.15 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.181 -0.949 . . . . 3.3 111.275 167.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.899 1.444 . . . . 4.56 114.899 -145.561 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 108.586 -1.805 . . . . 10.8 108.586 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m 75.85 -64.8 0.34 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.645 1.578 . . . . 10.26 112.286 170.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -152.66 35.71 0.5 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.0 1.32 . . . . 10.26 113.062 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.49 146.2 41.22 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.278 -1.008 . . . . 7.26 108.278 155.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -117.21 177.03 4.87 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.632 1.173 . . . . 6.02 109.535 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.474 ' CA ' ' HA ' ' A' ' 20' ' ' LEU . . . -99.91 128.3 9.53 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 121.259 -0.901 . . . . 2.09 114.342 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -119.91 177.14 5.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.385 1.074 . . . . 1.9 112.031 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.16 135.45 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.245 1.018 . . . . 1.16 108.605 164.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.73 139.32 56.34 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.891 1.071 . . . . 8.36 113.891 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -74.2 29.3 0.08 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.809 1.644 . . . . 4.0 114.967 177.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.7 p -69.9 134.37 87.87 Favored Pre-proline 0 CA--C 1.545 0.785 0 O-C-N 119.706 -1.871 . . . . 2.75 113.181 -159.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -72.2 -20.39 24.83 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.951 2.434 . . . . 2.26 112.073 169.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.39 122.83 6.24 Favored Glycine 0 CA--C 1.534 1.253 0 N-CA-C 108.678 -1.769 . . . . 3.52 108.678 162.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.83 -39.99 5.73 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.006 1.903 . . . . 4.09 112.34 -172.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -90.23 137.14 32.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.042 0.837 . . . . 4.48 110.784 -176.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 167.27 178.98 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.089 2.556 . . . . 3.16 112.139 -172.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.24 148.69 28.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.655 1.982 . . . . 1.95 114.001 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.04 155.65 45.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.788 1.635 . . . . 1.18 110.839 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -133.88 164.92 26.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.358 1.063 . . . . 2.45 112.15 -158.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.474 ' HA ' ' CA ' ' A' ' 6' ' ' GLY . 2.6 pt? -168.38 155.03 7.41 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.659 1.355 . . . . 1.42 114.659 164.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.9 m -76.03 136.86 39.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 107.874 -1.158 . . . . 1.57 107.874 151.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -149.02 136.04 19.89 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.265 1.026 . . . . 2.36 109.436 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.34 165.42 27.94 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.836 0.826 . . . . 3.47 112.774 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -114.87 89.91 20.89 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 114.132 -1.395 . . . . 0.88 110.16 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.14 -5.77 17.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 1.21 112.922 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.59 172.72 50.7 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.329 0.966 . . . . 1.0 113.333 175.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.79 -1.56 34.58 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 2.74 113.276 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 pp -119.09 159.04 46.58 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.866 1.666 . . . . 1.83 110.548 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -78.87 156.88 27.31 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.966 2.444 . . . . 1.19 112.317 -168.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.9 102.71 7.92 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.607 1.563 . . . . 2.28 109.732 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.3 ttp-105 -92.38 113.44 25.71 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.103 1.361 . . . . 3.63 111.031 172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.0 tp -103.95 109.67 21.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 128.324 2.65 . . . . 1.17 108.592 -171.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.2 m -99.79 -17.0 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.654 1.182 . . . . 0.68 113.377 -168.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.28 -168.25 39.35 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 123.95 0.786 . . . . 0.49 111.99 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -144.01 177.36 8.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.825 0.85 . . . . 0.78 110.901 175.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.9 ttt85 -163.45 128.44 2.99 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.496 1.043 . . . . 5.44 108.487 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 t -136.06 153.22 76.67 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-O 117.504 -1.236 . . . . 0.94 109.089 -177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.79 -28.63 86.76 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.125 1.883 . . . . 1.24 113.379 166.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.6 -5.1 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 115.036 1.495 . . . . 1.34 115.036 -168.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -142.68 170.44 15.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.321 1.448 . . . . 0.91 113.029 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -113.6 -81.4 0.6 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.76 1.624 . . . . 2.86 111.553 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.8 ttm-85 -80.98 111.18 17.22 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 120.971 -1.081 . . . . 3.69 109.105 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.86 131.72 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 126.461 1.905 . . . . 1.25 109.79 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -147.47 131.92 17.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.452 1.101 . . . . 2.08 110.539 -167.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.37 119.82 22.94 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.156 1.344 . . . . 0.82 110.672 170.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 10.6 m170 -109.65 157.8 18.71 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.332 1.853 . . . . 0.74 111.519 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -110.03 -176.53 3.02 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.837 0.855 . . . . 3.12 111.535 164.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 m -146.65 99.66 3.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.929 1.292 . . . . 1.09 107.609 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -106.29 -177.99 3.52 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.523 1.529 . . . . 2.05 112.636 -166.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -138.67 143.39 39.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.946 1.299 . . . . 3.08 110.673 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -155.39 159.59 40.01 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.227 1.411 . . . . 6.8 111.595 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -97.74 151.79 19.79 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.686 1.194 . . . . 3.73 112.253 -170.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.3 t -125.15 -92.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.365 1.466 . . . . 3.05 109.577 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -74.88 36.78 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.35 2.26 . . . . 4.69 110.873 171.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -18.2 0.63 Allowed Glycine 0 CA--C 1.538 1.499 0 O-C-N 120.421 -1.424 . . . . 2.06 113.398 -158.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -79.62 135.53 36.6 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.262 1.825 . . . . 3.72 109.628 -177.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.51 125.19 32.17 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.543 1.137 . . . . 6.04 112.915 -175.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.2 t -123.34 147.82 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.603 1.961 . . . . 1.51 109.408 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 11.9 ptp -94.95 155.62 16.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.533 1.133 . . . . 4.19 113.565 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.05 169.17 33.1 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 123.899 0.761 . . . . 1.06 113.251 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.6 mtt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.116 1.367 . . . . 2.55 110.153 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.0 mtp85 -159.1 150.14 16.26 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 117.282 -1.342 . . . . 5.85 110.03 175.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 10.0 Cg_endo -67.26 146.37 75.46 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 121.843 1.696 . . . . 0.79 110.142 164.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.4 m -113.56 160.27 32.34 Favored Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 126.028 1.731 . . . . 0.65 110.115 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.74 -24.36 47.47 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.212 1.941 . . . . 0.82 112.29 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -178.05 163.6 1.75 Allowed 'General case' 0 C--N 1.346 0.437 0 C-N-CA 125.836 1.654 . . . . 2.26 111.712 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -108.54 173.16 6.44 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.034 1.334 . . . . 1.03 109.38 150.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -150.39 161.61 42.17 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.366 -0.834 . . . . 2.99 111.852 162.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.4 t -129.69 126.04 22.5 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 126.254 1.821 . . . . 1.0 108.041 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.74 163.12 40.19 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.657 2.238 . . . . 0.92 110.374 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -61.7 136.66 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.645 2.23 . . . . 0.95 110.717 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt 67.15 2.62 2.85 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.821 2.049 . . . . 1.47 113.809 -174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.79 172.67 44.49 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.548 2.023 . . . . 0.96 111.395 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -156.14 147.48 22.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 112.392 -1.904 . . . . 3.94 111.923 -171.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.9 m -129.11 155.4 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.783 1.633 . . . . 1.98 110.716 168.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -128.52 114.11 16.33 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.802 -1.555 . . . . 3.97 106.802 167.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.78 91.62 3.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.086 1.354 . . . . 1.23 112.315 -166.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.27 146.2 39.5 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.634 1.174 . . . . 2.91 111.631 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.56 -17.87 58.06 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.929 2.419 . . . . 1.11 113.197 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -101.6 52.98 0.85 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.706 1.146 . . . . 1.12 111.486 165.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.9 -76.08 0.06 OUTLIER Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.591 1.091 . . . . 0.73 114.767 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -153.81 137.6 16.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.602 1.961 . . . . 1.9 110.026 -170.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -166.6 173.82 9.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.947 0.899 . . . . 0.87 110.294 -171.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -105.49 124.72 50.02 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 118.499 -0.762 . . . . 1.93 110.237 172.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.3 mmt -75.39 132.56 40.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.198 0.908 . . . . 1.0 109.568 163.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -111.28 132.42 54.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.578 1.151 . . . . 1.5 109.015 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.1 mt -137.63 117.15 12.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.069 2.147 . . . . 2.82 108.966 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.94 111.84 0.31 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.268 -1.133 . . . . 1.75 110.268 -170.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.4 mt -112.39 141.94 45.52 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.483 0.659 . . . . 1.54 111.279 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -82.73 1.91 36.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.655 0.782 . . . . 1.75 112.403 169.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -150.15 156.81 37.68 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 127.451 2.3 . . . . 4.07 111.151 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.23 165.29 32.9 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.166 1.911 . . . . 1.61 109.157 151.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -112.57 131.02 55.81 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.941 -0.763 . . . . 2.73 108.941 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.94 122.32 18.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.399 1.079 . . . . 3.53 108.265 -169.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.5 128.34 28.51 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.024 1.284 . . . . 1.4 112.482 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.46 45.23 8.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.487 0.565 . . . . 2.48 113.669 -172.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -134.97 165.76 24.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.454 -1.027 . . . . 2.71 109.199 141.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -115.34 155.32 27.56 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.168 0.987 . . . . 4.72 112.159 -168.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.72 118.41 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.488 1.915 . . . . 1.2 109.654 -173.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -71.61 146.28 48.45 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.753 0.311 . . . . 2.87 110.202 163.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.4 tt -155.29 126.18 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.558 0.743 . . . . 1.89 111.679 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.81 112.52 21.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 129.836 3.254 . . . . 2.19 111.347 173.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.5 mt -81.47 124.0 29.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.523 1.129 . . . . 1.13 108.566 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.5 mt -96.85 127.38 42.77 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.933 1.293 . . . . 0.68 109.878 -171.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 109' ' ' LYS . 97.0 m-85 -110.59 162.92 14.24 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 120.869 -1.145 . . . . 2.34 112.581 -178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.53 101.54 1.01 Allowed 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.786 -0.571 . . . . 1.73 111.472 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.35 -148.86 19.0 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.506 1.05 . . . . 3.03 111.601 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.56 54.55 4.37 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.23 0.919 . . . . 1.66 115.182 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 105' ' ' PHE . 14.1 ttpt -145.03 136.62 25.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.172 1.486 . . . . 4.58 112.39 172.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.0 p -148.08 134.57 12.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 125.75 1.62 . . . . 1.41 107.884 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.8 mt -143.85 124.93 14.43 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.081 1.352 . . . . 2.17 108.491 -170.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -89.75 150.55 22.24 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 115.077 1.51 . . . . 3.69 115.077 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -120.08 168.86 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 127.367 2.267 . . . . 1.15 108.87 163.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.52 141.83 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.368 1.067 . . . . 2.22 109.288 169.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.8 mt -131.85 131.69 22.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.319 1.848 . . . . 2.14 108.765 -173.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.91 155.51 43.36 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.53 2.153 . . . . 1.44 111.124 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.5 t -86.2 123.49 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.161 -1.051 . . . . 1.54 108.161 164.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.05 160.11 28.42 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.01 1.324 . . . . 3.37 110.615 -177.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.434 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . . . -82.55 51.52 1.87 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.809 1.04 . . . . 3.17 113.809 -168.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 . . . . . 0 C--O 1.248 0.978 0 C-N-CA 126.165 1.786 . . . . 5.39 112.331 -174.022 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.463 0 N-CA-C 109.454 -1.458 . . . . 12.13 109.454 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -70.65 -23.13 62.46 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 118.899 1.35 . . . . 13.43 114.409 -174.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -172.53 -176.56 1.56 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.95 2.9 . . . . 13.67 108.243 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.1 p -154.8 -43.51 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.076 2.151 . . . . 7.36 110.877 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -106.65 177.59 4.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.757 2.023 . . . . 5.81 111.513 -175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -86.88 162.94 34.5 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 126.347 1.927 . . . . 0.99 114.455 -172.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -147.92 150.11 33.48 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.749 0.819 . . . . 1.66 112.444 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -103.79 134.32 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.234 1.414 . . . . 1.11 108.267 172.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.2 ttt-85 -86.8 100.3 12.43 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.182 1.178 . . . . 4.57 114.182 -162.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.63 133.26 55.42 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.823 0.82 . . . . 2.81 110.773 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -162.91 157.36 17.96 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.965 1.706 . . . . 2.33 110.014 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -86.54 67.04 4.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.721 2.948 . . . . 3.21 110.219 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.98 164.29 28.89 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.693 1.037 . . . . 1.56 115.693 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -80.1 -9.72 14.02 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 124.64 3.56 . . . . 1.42 112.594 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -142.3 151.98 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.2 1.8 . . . . 2.08 111.072 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.61 -163.86 1.52 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.548 1.539 . . . . 1.15 111.237 -173.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.66 156.09 39.81 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.088 1.355 . . . . 1.21 110.66 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.92 148.76 45.09 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.948 0.899 . . . . 1.11 110.631 156.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -128.07 178.01 6.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.828 1.651 . . . . 2.58 110.124 172.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.533 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.5 pt? -169.92 161.15 8.78 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.137 1.775 . . . . 1.55 111.199 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.2 m -98.2 145.01 27.04 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.702 -1.592 . . . . 1.68 106.702 154.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.46 127.61 7.66 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.438 1.095 . . . . 2.63 110.377 -175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 151.26 29.0 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.467 1.507 . . . . 2.74 111.544 173.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -98.23 109.15 50.95 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.051 -0.977 . . . . 1.25 110.105 161.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.19 -8.87 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.884 2.389 . . . . 1.81 113.787 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.44 171.04 49.38 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.359 0.981 . . . . 1.63 113.271 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -94.98 -5.0 45.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.312 1.845 . . . . 3.04 112.66 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.58 158.06 39.74 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.83 2.052 . . . . 4.71 108.595 172.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.83 151.61 24.67 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.907 2.405 . . . . 1.23 111.62 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -102.23 133.14 47.59 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.06 0.944 . . . . 2.11 111.018 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -117.1 107.84 14.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.902 1.281 . . . . 2.86 110.501 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 tp -95.14 114.52 26.32 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 127.644 2.378 . . . . 0.7 109.192 -169.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.4 m -106.65 -9.44 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.506 1.122 . . . . 0.7 112.968 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.13 -171.54 44.61 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.481 1.039 . . . . 0.53 111.438 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.713 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -153.8 170.07 21.84 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.018 1.327 . . . . 0.87 110.735 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -158.39 115.59 2.87 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 120.057 1.298 . . . . 4.95 109.376 -165.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 t -127.03 159.33 65.33 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 117.759 -1.115 . . . . 0.84 109.353 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.93 -22.75 48.09 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.533 2.155 . . . . 0.88 113.685 164.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.253 3.9 m -87.91 8.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 115.383 1.623 . . . . 0.98 115.383 -171.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.94 161.94 41.31 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.805 -1.185 . . . . 0.89 113.677 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -96.7 -88.61 0.28 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.022 1.729 . . . . 2.96 110.516 174.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -81.48 121.54 26.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.062 1.345 . . . . 3.64 110.286 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -91.91 142.01 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 2.03 111.36 164.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -140.71 116.09 10.04 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.946 1.298 . . . . 2.23 110.091 166.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 84' ' ' PHE . 6.8 tt -76.83 119.19 20.25 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 120.897 1.681 . . . . 0.66 110.639 170.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -105.09 152.07 23.22 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.035 1.334 . . . . 0.58 112.549 177.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.46 179.82 5.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.606 1.962 . . . . 2.48 110.941 165.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.4 m -144.26 93.15 2.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.86 1.664 . . . . 1.08 107.906 168.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -90.79 146.4 23.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.42 1.105 . . . . 2.38 111.833 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -87.51 147.82 25.19 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.912 1.285 . . . . 4.39 110.34 165.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.57 152.75 23.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.564 1.546 . . . . 6.02 110.918 177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.59 141.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.122 -1.066 . . . . 4.06 108.122 156.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.88 120.6 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.535 1.534 . . . . 3.47 106.997 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 62.07 23.8 14.09 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.946 0.899 . . . . 3.36 111.602 -172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.88 -10.72 38.28 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.065 1.317 . . . . 2.14 114.275 -171.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -87.35 140.93 29.04 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.921 1.689 . . . . 3.22 109.705 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -79.65 128.28 33.2 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.424 -0.798 . . . . 3.92 111.003 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.3 t -135.69 150.13 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.864 1.665 . . . . 1.64 110.443 -170.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.7 tpp -119.85 138.88 53.13 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.255 1.422 . . . . 3.81 109.223 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.08 141.28 11.08 Favored Glycine 0 N--CA 1.47 0.959 0 CA-C-N 118.92 0.782 . . . . 1.31 113.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -89.3 165.31 14.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.717 0.807 . . . . 1.73 111.176 169.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 ttp85 -176.07 138.14 0.5 Allowed Pre-proline 0 N--CA 1.475 0.808 0 CA-C-O 116.455 -1.736 . . . . 4.47 111.146 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.84 139.03 38.96 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 CA-C-N 122.75 2.018 . . . . 0.61 111.607 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.67 156.07 42.99 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 126.033 1.733 . . . . 0.5 111.163 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.74 -17.21 33.28 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.989 2.46 . . . . 0.62 113.087 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -177.52 165.89 2.19 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.857 2.063 . . . . 1.78 111.424 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mt -112.51 173.5 6.34 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.952 1.701 . . . . 0.97 109.384 155.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.96 164.25 38.3 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.382 -0.824 . . . . 2.15 113.075 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -139.53 129.23 14.08 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.046 1.738 . . . . 0.98 109.03 -173.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -72.38 161.99 42.76 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.691 2.261 . . . . 0.81 111.727 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.21 135.93 65.31 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.772 2.981 . . . . 1.14 112.333 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt 68.08 1.02 2.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.316 1.847 . . . . 2.24 113.9 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.42 -178.48 45.46 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 126.109 1.814 . . . . 1.45 111.023 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -160.11 163.74 33.57 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.065 1.346 . . . . 4.62 112.425 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.91 154.2 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.376 1.47 . . . . 1.68 111.115 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.5 123.49 47.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.645 1.178 . . . . 3.36 109.448 164.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.3 146.34 43.23 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.945 -1.097 . . . . 1.72 109.645 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 9.2 ptpp? -153.99 151.12 23.99 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.89 0.876 . . . . 3.13 112.285 -163.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.59 -50.93 4.69 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.757 2.972 . . . . 0.94 112.233 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.27 90.44 1.56 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 109.07 -1.612 . . . . 1.3 109.07 162.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.57 -90.22 0.11 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 123.659 0.647 . . . . 0.79 114.075 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -153.26 140.24 19.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.287 1.435 . . . . 1.82 110.3 -170.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -162.64 156.59 20.84 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.239 0.616 . . . . 1.02 111.307 -173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 45' ' ' LEU . 71.5 m-85 -90.51 112.77 24.55 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 2.07 109.012 166.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.2 125.59 27.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.469 -0.938 . . . . 1.78 108.469 167.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.92 117.16 34.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 107.786 -1.19 . . . . 1.57 107.786 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.65 110.75 20.24 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.965 1.306 . . . . 3.17 108.188 -177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.21 98.52 0.7 Allowed Glycine 0 N--CA 1.47 0.904 0 C-N-CA 124.346 0.974 . . . . 1.59 111.19 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 30.9 mt -96.34 128.78 43.57 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.649 0.779 . . . . 0.98 110.916 -174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -18.74 53.85 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.493 0.923 . . . . 2.04 113.493 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.9 150.85 77.71 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 125.885 1.674 . . . . 4.35 108.268 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.98 118.59 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 107.048 -1.943 . . . . 1.4 107.048 155.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -62.39 108.54 1.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.177 1.391 . . . . 1.97 111.492 -160.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -80.45 105.05 11.42 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.149 -0.969 . . . . 4.66 110.885 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.47 111.86 0.79 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.715 -1.217 . . . . 1.6 107.715 152.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 5.89 34.41 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 117.312 -1.827 . . . . 2.36 116.228 -166.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.45 169.21 8.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.731 2.265 . . . . 3.03 111.748 160.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.76 141.66 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.633 1.573 . . . . 4.68 109.454 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.3 t -122.64 112.51 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.776 0.831 . . . . 1.23 110.815 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.89 148.31 51.66 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.999 0.52 . . . . 3.01 111.181 163.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.713 HD11 ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -153.77 116.71 4.5 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.415 1.102 . . . . 3.36 109.87 174.147 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.41 116.61 21.96 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 128.732 2.813 . . . . 1.99 111.029 170.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.0 mt -83.73 118.77 24.11 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.34 1.456 . . . . 2.09 110.313 -178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.5 mt -93.95 122.01 36.01 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.328 0.513 . . . . 0.76 109.785 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -120.31 152.57 37.63 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.296 1.046 . . . . 2.27 112.235 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.87 113.62 1.57 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.59 1.156 . . . . 1.63 112.993 -174.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.77 76.06 0.86 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.332 1.444 . . . . 3.34 113.268 173.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.26 -6.6 56.52 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 116.744 1.458 . . . . 2.22 116.744 163.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -86.98 128.01 35.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.183 1.991 . . . . 5.23 110.122 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.58 135.68 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 125.181 1.392 . . . . 1.38 108.957 168.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.7 mt -139.43 125.06 19.39 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.445 1.098 . . . . 2.12 110.26 -171.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.28 135.49 34.73 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.345 0.869 . . . . 2.66 113.345 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.46 175.57 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.565 1.546 . . . . 1.3 109.804 157.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -145.07 141.51 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.787 1.635 . . . . 2.16 107.742 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.7 mt -143.91 160.14 50.94 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.794 1.638 . . . . 2.15 111.267 -169.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.49 169.07 19.07 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.738 3.626 . . . . 1.18 112.679 168.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.1 t -107.2 133.28 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.43 1.892 . . . . 1.04 110.72 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 151.51 42.68 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.085 1.354 . . . . 4.9 111.044 170.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.33 85.35 6.88 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.074 -1.016 . . . . 2.26 110.62 163.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 117.244 -1.36 . . . . 7.71 111.54 171.7 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' H1 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.473 1.164 0 N-CA-C 107.496 -2.241 . . . . 9.45 107.496 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -157.58 161.34 38.71 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.055 0.428 . . . . 8.9 111.405 -142.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -71.38 26.48 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.319 1.048 . . . . 12.44 111.88 164.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 p 52.14 -179.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.649 2.38 . . . . 7.77 112.352 -143.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -153.03 36.38 0.48 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.074 1.75 . . . . 5.54 111.019 -176.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.78 174.73 55.19 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.506 1.05 . . . . 1.21 113.367 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -155.0 158.7 39.56 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.779 1.232 . . . . 2.27 112.069 -175.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.5 t -113.19 146.43 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 121.017 -1.052 . . . . 1.65 109.373 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.99 140.08 40.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 119.806 -0.758 . . . . 5.33 111.71 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -47.06 127.19 10.04 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.466 1.507 . . . . 3.74 110.953 160.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -174.5 106.0 0.28 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.909 2.084 . . . . 2.74 109.781 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -88.04 19.18 1.38 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.918 3.079 . . . . 2.8 111.707 170.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.1 -165.26 38.95 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.836 1.208 . . . . 1.36 113.724 -171.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.57 -19.39 21.66 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.029 2.486 . . . . 1.44 112.647 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -146.68 165.06 30.71 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.829 1.252 . . . . 1.96 113.186 -178.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.97 -179.92 8.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.441 1.497 . . . . 1.27 112.426 177.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.55 135.64 51.54 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.716 1.606 . . . . 1.09 110.065 172.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.37 123.81 41.32 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.205 0.526 . . . . 1.01 110.165 162.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -92.04 154.9 18.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.319 1.448 . . . . 1.92 108.238 164.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pp -166.63 136.78 3.18 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.27 -0.894 . . . . 1.56 113.028 175.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.2 m -79.35 148.28 32.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.011 -1.45 . . . . 1.26 107.613 165.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -155.13 141.0 18.2 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.035 1.734 . . . . 2.37 107.507 -176.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 20.2 pt-20 -144.31 132.49 21.75 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.881 -1.137 . . . . 3.28 110.579 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -92.63 109.6 39.7 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.341 1.456 . . . . 0.92 109.895 177.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.87 -9.88 14.27 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.629 2.219 . . . . 1.17 113.91 176.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.28 173.92 54.78 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.042 0.829 . . . . 1.12 113.961 -172.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -104.26 3.45 32.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.404 1.881 . . . . 3.09 112.491 178.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -116.33 164.58 17.6 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.691 1.996 . . . . 1.71 109.868 163.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.14 159.29 15.38 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.062 2.508 . . . . 1.06 112.048 -173.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 70.9 mt -106.6 154.59 20.69 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.624 1.17 . . . . 1.93 110.985 168.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.4 ttp-105 -141.93 114.92 8.69 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.248 1.419 . . . . 4.95 112.081 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.8 tp -96.94 118.52 33.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.262 3.025 . . . . 0.9 110.019 -176.128 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' HB2' ' A' ' 106' ' ' ALA . 35.0 m -115.86 -20.0 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.589 1.156 . . . . 0.77 113.768 -173.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.48 -164.15 16.81 Favored Glycine 0 C--N 1.339 0.699 0 O-C-N 121.509 -0.744 . . . . 1.1 111.688 175.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.939 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -154.75 176.89 11.88 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.851 0.86 . . . . 1.14 111.452 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 8.7 mmm180 -156.74 146.28 20.65 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.561 -0.903 . . . . 6.59 108.561 172.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -142.72 157.61 61.42 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.721 -1.133 . . . . 0.67 108.717 174.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.14 -25.34 50.85 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.352 2.035 . . . . 1.08 113.795 160.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.9 m -90.4 2.71 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 115.631 1.715 . . . . 0.85 115.631 -165.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.55 152.2 29.77 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.294 0.952 . . . . 0.93 113.367 -177.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -80.32 -88.34 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.558 1.943 . . . . 2.98 110.436 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -77.88 116.77 18.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.395 1.478 . . . . 4.38 109.34 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.34 134.93 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.68 1.592 . . . . 1.33 109.584 174.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.55 138.26 44.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.012 1.725 . . . . 1.95 110.606 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.508 HD13 ' CZ ' ' A' ' 84' ' ' PHE . 16.1 tp -84.51 109.89 18.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.486 1.114 . . . . 2.94 109.444 172.212 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -113.59 154.36 27.31 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.027 1.331 . . . . 1.11 113.682 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.4 164.92 11.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.912 2.085 . . . . 1.82 111.431 171.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.6 m -130.15 111.67 12.67 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.955 1.302 . . . . 1.44 108.551 170.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -112.67 154.79 25.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.805 1.242 . . . . 2.05 113.308 -174.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.06 159.12 15.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.693 1.197 . . . . 3.64 110.894 164.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.25 146.97 5.28 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.383 1.473 . . . . 8.4 111.399 -167.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.64 143.71 32.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.494 1.118 . . . . 5.05 112.352 175.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.97 133.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.955 1.702 . . . . 3.92 109.246 171.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 67.61 6.07 4.77 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.588 1.155 . . . . 3.84 112.641 -171.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.49 4.94 89.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.724 1.631 . . . . 2.83 113.789 -166.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -100.76 148.72 24.59 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.711 2.004 . . . . 3.54 110.99 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 149.27 25.46 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.375 -0.828 . . . . 4.3 112.423 -179.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.04 152.92 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.473 1.909 . . . . 3.33 109.366 175.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 33.5 mtm -112.56 155.45 24.33 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.181 0.992 . . . . 3.82 112.072 176.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.72 177.35 32.89 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.223 0.916 . . . . 1.44 112.731 173.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -125.17 157.79 35.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.17 1.388 . . . . 2.11 110.511 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.13 157.38 63.76 Favored Pre-proline 0 N--CA 1.478 0.951 0 CA-C-O 117.299 -1.334 . . . . 6.36 108.506 161.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.34 141.65 82.47 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 CA-C-N 120.903 1.358 . . . . 1.07 110.264 151.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.37 153.46 41.99 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 126.522 1.929 . . . . 0.78 110.27 178.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.01 -31.44 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.533 2.155 . . . . 1.23 112.943 -174.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.3 p90 164.47 148.17 0.02 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 126.807 2.043 . . . . 2.84 107.909 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.59 145.41 46.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.715 -1.13 . . . . 4.04 108.257 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.277 0.0 OUTLIER -141.27 155.24 46.02 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.803 1.038 . . . . 3.36 113.803 -175.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.8 t -139.25 132.18 15.57 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 113.919 -1.491 . . . . 0.95 109.443 -156.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.23 166.96 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.07 1.847 . . . . 0.8 112.074 179.24 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -55.96 140.64 86.25 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.561 2.84 . . . . 0.95 111.718 166.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm 67.65 -0.67 1.86 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.012 1.725 . . . . 1.73 113.532 -174.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.79 113.92 4.39 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 126.773 2.13 . . . . 0.91 113.363 -169.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -80.97 133.47 35.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.316 1.446 . . . . 4.16 109.9 162.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.5 m -144.9 168.88 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.738 1.615 . . . . 1.58 110.45 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -164.1 117.22 1.41 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.708 0.403 . . . . 3.68 111.373 -167.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.67 72.77 3.33 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.14 2.176 . . . . 1.35 110.267 178.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -80.72 148.0 64.2 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 126.041 1.736 . . . . 3.31 113.299 176.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -47.87 21.39 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.439 3.426 . . . . 0.85 114.29 -168.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.66 103.4 2.74 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 107.525 -2.23 . . . . 1.24 107.525 157.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.6 -102.71 0.28 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.494 1.997 . . . . 0.79 110.416 -162.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -149.1 158.76 44.44 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.46 1.504 . . . . 2.36 110.619 -175.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -165.34 158.52 16.25 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 120.847 -1.158 . . . . 1.08 110.313 -179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.508 ' CZ ' HD13 ' A' ' 45' ' ' LEU . 46.8 m-85 -96.59 117.28 30.63 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 121.595 -0.691 . . . . 2.45 109.295 171.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.27 121.54 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.064 1.346 . . . . 1.24 110.251 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.5 mt -108.02 106.29 16.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.69 1.996 . . . . 1.51 108.631 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -107.82 122.93 47.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.228 1.411 . . . . 2.78 109.384 -177.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.41 89.46 0.39 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.429 -1.068 . . . . 1.27 110.429 -175.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 35.7 mt -81.13 122.25 27.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.641 0.721 . . . . 0.81 111.682 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -74.44 -13.9 60.77 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.862 0.865 . . . . 1.69 112.955 172.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ptt85 -157.48 142.11 11.94 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.245 1.418 . . . . 5.77 110.41 165.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.76 141.8 38.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.834 3.023 . . . . 1.91 111.186 -176.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.82 78.99 9.42 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.9 -1.148 . . . . 2.92 107.9 177.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -69.45 162.84 26.6 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.736 0.779 . . . . 3.96 111.555 170.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.12 132.95 53.56 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.204 -1.035 . . . . 2.6 108.204 163.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.21 49.85 19.36 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.417 -0.657 . . . . 3.54 112.437 -171.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -126.22 167.55 15.28 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.538 1.135 . . . . 3.05 109.895 163.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -134.63 151.92 51.4 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.781 1.232 . . . . 4.35 111.353 172.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.59 121.17 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.713 2.005 . . . . 1.49 108.627 -171.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.54 149.68 33.02 Favored 'General case' 0 C--O 1.238 0.498 0 O-C-N 121.849 -0.532 . . . . 2.61 110.034 162.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.939 HD21 ' HB1' ' A' ' 35' ' ' ALA . 5.9 tt -149.41 125.55 10.71 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.63 0.372 . . . . 2.05 111.647 166.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -91.03 108.53 19.92 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.231 3.413 . . . . 2.44 110.067 178.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.31 131.37 37.01 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.304 1.042 . . . . 2.59 110.294 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -101.39 122.48 43.81 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.817 0.847 . . . . 0.91 110.733 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.96 137.33 52.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.585 0.958 . . . . 2.21 113.585 -172.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.442 ' HB2' HG11 ' A' ' 33' ' ' VAL . . . -76.57 73.21 3.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.67 1.188 . . . . 2.52 112.047 176.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.61 32.37 0.03 OUTLIER Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.529 1.061 . . . . 5.39 114.589 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.77 28.33 70.96 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 118.387 1.094 . . . . 2.63 113.869 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.26 141.37 52.13 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.815 1.246 . . . . 4.11 111.763 -178.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.8 136.86 45.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.131 1.772 . . . . 1.28 107.627 159.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.8 mt -144.68 124.82 13.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.476 1.11 . . . . 1.75 110.022 -174.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -91.53 149.2 21.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 115.542 1.682 . . . . 2.3 115.542 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.58 148.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.239 1.816 . . . . 2.3 109.613 167.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.92 133.2 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 125.184 1.393 . . . . 2.96 109.927 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -136.19 113.9 10.58 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.314 1.046 . . . . 2.07 111.033 -165.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.31 158.13 37.11 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.162 2.575 . . . . 1.5 111.593 171.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.2 t -100.61 129.88 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.388 1.475 . . . . 2.01 111.188 176.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.44 162.88 34.34 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.33 1.852 . . . . 3.49 108.916 175.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.68 51.76 0.38 Allowed 'General case' 0 CA--C 1.548 0.871 0 O-C-N 120.448 -1.408 . . . . 2.77 112.683 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.391 0 CA-C-O 114.021 -2.895 . . . . 4.54 117.173 -157.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.488 0 N-CA-C 109.981 -1.247 . . . . 11.57 109.981 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.3 m -138.25 157.1 46.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.468 1.107 . . . . 8.97 109.157 179.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -168.33 29.09 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.076 1.35 . . . . 11.22 111.011 -164.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 p -140.2 115.29 9.76 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.66 1.584 . . . . 6.33 109.293 -156.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -124.2 -131.53 0.26 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.684 1.193 . . . . 6.25 108.633 174.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.25 173.66 26.45 Favored Glycine 0 N--CA 1.471 0.977 0 CA-C-N 120.866 1.666 . . . . 1.46 115.116 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.3 p90 -154.74 154.28 32.6 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.537 1.16 . . . . 1.95 114.004 -178.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.54 144.86 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 107.04 -1.466 . . . . 1.27 107.04 158.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -90.4 117.5 29.15 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.087 0.555 . . . . 4.64 111.263 -179.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -48.8 130.35 17.73 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.782 1.233 . . . . 2.92 111.86 162.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.467 ' H ' ' HB2' ' A' ' 93' ' ' LEU . 33.9 m -163.4 129.73 2.33 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 128.831 2.852 . . . . 2.12 107.862 165.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -83.92 67.06 7.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.178 2.585 . . . . 2.39 109.707 -179.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.84 -174.43 20.45 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 115.128 0.811 . . . . 1.8 115.128 -172.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -83.48 -15.06 7.69 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 124.212 3.275 . . . . 1.8 113.191 177.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -131.0 157.75 42.14 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.704 1.602 . . . . 4.08 110.681 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.63 -164.35 1.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.064 1.746 . . . . 1.31 111.552 177.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.21 160.69 39.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.966 1.707 . . . . 1.24 110.764 -178.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.6 158.9 43.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.095 1.358 . . . . 0.94 112.394 171.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -162.02 152.91 17.72 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.263 2.225 . . . . 2.61 109.499 -173.185 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.23 157.74 26.16 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 120.893 -1.129 . . . . 1.65 112.381 -175.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.8 m -77.96 96.8 5.13 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.571 -1.27 . . . . 1.65 107.571 165.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 tt -88.3 148.94 24.06 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.931 1.692 . . . . 2.97 108.92 169.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -150.0 165.37 32.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.733 0.777 . . . . 4.16 112.896 168.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -120.88 101.62 45.11 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 126.007 1.723 . . . . 0.89 109.343 171.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.82 -5.48 15.35 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.95 2.433 . . . . 1.03 113.302 174.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.02 -177.78 51.54 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.883 1.23 . . . . 0.96 114.176 -177.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -112.69 1.75 15.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.275 1.43 . . . . 2.68 113.373 -170.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -116.15 162.18 27.37 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.91 1.684 . . . . 1.68 109.71 165.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.58 157.88 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.847 2.365 . . . . 1.05 111.825 -172.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 mt -107.81 149.06 28.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.917 0.887 . . . . 2.05 111.558 172.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -121.14 110.75 16.58 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.188 1.395 . . . . 6.34 109.232 168.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.8 tp -82.93 127.25 33.35 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 124.838 1.255 . . . . 0.77 108.173 175.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -119.6 -11.0 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.432 0.901 . . . . 0.57 113.432 -173.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.11 -162.74 33.36 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 121.564 0.536 . . . . 0.47 112.295 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.954 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -147.59 178.92 8.06 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.465 1.506 . . . . 0.81 110.154 175.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -161.59 139.76 9.29 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.129 0.877 . . . . 6.64 109.137 167.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.6 t -145.56 146.34 29.21 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.99 1.316 . . . . 0.7 108.811 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.91 -22.9 55.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.963 1.775 . . . . 1.31 113.132 178.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.77 0.15 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 114.42 1.267 . . . . 1.28 114.42 -174.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.04 168.01 9.82 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 116.068 1.877 . . . . 2.1 116.068 -169.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.37 -104.36 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 106.955 -1.498 . . . . 6.33 106.955 143.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -79.49 169.37 18.15 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.554 1.168 . . . . 4.19 112.464 167.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.6 132.02 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.868 1.667 . . . . 1.46 107.865 161.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -119.94 128.44 53.6 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.89 1.276 . . . . 1.97 109.705 -175.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 84' ' ' PHE . 5.5 tt -81.54 120.09 24.6 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 119.773 1.17 . . . . 0.66 110.628 169.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -110.33 153.05 25.44 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.592 1.557 . . . . 0.67 112.933 176.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.22 172.13 8.16 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.443 2.297 . . . . 2.18 110.699 165.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.1 m -133.19 92.65 3.04 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.115 1.366 . . . . 1.13 108.015 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -97.59 149.42 22.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.138 0.971 . . . . 2.25 113.161 -163.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.3 ttp -79.05 139.4 38.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.629 1.172 . . . . 4.64 110.086 172.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.58 113.93 2.61 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.54 0.736 . . . . 10.31 111.615 -175.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.01 153.69 19.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.158 0.983 . . . . 4.58 110.613 174.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.6 t -143.51 122.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.284 -1.376 . . . . 3.44 107.284 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 69.28 8.47 6.82 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.916 1.286 . . . . 3.98 111.984 -174.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.58 85.31 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.843 1.211 . . . . 1.79 113.82 -166.138 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -90.94 143.14 27.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.561 1.544 . . . . 3.0 110.225 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -75.16 132.84 41.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.713 1.605 . . . . 4.18 113.307 -165.322 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -149.31 172.26 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.421 0.629 . . . . 1.84 112.163 172.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.3 tpp -129.75 159.24 37.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.814 2.045 . . . . 3.76 110.133 174.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.45 177.75 22.06 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.009 1.766 . . . . 1.1 112.16 173.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.3 mtt -138.9 154.49 48.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.779 1.632 . . . . 2.16 109.66 173.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -169.82 144.0 2.24 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-O 116.401 -1.761 . . . . 4.56 111.333 -169.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.99 150.93 87.44 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 CA-C-N 121.716 1.648 . . . . 0.66 112.414 165.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.48 159.02 47.54 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 126.418 1.887 . . . . 0.65 110.703 173.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -70.93 -22.16 27.06 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.683 2.255 . . . . 0.68 112.801 173.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -175.92 171.27 2.65 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.939 1.696 . . . . 1.88 111.562 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.44 172.1 8.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.746 2.018 . . . . 0.99 109.136 159.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.15 161.56 41.2 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 120.917 -1.114 . . . . 2.54 111.651 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 t -150.62 136.43 10.59 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.262 1.025 . . . . 0.87 109.679 -166.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -71.72 170.02 19.69 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.549 2.166 . . . . 0.8 112.027 178.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -60.91 142.68 98.31 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.225 2.617 . . . . 0.88 111.599 166.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm 64.55 6.57 3.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.243 1.817 . . . . 1.36 113.506 -174.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.42 115.41 4.01 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 126.192 1.853 . . . . 0.97 111.164 -175.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.67 137.26 36.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.498 1.519 . . . . 4.87 110.151 166.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 m -145.06 129.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.163 0.985 . . . . 1.53 111.557 177.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -84.22 124.55 31.31 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.699 -0.852 . . . . 3.88 108.699 165.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.1 145.49 53.12 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.362 -0.977 . . . . 1.78 108.362 163.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -155.92 138.85 10.67 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 117.974 -1.012 . . . . 3.51 111.726 -166.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -66.79 -26.5 45.01 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.653 2.902 . . . . 1.14 113.587 -172.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.0 87.95 1.5 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 108.084 -2.006 . . . . 1.52 108.084 155.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.85 -97.26 0.18 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.214 0.911 . . . . 0.99 113.458 -171.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -150.91 146.45 26.3 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.703 2.001 . . . . 2.26 110.469 -167.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -153.91 159.32 41.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.841 -0.537 . . . . 0.91 111.124 -175.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 41.7 m-85 -94.7 118.61 32.01 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.299 -1.001 . . . . 1.88 108.299 164.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.09 123.15 33.1 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.425 -0.954 . . . . 1.08 108.425 173.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -105.14 122.55 46.13 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.286 1.434 . . . . 2.36 109.108 -174.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.95 151.91 39.15 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.37 1.068 . . . . 2.77 111.157 -170.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 56.85 42.65 92.2 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 123.95 0.786 . . . . 2.01 113.219 171.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.7 mt -53.64 141.39 26.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.192 1.797 . . . . 1.51 112.729 -171.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -70.61 -9.53 57.15 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.343 -0.848 . . . . 3.55 112.783 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -167.23 152.06 6.86 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.824 2.05 . . . . 7.24 111.271 173.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.29 149.22 85.23 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.847 2.365 . . . . 3.11 110.132 162.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.467 ' HB2' ' H ' ' A' ' 11' ' ' SER . 2.4 mm? -80.23 155.51 27.31 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.596 0.712 . . . . 2.96 111.786 178.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.99 -25.56 5.33 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.49 1.916 . . . . 4.52 112.18 177.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 80.62 161.57 0.17 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.745 2.818 . . . . 1.91 111.516 -175.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.52 57.78 16.32 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.462 -1.055 . . . . 2.68 110.462 -174.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -167.34 161.58 14.27 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.922 2.889 . . . . 3.94 107.351 -174.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.59 161.4 16.84 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.713 1.205 . . . . 3.79 112.022 -170.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.2 t -144.6 127.78 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 126.718 2.007 . . . . 1.36 109.886 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.1 140.21 41.72 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.931 0.492 . . . . 3.17 110.742 165.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.954 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.2 tt -148.08 135.57 20.65 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 122.458 1.123 . . . . 1.67 111.299 169.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.505 ' N ' HD23 ' A' ' 101' ' ' LEU . 4.5 m-20 -104.52 112.29 25.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.826 2.05 . . . . 2.28 110.68 -179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.14 118.38 18.82 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.411 1.484 . . . . 1.26 109.805 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.4 mt -93.9 121.38 35.3 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.368 0.667 . . . . 0.63 110.179 -173.106 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.14 124.36 47.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 122.477 1.132 . . . . 1.87 113.366 -176.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 58.33 -12.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 131.027 3.731 . . . . 2.86 117.574 170.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.5 7.03 57.2 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.528 1.537 . . . . 3.59 113.452 -163.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.75 -0.06 1.82 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 117.126 1.61 . . . . 1.91 117.126 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.4 156.81 43.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.459 1.904 . . . . 4.17 111.294 173.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 p -147.88 128.93 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 C-N-CA 124.82 1.248 . . . . 0.99 109.639 167.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.42 133.72 55.77 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.809 1.643 . . . . 2.36 109.055 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -85.48 134.94 34.03 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.042 -1.036 . . . . 2.46 111.474 176.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -118.7 164.45 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.987 1.315 . . . . 1.35 109.841 160.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.2 p -125.25 142.29 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 107.532 -1.284 . . . . 2.36 107.532 169.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.6 mt -136.76 138.78 27.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.918 1.287 . . . . 2.1 109.985 -169.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -81.11 150.05 17.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.701 2.934 . . . . 1.34 111.193 166.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.6 t -88.17 120.56 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.75 1.62 . . . . 1.56 109.092 167.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -142.49 162.06 36.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.818 1.247 . . . . 4.6 112.194 -170.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.23 126.41 41.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.941 0.897 . . . . 3.71 109.105 166.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 . . . . . 0 C--O 1.254 1.329 0 C-N-CA 129.553 3.141 . . . . 7.97 109.325 -171.371 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.323 0 N-CA-C 105.72 -2.952 . . . . 11.98 105.72 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 t 62.39 173.21 0.14 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.458 0.629 . . . . 10.32 110.524 -134.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -101.45 166.2 10.85 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.011 1.324 . . . . 9.34 108.473 157.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.4 p -96.43 167.24 11.28 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.271 0.628 . . . . 7.5 110.956 170.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -159.26 -134.4 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.173 0.989 . . . . 5.3 109.057 -163.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.89 -179.4 24.76 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.686 1.585 . . . . 1.24 114.667 175.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -170.48 156.63 5.58 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.708 1.603 . . . . 1.68 111.903 170.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -104.03 128.9 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 108.822 -0.807 . . . . 0.82 108.822 172.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -5.13 39.11 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 117.789 2.515 . . . . 3.81 117.789 -145.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 69.82 121.04 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 128.299 2.639 . . . . 4.01 112.248 -174.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -171.36 136.92 1.03 Allowed Pre-proline 0 CA--C 1.547 0.832 0 O-C-N 119.752 -1.843 . . . . 2.0 112.393 178.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -93.88 -5.33 2.63 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.622 3.548 . . . . 2.87 113.893 174.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.75 165.78 53.81 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 119.275 0.943 . . . . 1.28 112.53 177.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.08 -14.77 44.64 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.502 2.801 . . . . 1.59 114.54 -172.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -124.61 152.12 43.98 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.365 1.466 . . . . 4.22 111.822 172.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.1 -168.06 2.64 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.551 1.94 . . . . 1.19 111.223 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.59 156.27 44.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.523 1.129 . . . . 1.12 112.997 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -125.77 140.03 53.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.294 1.437 . . . . 0.97 111.559 169.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -119.83 150.79 39.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.575 1.55 . . . . 1.93 110.035 178.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 pp -162.83 158.74 23.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.673 0.99 . . . . 1.77 113.673 177.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -94.01 117.22 29.79 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 107.977 -1.119 . . . . 1.42 107.977 165.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.42 135.46 34.63 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.596 1.958 . . . . 2.38 108.136 175.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -145.75 146.3 31.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.971 1.1 . . . . 2.74 113.971 170.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -110.08 109.16 59.04 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 113.971 -1.468 . . . . 0.93 110.113 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -80.46 -9.88 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.669 2.246 . . . . 1.04 113.498 175.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.24 177.86 54.13 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.316 0.96 . . . . 0.95 114.035 -174.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -106.19 -1.63 23.4 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.911 1.685 . . . . 2.33 112.925 -178.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -110.95 162.67 19.74 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 126.128 1.771 . . . . 1.68 109.646 163.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.17 161.64 17.85 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.011 2.474 . . . . 1.09 112.018 -172.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.5 mt -109.0 154.5 22.1 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.341 1.056 . . . . 1.91 110.488 168.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -138.01 102.62 4.74 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.753 1.221 . . . . 4.04 109.635 177.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -84.38 103.8 13.86 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.258 1.823 . . . . 0.65 108.702 -172.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -97.79 -13.87 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.682 0.793 . . . . 0.68 112.736 -170.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.71 -164.39 35.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 123.603 0.621 . . . . 0.68 112.258 175.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.19 177.3 10.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.992 0.917 . . . . 0.93 111.951 167.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -144.35 148.42 34.72 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.928 1.291 . . . . 6.69 109.586 170.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -150.54 151.31 30.59 Favored Pre-proline 0 N--CA 1.468 0.441 0 C-N-CA 125.137 1.375 . . . . 0.72 108.344 -168.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.4 -24.73 16.13 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.91 1.74 . . . . 0.9 113.364 175.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 m -78.6 -19.67 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 114.704 1.372 . . . . 1.22 114.704 -170.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.58 149.33 45.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.038 0.935 . . . . 0.92 111.098 -172.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.34 -71.97 0.52 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.768 0.427 . . . . 3.05 111.427 -174.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -79.18 142.5 36.26 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.421 1.088 . . . . 3.84 108.193 167.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -153.7 135.67 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.944 1.298 . . . . 1.47 108.512 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -145.84 139.2 26.18 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.824 1.25 . . . . 2.13 110.144 -168.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 tt -81.95 119.44 23.96 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 122.454 1.121 . . . . 0.81 110.901 168.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 11.5 m170 -111.36 157.77 19.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.17 1.788 . . . . 1.03 111.623 176.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -111.35 168.45 9.52 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.664 1.985 . . . . 2.43 110.467 172.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -126.88 100.93 6.36 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.919 2.088 . . . . 1.15 108.195 172.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -97.73 156.45 16.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.964 1.098 . . . . 2.45 113.964 -167.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.5 ptp -85.94 148.77 25.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.808 0.843 . . . . 4.0 111.504 166.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -160.6 163.78 32.4 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.34 1.456 . . . . 5.54 111.093 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -128.5 157.87 39.95 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.39 1.876 . . . . 4.22 108.972 175.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.7 t -153.68 124.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 O-C-N 125.266 1.604 . . . . 4.26 107.756 168.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.93 15.46 6.09 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.286 1.434 . . . . 4.91 114.323 176.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.55 28.27 39.97 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.315 1.436 . . . . 3.42 113.785 -173.246 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -123.29 136.01 54.49 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.761 2.025 . . . . 3.83 111.148 168.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.31 144.41 42.45 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.562 -0.711 . . . . 9.06 112.686 -177.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.25 153.0 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.466 1.106 . . . . 3.17 110.582 173.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.98 131.95 52.14 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.483 1.113 . . . . 4.0 109.857 175.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -126.04 -179.55 15.8 Favored Glycine 0 N--CA 1.473 1.131 0 C-N-CA 124.976 1.274 . . . . 1.26 112.351 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.1 mtt -132.59 158.64 41.68 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.756 1.222 . . . . 2.83 111.643 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -171.63 157.61 4.5 Favored Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 125.954 1.702 . . . . 4.87 110.878 -178.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 2.9 Cg_endo -71.4 153.95 60.92 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.734 1.623 . . . . 0.79 112.11 169.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.1 m -117.85 154.77 51.3 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.731 1.612 . . . . 0.84 109.638 164.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.26 -10.33 25.56 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.933 2.422 . . . . 1.01 113.087 172.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -177.38 158.67 1.46 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.659 1.984 . . . . 2.6 110.474 179.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mt -107.07 171.04 7.59 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.165 1.386 . . . . 1.01 109.122 148.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -156.22 161.33 40.28 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 120.956 -1.09 . . . . 2.47 112.002 172.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.0 t -149.61 133.37 8.72 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 123.899 0.88 . . . . 1.07 109.675 -160.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.39 168.84 21.22 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.122 1.881 . . . . 1.07 111.801 177.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.43 142.11 97.63 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.645 2.897 . . . . 1.04 111.601 166.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm 66.56 3.65 2.99 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.965 1.706 . . . . 1.45 113.554 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.03 115.09 4.05 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 126.123 1.821 . . . . 1.1 112.259 -173.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -92.4 129.11 38.43 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.213 1.405 . . . . 4.45 109.98 160.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.0 m -144.69 156.84 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.346 1.858 . . . . 1.57 110.44 -177.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.17 120.45 31.37 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.141 -0.974 . . . . 3.71 112.52 -166.337 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.18 68.8 1.98 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.843 1.657 . . . . 1.23 109.36 168.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 ptpm? -77.67 149.16 77.47 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 125.988 1.715 . . . . 2.77 111.615 173.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -59.24 -31.81 95.85 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.783 2.322 . . . . 1.01 113.257 176.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.28 40.65 3.06 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.545 1.069 . . . . 1.15 113.111 169.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.26 -75.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.887 1.232 . . . . 0.95 114.931 -175.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -153.2 147.09 25.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.044 2.137 . . . . 1.86 109.449 -171.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -163.82 170.19 17.21 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.478 -1.389 . . . . 1.19 111.42 -175.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -104.21 120.05 40.3 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.557 -0.534 . . . . 1.9 109.557 170.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 mmt -76.32 129.23 36.32 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.945 0.898 . . . . 1.15 109.313 169.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.9 mt -108.06 124.91 50.91 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.594 1.558 . . . . 1.84 107.364 177.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.46 118.59 11.31 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.66 0.784 . . . . 2.69 109.933 -162.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.19 74.26 1.08 Allowed Glycine 0 N--CA 1.47 0.959 0 N-CA-C 109.771 -1.331 . . . . 1.37 109.771 -167.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.0 mt -72.84 90.04 1.42 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.897 0.856 . . . . 1.12 113.118 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -67.16 -11.35 57.07 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.919 1.081 . . . . 2.01 113.919 172.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 30.4 mtp-105 -138.12 136.05 19.15 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.984 1.714 . . . . 4.01 108.241 155.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.9 149.67 59.98 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.387 . . . . 1.76 110.267 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.65 97.05 9.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.894 0.478 . . . . 2.36 111.256 -175.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -77.96 129.38 35.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.863 1.265 . . . . 3.58 110.946 169.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 130.93 49.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.273 -0.892 . . . . 1.92 109.297 171.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.73 37.47 26.4 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 118.467 0.576 . . . . 2.45 112.92 -166.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.52 -179.28 3.87 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 106.979 -1.489 . . . . 2.57 106.979 151.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -126.85 149.56 49.66 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.269 1.027 . . . . 3.72 109.018 167.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.27 118.44 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.942 1.297 . . . . 0.98 109.702 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -81.65 146.51 30.02 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 122.438 1.113 . . . . 3.66 111.41 160.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.67 123.46 8.01 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.84 1.256 . . . . 1.44 110.903 -169.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -89.72 91.44 8.65 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 127.731 2.412 . . . . 2.26 110.037 178.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.67 115.96 13.69 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.575 0.75 . . . . 1.41 110.295 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.1 mt -88.2 124.77 34.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.794 1.238 . . . . 0.84 110.753 -173.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -125.09 124.01 40.97 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.955 0.724 . . . . 2.19 112.955 -178.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.04 22.34 0.58 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.864 2.065 . . . . 2.15 114.307 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.87 -56.21 1.76 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.17 1.367 . . . . 3.54 112.523 -163.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.43 8.85 52.23 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 117.499 1.76 . . . . 1.67 117.499 -165.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 152.26 48.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.917 2.087 . . . . 4.16 110.541 166.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.5 131.71 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.899 1.28 . . . . 1.16 110.82 169.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.59 111.34 18.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.154 1.381 . . . . 2.75 110.487 -177.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 85.76 5.31 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.191 0.996 . . . . 3.0 110.99 178.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.4 m -87.73 174.13 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.772 1.629 . . . . 1.54 111.255 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.4 151.51 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.057 1.343 . . . . 2.03 110.568 170.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -140.74 141.99 26.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 128.034 2.534 . . . . 1.64 109.044 176.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -70.32 149.29 63.1 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.123 1.882 . . . . 0.91 109.478 170.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.83 123.86 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.475 -1.305 . . . . 1.18 107.475 163.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.61 151.93 28.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.931 1.693 . . . . 3.02 108.068 -161.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.99 108.45 19.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.731 1.011 . . . . 2.8 113.731 -157.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.932 0 C-N-CA 124.921 1.288 . . . . 5.07 112.071 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.446 ' H1 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.472 1.077 0 N-CA-C 107.798 -2.121 . . . . 9.49 107.798 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p 163.17 -168.44 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.42 -0.956 . . . . 8.8 108.42 -135.134 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -61.33 -29.24 69.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.588 -0.695 . . . . 10.85 112.742 166.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m 101.98 134.82 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 1 C-N-CA 132.27 4.228 . . . . 7.15 108.474 -176.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.97 54.19 0.7 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.754 1.222 . . . . 6.27 110.981 -166.38 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.46 161.5 24.47 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 124.982 1.277 . . . . 0.98 112.865 -174.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.413 ' CD1' ' HB3' ' A' ' 118' ' ' GLU . 32.1 p90 -163.14 161.4 25.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 2.75 114.508 -175.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.61 150.03 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.049 0.94 . . . . 1.45 110.092 -177.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.9 ttt-85 -88.26 114.87 25.31 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.793 0.837 . . . . 4.18 111.477 177.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -43.81 120.57 2.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.052 2.141 . . . . 2.52 112.888 166.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -167.76 97.83 0.61 Allowed Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.727 1.611 . . . . 1.93 110.341 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.68 70.39 7.28 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.566 2.844 . . . . 3.56 109.253 176.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.03 -150.91 5.29 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.193 0.902 . . . . 2.01 114.034 -172.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.35 -21.29 11.87 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.981 2.454 . . . . 1.76 112.716 -179.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -157.71 167.96 28.58 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.779 1.232 . . . . 2.27 113.518 -175.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -163.04 -177.87 5.71 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.287 1.835 . . . . 1.13 112.309 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.39 146.57 52.33 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.695 1.598 . . . . 1.0 111.023 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.56 138.64 54.52 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.936 0.789 . . . . 0.84 111.592 167.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -120.29 147.73 44.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.535 1.934 . . . . 2.41 110.813 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pp -166.6 149.89 6.99 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.761 -1.212 . . . . 1.6 113.874 178.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.29 96.51 6.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 127.748 2.419 . . . . 2.03 108.385 168.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.65 126.69 34.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.971 -0.751 . . . . 2.98 108.971 174.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.446 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 17.7 pt-20 -137.77 145.84 42.89 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.273 1.429 . . . . 3.16 111.621 -175.129 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -116.08 105.68 50.64 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 123.428 0.691 . . . . 0.91 111.973 -173.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.48 -11.03 15.91 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.578 2.185 . . . . 0.98 113.298 171.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.66 163.25 53.47 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 125.59 1.567 . . . . 0.99 113.802 -177.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -80.08 -32.64 39.25 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.043 2.137 . . . . 4.98 112.65 175.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -98.28 163.98 18.11 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.478 1.911 . . . . 1.8 111.072 173.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -80.22 154.93 22.14 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.418 2.745 . . . . 1.32 112.012 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.3 mt -98.06 141.27 31.21 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.622 0.769 . . . . 2.35 110.305 171.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -125.85 109.97 13.13 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.509 1.124 . . . . 2.72 110.072 172.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.1 tp -89.08 122.74 32.7 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.579 1.952 . . . . 0.93 109.776 -176.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.62 -6.77 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.29 1.036 . . . . 0.62 113.456 -172.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.0 -163.74 34.07 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.821 1.201 . . . . 0.54 111.41 176.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.13 -175.73 5.58 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.469 1.508 . . . . 0.75 110.476 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -156.26 139.72 15.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.067 1.347 . . . . 6.45 108.932 170.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.26 146.38 45.56 Favored Pre-proline 0 N--CA 1.476 0.83 0 CA-C-O 117.2 -1.381 . . . . 0.74 108.464 -173.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.24 -13.12 35.44 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.548 2.165 . . . . 0.85 114.086 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.3 -3.94 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 115.28 1.585 . . . . 0.97 115.28 -176.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.65 147.39 40.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 121.094 1.77 . . . . 0.9 112.848 -172.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -83.71 -51.44 7.25 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.733 1.613 . . . . 3.1 110.787 178.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -111.44 141.18 45.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.536 1.134 . . . . 3.48 110.115 170.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 p -128.29 137.08 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.071 1.348 . . . . 1.25 109.104 160.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -128.93 131.78 47.57 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.267 1.827 . . . . 2.19 108.708 175.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.81 123.31 29.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 120.508 1.504 . . . . 0.81 110.406 169.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -107.74 155.2 20.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.076 1.751 . . . . 0.69 112.331 176.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -94.38 -174.15 3.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.651 1.981 . . . . 2.92 111.481 167.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.5 m -145.34 80.25 1.6 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.182 1.393 . . . . 1.4 109.18 166.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -70.27 143.79 52.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.952 0.882 . . . . 2.49 111.8 -172.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtp -108.03 34.77 3.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.004 1.722 . . . . 4.08 111.313 -172.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -70.34 156.89 38.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.42 1.488 . . . . 7.02 110.788 -167.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -46.7 159.54 0.09 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.781 0.833 . . . . 6.84 110.335 146.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -163.17 -29.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.566 1.946 . . . . 3.62 113.189 179.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -143.95 38.89 1.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.908 2.483 . . . . 4.71 109.277 170.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 -33.73 0.37 Allowed Glycine 0 N--CA 1.481 1.666 0 O-C-N 120.055 -1.653 . . . . 2.55 113.372 -160.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -61.08 135.22 57.71 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.655 1.982 . . . . 3.3 109.851 170.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -85.79 129.69 34.76 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 118.212 -0.899 . . . . 4.57 110.512 173.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.1 t -140.77 150.14 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.75 1.22 . . . . 1.83 109.572 -169.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.9 mtm -92.9 121.8 34.63 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.228 1.011 . . . . 3.41 112.406 172.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.73 163.59 25.52 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 125.146 1.355 . . . . 1.13 111.755 171.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -107.2 152.45 24.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.24 1.016 . . . . 1.5 112.462 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp-105 -149.64 145.5 19.19 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.317 2.247 . . . . 4.16 108.43 171.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.12 145.76 89.74 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 CA-C-N 121.42 1.543 . . . . 0.72 111.022 160.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.59 158.08 60.3 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.129 1.772 . . . . 0.76 111.149 -179.229 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.46 -21.16 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.556 2.171 . . . . 0.65 113.336 178.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -174.54 169.95 3.59 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 120.205 1.366 . . . . 1.97 112.66 -177.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.33 174.35 9.69 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 128.555 2.742 . . . . 1.09 108.871 162.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -157.67 168.68 26.56 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 120.632 -1.293 . . . . 2.24 112.708 174.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.2 t -146.41 131.3 8.94 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 125.359 1.463 . . . . 1.12 109.519 -175.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -74.0 161.05 41.96 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.607 2.205 . . . . 1.09 111.773 176.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.89 133.7 42.95 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.959 3.106 . . . . 0.99 111.706 179.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt 72.3 -2.32 2.63 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.226 2.21 . . . . 1.42 113.718 -178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.87 -179.02 37.66 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 126.049 1.785 . . . . 1.2 111.677 178.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -160.11 158.38 30.19 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.06 1.344 . . . . 4.15 114.571 177.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.83 172.18 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.962 2.105 . . . . 1.78 110.731 177.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -119.33 132.99 55.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.66 1.584 . . . . 5.56 109.048 170.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.82 81.31 6.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.832 1.301 . . . . 1.46 109.559 163.147 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 143.89 75.15 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.381 2.272 . . . . 4.09 113.472 -179.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.54 -40.19 76.37 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.771 2.314 . . . . 1.3 111.567 167.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.71 79.03 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.157 -1.177 . . . . 1.17 110.157 164.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.98 -73.22 0.12 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.177 1.37 . . . . 0.96 114.696 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -158.52 139.84 13.32 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.593 1.957 . . . . 2.45 109.154 -176.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -166.12 158.01 14.01 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 121.572 1.987 . . . . 1.11 110.983 -175.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -87.08 124.02 32.78 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.951 -0.388 . . . . 2.14 109.951 170.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.79 122.21 34.12 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.999 1.32 . . . . 1.78 108.63 169.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -103.13 135.92 43.9 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.874 1.67 . . . . 1.77 109.012 -177.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -141.31 125.64 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.769 1.228 . . . . 2.92 111.226 -171.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.72 104.64 0.04 OUTLIER Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.734 1.635 . . . . 1.28 110.987 -174.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.0 mt -102.11 115.68 31.06 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.792 1.296 . . . . 1.07 112.832 -166.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -66.32 -25.0 66.63 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.118 1.367 . . . . 1.52 112.923 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mmt-85 -152.78 146.54 18.22 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 127.164 2.186 . . . . 7.4 109.826 175.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.75 131.87 9.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.239 2.626 . . . . 1.74 111.617 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -76.35 127.68 33.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.907 1.283 . . . . 2.0 110.327 174.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.37 -166.49 1.16 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.981 0.896 . . . . 3.9 111.325 167.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.08 119.72 21.18 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.162 -0.961 . . . . 2.02 113.051 -162.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 90.91 -12.21 69.65 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 125.267 1.413 . . . . 4.27 114.901 174.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -74.51 154.24 38.76 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.05 1.13 . . . . 3.55 114.05 -157.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -80.65 90.7 5.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.539 1.936 . . . . 4.21 112.179 -166.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.59 106.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 O-C-N 121.121 -0.987 . . . . 1.03 109.382 166.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -68.75 139.34 55.32 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.255 1.026 . . . . 3.09 110.526 157.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -149.85 118.99 6.75 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.802 1.241 . . . . 1.59 109.502 -178.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.16 102.18 14.9 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.923 1.289 . . . . 2.55 108.438 173.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.35 128.04 34.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.543 1.137 . . . . 3.14 109.094 177.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -98.13 130.97 44.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.778 0.831 . . . . 0.6 110.323 -176.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -130.11 153.55 48.38 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.724 0.773 . . . . 1.88 112.54 -177.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.97 146.39 42.65 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.951 -0.468 . . . . 3.14 110.774 170.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.98 27.41 23.76 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.016 0.766 . . . . 4.44 115.016 -177.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 17.86 79.16 Favored Glycine 0 N--CA 1.476 1.325 0 CA-C-N 117.894 0.847 . . . . 1.74 113.757 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -94.51 140.47 29.8 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.574 -0.956 . . . . 4.37 112.349 -174.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.67 128.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 127.067 2.147 . . . . 1.07 107.772 177.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.8 mt -147.11 122.84 10.56 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.943 0.897 . . . . 1.58 111.697 -164.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -75.33 123.68 25.77 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.655 0.613 . . . . 2.56 112.655 177.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.5 m -93.14 159.92 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.692 0.797 . . . . 1.82 109.477 150.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.38 118.85 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.102 0.961 . . . . 1.99 108.543 167.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.6 mt -135.69 141.42 36.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 124.105 0.962 . . . . 2.11 111.544 -166.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.55 151.02 64.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.526 2.817 . . . . 1.05 111.753 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 74.7 t -79.21 130.72 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.004 0.922 . . . . 1.48 110.442 160.524 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -118.48 -152.39 0.5 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 128.043 2.537 . . . . 4.41 106.687 160.065 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.89 8.8 0.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 122.783 2.538 . . . . 2.93 117.501 -162.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.277 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 117.337 -1.315 . . . . 7.72 113.094 179.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.257 0 N-CA-C 105.968 -2.853 . . . . 10.91 105.968 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -59.64 166.65 2.39 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 117.348 0.574 . . . . 8.99 110.376 130.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -147.66 112.99 5.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.092 1.757 . . . . 10.81 106.814 178.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 5' ' ' GLU . 31.9 m 71.25 172.19 0.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.27 1.428 . . . . 7.74 107.78 -141.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 4' ' ' THR . 8.9 tp10 -145.42 144.97 30.94 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.326 -0.859 . . . . 4.75 109.374 166.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.44 -179.5 30.53 Favored Glycine 0 N--CA 1.469 0.861 0 C-N-CA 123.738 0.685 . . . . 1.01 114.473 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -159.62 152.21 21.36 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.262 1.025 . . . . 1.81 113.104 177.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.4 t -91.96 133.91 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 108.25 -1.019 . . . . 0.98 108.25 165.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 2.9 tmt_? -98.05 100.1 11.41 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.365 2.266 . . . . 3.88 109.017 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -57.55 148.69 23.21 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.077 0.942 . . . . 3.88 111.445 172.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.3 m -152.03 145.2 17.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.426 1.49 . . . . 2.22 110.01 161.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.81 71.42 7.05 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.083 3.189 . . . . 2.56 110.371 -176.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -159.54 -172.81 27.19 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.055 0.836 . . . . 1.39 113.701 -178.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.99 -3.57 13.3 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.163 3.242 . . . . 1.79 112.815 176.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -142.8 167.0 23.11 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.219 1.808 . . . . 2.4 112.521 -177.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.64 -176.24 3.07 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.524 1.929 . . . . 1.24 110.928 -170.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.53 157.62 39.64 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.133 0.879 . . . . 1.13 112.611 176.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.25 144.72 51.33 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.437 1.095 . . . . 0.91 110.422 165.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.85 152.33 51.09 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.296 1.439 . . . . 2.05 109.277 175.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -173.17 158.66 3.7 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.042 1.127 . . . . 1.53 114.042 175.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.1 m -82.71 130.89 35.2 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 126.767 2.027 . . . . 1.53 109.532 163.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.486 HD23 ' N ' ' A' ' 23' ' ' GLU . 6.4 tt -114.76 143.3 45.29 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.103 1.761 . . . . 3.08 108.858 169.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' N ' HD23 ' A' ' 22' ' ' LEU . 12.6 pt-20 -145.77 142.06 28.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.0 0.905 . . . . 3.13 112.191 170.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -100.86 106.13 42.18 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.768 1.627 . . . . 0.99 109.847 178.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.5 -9.36 17.36 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.418 2.079 . . . . 1.03 113.361 176.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.52 -178.57 52.5 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.332 0.969 . . . . 0.98 114.032 -176.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -111.77 1.28 16.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.756 1.623 . . . . 2.45 113.162 -172.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.07 160.03 37.1 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 125.924 1.69 . . . . 1.79 110.176 166.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.16 157.44 17.53 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.156 2.571 . . . . 1.1 111.721 -172.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.2 mt -107.53 157.61 17.89 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.601 1.16 . . . . 2.12 110.548 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -134.66 116.24 14.73 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.731 1.212 . . . . 2.93 109.291 169.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -97.66 117.16 31.32 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.337 2.255 . . . . 0.96 109.508 -171.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.71 -9.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 114.038 1.125 . . . . 0.65 114.038 -167.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.13 -163.77 32.7 Favored Glycine 0 C--N 1.34 0.791 0 O-C-N 121.418 -0.801 . . . . 0.8 112.548 176.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.565 ' HB1' HD11 ' A' ' 101' ' ' LEU . . . -145.33 -178.32 6.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.044 0.937 . . . . 1.16 111.183 172.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.73 136.16 3.61 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.88 1.218 . . . . 5.93 108.065 176.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -138.13 152.09 71.13 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 117.403 -1.285 . . . . 0.66 109.453 -178.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.46 -21.0 53.98 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.35 2.033 . . . . 1.0 113.568 169.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 m -90.3 4.78 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 114.549 1.314 . . . . 1.01 114.549 -174.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.52 -179.01 5.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.968 1.307 . . . . 1.16 110.787 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -101.57 -56.86 2.2 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.211 0.604 . . . . 3.16 110.353 173.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -120.06 161.59 20.71 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.748 0.785 . . . . 4.13 111.156 175.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.37 134.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.891 -1.05 . . . . 2.22 108.988 173.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -118.69 134.43 55.13 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 126.209 1.804 . . . . 2.01 108.798 -172.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -80.32 116.74 20.56 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.559 1.171 . . . . 0.89 110.568 169.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -103.75 148.45 26.07 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.333 1.54 . . . . 0.59 111.616 173.107 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -83.45 164.55 19.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.089 -1.414 . . . . 2.12 109.702 159.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.554 ' HB ' ' H ' ' A' ' 81' ' ' GLY . 91.2 m -140.77 93.39 2.6 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 106.56 -1.644 . . . . 1.33 106.56 167.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -90.43 173.53 8.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.711 1.604 . . . . 2.26 113.204 -162.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 56.1 mtm -113.32 131.34 55.99 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.37 -0.974 . . . . 3.35 108.37 146.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -150.18 164.48 35.56 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.551 1.94 . . . . 7.55 109.236 173.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -93.32 148.35 22.12 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.308 0.643 . . . . 3.72 111.87 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 p -144.62 -8.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.48 1.659 . . . . 4.05 115.48 -165.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -162.94 36.01 0.1 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.749 1.619 . . . . 3.24 109.451 -174.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.76 -11.2 1.3 Allowed Glycine 0 CA--C 1.539 1.545 0 O-C-N 120.642 -1.286 . . . . 2.37 113.703 -160.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -113.07 150.84 31.49 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.224 2.21 . . . . 2.62 111.196 -175.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.88 129.34 34.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.269 1.828 . . . . 6.13 113.579 -173.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -142.37 147.57 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.369 0.986 . . . . 1.74 111.358 -172.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.5 mtt -83.19 138.79 33.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.707 1.203 . . . . 3.62 113.477 171.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.89 167.3 33.19 Favored Glycine 0 N--CA 1.471 1.01 0 C-N-CA 124.128 0.87 . . . . 1.08 113.384 173.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -107.54 166.17 10.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.112 1.365 . . . . 1.72 111.718 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.71 136.04 0.29 Allowed Pre-proline 0 N--CA 1.476 0.848 0 CA-C-O 116.21 -1.852 . . . . 4.22 110.738 -175.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.93 143.03 64.68 Favored 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 122.254 1.841 . . . . 0.53 111.344 166.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.2 m -112.51 157.83 39.09 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.096 1.359 . . . . 0.59 110.0 172.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.25 -22.93 45.74 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.086 1.858 . . . . 0.76 112.262 174.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -173.96 165.74 4.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.503 1.521 . . . . 2.23 112.932 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mt -111.03 177.52 4.64 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.169 1.787 . . . . 1.21 109.306 150.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.53 171.02 19.38 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.663 -1.273 . . . . 2.26 111.638 175.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -151.57 134.53 8.9 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 118.36 -0.828 . . . . 1.33 110.189 -167.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.69 169.68 21.78 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 121.726 1.618 . . . . 1.09 111.434 171.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.92 142.27 74.62 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 124.005 3.137 . . . . 1.04 111.849 166.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 57.27 10.77 0.95 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.801 1.778 . . . . 1.36 115.801 -168.063 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.46 116.07 4.17 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 128.244 2.831 . . . . 1.37 110.889 -178.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -96.16 137.15 35.64 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.32 1.448 . . . . 3.93 110.173 162.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -144.33 144.0 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.787 1.635 . . . . 1.63 109.252 178.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -132.28 118.41 19.43 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.652 -0.499 . . . . 3.93 109.652 -165.061 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.44 75.84 3.18 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.138 1.375 . . . . 1.4 110.041 -173.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -72.11 131.0 85.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.55 -1.214 . . . . 4.48 108.651 175.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.5 -40.29 85.5 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.064 2.51 . . . . 1.05 113.018 -173.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.77 67.43 3.56 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 119.628 1.103 . . . . 1.37 111.111 164.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . 177.46 -82.17 0.07 OUTLIER Glycine 0 N--CA 1.469 0.861 0 C-N-CA 125.63 1.586 . . . . 1.01 112.637 -167.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -153.19 144.96 23.51 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 127.977 2.511 . . . . 1.86 108.927 -177.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -162.69 171.4 16.91 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.429 0.692 . . . . 0.83 110.568 -177.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -109.58 125.91 53.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.093 0.957 . . . . 2.17 111.208 173.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.2 mmt -89.78 121.86 32.32 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.403 1.081 . . . . 0.97 110.662 170.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.6 mt -96.68 138.96 33.45 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.7 1.6 . . . . 2.12 110.729 -178.143 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mt -144.1 140.19 29.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.175 0.806 . . . . 2.9 113.175 -177.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.55 57.96 3.44 Favored Glycine 0 N--CA 1.469 0.884 0 C-N-CA 124.303 0.954 . . . . 1.68 111.215 -176.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.8 mt -70.25 137.74 51.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.256 0.835 . . . . 0.85 113.256 -171.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -102.88 -3.43 26.23 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.756 1.223 . . . . 1.62 112.79 -172.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -139.01 158.56 69.46 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.106 1.362 . . . . 5.21 108.93 152.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -67.03 122.43 9.74 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 N-CA-C 106.255 -2.248 . . . . 1.85 106.255 138.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.17 120.96 21.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.102 0.953 . . . . 2.14 109.528 -166.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -67.49 109.38 3.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.511 1.125 . . . . 5.53 108.201 -179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -47.38 113.64 0.73 Allowed 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.141 -0.975 . . . . 1.91 113.004 172.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.65 49.47 6.58 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 123.812 0.72 . . . . 2.41 113.265 -166.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.31 -169.15 1.56 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.187 1.795 . . . . 2.7 108.662 146.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.6 162.0 33.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.735 1.214 . . . . 4.89 110.854 177.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.9 t -132.77 133.65 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.009 1.724 . . . . 0.98 109.847 -172.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -80.02 148.24 31.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.138 0.494 . . . . 3.15 111.512 164.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.565 HD11 ' HB1' ' A' ' 35' ' ' ALA . 1.1 tm? -151.81 120.63 6.57 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.091 1.356 . . . . 2.69 109.388 175.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.86 114.14 17.54 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.429 3.092 . . . . 2.09 109.951 170.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -81.14 122.51 27.45 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.813 1.188 . . . . 1.81 109.449 170.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.2 mt -97.53 127.88 43.83 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.057 0.943 . . . . 0.93 111.243 -171.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.64 151.33 48.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.168 0.985 . . . . 2.33 112.828 -176.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.62 158.82 35.51 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.717 -0.674 . . . . 2.33 111.987 172.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.84 22.32 74.78 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.586 -0.696 . . . . 4.77 113.899 176.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.51 63.8 2.07 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 118.219 1.01 . . . . 2.29 112.612 173.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -147.89 142.66 26.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.186 1.795 . . . . 3.94 110.867 178.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -152.92 139.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.393 1.877 . . . . 1.39 107.86 168.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.6 mt -143.49 108.21 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.534 1.134 . . . . 1.96 108.811 -175.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -92.53 150.39 20.78 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.86 1.059 . . . . 2.11 113.86 -177.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.49 159.51 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.795 1.238 . . . . 1.67 110.367 176.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.21 148.5 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.991 1.316 . . . . 2.45 109.849 168.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.1 mt -143.76 129.39 9.91 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.379 1.872 . . . . 1.66 109.051 -178.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.0 156.93 61.54 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.137 2.558 . . . . 1.05 112.561 175.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -88.92 113.37 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.102 1.361 . . . . 1.38 110.487 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -107.36 179.29 4.29 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 128.038 2.535 . . . . 4.49 108.595 164.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.27 123.3 17.84 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.663 -1.273 . . . . 2.49 109.755 171.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 4.1 tpt180 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 124.139 0.976 . . . . 4.69 113.311 -161.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.281 0 N-CA-C 108.828 -1.709 . . . . 12.41 108.828 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 t -84.39 -151.03 0.12 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 108.241 -1.022 . . . . 12.66 108.241 148.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -68.75 68.74 0.16 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.591 1.556 . . . . 18.28 110.85 167.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.0 p -148.03 -11.66 0.37 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 128.322 2.649 . . . . 7.71 113.675 -160.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -156.68 154.75 30.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 130.97 3.708 . . . . 5.64 106.867 -172.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -107.36 167.39 13.62 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 116.155 1.222 . . . . 1.13 116.155 -163.259 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -156.14 146.29 21.44 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.616 1.567 . . . . 1.87 112.497 173.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.7 139.82 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 N-CA-C 107.328 -1.36 . . . . 1.63 107.328 154.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.46 103.22 12.64 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.931 -0.481 . . . . 4.04 111.733 -173.128 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.93 110.0 1.22 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.591 1.186 . . . . 3.32 110.379 163.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -158.88 144.79 12.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 125.986 1.714 . . . . 2.27 108.58 161.572 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.76 74.23 5.3 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.061 3.174 . . . . 2.66 111.248 -175.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.92 148.31 19.5 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.05 1.309 . . . . 1.65 111.756 172.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -66.57 -25.04 47.88 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.981 2.454 . . . . 1.44 111.845 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -107.73 138.85 43.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.182 1.393 . . . . 3.99 108.982 153.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 163.78 31.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.551 1.94 . . . . 1.55 108.081 160.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.46 169.83 14.12 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.148 0.795 . . . . 1.2 113.148 -177.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.2 148.62 27.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.306 1.042 . . . . 1.1 112.482 165.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -143.04 159.81 41.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.017 1.727 . . . . 2.16 111.296 -172.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 2.6 pt? -163.47 146.37 10.1 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.448 1.277 . . . . 1.59 114.448 -175.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.6 m -79.87 128.27 33.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.661 -1.154 . . . . 2.03 109.679 166.429 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.9 tt -138.17 149.07 45.52 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.709 1.603 . . . . 2.76 110.987 -175.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -157.68 153.04 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.739 0.781 . . . . 3.04 111.491 174.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -104.8 105.0 49.12 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.251 1.42 . . . . 0.99 109.19 177.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.09 -11.23 13.61 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.834 2.356 . . . . 1.03 113.676 177.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.86 177.78 53.28 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 119.677 1.126 . . . . 0.99 113.467 -174.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -102.61 12.67 36.06 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.704 1.602 . . . . 2.38 111.588 178.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.03 158.65 34.47 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 127.059 2.144 . . . . 2.78 109.149 174.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.05 148.77 17.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.805 2.337 . . . . 1.4 110.266 172.364 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -121.61 119.56 32.22 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.405 1.082 . . . . 2.85 110.317 -178.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -109.06 106.46 16.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.526 1.53 . . . . 3.16 109.79 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.6 tp -92.3 116.23 28.78 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.103 2.161 . . . . 0.72 108.76 -173.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.78 -9.37 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.154 0.982 . . . . 0.57 112.714 -166.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 175.6 -162.66 32.07 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 124.875 1.226 . . . . 0.47 111.41 171.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.01 171.76 17.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.455 1.102 . . . . 0.71 110.539 168.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.83 130.4 16.85 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 106.622 -1.621 . . . . 6.03 106.622 -179.593 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.8 t -127.48 157.51 72.71 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-O 117.385 -1.293 . . . . 0.9 108.162 177.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -63.06 -25.36 73.46 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.036 1.824 . . . . 1.11 113.313 160.314 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 m -80.35 12.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 N-CA-C 114.904 1.446 . . . . 1.25 114.904 -172.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.31 153.68 49.01 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.313 1.445 . . . . 1.57 113.941 -172.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.88 -42.65 9.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.628 1.571 . . . . 4.03 111.581 168.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.13 176.25 12.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.062 1.345 . . . . 7.56 110.543 151.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -155.65 144.13 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 126.602 1.961 . . . . 1.86 109.569 -170.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -127.06 136.21 51.87 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.171 1.788 . . . . 2.26 110.566 -176.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -88.77 123.23 32.98 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.154 1.343 . . . . 0.76 112.067 169.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 13.3 m170 -110.88 153.54 25.31 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.762 2.025 . . . . 0.68 113.129 175.3 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -86.23 170.28 12.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.846 1.658 . . . . 2.33 111.278 161.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.3 m -146.73 126.86 13.77 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.015 1.326 . . . . 1.32 108.182 169.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -140.85 173.46 11.47 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.154 1.168 . . . . 2.42 114.154 -152.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -126.89 141.98 51.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.037 1.735 . . . . 3.98 108.676 159.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -149.45 165.67 31.4 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.066 1.746 . . . . 8.22 109.987 168.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.68 136.96 43.82 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.634 0.774 . . . . 3.89 110.092 169.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.96 -6.86 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 114.228 1.196 . . . . 2.91 114.228 173.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -168.37 27.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.873 2.069 . . . . 4.23 110.682 -179.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.42 -16.95 4.48 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.043 -1.661 . . . . 2.54 113.689 -163.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -82.58 142.13 32.03 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 118.736 1.268 . . . . 3.6 110.374 161.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.485 ' N ' ' HE2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.83 127.32 35.96 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.509 1.124 . . . . 5.01 109.358 177.766 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -135.72 145.22 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.029 1.332 . . . . 2.15 110.157 -170.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -82.97 158.45 22.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.62 1.568 . . . . 3.35 113.191 -176.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -174.59 -179.56 45.26 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.453 0.549 . . . . 1.42 113.957 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -132.35 158.06 42.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.905 1.682 . . . . 1.48 110.49 176.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.0 mtp85 -160.23 147.45 12.46 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.569 1.548 . . . . 5.68 109.924 169.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 46' ' ' HIS . 6.1 Cg_endo -63.72 148.14 92.24 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.655 1.57 . . . . 0.87 110.255 163.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.26 155.13 71.83 Favored Pre-proline 0 N--CA 1.472 0.647 0 C-N-CA 125.459 1.504 . . . . 0.58 110.734 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.99 -23.88 24.69 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.666 2.244 . . . . 0.7 112.541 178.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -171.78 165.68 6.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.388 1.075 . . . . 1.86 112.62 179.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mt -113.94 172.79 6.78 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.289 1.835 . . . . 1.0 109.188 155.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -154.61 167.86 28.71 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 121.543 -0.723 . . . . 2.05 111.518 166.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.6 t -144.37 130.07 9.71 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.042 1.737 . . . . 0.87 108.425 -169.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -70.43 164.7 34.23 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.319 2.013 . . . . 0.95 110.94 175.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.79 139.5 91.06 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.671 2.247 . . . . 1.1 110.547 171.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm 66.59 6.42 4.44 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.993 1.717 . . . . 1.57 113.549 -175.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.33 120.52 5.21 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 127.701 2.572 . . . . 1.16 112.623 -176.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -90.32 138.23 31.71 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.294 1.838 . . . . 4.0 111.424 167.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.09 125.02 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.976 1.31 . . . . 1.37 112.877 175.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.08 121.8 33.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.269 1.028 . . . . 4.23 111.586 170.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.69 147.12 46.0 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.333 1.063 . . . . 1.86 110.07 161.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -172.25 150.71 2.4 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.964 1.306 . . . . 2.6 111.197 -158.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.99 -47.9 9.6 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.758 2.305 . . . . 1.06 111.515 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.19 70.95 2.86 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 110.807 -0.917 . . . . 1.72 110.807 166.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 169.44 -96.45 0.12 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.363 1.458 . . . . 1.14 113.711 -176.068 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -149.37 138.32 21.21 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.949 1.699 . . . . 1.84 108.695 -172.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -157.97 162.28 38.2 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.231 -0.293 . . . . 0.69 110.794 -168.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -95.32 135.4 36.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.475 0.71 . . . . 2.1 110.468 169.21 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.9 mmt -95.67 126.72 41.14 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.112 1.365 . . . . 1.13 108.913 160.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.75 157.5 23.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.143 0.577 . . . . 2.36 110.33 173.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mt -143.29 78.32 1.6 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.484 1.135 . . . . 3.08 111.381 176.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.19 114.13 3.74 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.757 2.122 . . . . 1.66 110.299 -170.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.1 mt -99.16 126.31 44.91 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.606 1.163 . . . . 1.33 110.444 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -92.02 -25.11 18.97 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.194 0.812 . . . . 2.46 113.194 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.31 151.69 40.52 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.645 -0.872 . . . . 4.45 108.645 159.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.95 -14.53 23.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.569 2.179 . . . . 3.24 115.41 177.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.3 mt 66.71 102.34 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 130.996 3.719 . . . . 2.5 110.373 -178.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -106.88 143.21 35.31 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.881 0.873 . . . . 6.23 109.739 161.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -45.41 124.17 4.66 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.483 -0.78 . . . . 1.63 109.643 159.325 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.57 3.08 81.47 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 117.361 -1.799 . . . . 2.17 116.426 -176.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -73.73 161.52 30.15 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 121.15 2.475 . . . . 2.55 109.75 162.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -104.95 154.99 19.37 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.24 1.416 . . . . 3.81 110.993 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.8 t -132.15 112.52 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 126.044 1.737 . . . . 1.61 108.63 -176.117 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -74.22 142.29 45.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.231 -0.655 . . . . 3.13 109.231 155.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 mt -146.57 117.32 7.62 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.282 1.033 . . . . 1.55 111.326 175.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.9 92.4 8.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.678 3.191 . . . . 2.15 109.222 170.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.68 125.25 28.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.468 1.107 . . . . 1.36 109.68 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 26.6 mt -97.01 132.23 43.03 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.867 1.267 . . . . 0.74 111.243 -170.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -131.6 146.52 52.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.076 0.941 . . . . 2.2 112.789 -174.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.34 165.13 14.67 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.749 -0.594 . . . . 2.23 111.84 170.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.58 26.48 65.27 Favored Glycine 0 CA--C 1.533 1.171 0 O-C-N 121.461 -0.775 . . . . 4.68 113.272 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.87 63.04 3.48 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.823 1.201 . . . . 1.96 111.562 176.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -146.75 161.3 40.91 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 123.111 1.434 . . . . 4.29 113.028 -171.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 p -171.9 146.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.125 2.97 . . . . 1.36 108.137 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt -140.24 123.67 17.0 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.618 1.167 . . . . 1.73 109.192 179.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -81.42 126.92 32.22 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.522 0.601 . . . . 2.5 111.381 167.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 t -121.29 166.15 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.876 1.671 . . . . 3.12 108.381 168.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.8 p -132.2 130.32 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 125.316 1.447 . . . . 2.01 110.764 178.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mp -139.05 166.91 21.37 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.796 2.438 . . . . 2.6 109.37 -176.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.67 170.78 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.14 2.56 . . . . 1.62 113.581 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.8 t -95.77 136.79 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 127.656 2.383 . . . . 1.5 107.721 155.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -153.53 158.68 41.63 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.584 0.754 . . . . 5.05 111.548 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.21 3.35 24.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 116.358 1.984 . . . . 2.24 116.358 -164.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.937 0 N-CA-C 113.492 0.923 . . . . 6.16 113.492 -162.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.884 0 N-CA-C 108.075 -2.01 . . . . 12.21 108.075 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -41.23 96.39 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.196 0.998 . . . . 11.59 112.175 163.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -129.01 162.92 26.51 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.784 1.234 . . . . 8.57 111.151 172.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.3 p -163.2 97.96 0.92 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.969 2.508 . . . . 7.66 107.911 163.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -81.92 66.1 7.34 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.397 1.079 . . . . 7.17 110.733 -174.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.26 159.27 23.29 Favored Glycine 0 C--N 1.345 1.076 0 N-CA-C 115.929 1.131 . . . . 1.03 115.929 -169.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -150.41 136.99 18.95 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.609 1.164 . . . . 1.59 112.201 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.2 t -90.67 131.76 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.702 -0.851 . . . . 0.84 108.702 164.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 130.61 47.47 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.939 0.718 . . . . 7.86 112.939 -173.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -68.63 103.48 1.72 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.563 1.173 . . . . 4.0 110.993 163.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.89 140.71 0.57 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 125.854 1.661 . . . . 3.47 109.926 157.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.36 3.4 7.83 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.071 3.181 . . . . 3.7 114.471 -173.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.01 145.88 49.74 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 119.537 1.062 . . . . 1.77 113.028 -175.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -65.98 -15.07 47.38 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 124.113 3.209 . . . . 2.45 113.676 -171.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p30 -139.35 167.03 23.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.134 0.974 . . . . 2.83 111.794 159.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 159.65 174.08 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 130.493 3.517 . . . . 3.26 109.87 171.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.69 171.86 13.15 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.058 1.133 . . . . 2.07 114.058 -177.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.22 160.12 40.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.692 2.797 . . . . 1.9 109.151 170.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -144.0 158.28 43.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 122.101 0.953 . . . . 2.15 112.644 -164.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.48 159.57 28.15 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 113.582 0.956 . . . . 1.85 113.582 173.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.8 m -123.77 147.73 47.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.869 -1.514 . . . . 2.23 107.331 164.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tp -136.83 153.43 50.79 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.053 1.341 . . . . 4.34 110.985 -175.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -108.95 135.61 49.85 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.53 1.932 . . . . 3.98 108.094 168.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -102.46 91.34 2.62 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 119.02 -0.514 . . . . 1.32 109.967 160.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.45 -11.11 18.97 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.314 2.009 . . . . 1.85 113.487 178.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.33 164.33 52.41 Favored Glycine 0 C--N 1.34 0.774 0 CA-C-N 118.907 0.776 . . . . 1.48 113.195 -179.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.56 3.08 51.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.051 1.741 . . . . 2.9 113.609 -177.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -124.99 159.97 56.54 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.59 1.556 . . . . 2.21 110.799 174.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.34 166.17 22.66 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 122.845 2.363 . . . . 1.63 112.657 -164.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.0 mt -109.0 154.65 21.88 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.22 1.008 . . . . 3.03 111.008 165.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -148.88 104.99 3.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.177 1.791 . . . . 3.67 109.654 170.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.7 tp -91.64 111.8 23.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.634 2.374 . . . . 0.82 109.886 -168.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -97.85 -15.32 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.849 1.259 . . . . 0.64 112.857 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.65 -164.93 36.66 Favored Glycine 0 C--N 1.34 0.768 0 O-C-N 121.685 -0.634 . . . . 0.57 112.62 175.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.5 172.52 14.84 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.816 0.846 . . . . 0.83 111.242 166.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.78 144.49 23.53 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.717 0.689 . . . . 5.07 111.663 171.23 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 t -141.1 149.53 55.89 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 125.875 1.67 . . . . 0.65 108.93 -166.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.65 -19.23 42.1 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.124 1.883 . . . . 1.0 113.232 173.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 m -71.21 -4.39 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 114.331 1.234 . . . . 1.32 114.331 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.31 174.38 12.91 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 115.593 1.701 . . . . 1.48 115.593 -167.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -108.58 -42.92 4.41 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.897 2.079 . . . . 3.39 110.429 -177.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -129.61 161.88 29.53 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.216 1.406 . . . . 5.16 112.057 172.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -176.21 126.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 126.256 1.822 . . . . 1.95 108.798 -173.38 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -145.21 137.07 25.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.057 1.343 . . . . 4.45 109.475 -164.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.5 123.62 33.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.636 0.732 . . . . 0.81 111.461 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -107.83 153.8 22.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.719 1.608 . . . . 0.67 113.584 173.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -91.55 170.7 9.72 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.875 2.07 . . . . 2.2 110.715 158.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.9 m -149.46 114.59 5.45 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.608 1.563 . . . . 1.51 107.837 173.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -119.8 157.21 29.11 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.956 1.302 . . . . 2.34 112.841 -162.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -94.46 158.61 15.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.224 1.01 . . . . 3.52 110.555 160.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.37 150.22 14.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.289 1.436 . . . . 5.96 110.378 176.001 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.3 140.54 29.66 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.799 -0.815 . . . . 3.53 108.799 160.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -139.51 114.4 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.661 1.584 . . . . 2.62 107.365 -178.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 64.99 1.27 1.42 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.204 1.802 . . . . 4.7 112.569 -167.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.56 -11.76 58.05 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.644 1.593 . . . . 1.87 113.879 -166.51 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -76.77 136.55 39.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.275 1.537 . . . . 4.48 109.656 172.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -77.54 126.77 31.42 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.678 -0.639 . . . . 3.73 110.73 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.8 t -135.25 155.74 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.58 1.952 . . . . 2.15 109.097 -173.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 22.1 mtm -128.7 154.12 46.64 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.131 0.972 . . . . 3.58 110.785 171.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.55 -179.39 30.63 Favored Glycine 0 N--CA 1.468 0.827 0 C-N-CA 124.07 0.843 . . . . 1.25 113.333 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -136.56 161.42 35.92 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.47 1.508 . . . . 2.88 109.954 -177.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -165.62 134.55 2.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 CA-C-O 116.679 -1.629 . . . . 4.53 110.311 -173.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.56 146.37 84.49 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 122.322 1.865 . . . . 0.64 110.391 163.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.32 158.32 67.29 Favored Pre-proline 0 N--CA 1.478 0.932 0 C-N-CA 125.677 1.591 . . . . 0.66 111.237 -176.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.53 -24.5 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.822 2.348 . . . . 0.65 112.73 176.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -173.87 166.81 4.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.649 1.18 . . . . 1.73 113.176 178.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.19 170.14 8.43 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.408 1.883 . . . . 1.1 109.799 152.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -156.65 164.56 38.03 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.354 -0.841 . . . . 1.89 113.179 176.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -154.43 141.18 13.22 Favored Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.963 0.905 . . . . 0.99 110.452 -160.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.38 171.54 14.96 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.343 2.028 . . . . 0.89 112.651 168.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.71 148.43 92.13 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 124.28 3.32 . . . . 1.07 112.267 163.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 69.69 -2.96 1.8 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.71 2.004 . . . . 1.67 114.123 179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.61 115.88 4.18 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 125.824 1.678 . . . . 0.99 111.583 -178.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.04 128.98 36.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.115 0.566 . . . . 6.82 110.561 162.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.28 158.18 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.313 1.445 . . . . 1.76 112.087 -164.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -146.42 114.25 6.48 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.269 0.628 . . . . 4.07 109.684 -141.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.24 83.39 6.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.096 0.958 . . . . 1.64 109.13 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -72.4 142.18 84.0 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.539 -1.22 . . . . 2.76 109.769 178.027 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -58.51 -39.15 85.9 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.698 2.266 . . . . 1.38 112.516 -178.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.94 61.68 4.7 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.899 0.761 . . . . 1.8 111.394 165.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.65 -69.36 0.07 OUTLIER Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.746 1.165 . . . . 1.2 114.168 -177.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -154.12 143.67 21.58 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.043 1.737 . . . . 1.96 109.052 -171.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -167.25 165.49 15.25 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.494 -0.754 . . . . 1.05 110.219 -177.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -96.64 135.9 37.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.962 -0.385 . . . . 2.08 109.962 169.336 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.0 mmt -79.54 132.7 36.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.0 -0.741 . . . . 1.17 109.0 152.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.1 139.47 39.72 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.517 1.127 . . . . 1.97 108.687 164.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -137.38 136.42 37.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.683 1.193 . . . . 2.63 111.38 -175.648 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.13 42.73 99.4 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 1.66 111.301 178.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . 0.312 0.2 OUTLIER -68.76 87.48 0.35 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.434 1.588 . . . . 1.85 113.91 -173.736 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -67.64 5.55 0.8 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.04 2.536 . . . . 2.1 115.553 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -127.14 105.83 22.02 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.483 1.113 . . . . 6.31 109.514 146.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.87 144.81 60.21 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.165 2.576 . . . . 1.76 111.073 172.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.14 126.32 33.52 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.433 1.093 . . . . 2.07 110.839 -177.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -98.34 -31.2 12.16 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.705 1.202 . . . . 4.95 113.01 -175.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 122.06 150.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 1 C-N-CA 132.153 4.181 . . . . 1.5 110.468 175.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.23 37.0 93.51 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.355 -0.692 . . . . 1.94 113.569 178.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.92 -171.8 2.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.745 1.218 . . . . 2.91 108.629 178.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -141.99 162.06 36.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.197 0.999 . . . . 3.35 110.673 174.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -131.86 119.78 42.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.53 1.532 . . . . 0.84 109.894 -169.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.48 135.94 52.42 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.193 1.797 . . . . 3.08 110.456 162.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mt -155.94 124.4 5.88 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.816 0.846 . . . . 1.59 112.615 -175.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -90.67 105.57 17.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.739 1.616 . . . . 1.99 110.571 172.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.02 117.69 21.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.594 0.757 . . . . 1.22 110.418 176.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.2 mt -93.77 126.27 38.86 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.877 1.271 . . . . 0.58 111.045 -169.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -122.97 139.46 54.04 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.179 0.807 . . . . 1.84 113.179 -175.289 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -66.22 104.49 1.2 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.273 1.029 . . . . 2.75 112.634 -177.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.26 78.57 1.05 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.012 1.292 . . . . 4.73 113.087 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.28 -0.37 24.94 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 116.193 1.237 . . . . 1.96 116.193 169.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -110.13 132.18 54.4 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.014 1.407 . . . . 5.74 112.761 -170.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.35 134.31 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 125.794 1.638 . . . . 1.14 107.384 160.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.3 mt -120.15 110.16 16.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.937 -1.134 . . . . 1.99 107.937 177.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -80.04 127.6 32.48 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.16 -0.337 . . . . 2.47 110.886 176.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.5 m -125.96 161.87 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.87 1.668 . . . . 1.14 110.499 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.66 135.94 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.302 1.041 . . . . 1.93 108.709 165.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 mt -127.35 147.81 63.7 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 125.24 1.416 . . . . 1.59 108.943 172.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.26 161.43 44.48 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.151 2.568 . . . . 1.0 111.942 174.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -91.6 133.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.302 1.441 . . . . 1.26 108.595 165.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.64 153.82 25.47 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.52 1.128 . . . . 3.95 110.023 171.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 2.69 -113.32 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 130.163 3.385 . . . . 3.53 117.632 175.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.775 0 CA-C-O 114.866 -2.492 . . . . 9.12 112.348 178.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 N-CA-C 109.205 -1.558 . . . . 11.3 109.205 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 68.75 179.43 0.24 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.409 1.084 . . . . 8.63 113.312 -175.382 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -85.44 -24.52 27.42 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.677 1.191 . . . . 9.58 112.056 157.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.272 57.9 p 106.54 110.17 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 1 C-N-CA 133.345 4.658 . . . . 7.52 110.806 177.291 . . . . . . . . 3 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -85.16 87.63 7.4 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.86 0.864 . . . . 5.99 110.512 -172.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.07 171.46 29.32 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.577 1.561 . . . . 1.11 113.694 176.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -155.36 153.8 31.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.274 1.429 . . . . 1.56 112.126 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 99' ' ' VAL . 90.6 t -105.49 136.54 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.569 -1.271 . . . . 1.08 107.569 172.075 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -86.1 -0.31 55.31 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.486 2.032 . . . . 5.25 116.486 -153.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.5 t80 60.65 168.65 0.09 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.87 1.668 . . . . 3.25 112.511 -168.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 t -165.73 145.69 5.48 Favored Pre-proline 0 N--CA 1.47 0.559 0 O-C-N 120.457 -1.402 . . . . 3.44 112.372 162.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.32 -6.35 11.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.455 2.77 . . . . 3.33 112.486 164.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.65 171.31 15.52 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.405 1.479 . . . . 1.88 113.757 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.08 -3.16 13.16 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.931 3.754 . . . . 1.8 113.811 -176.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.0 p30 -121.83 156.51 33.1 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.215 1.806 . . . . 2.14 112.133 171.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.79 177.06 11.82 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.38 1.472 . . . . 1.3 112.091 -171.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.57 20.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.475 1.11 . . . . 1.02 112.753 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.31 159.3 38.7 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.072 1.138 . . . . 1.17 114.072 169.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -148.24 151.28 35.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.213 2.205 . . . . 2.49 110.634 -172.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -168.5 151.07 5.22 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.411 0.893 . . . . 1.64 113.411 179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.4 m -95.48 131.11 41.99 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.458 1.903 . . . . 1.62 108.92 171.115 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 tp -140.32 160.68 39.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.683 1.193 . . . . 4.48 111.173 178.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.98 127.29 10.62 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.967 0.907 . . . . 3.29 110.779 -169.316 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -85.97 116.34 65.34 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.278 1.031 . . . . 0.93 109.694 174.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -87.2 -14.01 4.18 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.082 2.522 . . . . 1.23 114.374 178.164 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.38 174.38 32.2 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 119.212 0.915 . . . . 1.16 113.206 -174.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.01 -2.48 58.14 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.571 1.548 . . . . 3.74 114.587 -178.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 pp -97.63 158.79 32.44 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.479 1.112 . . . . 2.02 111.138 173.656 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.59 157.52 12.29 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.377 2.718 . . . . 1.35 111.229 -176.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.21 108.02 9.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.634 0.73 . . . . 2.14 111.688 -170.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -99.96 106.23 18.0 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.696 1.198 . . . . 2.73 111.675 -177.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.1 tp -85.4 114.86 22.77 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.583 1.953 . . . . 0.7 109.431 -177.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.71 -12.19 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.829 0.851 . . . . 0.88 112.884 -171.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.45 -168.04 40.59 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 124.665 1.126 . . . . 0.81 111.098 173.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.37 140.69 20.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.638 0.775 . . . . 1.96 110.592 167.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -108.54 139.75 42.86 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.714 1.606 . . . . 6.89 108.538 -169.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -152.41 155.7 33.09 Favored Pre-proline 0 N--CA 1.472 0.644 0 C-N-CA 124.593 1.157 . . . . 0.84 109.874 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -86.58 -9.9 6.57 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.729 2.286 . . . . 1.41 113.527 165.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 m -70.27 -9.52 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.343 0.974 . . . . 1.98 113.443 176.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 160.74 30.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.171 1.351 . . . . 0.94 112.285 -169.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -98.28 -68.76 0.79 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.173 1.389 . . . . 3.01 109.14 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -82.01 111.9 18.6 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.078 -1.014 . . . . 3.63 109.405 171.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.62 145.78 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.524 1.13 . . . . 1.47 109.444 153.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -137.25 122.87 19.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.54 1.536 . . . . 2.14 108.542 162.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.26 119.79 22.11 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 120.934 1.697 . . . . 0.68 110.045 167.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -109.06 157.02 19.1 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.318 1.847 . . . . 0.59 112.247 176.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 12.1 pt-20 -104.38 168.18 9.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.852 -1.067 . . . . 2.37 110.264 161.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.7 m -130.03 107.48 9.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.342 1.457 . . . . 1.13 107.3 170.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -113.27 154.92 26.02 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.859 1.264 . . . . 2.33 112.508 -171.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -90.52 154.45 19.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.655 1.182 . . . . 3.31 112.334 172.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.41 15.53 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.033 1.333 . . . . 5.59 113.214 177.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -138.74 142.13 38.86 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.969 1.307 . . . . 4.82 109.473 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 p -152.59 128.28 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.501 1.12 . . . . 3.83 108.981 178.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 56.29 28.21 13.0 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 122.175 0.988 . . . . 4.17 111.011 -168.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.12 -0.42 11.74 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.506 2.003 . . . . 3.2 114.996 -173.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.69 126.11 30.29 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.444 1.498 . . . . 3.42 108.785 174.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.47 126.89 52.64 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.371 1.468 . . . . 6.21 110.785 -162.228 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.8 t -145.67 153.17 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.915 1.286 . . . . 1.59 110.586 -156.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.4 mtm -120.81 149.44 42.57 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.387 1.075 . . . . 2.84 110.413 161.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.64 158.64 27.75 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 123.917 0.77 . . . . 1.14 112.733 178.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -102.73 155.48 18.29 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.564 1.146 . . . . 1.63 111.897 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.412 ' HE ' ' CD ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -163.91 146.5 7.62 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-O 117.693 -1.146 . . . . 5.67 112.255 171.733 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -68.38 142.13 53.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.881 2.387 . . . . 0.64 111.419 172.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.76 157.54 38.19 Favored Pre-proline 0 N--CA 1.472 0.631 0 C-N-CA 125.303 1.441 . . . . 0.72 110.763 175.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.44 -18.66 38.4 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.434 2.089 . . . . 0.62 112.743 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -179.42 167.04 1.47 Allowed 'General case' 0 C--N 1.347 0.459 0 C-N-CA 126.128 1.771 . . . . 1.81 110.076 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mt -114.91 171.09 7.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.274 1.83 . . . . 0.99 108.89 157.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -157.32 167.76 29.35 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.142 -0.974 . . . . 2.52 113.353 167.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -139.75 134.69 16.21 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.053 1.341 . . . . 0.79 109.381 -172.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.42 164.58 33.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.223 1.949 . . . . 0.8 111.611 175.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.14 139.7 85.32 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.831 3.021 . . . . 0.84 111.919 174.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.54 1.67 1.4 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 126.345 1.858 . . . . 3.18 115.128 -171.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.27 118.44 4.78 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 127.669 2.556 . . . . 0.9 111.971 -178.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -91.79 137.03 32.69 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.874 1.27 . . . . 3.83 111.021 159.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.7 m -150.31 157.45 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.785 1.634 . . . . 1.52 110.705 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.12 152.62 34.35 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.392 1.091 . . . . 3.73 112.826 169.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -75.79 77.29 2.73 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.955 1.302 . . . . 1.4 108.733 161.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.2 137.51 78.71 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.393 1.077 . . . . 3.37 112.399 177.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.53 -34.56 85.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.905 3.07 . . . . 1.63 114.476 -169.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.7 121.54 6.29 Favored Glycine 0 N--CA 1.468 0.824 0 N-CA-C 106.889 -2.484 . . . . 1.47 106.889 150.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.86 -94.72 0.5 Allowed Glycine 0 N--CA 1.47 0.909 0 CA-C-N 119.786 1.793 . . . . 1.6 112.967 -161.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 54.7 m-85 -148.12 149.06 31.34 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.042 2.137 . . . . 1.92 111.633 -169.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.7 163.7 14.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.307 1.043 . . . . 1.01 109.982 -178.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -93.39 138.19 31.96 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 122.02 -0.425 . . . . 2.43 109.937 167.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 18.6 mmt -96.98 139.49 32.91 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.348 1.059 . . . . 0.84 109.421 157.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.58 142.62 51.48 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.484 1.513 . . . . 2.88 109.933 -178.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mt -145.99 133.65 21.03 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.899 1.68 . . . . 3.03 111.505 -174.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.74 74.37 1.09 Allowed Glycine 0 N--CA 1.476 1.304 0 N-CA-C 111.274 -0.73 . . . . 1.47 111.274 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -84.67 119.41 25.21 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.471 0.915 . . . . 1.13 113.471 -163.562 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -90.6 -8.99 48.66 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.896 1.443 . . . . 1.81 114.896 -169.684 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.22 145.08 56.16 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.204 1.401 . . . . 6.15 108.038 160.489 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.12 128.76 15.19 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 N-CA-C 107.169 -1.896 . . . . 2.08 107.169 168.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.37 95.76 0.33 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.087 1.355 . . . . 2.32 110.506 -168.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -68.99 111.81 5.23 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 120.657 -1.277 . . . . 4.99 108.693 177.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.94 108.93 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.123 -0.985 . . . . 1.78 110.431 167.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.06 16.65 40.37 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-O 117.213 -1.882 . . . . 1.79 116.036 -170.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.08 171.59 12.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.793 2.297 . . . . 4.39 109.045 150.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.219 1.408 . . . . 4.33 108.621 170.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 8' ' ' VAL . 58.9 t -98.41 119.66 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 123.916 0.887 . . . . 1.08 110.062 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.71 45.12 1.04 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 128.282 2.633 . . . . 5.6 113.185 -170.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.41 130.22 42.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.483 1.913 . . . . 1.79 113.902 -164.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -92.02 93.28 8.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.457 2.703 . . . . 2.32 110.892 175.353 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.1 mt -71.48 120.61 17.31 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.396 -0.815 . . . . 1.47 110.52 -179.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 mt -93.27 125.26 37.78 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.546 1.538 . . . . 1.0 111.114 -169.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.73 125.63 44.37 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.468 0.914 . . . . 1.86 113.468 -177.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 53.44 11.37 0.27 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.444 2.298 . . . . 2.11 116.685 167.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.92 4.02 46.22 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.959 -1.088 . . . . 3.34 114.409 -168.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -129.91 -4.71 4.6 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.727 1.156 . . . . 1.8 115.64 -171.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.69 158.37 43.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.423 2.289 . . . . 4.1 110.831 173.123 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -146.8 135.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.949 1.7 . . . . 1.54 107.582 165.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.61 115.33 12.9 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.86 1.264 . . . . 1.72 107.77 -173.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.283 0.0 OUTLIER -102.84 141.64 35.31 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.456 1.28 . . . . 2.72 114.456 -171.324 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.7 m -130.68 167.75 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.562 1.545 . . . . 1.52 110.09 -173.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.87 144.81 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 C-N-CA 124.641 1.176 . . . . 2.91 109.733 172.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.42 133.17 6.67 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.551 -0.738 . . . . 2.31 111.162 176.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.06 150.34 82.5 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.566 2.844 . . . . 1.51 112.623 -172.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.3 112.02 20.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.337 1.055 . . . . 1.61 108.492 166.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.88 -169.95 2.15 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.099 2.96 . . . . 3.74 108.649 178.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.53 53.0 1.8 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.202 1.556 . . . . 2.62 115.202 -161.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 115.58 -2.152 . . . . 8.37 115.045 178.599 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.455 0 N-CA-C 109.239 -1.544 . . . . 14.44 109.239 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -165.97 168.29 15.83 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.578 1.551 . . . . 10.68 108.5 -178.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -107.54 107.81 18.82 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.889 -1.523 . . . . 9.0 106.889 155.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 m -149.44 112.0 4.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 105.263 -2.125 . . . . 6.78 105.263 -177.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -116.47 125.42 51.94 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.016 -1.447 . . . . 4.42 109.53 -155.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.72 174.75 43.36 Favored Glycine 0 N--CA 1.465 0.592 0 O-C-N 121.94 -0.475 . . . . 1.15 113.96 -178.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -155.51 151.04 27.21 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.947 0.899 . . . . 1.38 112.167 -179.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.93 127.64 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.901 -0.499 . . . . 0.99 110.016 174.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 ttp85 -72.63 -11.0 60.46 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.441 1.645 . . . . 4.74 115.441 -159.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 67.94 160.81 0.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.372 1.469 . . . . 2.82 113.949 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t -165.82 149.93 7.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 126.048 1.739 . . . . 4.19 110.497 166.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -83.64 -9.92 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.25 2.633 . . . . 3.75 112.024 162.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.9 -168.14 13.27 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.96 1.743 . . . . 2.38 113.962 -174.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -74.0 -27.45 12.04 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.196 2.598 . . . . 2.11 114.955 -165.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -98.63 150.85 21.32 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.144 1.338 . . . . 3.0 112.425 177.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.4 -179.9 8.53 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.032 2.133 . . . . 1.28 111.599 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.76 167.35 21.32 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.15 1.78 . . . . 1.09 111.403 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.83 155.1 36.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.351 1.061 . . . . 1.1 112.376 172.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 142.57 24.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.362 1.865 . . . . 2.18 109.558 -171.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -171.24 159.37 5.8 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.318 1.599 . . . . 1.73 115.318 -174.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -71.9 138.48 48.19 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.305 1.842 . . . . 1.27 109.365 166.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.5 tt -125.62 146.25 49.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.118 1.767 . . . . 3.62 111.241 171.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -119.72 132.97 55.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.256 1.822 . . . . 5.05 114.002 -179.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -98.95 109.04 52.4 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.678 -0.692 . . . . 1.17 109.851 143.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -89.2 -10.62 3.91 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.53 2.82 . . . . 1.25 113.565 173.254 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.58 -174.25 47.15 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 125.116 1.341 . . . . 0.92 113.495 -174.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.56 -4.0 18.8 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.963 1.705 . . . . 2.32 113.147 -169.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.42 161.43 39.27 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.653 1.981 . . . . 1.87 109.644 169.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -77.71 163.09 29.44 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.826 2.351 . . . . 1.35 112.632 -167.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tp -126.26 127.56 45.8 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.884 1.274 . . . . 2.36 111.125 -174.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -111.16 112.98 25.16 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.907 1.283 . . . . 3.51 110.648 175.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 tp -85.76 133.12 34.01 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.144 1.377 . . . . 0.97 108.721 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.86 -13.02 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.034 0.934 . . . . 0.73 113.516 -175.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 177.48 -164.98 34.47 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 124.002 0.811 . . . . 0.98 111.74 171.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 102' ' ' ASP . . . -140.94 -175.92 4.48 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.459 0.704 . . . . 1.14 110.632 160.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.88 146.56 9.54 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.069 0.948 . . . . 5.22 111.644 171.075 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -140.34 152.32 66.5 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.017 1.727 . . . . 0.85 109.253 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.13 -34.05 29.5 Favored 'Trans proline' 0 C--N 1.35 0.628 0 CA-C-N 121.585 1.602 . . . . 0.96 112.613 173.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 m -70.77 -18.82 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 115.244 1.572 . . . . 1.29 115.244 -167.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.3 143.03 50.79 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.843 1.257 . . . . 0.92 111.078 -176.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -64.48 -53.83 42.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.262 1.025 . . . . 4.42 111.8 172.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.14 160.76 21.51 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.372 1.869 . . . . 7.24 111.055 -170.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 p -159.7 135.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.824 1.65 . . . . 1.15 110.661 -172.136 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -139.87 135.1 32.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.324 1.85 . . . . 2.41 109.72 177.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.5 tt -83.33 118.74 23.89 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.436 1.016 . . . . 0.79 111.012 168.144 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -106.41 155.25 19.74 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.178 1.791 . . . . 0.74 112.044 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -157.27 0.59 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.628 1.571 . . . . 3.75 111.019 174.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.8 m -151.32 123.98 8.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.478 2.311 . . . . 1.51 106.598 162.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -126.86 160.51 30.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.778 1.231 . . . . 2.48 112.431 -172.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 8.9 ptt? -134.24 122.18 22.38 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 122.988 1.375 . . . . 3.4 112.587 159.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -117.52 162.41 18.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.245 1.818 . . . . 7.85 110.927 -176.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.402 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 30.1 mp0 -77.19 144.42 38.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.893 1.677 . . . . 4.81 111.479 171.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -134.49 -96.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.602 1.561 . . . . 3.24 109.176 -176.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.02 31.15 0.11 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.088 1.355 . . . . 4.03 112.44 177.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.58 -13.28 8.48 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.365 -1.459 . . . . 2.73 112.594 -154.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 152.72 28.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.318 1.847 . . . . 4.41 110.763 178.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.402 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 41.6 mmtt -73.78 140.12 45.65 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.746 -0.596 . . . . 5.86 110.668 158.539 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -132.85 145.67 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.159 1.784 . . . . 2.07 108.259 165.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.8 tpp -101.52 146.9 27.04 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.229 2.212 . . . . 3.15 111.016 -175.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.11 -174.98 33.66 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.935 1.255 . . . . 1.44 113.64 174.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -138.38 152.2 48.19 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.672 1.589 . . . . 1.91 110.196 173.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.39 148.33 16.44 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 124.664 1.186 . . . . 4.45 110.932 -170.035 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.41 150.32 84.39 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 121.611 1.54 . . . . 0.76 112.49 167.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.89 159.11 73.93 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 126.559 1.944 . . . . 0.83 110.761 176.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.39 -18.35 14.02 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.039 2.493 . . . . 0.62 114.069 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -171.74 164.55 6.59 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.986 1.266 . . . . 2.03 112.552 -178.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.15 168.61 12.67 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.737 2.415 . . . . 1.06 108.572 161.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -161.88 163.82 28.99 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.975 -1.078 . . . . 2.18 113.274 176.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 t -149.2 140.69 14.44 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.3 1.04 . . . . 1.53 110.601 -169.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.35 167.34 20.74 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.997 2.465 . . . . 1.23 112.016 171.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.25 146.72 97.09 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.604 2.87 . . . . 1.0 112.796 175.224 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt 66.92 -2.45 1.13 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.373 1.869 . . . . 1.31 114.571 -178.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.97 117.86 4.58 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 126.65 2.071 . . . . 0.81 111.343 178.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.4 mtt-85 -83.34 145.35 29.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 114.834 -0.683 . . . . 6.39 110.229 151.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.78 179.54 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 126.03 1.732 . . . . 1.53 109.398 171.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -121.39 139.75 53.03 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.771 0.828 . . . . 3.7 111.217 166.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.16 76.69 1.27 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.805 -1.554 . . . . 1.15 106.805 143.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -82.87 142.19 44.8 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 117.672 -1.156 . . . . 3.79 109.94 -177.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.66 -55.13 4.38 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.355 3.37 . . . . 1.75 114.959 -169.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.1 70.83 2.81 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 110.748 -0.941 . . . . 1.16 110.748 172.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -179.84 -76.95 0.06 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.253 1.406 . . . . 0.9 114.046 -166.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -155.63 142.1 18.63 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.18 2.192 . . . . 1.82 108.351 -177.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -163.1 179.12 7.72 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.254 -0.903 . . . . 0.8 111.581 -172.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -109.29 139.92 43.61 Favored 'General case' 0 C--O 1.233 0.207 0 O-C-N 122.108 -0.37 . . . . 2.05 111.088 168.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 mmt -90.92 136.26 33.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.58 0.752 . . . . 1.16 109.477 155.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.11 140.01 53.04 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.694 1.597 . . . . 2.65 109.1 178.228 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.2 mt -138.16 152.8 49.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.047 0.939 . . . . 3.4 111.956 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.82 60.02 4.46 Favored Glycine 0 N--CA 1.47 0.901 0 C-N-CA 123.678 0.656 . . . . 1.59 111.719 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.0 mt -74.94 107.71 7.19 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.469 1.128 . . . . 1.34 110.866 -178.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -70.98 -6.33 37.97 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.565 1.546 . . . . 2.48 115.014 -175.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -143.41 158.45 57.56 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.687 2.395 . . . . 6.99 108.273 156.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.07 157.25 62.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.086 1.857 . . . . 2.02 109.741 156.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.78 166.67 10.52 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.399 1.479 . . . . 2.74 111.915 -176.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 134.08 38.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.917 1.287 . . . . 3.69 111.427 174.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 125.7 24.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.946 -1.096 . . . . 1.59 110.219 173.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.44 54.98 2.14 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.129 0.395 . . . . 2.21 112.629 -162.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -143.05 160.83 39.63 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.619 2.368 . . . . 2.75 109.015 165.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -102.49 120.47 40.58 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.968 2.107 . . . . 4.38 111.112 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.54 128.92 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.896 1.278 . . . . 0.96 109.638 169.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -79.11 140.21 37.89 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.002 0.43 . . . . 2.52 110.976 159.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -148.26 127.13 12.67 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.892 0.877 . . . . 1.88 112.092 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' ALA . 18.2 m-20 -98.34 103.73 15.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.465 1.906 . . . . 2.51 110.732 177.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 91.4 mt -68.86 112.43 5.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.997 0.817 . . . . 1.88 110.575 168.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.0 mt -87.15 129.65 34.86 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.734 1.213 . . . . 1.0 111.049 -176.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -130.81 117.67 19.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.536 0.684 . . . . 2.38 111.268 179.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.95 21.82 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.292 2.237 . . . . 1.97 116.729 168.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.47 -41.86 1.42 Allowed Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.228 1.394 . . . . 3.24 114.17 -174.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.58 -1.82 72.76 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.073 1.32 . . . . 2.4 114.877 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -148.47 157.15 43.29 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.372 1.469 . . . . 4.38 113.828 179.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.97 140.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 127.179 2.192 . . . . 1.87 108.224 168.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -125.55 111.97 15.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.881 1.272 . . . . 2.74 109.29 176.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -88.78 125.72 35.02 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.771 -0.58 . . . . 2.11 112.279 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.08 161.66 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.904 1.682 . . . . 1.63 111.208 171.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.7 m -106.66 143.58 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 2.38 109.235 163.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.38 145.87 39.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.606 1.163 . . . . 1.92 111.624 179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.15 142.8 34.72 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.231 2.621 . . . . 1.12 112.186 175.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -79.94 132.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.174 1.389 . . . . 1.09 109.481 165.044 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -147.02 139.37 24.72 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.766 2.427 . . . . 4.25 107.276 175.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.62 52.9 2.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.455 1.502 . . . . 2.79 112.117 -170.473 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 120' ' ' ARG 0.294 0.0 OUTLIER . . . . . 0 C--O 1.248 0.977 0 N-CA-C 117.414 2.375 . . . . 6.57 117.414 -154.064 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.421 0 N-CA-C 107.317 -2.313 . . . . 11.75 107.317 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 t 175.29 179.44 0.14 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.253 1.421 . . . . 9.54 108.561 -156.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -96.23 11.99 32.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.882 1.273 . . . . 10.72 113.027 169.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.55 149.09 46.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.409 1.884 . . . . 6.98 113.907 -178.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.35 -159.24 0.9 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 128.892 2.877 . . . . 6.41 108.298 171.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.4 -171.18 19.82 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 120.065 -1.647 . . . . 0.94 115.688 -177.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -167.48 158.46 11.49 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.109 1.763 . . . . 1.37 112.167 173.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -114.77 130.94 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.733 0.813 . . . . 0.93 110.028 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 ttt-85 -78.4 120.38 23.05 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 124.715 1.206 . . . . 4.1 111.615 -174.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -62.46 123.66 18.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.951 1.3 . . . . 3.24 110.459 164.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 m -155.83 160.93 30.44 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 125.866 1.666 . . . . 1.95 108.976 157.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.58 -159.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.303 3.335 . . . . 3.52 108.862 167.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.52 -161.5 46.58 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.88 0.752 . . . . 2.36 112.558 -174.038 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -87.22 -11.14 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.579 2.853 . . . . 2.15 113.201 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -149.45 160.13 43.71 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.696 1.198 . . . . 2.18 113.891 -168.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -161.5 -167.06 1.64 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.624 1.97 . . . . 1.26 110.385 -174.723 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.67 153.59 50.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.834 0.743 . . . . 1.23 112.689 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.9 153.03 46.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.69 1.196 . . . . 0.84 110.281 163.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.15 156.12 46.0 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.781 1.232 . . . . 2.31 111.2 174.485 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -163.13 153.4 16.06 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 113.679 0.992 . . . . 1.52 113.679 179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 m -78.54 140.09 38.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.607 -1.179 . . . . 1.24 107.956 151.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.21 134.73 26.3 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.73 1.212 . . . . 2.23 108.262 176.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -148.61 157.56 43.54 Favored 'General case' 0 C--N 1.335 -0.059 0 N-CA-C 114.13 1.159 . . . . 3.42 114.13 -170.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -115.3 105.32 52.62 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.98 110.931 -168.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.41 -15.67 9.84 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.577 2.185 . . . . 1.08 113.595 177.177 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 -167.91 41.35 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 119.263 0.938 . . . . 1.25 112.91 -177.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -117.02 16.29 15.06 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.5 1.52 . . . . 2.64 111.496 -173.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 mt -120.14 162.07 35.48 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.167 2.187 . . . . 3.19 109.244 -175.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -82.21 156.99 17.32 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.976 2.451 . . . . 1.58 110.901 175.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.29 103.55 4.95 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.273 1.029 . . . . 2.32 111.059 -171.608 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -96.38 106.16 18.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.972 1.309 . . . . 3.12 111.364 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.8 tp -86.73 113.84 22.91 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.126 2.17 . . . . 0.72 108.651 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.69 -11.11 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 124.173 0.989 . . . . 0.59 113.483 -169.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.49 -161.68 32.48 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.518 -0.739 . . . . 0.6 112.296 178.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.836 ' HB1' HD21 ' A' ' 101' ' ' LEU . . . -148.72 177.34 9.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.279 1.032 . . . . 1.03 111.374 176.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.25 129.79 5.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.924 -1.139 . . . . 5.41 107.924 172.502 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -135.31 147.36 61.8 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-O 117.748 -1.12 . . . . 1.03 109.232 178.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.68 -15.02 27.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.04 1.827 . . . . 1.42 112.712 171.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 m -75.19 -0.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.035 0.834 . . . . 0.85 113.236 174.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.47 -172.28 3.4 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.615 1.966 . . . . 1.24 110.311 176.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -106.63 -55.89 2.27 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.699 1.2 . . . . 3.03 110.566 166.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -119.85 165.92 13.97 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.758 1.223 . . . . 4.15 110.907 175.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.3 p -155.5 135.91 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.705 0.802 . . . . 2.08 109.48 171.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -120.13 132.51 55.44 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.954 1.702 . . . . 2.15 108.977 -173.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 tt -79.85 115.34 19.38 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.504 1.145 . . . . 0.95 109.855 170.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -103.16 150.87 23.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.337 -1.301 . . . . 0.64 111.995 176.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -94.64 164.59 12.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.513 2.325 . . . . 2.35 109.991 166.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.9 m -145.63 121.25 10.45 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.38 1.072 . . . . 1.35 108.152 167.784 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -135.49 153.48 51.73 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 123.894 0.878 . . . . 2.15 112.945 -151.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -111.33 47.89 0.98 Allowed 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 123.084 1.421 . . . . 6.12 111.868 -172.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -80.67 162.16 24.31 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.347 -1.751 . . . . 8.12 110.886 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -69.5 152.07 45.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.401 2.281 . . . . 4.04 111.42 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -129.04 -96.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.167 1.387 . . . . 2.97 107.645 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -73.65 43.22 0.14 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.28 1.832 . . . . 4.53 111.248 169.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.94 -26.96 0.78 Allowed Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.37 -1.456 . . . . 2.58 113.691 -167.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -74.07 145.3 44.55 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.67 1.588 . . . . 3.19 110.684 175.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -75.37 133.09 41.29 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.694 0.798 . . . . 5.15 109.996 173.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.9 t -136.05 149.74 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.416 1.086 . . . . 1.77 109.865 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.3 mtm -83.37 93.86 7.84 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.593 0.757 . . . . 3.86 112.985 175.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.38 165.67 22.7 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 124.367 0.984 . . . . 1.16 112.328 172.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -128.64 165.93 19.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.76 1.624 . . . . 2.59 111.098 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -178.74 144.78 0.46 Allowed Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 116.123 -1.894 . . . . 4.45 111.224 -175.198 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.69 143.11 60.65 Favored 'Trans proline' 0 C--N 1.347 0.472 0 CA-C-N 122.095 1.784 . . . . 0.71 111.607 160.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -110.56 157.28 38.76 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.202 1.401 . . . . 0.74 110.208 169.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.68 -15.78 33.65 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.758 2.305 . . . . 0.74 113.09 175.566 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -175.16 160.27 2.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.715 1.606 . . . . 2.72 111.955 177.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt -109.51 175.09 5.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.851 1.261 . . . . 1.17 108.867 147.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -156.0 166.89 32.13 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.042 -1.036 . . . . 2.33 112.837 170.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.55 132.79 16.59 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 1.09 109.899 -177.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.36 162.35 38.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.736 2.29 . . . . 0.97 110.835 171.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.18 140.56 84.2 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.945 2.43 . . . . 1.25 111.485 176.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt 71.98 -4.0 2.08 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.599 2.36 . . . . 1.48 114.318 -178.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.29 177.35 33.55 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 125.784 1.659 . . . . 1.09 112.286 177.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -144.17 151.02 38.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.863 1.665 . . . . 3.81 112.562 175.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.96 149.77 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.786 1.635 . . . . 2.1 108.349 164.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -135.33 109.62 8.38 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 106.685 -1.598 . . . . 4.29 106.685 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.75 77.69 6.36 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.86 1.314 . . . . 1.44 111.212 -164.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -67.37 138.74 94.26 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-O 117.26 -1.352 . . . . 5.07 110.005 174.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.19 -54.45 4.99 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.258 3.305 . . . . 1.02 113.435 -175.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.05 51.8 3.91 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.655 1.122 . . . . 1.89 111.708 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.58 -82.9 0.04 OUTLIER Glycine 0 N--CA 1.465 0.576 0 C-N-CA 128.663 3.03 . . . . 0.93 111.223 -171.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -150.8 143.37 24.4 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.427 2.291 . . . . 2.22 108.402 179.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -160.57 167.16 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.351 -0.843 . . . . 0.85 110.63 -175.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 14.3 m-85 -107.16 122.59 46.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.585 0.754 . . . . 2.11 110.566 174.284 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.3 mmt -85.93 117.64 24.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.606 1.162 . . . . 0.94 110.525 171.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.7 mt -93.46 136.15 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.931 1.292 . . . . 1.94 110.238 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mt -140.72 132.79 27.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.561 0.619 . . . . 2.65 112.299 -178.255 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.71 53.82 2.18 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 125.343 1.449 . . . . 1.66 112.506 -179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.48 115.17 4.4 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.884 0.698 . . . . 0.99 112.884 -168.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -86.94 -13.42 44.73 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.173 1.175 . . . . 1.65 114.173 -177.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -146.64 143.04 17.99 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.646 1.178 . . . . 5.55 110.251 177.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.52 134.58 17.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.088 2.526 . . . . 1.6 109.228 171.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.41 90.07 8.14 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.786 0.835 . . . . 2.25 111.358 -171.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -58.72 148.17 30.39 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.002 -1.061 . . . . 3.88 113.317 169.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.79 114.73 5.89 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.517 -0.739 . . . . 1.77 109.473 167.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.6 -9.7 7.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 116.63 -2.206 . . . . 1.93 116.816 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 173.29 10.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 121.449 2.624 . . . . 3.9 112.884 -177.209 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -100.16 162.12 13.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.229 1.412 . . . . 3.86 110.085 159.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.6 t -128.42 127.97 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.179 1.791 . . . . 1.05 108.155 172.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.2 136.81 35.89 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.533 1.533 . . . . 5.96 109.562 175.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.836 HD21 ' HB1' ' A' ' 35' ' ' ALA . 6.0 tt -154.3 130.01 10.03 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.743 1.258 . . . . 1.63 114.342 179.107 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.82 99.78 12.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.317 3.047 . . . . 2.76 110.989 173.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.48 117.16 17.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 120.941 -1.099 . . . . 1.14 109.173 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.2 mt -91.49 126.85 36.72 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.796 0.838 . . . . 0.8 110.382 -169.03 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.01 126.95 45.12 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.972 1.101 . . . . 1.77 113.972 -178.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 49.52 23.98 1.03 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.458 1.903 . . . . 2.32 114.603 169.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.01 -55.13 1.42 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.346 1.451 . . . . 3.93 113.004 -166.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.05 18.17 46.44 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.587 -1.674 . . . . 1.89 116.629 -169.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -141.93 157.73 44.61 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.869 2.468 . . . . 4.23 110.58 165.187 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.2 141.38 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 126.048 1.739 . . . . 1.01 107.851 162.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -120.4 106.89 12.28 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.668 1.187 . . . . 1.82 107.896 173.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -79.44 128.53 33.47 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.41 -0.806 . . . . 4.97 111.071 177.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.96 164.06 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.394 1.877 . . . . 1.48 110.443 178.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 m -105.26 155.6 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 125.441 1.496 . . . . 2.96 109.119 164.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.7 mt -141.52 149.52 54.44 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.546 1.939 . . . . 1.61 109.231 173.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.53 152.97 20.41 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.829 3.019 . . . . 0.93 112.348 176.127 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.3 t -80.38 142.04 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.276 1.03 . . . . 1.25 111.149 168.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.98 166.86 32.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.807 2.043 . . . . 2.94 111.204 -166.678 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.98 26.84 9.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.738 1.215 . . . . 2.0 113.392 -169.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.1 mtm105 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 116.606 -1.664 . . . . 5.88 112.382 -171.58 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 N-CA-C 106.581 -2.607 . . . . 12.75 106.581 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 p -59.03 157.07 10.67 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 118.892 -1.123 . . . . 12.47 109.754 129.373 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -132.92 8.76 4.12 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.618 0.97 . . . . 10.71 113.618 -176.447 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.5 p -69.15 131.05 44.35 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.135 2.174 . . . . 7.47 110.835 170.172 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.88 46.33 0.38 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.95 1.3 . . . . 7.28 111.848 172.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.56 151.97 17.03 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 124.949 1.261 . . . . 1.02 114.482 -172.828 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -155.85 162.97 40.36 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.96 1.304 . . . . 1.55 110.928 -177.36 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -118.66 126.82 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.718 0.77 . . . . 0.98 109.58 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 145.9 52.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.523 1.305 . . . . 9.47 114.523 -177.54 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -97.61 139.13 33.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.856 1.262 . . . . 2.85 108.773 162.255 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -164.28 158.12 15.61 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.798 1.239 . . . . 2.62 110.994 166.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -83.96 57.98 5.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.494 3.462 . . . . 2.71 110.824 177.283 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.55 160.3 27.9 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 119.199 -0.778 . . . . 1.57 113.709 -177.133 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -77.53 -3.87 14.05 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.005 3.137 . . . . 1.77 113.226 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -161.33 153.68 20.1 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.724 1.61 . . . . 2.21 112.854 -176.158 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -176.97 160.26 1.79 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.717 1.607 . . . . 2.54 112.045 172.703 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.94 133.77 45.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.182 1.793 . . . . 2.22 112.372 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -117.76 154.77 31.17 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.172 1.389 . . . . 1.43 111.328 172.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.07 154.39 48.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.832 0.853 . . . . 2.59 112.481 -159.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -171.54 154.96 3.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.786 1.234 . . . . 1.54 112.942 176.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.475 HG21 ' HD3' ' A' ' 74' ' ' ARG . 99.5 m -74.76 146.68 41.96 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.792 -0.447 . . . . 1.94 109.792 152.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.98 124.75 43.85 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.35 2.26 . . . . 2.39 107.979 173.53 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -102.62 134.46 45.94 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.613 1.965 . . . . 4.77 113.315 175.612 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -99.11 106.99 41.8 Favored Pre-proline 0 CA--C 1.541 0.61 0 O-C-N 121.573 -0.704 . . . . 1.28 109.621 162.151 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.23 -11.15 10.99 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.584 2.19 . . . . 1.22 112.989 174.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.46 176.17 51.21 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 124.644 1.116 . . . . 1.16 113.505 -177.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -99.59 -7.22 26.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.443 1.897 . . . . 2.65 112.818 -175.412 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 pp -118.05 160.5 38.78 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.629 1.971 . . . . 2.2 109.894 170.012 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.74 149.98 23.82 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.061 2.508 . . . . 1.85 112.435 -168.94 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 mt -96.09 154.93 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.988 0.915 . . . . 1.97 110.784 170.71 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.403 HH21 ' CD ' ' A' ' 68' ' ' GLU . 20.9 ttm180 -135.83 107.72 7.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.489 1.516 . . . . 3.71 108.979 171.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.6 tp -86.03 116.3 24.16 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.403 2.281 . . . . 0.7 108.818 -176.745 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.96 -13.16 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.476 1.11 . . . . 0.54 112.772 -172.566 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.13 -169.19 42.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.294 1.426 . . . . 0.58 111.636 177.58 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.43 159.57 38.8 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.0 1.32 . . . . 1.17 111.138 168.541 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -132.16 136.9 47.42 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.68 -1.262 . . . . 6.43 110.321 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -140.0 155.4 70.85 Favored Pre-proline 0 N--CA 1.471 0.59 0 C-N-CA 124.875 1.27 . . . . 0.76 108.952 -174.381 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.06 -31.49 45.83 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.938 1.758 . . . . 1.04 113.017 160.348 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -77.01 5.86 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.852 1.427 . . . . 1.4 114.852 -167.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.21 156.72 29.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.851 1.66 . . . . 1.19 111.4 -178.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -87.21 -81.71 0.23 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.44 0.296 . . . . 2.91 111.055 -178.685 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -71.72 161.24 31.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.984 0.897 . . . . 3.82 110.709 174.465 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -122.2 138.8 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.151 -1.386 . . . . 2.2 108.268 159.078 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -133.14 124.17 27.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.442 -1.688 . . . . 2.2 106.442 160.666 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.14 121.62 26.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 120.163 1.347 . . . . 0.72 109.288 166.024 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -104.85 158.1 16.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.962 1.305 . . . . 0.65 112.346 176.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.21 -175.65 2.85 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.673 2.389 . . . . 2.21 111.627 172.333 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.1 m -134.72 104.11 5.9 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.003 1.721 . . . . 1.74 106.407 153.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -84.45 150.4 25.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.006 0.523 . . . . 2.3 110.805 178.858 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -106.95 135.86 47.79 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.208 1.003 . . . . 4.33 110.859 170.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.21 -172.97 2.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.679 1.192 . . . . 6.68 113.087 -172.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.25 149.01 11.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.601 2.761 . . . . 4.86 106.666 -170.958 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.04 -42.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.454 1.502 . . . . 5.56 112.641 177.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -81.35 10.53 5.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.021 1.728 . . . . 4.86 112.519 168.089 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.65 -7.29 1.06 Allowed Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.306 1.432 . . . . 1.86 115.147 -167.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -72.95 133.59 44.4 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.721 -1.458 . . . . 3.58 108.474 158.973 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.72 142.84 36.74 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.287 -0.634 . . . . 5.92 109.287 166.889 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -147.89 152.37 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 126.819 2.047 . . . . 1.87 109.067 -166.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.8 mtm -123.75 143.34 50.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.618 1.167 . . . . 3.65 111.232 167.72 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.92 159.05 28.51 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.1 0.857 . . . . 1.46 113.689 -179.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.577 1.151 . . . . 1.66 112.618 -175.44 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -177.14 142.66 0.51 Allowed Pre-proline 0 N--CA 1.475 0.81 0 CA-C-O 116.663 -1.637 . . . . 4.35 110.764 -171.196 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -71.83 142.67 39.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 CA-C-N 122.204 1.823 . . . . 0.6 111.827 167.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.64 157.48 47.73 Favored Pre-proline 0 N--CA 1.474 0.763 0 C-N-CA 126.052 1.741 . . . . 0.56 110.473 178.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.13 -17.91 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.436 2.09 . . . . 0.6 113.025 176.398 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -175.69 169.06 3.08 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.135 1.374 . . . . 2.01 111.321 -177.224 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.21 175.18 5.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.645 1.978 . . . . 1.15 108.961 156.035 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 31' ' ' ARG . 11.3 pt-20 -152.47 164.26 37.91 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.105 -0.997 . . . . 2.66 111.511 176.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.3 t -147.58 129.06 7.28 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.17 0.988 . . . . 1.14 110.311 -172.001 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.65 157.49 35.84 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.996 2.464 . . . . 1.48 111.934 179.65 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.89 137.56 73.25 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.374 3.383 . . . . 1.46 113.293 -174.908 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 68.88 -5.46 1.01 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.261 2.224 . . . . 1.23 114.42 -176.494 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.62 137.2 14.15 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 126.498 1.999 . . . . 1.33 109.838 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.475 ' HD3' HG21 ' A' ' 21' ' ' THR . 7.6 ptp180 -107.26 136.79 46.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.061 -1.07 . . . . 5.05 110.561 158.493 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.21 149.07 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 125.378 1.471 . . . . 2.38 110.702 -178.372 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -100.95 134.5 43.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.151 1.908 . . . . 4.02 116.151 -167.866 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 mp -73.29 78.68 1.33 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.505 1.522 . . . . 1.14 107.453 155.455 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -83.17 139.55 42.26 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.556 1.142 . . . . 2.86 110.364 178.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.8 -53.35 7.06 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.851 3.034 . . . . 1.25 113.915 -169.147 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.04 90.45 1.68 Allowed Glycine 0 N--CA 1.469 0.894 0 N-CA-C 109.622 -1.391 . . . . 1.56 109.622 166.017 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.15 -74.29 0.22 Allowed Glycine 0 N--CA 1.468 0.794 0 C-N-CA 124.843 1.211 . . . . 1.25 112.767 -168.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -156.02 144.86 20.37 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.52 1.928 . . . . 1.96 109.346 177.101 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -167.73 164.91 14.39 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 120.977 -1.077 . . . . 0.78 109.629 -176.251 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -95.92 120.33 36.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 122.826 0.45 . . . . 2.03 110.183 175.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.1 mmt -76.9 100.05 5.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 122.643 1.211 . . . . 1.09 109.365 163.793 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -102.02 111.11 23.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.663 -1.608 . . . . 1.94 108.268 178.63 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.56 52.3 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.0 1.72 . . . . 3.43 109.124 -173.524 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.96 63.09 2.12 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.797 -0.921 . . . . 1.56 110.797 -174.855 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.97 117.23 13.32 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.387 0.675 . . . . 1.48 111.427 -176.068 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -82.82 -6.93 59.66 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.689 1.366 . . . . 1.49 114.689 -165.335 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -122.87 153.22 63.64 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 106.921 -1.511 . . . . 4.62 106.921 152.451 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.34 123.71 9.79 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 N-CA-C 107.371 -1.819 . . . . 1.71 107.371 151.34 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.35 154.36 41.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.935 1.294 . . . . 2.08 112.069 -166.363 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -131.38 129.1 40.91 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.564 1.146 . . . . 6.09 110.931 165.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.05 121.86 8.25 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.795 -0.816 . . . . 1.61 108.795 169.647 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.55 1.84 56.53 Favored Glycine 0 CA--C 1.539 1.544 0 CA-C-O 117.998 -1.446 . . . . 1.89 116.127 -169.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -78.79 170.22 17.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 120.182 1.991 . . . . 2.72 110.243 162.159 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -116.15 149.78 38.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.812 2.045 . . . . 5.07 109.811 177.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 80.4 t -127.62 113.94 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.404 1.081 . . . . 1.19 109.722 -178.343 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.428 ' OE2' ' HE2' ' A' ' 112' ' ' LYS . 1.2 mt-10 -68.95 134.55 49.68 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.981 0.8 . . . . 3.09 109.646 159.459 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mt -147.4 116.96 7.04 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.565 1.146 . . . . 1.57 112.372 177.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -89.68 94.58 9.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.688 2.795 . . . . 2.18 110.543 177.651 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.8 mt -74.13 123.31 24.2 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.796 1.239 . . . . 1.19 110.815 -177.017 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.1 mt -96.8 129.69 44.19 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.831 1.252 . . . . 0.68 111.23 -172.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.57 129.82 41.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.049 0.928 . . . . 1.89 113.172 -173.463 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 32.37 50.41 0.18 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.671 2.388 . . . . 1.63 113.935 175.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.26 -90.88 0.53 Allowed Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.897 1.237 . . . . 3.64 112.053 -172.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.19 15.94 19.75 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 117.399 1.719 . . . . 1.59 117.399 -164.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.0 145.21 42.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.784 2.292 . . . . 5.23 109.363 166.323 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -147.8 137.66 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 124.906 1.282 . . . . 1.1 108.96 167.684 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.5 mt -142.14 124.62 15.74 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.48 1.512 . . . . 1.84 107.858 -175.475 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.428 ' HE2' ' OE2' ' A' ' 100' ' ' GLU . 10.0 ptmt -102.96 150.12 23.85 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 115.437 1.643 . . . . 2.43 115.437 -174.258 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.78 160.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.233 1.813 . . . . 1.22 110.284 178.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -117.05 118.71 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.578 1.151 . . . . 1.89 110.261 171.394 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.2 mt -108.9 150.42 40.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.331 1.852 . . . . 1.5 109.769 178.398 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.24 155.43 19.29 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.455 2.77 . . . . 0.91 111.698 170.068 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.42 145.36 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.924 1.29 . . . . 1.26 109.258 163.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.64 171.14 16.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.545 1.938 . . . . 3.27 108.797 -176.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -74.57 3.58 7.5 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 116.436 2.013 . . . . 3.01 116.436 -160.476 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 130.209 3.403 . . . . 4.76 109.272 -167.561 . . . . . . . . 1 1 . 1 stop_ save_